Citrus Sinensis ID: 002410
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 927 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGI2 | 929 | Probable LRR receptor-lik | yes | no | 0.989 | 0.987 | 0.720 | 0.0 | |
| Q8LKZ1 | 924 | Nodulation receptor kinas | N/A | no | 0.916 | 0.919 | 0.361 | 1e-131 | |
| C0LGG4 | 890 | Probable LRR receptor-lik | no | no | 0.899 | 0.937 | 0.333 | 1e-127 | |
| Q9ZQQ7 | 886 | Putative leucine-rich rep | no | no | 0.884 | 0.925 | 0.347 | 1e-127 | |
| Q9ZQR3 | 868 | Leucine-rich repeat recep | no | no | 0.871 | 0.930 | 0.344 | 1e-126 | |
| Q8L4H4 | 925 | Nodulation receptor kinas | N/A | no | 0.927 | 0.929 | 0.347 | 1e-126 | |
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.880 | 0.926 | 0.327 | 1e-123 | |
| Q9FZB8 | 871 | Probable LRR receptor-lik | no | no | 0.865 | 0.920 | 0.333 | 1e-122 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.872 | 0.927 | 0.333 | 1e-122 | |
| C0LGD6 | 852 | Probable LRR receptor-lik | no | no | 0.874 | 0.951 | 0.345 | 1e-122 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1355 bits (3508), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 670/930 (72%), Positives = 776/930 (83%), Gaps = 13/930 (1%)
Query: 5 SHFLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPS 64
+ V L + V+SQVTEF+SIDCG +SNYTDP TGL W+SD I+ GK V + N +
Sbjct: 6 AQLAVTCLFLVPFVLSQVTEFVSIDCGCSSNYTDPRTGLGWVSDSEIIKQGKPVTLANTN 65
Query: 65 GNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLW 124
N MQYR RRD P DNKKYCY L TKERRRY+VR TF YG LGSE +YPKFQLYLDAT W
Sbjct: 66 WNSMQYRRRRDFPTDNKKYCYRLSTKERRRYIVRTTFLYGGLGSEEAYPKFQLYLDATKW 125
Query: 125 STVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNF 184
+TVT+ + SRVY +E+I+RA S +DVC+CCA+TGSPF+STLELRPLNLSMYATD+EDNF
Sbjct: 126 ATVTIQEVSRVYVEELIVRATSSYVDVCVCCAITGSPFMSTLELRPLNLSMYATDYEDNF 185
Query: 185 FLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRT 244
FLKVAARVNFGA DALRYPDDPYDRIW+SD+++RPN++VG A GT RINT+K I T T
Sbjct: 186 FLKVAARVNFGAPNMDALRYPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLT 245
Query: 245 REYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYF 304
REYPP+KVMQTAVVGT+G++SYRLNLEDFPANARA+AYFAEI++LG +ETRKFKL QPYF
Sbjct: 246 REYPPMKVMQTAVVGTQGLISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYF 305
Query: 305 ADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQK 364
DYSNAVVNIAENANGSYTLYEPSYMNVTL+FVL+FSF KT+DST GPLLNAIEISKY
Sbjct: 306 PDYSNAVVNIAENANGSYTLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLP 365
Query: 365 IAAKTEWQD----EALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKN 420
I+ KT+ D +A+RS+S +S+ ++ GDPC+PV W WV CS+T+PPR+TKIALS KN
Sbjct: 366 ISVKTDRSDVSVLDAIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKN 425
Query: 421 LKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLP 480
L+GEIPP + MEALTELWLD N LTG LPDMS+L++L+I+HLENN+L+GSLP Y+ LP
Sbjct: 426 LRGEIPPGINYMEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLP 485
Query: 481 NLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILL 540
NLQEL IENNSF G+IP ALL GKV+FKY+NNP+L E++R+ F ILG SI +AILL
Sbjct: 486 NLQELSIENNSFKGKIPSALLKGKVLFKYNNNPELQNEAQRK-HFWQILGISIAAVAILL 544
Query: 541 VLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLP 600
+L SL++L LR+ K +K DS T K AYS RGGH +DEGVAYFI LP
Sbjct: 545 LLVGGSLVLLCALRK----TKRADKGDSTETKKK-GLVAYSAVRGGHLLDEGVAYFISLP 599
Query: 601 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 660
LEEAT+NF KK+G+GSFGSVYYG+MKDGKEVAVKI AD SH +QFVTEVALLSRIHH
Sbjct: 600 VLEEATDNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHH 659
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
RNLVPLIGYCEE +RILVYEYMHNG+L D LHGS + KPLDWLTRLQIA DAAKGLEYL
Sbjct: 660 RNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYL 719
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 780
HTGCNP IIHRDVKSSNILLDINMRAKVSDFGLSRQ EEDLTH+SSVA+GTVGYLDPEYY
Sbjct: 720 HTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYY 779
Query: 781 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840
+QQLTEKSDVYSFGVVL EL+SGKKPVS EDFG ELNIVHWARS+I+KGDV I+DP +
Sbjct: 780 ASQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGIIDPCI 839
Query: 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF---SSSSSK 897
NVKIES+WR+AEVA QCVEQRG +RP+MQE+++AIQD+I+IE+G + SSSSSK
Sbjct: 840 ASNVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIERGNENGLKSSSSSSSK 899
Query: 898 GQSSRKTLLTSFLEIESPDLSNECLAPAAR 927
QSSRKTLLTSFLE+ESPD+S LAPAAR
Sbjct: 900 AQSSRKTLLTSFLELESPDISRNSLAPAAR 929
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8LKZ1|NORK_PEA Nodulation receptor kinase OS=Pisum sativum GN=NORK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 468 bits (1205), Expect = e-131, Method: Compositional matrix adjust.
Identities = 332/919 (36%), Positives = 487/919 (52%), Gaps = 69/919 (7%)
Query: 13 LFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRT 72
+F+ S S F SI C + SNYTDP T L + +D ++ + + + P + +R+
Sbjct: 22 IFIRSASSATEGFESIACCADSNYTDPKTNLNYTTDYRWYSDKSNCR-QIPE-ILLSHRS 79
Query: 73 R---RDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTV 129
R ID K CYNL T + + YL+R TF + S+ + F + + AT VT
Sbjct: 80 NINFRLFDIDEGKRCYNLPTIKDQVYLIRGTFPFDSVNT-----SFYVSIGATELGEVT- 133
Query: 130 LDASRVYAKEM--IIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLK 187
+SR+ E+ + RAP D+ID C+ +PFIS LELRPL Y DF N LK
Sbjct: 134 --SSRLEDLEIEGVFRAPKDNIDFCLLKEDV-NPFISQLELRPLP-EEYLHDFSTNV-LK 188
Query: 188 VAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREY 247
+ +R N + +D +R+P D DRIW + P++ + + N + N+E +
Sbjct: 189 LISRNNLCGI-EDDIRFPVDQNDRIWKAT--STPSYAL-----PLSFNVS-NVELNGKVT 239
Query: 248 PPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADY 307
PP++V+QTA+ E + + LE YF E+ D K Q F Y
Sbjct: 240 PPLQVLQTALTHPERLEFVHVGLETDDYEYSVLLYFLELND-------TLKAGQRVFDIY 292
Query: 308 SNAVV-----NIAENANG-SYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISK 361
N+ + ++ E + SYT+ +N++ N L+ + VK S GPLLNA EI +
Sbjct: 293 LNSEIKKEGFDVLEGGSKYSYTV-----LNISANGSLNITLVKASGSKFGPLLNAYEILQ 347
Query: 362 YQKIAAKTEWQD---------EALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPR-I 411
+ +T+ D E L D + GDPC+ PW+ V C + I
Sbjct: 348 ARPWIDETDQTDLEVIQKMRKELLLQNQDNEALESWSGDPCMLFPWKGVACDGSNGSSVI 407
Query: 412 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS 471
TK+ LS NLKG IP + M L L L N G +P L V L N+LTG
Sbjct: 408 TKLDLSSSNLKGTIPSSVTEMTKLQILNLSHNHFDGYIPSFPPSSLLISVDLSYNDLTGQ 467
Query: 472 LPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRF-KLILG 530
LP + SLP+L L+ N + + A L +I N + + ++ +F ++ +
Sbjct: 468 LPESIISLPHLNSLYFGCNQHMRDDDEAKLNSSLI-----NTDYGRCNAKKPKFGQVFMI 522
Query: 531 TSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMD 590
+I +IL+ L + L R + I+ + K + T N +S+ F
Sbjct: 523 GAITSGSILITLAVVILFFCRYRHKSITLEGFGGKTYPMAT-----NIIFSLPSKDDFFI 577
Query: 591 EGVAYF-IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFV 649
+ V+ L +E AT + IG+G FGSVY G + DG+EVAVK+ + + + T++F
Sbjct: 578 KSVSVKPFTLEYIELATEKYKTLIGEGGFGSVYRGTLDDGQEVAVKVRSATSTQGTREFD 637
Query: 650 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-VNQKPLDWLTRLQ 708
E+ LLS I H NLVPL+GYC E Q+ILVY +M NG+L DRL+G +K LDW TRL
Sbjct: 638 NELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEPAKRKILDWPTRLS 697
Query: 709 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSV 767
IA AA+GL YLHT +IHRDVKSSNILLD +M AKV+DFG S+ A +E +++S
Sbjct: 698 IALGAARGLAYLHTFPGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSYVSLE 757
Query: 768 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 827
RGT GYLDPEYY QQL+EKSDV+SFGVVLLE++SG++P++++ E ++V WA+ I
Sbjct: 758 VRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRVEWSLVEWAKPYI 817
Query: 828 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 887
+ V IVDP + G E++WR+ EVA+QC+E RP M +IV ++D++ IE
Sbjct: 818 RASKVDEIVDPGIKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALIIENNA 877
Query: 888 DQKFSSSSSKGQSSRKTLL 906
+ S S G S+R +++
Sbjct: 878 SEYMKSIDSLGGSNRYSIV 896
|
Involved in the perception of symbiotic fungi and bacteria and required for the calcium spiking. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Pisum sativum (taxid: 3888) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 458 bits (1178), Expect = e-127, Method: Compositional matrix adjust.
Identities = 309/926 (33%), Positives = 490/926 (52%), Gaps = 92/926 (9%)
Query: 4 YSHFLVIYLLFLSSVVSQ-VTEFISIDCG---STSNYTDPSTGLAWISDIGIMNNGKSVK 59
+ H L+I L SV +Q FIS+DCG + YT+ ST + + SD+ +++G K
Sbjct: 7 FLHLLIIAFTVLRSVEAQNQAGFISLDCGLVPKETTYTEKSTNITYKSDVDYIDSGLVGK 66
Query: 60 VENPSGNWMQYRTR--RDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQL 117
+ + Q + R P+ ++ CYN+ +YL+R TF YG+ +P F L
Sbjct: 67 INDAYKTQFQQQVWAVRSFPV-GQRNCYNVNLTANNKYLIRGTFVYGNYDGLNQFPSFDL 125
Query: 118 YLDATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYA 177
++ WS+V +L + E+I P DS++VC+ +PFIS+LE+RPLN Y
Sbjct: 126 HIGPNKWSSVKILGVTNTSMHEIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPLNNESYL 185
Query: 178 TDFEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTT 237
T L + ARV F + + +RY +D +DR+W+S D TV I+T
Sbjct: 186 TQSGS---LMLFARVYFPSSSSSFIRYDEDIHDRVWNSFTDDE----------TVWISTD 232
Query: 238 KNIETRTREYPPVKVMQTAVVGTEGVLSYRL--NLEDFPANARAFAYFAEIQDLGPSETR 295
I+T P VM+TA V + L L++ A + + +FAE+Q+L +ETR
Sbjct: 233 LPIDTSNSYDMPQSVMKTAAVPKNASEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETR 292
Query: 296 KFKLEQP----YFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLG 351
+F + +F+ ++I+ T++ P ++ + N + +F+F T +STL
Sbjct: 293 EFNITYNGGLRWFSYLRPPNLSIS-------TIFNPRAVSSS-NGIFNFTFAMTGNSTLP 344
Query: 352 PLLNAIEISKYQKIAAKTEWQDE--ALRSISDE---SERTNDRGDPCVP--VPWEWVTCS 404
PLLNA+EI I +DE A+ +I + S++ + +GDPC P WE + CS
Sbjct: 345 PLLNALEIYTVVDILQLETNKDEVSAMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCS 404
Query: 405 --TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVH 462
+ RI + L+G L G I D+S+L L ++
Sbjct: 405 YPDSEGSRIISLNLNGSELTGSI-----------------------TSDISKLTLLTVLD 441
Query: 463 LENNELTGSLPSYMGSLPNLQELHIENNSFVG--EIPPAL---LTGK--VIFKYDNNPKL 515
L NN+L+G +P++ + +L+ +++ N + IP +L + K + +N
Sbjct: 442 LSNNDLSGDIPTFFAEMKSLKLINLSGNPNLNLTAIPDSLQQRVNSKSLTLILGENLTLT 501
Query: 516 HKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLR-RKISNQKSYEKADSLRTSTK 574
K+ +++ I + GV A+L++L + +I + ++ K +++ T+
Sbjct: 502 PKKESKKVPMVAIAASVAGVFALLVILAIFFVIKRKNVKAHKSPGPPPLVTPGIVKSETR 561
Query: 575 PSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAV 634
SN + I R + + Y PE+ + TNNF + +GKG FG+VY+G + DG EVAV
Sbjct: 562 SSNPSI-ITR-----ERKITY----PEVLKMTNNFERVLGKGGFGTVYHGNL-DGAEVAV 610
Query: 635 KIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 694
K+++ S + ++F EV LL R+HHR+LV L+GYC++ L+YEYM NG LR+ + G
Sbjct: 611 KMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSG 670
Query: 695 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 754
L W R+QIA +AA+GLEYLH GC P ++HRDVK++NILL+ AK++DFGLS
Sbjct: 671 KRGGNVLTWENRMQIAVEAAQGLEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLS 730
Query: 755 RQAEED-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 813
R D H+S+V GT GYLDPEYY L+EKSDVYSFGVVLLE+++ +PV ++
Sbjct: 731 RSFPIDGECHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVT-NQPV-IDKT 788
Query: 814 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI 873
+I W M+ KGD+ SIVDP L+G+ W+I E+A+ CV RP M +
Sbjct: 789 RERPHINDWVGFMLTKGDIKSIVDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHV 848
Query: 874 VLAIQDSIKIE----KGGDQKFSSSS 895
V+ + D + +E +G ++ +S S
Sbjct: 849 VMELNDCVALENARRQGSEEMYSMGS 874
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQQ7|Y2144_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14440 OS=Arabidopsis thaliana GN=At2g14440 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 457 bits (1177), Expect = e-127, Method: Compositional matrix adjust.
Identities = 314/903 (34%), Positives = 476/903 (52%), Gaps = 83/903 (9%)
Query: 25 FISIDCGSTSN---YTDPSTGLAWISDIGIMNNGKSVKVENPSG---NWMQYRTRRDLPI 78
FIS+ CG SN Y +P T L +ISD+ + GK+ ++N S Y+ R P
Sbjct: 29 FISLYCGLPSNESPYIEPLTNLTYISDVNFVRGGKTGNIKNNSDIDFTSRPYKVLRYFP- 87
Query: 79 DNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTV--LDASRVY 136
+ + CY+L K+ +YL+R F YG+ + P+F L+L +W++V V +D
Sbjct: 88 EGIRNCYSLSVKQGTKYLIRTLFFYGNYDGLNTSPRFDLFLGPNIWTSVDVQKVDGGDGV 147
Query: 137 AKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGA 196
+E+I + +D+C+ T +P IS +ELRPL Y LK F
Sbjct: 148 IEEIIHVTRCNILDICLVKTGTTTPMISAIELRPLRYDTYTARTGS---LKKILHFYFTN 204
Query: 197 LTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREY-PPVKVMQT 255
K+ +RYP+D YDR+W + + +INTT+N+ + Y PP V++T
Sbjct: 205 SGKE-VRYPEDVYDRVW----------IPHSQPEWTQINTTRNVSGFSDGYNPPQDVIKT 253
Query: 256 AVVGTE--GVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKL--EQPYFADYSNAV 311
A + T L++ E A+ YFAEIQ L +ETR+FK+ Y+ DY
Sbjct: 254 ASIPTNVSEPLTFTWMSESSDDETYAYLYFAEIQQLKANETRQFKILVNGVYYIDY---- 309
Query: 312 VNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEW 371
+ TL P+ + V KT STL P +NAIEI +
Sbjct: 310 ---IPRKFEAETLITPAALKCG-GGVCRVQLSKTPKSTLPPQMNAIEIFSVIQFPQSDTN 365
Query: 372 QDE--ALRSISD--ESERTNDRGDPCVPVPWEW--VTCST---TTPPRITKIALSGKNLK 422
DE A+++I + R + +GDPCVP+ + W V+C+ +TPPRI + LS L
Sbjct: 366 TDEVIAIKNIQSTYKVSRISWQGDPCVPIQFSWMGVSCNVIDISTPPRIISLDLSSSGLT 425
Query: 423 GEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPN 481
G I P ++N+ L EL L N LTG +P + L LR + L NN LTG +P ++ ++
Sbjct: 426 GVITPSIQNLTMLRELDLSNNNLTGVIPPSLQNLTMLRELDLSNNNLTGEVPEFLATIKP 485
Query: 482 LQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLV 541
L +H+ N+ G +P AL + ++ KL + + + + + SI +A+ ++
Sbjct: 486 LLVIHLRGNNLRGSVPQALQDRE----NNDGLKLLRGKHQPKSWLVAIVASISCVAVTII 541
Query: 542 LFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPE 601
+ L + + R RRK S +K +R S + N + + E
Sbjct: 542 V-LVLIFIFR--RRKSSTRKV------IRPSLEMKNRRFKYS-----------------E 575
Query: 602 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 661
++E TNNF +GKG FG VY+G + + ++VAVK+++ S + ++F TEV LL R+HH
Sbjct: 576 VKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHHV 634
Query: 662 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
NLV L+GYC++ + L+YE+M NG L++ L G L+W RL+IA ++A G+EYLH
Sbjct: 635 NLVSLVGYCDKGNDLALIYEFMENGNLKEHLSGKRGGPVLNWPGRLKIAIESALGIEYLH 694
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYY 780
GC P ++HRDVKS+NILL + AK++DFGLSR TH+S+ GT+GYLDPEYY
Sbjct: 695 IGCKPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQTHVSTNVAGTLGYLDPEYY 754
Query: 781 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840
LTEKSDVYSFG+VLLE+I+G +PV +E + IV WA+SM+ GD+ SI+D L
Sbjct: 755 QKNWLTEKSDVYSFGIVLLEIITG-QPV-IEQSRDKSYIVEWAKSMLANGDIESIMDRNL 812
Query: 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI---EKGGDQKFSSSSSK 897
+ S W+ E+A+ C+ RP M + + + ++I K Q +SS S
Sbjct: 813 HQDYDTSSSWKALELAMLCINPSSTLRPNMTRVAHELNECLEIYNLTKRRSQDQNSSKSS 872
Query: 898 GQS 900
G +
Sbjct: 873 GHT 875
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQR3|Y2451_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14510 OS=Arabidopsis thaliana GN=At2g14510 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1169), Expect = e-126, Method: Compositional matrix adjust.
Identities = 317/920 (34%), Positives = 483/920 (52%), Gaps = 112/920 (12%)
Query: 15 LSSVVSQVTE-FISIDCG--STSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGN---WM 68
+S V SQ + FIS+DCG S +Y +PS+ L +ISD+ + GK+ ++N S +
Sbjct: 18 MSLVKSQNQQGFISLDCGLPSKESYIEPSSNLTFISDVNFIRGGKTGNIQNNSRTNFIFK 77
Query: 69 QYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVT 128
++ R P D + CY+L K+ +YL+R F YG+ + P+F L+L +W++V
Sbjct: 78 PFKVLRYFP-DGIRNCYSLSVKQGTKYLIRTLFYYGNYDGLNTSPRFDLFLGPNIWTSVD 136
Query: 129 VL--DASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFL 186
VL D +E++ S+ +D+C+ T +P IS +ELRPL Y L
Sbjct: 137 VLIADVGDGVVEEIVHVTRSNILDICLVKTGTSTPMISAIELRPLRYDTYTARTGS---L 193
Query: 187 KVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTRE 246
K A F + +A+RYP+D YDR+W +P + +INTT+N+ +
Sbjct: 194 KSMAHFYFTN-SDEAIRYPEDVYDRVWMPY--SQPEWT--------QINTTRNVSGFSDG 242
Query: 247 Y-PPVKVMQTAVVGTEGV--LSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPY 303
Y PP V+QTA + T G L++ NLE A+ +FAEIQ L +ETR+FK+
Sbjct: 243 YNPPQGVIQTASIPTNGSEPLTFTWNLESSDDETYAYLFFAEIQQLKVNETREFKI---- 298
Query: 304 FADYSNAV--VNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISK 361
+N V ++ + TL P+ + V KT STL PL+NAIEI
Sbjct: 299 ---LANGVDYIDYTPWKFEARTLSNPAPLKCE-GGVCRVQLSKTPKSTLPPLMNAIEIFS 354
Query: 362 YQKIAAKTEWQDE--ALRSISDESE--RTNDRGDPCVPVPWEW--VTCST---TTPPRIT 412
+ DE A++ I + R + +GDPCVP + W V+C+ +TPPRI
Sbjct: 355 VIQFPQSDTNTDEVIAIKKIQSTYQLSRISWQGDPCVPKQFSWMGVSCNVIDISTPPRII 414
Query: 413 KIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSL 472
+ LS L G I P ++N+ L EL L NN LTG +
Sbjct: 415 SLDLSLSGLTGVISPSIQNLTMLREL-----------------------DLSNNNLTGEV 451
Query: 473 PSYMGSLPNLQELHIENNSFVGEIPPALLT-----GKVIFKYDNNPKLHKESRRRMRFKL 527
P ++ ++ L +H+ N+ G +P AL G +F +P + + + + + L
Sbjct: 452 PEFLATIKPLLVIHLRGNNLRGSVPQALQDREKNDGLKLFV---DPNITRRGKHQPKSWL 508
Query: 528 I-LGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGG 586
+ + SI +A+ +++ L + + R RRK S +K +R S + N + +
Sbjct: 509 VAIVASISCVAVTIIV-LVLIFIFR--RRKSSTRKV------IRPSLEMKNRRFKYS--- 556
Query: 587 HFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ 646
E++E TNNF +GKG FG VY+G + + ++VAVK+++ S + +
Sbjct: 557 --------------EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYK 601
Query: 647 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 706
+F TEV LL R+HH NLV L+GYC+E L+YE+M NG L++ L G L+W +R
Sbjct: 602 EFKTEVELLLRVHHVNLVSLVGYCDEGIDLALIYEFMENGNLKEHLSGKRGGSVLNWSSR 661
Query: 707 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHIS 765
L+IA ++A G+EYLH GC P ++HRDVKS+NILL + AK++DFGLSR H+S
Sbjct: 662 LKIAIESALGIEYLHIGCQPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQAHVS 721
Query: 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 825
+ GT+GYLDPEYY LTEKSDVYSFG+VLLE I+G +PV +E + IV WA+S
Sbjct: 722 TNVAGTLGYLDPEYYLKNWLTEKSDVYSFGIVLLESITG-QPV-IEQSRDKSYIVEWAKS 779
Query: 826 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885
M+ GD+ SI+DP L + S W+ E+A+ C+ RP M + + + ++I
Sbjct: 780 MLANGDIESIMDPNLHQDYDSSSSWKALELAMLCINPSSTQRPNMTRVAHELNECLEI-- 837
Query: 886 GGDQKFSSSSSKGQSSRKTL 905
+ S+ Q+S K+L
Sbjct: 838 ---YNLTKIRSQDQNSSKSL 854
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L4H4|NORK_MEDTR Nodulation receptor kinase OS=Medicago truncatula GN=NORK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 454 bits (1167), Expect = e-126, Method: Compositional matrix adjust.
Identities = 320/922 (34%), Positives = 477/922 (51%), Gaps = 62/922 (6%)
Query: 7 FLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVK-VENPSG 65
F++ +F+ S S F SI C + SNYTDP T L + +D ++ +S + +
Sbjct: 16 FVLCLCIFIRSASSATKGFESIACCADSNYTDPKTTLTYTTDHIWFSDKRSCRQIPEILF 75
Query: 66 NWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWS 125
+ + R I K CYNL T + + YL+R F + SL S F + + T
Sbjct: 76 SHRSNKNVRKFEIYEGKRCYNLPTVKDQVYLIRGIFPFDSLNS-----SFYVSIGVT--- 127
Query: 126 TVTVLDASRVYAKEM--IIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDN 183
+ L +SR+ E+ + RA D ID C+ +PFIS +ELRPL Y F +
Sbjct: 128 ELGELRSSRLEDLEIEGVFRATKDYIDFCLLKEDV-NPFISQIELRPLP-EEYLHGFGTS 185
Query: 184 FFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETR 243
LK+ +R N G T D +R+PDD DRIW +R ++ + N + N++ +
Sbjct: 186 V-LKLISRNNLGD-TNDDIRFPDDQNDRIW-----KRKETSTPTSALPLSFNVS-NVDLK 237
Query: 244 TREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPY 303
PP++V+QTA+ E + LE F +F E+ + R F +
Sbjct: 238 DSVTPPLQVLQTALTHPERLEFVHDGLETDDYEYSVFLHFLELNGTVRAGQRVFDI---- 293
Query: 304 FADYSNAVVN------IAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAI 357
Y N + +A + SYT +N++ N L+ + VK S GPLLNA
Sbjct: 294 ---YLNNEIKKEKFDVLAGGSKNSYTA-----LNISANGSLNITLVKASGSEFGPLLNAY 345
Query: 358 EISKYQKIAAKTEWQD-EALRSISDESERTNDR--------GDPCVPVPWEWVTCSTTTP 408
EI + + +T +D E ++ + +E N GDPC+ PW+ +TC +T
Sbjct: 346 EILQARSWIEETNQKDLEVIQKMREELLLHNQENEALESWSGDPCMIFPWKGITCDDSTG 405
Query: 409 PRI-TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 467
I TK+ LS NLKG IP + M L L L N P L + L N+
Sbjct: 406 SSIITKLDLSSNNLKGAIPSIVTKMTNLQILNLSHNQFDMLFPSFPPSSLLISLDLSYND 465
Query: 468 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKL 527
L+G LP + SLP+L+ L+ N + + L +I N + ++ +F
Sbjct: 466 LSGWLPESIISLPHLKSLYFGCNPSMSDEDTTKLNSSLI-----NTDYGRCKAKKPKFGQ 520
Query: 528 ILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGH 587
+ LL+ ++ + R K + + K + T N +S+
Sbjct: 521 VFVIGAITSGSLLITLAVGILFFCRYRHKSITLEGFGKTYPMAT-----NIIFSLPSKDD 575
Query: 588 FMDEGVAYF-IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ 646
F + V+ L +E+AT + IG+G FGSVY G + DG+EVAVK+ + + + T+
Sbjct: 576 FFIKSVSVKPFTLEYIEQATEQYKTLIGEGGFGSVYRGTLDDGQEVAVKVRSSTSTQGTR 635
Query: 647 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLT 705
+F E+ LLS I H NLVPL+GYC E Q+ILVY +M NG+L DRL+G ++ K LDW T
Sbjct: 636 EFDNELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEASKRKILDWPT 695
Query: 706 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHI 764
RL IA AA+GL YLHT +IHRDVKSSNILLD +M AKV+DFG S+ A +E +++
Sbjct: 696 RLSIALGAARGLAYLHTFPGRSVIHRDVKSSNILLDQSMCAKVADFGFSKYAPQEGDSYV 755
Query: 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 824
S RGT GYLDPEYY QQL+EKSDV+SFGVVLLE++SG++P++++ E ++V WA+
Sbjct: 756 SLEVRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRIEWSLVEWAK 815
Query: 825 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884
I+ V IVDP + G E++WR+ EVA+QC+E RP M +IV ++D++ IE
Sbjct: 816 PYIRASKVDEIVDPGIKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALIIE 875
Query: 885 KGGDQKFSSSSSKGQSSRKTLL 906
+ S S G S+R +++
Sbjct: 876 NNASEYMKSIDSLGGSNRYSIV 897
|
Involved in the perception of symbiotic fungi and bacteria. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Medicago truncatula (taxid: 3880) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 443 bits (1139), Expect = e-123, Method: Compositional matrix adjust.
Identities = 306/933 (32%), Positives = 473/933 (50%), Gaps = 117/933 (12%)
Query: 1 MVLYSHFLVIYLLFLSSVVSQVTEFISIDCG--STSNYTDPSTGLAWISDIGIMNNGKSV 58
+++++ F +++L + + + F+SIDCG S+Y D +T + ++SD + +G
Sbjct: 9 LIIFACFFAVFVLLVRA--QDQSGFVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGTIH 66
Query: 59 KVE---NPSGNWMQYRTRRDLPIDNKKYCYNLITKERR--RYLVRATFQYGSLGSEASYP 113
++ S Q++ R P N+ CY++ + + +YL+R F YG+ + P
Sbjct: 67 SIDPEFQTSSLEKQFQNVRSFPEGNRN-CYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAP 125
Query: 114 KFQLYLDATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNL 173
F LYL +W +VT+ +A+ + KE+I SD + VC+ G+PF+S LE+R L
Sbjct: 126 DFDLYLGFNIWDSVTIDNATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLKS 185
Query: 174 SMYATDFEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVR 233
+ Y T ++ K R + G L +RY DD +DRIW R P + + AS T+
Sbjct: 186 NTYETPYDSLILFK---RWDLGGLGALPVRYKDDVFDRIWIPL--RFPKYTIFNASLTID 240
Query: 234 INTTKNIETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAY--FAEIQDLGP 291
N + + P VM TA + + E + F Y FAE+ +L
Sbjct: 241 SNNNEGFQ------PARFVMNTATSPEDLSQDIIFSWEPKDPTWKYFVYMHFAEVVELPS 294
Query: 292 SETRKFKLEQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFV--------LSFSFV 343
+ETR+FK+ ++N E S++ P Y+ FV L F
Sbjct: 295 NETREFKV-----------LLNEKEINMSSFS---PRYLYTDTLFVQNPVSGPKLEFRLQ 340
Query: 344 KTRDSTLGPLLNAIEISKYQK-IAAKTEWQD--EALRSISDESERTNDRGDPCVPV--PW 398
+T STL P++NAIE + + + + T+ QD +R S + + GDPC PV PW
Sbjct: 341 QTPRSTLPPIINAIETYRVNEFLQSPTDQQDVDAIMRIKSKYGVKKSWLGDPCAPVKYPW 400
Query: 399 EWVTCS--TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLI 456
+ + CS PRI + LS L GEI D F S L
Sbjct: 401 KDINCSYVDNESPRIISVNLSSSGLTGEI---------------DAAF--------SNLT 437
Query: 457 DLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGK----VIFKYDNN 512
L I+ L NN LTG +P ++G+L NL EL++E N G IP LL ++ + D N
Sbjct: 438 LLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLERSNKKLILLRIDGN 497
Query: 513 PKL---------HKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSY 563
P L +++++ + ++ + +GVL ++L + +L +L K R +
Sbjct: 498 PDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVLAI---ALFLLYKKRHRRGGSGGV 554
Query: 564 EKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYY 623
+A L T+ + + E+ + TNNF + +G+G FG VY+
Sbjct: 555 -RAGPLDTTKR---------------------YYKYSEVVKVTNNFERVLGQGGFGKVYH 592
Query: 624 GKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683
G + D +VAVKI+++S + ++F EV LL R+HH+NL LIGYC E + L+YE+M
Sbjct: 593 GVLND-DQVAVKILSESSAQGYKEFRAEVELLLRVHHKNLTALIGYCHEGKKMALIYEFM 651
Query: 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 743
NGTL D L G L W RLQI+ DAA+GLEYLH GC P I+ RDVK +NIL++
Sbjct: 652 ANGTLGDYLSGE-KSYVLSWEERLQISLDAAQGLEYLHNGCKPPIVQRDVKPANILINEK 710
Query: 744 MRAKVSDFGLSRQAEEDLTHISSVA-RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI 802
++AK++DFGLSR D + + A GT+GYLDPEY+ Q+L+EKSD+YSFGVVLLE++
Sbjct: 711 LQAKIADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEVV 770
Query: 803 SGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVE 861
SG+ ++ AE ++I M+ GD+ IVDP L S W+I EVA+ C
Sbjct: 771 SGQPVIARSRTTAENIHITDRVDLMLSTGDIRGIVDPKLGERFDAGSAWKITEVAMACAS 830
Query: 862 QRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSS 894
+RP M +V +++S+ + G +SS
Sbjct: 831 SSSKNRPTMSHVVAELKESVSRARAGGGSGASS 863
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 440 bits (1131), Expect = e-122, Method: Compositional matrix adjust.
Identities = 308/923 (33%), Positives = 475/923 (51%), Gaps = 121/923 (13%)
Query: 7 FLVIYLLFLSSVVSQ-VTEFISIDCGST---SNYTDPSTGLAWISDIGIMNNGKSVKV-- 60
F VI+ L L V +Q FI++DCG + S Y + STGL + SD G + +GK K+
Sbjct: 7 FFVIFSLILHLVQAQDPIGFINLDCGLSIQGSPYKESSTGLTYTSDDGFVQSGKIGKITK 66
Query: 61 ENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLD 120
E S RT R P D + C++L +YL++ TF YG+ P F LY+
Sbjct: 67 ELESLYKKPERTLRYFP-DGVRNCFSLNVTRGTKYLIKPTFLYGNYDGRNVIPDFDLYIG 125
Query: 121 ATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDF 180
+W TV + KE++ + S+++ VC+ T P+I+TLELRPL +Y +
Sbjct: 126 PNMWITVNTDNT----IKEILHVSKSNTLQVCLVKTGTSIPYINTLELRPLADDIYTNES 181
Query: 181 EDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNI 240
L RV + L K + YPDD +DRIW L + ++ + ++IN + +
Sbjct: 182 GS---LNYLFRVYYSNL-KGYIEYPDDVHDRIWKQILPYQDWQIL---TTNLQINVSNDY 234
Query: 241 ETRTREYPPVKVMQTAVV---GTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKF 297
+ P +VM+TAV + + + NLE + F +FAE+Q L +ETR+F
Sbjct: 235 DL------PQRVMKTAVTPIKASTTTMEFPWNLEPPTSQFYLFLHFAELQSLQANETREF 288
Query: 298 KLEQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLS----------FSFVKTRD 347
N+ N N ++ Y P ++ + + + VKT
Sbjct: 289 ---------------NVVLNGNVTFKSYSPKFLEMQTVYSTAPKQCDGGKCLLQLVKTSR 333
Query: 348 STLGPLLNAIEISKYQKIAAKTEWQDE--ALRSISDES--ERTNDRGDPCVPVP--WEWV 401
STL PL+NA+E DE A+++I +T +GDPCVP W+ +
Sbjct: 334 STLPPLINAMEAYTVLDFPQIETNVDEVIAIKNIQSTYGLSKTTWQGDPCVPKKFLWDGL 393
Query: 402 TCSTT---TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDL 458
C+ + TPP IT + LS L G I ++N+ L EL
Sbjct: 394 NCNNSDDSTPPIITSLNLSSSGLTGIIVLTIQNLANLQEL-------------------- 433
Query: 459 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVI-FKYDNNPKLH- 516
L NN L+G +P ++ + +L +++ N+ G +P L+ K++ + NPKL+
Sbjct: 434 ---DLSNNNLSGGVPEFLADMKSLLVINLSGNNLSGVVPQKLIEKKMLKLNIEGNPKLNC 490
Query: 517 ---------KESRRRMRFKLI-LGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKA 566
+E R+++ I + SIG + V F +L++ +R+ N S ++A
Sbjct: 491 TVESCVNKDEEGGRQIKSMTIPIVASIGSV----VAFTVALMIFCVVRK---NNPSNDEA 543
Query: 567 DSLRTSTKPSNTAYS----IARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVY 622
+ + P+++ S + + F E+ TNNF K +GKG FG VY
Sbjct: 544 PT--SCMLPADSRSSEPTIVTKNKKFT---------YAEVLTMTNNFQKILGKGGFGIVY 592
Query: 623 YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682
YG + ++VAVK+++ S + +QF EV LL R+HH+NLV L+GYCEE + L+YEY
Sbjct: 593 YGSVNGTEQVAVKMLSHSSAQGYKQFKAEVELLLRVHHKNLVGLVGYCEEGDKLALIYEY 652
Query: 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 742
M NG L + + G L+W TRL+IA +AA+GLEYLH GC P ++HRDVK++NILL+
Sbjct: 653 MANGDLDEHMSGKRGGSILNWGTRLKIALEAAQGLEYLHNGCKPLMVHRDVKTTNILLNE 712
Query: 743 NMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLEL 801
+ K++DFGLSR E TH+S+V GT+GYLDPEYY LTEKSDVYSFGVVLL +
Sbjct: 713 HFDTKLADFGLSRSFPIEGETHVSTVVAGTIGYLDPEYYRTNWLTEKSDVYSFGVVLLVM 772
Query: 802 ISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVE 861
I+ +PV ++ + +I W M+ KGD+ SI DP L+G+ S+W+ E+A+ C+
Sbjct: 773 IT-NQPV-IDQNREKRHIAEWVGGMLTKGDIKSITDPNLLGDYNSGSVWKAVELAMSCMN 830
Query: 862 QRGFSRPKMQEIVLAIQDSIKIE 884
+RP M ++V +++ + E
Sbjct: 831 PSSMTRPTMSQVVFELKECLASE 853
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 439 bits (1129), Expect = e-122, Method: Compositional matrix adjust.
Identities = 304/911 (33%), Positives = 468/911 (51%), Gaps = 102/911 (11%)
Query: 7 FLVIYLLFLSSVVSQ-VTEFISIDCG---STSNYTDPSTGLAWISDIGIMNNG--KSVKV 60
FL+ + L SV +Q FIS+DCG + YT+ +T + + SD +++G +
Sbjct: 10 FLITAYVILESVQAQDQLGFISLDCGLVPKNATYTEKTTNITYKSDANYIDSGLVGRISA 69
Query: 61 ENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLD 120
E + Q T R P + ++ CYN + RYL+RATF YG+ PKF +++
Sbjct: 70 EYKAQLQQQTWTVRSFP-EGERNCYNFNLTAKSRYLIRATFTYGNYDGLRQVPKFDIHIG 128
Query: 121 ATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDF 180
+ W++V + EMI D + +C+ G PFIS+LELRPLN + Y T
Sbjct: 129 PSKWTSVKLDGVGNGAVLEMIHVLTQDRLQICLVKTGKGIPFISSLELRPLNNNTYLTQS 188
Query: 181 EDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNI 240
L ARV F A T +RY +D +DR+W V +G I+T +
Sbjct: 189 GS---LIGFARVFFSA-TPTFIRYDEDIHDRVW----------VRQFGNGLKSISTDLLV 234
Query: 241 ETRTREYPPVKVMQTAVVGTEGV--LSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFK 298
+T P V +TA V + L + L++ + + + +FAEIQ L ++ R+F
Sbjct: 235 DTSNPYDVPQAVAKTACVPSNASQPLIFDWTLDNITSQSYVYMHFAEIQTLKDNDIREF- 293
Query: 299 LEQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNF----------VLSFSFVKTRDS 348
N N +N Y+ P ++ F S SF KT +S
Sbjct: 294 ----------NITYNGGQNV---YSYLRPEKFEISTLFDSKPLSSPDGSFSLSFTKTGNS 340
Query: 349 TLGPLLNAIEISKYQKIAAKTEWQDEA-----LRSISDESERTNDRGDPCVPVPWEW--V 401
TL PL+N +EI K + QDE +++ D S++ + +GDPC P ++W +
Sbjct: 341 TLPPLINGLEIYKVLDLLELETDQDEVSAMINIKATYDLSKKVSWQGDPCAPKSYQWEGL 400
Query: 402 TCS--TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 459
CS + PRI + L+ L G I PE+ + L EL L N L+G +P+ D++
Sbjct: 401 NCSYPNSDQPRIISLNLAENKLTGTITPEISKLTQLIELDLSKNDLSGEIPEF--FADMK 458
Query: 460 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKES 519
++ L N L+G+L ++P+ + +++ S + L+ K + K K
Sbjct: 459 LLKLIN--LSGNL-GLNSTIPDSIQQRLDSKSLI------LILSKTVTK----TVTLKGK 505
Query: 520 RRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTA 579
+++ I+ + GV A+L++L + ++ RRK N +S K + TK
Sbjct: 506 SKKVPMIPIVASVAGVFALLVILAIFFVV-----RRK--NGES-NKGTNPSIITKERRIT 557
Query: 580 YSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMAD 639
Y PE+ + TNNF + +GKG FG+VY+G ++D +VAVK+++
Sbjct: 558 Y-------------------PEVLKMTNNFERVLGKGGFGTVYHGNLED-TQVAVKMLSH 597
Query: 640 SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK 699
S + ++F EV LL R+HHRNLV L+GYC++ L+YEYM NG L++ + G
Sbjct: 598 SSAQGYKEFKAEVELLLRVHHRNLVGLVGYCDDGDNLALIYEYMANGDLKENMSGKRGGN 657
Query: 700 PLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759
L W R+QIA +AA+GLEYLH GC P ++HRDVK++NILL+ AK++DFGLSR
Sbjct: 658 VLTWENRMQIAVEAAQGLEYLHNGCTPPMVHRDVKTTNILLNERYGAKLADFGLSRSFPV 717
Query: 760 D-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 818
D +H+S+V GT GYLDPEYY L+EKSDVYSFGVVLLE+++ +PV+ + +
Sbjct: 718 DGESHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVT-NQPVT-DKTRERTH 775
Query: 819 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878
I W SM+ KGD+ SI+DP L+G+ W+I E+A+ CV RP M +V +
Sbjct: 776 INEWVGSMLTKGDIKSILDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVTELN 835
Query: 879 DSIKIEKGGDQ 889
+ + +E Q
Sbjct: 836 ECVALENARRQ 846
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD6|Y1570_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g05700 OS=Arabidopsis thaliana GN=At1g05700 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 438 bits (1127), Expect = e-122, Method: Compositional matrix adjust.
Identities = 315/912 (34%), Positives = 462/912 (50%), Gaps = 101/912 (11%)
Query: 7 FLVIYLLF-----LSSVVSQVTE----FISIDCG--STSNYTDPSTGLAWISDIGIMNNG 55
F +YL++ L VVS + + FISIDCG S S+Y D +TG+ ++SD + G
Sbjct: 4 FRFLYLIYSAAFALCLVVSVLAQDQSGFISIDCGIPSGSSYKDDTTGINYVSDSSFVETG 63
Query: 56 KSVKVENPSGNWMQYRTRRDLPIDNKKYCYNLI--TKERRRYLVRATFQYGSLGSEASYP 113
S + P Q + R P + + CY LI + ++YL+RA+F YG+ E P
Sbjct: 64 VSKSI--PFTAQRQLQNLRSFP-EGSRNCYTLIPIQGKGKKYLIRASFMYGNYDGENGSP 120
Query: 114 KFQLYLDATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNL 173
+F L+L +W TV + + S + +KE++ + S++I VC+ G+PFISTLELR L
Sbjct: 121 EFDLFLGGNIWDTVLLSNGSSIVSKEVVYLSQSENIFVCLGNKGKGTPFISTLELRFLGN 180
Query: 174 SMYATDFEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVR 233
D N L + R + +L +RY DD YDRIW + R NF G R
Sbjct: 181 DNTTYD-SPNGALFFSRRWDLRSLMGSPVRYDDDVYDRIW---IPR--NF------GYCR 228
Query: 234 -INTTKNIETRTREYPPVK-VMQTAVVGTEGVLSYRLNLEDFPANARAFAY--FAEIQDL 289
INT+ + + Y VM TA+ + LE+ N R F Y FAE++DL
Sbjct: 229 EINTSLPVTSDNNSYSLSSLVMSTAMTPINTTRPITMTLENSDPNVRYFVYMHFAEVEDL 288
Query: 290 G--PSETRKFKLEQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRD 347
P++TR+F D S V +A + Y ++N ++FS V+T
Sbjct: 289 SLKPNQTREF--------DISINGVTVAAGFSPKYLQTNTFFLNPESQSKIAFSLVRTPK 340
Query: 348 STLGPLLNAIEI---SKYQKIAAKTEWQDEALRSISDESERTNDRGDPCVP--VPWEWVT 402
STL P++NA+EI + + + E D + + N GDPC+P WE +
Sbjct: 341 STLPPIVNALEIYVANSFSQSLTNQEDGDAVTSLKTSYKVKKNWHGDPCLPNDYIWEGLN 400
Query: 403 CS--TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRI 460
CS + TPPRIT + LS L G I N+ + EL
Sbjct: 401 CSYDSLTPPRITSLNLSSSGLTGHISSSFSNLTMIQEL---------------------- 438
Query: 461 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL----TGKVIFKYDNNPKLH 516
L NN LTG +P ++ L L+ L++ENN+ G +P LL TG + NP L
Sbjct: 439 -DLSNNGLTGDIPEFLSKLKFLRVLNLENNTLTGSVPSELLERSNTGSFSLRLGENPGLC 497
Query: 517 KE-SRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKP 575
E S R+ K ++ + A L +L L S + R R+ KS A K
Sbjct: 498 TEISCRKSNSKKLVIPLVASFAALFILLLLSGVFWRIRNRR---NKSVNSAPQTSPMAKS 554
Query: 576 SNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVK 635
N ++ + TNNF + +GKG FG+VY+G D +VAVK
Sbjct: 555 EN----------------KLLFTFADVIKMTNNFGQVLGKGGFGTVYHG-FYDNLQVAVK 597
Query: 636 IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS 695
+++++ + ++F +EV +L R+HH NL LIGY E Q L+YE+M NG + D L G
Sbjct: 598 LLSETSAQGFKEFRSEVEVLVRVHHVNLTALIGYFHEGDQMGLIYEFMANGNMADHLAGK 657
Query: 696 VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755
Q L W RLQIA DAA+GLEYLH GC P I+HRDVK+SNILL+ RAK++DFGLSR
Sbjct: 658 Y-QHTLSWRQRLQIALDAAQGLEYLHCGCKPPIVHRDVKTSNILLNEKNRAKLADFGLSR 716
Query: 756 QAE-EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 814
E +H+S++ GT GYLDP + L EKSD+YSFGVVLLE+I+GK + E
Sbjct: 717 SFHTESRSHVSTLVAGTPGYLDPLCFETNGLNEKSDIYSFGVVLLEMITGKTVIK-ESQT 775
Query: 815 AELNIVHWARSMIKK-GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI 873
+++ W S+++ DV +++D + + + S+W++ E+A+ V Q RP M I
Sbjct: 776 KRVHVSDWVISILRSTNDVNNVIDSKMAKDFDVNSVWKVVELALSSVSQNVSDRPNMPHI 835
Query: 874 VLAIQDSIKIEK 885
V + + ++ E+
Sbjct: 836 VRGLNECLQREE 847
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 927 | ||||||
| 224107699 | 934 | predicted protein [Populus trichocarpa] | 0.997 | 0.990 | 0.790 | 0.0 | |
| 224100089 | 932 | predicted protein [Populus trichocarpa] | 0.997 | 0.992 | 0.792 | 0.0 | |
| 255547926 | 911 | protein with unknown function [Ricinus c | 0.974 | 0.991 | 0.776 | 0.0 | |
| 225425928 | 930 | PREDICTED: probable LRR receptor-like se | 0.996 | 0.993 | 0.758 | 0.0 | |
| 297738322 | 926 | unnamed protein product [Vitis vinifera] | 0.992 | 0.993 | 0.756 | 0.0 | |
| 356567402 | 929 | PREDICTED: probable LRR receptor-like se | 0.978 | 0.976 | 0.750 | 0.0 | |
| 449512995 | 956 | PREDICTED: probable LRR receptor-like se | 0.983 | 0.953 | 0.757 | 0.0 | |
| 449435025 | 923 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.979 | 0.983 | 0.760 | 0.0 | |
| 356538111 | 930 | PREDICTED: probable LRR receptor-like se | 0.976 | 0.973 | 0.746 | 0.0 | |
| 357463139 | 930 | Leucine-rich repeat family protein / pro | 0.979 | 0.976 | 0.733 | 0.0 |
| >gi|224107699|ref|XP_002314568.1| predicted protein [Populus trichocarpa] gi|222863608|gb|EEF00739.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1535 bits (3975), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 740/936 (79%), Positives = 826/936 (88%), Gaps = 11/936 (1%)
Query: 1 MVLYSHFLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIG-IMNNGKSVK 59
M YSHFL++YL +SSV+ QVTEFISIDCG TSNYTDP TGLAW+SD G IMN GKS +
Sbjct: 1 MASYSHFLLLYLFLMSSVICQVTEFISIDCGGTSNYTDPITGLAWVSDNGAIMNYGKSAE 60
Query: 60 VENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYL 119
VE P+GN MQYR RRD PID+KKYCY L TKERRRYLVRATFQYG LG+ +YPKF LYL
Sbjct: 61 VEIPNGN-MQYRRRRDFPIDSKKYCYTLGTKERRRYLVRATFQYGILGNGDAYPKFDLYL 119
Query: 120 DATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATD 179
DAT WSTV VLDASRVY KEMIIRAPS SIDVCICCA TGSPFISTLELRPLNLSMYATD
Sbjct: 120 DATKWSTVVVLDASRVYVKEMIIRAPSSSIDVCICCASTGSPFISTLELRPLNLSMYATD 179
Query: 180 FEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKN 239
FEDNFFL+VAARVNFGAL+KD +RYPDDPYDRIWDSDL++R N++VG A GTVRINT+K
Sbjct: 180 FEDNFFLEVAARVNFGALSKDVIRYPDDPYDRIWDSDLEKRQNYLVGVAPGTVRINTSKY 239
Query: 240 IETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKL 299
I+TRTREYPPVKVMQTAVVGT+G+LSYRLNL+DFPANARA+AYFAEI+DLG +ETRKFKL
Sbjct: 240 IDTRTREYPPVKVMQTAVVGTQGILSYRLNLDDFPANARAYAYFAEIEDLGANETRKFKL 299
Query: 300 EQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEI 359
+QPYF DYSNAVVNIAENANGS+TLYEPSYMNVTL+FVLSFSFVKTRDST GPLLNAIEI
Sbjct: 300 QQPYFPDYSNAVVNIAENANGSHTLYEPSYMNVTLDFVLSFSFVKTRDSTQGPLLNAIEI 359
Query: 360 SKYQKIAAKTEWQD----EALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIA 415
SKY KI +T+ QD ALRS+S ES TN++GDPCVP W+WV C++TTPPRITKIA
Sbjct: 360 SKYLKIEPRTDSQDVTVLNALRSLSAESAWTNEQGDPCVPAHWDWVNCTSTTPPRITKIA 419
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 475
LSGKNLKGEIPPE+ NME LTELWLDGNFLTGP+P +S L++L+IVHLENN+L+G LP Y
Sbjct: 420 LSGKNLKGEIPPEINNMETLTELWLDGNFLTGPIPSISNLVNLKIVHLENNKLSGQLPKY 479
Query: 476 MGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGV 535
+GSLP+LQEL+I+NN F GEIP LLTGKVI Y++NP LHKE+ ++ KLILG SIG+
Sbjct: 480 LGSLPDLQELYIQNNYFSGEIPSGLLTGKVIINYEHNPGLHKEAGKKKHSKLILGVSIGI 539
Query: 536 LAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAY 595
LA LLV+ + SL+ LR L+RK S+QK+ + SLR S KPS TAYS++RG H MDEGV+Y
Sbjct: 540 LAALLVVLIGSLLFLRNLQRKTSHQKTAVQGSSLRVSAKPS-TAYSVSRGWHMMDEGVSY 598
Query: 596 FIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALL 655
+IPL E+EEAT NF KKIG+GSFG+VYYG+MK+GKEVAVKIM DS +H TQQFVTEVALL
Sbjct: 599 YIPLSEIEEATKNFSKKIGRGSFGTVYYGQMKEGKEVAVKIMGDSTTHMTQQFVTEVALL 658
Query: 656 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 715
SRIHHRNLVPLIGYCEEE+QRILVYEYMHNGTLRD +HGSVNQK LDWL RLQIA D+AK
Sbjct: 659 SRIHHRNLVPLIGYCEEENQRILVYEYMHNGTLRDHIHGSVNQKRLDWLARLQIAEDSAK 718
Query: 716 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 775
GLEYLHTGCNP IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYL
Sbjct: 719 GLEYLHTGCNPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYL 778
Query: 776 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835
DPEYY NQQLTEKSDVYSFGVVLLEL+SGKKPVS EDFGAE+NIVHWAR++I+KGD +SI
Sbjct: 779 DPEYYANQQLTEKSDVYSFGVVLLELLSGKKPVSTEDFGAEMNIVHWARALIRKGDAMSI 838
Query: 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSS 893
VDPVLIGNVKIESIWRIAEVAIQCVEQR SRP+MQEI+LAIQ++ KIEKG G QK S
Sbjct: 839 VDPVLIGNVKIESIWRIAEVAIQCVEQRAVSRPRMQEIILAIQEANKIEKGTYGSQKLPS 898
Query: 894 SSSKGQSSRKTLLTSFLEIE--SPDLSNECLAPAAR 927
SSK QSSRKTLLTSFLEIE SPDLSN CL PAAR
Sbjct: 899 GSSKAQSSRKTLLTSFLEIESQSPDLSNGCLVPAAR 934
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100089|ref|XP_002311739.1| predicted protein [Populus trichocarpa] gi|222851559|gb|EEE89106.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1518 bits (3930), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 740/934 (79%), Positives = 823/934 (88%), Gaps = 9/934 (0%)
Query: 1 MVLYSHFLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIG-IMNNGKSVK 59
M LYSHFLV+YL F+SSV+ QVTEFISIDCG TSNYTDP TGLAW+SD G IM GKS +
Sbjct: 1 MALYSHFLVLYLFFVSSVICQVTEFISIDCGGTSNYTDPRTGLAWVSDNGTIMKYGKSSE 60
Query: 60 VENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYL 119
+ +GN QY+ RRD PID+ KYCY L TKERRRYLVRATFQYGS +E +YPKF LYL
Sbjct: 61 AQVSNGN-TQYQRRRDFPIDSNKYCYTLGTKERRRYLVRATFQYGSSENEDAYPKFDLYL 119
Query: 120 DATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATD 179
D T WST+ VLDASRVY KEMIIRAPS SIDVCICCA TGSPFISTLELRPLNLSMYATD
Sbjct: 120 DTTKWSTMVVLDASRVYVKEMIIRAPSSSIDVCICCATTGSPFISTLELRPLNLSMYATD 179
Query: 180 FEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKN 239
FEDNFFL+VAARVNFGAL+KDA+RYPDDPYDRIW SDL++R N++VG A GTVRINT+K
Sbjct: 180 FEDNFFLEVAARVNFGALSKDAIRYPDDPYDRIWGSDLEKRQNYLVGVAPGTVRINTSKY 239
Query: 240 IETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKL 299
++TRTREYPPVKVMQTAVVGTEG+LSYRLNLEDFPANARA+AYFAEI+DLG +ETRKFKL
Sbjct: 240 VDTRTREYPPVKVMQTAVVGTEGILSYRLNLEDFPANARAYAYFAEIEDLGANETRKFKL 299
Query: 300 EQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEI 359
+QP+ +DYSNAVVNIAENANGSYTLYEPSYMNV+L+FVLSFSF KTRDSTLGPLLNAIEI
Sbjct: 300 QQPFLSDYSNAVVNIAENANGSYTLYEPSYMNVSLDFVLSFSFAKTRDSTLGPLLNAIEI 359
Query: 360 SKYQKIAAKTEWQD----EALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIA 415
SKY KI KT+ +D ALR +S ES N++GDPCVP WEWV CS+TTPPRITKIA
Sbjct: 360 SKYLKIEPKTDSKDVTVLNALRFLSAESAWANEQGDPCVPAHWEWVNCSSTTPPRITKIA 419
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 475
LSGKNLKGEIPPE+ NME LTELWLDGNFLTGP+P +S L++L+IVHLENN+L G LP Y
Sbjct: 420 LSGKNLKGEIPPEINNMEQLTELWLDGNFLTGPIPGISNLVNLKIVHLENNKLNGPLPKY 479
Query: 476 MGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGV 535
+GSLP LQ L+I+NNSF GEIP LTGKVIF Y++NP LHKE+R++M KLI+G SIG+
Sbjct: 480 LGSLPKLQALYIQNNSFSGEIPSEFLTGKVIFNYEHNPGLHKEARKKMHLKLIVGISIGI 539
Query: 536 LAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAY 595
LA LLV+ + SL+ LR L+RK S++KS + +SLR STKPS TAYS+ARG H MDEGV+Y
Sbjct: 540 LAGLLVVVIGSLLFLRNLQRKTSHKKSEVQGNSLRASTKPS-TAYSVARGWHMMDEGVSY 598
Query: 596 FIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALL 655
+IPLPELEEAT NF KKIG+GSFG+VYYG+MKDGKEVAVKIMADS +H T QFVTEVALL
Sbjct: 599 YIPLPELEEATKNFSKKIGRGSFGTVYYGQMKDGKEVAVKIMADSSTHLTLQFVTEVALL 658
Query: 656 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 715
SRIHHRNLVPL+GYCEEEHQRILVYEYMHNGTLRD +HG VNQK LDWL RLQIA DAAK
Sbjct: 659 SRIHHRNLVPLLGYCEEEHQRILVYEYMHNGTLRDHIHGPVNQKRLDWLARLQIAEDAAK 718
Query: 716 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 775
GLEYLHTGCNP IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYL
Sbjct: 719 GLEYLHTGCNPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYL 778
Query: 776 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835
DPEYY NQQLTEKSDVYSFGVVLLEL+SGKKPVS EDFG+ELNIVHWARS+I+KGDV+SI
Sbjct: 779 DPEYYANQQLTEKSDVYSFGVVLLELVSGKKPVSTEDFGSELNIVHWARSLIRKGDVMSI 838
Query: 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSS 893
VDPVLIGN KIESIWRIAEVAIQCVEQR FSRP+M EI+LAIQ++ KIEKG G QK S
Sbjct: 839 VDPVLIGNAKIESIWRIAEVAIQCVEQRAFSRPRMHEIILAIQEANKIEKGTDGSQKQQS 898
Query: 894 SSSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 927
+SSK QSSRKTLLTSFLEIESPDLSN CL PAAR
Sbjct: 899 ASSKAQSSRKTLLTSFLEIESPDLSNGCLVPAAR 932
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255547926|ref|XP_002515020.1| protein with unknown function [Ricinus communis] gi|223546071|gb|EEF47574.1| protein with unknown function [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1460 bits (3780), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 726/935 (77%), Positives = 805/935 (86%), Gaps = 32/935 (3%)
Query: 1 MVLYSH-FLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVK 59
M LYSH +LV+Y+ +SS+V QVTEFISIDCGSTSNYTD TGL WISD GIMN+GKSV+
Sbjct: 1 MALYSHIYLVLYISLVSSIVCQVTEFISIDCGSTSNYTDKRTGLEWISDNGIMNHGKSVE 60
Query: 60 VENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYL 119
V+NP G W QY RRD PID+KKYCYNL TKERRRYLVRATFQYGSL +E SYPKF LYL
Sbjct: 61 VKNPDGYWAQYGKRRDFPIDSKKYCYNLGTKERRRYLVRATFQYGSLENEDSYPKFDLYL 120
Query: 120 DATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATD 179
DAT WSTVTVL+ASR+Y KEMIIRAPS SIDVCICCA TGSPFISTLELRPLNLSMYATD
Sbjct: 121 DATKWSTVTVLEASRIYVKEMIIRAPSSSIDVCICCATTGSPFISTLELRPLNLSMYATD 180
Query: 180 FEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKN 239
+ED FFLK+AARVNFGA + ALRYPDDPYDRIWDSDL +R NF+VG A GTVRINT+KN
Sbjct: 181 YEDRFFLKLAARVNFGAPDEFALRYPDDPYDRIWDSDLAKRQNFLVGVAPGTVRINTSKN 240
Query: 240 IETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKL 299
I+ +TREYPPVKVMQTAVVGTEG+LSYRLNLEDFPANARA+AYF+EI+DLG +ETRKFKL
Sbjct: 241 IDIQTREYPPVKVMQTAVVGTEGLLSYRLNLEDFPANARAYAYFSEIEDLGSNETRKFKL 300
Query: 300 EQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEI 359
+PY +DYSNAVVNIAENANGSY LYEPSYMNVTL+FVLSFSFVKTRDST GPL+NAIEI
Sbjct: 301 MKPYISDYSNAVVNIAENANGSYRLYEPSYMNVTLDFVLSFSFVKTRDSTQGPLINAIEI 360
Query: 360 SKYQKIAAKTEWQD----EALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIA 415
SKY KI +KT+ QD A RSIS S T + GDPCVP WEWV CS+T+PPRITKIA
Sbjct: 361 SKYLKIESKTDIQDANVLNAFRSISAGSYWTTEGGDPCVPAQWEWVNCSSTSPPRITKIA 420
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 475
LSGKNLKGE+PPE+ NM L+EL HLENN+L+GSLP Y
Sbjct: 421 LSGKNLKGEVPPEINNMVELSEL-----------------------HLENNKLSGSLPKY 457
Query: 476 MGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGV 535
+GSLPNL+EL+I+NNSFVG++P ALLTGKV Y++NP LHKE ++M FKL LG SIGV
Sbjct: 458 LGSLPNLRELYIQNNSFVGKVPAALLTGKVNLNYEDNPGLHKEVAKKMHFKLTLGISIGV 517
Query: 536 LAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAY 595
LAILLVL L +LI LR+L+RK S+QK+ +S+R STKPS TAYSI RG H MDEG +Y
Sbjct: 518 LAILLVLLLGTLIYLRRLQRKTSHQKTDNPGNSMRASTKPS-TAYSITRGWHLMDEGGSY 576
Query: 596 FIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALL 655
+I ELEEAT NF KKIGKGSFGSVYYG+MKDGKEVAVKIMADSCSH TQQFVTEVALL
Sbjct: 577 YISFAELEEATKNFFKKIGKGSFGSVYYGQMKDGKEVAVKIMADSCSHLTQQFVTEVALL 636
Query: 656 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 715
SRIHHRNLVPLIG+CEEEHQRILVYEYMHNGTLRD +HG N+K LDWLTRLQIA DAAK
Sbjct: 637 SRIHHRNLVPLIGFCEEEHQRILVYEYMHNGTLRDHIHGIDNRKSLDWLTRLQIAEDAAK 696
Query: 716 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 775
GLEYLHTGC+P IIHRDVK+SNILLDINMRAKVSDFGLSRQAE+DLTHISSVARGTVGYL
Sbjct: 697 GLEYLHTGCSPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEDDLTHISSVARGTVGYL 756
Query: 776 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835
DPEYY NQQLTEKSDVYSFGVVLLELISGKKPVS EDFGAE+NIVHWAR++I+KGDV+SI
Sbjct: 757 DPEYYANQQLTEKSDVYSFGVVLLELISGKKPVSTEDFGAEMNIVHWARALIRKGDVVSI 816
Query: 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSS 893
VDPVLIGNVKIESIWR+AEVAIQCV+QR SRP+MQE++L+IQ++IKIEKG G QK S+
Sbjct: 817 VDPVLIGNVKIESIWRVAEVAIQCVQQRAVSRPRMQEVILSIQEAIKIEKGTDGSQKLSN 876
Query: 894 S-SSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 927
S SSK QSSRKTLLTSFLEIESPDLSN CL PAAR
Sbjct: 877 SGSSKAQSSRKTLLTSFLEIESPDLSNGCLVPAAR 911
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225425928|ref|XP_002267668.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1446 bits (3742), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 708/933 (75%), Positives = 800/933 (85%), Gaps = 9/933 (0%)
Query: 1 MVLYSHFLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKV 60
M L+SHFLV +L +++ + QVTEFISIDCG TSNYTD TGL WISD G ++ GKSV+V
Sbjct: 1 MGLFSHFLVSFLCLITTTLCQVTEFISIDCGGTSNYTDSRTGLQWISDTGAISYGKSVQV 60
Query: 61 ENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLD 120
ENP G W+QY+ RRD P ++K YCY L T+ERRRYLVRATFQYGSL SE +YPKFQLYLD
Sbjct: 61 ENPYGGWLQYQQRRDFPTESK-YCYTLKTEERRRYLVRATFQYGSLESEGTYPKFQLYLD 119
Query: 121 ATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDF 180
AT W+TVTVL+++RVY KEMIIRAPS SIDVC+CCA TGSPFISTLELRPLNLSMYATDF
Sbjct: 120 ATKWATVTVLESARVYVKEMIIRAPSSSIDVCLCCATTGSPFISTLELRPLNLSMYATDF 179
Query: 181 EDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNI 240
ED FFLKV+ARVNFGA ++D +RYPDDPYDRIW+SDL +R N++VG A GT R+NT+K I
Sbjct: 180 EDGFFLKVSARVNFGAPSEDPIRYPDDPYDRIWESDLVKRQNYLVGVAPGTERVNTSKQI 239
Query: 241 ETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLE 300
+ RTREYPPVKVMQTAVVGT G LSYRLNLEDFPANARA+A+FAEI++LG +ETRKF++E
Sbjct: 240 DVRTREYPPVKVMQTAVVGTRGRLSYRLNLEDFPANARAYAFFAEIEELGVNETRKFRME 299
Query: 301 QPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEIS 360
+PY DYSNAVVNIAENANGSY+LYEPSYMNVT++FVLSFSFVKTRDST GPLL+AIEIS
Sbjct: 300 RPYLPDYSNAVVNIAENANGSYSLYEPSYMNVTMDFVLSFSFVKTRDSTRGPLLSAIEIS 359
Query: 361 KYQKIAAKTEWQD----EALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIAL 416
KY +IA KT+ D AL ++S ES +N+ DPCVP W WV CS TT PRITKI L
Sbjct: 360 KYVQIAPKTDKGDVTVLNALCAMSTESAWSNEGRDPCVPAHWSWVACSPTTTPRITKITL 419
Query: 417 SGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM 476
SGKNL G IP ELKNME LTELWLDGN+LTGP+PDMS LI L+IVHLENN LTG LPSY+
Sbjct: 420 SGKNLNGVIPSELKNMEGLTELWLDGNYLTGPIPDMSNLISLKIVHLENNRLTGPLPSYL 479
Query: 477 GSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVL 536
GSLP+LQELH++NN GEIPPALLTGKVIF Y+ N KLHKE+ + FKLILG S+G+L
Sbjct: 480 GSLPSLQELHVQNNLLSGEIPPALLTGKVIFNYEGNSKLHKEAHK-THFKLILGASVGLL 538
Query: 537 AILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYF 596
A+LLVL + SL +L RRK S KS +K SLRTSTK S T+YSIARGG+ MDEGVA +
Sbjct: 539 ALLLVLCIGSLFLLCNTRRKESQSKSNDKGSSLRTSTKAS-TSYSIARGGNLMDEGVACY 597
Query: 597 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLS 656
I L +LEEAT NF K+IG+GSFG VYYGKM DGKE+AVKIMADS SH TQQFVTEVALLS
Sbjct: 598 ISLSDLEEATKNFAKQIGRGSFGPVYYGKMPDGKEIAVKIMADSSSHGTQQFVTEVALLS 657
Query: 657 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 716
RIHHRNLVPLIGYCE+EHQ +LVYEYMHNGTLR+ +H S NQK LDWL RL +A DAAKG
Sbjct: 658 RIHHRNLVPLIGYCEDEHQHLLVYEYMHNGTLRNHIHDSTNQKCLDWLGRLYVAEDAAKG 717
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 776
LEYLHTGCNP IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLD
Sbjct: 718 LEYLHTGCNPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLD 777
Query: 777 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836
PEYY NQQLTEKSDVYSFG+VLLELISG+KPVS ED+GAE NIVHWARS+I GDVISIV
Sbjct: 778 PEYYANQQLTEKSDVYSFGIVLLELISGRKPVSPEDYGAEWNIVHWARSLICNGDVISIV 837
Query: 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSS 894
DP L+GNVKIESIWRIAE+AI CVEQ G SRPKMQEI+LAIQD+IKIE+G GD K S
Sbjct: 838 DPFLLGNVKIESIWRIAEIAILCVEQHGTSRPKMQEIILAIQDAIKIERGNEGDHKACSG 897
Query: 895 SSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 927
SSKGQSSRKTLLT+FL+IESPDLSN+CL P+AR
Sbjct: 898 SSKGQSSRKTLLTNFLDIESPDLSNDCLVPSAR 930
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297738322|emb|CBI27523.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1438 bits (3723), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 706/933 (75%), Positives = 798/933 (85%), Gaps = 13/933 (1%)
Query: 1 MVLYSHFLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKV 60
M L+SHFLV +L +++ + QVTEFISIDCG TSNYTD TGL WISD G ++ GKSV+V
Sbjct: 1 MGLFSHFLVSFLCLITTTLCQVTEFISIDCGGTSNYTDSRTGLQWISDTGAISYGKSVQV 60
Query: 61 ENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLD 120
ENP G W+QY+ RRD P ++K YCY L T+ERRRYLVRATFQYGSL SE +YPKFQLYLD
Sbjct: 61 ENPYGGWLQYQQRRDFPTESK-YCYTLKTEERRRYLVRATFQYGSLESEGTYPKFQLYLD 119
Query: 121 ATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDF 180
AT W+TVTVL+++RVY KEMIIRAPS SIDVC+CCA TGSPFISTLELRPLNLSMYATDF
Sbjct: 120 ATKWATVTVLESARVYVKEMIIRAPSSSIDVCLCCATTGSPFISTLELRPLNLSMYATDF 179
Query: 181 EDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNI 240
ED FFLKV+ARVNFGA ++D +RYPDDPYDRIW+SDL +R N++VG A GT R+NT+K I
Sbjct: 180 EDGFFLKVSARVNFGAPSEDPIRYPDDPYDRIWESDLVKRQNYLVGVAPGTERVNTSKQI 239
Query: 241 ETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLE 300
+ RTREYPPVKVMQTAVVGT G LSYRLNLEDFPANARA+A+FAEI++LG +ETRKF++E
Sbjct: 240 DVRTREYPPVKVMQTAVVGTRGRLSYRLNLEDFPANARAYAFFAEIEELGVNETRKFRME 299
Query: 301 QPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEIS 360
+PY DYSNAVVNIAENANGSY+LYEPSYMNVT++FVLSFSFVKTRDST GPLL+AIEIS
Sbjct: 300 RPYLPDYSNAVVNIAENANGSYSLYEPSYMNVTMDFVLSFSFVKTRDSTRGPLLSAIEIS 359
Query: 361 KYQKIAAKTEWQD----EALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIAL 416
KY +IA KT+ D AL ++S ES +N+ DPCVP W WV CS TT PRITKI L
Sbjct: 360 KYVQIAPKTDKGDVTVLNALCAMSTESAWSNEGRDPCVPAHWSWVACSPTTTPRITKITL 419
Query: 417 SGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM 476
SGKNL G IP ELKNME LTELWLDGN+LTGP+PDMS LI L+IVHLENN LTG LPSY+
Sbjct: 420 SGKNLNGVIPSELKNMEGLTELWLDGNYLTGPIPDMSNLISLKIVHLENNRLTGPLPSYL 479
Query: 477 GSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVL 536
GSLP+LQELH++NN GEIPPALLTGKVIF Y+ N KLHKE+ + FKLILG S+G+L
Sbjct: 480 GSLPSLQELHVQNNLLSGEIPPALLTGKVIFNYEGNSKLHKEAHK-THFKLILGASVGLL 538
Query: 537 AILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYF 596
A+LLVL + SL +L RRK +S K SLRTSTK S T+YSIARGG+ MDEGVA +
Sbjct: 539 ALLLVLCIGSLFLLCNTRRK----ESQSKRSSLRTSTKAS-TSYSIARGGNLMDEGVACY 593
Query: 597 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLS 656
I L +LEEAT NF K+IG+GSFG VYYGKM DGKE+AVKIMADS SH TQQFVTEVALLS
Sbjct: 594 ISLSDLEEATKNFAKQIGRGSFGPVYYGKMPDGKEIAVKIMADSSSHGTQQFVTEVALLS 653
Query: 657 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 716
RIHHRNLVPLIGYCE+EHQ +LVYEYMHNGTLR+ +H S NQK LDWL RL +A DAAKG
Sbjct: 654 RIHHRNLVPLIGYCEDEHQHLLVYEYMHNGTLRNHIHDSTNQKCLDWLGRLYVAEDAAKG 713
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 776
LEYLHTGCNP IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLD
Sbjct: 714 LEYLHTGCNPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLD 773
Query: 777 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836
PEYY NQQLTEKSDVYSFG+VLLELISG+KPVS ED+GAE NIVHWARS+I GDVISIV
Sbjct: 774 PEYYANQQLTEKSDVYSFGIVLLELISGRKPVSPEDYGAEWNIVHWARSLICNGDVISIV 833
Query: 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSS 894
DP L+GNVKIESIWRIAE+AI CVEQ G SRPKMQEI+LAIQD+IKIE+G GD K S
Sbjct: 834 DPFLLGNVKIESIWRIAEIAILCVEQHGTSRPKMQEIILAIQDAIKIERGNEGDHKACSG 893
Query: 895 SSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 927
SSKGQSSRKTLLT+FL+IESPDLSN+CL P+AR
Sbjct: 894 SSKGQSSRKTLLTNFLDIESPDLSNDCLVPSAR 926
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567402|ref|XP_003551909.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1398 bits (3618), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 690/919 (75%), Positives = 780/919 (84%), Gaps = 12/919 (1%)
Query: 16 SSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRD 75
S V Q+ EFISIDCG T+NYTD STGLAWISD GIM +GK V+V+NPSGN +QY+ RR+
Sbjct: 16 SYAVCQLEEFISIDCGGTNNYTDKSTGLAWISDYGIMKHGKPVEVQNPSGNKVQYQRRRE 75
Query: 76 LPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRV 135
PID++KYCY L T+ERRR+LVRATFQYGSL +YP+FQLYLDAT W+TV++ DASR+
Sbjct: 76 FPIDSRKYCYTLGTEERRRHLVRATFQYGSLDDGDTYPQFQLYLDATKWATVSIYDASRI 135
Query: 136 YAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFG 195
Y KEMI RAPS+SIDVC+CCA TGSPFISTLELRPLNLSMYATDFE +FFLKVAAR+NFG
Sbjct: 136 YVKEMIFRAPSNSIDVCMCCATTGSPFISTLELRPLNLSMYATDFEGSFFLKVAARINFG 195
Query: 196 ALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQT 255
A ++D +RYPDDPYDRIW+SDL +R N++VG A GT RINTTK IE TREYPPVKVMQT
Sbjct: 196 APSEDVVRYPDDPYDRIWESDLIKRQNYLVGVAPGTERINTTKKIEIETREYPPVKVMQT 255
Query: 256 AVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIA 315
AVVGT+G+LSYRLNLEDFP NARA+AYFAEI+DL +ETRKFKLEQPY ADYSNAVVNIA
Sbjct: 256 AVVGTKGILSYRLNLEDFPGNARAYAYFAEIEDLPKNETRKFKLEQPYIADYSNAVVNIA 315
Query: 316 ENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQD-- 373
ENANGSYTLYEPSYMNV+L FVLSFSFVKTRDST GPLLNA+EISKY IA+KT+ QD
Sbjct: 316 ENANGSYTLYEPSYMNVSLEFVLSFSFVKTRDSTQGPLLNAMEISKYVSIASKTDRQDSN 375
Query: 374 --EALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKN 431
A R +S ES N+ GDPCVP PWEWV CSTTTPPRITKI LS +N+KGEIP EL N
Sbjct: 376 FVNAFRFLSAESVLKNE-GDPCVPTPWEWVNCSTTTPPRITKINLSRRNMKGEIPRELNN 434
Query: 432 MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 491
MEALTELWLDGN LTG LPDM LI+L+IVHLENN+L+G LPSY+GSLP+LQ L I+NNS
Sbjct: 435 MEALTELWLDGNMLTGQLPDMRNLINLKIVHLENNKLSGPLPSYLGSLPSLQALFIQNNS 494
Query: 492 FVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLR 551
F G IP LL+GK+IF +D+NP+LHK +++ F+L+LG SIGVLAILL+LFL SL++L
Sbjct: 495 FSGVIPSGLLSGKIIFNFDDNPELHKGNKK--HFQLMLGISIGVLAILLILFLTSLVLLL 552
Query: 552 KLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCK 611
LRRK S QK EK S R+STKP T YS R G+ MDEG AY+I L EL+EATNNF K
Sbjct: 553 NLRRKTSRQKCDEKGISGRSSTKPL-TGYSFGRNGNIMDEGTAYYITLSELKEATNNFSK 611
Query: 612 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 671
IGKGSFGSVYYGKMKDGKEVAVK M D S+ QQFV EVALLSRIHHRNLVPLIGYCE
Sbjct: 612 NIGKGSFGSVYYGKMKDGKEVAVKTMTDPSSYGNQQFVNEVALLSRIHHRNLVPLIGYCE 671
Query: 672 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 731
EE+Q ILVYEYMHNGTLR+ +H +QK LDWL RL+IA DA+KGLEYLHTGCNP IIHR
Sbjct: 672 EEYQHILVYEYMHNGTLREYIHECSSQKQLDWLARLRIAEDASKGLEYLHTGCNPSIIHR 731
Query: 732 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 791
DVK+SNILLDINMRAKVSDFGLSR AEEDLTHISSVARGTVGYLDPEYY NQQLTEKSDV
Sbjct: 732 DVKTSNILLDINMRAKVSDFGLSRLAEEDLTHISSVARGTVGYLDPEYYANQQLTEKSDV 791
Query: 792 YSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 851
YSFGVVLLELISGKKPVS ED+G E+NIVHWARS+I+KGDVISI+DP L+GNVK ES+WR
Sbjct: 792 YSFGVVLLELISGKKPVSSEDYGPEMNIVHWARSLIRKGDVISIMDPSLVGNVKTESVWR 851
Query: 852 IAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF---SSSSSKGQSSRKTLLTS 908
+AE+AIQCVEQ G RP+MQE++LAIQD+ IEKG + + SS SK QSSRKTLL S
Sbjct: 852 VAEIAIQCVEQHGACRPRMQEVILAIQDASNIEKGSEIQLKLSSSGGSKPQSSRKTLLAS 911
Query: 909 FLEIESPDLSNECLAPAAR 927
FLEIESPDLSN CL P+AR
Sbjct: 912 FLEIESPDLSNSCL-PSAR 929
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449512995|ref|XP_004164199.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1392 bits (3604), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 704/929 (75%), Positives = 789/929 (84%), Gaps = 17/929 (1%)
Query: 5 SHFLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPS 64
S + +I LL +SSV QV EFISIDCG T NYTDP TGLAWISD GIMN G S VENP+
Sbjct: 39 SFWGLILLLVVSSVHCQVKEFISIDCGGTKNYTDPVTGLAWISDAGIMNAGGSSPVENPN 98
Query: 65 GNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLW 124
GN MQY+TRRD PID+KKYCY L T+ERRRYLVRATFQYGSL E +YPKFQLYLDAT W
Sbjct: 99 GNLMQYQTRRDFPIDDKKYCYTLKTEERRRYLVRATFQYGSLKDEETYPKFQLYLDATKW 158
Query: 125 STVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNF 184
STVT+ DASRVY KEMIIRAPS+S DVCICCA TGSPFISTLELRP NLSMYATDFEDNF
Sbjct: 159 STVTIFDASRVYVKEMIIRAPSNSFDVCICCATTGSPFISTLELRPFNLSMYATDFEDNF 218
Query: 185 FLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRT 244
FL+VAARVNFGALTKDA+RYPDDPYDRIWDSDL++R N++VG A GT RI+T NI T
Sbjct: 219 FLEVAARVNFGALTKDAIRYPDDPYDRIWDSDLEKRQNYLVGVAPGTERISTLNNINVMT 278
Query: 245 REYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYF 304
REYPPVKVMQTAV+GT+GVLSYRLNL+DFPANARA+AYFAEI+DLG +ETRKFKLE+P
Sbjct: 279 REYPPVKVMQTAVLGTKGVLSYRLNLDDFPANARAYAYFAEIEDLGWNETRKFKLEEPNI 338
Query: 305 ADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQK 364
D SNAVVNIAENANG+YTLYEPSYMNVTL+FVLSFSFVKTRDST GPLLNA+EIS+Y +
Sbjct: 339 PDSSNAVVNIAENANGTYTLYEPSYMNVTLSFVLSFSFVKTRDSTRGPLLNALEISRYVE 398
Query: 365 IAAKTEWQDEAL----RSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKN 420
IA KT+ +DEA+ R++S E+ +N GDPCVP WEWVTCS T PPRITKI LS KN
Sbjct: 399 IAPKTDGRDEAVANIFRNVSAENVWSN-IGDPCVPTSWEWVTCSATQPPRITKIELSRKN 457
Query: 421 LKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLP 480
LKGEIPPE+ M+ L ELWLDGN L GPLPDMS LI+L+I+HLENN+LTG+LPSY+ SLP
Sbjct: 458 LKGEIPPEINTMDGLVELWLDGNSLAGPLPDMSNLINLKILHLENNKLTGTLPSYLCSLP 517
Query: 481 NLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILL 540
NLQEL+I+NN+F GEIP LL K+IFKYD N LHK R ++ KLILG S+GVL +L+
Sbjct: 518 NLQELYIQNNTFSGEIPSELLAKKLIFKYDGNVGLHKTERYKVHSKLILGVSLGVLVLLV 577
Query: 541 VLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLP 600
+L L SL++LRKLRRK + + +K SL STK S +AYSI +G DEG+AY++ L
Sbjct: 578 ILLLGSLLLLRKLRRKTAPYQ--KKGGSLNISTKRS-SAYSIGKG----DEGMAYYLSLS 630
Query: 601 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 660
ELEEATNNF KKIGKGSFGSV+YGKM DGKEVAVKIMA+S +H QQF+TEVALLSRIHH
Sbjct: 631 ELEEATNNFSKKIGKGSFGSVFYGKMIDGKEVAVKIMAESSTHGNQQFMTEVALLSRIHH 690
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
RNLVPLIGYCEEEHQRILVYEYMHNGTLRD L+GS QK LDWL RL IA DAAKGLEYL
Sbjct: 691 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDHLYGSTTQKHLDWLARLHIAEDAAKGLEYL 750
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 780
HTGC+P IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEYY
Sbjct: 751 HTGCSPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEYY 810
Query: 781 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840
QQLTEKSDVYSFGVVLLELISGKKPVS ED+G ELNIVHWARS++ KGDV SIVDP L
Sbjct: 811 ACQQLTEKSDVYSFGVVLLELISGKKPVSPEDYGNELNIVHWARSLVHKGDVTSIVDPFL 870
Query: 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSKG 898
G VKIES+WRIAEVAIQCV+Q G SRP+MQE++LAIQD+IKIE G G+QK SS + K
Sbjct: 871 EGKVKIESVWRIAEVAIQCVQQHGVSRPRMQEVILAIQDAIKIEHGTEGNQKLSSENLKA 930
Query: 899 QSSRKTLLTSFLEIESPDLSNECLAPAAR 927
QSSRKTLLT+FLEIESPD S L P+AR
Sbjct: 931 QSSRKTLLTTFLEIESPDGS---LLPSAR 956
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449435025|ref|XP_004135296.1| PREDICTED: LOW QUALITY PROTEIN: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1389 bits (3594), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 704/926 (76%), Positives = 787/926 (84%), Gaps = 18/926 (1%)
Query: 9 VIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWM 68
+I LL +SSV QV EFISIDCG T NYTDP TGLAWISD GIMN G S VENP+GN M
Sbjct: 9 LILLLVVSSVHCQVKEFISIDCGGTKNYTDPVTGLAWISDAGIMNAGGSSPVENPNGNLM 68
Query: 69 QYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVT 128
QY+TRRD PID+KKYCY L T+ERRRYLVRATFQYGSL E +YPKFQLYLDAT WSTVT
Sbjct: 69 QYQTRRDFPIDDKKYCYTLKTEERRRYLVRATFQYGSLKDEETYPKFQLYLDATKWSTVT 128
Query: 129 VLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKV 188
+ DASRVY KEMIIRAPS+S DVCICCA TGSPFISTLELRP NLSMYATDFEDNFFL+V
Sbjct: 129 IFDASRVYVKEMIIRAPSNSFDVCICCATTGSPFISTLELRPFNLSMYATDFEDNFFLEV 188
Query: 189 AARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYP 248
AARVNFGALTKDA+RYPDDPYDRIWDSDL++R N++VG A GT RI+T NI TREYP
Sbjct: 189 AARVNFGALTKDAIRYPDDPYDRIWDSDLEKRQNYLVGVAPGTERISTLNNINVMTREYP 248
Query: 249 PVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYS 308
PVKVMQTAV+GT+GVLSYRLNL+DFPANARA+AYFAEI+DLG +ETRKFKLE+P D S
Sbjct: 249 PVKVMQTAVLGTKGVLSYRLNLDDFPANARAYAYFAEIEDLGWNETRKFKLEEPNIPDSS 308
Query: 309 NAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAK 368
NAVVNIAENANG+YTLYEPSYMNVTL+FVLSFSFVKTRDST GPLLNA+EIS+Y +IA K
Sbjct: 309 NAVVNIAENANGTYTLYEPSYMNVTLSFVLSFSFVKTRDSTRGPLLNALEISRYVEIAPK 368
Query: 369 TEWQDEAL----RSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGE 424
T+ +DEA+ R++S E+ TN GDPCVP WEWVTCS T PPRITKI LS KNLKGE
Sbjct: 369 TDGRDEAVANIFRNVSAENVWTN-IGDPCVPTSWEWVTCSATQPPRITKIELSRKNLKGE 427
Query: 425 IPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQE 484
IPPE+ M+ L ELWLDGN L GPLPDMS LI+L+I+HLENN+LTG+LPSY+ SLPNLQE
Sbjct: 428 IPPEINTMDGLVELWLDGNSLAGPLPDMSNLINLKILHLENNKLTGTLPSYLCSLPNLQE 487
Query: 485 LHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFL 544
L+I+NN+F GEIP LL K+IFKYD N LHK R ++ KLILG S+GVL +L++L L
Sbjct: 488 LYIQNNTFSGEIPSELLAKKLIFKYDGNVGLHKTERYKVHSKLILGVSLGVLVLLVILLL 547
Query: 545 CSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEE 604
SL++LRKLRRK + + +K SL STK S +AYSI +G DEG+AY++ L ELEE
Sbjct: 548 GSLLLLRKLRRKTAPYQ--KKGGSLNISTKRS-SAYSIGKG----DEGMAYYLSLSELEE 600
Query: 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 664
ATNNF KKIGKGSFGSV+YGKM DGKEVAVKIMA+S +H QQF+TEVALLSRIHHRNLV
Sbjct: 601 ATNNFSKKIGKGSFGSVFYGKMIDGKEVAVKIMAESSTHGNQQFMTEVALLSRIHHRNLV 660
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
PLIGYCEEEHQRILVYEYMHNGTLRD L+GS QK LDWL RL IA DAAKGLEYLHTGC
Sbjct: 661 PLIGYCEEEHQRILVYEYMHNGTLRDHLYGSTTQKHLDWLARLHIAEDAAKGLEYLHTGC 720
Query: 725 NPG-IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 783
+P IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEYY Q
Sbjct: 721 SPSIIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEYYACQ 780
Query: 784 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843
QLTEKSDVYSFGVVLLELISGKKPVS ED+G ELNIVHWARS++ KGDV SIVDP L G
Sbjct: 781 QLTEKSDVYSFGVVLLELISGKKPVSPEDYGNELNIVHWARSLVHKGDVTSIVDPFLEGK 840
Query: 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSKGQSS 901
VKIES+WRIAEVAIQCV+Q G SRP+MQE++LAIQD+IKIE G G+QK SS + K QSS
Sbjct: 841 VKIESVWRIAEVAIQCVQQHGVSRPRMQEVILAIQDAIKIEHGTEGNQKLSSENLKAQSS 900
Query: 902 RKTLLTSFLEIESPDLSNECLAPAAR 927
RKTLLT+FLEIESPD S L P+AR
Sbjct: 901 RKTLLTTFLEIESPDGS---LLPSAR 923
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356538111|ref|XP_003537548.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1380 bits (3573), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 685/918 (74%), Positives = 778/918 (84%), Gaps = 13/918 (1%)
Query: 18 VVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLP 77
V Q+ EFISIDCG TSNYTD STGLAWISD GIM +GK V+V+NPSGN QY+ RR+ P
Sbjct: 18 AVCQLEEFISIDCGGTSNYTDKSTGLAWISDSGIMKHGKPVEVQNPSGNKFQYQRRREFP 77
Query: 78 IDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYA 137
ID++KYCY L+T+ERRRYLVRATF+YG+L +YP+FQLYLDAT W+TV++ DASR+YA
Sbjct: 78 IDSRKYCYTLVTEERRRYLVRATFKYGNLDDGDTYPQFQLYLDATKWATVSIYDASRIYA 137
Query: 138 KEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGAL 197
KEMI RAPS+SIDVC+CCA TGSPFISTLELRPLNLSMYATDFE +FFLKVAAR+NFGA
Sbjct: 138 KEMIFRAPSNSIDVCMCCATTGSPFISTLELRPLNLSMYATDFEGSFFLKVAARINFGAP 197
Query: 198 TKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAV 257
++D +RYPDDPYDRIW+SDL +R N++VG A GT RINTTK IE TRE PPVKVMQTAV
Sbjct: 198 SEDVVRYPDDPYDRIWESDLIKRQNYLVGVAPGTERINTTKKIEIETRENPPVKVMQTAV 257
Query: 258 VGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAEN 317
VGT+G+LSYRLNLEDFP NARA+AYFAEI+DL +ETRKFKLEQPY ADYSNAVVNIAEN
Sbjct: 258 VGTKGILSYRLNLEDFPGNARAYAYFAEIEDLPKNETRKFKLEQPYIADYSNAVVNIAEN 317
Query: 318 ANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQD---- 373
ANGSYTLYEPSYMNV+L FVLSFSFVKTRDST GPLLNA+EISKY IA+KT+ QD
Sbjct: 318 ANGSYTLYEPSYMNVSLEFVLSFSFVKTRDSTQGPLLNAMEISKYMPIASKTDRQDSNFV 377
Query: 374 EALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNME 433
A R +S ES N+ GDPCVP PWEWV CSTTTPPRITKI LS +NLKGEIP +L NME
Sbjct: 378 NAFRFLSAESVLKNE-GDPCVPTPWEWVNCSTTTPPRITKINLSRRNLKGEIPGKLNNME 436
Query: 434 ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 493
ALTELWLDGN LTG LPDMS LI+++I+HLENN+LTG LPSY+GSLP+LQ L I+NNSF
Sbjct: 437 ALTELWLDGNMLTGQLPDMSNLINVKIMHLENNKLTGPLPSYLGSLPSLQALFIQNNSFS 496
Query: 494 GEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKL 553
G IP LL+GK+IF +D+NP+LHK +++ F+L+LG SIGVL ILL+LFL SL++L L
Sbjct: 497 GVIPSGLLSGKIIFNFDDNPELHKGNKK--HFQLMLGISIGVLVILLILFLTSLVLLLIL 554
Query: 554 RRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKI 613
RRK S QK EK S R+STKP T YS R G+ MDEG AY+I L EL+EATNNF K I
Sbjct: 555 RRKTSQQKRDEKGVSGRSSTKPL-TGYSFGRDGNIMDEGTAYYITLSELKEATNNFSKNI 613
Query: 614 GKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 673
GKGSFGSVYYGKMKDGKEVAVK M D S+ QQFV EVALLSRIHHRNLVPLIGYCEEE
Sbjct: 614 GKGSFGSVYYGKMKDGKEVAVKTMTDPSSYGNQQFVNEVALLSRIHHRNLVPLIGYCEEE 673
Query: 674 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV 733
+Q ILVYEYMHNGTLR+ +H +QK LDWL RL+IA DAAKGLEYLHTGCNP IIHRDV
Sbjct: 674 YQHILVYEYMHNGTLREYIHECSSQKQLDWLARLRIAEDAAKGLEYLHTGCNPSIIHRDV 733
Query: 734 KSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYS 793
K+SNILLDINMRAKVSDFGLSR AEEDLTHISSVARGTVGYLDPEYY NQQLTEKSDVYS
Sbjct: 734 KTSNILLDINMRAKVSDFGLSRLAEEDLTHISSVARGTVGYLDPEYYANQQLTEKSDVYS 793
Query: 794 FGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIA 853
FGVVLLEL+SGKK VS ED+G E+NIVHWARS+I+KGDVISI+DP L+GN+K ES+WR+A
Sbjct: 794 FGVVLLELLSGKKAVSSEDYGPEMNIVHWARSLIRKGDVISIMDPSLVGNLKTESVWRVA 853
Query: 854 EVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSSKG----QSSRKTLLTSF 909
E+A+QCVEQ G RP+MQE++LAIQD+ IEKG + + SSS G QSSRKTLL SF
Sbjct: 854 EIAMQCVEQHGACRPRMQEVILAIQDASNIEKGTESQLKLSSSGGNSKPQSSRKTLLASF 913
Query: 910 LEIESPDLSNECLAPAAR 927
LEIESPDLSN CL P+AR
Sbjct: 914 LEIESPDLSNSCL-PSAR 930
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357463139|ref|XP_003601851.1| Leucine-rich repeat family protein / protein kinase family protein [Medicago truncatula] gi|355490899|gb|AES72102.1| Leucine-rich repeat family protein / protein kinase family protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1376 bits (3561), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 676/921 (73%), Positives = 774/921 (84%), Gaps = 13/921 (1%)
Query: 15 LSSVVSQVTEFISIDCGST-SNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTR 73
+S Q+ EFISIDCG T SNYTD +TGL WISD IM +G++V+V+NP+GN +QY+ R
Sbjct: 15 ISCASCQLQEFISIDCGGTRSNYTDTTTGLTWISDSEIMKHGETVEVKNPNGNKVQYQKR 74
Query: 74 RDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDAS 133
RD P D++KYCY L +ERRRYLVRATFQYGSL + +YP+FQLYLDAT W+TV++ D S
Sbjct: 75 RDFPTDSRKYCYTLEAEERRRYLVRATFQYGSLQNGDTYPQFQLYLDATKWATVSIYDES 134
Query: 134 RVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVN 193
R+Y KEMI RAPS+S+DVCICCA TGSPFIST+ELRPLNLSMYATDFED+FFLKVAAR+N
Sbjct: 135 RIYVKEMIFRAPSNSVDVCICCATTGSPFISTIELRPLNLSMYATDFEDDFFLKVAARIN 194
Query: 194 FGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVM 253
FGA T DA+RYP+DPYDRIW+SDL +R NF+VG A+GT RINTT+NI TREYPPVKVM
Sbjct: 195 FGAPTGDAVRYPEDPYDRIWESDLGKRQNFLVGVAAGTERINTTRNIAIETREYPPVKVM 254
Query: 254 QTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVN 313
Q+AVVGT+G+LSYRLNLEDFP NARA+AY AEI+DL +ETRKFKLEQP+ ADYSNAVVN
Sbjct: 255 QSAVVGTKGLLSYRLNLEDFPGNARAYAYLAEIEDLSQNETRKFKLEQPFIADYSNAVVN 314
Query: 314 IAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQD 373
IAENANGSYTLYEPSYMNV+L FVLSFSF +T DST GPLLNA+EISKYQ+IA+KT QD
Sbjct: 315 IAENANGSYTLYEPSYMNVSLEFVLSFSFKRTPDSTRGPLLNAMEISKYQEIASKTFKQD 374
Query: 374 ----EALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPEL 429
A S+SDE N+ GDPCVP PWEWV CST TP RIT I LSG+NL GEIP EL
Sbjct: 375 SNFVNAFSSLSDEIIPKNE-GDPCVPTPWEWVNCSTATPARITNINLSGRNLTGEIPREL 433
Query: 430 KNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 489
NMEALTELWLD N LTG LPDMS LI+L+I+HLENN+LTG LP+Y+GSLP LQ L+I+N
Sbjct: 434 NNMEALTELWLDRNLLTGQLPDMSNLINLKIMHLENNKLTGPLPTYLGSLPGLQALYIQN 493
Query: 490 NSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIV 549
NSF G+IP LL+ K+ F YD+NP LHK S++ F L++G SIGVL IL+V+FL SL++
Sbjct: 494 NSFTGDIPAGLLSTKITFIYDDNPGLHKRSKK--HFPLMIGISIGVLVILMVMFLASLVL 551
Query: 550 LRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNF 609
LR LRRK S QKS E+A S RT TK T YS R G+ MDEG AY+I L +L+ ATNNF
Sbjct: 552 LRYLRRKASQQKSDERAISGRTGTK-HLTGYSFGRDGNLMDEGTAYYITLSDLKVATNNF 610
Query: 610 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
KKIGKGSFGSVYYGKMKDGKE+AVK M D SH QFVTEVALLSRIHHRNLVPLIGY
Sbjct: 611 SKKIGKGSFGSVYYGKMKDGKEIAVKTMTDPSSHGNHQFVTEVALLSRIHHRNLVPLIGY 670
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 729
CEEE+Q ILVYEYMHNGTLRD +H ++K LDWLTRL+IA DAAKGLEYLHTGCNP II
Sbjct: 671 CEEEYQHILVYEYMHNGTLRDHIHECSSEKRLDWLTRLRIAEDAAKGLEYLHTGCNPSII 730
Query: 730 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 789
HRDVK+SNILLDINMRAKVSDFGLSR AEEDLTHISSVA+GTVGYLDPEYY NQQLTEKS
Sbjct: 731 HRDVKTSNILLDINMRAKVSDFGLSRLAEEDLTHISSVAKGTVGYLDPEYYANQQLTEKS 790
Query: 790 DVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESI 849
DVYSFGVVLLELI GKKPVS ED+G E+NIVHWARS+I+KGD+ISI+DP+LIGNVK ESI
Sbjct: 791 DVYSFGVVLLELICGKKPVSPEDYGPEMNIVHWARSLIRKGDIISIMDPLLIGNVKTESI 850
Query: 850 WRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFS---SSSSKGQSSRKTLL 906
WR+AE+A+QCVE G SRP+MQE++LAIQD+ KIEKG + + SSSS QSSRKTLL
Sbjct: 851 WRVAEIAMQCVEPHGASRPRMQEVILAIQDASKIEKGTESQLKVSSSSSSIPQSSRKTLL 910
Query: 907 TSFLEIESPDLSNECLAPAAR 927
TSFLEIESPDLSN CL P+AR
Sbjct: 911 TSFLEIESPDLSNGCL-PSAR 930
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 927 | ||||||
| TAIR|locus:2008565 | 929 | AT1G67720 [Arabidopsis thalian | 0.985 | 0.983 | 0.703 | 0.0 | |
| TAIR|locus:2057991 | 934 | AT2G37050 [Arabidopsis thalian | 0.934 | 0.927 | 0.483 | 3.5e-217 | |
| TAIR|locus:2055165 | 868 | AT2G14510 [Arabidopsis thalian | 0.302 | 0.322 | 0.464 | 4.5e-124 | |
| TAIR|locus:2055160 | 886 | AT2G14440 [Arabidopsis thalian | 0.302 | 0.316 | 0.461 | 1.5e-123 | |
| TAIR|locus:2028446 | 888 | AT1G49100 [Arabidopsis thalian | 0.304 | 0.317 | 0.491 | 1.1e-122 | |
| TAIR|locus:2195850 | 890 | AT1G51860 [Arabidopsis thalian | 0.307 | 0.320 | 0.477 | 2.5e-121 | |
| TAIR|locus:2078191 | 838 | AT3G46420 [Arabidopsis thalian | 0.300 | 0.332 | 0.471 | 6.7e-119 | |
| TAIR|locus:2066158 | 884 | AT2G28990 [Arabidopsis thalian | 0.471 | 0.494 | 0.372 | 4.2e-117 | |
| TAIR|locus:2078171 | 883 | AT3G46400 [Arabidopsis thalian | 0.304 | 0.319 | 0.470 | 5.3e-117 | |
| TAIR|locus:2066163 | 872 | AT2G29000 [Arabidopsis thalian | 0.304 | 0.323 | 0.466 | 7.7e-116 |
| TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3398 (1201.2 bits), Expect = 0., P = 0.
Identities = 653/928 (70%), Positives = 752/928 (81%)
Query: 8 LVIYLLFLSS-VVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGN 66
L + LFL V+SQVTEF+SIDCG +SNYTDP TGL W+SD I+ GK V + N + N
Sbjct: 8 LAVTCLFLVPFVLSQVTEFVSIDCGCSSNYTDPRTGLGWVSDSEIIKQGKPVTLANTNWN 67
Query: 67 WMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWST 126
MQYR RRD P DNKKYCY L TKERRRY+VR TF YG LGSE +YPKFQLYLDAT W+T
Sbjct: 68 SMQYRRRRDFPTDNKKYCYRLSTKERRRYIVRTTFLYGGLGSEEAYPKFQLYLDATKWAT 127
Query: 127 VTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFL 186
VT+ + SRVY +E+I+RA S +DVC+CCA+TGSPF+STLELRPLNLSMYATD+EDNFFL
Sbjct: 128 VTIQEVSRVYVEELIVRATSSYVDVCVCCAITGSPFMSTLELRPLNLSMYATDYEDNFFL 187
Query: 187 KVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTRE 246
KVAARVNFGA DALRYPDDPYDRIW+SD+++RPN++VG A GT RINT+K I T TRE
Sbjct: 188 KVAARVNFGAPNMDALRYPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLTRE 247
Query: 247 YPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFAD 306
YPP+KVMQTAVVGT+G++SYRLNLEDFPANARA+AYFAEI++LG +ETRKFKL QPYF D
Sbjct: 248 YPPMKVMQTAVVGTQGLISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPD 307
Query: 307 YSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIA 366
YSNAVVNIAENANGSYTLYEPSYMNVTL+FVL+FSF KT+DST GPLLNAIEISKY I+
Sbjct: 308 YSNAVVNIAENANGSYTLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPIS 367
Query: 367 AKTEWQD----EALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLK 422
KT+ D +A+RS+S +S+ ++ GDPC+PV W WV CS+T+PPR+TKIALS KNL+
Sbjct: 368 VKTDRSDVSVLDAIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNLR 427
Query: 423 GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 482
GEIPP + MEALTELWLD N LTG LPDMS+L++L+I+HLENN+L+GSLP Y+ LPNL
Sbjct: 428 GEIPPGINYMEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLPNL 487
Query: 483 QELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSXXXXXXXXXX 542
QEL IENNSF G+IP ALL GKV+FKY+NNP+L E++R+ F ILG S
Sbjct: 488 QELSIENNSFKGKIPSALLKGKVLFKYNNNPELQNEAQRK-HFWQILGISIAAVAILLLL 546
Query: 543 XXXXXXXXRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPEL 602
LR+ K +K DS T K AYS RGGH +DEGVAYFI LP L
Sbjct: 547 VGGSLVLLCALRKT----KRADKGDSTETKKK-GLVAYSAVRGGHLLDEGVAYFISLPVL 601
Query: 603 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN 662
EEAT+NF KK+G+GSFGSVYYG+MKDGKEVAVKI AD SH +QFVTEVALLSRIHHRN
Sbjct: 602 EEATDNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRN 661
Query: 663 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
LVPLIGYCEE +RILVYEYMHNG+L D LHGS + KPLDWLTRLQIA DAAKGLEYLHT
Sbjct: 662 LVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYLHT 721
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
GCNP IIHRDVKSSNILLDINMRAKVSDFGLSRQ EEDLTH+SSVA+GTVGYLDPEYY +
Sbjct: 722 GCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYAS 781
Query: 783 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842
QQLTEKSDVYSFGVVL EL+SGKKPVS EDFG ELNIVHWARS+I+KGDV I+DP +
Sbjct: 782 QQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGIIDPCIAS 841
Query: 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEXXXXX---XXXXXXXXXX 899
NVKIES+WR+AEVA QCVEQRG +RP+MQE+++AIQD+I+IE
Sbjct: 842 NVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIERGNENGLKSSSSSSSKAQ 901
Query: 900 XXRKTLLTSFLEIESPDLSNECLAPAAR 927
RKTLLTSFLE+ESPD+S LAPAAR
Sbjct: 902 SSRKTLLTSFLELESPDISRNSLAPAAR 929
|
|
| TAIR|locus:2057991 AT2G37050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2098 (743.6 bits), Expect = 3.5e-217, P = 3.5e-217
Identities = 427/884 (48%), Positives = 569/884 (64%)
Query: 8 LVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNW 67
LV LF SS +Q F+S+DCG +TD GL W D ++ G++ + + +
Sbjct: 12 LVSTCLFTSSS-AQAPGFVSLDCGGAEPFTD-ELGLKWSPDNHLIY-GETANISSVNETR 68
Query: 68 MQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSL-GSEASYPKFQLYLDATLWST 126
QY T R P D++KYCY L R RYL+RATF YG+ S YPKF + L AT W+T
Sbjct: 69 TQYTTLRHFPADSRKYCYTLNVTSRNRYLIRATFLYGNFDNSNNVYPKFDISLGATHWAT 128
Query: 127 VTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDF-EDNFF 185
+ + + + E++ A S ++ VC+ A TG PFISTLELR L+ SMY + ED F+
Sbjct: 129 IVISETYIIETAELVFLASSPTVSVCLSNATTGQPFISTLELRQLSGSMYGSMLSEDRFY 188
Query: 186 LKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTR 245
L VAAR+NFGA ++ ++RYPDDPYDRIW+SDL ++PN++V A+GTVR++TT IE+R
Sbjct: 189 LSVAARINFGAESEASVRYPDDPYDRIWESDLQKKPNYLVDVAAGTVRVSTTLPIESRVD 248
Query: 246 EYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFA 305
+ PP KVMQTAVVGT G L+YR+NL+ FP AF YFAEI+DL E+RKF+L P
Sbjct: 249 DRPPQKVMQTAVVGTNGSLTYRMNLDGFPGFGWAFTYFAEIEDLAEDESRKFRLVLPEQP 308
Query: 306 DYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKY-QK 364
+YS +VVNI EN Y +Y P Y N+TL FVL+F F KT DS+ GP+LNA+EISKY +K
Sbjct: 309 EYSKSVVNIKENTQRPYRVYAPGYPNITLPFVLNFRFAKTADSSRGPILNAMEISKYLRK 368
Query: 365 IAAKTEWQDEA-LRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKG 423
+ A + S+ +E + GDPC P PW WV C++ PR+ I LS NL G
Sbjct: 369 SDGSVDATVMANVASLYSSTEWAQEGGDPCSPSPWSWVQCNSDPQPRVVAIKLSSMNLTG 428
Query: 424 EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 483
IP +L + L ELWLDGN TGP+PD SR +L I+HLENN LTG +PS + LPNL+
Sbjct: 429 NIPSDLVKLTGLVELWLDGNSFTGPIPDFSRCPNLEIIHLENNRLTGKIPSSLTKLPNLK 488
Query: 484 ELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSXXXXXXXXXXX 543
EL+++NN G IP L VI + N L K + + +I+G S
Sbjct: 489 ELYLQNNVLTGTIPSDLAKD-VISNFSGNLNLEKSGDKGKKLGVIIGASVGAFVLLIATI 547
Query: 544 XXXXXXXRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELE 603
+ + + S E + + S+T S A G A+ L E+E
Sbjct: 548 ISCIVMCKSKKNNKLGKTSAELTNRPLPIQRVSSTL-SEAHGD------AAHCFTLYEIE 600
Query: 604 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL 663
EAT F K+IG G FG VYYGK ++GKE+AVK++A++ ++F EV LLSRIHHRNL
Sbjct: 601 EATKKFEKRIGSGGFGIVYYGKTREGKEIAVKVLANNSYQGKREFANEVTLLSRIHHRNL 660
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHT 722
V +GYC+EE + +LVYE+MHNGTL++ L+G V + + W+ RL+IA DAA+G+EYLHT
Sbjct: 661 VQFLGYCQEEGKNMLVYEFMHNGTLKEHLYGVVPRDRRISWIKRLEIAEDAARGIEYLHT 720
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
GC P IIHRD+K+SNILLD +MRAKVSDFGLS+ A + +H+SS+ RGTVGYLDPEYY +
Sbjct: 721 GCVPAIIHRDLKTSNILLDKHMRAKVSDFGLSKFAVDGTSHVSSIVRGTVGYLDPEYYIS 780
Query: 783 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSMIKKGDVISIVDPVLI 841
QQLTEKSDVYSFGV+LLEL+SG++ +S E FG NIV WA+ I GD+ I+DP L
Sbjct: 781 QQLTEKSDVYSFGVILLELMSGQEAISNESFGVNCRNIVQWAKMHIDNGDIRGIIDPALA 840
Query: 842 -GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884
+ ++S+W+IAE A+ CV+ G RP M E+ IQD+I+IE
Sbjct: 841 EDDYSLQSMWKIAEKALLCVKPHGNMRPSMSEVQKDIQDAIRIE 884
|
|
| TAIR|locus:2055165 AT2G14510 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 658 (236.7 bits), Expect = 4.5e-124, Sum P(2) = 4.5e-124
Identities = 132/284 (46%), Positives = 187/284 (65%)
Query: 601 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 660
E++E TNNF +GKG FG VY+G + + ++VAVK+++ S + ++F TEV LL R+HH
Sbjct: 557 EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHH 615
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
NLV L+GYC+E L+YE+M NG L++ L G L+W +RL+IA ++A G+EYL
Sbjct: 616 VNLVSLVGYCDEGIDLALIYEFMENGNLKEHLSGKRGGSVLNWSSRLKIAIESALGIEYL 675
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 779
H GC P ++HRDVKS+NILL + AK++DFGLSR H+S+ GT+GYLDPEY
Sbjct: 676 HIGCQPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQAHVSTNVAGTLGYLDPEY 735
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839
Y LTEKSDVYSFG+VLLE I+G+ PV +E + IV WA+SM+ GD+ SI+DP
Sbjct: 736 YLKNWLTEKSDVYSFGIVLLESITGQ-PV-IEQSRDKSYIVEWAKSMLANGDIESIMDPN 793
Query: 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883
L + S W+ E+A+ C+ RP M + + + ++I
Sbjct: 794 LHQDYDSSSSWKALELAMLCINPSSTQRPNMTRVAHELNECLEI 837
|
|
| TAIR|locus:2055160 AT2G14440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 654 (235.3 bits), Expect = 1.5e-123, Sum P(2) = 1.5e-123
Identities = 131/284 (46%), Positives = 188/284 (66%)
Query: 601 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 660
E++E TNNF +GKG FG VY+G + + ++VAVK+++ S + ++F TEV LL R+HH
Sbjct: 575 EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHH 633
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
NLV L+GYC++ + L+YE+M NG L++ L G L+W RL+IA ++A G+EYL
Sbjct: 634 VNLVSLVGYCDKGNDLALIYEFMENGNLKEHLSGKRGGPVLNWPGRLKIAIESALGIEYL 693
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 779
H GC P ++HRDVKS+NILL + AK++DFGLSR TH+S+ GT+GYLDPEY
Sbjct: 694 HIGCKPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQTHVSTNVAGTLGYLDPEY 753
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839
Y LTEKSDVYSFG+VLLE+I+G+ PV +E + IV WA+SM+ GD+ SI+D
Sbjct: 754 YQKNWLTEKSDVYSFGIVLLEIITGQ-PV-IEQSRDKSYIVEWAKSMLANGDIESIMDRN 811
Query: 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883
L + S W+ E+A+ C+ RP M + + + ++I
Sbjct: 812 LHQDYDTSSSWKALELAMLCINPSSTLRPNMTRVAHELNECLEI 855
|
|
| TAIR|locus:2028446 AT1G49100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 720 (258.5 bits), Expect = 1.1e-122, Sum P(2) = 1.1e-122
Identities = 140/285 (49%), Positives = 192/285 (67%)
Query: 601 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 660
E+ E TNNF +GKG FG VY+G + ++VAVK+++ + H +QF EV LL R+HH
Sbjct: 575 EVTEMTNNFRSVLGKGGFGMVYHGYVNGREQVAVKVLSHASKHGHKQFKAEVELLLRVHH 634
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
+NLV L+GYCE+ + LVYEYM NG L++ G L W TRLQIA +AA+GLEYL
Sbjct: 635 KNLVSLVGYCEKGKELALVYEYMANGDLKEFFSGKRGDDVLRWETRLQIAVEAAQGLEYL 694
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 779
H GC P I+HRDVK++NILLD + +AK++DFGLSR E +H+S+V GT+GYLDPEY
Sbjct: 695 HKGCRPPIVHRDVKTANILLDEHFQAKLADFGLSRSFLNEGESHVSTVVAGTIGYLDPEY 754
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839
Y LTEKSDVYSFGVVLLE+I+ ++ + E + +I W MI KGD+ IVDP
Sbjct: 755 YRTNWLTEKSDVYSFGVVLLEIITNQRVI--ERTREKPHIAEWVNLMITKGDIRKIVDPN 812
Query: 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884
L G+ +S+W+ E+A+ CV +RP M ++V + + + +E
Sbjct: 813 LKGDYHSDSVWKFVELAMTCVNDSSATRPTMTQVVTELTECVTLE 857
|
|
| TAIR|locus:2195850 AT1G51860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 693 (249.0 bits), Expect = 2.5e-121, Sum P(2) = 2.5e-121
Identities = 138/289 (47%), Positives = 191/289 (66%)
Query: 597 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLS 656
I PE+ + TNNF + +GKG FG+VY+G + DG EVAVK+++ S + ++F EV LL
Sbjct: 574 ITYPEVLKMTNNFERVLGKGGFGTVYHGNL-DGAEVAVKMLSHSSAQGYKEFKAEVELLL 632
Query: 657 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 716
R+HHR+LV L+GYC++ L+YEYM NG LR+ + G L W R+QIA +AA+G
Sbjct: 633 RVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGKRGGNVLTWENRMQIAVEAAQG 692
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYL 775
LEYLH GC P ++HRDVK++NILL+ AK++DFGLSR D H+S+V GT GYL
Sbjct: 693 LEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYL 752
Query: 776 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835
DPEYY L+EKSDVYSFGVVLLE+++ + PV ++ +I W M+ KGD+ SI
Sbjct: 753 DPEYYRTNWLSEKSDVYSFGVVLLEIVTNQ-PV-IDKTRERPHINDWVGFMLTKGDIKSI 810
Query: 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884
VDP L+G+ W+I E+A+ CV RP M +V+ + D + +E
Sbjct: 811 VDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVMELNDCVALE 859
|
|
| TAIR|locus:2078191 AT3G46420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 688 (247.2 bits), Expect = 6.7e-119, Sum P(2) = 6.7e-119
Identities = 133/282 (47%), Positives = 184/282 (65%)
Query: 604 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL 663
+ TNNF + +G+G FG VY+G + ++VAVK+++ S ++F EV LL R+HH NL
Sbjct: 528 DMTNNFQRALGEGGFGVVYHGYLNGSEQVAVKLLSQSSVQGYKEFKAEVELLLRVHHINL 587
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
V L+GYC++ + LVYEYM NG L+ L G N L W TRLQIA DAA GLEYLH G
Sbjct: 588 VSLVGYCDDRNHLALVYEYMSNGDLKHHLSGRNNGFVLSWSTRLQIAVDAALGLEYLHIG 647
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGN 782
C P ++HRDVKS+NILL AK++DFGLSR + D HIS+V GT GYLDPEYY
Sbjct: 648 CRPSMVHRDVKSTNILLGEQFTAKMADFGLSRSFQIGDENHISTVVAGTPGYLDPEYYRT 707
Query: 783 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842
+L EKSD+YSFG+VLLE+I+ + +++ + +I W S+I +GD+ I+DP L G
Sbjct: 708 SRLAEKSDIYSFGIVLLEMITSQH--AIDRTRVKHHITDWVVSLISRGDITRIIDPNLQG 765
Query: 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884
N S+WR E+A+ C RP M ++V+ +++ + E
Sbjct: 766 NYNSRSVWRALELAMSCANPTSEKRPNMSQVVIDLKECLATE 807
|
|
| TAIR|locus:2066158 AT2G28990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 746 (267.7 bits), Expect = 4.2e-117, Sum P(2) = 4.2e-117
Identities = 169/454 (37%), Positives = 256/454 (56%)
Query: 435 LTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 493
+ L L + L G +P + L+ + L NN LTG +P ++ ++ L +++ N+
Sbjct: 407 IISLDLSKSGLNGSIPQILQNFTQLQELDLSNNSLTGPVPIFLANMKTLSLINLSGNNLS 466
Query: 494 GEIPPALLTGK---VIFKYDNNPKLHKES--RRRMRFKLILGTSXXXXXXXXXXXXXXXX 548
G +P ALL + ++ K + NP L K S + K +L
Sbjct: 467 GSVPQALLDKEKEGLVLKLEGNPDLCKSSFCNTEKKNKFLLPVIASAASLVIVVVVVALF 526
Query: 549 XXRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN 608
R+K ++ + S+ S P + + S + F + + + E++E TNN
Sbjct: 527 FV--FRKKKASPSNLHAPPSMPVSN-PGHNSQSESS---FTSKKIRF--TYSEVQEMTNN 578
Query: 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
F K +G+G FG VY+G + ++VAVK+++ S S + F EV LL R+HH NLV L+G
Sbjct: 579 FDKALGEGGFGVVYHGFVNVIEQVAVKLLSQSSSQGYKHFKAEVELLMRVHHINLVSLVG 638
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
YC+E L+YEYM NG L+ L G L W +RL+I DAA GLEYLHTGC P +
Sbjct: 639 YCDEGEHLALIYEYMPNGDLKQHLSGKHGGFVLSWESRLKIVLDAALGLEYLHTGCVPPM 698
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTE 787
+HRD+K++NILLD +++AK++DFGLSR + ++S+V GT GYLDPEYY LTE
Sbjct: 699 VHRDIKTTNILLDQHLQAKLADFGLSRSFPIGNEKNVSTVVAGTPGYLDPEYYQTNWLTE 758
Query: 788 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 847
KSD+YSFG+VLLE+IS + P+ ++ + +IV W MI KGD+ SI+DP L + I
Sbjct: 759 KSDIYSFGIVLLEIISNR-PI-IQQSREKPHIVEWVSFMITKGDLRSIMDPNLHQDYDIG 816
Query: 848 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881
S+W+ E+A+ CV RP M +V +++ +
Sbjct: 817 SVWKAIELAMSCVSLSSARRPNMSRVVNELKECL 850
|
|
| TAIR|locus:2078171 AT3G46400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 692 (248.7 bits), Expect = 5.3e-117, Sum P(2) = 5.3e-117
Identities = 134/285 (47%), Positives = 184/285 (64%)
Query: 601 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 660
E+ E T F K +G+G FG VY+G +K+ ++VAVK+++ S S + F EV LL R+HH
Sbjct: 570 EVVEMTKKFEKALGEGGFGIVYHGYLKNVEQVAVKVLSQSSSQGYKHFKAEVELLLRVHH 629
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
NLV L+GYC+E+ L+YEYM NG L+D L G L+W TRLQIA D A GLEYL
Sbjct: 630 INLVSLVGYCDEKDHLALIYEYMPNGDLKDHLSGKQGDSVLEWTTRLQIAVDVALGLEYL 689
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYLDPEY 779
H GC P ++HRDVKS+NILLD AK++DFGLSR + D + IS+V GT GYLDPEY
Sbjct: 690 HYGCRPSMVHRDVKSTNILLDDQFMAKIADFGLSRSFKVGDESEISTVVAGTPGYLDPEY 749
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839
Y +L E SDVYSFG+VLLE+I+ ++ + +++I W M+ +GD+ IVDP
Sbjct: 750 YRTSRLAEMSDVYSFGIVLLEIITNQRVF--DQARGKIHITEWVAFMLNRGDITRIVDPN 807
Query: 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884
L G S+WR E+A+ C RP M ++V+ +++ + E
Sbjct: 808 LHGEYNSRSVWRAVELAMSCANPSSEYRPNMSQVVIELKECLTTE 852
|
|
| TAIR|locus:2066163 AT2G29000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 673 (242.0 bits), Expect = 7.7e-116, Sum P(2) = 7.7e-116
Identities = 133/285 (46%), Positives = 185/285 (64%)
Query: 601 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 660
E+E TN F + IG+G FG VY+G + D ++VAVK+++ S + +QF EV LL R+HH
Sbjct: 559 EVEAVTNKFERVIGEGGFGIVYHGHLNDTEQVAVKLLSHSSTQGYKQFKAEVELLLRVHH 618
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
NLV L+GYC EE LVYEY NG L+ L G + L+W +RL IA + A+GLEYL
Sbjct: 619 TNLVNLVGYCNEEDHLALVYEYAANGDLKQHLSGESSSAALNWASRLGIATETAQGLEYL 678
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEY 779
H GC P +IHRDVK++NILLD + AK++DFGLSR + +H+S+ GT GYLDPEY
Sbjct: 679 HIGCEPPMIHRDVKTTNILLDEHFHAKLADFGLSRSFPVGVESHVSTNVAGTPGYLDPEY 738
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839
Y LTEKSDVYS G+VLLE+I+ + PV ++ + +I W M+ KGD+ SI+DP
Sbjct: 739 YRTNWLTEKSDVYSMGIVLLEIITNQ-PV-IQQVREKPHIAEWVGLMLTKGDIKSIMDPK 796
Query: 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884
L G S+W+ E+A+ CV RP M +++ +++ + E
Sbjct: 797 LNGEYDSSSVWKALELAMSCVNPSSGGRPTMSQVISELKECLIYE 841
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGI2 | Y1677_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7204 | 0.9892 | 0.9870 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00100504 | hypothetical protein (934 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 927 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 3e-90 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-52 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-39 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-35 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-32 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-32 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-29 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-29 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-28 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-28 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-27 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-27 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-26 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-25 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-24 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-23 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-20 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-20 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-15 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-14 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.003 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 289 bits (742), Expect = 3e-90
Identities = 134/355 (37%), Positives = 185/355 (52%), Gaps = 40/355 (11%)
Query: 28 IDCGSTSN--YTDPSTGLAWISDIGIMNNGKSVKV-ENPSGNWM--QYRTRRDLPIDNKK 82
IDCG SN YTDPSTG+ W+SD G ++ GKS + + S +++ Y+T R P D K+
Sbjct: 1 IDCGLPSNESYTDPSTGITWVSDAGFIDTGKSGNISKENSSSFLSKPYKTLRSFP-DGKR 59
Query: 83 YCYNL--ITKERRRYLVRATFQYGS---LGSEASYPKFQLYLDATLWSTV-TVLDASRVY 136
CY L + +YL+RATF YG+ L S +S P F LYL LW+TV D+
Sbjct: 60 NCYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSFDLYLGVNLWTTVNLSNDSGDSV 119
Query: 137 AKEMIIRAP-SDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFG 195
KE II SD++ VC+ TG+PFIS LELRPL S+Y + + LK+ AR+NFG
Sbjct: 120 VKEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYPSSG-GSQALKLVARLNFG 178
Query: 196 ALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNI---ETRTREYPPVKV 252
++ +RYPDD YDRIW+ + G +I+T+ ++ PP V
Sbjct: 179 G-SEGTIRYPDDVYDRIWEPFFS---------SPGWSQISTSLSVDISSNNAPYIPPSAV 228
Query: 253 MQTAVVGTEGVLSYRL--NLEDFPANARAFAYFAEIQDLGPSETRKFKL---EQPYFADY 307
+QTAV T +L D + +FAEIQ L ETR+F + + + D
Sbjct: 229 LQTAVTPTNASAPLNFTWDLVDPNFEYYVYLHFAEIQSL---ETREFDIYINGKTVYGDV 285
Query: 308 SNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKY 362
S + LY +NV+ +L+ S V T STL PLLNA+EI K
Sbjct: 286 S-----PKYLGTDTGALYLDFPVNVSGGGLLNISLVPTSGSTLPPLLNALEIFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 4e-53
Identities = 73/207 (35%), Positives = 115/207 (55%), Gaps = 13/207 (6%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 662
KK+G+G+FG VY G +K E VAVK + + S ++ F+ E +++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 663 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
+V L+G C + +V EYM G L D L + + L LQ+A AKG+EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR--KHGEKLTLKDLLQMALQIAKGMEYLE- 119
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV-ARGTVGYLDPEYYG 781
+ +HRD+ + N L+ N+ K+SDFGLSR ED + + + ++ PE
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 782 NQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ + T KSDV+SFGV+L E+ + G++P
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 2e-52
Identities = 77/193 (39%), Positives = 113/193 (58%), Gaps = 10/193 (5%)
Query: 613 IGKGSFGSVYYGK-MKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 670
+G+G FG+VY + K GK+VA+KI+ + S ++ + E+ +L +++H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 671 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 730
E+E+ LV EY G+L+D L N+ L L+I +GLEYLH + GIIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 731 RDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQQLTEK 788
RD+K NILLD N + K++DFGLS+ D + GT Y+ PE G +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 789 SDVYSFGVVLLEL 801
SD++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 3e-52
Identities = 74/206 (35%), Positives = 113/206 (54%), Gaps = 11/206 (5%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGK-----EVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 662
KK+G+G+FG VY G +K EVAVK + + S + + F+ E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 663 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
+V L+G C EE ++V EYM G L D L + K L L A A+G+EYL +
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLES 121
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
IHRD+ + N L+ N+ K+SDFGLSR +D + + + ++ PE
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 783 QQLTEKSDVYSFGVVLLELIS-GKKP 807
+ T KSDV+SFGV+L E+ + G++P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 6e-52
Identities = 74/206 (35%), Positives = 113/206 (54%), Gaps = 12/206 (5%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGK-----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRN 662
KK+G+G+FG VY GK+K EVAVK + + S + ++F+ E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 663 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
+V L+G C EE +V EYM G L L N+ L L A A+G+EYL +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLES 120
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
IHRD+ + N L+ N+ K+SDFGLSR +D + + + ++ PE
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 783 QQLTEKSDVYSFGVVLLELIS-GKKP 807
+ T KSDV+SFGV+L E+ + G++P
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 5e-48
Identities = 70/199 (35%), Positives = 105/199 (52%), Gaps = 10/199 (5%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
+K+G+GSFG VY + K GK VA+K++ ++ + E+ +L ++ H N+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
E+E + LV EY G L D L + L LEYLH + GI
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLH---SKGI 118
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
+HRD+K NILLD + K++DFGL+RQ + + V GT Y+ PE + +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV--GTPEYMAPEVLLGKGYGKA 176
Query: 789 SDVYSFGVVLLELISGKKP 807
D++S GV+L EL++GK P
Sbjct: 177 VDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 6e-48
Identities = 75/210 (35%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 611 KKIGKGSFGSVYYGKMKDGK----EVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVP 665
KK+G+G+FG VY GK+K EVAVK + + S + F+ E ++ ++ H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRL------HGSVNQKPLDWLTRLQIAHDAAKGLEY 719
L+G C EE LV EYM G L D L S + L L A AKG+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT-VGYLDPE 778
L + +HRD+ + N L+ ++ K+SDFGLSR +D + + ++ PE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 779 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ T KSDV+SFGV+L E+ + G P
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 82/203 (40%), Positives = 112/203 (55%), Gaps = 15/203 (7%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIM----ADSCSHRTQQFVTEVALLSRIHHRNLVP 665
+K+G GSFG+VY K K GK VAVKI+ S + Q E+ +L R+ H N+V
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSK--KDQTARREIRILRRLSHPNIVR 62
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
LI E++ LV EY G L D L PL +IA +GLEYLH +
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---S 116
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQ 784
GIIHRD+K NILLD N K++DFGL+++ + + +++ GT Y+ PE G
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNG 175
Query: 785 LTEKSDVYSFGVVLLELISGKKP 807
K DV+S GV+L EL++GK P
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 16/205 (7%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 667
+ +G+GSFGSVY KD G+ +AVK + S + E+ +LS + H N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 668 G-YCEEEHQRILVY-EYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
G +EE + ++ EY+ G+L L G + + + TR QI GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTR-QILE----GLAYLH-- 118
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGN 782
+ GI+HRD+K +NIL+D + K++DFG +++ + + + RGT ++ PE
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 783 QQLTEKSDVYSFGVVLLELISGKKP 807
++ +D++S G ++E+ +GK P
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 74/201 (36%), Positives = 112/201 (55%), Gaps = 14/201 (6%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
+KIGKG FG VY + K GKEVA+K++ + ++ + E+ +L + H N+V G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 726
++ + +V E+ G+L+D L + NQ LT QIA + KGLEYLH +
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKST-NQT----LTESQIAYVCKELLKGLEYLH---SN 117
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 786
GIIHRD+K++NILL + K+ DFGLS Q + + V GT ++ PE +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYD 175
Query: 787 EKSDVYSFGVVLLELISGKKP 807
K+D++S G+ +EL GK P
Sbjct: 176 YKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-35
Identities = 125/487 (25%), Positives = 210/487 (43%), Gaps = 45/487 (9%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 467
+ ++ LS L GEIP EL + + L L L N L+G +P S + L + L N+
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558
Query: 468 LTGSLPSYMGSLPNLQELHIENNSFVGEIPP--ALL-------TGKVIFKYDNNPKLHKE 518
L+G +P +G++ +L +++I +N G +P A L G + +
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPP 618
Query: 519 SRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNT 578
+R + L LVL L + + R K E D
Sbjct: 619 CKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWEL------ 672
Query: 579 AYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIM 637
F D V+ I + ++ + I +G G+ Y GK +K+G + VK +
Sbjct: 673 --------QFFDSKVSKSITINDILSSLKEE-NVISRGKKGASYKGKSIKNGMQFVVKEI 723
Query: 638 ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVN 697
D S + +E+A + ++ H N+V LIG C E L++EY+ L + L
Sbjct: 724 NDVNSIPS----SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--- 776
Query: 698 QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757
L W R +IA AK L +LH C+P ++ ++ I++D + L
Sbjct: 777 ---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832
Query: 758 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 817
D S A Y+ PE + +TEKSD+Y FG++L+EL++GK P E FG
Sbjct: 833 CTDTKCFISSA-----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE-FGVHG 886
Query: 818 NIVHWARSMIKKGDVISIVDPVLIGNVKIES--IWRIAEVAIQCVEQRGFSRPKMQEIVL 875
+IV WAR + +DP + G+V + I + +A+ C +RP +++
Sbjct: 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946
Query: 876 AIQDSIK 882
++ + +
Sbjct: 947 TLESASR 953
|
Length = 968 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 75/216 (34%), Positives = 105/216 (48%), Gaps = 38/216 (17%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLI 667
K+IGKGSFG VY + K DGK +K + S + + EV +L +++H N+ I
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI---I 62
Query: 668 GYCE--EEHQRIL-VYEYMHNGTLRDRLHGSVNQKP----------LDWLTRLQIAHDAA 714
Y E EE ++ V EY G L ++ QK LDW Q+
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIK---KQKKEGKPFPEEQILDWFV--QLC---- 113
Query: 715 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG- 773
L+YLH+ I+HRD+K NI L N K+ DFG+S+ L+ +A+ VG
Sbjct: 114 LALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKV----LSSTVDLAKTVVGT 166
Query: 774 --YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
YL PE N+ KSD++S G VL EL + K P
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 69/196 (35%), Positives = 110/196 (56%), Gaps = 11/196 (5%)
Query: 613 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 672
IGKG FG V G + G++VAVK + D S Q F+ E ++++ + H NLV L+G +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 673 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRD 732
+ +V EYM G+L D L S + + +L A D +G+EYL +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLR-SRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRD 127
Query: 733 VKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVY 792
+ + N+L+ ++ AKVSDFGL+++A + + V + PE ++ + KSDV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQD----SGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 793 SFGVVLLELIS-GKKP 807
SFG++L E+ S G+ P
Sbjct: 184 SFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 72/208 (34%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
K +G+GS G VY + K GK A+K I D +Q + E+ L +V G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 669 -YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
+ +E I V EYM G+L D L G + + L ++ R QI GL+YLHT +
Sbjct: 67 AFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAYIAR-QILK----GLDYLHTKRH 120
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGY-----LDPEY 779
IIHRD+K SN+L++ K++DFG+S+ E L + V GTV Y + E
Sbjct: 121 --IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV--GTVTYMSPERIQGES 176
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKP 807
Y +D++S G+ LLE GK P
Sbjct: 177 YSY-----AADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-32
Identities = 138/578 (23%), Positives = 232/578 (40%), Gaps = 68/578 (11%)
Query: 14 FLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTR 73
L+S+ S + I CG+ N T W D G PS +T
Sbjct: 14 VLASLASPEPFTMRISCGARVNVRTAPTNTLWYKDFA-YTGGIPANATRPSFIAPPLKTL 72
Query: 74 RDLPI-DNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATL-------WS 125
R P+ D + CYN+ + Y VR F + + S P F + ++ T WS
Sbjct: 73 RYFPLSDGPENCYNINRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWS 132
Query: 126 TVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMY--ATDFEDN 183
+ +V+A E ++ S +C G P I ++E+ ++ Y +
Sbjct: 133 S----HDEQVFA-EALVFLTDGSASICFHSTGHGDPAILSIEILQVDDKAYNFGPSWGQG 187
Query: 184 FFLKVAARVNFGA-LTKDALRYPDDPY--DRIWDSDLDRRPNFVVGAASGTVRINTTKNI 240
L+ A R++ GA +K Y D + DR W+ F G+ N K
Sbjct: 188 VILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRM----QTFGSGSDQAISTENVIKKA 243
Query: 241 ETRTREYPPVKVMQTAVVGTEGV--LSYRLNLEDFP-ANARAFAYFAEI-QDLGPSETRK 296
YP + Q+A+V T+ LSY ++++ P N + +FAEI + R
Sbjct: 244 SNAPNFYPE-SLYQSALVSTDTQPDLSYTMDVD--PNRNYSVWLHFAEIDNSITAEGKRV 300
Query: 297 FKL---EQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNF---VLSFSFVKTRDSTL 350
F + F D V+I + + YT +N T+ L+ + +
Sbjct: 301 FDVLINGDTAFKD-----VDIVKMSGERYTAL---VLNKTVAVSGRTLTIVLQPKKGTH- 351
Query: 351 GPLLNAIEISKYQKIAAKTEWQDEALRSISDESE------RTNDRGDPCVPV--PWEWVT 402
++NAIE+ ++ I A+++ E + ++ R GDPCVP PW
Sbjct: 352 -AIINAIEV--FEIITAESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGAD 408
Query: 403 C---STTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDL 458
C ST I + L + L+G IP ++ + L + L GN + G +P + + L
Sbjct: 409 CQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSL 468
Query: 459 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL---LTGKVIFKYDNNPKL 515
++ L N GS+P +G L +L+ L++ NS G +P AL L + F + +N L
Sbjct: 469 EVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGL 528
Query: 516 -----HKESRRRMRFKLILGTSIGVLAILLVLFLCSLI 548
+ + +G + GV L L +C++
Sbjct: 529 CGIPGLRACGPHLSVGAKIGIAFGVSVAFLFLVICAMC 566
|
Length = 623 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 71/201 (35%), Positives = 107/201 (53%), Gaps = 17/201 (8%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVP 665
+KIGKG+FG VY G +K EVAVK +C ++F+ E +L + H N+V
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVK----TCRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
LIG C ++ +V E + G+L L N+ + L LQ++ DAA G+EYL +
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKL--LQMSLDAAAGMEYLESKN- 113
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDPEYYGNQ 783
IHRD+ + N L+ N K+SDFG+SR+ EE + S + + PE
Sbjct: 114 --CIHRDLAARNCLVGENNVLKISDFGMSRE-EEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 784 QLTEKSDVYSFGVVLLELISG 804
+ T +SDV+S+G++L E S
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 128 bits (321), Expect = 7e-32
Identities = 75/218 (34%), Positives = 114/218 (52%), Gaps = 18/218 (8%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRI-HHRNL 663
+K+G+GSFG VY + D K VA+K++A +S S ++F+ E+ +L+ + H N+
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
V L + ++E LV EY+ G+L D L + PL L I LEYLH+
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 724 CNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTH-----ISSVARGTVGYLDP 777
GIIHRD+K NILLD + K+ DFGL++ + + + S + GT GY+ P
Sbjct: 121 ---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 778 EYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
E + SD++S G+ L EL++G P E
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 609 FCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHR 661
F K++G+G FG V + G++VAVK + S HR+ F E+ +L + H
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-FEREIEILRTLDHE 66
Query: 662 NLVPLIGYCEEEHQRI--LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 719
N+V G CE+ R L+ EY+ +G+LRD L +Q ++ L + KG++Y
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDY 124
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDP 777
L + IHRD+ + NIL++ K+SDFGL++ ED + G + + P
Sbjct: 125 LG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 778 EYYGNQQLTEKSDVYSFGVVLLELIS 803
E + + SDV+SFGV L EL +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 612 KIGKGSFGSVYYG-KMKDGKEVAVK--IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
IG+G+FG VY G ++ G VA+K + + + E+ LL + H N+V IG
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCN 725
E ++ EY NG+LR + K +A + +GL YLH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQII------KKFGPFPESLVAVYVYQVLQGLAYLH---E 117
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 785
G+IHRD+K++NIL + K++DFG++ + + +SV GT ++ PE
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-GTPYWMAPEVIEMSGA 176
Query: 786 TEKSDVYSFGVVLLELISGKKP 807
+ SD++S G ++EL++G P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 608 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 666
+KIG+G+ G VY + GKEVA+K M + + E+ ++ H N+V
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 667 IG-YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 722
Y + +V EYM G+L D + Q + + QIA + +GLEYLH+
Sbjct: 81 YDSYLVGDEL-WVVMEYMDGGSLTD----IITQNFVR-MNEPQIAYVCREVLQGLEYLHS 134
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
+IHRD+KS NILL + K++DFG + Q ++ + +SV GT ++ PE
Sbjct: 135 Q---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKR 190
Query: 783 QQLTEKSDVYSFGVVLLELISGKKP 807
+ K D++S G++ +E+ G+ P
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 68/200 (34%), Positives = 108/200 (54%), Gaps = 7/200 (3%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
F K++G G FG V+ GK + +VA+K++ + + F+ E ++ ++ H NLV L G
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
C ++ +V EYM NG L + L + +WL L + D + +EYL +
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---F 121
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
IHRD+ + N L+ + KVSDFGL+R +D S + V + PE + + + K
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 789 SDVYSFGVVLLELIS-GKKP 807
SDV+SFGV++ E+ S GK P
Sbjct: 182 SDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 72/225 (32%), Positives = 110/225 (48%), Gaps = 34/225 (15%)
Query: 609 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVT-EVALLSRI-HHRNL 663
F K IG+GSF +V K K KE A+KI+ + ++V E +L+R+ H +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
+ L ++E V EY NG L R +GS+++K TR A + LEYLH
Sbjct: 65 IKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK----CTRF-YAAEILLALEYLH 119
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFG---------LSRQAEEDLTHISSVAR--- 769
+ GIIHRD+K NILLD +M K++DFG + D T+I S
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 770 -------GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
GT Y+ PE + + SD+++ G ++ ++++GK P
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 6/202 (2%)
Query: 601 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 659
E+E K+G G +G VY G K VAVK + + + ++F+ E A++ I
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 60
Query: 660 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 719
H NLV L+G C E ++ E+M G L D L N++ ++ + L +A + +EY
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 119
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 779
L IHRD+ + N L+ N KV+DFGLSR D + A+ + + PE
Sbjct: 120 LEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176
Query: 780 YGNQQLTEKSDVYSFGVVLLEL 801
+ + KSDV++FGV+L E+
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 65/199 (32%), Positives = 106/199 (53%), Gaps = 6/199 (3%)
Query: 610 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
+K+G G FG V+ G K+ VA+KI+ + Q F EV L R+ H++L+ L
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 729
C ++ E M G+L L S + L + + +A A+G+ YL I
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSI 126
Query: 730 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 789
HRD+ + NIL+ ++ KV+DFGL+R +ED+ ++SS + + PE + + KS
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHGTFSTKS 185
Query: 790 DVYSFGVVLLELIS-GKKP 807
DV+SFG++L E+ + G+ P
Sbjct: 186 DVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 71/201 (35%), Positives = 109/201 (54%), Gaps = 9/201 (4%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
F K++G G FG V YGK + +VA+K++ + S +F+ E ++ ++ H LV L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
C ++ +V EYM NG L + L K L++ D +G+ YL +
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQF 121
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV-ARGTVGYLDPEYYGNQQLTE 787
IHRD+ + N L+D KVSDFGLSR +D + SSV ++ V + PE + +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 788 KSDVYSFGVVLLELIS-GKKP 807
KSDV++FGV++ E+ S GK P
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 71/206 (34%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 613 IGKGSFGSVYYGKMKD-GKEVAVKIM--ADSCSHRTQQFV-TEVALLSRIHHRNLVPLIG 668
+GKGSFG V + KD GK A+K++ + + TE +LSRI+H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 669 YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
+ E + LV EY G L L G +++ R A + LEYLH +
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE----RARFYAA-EIVLALEYLH---SL 112
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 786
GII+RD+K NILLD + K++DFGL+++ + + ++ GT YL PE +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYG 171
Query: 787 EKSDVYSFGVVLLELISGKKPVSVED 812
+ D +S GV+L E+++GK P ED
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAED 197
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 70/218 (32%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVK-----IMADSCSHRTQQFVTEVALLSRIHHRNLV 664
+ IGKGSFG+V + K DGK + K M QQ V+EV +L + H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT---EKEKQQLVSEVNILRELKHPNIV 62
Query: 665 PLIGYCEEEH----QRI-LVYEYMHNGTLRDRL-HGSVNQKPLD----WLTRLQIAHDAA 714
Y + Q + +V EY G L + +K ++ W Q+
Sbjct: 63 ---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL--- 116
Query: 715 KGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 772
L H +PG ++HRD+K +NI LD N K+ DFGL++ L H SS A+ V
Sbjct: 117 -ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK----ILGHDSSFAKTYV 171
Query: 773 G---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
G Y+ PE + EKSD++S G ++ EL + P
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 69/201 (34%), Positives = 107/201 (53%), Gaps = 12/201 (5%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 670
+K+G G FG V+ G +VAVK + + + F+ E ++ ++ H LV L C
Sbjct: 12 RKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 671 EEEHQRILVYEYMHNGTLRDRLH-GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 729
EE +V EYM G+L D L G + L L + +A A+G+ YL + I
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL--VDMAAQIAEGMAYLES---RNYI 125
Query: 730 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--YYGNQQLTE 787
HRD+ + NIL+ N+ K++DFGL+R E+D A+ + + PE YG T
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR--FTI 183
Query: 788 KSDVYSFGVVLLELIS-GKKP 807
KSDV+SFG++L E+++ G+ P
Sbjct: 184 KSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 64/204 (31%), Positives = 110/204 (53%), Gaps = 12/204 (5%)
Query: 611 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVP 665
K IG G FG V G++ K +VA+K + S + + F+TE +++ + H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
L G + +++ EYM NG+L L N + + A G++YL
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYL---SE 124
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQ 784
+HRD+ + NIL++ N+ KVSDFGLSR+ E+ + T+ + + + + PE ++
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 785 LTEKSDVYSFGVVLLELIS-GKKP 807
T SDV+SFG+V+ E++S G++P
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 7e-28
Identities = 70/219 (31%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 661
+++G+G+FG V+ G+ + VAVK + ++ S+ ++ F E LL+ H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 662 NLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG------SVNQKPLDWLTR---LQIA 710
N+V G C E I+V+EYM +G L R HG P+ LT LQIA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 711 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVAR 769
A G+ YL + +HRD+ + N L+ ++ K+ DFG+SR D +
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 770 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ ++ PE ++ T +SDV+SFGVVL E+ + GK+P
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 72/203 (35%), Positives = 115/203 (56%), Gaps = 23/203 (11%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 670
+ IG+G FG+V G+ G++VAVK + C Q F+ E A+++++HH+NLV L+G
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 671 EEEHQRI-LVYEYMHNGTL----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
H + +V E M G L R R V+ L LQ + D A+G+EYL +
Sbjct: 69 L--HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQL-----LQFSLDVAEGMEYLES--- 118
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 785
++HRD+ + NIL+ + AKVSDFGL+R + + ++ V + PE +++
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN----SKLPVKWTAPEALKHKKF 174
Query: 786 TEKSDVYSFGVVLLELIS-GKKP 807
+ KSDV+S+GV+L E+ S G+ P
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 67/203 (33%), Positives = 109/203 (53%), Gaps = 13/203 (6%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
++IG G FG V+ G + ++VA+K + + + + F+ E ++ ++ H LV L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLH---GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
C E LV+E+M +G L D L G +Q+ L L + D +G+ YL +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN- 120
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 785
+IHRD+ + N L+ N KVSDFG++R +D S+ + V + PE + +
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 786 TEKSDVYSFGVVLLELIS-GKKP 807
+ KSDV+SFGV++ E+ S GK P
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 23/270 (8%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
F K++G G FG V+ GK + +VA+K + + + + F+ E ++ ++ H LV L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
C ++ +V E+M NG L + L + D L L + D +G+EYL
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERN---SF 121
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
IHRD+ + N L+ KVSDFG++R +D SS A+ V + PE + + + K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 789 SDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 847
SDV+SFGV++ E+ + GK P + + +V MI +G + P L
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKK---SNYEVV----EMISRGF--RLYRPKLASMT--- 229
Query: 848 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 877
+ EV C ++ RP E++ AI
Sbjct: 230 ----VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 75/233 (32%), Positives = 117/233 (50%), Gaps = 30/233 (12%)
Query: 597 IPLPELEEATNNFCKKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQ-FV 649
IPL + F +++G+G+FG VY G+ VA+K + ++ + QQ F
Sbjct: 2 IPLSAVR-----FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR 56
Query: 650 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVN------- 697
E L+S + H N+V L+G C +E +++EY+ +G L + L H V
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116
Query: 698 -QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756
+ LD L IA A G+EYL + +HRD+ + N L+ + K+SDFGLSR
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRD 173
Query: 757 A-EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
D + S + V ++ PE + T +SD++SFGVVL E+ S G +P
Sbjct: 174 IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 68/197 (34%), Positives = 109/197 (55%), Gaps = 13/197 (6%)
Query: 613 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 672
IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G E
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 673 EHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 731
E + +V EYM G+L D L S + L L+ + D + +EYL +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHR 126
Query: 732 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 791
D+ + N+L+ + AKVSDFGL+++A + + V + PE ++ + KSDV
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 792 YSFGVVLLELIS-GKKP 807
+SFG++L E+ S G+ P
Sbjct: 183 WSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 611 KKIGKGSFGSVYYG-KMKDGKEVAVKIMA--DSCSHRTQQFVTEVALLSRIHHRNLVPLI 667
KIG G+FG VY + G+ +AVK + D+ ++ E+ +L + H NLV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 668 GYCEEEHQRILVY-EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
G E +++ ++ EY GTL + L + LD +GL YLH+
Sbjct: 66 G-VEVHREKVYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGNQ 783
GI+HRD+K +NI LD N K+ DFG + + + + T + + G Y+ PE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 784 QLTEK---SDVYSFGVVLLELISGKKP 807
+ +D++S G V+LE+ +GK+P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 64/220 (29%), Positives = 119/220 (54%), Gaps = 25/220 (11%)
Query: 613 IGKGSFGSVYY------GKMKDGKEVAV-KIMADSCSHRTQQFV----TEVALLSRIHHR 661
IGKG++G VY G+M K+V + +A R + V +E+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 662 NLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEY 719
N+V +G+ E + EY+ G++ R +G ++ + + T Q+ +GL Y
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-QVL----EGLAY 123
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-RGTVGYLDPE 778
LH + GI+HRD+K+ N+L+D + K+SDFG+S+++++ + +++ +G+V ++ PE
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 779 YYGNQQ--LTEKSDVYSFGVVLLELISGKKPVS-VEDFGA 815
+ + K D++S G V+LE+ +G++P S E A
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 75/218 (34%), Positives = 112/218 (51%), Gaps = 20/218 (9%)
Query: 613 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLVPL 666
+G GSFGSVY G + DG AVK + Q+ V E+ALLS++ H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
+G EE + E + G+L L +GS + + TR QI GLEYLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QIL----LGLEYLH--- 119
Query: 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 784
+ +HRD+K +NIL+D N K++DFG+++Q E + S +G+ ++ PE Q
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE-FSFAKSF-KGSPYWMAPEVIAQQG 177
Query: 785 L-TEKSDVYSFGVVLLELISGKKPVS-VEDFGAELNIV 820
+D++S G +LE+ +GK P S +E A I
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG 215
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 73/209 (34%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 611 KKIGKGSFGSVYYG--KMKDGKE--VAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 665
K++G G+FGSV G MK GKE VAVK + ++F+ E ++++++ H +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
LIG C+ E +LV E G L L + L ++AH A G+ YL
Sbjct: 61 LIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLE-S 113
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE--Y 779
+ +HRD+ + N+LL +AK+SDFG+SR A D ++ R + + PE
Sbjct: 114 KH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 780 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
YG + + KSDV+S+GV L E S G KP
Sbjct: 172 YG--KFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 71/216 (32%), Positives = 113/216 (52%), Gaps = 24/216 (11%)
Query: 611 KKIGKGSFGSVYYGKMK--DGK--EVAVKIM-ADSCSHR-TQQFVTEVALLSRIHHRNLV 664
K +G+G FGSV G++ DG +VAVK M D ++ ++F++E A + H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 665 PLIGYC--EEEHQRI----LVYEYMHNGTLRD-----RLHGSVNQKPLDWLTRLQIAHDA 713
LIG C Q+I ++ +M +G L RL G + PL L + + D
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV--DI 122
Query: 714 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 772
A G+EYL N IHRD+ + N +L +M V+DFGLS++ D +A+ V
Sbjct: 123 ALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 773 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
++ E ++ T KSDV++FGV + E+ + G+ P
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 19/213 (8%)
Query: 611 KKIGKGSFGSVYYGKMK---DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPL 666
++G G+ G V K+ GK +AVK + + +Q + E+ +L + + +V
Sbjct: 7 GELGAGNSGVVS--KVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
G + EYM G+L L + P L ++ +A KGL YLH
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA--VLKGLTYLHE--KH 120
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQ 783
IIHRDVK SNIL++ + K+ DFG+S Q ++S+A+ GT Y+ PE
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL------VNSLAKTFVGTSSYMAPERIQGN 174
Query: 784 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 816
+ KSD++S G+ L+EL +G+ P E+ +
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPD 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 70/219 (31%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 600 PELEEATNNFCKKIGKGSFGSVYYGKM--KDGK----EVAVKIMADSCSHRTQQ-FVTEV 652
PE+ + + +G G+FG VY G +DG +VAVK + +SCS + + F+ E
Sbjct: 1 PEVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA 60
Query: 653 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS----VNQKPLDWLTRLQ 708
++S+ +H+N+V LIG E R ++ E M G L+ L + L L
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 709 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQA-EEDLTHI 764
A D AKG +YL IHRD+ + N LL AK++DFG++R
Sbjct: 121 CARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177
Query: 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 803
A + ++ PE + + T K+DV+SFGV+L E+ S
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 14/210 (6%)
Query: 603 EEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALLSR 657
EE F +++GKG+FGSV Y ++D G+ VAVK + S + + F E+ +L
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS 61
Query: 658 IHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 715
+ H N+V G C +R LV EY+ G+LRD L +++ LD L A K
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICK 119
Query: 716 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVG 773
G+EYL + +HRD+ + NIL++ R K+ DFGL++ +D + + +
Sbjct: 120 GMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176
Query: 774 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS 803
+ PE + + SDV+SFGVVL EL +
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 6/208 (2%)
Query: 601 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 660
E++ + +K+G G FG V+ G + VAVK + + + F+ E ++ ++ H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRH 60
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
L+ L C E +V E M G+L + L G + L + +A A G+ YL
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYL 119
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 780
IHRD+ + N+L+ N KV+DFGL+R +ED+ A+ + + PE
Sbjct: 120 EA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAA 176
Query: 781 GNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ + KSDV+SFG++L E+++ G+ P
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 72/213 (33%), Positives = 112/213 (52%), Gaps = 27/213 (12%)
Query: 613 IGKGSFGSVYYG-KMKDGKEVAVK------IMADSCSHRT---QQFVTEVALLSRIHHRN 662
IG GSFGSVY G G+ +AVK + A S + E+ALL + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 663 LVPLIG-YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 719
+V +G + +H I + EY+ G++ L +G+ + + R QI KGL Y
Sbjct: 68 IVQYLGSSLDADHLNIFL-EYVPGGSVAALLNNYGAFEETLVRNFVR-QIL----KGLNY 121
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-----RGTVGY 774
LH N GIIHRD+K +NIL+D K+SDFG+S++ E + + +G+V +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 775 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
+ PE T K+D++S G +++E+++GK P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 611 KKIGKGSFGSVYYGKMKDG------KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 664
KKIG+GSFG +Y K K KE+ + M +++ EV LL+++ H N+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIV 62
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRL---HGSV--NQKPLDWLTRLQIAHDAAKGLEY 719
+E + +V EY G L R+ G + + L W ++ + GL++
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKH 116
Query: 720 LHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 778
+H + I+HRD+KS NI L N M AK+ DFG++RQ D ++ GT YL PE
Sbjct: 117 IH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPE 172
Query: 779 YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
N+ K+D++S G VL EL + K P
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 78/272 (28%), Positives = 133/272 (48%), Gaps = 29/272 (10%)
Query: 611 KKIGKGSFGSVYYG--KMKDGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVP 665
K IG G FG V+ G KM KEVAV I + Q F++E +++ + H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
L G + +++ EYM NG L L + + + A G++YL +
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYL---SD 125
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYYGNQ 783
+HRD+ + NIL++ N+ KVSDFGLSR E+D T+ +S + + + PE +
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 784 QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842
+ T SDV+SFG+V+ E++S G++P +W S +V+ ++
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERP-------------YWDMS---NHEVMKAINDGFRL 229
Query: 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 874
++ + ++ +QC +Q RP+ +IV
Sbjct: 230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIV 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 11/209 (5%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVP 665
+ IG G+ VY E VA+K + + C + EV +S+ +H N+V
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
+ LV Y+ G+L D + S + LD + + KGLEYLH+
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN-- 121
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEYYG 781
G IHRD+K+ NILL + K++DFG+S + + R GT ++ PE
Sbjct: 122 -GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG-GDRTRKVRKTFVGTPCWMAPEVME 179
Query: 782 NQQ-LTEKSDVYSFGVVLLELISGKKPVS 809
K+D++SFG+ +EL +G P S
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 29/210 (13%)
Query: 612 KIGKGSFGSVYYGKMKDGKEV-AVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
++G+G+ GSV ++K+ + A+K I D +Q + E+ + +V G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 670 CEEEHQRIL--VYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYL 720
+E + EY G+L D ++ V +K L +IA KGL YL
Sbjct: 68 FLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVL-----GKIAESVLKGLSYL 121
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDP 777
H+ IIHRD+K SNILL + K+ DFG+S + ++S+A GT Y+ P
Sbjct: 122 HS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL------VNSLAGTFTGTSFYMAP 172
Query: 778 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
E + + SDV+S G+ LLE+ + P
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 67/206 (32%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 611 KKIGKGSFGSVYYGKMKD--GK--EVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVP 665
KK+G GSFG V G+ GK VAVK + +D S F+ E A++ + H NL+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL-QIAHDAAKGLEYLHTGC 724
L G H ++V E G+L DRL + ++ L A A G+ YL +
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLRK--DALGHFLISTLCDYAVQIANGMRYLES-- 115
Query: 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV--GYLDPEYYGN 782
IHRD+ + NILL + + K+ DFGL R ++ H V + PE
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 783 QQLTEKSDVYSFGVVLLELIS-GKKP 807
+ + SDV+ FGV L E+ + G++P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 611 KKIGKGSFGSVYYGKMKDGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 665
+ IG+G FG VY G + VAVK + S ++F+ E ++ + H ++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
LIG E I V E G LR L VN+ LD + + ++ + L YL +
Sbjct: 72 LIGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES--- 125
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 785
+HRD+ + N+L+ K+ DFGLSR E++ + +S + + ++ PE ++
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 786 TEKSDVYSFGVVLLELIS-GKKP 807
T SDV+ FGV + E++ G KP
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 64/198 (32%), Positives = 107/198 (54%), Gaps = 12/198 (6%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIG 668
++IG+G+FG V+ G+++ D VAVK ++ + +F+ E +L + H N+V LIG
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPG 727
C ++ +V E + G L + P L +Q+ +AA G+EYL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLESKH--- 114
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVGYLDPEYYGNQQL 785
IHRD+ + N L+ K+SDFG+SR+ EED + S+ + + V + PE +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 786 TEKSDVYSFGVVLLELIS 803
+ +SDV+SFG++L E S
Sbjct: 174 SSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 72/262 (27%), Positives = 128/262 (48%), Gaps = 21/262 (8%)
Query: 613 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIGYCE 671
+GKG+FG V+ G +KD VAVK + + +F++E +L + H N+V LIG C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 672 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 731
+ +V E + G L ++ L + + DAA G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL--DAAAGMAYLES---KNCIHR 117
Query: 732 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 791
D+ + N L+ N K+SDFG+SRQ ++ + S + + + + PE + + +SDV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 792 YSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 851
+S+G++L E S + V + N AR ++KG +S + +++
Sbjct: 178 WSYGILLWETFS----LGVCPYPGMTN--QQAREQVEKGYRMSCPQKC------PDDVYK 225
Query: 852 IAEVAIQCVEQRGFSRPKMQEI 873
+ + +C + + +RPK E+
Sbjct: 226 VMQ---RCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 15/202 (7%)
Query: 612 KIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 670
K+G+GS+GSVY + G+ VA+K++ Q+ + E+++L + +V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 671 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNPG 727
+ +V EY G++ D + + K L T +IA + KGLEYLH +
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIM--KITNKTL---TEEEIAAILYQTLKGLEYLH---SNK 119
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 787
IHRD+K+ NILL+ +AK++DFG+S Q + + ++V GT ++ PE
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNN 178
Query: 788 KSDVYSFGVVLLELISGKKPVS 809
K+D++S G+ +E+ GK P S
Sbjct: 179 KADIWSLGITAIEMAEGKPPYS 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 77/275 (28%), Positives = 135/275 (49%), Gaps = 35/275 (12%)
Query: 611 KKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVP 665
K IG G FG V G++K +E+ V I + +Q F++E +++ + H N++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 722
L G + ++V EYM NG+L L Q T +Q+ A G++YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-----FTVIQLVGMLRGIASGMKYL-- 122
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYY 780
+ G +HRD+ + NIL++ N+ KVSDFGLSR E+D + + + + + PE
Sbjct: 123 -SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
Query: 781 GNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839
++ T SDV+S+G+V+ E++S G++P +W S DVI ++
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERP-------------YWEMS---NQDVIKAIEEG 225
Query: 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 874
++ + ++ + C ++ RPK ++IV
Sbjct: 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 14/217 (6%)
Query: 599 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEV 652
L L+E K +G G+FG+VY G E VA+K++ + S + + + E
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEA 60
Query: 653 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 712
+++ + H ++V L+G C Q L+ + M G L D + ++ + L
Sbjct: 61 YVMASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQ 117
Query: 713 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGT 771
AKG+ YL ++HRD+ + N+L+ K++DFGL++ + D + +
Sbjct: 118 IAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174
Query: 772 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ ++ E ++ T KSDV+S+GV + EL++ G KP
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 38/214 (17%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF-VT---EVALLSRIHHRNLVP 665
+IG+G++G VY + K G+ VA+K + + + F +T E+ LL ++ H N+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 666 LIGYCEEEHQR--ILVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEY 719
L + + +V+EYM H+ T L S K T QI +GL+Y
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLT---GLLDSPEVK----FTESQIKCYMKQLLEGLQY 115
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG-------TV 772
LH + GI+HRD+K SNIL++ + K++DFGL+R + T+
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLAR-------PYTKRNSADYTNRVITL 165
Query: 773 GYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 805
Y PE G + + D++S G +L EL GK
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 22/209 (10%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNLV 664
K +G+G+FG VY D G+E+AVK + + E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 665 PLIGYCEEEHQRILVY-EYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
G C + + + ++ EYM G+++D + +G++ + TR QI G+EYLH
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-QILE----GVEYLH 121
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDPE 778
+ I+HRD+K +NIL D K+ DFG S++ + T + SV GT ++ PE
Sbjct: 122 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSPE 177
Query: 779 YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
+ K+DV+S G ++E+++ K P
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 66/199 (33%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 613 IGKGSFGSVYYGKMKDGKEV-AVKIMADS-C--SHRTQQFVTEVALLSRIHHRNLVPLIG 668
IGKG+FG V + +D K++ A+K M C + + E +L ++H LV L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
++E LV + + G LR H S K + + I + LEYLH + GI
Sbjct: 68 SFQDEENMYLVVDLLLGGDLR--YHLSQKVKFSEEQVKFWIC-EIVLALEYLH---SKGI 121
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
IHRD+K NILLD ++DF ++ + D T +S + GT GY+ PE Q +
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTS-GTPGYMAPEVLCRQGYSVA 179
Query: 789 SDVYSFGVVLLELISGKKP 807
D +S GV E + GK+P
Sbjct: 180 VDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 10/208 (4%)
Query: 612 KIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ--FVTEVALLSRIHHRNLVPLIG 668
KIGKGSFG V+ K K V A+K + S +R ++ + E +L+++ ++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
++ + +V EY NG L L + P D + R I GL +LH+
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QILLGLAHLHSK---K 121
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 787
I+HRD+KS N+ LD K+ D G+++ D T+ ++ GT YL PE ++ E
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 788 KSDVYSFGVVLLELISGKKPVSVEDFGA 815
KSDV++ GVVL E +GK P + GA
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGA 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 611 KKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
++IG G++G VY + G+ VA+K++ + E+++L H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNP 726
+ +V EY G+L+D V + PL + LQIA+ + KGL YLH
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQ--VTRGPL---SELQIAYVCRETLKGLAYLH---ET 120
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLDPEYYG 781
G IHRD+K +NILL + K++DFG+S Q LT ++A+ GT ++ PE
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQ----LTA--TIAKRKSFIGTPYWMAPEVAA 174
Query: 782 NQQL---TEKSDVYSFGVVLLELISGKKPVS 809
++ K D+++ G+ +EL + P+
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMF 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 7e-23
Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 18/206 (8%)
Query: 613 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRNLVPLI 667
IGKG FG VY+G + D + S + T +QF+ E ++ H N++ L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 668 GYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR--LQIAHDAAKGLEYLHTGC 724
G C E ++V YM +G LR+ + + + L LQ+A KG+EYL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVA----KGMEYL---A 115
Query: 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPEYYG 781
+ +HRD+ + N +LD + KV+DFGL+R E H + A+ V ++ E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 782 NQQLTEKSDVYSFGVVLLELISGKKP 807
Q+ T KSDV+SFGV+L EL++ P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 7e-23
Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 611 KKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 664
+++G+G+FG V+ + +D VAVK + D+ + + F E LL+ + H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS-----VNQKPLDWLTR---LQIAHDAA 714
G C E I+V+EYM +G L R HG LT+ L IA A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 715 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVG 773
G+ YL + +HRD+ + N L+ N+ K+ DFG+SR D + +
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 774 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
++ PE ++ T +SDV+S GVVL E+ + GK+P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 70/216 (32%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 613 IGKGSFGSVYYGKMK-DGKEVAVKIM--AD-SCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
I KG++G V+ K K G A+K++ AD ++ Q +TE +LS+ +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
+ + LV EY+ G L L +V D R+ IA + LEYLH + GI
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDV-ARIYIA-EIVLALEYLH---SNGI 114
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQ--------AEEDLTHISSVARGTVGYLDPEYY 780
IHRD+K NIL+D N K++DFGLS+ +D + GT Y+ PE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAPEVI 173
Query: 781 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 816
Q ++ D +S G +L E + G P F E
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPP-----FHGE 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 2e-22
Identities = 71/235 (30%), Positives = 107/235 (45%), Gaps = 47/235 (20%)
Query: 609 FCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHR 661
+ + IG+G+FG V+ + + VAVK++ + S Q F E AL++ H
Sbjct: 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 662 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL------------HGSV-------NQKPLD 702
N+V L+G C L++EYM G L + L H + N PL
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 703 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ------ 756
+L IA A G+ YL +HRD+ + N L+ NM K++DFGLSR
Sbjct: 129 CTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 757 ---AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+E D I ++ PE + T +SDV+++GVVL E+ S G +P
Sbjct: 186 YKASENDAIPIR--------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 8/209 (3%)
Query: 601 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 660
E+ + KK+G G FG V+ G + +VAVK + + Q F+ E L+ + H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQH 60
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL-QIAHDAAKGLEY 719
LV L +E ++ EYM G+L D L K L L +L + A+G+ Y
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL--LPKLIDFSAQIAEGMAY 118
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 779
+ IHRD++++N+L+ ++ K++DFGL+R E++ A+ + + PE
Sbjct: 119 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175
Query: 780 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
T KSDV+SFG++L E+++ GK P
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 601 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 660
E+ T KK+G G FG V+ G +VA+K + S + F+ E L+ ++ H
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQH 60
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
LV L +E I + EYM NG+L D L K L + +A A+G+ ++
Sbjct: 61 PRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFI 118
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 780
IHRD++++NIL+ + K++DFGL+R E++ A+ + + PE
Sbjct: 119 ER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 781 GNQQLTEKSDVYSFGVVLLELIS-GKKP 807
T KSDV+SFG++L E+++ G+ P
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 17/209 (8%)
Query: 613 IGKGSFGSVYYGKMK----DGKE--VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVP 665
+G+G FG V+ K K +G E V VK + + Q F E+ + ++ H+N+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGS------VNQKPLDWLTRLQIAHDAAKGLEY 719
L+G C E ++ EY G L+ L + + PL ++ + A G+++
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 779
L +HRD+ + N L+ KVS LS+ + A + +L PE
Sbjct: 133 LSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 780 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ KSDV+SFGV++ E+ + G+ P
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 33/218 (15%)
Query: 613 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG-- 668
IG+G++G VY + K G+ VA+KIM D ++ E +L + +H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 669 ----YCEEEHQRILVYEYMHNGTLRD---RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
+ Q LV E G++ D L + +W+ I + +GL YLH
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA--YILRETLRGLAYLH 130
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 776
+IHRD+K NILL N K+ DFG+S Q + S++ R GT ++
Sbjct: 131 ---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD------STLGRRNTFIGTPYWMA 181
Query: 777 PE-----YYGNQQLTEKSDVYSFGVVLLELISGKKPVS 809
PE + +SDV+S G+ +EL GK P+
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 5e-22
Identities = 68/204 (33%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 666
++IG GSFG+VY+ + ++ + VA+K M+ S Q + EV L ++ H N +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
G EH LV EY G+ D L V++KPL + I H A +GL YLH+
Sbjct: 81 KGCYLREHTAWLVMEYCL-GSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLHSHER- 136
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY---YGNQ 783
IHRD+K+ NILL K++DFG + + + GT ++ PE
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEG 189
Query: 784 QLTEKSDVYSFGVVLLELISGKKP 807
Q K DV+S G+ +EL K P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 5e-22
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 24/218 (11%)
Query: 611 KKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 664
+++G+G+FG V+ + KD VAVK + D + F E LL+ + H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS-----VNQKP------LDWLTRLQIAH 711
G C + I+V+EYM +G L R HG V+ +P L L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 712 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARG 770
A G+ YL + +HRD+ + N L+ N+ K+ DFG+SR D +
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 771 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ ++ PE ++ T +SDV+SFGV+L E+ + GK+P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 8e-22
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 23/216 (10%)
Query: 612 KIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 665
++G+G+FG V+ + +D VAVK + ++ Q F E LL+ + H+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRD--RLHG----------SVNQKPLDWLTRLQIAHDA 713
G C E ++V+EYM +G L R HG V L L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 714 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 772
A G+ YL + +HRD+ + N L+ + K+ DFG+SR D + +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 773 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
++ PE ++ T +SD++SFGVVL E+ + GK+P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 9e-22
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 608 NFCKKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 666
NF KIG+GS G V G++VAVK M R + EV ++ H N+V +
Sbjct: 23 NF-VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 722
+ +V E++ G L D + H +N++ QIA K L +LH
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--------QIATVCLAVLKALSFLHA 133
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
G+IHRD+KS +ILL + R K+SDFG Q +++ S+ GT ++ PE
Sbjct: 134 ---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISR 189
Query: 783 QQLTEKSDVYSFGVVLLELISGKKP 807
+ D++S G++++E++ G+ P
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 610 CKKIGKGSFGSVYYGKMKD-GKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 667
+ IGKGSFG VY K + VA+K++ + + E+ LS+ +
Sbjct: 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
G + + ++ EY G+ D L LD I + GLEYLH G
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH---EEG 118
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGNQQ 784
IHRD+K++NILL K++DFG+S Q LT S VG ++ PE
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQ----LTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 785 LTEKSDVYSFGVVLLELISGKKPVS 809
EK+D++S G+ +EL G+ P+S
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLS 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 67/229 (29%), Positives = 115/229 (50%), Gaps = 25/229 (10%)
Query: 601 ELEEATNNFCKKIGKGSFGSVYYGK-----MKDGKEVAVKIMAD-SCSHRTQQFVTEVAL 654
EL + F +++G+ +FG +Y G M + VA+K + D + + +F E +L
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 655 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVN---------QKP 700
++ +HH N+V L+G +E +++EY++ G L + L H V +
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 701 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EE 759
LD L IA A G+EYL + +H+D+ + NIL+ + K+SD GLSR+
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 760 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
D + + + ++ PE + + SD++SFGVVL E+ S G +P
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 2e-21
Identities = 77/235 (32%), Positives = 115/235 (48%), Gaps = 19/235 (8%)
Query: 581 SIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMAD 639
S +R G D +A + E+ + ++IG GSFG+VY+ + ++ + VA+K M+
Sbjct: 2 STSRAGSLKDPEIAELFFKEDPEKLFTDL-REIGHGSFGAVYFARDVRTNEVVAIKKMSY 60
Query: 640 SCSHRT---QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV 696
S Q + EV L RI H N + G EH LV EY G+ D L V
Sbjct: 61 SGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE--V 117
Query: 697 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756
++KPL + I H A +GL YLH+ +IHRD+K+ NILL + K++DFG +
Sbjct: 118 HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI 174
Query: 757 AEEDLTHISSVARGTVGYLDPEY---YGNQQLTEKSDVYSFGVVLLELISGKKPV 808
A + + GT ++ PE Q K DV+S G+ +EL K P+
Sbjct: 175 ASPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 65/205 (31%), Positives = 114/205 (55%), Gaps = 15/205 (7%)
Query: 613 IGKGSFGSVYYGKMK-DGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLI 667
IG G FG V G++K GK VA+K + + + ++ F++E +++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
G + +++ E+M NG L L + Q + L + + A G++YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL--VGMLRGIAAGMKYL---SEMN 126
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVA-RGTVGYLDPEYYGNQ 783
+HRD+ + NIL++ N+ KVSDFGLSR E+ D T+ SS+ + + + PE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 784 QLTEKSDVYSFGVVLLELIS-GKKP 807
+ T SDV+S+G+V+ E++S G++P
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 66/223 (29%), Positives = 111/223 (49%), Gaps = 33/223 (14%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ----FVTEVALLSRIHHRNLVP 665
KK+GKGS+GSVY K + D + A+K + +Q+ V E+ +L+ ++H N+
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEV--DLGSMSQKEREDAVNEIRILASVNHPNI-- 61
Query: 666 LIGYCE---EEHQRILVYEYMHNGTLRDRLHGSVNQKPL-----DWLTRLQIAHDAAKGL 717
I Y E + ++ +V EY G L + ++ L W +Q+ +GL
Sbjct: 62 -ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGL 116
Query: 718 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL--THISSVARGTVGYL 775
+ LH I+HRD+KS+NILL N K+ D G+S+ ++++ T I GT Y+
Sbjct: 117 QALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-----GTPHYM 168
Query: 776 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 818
PE + + + KSD++S G +L E+ + P +L
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-QDLR 210
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 612 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ-----QFVTEVALLSRIHHRNLVP 665
+IG+G+ G V+ K + G+ VA+K + R + Q + E+ L H +V
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKV---ALRRLEGGIPNQALREIKALQACQHPYVVK 63
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEYLHT 722
L+ +LV EYM L + L ++PL Q+ KG+ Y+H
Sbjct: 64 LLDVFPHGSGFVLVMEYM-PSDLSEVLRDE--ERPL---PEAQVKSYMRMLLKGVAYMH- 116
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 781
GI+HRD+K +N+L+ + K++DFGL+R E+ + S T Y PE YG
Sbjct: 117 --ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 782 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 820
++ D+++ G + EL++G E+ +L IV
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV 213
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 613 IGKGSFGS-VYYGKMKDGKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLIGY 669
+GKG+FG Y + +D V K + S + ++ E+ +LS + H N++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH--DAAKGLEYLHTGCNPG 727
+++ ++ EY + GTL D++ V QK + + + + + Y+H G
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---G 121
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 787
I+HRD+K+ NI L K+ DFG+S+ + + +V GT Y+ PE +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYNF 180
Query: 788 KSDVYSFGVVLLELISGKK 806
KSD+++ G VL EL++ K+
Sbjct: 181 KSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-21
Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 7/198 (3%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 670
KK+G G FG V+ G +VAVK + + + F+ E ++ ++ H LV L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 671 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 730
EE I V EYM G+L D L + L + +A A G+ Y+ IH
Sbjct: 71 SEEPIYI-VTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 731 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 790
RD++S+NIL+ + K++DFGL+R E++ A+ + + PE + T KSD
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 791 VYSFGVVLLELIS-GKKP 807
V+SFG++L EL++ G+ P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 4e-21
Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 612 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 671
K+G+G FG V+ G +VA+K + + + F+ E ++ ++ H LVPL
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 672 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 731
EE I V E+M G+L D L + K L + +A A G+ Y+ IHR
Sbjct: 72 EEPIYI-VTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 732 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 791
D++++NIL+ N+ K++DFGL+R E++ A+ + + PE + T KSDV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 792 YSFGVVLLELIS-GKKP 807
+SFG++L EL++ G+ P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 5e-21
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 612 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 671
K+G+G FG V+ G VA+K + + + F+ E ++ ++ H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 672 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 731
EE I V EYM G+L D L G + K L + +A A G+ Y+ +HR
Sbjct: 72 EEPIYI-VTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 732 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 791
D++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T KSDV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 792 YSFGVVLLELIS-GKKP 807
+SFG++L EL + G+ P
Sbjct: 187 WSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 7e-21
Identities = 69/232 (29%), Positives = 113/232 (48%), Gaps = 33/232 (14%)
Query: 598 PLPELEEATNNFCKKIGKGSFGSVYYG------KMKDGKEVAVKIM-ADSCSHRTQQFVT 650
P EL K +G+G+FG V + VAVK++ D+ V+
Sbjct: 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS 64
Query: 651 EVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQK-------- 699
E+ ++ I H+N++ L+G C +E +V EY +G LRD R +
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 700 PLDWLTR---LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756
P + LT+ + A+ A+G+E+L + IHRD+ + N+L+ + K++DFGL+R
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLAR- 180
Query: 757 AEEDLTHISSVARGTVGYLD-----PEYYGNQQLTEKSDVYSFGVVLLELIS 803
D+ HI + T G L PE ++ T +SDV+SFGV+L E+ +
Sbjct: 181 ---DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 9e-21
Identities = 75/224 (33%), Positives = 111/224 (49%), Gaps = 27/224 (12%)
Query: 600 PELEEATNNFCKKIGKGSFGSVYYGKM-KDG--KEVAVKIMADSCS---HRTQQFVTEVA 653
P LE F IG+G+FG V ++ KDG + A+K M + S HR F E+
Sbjct: 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELE 59
Query: 654 LLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS----------VNQKPLD 702
+L ++ HH N++ L+G CE L EY +G L D L S +
Sbjct: 60 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119
Query: 703 WLTRLQIAH---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759
L+ Q+ H D A+G++YL IHRD+ + NIL+ N AK++DFGLSR E
Sbjct: 120 TLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176
Query: 760 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 803
+ ++ R V ++ E T SDV+S+GV+L E++S
Sbjct: 177 YVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 27/211 (12%)
Query: 613 IGKGSFGSVYYGKMK-DGKEV--AVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLI 667
IG+G+FG V +K DG ++ A+K++ + S + F E+ +L ++ HH N++ L+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 668 GYCEEEHQRILVYEYMHNGTLRD---------------RLHGSVNQKPLDWLTRLQIAHD 712
G CE + EY G L D + HG+ + L LQ A D
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST--LTSQQLLQFASD 127
Query: 713 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 772
A G++YL IHRD+ + N+L+ N+ +K++DFGLSR E++ ++ R V
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG--EEVYVKKTMGRLPV 182
Query: 773 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 803
++ E T KSDV+SFGV+L E++S
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 613 IGKGSFGSVYYGKMKDGKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHHRNLVPL 666
+GKG++G+VY G G+ +AVK + + ++ EV LL + H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
+G C +++ + E++ G++ L+ G + + T+ QI G+ YLH C
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QIL----DGVAYLHNNC 122
Query: 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTH--ISSVARGTVGYLDPEY 779
++HRD+K +N++L N K+ DFG +R+ TH + GT ++ PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
KSD++S G + E+ +GK P++ D
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 68/276 (24%), Positives = 126/276 (45%), Gaps = 31/276 (11%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ------FVTEVALLSRIHHRNL 663
+++G G+F S Y + +K G +AVK + + ++Q E+ L++R++H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 664 VPLIG-YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
+ ++G CE+ H + V E+M G++ L + +GL YLH
Sbjct: 66 IRMLGATCEDSHFNLFV-EWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLH- 120
Query: 723 GCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLT---HISSVARGTVGYLDPE 778
IIHRDVK +N+L+D R +++DFG + + T GT+ ++ PE
Sbjct: 121 --ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 779 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838
+Q DV+S G V++E+ + K P + E L ++ S + + P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238
Query: 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 874
L +V ++C+E + RP +E++
Sbjct: 239 GL------------RDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 612 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 670
KIG+GS G V + K G++VAVK+M R + EV ++ H+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 671 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 730
+ ++ E++ G L D V+Q L+ + + L YLH+ G+IH
Sbjct: 88 LVGEELWVLMEFLQGGALTD----IVSQTRLNEEQIATVCESVLQALCYLHS---QGVIH 140
Query: 731 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 790
RD+KS +ILL ++ R K+SDFG Q +D+ S+ GT ++ PE + D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVD 199
Query: 791 VYSFGVVLLELISGKKP 807
++S G++++E++ G+ P
Sbjct: 200 IWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 19/213 (8%)
Query: 611 KKIGKGSFGSVYYGKMKDGK---EVAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVP 665
K +G+G FGSV G++ +VAVK M + R++ F++E + H N++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 666 LIGYCEEEHQR------ILVYEYMHNGTLRD-RLHGSVNQKPLDWLTRL--QIAHDAAKG 716
LIG C + + +++ +M +G L L+ + P T++ + D A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYL 775
+EYL + IHRD+ + N +L+ NM V+DFGLS++ D +A+ V ++
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 776 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
E ++ T KSDV+SFGV + E+ + G+ P
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 27/211 (12%)
Query: 613 IGKGSFGSVYYGKMK-DGKEV--AVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLI 667
IG+G+FG V ++K DG + A+K M + S + F E+ +L ++ HH N++ L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 668 GYCEEEHQRILVYEYMHNGTLRD---------------RLHGSVNQKPLDWLTRLQIAHD 712
G CE L EY +G L D + + + L L A D
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST--LSSQQLLHFAAD 120
Query: 713 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 772
A+G++YL IHRD+ + NIL+ N AK++DFGLSR +++ ++ R V
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKTMGRLPV 175
Query: 773 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 803
++ E T SDV+S+GV+L E++S
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 70/208 (33%), Positives = 105/208 (50%), Gaps = 24/208 (11%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 666
++IG GSFG+VY+ + +++ + VA+K M+ S + + Q + EV L ++ H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
G EH LV EY G+ D L V++KPL + + H A +GL YLH +
Sbjct: 81 RGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEY---Y 780
+IHRDVK+ NILL K+ DFG + I + A VG ++ PE
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSAS--------IMAPANXFVGTPYWMAPEVILAM 186
Query: 781 GNQQLTEKSDVYSFGVVLLELISGKKPV 808
Q K DV+S G+ +EL K P+
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 70/204 (34%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 612 KIGKGSFGSVYYGKMKDGKE-VAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLI 667
+IG GSFG+VY+ E VAVK M+ S + + Q + EV L ++ H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
G +EH LV EY G+ D L V++KPL + I H A +GL YLH+
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY---YGNQQ 784
+IHRD+K+ NILL + K++DFG + ++ + + GT ++ PE Q
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQ 196
Query: 785 LTEKSDVYSFGVVLLELISGKKPV 808
K DV+S G+ +EL K P+
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 66/214 (30%), Positives = 110/214 (51%), Gaps = 20/214 (9%)
Query: 611 KKIGKGSFGSVYYGKMK----DGKEVAVKIM-AD-SCSHRTQQFVTEVALLSRIHHRNLV 664
+ +GKG FGSV ++K ++VAVK++ AD S ++F+ E A + H N++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 665 PLIGYC--EEEHQRI----LVYEYMHNGTLRDRLHGS-VNQKP--LDWLTRLQIAHDAAK 715
LIG R+ ++ +M +G L L S + ++P L T ++ D A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 716 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGY 774
G+EYL + IHRD+ + N +L+ NM V+DFGLS++ D ++ V +
Sbjct: 125 GMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 775 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
L E + T SDV++FGV + E+++ G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 612 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 670
KIG+GS G V K GK+VAVK M R + EV ++ HH N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 671 EEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 729
+ +V E++ G L D + H +N++ + + + L YLH N G+I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLH---NQGVI 140
Query: 730 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 789
HRD+KS +ILL + R K+SDFG Q +++ S+ GT ++ PE +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199
Query: 790 DVYSFGVVLLELISGKKP 807
D++S G++++E+I G+ P
Sbjct: 200 DIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 6e-20
Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 609 FCKKIGKGSFGSVY----YGKMKDGK--EVAVKIMADSCSHRT--QQFVTEVALLSRI-H 659
F K +G G+FG V YG K +VAVK M +H + + ++E+ ++S + +
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVK-MLKPTAHSSEREALMSELKIMSHLGN 97
Query: 660 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 719
H N+V L+G C +++ EY G L + L + L L ++ AKG+ +
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 720 LHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVARGTVGYLDP 777
L + C IHRD+ + N+LL K+ DFGL+R D ++ AR V ++ P
Sbjct: 157 LASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212
Query: 778 EYYGNQQLTEKSDVYSFGVVLLELIS 803
E N T +SDV+S+G++L E+ S
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 611 KKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 663
+++G+GSFG VY G K VA+K + ++ S R + +F+ E +++ + ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----SVNQKPLDWLTR---LQIAHDAAKG 716
V L+G ++V E M G L+ L + N L T +Q+A + A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 775
+ YL +HRD+ + N ++ ++ K+ DFG++R E D V ++
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 776 DPEYYGNQQLTEKSDVYSFGVVLLELIS 803
PE + T KSDV+SFGVVL E+ +
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 9e-20
Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 9/209 (4%)
Query: 601 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 660
E+ + KK+G G FG V+ +VAVK M S + F+ E ++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQH 60
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEY 719
LV L +E I+ E+M G+L D L +++PL L + + A+G+ +
Sbjct: 61 DKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKL--IDFSAQIAEGMAF 117
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 779
+ IHRD++++NIL+ ++ K++DFGL+R E++ A+ + + PE
Sbjct: 118 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174
Query: 780 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
T KSDV+SFG++L+E+++ G+ P
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (225), Expect = 9e-20
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 610 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMA---------DSCSHRTQQFVTEVALLSRIH 659
+K+G+G++G VY + K G+ VA+K + + + E++LL +
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA-------LREISLLKELK 56
Query: 660 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 719
H N+V L+ E + LV+EY L+ L PL I + +GL Y
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLD--KRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 778
H+ I+HRD+K NIL++ + K++DFGL+R L T+ V T+ Y PE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPE 168
Query: 779 -YYGNQQLTEKSDVYSFGVVLLELISGK 805
G++ + D++S G + E+I+GK
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 609 FCKKI---GKGSFGSVY---YGKMKD--GKEVAVKIMADSCSHR-TQQFVTEVALLSRIH 659
+ KKI G+G FG V Y D G+ VAVK + C + T + E+ +L ++
Sbjct: 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64
Query: 660 HRNLVPLIGYCEEEHQRI--LVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKG 716
H N+V G C E+ + L+ EY+ G+LRD L +N L L A +G
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEG 119
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGY 774
+ YLH+ IHRD+ + N+LLD + K+ DFGL++ E + + V +
Sbjct: 120 MAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 775 LDPEYYGNQQLTEKSDVYSFGVVLLELIS 803
E + + SDV+SFGV L EL++
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 611 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQF----VTEVALLSRIHHRNLVP 665
KIG+G++G VY + K E VA+K + ++ + E+ LL ++H N++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKI--KLRFESEGIPKTALREIKLLKELNHPNIIK 62
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
L+ + LV+E+M L + Q+ L + +GL + H+
Sbjct: 63 LLDVFRHKGDLYLVFEFMDT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH-- 117
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHISSVARGTVGYLDPE-YYG 781
GI+HRD+K N+L++ K++DFGL+R TH T Y PE G
Sbjct: 118 -GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV----TRWYRAPELLLG 172
Query: 782 NQQLTEKSDVYSFGVVLLELISGK 805
++ + D++S G + EL+S +
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 67/211 (31%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR-----NLV 664
K I KG+FGSVY K + G A+K++ S Q VT V I +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESPYVA 60
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYL 720
L + + LV EY++ G S+ + P DW Q + G+E L
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDC-----ASLIKTLGGLPEDWAK--QYIAEVVLGVEDL 113
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 780
H GIIHRD+K N+L+D K++DFGLSR E+ + GT YL PE
Sbjct: 114 H---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYLAPETI 165
Query: 781 GNQQLTEKSDVYSFGVVLLELISGKKPVSVE 811
+ SD +S G V+ E + G P E
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 610 CKKIGKGSFGSVY----YGKMKDGKE--VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRN 662
+++G+GSFG VY G +KD E VA+K + ++ S R + +F+ E +++ + +
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 663 LVPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAK 715
+V L+G + +++ E M G +LR + + Q P +Q+A + A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 716 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGY 774
G+ YL+ +HRD+ + N ++ + K+ DFG++R E D V +
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 775 LDPEYYGNQQLTEKSDVYSFGVVLLEL 801
+ PE + T SDV+SFGVVL E+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 63/227 (27%), Positives = 112/227 (49%), Gaps = 33/227 (14%)
Query: 611 KKIGKGSFGSVYYGKMKDGK------EVAVKIMAD-SCSHRTQQFVTEVALLSRIHHRNL 663
K +G+G FG V K VAVK++ + + S + ++E LL +++H ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------------GSVN--------QKPLD 702
+ L G C ++ +L+ EY G+LR L G+ N ++ L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 703 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762
+ A ++G++YL ++HRD+ + N+L+ + K+SDFGLSR E+ +
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 763 HIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
++ S R V ++ E + T +SDV+SFGV+L E+++ G P
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-19
Identities = 62/222 (27%), Positives = 109/222 (49%), Gaps = 28/222 (12%)
Query: 611 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 660
K +G+G FG V K K+ VAVK++ D + + V+E+ ++ I H
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRL 707
+N++ L+G C ++ ++ EY G LR+ L V + + + +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 708 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 766
+ A+G+EYL + IHRD+ + N+L+ N K++DFGL+R D ++
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 767 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
R V ++ PE ++ T +SDV+SFGV++ E+ + G P
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-19
Identities = 64/218 (29%), Positives = 113/218 (51%), Gaps = 29/218 (13%)
Query: 611 KKIGKGSFGSVY----YGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRI-HH 660
K +G+G FG V YG K + VAVK++ D+ + + ++E+ L+ I H
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTRL 707
+N++ L+G C +E ++ EY G LR+ L V ++ L + +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 708 QIAHDAAKGLEYLHTG-CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHIS 765
A+ A+G+EYL + C IHRD+ + N+L+ + K++DFGL+R + D +
Sbjct: 138 SCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 803
S R V ++ PE ++ T +SDV+SFG+++ E+ +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 5e-19
Identities = 66/254 (25%), Positives = 105/254 (41%), Gaps = 41/254 (16%)
Query: 607 NNFC--KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHH 660
++F K IG+G+FG V+ + KD +V A+K++ S + Q E +L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
+V L ++E LV EYM G L L + P + R IA + L+ +
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEET-ARFYIA-ELVLALDSV 117
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS-------------------------- 754
H G IHRD+K NIL+D + K++DFGL
Sbjct: 118 H---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 755 --RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
R+ + ++ GT Y+ PE + D +S GV+L E++ G P +
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234
Query: 813 -FGAELNIVHWARS 825
I++W S
Sbjct: 235 LQETYNKIINWKES 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 664
K +G+G+FG VY D G+E+AVK + D S T + V E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 665 PLIGYCEEEHQRIL--VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
G + +R L E+M G+++D+L +G++ + TR QI +G+ YL
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR-QIL----EGVSYL 122
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 777
H+ I+HRD+K +NIL D K+ DFG S++ + T + SV GT ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-GTPYWMSP 178
Query: 778 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
E + K+D++S G ++E+++ K P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 616 GSFGSVYYGKMKDGK-----EVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGY 669
G+FG ++YG + D K EV VK + D S + + E LL + H+N++P++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 670 CEEEHQRILV-YEYMHNGTLRDRL----HGSVNQKPLDWLTRLQIAHDA---AKGLEYLH 721
C E+ + V Y YM+ G L+ L G N L+ Q+ H A A G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA--LSTQQLVHMAIQIACGMSYLH 134
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYY 780
G+IH+D+ + N ++D ++ K++D LSR H + V ++ E
Sbjct: 135 ---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL 191
Query: 781 GNQQLTEKSDVYSFGVVLLELIS-GKKP 807
N++ + SDV+SFGV+L EL++ G+ P
Sbjct: 192 VNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 611 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
+KIG+G+ G+VY + G+EVA+K M + + + E+ ++ H N+V +
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 729
+ +V EY+ G+L D V + +D + + + LE+LH+ +I
Sbjct: 85 YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 730 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 789
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 790 DVYSFGVVLLELISGKKP 807
D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 611 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 665
++G G+FG+V Y K K VAVKI+ + + + + E ++ ++ + +V
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
+IG CE E +LV E G L L + V +K + ++ H + G++YL
Sbjct: 61 MIGICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLE-- 112
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDPEYYG 781
+HRD+ + N+LL AK+SDFGLS+ D + + G V + PE
Sbjct: 113 -ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171
Query: 782 NQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ + KSDV+SFGV++ E S G+KP
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 612 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 670
KIG+GS G V +K GK VAVK M R + EV ++ H N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 671 EEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 729
+ +V E++ G L D + H +N++ + + K L LH G+I
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QGVI 138
Query: 730 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 789
HRD+KS +ILL + R K+SDFG Q +++ S+ GT ++ PE +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEV 197
Query: 790 DVYSFGVVLLELISGKKP 807
D++S G++++E++ G+ P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 30/223 (13%)
Query: 608 NFCKKIGKGSFGSVYYGKM--------KDGKE---------VAVKIM-ADSCSHRTQQFV 649
NF +K+G+G FG V+ + K E VAVK++ D+ + + F+
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 650 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPL 701
EV +LSR+ N+ L+G C + ++ EYM NG L L V N K L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 702 DWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EED 760
+ T L +A A G+ YL + +HRD+ + N L+ N K++DFG+SR D
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 803
+ A + ++ E + T KSDV++FGV L E+++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 68/210 (32%), Positives = 109/210 (51%), Gaps = 22/210 (10%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 664
K +G+G+FG VY D G+E+AVK + D S T + V E+ LL + H +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 665 PLIGYCEEEHQRIL--VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
G + ++ L EYM G+++D+L +G++ + TR QI +G+ YL
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-QIL----QGVSYL 122
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 777
H+ I+HRD+K +NIL D K+ DFG S++ + T I SV GT ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT-GTPYWMSP 178
Query: 778 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
E + K+DV+S ++E+++ K P
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 613 IGKGSFGSVYYGKMKD----GKE---VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLV 664
+G G+FG VY G D G VAVK + + + + +F+ E L+S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK---PLDWLTRL-QIAHDAAKGLEYL 720
L+G C + ++ E M G L L + ++ PL L L I D AKG YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 721 HTGCNPGIIHRDVKSSNILL-----DINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGY 774
IHRD+ + N L+ D + K+ DFGL+R + D V +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 775 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ PE + + T +SDV+SFGV++ E+++ G++P
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 68/210 (32%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 664
K +G+G+FG VY D G+E+A K + D S T + V+ E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 665 PLIGYCEEEHQRILV--YEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
G + ++ L EYM G+++D+L +G++ + TR QI +G+ YL
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR-QIL----EGMSYL 122
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 777
H+ I+HRD+K +NIL D K+ DFG S++ + T I SV GT ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT-GTPYWMSP 178
Query: 778 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
E + K+DV+S G ++E+++ K P
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLI 667
KKIG+GSFG K K DGK+ +K + S ++ EVA+LS + H N+V
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRLHGS-----VNQKPLDWLTRLQIAHDAAKGLEYLHT 722
EE +V +Y G L +++ + LDW ++ +A L+++H
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVH- 118
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEY 779
+ I+HRD+KS NI L + K+ DFG++R L +AR GT YL PE
Sbjct: 119 --DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV----LNSTVELARTCIGTPYYLSPEI 172
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGK 805
N+ KSD+++ G VL E+ + K
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 613 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 671
+GKG++G VY + + +A+K + + S Q E+AL S + HRN+V +G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 672 EEHQRILVYEYMHNGTLRDRLHG-----SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
E + E + G+L L N++ + + T+ QI +GL+YLH +
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QI----LEGLKYLH---DN 127
Query: 727 GIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY--YGNQ 783
I+HRD+K N+L++ + K+SDFG S++ + + GT+ Y+ PE G +
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 784 QLTEKSDVYSFGVVLLELISGKKP 807
+D++S G ++E+ +GK P
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLI 667
+ +G+G+FG V+ + K D K V +K I + + + E +L + H N+ I
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI---I 62
Query: 668 GYCE---EEHQRILVYEYMHNGTLRDRLHGSVN-----QKPLDWLTRLQIAHDAAKGLEY 719
Y E E+ ++V EY GTL + + N L + ++ +A L +
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------LHH 116
Query: 720 LHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 778
+HT I+HRD+K+ NILLD + M K+ DFG+S+ + V GT Y+ PE
Sbjct: 117 VHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV--GTPCYISPE 171
Query: 779 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 815
+ +KSD+++ G VL EL S K+ + A
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 7e-18
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 613 IGKGSFGSVYYGK-MKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY- 669
IG+G++G+VY GK + G+ VA+KI+ D+ EVALLS++ + Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 670 -CEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
+ R+ ++ EY G++R + P+ I + L+Y+H G
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---G 121
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQQLT 786
+IHRD+K++NIL+ K+ DFG++ ++ + S+ GT ++ PE +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYD 180
Query: 787 EKSDVYSFGVVLLELISGKKPVSVED 812
K+D++S G+ + E+ +G P S D
Sbjct: 181 TKADIWSLGITIYEMATGNPPYSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-17
Identities = 58/194 (29%), Positives = 92/194 (47%), Gaps = 21/194 (10%)
Query: 629 GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL-VYEYMH 684
G EVA+K++ H+ +F E AL +R++H N+V L+ E + V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---D 741
TLR+ L L ++ L H N GI+HRD+K NI++
Sbjct: 63 GRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116
Query: 742 INMRAKVSDFGLS-------RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSF 794
+ AKV DFG+ LT + V GT Y PE + +T SD+Y++
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVL-GTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 795 GVVLLELISGKKPV 808
G++ LE ++G++ V
Sbjct: 176 GLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 608 NFCKKIGKGSFGS--VYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 665
N + +G+GSFG + D K +I S + E LL+++ H N+V
Sbjct: 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRL---HGSV--NQKPLDWLTRLQIAHDAAKGLEYL 720
E + +V EY G L ++ G + L W ++ + G++++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDP 777
H ++HRD+KS NI L N + K+ DFG +R LT + A VG Y+ P
Sbjct: 117 H---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL----LTSPGAYACTYVGTPYYVPP 169
Query: 778 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
E + N KSD++S G +L EL + K P
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 69/235 (29%), Positives = 119/235 (50%), Gaps = 39/235 (16%)
Query: 611 KKIGKGSFGSVYYG------KMKDGK--EVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 660
K +G+G FG V K K + +VAVK++ +D+ ++E+ ++ I H
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLTR---L 707
+N++ L+G C ++ ++ EY G LR+ L + Q P + L+ +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 708 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 767
A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+R D+ HI
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 196
Query: 768 ARGTVG-----YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP---VSVEDF 813
+ T G ++ PE ++ T +SDV+SFGV+L E+ + G P V VE+
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 64/220 (29%), Positives = 114/220 (51%), Gaps = 13/220 (5%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEV----AVKIMADSCSHRTQQFVT--EVALLSRIHHRNLV 664
K +G+GSFG V+ + G + A+K++ + + T E +L+ ++H +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
L + E + L+ +++ G L RL V D + +A + A L++LH+
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED--VKFYLA-ELALALDHLHS-- 116
Query: 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 784
GII+RD+K NILLD K++DFGLS+++ + S GTV Y+ PE +
Sbjct: 117 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRRG 174
Query: 785 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 824
T+ +D +SFGV++ E+++G P +D + ++ A+
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 3e-17
Identities = 70/210 (33%), Positives = 112/210 (53%), Gaps = 27/210 (12%)
Query: 611 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRT--QQFVTEVALLSRI-HHRNLVPL 666
+K+GKG++G V+ + KE VA+K + D+ + T Q+ E+ L + H N+V L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 667 IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
+ + E+ + LV+EYM D LH + L+ + + I + K L+Y+H+G
Sbjct: 73 LNVIKAENDKDIYLVFEYMET----D-LHAVIRANILEDVHKRYIMYQLLKALKYIHSG- 126
Query: 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR--------QAEEDLTHISSVARGTVGYLD 776
+IHRD+K SNILL+ + R K++DFGL+R LT VA T Y
Sbjct: 127 --NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY--VA--TRWYRA 180
Query: 777 PE-YYGNQQLTEKSDVYSFGVVLLELISGK 805
PE G+ + T+ D++S G +L E++ GK
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
+G G+ GSV K + G +A K + + S +Q + E+ ++ +V G
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
E+ + E+M G+L DR++ P++ L + IA +GL YL+ I
Sbjct: 71 AFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR--I 125
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQL 785
+HRD+K SNIL++ + K+ DFG+S + I+S+A GT Y+ PE +
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGEL------INSIADTFVGTSTYMSPERIQGGKY 179
Query: 786 TEKSDVYSFGVVLLELISGKKPVS 809
T KSDV+S G+ ++EL GK P +
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-17
Identities = 67/235 (28%), Positives = 114/235 (48%), Gaps = 28/235 (11%)
Query: 598 PLPELEEATNNFCKKIGKGSFGSVYYG------KMKDGK--EVAVKIMADSCSHRT-QQF 648
P EL K +G+G FG V K K K VAVK++ D + +
Sbjct: 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL 64
Query: 649 VTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG------------- 694
V+E+ ++ I H+N++ L+G C ++ ++ EY G LR+ L
Sbjct: 65 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124
Query: 695 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 754
+ ++ L + + A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 755 RQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
R D ++ R V ++ PE ++ T +SDV+SFGV+L E+ + G P
Sbjct: 182 RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 46/218 (21%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVK-I------MADSCSHRTQQFVTEVALLSRIHHRN 662
KK+G+G++ VY + K G+ VA+K I A + T + E+ LL + H N
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTA--LREIKLLQELKHPN 63
Query: 663 LVPLIG-YCEEEHQRI-LVYEYMHN---GTLRDRLHGSVNQKPLDWLTRLQIAHDAA--- 714
++ L+ + + I LV+E+M ++D+ L A +
Sbjct: 64 IIGLLDVFGHK--SNINLVFEFMETDLEKVIKDKS------------IVLTPADIKSYML 109
Query: 715 ---KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVA 768
+GLEYLH + I+HRD+K +N+L+ + K++DFGL+R +TH V
Sbjct: 110 MTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH--QVV 164
Query: 769 RGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 805
T Y PE +G + D++S G + EL+
Sbjct: 165 --TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 612 KIGKGSFGSVYYG--KMKDGK-EVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLI 667
++G G+FG V G KM+ + +VA+K++ + + + E ++ ++ + +V +I
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
G CE E +LV E G L L G ++ + + L H + G++YL
Sbjct: 62 GVCEAE-ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELM--HQVSMGMKYLE---GKN 115
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQQL 785
+HRD+ + N+LL AK+SDFGLS+ A++ S + + + PE ++
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 786 TEKSDVYSFGVVLLELIS-GKKP 807
+ +SDV+S+G+ + E S G+KP
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 31/230 (13%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKE---------------VAVKIM-ADSCSHRTQQFVTEV 652
+K+G+G FG V+ + + E VAVK++ AD F+ E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 653 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL---------RDRLHGSVNQKPLDW 703
++SR+ + N++ L+G C + ++ EYM NG L + N +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 704 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLT 762
L +A A G++YL + +HRD+ + N L+ + K++DFG+SR D
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSV 810
I A + ++ E + T SDV++FGV L E+ + ++P S+
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 611 KKIGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
+KIGKGSFG V+ G + K VA+KI+ + + E+ +LS+ + G
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
++ + ++ EY+ G+ D L PLD I + KGL+YLH+
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHS---EKK 122
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVARGTVGYLDPEYYGNQQLTE 787
IHRD+K++N+LL + K++DFG++ Q + T I + GT ++ PE
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 788 KSDVYSFGVVLLELISGKKPVS 809
K+D++S G+ +EL G+ P S
Sbjct: 181 KADIWSLGITAIELAKGEPPHS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 612 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS----HRTQQFVTEVALLSRIHHRNLVPL 666
+G+G++G V + K G+ VA+K +S +T + EV +L ++ H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA--LREVKVLRQLRHENIVNL 65
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
+ + LV+EY+ TL + L S P D R I + + Y H+
Sbjct: 66 KEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPD-AVRSYI-WQLLQAIAYCHSH--- 119
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQ----AEEDLTHISSVARGTVGYLDPEYY-G 781
IIHRD+K NIL+ + K+ DFG +R LT VA T Y PE G
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT--DYVA--TRWYRAPELLVG 175
Query: 782 NQQLTEKSDVYSFGVVLLELISG 804
+ + DV++ G ++ EL+ G
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 606 TNNFC--KKIGKGSFGSVYYGKMK-DGKEVA---VKIMADSCSHRTQQFVTEVALLSRIH 659
NF KKIGKG F VY DG+ VA V+I + Q + E+ LL ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 660 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL-----DWLTRLQIAHDAA 714
H N++ + E ++ +V E G L + QK L W +Q+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC---- 116
Query: 715 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 774
LE++H+ I+HRD+K +N+ + K+ D GL R T S+ GT Y
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 172
Query: 775 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
+ PE KSD++S G +L E+ + + P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 5e-17
Identities = 55/198 (27%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 611 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
+KIG+G+ G+VY + G+EVA++ M + + + E+ ++ + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 729
+ +V EY+ G+L D V + +D + + + LE+LH+ +I
Sbjct: 86 YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 730 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 789
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 790 DVYSFGVVLLELISGKKP 807
D++S G++ +E+I G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-17
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 10/199 (5%)
Query: 613 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVPLIG 668
+GKG FG V ++K GK A K + + + + E +L ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
E + LV M+ G L+ ++ +V + + A GLE+LH I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIY-NVGEPGFPEARAIFYAAQIICGLEHLH---QRRI 116
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
++RD+K N+LLD + ++SD GL+ + + GT GY+ PE +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA--GTPGYMAPEVLQGEVYDFS 174
Query: 789 SDVYSFGVVLLELISGKKP 807
D ++ G L E+I+G+ P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 6e-17
Identities = 54/198 (27%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 611 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
+KIG+G+ G+VY + G+EVA+K M + + + E+ ++ + N+V +
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 729
+ +V EY+ G+L D V + +D + + + L++LH+ +I
Sbjct: 85 YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 730 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 789
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 790 DVYSFGVVLLELISGKKP 807
D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 7e-17
Identities = 52/198 (26%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
+KIG+G+ G+V+ + G+EVA+K + + + + E+ ++ + + N+V +
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 729
+ +V EY+ G+L D V + +D + + + LE+LH +I
Sbjct: 85 FLVGDELFVVMEYLAGGSLTD----VVTETCMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 730 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 789
HRD+KS N+LL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 790 DVYSFGVVLLELISGKKP 807
D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-17
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 601 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKE---VAVKIMADSCSHRTQQ-FVTEVALL 655
EL+ + + +G G FG + G +K K VA+ + CS + ++ F+ E L
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 656 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 715
+ H N+V L G + ++V EYM NG L L Q L + + A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLAS 118
Query: 716 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG--TVG 773
G++YL G +H+ + + +L++ ++ K+S F R E+ I + G V
Sbjct: 119 GMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVL 173
Query: 774 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ PE + SDV+SFG+V+ E++S G++P
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 8e-17
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 32/213 (15%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 667
K IG G++G V K G++VA+K +++ ++ + E+ LL + H N++ L+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 668 -----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEY 719
E+ + +V E M D LH V + P LT I + +GL+Y
Sbjct: 66 DILRPPSPEDFNDVYIVTELMET----D-LH-KVIKSPQP-LTDDHIQYFLYQILRGLKY 118
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 779
LH+ +IHRD+K SNIL++ N K+ DFGL+R + D Y+ +
Sbjct: 119 LHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE----KGFLTEYVVTRW 171
Query: 780 Y-------GNQQLTEKSDVYSFGVVLLELISGK 805
Y + + T+ D++S G + EL++ K
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 38/230 (16%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKE-----------------VAVKIM-ADSCSHRTQQFVT 650
F +K+G+G FG V+ ++ + ++ VAVKI+ D+ + F+
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 651 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL------RDRLHGSVNQKPLD-- 702
EV +LSR+ N++ L+G C +E ++ EYM NG L N
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 703 --------WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 754
+ + L +A A G++YL + +HRD+ + N L+ N+ K++DFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 755 RQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 803
R D I A + ++ E + T SDV++FGV L E++
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 608 NFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHH 660
+++G+GSFG VY G +D VAVK + +S S R + +F+ E +++
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----SVNQ--KPLDWLTRL-QIAHDA 713
++V L+G + ++V E M +G L+ L + N +P L + Q+A +
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 714 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 772
A G+ YL+ +HRD+ + N ++ + K+ DFG++R E D V
Sbjct: 129 ADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 773 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 803
++ PE + T SD++SFGVVL E+ S
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVA---VKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 666
+IG G FG V G+ G A VK + S + Q F+ EV ++H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
+G C E +LV E+ G L++ L G V Q ++A + A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMA-QKDVLQRMACEVASGLLWLHQA 119
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEYYGN 782
IH D+ N L ++ K+ D+GL+ Q ED + +L PE
Sbjct: 120 ---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 783 QQ-------LTEKSDVYSFGVVLLEL 801
+ T+KS+++S GV + EL
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 609 FCKKI---GKGSFGSV---YYGKMKD--GKEVAVK-IMADSCSHRTQQFVTEVALLSRIH 659
F K+I G+G FG V Y D G++VAVK + +S + E+ +L ++
Sbjct: 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64
Query: 660 HRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 717
H N+V G C E+ L+ E++ +G+L++ L + N+ L +L+ A KG+
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--QQLKYAVQICKGM 122
Query: 718 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYL 775
+YL + +HRD+ + N+L++ + K+ DFGL++ E D + + V +
Sbjct: 123 DYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179
Query: 776 DPEYYGNQQLTEKSDVYSFGVVLLELIS 803
PE + SDV+SFGV L EL++
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 3e-16
Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 613 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYC 670
+G G++G VY G+ +K G+ A+K+M D ++ E+ +L + HHRN+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 671 EEEH------QRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTG 723
+++ Q LV E+ G++ D + + N +W+ I + +GL +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLH-- 128
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 783
+IHRD+K N+LL N K+ DFG+S Q + + ++ GT ++ PE
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 186
Query: 784 QLTE-----KSDVYSFGVVLLELISGKKPV 808
+ + KSD++S G+ +E+ G P+
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 10/201 (4%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEV-AVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
++IGKGSFG VY G KEV A+KI+ + + E+ +LS+ + G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
+ + ++ EY+ G+ D L PL+ I + KGL+YLH+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERK--- 122
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
IHRD+K++N+LL K++DFG++ Q + ++ GT ++ PE K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFK 181
Query: 789 SDVYSFGVVLLELISGKKPVS 809
+D++S G+ +EL G+ P S
Sbjct: 182 ADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 613 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY- 669
+G G++G VY G+ +K G+ A+K+M D ++ E+ +L + HHRN+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVM-DVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 670 -----CEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTG 723
+ Q LV E+ G++ D + + N DW+ I + +GL +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLHAH 140
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 783
+IHRD+K N+LL N K+ DFG+S Q + + ++ GT ++ PE
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 196
Query: 784 QLTE-----KSDVYSFGVVLLELISGKKPV 808
+ + +SD++S G+ +E+ G P+
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 5e-16
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 598 PLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM----ADSCSHRTQQFVTEV 652
L ELE +IG G+ G+VY + G+ A+K++ D+ +Q E+
Sbjct: 72 SLSELERV-----NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR---RQICREI 123
Query: 653 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 712
+L ++H N+V + + ++ E+M G+L + + +A
Sbjct: 124 EILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT---HIADEQ-------FLADV 173
Query: 713 AAK---GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVA 768
A + G+ YLH I+HRD+K SN+L++ K++DFG+SR + + SSV
Sbjct: 174 ARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV- 229
Query: 769 RGTVGYLDPEYYGNQQLTE------KSDVYSFGVVLLELISGKKPVSV 810
GT+ Y+ PE N L D++S GV +LE G+ P V
Sbjct: 230 -GTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275
|
Length = 353 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 613 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-GYC 670
+G G+FG VY + K+ G A KI+ + F+ E+ +LS H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 671 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNPG 727
E IL+ E+ G L S+ + LT QI + L +LH +
Sbjct: 73 YENKLWILI-EFCDGGAL-----DSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHK 123
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEY-----YG 781
+IHRD+K+ NILL ++ K++DFG+S + + + GT ++ PE +
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETFK 181
Query: 782 NQQLTEKSDVYSFGVVLLELISGKKP 807
+ K+D++S G+ L+EL + P
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 8e-16
Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 21/200 (10%)
Query: 613 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 670
+G G+ G+VY + + +AVK I D +Q ++E+ +L + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 671 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 730
E++ + E+M G+L ++ + P L R+ +A KGL YL + I+H
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKI---PEHVLGRIAVA--VVKGLTYLWS---LKILH 118
Query: 731 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQLTE 787
RDVK SN+L++ + K+ DFG+S Q ++S+A+ GT Y+ PE +Q
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL------VNSIAKTYVGTNAYMAPERISGEQYGI 172
Query: 788 KSDVYSFGVVLLELISGKKP 807
SDV+S G+ +EL G+ P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 8e-16
Identities = 64/218 (29%), Positives = 116/218 (53%), Gaps = 22/218 (10%)
Query: 602 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRTQ-QFVTEVALL 655
L+E K +G G+FG+VY G + +G+ V A+KI+ ++ + +F+ E ++
Sbjct: 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63
Query: 656 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVN----QKPLDWLTRLQIAH 711
+ + H +LV L+G C + LV + M +G L D +H + Q L+W ++
Sbjct: 64 ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI---- 118
Query: 712 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS-VARG 770
AKG+ YL ++HRD+ + N+L+ K++DFGL+R E D ++ +
Sbjct: 119 --AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 173
Query: 771 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ ++ E ++ T +SDV+S+GV + EL++ G KP
Sbjct: 174 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 74/228 (32%), Positives = 113/228 (49%), Gaps = 22/228 (9%)
Query: 597 IPLPELEEATNNF--CKKIGKGSFGSVY-YGKMKDGKEVAVKIMADSCSHRTQQFVTEVA 653
+ L L + T+ + + IGKG++G VY KDG AVKI+ D S ++ E
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-DPISDVDEEIEAEYN 70
Query: 654 LLSRI-HHRNLVPLIG-YCEEEH----QRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLTR 706
+L + +H N+V G + + + Q LV E + G++ + + G + + LD
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 707 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHIS 765
I + A GL++LH N IIHRDVK +NILL K+ DFG+S Q L +
Sbjct: 131 SYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187
Query: 766 SVARGTVGYLDPEYYGNQQLTEKS-----DVYSFGVVLLELISGKKPV 808
SV GT ++ PE +Q + S DV+S G+ +EL G P+
Sbjct: 188 SV--GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 54/198 (27%), Positives = 104/198 (52%), Gaps = 8/198 (4%)
Query: 611 KKIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
+K+G+G++ +VY G+ + E VA+K I D+ + E++L+ + H N+V L
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
E++ +LV+EYM + L+ + + LD T + KG+ + H +
Sbjct: 66 VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTE 787
+HRD+K N+L++ K++DFGL+R + S+ T+ Y P+ G++ +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYST 180
Query: 788 KSDVYSFGVVLLELISGK 805
D++S G ++ E+I+G+
Sbjct: 181 SIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 612 KIGKGSFGSVYYGKMKD-GKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIG 668
+G+GS+G V K K+ G+ VA+K +S + + E+ +L ++ H NLV LI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
+ + LV+E++ + T+ D L N LD + +G+E+ H + I
Sbjct: 68 VFRRKKRLYLVFEFVDH-TVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCH---SHNI 121
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYY-GNQQLT 786
IHRD+K NIL+ + K+ DFG +R A + VA T Y PE G+ +
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA--TRWYRAPELLVGDTKYG 179
Query: 787 EKSDVYSFGVVLLELISG 804
D+++ G ++ E+++G
Sbjct: 180 RAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 609 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVP 665
F + +GKGS+G V + + DGK+ +K + ++ + E LLS++ H N+V
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 666 LIGYCE-EEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEY 719
E E+ +V + G L +L + + ++W ++ +A L+Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQY 117
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 779
LH I+HRD+K+ N+ L KV D G++R E+ ++S GT Y+ PE
Sbjct: 118 LH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPEL 173
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 815
+ N+ KSDV++ G + E+ + K + +D +
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 613 IGKGSFGSVYYGKMKDGKE-VAVKIMA---DSCSH--RTQQFVTEVALLSRIHHRNLVPL 666
+G G++G V VA+K ++ S H RT + E+ LL + H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR---ELRLLKHMDHENVIGL 79
Query: 667 IG-YCEEEHQRIL--VYEYMHNGTLRDR-LHGSVNQKPL--DWLTRL--QIAHDAAKGLE 718
+ + VY H L L+ V + L D + L QI +GL+
Sbjct: 80 LDVFTPASSLEDFQDVYLVTH---LMGADLNNIVKCQKLSDDHIQFLVYQIL----RGLK 132
Query: 719 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 778
Y+H+ GIIHRD+K SNI ++ + K+ DFGL+R ++++T VA T Y PE
Sbjct: 133 YIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT--GYVA--TRWYRAPE 185
Query: 779 YYGN-QQLTEKSDVYSFGVVLLELISGK 805
N + D++S G ++ EL++GK
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 49/144 (34%), Positives = 74/144 (51%), Gaps = 15/144 (10%)
Query: 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 740
E+M G+L D++ + P + L ++ IA +GL YL I+HRDVK SNIL+
Sbjct: 79 EHMDGGSL-DQVLKKAGRIPENILGKISIA--VLRGLTYLRE--KHKIMHRDVKPSNILV 133
Query: 741 DINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVV 797
+ K+ DFG+S Q I S+A GT Y+ PE T +SD++S G+
Sbjct: 134 NSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLS 187
Query: 798 LLELISGKKPVSVEDFGAELNIVH 821
L+E+ G+ P+ D EL +
Sbjct: 188 LVEMAIGRYPIPPPD-AKELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 611 KKIGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
++IGKGSFG V+ G + + VA+KI+ + + E+ +LS+ + G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
+ + ++ EY+ G+ D L P D + + KGL+YLH+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHS---EKK 122
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
IHRD+K++N+LL K++DFG++ Q + ++ GT ++ PE K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSK 181
Query: 789 SDVYSFGVVLLELISGKKPVS 809
+D++S G+ +EL G+ P S
Sbjct: 182 ADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 613 IGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 664
+G+G+F ++ G ++ EV +K++ S + ++ F +++S++ H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
G C + I+V EY+ G+L L + N + W +L++A A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE--- 117
Query: 725 NPGIIHRDVKSSNILLDINMRA--------KVSDFGLS--RQAEEDLTHISSVARGTVGY 774
+ G+ H +V + N+LL K+SD G+S +E L + +
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE-------RIPW 170
Query: 775 LDPEYYGN-QQLTEKSDVYSFGVVLLELISG-KKPVSVED 812
+ PE N Q L+ +D +SFG L E+ SG KP+S D
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 53/220 (24%)
Query: 611 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQF--------VTEVALLSRI-HH 660
K++G G+FGSVY + K+ E VA+K M ++F + EV L ++ H
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEH 57
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHN---GTLRDRLHGSVNQKPL------DWLTRLQIAH 711
N+V L E + V+EYM ++DR KP + QI
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDR-----KGKPFSESVIRSII--YQIL- 109
Query: 712 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 771
+GL ++H G HRD+K N+L+ K++DFGL+R+ + V T
Sbjct: 110 ---QGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV--ST 161
Query: 772 VGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGK 805
Y PE Y + + D+++ G ++ EL + +
Sbjct: 162 RWYRAPEILLRSTSY-SSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 5e-15
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 40/216 (18%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMAD------SCSHRTQQFVTEVALLSRIHHRNL 663
+ IG G+FG V+ +DGK VA+K M + SC ++ E+ +L H N+
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSC----KRVFRELKMLCFFKHDNV 61
Query: 664 V--------PLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-VNQKPLD----WLTRLQIA 710
+ P I EE + +V E M + LH V+ +PL + QI
Sbjct: 62 LSALDILQPPHIDPFEEIY---VVTELMQSD-----LHKIIVSPQPLSSDHVKVFLYQIL 113
Query: 711 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 770
+GL+YLH+ GI+HRD+K N+L++ N K+ DFGL+R E D + +
Sbjct: 114 ----RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
Query: 771 TVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 805
T Y PE G++ T D++S G + EL+ +
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 613 IGKGSFGSVYYGKMKDG-------KEVAVKIMADSCSHRTQ-----QFVTEVALL-SRIH 659
+G G+FG VY + K+ KE+ V A R + V+EV ++ ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 660 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL------HGSVNQKPLDWLTRLQIAHDA 713
H N+V E + +V + + L + ++ + W +Q+
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-WNIFVQMV--- 123
Query: 714 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 773
L YLH I+HRD+ +NI+L + + ++DFGL++Q + + + ++SV GT+
Sbjct: 124 -LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLTSVV-GTIL 178
Query: 774 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
Y PE N+ EK+DV++FG +L ++ + + P
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
++IG G++G VY + + G+ A+K++ E+ ++ H N+V G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 729
+ + E+ G+L+D H + PL ++ + +GL YLH + G +
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLH---SKGKM 128
Query: 730 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ---LT 786
HRD+K +NILL N K++DFG+S Q + S GT ++ PE ++
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYN 187
Query: 787 EKSDVYSFGVVLLELISGKKPV 808
+ D+++ G+ +EL + P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 613 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 668
+GKG FG V +++ GK A K + + + + E +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
E + LV M+ G L+ ++ + + + + A + GLE LH I
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDLH---QERI 123
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
++RD+K NILLD + ++SD GL+ E T V GTVGY+ PE N++ T
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERYTFS 181
Query: 789 SDVYSFGVVLLELISGKKP 807
D ++ G +L E+I+G+ P
Sbjct: 182 PDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 21/198 (10%)
Query: 620 SVYYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIGY----CEE 672
S+Y G + KEV ++ E+ L RI N++ + G+ ++
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 673 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN-PGIIHR 731
+ L+ EY G LR+ L +K L + T+L +A D KGL L+ N P ++
Sbjct: 94 LPRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YK 147
Query: 732 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKS 789
++ S + L+ N + K+ GL E+ L+ + Y + + + T K
Sbjct: 148 NLTSVSFLVTENYKLKIICHGL----EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKD 203
Query: 790 DVYSFGVVLLELISGKKP 807
D+YS GVVL E+ +GK P
Sbjct: 204 DIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 613 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVPLIG 668
+GKG FG V +M+ GK A K + + + + + E +L+++H R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPG 727
+ + LV M+ G LR ++ + P GLE+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 787
II+RD+K N+LLD + ++SD GL+ + ++ + A GT G++ PE ++
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYDF 176
Query: 788 KSDVYSFGVVLLELISGKKP 807
D ++ GV L E+I+ + P
Sbjct: 177 SVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 612 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVP 665
IG+G++G VY K K DGKE A+K T Q E+ALL + H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 666 LIGYCEEEHQRI--LVYEY----------MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 713
L+ E + L+++Y H R + S+ K L W QI +
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM-VKSLLW----QILN-- 119
Query: 714 AKGLEYLHTGCNPGIIHRDVKSSNILL--DINMRA--KVSDFGLSRQAEEDLTHISSVAR 769
G+ YLH+ ++HRD+K +NIL+ + R K+ D GL+R L ++ +
Sbjct: 120 --GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 770 G--TVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELIS 803
T+ Y PE G + T+ D+++ G + EL++
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-14
Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 26/225 (11%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD---SCSHRTQQFVTEVALLSRIHHRNLVPL 666
K IG+G+FG V K+K+ +V A+KI+ T F E +L ++ + L
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAAKGLEYLHT 722
++E+ LV +Y G L L ++ P D +L + IA D+ L Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-- 780
+HRD+K NIL+D+N +++DFG + ED T SSVA GT Y+ PE
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 781 ---GNQQLTEKSDVYSFGVVLLELISGKKPVS----VEDFGAELN 818
G + + D +S GV + E++ G+ P VE +G +N
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 613 IGKGSFGSVYYGKMK-DGKEVAVKIMA-DSCSHRTQQ--FVTEVALLSRIHHRNLVPLIG 668
+G G FG V K+K + A+K + QQ +E +L +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
+++ ++ EY G L L G + ++ R IA EYLH N
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFD----EYTARFYIAC-VVLAFEYLH---NR 112
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLDPEYYG 781
GII+RD+K N+LLD N K+ DFG +++ + S + GT Y+ PE
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKK-------LKSGQKTWTFCGTPEYVAPEIIL 165
Query: 782 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
N+ D +S G++L EL++G+ P +D
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 58/229 (25%), Positives = 108/229 (47%), Gaps = 25/229 (10%)
Query: 601 ELEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVA 653
E+ +T F +++G+ FG VY G + + + VA+K + D ++F E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 654 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVNQKPLDWLTR-- 706
+ SR+ H N+V L+G +E +++ Y + L + L H V D +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 707 ------LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EE 759
+ I A G+E+L + ++H+D+ + N+L+ + K+SD GL R+
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 760 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
D + + + ++ PE + + SD++S+GVVL E+ S G +P
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 612 KIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLI 667
++G+G +G V+ K KD E VA+K M S + + +TE +L+ LV L+
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 668 GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD------WLTRLQIAHDAAKGLEYL 720
Y ++ + + L EY+ G R L N L ++ + A DA L
Sbjct: 68 -YAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFEAVDA------L 117
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 780
H G IHRD+K N L+D + K++DFGLS+ +T+ +SV G+ Y+ PE
Sbjct: 118 H---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANSVV-GSPDYMAPEVL 170
Query: 781 GNQQLTEKSDVYSFGVVLLELISGKKPVS 809
+ D +S G +L E + G P S
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 613 IGKGSFGSVY-YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIG-Y 669
IGKG++G V+ K+G + AVKI+ D ++ E +L + H N+V G Y
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 670 CEEE----HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 722
+++ Q LV E + G++ D + G + + + + IA H+A GL++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG--ERMEEPIIAYILHEALMGLQHLH- 141
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG- 781
IHRDVK +NILL K+ DFG+S Q + + GT ++ PE
Sbjct: 142 --VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL-TSTRLRRNTSVGTPFWMAPEVIAC 198
Query: 782 NQQL----TEKSDVYSFGVVLLELISGKKPVS 809
QQL + DV+S G+ +EL G P++
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 74/261 (28%), Positives = 114/261 (43%), Gaps = 65/261 (24%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVA---VKIM-----ADSCSHRTQQFVTEVALLSRIHHRN 662
+++GKGSFG+VY +KD K VA +K++ + + T Q E LLS++ H
Sbjct: 6 QRLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 663 LVP-------------LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI 709
+V + YCE + E H G S NQ +W +L +
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL-----SENQV-CEWFIQLLL 117
Query: 710 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSV 767
G+ Y+H I+HRD+K+ NI L N+ K+ DFG+SR DL ++
Sbjct: 118 ------GVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDL---ATT 164
Query: 768 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLEL-------------------ISGKKPV 808
GT Y+ PE +Q KSD++S G +L E+ + G P
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS 224
Query: 809 SVEDFGAELNIVHWARSMIKK 829
E + +LN + +SM+ K
Sbjct: 225 LPETYSRQLNSI--MQSMLNK 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRIHHRNL 663
K +GKGSFG V ++K E A+K ++ D T V L H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECT--MVERRVLALAWEHPFL 58
Query: 664 VPLIGYC--EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
L +C + + V EY++ G D + + D A + GL++LH
Sbjct: 59 THL--FCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 781
GII+RD+K N+LLD + K++DFG+ ++ + +S GT Y+ PE
Sbjct: 114 KK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGTPDYIAPEILK 169
Query: 782 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
Q+ E D +SFGV+L E++ G+ P ED
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 48/228 (21%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA--------DSCSHRTQQFVTEVALLSRI 658
NF +GKGSFG V + K E+ A+KI+ D ++ V +AL +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRV--LALPGKP 60
Query: 659 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI--------- 709
L L + + V EY++ G D + +Q
Sbjct: 61 PF--LTQLHSCFQTMDRLYFVMEYVNGG---------------DLMYHIQQVGKFKEPHA 103
Query: 710 ---AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHI 764
A + A GL +LH+ GII+RD+K N++LD K++DFG+ ++ T
Sbjct: 104 VFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160
Query: 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
GT Y+ PE Q + D ++FGV+L E+++G+ P ED
Sbjct: 161 FC---GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 67/217 (30%), Positives = 111/217 (51%), Gaps = 35/217 (16%)
Query: 613 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF----VTEVALLSRIHHRNLVPL- 666
IG+G++G VY + KD G+ VA+K + + + F + E+ +L +++HRN+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKV--RLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 667 ---------IGYCEEEHQRILVYEYM-HN--GTLRDRLHGSVNQKPLDWLTRLQIAHDAA 714
+ + +++ LV+EYM H+ G L L ++ +L
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL------L 126
Query: 715 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTV 772
+GL Y H +HRD+K SNILL+ + K++DFGL+R +EE + + V T+
Sbjct: 127 EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI--TL 181
Query: 773 GYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPV 808
Y PE G ++ DV+S G +L EL + KKP+
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 58/211 (27%), Positives = 109/211 (51%), Gaps = 22/211 (10%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRTQQFVTEVAL-LSRIHHRNLV 664
K +G G FG+V+ G + +G VA+K + D +T Q +T+ L + + H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRLH---GSVN-QKPLDWLTRLQIAHDAAKGLEYL 720
L+G C + LV + G+L D + S++ Q+ L+W ++ AKG+ YL
Sbjct: 73 RLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYL 125
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYLDPEY 779
++HR++ + NILL + +++DFG++ +D + S + + ++ E
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 780 YGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 809
+ T +SDV+S+GV + E++S G +P +
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 611 KKIGKGSFGSVYYGKMKDGKE-VAVKIMA--DSCSHRTQQFV-TEVALLSRIHHRNLVPL 666
K +G G+FG V+ + + + A+K+MA + + +Q V E +L + H ++ L
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 667 IGYCEEEHQRIL--VYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
+ E QR L + EY+ G L R G + T L A + LEYLH+
Sbjct: 67 --FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNS-----TGLFYASEIVCALEYLHS 119
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
I++RD+K NILLD K++DFG +++ + + GT YL PE +
Sbjct: 120 ---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTPEYLAPEVIQS 172
Query: 783 QQLTEKSDVYSFGVVLLELISGKKP 807
+ + D ++ G+++ E++ G P
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 31/215 (14%)
Query: 604 EATNNFC--KKIGKGSFGSVYYGK-MKDGKEVAVK-IMAD-SCSHRTQQFVTEVALLSRI 658
E TN + + +G G+FG V + G+ VA+K IM S ++ E+ LL +
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66
Query: 659 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 717
H N++ L + I V E + GT LH + +PL+ + +GL
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELL--GT---DLHRLLTSRPLEKQFIQYFLYQILRGL 121
Query: 718 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 777
+Y+H+ G++HRD+K SNIL++ N K+ DFGL+R + +T GY+
Sbjct: 122 KYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMT----------GYVST 168
Query: 778 EYYGN-------QQLTEKSDVYSFGVVLLELISGK 805
YY Q+ + D++S G + E++ GK
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 25/213 (11%)
Query: 609 FCKKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPL 666
++GKG++GSVY + G +A+K I + + Q + E+ +L + +V
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
G E + EYM G+L D+L+ + P D L R I + KGL++L
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEE 121
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEY- 779
N IIHRDVK +N+L++ N + K+ DFG+S +S+A+ +G Y+ PE
Sbjct: 122 HN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV------ASLAKTNIGCQSYMAPERI 173
Query: 780 -----YGNQQLTEKSDVYSFGVVLLELISGKKP 807
N T +SDV+S G+ +LE+ G+ P
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 5e-14
Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 30/222 (13%)
Query: 609 FCKKIGKGSFGSVYYGK---MKDGKE--------------VAVKIM-ADSCSHRTQQFVT 650
F +K+G+G FG V+ + M+ + VAVK++ D+ + F+
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 651 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL-----RDRLHGSV---NQKPLD 702
E+ ++SR+ N++ L+ C ++ EYM NG L R + + +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 703 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DL 761
+ T + +A A G++YL + +HRD+ + N L+ N K++DFG+SR D
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 803
I A + ++ E + T SDV++FGV L E+++
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 67/208 (32%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 613 IGKGSFGSVYYGKM---KDGKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHR--NLV 664
IG G+ G VY KM K G +AVK M + + + + +V L S H +V
Sbjct: 23 IGSGTCGQVY--KMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---HDCPYIV 77
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTG 723
GY + + E M T D+L + P D L ++ +A K L YL
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVA--IVKALHYLKE- 132
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 783
G+IHRDVK SNILLD + K+ DFG+S + + S G Y+ PE
Sbjct: 133 -KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCAAYMAPERIDPP 189
Query: 784 QLTEK----SDVYSFGVVLLELISGKKP 807
K +DV+S G+ L+EL +G+ P
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 6e-14
Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 46/229 (20%)
Query: 608 NFCKKIGKGSFGSVYYG-KMKDGKEVAVK--IMADSCSHRTQQF-VT---EVALLSRIHH 660
K+G+G+FG VY ++K G+ VA+K +M + F +T E+ +L ++ H
Sbjct: 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILM----HNEKDGFPITALREIKILKKLKH 66
Query: 661 RNLVPLIGYCEEEHQRI--------LVYEYM-H--NGTLRD-RLHGSVNQ-KPLDWLTRL 707
N+VPLI E + +V YM H +G L + + + +Q K L
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK----CYML 122
Query: 708 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHI 764
Q+ G+ YLH N I+HRD+K++NIL+D K++DFGL+R +
Sbjct: 123 QLLE----GINYLH--EN-HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 765 SSVARG-------TVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 805
T Y PE G ++ T D++ G V E+ + +
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 612 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIG 668
KIG+GS+G V+ + ++ G+ VA+K +S + + E+ +L ++ H NLV LI
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT-GCNPG 727
+ + LV+EY + T+ + L N + + +I + + + H C
Sbjct: 68 VFRRKRKLHLVFEYCDH-TVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHNC--- 121
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPEYY-GNQ 783
IHRDVK NIL+ + K+ DFG +R +D T VA T Y PE G+
Sbjct: 122 -IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT--DYVA--TRWYRAPELLVGDT 176
Query: 784 QLTEKSDVYSFGVVLLELISG 804
Q DV++ G V EL++G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 14/204 (6%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHHRNL 663
F K +G GSFG V + K + A+KI++ + + +Q + E +L I H L
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
V L G +++ LV EY+ G L L + P R A LEYLH
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEPV-ARFYAA-QVVLALEYLH-- 118
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 783
+ I++RD+K N+LLD + K++DFG +++ + + GT YL PE ++
Sbjct: 119 -SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAPEIILSK 173
Query: 784 QLTEKSDVYSFGVVLLELISGKKP 807
+ D ++ G+++ E+++G P
Sbjct: 174 GYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 9e-14
Identities = 40/102 (39%), Positives = 61/102 (59%), Gaps = 6/102 (5%)
Query: 398 WEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRL 455
W+ +TC+ ++ R+ I LSGKN+ G+I + + + + L N L+GP+PD +
Sbjct: 60 WQGITCNNSS--RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTS 117
Query: 456 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 497
LR ++L NN TGS+P GS+PNL+ L + NN GEIP
Sbjct: 118 SSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIP 157
|
Length = 968 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 9e-14
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 11/206 (5%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 666
K +GKG+FG V + K GK A+KI+ +TE +L H L L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
+ + + V EY++ G L H S + + TR A + L+YLH+G
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELF--FHLSRERVFSEDRTRFYGA-EIVSALDYLHSG--- 114
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 786
I++RD+K N++LD + K++DFGL ++ D + + GT YL PE +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYG 173
Query: 787 EKSDVYSFGVVLLELISGKKPVSVED 812
D + GVV+ E++ G+ P +D
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 613 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIG 668
+GKGSFG V ++K G+ AVK++ + +TE +LS + + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 669 YCEEEHQRIL-VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
C + R+ V E+++ G L + S + D A + L +LH + G
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEITSALMFLH---DKG 116
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 787
II+RD+K N+LLD K++DFG+ ++ + S+ GT Y+ PE
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLYGP 175
Query: 788 KSDVYSFGVVLLELISGKKPVSVED----FGAELN 818
D ++ GV+L E++ G P E+ F A LN
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 613 IGKGSFGSV------YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 666
+GKG FG V GKM K++ K + + E +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGEAMALNEKQILEKVNSRFVVSL 65
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
E + LV M+ G L+ ++ ++ D + A + GLE LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIY-NMGNPGFDEERAVFYAAEITCGLEDLHR---E 121
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 786
I++RD+K NILLD ++SD GL+ + E T V GTVGY+ PE N++ T
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEVVKNERYT 179
Query: 787 EKSDVYSFGVVLLELISGKKP 807
D + G ++ E+I GK P
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-------DSCSHRTQQFVTEVALLSRIHHRN 662
K +GKG+FG V + K GK A+KI+ D +H +TE +L H
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT----LTESRVLQNTRHPF 56
Query: 663 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
L L Y + H R+ V EY + G L H S + + R A + L YLH
Sbjct: 57 LTAL-KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALGYLH 112
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEY 779
+ +++RD+K N++LD + K++DFGL + E ++ +++ GT YL PE
Sbjct: 113 SC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEV 166
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
+ D + GVV+ E++ G+ P +D
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 64/220 (29%), Positives = 92/220 (41%), Gaps = 29/220 (13%)
Query: 609 FCKKIGKGSFG--SVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNL 663
IGK V+ K K VAVK + DSCS + + E+ ++ H N+
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYL 720
+P + + + +V M G+ D L + L L IA D L+Y+
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP----EGLPELAIAFILKDVLNALDYI 117
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS--------RQAEEDLTHISSVARGTV 772
H + G IHR VK+S+ILL + + +S S RQ SSV +
Sbjct: 118 H---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK--NL 172
Query: 773 GYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKPVS 809
+L PE Q L EKSD+YS G+ EL +G P
Sbjct: 173 PWLSPEVL-QQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 611 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
+++G G++G VY + G+ AVKI+ E+ ++ H N+V G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNP 726
+ + EY G+L+D H + PL + LQIA+ + +GL YLH+
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVT---GPL---SELQIAYVCRETLQGLAYLHS---K 125
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG---NQ 783
G +HRD+K +NILL N K++DFG++ + + S GT ++ PE N
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNG 184
Query: 784 QLTEKSDVYSFGVVLLELISGKKPV 808
+ D+++ G+ +EL + P+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 610 CKKIGKGSFGSVYYGKM---KDGKEVAVK-IMADSCSHRTQQFVTEV-ALLSRIHHRNLV 664
+IG+G+FG+V KM G +AVK I + ++ + ++ ++ +V
Sbjct: 9 LGEIGRGAFGTVN--KMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIV 66
Query: 665 PLIGYCEEEHQRILVYEYMHNG--TLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLH 721
G E + E M ++ + P + L + IA K L YL
Sbjct: 67 KFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK--IAVATVKALNYLK 124
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 777
IIHRDVK SNILLD N K+ DFG+S Q + S+A+ G Y+ P
Sbjct: 125 EELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD------SIAKTRDAGCRPYMAP 176
Query: 778 EY---YGNQQLTEKSDVYSFGVVLLELISGKKP 807
E +SDV+S G+ L E+ +GK P
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 51/219 (23%)
Query: 612 KIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQ--------FVTEVALLSRIHHRN 662
+IG+G++G VY + E VA+K + R + E+ LL + H N
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKV------RMDNERDGIPISSLREITLLLNLRHPN 67
Query: 663 LVPL---------------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL 707
+V L + YCE++ +L D + ++ + L L
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLL-----------DNMPTPFSESQVKCLM-L 115
Query: 708 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 767
Q+ +GL+YLH IIHRD+K SN+LL K++DFGL+R ++
Sbjct: 116 QLL----RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK 168
Query: 768 ARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 805
T+ Y PE G T D+++ G +L EL++ K
Sbjct: 169 VV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 613 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRI---HHRNLVPL 666
IG+G++G+VY + + G+ VA+K + S + E+ALL ++ H N+V L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 667 IGYC-----EEEHQRILVYEYMHNGTLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLE 718
+ C + E + LV+E++ +D L + L T + +G++
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVD----QD-LATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 719 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 778
+LH+ I+HRD+K NIL+ + + K++DFGL+R ++ S V T+ Y PE
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPE 176
Query: 779 YYGNQQLTEKSDVYSFGVVLLEL 801
D++S G + EL
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 67/217 (30%), Positives = 95/217 (43%), Gaps = 13/217 (5%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ----FVTEVALLSRIHHRNLVP 665
K IGKGSFG V K K DG AVK++ + ++ LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
L + + V +Y++ G L H + L+ R A + A + YLH+
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELF--FHLQRERCFLEPRARFYAA-EVASAIGYLHS--- 114
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 785
II+RD+K NILLD ++DFGL ++ E S+ GT YL PE +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEPY 173
Query: 786 TEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVH 821
D + G VL E++ G P D NI+H
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIG 668
+K+G+GS+ +VY GK K +GK VA+K++ T + E +LL + H N+V L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 669 YCEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
+ LV+EY+H + D+ G ++ + + L Q+ +GL Y+H
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVK-LFLFQLL----RGLSYIH---QR 122
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 785
I+HRD+K N+L+ K++DFGL+R A+ +H S T+ Y P+ G+ +
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 786 TEKSDVYSFGVVLLELISG 804
+ D++ G + +E+I G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 61/257 (23%), Positives = 98/257 (38%), Gaps = 68/257 (26%)
Query: 589 MDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVY-YGKMKDGKEVAVKIM------ADSC 641
+I +G+G++G V GK VA+K + D
Sbjct: 3 SFSISERYIQKG----------AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVT 52
Query: 642 SHRTQ------QFVT--EVALLSRIHHRNLVPLIG-YCEEEHQRILVYEYMHNGTLRDRL 692
R F T E+ +++ I H N++ L+ Y E + LV + M L+
Sbjct: 53 KDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFIN-LVMDIMA-SDLK--- 107
Query: 693 HGSVNQKPLDWLTRLQIAH------DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 746
K +D RL + GL LH +HRD+ +NI ++
Sbjct: 108 ------KVVDRKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGIC 158
Query: 747 KVSDFGLSR-----------------QAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEK 788
K++DFGL+R Q E++T S V T+ Y PE G ++
Sbjct: 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMT--SKVV--TLWYRAPELLMGAEKYHFA 214
Query: 789 SDVYSFGVVLLELISGK 805
D++S G + EL++GK
Sbjct: 215 VDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 611 KKIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 666
K+IG G FG V G++ G +V VK + S S + Q +F+ E + H NL+
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL--DWLTRLQIAHDAAKGLEYLHTGC 724
+G C E +LV E+ G L+ L + + D T ++A + A GL +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS-----VARGTVGYLDPEY 779
IH D+ N LL ++ K+ D+GLS ++ +++ R L E
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 780 YGNQQL---TEKSDVYSFGVVLLELIS-GKKP 807
+GN + T++S+V+S GV + EL G +P
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-13
Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 42/233 (18%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEV-AVKIM--------ADSCSHRTQQFVT---EVALLSRI 658
K IG+G+FG V KMK + + A+KI+ A++ R ++ V + ++ +
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66
Query: 659 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAA 714
H+ ++E+ LV +Y G L L ++ P D ++ + +A +
Sbjct: 67 HYA--------FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 715 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 774
L Y +HRD+K N+LLD+N +++DFG + +D T SSVA GT Y
Sbjct: 119 HQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDY 169
Query: 775 LDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVS----VEDFGAELN 818
+ PE G + + D +S GV + E++ G+ P VE +G +N
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 68/231 (29%), Positives = 105/231 (45%), Gaps = 38/231 (16%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEV-AVKIM---------ADSCSHRTQQFVTEVALLSRIHH 660
K IG+G+FG V KMK+ +V A+KI+ +C F E +L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC------FREERDVLVNGDR 60
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAAKG 716
R + L ++E+ LV +Y G L L ++ P D +L + +A D+
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 776
L Y +HRD+K N+LLD N +++DFG + D T S+VA GT Y+
Sbjct: 121 LGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171
Query: 777 PEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPV----SVEDFGAELN 818
PE G + + D +S GV + E++ G+ P VE +G +N
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 31/212 (14%)
Query: 613 IGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQ-QFVTEVALLSR-IHHRNLVPLI 667
+G+G++G V KM+ G +AVK + + + + Q + + ++ + R + V
Sbjct: 9 LGRGAYGVVD--KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL----DWLTRLQIAHDAAKGLEYLHTG 723
G E + E M T D+ + V K L D L + IA K LEYLH+
Sbjct: 67 GALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLHSK 122
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 779
+ +IHRDVK SN+L++ N + K+ DFG+S + SVA+ G Y+ PE
Sbjct: 123 LS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL------VDSVAKTIDAGCKPYMAPER 174
Query: 780 Y---GNQQLTE-KSDVYSFGVVLLELISGKKP 807
NQ+ + KSDV+S G+ ++EL +G+ P
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 613 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 668
+GKG FG V +++ GK A K + + + + E +L +++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
E + LV M+ G L+ ++ N + L A + GLE LH
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLH---RENT 123
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
++RD+K NILLD ++SD GL+ + E + V GTVGY+ PE NQ+ T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLNNQRYTLS 181
Query: 789 SDVYSFGVVLLELISGKKP 807
D + G ++ E+I G+ P
Sbjct: 182 PDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 27/218 (12%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA--------DSCSHRTQQFVTEVALLSRI 658
+G+G FG V + K E+ A+K + + S ++ + E A +
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETA--NSE 59
Query: 659 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKG 716
H LV L C + + V EY G L +H V +P R A G
Sbjct: 60 RHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----RAVFYAACVVLG 113
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGY 774
L+YLH I++RD+K N+LLD K++DFGL + E + + GT +
Sbjct: 114 LQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEF 167
Query: 775 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
L PE T D + GV++ E++ G+ P +D
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-13
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 12/207 (5%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVP 665
K +GKGSFG V+ ++K + A+K + + + E +LS H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
L + + V EY++ G L H K D A + GL++LH+
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLM--FHIQSCHK-FDLPRATFYAAEIICGLQFLHS--- 114
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 785
GI++RD+K NILLD + K++DFG+ ++ + GT Y+ PE Q+
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKY 173
Query: 786 TEKSDVYSFGVVLLELISGKKPVSVED 812
D +SFGV+L E++ G+ P D
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-13
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQ--FVTEVALLSRIHHRNL 663
+ K IG+G+FG V + K K+V A+K+++ R+ F E +++ + +
Sbjct: 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWI 105
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
V L +++ +V EYM G L + + S P W R A + L+ +H
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKW-ARFYTA-EVVLALDAIH-- 159
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 783
+ G IHRDVK N+LLD + K++DFG + + + A GT Y+ PE +Q
Sbjct: 160 -SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 784 ----QLTEKSDVYSFGVVLLELISGKKP 807
+ D +S GV L E++ G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-13
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 42/225 (18%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMAD---------SCS---HRTQQFVTEVAL 654
NF +GKGSFG V + K E+ A+KI+ C+ R +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 655 LSRIHHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH-- 711
L+++H C + R+ V EY++ G L ++ + R + H
Sbjct: 63 LTQLHS---------CFQTMDRLYFVMEYVNGGDLMYQIQQ---------VGRFKEPHAV 104
Query: 712 ----DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 767
+ A GL +LH+ GII+RD+K N++LD K++DFG+ ++ D +
Sbjct: 105 FYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTF 161
Query: 768 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
GT Y+ PE Q + D ++FGV+L E+++G+ P ED
Sbjct: 162 C-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 58/210 (27%), Positives = 112/210 (53%), Gaps = 24/210 (11%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLV 664
K +G G+FG+VY G + +G++ VA+K + ++ S + ++ + E +++ + + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAHDAAKGLEYL 720
L+G C + L+ + M G L D R H +Q L+W ++ AKG+ YL
Sbjct: 73 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 125
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE 778
++HRD+ + N+L+ K++DFGL++ A+E H + + ++ E
Sbjct: 126 E---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG-GKVPIKWMALE 181
Query: 779 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
++ T +SDV+S+GV + EL++ G KP
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 21/231 (9%)
Query: 611 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRN 662
K +G G++G V+ + GK A+K++ + + T+ TE +L I
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 663 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKGLEYL 720
+ + Y + ++ L+ +Y++ G L L K +QI + + LE+L
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIVLALEHL 121
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 780
H GII+RD+K NILLD N ++DFGLS++ ED + GT+ Y+ P+
Sbjct: 122 H---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 781 --GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 829
G+ + D +S GV++ EL++G P +V+ G + + +R ++K
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD--GEKNSQAEISRRILKS 227
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 20/208 (9%)
Query: 608 NFCK--KIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRN 662
NF K KIG+G++G VY + K G+ VA+K I D+ + + E++LL ++H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 663 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 719
+V L+ E++ LV+E++H L ++ PL + I +GL +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQD-----LKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 778
H+ ++HRD+K N+L++ K++DFGL+R + T+ V T+ Y PE
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 170
Query: 779 -YYGNQQLTEKSDVYSFGVVLLELISGK 805
G + + D++S G + E+++ +
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 71/225 (31%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVA----LLSRIHHRNLVP 665
K IGKGSFG V K K DGK AVK++ + ++ +A LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 666 LIGYCEEEHQRILVYEYMHNGTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
L + + V +Y++ G L R+R + A + A L YL
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRAR--------FYAAEIASALGYL 112
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPE 778
H+ II+RD+K NILLD ++DFGL ++ T S GT YL PE
Sbjct: 113 HS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT---STFCGTPEYLAPE 166
Query: 779 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVH 821
Q D + G VL E++ G P D AE+ NI++
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-AEMYDNILN 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRNLV 664
KKIG+G F VY + D K VA+K M D+ + Q V E+ LL +++H N++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR--QDCVKEIDLLKQLNHPNVI 65
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEY 719
+ E+++ +V E G L + QK L W +Q+ +E+
Sbjct: 66 KYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEH 121
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 779
+H+ ++HRD+K +N+ + K+ D GL R T S+ GT Y+ PE
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 819
KSD++S G +L E+ + + P +G ++N+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 71/220 (32%), Positives = 102/220 (46%), Gaps = 19/220 (8%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVT--EVALLSRIHHRNLVP 665
K IGKGSFG V K K DGK AVK++ + + Q+ + LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
L + + V ++++ G L H + + R A + A L YLH+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELF--FHLQRERSFPEPRARFYAA-EIASALGYLHS--- 114
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQ 783
I++RD+K NILLD ++DFGL ++ A+ D T + GT YL PE Q
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRKQ 171
Query: 784 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVH 821
D + G VL E++ G P D AE+ NI+H
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-AEMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 612 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQF-VTEVALLSRIHHRNLVPLIG 668
KIG+G++G+V+ K ++ E VA+K + D + E+ LL + H+N+V L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 669 YCEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
+ + LV+EY + D +G ++ + + Q+ KGL + H+
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM-FQLL----KGLAFCHS---H 118
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 785
++HRD+K N+L++ N K++DFGL+R + S+ T+ Y P+ +G +
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLY 177
Query: 786 TEKSDVYSFGVVLLELISGKKPV----SVED 812
+ D++S G + EL + +P+ V+D
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDD 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 54/202 (26%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 612 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 670
++G G+FG VY K K+ G A K++ + ++ E+ +L+ +H +V L+G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 671 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 730
+ + ++ E+ G + D + +++ LT QI + LE L + IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAV-DAIMLELDRG----LTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 731 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE--- 787
RD+K+ N+LL ++ K++DFG+S + + L S GT ++ PE + + +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTPY 192
Query: 788 --KSDVYSFGVVLLELISGKKP 807
K+D++S G+ L+E+ + P
Sbjct: 193 DYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVK---IMADSCSHRTQQFVTEVALLSRIHHRNLVPL 666
KKIG+G F VY + DG VA+K I + + E+ LL +++H N++
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEYLH 721
E+++ +V E G L + QK L W +Q+ LE++H
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHMH 123
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 781
+ ++HRD+K +N+ + K+ D GL R T S+ GT Y+ PE
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
Query: 782 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 819
KSD++S G +L E+ + + P +G ++N+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-------DSCSHRTQQFVTEVALLSRIHHRN 662
K +GKG+FG V K K G+ A+KI+ D +H +TE +L H
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT----LTENRVLQNSRHPF 56
Query: 663 LVPLIGYCEEEHQRI-LVYEYMHNGTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKG 716
L L Y + H R+ V EY + G L R+R+ + +
Sbjct: 57 LTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR--------FYGAEIVSA 107
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 776
L+YLH+ N +++RD+K N++LD + K++DFGL ++ +D + + GT YL
Sbjct: 108 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLA 164
Query: 777 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
PE + D + GVV+ E++ G+ P +D
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 613 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 668
+GKG FG V +++ GK A K + + + + E +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
E + LV M+ G L+ ++ N D + A + GLE L I
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELCCGLEDLQ---RERI 123
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
++RD+K NILLD ++SD GL+ Q E T V GTVGY+ PE N++ T
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVINNEKYTFS 181
Query: 789 SDVYSFGVVLLELISGKKP 807
D + G ++ E+I G+ P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIHHRN 662
K +GKG+FG V + K G+ A+KI+ D +H VTE +L H
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT----VTESRVLQNTRHPF 56
Query: 663 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
L L Y + H R+ V EY + G L H S + + R A + LEYLH
Sbjct: 57 LTAL-KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLH 112
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 781
+ +++RD+K N++LD + K++DFGL ++ D + + GT YL PE
Sbjct: 113 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLE 168
Query: 782 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
+ D + GVV+ E++ G+ P +D
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 45/213 (21%)
Query: 612 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT---EVALLSRI-HHRNLVPL 666
KIG+G+F V + K GK A+K M Q V E+ L R+ H N++ L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ--VNNLREIQALRRLSPHPNILRL 63
Query: 667 IGYC-EEEHQRI-LV--------YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 716
I + + R+ LV YE + + R ++ ++ +L K
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELI-----KGRKRPLPEKRVKSYMYQL------LKS 112
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 776
L+++H GI HRD+K NIL+ + K++DFG R + ++ T Y
Sbjct: 113 LDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIS--TRWYRA 166
Query: 777 PE------YYGNQQLTEKSDVYSFGVVLLELIS 803
PE YYG K D+++ G V E++S
Sbjct: 167 PECLLTDGYYG-----PKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 63/221 (28%), Positives = 116/221 (52%), Gaps = 28/221 (12%)
Query: 602 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRT-QQFVTEVALL 655
L+E K +G G+FG+VY G + DG+ VA+K++ ++ S + ++ + E ++
Sbjct: 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVM 63
Query: 656 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL-------RDRLHGSVNQKPLDWLTRLQ 708
+ + + L+G C + LV + M G L +DR+ GS Q L+W ++
Sbjct: 64 AGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRI-GS--QDLLNWCVQI- 118
Query: 709 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV 767
AKG+ YL ++HRD+ + N+L+ K++DFGL+R + D T +
Sbjct: 119 -----AKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG 170
Query: 768 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ + ++ E +++ T +SDV+S+GV + EL++ G KP
Sbjct: 171 GKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 81/324 (25%), Positives = 145/324 (44%), Gaps = 48/324 (14%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVK-------IMAD--SCS---HRTQQFVTEVALLSR 657
K +GKGSFG V ++K G+ AVK ++ D C+ R E L+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 658 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 717
++ + +EH V E+++ G L + ++ D A + GL
Sbjct: 61 LY-------CTFQTKEHL-FFVMEFLNGGDLMFHIQ---DKGRFDLYRATFYAAEIVCGL 109
Query: 718 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 777
++LH+ GII+RD+K N++LD + K++DFG+ ++ S+ GT Y+ P
Sbjct: 110 QFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAP 165
Query: 778 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED----FGA-ELNIVHWARSMIKKG-D 831
E + T D +SFGV+L E++ G+ P +D F + ++ H+ R + K+ D
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKD 225
Query: 832 VISIV---DPV----LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884
++ + DP ++GN++ ++ +E+R P + V + D
Sbjct: 226 ILEKLFERDPTRRLGVVGNIRGHPFFKTINWTA--LEKRELD-PPFKPKVKSPSDYSNF- 281
Query: 885 KGGDQKFSSSSSKGQSSRKTLLTS 908
D++F S + S K L+ S
Sbjct: 282 ---DREFLSEKPRLSYSDKNLIDS 302
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 611 KKIGKGSFGSVYYGKMKDGKE--VAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVPL 666
K I G++G+VY + K+ ++ KI + R Q Q E +L+ + +V +
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 667 IGYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
+C E +R L V EY+ G L ++ P+D + R+ A + LEYLH
Sbjct: 67 --FCSFETKRHLCMVMEYVEGGDCATLLK-NIGALPVD-MARMYFA-ETVLALEYLH--- 118
Query: 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT------HISSVAR--------G 770
N GI+HRD+K N+L+ K++DFGLS+ LT HI R G
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178
Query: 771 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
T Y+ PE Q + D ++ G++L E + G P
Sbjct: 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 35/212 (16%)
Query: 612 KIGKGSFGSVYYGKMK-DGKEVAVK-IMAD-------SCSHRTQQFVTEVALLSRIHHRN 662
KIG+G++G VY + K G+ VA+K I + S + R E++LL ++H N
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR------EISLLKELNHPN 59
Query: 663 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 719
+V L+ E++ LV+E++ L ++ PL L I + +G+ Y
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDLD-----LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL---THISSVARGTVGYLD 776
H+ ++HRD+K N+L+D K++DFGL+R + TH V T+ Y
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH--EVV--TLWYRA 167
Query: 777 PE-YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
PE G++Q + D++S G + E+++ ++P
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 8e-12
Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 14/169 (8%)
Query: 647 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 706
Q + E+ +L + +V G + + + E+M G+L D++ + P + L +
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGK 107
Query: 707 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 766
+ IA +GL YL I+HRDVK SNIL++ K+ DFG+S Q I S
Sbjct: 108 VSIA--VLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDS 157
Query: 767 VAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
+A GT Y+ PE + +SD++S G+ L+EL G+ P+ D
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 9e-12
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 613 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPLIG 668
+G GSFG V K K G+ A+K + + +Q E ++L + H +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK--------GLEYL 720
++E++ + E++ G L L + P +D AK EYL
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLR-KAGRFP----------NDVAKFYHAELVLAFEYL 134
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 780
H + II+RD+K N+LLD KV+DFG +++ + + GT YL PE
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC----GTPEYLAPEVI 187
Query: 781 GNQQLTEKSDVYSFGVVLLELISGKKP 807
++ + D ++ GV+L E I+G P
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 606 TNNFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHR 661
NF +GKGSFG V + K E+ A+KI+ + + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 662 NLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLE 718
+ + C + R+ V EY++ G L + G + + A + + GL
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-----QAVFYAAEISVGLF 115
Query: 719 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 778
+LH GII+RD+K N++LD K++DFG+ ++ D + GT Y+ PE
Sbjct: 116 FLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPE 171
Query: 779 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
Q + D +++GV+L E+++G+ P ED
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 612 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQ--------QFVTEVALLSRIH--- 659
+IG G++G+VY + G VA+K S R Q V EVALL R+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALK------SVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 660 HRNLVPLIGYC-----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 714
H N+V L+ C + E + LV+E++ + LR L V L T +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLD-KVPPPGLPAETIKDLMRQFL 118
Query: 715 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 774
+GL++LH C I+HRD+K NIL+ + K++DFGL+R + V T+ Y
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWY 173
Query: 775 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 808
PE D++S G + E+ +KP+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 612 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYC 670
++G G+FG VY + K+ +A + D+ S + ++ E+ +L+ H N+V L+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 671 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 730
E+ ++ E+ G + D + + ++PL + + L YLH IIH
Sbjct: 72 YYENNLWILIEFCAGGAV-DAVMLEL-ERPLTEPQIRVVCKQTLEALNYLH---ENKIIH 126
Query: 731 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-----GNQQL 785
RD+K+ NIL ++ K++DFG+S + + S GT ++ PE ++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPY 185
Query: 786 TEKSDVYSFGVVLLELISGKKP 807
K+DV+S G+ L+E+ + P
Sbjct: 186 DYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 25/233 (10%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRIHHRNL 663
K +GKGSFG V ++K E+ AVK I+ D T +AL + H L
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFL 58
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
L + + + V EY++ G L + D A + GL++LH
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLH-- 113
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDPEYYG 781
GII+RD+K N+LLD K++DFG+ ++ T S GT Y+ PE
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEILS 169
Query: 782 NQQLTEKSDVYSFGVVLLELISGKKPVSVED----FGAELNI-VHWARSMIKK 829
Q D ++ GV+L E+++G+ P +D F + L V + R + K+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKE 222
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 667
+KIG+G++G VY G+ K G+ VA+K I +S + E++LL + H N+V L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
+E + L++E++ + L+ L + +D + +G+ + H+
Sbjct: 66 DVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RR 121
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE-YYGNQ 783
++HRD+K N+L+D K++DFGL+R TH V T+ Y PE G+
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH--EVV--TLWYRAPEVLLGSP 177
Query: 784 QLTEKSDVYSFGVVLLELISGKKPV 808
+ + D++S G + E+ + KKP+
Sbjct: 178 RYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 613 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV-----PL 666
IG+G FG VY + D GK A+K + D + +Q T +AL RI +LV P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGET-LALNERIM-LSLVSTGDCPF 58
Query: 667 I---GYCEEEHQRI-LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
I Y ++ + + M+ G L L HG ++ + + A + GLE++
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY-----AAEIILGLEHM 113
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 780
H N +++RD+K +NILLD + ++SD GL+ + H S GT GY+ PE
Sbjct: 114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 781 GNQQLTEKS-DVYSFGVVLLELISGKKP 807
+ S D +S G +L +L+ G P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 33/218 (15%)
Query: 613 IGKGSFGSVYYGKMKD---------GKEVAVKI-MADSCSHRTQQFVTEVALLSRIHHRN 662
+G+G+F ++Y G ++ G+EV+V + + S + F +L+S++ H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 663 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
LV L G C +E+ I+V EY+ G L LH N L W L +A A L YL
Sbjct: 63 LVKLYGVCVRDEN--IMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLE 118
Query: 722 TGCNPGIIHRDVKSSNILL---DINMR----AKVSDFGLSRQAEEDLTHISSVARGTVGY 774
+ ++H +V NIL+ +N K+SD G+ L+ V R + +
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV---LSREERVER--IPW 170
Query: 775 LDPEYYGNQQ--LTEKSDVYSFGVVLLELIS-GKKPVS 809
+ PE N Q LT +D +SFG LLE+ S G++P+S
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-11
Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 53/237 (22%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR------TQQFVTEVALLSRIHHRNLV 664
KKIG G FG V+ K K +E + S+R Q V EV ++ + H+N+V
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEF---FCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIV 75
Query: 665 PLIG-YCEEEHQRI-LVYEYMHNGTLRD------RLHGSVNQKPLDWLTRLQIAHDAAKG 716
I + + +Q++ ++ E+ G L ++ G + + + +TR Q+ H
Sbjct: 76 RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR-QLLH----A 130
Query: 717 LEYLHT---GCN-PGIIHRDVKSSNILLDINMR-----------------AKVSDFGLSR 755
L Y H G N ++HRD+K NI L +R AK+ DFGLS+
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
Query: 756 QAEEDLTHISSVARGTVG---YLDPEY--YGNQQLTEKSDVYSFGVVLLELISGKKP 807
I S+A VG Y PE + + +KSD+++ G ++ EL SGK P
Sbjct: 191 N-----IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLI 667
K IG+G++G V K + ++VA+K +A++ +R T E+ LL + H N++ +
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 668 GYCEEEHQRI-----LVYEYMHNGTLRDRLHGSV--NQKPLD-----WLTRLQIAHDAAK 715
H+ +VYE M LH + +Q D +L +L +
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQL------LR 119
Query: 716 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVG 773
GL+Y+H+ ++HRD+K SN+LL+ N K+ DFGL+R E ++ V R
Sbjct: 120 GLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR---W 173
Query: 774 YLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPV 808
Y PE N + T DV+S G + EL+ G+KP+
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 613 IGKGSFGSV------YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 666
+GKG FG V GKM K++ K + + + E +L +++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMA--LLEKEILEKVNSPFIVNL 58
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
E + LV M+ G L+ ++ +V ++ L+ + + G+ +LH+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIY-NVGERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 786
I++RD+K N+LLD ++SD GL+ + ++ T I+ A GT GY+ PE + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-ITQRA-GTNGYMAPEILKEEPYS 172
Query: 787 EKSDVYSFGVVLLELISGKKP 807
D ++ G + E+++G+ P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 52/169 (30%), Positives = 83/169 (49%), Gaps = 14/169 (8%)
Query: 647 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 706
Q + E+ +L + +V G + + + E+M G+L D++ + P L +
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 107
Query: 707 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 766
+ IA KGL YL I+HRDVK SNIL++ K+ DFG+S Q I S
Sbjct: 108 VSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDS 157
Query: 767 VAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
+A GT Y+ PE + +SD++S G+ L+E+ G+ P+ D
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 36/213 (16%)
Query: 612 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI- 667
IG+G++G V K G +VA+K ++ H+T Q+ + E+ +L R H N++ ++
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFKHENIIGILD 70
Query: 668 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL--DWLTRL--QIAHDAAKGLEY 719
E + +V E M L+ + + L D + QI +GL+Y
Sbjct: 71 IIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQIL----RGLKY 121
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS------VARGTVG 773
+H N ++HRD+K SN+LL+ N K+ DFGL+R A D H + VA T
Sbjct: 122 IH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIA--DPEHDHTGFLTEYVA--TRW 174
Query: 774 YLDPEYYGNQQLTEKS-DVYSFGVVLLELISGK 805
Y PE N + K+ D++S G +L E++S +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 65/244 (26%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 611 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQFVT----EVALLSRIHHRN 662
K +GKG +G V+ + G + A+K++ + R Q+ E +L + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 663 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS---VNQKPLDWLTRLQIAHDAAKGLEY 719
+V LI + + L+ EY+ G L L + +L+ + +A LE+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA------LEH 115
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDP 777
LH GII+RD+K NILLD K++DFGL +++ E +TH GT+ Y+ P
Sbjct: 116 LHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMAP 169
Query: 778 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED--------FGAELNI----VHWARS 825
E + D +S G ++ ++++G P + E+ +LN+ AR
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARD 229
Query: 826 MIKK 829
++KK
Sbjct: 230 LLKK 233
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 32/210 (15%)
Query: 611 KKIGKGSFGSVYYG-KMKDGKEVAVK-----IMADSCSHRTQQFVTEVALLSRIHHRNLV 664
K++G G++G+V + G +VA+K ++ + R + E+ LL + H N++
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR---ELRLLKHMKHENVI 77
Query: 665 PLIGY------CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKG 716
L+ + H LV +M GT +L H +++ + +L + KG
Sbjct: 78 GLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLV-----YQMLKG 130
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 776
L+Y+H GIIHRD+K N+ ++ + K+ DFGL+RQ + ++T T Y
Sbjct: 131 LKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV----TRWYRA 183
Query: 777 PEYYGN-QQLTEKSDVYSFGVVLLELISGK 805
PE N T+ D++S G ++ E+++GK
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 41/111 (36%), Positives = 63/111 (56%), Gaps = 7/111 (6%)
Query: 700 PLDWLTRLQIAHDAAKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758
PLD L+ + A+G+++L + C IHRDV + N+LL AK+ DFGL+R
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIM 263
Query: 759 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
D + + AR V ++ PE + T +SDV+S+G++L E+ S GK P
Sbjct: 264 NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 23/216 (10%)
Query: 611 KKIGKGSFGSVYY----GKMKDGKEVAVKIMADSC---SHRTQQFV-TEVALLSRIHHRN 662
+ +G G++G V+ G GK A+K++ + +T + TE +L +
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 663 -LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
LV L + + + L+ +Y++ G L L+ + + R+ IA + L++LH
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESE--VRVYIA-EIVLALDHLH 122
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 778
GII+RD+K NILLD ++DFGLS++ EE+ + GT+ Y+ PE
Sbjct: 123 ---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC---GTIEYMAPE 176
Query: 779 YY--GNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
G+ + D +S GV+ EL++G P +V+
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-11
Identities = 34/81 (41%), Positives = 50/81 (61%), Gaps = 1/81 (1%)
Query: 421 LKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSL 479
L G IPP + +++ L L L N L+G +P++ +L +L I+HL +N TG +P + SL
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
Query: 480 PNLQELHIENNSFVGEIPPAL 500
P LQ L + +N F GEIP L
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNL 352
|
Length = 968 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-11
Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 34/233 (14%)
Query: 611 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 666
+ IGKG G VY + VA+K + + S ++F+ E + + + H +VP+
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTR----LQIAHDAAKGL 717
C + Y+ TL+ L SV Q K L T L I H +
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLK-SVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 718 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG--LSRQAEEDLTHISSVAR------ 769
EY+H+ G++HRD+K NILL + + D+G + ++ EE+ V
Sbjct: 127 EYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 770 ---------GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 813
GT Y+ PE +E +D+Y+ GV+L ++++ P +
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236
|
Length = 932 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 42/232 (18%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 666
K +GKG G V+ ++K ++ A+K++ ++ ++ +TE +L+ + H L L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK---GLEYLHTG 723
+ E LV +Y G L + ++P L+ AA+ LEYLH
Sbjct: 67 YASFQTETYLCLVMDYCPGG----ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH-- 120
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA----------------------EEDL 761
GI++RD+K NILL + +SDF LS+Q+
Sbjct: 121 -LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 762 THI-SSVAR-----GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
T R GT Y+ PE D ++ G++L E++ G P
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLS-RIHHRNLVP 665
K +GKGSFG V ++K EV A+K++ + +TE +L+ H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
L + + + V EY++ G L ++ S + D A + L +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH-- 115
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQ 783
G+I+RD+K NILLD K++DFG+ ++ T + GT Y+ PE
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQEL 171
Query: 784 QLTEKSDVYSFGVVLLELISGKKPVSVED 812
+ D ++ GV++ E+++G+ P ++
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 612 KIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVT---EVALLSRIHHRNLVPL 666
+I +G++G VY + K G+ VA+K + + + +T E+ +L ++ H N+V +
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEK--EKEGFPITSLREINILLKLQHPNIVTV 69
Query: 667 --IGYCEEEHQRILVYEYMHNG--TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
+ + +V EY+ + +L + + Q + L LQ+ G+ +LH
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM-LQLL----SGVAHLHD 124
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 781
I+HRD+K+SN+LL+ K+ DFGL+R+ L + + T+ Y PE G
Sbjct: 125 NW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLLG 180
Query: 782 NQQLTEKSDVYSFGVVLLELISGKKPV 808
++ + D++S G + EL++ KKP+
Sbjct: 181 AKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 33/211 (15%)
Query: 613 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI--GY 669
IG+G FG VY + D GK A+K + D + +Q T +AL RI ++ L+ G
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGET-LALNERI----MLSLVSTGD 55
Query: 670 C----------EEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 717
C + + + M+ G L L HG ++K + + A + GL
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY-----ATEIILGL 110
Query: 718 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 777
E++H N +++RD+K +NILLD + ++SD GL+ + H S GT GY+ P
Sbjct: 111 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 164
Query: 778 EYYGNQQLTEKS-DVYSFGVVLLELISGKKP 807
E + S D +S G +L +L+ G P
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 69/268 (25%), Positives = 112/268 (41%), Gaps = 75/268 (27%)
Query: 611 KKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRN 662
K +G G+FG V K VAVK++ + + + ++E+ +L I +H N
Sbjct: 13 KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLN 72
Query: 663 LVPLIGYCEEEHQRILV-YEYMHNGTL---------------------RDRLHGSVNQKP 700
+V L+G C + + ++V E+ G L R R V Q
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 701 LD--------------------------------WLTRLQI------AHDAAKGLEYLHT 722
+D W + L + + A+G+E+L +
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192
Query: 723 -GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYY 780
C IHRD+ + NILL N K+ DFGL+R +D ++ AR + ++ PE
Sbjct: 193 RKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248
Query: 781 GNQQLTEKSDVYSFGVVLLELIS-GKKP 807
++ T +SDV+SFGV+L E+ S G P
Sbjct: 249 FDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-11
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 611 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 667
K IG G+ G V G VAVK ++ ++T ++ E+ LL ++H+N++ L+
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 668 GY------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
EE LV E M + L +H ++ + + +L + G+++LH
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQMLC-----GIKHLH 140
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 781
+ GIIHRD+K SNI++ + K+ DFGL+R A + V T Y PE
Sbjct: 141 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVIL 195
Query: 782 NQQLTEKSDVYSFGVVLLELISG 804
E D++S G ++ EL+ G
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-11
Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 30/207 (14%)
Query: 613 IGKGSFGSV---YYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPL 666
+G G++GSV Y +++ ++VAVK ++ S H + + E+ LL + H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGL 79
Query: 667 IGY------CEEEHQRILVYEYMHNGTLRDRLHGSVN-QKPLDWLTRLQIAHDAAKGLEY 719
+ E ++ LV M L+ V QK D + I + +GL+Y
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGAD-----LNNIVKCQKLSDEHVQFLI-YQLLRGLKY 133
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 779
+H+ GIIHRD+K SN+ ++ + ++ DFGL+RQA++++T VA T Y PE
Sbjct: 134 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT--GYVA--TRWYRAPEI 186
Query: 780 YGN-QQLTEKSDVYSFGVVLLELISGK 805
N + D++S G ++ EL+ GK
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 36/223 (16%)
Query: 613 IGKGSFGSVYYGK-MKDGKEVAVKI-----MADSCSHRTQQFVTEVALLSRIH------- 659
+G G+ G+V K + DG+ AVK+ M+++ +R Q EV L
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ---AEVCCLLNCDFFSIVKC 96
Query: 660 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 718
H + E I LV +Y + G LR + R H+A GL
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT------NRTFREHEA--GLL 148
Query: 719 YL------HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--- 769
++ H + +IHRD+KS+NILL N K+ DFG S+ ++ V R
Sbjct: 149 FIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS--DDVGRTFC 206
Query: 770 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
GT Y+ PE + + ++K+D++S GV+L EL++ K+P E+
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEV-ALLSRIHHRNLVP 665
K IGKGSFG V + K + K AVK++ + ++E LL + H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
L + + V +Y++ G L H + L+ R A + A L YLH+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELF--YHLQRERCFLEPRARFYAA-EIASALGYLHS--- 114
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 785
I++RD+K NILLD ++DFGL ++ E S+ GT YL PE Q
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQPY 173
Query: 786 TEKSDVYSFGVVLLELISGKKP 807
D + G VL E++ G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 27/207 (13%)
Query: 611 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 665
K++G G++GSV + G++VA+K + S +++ F E+ LL + H N++
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLKHMQHENVIG 78
Query: 666 LIGY------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 719
L+ +E LV YM + H +++ + +L + GL+Y
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH-PLSEDKVQYLV-----YQMLCGLKY 132
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 779
+H+ GIIHRD+K N+ ++ + K+ DFGL+R A+ ++T T Y PE
Sbjct: 133 IHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEV 185
Query: 780 YGN-QQLTEKSDVYSFGVVLLELISGK 805
N + D++S G ++ E+++GK
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 613 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 667
+G G++GSV K G VAVK ++ S H + + E+ LL + H N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 668 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
EE + + ++ L + + QK D + I + +GL+Y+H+
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 139
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 782
IIHRD+K SN+ ++ + K+ DFGL+R ++++T VA T Y PE N
Sbjct: 140 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVA--TRWYRAPEIMLNW 192
Query: 783 QQLTEKSDVYSFGVVLLELISGK 805
+ D++S G ++ EL++G+
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVT-----EVALLSRIHHRNLV 664
+K+G+GS+ +VY G + +G+ VA+K++ S +T++ V E +LL + H N+V
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVI----SMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP--LDWLTRLQIAHDAAKGLEYLHT 722
L + V+EYMH L + Q P L +GL Y+H
Sbjct: 67 LLHDIIHTKETLTFVFEYMHTD-----LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH- 120
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPE-YY 780
I+HRD+K N+L+ K++DFGL+R ++ T+ S V T+ Y P+
Sbjct: 121 --GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLL 176
Query: 781 GNQQLTEKSDVYSFGVVLLELISGK 805
G + D++ G + +E++ G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 613 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 663
IG+GS+ V ++K ++ A+K++ H +T++ V E A + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF----L 58
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
V L + + LV EY++ G L H +K + R A + L +LH
Sbjct: 59 VGLHSCFQTTSRLFLVIEYVNGGDLM--FHMQRQRKLPEEHARFYAA-EICIALNFLH-- 113
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 783
GII+RD+K N+LLD + K++D+G+ ++ S+ GT Y+ PE +
Sbjct: 114 -ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEILRGE 171
Query: 784 QLTEKSDVYSFGVVLLELISGKKPVSV 810
+ D ++ GV++ E+++G+ P +
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD-SCSHRTQQ--FVTEVALLSRIHHRNLVPL 666
K IG+G+FG V + K ++V A+K+++ R+ F E +++ + +V L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
+++ +V EYM G L + + S P W + A + L+ +H+
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKW-AKFYTA-EVVLALDAIHS---M 161
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-------- 778
G+IHRDVK N+LLD + K++DFG + +E A GT Y+ PE
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 779 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
YYG + D +S GV L E++ G P
Sbjct: 222 GYYGRE-----CDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 613 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRN---LVP 665
IGKG+FG VY + KD + + A+K+++ ++ + E +L R +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
L + + LV +YM G L L G ++ + IA + LE+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDR----AKFYIA-ELVLALEHLHKY 115
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYG 781
I++RD+K NILLD + DFGLS+ + T+ GT YL PE
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEYLAPEVLL 169
Query: 782 NQQ-LTEKSDVYSFGVVLLELISGKKPVSVED 812
+++ T+ D +S GV++ E+ G P ED
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-10
Identities = 36/100 (36%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 408 PPRITKIA------LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRI 460
P +T + L+ L G+IP EL M++L ++L N L+G +P ++ L L
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
Query: 461 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
+ L N LTG +PS +G+L NLQ L + N G IPP++
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI 280
|
Length = 968 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 68/272 (25%), Positives = 108/272 (39%), Gaps = 64/272 (23%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 666
K IG+G+FG V + KD G A+K + S +Q E +L+ + +V L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 667 IGYC--EEEHQRILVYEYMHNG---TL---RDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 718
Y ++E+ L+ EY+ G TL +D TR IA + ++
Sbjct: 67 --YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE--------TRFYIA-ETILAID 115
Query: 719 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL--------SRQAEEDLTHISS---- 766
+H G IHRD+K N+LLD K+SDFGL + L+H
Sbjct: 116 SIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 767 ----------------------VARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLEL 801
+A TVG Y+ PE + ++ D +S GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 802 ISGKKP-VSVEDFGAELNIVHWARSMIKKGDV 832
+ G P S I++W ++ +V
Sbjct: 233 LVGYPPFCSDNPQETYRKIINWKETLQFPDEV 264
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 613 IGKGSFGSVYYGKMKDGKEV-AVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIG 668
IGKGSFG V + +D + + A+K + + + E +L++++ +VPL
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
+ + LV +++ G L L G + R A + LE LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDL----SRARFYTA-ELLCALENLHKF--- 112
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQ 784
+I+RD+K NILLD + DFGL + ++D T+ GT YL PE
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC---GTPEYLAPELLLGHG 169
Query: 785 LTEKSDVYSFGVVLLELISGKKPVSVED 812
T+ D ++ GV+L E+++G P E+
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDEN 197
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 30/232 (12%)
Query: 613 IGKGSFGSVYYGKMKDGKEV-AVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIG 668
+G+G FG V + K ++ A+K+M S F E +LS + + L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD------WLTRLQIAHDAAKGLEYLHT 722
+++ LV EY G L L + + D +L L +A +H+
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLA---------IHS 117
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY--- 779
G +HRD+K N+L+D K++DFG + + + S + GT Y+ PE
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 780 ---YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVHWARSM 826
G + D +S GV+ E+I G+ P E A+ NI+++ R +
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH-EGTSAKTYNNIMNFQRFL 228
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 38/97 (39%), Positives = 58/97 (59%), Gaps = 7/97 (7%)
Query: 714 AKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGT 771
A+G+E+L + C IHRD+ + NILL N K+ DFGL+R +D ++ AR
Sbjct: 183 ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 772 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ ++ PE ++ T +SDV+SFGV+L E+ S G P
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 612 KIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
K+G+G++ +V+ G+ K VA+K I + + EV+LL + H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA-------KGLEYLHT 722
E LV+EY+ + ++ LD L H+ +GL Y H
Sbjct: 72 IHTERCLTLVFEYLDSDL----------KQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH- 120
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 781
I+HRD+K N+L++ K++DFGL+R A+ T S T+ Y P+ G
Sbjct: 121 --KRKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLG 177
Query: 782 NQQLTEKSDVYSFGVVLLELISGK 805
+ + + D++ G +L E+ +G+
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-10
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 600 PELEEATNNFCKKIGKGSFGSVYYG-KMKDGKEVAVKIMADS---CSHRTQQFVTEVALL 655
P +EE K I +G+FG VY G K + K AVK++ + + Q E L
Sbjct: 1 PSIEEFV--IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDAL 58
Query: 656 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDA 713
+ +V L + + LV EY+ G ++ LH G +++ ++ +
Sbjct: 59 ALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE-----MAVKYISEV 113
Query: 714 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755
A L+YLH GIIHRD+K N+L+ K++DFGLS+
Sbjct: 114 ALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-10
Identities = 42/160 (26%), Positives = 83/160 (51%), Gaps = 5/160 (3%)
Query: 650 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQ 708
+E+ L+ H +V + + + +L+ EY G L ++ + + P
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 709 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSV 767
+ + L+ +H+ ++HRD+KS+NI L K+ DFG S+Q + ++ ++S
Sbjct: 174 LFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 768 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
GT YL PE + ++ ++K+D++S GV+L EL++ +P
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 5e-10
Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 36/212 (16%)
Query: 611 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRTQQFVT-------EVALLSRIHH 660
K IG G+ G V Y G+ VA+K ++ R Q VT E+ L+ ++H
Sbjct: 22 KPIGSGAQGIVCAAYD--TVTGQNVAIKKLS-----RPFQNVTHAKRAYRELVLMKLVNH 74
Query: 661 RNLVPLIGYCE-----EEHQRI-LVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 713
+N++ L+ EE Q + LV E M N L V Q LD + +
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN------LC-QVIQMDLDHERMSYLLYQM 127
Query: 714 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 773
G+++LH + GIIHRD+K SNI++ + K+ DFGL+R A V T
Sbjct: 128 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 182
Query: 774 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 805
Y PE E D++S G ++ E+I G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 9e-10
Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 45/236 (19%)
Query: 609 FCKKIGKGSFG---SVYYGKMKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRIH-HRN 662
K++G+G++G S + + + VA+K + + S + ++ + E+ LL H+N
Sbjct: 4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKN 63
Query: 663 LVPLI--------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH--- 711
+ L + E + +YE + L + L AH
Sbjct: 64 ITCLYDMDIVFPGNFNE-----LYLYEELMEADLHQIIRSGQ---------PLTDAHFQS 109
Query: 712 ---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR----QAEEDLTHI 764
GL+Y+H+ ++HRD+K N+L++ + K+ DFGL+R E+ +
Sbjct: 110 FIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166
Query: 765 SS-VARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 818
+ VA T Y PE Q T+ DV+S G +L EL+ K +D+ +LN
Sbjct: 167 TEYVA--TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLN 220
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-10
Identities = 39/109 (35%), Positives = 58/109 (53%), Gaps = 5/109 (4%)
Query: 701 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760
LD L ++ AKG+ +L + IHRD+ + NILL K+ DFGL+R D
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 761 LTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ + AR V ++ PE N T +SDV+S+G++L E+ S G P
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 613 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 663
IG+GS+ V ++K + + A+K++ + +T++ V E A +H L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----SNHPFL 58
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
V L + E + V EY++ G L H +K + R A + + L YLH
Sbjct: 59 VGLHSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPEEHARFYSA-EISLALNYLH-- 113
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 783
GII+RD+K N+LLD K++D+G+ ++ +S GT Y+ PE +
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGE 171
Query: 784 QLTEKSDVYSFGVVLLELISGKKPVSV 810
D ++ GV++ E+++G+ P +
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD-SCSHRTQQ--FVTEVALLSRIHHRNLVPL 666
K IG+G+FG V + K ++V A+K+++ R+ F E +++ + +V L
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
+++ +V EYM G L + + S P W R A + L+ +H+
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EVVLALDAIHS---M 161
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-------- 778
G IHRDVK N+LLD + K++DFG + ++ A GT Y+ PE
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 779 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
YYG + D +S GV L E++ G P
Sbjct: 222 GYYGRE-----CDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 613 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVP---- 665
IGKGS+G V G++VA+K + D H + + + E+ LL + H ++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 666 LIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 721
++ E + I +V+E M + LH + K D LT + + L+Y+H
Sbjct: 68 MLPPSRREFKDIYVVFELMESD-----LHQVI--KANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THI---SSVARGTVGYLDP 777
T + HRD+K NIL + + + K+ DFGL+R A D T I VA T Y P
Sbjct: 121 TA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA--TRWYRAP 175
Query: 778 EYYGN--QQLTEKSDVYSFGVVLLELISGK 805
E G+ + T D++S G + E+++GK
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 39/97 (40%), Positives = 58/97 (59%), Gaps = 7/97 (7%)
Query: 714 AKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGT 771
AKG+E+L + C IHRD+ + NILL N K+ DFGL+R +D ++ AR
Sbjct: 189 AKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 772 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ ++ PE ++ T +SDV+SFGV+L E+ S G P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 612 KIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 666
K+G+G++G VY K KDG KE A+K + + + E+ALL + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQK 65
Query: 667 IGYCEEEHQRILVYEYMHNG---TLRDRLHGSVNQKPLDWLTRL--QIAHDAAKGLEYLH 721
+ + + L+++Y + ++ N+KP+ + + + G+ YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 722 TGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSV--ARGTVGYL 775
++HRD+K +NIL+ R K++D G +R L ++ + T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 776 DPE-YYGNQQLTEKSDVYSFGVVLLELISGK 805
PE G + T+ D+++ G + EL++ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 60/241 (24%), Positives = 111/241 (46%), Gaps = 53/241 (21%)
Query: 612 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQF----VTEVALLSRIHHRNLVP 665
KIG+G+FG V+ + K K+ VA+K ++ + + + F + E+ +L + H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLME---NEKEGFPITALREIKILQLLKHENVVN 75
Query: 666 LIGYCEEEHQR--------ILVYEYM-HNGTLRDRLHGSVNQKPLDW-LTRLQ-IAHDAA 714
LI C + LV+E+ H+ L G ++ K + + L+ ++ +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEHD------LAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 715 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGT 771
GL Y+H I+HRD+K++NIL+ + K++DFGL+R ++ + + T
Sbjct: 130 NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 772 VGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 830
+ Y PE G + D++ G ++ E+ W RS I +G
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEM--------------------WTRSPIMQG 226
Query: 831 D 831
+
Sbjct: 227 N 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 611 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 666
K IG G+ G V Y + D + VA+K ++ ++T ++ E+ L+ ++H+N++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 667 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
+ EE Q + + + + L + ++ + + +L + G+++LH
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 136
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 781
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 191
Query: 782 NQQLTEKSDVYSFGVVLLELISGK 805
E D++S G ++ E++ K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 611 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 666
K IG G+ G V Y + + + VA+K ++ ++T ++ E+ L+ ++H+N++ L
Sbjct: 30 KPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 667 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
+ EE Q + + + + L + ++ + + +L + G+++LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 143
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 781
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 198
Query: 782 NQQLTEKSDVYSFGVVLLELISGK 805
E D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 53/219 (24%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 611 KKIGKGSFGSVYY----GKMKDGKEVAVKIMADSC---SHRTQQFV-TEVALLSRIHHRN 662
K +G G++G V+ GK A+K++ + +T + TE +L +
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 663 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK------ 715
+ + Y + ++ L+ +Y+ G + L+ R + D +
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-----------QRDNFSEDEVRFYSGEI 114
Query: 716 --GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 773
LE+LH GI++RD+K NILLD ++DFGLS++ + + GT+
Sbjct: 115 ILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 774 YLDPEYYGNQQLTEKS-DVYSFGVVLLELISGKKPVSVE 811
Y+ PE + K+ D +S G+++ EL++G P ++E
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 37/219 (16%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-- 667
+ +G GS G V+ D K VAVK + + + + E+ ++ R+ H N+V +
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 668 ----GYCEEEHQRIL--------VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 715
G E L V EYM L + Q PL + +
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLSEEHARLFMYQLLR 125
Query: 716 GLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVG- 773
GL+Y+H+ ++HRD+K +N+ ++ ++ K+ DFGL+R + +H ++ G V
Sbjct: 126 GLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 774 -------YLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 805
L P Y T+ D+++ G + E+++GK
Sbjct: 183 WYRSPRLLLSPNNY-----TKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 37/213 (17%)
Query: 611 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQ--------FVTEVALLSRIHHR 661
+KIG+G++G VY + + E +A+K + R +Q + E++LL + H
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKI------RLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 662 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA----HDAAKGL 717
N+V L E + LV+EY L L ++ P D+ ++ + +G+
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSP-DFAKNPRLIKTYLYQILRGI 115
Query: 718 EYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGTVG 773
Y H+ ++HRD+K N+L+D A K++DFGL+R TH V T+
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH--EVV--TLW 168
Query: 774 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 805
Y PE G++ + D++S G + E+++ K
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-09
Identities = 35/85 (41%), Positives = 49/85 (57%), Gaps = 1/85 (1%)
Query: 414 IALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSL 472
I L NL GEIP E+ + +L L L N LTGP+P + L +L+ + L N+L+G +
Sbjct: 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276
Query: 473 PSYMGSLPNLQELHIENNSFVGEIP 497
P + SL L L + +NS GEIP
Sbjct: 277 PPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 53/212 (25%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 612 KIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 666
K+G+G++G VY K KDG ++ A+K + + + E+ALL + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 65
Query: 667 IGYCEEEHQRILVYEYMHNG---TLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYL 720
+ + + L+++Y + ++ N+KP+ L R + + G+ YL
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ-LPRGMVKSLLYQILDGIHYL 124
Query: 721 HTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSV--ARGTVGY 774
H ++HRD+K +NIL+ R K++D G +R L ++ + T Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 775 LDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 805
PE G + T+ D+++ G + EL++ +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 612 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
K+G+G++ +VY G+ K VA+K I + + EV+LL + H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 670 CEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
E LV+EY+ + D S+N + L Q+ +GL Y H
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVK-LFLFQLL----RGLNYCH---RRK 124
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLT 786
++HRD+K N+L++ K++DFGL+R A+ T S T+ Y P+ G+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 787 EKSDVYSFGVVLLELISGK 805
+ D++ G + E+ +G+
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 36/209 (17%)
Query: 612 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ-------FVTEVALLSRIHHRNL 663
K+G+GS+ +VY G+ K G+ VA+K + R + + E +LL + H N+
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEI------RLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA-------KG 716
V L + LV+EY+ D ++ +D H+ +G
Sbjct: 66 VTLHDIIHTKKTLTLVFEYLD----TDL------KQYMDDCGGGLSMHNVRLFLFQLLRG 115
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 776
L Y H ++HRD+K N+L+ K++DFGL+R A+ + S T+ Y
Sbjct: 116 LAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRP 171
Query: 777 PE-YYGNQQLTEKSDVYSFGVVLLELISG 804
P+ G+ + + D++ G + E+ +G
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 613 IGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLIGY 669
+G+G++G V + K+ KE VA+K DS + + T E+ +L + N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 670 CEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
+ LV+EY+ L + +G +K ++ +L K + + H
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL------IKAIHWCHKN--- 119
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGYLDPEYYGNQQ 784
I+HRD+K N+L+ N K+ DFG +R E + + VA T Y PE
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA--TRWYRSPELLLGAP 177
Query: 785 LTEKSDVYSFGVVLLELISGK 805
+ D++S G +L EL G+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 613 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 663
IG+GS+ V ++K + + A+K++ + +T++ V E A +H L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETA----SNHPFL 58
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
V L + E + V E++ G L H +K + R A + + L +LH
Sbjct: 59 VGLHSCFQTESRLFFVIEFVSGGDLM--FHMQRQRKLPEEHARFYSA-EISLALNFLHER 115
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDPEYYG 781
GII+RD+K N+LLD K++D+G+ ++ D T S GT Y+ PE
Sbjct: 116 ---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILR 169
Query: 782 NQQLTEKSDVYSFGVVLLELISGKKP 807
+ D ++ GV++ E+++G+ P
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 54/200 (27%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 611 KKIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
+K+G+G++ +V+ G+ K + VA+K I + + EV+LL + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
+ LV+EY+ + L+ + G++ + QI +GL Y H
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQIL----RGLAYCH---RR 123
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 785
++HRD+K N+L++ K++DFGL+R A+ T S T+ Y P+ G+ +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 786 TEKSDVYSFGVVLLELISGK 805
+ + D++ G + E+ SG+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGK--EVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRN 662
NF + +G GSFG V K+ VA+K S + +Q +E +L+ I+H
Sbjct: 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 663 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
V L G ++E LV E++ G L + + P D A EYL +
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPND--VGCFYAAQIVLIFEYLQS 149
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
I++RD+K N+LLD + K++DFG ++ + + GT Y+ PE N
Sbjct: 150 ---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC----GTPEYIAPEILLN 202
Query: 783 QQLTEKSDVYSFGVVLLELISGKKP 807
+ +D ++ G+ + E++ G P
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 612 KIGKGSFGSVYYG-KMKDGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVP 665
IG G++G V + GK+VA+K + + + RT + E+ +L H N++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT---LRELKILRHFKHDNIIA 68
Query: 666 L--IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL---QIAHDAAKGLE 718
+ I + +V + M + L +H +Q + R Q+ +GL+
Sbjct: 69 IRDILRPPGADFKDVYVVMDLMES-DLHHIIHS--DQPLTEEHIRYFLYQLL----RGLK 121
Query: 719 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA----EEDLTHISS-VARGTVG 773
Y+H+ +IHRD+K SN+L++ + ++ DFG++R E ++ VA T
Sbjct: 122 YIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA--TRW 176
Query: 774 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPV 808
Y PE + T D++S G + E++ G++ +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVA---VKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 666
++IG G FG V ++ VA VK + + S + Q +F+ + + H N++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKGLEYLHTGCN 725
+G C E +LV+EY G L+ L + L LQ +A + A G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEYYGNQQ 784
+H D+ N L ++ KV D+G+ + +ED + +L PE G
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 785 -------LTEKSDVYSFGVVLLELI-SGKKPVS 809
T+ S+V++ GV L EL + +P S
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-08
Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 24/194 (12%)
Query: 620 SVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV--------PLIGYCE 671
S GK K + +A ++ A S Q E+ L R++H N++ Y
Sbjct: 184 STNQGKPKCERLIAKRVKAGS--RAAIQLENEILALGRLNHENILKIEEILRSEANTYMI 241
Query: 672 EEHQRILVYEYMHNGTL--RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 729
+ +Y +M++ +DR PL TR I +EY+H + +I
Sbjct: 242 TQKYDFDLYSFMYDEAFDWKDR--------PLLKQTR-AIMKQLLCAVEYIH---DKKLI 289
Query: 730 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 789
HRD+K NI L+ + + + DFG + E++ GTV PE E +
Sbjct: 290 HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEIT 349
Query: 790 DVYSFGVVLLELIS 803
D++S G++LL+++S
Sbjct: 350 DIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 5e-08
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 15/145 (10%)
Query: 677 ILVYEYMHNGTLRDRLHGSVNQKPLDW-LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKS 735
+L+ +Y+ +G L D L + L + I + L LH IIH D+K
Sbjct: 85 VLIMDYIKDGDLFDLLK---KEGKLSEAEVKK-IIRQLVEALNDLH---KHNIIHNDIKL 137
Query: 736 SNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSF 794
N+L D R + D+GL + + S GT+ Y PE D ++
Sbjct: 138 ENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAV 192
Query: 795 GVVLLELISGKKPVSVEDFGAELNI 819
GV+ EL++GK P ED EL++
Sbjct: 193 GVLTYELLTGKHPF-KEDEDEELDL 216
|
Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-08
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 1/94 (1%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS 474
LS +L GEIP + ++ L L L N TG +P ++ L L+++ L +N+ +G +P
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350
Query: 475 YMGSLPNLQELHIENNSFVGEIPPALLTGKVIFK 508
+G NL L + N+ GEIP L + +FK
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK 384
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-08
Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 1/90 (1%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE 467
P + + LS L GEIP ++ + +L L L GN L G +P ++ L L + L +N+
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199
Query: 468 LTGSLPSYMGSLPNLQELHIENNSFVGEIP 497
L G +P +G + +L+ +++ N+ GEIP
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIP 229
|
Length = 968 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 686 GTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 744
T RD L +N+ P L ++ + ++ A G+E+L + +HRD+ + N+L+
Sbjct: 223 RTRRDTL---INESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGK 276
Query: 745 RAKVSDFGLSRQAEEDLTHISSVARGT----VGYLDPEYYGNQQLTEKSDVYSFGVVLLE 800
K+ DFGL+R D +IS +G+ + ++ PE N T SDV+SFG++L E
Sbjct: 277 LVKICDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE 333
Query: 801 LIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQC 859
+ + G P EL + + IK+G + P + I E+ +C
Sbjct: 334 IFTLGGTPYP------ELPMNEQFYNAIKRG--YRMAKPAHASD-------EIYEIMQKC 378
Query: 860 VEQRGFSRPKMQEIVLAIQD 879
E++ RP ++V + D
Sbjct: 379 WEEKFEIRPDFSQLVHLVGD 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKI----MADSCSHRTQQFVTEVALLSRIHHRN-LV 664
+KIG+G++G VY + K+ GK VA+K M + T + E++LL + +V
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIYIV 64
Query: 665 PLIG--YCEEEHQRI---LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 717
L+ + EE++ + LV+EY+ + L+ + +G +PL T + KG+
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 718 EYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDL---THISSVARGTVG 773
+ H G++HRD+K N+L+D K++D GL R + TH V T+
Sbjct: 124 AHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH-EIV---TLW 176
Query: 774 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISG 804
Y PE G+ + D++S G + E+
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 36/108 (33%), Positives = 60/108 (55%), Gaps = 12/108 (11%)
Query: 701 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760
L L L + A+G+E+L + +HRD+ + N+LL K+ DFGL+R D
Sbjct: 234 LTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR----D 286
Query: 761 LTHISS-VARGT----VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 803
+ H S+ V++G+ V ++ PE + T SDV+S+G++L E+ S
Sbjct: 287 IMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 9e-08
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 628 DGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685
+G+E+ V + SHR F +L+S++ H +L + G C + I+V E++ +
Sbjct: 41 NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 686 GTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 740
G L +++ P+ W ++ +A A L YL + ++H +V + NILL
Sbjct: 101 GPLDVCLRKEKGR-----VPVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNILL 150
Query: 741 DINMRA-------KVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEKSDVY 792
A K+SD G+S A L+ V R + ++ PE G L+ +D +
Sbjct: 151 ARLGLAEGTSPFIKLSDPGVSFTA---LSREERVER--IPWIAPECVPGGNSLSTAADKW 205
Query: 793 SFGVVLLEL-------ISGKKPVSVEDF 813
SFG LLE+ + + P E F
Sbjct: 206 SFGTTLLEICFDGEVPLKERTPSEKERF 233
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 39/206 (18%)
Query: 611 KKIGKGSFGSVYYGKMKDGKE--VAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 666
K + GS G V+ K G+ V +KI + + E LL ++H +++ +
Sbjct: 72 KTLTPGSEGRVFVAT-KPGQPDPVVLKIGQKGTT------LIEAMLLQNVNHPSVIRMKD 124
Query: 667 ------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
I H +Y Y+ T R R PL L I +GL YL
Sbjct: 125 TLVSGAITCMVLPHYSSDLYTYL---TKRSR--------PLPIDQALIIEKQILEGLRYL 173
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDP 777
H IIHRDVK+ NI ++ + + D G ++ A L +A GTV P
Sbjct: 174 HA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL----GLA-GTVETNAP 225
Query: 778 EYYGNQQLTEKSDVYSFGVVLLELIS 803
E + K+D++S G+VL E+++
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 1/92 (1%)
Query: 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNEL 468
R+ + LS G +P +L ++ L +L L N L+G +PD +S L + L +N+L
Sbjct: 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
+G +P+ +P L +L + N GEIP L
Sbjct: 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567
|
Length = 968 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 63/275 (22%), Positives = 107/275 (38%), Gaps = 42/275 (15%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-IGY 669
K IG G FG VY + + + +A + + V E + + I+ + + L
Sbjct: 18 KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI 77
Query: 670 CEEEHQRILVY---------EYMHNGTLRDRLHGSVNQ---------KPLDWLTRLQIAH 711
+H I Y + L ++L + + K L I
Sbjct: 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKL----IKNIMK 133
Query: 712 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS------ 765
D LEY+H GI H D+K NI++D N R + D+G++ HI
Sbjct: 134 DMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190
Query: 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 825
+ RGT+ Y + + +T + D+ S G +L+ + + FG N++H A
Sbjct: 191 DLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKW--AGIKLPWKGFGHNGNLIHAA-- 246
Query: 826 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCV 860
K D I + G +KI++ + I+CV
Sbjct: 247 ---KCDFIKRLHE---GKIKIKNANKFIYDFIECV 275
|
Length = 294 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-07
Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 416 LSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP 473
LS N G IP + N+E L L N L+G +P D+ L+++ L N L G +P
Sbjct: 125 LSNNNFTGSIPRGSIPNLETLD---LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181
Query: 474 SYMGSLPNLQELHIENNSFVGEIPPAL 500
+ + +L +L+ L + +N VG+IP L
Sbjct: 182 NSLTNLTSLEFLTLASNQLVGQIPREL 208
|
Length = 968 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 32/215 (14%)
Query: 612 KIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSHRTQQFVT--EVALLSRIH---HRN 662
+IG+G++G V+ K +D G+ VA+K + T EVA+L + H N
Sbjct: 8 EIGEGAYGKVF--KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 663 LVPLIGYC-----EEEHQRILVYEYMHNG--TLRDRLH--GSVNQKPLDWLTRLQIAHDA 713
+V L C + E + LV+E++ T D++ G + D + +L
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL------ 119
Query: 714 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 773
+GL++LH+ ++HRD+K NIL+ + + K++DFGL+R + T+
Sbjct: 120 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLW 174
Query: 774 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 808
Y PE D++S G + E+ +KP+
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 50/178 (28%), Positives = 78/178 (43%), Gaps = 22/178 (12%)
Query: 662 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
N+V L Y E LV ++ G L + P + + R A + L+ LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-SKFLNIPEECVKRW--AAEMVVALDALH 102
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGYLDPEY 779
GI+ RD+ +NILLD +++ F + E+ D + ++ Y PE
Sbjct: 103 ---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEV 153
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG----AELNIVHW----ARSMIKK 829
G + TE D +S G +L EL++GK V G LNI W ARS++++
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQ 211
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-07
Identities = 34/105 (32%), Positives = 50/105 (47%)
Query: 406 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 465
T P + + +S NL+G I +M +L L L N G LPD L + L
Sbjct: 425 TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSR 484
Query: 466 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYD 510
N+ +G++P +GSL L +L + N GEIP L + K + D
Sbjct: 485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLD 529
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-07
Identities = 34/87 (39%), Positives = 45/87 (51%), Gaps = 1/87 (1%)
Query: 411 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELT 469
+T + LS NL GEIP L + L +L L N L G +P + LR V L++N +
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417
Query: 470 GSLPSYMGSLPNLQELHIENNSFVGEI 496
G LPS LP + L I NN+ G I
Sbjct: 418 GELPSEFTKLPLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 42/223 (18%)
Query: 613 IGKGSFGSVYYGKMKD-----------GKEVAVKIMADSCSHR--TQQFVTEVALLSRIH 659
+G+G+ +Y G + KE+ V + SHR + F +++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 660 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 719
H+++V L G C + + I+V E++ G L +H + W + ++A A L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 720 LHTGCNPGIIHRDVKSSNILL-------DINMRAKVSDFG-----LSRQAEEDLTHISSV 767
L + ++H +V + NILL + K+SD G LSRQ E + I +
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ--ECVERIPWI 175
Query: 768 ARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLEL-ISGKKPV 808
A PE ++ L+ +D +SFG L E+ +G+ P+
Sbjct: 176 A--------PECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 52/186 (27%), Positives = 81/186 (43%), Gaps = 23/186 (12%)
Query: 650 TEVALLSRIHHRNLVPLI-GYCEEEHQRILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRL 707
E+ +L I HR ++ LI Y + +++ +Y + T DR PL +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS------GPLPLEQAI 188
Query: 708 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 767
I + L YLH GIIHRDVK+ NI LD A + DFG + + + H +
Sbjct: 189 TIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA---HPDTP 242
Query: 768 A----RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-HW 822
GT+ PE K+D++S G+VL E+ + FG ++
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL----FGKQVKSSSSQ 298
Query: 823 ARSMIK 828
RS+I+
Sbjct: 299 LRSIIR 304
|
Length = 392 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-06
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 26/206 (12%)
Query: 613 IGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 671
IG GSFG VY D E VA+K + ++ + E+ ++ ++H N++ L Y
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNHINIIFLKDYYY 129
Query: 672 EEHQRI--------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
E + +V E++ + H + N L ++ + L Y+H+
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK 189
Query: 724 CNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE- 778
I HRD+K N+L+D N K+ DFG ++ + +++I S Y PE
Sbjct: 190 F---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRAPEL 241
Query: 779 YYGNQQLTEKSDVYSFGVVLLELISG 804
G T D++S G ++ E+I G
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 42/166 (25%), Positives = 67/166 (40%), Gaps = 47/166 (28%)
Query: 704 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL---------- 753
L R IA + +E +H G IHRD+K NIL+D + K++DFGL
Sbjct: 102 LARFYIA-ELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 754 --------SRQ---------AEEDLTHISSVAR---------------GTVGYLDPEYYG 781
RQ +E D + + R GT Y+ PE
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217
Query: 782 NQQLTEKSDVYSFGVVLLELISGKKPVSVED-FGAELNIVHWARSM 826
T+ D +S GV+L E++ G+ P + +L +++W ++
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 61/245 (24%), Positives = 96/245 (39%), Gaps = 56/245 (22%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 666
K IG+G+FG V + KD G A+KI+ + +Q E +L +V +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 667 IGYCEEEHQRILVYEYMHNGTL------RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
+++ L+ E++ G + +D L Q ++ +A DA L
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF---YIAETVLAIDAIHQL--- 120
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL--------------------------- 753
G IHRD+K N+LLD K+SDFGL
Sbjct: 121 ------GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 754 ----SRQAEEDLTHISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK 806
R+AE + +A TVG Y+ PE + + D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 807 PVSVE 811
P E
Sbjct: 235 PFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 13/99 (13%)
Query: 406 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-------MSRLIDL 458
T+ PR+ + L GEIP L LT L L N LTG +P+ + +LI
Sbjct: 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI-- 386
Query: 459 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 497
L +N L G +P +G+ +L+ + +++NSF GE+P
Sbjct: 387 ----LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421
|
Length = 968 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 48/193 (24%), Positives = 91/193 (47%), Gaps = 22/193 (11%)
Query: 629 GKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 686
G+ V V+ I ++C++ F+ E+ + +H N+VP +++ +V +M G
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84
Query: 687 TLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 743
+ +D + +D ++ L IA+ K L+Y+H + G +HR VK+S+IL+ ++
Sbjct: 85 SAKDLICTHF----MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVD 137
Query: 744 ----MRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGN--QQLTEKSDVYSF 794
+ S+ + + L + + +V +L PE Q KSD+YS
Sbjct: 138 GKVYLSGLRSNLSMINHGQR-LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196
Query: 795 GVVLLELISGKKP 807
G+ EL +G P
Sbjct: 197 GITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 44/239 (18%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 666
K IG+G+FG V + KD G A+KI+ + +Q E +L +V +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
+++ L+ E++ G + L D LT + A+ + + +
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKK------DTLTEEETQFYIAETVLAIDSIHQL 120
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGL-------------------------------SR 755
G IHRD+K N+LLD K+SDFGL R
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 756 QAEEDLTHISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 811
+AE + +A TVG Y+ PE + + D +S GV++ E++ G P E
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 7e-06
Identities = 63/258 (24%), Positives = 98/258 (37%), Gaps = 68/258 (26%)
Query: 611 KKIGKGSFGSV-YYGKMKDGKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 666
K IGKG+FG V K GK A+K + S + Q E +L+ +V L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW------LTRLQIAHDAAKGLEYL 720
++ L+ E++ G L L + + +TR +A + +E +
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFSEDVTRFYMA-ECVLAIEAV 117
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS---------------RQAEEDLTHIS 765
H G IHRD+K NIL+D K+SDFGLS Q + + I
Sbjct: 118 H---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 766 S----------------------------VARGTVG---YLDPEYYGNQQLTEKSDVYSF 794
+ +A TVG Y+ PE + Q ++ D +S
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234
Query: 795 GVVLLELISGKKPVSVED 812
G ++ E + G P E+
Sbjct: 235 GAIMFECLIGWPPFCSEN 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-05
Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 1/86 (1%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 474
L N G+IP L ++ L L L N +G +P ++ + +L ++ L N LTG +P
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374
Query: 475 YMGSLPNLQELHIENNSFVGEIPPAL 500
+ S NL +L + +NS GEIP +L
Sbjct: 375 GLCSSGNLFKLILFSNSLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 36/150 (24%), Positives = 61/150 (40%), Gaps = 53/150 (35%)
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGL--------------------------------- 753
G IHRD+K NIL+D++ K++DFGL
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 754 ----------------SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVV 797
++Q + L H S V GT Y+ PE + T+ D +S GV+
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAH-SLV--GTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 798 LLELISGKKP-VSVEDFGAELNIVHWARSM 826
L E++ G+ P ++ +L +++W ++
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 612 KIGKG--SFGSVYYGK-MKDGKEVAVKIM-ADSCS-HRTQQFVTEVALLSRIHHRNLVPL 666
+IG+G + SVY + G V V+I ++C+ + EV L H N++
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
++ +M G+ L + + L I A +GL YLH
Sbjct: 65 WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG-NILFGALRGLNYLHQN--- 120
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSR--------QAEEDLTHISSVARGTVGYLDPE 778
G IHR++K+S+IL I+ VS GLS Q + + + + +L PE
Sbjct: 121 GYIHRNIKASHIL--ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 779 YYGNQQL---TEKSDVYSFGVVLLELISGKKP 807
Q L KSD+YS G+ EL +G+ P
Sbjct: 179 LL-RQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 36/147 (24%), Positives = 58/147 (39%), Gaps = 47/147 (31%)
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLS------------------RQAEEDLT------ 762
G IHRD+K NIL+D + K++DFGL RQ D +
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 763 -------------------HISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLE 800
H +A VG Y+ PE T+ D +S GV+L E
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240
Query: 801 LISGKKP-VSVEDFGAELNIVHWARSM 826
++ G+ P ++ ++ +++W S+
Sbjct: 241 MLVGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 26/99 (26%), Positives = 43/99 (43%), Gaps = 3/99 (3%)
Query: 707 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 766
L I + ++YLH IIHRD+K+ NI ++ + DFG + + +
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 767 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 805
GT+ PE D++S G+VL E+ +
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 32/149 (21%), Positives = 54/149 (36%), Gaps = 17/149 (11%)
Query: 610 CKKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VP-L 666
K + G VY + E +KI + EVA+L + + L VP +
Sbjct: 3 IKLLKGGLTNRVY--LLGTKDEDYVLKINPSR--EKGADREREVAILQLLARKGLPVPKV 58
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
+ E + L+ E++ TL + + IA A+ L LH
Sbjct: 59 LASGESDGWSYLLMEWIEGETL----------DEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSR 755
+ H D+ NIL+D + D+ +
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 7e-04
Identities = 29/105 (27%), Positives = 48/105 (45%), Gaps = 8/105 (7%)
Query: 699 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758
+PL +A ++Y+H GIIHRD+K+ N+L++ + DFG + A
Sbjct: 255 RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311
Query: 759 EDLTHISSVARGTVGYLD---PEYYGNQQLTEKSDVYSFGVVLLE 800
+ + G G +D PE T D++S G+V+ E
Sbjct: 312 GSWS--TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 10/89 (11%)
Query: 609 FCKKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ--FVTEVALLSRI-H 659
F K +G G+FG V GK + VAVK M + +H ++ ++E+ +LS +
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVK-MLKASAHTDEREALMSELKILSHLGQ 100
Query: 660 HRNLVPLIGYCEEEHQRILVYEYMHNGTL 688
H+N+V L+G C +++ EY G L
Sbjct: 101 HKNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 20/60 (33%), Positives = 30/60 (50%), Gaps = 3/60 (5%)
Query: 435 LTELWLDGNFLTGPLPDMS--RLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 492
L L L N LT +PD + L +L+++ L N LT P LP+L+ L + N+
Sbjct: 2 LKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.003
Identities = 30/83 (36%), Positives = 46/83 (55%), Gaps = 2/83 (2%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 467
+ + LSG N ++PPE++ + AL EL L N + L +S L +L + L NN+
Sbjct: 185 LSNLNNLDLSG-NKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNK 243
Query: 468 LTGSLPSYMGSLPNLQELHIENN 490
L LP +G+L NL+ L + NN
Sbjct: 244 LE-DLPESIGNLSNLETLDLSNN 265
|
Length = 394 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 927 | |||
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.69 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.63 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.54 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.53 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.37 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.19 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.03 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.94 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.92 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.9 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.85 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.82 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.74 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.72 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.72 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.68 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.64 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.56 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.52 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.51 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.5 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.45 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.45 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.44 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.42 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.39 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.37 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.37 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.31 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.3 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.25 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.19 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.17 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.17 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.12 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.11 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.1 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.09 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.09 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.07 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.06 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.02 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.01 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.01 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 97.99 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.94 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 97.93 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 97.86 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.84 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 97.8 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 97.77 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.73 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 97.72 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 97.71 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.7 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.69 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.68 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 97.68 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.65 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 97.63 |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-81 Score=753.94 Aligned_cols=528 Identities=24% Similarity=0.401 Sum_probs=409.7
Q ss_pred HHHHHHHHHhhhcccCCeEEEecCCCCCccCCCCCeEEecCCccccCCceeeecCCCCCcccccccccccC-CCccceee
Q 002410 8 LVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPI-DNKKYCYN 86 (927)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~idcg~~~~~~~~~~~~~~~~d~~~~~~g~~~~~~~~~~~~~~~~tlr~fp~-~~~~~cy~ 86 (927)
+..+++++.+.+.++.++++||||++++++.+.+|++|++|..|+. |....+..+....+++.|+|+||. .|++|||+
T Consensus 8 ~~~~~~~~~~~~~~~~~~~~I~CGs~~~~~~d~~~~~w~~D~~~~~-~~~~~~~~~~~~~~~~~t~R~F~~~~g~~~cY~ 86 (623)
T PLN03150 8 ASALLAVLASLASPEPFTMRISCGARVNVRTAPTNTLWYKDFAYTG-GIPANATRPSFIAPPLKTLRYFPLSDGPENCYN 86 (623)
T ss_pred HHHHHHhhcccccCCCccEEEeCCCCCCcccCCCCCEEcCCccccc-CccccccCcccccchhhccccCCcccccccceE
Confidence 3344566667777888999999999988843368999999999854 454444445556788999999996 58999999
Q ss_pred ecccCCceeEEEEEeeecCCCCCCCCCeEEEEEcCceeEEEEec--CCccceEEEEEEecCCCCcccceecccCCCceee
Q 002410 87 LITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVL--DASRVYAKEMIIRAPSDSIDVCICCAVTGSPFIS 164 (927)
Q Consensus 87 l~~~~~~~ylvr~~~~yg~yd~~~~~p~fd~~~~~~~w~~v~~~--~~~~~~~~e~~~~~~~~~~~vcl~~~~~~~pfis 164 (927)
||+++++|||||++|+|||||+++++|.|||++|||+|.+|... ..+...++|+|+.+++++++|||+++++|+||||
T Consensus 87 ~~~~~~g~ylVRl~F~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pFIs 166 (623)
T PLN03150 87 INRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAIL 166 (623)
T ss_pred eeecCCCcEEEEEEeecCCcCCCCCCCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCcee
Confidence 99999999999999999999999999999999999999999752 2344566899999999999999999999999999
Q ss_pred eeeeeecCCCCCccc--ccccceEEEEEeeccCCCC-CCcccCCCCCC--CCcccCCCCCCCCcccccCCceeeeeeccc
Q 002410 165 TLELRPLNLSMYATD--FEDNFFLKVAARVNFGALT-KDALRYPDDPY--DRIWDSDLDRRPNFVVGAASGTVRINTTKN 239 (927)
Q Consensus 165 ~le~~~l~~~~y~~~--~~~~~~l~l~~r~~~g~~~-~~~~~~~~d~~--dR~W~~~~~~~~~~~~~~~~~~~~i~~~~~ 239 (927)
+||||||++++|... .+.+.+|.++.|+|+|+.+ ...+|||+|+| ||+|.|+.+..+ +.+..+++...
T Consensus 167 ~iEv~~l~~~~y~~~~~~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~-------~~~~~~st~~~ 239 (623)
T PLN03150 167 SIEILQVDDKAYNFGPSWGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGS-------GSDQAISTENV 239 (623)
T ss_pred EEEEEEcCcccccccccccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCC-------Ccccccccccc
Confidence 999999999999543 2346679999999999864 33699999999 999998754211 12334455555
Q ss_pred ccC--CCCCCChhhhhccceecCCc--eEEEeecCCCCCccceEEEecccccc-cCCCcceeEeeecCcccccCCceeee
Q 002410 240 IET--RTREYPPVKVMQTAVVGTEG--VLSYRLNLEDFPANARAFAYFAEIQD-LGPSETRKFKLEQPYFADYSNAVVNI 314 (927)
Q Consensus 240 i~~--~~~~~pP~~v~qtA~~~~~~--~~~~~~~~~~~~~~~~~~lyFae~~~-~~~~~~R~F~i~~~~~~~~~~~~~~~ 314 (927)
|+. ..++.+|+.|||||.+..++ .+++.|+. +....|+++|||||++. ....++|+|||+++..... ..+++
T Consensus 240 I~~~~~~~~~~P~~VyqTA~~~~~~~~~lty~~~v-~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~--~~~di 316 (623)
T PLN03150 240 IKKASNAPNFYPESLYQSALVSTDTQPDLSYTMDV-DPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAF--KDVDI 316 (623)
T ss_pred cccccCCCccChHHHhhhhccccCCCCceEEEeec-CCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEee--cccCh
Confidence 542 35677899999999877653 46666663 33457889999999985 5677999999966643222 23344
Q ss_pred eecCCCceeeeccccce---eeeeeEEEEEeeecCCCCccchhhhhhhhhhcccccCChhHH-HHHHHhhhhccC---CC
Q 002410 315 AENANGSYTLYEPSYMN---VTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQD-EALRSISDESER---TN 387 (927)
Q Consensus 315 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~s~l~p~~~~~e~~~~~~~~~~t~~~~-~al~~~~~~~~~---~~ 387 (927)
.....+. +.|-+.. .+..+.+++++.|+.++ +|+|||+|||++.+.+..|..++ .||+.+|..+.. .+
T Consensus 317 ~~~~g~~---~~~~~~~~~v~~~~g~l~isl~p~~~s--~pilNaiEI~~~~~~~~~t~~~~~~aL~~~k~~~~~~~~~~ 391 (623)
T PLN03150 317 VKMSGER---YTALVLNKTVAVSGRTLTIVLQPKKGT--HAIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFG 391 (623)
T ss_pred hhhcCCc---ccceEEEeEEeecCCeEEEEEeeCCCC--cceeeeeeeeeccccccccCchHHHHHHHHHHhcCCcccCC
Confidence 3222211 1122221 11236788999998765 69999999999999887776655 899999988763 38
Q ss_pred CCCCCCCCC--CCccEEEeCCC---CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCccccccee
Q 002410 388 DRGDPCVPV--PWEWVTCSTTT---PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIV 461 (927)
Q Consensus 388 w~gdpC~~~--~w~~~~c~~~~---~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L 461 (927)
|+||||+|+ +|.|+.|+... ...++.|+|++|+|.|.+|..|++|++|+.|+|++|+|+|.+|. ++.|++|+.|
T Consensus 392 W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L 471 (623)
T PLN03150 392 WNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL 471 (623)
T ss_pred CCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEE
Confidence 999999875 68888885332 23599999999999999999999999999999999999999995 9999999999
Q ss_pred ecccccccCCCCCcCCCccccccccccccCCCCCCCccccC---CceeeeecCCCCCcccc----cc-cceeeeeeeech
Q 002410 462 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES----RR-RMRFKLILGTSI 533 (927)
Q Consensus 462 ~Ls~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~~---~~~~~~~~~N~~~c~~~----~~-~~~~~iil~~~i 533 (927)
+|++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|..+.. ....+.+.+|+.+|+.+ |. ......++++++
T Consensus 472 dLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~~~~~~~~~i~~~~ 551 (623)
T PLN03150 472 DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLSVGAKIGIAF 551 (623)
T ss_pred ECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCCCCCCcccCCCceEEEEEh
Confidence 99999999999999999999999999999999999998764 33467889999999642 22 123344555555
Q ss_pred hhhHHHHHHhhhhheeee
Q 002410 534 GVLAILLVLFLCSLIVLR 551 (927)
Q Consensus 534 g~l~vllvl~l~~~~~~r 551 (927)
++++++++++++.+++++
T Consensus 552 ~~~~~~l~~~~~~~~~~~ 569 (623)
T PLN03150 552 GVSVAFLFLVICAMCWWK 569 (623)
T ss_pred HHHHHHHHHHHHHhhhee
Confidence 555444444444333333
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-62 Score=544.43 Aligned_cols=322 Identities=36% Similarity=0.539 Sum_probs=255.2
Q ss_pred EecCCCCC---ccCCCCCeEEecCCccccCCceeeec-----CCCCCcccccccccccCCCccceeeeccc--CCceeEE
Q 002410 28 IDCGSTSN---YTDPSTGLAWISDIGIMNNGKSVKVE-----NPSGNWMQYRTRRDLPIDNKKYCYNLITK--ERRRYLV 97 (927)
Q Consensus 28 idcg~~~~---~~~~~~~~~~~~d~~~~~~g~~~~~~-----~~~~~~~~~~tlr~fp~~~~~~cy~l~~~--~~~~ylv 97 (927)
||||++.+ |+|+.||++|++|.+|+++|++++|+ ......+++.|+|+|| +|.||||+||+. +|+||||
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~~y~taR~F~-~g~r~cY~l~~~~~~~~~yli 79 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPDSSSSDSSPPYQTARIFP-EGSRNCYTLPVTPPGGGKYLI 79 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccCCcCCccccccceEEEcC-CCCccEEEeeccCCCCceEEE
Confidence 89997644 88999999999999999999999883 1234578899999999 777899999998 6779999
Q ss_pred EEEeeecCCCCCC-----CCCeEEEEEcCceeEEEEecCCc-cceEEE-EEEecCCCCcccceecccCCC-ceeeeeeee
Q 002410 98 RATFQYGSLGSEA-----SYPKFQLYLDATLWSTVTVLDAS-RVYAKE-MIIRAPSDSIDVCICCAVTGS-PFISTLELR 169 (927)
Q Consensus 98 r~~~~yg~yd~~~-----~~p~fd~~~~~~~w~~v~~~~~~-~~~~~e-~~~~~~~~~~~vcl~~~~~~~-pfis~le~~ 169 (927)
|+.|+|||||+++ +||.|||++|++.|++|+..+.. ..+.+| +|+++++++++|||+++++|+ ||||+||||
T Consensus 80 Rl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl~ 159 (347)
T PF12819_consen 80 RLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIELR 159 (347)
T ss_pred EEEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEEE
Confidence 9999999999874 47899999999999999887621 346788 666666899999999999999 999999999
Q ss_pred ecCCCCCc-ccccccceEEEEEeeccCCCCCCcccCCCCCCCCcccCCCCCCCCcccccCCceeeeeeccccc---CCCC
Q 002410 170 PLNLSMYA-TDFEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIE---TRTR 245 (927)
Q Consensus 170 ~l~~~~y~-~~~~~~~~l~l~~r~~~g~~~~~~~~~~~d~~dR~W~~~~~~~~~~~~~~~~~~~~i~~~~~i~---~~~~ 245 (927)
||++++|+ .....+.+|.++.|.|+|+.. ..+|||+|+|||+|+|+.. . +.|..++++.+|+ ...+
T Consensus 160 ~lp~~ly~~~~~~~s~~L~~~~R~n~G~~~-~~iryp~D~~dR~W~~~~~-~--------~~~~~ist~~~i~~~~~~~~ 229 (347)
T PF12819_consen 160 PLPDSLYPDTDANSSQALETVYRLNVGGSS-SFIRYPDDTYDRIWQPYSS-S--------PGWSNISTTSNININSSNNP 229 (347)
T ss_pred ECCccceeccccCCCceeEEEEeecCCCcc-cccCCCCCcceeecccccc-C--------ccccccccceeeecccCCcc
Confidence 99999995 223557889999999999854 3599999999999998621 2 2455566666665 2367
Q ss_pred CCChhhhhccceecCCce--EEEeecCCCCCccceEEEecccccccC-CCcceeEeeecCcccccCCceeeeeecCCCce
Q 002410 246 EYPPVKVMQTAVVGTEGV--LSYRLNLEDFPANARAFAYFAEIQDLG-PSETRKFKLEQPYFADYSNAVVNIAENANGSY 322 (927)
Q Consensus 246 ~~pP~~v~qtA~~~~~~~--~~~~~~~~~~~~~~~~~lyFae~~~~~-~~~~R~F~i~~~~~~~~~~~~~~~~~~~~~~~ 322 (927)
+.||.+|||||++..+.+ +.+.|...+...+|+++|||||++.+. .+++|+|+|+++.-..++ .+.+.. ......
T Consensus 230 ~~~P~~V~~TA~~~~~~s~~~nltw~~~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~-~~~~~~-~~~~~~ 307 (347)
T PF12819_consen 230 YDAPSAVYQTARTPSNSSDPLNLTWSFVDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYS-DVSPPY-LGADTV 307 (347)
T ss_pred CcChHHHHHhhhcccccccceEEEeccCCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccC-ccCccc-ccCcce
Confidence 889999999999887665 888888855556889999999999975 445899999655444332 222111 111122
Q ss_pred eeeccccceeeeeeEEEEEeeecCCCCccchhhhhhhhhh
Q 002410 323 TLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKY 362 (927)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~s~l~p~~~~~e~~~~ 362 (927)
.+|......+...+.+.++|.++.+|+|||+|||+|||++
T Consensus 308 ~~~~d~~~~~~~~~~~~isL~~t~~S~lppiLNalEIy~v 347 (347)
T PF12819_consen 308 PYYSDYVVNVPDSGFLNISLGPTPDSTLPPILNALEIYKV 347 (347)
T ss_pred EeecceEEEecCCCEEEEEEEeCCCCCcCceeEeeeeEeC
Confidence 2344344455555678899999999999999999999975
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-51 Score=520.45 Aligned_cols=443 Identities=27% Similarity=0.483 Sum_probs=305.2
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
+.++.|+|++|++.|.+|..+.+|++|+.|+|++|+++|.+|. +..+++|+.|+|++|+++|.+|..+..+++|+.|++
T Consensus 499 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l 578 (968)
T PLN00113 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI 578 (968)
T ss_pred hccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEec
Confidence 4566677777777777777777777777777777777777764 677777777777777777777777777777777777
Q ss_pred cccCCCCCCCcccc-CCceeeeecCCCCCcccc-------ccc----ceeeeeeeechhhhHHHHHHhhhhheeeeehhc
Q 002410 488 ENNSFVGEIPPALL-TGKVIFKYDNNPKLHKES-------RRR----MRFKLILGTSIGVLAILLVLFLCSLIVLRKLRR 555 (927)
Q Consensus 488 ~~N~l~g~iP~~~~-~~~~~~~~~~N~~~c~~~-------~~~----~~~~iil~~~ig~l~vllvl~l~~~~~~rr~rr 555 (927)
++|+++|.+|..-. .......+.+|+.+|... |.. ....++++++++++++++++++ .+++.+ +|+
T Consensus 579 s~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~ 656 (968)
T PLN00113 579 SHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAF-GFVFIR-GRN 656 (968)
T ss_pred cCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHH-HHHHHH-hhh
Confidence 77777777775321 122334567888888532 211 1112222222222222222211 122212 111
Q ss_pred cccccchhcccccccccCCCCCcccccccCCccccCCcccccChhhHHHHHHhhcccccccccEEEEEEEEC-CCcEEEE
Q 002410 556 KISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAV 634 (927)
Q Consensus 556 r~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAv 634 (927)
+ ...+..+.... . +.. .+........+.+.++.. .+...+.||+|+||.||+|+.. +++.|||
T Consensus 657 ~-~~~~~~~~~~~-------~---~~~----~~~~~~~~~~~~~~~~~~-~~~~~~~ig~G~~g~Vy~~~~~~~~~~vav 720 (968)
T PLN00113 657 N-LELKRVENEDG-------T---WEL----QFFDSKVSKSITINDILS-SLKEENVISRGKKGASYKGKSIKNGMQFVV 720 (968)
T ss_pred c-ccccccccccc-------c---ccc----cccccccchhhhHHHHHh-hCCcccEEccCCCeeEEEEEECCCCcEEEE
Confidence 1 11111110000 0 000 000111111233344433 2344678999999999999974 7899999
Q ss_pred EEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 002410 635 KIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 714 (927)
Q Consensus 635 K~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia 714 (927)
|++...... ..+|++.+++++||||++++++|.+.+..++||||+++|+|.++++ .++|.++.+|+.|++
T Consensus 721 K~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia 790 (968)
T PLN00113 721 KEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIA 790 (968)
T ss_pred EEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHH
Confidence 998753322 2346889999999999999999999999999999999999999996 278999999999999
Q ss_pred HHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHH
Q 002410 715 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSF 794 (927)
Q Consensus 715 ~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSl 794 (927)
+||+|||+.+.++|+||||||+||+++.++..++. ||........ ....++..|+|||++.+..++.++|||||
T Consensus 791 ~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~ 864 (968)
T PLN00113 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGF 864 (968)
T ss_pred HHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhH
Confidence 99999997666899999999999999999888876 6654432211 12257899999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC--CCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 002410 795 GVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN--VKIESIWRIAEVAIQCVEQRGFSRPKMQE 872 (927)
Q Consensus 795 GvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 872 (927)
||++|||+||+.||+ ........+.+|.+...........+|+.+... ...++..++.+++.+|++.+|++||+|+|
T Consensus 865 Gvvl~el~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~e 943 (968)
T PLN00113 865 GLILIELLTGKSPAD-AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAND 943 (968)
T ss_pred HHHHHHHHhCCCCCC-cccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHH
Confidence 999999999999996 333444567777776655555556667666432 34566778899999999999999999999
Q ss_pred HHHHHHhhhhhccC
Q 002410 873 IVLAIQDSIKIEKG 886 (927)
Q Consensus 873 Vl~~L~~~~~~e~~ 886 (927)
|+++|+++.+....
T Consensus 944 vl~~L~~~~~~~~~ 957 (968)
T PLN00113 944 VLKTLESASRSSSS 957 (968)
T ss_pred HHHHHHHhhccccc
Confidence 99999988775443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=448.21 Aligned_cols=289 Identities=49% Similarity=0.835 Sum_probs=253.9
Q ss_pred ccccChhhHHHHHHhhc--ccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeee
Q 002410 594 AYFIPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 671 (927)
Q Consensus 594 ~~~~~~~el~~~~~~~~--~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~ 671 (927)
...+++.+|..+|.+|. +.||+|+||.||+|.+.+|+.||||++........++|.+|++++.+++|||+|+|+|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 34578999999999997 6999999999999999999999999887654331456999999999999999999999999
Q ss_pred cCc-eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEee
Q 002410 672 EEH-QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 750 (927)
Q Consensus 672 ~~~-~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~D 750 (927)
+.+ +.+||||||++|+|.++|+..... .++|.+|++|+.++|+||+|||+.+.+.|+||||||+|||+|+++++||+|
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 988 599999999999999999975433 899999999999999999999998888999999999999999999999999
Q ss_pred ccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcC
Q 002410 751 FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 830 (927)
Q Consensus 751 FGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 830 (927)
||+|+..............||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+.........+++|++..+.++
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99997655411111111169999999999999999999999999999999999999987544345566999999999999
Q ss_pred Ceeeecccccc-CCCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 831 DVISIVDPVLI-GNVKI-ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 831 ~~~~~~d~~l~-~~~~~-~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
.+.+++|+.+. ..+.. +++.++..++.+|++.+|++||+|.||+++|+.+...
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99999999987 56664 6888999999999999999999999999999666554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=387.94 Aligned_cols=262 Identities=36% Similarity=0.541 Sum_probs=214.4
Q ss_pred HHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchh--HHHHHHHHHHHHhcCCCceeeeeeeeecCc-eEEE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRIL 678 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~--~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-~~~L 678 (927)
+......+.+.||+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 3334444566799999999999999954449999998654322 568999999999999999999999999887 7999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCcccccCCC-cEEEeecccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-IIHRDVKSSNILLDINM-RAKVSDFGLSRQ 756 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~-ivH~DLkp~NILld~~~-~~kL~DFGla~~ 756 (927)
|||||++|+|.++++.. .+..+++..+++|+.|||+||.|||+ .+ ||||||||+|||++.++ ++||+|||+++.
T Consensus 118 VtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 99999999999999864 46789999999999999999999998 66 99999999999999997 999999999987
Q ss_pred ccccccccccccccCCCccCCCccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYG--NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
..... .......||..|||||++. ...++.|+||||||+++|||+||+.||..... .+-+......+...
T Consensus 194 ~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp- 265 (362)
T KOG0192|consen 194 KVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRP- 265 (362)
T ss_pred ecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCC-
Confidence 65433 2222356999999999999 66999999999999999999999999984432 11122222222221
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
..+......+..++.+||..||.+||++.|++..|+.+...
T Consensus 266 --------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 266 --------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred --------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 11222445788999999999999999999999999988764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=373.69 Aligned_cols=251 Identities=27% Similarity=0.393 Sum_probs=210.1
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCc-cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCc-eEEEEEEecC
Q 002410 608 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRILVYEYMH 684 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-~~~LV~E~~~ 684 (927)
+..+.||+|..|+||+++++ +++.+|+|++... .....+++.+|++++++.+||+||+++|.|..++ ...++||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 34578999999999999998 5888999999543 3445689999999999999999999999999988 5999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+|||.+++.. .+.+++...-+|+.++++||.|||+ .++||||||||+|||++..|++||||||.++.+.+. .
T Consensus 162 gGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~ 233 (364)
T KOG0581|consen 162 GGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---I 233 (364)
T ss_pred CCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---h
Confidence 9999999984 4779999999999999999999996 499999999999999999999999999999887654 4
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 844 (927)
....+||..|||||.+++..|+.++||||||++++|+.+|+.||... ......+.+.+...+.+ .. |.+...
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~-~~~~~~~~~Ll~~Iv~~-pp-----P~lP~~- 305 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP-NPPYLDIFELLCAIVDE-PP-----PRLPEG- 305 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc-CCCCCCHHHHHHHHhcC-CC-----CCCCcc-
Confidence 45677999999999999999999999999999999999999999843 12122333333332221 11 222221
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 845 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 845 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
....++.+++..||++||.+||+++|++++
T Consensus 306 --~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 --EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred --cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 234578899999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=387.44 Aligned_cols=264 Identities=28% Similarity=0.468 Sum_probs=223.6
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 600 PELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 600 ~el~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
.++......+.+.||+|.||.||.|.++....||+|.++.. ....++|.+|+++|++|+|+|||+++++|..++..+||
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 46677778899999999999999999998889999999865 33457899999999999999999999999998899999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
||||+.|+|.++|+.. .+..+...+.+.++.|||+||+||++ +++|||||.++||||+++..+||+|||+|+...+
T Consensus 280 tE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCC
Confidence 9999999999999963 46789999999999999999999998 9999999999999999999999999999997665
Q ss_pred cccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 760 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
+....+....-+..|.|||.+..+.++.|||||||||+||||+| |+.|+......+ .++ .+..|-
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---v~~----~le~Gy------- 421 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---VLE----LLERGY------- 421 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---HHH----HHhccC-------
Confidence 55444444445779999999999999999999999999999999 899987443322 111 222221
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
+-..+..++..+.+++..||..+|++|||++.+...|+++....
T Consensus 422 --Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 422 --RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred --cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 11223445668899999999999999999999999998876543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=365.91 Aligned_cols=198 Identities=33% Similarity=0.561 Sum_probs=178.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|.+.+.||+|.||+||+|+++ ++.+||||.+... .....+.+..|+++|+.++|||||++++++..++..+||||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 455677999999999999987 5899999999765 4556677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC------CcEEEeeccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN------MRAKVSDFGLSRQA 757 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~------~~~kL~DFGla~~~ 757 (927)
.||+|.++++ ..+.+++..++.++.|||.||++||+ ++||||||||+||||+.. -.+||+|||+|+..
T Consensus 92 ~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 92 NGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred CCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999 45689999999999999999999998 999999999999999764 46899999999998
Q ss_pred cccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~ 812 (927)
.+. ......+|++-|||||+++.++|+.|+|+||+|++||||++|+.||+...
T Consensus 166 ~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 166 QPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred Cch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 743 34456779999999999999999999999999999999999999998433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=381.89 Aligned_cols=248 Identities=27% Similarity=0.454 Sum_probs=210.6
Q ss_pred HHHhhcccccccccEEEEEEEE-CCCcEEEEEEccCc---cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~-~~g~~vAvK~l~~~---~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
.+|...+.||+|||+.||+++. ..|+.||+|++.+. .....+.+.+|+++.++|+|||||+++++|++.+..|+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5677789999999999999998 78999999999763 2345677899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
|+|+.++|..+++ ..+++++.+++.+++||+.||.|||+ ++|+|||||..|+|+++++++||+|||+|.....+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999998 46889999999999999999999998 99999999999999999999999999999987654
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
.. ...+.+|||.|+|||++.....+..+||||+||++|-||+|++||+.....+..+ .++..+. .-|.
T Consensus 172 ~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~-------~Ik~~~Y---~~P~- 239 (592)
T KOG0575|consen 172 GE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN-------KIKLNEY---SMPS- 239 (592)
T ss_pred cc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH-------HHHhcCc---cccc-
Confidence 33 3445679999999999999999999999999999999999999998443322221 1211111 0111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
....+..+||.++|+.||.+|||+++|+..
T Consensus 240 ------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 240 ------HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ------ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 112256799999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=354.84 Aligned_cols=265 Identities=28% Similarity=0.363 Sum_probs=216.3
Q ss_pred HHHHHHhhcccccccccEEEEEEEE-CCCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeee-eeecCce-E
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIG-YCEEEHQ-R 676 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~-~~~~~~~-~ 676 (927)
...+.|++.++||+|.||+||++.. .+|..||.|.++-. .....++...|+.+|++|+|||||++++ .+.++.. .
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 3446788899999999999999975 48999999998732 2345677899999999999999999998 4444444 8
Q ss_pred EEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCcccccCCCcEEEeecccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLS 754 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~-~ivH~DLkp~NILld~~~~~kL~DFGla 754 (927)
++|||+|.+|+|.++++..+ .++.+++..+++++.|++.||.++|+..++ -|+||||||.||+++.+|.+||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 89999999999999997654 456799999999999999999999974333 3789999999999999999999999999
Q ss_pred ccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 755 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 755 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
+.+....... ...+|||.||+||.+.+..|+.||||||+||++|||+.-+.||.+. ++.+ ....+.+++...
T Consensus 176 r~l~s~~tfA-~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~-L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 176 RFLSSKTTFA-HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLS-LCKKIEQGDYPP 247 (375)
T ss_pred hHhcchhHHH-HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHH-HHHHHHcCCCCC
Confidence 9987665443 3456999999999999999999999999999999999999999854 2333 334455555433
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
+.+ .-...++.+|+..|+..||+.||+...+++.++.-++
T Consensus 248 ~p~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l~ 287 (375)
T KOG0591|consen 248 LPD--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSELD 287 (375)
T ss_pred CcH--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHhc
Confidence 322 2334578899999999999999997777766665443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=367.17 Aligned_cols=258 Identities=28% Similarity=0.378 Sum_probs=208.0
Q ss_pred hhhHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccch-------hHHHHHHHHHHHHhcCCCceeeeeeee
Q 002410 599 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-------RTQQFVTEVALLSRIHHRNLVPLIGYC 670 (927)
Q Consensus 599 ~~el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~-------~~~~~~~E~~~L~~l~HpnIv~l~~~~ 670 (927)
.++.....|-+.+.||+|+||.|-+|..+ +|+.||||++++.... ......+|+++|++|+|||||++++++
T Consensus 166 ~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f 245 (475)
T KOG0615|consen 166 PPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF 245 (475)
T ss_pred ccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence 34555666777899999999999999765 7999999999763211 223467999999999999999999999
Q ss_pred ecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC---CcEE
Q 002410 671 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAK 747 (927)
Q Consensus 671 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~---~~~k 747 (927)
...+..|+||||++||+|.+++- ..+.+.+..-..+++|++.|+.|||+ +||+||||||+|||+..+ -.+|
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llK 319 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLK 319 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEE
Confidence 99999999999999999999998 45678888889999999999999998 999999999999999765 7799
Q ss_pred EeeccccccccccccccccccccCCCccCCCccCCCC--C-CcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH
Q 002410 748 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ--L-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 824 (927)
Q Consensus 748 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~ 824 (927)
|+|||+|+..+. .....+.+||+.|.|||++.+.. + ..+.|+||+||+||-+++|.+||....... . +.
T Consensus 320 ItDFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--s----l~ 391 (475)
T KOG0615|consen 320 ITDFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--S----LK 391 (475)
T ss_pred ecccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--c----HH
Confidence 999999998763 33455678999999999997653 3 348899999999999999999998433221 1 22
Q ss_pred HhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 825 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 825 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+++..|+.... .....+..++.++||.+||..||++|||+.|+++.
T Consensus 392 eQI~~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 392 EQILKGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HHHhcCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 23333433211 11223445578899999999999999999999863
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=385.51 Aligned_cols=266 Identities=31% Similarity=0.501 Sum_probs=223.3
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCccch-hHHHHHHHHHHHHhcCCCceeeeeeeeec
Q 002410 600 PELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEE 672 (927)
Q Consensus 600 ~el~~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~~~-~~~~~~~E~~~L~~l~HpnIv~l~~~~~~ 672 (927)
.++......+.+.||+|.||+||+|+.. +.+.||||.+++.... ..++|++|+++++.++|||||+++|+|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 4566666778899999999999999854 3467999999987666 67899999999999999999999999999
Q ss_pred CceEEEEEEecCCCCHHHHhccCC-------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc
Q 002410 673 EHQRILVYEYMHNGTLRDRLHGSV-------N----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 741 (927)
Q Consensus 673 ~~~~~LV~E~~~~gsL~~~L~~~~-------~----~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld 741 (927)
++.+++|+|||..|||.++|+... . ..+++..+.+.||.|||.||+||-+ +.+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceec
Confidence 999999999999999999997543 1 2348899999999999999999998 9999999999999999
Q ss_pred CCCcEEEeeccccccccc-cccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhH
Q 002410 742 INMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 819 (927)
Q Consensus 742 ~~~~~kL~DFGla~~~~~-~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l 819 (927)
++..+||+|||+++..-. +.........-..+|||||.+..++++.+||||||||+|||+++ |+.|+.+....+
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---- 713 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---- 713 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH----
Confidence 999999999999998533 33333323445779999999999999999999999999999999 999987444322
Q ss_pred HHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 820 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 820 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
+.+.++++++.+ .+..++.++.+|+..||+.+|++||+++||-..|+......
T Consensus 714 ---VIe~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 ---VIECIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred ---HHHHHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 233444454422 23455668999999999999999999999999999876643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=344.29 Aligned_cols=241 Identities=29% Similarity=0.399 Sum_probs=200.6
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
..+++.++||+|+||+||.++.+ .++.+|+|++++.. ....+...+|..+|.+++||.||+++-.|++.+.+|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 44567899999999999999876 48899999998642 234677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+.||.|..+|+ .++.+++..+.-++..|+.||.|||+ ++||||||||+|||+|++|+++|+|||+++.....
T Consensus 105 d~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 105 DYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred eccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 9999999999998 46789999999999999999999998 99999999999999999999999999999964333
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
. ......+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+.. .+..... .++.. .
T Consensus 179 ~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~-~~k~~------~ 244 (357)
T KOG0598|consen 179 G-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKIL-KGKLP------L 244 (357)
T ss_pred C-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHh-cCcCC------C
Confidence 2 2334468999999999999999999999999999999999999999854432 2222222 22210 0
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCC
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRP 868 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 868 (927)
.+. -......+++.++|..||++|.
T Consensus 245 ~p~---~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 245 PPG---YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCc---cCCHHHHHHHHHHhccCHHHhc
Confidence 011 1122567899999999999996
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=332.76 Aligned_cols=263 Identities=22% Similarity=0.288 Sum_probs=205.2
Q ss_pred HhhcccccccccEEEEEEEECC-CcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|+...++|+|+||.||+.+.++ |+.||||++..... .-.+-.++|+++|++++|+|+|.++++|......+||+|||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 4556789999999999999884 99999999976543 23456789999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
+..-|.+.-+ ....++...+.+++.|++.|+.|+|+ ++++||||||+||||+.+|.+||||||+|+.+... ..
T Consensus 84 dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd 156 (396)
T KOG0593|consen 84 DHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GD 156 (396)
T ss_pred chHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC-cc
Confidence 8755555433 35668899999999999999999998 99999999999999999999999999999987642 22
Q ss_pred cccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH--------HhhhcC-Cee
Q 002410 764 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMIKKG-DVI 833 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~--------~~~~~~-~~~ 833 (927)
..+..+.|..|+|||.+-+ .+|+...||||+||++.||++|.+.|.+.+.-+....+.... ...... .+.
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 2334568999999999877 699999999999999999999999998665544333222211 111111 111
Q ss_pred ee-----ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 834 SI-----VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 834 ~~-----~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.+ -++.......+.....+++++..||+.||.+|++-+|++..
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11 11111111112233368899999999999999999999853
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=344.55 Aligned_cols=258 Identities=28% Similarity=0.406 Sum_probs=204.8
Q ss_pred HHhhcccccccccEEEEEEEECC-CcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCc--eEEEEEEe
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYEY 682 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~--~~~LV~E~ 682 (927)
.+...+.||+|.||+||++...+ |+..|||.+........+.+.+|+++|.+++|||||+.+|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 34557899999999999999875 8999999987654334677899999999999999999999854444 68899999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC-CCcEEEeeccccccccc--
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEE-- 759 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFGla~~~~~-- 759 (927)
+++|+|.+++.... + .+++..+..++.||++||+|||+ +||+||||||+|||++. ++.+||+|||+++....
T Consensus 98 ~~~GsL~~~~~~~g-~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 98 APGGSLSDLIKRYG-G-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred cCCCcHHHHHHHcC-C-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999998653 2 79999999999999999999998 99999999999999999 79999999999987663
Q ss_pred cccccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 760 DLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
..........||+.|||||++..+ ....++||||+||++.||+||+.||... . ....+.-........ |
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~----~~~~~~~~ig~~~~~-----P 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-F----EEAEALLLIGREDSL-----P 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-c----chHHHHHHHhccCCC-----C
Confidence 222333456799999999999854 3446999999999999999999999732 1 111111111112111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
.+ +.....+..+++.+|++.+|++|||++|+++..--...
T Consensus 243 ~i----p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 243 EI----PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred CC----CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 11 12233467899999999999999999999987654443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=351.58 Aligned_cols=249 Identities=26% Similarity=0.382 Sum_probs=206.1
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV 679 (927)
..+.|++.||+|+|++|++|+.+ .++++|||++.+..- ...+-+..|-..|.+| .||.|++|+..|.++..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 45668999999999999999876 589999999976422 2235577899999999 899999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
+||+++|+|.++|++ .+.+++...+.++.+|+.||+|||+ +|||||||||+|||+|.||++||+|||.|+.+.+
T Consensus 153 Le~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999994 5789999999999999999999998 9999999999999999999999999999998754
Q ss_pred cccc----------c--ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhh
Q 002410 760 DLTH----------I--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 827 (927)
Q Consensus 760 ~~~~----------~--~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~ 827 (927)
.... . ...++||..|.+||++.....++.+|+|+|||+||+|+.|++||..... ..+.+.+...
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---yliFqkI~~l- 302 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---YLIFQKIQAL- 302 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---HHHHHHHHHh-
Confidence 3221 1 1346799999999999999999999999999999999999999984322 2222211110
Q ss_pred hcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 828 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 828 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+-.+ +...+..+.+|+.+.|..||.+|++.+||.+.
T Consensus 303 ---------~y~f----p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 303 ---------DYEF----PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ---------cccC----CCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1111 11222467899999999999999999988775
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=347.80 Aligned_cols=266 Identities=22% Similarity=0.278 Sum_probs=209.8
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcC-CCceeeeeeeeecCc-eEEE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH-QRIL 678 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~-~~~L 678 (927)
...+|.+.++||.|.||.||+|+-+ .|+.||||++++.-. .+...=++|++.|++|+ ||||+++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 3567889999999999999999865 689999999986432 33344578999999998 999999999998888 9999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
|||||+ .+|+++++.. ++.+++..+..|+.||++||+|+|+ +|+.|||+||+|||+.....+||+|||+|+.+.
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence 999995 5999999865 7889999999999999999999998 999999999999999989999999999999876
Q ss_pred ccccccccccccCCCccCCCcc-CCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeee---
Q 002410 759 EDLTHISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS--- 834 (927)
Q Consensus 759 ~~~~~~~~~~~gt~~Y~APE~l-~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~--- 834 (927)
..... +..+.|..|+|||++ +.+.|+.+.|+||+|||++|+.+-++.|.+.+..++...+-.+.....+....+
T Consensus 162 SkpPY--TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 SKPPY--TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cCCCc--chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 65433 345579999999986 677899999999999999999999999986654333221111111111111100
Q ss_pred ---ecc---cccc----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 835 ---IVD---PVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 835 ---~~d---~~l~----~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.+. |... +..-.....+.++++.+|+++||.+|||++|.+++
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 000 0000 11112245578899999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=353.61 Aligned_cols=263 Identities=27% Similarity=0.453 Sum_probs=206.7
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCccc-hhHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 673 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~ 673 (927)
+....+++.++||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+.+++++ +||||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 34566788999999999999999752 356899999975432 3456789999999999 899999999988764
Q ss_pred -ceEEEEEEecCCCCHHHHhccCCC-------------------------------------------------------
Q 002410 674 -HQRILVYEYMHNGTLRDRLHGSVN------------------------------------------------------- 697 (927)
Q Consensus 674 -~~~~LV~E~~~~gsL~~~L~~~~~------------------------------------------------------- 697 (927)
+..++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 458899999999999999874311
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc-ccccccCC
Q 002410 698 ----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTV 772 (927)
Q Consensus 698 ----~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~ 772 (927)
...+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++......... .....++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 2347888999999999999999998 999999999999999999999999999998654322211 22234567
Q ss_pred CccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHH
Q 002410 773 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 851 (927)
Q Consensus 773 ~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 851 (927)
.|+|||++.+..++.++|||||||++|||++ |..||....... ... ..+..+.... . +......
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~----~~~~~~~~~~-----~----~~~~~~~ 305 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFC----QRLKDGTRMR-----A----PENATPE 305 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHH----HHHhcCCCCC-----C----CCCCCHH
Confidence 8999999998899999999999999999997 999997433221 111 1122221111 1 1112346
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 852 IAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 852 l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
+.+++.+||+.||++||++.||++.|++++.
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=379.99 Aligned_cols=270 Identities=31% Similarity=0.494 Sum_probs=223.0
Q ss_pred ChhhHHHHHHhhcccccccccEEEEEEEECC--Cc----EEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeee
Q 002410 598 PLPELEEATNNFCKKIGKGSFGSVYYGKMKD--GK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYC 670 (927)
Q Consensus 598 ~~~el~~~~~~~~~~LG~G~~G~Vy~a~~~~--g~----~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~ 670 (927)
+++++......+.+.||+|+||.||+|+..+ |. .||||.+++.. .+...+|++|..+|++++|||||+++|+|
T Consensus 685 ~lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~ 764 (1025)
T KOG1095|consen 685 SLPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVC 764 (1025)
T ss_pred ccccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEee
Confidence 3667777788889999999999999998764 43 49999998754 45668899999999999999999999999
Q ss_pred ecCceEEEEEEecCCCCHHHHhccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcE
Q 002410 671 EEEHQRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 746 (927)
Q Consensus 671 ~~~~~~~LV~E~~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~ 746 (927)
.+....++++|||++|+|..+|++.+ ....+.....+.++.|||+|+.|||+ +++|||||.++|+||+....+
T Consensus 765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~V 841 (1025)
T KOG1095|consen 765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVV 841 (1025)
T ss_pred cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcE
Confidence 99999999999999999999999754 25678999999999999999999998 999999999999999999999
Q ss_pred EEeecccccccc-ccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHH
Q 002410 747 KVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 824 (927)
Q Consensus 747 kL~DFGla~~~~-~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 824 (927)
||+|||+|+.+. .+.........-...|||||.++.+.++.|+|||||||+|||++| |..||...+..+ + +.
T Consensus 842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---v---~~ 915 (1025)
T KOG1095|consen 842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---V---LL 915 (1025)
T ss_pred EEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---H---HH
Confidence 999999999543 333333323234579999999999999999999999999999999 899997333211 1 11
Q ss_pred HhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhccC
Q 002410 825 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 886 (927)
Q Consensus 825 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~~ 886 (927)
...+.+++ ..+..++..+.+++..||+.+|++||++.+|++++..++..-..
T Consensus 916 ~~~~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 916 DVLEGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred HHHhCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 12223311 22345667889999999999999999999999999988765444
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=344.52 Aligned_cols=267 Identities=24% Similarity=0.262 Sum_probs=210.3
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecC--ceE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQR 676 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~~ 676 (927)
.....|+-.++||+|.||.||+|+.. +|+.||+|+++-+. .....-..+|+.+|++|+||||++|.+...+. ...
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 34556667789999999999999854 79999999987544 33445678999999999999999999988765 689
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
|||+|||+. +|.-++.. ..-.+++.++..+++||+.||+|||. ++|+|||||.+|||||.+|.+||+|||+|++
T Consensus 194 YlVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceee
Confidence 999999976 78877763 35679999999999999999999998 9999999999999999999999999999998
Q ss_pred ccccccccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
+........+..+-|..|+|||++.+. .|+.+.|+||.||||.||++|++.|.+....++.+.+-.+.....+..+. .
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~ 346 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-V 346 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-c
Confidence 876665555566689999999998765 89999999999999999999999998766544444333222222111111 1
Q ss_pred cc-c-----cccCCCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 836 VD-P-----VLIGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 836 ~d-~-----~l~~~~~-------~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.+ | .....+. .......++|+..+|..||.+|.|+.++++
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00 0 0001111 112235679999999999999999999875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=338.03 Aligned_cols=262 Identities=25% Similarity=0.340 Sum_probs=209.2
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccC-ccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD-SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~-~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
...|++.++||.|..++||+|+.. .++.||||++.- .+....+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 356778899999999999999865 689999999974 344457889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
||.+||+.++++... ...+++..+..|++++++||.|||+ +|.||||||+.||||+.+|.+||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999998765 4459999999999999999999998 999999999999999999999999999877654332
Q ss_pred ccc--c-cccccCCCccCCCccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 762 THI--S-SVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 762 ~~~--~-~~~~gt~~Y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
... . ....||+.|||||+++. ..|+.|+||||||++..||.+|+.||..... ...+ ...+++ ......
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP--mkvL----l~tLqn-~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP--MKVL----LLTLQN-DPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh--HHHH----HHHhcC-CCCCcc
Confidence 211 1 34579999999999643 3689999999999999999999999973322 1111 112222 221111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
-..+..+........+.+++..||+.||++|||++++++.
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1111112222334478899999999999999999999863
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=367.19 Aligned_cols=266 Identities=26% Similarity=0.458 Sum_probs=221.5
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEECC----CcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCc
Q 002410 600 PELEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 674 (927)
Q Consensus 600 ~el~~~~~~~~~~LG~G~~G~Vy~a~~~~----g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~ 674 (927)
.||..+...+.++||.|.||.||+|+++- ...||||.++.... ....+|+.|+.||.++.||||++|.|+.....
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 45556666667899999999999999873 35799999997654 45678999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccc
Q 002410 675 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 754 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 754 (927)
...+|.|||++|+|..+|+.. .+.+.+.++..++++||.|++||.. .++|||||.++|||++.+..+|++|||++
T Consensus 704 PvMIiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccce
Confidence 999999999999999999975 4569999999999999999999997 99999999999999999999999999999
Q ss_pred cccccccccccccccc--CCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCC
Q 002410 755 RQAEEDLTHISSVARG--TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 831 (927)
Q Consensus 755 ~~~~~~~~~~~~~~~g--t~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 831 (927)
+.+.++.........| +.+|.|||.+..++++.++||||||+++||.++ |++||......+- ...+++
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV-------IkaIe~-- 849 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-------IKAIEQ-- 849 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH-------HHHHHh--
Confidence 9876654332222222 468999999999999999999999999999887 9999973332211 111211
Q ss_pred eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhccC
Q 002410 832 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 886 (927)
Q Consensus 832 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~~ 886 (927)
..+-..+.+++..|.+|++.||++|-.+||.+.+|+..|.++++....
T Consensus 850 -------gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 850 -------GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred -------ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 122223445677899999999999999999999999999999876543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=347.61 Aligned_cols=250 Identities=30% Similarity=0.487 Sum_probs=209.6
Q ss_pred cccChhhHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCc
Q 002410 595 YFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 674 (927)
Q Consensus 595 ~~~~~~el~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~ 674 (927)
+.+++++|.+. +-||.|+.|.||+|+++ ++.||||+++.. -..+++-|++|+||||+.+.|+|....
T Consensus 119 WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 119 WEIPFEEISEL-----EWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred ccCCHHHhhhh-----hhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCc
Confidence 44556665443 45999999999999998 789999988642 235788999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccc
Q 002410 675 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 754 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 754 (927)
.+|||||||..|-|...|+ .+..+.......|..+||.|+.|||. ++|||||||.-||||..+..+||+|||-+
T Consensus 186 cyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred eeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccch
Confidence 9999999999999999999 56788999999999999999999998 99999999999999999999999999999
Q ss_pred ccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 755 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 755 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
+...+..+ .-.++||..|||||++++...++|.||||||||||||+||..||..-+.... +..
T Consensus 260 ~e~~~~ST--kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---------------IwG 322 (904)
T KOG4721|consen 260 KELSDKST--KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---------------IWG 322 (904)
T ss_pred Hhhhhhhh--hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---------------EEe
Confidence 88765522 2235699999999999999999999999999999999999999973332110 111
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
+-...+.-..+..+++.+.-|+++||+..|..||++.+|+..|+-.
T Consensus 323 VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 323 VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 1112222234556777899999999999999999999999999843
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=316.47 Aligned_cols=264 Identities=21% Similarity=0.255 Sum_probs=208.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
+|...++||+|.||.||+|+.. +|+.||||+++-.... -.....+|++.|+.++|+||+.++++|.+.+..-||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4556789999999999999865 6999999999754322 235678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
|+ .+|...++. ....++..++..++.++++||+|||+ +.|+||||||.|+|++.+|.+||+|||+|+.+.....
T Consensus 83 m~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 83 MP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 96 599999986 36789999999999999999999998 9999999999999999999999999999999876544
Q ss_pred ccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee---cc-
Q 002410 763 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI---VD- 837 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~---~d- 837 (927)
.... .+.|..|+|||++.| ..|+...||||.||++.||+-|.+-|.+...-++....-.+..-..+..+.++ -|
T Consensus 157 ~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 157 IQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 3222 257899999998876 47999999999999999999999888765544443333222221111111111 11
Q ss_pred -------ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 838 -------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 838 -------~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.......-.......++|+.+|+..||.+|++++|++++
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 001111222344467899999999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=350.26 Aligned_cols=248 Identities=27% Similarity=0.418 Sum_probs=208.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
|.-.++||+|+.|.||.|... +++.||||++........+-+.+|+.+|+..+|+|||++++.+...+++|+|||||+|
T Consensus 275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~g 354 (550)
T KOG0578|consen 275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEG 354 (550)
T ss_pred hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCC
Confidence 334578999999999999754 6889999999877777778899999999999999999999999989999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
|+|.|.+.. ..+++.++..|+.++++||+|||. ++|+|||||.+|||++.+|.+||+|||++..+..... ..
T Consensus 355 gsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR 426 (550)
T KOG0578|consen 355 GSLTDVVTK----TRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR 426 (550)
T ss_pred Cchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence 999999973 459999999999999999999998 9999999999999999999999999999998876654 34
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
...+||+.|||||+.....|++|.||||||++++||+-|++||-.+..-. +...+......++-.+
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-------AlyLIa~ng~P~lk~~------- 492 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNGTPKLKNP------- 492 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-------HHHHHhhcCCCCcCCc-------
Confidence 45569999999999999999999999999999999999999997322211 1111222222222221
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 846 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 846 ~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
......+.+++.+||+.|+++||+++|+|+.
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1223368899999999999999999999974
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=350.40 Aligned_cols=264 Identities=28% Similarity=0.492 Sum_probs=210.0
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 600 PELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 600 ~el~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
.|+......+.+.||+|.||+||+|.|. ..||||+++.. ..+..+.|++|+..+++-+|.||+-+.|+|..... .
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 4444455557899999999999999997 35999999754 34467889999999999999999999999998877 9
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+|+.+|+|-+|+.+|+.. ...++..+.+.|++|||+|+.|||. ++|||||||..|||+.+++.|||+|||++..-
T Consensus 464 IiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeee
Confidence 999999999999999964 4678889999999999999999999 99999999999999999999999999998753
Q ss_pred ccc-ccccccccccCCCccCCCccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCee
Q 002410 758 EED-LTHISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 833 (927)
Q Consensus 758 ~~~-~~~~~~~~~gt~~Y~APE~l~~~---~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 833 (927)
..- .........|...|||||+++.. .|++.+||||||+|+|||+||..||.....+. +.-++..|-.
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq-------IifmVGrG~l- 610 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ-------IIFMVGRGYL- 610 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh-------eEEEeccccc-
Confidence 221 11111223477899999998643 78999999999999999999999997222111 0001111110
Q ss_pred eeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 834 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 834 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
..|.. ......++++.+|+..||..++++||.+.+|+..|++++..
T Consensus 611 -~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 611 -MPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred -Cccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 01110 11234566889999999999999999999999999998884
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=345.59 Aligned_cols=247 Identities=28% Similarity=0.415 Sum_probs=204.1
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc----cc-hhHHHHHHHHHHHHhcC-CCceeeeeeeeecCce
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS----CS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQ 675 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~----~~-~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~ 675 (927)
....|.+.+.||+|.||+|++|.+. +++.||+|++... .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3446777899999999999999765 6899999977653 11 23456778999999998 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC-CcEEEeecccc
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLS 754 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFGla 754 (927)
.++||||+.||+|.+++.. .+++.+.....+++|++.|++|||+ ++|+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999984 5778889999999999999999998 999999999999999999 99999999999
Q ss_pred ccccccccccccccccCCCccCCCccCCCC-CC-cchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCe
Q 002410 755 RQAEEDLTHISSVARGTVGYLDPEYYGNQQ-LT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832 (927)
Q Consensus 755 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~s-~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 832 (927)
.... ..........||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.... ....+. +..+.+
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~k-i~~~~~ 240 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRK-IRKGEF 240 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHH-HhcCCc
Confidence 9874 2223345567999999999999876 75 799999999999999999999984221 111111 222221
Q ss_pred --eeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 002410 833 --ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 874 (927)
Q Consensus 833 --~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl 874 (927)
...+. ..++..|+.+||..||.+|+++.||+
T Consensus 241 ~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 241 KIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred cCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11110 33678999999999999999999999
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=332.97 Aligned_cols=258 Identities=22% Similarity=0.401 Sum_probs=206.9
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC----CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~----~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
+....+++.+.||+|+||.||+|.++ .+..||+|.++.... ...+.+.+|+.++++++||||+++++++..++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 34556778899999999999999864 356899999986533 3446789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.++++|||.+..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 9999999999999998743 3568999999999999999999998 9999999999999999999999999998765
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
.............++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ...+. +..+....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~----~~~~~~~~- 228 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKA----VEDGFRLP- 228 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHH----HHCCCCCC-
Confidence 43222211222335678999999999999999999999999999875 99999743221 11221 12211100
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
.....+..+.+++.+||+.+|++||+++||++.|+++
T Consensus 229 --------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 --------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1112344688999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=341.23 Aligned_cols=246 Identities=28% Similarity=0.392 Sum_probs=209.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
.|.+.+.||+|.||.||||+.+ +.+.||+|.+.+.. ..+.+.+.+|+++++.++||||+.+++.|+...+.++|.||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 3556789999999999999877 57899999997643 34567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+.| +|..+|. ..+.++++.+..++.|+..||.|||+ .+|+|||+||.|||++.+|.+|+||||+|+.+... +
T Consensus 83 a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t 154 (808)
T KOG0597|consen 83 AVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-T 154 (808)
T ss_pred hhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC-c
Confidence 976 9999998 56789999999999999999999998 99999999999999999999999999999987653 4
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
.......||+-|||||+..++.|+..+|.||+||++|||++|++||-. ..+.+.++....+.. .
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~d~v--------~-- 218 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILKDPV--------K-- 218 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhcCCC--------C--
Confidence 445556799999999999999999999999999999999999999962 233343443333211 1
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.+......+.+++...|.+||.+|.+-.+++..
T Consensus 219 -~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 -PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 112334478899999999999999999998764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=351.71 Aligned_cols=266 Identities=32% Similarity=0.474 Sum_probs=215.2
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEECC--C--cE-EEEEEccC---ccchhHHHHHHHHHHHHhcCCCceeeeeeeee
Q 002410 600 PELEEATNNFCKKIGKGSFGSVYYGKMKD--G--KE-VAVKIMAD---SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 671 (927)
Q Consensus 600 ~el~~~~~~~~~~LG~G~~G~Vy~a~~~~--g--~~-vAvK~l~~---~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~ 671 (927)
.+|......+.++||+|+||.||+|+++. + .. ||||..+. .......+|++|+++|++++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 35555555667999999999999998763 2 23 89999885 23556788999999999999999999999999
Q ss_pred cCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeec
Q 002410 672 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF 751 (927)
Q Consensus 672 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DF 751 (927)
.+...++|||+|.||+|.++|+.. +..++..+++.++.+.|.||+|||+ ++++||||.++|+|++.++.+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCcc
Confidence 999999999999999999999964 3369999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhh-hc
Q 002410 752 GLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI-KK 829 (927)
Q Consensus 752 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~-~~ 829 (927)
|+++.... .........-+..|+|||.+....+++++|||||||++||+++ |..||.+.... . ++..+ .+
T Consensus 307 GLs~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~----v~~kI~~~ 378 (474)
T KOG0194|consen 307 GLSRAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---E----VKAKIVKN 378 (474)
T ss_pred ccccCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---H----HHHHHHhc
Confidence 99886541 1111111234679999999999999999999999999999999 88899744322 1 22222 22
Q ss_pred CCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhccCC
Q 002410 830 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 887 (927)
Q Consensus 830 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~~~ 887 (927)
+-... .+...+..+..++.+|+..+|++||+|.++.+.|+.+.......
T Consensus 379 ~~r~~---------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 379 GYRMP---------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred CccCC---------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 21111 11234557788889999999999999999999999988766543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=335.26 Aligned_cols=246 Identities=24% Similarity=0.352 Sum_probs=199.3
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCccchh---HHHHHHHHHHHHhcCCCceeeeeeeeec----CceEEEEEEec
Q 002410 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVYEYM 683 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~---~~~~~~E~~~L~~l~HpnIv~l~~~~~~----~~~~~LV~E~~ 683 (927)
..||+|++|.||+|.+ +|+.||||+++...... .+.+.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 48999999997643322 4678899999999999999999999866 34688999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++|+|.+++.. ...+++....+++.|++.||+|||+ ..+++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999984 4578899999999999999999997 2488899999999999999999999999988654321
Q ss_pred cccccccCCCccCCCccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 764 ISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .+.. .....+.. +.
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~---~i~~~~~~-----~~-- 242 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYD---LIINKNNS-----LK-- 242 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHHhcCCC-----CC--
Confidence 12347889999999976 68899999999999999999999999743321 1111 11111111 01
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
.+......+.+++.+||+.||++|||++||++.|++..
T Consensus 243 --~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 243 --LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred --CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11123447889999999999999999999999998764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=337.55 Aligned_cols=264 Identities=26% Similarity=0.403 Sum_probs=203.9
Q ss_pred HHHHhhcccccccccEEEEEEEECC-----------------CcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceee
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMKD-----------------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVP 665 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~~-----------------g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~ 665 (927)
...|.+.++||+|+||.||++.+++ +..||+|.+.... .....++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4567788999999999999998643 3469999987643 334567999999999999999999
Q ss_pred eeeeeecCceEEEEEEecCCCCHHHHhccCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 002410 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV----------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 729 (927)
Q Consensus 666 l~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~----------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~iv 729 (927)
+++++.+.+..++||||+++|+|.+++.... ....+++..+.+++.||+.||+|||+ .+|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcc
Confidence 9999999999999999999999999886422 11347888999999999999999998 8999
Q ss_pred ecCCCCCcccccCCCcEEEeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh--CCC
Q 002410 730 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKK 806 (927)
Q Consensus 730 H~DLkp~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt--G~~ 806 (927)
||||||+|||++.++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999986543221 12223345788999999988899999999999999999987 556
Q ss_pred CCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 807 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 807 Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
||..... ......+............. ..+...+..+.+++.+||+.+|++|||++||.+.|++
T Consensus 241 p~~~~~~---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTD---EQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCH---HHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7753322 12222222222211110000 0011233478899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=346.69 Aligned_cols=245 Identities=26% Similarity=0.407 Sum_probs=206.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
+++++.||.|+.|.|-+|++. +|+.+|||++.+.. ......+.+|+-+|+.+.|||++++++++++..++|+|+||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 345789999999999999876 69999999997652 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|-|.+++- .++++++.+..+++.||+.|+.|+|+ .+|+||||||+|+|+|..+++||+|||+|....++.
T Consensus 94 v~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk- 166 (786)
T KOG0588|consen 94 VPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK- 166 (786)
T ss_pred cCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence 99999999998 46889999999999999999999998 999999999999999999999999999998765432
Q ss_pred ccccccccCCCccCCCccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 763 HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
.-.+.+|++.|.|||++++..| +.++||||+|||||.||||+.||+++. ...+.. .++.|.+
T Consensus 167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLl----KV~~G~f--------- 229 (786)
T KOG0588|consen 167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLL----KVQRGVF--------- 229 (786)
T ss_pred -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHH----HHHcCcc---------
Confidence 2345579999999999999887 579999999999999999999998322 222222 2222322
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+.+.....+..+|+.+|+..||++|.|++||++.
T Consensus 230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1112223367899999999999999999999986
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=349.89 Aligned_cols=261 Identities=28% Similarity=0.441 Sum_probs=205.9
Q ss_pred HHHHHHhhcccccccccEEEEEEEE------CCCcEEEEEEccCcc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 673 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~ 673 (927)
+....+++.+.||+|+||.||+|++ .++..||||+++... ....+.+.+|+++++.+ +||||++++++|.+.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3455678899999999999999974 235689999997543 33456789999999999 899999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCC---------------------------------------------------------
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSV--------------------------------------------------------- 696 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~--------------------------------------------------------- 696 (927)
+..++||||+++|+|.++++...
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999986421
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 697 ---------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 697 ---------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
....+++..+++++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 01257888999999999999999998 999999999999999999999999999998654332
Q ss_pred cc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 762 TH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 762 ~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
.. ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ....+... .+.... .+
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~~----~~~~~~--~~- 339 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMIK----EGYRML--SP- 339 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHHH----hCccCC--CC-
Confidence 21 1122334668999999999999999999999999999998 88898633221 12222221 111100 01
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
.....++.+++.+||+.||++||+++||++.|++.
T Consensus 340 ------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11124688999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=327.37 Aligned_cols=256 Identities=26% Similarity=0.453 Sum_probs=208.2
Q ss_pred HHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
....+++.++||+|++|.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..++++||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 345677789999999999999998888999999987532 3457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++++|.++++.. ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 83 MAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999998754 34568889999999999999999998 9999999999999999999999999999987654322
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .....+ ..+... +.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~~~~~----~~-- 225 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSAL----QRGYRM----PR-- 225 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHH----HcCCCC----CC--
Confidence 22222335678999999988889999999999999999998 99999633221 112211 111110 00
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
....+..+.+++.+|+..+|++||+++++++.|++
T Consensus 226 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 ---MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ---CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01123468899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=326.41 Aligned_cols=258 Identities=26% Similarity=0.474 Sum_probs=208.7
Q ss_pred HHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
+....+++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++|+||+++++++...+..++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 4456678889999999999999998888899999987543 335678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++++|.+++.... ...+++..+..++.|++.||.|||+ ++++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999997542 4568999999999999999999998 899999999999999999999999999998765332
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
.........+..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... .+......
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~------- 223 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQ----QVDQGYRM------- 223 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHHcCCCC-------
Confidence 211111223457999999998899999999999999999999 99999733211 1111 11111100
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
.........+.+++.+|++.+|++||+++++++.|++.
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 01112235788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=326.82 Aligned_cols=257 Identities=30% Similarity=0.465 Sum_probs=207.6
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
....+.+.++||+|++|.||+|..+ .++.||+|++... ....+++.+|++++++++|+||+++++++..++..+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 3445667889999999999999876 4889999998754 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++++|.+++... ....+++..++.++.|+++||+|||+ ++++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 83 FMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred eCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999998753 24568999999999999999999998 899999999999999999999999999998765432
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
........++..|+|||.+.+..++.++|||||||++|||++ |..||...+.. ...+. +..+.. +
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~----~~~~~~-----~-- 224 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL----LEKGYR-----M-- 224 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HHCCCC-----C--
Confidence 222222234568999999998899999999999999999998 99998743321 11111 111100 0
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
......+..+.+++.+|++.+|++||++.|++++|+++
T Consensus 225 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 --ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11112234788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=337.44 Aligned_cols=263 Identities=22% Similarity=0.299 Sum_probs=204.2
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
....|++.+.||+|+||.||+++.+ ++..+|+|++..... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 3455677899999999999999987 588899999875432 34567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 83 EHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 99999999999974 4568899999999999999999997 246999999999999999999999999998765432
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcC---Cee----
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVI---- 833 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~---~~~---- 833 (927)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||...+..+ +..........+ ...
T Consensus 158 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred c---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCc
Confidence 2 223458999999999999999999999999999999999999997433211 111111000000 000
Q ss_pred -----------------------eecc----ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 834 -----------------------SIVD----PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 834 -----------------------~~~d----~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+..+ .............++.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 000000001233478899999999999999999999876
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=331.41 Aligned_cols=250 Identities=24% Similarity=0.304 Sum_probs=199.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
|+..+.||+|+||.||+|... +|+.||+|.+.... ......+.+|++++++++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 455789999999999999875 68999999986432 22335678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.+++... ....+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 9999999887643 23468999999999999999999998 9999999999999999999999999999987543221
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......... +.....+.....
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~---------- 222 (285)
T cd05631 158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQE---------- 222 (285)
T ss_pred --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhcccc----------
Confidence 12345899999999999999999999999999999999999999744332111 111111111100
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 875 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~eVl~ 875 (927)
.+.......+.+|+.+||+.||++||+ ++|+++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 111122346789999999999999997 788776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=347.36 Aligned_cols=263 Identities=30% Similarity=0.467 Sum_probs=206.6
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeec
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE 672 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~ 672 (927)
.+....+++.+.||+|+||.||+|... +++.||||+++... ......+.+|+++++.+ +|+||++++++|..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 345567888999999999999999753 24579999997543 33456788999999999 89999999999999
Q ss_pred CceEEEEEEecCCCCHHHHhccCC--------------------------------------------------------
Q 002410 673 EHQRILVYEYMHNGTLRDRLHGSV-------------------------------------------------------- 696 (927)
Q Consensus 673 ~~~~~LV~E~~~~gsL~~~L~~~~-------------------------------------------------------- 696 (927)
.+..++||||+++|+|.++++...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 999999999999999999885321
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc-c
Q 002410 697 -----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-I 764 (927)
Q Consensus 697 -----------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~-~ 764 (927)
....+++.++++++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++........ .
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 11347888999999999999999998 99999999999999999999999999999765432211 1
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||....... .... ....+.. ...+
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~----~~~~~~~--~~~~----- 337 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK----MVKRGYQ--MSRP----- 337 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH----HHHcccC--ccCC-----
Confidence 122235668999999998899999999999999999997 999997432211 1111 1111110 0001
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
...+..+.+++.+||+.||++||++.||++.|++++
T Consensus 338 --~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 --DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 011346889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=337.89 Aligned_cols=271 Identities=27% Similarity=0.440 Sum_probs=222.5
Q ss_pred ChhhHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 598 PLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 598 ~~~el~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~-~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
.++|.......|.++||+|-||.|.+.+...+..||||+++..... ...+|.+|+++|.+++||||++++|+|..++..
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 4567788888899999999999999999998899999999986544 458999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++|+|||++|+|.+++..+.. ..+.-....+|+.||+.||+||.+ .++|||||.++|+|+|.++++||+|||+++.
T Consensus 611 cmI~EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccc
Confidence 999999999999999986532 224556678899999999999998 9999999999999999999999999999996
Q ss_pred ccc-cccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCcccccchhhHHHHHHHhhhcCCee
Q 002410 757 AEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFGAELNIVHWARSMIKKGDVI 833 (927)
Q Consensus 757 ~~~-~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt--G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 833 (927)
+-. +..+.....+-+.+|||||.+..++++.++|||+||+++||+++ .+.||.... ....++........+...
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGEFFRDQGRQ 763 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhhhcCCCCcc
Confidence 433 33333444556789999999999999999999999999999876 788886322 223334333333322221
Q ss_pred eeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 834 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 834 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
..+ ..+..++.++.+++.+||..+-++||+++++...|++..
T Consensus 764 ~~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 764 VVL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred eec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 111 123345668899999999999999999999999998753
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=323.92 Aligned_cols=252 Identities=31% Similarity=0.507 Sum_probs=203.4
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
..+++.+.||+|+||.||+++++++..+|+|.+.... ...+++.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3456778999999999999999888899999886432 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+|+|.++++.. ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||.++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999998743 2458899999999999999999998 999999999999999999999999999988654322222
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+. ......+. .+.. ...+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~----~~~~--~~~~~---- 224 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMIS----RGFR--LYRPK---- 224 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH----CCCC--CCCCC----
Confidence 222235668999999988889999999999999999999 8999974322 12222221 1111 11111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
.....+.+++.+|++.+|++||+++|+++.|.
T Consensus 225 ---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 ---LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11246889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=339.66 Aligned_cols=242 Identities=24% Similarity=0.349 Sum_probs=197.0
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 686 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~g 686 (927)
+.||+|+||.||+++.+ +|+.||+|+++... ......+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999876 68999999987532 233456788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccccc
Q 002410 687 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 766 (927)
Q Consensus 687 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 766 (927)
+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~ 153 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-ccc
Confidence 99999873 4678999999999999999999998 9999999999999999999999999999875322211 122
Q ss_pred ccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCH
Q 002410 767 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 846 (927)
Q Consensus 767 ~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 846 (927)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .... .+..+.. .+ +.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~----~~~~~~~------~~----p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE----LILMEEI------RF----PR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHH----HHHcCCC------CC----CC
Confidence 345899999999999999999999999999999999999999743221 1111 1111111 11 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002410 847 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 876 (927)
Q Consensus 847 ~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~~ 876 (927)
.....+.+++.+||+.||++|| +++|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 2234678999999999999999 79998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=324.81 Aligned_cols=256 Identities=27% Similarity=0.440 Sum_probs=211.4
Q ss_pred HHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
...|.+.++||.|++|.||+|...+++.+++|.+.........++.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45678899999999999999999889999999998766556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++++|.+++... ....+++.++..++.|++.||+|||+ ++++|+||||+||++++++.+||+|||.+.........
T Consensus 85 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999999854 34568999999999999999999998 89999999999999999999999999999876443222
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
.. ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ....... .+...
T Consensus 161 ~~-~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~~--------- 223 (261)
T cd05148 161 SS-DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQIT----AGYRM--------- 223 (261)
T ss_pred cc-CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHH----hCCcC---------
Confidence 11 2335678999999988899999999999999999998 89999643321 1112111 11000
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
.........+.+++.+|++.+|++|||++++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 01112234688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=331.43 Aligned_cols=263 Identities=19% Similarity=0.205 Sum_probs=201.2
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|++.+.||+|+||.||+|+.+ +++.||+|+++... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 567889999999999999987 57899999987532 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
+++.+..+.. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 83 EKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 9887765543 24568999999999999999999998 99999999999999999999999999999876443322
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHH---------HHhhhcCCeee
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA---------RSMIKKGDVIS 834 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~---------~~~~~~~~~~~ 834 (927)
......|++.|+|||++.+..++.++|||||||++|||++|+.||......+........ ...........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 233345899999999999888999999999999999999999999754322211111110 00000101101
Q ss_pred eccccccC------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 835 IVDPVLIG------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 835 ~~d~~l~~------~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
...+.... .........+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00010000 001112346899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=309.64 Aligned_cols=234 Identities=26% Similarity=0.374 Sum_probs=198.3
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccch---hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~---~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
..+++.+.||.|+||+|.+++.+ +|..+|+|++.+..-- ..+...+|..+|+.+.||+++++++.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 34567789999999999999987 5889999999865433 3456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||++||.|..+++ ..+.+++..++-++.||+.||+|||+ .+|++|||||+|||+|.+|.+||+|||.|+.....
T Consensus 124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999999 45679999999999999999999998 99999999999999999999999999999987543
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCC--eeeeccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD--VISIVDP 838 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~--~~~~~d~ 838 (927)
..+.+||+.|+|||+++...+..++|-|||||++|||+.|.+||..... ..+. +.+-+++ +...+.
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY----~KI~~~~v~fP~~fs- 265 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIY----EKILEGKVKFPSYFS- 265 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHH----HHHHhCcccCCcccC-
Confidence 3456799999999999999999999999999999999999999974332 1111 1222222 222222
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCC
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSR 867 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R 867 (927)
..+.+|+.+.|+.|-.+|
T Consensus 266 -----------~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 266 -----------SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -----------HHHHHHHHHHHhhhhHhh
Confidence 257799999999999999
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=334.14 Aligned_cols=247 Identities=26% Similarity=0.377 Sum_probs=207.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
|+-.+.||+|.||.||+|... .++.||+|++.-.. ....+++.+|+.+|.+++++||.++++.+..+..++++||||.
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 344588999999999999876 58899999997543 3456789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
||++.+.++ .+..+++..+.-|+++++.||.|||. ++.+|||||+.|||+..+|.+||+|||.+..........
T Consensus 95 gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 95 GGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred Ccchhhhhc---cCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 999999998 34555888888999999999999998 999999999999999999999999999998876654444
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 844 (927)
...+||+.|||||++++..|+.|+||||||++.+||++|.+|+..... -++.-++.....+..
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------------mrvlflIpk~~PP~L 231 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------------MRVLFLIPKSAPPRL 231 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------------ceEEEeccCCCCCcc
Confidence 567799999999999988999999999999999999999999973322 122222222222222
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 845 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 845 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.......+.+++..||.+||+.||+++++++.
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 23344568899999999999999999999864
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=306.67 Aligned_cols=264 Identities=22% Similarity=0.308 Sum_probs=210.8
Q ss_pred HHHHHhhcccccccccEEEEEEE-ECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----ceE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQR 676 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-----~~~ 676 (927)
...+|++.+.||+|||+-||+++ ..+++.+|+|++.-...++.+..++|++..++++|||++++++++..+ ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34578889999999999999998 457899999999877677788899999999999999999999987443 458
Q ss_pred EEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
|++++|...|+|.+.+.... .+..+++.+++.|+.+|++||++||+. ..+++||||||.|||+.+++.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999998655 455899999999999999999999982 2349999999999999999999999999987
Q ss_pred ccccccccc--------ccccccCCCccCCCccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH
Q 002410 756 QAEEDLTHI--------SSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 824 (927)
Q Consensus 756 ~~~~~~~~~--------~~~~~gt~~Y~APE~l~---~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~ 824 (927)
...-..... ......|..|+|||.+. +...++++|||||||+||+|+.|..||+..-
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~------------ 245 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY------------ 245 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh------------
Confidence 643221111 11224788999999984 5577899999999999999999999997111
Q ss_pred HhhhcCCeee-eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 825 SMIKKGDVIS-IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 825 ~~~~~~~~~~-~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
.+.+.+.- +..+.+.-.......+.+.+++..|++.||.+||++.|++..+++++
T Consensus 246 --~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 246 --QQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --hcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 01122211 11222221122235668999999999999999999999999998765
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=339.78 Aligned_cols=251 Identities=23% Similarity=0.314 Sum_probs=202.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
|++.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 556789999999999999987 48899999987542 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 83 VPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 999999999973 4568899999999999999999998 9999999999999999999999999999986543
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...+..+.... +.............++
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~---- 225 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN---LKYWKETLQRPVYDDP---- 225 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH---HHhccccccCCCCCcc----
Confidence 22334589999999999998999999999999999999999999974433221111 1110000000000110
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.......+.+++.+||..+|++||+++|+++.
T Consensus 226 --~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 --RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred --ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 01223467899999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=330.28 Aligned_cols=263 Identities=22% Similarity=0.284 Sum_probs=198.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
.|.+.++||+|+||.||+|..+ +++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 3667889999999999999876 68899999987532 223456789999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++ +|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 86 ~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 86 DS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred Cc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 74 899988642 3457889999999999999999998 99999999999999999999999999998764332211
Q ss_pred cccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhh---------hcCCee
Q 002410 764 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI---------KKGDVI 833 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~---------~~~~~~ 833 (927)
.....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+............ ......
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 160 -YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred -ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 223457899999998865 568999999999999999999999997544332221111000000 000000
Q ss_pred eeccccccCCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 834 SIVDPVLIGNV----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 834 ~~~d~~l~~~~----~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
....+...... ......++.+++.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11111100000 0112236789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=325.87 Aligned_cols=258 Identities=28% Similarity=0.472 Sum_probs=208.0
Q ss_pred HHHHHhhcccccccccEEEEEEEECC------CcEEEEEEccCccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCce
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 675 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~~------g~~vAvK~l~~~~~~-~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~ 675 (927)
...++.+.+.||+|+||.||+|...+ ++.||||.++..... ..+.+.+|++++++++|+||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 34667888999999999999998743 478999999765444 45789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC
Q 002410 676 RILVYEYMHNGTLRDRLHGSV-----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 744 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~-----------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~ 744 (927)
.++||||+++++|.+++.... ....+++.++..++.|++.||+|||+ ++++||||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCC
Confidence 999999999999999997532 23457889999999999999999998 8999999999999999999
Q ss_pred cEEEeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHH
Q 002410 745 RAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW 822 (927)
Q Consensus 745 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~ 822 (927)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... ...+.
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~ 236 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIEC 236 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH
Confidence 999999999876432211 11223345778999999999999999999999999999999 99998633321 12221
Q ss_pred HHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 823 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 823 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
. ..+..... .......+.+++.+||+.||++||+++||++.|++
T Consensus 237 ~----~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 I----TQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred H----HcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1 12221111 11223478899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=332.80 Aligned_cols=243 Identities=23% Similarity=0.310 Sum_probs=198.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 566789999999999999987 68999999986432 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 83 VPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 999999999973 4578999999999999999999998 999999999999999999999999999998754321
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+ . +..+.. .+..
T Consensus 156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~---~-i~~~~~------~~~~ 219 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIYE---K-ILAGKL------EFPR 219 (291)
T ss_pred ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HHhCCc------CCCc
Confidence 2245899999999999988999999999999999999999999743321 1111 1 111111 0111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA 876 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~eVl~~ 876 (927)
.....+.+++.+||+.||.+||+ ++|+++.
T Consensus 220 ----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 220 ----HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11236789999999999999995 7777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=333.63 Aligned_cols=202 Identities=26% Similarity=0.393 Sum_probs=176.3
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
+....|++.++||+|+||.||++.++ +++.+|+|++..... .....+.+|++++++++|+||+++++++.+++..++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 44567888999999999999999987 588899998875432 3456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ..+|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 82 MEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 999999999999973 4568899999999999999999997 25799999999999999999999999999876533
Q ss_pred cccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 002410 760 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 811 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~ 811 (927)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 21 12345889999999999989999999999999999999999999743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=327.17 Aligned_cols=249 Identities=40% Similarity=0.614 Sum_probs=195.0
Q ss_pred hcccccccccEEEEEEEEC-----CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 609 FCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 609 ~~~~LG~G~~G~Vy~a~~~-----~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
+.+.||.|.||.||+|.+. .+..|+||.++.... ...+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 257899999976433 3478899999999999999999999999988889999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc-c
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-L 761 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~-~ 761 (927)
+++|+|.++|... ....+++..+..|+.||++||+|||+ ++++|+||+++||+++.++.+||+|||++...... .
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999864 35679999999999999999999998 89999999999999999999999999999876322 1
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
............|+|||.+.+..++.++||||||+++|||++ |+.||.... ...+...+ .++.....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~~~~----~~~~~~~~----- 226 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEIIEKL----KQGQRLPI----- 226 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHHHHH----HTTEETTS-----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccc----ccccccee-----
Confidence 122233346778999999998889999999999999999999 788886332 12222222 22221111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 877 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L 877 (927)
+......+.+++.+||+.+|++||+++||++.|
T Consensus 227 ----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 ----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111234688999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=350.28 Aligned_cols=260 Identities=22% Similarity=0.284 Sum_probs=211.4
Q ss_pred HHhhcccccccccEEEEEEEECCC-cEEEEEEccCccchhHHHHHHHHHHHHhcC-CCceeeeeeee-e---c---CceE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKDG-KEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYC-E---E---EHQR 676 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~g-~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~-~---~---~~~~ 676 (927)
..++.+.|.+|||+.||.|+...+ ..+|+|++-.......+.+.+|+++|++|+ |+|||.+++.. . . .-+.
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 445678999999999999998876 999999987777778889999999999996 99999999932 1 1 2367
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
+|.||||+||.|-|++..... ..|++.++++|+.|+++|+++||. +..+|||||||.+||||..+++.||||||.+..
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 899999999999999986643 349999999999999999999997 567899999999999999999999999999876
Q ss_pred ccccccccc--------cccccCCCccCCCcc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 002410 757 AEEDLTHIS--------SVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 825 (927)
Q Consensus 757 ~~~~~~~~~--------~~~~gt~~Y~APE~l---~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 825 (927)
......... -...-|+.|+|||.+ .+..+++|+|||+|||+||-|+....||+...
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------- 262 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------- 262 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------------
Confidence 432221110 112358999999975 67789999999999999999999999997321
Q ss_pred hhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhccC
Q 002410 826 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 886 (927)
Q Consensus 826 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~~ 886 (927)
...+++....---...+...+.+||+.||+.||.+||++-+|+..+.++...+..
T Consensus 263 ------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 263 ------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred ------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 1122222222112245667899999999999999999999999999998776553
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=333.30 Aligned_cols=242 Identities=24% Similarity=0.356 Sum_probs=195.8
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 686 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~g 686 (927)
+.||+|+||.||+++.+ +|+.||+|+++... ......+.+|++++++++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999876 68999999987532 234456788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccccc
Q 002410 687 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 766 (927)
Q Consensus 687 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 766 (927)
+|..++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 153 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccc
Confidence 99998873 4578999999999999999999998 9999999999999999999999999999875322211 122
Q ss_pred ccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCH
Q 002410 767 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 846 (927)
Q Consensus 767 ~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 846 (927)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...+... ... .... ... .+..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~---~~~~-~~~------~~p~---- 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE---LILM-EEI------RFPR---- 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHhc-CCC------CCCC----
Confidence 3458999999999999999999999999999999999999997433211 111 1111 110 0111
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002410 847 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 876 (927)
Q Consensus 847 ~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~~ 876 (927)
.....+.+++.+||+.||++|| ++.++++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1234678999999999999998 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.88 Aligned_cols=256 Identities=30% Similarity=0.526 Sum_probs=205.7
Q ss_pred HHHhhcccccccccEEEEEEEECC------CcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~------g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
..+++.+.||+|+||.||+|.... .+.||+|.++.... .....+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 356678999999999999998653 25799999875433 34567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC
Q 002410 678 LVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 744 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~ 744 (927)
++|||+++|+|.+++..... ...+++..++.++.|++.||+|||+ ++++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 99999999999999975321 1468889999999999999999998 8999999999999999999
Q ss_pred cEEEeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHH
Q 002410 745 RAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW 822 (927)
Q Consensus 745 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~ 822 (927)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .+.+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~- 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIE- 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH-
Confidence 999999999876533221 12223346788999999988899999999999999999998 99999743321 1222
Q ss_pred HHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 823 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 823 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
.+..+.... .....+..+.+|+.+||+.||++||+++||++.|+.
T Consensus 238 ---~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 ---MIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 122222111 112234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=333.70 Aligned_cols=239 Identities=25% Similarity=0.338 Sum_probs=193.4
Q ss_pred ccccccEEEEEEEEC-CCcEEEEEEccCc---cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCH
Q 002410 613 IGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 688 (927)
Q Consensus 613 LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL 688 (927)
||+|+||.||+|+.. +++.||+|+++.. .......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999986 5889999998653 223456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccccccc
Q 002410 689 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 768 (927)
Q Consensus 689 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 768 (927)
.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 153 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTF 153 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccc
Confidence 999973 4568999999999999999999998 9999999999999999999999999999876432221 22334
Q ss_pred ccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHH
Q 002410 769 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 848 (927)
Q Consensus 769 ~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 848 (927)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....... +.. .+ +...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~-~~~------~~----~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQ-EPL------RF----PDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHc-CCC------CC----CCcC
Confidence 5899999999999999999999999999999999999999743221 11112111 111 01 1112
Q ss_pred HHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 002410 849 IWRIAEVAIQCVEQRGFSRPK---MQEIVL 875 (927)
Q Consensus 849 ~~~l~~Li~~Cl~~dP~~RPs---~~eVl~ 875 (927)
...+.+++.+||+.||++||+ +.|+++
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 246789999999999999986 555554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=335.10 Aligned_cols=242 Identities=25% Similarity=0.352 Sum_probs=196.9
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 686 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~g 686 (927)
+.||+|+||.||+++.+ +|+.||+|++.... ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999876 58999999997532 234567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccccc
Q 002410 687 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 766 (927)
Q Consensus 687 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 766 (927)
+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 153 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMK 153 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccc
Confidence 99998873 4578999999999999999999998 9999999999999999999999999999876432211 122
Q ss_pred ccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCH
Q 002410 767 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 846 (927)
Q Consensus 767 ~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 846 (927)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||...+... .. .. +..+.. .+. .
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~---~~-~~~~~~------~~p----~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LF---EL-ILMEDI------KFP----R 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HH---HH-hccCCc------cCC----C
Confidence 3458999999999998899999999999999999999999997433211 11 11 111110 111 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002410 847 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 876 (927)
Q Consensus 847 ~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~~ 876 (927)
.....+.+++.+||+.||++|| +++|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1233678999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=329.60 Aligned_cols=244 Identities=24% Similarity=0.361 Sum_probs=200.1
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
..+++.+.||+|+||.||+|+-+ +|+.+|+|++++..- ...+.++.|-.+|....+|+||+++..|++.+.+||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 34456789999999999999876 599999999987543 34567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc-
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE- 759 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~- 759 (927)
||++||++..+|. ....|++.....++.+++.|++.||+ .|+|||||||+|+|||..|++||+|||++.-+..
T Consensus 221 EylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 221 EYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999998 56889999999999999999999998 9999999999999999999999999999853211
Q ss_pred ----------------------cccc---cc--------------------cccccCCCccCCCccCCCCCCcchhHHHH
Q 002410 760 ----------------------DLTH---IS--------------------SVARGTVGYLDPEYYGNQQLTEKSDVYSF 794 (927)
Q Consensus 760 ----------------------~~~~---~~--------------------~~~~gt~~Y~APE~l~~~~~s~ksDVwSl 794 (927)
+... .. ...+|||.|||||++.+..|+..+|.||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000 00 12359999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCcccccch-hhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 002410 795 GVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK 869 (927)
Q Consensus 795 GvlL~eLltG~~Pf~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs 869 (927)
|||+||||.|.+||..++..+. .++..|......... .....+..+||.+|+. ||++|-.
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999999986655432 345555433221110 0111467799999999 9999986
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=336.19 Aligned_cols=245 Identities=24% Similarity=0.335 Sum_probs=200.4
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
..|++.+.||+|+||.||+|+.+ +++.||+|+++... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 45677899999999999999987 58899999987532 223467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999973 4568889999999999999999998 99999999999999999999999999999875432
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
. ....|++.|+|||++.+..++.++|||||||++|||++|+.||..... .... ..+..+... +
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~----~~i~~~~~~------~ 234 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---FRIY----EKILAGRLK------F 234 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---HHHH----HHHhcCCcC------C
Confidence 2 234589999999999998999999999999999999999999973321 1111 112222110 0
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA 876 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~eVl~~ 876 (927)
... ....+.+++.+||+.||++||+ ++|+++.
T Consensus 235 p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 235 PNW----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011 1235789999999999999997 6777644
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.24 Aligned_cols=251 Identities=29% Similarity=0.481 Sum_probs=202.2
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
..+++.+.||+|++|.||+|.++++..+|+|++..... ....+.+|++++++++|+||+++++++...+..++|+||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 34667899999999999999988788899999864322 34568889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999999743 3468999999999999999999998 899999999999999999999999999987654332221
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+.. ..... +..+.. . .
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----~~~~~~-----~----~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVES----VSAGYR-----L----Y 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHH----HHcCCc-----C----C
Confidence 112223457999999998899999999999999999999 89998743321 11111 111100 0 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 877 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L 877 (927)
.+...+..+.+++.+|+..+|++||++.|+++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0111344788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.41 Aligned_cols=256 Identities=27% Similarity=0.475 Sum_probs=205.2
Q ss_pred HHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
+....+++.++||+|++|.||+|..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...+++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTE 80 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEE
Confidence 34556788999999999999999988888999999875433 34678999999999999999999998854 56789999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++++|.++++.. ....+++.+++.++.|++.||+|||+ ++++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 81 YMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999999753 24468999999999999999999998 899999999999999999999999999997654332
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
........++..|+|||.+.+..++.++||||||+++|||++ |..||...+.. ...+. +..+...
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~----~~~~~~~------- 222 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQ----VERGYRM------- 222 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HHcCCCC-------
Confidence 222222235668999999988889999999999999999999 89999643221 11121 1111100
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
..+......+.+++.+|+..+|++|||+.++.+.|++
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 --PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=323.39 Aligned_cols=256 Identities=27% Similarity=0.472 Sum_probs=206.0
Q ss_pred HHHhhcccccccccEEEEEEEECC----CcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~----g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
..+.+.+.||+|+||.||+|.++. ...||||.++... ......|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 456678999999999999998853 4579999987543 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
|||+++++|.+++... ...+++..+++++.|++.||+|||+ ++|+||||||+||++++++.++|+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999999753 3478999999999999999999998 9999999999999999999999999999987652
Q ss_pred ccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 760 DLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 760 ~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
... .......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ....+. +..+....
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~~~--- 228 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKA----VEDGYRLP--- 228 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHH----HHcCCCCC---
Confidence 211 11222234678999999998899999999999999999998 9999863221 112221 11111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
.....+..+.+++.+|++.+|++||+++||++.|++++
T Consensus 229 ------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 229 ------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 01122346889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=323.82 Aligned_cols=252 Identities=30% Similarity=0.491 Sum_probs=203.2
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
..+.+.+.||+|++|.||+|.++++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4567788999999999999998877789999987543 234678999999999999999999999998889999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+|+|.+++... ...+++..++.++.||+.||+|||+ ++++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999998753 3368999999999999999999998 999999999999999999999999999987654332222
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .....+ ..+..... +
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~----~~~~~~~~--~----- 223 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKV----SQGLRLYR--P----- 223 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH----hcCCCCCC--C-----
Confidence 222235678999999988889999999999999999999 99998633221 111111 11111000 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 224 --~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 --HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112347889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=316.86 Aligned_cols=248 Identities=23% Similarity=0.366 Sum_probs=211.2
Q ss_pred HHHHHhhcccccccccEEEEEEEE-CCCcEEEEEEccCccch---hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~-~~g~~vAvK~l~~~~~~---~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~L 678 (927)
..-+|+|.+.||+|.||.|-+|.. ..|+.||||.++++.-. +.-.+.+|+++|..|+||||+.++.+|++.+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 456788999999999999999975 67999999999875433 34457899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
||||..+|.|+|++.. .+.+++.+...++.||..|+.|+|. ++++|||||.+|||+|.++++||+|||++..+.
T Consensus 131 vMEYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999999984 5789999999999999999999998 999999999999999999999999999998876
Q ss_pred ccccccccccccCCCccCCCccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 759 EDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 759 ~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
.+ ..-..++|++-|.+||++.+..| .+..|-|||||+||.|+.|..||++.+.. . +-.++..|...+--.
T Consensus 205 ~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~----lvrQIs~GaYrEP~~ 275 (668)
T KOG0611|consen 205 DK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---R----LVRQISRGAYREPET 275 (668)
T ss_pred cc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---H----HHHHhhcccccCCCC
Confidence 54 23445779999999999999887 58999999999999999999999865542 1 222344444433222
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
| ....-||+.||..+|++|.|+++|...
T Consensus 276 P-----------SdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 276 P-----------SDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred C-----------chHHHHHHHHHhcCcccchhHHHHhhh
Confidence 2 244578999999999999999999865
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=325.27 Aligned_cols=260 Identities=27% Similarity=0.454 Sum_probs=210.2
Q ss_pred HHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~L 678 (927)
..+.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 44566789999999999999753 356799999887666666789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCc
Q 002410 679 VYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 745 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~ 745 (927)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999997432 12458899999999999999999998 99999999999999999999
Q ss_pred EEEeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHH
Q 002410 746 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 823 (927)
Q Consensus 746 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~ 823 (927)
++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||+| |+.||...... ...+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~-- 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIE-- 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--
Confidence 99999999976543221 12223346788999999999899999999999999999999 99998633221 1111
Q ss_pred HHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 824 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 824 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
.+..+..... ....+..+.+++.+||+.+|++||++++|+++|+++...
T Consensus 237 --~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 --CITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred --HHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1222222111 111234688999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=334.36 Aligned_cols=248 Identities=23% Similarity=0.391 Sum_probs=194.1
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
..+++.++||+|+||.||+|++. +++.||||++..... ...+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34556789999999999999876 689999999865433 3356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.+.. ...+..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986532 34567888999999999999998 9999999999999999999999999999987543322
Q ss_pred ccccccccCCCccCCCccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 763 HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
. .....|+..|+|||.+.. ...+.++|||||||++|||++|+.||......+...+.. .... ...
T Consensus 224 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~-~~~----- 293 (353)
T PLN00034 224 P-CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---AICM-SQP----- 293 (353)
T ss_pred c-ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---HHhc-cCC-----
Confidence 1 223458999999998743 234569999999999999999999997332222111111 1110 000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+ .........+.+++.+||+.||++||+++|+++.
T Consensus 294 ~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 P----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred C----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0111223468899999999999999999999874
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.97 Aligned_cols=256 Identities=27% Similarity=0.440 Sum_probs=205.3
Q ss_pred HHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
...|++.++||+|++|.||+|+++++..||+|+++.... ..+.+.+|++++++++|+||+++++.+.. +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 456788999999999999999988777899999975332 34678999999999999999999998754 5578999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++|+|.+++... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||.++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999753 24467899999999999999999998 99999999999999999999999999999766443322
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
......++..|+|||...+..++.++|||||||++|||++ |+.||....... ... .+..+...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~----~~~~~~~~--------- 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD----QVERGYRM--------- 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHH----HHhcCCCC---------
Confidence 2223345678999999988899999999999999999999 888886332211 111 11111100
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
......+..+.+++.+|++.+|++||+++++++.|++..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 011233457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=322.87 Aligned_cols=252 Identities=28% Similarity=0.378 Sum_probs=197.0
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--------------hhHHHHHHHHHHHHhcCCCceeeeeee
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------------HRTQQFVTEVALLSRIHHRNLVPLIGY 669 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--------------~~~~~~~~E~~~L~~l~HpnIv~l~~~ 669 (927)
..|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+...+|+.+|++++|||||+|+.+
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 45677899999999999999876 689999999965311 123578899999999999999999999
Q ss_pred eec--CceEEEEEEecCCCCHHHHhccCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcE
Q 002410 670 CEE--EHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 746 (927)
Q Consensus 670 ~~~--~~~~~LV~E~~~~gsL~~~L~~~~~~~~-l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~ 746 (927)
..+ .+..|||+|||..|.+...= ..++ +++.+.++++.++..||+|||. +|||||||||+|+||+++|++
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcE
Confidence 865 56799999999998875432 2344 9999999999999999999998 999999999999999999999
Q ss_pred EEeecccccccccc----ccccccccccCCCccCCCccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhh
Q 002410 747 KVSDFGLSRQAEED----LTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 818 (927)
Q Consensus 747 kL~DFGla~~~~~~----~~~~~~~~~gt~~Y~APE~l~~~----~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~ 818 (927)
||+|||.+...... ....-....||+.|+|||...++ ..+.+.||||+||+||.|+.|+.||.++..
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----- 324 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----- 324 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-----
Confidence 99999998865222 11112235799999999998663 246789999999999999999999973221
Q ss_pred HHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 819 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 819 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
.+. ...+.+..+ ......+....+.+||.+||++||++|.+..+|....=
T Consensus 325 -~~l-~~KIvn~pL--------~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 325 -LEL-FDKIVNDPL--------EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred -HHH-HHHHhcCcc--------cCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 111 112222221 11111234457889999999999999999999876543
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.12 Aligned_cols=266 Identities=25% Similarity=0.388 Sum_probs=202.0
Q ss_pred hhcccccccccEEEEEEEE-----CCCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecC--ceEEEE
Q 002410 608 NFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILV 679 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~-----~~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~~~LV 679 (927)
.+.+.||+|+||+||++.. .+++.||+|.++.... .....+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6678999999999988753 3578899999876433 3456788999999999999999999987653 457899
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
|||+++++|.+++.. ..+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999873 358999999999999999999998 8999999999999999999999999999987643
Q ss_pred cccc--cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 760 DLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 760 ~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
.... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... .....................+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhhh
Confidence 3221 111223566799999998888999999999999999999999998633211 0111110000000001111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
.......+...+..+.+++.+|++.+|++||++++|++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111112233457899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=326.96 Aligned_cols=262 Identities=27% Similarity=0.461 Sum_probs=210.0
Q ss_pred HHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
++..+.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3456677899999999999999752 3456999998876656667899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcE
Q 002410 677 ILVYEYMHNGTLRDRLHGSV----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 746 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~----------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~ 746 (927)
++|+||+++++|.+++.... ....+++.+++.++.|++.||+|||+ ++++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence 99999999999999987432 12358999999999999999999998 999999999999999999999
Q ss_pred EEeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHH
Q 002410 747 KVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 824 (927)
Q Consensus 747 kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 824 (927)
||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ....
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~--- 233 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE--- 233 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---
Confidence 9999999986543221 11222335678999999998899999999999999999998 89998633221 1111
Q ss_pred HhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 825 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 825 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
.+..+..... .. .....+.+++.+||+.+|.+||+++||++.|+++...
T Consensus 234 -~i~~~~~~~~-----~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 -CITQGRVLQR-----PR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -HHHcCCcCCC-----CC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1222221111 11 1224688999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.14 Aligned_cols=257 Identities=26% Similarity=0.445 Sum_probs=207.7
Q ss_pred hHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
++...++++.++||+|+||.||+|..++++.||+|.+..... ...++.+|+.++++++|+||+++++++. .+..++++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 455678889999999999999999998999999999875433 3467899999999999999999999874 45689999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++++|.+++... ....+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 80 EYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999998754 34568999999999999999999998 99999999999999999999999999999776532
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...... ..+....
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~----~~~~~~~----- 223 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQNL----ERGYRMP----- 223 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHHH----HcCCCCC-----
Confidence 2222222335678999999988889999999999999999999 99999743321 122211 1111100
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
. ....+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 224 ~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 R----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0 11123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.15 Aligned_cols=248 Identities=28% Similarity=0.453 Sum_probs=197.8
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCH
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 688 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL 688 (927)
+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999876 68999999886543 33456799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc-cc
Q 002410 689 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SV 767 (927)
Q Consensus 689 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~-~~ 767 (927)
.+++... ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998742 3468899999999999999999998 9999999999999999999999999999876443211111 11
Q ss_pred cccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCH
Q 002410 768 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 846 (927)
Q Consensus 768 ~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 846 (927)
...+..|+|||.+.+..++.++|||||||++|||++ |..||...... ... ..+...... ....
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~----~~~~~~~~~---------~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTR----EAIEQGVRL---------PCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHH----HHHHcCCCC---------CCcc
Confidence 123457999999998899999999999999999998 88888632211 111 111111000 1111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 847 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 847 ~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
..+..+.+++.+|++.+|++||++.||+++|++
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 223478899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=323.09 Aligned_cols=268 Identities=26% Similarity=0.399 Sum_probs=205.7
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHh--cCCCceeeeeeeeecCc----eEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSR--IHHRNLVPLIGYCEEEH----QRILVY 680 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~--l~HpnIv~l~~~~~~~~----~~~LV~ 680 (927)
.++.+.||+|+||.||+|++. ++.||||++. ....+.|.+|-++.+. ++|+||++++++-.... +++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 345689999999999999998 6999999997 3456778888888776 48999999999876555 889999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEecCCCCCcccccCCCcEEEeecccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG------CNPGIIHRDVKSSNILLDINMRAKVSDFGLS 754 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~------~~~~ivH~DLkp~NILld~~~~~kL~DFGla 754 (927)
||.+.|+|.++|+ ...++|....+|+..+++||+|||+. ++++|+|||||.+||||..|+.+.|+|||+|
T Consensus 288 ~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 288 EFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 9999999999998 45799999999999999999999974 4678999999999999999999999999999
Q ss_pred cccccccccc-ccccccCCCccCCCccCCCC-CC-----cchhHHHHHHHHHHHHhCCCCCCc-ccc----------cch
Q 002410 755 RQAEEDLTHI-SSVARGTVGYLDPEYYGNQQ-LT-----EKSDVYSFGVVLLELISGKKPVSV-EDF----------GAE 816 (927)
Q Consensus 755 ~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~-~s-----~ksDVwSlGvlL~eLltG~~Pf~~-~~~----------~~~ 816 (927)
..+....... .-..+||.+|||||++.+.. +. .+.||||+|.|||||++...-+.. ... +..
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 9876543322 22357999999999997652 22 378999999999999997544421 100 011
Q ss_pred hhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhccC
Q 002410 817 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 886 (927)
Q Consensus 817 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~~ 886 (927)
..+.+.-.-.+++.....+-+.-. ....+..+.+.+..||..||+.|.|+.=|.+.+.++....+.
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWR----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhh----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 111111111111111111111111 124566788999999999999999999999999999887765
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=331.33 Aligned_cols=262 Identities=29% Similarity=0.439 Sum_probs=221.8
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEECC-CcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEE
Q 002410 600 PELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 600 ~el~~~~~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~L 678 (927)
.|++.....+.++||-|.||.||.|.|+. .-.||||.++.+ .-..++|+.|+.+|+.++|||+|+++|+|..+...||
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 46666777778999999999999999985 567999999865 4457899999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
|+|||..|+|.++|++. +...++....+.++.||+.|++||.. +++|||||.++|+|+.++..+|++|||+++.+.
T Consensus 341 iTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999999976 46667888889999999999999998 999999999999999999999999999999986
Q ss_pred ccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 759 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 759 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
.+.........-.+.|.|||-+....++.|+|||+|||+|||+.| |..||.+-+......+. ++
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL-------Ek-------- 481 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL-------EK-------- 481 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH-------hc--------
Confidence 654433333334678999999999999999999999999999999 89999755443322222 22
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
..+-+.+..++.++.+|++.||+++|.+||++.|+.+.++.+..
T Consensus 482 -gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 482 -GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred -cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 22223344566789999999999999999999999999997654
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=317.85 Aligned_cols=259 Identities=23% Similarity=0.318 Sum_probs=206.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc---cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.+.||+|+||.||+|+.. +++.||||.++.. .......+.+|++++++++||||+++++++...+..++|+|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 3567789999999999999876 6899999987542 23344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 682 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
|+++|+|.+++.... ....+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 999999998886432 23458899999999999999999998 99999999999999999999999999998876433
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ....+.+. +....... .
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~----~~~~~~~~-----~ 228 (267)
T cd08228 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQK----IEQCDYPP-----L 228 (267)
T ss_pred hHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHHH----HhcCCCCC-----C
Confidence 221 1223478899999999888899999999999999999999999863322 11112221 11111111 0
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
........+.+++.+||+.+|++||+++||++.|+++.
T Consensus 229 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 ---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 11123356889999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=329.26 Aligned_cols=242 Identities=26% Similarity=0.368 Sum_probs=194.9
Q ss_pred ccccccccEEEEEEEEC----CCcEEEEEEccCcc----chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 611 KKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~----~g~~vAvK~l~~~~----~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
+.||+|+||.||+++.. .++.||+|+++... ......+.+|++++++++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999863 57899999987532 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.+++.. ...+.+..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999999873 4567888899999999999999998 9999999999999999999999999999875432221
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...+.. ....... .+.. .+
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~-~~~~------~~-- 219 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKIL-KGKL------NL-- 219 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHH-cCCC------CC--
Confidence 122345899999999999888999999999999999999999999743321 1111111 1111 01
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 876 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~~ 876 (927)
+......+.+++.+||+.+|++|| +++++++.
T Consensus 220 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 --PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 111223678999999999999999 78888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=327.72 Aligned_cols=261 Identities=24% Similarity=0.432 Sum_probs=206.0
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-CCc----EEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCce
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 675 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~----~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~ 675 (927)
+....++..+.||+|+||.||+|++. +++ .||+|+++... ....+++.+|+.+++.++||||++++++|... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 44566777899999999999999865 333 48999987543 34557899999999999999999999999765 5
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
.++|+||+++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred ceeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccc
Confidence 67999999999999999853 3468889999999999999999998 999999999999999999999999999998
Q ss_pred cccccccccc-cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCee
Q 002410 756 QAEEDLTHIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 833 (927)
Q Consensus 756 ~~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 833 (927)
.......... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+.. ....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~ 230 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISS----ILEKGERL 230 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHhCCCCC
Confidence 7654322211 12224668999999999999999999999999999998 99999743221 1111 11111110
Q ss_pred eeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 834 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 834 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
. .+ ......+.+++.+||+.+|++||++.++++.|.++....
T Consensus 231 ~--~~-------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 231 P--QP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred C--CC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0 00 112236789999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=313.42 Aligned_cols=247 Identities=29% Similarity=0.463 Sum_probs=200.2
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCHH
Q 002410 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 689 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL~ 689 (927)
++||+|+||.||+|...+++.+|+|.++.... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47999999999999988899999999876543 33457889999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccccccc
Q 002410 690 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 769 (927)
Q Consensus 690 ~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 769 (927)
+++... ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 998743 3457899999999999999999998 99999999999999999999999999998764433222222223
Q ss_pred cCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHH
Q 002410 770 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 848 (927)
Q Consensus 770 gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 848 (927)
++..|+|||++.+..++.++||||||+++|||++ |..||...... .... .+..+... ......
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~----~~~~~~~~---------~~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QARE----QVEKGYRM---------SCPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHH----HHHcCCCC---------CCCCCC
Confidence 4668999999998899999999999999999998 99999733221 1111 11111110 011122
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 849 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 849 ~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
+..+.+++.+|++.+|++||++.|++++|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=321.06 Aligned_cols=258 Identities=24% Similarity=0.430 Sum_probs=203.5
Q ss_pred HHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCce
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 675 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~ 675 (927)
....+++.+.||+|++|.||+|.++ .++.||+|++.... .....++.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4556778899999999999999764 25679999986532 2345678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEE
Q 002410 676 RILVYEYMHNGTLRDRLHGSVN-------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 748 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL 748 (927)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+ .+++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999875321 2346788899999999999999998 89999999999999999999999
Q ss_pred eeccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHh
Q 002410 749 SDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 826 (927)
Q Consensus 749 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 826 (927)
+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~----~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLR----F 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----H
Confidence 999998765432221 1112235678999999998899999999999999999999 78888633221 1111 1
Q ss_pred hhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 827 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 827 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
...+..... ....+..+.+++.+|++.+|++||++.|+++.|++
T Consensus 234 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111111 11223468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=340.62 Aligned_cols=262 Identities=24% Similarity=0.404 Sum_probs=206.2
Q ss_pred HHHHHhhcccccccccEEEEEEEECC------CcEEEEEEccCccc-hhHHHHHHHHHHHHhcC-CCceeeeeeeeecCc
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH 674 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~~------g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~ 674 (927)
....+.+.++||+|+||.||+|+... +..||||+++.... ...+.+.+|+++++++. ||||+++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 34566778999999999999998631 34799999975433 33467999999999996 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCC----------------------------------------------------------
Q 002410 675 QRILVYEYMHNGTLRDRLHGSV---------------------------------------------------------- 696 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~---------------------------------------------------------- 696 (927)
..++||||+++|+|.+++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999886421
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc
Q 002410 697 -----------------------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 741 (927)
Q Consensus 697 -----------------------------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld 741 (927)
....+++..++.++.|+++||+|||+ .+|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 01247788899999999999999998 9999999999999999
Q ss_pred CCCcEEEeeccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhH
Q 002410 742 INMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 819 (927)
Q Consensus 742 ~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l 819 (927)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~ 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TF 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HH
Confidence 9999999999999865432221 1222346778999999998899999999999999999997 999986332211 11
Q ss_pred HHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 820 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 820 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
.. .+..+.... ........+.+++.+||+.+|++||++.+|.++|+++..
T Consensus 350 ~~----~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 YN----KIKSGYRMA---------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HH----HHhcCCCCC---------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11 111111100 111234578899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=334.55 Aligned_cols=263 Identities=22% Similarity=0.301 Sum_probs=195.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----ceEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 678 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-----~~~~L 678 (927)
|++.++||+|+||.||+|+.. +|+.||||++... ......++.+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 566789999999999999876 6899999998743 223445788999999999999999999987543 35799
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
||||++ ++|.+++.. ...+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 82 v~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 82 VFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999995 689998873 4568999999999999999999998 999999999999999999999999999998643
Q ss_pred cccc--ccccccccCCCccCCCccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH--------Hh
Q 002410 759 EDLT--HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SM 826 (927)
Q Consensus 759 ~~~~--~~~~~~~gt~~Y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~--------~~ 826 (927)
.... .......|++.|+|||++.+ ..++.++|||||||++|||++|+.||...+............ ..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2211 11223458999999999865 678999999999999999999999997443221111100000 00
Q ss_pred hhcCCeeee---ccccccC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 827 IKKGDVISI---VDPVLIG---NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 827 ~~~~~~~~~---~d~~l~~---~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+........ +.+.... .........+.+++.+||+.||++||+++|+++.
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000 0000000 0000122357899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=321.75 Aligned_cols=256 Identities=26% Similarity=0.470 Sum_probs=203.2
Q ss_pred HHHhhcccccccccEEEEEEEE-----CCCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~L 678 (927)
..+++.+.||+|+||.||+|.. .+++.|++|.+.... ......+.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567789999999999999985 246789999997533 3344678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC
Q 002410 679 VYEYMHNGTLRDRLHGSV--------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 744 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~--------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~ 744 (927)
||||+++++|.+++.... ....+++.+++.++.|++.||+|||+ ++++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 999999999999985321 12357889999999999999999998 8999999999999999999
Q ss_pred cEEEeeccccccccccc-cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHH
Q 002410 745 RAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW 822 (927)
Q Consensus 745 ~~kL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~ 822 (927)
.+||+|||+++...... ........++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..+.+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 99999999998753322 112223335678999999988889999999999999999998 9999863321 122221
Q ss_pred HHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 823 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 823 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
+....... . .......+.+++.+|++.+|++||++.+|+++|+.
T Consensus 239 ----~~~~~~~~-----~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 ----VRKRQLLP-----C----SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHcCCcCC-----C----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111 1 11123467899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=324.45 Aligned_cols=262 Identities=22% Similarity=0.285 Sum_probs=196.8
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
..|++.+.||+|+||.||+|+.+ +++.||||+++.... .....+.+|+.++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 34667899999999999999987 688999999875432 2334678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
++ ++|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 85 VH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred CC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 95 6888877642 4568889999999999999999998 9999999999999999999999999999875432221
Q ss_pred ccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcC---Ceee----
Q 002410 763 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVIS---- 834 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~---~~~~---- 834 (927)
......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...... ....+.+....... ....
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 159 -TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred -cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhc
Confidence 1223457899999998865 46789999999999999999999999743221 11111111111000 0000
Q ss_pred -ecccc-cc--CCCCH-------HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 835 -IVDPV-LI--GNVKI-------ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 835 -~~d~~-l~--~~~~~-------~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..++. .. ..... .....+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 00 00000 01235779999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=335.57 Aligned_cols=248 Identities=24% Similarity=0.297 Sum_probs=201.3
Q ss_pred HHHHHHhhcccccccccEEEEEEEECC--CcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~--g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
+....|.+.+.||+|+||.||+|.++. +..||+|++.... ....+.+.+|+++++.++||||+++++++.+++..
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 344567788999999999999998653 3689999986432 23346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 107 ~lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 999999999999999973 4568999999999999999999998 9999999999999999999999999999986
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ...+ .+..+..
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~----~i~~~~~---- 245 (340)
T PTZ00426 181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LIYQ----KILEGII---- 245 (340)
T ss_pred cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HHHH----HHhcCCC----
Confidence 5432 12345899999999999888999999999999999999999999743221 1111 1111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 876 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~~ 876 (927)
.+ +......+.+++.+|++.||++|+ +++|+++.
T Consensus 246 --~~----p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 --YF----PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --CC----CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 00 111123577999999999999995 88888765
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=336.39 Aligned_cols=242 Identities=24% Similarity=0.363 Sum_probs=202.2
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~L 678 (927)
....++.++||+|.||+|+++..+ +++.+|||++++.. .++.+..+.|.+++... +||.++.++..|+..++.++
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 344567899999999999999988 57899999998753 45567788899998888 59999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
||||+.||++..+.+ ...+++..+.-++..|+.||+|||+ ++|||||||.+|||+|.+|.+||+|||+++..-
T Consensus 447 vmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccC
Confidence 999999999555444 5679999999999999999999998 999999999999999999999999999998743
Q ss_pred ccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 759 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 759 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
.. ....++.+||+.|||||++.+..|+.+.|-|||||+|||||.|+.||.+++.++..+ .+... |+
T Consensus 520 ~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd-------sI~~d------~~ 585 (694)
T KOG0694|consen 520 GQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD-------SIVND------EV 585 (694)
T ss_pred CC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-------HHhcC------CC
Confidence 22 224567789999999999999999999999999999999999999998665433211 11111 11
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 870 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 870 (927)
.++.-...+.+++++++|..+|++|..+
T Consensus 586 ----~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 ----RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1233344577899999999999999977
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=346.35 Aligned_cols=250 Identities=21% Similarity=0.336 Sum_probs=202.4
Q ss_pred HhhcccccccccEEEEEEEEC-C-CcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-D-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~-g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
|.+.+.||+|++|.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 667899999999999999765 3 67888888765555555678889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc-
Q 002410 685 NGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT- 762 (927)
Q Consensus 685 ~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~- 762 (927)
+|+|.+++.... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 999999886432 34568899999999999999999998 9999999999999999999999999999987644322
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. .... .+... + .
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~---~~~~-~~~~~----~-~-- 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIM---QQVL-YGKYD----P-F-- 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHH-hCCCC----C-C--
Confidence 1233445899999999999999999999999999999999999999743221 111 1111 11111 0 0
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+......+.+++.+||+.+|++||+++++++
T Consensus 292 --~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 --PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1112246889999999999999999999875
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.10 Aligned_cols=260 Identities=21% Similarity=0.277 Sum_probs=193.8
Q ss_pred HHhhcccccccccEEEEEEEEC--CCcEEEEEEccCccc--hhHHHHHHHHHHHHhc---CCCceeeeeeeee-----cC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCE-----EE 673 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~--~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l---~HpnIv~l~~~~~-----~~ 673 (927)
.|++.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+.+++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 3667889999999999999874 468899999864322 2234566777777766 6999999999885 34
Q ss_pred ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccc
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 753 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 753 (927)
...++|+||++ ++|.+++... ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 56899999996 6999998754 24568999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhh---cC
Q 002410 754 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---KG 830 (927)
Q Consensus 754 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~---~~ 830 (927)
++..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+. ...+..... ..
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~~~i~~~~~~~~~~ 231 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPGEE 231 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCChh
Confidence 9765433 222334589999999999888999999999999999999999999974432211 111111110 00
Q ss_pred Ceee-------ecccccc---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 831 DVIS-------IVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 831 ~~~~-------~~d~~l~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.... ...+... ..........+.+++.+||+.||++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 0000000 0000112346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=330.21 Aligned_cols=262 Identities=28% Similarity=0.473 Sum_probs=205.9
Q ss_pred HHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeec-C
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE-E 673 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~-~ 673 (927)
....|++.+.||+|+||.||+|... .++.||+|+++... ....+.+.+|+.+++++ +|+||++++++|.. +
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3557888999999999999999643 25789999987543 23346788999999999 89999999998864 4
Q ss_pred ceEEEEEEecCCCCHHHHhccCCC--------------------------------------------------------
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSVN-------------------------------------------------------- 697 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~~-------------------------------------------------------- 697 (927)
...++++||+++++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 568899999999999999864221
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc-ccccccCCCc
Q 002410 698 --QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGY 774 (927)
Q Consensus 698 --~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y 774 (927)
...+++..+.+++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||+++......... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 1368899999999999999999998 999999999999999999999999999998754332211 2223456789
Q ss_pred cCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHH
Q 002410 775 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIA 853 (927)
Q Consensus 775 ~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 853 (927)
+|||++.+..++.++|||||||++|||++ |..||......+ .+. ..+..+..... +......+.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~----~~~~~~~~~~~---------~~~~~~~~~ 306 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFC----RRLKEGTRMRA---------PEYATPEIY 306 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHH----HHHhccCCCCC---------CccCCHHHH
Confidence 99999999999999999999999999998 999997432211 111 11222111100 111234688
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 854 EVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 854 ~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
+++.+||+.+|++||+++||++.|++++.
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.28 Aligned_cols=264 Identities=30% Similarity=0.453 Sum_probs=222.8
Q ss_pred hHHHHHHhhcccccccccEEEEEEEECC---C--cEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCc
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMKD---G--KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 674 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~~---g--~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~ 674 (927)
+|..+...+.++||+|-||.||+|...+ | -.||||..+.++ ....+.|+.|..+|++++||||++++|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 5666666778999999999999998653 3 358999998744 45578899999999999999999999999864
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccc
Q 002410 675 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 754 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 754 (927)
..++|||.++.|.|+.+|+. ++..++......++.||+.||+|||+ +++|||||..+|||+.....+||+|||++
T Consensus 464 P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchh
Confidence 58999999999999999986 35678999999999999999999999 99999999999999999999999999999
Q ss_pred ccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCee
Q 002410 755 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 833 (927)
Q Consensus 755 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 833 (927)
+.+.++.....+...-+..|||||.+.-.+++.++|||-|||.+||++. |..||.+-.. .++.
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------------sDVI 602 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------------SDVI 602 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------------cceE
Confidence 9988777666666556789999999999999999999999999999887 9999984332 2222
Q ss_pred eeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhccC
Q 002410 834 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 886 (927)
Q Consensus 834 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~~ 886 (927)
-.++..-+-..++.++..|..|+.+||..+|.+||...|+...|.+++..|..
T Consensus 603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~ 655 (974)
T KOG4257|consen 603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI 655 (974)
T ss_pred EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence 22222222233455666888999999999999999999999999998875543
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=331.54 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=198.1
Q ss_pred HhhcccccccccEEEEEEEEC----CCcEEEEEEccCcc----chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~----~g~~vAvK~l~~~~----~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~ 677 (927)
|++.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+++++++ +|+||+++++++..++..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 456789999999999999763 57899999986532 22345678899999999 5999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 82 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 82 LILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999873 4568999999999999999999998 99999999999999999999999999999865
Q ss_pred cccccccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
............||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......... . +...+...
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~-~~~~~~~~------ 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--E-VSRRILKC------ 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--H-HHHHHhcC------
Confidence 43333333345689999999998765 47889999999999999999999997433221111 1 11111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 876 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~~ 876 (927)
++.+.. .....+.+++.+||+.||++|| +++++++.
T Consensus 227 ~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 DPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111111 1223678999999999999999 67777753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.66 Aligned_cols=261 Identities=29% Similarity=0.437 Sum_probs=201.8
Q ss_pred HHhhcccccccccEEEEEEEEC-----CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeec--CceEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRIL 678 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-----~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~~~~L 678 (927)
.+++.+.||+|+||.||++..+ +++.||+|++........+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 4567789999999999999753 578999999987666667789999999999999999999998743 346889
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
|+||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++....
T Consensus 85 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 85 VMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 99999999999999743 3468999999999999999999998 999999999999999999999999999998764
Q ss_pred cccccc--ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccch---------hhHHHHHHHhh
Q 002410 759 EDLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE---------LNIVHWARSMI 827 (927)
Q Consensus 759 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~---------~~l~~~~~~~~ 827 (927)
...... .....++..|+|||.+.+..++.++|||||||++|||++|..|+........ ..........+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 332211 1112234569999999988999999999999999999998877642211100 00000011111
Q ss_pred hcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 828 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 828 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
..+.. ..........+.+++.+||+.+|++|||++||++.|+.+
T Consensus 240 ~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGR---------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11100 001112234788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=315.70 Aligned_cols=254 Identities=27% Similarity=0.437 Sum_probs=203.1
Q ss_pred HHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
...+++.+.||+|++|.||+|..+++..+|+|.+.... ...+.+.+|++++++++|+|++++++++.. +..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 34577889999999999999998877789999886543 234678899999999999999999998754 5678999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++++|.++++.. ....+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999999753 24458899999999999999999998 89999999999999999999999999999765433222
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
......++..|+|||...+..++.++||||||+++|||++ |+.||...... ...++. ..+...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~----~~~~~~--------- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQV----ERGYRM--------- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCCC---------
Confidence 2222335678999999988899999999999999999999 89999743221 111111 111100
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
......+..+.+++.+||+.+|++||++++|++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111234578899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=330.88 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=211.4
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCce-EEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ-RILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~-~~LV~ 680 (927)
..|...+.+|+|+||.++.++++ +++.+++|.+.-.. ....+...+|+.++++++|||||.+.+.+.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 35677899999999999999887 57889999986432 2334577899999999999999999999999888 99999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
+|++||+|.+.+...+ +..++++++.+|+.|++.|+.|||+ ++|+|||||+.|||++.++.+||+|||+|+.....
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998653 6779999999999999999999998 99999999999999999999999999999998776
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
.. ......||+.||.||++.+..|..|+|||||||++|||++-+++|...+... ++ ....+ + ..+|
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li---~ki~~-~----~~~P-- 225 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LI---LKINR-G----LYSP-- 225 (426)
T ss_pred hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HH---HHHhh-c----cCCC--
Confidence 52 3445679999999999999999999999999999999999999998554421 11 11111 1 1122
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.+......+..++..||+.+|+.||++.+++.+
T Consensus 226 ---lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 ---LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 222334578899999999999999999999987
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=315.89 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=207.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.+.||+|++|.||+|... +++.+|||.+.... .....++.+|+++++.++|+||+++++++..++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 4667889999999999999865 78999999876432 2344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 682 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
|+++++|.+++.... ....+++..++.++.||+.||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999999886422 24568999999999999999999998 99999999999999999999999999998765433
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
... .....++..|+|||.+.+..++.++||||||+++|||++|..||...... .....+. +.... .+..
T Consensus 160 ~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~~~-----~~~~ 228 (267)
T cd08229 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-IEQCD-----YPPL 228 (267)
T ss_pred Ccc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhh-hhcCC-----CCCC
Confidence 221 12235788999999998888999999999999999999999999633221 1111111 11111 1111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
. .......+.+++.+|++.+|++|||+.+|++.++++.
T Consensus 229 ~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 P---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred C---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1 1123447889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=322.94 Aligned_cols=262 Identities=27% Similarity=0.455 Sum_probs=208.2
Q ss_pred hHHHHHHhhcccccccccEEEEEEEECC------CcEEEEEEccCcc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeec
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE 672 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~~------g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~ 672 (927)
++....+++.+.||+|++|.||++...+ ...+|+|.+.... ......+.+|+++++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3445566778999999999999998752 3679999987542 33456788999999999 79999999999999
Q ss_pred CceEEEEEEecCCCCHHHHhccC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccc
Q 002410 673 EHQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 739 (927)
Q Consensus 673 ~~~~~LV~E~~~~gsL~~~L~~~-------------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NIL 739 (927)
++..+++|||+++|+|.++++.. .....+++..++.++.|++.||+|||+ ++|+||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEE
Confidence 99999999999999999998642 124568999999999999999999998 99999999999999
Q ss_pred ccCCCcEEEeeccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchh
Q 002410 740 LDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAEL 817 (927)
Q Consensus 740 ld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~ 817 (927)
+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 242 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-- 242 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--
Confidence 999999999999999875433211 1122234678999999988899999999999999999998 999986332211
Q ss_pred hHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 818 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 818 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
..+ .+..+... ..+......+.+++.+|++.+|++|||++|+++.|++++
T Consensus 243 -~~~----~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 -LFK----LLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHH----HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111 11111110 011122347889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=335.74 Aligned_cols=258 Identities=19% Similarity=0.201 Sum_probs=196.9
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
...|.+.+.||+|+||.||++... .++.||+|... ...+.+|++++++++||||+++++++..+...++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 345778899999999999999876 58899999754 23567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+. ++|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 95 789888863 4568899999999999999999998 8999999999999999999999999999976433222
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc-----chhhHHHHHHHhhhcC--Ce---
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-----AELNIVHWARSMIKKG--DV--- 832 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~-----~~~~l~~~~~~~~~~~--~~--- 832 (927)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ....+..... ..... ..
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~-~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR-RSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHH-HhcCChhhcCcc
Confidence 2233456899999999999989999999999999999999999887532211 0011111110 00000 00
Q ss_pred -----eee---------ccccccCCC--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 833 -----ISI---------VDPVLIGNV--KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 833 -----~~~---------~d~~l~~~~--~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
... ..+...... ....+..+.+|+.+||+.||++|||++|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 000000000 0123457889999999999999999999985
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=323.25 Aligned_cols=268 Identities=24% Similarity=0.450 Sum_probs=212.5
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC--------CCcEEEEEEccCcc-chhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 670 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~ 670 (927)
++....+.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 455667778899999999999999742 24579999987543 34457789999999999 899999999999
Q ss_pred ecCceEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 002410 671 EEEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 737 (927)
Q Consensus 671 ~~~~~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~N 737 (927)
...+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ ++++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccce
Confidence 99999999999999999999997532 12457888999999999999999998 899999999999
Q ss_pred ccccCCCcEEEeecccccccccccccc-ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccc
Q 002410 738 ILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 815 (927)
Q Consensus 738 ILld~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~ 815 (927)
|+++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~- 246 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 246 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-
Confidence 999999999999999998764332221 222335678999999998889999999999999999998 78888633221
Q ss_pred hhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhccCC
Q 002410 816 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 887 (927)
Q Consensus 816 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~~~ 887 (927)
.+.+ .+..+.... ........+.+++.+||+.+|++||++.||++.|++++..+...
T Consensus 247 --~~~~----~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~~ 303 (304)
T cd05101 247 --ELFK----LLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTNE 303 (304)
T ss_pred --HHHH----HHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhcC
Confidence 1111 122211110 01123347889999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=329.79 Aligned_cols=248 Identities=22% Similarity=0.346 Sum_probs=196.8
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.||+|+||.||+|+.+ +++.||+|+++... ....+.+.+|..+++++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999876 58899999997532 23345688899999998 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTT 153 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccc
Confidence 999998863 4679999999999999999999998 999999999999999999999999999987532211 122
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc--hhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--ELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....++....+..... .+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~- 226 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPR- 226 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCC-
Confidence 23468999999999999999999999999999999999999996332211 11222233332322211 1111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCC------HHHHHH
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPK------MQEIVL 875 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs------~~eVl~ 875 (927)
.....+.+++.+||+.||.+||+ ++|+++
T Consensus 227 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 227 ---SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ---CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 12236789999999999999997 567664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=320.25 Aligned_cols=257 Identities=24% Similarity=0.419 Sum_probs=204.1
Q ss_pred HHHHhhcccccccccEEEEEEEECC------CcEEEEEEccCccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~~------g~~vAvK~l~~~~~~-~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
...+++.++||+|+||.||+|...+ ++.||+|+++..... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 3567788999999999999998642 578999999865433 346688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC
Q 002410 677 ILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 743 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~ 743 (927)
++++||+++++|.+++.... ....+++..+..++.|++.||+|||+ ++|+||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCC
Confidence 99999999999999985321 12357888999999999999999998 999999999999999999
Q ss_pred CcEEEeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHH
Q 002410 744 MRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVH 821 (927)
Q Consensus 744 ~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~ 821 (927)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ..+.+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~ 237 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVIE 237 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH
Confidence 9999999999886533221 11223345778999999988889999999999999999998 8888863322 11222
Q ss_pred HHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 822 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 822 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
.+..+.... .....+..+.+++.+|++.+|++||+++||++.|+.
T Consensus 238 ----~i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 ----MIRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ----HHHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 122221111 111234468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=332.37 Aligned_cols=243 Identities=24% Similarity=0.354 Sum_probs=195.8
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 686 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~g 686 (927)
+.||+|+||.||++... +|+.||+|+++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 68999999987532 233456788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccccc
Q 002410 687 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 766 (927)
Q Consensus 687 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 766 (927)
+|.+++.. ...+++..+..++.||+.||+|||+ .++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMK 154 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccc
Confidence 99998873 4578999999999999999999996 36999999999999999999999999999875332211 122
Q ss_pred ccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCH
Q 002410 767 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 846 (927)
Q Consensus 767 ~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 846 (927)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ... .+..... .+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~~----~i~~~~~------~~p~---- 217 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFE----LILMEEI------RFPR---- 217 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HHH----HHhcCCC------CCCC----
Confidence 3458999999999999999999999999999999999999997433211 111 1111110 0111
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002410 847 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 876 (927)
Q Consensus 847 ~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~~ 876 (927)
.....+.+++.+||+.||++|+ +++++++.
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1223678999999999999996 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=315.41 Aligned_cols=257 Identities=28% Similarity=0.476 Sum_probs=207.8
Q ss_pred HHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
+....+.+.++||+|++|.||+|..++++.||||.+.... ...+++.+|+.++++++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4455677889999999999999998888999999987543 334678999999999999999999999999889999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++++|.+++... ....+++..+..++.|++.||+|||+ ++++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999754 24568999999999999999999998 899999999999999999999999999988765422
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...+... .+.. .
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~----~~~~-~------ 223 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVE----RGYR-M------ 223 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----cCCC-C------
Confidence 222222234568999999998889999999999999999999 99999633221 1111111 1100 0
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
..+...+..+.+++.+|++.+|++||+++|+++.|++
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 --PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011123478899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=320.05 Aligned_cols=257 Identities=25% Similarity=0.301 Sum_probs=195.5
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCc-----eEEEEEEec
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRILVYEYM 683 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-----~~~LV~E~~ 683 (927)
.+++|+|+||.||+|.+. +++.||||+...+.. --.+|+++|+++.|||||+++-+|.... ...+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 478999999999999876 468999999865432 1246999999999999999998885432 234899999
Q ss_pred CCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC-CcEEEeeccccccccccc
Q 002410 684 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 684 ~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFGla~~~~~~~ 761 (927)
+. +|.+.++... .+..++...+.-+..||++||+|||+ .+|+||||||.|+|+|.+ |.+||||||.|+......
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 75 8988887432 35678888889999999999999998 999999999999999976 999999999999987655
Q ss_pred cccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH-----hhhcC--Cee
Q 002410 762 THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS-----MIKKG--DVI 833 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~-----~~~~~--~~~ 833 (927)
...+ ...|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+++..++....-.+.. .+... ...
T Consensus 181 pniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 181 PNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred Ccee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 5443 3468899999998765 899999999999999999999999987654433222211111 11110 111
Q ss_pred eeccccccCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 834 SIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 834 ~~~d~~l~~~-----~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+...|.+... .......+..+++.++|+.+|.+|.++.|++..
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1111222111 222344578899999999999999999999864
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=328.67 Aligned_cols=244 Identities=24% Similarity=0.343 Sum_probs=193.2
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHH---HhcCCCceeeeeeeeecCceEEEEE
Q 002410 608 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALL---SRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L---~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
++.+.||+|+||.||+|..+ +++.||||+++... ....+.+.+|++++ +.++||||+++++++...+..++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 46789999999999999876 58999999997532 22345566776665 4567999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++|+|..+++ ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 82 EYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred cCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999998886 3468999999999999999999998 99999999999999999999999999998753322
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
.. ......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+..+ ... . +..+.. ..
T Consensus 155 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---~~~---~-i~~~~~------~~ 220 (324)
T cd05589 155 GD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---VFD---S-IVNDEV------RY 220 (324)
T ss_pred CC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---HHH---H-HHhCCC------CC
Confidence 11 2233568999999999999999999999999999999999999997443211 111 1 111111 01
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 876 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~~ 876 (927)
+......+.+++.+||+.||.+|| +++++++.
T Consensus 221 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 221 ----PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ----CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 111234678999999999999999 56666553
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=327.03 Aligned_cols=240 Identities=28% Similarity=0.399 Sum_probs=190.7
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.||+|+||.||+|+.+ +++.||+|+++... ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999986 57899999987532 22344556677777654 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 999999873 4568999999999999999999998 999999999999999999999999999997643322 222
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.. .+.. . +.... +.+ +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~---~-i~~~~------~~~----~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFD---S-ILNDR------PHF----P 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HHcCC------CCC----C
Confidence 3345899999999999989999999999999999999999999744321 1111 1 11111 011 1
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 002410 846 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 874 (927)
Q Consensus 846 ~~~~~~l~~Li~~Cl~~dP~~RPs~~-eVl 874 (927)
......+.+++.+||+.+|++||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11223678999999999999999875 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=318.03 Aligned_cols=247 Identities=23% Similarity=0.300 Sum_probs=195.6
Q ss_pred ccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCH
Q 002410 613 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 688 (927)
Q Consensus 613 LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL 688 (927)
||+|+||+||++..+ +++.||+|++..... ...+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999876 688999999865322 2335678899999999999999999999999999999999999999
Q ss_pred HHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccccc
Q 002410 689 RDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 767 (927)
Q Consensus 689 ~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 767 (927)
.+.+.... ....+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 98875322 34578999999999999999999998 99999999999999999999999999999765443222 223
Q ss_pred cccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHH
Q 002410 768 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 847 (927)
Q Consensus 768 ~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 847 (927)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||........ ....... +..... .....
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~-~~~~~~----------~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQR-ILNDSV----------TYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHh-hcccCC----------CCccc
Confidence 4589999999999999999999999999999999999999974332111 1111111 111100 11112
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002410 848 SIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 876 (927)
Q Consensus 848 ~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~~ 876 (927)
....+.+++.+||+.||++|| +++|+++.
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 334688999999999999999 66777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=315.60 Aligned_cols=245 Identities=28% Similarity=0.459 Sum_probs=196.2
Q ss_pred cccccccEEEEEEEEC---CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCC
Q 002410 612 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 686 (927)
Q Consensus 612 ~LG~G~~G~Vy~a~~~---~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~g 686 (927)
+||+|+||.||+|.++ +++.+|+|+++... ....+++.+|+.++++++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 6899999999999753 57889999986543 2345678999999999999999999998864 5678999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc--
Q 002410 687 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-- 764 (927)
Q Consensus 687 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~-- 764 (927)
+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999973 4568999999999999999999998 999999999999999999999999999998764433211
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
.....++..|+|||.+....++.++|||||||++|||++ |+.||...... ...+ .+..+.....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~i~~~~~~~~-------- 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQ----MIESGERMEC-------- 219 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHCCCCCCC--------
Confidence 112224578999999988889999999999999999998 99999733221 1222 1222221111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
+......+.+++.+|++.||++||++.+|.+.|++
T Consensus 220 -~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 -PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11223468899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=322.61 Aligned_cols=266 Identities=24% Similarity=0.441 Sum_probs=209.8
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC--------CCcEEEEEEccCcc-chhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 670 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~ 670 (927)
++....|.+.+.||+|+||.||+|... ++..+|+|.++... ......+.+|+++++++ +|+||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 444567888999999999999999763 23579999997643 33456788999999999 799999999999
Q ss_pred ecCceEEEEEEecCCCCHHHHhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 002410 671 EEEHQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 737 (927)
Q Consensus 671 ~~~~~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~N 737 (927)
...+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+ ++++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHh
Confidence 999999999999999999999975321 2358899999999999999999998 999999999999
Q ss_pred ccccCCCcEEEeecccccccccccccc-ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccc
Q 002410 738 ILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 815 (927)
Q Consensus 738 ILld~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~ 815 (927)
|+++.++.+||+|||.++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~- 249 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 249 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-
Confidence 999999999999999987654321111 111224568999999998889999999999999999998 88888633221
Q ss_pred hhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 816 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 816 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
.+.. .+..+.... .+......+.+++.+|+..+|++||++.||++.|++++....
T Consensus 250 --~~~~----~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 250 --ELFK----LLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred --HHHH----HHHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 1111 122211111 111223478899999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=328.40 Aligned_cols=249 Identities=23% Similarity=0.348 Sum_probs=195.7
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.||+|+||.||+|+.+ +++.||+|+++... ....+.+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 57899999987532 23445678899988877 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT 153 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence 999988863 4578999999999999999999998 9999999999999999999999999999875322211 12
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc--chhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG--AELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~--~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......+....+..... .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~--- 224 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI--- 224 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CC---
Confidence 2345899999999999999999999999999999999999999632211 111122222222222211 01
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPK------MQEIVLA 876 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs------~~eVl~~ 876 (927)
+......+.+++.+||+.||++||+ +.|+++.
T Consensus 225 -p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 -PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred -CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1112346789999999999999998 4566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=335.66 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=201.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
|.+.+.||+|+||.||+|+.. +|+.||+|+++... ......+.+|+++++.++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 566789999999999999987 68999999987532 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc-
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 761 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~- 761 (927)
+++++|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 83 MPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999984 3678999999999999999999998 999999999999999999999999999998754432
Q ss_pred ---------------------------cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 002410 762 ---------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 814 (927)
Q Consensus 762 ---------------------------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~ 814 (927)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11222345899999999999999999999999999999999999999744321
Q ss_pred chhhHHHHHHHhhhc-CCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 002410 815 AELNIVHWARSMIKK-GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVLA 876 (927)
Q Consensus 815 ~~~~l~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-~~eVl~~ 876 (927)
.. ....... .... . +. .......+.+++.+|++ +|.+||+ ++|+++.
T Consensus 237 ~~------~~~i~~~~~~~~--~-p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ET------YNKIINWKESLR--F-PP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH------HHHHhccCCccc--C-CC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11 1111110 0000 0 00 00123467899999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=328.15 Aligned_cols=236 Identities=25% Similarity=0.384 Sum_probs=190.8
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.||+|+||.||+|+.+ +++.||||++.... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999986 58899999987532 23445677888888877 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TT 153 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cc
Confidence 999998873 4568999999999999999999998 9999999999999999999999999999875422211 12
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+.+ .+..+... . +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~----~i~~~~~~------~----~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLFE----AILNDEVV------Y----P 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHH----HHhcCCCC------C----C
Confidence 2345899999999999989999999999999999999999999743321 1111 11111110 0 1
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCH
Q 002410 846 IESIWRIAEVAIQCVEQRGFSRPKM 870 (927)
Q Consensus 846 ~~~~~~l~~Li~~Cl~~dP~~RPs~ 870 (927)
......+.+++.+||+.||++||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1122367899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.32 Aligned_cols=251 Identities=30% Similarity=0.513 Sum_probs=205.8
Q ss_pred HHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
...+++.+.||+|++|.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 345677899999999999999876 88999999986544 5678999999999999999999999999899999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++++|.+++... ....+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 999999999753 23468999999999999999999998 9999999999999999999999999999987643222
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
....+..|+|||.+.+..++.++||||||+++|||++ |..||...... .+... +..+....
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----~~~~~~~~-------- 219 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPH----VEKGYRME-------- 219 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HhcCCCCC--------
Confidence 2224568999999988889999999999999999997 99998633221 11111 11111100
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
.+...+..+.+++.+||..+|++||+++|++++|+++
T Consensus 220 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 -APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0112234788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=319.01 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=204.4
Q ss_pred HhhcccccccccEEEEEEEEC------CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
+++.+.||+|+||.||+|... ....+++|.+..... ...+++.+|+.+++.++||||+++++.+..++..+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 356789999999999999864 235799998875433 3456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcc
Q 002410 680 YEYMHNGTLRDRLHGSV---------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 738 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NI 738 (927)
+||+++|+|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheE
Confidence 99999999999986421 12357899999999999999999998 9999999999999
Q ss_pred cccCCCcEEEeecccccccccccccc-ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccch
Q 002410 739 LLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 816 (927)
Q Consensus 739 Lld~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~ 816 (927)
++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--- 235 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--- 235 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH---
Confidence 99999999999999998653332211 122335678999999988889999999999999999999 9999963322
Q ss_pred hhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 817 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 817 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
..+.+... .+.. . .........+.+++.+|++.+|++||+++|+++.|++++.
T Consensus 236 ~~~~~~~~----~~~~-----~----~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ERLFNLLK----TGYR-----M----ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHh----CCCC-----C----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 12222211 1110 0 0111223478899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=320.24 Aligned_cols=265 Identities=23% Similarity=0.373 Sum_probs=202.6
Q ss_pred HHHHHhhcccccccccEEEEEEEECC---------------CcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeee
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMKD---------------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPL 666 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~~---------------g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l 666 (927)
....|++.+.||+|+||.||+++..+ ...||+|+++... ......+.+|++++++++|+|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 45567788999999999999987642 2358999987643 3345679999999999999999999
Q ss_pred eeeeecCceEEEEEEecCCCCHHHHhccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 002410 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSV---------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 737 (927)
Q Consensus 667 ~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~---------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~N 737 (927)
++++...+..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhh
Confidence 999999999999999999999999986431 11246888999999999999999998 999999999999
Q ss_pred ccccCCCcEEEeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCccccc
Q 002410 738 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 814 (927)
Q Consensus 738 ILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt--G~~Pf~~~~~~ 814 (927)
|++++++.+||+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ +..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999876533221 11222335678999999988889999999999999999998 56677633221
Q ss_pred chhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 815 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 815 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
................... ......+..+.+++.+|++.+|++||++++|++.|++
T Consensus 240 ---~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 ---QVIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111111111000000 0011123478999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=323.36 Aligned_cols=264 Identities=30% Similarity=0.503 Sum_probs=206.7
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CCc--EEEEEEccCcc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCce
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 675 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~--~vAvK~l~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~ 675 (927)
.+....+++.+.||+|+||.||+|.++ ++. .+++|.++... ....+.+.+|++++.++ +|+||+++++++..++.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 455567788899999999999999875 344 46778776532 33456788999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC
Q 002410 676 RILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 742 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~ 742 (927)
.++|+||+++|+|.++++... ....+++.+++.++.|++.||+|||+ ++++||||||+|||++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecC
Confidence 999999999999999997432 12358899999999999999999998 99999999999999999
Q ss_pred CCcEEEeeccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHH
Q 002410 743 NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVH 821 (927)
Q Consensus 743 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~ 821 (927)
++.+||+|||++........ .....++..|+|||.+.+..++.++|||||||++|||+| |..||...+.. ...+
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~ 234 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE 234 (303)
T ss_pred CCcEEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHH
Confidence 99999999999864321111 111224567999999988889999999999999999998 99999633321 1111
Q ss_pred HHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 822 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 822 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
. ...+.... ........+.+++.+|++.+|++||+++++++.|++++..+.
T Consensus 235 ~----~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 235 K----LPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred H----HhcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 1 11110000 011123367899999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=327.61 Aligned_cols=242 Identities=24% Similarity=0.387 Sum_probs=194.4
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.||+|+||.||+|+.+ +++.||+|+++... ....+.+..|.++++.+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999886 47899999987532 23345677899998876 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
|+|.+.+.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TT 153 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cc
Confidence 999998873 4568899999999999999999998 9999999999999999999999999999875432221 12
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ...+ ... .+.. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~---~i~-~~~~---~~p------- 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFE---SIL-HDDV---LYP------- 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHH---HHH-cCCC---CCC-------
Confidence 2345899999999999989999999999999999999999999743321 1111 111 1111 001
Q ss_pred HHHHHHHHHHHHHhhccCCCCCC-------CHHHHHHH
Q 002410 846 IESIWRIAEVAIQCVEQRGFSRP-------KMQEIVLA 876 (927)
Q Consensus 846 ~~~~~~l~~Li~~Cl~~dP~~RP-------s~~eVl~~ 876 (927)
......+.+++.+||+.||++|| +++++++.
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11123678999999999999999 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.42 Aligned_cols=248 Identities=21% Similarity=0.303 Sum_probs=195.1
Q ss_pred ccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCH
Q 002410 613 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 688 (927)
Q Consensus 613 LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL 688 (927)
||+|+||.||+++.+ +|+.||+|.+.... ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999876 58999999986422 12234566799999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccccccc
Q 002410 689 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 768 (927)
Q Consensus 689 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 768 (927)
.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~ 154 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQR 154 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eecc
Confidence 9888643 34468899999999999999999998 9999999999999999999999999999877543322 1234
Q ss_pred ccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHH
Q 002410 769 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 848 (927)
Q Consensus 769 ~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 848 (927)
.|+..|+|||++.+..++.++||||+||++|||++|+.||...... ....+..+.... ..... ... ..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~-~~~~~-----~~~----~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRTLE-DEVKF-----EHQ----NF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHhhc-ccccc-----ccc----cC
Confidence 5889999999998888999999999999999999999999733221 111111111111 11100 001 12
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 849 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 849 ~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
..++.+++.+||+.||++||+++|+++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 336789999999999999999988765444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.49 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=198.8
Q ss_pred hcccccccccEEEEEEEECCC-c--EEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecC------ceEE
Q 002410 609 FCKKIGKGSFGSVYYGKMKDG-K--EVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRI 677 (927)
Q Consensus 609 ~~~~LG~G~~G~Vy~a~~~~g-~--~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------~~~~ 677 (927)
+.+.||+|+||.||+|++.+. + .+|+|.++.. .....+.+.+|++++++++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 568899999999999998643 2 5899988653 234457789999999999999999999987432 2468
Q ss_pred EEEEecCCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccc
Q 002410 678 LVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 754 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 754 (927)
+++||+++|+|.+++.... ....+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999998874322 23458999999999999999999998 99999999999999999999999999999
Q ss_pred ccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCe
Q 002410 755 RQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 832 (927)
Q Consensus 755 ~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 832 (927)
+........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+.+ .+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~----~~~~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYD----YLRQGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----HHHcCCC
Confidence 876433221 1122235678999999999999999999999999999999 8899864322 11212 2222221
Q ss_pred eeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 833 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 833 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
... .......+.+++.+||+.+|++||++.||++.|++++
T Consensus 233 ~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 233 LKQ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred CCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 110 1122346889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=314.07 Aligned_cols=256 Identities=25% Similarity=0.443 Sum_probs=206.4
Q ss_pred HHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
+...++++.++||+|+||.||+|...++..+|+|.++.. ....+.+.+|++++++++|+||+++++++.. ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 445667788999999999999999888888999988754 2345678999999999999999999999887 77899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++++|.+++... ....+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999754 24568889999999999999999998 899999999999999999999999999987654322
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
........++..|+|||++....++.++|||||||++|++++ |+.||...+.. ..... +..+....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~~~~~~~------ 223 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRA----LERGYRMP------ 223 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HhCCCCCC------
Confidence 222222335678999999998889999999999999999999 99999743221 12221 11111111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
.....+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 224 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 ---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=317.46 Aligned_cols=257 Identities=29% Similarity=0.461 Sum_probs=201.9
Q ss_pred HHHHhhcccccccccEEEEEEEECC------CcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~~------g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
...+.+.+.||+|++|.||+|.+.+ +..|++|.+..... .....+.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 3456678899999999999998864 56789998875433 3446799999999999999999999999988899
Q ss_pred EEEEEecCCCCHHHHhccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC---cEEEe
Q 002410 677 ILVYEYMHNGTLRDRLHGSVN----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAKVS 749 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~----~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~---~~kL~ 749 (927)
++||||+++++|.+++..... ...+++..+++++.||+.||+|||+ ++++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 999999999999999875431 2358999999999999999999998 8999999999999998654 59999
Q ss_pred eccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhh
Q 002410 750 DFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI 827 (927)
Q Consensus 750 DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~ 827 (927)
|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||....... +...+ .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~~---~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEFV---T 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---H
Confidence 99999876332111 1112223568999999998899999999999999999997 999997433221 11111 1
Q ss_pred hcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 828 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 828 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
..... ..+...+..+.+++.+|++.+|++||++.||++.|++
T Consensus 236 ~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 236 GGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred cCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 11111 0111223478899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=335.26 Aligned_cols=255 Identities=23% Similarity=0.349 Sum_probs=201.8
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
+....|++.+.||+|+||.||+++.+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34566778899999999999999886 58899999986422 223455788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999873 357888899999999999999998 99999999999999999999999999999876
Q ss_pred cccccccccccccCCCccCCCccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCee
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 833 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~~~----~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 833 (927)
............||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+... . ...........
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~---~~~i~~~~~~~ 266 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---T---YSKIMDHKNSL 266 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH---H---HHHHHcCCCcC
Confidence 44332223345689999999998643 47899999999999999999999997443211 1 11111111100
Q ss_pred eeccccccCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002410 834 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 876 (927)
Q Consensus 834 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPs~~eVl~~ 876 (927)
.. + . .......+.+++.+||+.+|++ ||+++|+++.
T Consensus 267 ~~--~---~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TF--P---D--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CC--C---C--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 0 0 0112346789999999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=311.80 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=208.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc---cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|.+.+.||+|++|.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 4567889999999999999987 7999999988642 22335678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 682 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
|+++|+|.+++.... ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 999999999986532 34568999999999999999999998 99999999999999999999999999998765433
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...+... .+..+.....
T Consensus 160 ~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~-~~~~~~~~~~----- 228 (267)
T cd08224 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCK-KIEKCDYPPL----- 228 (267)
T ss_pred Ccc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHh-hhhcCCCCCC-----
Confidence 221 2223478899999999888899999999999999999999999963322 1111111 1111111110
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
........+.+++.+||..+|++||++.+|+++|+++.
T Consensus 229 ---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 ---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 01123347889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=304.07 Aligned_cols=295 Identities=19% Similarity=0.206 Sum_probs=216.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchh--HHHHHHHHHHHHhcCCCceeeeeeeee--cCceEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQRILVY 680 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~--~~~~~~E~~~L~~l~HpnIv~l~~~~~--~~~~~~LV~ 680 (927)
.|+..+.|++|.||.||+|+.+ +++.||+|+++-..... .-.-++|+.+|.+++|||||.+-.+.. +-+..|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 4555788999999999999987 68899999997543221 134578999999999999999998874 345799999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
|||+. +|...++.. .+++...++..++.|+++|++|||. ..|+|||||++|+|+.+.|.+||+|||+|+.++..
T Consensus 157 e~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 99975 899988853 4678899999999999999999998 99999999999999999999999999999998776
Q ss_pred ccccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
.... +..+-|..|+|||++.+. .|+.+.|+||+|||+.||+++++.|.+....++.+.+-.......+..+..+.+..
T Consensus 231 ~k~~-T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 LKPY-TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred cccC-cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 4433 334579999999998764 79999999999999999999999998665544333222222111111111111111
Q ss_pred --------------ccCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHh-hhhhccCCCCccccCCCCCCCc
Q 002410 840 --------------LIGNVKIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQD-SIKIEKGGDQKFSSSSSKGQSS 901 (927)
Q Consensus 840 --------------l~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~--L~~-~~~~e~~~~~~~s~~~s~~~~~ 901 (927)
+.+.+... ..+.-.+|+..+|..||++|.|++|.++. +.+ -+......-..|...+......
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~~~~~~ 389 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQQRVK 389 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccccccccCC
Confidence 11111111 22355789999999999999999998864 222 1233334445666666655544
Q ss_pred cccccc
Q 002410 902 RKTLLT 907 (927)
Q Consensus 902 ~~~~~~ 907 (927)
+.+...
T Consensus 390 ~~~~~~ 395 (419)
T KOG0663|consen 390 RGTSPR 395 (419)
T ss_pred CCCCCC
Confidence 444433
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=316.80 Aligned_cols=254 Identities=27% Similarity=0.440 Sum_probs=200.7
Q ss_pred hhcccccccccEEEEEEEECC----CcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCce------
Q 002410 608 NFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------ 675 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~~----g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~------ 675 (927)
.+.+.||+|+||.||+|.+.. +..||+|+++... ......+.+|++.++.++|+||+++++++...+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 457899999999999998753 3679999987532 2345678999999999999999999998866544
Q ss_pred EEEEEEecCCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecc
Q 002410 676 RILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 752 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 752 (927)
.++++||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence 789999999999999985432 23468999999999999999999998 899999999999999999999999999
Q ss_pred cccccccccccc-ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcC
Q 002410 753 LSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 830 (927)
Q Consensus 753 la~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 830 (927)
+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..+.+.. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~----~~~ 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYL----RHG 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcC
Confidence 998754332211 112234678999999988899999999999999999999 8898863321 1222221 111
Q ss_pred CeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 831 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 831 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
.... ........+.+++.+||+.||++||++.||++.|+++
T Consensus 232 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 1112334788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=317.11 Aligned_cols=256 Identities=23% Similarity=0.373 Sum_probs=202.5
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
....|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++..++..++|+|
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 3456788899999999999999975 688999999976555556678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++++|.++++. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 87 YCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 9999999999873 4568999999999999999999998 999999999999999999999999999998654322
Q ss_pred cccccccccCCCccCCCccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 762 THISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
.. .....++..|+|||.+. ...++.++|||||||++|||++|+.||........ ... +.... ...+
T Consensus 161 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~~-----~~~~~---~~~~ 229 (267)
T cd06646 161 AK-RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFL-----MSKSN---FQPP 229 (267)
T ss_pred cc-cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--hee-----eecCC---CCCC
Confidence 11 12235788999999874 34578899999999999999999999863221110 000 00000 0011
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 877 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L 877 (927)
.... .......+.+++.+||+.+|++||+++++++.|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1110 112234788999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=316.80 Aligned_cols=256 Identities=29% Similarity=0.500 Sum_probs=203.8
Q ss_pred HHHhhcccccccccEEEEEEEECC-C---cEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~-g---~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
..++..+.||+|++|.||+|.... + ..+|+|.++... ....+.+.+|++++++++|+||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 445667899999999999998763 3 379999987543 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
|||+++++|.+++... ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999998742 3568999999999999999999998 8999999999999999999999999999876543
Q ss_pred ccccccc--ccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 760 DLTHISS--VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 760 ~~~~~~~--~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
....... ....+..|+|||++.+..++.++|||||||++|||++ |+.||..... ..... . +..+...
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~---~-i~~~~~~--- 229 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMK---A-INDGFRL--- 229 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHH---H-HhcCCCC---
Confidence 2221111 1123457999999988889999999999999999998 9999963322 11111 1 1111100
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
+ ........+.+++.+|++.+|++||++.+|++.|++++
T Consensus 230 -~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 230 -P-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred -C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 0 01122346889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=316.85 Aligned_cols=261 Identities=26% Similarity=0.440 Sum_probs=208.5
Q ss_pred HHHHHhhcccccccccEEEEEEEECC-----CcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeec-Cce
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQ 675 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~~-----g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-~~~ 675 (927)
....+.+.+.||+|+||.||+|.+.+ ++.|++|++.... ....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34567778999999999999999876 7889999987543 3445778999999999999999999998765 567
Q ss_pred EEEEEEecCCCCHHHHhccCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEee
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 750 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~-----~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~D 750 (927)
.++++||+++++|.+++...... ..+++.+++.++.|++.||+|||+ ++++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998754322 568999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhh
Q 002410 751 FGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIK 828 (927)
Q Consensus 751 FGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 828 (927)
||+++........ ......++..|+|||.+.+..++.++|||||||++||+++ |+.||..... ..+..+..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~---- 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLK---- 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHH----
Confidence 9999865432221 1122335678999999988889999999999999999999 9999973321 22222222
Q ss_pred cCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 829 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 829 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
.+.... .....+..+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 234 ~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 DGYRLA---------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cCCCCC---------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111000 011123468899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=320.40 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=204.3
Q ss_pred HHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
...+.+.++||+|+||.||++... ++..+|+|.+..........+.+|++++++++|+||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 345566889999999999999643 35689999988766666778999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCc
Q 002410 678 LVYEYMHNGTLRDRLHGSVN------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 745 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~ 745 (927)
+++||+++++|.+++..... ...+++..++.++.|++.||+|||+ ++++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCC
Confidence 99999999999999875321 1358899999999999999999998 99999999999999999999
Q ss_pred EEEeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHH
Q 002410 746 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 823 (927)
Q Consensus 746 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~ 823 (927)
+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+ ..+.
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~- 236 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AIEC- 236 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HHHH-
Confidence 99999999876433221 11222335678999999998899999999999999999998 899986322211 1111
Q ss_pred HHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 824 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 824 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
...+.... . ....+..+.+++.+||+.||++||+++||++.|++
T Consensus 237 ---~~~~~~~~--~-------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 ---ITQGRELE--R-------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ---HHcCccCC--C-------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111100 0 11123467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=330.96 Aligned_cols=238 Identities=25% Similarity=0.354 Sum_probs=192.5
Q ss_pred ccccccccEEEEEEEE----CCCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 611 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~----~~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
+.||+|+||.||+++. .+|+.||+|++..... .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999975 2578999999975322 234567789999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++....... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~ 154 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-K 154 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-c
Confidence 9999999873 4568999999999999999999998 9999999999999999999999999999886543322 1
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 844 (927)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||...+.. .... ... .... . .
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~---~i~-~~~~------~----~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMT---MIL-KAKL------G----M 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHH---HHH-cCCC------C----C
Confidence 22345899999999999888999999999999999999999999743221 1111 111 1111 0 0
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 002410 845 KIESIWRIAEVAIQCVEQRGFSRPKMQE 872 (927)
Q Consensus 845 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 872 (927)
+......+.+++.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1112236789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=326.35 Aligned_cols=240 Identities=25% Similarity=0.345 Sum_probs=192.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCC-CceeeeeeeeecCceEEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~H-pnIv~l~~~~~~~~~~~LV~E 681 (927)
|++.+.||+|+||.||+|+.+ +++.||||+++... ....+.+..|.++++.++| ++|+++++++.+.+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 456789999999999999877 47899999987532 2345678889999999976 568889999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 82 YVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999873 4568899999999999999999998 999999999999999999999999999987532211
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. ..... +..... .+
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~----i~~~~~------~~- 220 (324)
T cd05587 156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQS----IMEHNV------SY- 220 (324)
T ss_pred C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH----HHcCCC------CC-
Confidence 1 122345899999999999999999999999999999999999999743321 11111 111110 01
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 870 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 870 (927)
+......+.+++.+||+.||++|++.
T Consensus 221 ---~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 ---PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11122367899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=296.18 Aligned_cols=247 Identities=26% Similarity=0.409 Sum_probs=205.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
..++++.||+|.||.||.|+.+ ++-.||+|++.+.. ....+++.+|+++-..|+||||++++++|.+....||++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 4567899999999999999877 56789999987643 2334789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|..+|.|...|... ....+++.....++.|+|.||.|+|. ++|+||||||+|+|++..+..||+|||-+....
T Consensus 103 ya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 103 YAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred ecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 99999999999854 35668888999999999999999998 999999999999999999999999999886543
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
.......+||..|.+||...+...+.+.|+|++|++.||++.|.+||......+ .... +.. .++.+|
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e--tYkr-----I~k---~~~~~p--- 242 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE--TYKR-----IRK---VDLKFP--- 242 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH--HHHH-----HHH---ccccCC---
Confidence 334455679999999999999999999999999999999999999998444221 1111 111 112222
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
........++|.+|+..+|.+|....|+++.
T Consensus 243 ----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 ----STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1122367899999999999999999999864
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=318.70 Aligned_cols=251 Identities=25% Similarity=0.309 Sum_probs=200.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
|+..++||+|+||+||++... +++.||+|++..... .....+.+|+.++++++||||+++++.+..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 556789999999999999875 689999999865322 2235578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.+++... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 82 MNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 9999999888643 24568999999999999999999998 8999999999999999999999999999876543222
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||........ .+.+...+.... .
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~----------~ 222 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKEDQ----------E 222 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhhcc----------c
Confidence 1223588999999999988999999999999999999999999974332111 111111111111 0
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 876 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~~ 876 (927)
.+.......+.+++.+|++.||++|| +++++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11122334678999999999999999 78888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.38 Aligned_cols=258 Identities=30% Similarity=0.490 Sum_probs=202.8
Q ss_pred HHhhcccccccccEEEEEEEECC-Cc--EEEEEEccCc-cchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKD-GK--EVAVKIMADS-CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~-g~--~vAvK~l~~~-~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
.+++.+.||+|+||.||+|..++ +. .+++|.++.. .....+.+.+|+++++++ +||||+++++++...+..++|+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 35677899999999999998764 33 4788888753 234456789999999999 7999999999999999999999
Q ss_pred EecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEE
Q 002410 681 EYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 747 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~k 747 (927)
||+++++|.+++.... ....+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEE
Confidence 9999999999997532 12358899999999999999999998 9999999999999999999999
Q ss_pred EeeccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHh
Q 002410 748 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 826 (927)
Q Consensus 748 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 826 (927)
|+|||++........ ......+..|+|||.+.+..++.++|||||||++|||++ |..||......+ ..+ .
T Consensus 160 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~---~- 230 (297)
T cd05089 160 IADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYE---K- 230 (297)
T ss_pred ECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---H-
Confidence 999999864322111 111123557999999988889999999999999999998 999997433211 111 1
Q ss_pred hhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 827 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 827 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
+..+.. + ..+......+.+++.+|++.+|.+||+++++++.|++++...
T Consensus 231 ~~~~~~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 231 LPQGYR-----M----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HhcCCC-----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111110 0 001112346789999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=334.44 Aligned_cols=251 Identities=21% Similarity=0.302 Sum_probs=194.5
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
+.+.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 456789999999999999876 58899999997532 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 83 IPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999873 4568899999999999999999998 9999999999999999999999999999754311000
Q ss_pred ----------------------------------------------ccccccccCCCccCCCccCCCCCCcchhHHHHHH
Q 002410 763 ----------------------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 796 (927)
Q Consensus 763 ----------------------------------------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGv 796 (927)
.......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0011245899999999999888999999999999
Q ss_pred HHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHH--hhccCCCCCCCHHHHH
Q 002410 797 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQ--CVEQRGFSRPKMQEIV 874 (927)
Q Consensus 797 lL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~--Cl~~dP~~RPs~~eVl 874 (927)
++|||++|+.||......+. . ...+........ .+ ... ...++.+++.+ |+..+|..||+++|++
T Consensus 237 il~elltG~~Pf~~~~~~~~---~---~~i~~~~~~~~~-~~--~~~----~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTET---Q---LKVINWENTLHI-PP--QVK----LSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHH---H---HHHHccccccCC-CC--CCC----CCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 99999999999974332111 0 111110000000 00 001 12356677777 5566667799999998
Q ss_pred HH
Q 002410 875 LA 876 (927)
Q Consensus 875 ~~ 876 (927)
+.
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 75
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=324.39 Aligned_cols=241 Identities=25% Similarity=0.386 Sum_probs=192.0
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.||+|+||.||+|+.. +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999987 47899999987542 23345567788888764 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
|+|.+++.. ...+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence 999999873 4568899999999999999999998 9999999999999999999999999999875322111 12
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.. .+.+.+ .... +...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i----~~~~------~~~~---- 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSI----RMDN------PCYP---- 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHH----HhCC------CCCC----
Confidence 2345899999999999989999999999999999999999999743321 111111 1111 1111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 002410 846 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIVL 875 (927)
Q Consensus 846 ~~~~~~l~~Li~~Cl~~dP~~RPs~~-eVl~ 875 (927)
......+.+++.+||+.||++||++. ++.+
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11223678999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.87 Aligned_cols=260 Identities=25% Similarity=0.416 Sum_probs=206.6
Q ss_pred HHHHHhhcccccccccEEEEEEEECCC----cEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMKDG----KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~~g----~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
....+.+.+.||+|+||.||+|.+.+. ..|++|...... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 345567789999999999999987542 468999887654 3455789999999999999999999999876 4578
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 83 IVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999999753 3458999999999999999999998 99999999999999999999999999998876
Q ss_pred cccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
............++..|+|||.+....++.++||||||+++|||++ |+.||......+ .... +..+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~----~~~~~~~~-- 228 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIGR----IENGERLP-- 228 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHH----HHcCCcCC--
Confidence 4432222222334568999999988889999999999999999996 999997443221 1111 11111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
. ....+..+.+++.+|+..+|++||++.|+++.|+++...+
T Consensus 229 ---~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 229 ---M----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred ---C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 1122346889999999999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=334.36 Aligned_cols=263 Identities=26% Similarity=0.439 Sum_probs=206.8
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcC-CCceeeeeeeeec
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEE 672 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~ 672 (927)
++....+.+.++||+|+||.||+|++. .++.||+|+++.... ...+.+.+|+++|.++. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 555566777899999999999999864 246899999976433 33457889999999997 9999999999999
Q ss_pred CceEEEEEEecCCCCHHHHhccCCC-------------------------------------------------------
Q 002410 673 EHQRILVYEYMHNGTLRDRLHGSVN------------------------------------------------------- 697 (927)
Q Consensus 673 ~~~~~LV~E~~~~gsL~~~L~~~~~------------------------------------------------------- 697 (927)
.+..++|+||+++|+|.++++....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 9999999999999999999964311
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 002410 698 ----------------------------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 737 (927)
Q Consensus 698 ----------------------------------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~N 737 (927)
...+++..++.++.||+.||+|||+ ++++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcce
Confidence 1246778889999999999999998 899999999999
Q ss_pred ccccCCCcEEEeeccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccc
Q 002410 738 ILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 815 (927)
Q Consensus 738 ILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~ 815 (927)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 99999999999999999865332211 1122346788999999988889999999999999999998 899986332211
Q ss_pred hhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 816 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 816 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
.. ...+..+.... .+......+.+++.+||..+|++||+++||++.|++++
T Consensus 350 --~~----~~~~~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 --QF----YNAIKRGYRMA---------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --HH----HHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11 11111111100 01112347889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=325.16 Aligned_cols=240 Identities=26% Similarity=0.378 Sum_probs=191.8
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.||+|+||.||+|+.+ +|+.||+|+++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999987 58899999987532 22345567788888765 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence 999999873 4568899999999999999999998 999999999999999999999999999987532211 122
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.+. +.... +.+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~----~~~~~------~~~~~--- 217 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFES----IRVDT------PHYPR--- 217 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhCC------CCCCC---
Confidence 3345899999999999999999999999999999999999999743321 11111 11111 11111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 002410 846 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 874 (927)
Q Consensus 846 ~~~~~~l~~Li~~Cl~~dP~~RPs~~-eVl 874 (927)
....++.+++.+||+.||++||++. +++
T Consensus 218 -~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 -WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1223678999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=322.57 Aligned_cols=261 Identities=28% Similarity=0.444 Sum_probs=207.0
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeec
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE 672 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~ 672 (927)
++....+.+.+.||+|+||.||+|... .+..||+|+++... ....+.+.+|+++++++ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 344556778899999999999999752 35579999987543 33456789999999999 79999999999999
Q ss_pred CceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecc
Q 002410 673 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 752 (927)
Q Consensus 673 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 752 (927)
.+..++||||+++|+|.++++... ...+++.++..++.|++.||+|||+ ++|+|+||||+||+++.++.++|+|||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCc
Confidence 999999999999999999997432 3348999999999999999999998 899999999999999999999999999
Q ss_pred ccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcC
Q 002410 753 LSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 830 (927)
Q Consensus 753 la~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 830 (927)
+++........ ......++..|+|||.+.+..++.++||||+||++|||++ |..||......+ .... ....+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~----~~~~~ 260 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYK----LIKEG 260 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHH----HHHcC
Confidence 99865433221 1122335678999999998899999999999999999998 999987433211 1111 11111
Q ss_pred CeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 831 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 831 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
.... ........+.+++.+|+..+|++||++.||++.|+++
T Consensus 261 ~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 YRMA---------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CcCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1100 0011234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=320.07 Aligned_cols=263 Identities=23% Similarity=0.409 Sum_probs=204.2
Q ss_pred HHHHhhcccccccccEEEEEEEEC-----CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecC--ce
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQ 675 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-----~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~ 675 (927)
...+.+.+.||+|+||.||++... +++.||+|.++... ....+.+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 345677899999999999999753 47889999987543 33456799999999999999999999998765 56
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||+++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence 88999999999999998643 3468999999999999999999998 999999999999999999999999999998
Q ss_pred cccccccc--cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc---------chhhHHHHHH
Q 002410 756 QAEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG---------AELNIVHWAR 824 (927)
Q Consensus 756 ~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~---------~~~~l~~~~~ 824 (927)
........ ......++..|+|||.+.+..++.++|||||||++|||++++.|....... ........ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL-V 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH-H
Confidence 75433221 112334667899999998888999999999999999999987765321100 00011111 1
Q ss_pred HhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 825 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 825 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
.....+.... ........+.+++.+||+.+|++||+++|+++.|++++
T Consensus 237 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 237 RVLEEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred HHHHcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 1111111111 01123457889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=319.14 Aligned_cols=264 Identities=28% Similarity=0.443 Sum_probs=205.5
Q ss_pred HHHHhhcccccccccEEEEEEEECC-----------------CcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceee
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMKD-----------------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVP 665 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~~-----------------g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~ 665 (927)
...+++.+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3567788999999999999998653 2468999987643 334578899999999999999999
Q ss_pred eeeeeecCceEEEEEEecCCCCHHHHhccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 002410 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 737 (927)
Q Consensus 666 l~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~N 737 (927)
+++++..++..++++||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 9999999999999999999999999987532 12368999999999999999999998 999999999999
Q ss_pred ccccCCCcEEEeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCccccc
Q 002410 738 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 814 (927)
Q Consensus 738 ILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt--G~~Pf~~~~~~ 814 (927)
|+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ +..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999876533221 12223346778999999988889999999999999999998 6777753221
Q ss_pred chhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 815 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 815 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
....................+ .....+..+.+++.+|++.||++||++.||++.|++
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 112222222111111111111 111223478999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=315.41 Aligned_cols=256 Identities=24% Similarity=0.389 Sum_probs=201.1
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCc----EEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~----~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~L 678 (927)
..+++.+.||+|+||.||+|.+. +++ .+++|.+..... ....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 45566789999999999999875 344 478888764332 334678889999999999999999998864 45788
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
++||+++|+|.+++... ...+++..++.++.||+.||+|||+ ++++||||||+||++++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999743 4568999999999999999999998 899999999999999999999999999998654
Q ss_pred cccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 759 EDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 759 ~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
.... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ...+ .+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~~-- 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EVPD----LLEKGERLA-- 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHCCCcCC--
Confidence 3222 11223446778999999998899999999999999999998 99999743221 1111 122222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
.+.. ....+.+++.+|+..+|++||++.|+++.|+.+.+
T Consensus 232 ~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 QPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1111 12356789999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.54 Aligned_cols=256 Identities=28% Similarity=0.507 Sum_probs=204.7
Q ss_pred HHHhhcccccccccEEEEEEEEC----CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~----~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
..+++.+.||+|+||.||+|.+. .+..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45667899999999999999874 23479999987543 33456889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+ ++++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999753 3468999999999999999999998 9999999999999999999999999999987654
Q ss_pred cccccccc--cccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 760 DLTHISSV--ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 760 ~~~~~~~~--~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
........ ..++..|+|||.+.+..++.++||||||+++||+++ |+.||...... .....+. .+...
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~----~~~~~--- 228 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIE----EGYRL--- 228 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHh----CCCcC---
Confidence 33222111 123567999999998889999999999999999887 99999733221 1222111 11100
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
+. ....+..+.+++.+|++.+|++||++.++++.|++++
T Consensus 229 -~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 229 -PA-----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred -CC-----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 00 1112346789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.18 Aligned_cols=247 Identities=25% Similarity=0.454 Sum_probs=196.0
Q ss_pred cccccccEEEEEEEEC---CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCC
Q 002410 612 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 687 (927)
Q Consensus 612 ~LG~G~~G~Vy~a~~~---~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gs 687 (927)
.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++|+||+++++++.. +..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999865 355799999876543 334678999999999999999999998864 56899999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc--
Q 002410 688 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-- 765 (927)
Q Consensus 688 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~-- 765 (927)
|.+++... ...+++..+++++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99998742 4568999999999999999999998 8999999999999999999999999999986543322111
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 844 (927)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .... .+..+... ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~---------~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMS----FIEQGKRL---------DC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH----HHHCCCCC---------CC
Confidence 11223578999999988889999999999999999996 99999733221 1111 11111111 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 845 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 845 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
+.....++.+++.+||+.+|++||++.+|.+.|+..
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 112235788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=324.86 Aligned_cols=242 Identities=26% Similarity=0.363 Sum_probs=194.8
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.||+|+||.||+|..+ +++.||||+++... ......+.+|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999887 47899999987532 23345677899999888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT 153 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence 999998873 4578999999999999999999998 9999999999999999999999999999875322211 12
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...+.. .... .+..... .. +
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~----~i~~~~~------~~----~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQ----SILEDEV------RY----P 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHH----HHHcCCC------CC----C
Confidence 2345899999999999999999999999999999999999999743321 1111 1111111 00 1
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 002410 846 IESIWRIAEVAIQCVEQRGFSRPKM-----QEIVLA 876 (927)
Q Consensus 846 ~~~~~~l~~Li~~Cl~~dP~~RPs~-----~eVl~~ 876 (927)
......+.+++.+||+.||++||++ .++++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1123467899999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=323.07 Aligned_cols=267 Identities=25% Similarity=0.453 Sum_probs=210.8
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEECC--------CcEEEEEEccCcc-chhHHHHHHHHHHHHhc-CCCceeeeeee
Q 002410 600 PELEEATNNFCKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGY 669 (927)
Q Consensus 600 ~el~~~~~~~~~~LG~G~~G~Vy~a~~~~--------g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~ 669 (927)
.++...++++.+.||+|+||.||+|+... +..||+|.++... ....+++.+|+++++++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 46666788899999999999999997531 2368999887543 33457899999999999 79999999999
Q ss_pred eecCceEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 002410 670 CEEEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 736 (927)
Q Consensus 670 ~~~~~~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~ 736 (927)
+..++..++++||+++|+|.+++.... ....+++.+++.++.|++.||+|||+ ++++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccc
Confidence 999999999999999999999987532 23458889999999999999999998 99999999999
Q ss_pred cccccCCCcEEEeecccccccccccccc-ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccc
Q 002410 737 NILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFG 814 (927)
Q Consensus 737 NILld~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~ 814 (927)
||+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999998654322111 111224567999999999999999999999999999998 88888643221
Q ss_pred chhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 815 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 815 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
+ ... .+..+..... .......+.+++.+|++.+|++||++.|+++.|+++.....
T Consensus 244 ~---~~~----~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 244 E---LFK----LLKEGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred H---HHH----HHHcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 1 111 1111111111 11223478899999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.79 Aligned_cols=259 Identities=25% Similarity=0.441 Sum_probs=206.7
Q ss_pred HHHHHHhhcccccccccEEEEEEEECC------CcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCc
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 674 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~------g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~ 674 (927)
+....+.+.+.||+|+||.||+|..++ +..||+|.+.... ......+.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 445667788999999999999998753 4689999987543 234567889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEE
Q 002410 675 QRILVYEYMHNGTLRDRLHGSVN-------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 747 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~k 747 (927)
..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEE
Confidence 99999999999999999875321 2347889999999999999999998 9999999999999999999999
Q ss_pred Eeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHH
Q 002410 748 VSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 825 (927)
Q Consensus 748 L~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 825 (927)
|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||...+.. .......
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~~- 235 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLKFVI- 235 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHHHHh-
Confidence 999999886543321 12223346788999999988889999999999999999998 99998633221 1222111
Q ss_pred hhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 826 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 826 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
.+..... +......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 236 ---~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 ---DGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ---cCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111111 11124578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=333.05 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=197.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+++++.++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 556789999999999999986 58999999997532 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 83 LPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999873 4568999999999999999999998 9999999999999999999999999999875432110
Q ss_pred c-------------------------------------cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCC
Q 002410 763 H-------------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 805 (927)
Q Consensus 763 ~-------------------------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~ 805 (927)
. ......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 011235899999999999989999999999999999999999
Q ss_pred CCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 002410 806 KPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVLA 876 (927)
Q Consensus 806 ~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs---~~eVl~~ 876 (927)
.||......+ . ............. + . .......+.+++.+|+. +|.+|++ ++|+++.
T Consensus 237 ~Pf~~~~~~~---~---~~~i~~~~~~~~~--~---~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQE---T---YRKIINWKETLQF--P---D--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHH---H---HHHHHcCCCccCC--C---C--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9997433211 1 1111111100000 0 0 00112367789999996 8999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=308.29 Aligned_cols=249 Identities=27% Similarity=0.399 Sum_probs=203.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|.+.+.||+|++|.||+|..+ +++.|++|.+... .....+.+.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 456788999999999999886 5889999998643 3345678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++++|.++++.. ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++........
T Consensus 82 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 82 ENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 999999999854 24678999999999999999999998 89999999999999999999999999998876543222
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||..... ..... . ...+....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~---~-~~~~~~~~--------- 220 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALIL---K-IIRGVFPP--------- 220 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHH---H-HHcCCCCC---------
Confidence 2233578899999999998899999999999999999999999974431 11111 1 11111111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
........+.+++.+|++.+|++||++.|+++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111223478899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=324.25 Aligned_cols=243 Identities=22% Similarity=0.337 Sum_probs=193.3
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57899999997542 23345688899999888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TT 153 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ce
Confidence 999998873 4579999999999999999999998 9999999999999999999999999999875322111 12
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
....||+.|+|||++.+..++.++|||||||++|||++|+.||............++....+..... .+ +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~----p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RI----P 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CC----C
Confidence 3345899999999999999999999999999999999999999643322222222222222222111 01 1
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCH
Q 002410 846 IESIWRIAEVAIQCVEQRGFSRPKM 870 (927)
Q Consensus 846 ~~~~~~l~~Li~~Cl~~dP~~RPs~ 870 (927)
......+.+++.+||+.||++|+++
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1112357799999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=330.60 Aligned_cols=260 Identities=25% Similarity=0.343 Sum_probs=197.5
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCc-----eEEEE
Q 002410 608 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRILV 679 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-----~~~LV 679 (927)
++.+.||+|+||.||+|... +|+.||||++.... ....+++.+|+++++.++|+||+++++++...+ ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 45689999999999999875 68999999986532 234567889999999999999999999998766 78999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
+||+. ++|.+.+. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 83 TELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred eeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99996 57888776 34678999999999999999999998 9999999999999999999999999999986543
Q ss_pred cccccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHH----------------
Q 002410 760 DLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW---------------- 822 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~---------------- 822 (927)
..........+++.|+|||.+.+. .++.++||||+||++|||++|+.||...+..........
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 332223334578899999998764 578999999999999999999999975443221111100
Q ss_pred HHHhhhcCCe-eeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 823 ARSMIKKGDV-ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 823 ~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
....+..... ..... .+ ..........+.+++.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLP-VL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchH-Hh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000 00000 00 00111123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=331.36 Aligned_cols=251 Identities=21% Similarity=0.265 Sum_probs=200.5
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
|++.+.||+|+||.||++..+ +|+.||+|+++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 556789999999999999876 689999999975422 2446688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 83 QPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 9999999999753 3578999999999999999999998 9999999999999999999999999999987654433
Q ss_pred ccccccccCCCccCCCccC------CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 763 HISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~------~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ...............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~~~ 231 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFLKFP 231 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCccCCC
Confidence 3333446899999999986 4567899999999999999999999997433211 111111111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+ .......+.+++.+|++ +|++||+++++++.
T Consensus 232 ~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 232 E-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred C-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 01123467889999998 99999999998853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=326.66 Aligned_cols=237 Identities=29% Similarity=0.387 Sum_probs=188.8
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHH-HHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~-~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.||+|+||+||+|+.+ +|+.||+|++.... ....+.+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999986 68999999986532 122344555554 56789999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTT 153 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccc
Confidence 999999873 4578899999999999999999998 999999999999999999999999999987532221 122
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +....... +.. .+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~-~~~------~~~~--- 217 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNILN-KPL------RLKP--- 217 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHHc-CCC------CCCC---
Confidence 3345899999999999999999999999999999999999999743321 11111111 111 1111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH
Q 002410 846 IESIWRIAEVAIQCVEQRGFSRPKMQ 871 (927)
Q Consensus 846 ~~~~~~l~~Li~~Cl~~dP~~RPs~~ 871 (927)
.....+.+++.+||+.||++||+++
T Consensus 218 -~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 -NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1134678999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.12 Aligned_cols=260 Identities=23% Similarity=0.346 Sum_probs=201.4
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccC--ccchhHHHHHHHHHHHHhcCCCceeeeeeeeec-----CceEEEEEE
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQRILVYE 681 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~--~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-----~~~~~LV~E 681 (927)
.+.||+|++|.|+.|..+ +|+.||||++.. ......++-.+|+++|+.++|+||+.+.+++.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 578999999999999876 689999999974 334456788999999999999999999998854 456899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc-
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED- 760 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~- 760 (927)
+| +.+|.+.++ .++.++...+.-++.||++||+|+|+ .+|+||||||+|+|++.+..+||+|||+|+.....
T Consensus 107 lM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 107 LM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred HH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99 579999998 45669999999999999999999999 99999999999999999999999999999987543
Q ss_pred ccccccccccCCCccCCCccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee----
Q 002410 761 LTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI---- 835 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~---- 835 (927)
.....+..+.|..|+|||++. ...|+.+.||||.||++.||++|++.|.+.+.-++..+.........+..+..+
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 111223456799999999874 568999999999999999999999999877655444333222111111000000
Q ss_pred ----cc---ccccC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 836 ----VD---PVLIG---NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 836 ----~d---~~l~~---~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+. ..... ..-+......++|+.+||..||.+|+|++|.++.
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 00000 0001122256799999999999999999999875
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=330.22 Aligned_cols=199 Identities=25% Similarity=0.396 Sum_probs=172.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
|++.+.||+|+||+||+|... +++.||+|+++... ......+.+|+.++++++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 456789999999999999876 58899999997532 22345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 83 LPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999973 4678999999999999999999998 9999999999999999999999999999875432110
Q ss_pred ----------------------------------ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 002410 763 ----------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 808 (927)
Q Consensus 763 ----------------------------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf 808 (927)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0011346899999999999999999999999999999999999999
Q ss_pred Ccc
Q 002410 809 SVE 811 (927)
Q Consensus 809 ~~~ 811 (927)
...
T Consensus 237 ~~~ 239 (363)
T cd05628 237 CSE 239 (363)
T ss_pred CCC
Confidence 743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=332.52 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=198.3
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
...|++.+.||+|+||.||+++.+ +++.+|+|++.+.. ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 456777899999999999999987 57899999986421 22345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 122 MEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999999863 357888999999999999999998 9999999999999999999999999999987644
Q ss_pred cccccccccccCCCccCCCccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 760 DLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~~----~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
..........||+.|+|||++.+. .++.++||||+||++|||++|+.||...+... ..............
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~~i~~~~~~~~~ 268 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYSKIMDHKNSLNF 268 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCcccCC
Confidence 332223345699999999998653 37889999999999999999999997443211 11111111111010
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 876 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPs~~eVl~~ 876 (927)
.. .......+.+++.+|++.++.+ ||+++|+++.
T Consensus 269 -----p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 -----PE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----CC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00 1112346778899999865544 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.31 Aligned_cols=256 Identities=26% Similarity=0.467 Sum_probs=203.7
Q ss_pred HHHhhcccccccccEEEEEEEECC-C---cEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~-g---~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
..+++.+.||+|+||.||+|.++. + ..||||.+.... ....++|..|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 346778999999999999998763 3 369999987642 34457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998753 3568999999999999999999998 9999999999999999999999999999876543
Q ss_pred cccccc--cccc--cCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 760 DLTHIS--SVAR--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 760 ~~~~~~--~~~~--gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
...... .... .+..|+|||.+.+..++.++|||||||++|||++ |..||..... .....++.. .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~---~~~~~- 231 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQ---DYRLP- 231 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHc---CCcCC-
Confidence 222111 1111 2357999999999899999999999999999887 9999963322 122222211 00000
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
...+.+..+.+++.+|++.+|++||++++|++.|++++
T Consensus 232 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 269 (269)
T cd05065 232 ---------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269 (269)
T ss_pred ---------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 01122346789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=319.62 Aligned_cols=265 Identities=25% Similarity=0.452 Sum_probs=208.2
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC--------CCcEEEEEEccCcc-chhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 670 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~ 670 (927)
++....+.+.++||+|+||.||+|+.. ....+|+|.++... ......+.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344456778899999999999999752 24579999987543 33456788999999999 699999999999
Q ss_pred ecCceEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 002410 671 EEEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 737 (927)
Q Consensus 671 ~~~~~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~N 737 (927)
..++..++|+||+++|+|.+++.... ....+++.++..++.|++.||+|||+ ++++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecccccee
Confidence 99999999999999999999997532 12458899999999999999999998 999999999999
Q ss_pred ccccCCCcEEEeecccccccccccccc-ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccc
Q 002410 738 ILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 815 (927)
Q Consensus 738 ILld~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~ 815 (927)
|++++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~- 243 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE- 243 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 999999999999999998754322111 111224567999999998899999999999999999999 88998633221
Q ss_pred hhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 816 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 816 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
.... .+..+..... .......+.+++.+|++.+|++||++.|+++.|+++....
T Consensus 244 --~~~~----~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 244 --ELFK----LLREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred --HHHH----HHHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 1111 1111111111 1122346789999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.58 Aligned_cols=268 Identities=21% Similarity=0.273 Sum_probs=203.0
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCc-eeeeeeeeecCc-----
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEH----- 674 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~Hpn-Iv~l~~~~~~~~----- 674 (927)
...+...++||+|.||+||+|+.+ +|+.||+|+++-... .......+|+.+|++++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345566788999999999999876 689999999975433 23355689999999999999 999999998877
Q ss_pred -eEEEEEEecCCCCHHHHhccCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecc
Q 002410 675 -QRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 752 (927)
Q Consensus 675 -~~~LV~E~~~~gsL~~~L~~~~~~-~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 752 (927)
..++|+||++ -+|.+++...... ..++...+..++.||+.||+|||+ ++|+||||||+||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccc
Confidence 7889999995 5999999865322 467778999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCC
Q 002410 753 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 831 (927)
Q Consensus 753 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 831 (927)
+|+...-.... ....++|..|+|||++.+. .|+...||||+||++.||++++..|.+....+....+-.......+..
T Consensus 166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 99976533222 2334588999999998776 799999999999999999999999985554222111111111111111
Q ss_pred eeeec---c--ccccCC-----CCHHHH---HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 832 VISIV---D--PVLIGN-----VKIESI---WRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 832 ~~~~~---d--~~l~~~-----~~~~~~---~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
..... + ...... ...... ....+++.+||+.+|.+|.|++.++++
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11111 0 000000 001111 267899999999999999999999875
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=317.51 Aligned_cols=248 Identities=24% Similarity=0.372 Sum_probs=201.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
+|++.+.||+|++|.||+|... +++.|++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 5666789999999999999865 688999999876555556788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+++|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 101 ~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 172 (296)
T cd06654 101 GGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (296)
T ss_pred CCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence 9999999863 357899999999999999999998 99999999999999999999999999998765432211
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 844 (927)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... .+... ...+. ... ..
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~----~~~~~-~~~-------~~ 238 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLI----ATNGT-PEL-------QN 238 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHH----hcCCC-CCC-------CC
Confidence 222357889999999998889999999999999999999999997433211 11111 11110 000 01
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 845 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 845 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.......+.+++.+||..+|++||+++|+++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 1122346789999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=318.67 Aligned_cols=262 Identities=26% Similarity=0.440 Sum_probs=205.2
Q ss_pred HHHHHHhhcccccccccEEEEEEEECC------CcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCc
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 674 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~------g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~ 674 (927)
+....|++.++||+|+||.||+|..++ +..||+|.+..... .....+.+|+.++++++||||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 345677888999999999999997642 45899999875432 33456889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEE
Q 002410 675 QRILVYEYMHNGTLRDRLHGSVN-------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 747 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~k 747 (927)
..++||||+++|+|.+++..... ...+++..+.+++.|++.||+|||+ ++|+||||||+||+++.++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999975321 2345677889999999999999998 9999999999999999999999
Q ss_pred Eeeccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHH
Q 002410 748 VSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 825 (927)
Q Consensus 748 L~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 825 (927)
|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ...+ .
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~---~ 233 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLK---F 233 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---H
Confidence 9999998865332211 1122235678999999998899999999999999999999 78888633221 1111 1
Q ss_pred hhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 826 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 826 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
+..+..... .......+.+++.+|++.+|++||++.|+++.|++.+.
T Consensus 234 -~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 234 -VMDGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred -HHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 111111110 11123478899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=324.72 Aligned_cols=240 Identities=25% Similarity=0.348 Sum_probs=192.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
|++.+.||+|+||.||+|+.+ +++.||+|+++... ....+.+..|..++..+ +|++|+++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 456789999999999999877 47899999987532 22334567788888877 58999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 82 YVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999999873 4568899999999999999999998 999999999999999999999999999987543221
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.+.+ . .... .
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i---~-~~~~------~-- 219 (323)
T cd05616 156 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSI---M-EHNV------A-- 219 (323)
T ss_pred C-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHH---H-hCCC------C--
Confidence 1 122345899999999999999999999999999999999999999743321 121111 1 1111 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 870 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 870 (927)
.+.....++.+++.+||+.+|++|++.
T Consensus 220 --~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 --YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 111123467899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=308.44 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=199.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-----chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
+...+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 456789999999999999875 58999999986432 123457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++.....
T Consensus 84 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 84 EYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999873 4568889999999999999999998 99999999999999999999999999998765432
Q ss_pred ccccc--cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 761 LTHIS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 761 ~~~~~--~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
..... ....++..|+|||.+.+..++.++||||+|+++|||++|+.||...... .... ........ +
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~---~~~~~~~~-----~ 226 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AAIF---KIATQPTN-----P 226 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HHHH---HHhccCCC-----C
Confidence 21111 2334778999999999988999999999999999999999999633211 1111 11111100 0
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
..+......+.+++.+||..+|++||++.|+++.
T Consensus 227 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 ----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111223467899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=322.23 Aligned_cols=263 Identities=21% Similarity=0.289 Sum_probs=197.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
+|.+.++||+|+||.||+|+.+ +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 4566789999999999999876 578899999875432 23356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++ +|.+++... +..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 87 ~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 87 DK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 75 888887643 3457889999999999999999998 99999999999999999999999999998764332221
Q ss_pred cccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee------c
Q 002410 764 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI------V 836 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~------~ 836 (927)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+...................+ .
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 161 -YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred -cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 222347889999998865 46889999999999999999999999755433222221111000000000000 0
Q ss_pred cccccC-------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 837 DPVLIG-------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 837 d~~l~~-------~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+..... .........+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000 000112346789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=312.77 Aligned_cols=251 Identities=32% Similarity=0.515 Sum_probs=200.2
Q ss_pred HhhcccccccccEEEEEEEECC-CcEEEEEEccCccchhHH--HHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~~~~~--~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|++.+.||+|+||+||+++... ++.+|+|++......... ...+|+.++++++||||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999999874 668999999876444332 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++++|.+++. ....+++..++.++.|+++||++||+ .+++|+||||+||+++.++.++|+|||.+..... ...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNE 153 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTS
T ss_pred cccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-ccc
Confidence 9999999998 35678999999999999999999999 9999999999999999999999999999876421 122
Q ss_pred cccccccCCCccCCCccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH-hhhcCCeeeecccccc
Q 002410 764 ISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS-MIKKGDVISIVDPVLI 841 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~-~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~-~~~~~~~~~~~d~~l~ 841 (927)
......++..|+|||.+. +..++.++||||+|+++|+|++|..||................. .... . .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------~-~- 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS--------S-S- 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH--------H-T-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc--------c-c-
Confidence 233455789999999998 88999999999999999999999999984421111111111110 0000 0 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.........+.+++.+||+.||++||+++|+++
T Consensus 224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011257899999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.83 Aligned_cols=248 Identities=29% Similarity=0.451 Sum_probs=198.4
Q ss_pred ccccccccEEEEEEEECC----CcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~----g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
++||+|+||.||+|.+.. +..+|+|.+..... ...+++.+|+++++++.|+||+++++++.. +..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 479999999999997642 26899999886543 355779999999999999999999998764 467999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
|+|.+++.. ...+++..++.++.|++.||+|||. .+++|+||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999984 3478999999999999999999998 8999999999999999999999999999987644332221
Q ss_pred cc--cccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 766 SV--ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 766 ~~--~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
.. ..++..|+|||.+.+..++.++|||||||++|||++ |..||...+. ..+..++. ......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~----~~~~~~-------- 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE----SGERLP-------- 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH----cCCcCC--------
Confidence 11 123467999999998899999999999999999998 9999974322 22222221 111110
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
........+.+++.+||..+|++||++.+|++.|+++.
T Consensus 219 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 -RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11112347889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=311.14 Aligned_cols=250 Identities=30% Similarity=0.521 Sum_probs=197.1
Q ss_pred ccccccccEEEEEEEECC-Cc--EEEEEEccCcc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMKD-GK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~-g~--~vAvK~l~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.||+|+||.||+|.+++ +. .+++|.++... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999864 43 47888887533 34456789999999999 799999999999999999999999999
Q ss_pred CCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecc
Q 002410 686 GTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 752 (927)
Q Consensus 686 gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 752 (927)
|+|.+++.... ....+++.+++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999987532 12357899999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCC
Q 002410 753 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 831 (927)
Q Consensus 753 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 831 (927)
++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||...+..+ ..+ . +..+.
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~---~-~~~~~ 228 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE---K-LPQGY 228 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHH---H-HhCCC
Confidence 9864321111 111223567999999988889999999999999999997 999996432211 111 1 11111
Q ss_pred eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 832 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 832 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
..+ ........+.+++.+|++.+|.+||++.|+++.|++++
T Consensus 229 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 100 01112346789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=311.99 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=196.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
+++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 456789999999999999865 68899999986542 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+++|..+. .+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 83 GGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 99996542 36788889999999999999998 999999999999999999999999999997654321
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchh-hHHHHHHHhhhcCCeeeeccccccCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||......... ........ +..... +.+.
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~-- 221 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-IVDEDP-----PVLP-- 221 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-HhccCC-----CCCC--
Confidence 22345889999999999889999999999999999999999999643221111 11111111 111110 1110
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.......+.+++.+|++.+|++||+++|+++.
T Consensus 222 -~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 -VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01122367899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=316.18 Aligned_cols=264 Identities=24% Similarity=0.400 Sum_probs=202.6
Q ss_pred HHHHhhcccccccccEEEEEEEEC-----------------CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceee
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-----------------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVP 665 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-----------------~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~ 665 (927)
...+++.++||+|+||.||++... ++..||+|+++... .....++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 345778899999999999998643 23468999997543 334568999999999999999999
Q ss_pred eeeeeecCceEEEEEEecCCCCHHHHhccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 002410 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVN--------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 737 (927)
Q Consensus 666 l~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~--------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~N 737 (927)
+++++...+..++||||+++|+|.+++..... ...+++.++..++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence 99999999999999999999999999875321 2347788999999999999999998 899999999999
Q ss_pred ccccCCCcEEEeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCccccc
Q 002410 738 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 814 (927)
Q Consensus 738 ILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt--G~~Pf~~~~~~ 814 (927)
|+++.++.++|+|||+++....... .......++..|+|||...++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999886533221 11122234678999999888889999999999999999998 77888633222
Q ss_pred chhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 815 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 815 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
+ .................. +. ....+..+.+++.+||+.||++||++.||++.|++
T Consensus 241 ~---~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 Q---VIENTGEFFRDQGRQVYL-PK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H---HHHHHHHHHhhccccccC-CC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 111111111111100000 00 11123578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=326.79 Aligned_cols=243 Identities=28% Similarity=0.411 Sum_probs=191.5
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHH-HHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~-~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.||+|+||.||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999876 68999999986532 223345555655 46778999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
|+|..++. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TT 153 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cc
Confidence 99999887 35678999999999999999999998 9999999999999999999999999999875322211 12
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...+..+ . ...... ... .+.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~---~~~~~~-~~~--~~~~------- 217 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---M---YDNILH-KPL--VLRP------- 217 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---H---HHHHHc-CCc--cCCC-------
Confidence 33458999999999999999999999999999999999999997433211 1 111111 111 0111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002410 846 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 877 (927)
Q Consensus 846 ~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L 877 (927)
.....+.+++.+|++.+|++||++++.++.+
T Consensus 218 -~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 218 -GASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred -CCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 1223677999999999999999987544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=308.98 Aligned_cols=251 Identities=30% Similarity=0.522 Sum_probs=202.1
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
.+++.+.||+|++|.||+|.+.+++.+|+|.+..... ...++.+|++++++++|||++++++++......++|+||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 4567789999999999999988788999999875422 345788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++...........
T Consensus 84 ~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 84 GCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 9999998743 3457899999999999999999998 8999999999999999999999999999876543322212
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 844 (927)
....++.+|+|||.+.+..++.++||||||+++|||++ |..||...... ...+. +..+. ....+..
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~~~~--~~~~~~~---- 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVET----INAGF--RLYKPRL---- 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHH----HhCCC--CCCCCCC----
Confidence 22234678999999998899999999999999999998 99999633221 11111 11110 1111111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 845 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 845 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
....+.+++.+||+.+|++||+++|++++|.
T Consensus 226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1246889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.50 Aligned_cols=250 Identities=30% Similarity=0.500 Sum_probs=200.6
Q ss_pred HHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeee-ecCceEEEEEEe
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC-EEEHQRILVYEY 682 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~-~~~~~~~LV~E~ 682 (927)
...+.+.+.||+|++|.||++..+ |+.||+|.++... ..+.+.+|+.++++++|+|++++++++ ..++..++|+||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 345677899999999999999876 7889999986532 346789999999999999999999975 455678999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++++|.+++... ....+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 82 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999998753 23458899999999999999999998 999999999999999999999999999987643322
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+... +..+....
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~~~------- 219 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR----VEKGYKMD------- 219 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HhcCCCCC-------
Confidence 12234568999999998899999999999999999998 9999863322 111111 11111111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
.....+..+.+++.+|++.+|++||+++++++.|+++
T Consensus 220 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 --APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1112234788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=307.45 Aligned_cols=248 Identities=29% Similarity=0.437 Sum_probs=200.4
Q ss_pred ccccccccEEEEEEEECC--C--cEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMKD--G--KEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~--g--~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998753 3 3699999987655 566789999999999999999999999988 889999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc--
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-- 763 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~-- 763 (927)
++|.+++..... ..+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999985422 568999999999999999999998 99999999999999999999999999999876442221
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ....... .......
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~---~~~~~~~-------- 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKID---KEGERLE-------- 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---hcCCcCC--------
Confidence 1112346788999999998899999999999999999999 99999633221 1111111 1111100
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
.....+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01122347889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=325.60 Aligned_cols=245 Identities=26% Similarity=0.377 Sum_probs=191.3
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHH-HHHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEV-ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~-~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.||+|+||.||+|+.+ +++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999987 57889999987532 12223444444 456788999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
|+|.+++.. ...+.+..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~ 153 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TT 153 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cc
Confidence 999999873 4567888889999999999999998 9999999999999999999999999999875432211 22
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ..+ .... ... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~---~i~~-~~~--~~~~------- 217 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYD---NILN-KPL--QLKP------- 217 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHH---HHHh-CCc--CCCC-------
Confidence 33458999999999999999999999999999999999999997433211 111 1111 110 0111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 846 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 846 ~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
.....+.+++.+||+.+|.+||++.+.+.++.+
T Consensus 218 -~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 218 -NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred -CCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 123367899999999999999998865544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=308.59 Aligned_cols=248 Identities=32% Similarity=0.480 Sum_probs=200.1
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCHH
Q 002410 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 689 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~-~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL~ 689 (927)
++||+|++|.||++...+++.|++|.+...... ....+.+|++++++++|+||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999887999999998765443 5578999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc-ccc
Q 002410 690 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVA 768 (927)
Q Consensus 690 ~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~-~~~ 768 (927)
+++... ...+++..+..++.+++.||+|||+ ++++||||||+||+++.++.+||+|||++........... ...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 999743 3467899999999999999999998 8999999999999999999999999999886543221111 112
Q ss_pred ccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHH
Q 002410 769 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 847 (927)
Q Consensus 769 ~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 847 (927)
..+..|+|||.+.+..++.++|||||||++|||++ |..||...... .... .+..... . ..+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~~----~~~~~~~--~-------~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRE----RIESGYR--M-------PAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHHH----HHhcCCC--C-------CCCcc
Confidence 23567999999988899999999999999999999 88888633221 1111 1111100 0 01112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 848 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 848 ~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
.+..+.+++.+|++.+|++||++.||++.|+.
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 23478899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=307.31 Aligned_cols=249 Identities=33% Similarity=0.548 Sum_probs=203.5
Q ss_pred ccccccccEEEEEEEECC----CcEEEEEEccCccchh-HHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~----g~~vAvK~l~~~~~~~-~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.||+|+||.||+|.... +..|++|.++...... .+.+.+|+++++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998864 7889999998654433 67899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 686 GTLRDRLHGSVN------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 686 gsL~~~L~~~~~------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
++|.+++..... ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999985421 3679999999999999999999998 9999999999999999999999999999987654
Q ss_pred ccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 760 DLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 760 ~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
... .......++..|+|||.+.+..++.++||||+|+++|||++ |..||..... ..+.+. +..+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~~~--- 227 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEY----LRKGYRLP--- 227 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH----HHcCCCCC---
Confidence 321 11223346889999999988889999999999999999999 6999974422 122221 11111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
........+.+++.+|++.+|++||+++|+++.|+
T Consensus 228 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 ------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11112347889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=329.21 Aligned_cols=257 Identities=23% Similarity=0.325 Sum_probs=200.0
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
++....|++.+.||+|+||.||+++.+ +++.+|+|++.... ....+.+.+|+.+++.++||||+++++.+.+++..
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 334567788899999999999999987 57899999986422 22345678899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++||||+++|+|.+++.. ..++...+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 119 ~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 999999999999999863 357888899999999999999998 9999999999999999999999999999987
Q ss_pred ccccccccccccccCCCccCCCccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCe
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 832 (927)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||...+... ...........
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~~ 265 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMNHKNS 265 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCCc
Confidence 654333233345699999999998653 37899999999999999999999997443211 11111111111
Q ss_pred eeeccccccCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 002410 833 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLAI 877 (927)
Q Consensus 833 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPs~~eVl~~L 877 (927)
....+. ......+.+++.+||..++.+ ||+++|+++..
T Consensus 266 ~~~~~~-------~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 266 LTFPDD-------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ccCCCc-------CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111110 112336778999999844433 78999988753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=301.03 Aligned_cols=252 Identities=25% Similarity=0.342 Sum_probs=201.5
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccC--ccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~--~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
....|++.+.||+|.|+.||+..+. .|+.+|+|++.- -...+.+.+.+|+++.+.|+||||+++.+.+.+.+..++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3456778899999999999998765 689999988753 2344678899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC---CCcEEEeecccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ 756 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~---~~~~kL~DFGla~~ 756 (927)
+|+|.|++|..-+-. ....++..+-..++||+++|.|+|. ++|||||+||+|+++.. .--+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999999655542 3457788888999999999999998 99999999999999953 44589999999998
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
... ........|||+|||||+++..+|+..+|||+.||+||-|+.|.+||.+++.. .+.+ .+..+.. -+
T Consensus 163 l~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye----~I~~g~y--d~ 231 (355)
T KOG0033|consen 163 VND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYE----QIKAGAY--DY 231 (355)
T ss_pred eCC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHH----HHhcccc--CC
Confidence 873 23344567999999999999999999999999999999999999999854332 2222 2222221 01
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
++.-.+.. .+...+|+++||..||.+|.|+.|.++
T Consensus 232 ~~~~w~~i----s~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 232 PSPEWDTV----TPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CCcccCcC----CHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11111111 225679999999999999999998774
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=339.59 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=201.4
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCc-------
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------- 674 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~------- 674 (927)
..|.+.+.||+|+||+||+|+.. +|+.||||++... .......+.+|+.++..++|+||++++..+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 46777899999999999999865 6899999998653 2344567889999999999999999988764322
Q ss_pred -eEEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecc
Q 002410 675 -QRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 752 (927)
Q Consensus 675 -~~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 752 (927)
..++||||+++|+|.++++... ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 3679999999999999987532 34578999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCC
Q 002410 753 LSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 831 (927)
Q Consensus 753 la~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 831 (927)
+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +...... .+.
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~~~~-~~~ 261 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMHKTL-AGR 261 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHh-cCC
Confidence 9987543221 1223456899999999999999999999999999999999999999743321 1111111 111
Q ss_pred eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 832 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 832 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
... + +......+.+++.+||+.||++||++.++++.
T Consensus 262 ~~~-----~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 YDP-----L----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC-----C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 110 1 11223468899999999999999999999864
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=322.87 Aligned_cols=263 Identities=27% Similarity=0.457 Sum_probs=204.2
Q ss_pred HHHHHHhhcccccccccEEEEEEEE------CCCcEEEEEEccCcc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeec-
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE- 672 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~- 672 (927)
+....|++.+.||+|+||.||+|.+ .+++.||||+++... ......+.+|+.++.++ +||||+++++++..
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 4456788999999999999999974 247889999997543 23456788999999999 68999999998865
Q ss_pred CceEEEEEEecCCCCHHHHhccCCC-------------------------------------------------------
Q 002410 673 EHQRILVYEYMHNGTLRDRLHGSVN------------------------------------------------------- 697 (927)
Q Consensus 673 ~~~~~LV~E~~~~gsL~~~L~~~~~------------------------------------------------------- 697 (927)
+...++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4467899999999999999864210
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc-cccc
Q 002410 698 ---------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSV 767 (927)
Q Consensus 698 ---------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~ 767 (927)
...+++..+..++.||++||+|||+ ++|+||||||+||+++.++.+||+|||++......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 1246788899999999999999998 99999999999999999999999999998865332221 1122
Q ss_pred cccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCH
Q 002410 768 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 846 (927)
Q Consensus 768 ~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 846 (927)
..++..|+|||.+.+..++.++||||||+++|||++ |..||....... ... ..+.++..... + ..
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~~~~~~~--~---~~--- 306 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEGTRMRA--P---DY--- 306 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH----HHHhccCCCCC--C---CC---
Confidence 335678999999988899999999999999999997 999986432211 111 11222211110 0 00
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 847 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 847 ~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
....+.+++.+||+.+|++||++.||++.|+.+++
T Consensus 307 -~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 -TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred -CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12367899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=332.47 Aligned_cols=250 Identities=25% Similarity=0.336 Sum_probs=194.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
|.+.++||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 456789999999999999876 68999999986532 23346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 83 LPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999973 4568899999999999999999998 9999999999999999999999999999864211000
Q ss_pred ------------c----------------------------------cccccccCCCccCCCccCCCCCCcchhHHHHHH
Q 002410 763 ------------H----------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 796 (927)
Q Consensus 763 ------------~----------------------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGv 796 (927)
. ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001235899999999999989999999999999
Q ss_pred HHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCC---CCHHHH
Q 002410 797 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR---PKMQEI 873 (927)
Q Consensus 797 lL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R---Ps~~eV 873 (927)
++|||++|+.||......+ .. ............ + . .......+.+++.+|+. +|.+| +++.|+
T Consensus 237 il~elltG~~Pf~~~~~~~---~~---~~i~~~~~~~~~--p---~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 237 IMFECLIGWPPFCSENSHE---TY---RKIINWRETLYF--P---D--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhcCCCCCCCCCHHH---HH---HHHHccCCccCC--C---C--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 9999999999997433211 11 111110000000 0 0 00112367799999997 66665 599998
Q ss_pred HHH
Q 002410 874 VLA 876 (927)
Q Consensus 874 l~~ 876 (927)
++.
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=309.54 Aligned_cols=240 Identities=23% Similarity=0.411 Sum_probs=190.8
Q ss_pred ccccccccEEEEEEEECC-------------CcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 611 KKIGKGSFGSVYYGKMKD-------------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~-------------g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
+.||+|+||.||+|.+.+ ...|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998642 2358999987655555667899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCc-------EEEee
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-------AKVSD 750 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~-------~kL~D 750 (927)
+||||+++|+|..++... ...+++..+++++.||++||+|||+ ++|+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999988642 3568999999999999999999998 99999999999999987664 89999
Q ss_pred ccccccccccccccccccccCCCccCCCccC-CCCCCcchhHHHHHHHHHHHH-hCCCCCCcccccchhhHHHHHHHhhh
Q 002410 751 FGLSRQAEEDLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAELNIVHWARSMIK 828 (927)
Q Consensus 751 FGla~~~~~~~~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDVwSlGvlL~eLl-tG~~Pf~~~~~~~~~~l~~~~~~~~~ 828 (927)
||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+......+... ..
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------~~- 222 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-------FY- 222 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-------HH-
Confidence 9998764322 1234678899999886 567899999999999999998 5888886332211110 00
Q ss_pred cCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 829 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 829 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
.+.. ... ......+.+++.+||+.||++||+++||++.|+
T Consensus 223 ~~~~-~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQC-MLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcCc-cCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1110 011 112346789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=333.45 Aligned_cols=250 Identities=22% Similarity=0.282 Sum_probs=194.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++|+||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 566789999999999999876 58899999986532 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc-
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 761 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~- 761 (927)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 83 IPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999974 4568889999999999999999998 999999999999999999999999999975321000
Q ss_pred -----------------------------------------cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHH
Q 002410 762 -----------------------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLE 800 (927)
Q Consensus 762 -----------------------------------------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~e 800 (927)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000112358999999999999999999999999999999
Q ss_pred HHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCC---CHHHHHHH
Q 002410 801 LISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP---KMQEIVLA 876 (927)
Q Consensus 801 LltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP---s~~eVl~~ 876 (927)
|++|+.||......+.. ............ +. .......+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 237 ll~G~~Pf~~~~~~~~~------~~i~~~~~~~~~--~~-----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAETQ------LKVINWETTLHI--PS-----QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHHH------HHHhccCccccC--CC-----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999744322111 111110000000 00 0112235667888876 5999999 88998865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=332.57 Aligned_cols=250 Identities=22% Similarity=0.264 Sum_probs=192.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
+.+.++||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++|+||+++++.+.+++..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 456789999999999999876 58899999987532 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc-
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 761 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~- 761 (927)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 83 IPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999874 3568889999999999999999998 999999999999999999999999999975321000
Q ss_pred ---------------------------------------------cccccccccCCCccCCCccCCCCCCcchhHHHHHH
Q 002410 762 ---------------------------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 796 (927)
Q Consensus 762 ---------------------------------------------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGv 796 (927)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00011235899999999999989999999999999
Q ss_pred HHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHH
Q 002410 797 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEI 873 (927)
Q Consensus 797 lL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs---~~eV 873 (927)
++|||++|+.||...+..+. ............. +. ... ....+.+++.+|+ .+|++|++ ++|+
T Consensus 237 il~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~--p~-~~~----~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLET------QMKVINWQTSLHI--PP-QAK----LSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHH------HHHHHccCCCcCC--CC-ccc----CCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 99999999999974332111 1111110000000 00 001 1235667777776 49999997 8887
Q ss_pred HHH
Q 002410 874 VLA 876 (927)
Q Consensus 874 l~~ 876 (927)
++.
T Consensus 303 ~~h 305 (382)
T cd05625 303 KAH 305 (382)
T ss_pred hcC
Confidence 653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=309.46 Aligned_cols=253 Identities=23% Similarity=0.359 Sum_probs=201.3
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
...|.+.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 346778899999999999999875 5889999998766555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++++|.+++.. ...+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 999999999873 4578999999999999999999998 8999999999999999999999999999876543222
Q ss_pred ccccccccCCCccCCCccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 763 HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
......|+..|+|||.+. ...++.++|||||||++|||++|+.||....... ..... . .... ..+.
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~~~~----~-~~~~---~~~~ 230 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFLM----T-KSNF---QPPK 230 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hHHhh----h-ccCC---CCCc
Confidence 122345889999999874 4568899999999999999999999986322111 11110 0 0110 0011
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
... .......+.+++.+||+.+|++||++++|++
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 100 0012236789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=312.58 Aligned_cols=259 Identities=25% Similarity=0.367 Sum_probs=207.6
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
|....+++.+.||+|++|+||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 44567888999999999999999876 58899999876543 33457889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
+||+++++|.+++.. .+.+++..+..++.+++.||.|||+ .++++||||||+||++++++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 82 MEFMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EecCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999999999999874 4568999999999999999999996 36899999999999999999999999999875432
Q ss_pred cccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc-----chhhHHHHHHHhhhcCCeee
Q 002410 760 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-----AELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~-----~~~~l~~~~~~~~~~~~~~~ 834 (927)
.. .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...... ....+..+....+....
T Consensus 157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 230 (284)
T cd06620 157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--- 230 (284)
T ss_pred hc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC---
Confidence 21 12345889999999998889999999999999999999999999744331 11122233322222110
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 877 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L 877 (927)
+.+. ....+..+.+++.+|++.||++||+++|++++.
T Consensus 231 ---~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 ---PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1111 111334688999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=312.15 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=203.6
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCc----EEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~----~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
....+++.++||+|+||+||+|++. +++ .||+|+++... ....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 3455667899999999999999864 444 48999987543 34456789999999999999999999999754 46
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++++||+++|+|.++++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.
T Consensus 84 ~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 84 QLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceee
Confidence 7999999999999999743 3568999999999999999999998 9999999999999999999999999999987
Q ss_pred cccccccc-ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 757 AEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 757 ~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..+..++. .+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~----~~~~~~ 231 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLLE----KGERLP 231 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH----CCCcCC
Confidence 64322211 111234678999999988899999999999999999998 8999863322 12222221 111111
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
. .......+.+++.+||+.||++||++.|+++.|+++...
T Consensus 232 ~---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 232 Q---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred C---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 0 111234678999999999999999999999999877553
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=323.56 Aligned_cols=237 Identities=27% Similarity=0.383 Sum_probs=187.9
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHH-HHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~-~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.||+|+||.||+|+.. +++.||+|++.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999986 58899999986532 122344555554 67889999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
|+|.+.+.. ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT 153 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence 999988873 4568889999999999999999998 999999999999999999999999999987532221 122
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||...+.. ...+ ... .... . .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~---~i~-~~~~------~----~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYD---NIL-HKPL------Q----LP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHH---HHh-cCCC------C----CC
Confidence 3345899999999999889999999999999999999999999743321 1111 111 1111 0 11
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH
Q 002410 846 IESIWRIAEVAIQCVEQRGFSRPKMQ 871 (927)
Q Consensus 846 ~~~~~~l~~Li~~Cl~~dP~~RPs~~ 871 (927)
......+.+++.+||+.+|++||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11233678999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.96 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=200.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
-|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++..++..++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3667889999999999999987 477889999876555566788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+++|..++.. ....+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++........ .
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 9999988764 24568999999999999999999998 9999999999999999999999999999876533221 1
Q ss_pred ccccccCCCccCCCccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 765 SSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
.....++..|+|||++. +..++.++|||||||++|||++|+.||...+. ...... ... ........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~----~~~-~~~~~~~~-- 230 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--MRVLLK----IAK-SEPPTLAQ-- 230 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--HHHHHH----Hhh-cCCCCCCC--
Confidence 22345789999999984 44577899999999999999999999973321 111111 111 11101111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+......+.+++.+||+.+|.+||++.++++.
T Consensus 231 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 231 -----PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11123468899999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=314.08 Aligned_cols=257 Identities=29% Similarity=0.473 Sum_probs=203.5
Q ss_pred HHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
...+++.+.||+|+||.||+|... ++..||+|++..... ...+++.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 345667889999999999999864 467899999876433 3456799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 002410 677 ILVYEYMHNGTLRDRLHGSV-------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 737 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~-------------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~N 737 (927)
++|+||+++|+|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999997421 12357888999999999999999998 899999999999
Q ss_pred ccccCCCcEEEeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccc
Q 002410 738 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 815 (927)
Q Consensus 738 ILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~ 815 (927)
|+++.++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999876433221 11112234667999999988899999999999999999998 88888633221
Q ss_pred hhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 816 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 816 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
.... .+..+..... ....+..+.+++.+|++.+|++||++.|+++.|++
T Consensus 240 --~~~~----~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 --EVIY----YVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHHH----HHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111 1222222111 11123478899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=312.23 Aligned_cols=248 Identities=27% Similarity=0.399 Sum_probs=201.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
+.|...+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45667789999999999999876 57889999987443 34456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++++|.+++. ...+++..+..++.|++.||.|||+ ++++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999886 3468899999999999999999998 9999999999999999999999999999876543321
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
......++..|+|||.+.+..++.++|||||||++|||++|+.|+....... ... .+..+. .+.+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~----~~~~~~-----~~~~-- 221 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLF----LIPKNS-----PPTL-- 221 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHh----hhhcCC-----CCCC--
Confidence 1222357889999999998889999999999999999999999986322111 111 111111 1111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.......+.+++.+|++.+|++||++.||++.
T Consensus 222 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 --EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred --CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 12234568899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.26 Aligned_cols=262 Identities=27% Similarity=0.462 Sum_probs=205.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-----CCcEEEEEEccCccch-hHHHHHHHHHHHHhcCCCceeeeeeeeec--CceE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQR 676 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-----~g~~vAvK~l~~~~~~-~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~~~ 676 (927)
..+++.+.||+|+||.||+|++. .++.+|||++...... ..+.+.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 34567789999999999999865 3688999999865443 56789999999999999999999999877 5678
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999753 3368999999999999999999998 8999999999999999999999999999987
Q ss_pred ccccccc--cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchh--------hHHHHHHHh
Q 002410 757 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--------NIVHWARSM 826 (927)
Q Consensus 757 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~--------~l~~~~~~~ 826 (927)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6532221 111223456799999998889999999999999999999999998633221100 001111111
Q ss_pred hhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 827 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 827 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
+..+... ......+..+.+++.+|++.+|++||++.||+++|+++
T Consensus 239 ~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERL---------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcC---------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111110 01112235788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=297.10 Aligned_cols=257 Identities=26% Similarity=0.349 Sum_probs=204.5
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--------chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--------SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--------~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~ 676 (927)
|.-.+.||+|..+.|.+..++ .|++.|+|++.... .+-.+.-.+|+.+|+++ .||+|+++.++++.+...
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 334678999999999988776 68899999985321 11234567799999998 699999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++|+|.|+.|.|.|+|. ..-.++++...+|+.|+.+|++|||. ++||||||||+|||+|++.++||+|||+++.
T Consensus 99 FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeec
Confidence 99999999999999998 46789999999999999999999998 9999999999999999999999999999998
Q ss_pred ccccccccccccccCCCccCCCccC------CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcC
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 830 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~------~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 830 (927)
+.++. .-...+|||+|+|||.+. ...|+...|+||+||++|.|+.|.+||.... .-.+.+.+.+|
T Consensus 173 l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlMLR~ImeG 243 (411)
T KOG0599|consen 173 LEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLMLRMIMEG 243 (411)
T ss_pred cCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHHHHHHhc
Confidence 76543 234567999999999984 3468889999999999999999999997221 11122333333
Q ss_pred CeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhhhc
Q 002410 831 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIKIE 884 (927)
Q Consensus 831 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~--L~~~~~~e 884 (927)
...- -.|. -.+......+||.+||+.||.+|.|++|+++. +.++...+
T Consensus 244 kyqF-~spe-----Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~ 293 (411)
T KOG0599|consen 244 KYQF-RSPE-----WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQ 293 (411)
T ss_pred cccc-CCcc-----hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhc
Confidence 3211 1111 11223367899999999999999999999874 44444433
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=307.20 Aligned_cols=249 Identities=26% Similarity=0.375 Sum_probs=201.5
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc-cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
|++.+.||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+..++..++|+||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 456789999999999999876 5889999998643 23445778899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+|+|.+++... ....+++..++.++.|++.||.|||+ ++|+|+||||+||++++++.++|+|||++........ .
T Consensus 82 ~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 82 GGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 99999988643 24567899999999999999999998 9999999999999999999999999999876543222 1
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 844 (927)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||...+.. .. .. .+..+.....
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~---~~-~~~~~~~~~~--------- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---NL---IL-KVCQGSYKPL--------- 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---HH---HH-HHhcCCCCCC---------
Confidence 22345788999999999888999999999999999999999999743221 11 11 1111211111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 845 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 845 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+......+.+++.+||+.||++||+++|++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11122367899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=310.07 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=203.3
Q ss_pred HHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~~~-~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
..+...+.||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 44556788999999999999865 2467999988754433 4577999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeec
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQ------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF 751 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DF 751 (927)
+||||+++|+|.+++...... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999754322 268999999999999999999998 89999999999999999999999999
Q ss_pred cccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcC
Q 002410 752 GLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 830 (927)
Q Consensus 752 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 830 (927)
|++...............++..|+|||.+.+...+.++||||||+++|+|++ |..||..... ...... ...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~----~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNR----LQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHH----HHcC
Confidence 9987543322222222345778999999988888999999999999999999 7888863221 112221 1111
Q ss_pred CeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 831 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 831 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
...... ....+..+.+++.+||+.+|++||++.|+++.|++
T Consensus 235 ~~~~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 235 KLELPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CcCCCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 111100 11223478899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=312.80 Aligned_cols=250 Identities=25% Similarity=0.312 Sum_probs=198.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
++..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++|+|++++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 445688999999999999876 58899999986532 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++++|.+++... ....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999988643 23468999999999999999999998 9999999999999999999999999999876543222
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
. ....|+..|+|||.+.+..++.++||||+||++|||++|+.||............. ....... ...
T Consensus 158 ~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~~~~------~~~-- 224 (285)
T cd05630 158 I--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKEVQ------EEY-- 224 (285)
T ss_pred c--cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhhhhh------hhc--
Confidence 1 22358999999999999899999999999999999999999997433211111111 1111000 001
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 875 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~eVl~ 875 (927)
.......+.+++.+||+.||++||+ ++|+++
T Consensus 225 --~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 --SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1112235789999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=321.39 Aligned_cols=240 Identities=24% Similarity=0.338 Sum_probs=192.2
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~LV~E 681 (927)
+++.+.||+|+||.||+|..+ +|+.||+|++.... ....+.+..|..+++.+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 456789999999999999876 58899999987532 233456788999998885 5778889999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++|+|.+++.. ...+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 y~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 82 YVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999873 4568999999999999999999998 999999999999999999999999999987643221
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+ . .... .
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i---~-~~~~------~-- 219 (323)
T cd05615 156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSI---M-EHNV------S-- 219 (323)
T ss_pred c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHH---H-hCCC------C--
Confidence 1 12234589999999999988999999999999999999999999974332 1111111 1 1111 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 870 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 870 (927)
.+......+.+++.+||+.+|.+|++.
T Consensus 220 --~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 --YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 011122367899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=310.93 Aligned_cols=239 Identities=24% Similarity=0.383 Sum_probs=188.6
Q ss_pred cccccccEEEEEEEECC-------------------------CcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeee
Q 002410 612 KIGKGSFGSVYYGKMKD-------------------------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 666 (927)
Q Consensus 612 ~LG~G~~G~Vy~a~~~~-------------------------g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l 666 (927)
+||+|+||.||+|.+.. ...|++|++..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13589999876555555678899999999999999999
Q ss_pred eeeeecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC--
Q 002410 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-- 744 (927)
Q Consensus 667 ~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~-- 744 (927)
++++..+...++||||+++|+|..++... ...+++..++.++.||++||+|||+ ++|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999998742 4568899999999999999999998 9999999999999997643
Q ss_pred -----cEEEeeccccccccccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHH-hCCCCCCcccccchh
Q 002410 745 -----RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAEL 817 (927)
Q Consensus 745 -----~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLl-tG~~Pf~~~~~~~~~ 817 (927)
.+|++|||++....... ...++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+.
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~- 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK- 230 (274)
T ss_pred cCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence 38999999876543221 1246788999998865 56899999999999999985 69999874332111
Q ss_pred hHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 818 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 818 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
...... ... +.. .....+.+++.+||+.+|++||++++|++.|.
T Consensus 231 --~~~~~~---~~~--------~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 --ERFYEK---KHR--------LPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHHHHh---ccC--------CCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111110 000 000 01136789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=316.19 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=197.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
.|.+.+.||+|+||.||+|..+ +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++|+||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 4667789999999999999876 58899999986432 223456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
+ ++|.+++... ...+++..+..++.|+++||+|||+ .+|+|+||||+||+++.++.+||+|||++.........
T Consensus 87 ~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 87 D-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred c-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 7 5898888643 4468899999999999999999998 99999999999999999999999999998764332211
Q ss_pred cccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhh---cCCeeeecc--
Q 002410 764 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---KGDVISIVD-- 837 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d-- 837 (927)
.....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+.. ..+..... ......+.+
T Consensus 161 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 161 -YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred -ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCChhhchhhhccc
Confidence 122346889999998865 45788999999999999999999999754432211 11111110 000000000
Q ss_pred -------ccccC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 838 -------PVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 838 -------~~l~~----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+.... .........+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 001112336789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=307.77 Aligned_cols=253 Identities=27% Similarity=0.398 Sum_probs=192.7
Q ss_pred ccccccccEEEEEEEECC---CcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCC
Q 002410 611 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 686 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~---g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~g 686 (927)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998754 45799999876433 34457889999999999999999999999999999999999999
Q ss_pred CHHHHhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 687 TLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 687 sL~~~L~~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+|.+++.... .....++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997532 22356777888999999999999998 999999999999999999999999999987643322211
Q ss_pred -ccccccCCCccCCCccCCC-------CCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 765 -SSVARGTVGYLDPEYYGNQ-------QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 765 -~~~~~gt~~Y~APE~l~~~-------~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||......+ .... ... +.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~---~~~-~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTY---TVR-EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHH---Hhh-cccCCC
Confidence 1223467889999998542 35789999999999999996 999996332211 1111 111 111112
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
.++.+.. .....+.+++.+|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222211 12235778999998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=312.09 Aligned_cols=261 Identities=20% Similarity=0.253 Sum_probs=197.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|++.+.||+|++|.||+|+.+ +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+++..++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 456789999999999999986 68999999986432 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
+ ++|.+++........+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR- 156 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-
Confidence 7 6898888755445678999999999999999999998 9999999999999999999999999999876533211
Q ss_pred cccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhh--cCC---------
Q 002410 764 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK--KGD--------- 831 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~--~~~--------- 831 (927)
......+++.|+|||.+.+. .++.++|||||||++|||+||+.||........ .......... +..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhhHH
Confidence 11223468899999988654 578999999999999999999999974332111 1110000000 000
Q ss_pred ----eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 832 ----VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 832 ----~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
......... .........++.+++.+||+.||++|||++||++
T Consensus 235 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 0000112346779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=308.30 Aligned_cols=267 Identities=25% Similarity=0.378 Sum_probs=206.4
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhc--CCCceeeeeeeeecC----ceEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEE----HQRILV 679 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l--~HpnIv~l~~~~~~~----~~~~LV 679 (927)
+..+.+.||+|.||.||+|.|+ |+.||||++.. .+++.+.+|.++++.+ +|+||+.+++.-..+ .+++||
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred eeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 3456789999999999999998 89999999974 4567788899998864 999999999876433 268999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEecCCCCCcccccCCCcEEEeecccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT-----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 754 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~-----~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 754 (927)
.+|.+.|||+|+|. ...++....++++..+|.||+|||. +.++.|.|||||++||||..++.+.|+|+|+|
T Consensus 288 TdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred eecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 99999999999997 4679999999999999999999995 24688999999999999999999999999999
Q ss_pred cccccccc---ccccccccCCCccCCCccCCCC------CCcchhHHHHHHHHHHHHhC----------CCCCCcccccc
Q 002410 755 RQAEEDLT---HISSVARGTVGYLDPEYYGNQQ------LTEKSDVYSFGVVLLELISG----------KKPVSVEDFGA 815 (927)
Q Consensus 755 ~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~------~s~ksDVwSlGvlL~eLltG----------~~Pf~~~~~~~ 815 (927)
........ ......+||.+|||||++.... .-..+||||||.|+||+.-. +.||.+- .+.
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~-Vp~ 442 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV-VPS 442 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC-CCC
Confidence 87655432 2233457999999999985431 12368999999999999862 4666421 111
Q ss_pred hhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 816 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 816 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
+..+.+ ++..+--.+....++.+ -.+.+.+..+.++++.||..+|..|-|+=.|.+.|.++...++
T Consensus 443 DPs~ee-MrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e 508 (513)
T KOG2052|consen 443 DPSFEE-MRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE 508 (513)
T ss_pred CCCHHH-HhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence 222222 22222222222222222 1245778899999999999999999999999999998886544
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=309.18 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=201.0
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
..|++.++||+|+||.||+|+.. +++.+++|.+........+.+.+|++++++++|+||+++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45778899999999999999986 48899999998766666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++++|..++... ...+++..+..++.|++.+|+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 999998887642 3568999999999999999999998 99999999999999999999999999988764332211
Q ss_pred cccccccCCCccCCCccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 764 ISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
.....++..|+|||++. ...++.++|||||||++|||++|+.||..... .... .... .........
T Consensus 167 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~----~~~~-~~~~~~~~~- 237 (292)
T cd06644 167 -RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVL----LKIA-KSEPPTLSQ- 237 (292)
T ss_pred -cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--HHHH----HHHh-cCCCccCCC-
Confidence 22334788999999984 34567899999999999999999999963321 1111 1111 111111100
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.......+.+++.+||+.+|++||+++|+++
T Consensus 238 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 238 ------PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ------CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1122336789999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=313.38 Aligned_cols=261 Identities=25% Similarity=0.316 Sum_probs=192.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--hhHHHHHHHHHHHHhc---CCCceeeeeeeeec-----Cce
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCEE-----EHQ 675 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l---~HpnIv~l~~~~~~-----~~~ 675 (927)
|++.+.||+|+||.||+|+.+ +++.||+|.++.... .....+.+|+++++++ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 556789999999999999877 588999999875322 1234556777777665 69999999998754 345
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
.++|+||++ ++|.+++... ....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred EEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 789999997 5898888743 23458999999999999999999998 999999999999999999999999999998
Q ss_pred cccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchh-hHHHHHHHhhhcCCeee
Q 002410 756 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSMIKKGDVIS 834 (927)
Q Consensus 756 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~-~l~~~~~~~~~~~~~~~ 834 (927)
....... .....++..|+|||++.+..++.++||||+||++|||++|++||......... .+...... ........
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~ 233 (288)
T cd07863 157 IYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL-PPEDDWPR 233 (288)
T ss_pred cccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCC-CChhhCcc
Confidence 7543221 12345788999999999889999999999999999999999999743322111 11111000 00000000
Q ss_pred -------eccccc---cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 835 -------IVDPVL---IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 835 -------~~d~~l---~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
...+.. ...........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 00111123346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=319.87 Aligned_cols=252 Identities=27% Similarity=0.381 Sum_probs=210.0
Q ss_pred HHHHHhhcccccccccEEEEEEEECC-CcEEEEEEccCccch---hHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH---RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~~---~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~ 677 (927)
....|.+.+.||+|.||.||+++.+. |+.+|+|.+.+.... ....+.+|+++|+++. |||||.+.+.+++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34557778999999999999999885 999999999765432 3468999999999998 999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC----CCcEEEeeccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFGL 753 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~----~~~~kL~DFGl 753 (927)
+|||++.||.|.+.+... .+++.....++.|++.+++|||+ .||+||||||+|+|+.. ++.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999854 39999999999999999999998 99999999999999964 35799999999
Q ss_pred cccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCee
Q 002410 754 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 833 (927)
Q Consensus 754 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 833 (927)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.+........ .+..++.
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~- 255 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF- 255 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC-
Confidence 998766 334456679999999999999999999999999999999999999998554322211 2222222
Q ss_pred eeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 834 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 834 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
......-........+++.+|+..||.+|+++.++++.
T Consensus 256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111122234467899999999999999999999984
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=314.26 Aligned_cols=256 Identities=23% Similarity=0.325 Sum_probs=200.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
+++.+.||+|+||.||++... +++.+|+|.++.... ....++.+|++++++++||||+++++++.+++..++|+||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 456789999999999999876 578899998875432 344678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+++|.++++. ...+++..+..++.|+++||+|||+ ..+++|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 83 GGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 9999999974 3568899999999999999999996 2589999999999999999999999999987653321
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCee-----------
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI----------- 833 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~----------- 833 (927)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||...+... ...+...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCCC
Confidence 223457899999999988889999999999999999999999996433211 111111100000000
Q ss_pred ---------eec-------cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 834 ---------SIV-------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 834 ---------~~~-------d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+.. .+.+. .......+.+++.+||+.+|++||+++||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLP---SGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCc---CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00000 00123468899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.60 Aligned_cols=251 Identities=30% Similarity=0.464 Sum_probs=194.3
Q ss_pred ccccccccEEEEEEEECC----CcEEEEEEccCc-cchhHHHHHHHHHHHHhcCCCceeeeeeeee-cCceEEEEEEecC
Q 002410 611 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCE-EEHQRILVYEYMH 684 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~----g~~vAvK~l~~~-~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~-~~~~~~LV~E~~~ 684 (927)
+.||+|+||.||+|.+.+ +..||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 457999998643 2345678889999999999999999999775 4556889999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc-
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH- 763 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~- 763 (927)
+|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999999743 3446778889999999999999998 89999999999999999999999999998765332111
Q ss_pred --cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 764 --ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 764 --~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
......++..|+|||.+.+..++.++|||||||++|||++| ..||.... ...+...+ ..+.... .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~----~~~~~~~-----~ 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVYL----LQGRRLL-----Q 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH----hcCCCCC-----C
Confidence 11122356789999999888999999999999999999995 55564221 11222211 1111100 0
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
+...+..+.+++.+||+.+|++||++.||++.|+++..
T Consensus 224 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 224 ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 01123468899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=321.38 Aligned_cols=253 Identities=25% Similarity=0.316 Sum_probs=195.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc---cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.+++.++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 567889999999999999976 5899999998642 122345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 83 YVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred CCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 9999999999742 4568899999999999999999998 9999999999999999999999999999876544333
Q ss_pred ccccccccCCCccCCCccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 763 HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... +.............+ .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~-~ 230 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQF-P 230 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCcccC-C
Confidence 22333458999999999863 45788999999999999999999999743321 111111111111111 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCC--CCCCCHHHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRG--FSRPKMQEIVLA 876 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP--~~RPs~~eVl~~ 876 (927)
+. .......+.+++.+|+..++ ..||+++++++.
T Consensus 231 ~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 231 PD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred Cc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 01123356788888775533 348899998876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=305.06 Aligned_cols=249 Identities=28% Similarity=0.421 Sum_probs=202.5
Q ss_pred HHHhhcccccccccEEEEEEEECC-CcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
..|++.+.||+|++|.||+|...+ ++.+++|.+..... .+++.+|++++++++|+||+++++++.++...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 356678899999999999999875 78999999875432 678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++++|.+++... ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999998642 4578999999999999999999998 8999999999999999999999999999887654322
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .. ....... +.+ .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~-----~~~~~~~-----~~~--~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IF-----MIPNKPP-----PTL--S 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hh-----hhccCCC-----CCC--C
Confidence 22233478899999999988999999999999999999999999973322110 00 0000000 000 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
........+.+++.+|++.+|++||+++||++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11122346889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=306.04 Aligned_cols=238 Identities=26% Similarity=0.440 Sum_probs=190.4
Q ss_pred ccccccccEEEEEEEECCCc-----------EEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 611 KKIGKGSFGSVYYGKMKDGK-----------EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g~-----------~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999987433 5788887654333 6788999999999999999999999988 778999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC-------cEEEeecc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-------RAKVSDFG 752 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~-------~~kL~DFG 752 (927)
+||+++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999999853 2368899999999999999999998 9999999999999999887 79999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCC--CCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhc
Q 002410 753 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKK 829 (927)
Q Consensus 753 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 829 (927)
++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||....... ...+.. .
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~~----~ 221 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFYQ----D 221 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHHh----c
Confidence 9887543 1223466789999999876 78999999999999999999 577776332111 111110 0
Q ss_pred CCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 830 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 830 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
..... .+ ....+.+++.+||..+|.+||++.||++.|+
T Consensus 222 ~~~~~--~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QHRLP--MP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCCC--CC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 00 0147889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=313.20 Aligned_cols=249 Identities=22% Similarity=0.377 Sum_probs=201.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.|++.+.||.|++|.||+|... +++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 3566789999999999999864 689999999876555556788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+++|.+++.. ..+++.++..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++.........
T Consensus 100 ~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 171 (296)
T cd06655 100 GGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK- 171 (296)
T ss_pred CCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence 9999998863 458999999999999999999998 99999999999999999999999999998765433221
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 844 (927)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.... ... ... ........
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~~----~~~-~~~~~~~~------- 237 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL----IAT-NGTPELQN------- 237 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----HHh-cCCcccCC-------
Confidence 2233578899999999988899999999999999999999999974432111 111 111 11100000
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 845 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 845 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.......+.+++.+||..+|++||++.++++.
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 11122367899999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.83 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=195.4
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCH
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 688 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL 688 (927)
...||+|+||.||+|... +++.|++|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 457999999999999866 5788999998876666677899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC-CCcEEEeeccccccccccccccccc
Q 002410 689 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSV 767 (927)
Q Consensus 689 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFGla~~~~~~~~~~~~~ 767 (927)
.+++.........++..+..++.||+.||+|||+ ++|+||||||+||+++. ++.++|+|||++........ ....
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 168 (268)
T cd06624 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTET 168 (268)
T ss_pred HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cccc
Confidence 9999753222223788889999999999999998 99999999999999976 67999999999876543222 1222
Q ss_pred cccCCCccCCCccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 768 ARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 768 ~~gt~~Y~APE~l~~~--~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
..++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... ...+...... . .+ ..+
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~---~----~~----~~~ 234 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK---I----HP----EIP 234 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc---c----CC----CCC
Confidence 3478899999998654 37889999999999999999999996322211 1111110000 0 01 111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 846 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 846 ~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
......+.+++.+||+.+|++||+++|+++
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 222346789999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=307.53 Aligned_cols=248 Identities=26% Similarity=0.390 Sum_probs=203.2
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
..|+..+.||.|+||.||+|..+ +++.||+|.+.... ......+.+|++++++++|+||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45666789999999999999876 58899999987543 34567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.+++.. ..+++.++..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999999863 458889999999999999999998 9999999999999999999999999999977543322
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
......++..|+|||.+.+..++.++|||||||++|||++|+.||....... ... .+..+. ..
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~----~~~~~~---------~~ 219 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VLF----LIPKNN---------PP 219 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---Hhh----hhhcCC---------CC
Confidence 1223357889999999988889999999999999999999999997332211 110 011111 11
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
......+..+.+++.+||+.+|++||+++|+++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2223455678899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=312.58 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=202.7
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
..|.+.+.||+|++|.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 56777899999999999999874 68999999997655555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++++|.+++.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 99999999863 457889999999999999999998 99999999999999999999999999998765433221
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..... . .....+ . +.. .
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--~----~~~~~~-~-----~~~--~ 236 (297)
T cd06656 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--Y----LIATNG-T-----PEL--Q 236 (297)
T ss_pred -cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe--e----eeccCC-C-----CCC--C
Confidence 22335788999999999888999999999999999999999999743321110 0 000000 0 000 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
........+.+++.+||+.+|++||+++||++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11122345789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.63 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=201.1
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc-cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
.+++.+.||+|+||.||++..+ +++.||+|.++.. .......+.+|++++++++|+||+++++.+...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4677899999999999999987 6899999988754 2334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++++|.+++........+++..+..++.|++.||.|||+ ..+|+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 999999998754334578999999999999999999996 2599999999999999999999999999987653322
Q ss_pred cccccccCCCccCCCccCCC------CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 764 ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~------~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ....... +..+...
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~-~~~~~~~---- 228 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSA-IVDGDPP---- 228 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHH-HhhcCCC----
Confidence 1223478899999998554 34889999999999999999999996432211 1111111 1111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
. ........+.+++.+|++.+|++||+++++++.
T Consensus 229 -~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 -T----LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -C----CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1 111234467899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=310.50 Aligned_cols=251 Identities=23% Similarity=0.293 Sum_probs=197.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
++..+.||+|+||+||+|... +++.||+|.+..... .....+.+|++++++++|+||+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 345678999999999999876 688999999865322 2234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++++|.+++... ....+++..+..++.|++.||.|||+ ++|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999999888643 23469999999999999999999998 9999999999999999999999999999876433211
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
.....|+..|+|||.+.+..++.++|+|||||++|||++|+.||........ ... +......... .
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~-~~~~~~~~~~--~------- 223 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REE-VDRRVLETEE--V------- 223 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHhhhcccc--c-------
Confidence 1234589999999999988999999999999999999999999974322111 111 1111111110 0
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA 876 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~eVl~~ 876 (927)
+.......+.+++.+|++.||++||+ ++|+++.
T Consensus 224 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 224 -YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11112336789999999999999999 5666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=310.25 Aligned_cols=250 Identities=28% Similarity=0.452 Sum_probs=198.2
Q ss_pred ccccccccEEEEEEEECC-------CcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 611 KKIGKGSFGSVYYGKMKD-------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~-------g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999998753 2579999886543 24456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC-----cEEEeeccc
Q 002410 683 MHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-----RAKVSDFGL 753 (927)
Q Consensus 683 ~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~-----~~kL~DFGl 753 (927)
+++++|.+++.... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 22457889999999999999999998 8999999999999999877 899999999
Q ss_pred ccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCC
Q 002410 754 SRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 831 (927)
Q Consensus 754 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 831 (927)
++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ......+ ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~----~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHV----TAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHH----hcCC
Confidence 876533211 11122335678999999999999999999999999999998 9999863321 1122111 1111
Q ss_pred eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 832 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 832 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
.. ......+..+.+++.+||+.+|++||++++|++.|++
T Consensus 231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 10 0111234578899999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=333.29 Aligned_cols=259 Identities=22% Similarity=0.257 Sum_probs=190.9
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC--------ce
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--------HQ 675 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--------~~ 675 (927)
..|.+.++||+|+||.||+|... +++.||||++.... ....+|+.++++++||||+++++++... ..
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 35677899999999999999876 58899999886432 2345799999999999999999876321 24
Q ss_pred EEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC-cEEEeeccc
Q 002410 676 RILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGL 753 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGl 753 (927)
.++||||+++ +|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 6799999975 6777664321 35678999999999999999999998 9999999999999998665 699999999
Q ss_pred cccccccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc---
Q 002410 754 SRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK--- 829 (927)
Q Consensus 754 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~--- 829 (927)
++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+....+ .+....+ ....
T Consensus 218 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~-~~~~p~~ 292 (440)
T PTZ00036 218 AKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQ-VLGTPTE 292 (440)
T ss_pred chhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHH-HhCCCCH
Confidence 987543222 123457999999998865 468999999999999999999999997543321 1111111 0000
Q ss_pred -------CCeee-----eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 830 -------GDVIS-----IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 830 -------~~~~~-----~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
..... .....+....+.....++.+|+.+||+.||.+|||+.|+++.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000 000011111111223478899999999999999999999854
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=315.72 Aligned_cols=196 Identities=24% Similarity=0.383 Sum_probs=160.8
Q ss_pred cccccccccEEEEEEEEC---CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeec--CceEEEEEEecC
Q 002410 610 CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYEYMH 684 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~---~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~~~~LV~E~~~ 684 (927)
.++||+|+||+||+|+.+ +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999875 46789999987532 23457789999999999999999998853 456889999985
Q ss_pred CCCHHHHhccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc----cCCCcEEEeecccc
Q 002410 685 NGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLS 754 (927)
Q Consensus 685 ~gsL~~~L~~~~------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl----d~~~~~kL~DFGla 754 (927)
++|.+++.... ....+++..+..++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58888775321 12358899999999999999999998 999999999999999 45678999999999
Q ss_pred ccccccccc--cccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 002410 755 RQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVE 811 (927)
Q Consensus 755 ~~~~~~~~~--~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~ 811 (927)
+........ ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876443221 1223468999999999876 46899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=343.14 Aligned_cols=262 Identities=23% Similarity=0.358 Sum_probs=204.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.++||+|+||.||+|... +|+.||+|++.... ....+++.+|++++++++||||+++++++.+++..++|||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 3567789999999999999876 58999999987532 2234679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccc
Q 002410 682 YMHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 753 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 753 (927)
|++||+|.+++.... .....++..+++++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999986421 12345677889999999999999998 8999999999999999999999999999
Q ss_pred ccccccccc-----------------ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccch
Q 002410 754 SRQAEEDLT-----------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 816 (927)
Q Consensus 754 a~~~~~~~~-----------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~ 816 (927)
++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...+...
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k- 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK- 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh-
Confidence 986521100 01112458999999999999999999999999999999999999997422211
Q ss_pred hhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhhhhc
Q 002410 817 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKIE 884 (927)
Q Consensus 817 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-s~~eVl~~L~~~~~~e 884 (927)
... .... .++.-. ......+..+.+++.+|++.||++|| +++++++.|+..+..+
T Consensus 239 --i~~--~~~i--------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 239 --ISY--RDVI--------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred --hhh--hhhc--------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 100 0000 000000 00012234678999999999999995 6788888888876643
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=323.85 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=204.6
Q ss_pred cccccccEEEEEEEECC-CcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCHHH
Q 002410 612 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD 690 (927)
Q Consensus 612 ~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL~~ 690 (927)
+||+|.||+||.|+..+ ...+|||.+........+.+.+|+.+.++|+|.|||+++|.+.+++..-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999875 55799999988777778889999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc-CCCcEEEeeccccccccccccccccccc
Q 002410 691 RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVAR 769 (927)
Q Consensus 691 ~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld-~~~~~kL~DFGla~~~~~~~~~~~~~~~ 769 (927)
.|+..-+.-.-++..+-.+.+||++||.|||+ ..|||||||-+||||+ -.|.+||+|||-++....- ........
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccC-Cccccccc
Confidence 99864333333788888999999999999998 9999999999999996 5789999999999886543 33455667
Q ss_pred cCCCccCCCccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHH
Q 002410 770 GTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 847 (927)
Q Consensus 770 gt~~Y~APE~l~~~--~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 847 (927)
||..|||||++..+ .|+.++|||||||++.||.||++||.....+.. . +.+-|.. ...+..+.+
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---A-----MFkVGmy------KvHP~iPee 803 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---A-----MFKVGMY------KVHPPIPEE 803 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---h-----hhhhcce------ecCCCCcHH
Confidence 99999999999655 689999999999999999999999973322210 0 1111111 112334556
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 848 SIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 848 ~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
...+...+|.+|+.+||.+||+++++++.
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 66788999999999999999999999863
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=324.36 Aligned_cols=257 Identities=25% Similarity=0.371 Sum_probs=209.3
Q ss_pred HhhcccccccccEEEEEEEECC--Cc--EEEEEEccCccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKD--GK--EVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~--g~--~vAvK~l~~~~~~-~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
..+.|+||+|.||.|++|.|+. |+ .||||.++..... ...+|++|+.+|.+|+|+|+++|+|+..+ ....+|+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 3467899999999999999873 44 5899999876544 67899999999999999999999999987 67889999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
.++.|+|.+.|++ ..+..+.......++.|||.||.||.+ +++|||||..+|+|+-....+||+|||+.+.+....
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999997 356778889999999999999999998 999999999999999999999999999999875433
Q ss_pred c--ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 762 T--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 762 ~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
. .+.....-...|+|||.++...++.++|||+|||+||||+| |+.||.+.... .+.+. +|.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---qIL~~-------------iD~ 330 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---QILKN-------------IDA 330 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH---HHHHh-------------ccc
Confidence 2 22223334668999999999999999999999999999999 88999744322 22221 111
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhhhc
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIKIE 884 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~--L~~~~~~e 884 (927)
.-.-..+..+.+.+.+++..||..+|++||++..|.+. |.+....+
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp~~ 378 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQPAV 378 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCCce
Confidence 11112244567789999999999999999999999743 44444333
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=303.07 Aligned_cols=257 Identities=25% Similarity=0.281 Sum_probs=207.4
Q ss_pred hHHHHHHhhcccccccccEEEEEEEECC-CcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
.|.-...++.+.||.|.-|+||++++++ +..+|+|++.+..- ....+...|-+||+.+.||.++.|++.++.++..
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 4445566778999999999999999985 58999999976533 3445677899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
|+|||||+||+|...+++. .++.+++..++-++..++.||+|||- .|||+|||||+||||.++|++.|+||.++..
T Consensus 153 cl~meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EEEEecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeecccccc
Confidence 9999999999999988754 67789999999999999999999998 9999999999999999999999999998753
Q ss_pred ccc---------------------------------ccc----------------------ccccccccCCCccCCCccC
Q 002410 757 AEE---------------------------------DLT----------------------HISSVARGTVGYLDPEYYG 781 (927)
Q Consensus 757 ~~~---------------------------------~~~----------------------~~~~~~~gt~~Y~APE~l~ 781 (927)
... ... ..+...+||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 210 000 0011235999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhc
Q 002410 782 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVE 861 (927)
Q Consensus 782 ~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~ 861 (927)
+...+.+.|-|+|||++|||+.|..||.+....+. +...+.+ .+.-.........+.+||++.|.
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--l~NIv~~-------------~l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--LRNIVGQ-------------PLKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh--HHHHhcC-------------CCcCCCCCcchhHHHHHHHHHhc
Confidence 99999999999999999999999999986654322 2221111 11111111334578899999999
Q ss_pred cCCCCCCC----HHHHHHH
Q 002410 862 QRGFSRPK----MQEIVLA 876 (927)
Q Consensus 862 ~dP~~RPs----~~eVl~~ 876 (927)
+||++|.. +.||.+.
T Consensus 374 KdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred cChhhhhccccchHHhhcC
Confidence 99999998 7777653
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.99 Aligned_cols=247 Identities=28% Similarity=0.427 Sum_probs=198.0
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccch---------hHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~---------~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
+.+.+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 345688999999999999875 5889999988643221 225688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999973 4568889999999999999999998 8999999999999999999999999999887
Q ss_pred ccccccc-----cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCC
Q 002410 757 AEEDLTH-----ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 831 (927)
Q Consensus 757 ~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 831 (927)
....... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...... ... .. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~---~~-~~~~- 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAI---FK-IGEN- 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHH---HH-Hhcc-
Confidence 6532111 111234788999999999888999999999999999999999999733211 111 11 1111
Q ss_pred eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 832 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 832 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..+.+ +......+.+++.+||+.+|++||++.||++
T Consensus 228 ----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ----ASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----CCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11111 1123347889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=309.04 Aligned_cols=240 Identities=25% Similarity=0.438 Sum_probs=190.3
Q ss_pred ccccccccEEEEEEEECC--------CcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 611 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~--------g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
+.||+|+||.||+|..+. ...+++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999998652 235888888765555567889999999999999999999999998899999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCc--------EEEeecccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--------AKVSDFGLS 754 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~--------~kL~DFGla 754 (927)
+++|+|.++++.. +..+++..++.++.||+.||+|||+ ++|+||||||+||+++.++. ++++|||.+
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999753 3468899999999999999999998 99999999999999987765 699999988
Q ss_pred ccccccccccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCC-CCCCcccccchhhHHHHHHHhhhcCCe
Q 002410 755 RQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAELNIVHWARSMIKKGDV 832 (927)
Q Consensus 755 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~-~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 832 (927)
...... ....++..|+|||++.+. .++.++|||||||++|||++|. .|+...+... ...... ....
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~~~~~---~~~~- 223 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQFYE---DRHQ- 223 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HHHHHH---cccc-
Confidence 654322 223478899999999764 5799999999999999999985 5554222111 111000 0000
Q ss_pred eeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 833 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 833 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
.+.....++.+++.+||+.+|++||+++|+++.|+
T Consensus 224 -----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 224 -----------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11111236889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=306.82 Aligned_cols=252 Identities=24% Similarity=0.369 Sum_probs=202.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
..|++.+.||.|++|.||+|... +++.+|+|.+........+.+.+|++++++++|+||+++++.+..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 35778899999999999999876 58899999997665666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++++|.+++... ...+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 85 DGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred CCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999998742 3568999999999999999999998 99999999999999999999999999988765432221
Q ss_pred cccccccCCCccCCCccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 764 ISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
.....++..|+|||.+. ...++.++||||||+++|||++|+.||...+... ... . +..+.......
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~----~-~~~~~~~~~~~- 230 (280)
T cd06611 160 -RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLL----K-ILKSEPPTLDQ- 230 (280)
T ss_pred -cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHH----H-HhcCCCCCcCC-
Confidence 22345788999999874 3456789999999999999999999997432211 111 1 11111111100
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+......+.+++.+||+.+|.+||+++++++.
T Consensus 231 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 231 ------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11123467899999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=305.49 Aligned_cols=250 Identities=24% Similarity=0.411 Sum_probs=196.0
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeeec------CceE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE------EHQR 676 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~------~~~~ 676 (927)
..|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +|+||+++++++.. ....
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 45667789999999999999876 58889999986543 3346788999999998 69999999999864 2468
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++||||+++++|.+++... ....+++..+..++.|++.||+|||+ ++|+|+||||+||++++++.++|+|||++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 8999999999999998753 24568899999999999999999998 8999999999999999999999999999876
Q ss_pred ccccccccccccccCCCccCCCccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCC
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 831 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 831 (927)
...... ......|+..|+|||++. +..++.++|||||||++|||++|+.||........ .. ......
T Consensus 161 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~---~~----~~~~~~ 232 (272)
T cd06637 161 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---LF----LIPRNP 232 (272)
T ss_pred cccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH---HH----HHhcCC
Confidence 543222 223345888999999985 34678899999999999999999999963221111 00 001111
Q ss_pred eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 832 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 832 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..... .......+.+++.+||..+|.+||+++|+++
T Consensus 233 ~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 APRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 10111 1112346889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=325.09 Aligned_cols=263 Identities=22% Similarity=0.250 Sum_probs=200.3
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC---CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~---~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~L 678 (927)
+....|++.+.||+|+||.||++... .++.||+|.+... +...+|++++++++||||+++++++......++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 34456788899999999999999764 3578999988643 235689999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
|||++. ++|.+++. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.++|+|||+++...
T Consensus 164 v~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 164 VMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred EehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 999995 68888885 35678999999999999999999998 999999999999999999999999999997654
Q ss_pred ccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCee--e-
Q 002410 759 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI--S- 834 (927)
Q Consensus 759 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~--~- 834 (927)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+...+...... .
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 43221 2223468999999999999999999999999999999999999997544332111111111111100000 0
Q ss_pred ----------eccccccCCCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 835 ----------IVDPVLIGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 835 ----------~~d~~l~~~~~-------~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.........+. ......+.+++.+||..||++||++.|++..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0112367789999999999999999999875
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=303.54 Aligned_cols=249 Identities=25% Similarity=0.408 Sum_probs=198.6
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCcc------chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC------SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~------~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
+.+.+.||+|+||.||+|...+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|+
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 34568899999999999998889999999886432 122356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 82 EFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999973 3467899999999999999999998 89999999999999999999999999998764321
Q ss_pred c-----cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 761 L-----THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 761 ~-----~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
. ........++..|+|||.+.+..++.++|||||||++|||++|+.||...+.... ... . ....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~~-~--~~~~~~~--- 227 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--MFY-I--GAHRGLM--- 227 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--HHH-h--hhccCCC---
Confidence 1 1112234578899999999988899999999999999999999999973322111 110 0 0000111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+.+. ......+.+++.+||+.+|++||++.|+++
T Consensus 228 --~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 --PRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --CCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 122346789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=315.47 Aligned_cols=256 Identities=21% Similarity=0.296 Sum_probs=193.9
Q ss_pred hccccccc--ccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 609 FCKKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 609 ~~~~LG~G--~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
+.++||+| +|++||++..+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78999999876 68999999987542 233456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++|+|.+++.... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999986432 3458999999999999999999998 99999999999999999999999999865443211110
Q ss_pred ------cccccccCCCccCCCccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 764 ------ISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 764 ------~~~~~~gt~~Y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ....... +.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~-----~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLN-----GTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhc-----CCcccc
Confidence 1112246778999999875 468899999999999999999999997332211 1111000 000000
Q ss_pred cc-------------------cc-----------------ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 836 VD-------------------PV-----------------LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 836 ~d-------------------~~-----------------l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.+ .. ............+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 00 000011123347889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=318.99 Aligned_cols=262 Identities=23% Similarity=0.280 Sum_probs=195.4
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCc------
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------ 674 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~------ 674 (927)
...|++.+.||+|+||.||++... +|+.||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 356777899999999999999875 5899999998653 2334567889999999999999999999886443
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccc
Q 002410 675 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 754 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 754 (927)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 57999999965 5666654 247888899999999999999998 99999999999999999999999999999
Q ss_pred ccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhh------------H---
Q 002410 755 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN------------I--- 819 (927)
Q Consensus 755 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~------------l--- 819 (927)
+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+...... .
T Consensus 171 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 171 RTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 7643321 1223457899999999999999999999999999999999999997543221100 0
Q ss_pred -HHHHHHhhhcCC-e-----eeecccccc---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 820 -VHWARSMIKKGD-V-----ISIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 820 -~~~~~~~~~~~~-~-----~~~~d~~l~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
............ . .+....... ..........+.+++.+||+.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000011110000 0 000000000 00011123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.20 Aligned_cols=247 Identities=29% Similarity=0.420 Sum_probs=201.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
.|++.+.||.|++|.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 4667789999999999999876 58899999987543 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++++|.+++.. ..+++..+..++.|++.||.|||+ ++++|+||+|+||++++++.++|+|||+++.......
T Consensus 82 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 82 GGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 99999999873 278999999999999999999998 9999999999999999999999999999987654322
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. .... .+..... +.+...
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~~~~----~~~~~~~-----~~~~~~ 221 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---RVLF----LIPKNNP-----PSLEGN 221 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---HHHH----HhhhcCC-----CCCccc
Confidence 122345788999999999888999999999999999999999999743311 1111 1111111 111111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.....+.+++.+||..+|++||+++++++
T Consensus 222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 02346789999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=306.95 Aligned_cols=258 Identities=26% Similarity=0.445 Sum_probs=205.5
Q ss_pred HHHHHhhcccccccccEEEEEEEECC-Cc----EEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMKD-GK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~~-g~----~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
....+++.+.||+|+||.||+|.+++ |+ .+|+|.+..... .....+.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 44566788999999999999998753 33 589998876543 345678999999999999999999999987 788
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++|+||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 9999999999999999753 3458999999999999999999998 9999999999999999999999999999987
Q ss_pred ccccccccc-cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 757 AEEDLTHIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 757 ~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
......... ....++..|+|||.+....++.++||||||+++||+++ |+.||...... .+.+ .+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~~ 231 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPD----LLEKGERLP 231 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHH----HHhCCCCCC
Confidence 653322211 11223568999999988889999999999999999999 99999743221 1222 111111100
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
.+ ......+.+++.+||..+|.+||++.++++.|+++.+
T Consensus 232 --~~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 232 --QP-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred --CC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 01 1122367899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.87 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=203.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.|++.+.||.|++|.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++..++..+++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 4567789999999999999876 578899999986655567889999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+++|.+++... ...+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........ .
T Consensus 84 ~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 84 GGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred CCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 99999998742 3568999999999999999999998 9999999999999999999999999999876543221 1
Q ss_pred ccccccCCCccCCCccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 765 SSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~---~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||....... ..... ..... ..+.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~~-----~~~~~---~~~~~- 226 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFLI-----SKSNF---PPPKL- 226 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH-----HhccC---CCccc-
Confidence 2234578899999998776 88999999999999999999999997433211 11111 11100 00011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.........+.+++.+|+..+|.+||++++|+.
T Consensus 227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 -KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112233457889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=303.74 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=190.1
Q ss_pred ccccccccEEEEEEEECC---CcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCC
Q 002410 611 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 686 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~---g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~g 686 (927)
+.||+|+||.||+|...+ ...+++|.+.... ......+.+|++.++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 469999999999997653 3468888876543 234467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc-c
Q 002410 687 TLRDRLHGSVN--QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-H 763 (927)
Q Consensus 687 sL~~~L~~~~~--~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~-~ 763 (927)
+|.+++..... ....++.....++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999975432 2335678889999999999999998 9999999999999999999999999999875432211 1
Q ss_pred cccccccCCCccCCCccC-------CCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 764 ISSVARGTVGYLDPEYYG-------NQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~-------~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
......++..|+|||++. ...++.++|||||||++|||++ |..||...... .. ....+.... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~---~~~~~~~~~-~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QV---LKQVVREQD-IKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HH---HHHHhhccC-ccC
Confidence 112233567899999874 2456889999999999999999 78888633211 11 111122111 112
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
.++.+. ......+.+++..|+ .||++||+++||++.|.
T Consensus 231 ~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222221 122345667888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=318.98 Aligned_cols=192 Identities=24% Similarity=0.334 Sum_probs=164.1
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
....|++.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++|+||+++++++...+..++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3345778899999999999999987 4678999985432 23569999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
++. ++|.+++.. ....+++..++.|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 995 688888864 34578999999999999999999998 899999999999999999999999999987533221
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 808 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf 808 (927)
......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 122345899999999999999999999999999999999965554
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.90 Aligned_cols=250 Identities=33% Similarity=0.556 Sum_probs=201.6
Q ss_pred hhcccccccccEEEEEEEECC-----CcEEEEEEccCccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 608 NFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~~-----g~~vAvK~l~~~~~~-~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.+.+.||+|+||.||++...+ +..||+|++...... ..+.+.+|+++++.++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 356889999999999998874 488999999765443 56789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++++|.+++.... ...+++.++..++.|++.||++||+ .+++|+||||+||+++.++.++|+|||+++......
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999997532 2228999999999999999999998 899999999999999999999999999998765442
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
........++..|+|||.+.+..++.++||||+|++++||++ |..||..... ....+.. ..+.....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~~~----- 225 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYL----KKGYRLPK----- 225 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----hcCCCCCC-----
Confidence 222222336789999999988889999999999999999998 7888863221 1222211 11111110
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 877 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L 877 (927)
.......+.+++.+|+..+|++|||+.|+++.|
T Consensus 226 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111334688999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=301.46 Aligned_cols=249 Identities=26% Similarity=0.397 Sum_probs=199.5
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeec-CceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-~~~~~LV~E~ 682 (927)
|++.+.||+|++|.||++..+ +++.||+|.+.... ....+.+.+|++++++++|+|++++++.+.. +...+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 567899999999999999876 57889999986432 2345678899999999999999999998764 4467899999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++++|.+++... ....+++.+++.++.|++.||++||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 82 CEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred cCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 9999999999753 24568999999999999999999998 9999999999999999999999999999876543222
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
......+++.|+|||.+.+..++.++||||||+++++|++|+.||...+.. ...... ..+....
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~-~~~~~~~-------- 221 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRI-IEGKLPP-------- 221 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHH-HhcCCCC--------
Confidence 223345788999999999999999999999999999999999999733221 111111 1111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
........+.+++.+|++.+|++||++.|+++.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 -MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111233468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=319.23 Aligned_cols=253 Identities=24% Similarity=0.305 Sum_probs=195.6
Q ss_pred HhhcccccccccEEEEEEEECC-CcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
|++.++||+|+||.||+++.+. ++.+|+|++.+.. ......+.+|+.++..++|+||+++++.+.+.+..++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 5567899999999999999874 7789999986421 22334588899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 83 YVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 9999999999742 3568899999999999999999998 9999999999999999999999999999876543333
Q ss_pred ccccccccCCCccCCCccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 763 HISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+ ............. +.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~-~p 230 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKERFQ-FP 230 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCcccc-CC
Confidence 3333456899999999985 3467899999999999999999999997433211 1111111111000 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 876 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPs~~eVl~~ 876 (927)
. . .......+.+++.+|+..++.+ |++++|+++.
T Consensus 231 ~-~----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 231 A-Q----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred C-c----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0 0112346778888988654444 7899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=324.92 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=194.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
+++.+.||+|+||.||+++.+ +++.||+|+++... ......+.+|+.++.+++|+||+++++.+.+++..++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 456789999999999999876 58899999987432 23346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 83 LPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 999999999973 4568999999999999999999998 9999999999999999999999999999875432110
Q ss_pred ----------------------------------ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 002410 763 ----------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 808 (927)
Q Consensus 763 ----------------------------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf 808 (927)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0011245899999999999999999999999999999999999999
Q ss_pred CcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 002410 809 SVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVLA 876 (927)
Q Consensus 809 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs---~~eVl~~ 876 (927)
........ ........... .+.+.. .....+.+++.+|+. +|++|++ ++|+++.
T Consensus 237 ~~~~~~~~------~~~i~~~~~~~-~~p~~~------~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETPQET------YRKVMNWKETL-VFPPEV------PISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHHH------HHHHHcCCCce-ecCCCC------CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 74332211 11111111000 011110 112356778888774 9999995 5665544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=323.51 Aligned_cols=275 Identities=22% Similarity=0.241 Sum_probs=211.4
Q ss_pred CcccccChhhHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcC-C-----Ccee
Q 002410 592 GVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-H-----RNLV 664 (927)
Q Consensus 592 ~~~~~~~~~el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-H-----pnIv 664 (927)
+..+.+-..|....+|.+.+.||+|.||.|-++... +++.||||++++. .....+-..|+.+|..|+ | -|+|
T Consensus 173 ~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~V 251 (586)
T KOG0667|consen 173 DGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIV 251 (586)
T ss_pred CCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEE
Confidence 333334444555558888999999999999999765 6999999999865 334566778999999997 4 4899
Q ss_pred eeeeeeecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC-
Q 002410 665 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN- 743 (927)
Q Consensus 665 ~l~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~- 743 (927)
+++++|...++.|||+|.+ .-+|+++|+... -..++...++.++.||+.||.+||+ .+|||+||||+||||.+.
T Consensus 252 rm~d~F~fr~HlciVfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~ 326 (586)
T KOG0667|consen 252 RMLDYFYFRNHLCIVFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPK 326 (586)
T ss_pred Eeeeccccccceeeeehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCC
Confidence 9999999999999999999 569999999763 5569999999999999999999998 999999999999999753
Q ss_pred -CcEEEeeccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHH
Q 002410 744 -MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 822 (927)
Q Consensus 744 -~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~ 822 (927)
..+||+|||.|+....... ....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+++..+....+..
T Consensus 327 r~~vKVIDFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e 402 (586)
T KOG0667|consen 327 RSRIKVIDFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIE 402 (586)
T ss_pred cCceeEEecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHH
Confidence 3699999999988654322 44578899999999999999999999999999999999999986654433322221
Q ss_pred HHHh---------------hhc-CCeee-e---------------------ccccccC--------CCCHHHHHHHHHHH
Q 002410 823 ARSM---------------IKK-GDVIS-I---------------------VDPVLIG--------NVKIESIWRIAEVA 856 (927)
Q Consensus 823 ~~~~---------------~~~-~~~~~-~---------------------~d~~l~~--------~~~~~~~~~l~~Li 856 (927)
+... ... ..... . .+..... ......-..+++++
T Consensus 403 ~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dfl 482 (586)
T KOG0667|consen 403 VLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFL 482 (586)
T ss_pred HhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHH
Confidence 1100 001 00000 0 0000000 01113345789999
Q ss_pred HHhhccCCCCCCCHHHHHHH
Q 002410 857 IQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 857 ~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.+||+.||.+|+|..|+++.
T Consensus 483 k~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 483 KRCLEWDPAERITPAQALNH 502 (586)
T ss_pred HHHhccCchhcCCHHHHhcC
Confidence 99999999999999999875
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=301.20 Aligned_cols=246 Identities=28% Similarity=0.396 Sum_probs=198.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-----chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
|+..+.||+|++|.||+|..+ +++.|++|.+.... ....+.+.+|++++++++|+||+++++++......++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 445688999999999999987 78999999986432 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 82 ELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999974 3468899999999999999999998 89999999999999999999999999998765433
Q ss_pred ccccccccccCCCccCCCccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||..... .... ...........
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~~~~----~~~~~~~~~~~----- 222 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--VAAV----FKIGRSKELPP----- 222 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--HHHH----HHHHhcccCCC-----
Confidence 2 122345788999999987766 89999999999999999999999973321 1111 11111011100
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.+......+.+++.+||+.+|.+||+++|+++
T Consensus 223 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 ----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11112346789999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=303.49 Aligned_cols=251 Identities=24% Similarity=0.416 Sum_probs=199.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc------chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC------SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~------~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
|+..+.||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 345688999999999999864 68999999986432 12346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC-cEEEeecccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAE 758 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla~~~~ 758 (927)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+ ++++|+||||+||+++.++ .+||+|||.+....
T Consensus 82 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 82 VEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999973 4568899999999999999999998 9999999999999998776 59999999987764
Q ss_pred ccccc---cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 759 EDLTH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 759 ~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
..... ......++..|+|||.+.+..++.++||||+|+++++|++|+.||............ ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~---- 228 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKIASATT---- 228 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---HHHhccCC----
Confidence 43211 122335788999999998888999999999999999999999999743332211111 11110000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
....+......+.+++.+|++.+|.+||++.|+++
T Consensus 229 -----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 -----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -----CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01112223357889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=319.16 Aligned_cols=253 Identities=23% Similarity=0.296 Sum_probs=196.5
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
|++.+.||+|+||.||+++.+ +++.||+|++.... ......+.+|..++..++|+||+++++++.+++..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 566789999999999999976 57889999986521 22345588899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 83 YVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999742 3568899999999999999999998 9999999999999999999999999999987654333
Q ss_pred ccccccccCCCccCCCccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 763 HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
.......|++.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+ ............. +.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~-~p 230 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEERFQ-FP 230 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCccc-CC
Confidence 33334568999999999865 467889999999999999999999997433211 1111111111000 01
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 876 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPs~~eVl~~ 876 (927)
+.. ......+.+++.+|+..++++ |++++++++.
T Consensus 231 ~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 231 SHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred Ccc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 111 112346788999999876544 5688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=300.67 Aligned_cols=249 Identities=22% Similarity=0.354 Sum_probs=202.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|++.+.||.|+||.||.++.. +++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 566789999999999999865 5889999987643 2344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++++|.+++.... ...+++.++..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 82 NGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred CCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999997542 4568999999999999999999998 8999999999999999999999999999887644332
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||...... +...... .+.....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~-~~~~~~~-------- 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIV-QGNYTPV-------- 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-cCCCCCC--------
Confidence 222345889999999998888899999999999999999999999743221 1111111 1211111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.......+.+++.+||+.+|++||+++|+++.
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 -VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11223468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=303.19 Aligned_cols=254 Identities=22% Similarity=0.372 Sum_probs=201.0
Q ss_pred HhhcccccccccEEEEEEEECC--CcEEEEEEccCc----------cchhHHHHHHHHHHHHh-cCCCceeeeeeeeecC
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADS----------CSHRTQQFVTEVALLSR-IHHRNLVPLIGYCEEE 673 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~--g~~vAvK~l~~~----------~~~~~~~~~~E~~~L~~-l~HpnIv~l~~~~~~~ 673 (927)
|.+.+.||+|+||.||+|.++. ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4567899999999999999875 688999987532 12234567789888875 6999999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecc
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 752 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 752 (927)
+..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+ ..+++|+||+|+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEeccc
Confidence 99999999999999999875422 34568999999999999999999995 3689999999999999999999999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCe
Q 002410 753 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832 (927)
Q Consensus 753 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 832 (927)
++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... .... . +..+..
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~~~---~-~~~~~~ 230 (269)
T cd08528 160 LAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SLAT---K-IVEAVY 230 (269)
T ss_pred ceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HHHH---H-HhhccC
Confidence 998754432 223345788999999999888999999999999999999999999633221 1111 1 111111
Q ss_pred eeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 833 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 833 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
....+ ......+.+++.+||+.||++||++.|+.+++++
T Consensus 231 ~~~~~--------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 EPLPE--------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CcCCc--------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11100 1123468899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=325.90 Aligned_cols=259 Identities=21% Similarity=0.255 Sum_probs=193.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.|.+.+.||+|+||.||+|.+. .++.||||... ...+.+|+++|++++|+||+++++++..++..++|||++.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 3556789999999999999987 47889999643 2345789999999999999999999999999999999995
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc-
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH- 763 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~- 763 (927)
++|.+++... ...+++.+++.|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 244 -~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 244 -SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred -CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 7888888642 3469999999999999999999998 99999999999999999999999999999865432221
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc-----chhhHHHHHHHhhhc-CCeeeecc
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-----AELNIVHWARSMIKK-GDVISIVD 837 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~-----~~~~l~~~~~~~~~~-~~~~~~~d 837 (927)
......||..|+|||++.+..++.++|||||||++|||++|..|+...... ....+.+.++..... ........
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 122345899999999999999999999999999999999988765322111 111122222111000 00000000
Q ss_pred ccc------------cCCCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 838 PVL------------IGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 838 ~~l------------~~~~~-------~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
..+ ..... ......+.+|+.+||+.||++|||+.|+++.
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 00000 0111257899999999999999999999874
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=301.87 Aligned_cols=247 Identities=30% Similarity=0.486 Sum_probs=198.6
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
..+++.+.||+|+||.||++.. .++.||+|.++... ..+.+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4577889999999999999975 57889999986532 346788999999999999999999998765 4789999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~-- 155 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-- 155 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccCC--
Confidence 99999999754 24468899999999999999999998 9999999999999999999999999999876432211
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
....+..|+|||.+.+..++.++|||||||++|||++ |+.||......+ ..+ .+..+.....
T Consensus 156 --~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~~~~~-------- 218 (254)
T cd05083 156 --NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---VKE----CVEKGYRMEP-------- 218 (254)
T ss_pred --CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---HHH----HHhCCCCCCC--------
Confidence 1224568999999988899999999999999999998 999987433211 111 1111111110
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
....+..+.+++.+||+.+|++||+++++++.|++
T Consensus 219 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 -PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11223467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=307.17 Aligned_cols=261 Identities=23% Similarity=0.298 Sum_probs=201.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|++.+.||+|++|.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 567789999999999999976 68999999987543 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
+++|.+++... ...+++.+++.++.||++||+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 82 -~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 82 -PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred -CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99999998753 3668999999999999999999998 89999999999999999999999999999876543322
Q ss_pred cccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCC-----------
Q 002410 764 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD----------- 831 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~----------- 831 (927)
......++..|+|||.+.+. .++.++||||+|+++|||++|.+||....... .............
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCcc
Confidence 22334588899999998654 46899999999999999999988886433211 1111111110000
Q ss_pred -eeeeccccc----cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 832 -VISIVDPVL----IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 832 -~~~~~d~~l----~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
...+..+.. ......+....+.+++.+||+.+|++||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 000011223678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=307.96 Aligned_cols=264 Identities=20% Similarity=0.248 Sum_probs=201.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
.|++.+.||+|++|.||+|..+ +++.||+|+++... ....+.+.+|++++++++|+||+++++++..++..++|+||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 3567889999999999999987 58899999987532 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
++++.+..+.. ....+++.++..++.||+.||+|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 82 VERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99877776655 24558999999999999999999998 8999999999999999999999999999987655433
Q ss_pred ccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh--------h-hcCCe
Q 002410 763 HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM--------I-KKGDV 832 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~--------~-~~~~~ 832 (927)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+........... . .....
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 223334578899999999887 8899999999999999999999999744322111110000000 0 00000
Q ss_pred -----eeeccccc-cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 833 -----ISIVDPVL-IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 833 -----~~~~d~~l-~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
....++.. ...+......++.+++.+||..+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000 00111122567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=309.55 Aligned_cols=259 Identities=28% Similarity=0.460 Sum_probs=201.9
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCc----EEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~----~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
...++..+.||+|+||.||+|.+. +|+ .||+|.+..... .....+.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 344556789999999999999875 343 578998875433 3345788999999999999999999998754 467
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+++||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccc
Confidence 999999999999998743 3468899999999999999999998 99999999999999999999999999999875
Q ss_pred ccccccc-ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 758 EEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 758 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
....... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ....+++ ..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~~~~~- 231 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDLL----EKGERLP- 231 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HCCCCCC-
Confidence 4322211 112235678999999998899999999999999999998 9999864322 1122222 1111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
.+ ......+.+++.+|+..+|++||+++|+++.|+++...+
T Consensus 232 -~~-------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 232 -QP-------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred -CC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 00 112246789999999999999999999999999875543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=301.57 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=189.9
Q ss_pred ccccccccEEEEEEEECCC---cEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCC
Q 002410 611 KKIGKGSFGSVYYGKMKDG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 686 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g---~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~g 686 (927)
++||+|+||.||+|+..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999976543 346677765433 334578999999999999999999999999999999999999999
Q ss_pred CHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc-cccc
Q 002410 687 TLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHI 764 (927)
Q Consensus 687 sL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~-~~~~ 764 (927)
+|.++++... .....++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997542 22456777888999999999999998 89999999999999999999999999998643211 1111
Q ss_pred ccccccCCCccCCCccCC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 765 SSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~-------~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||..... ... ....+.+ ......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~---~~~~~~~-~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REV---LNHVIKD-QQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHH---HHHHHhh-cccccC
Confidence 223457889999998753 245789999999999999997 5667753221 111 1111211 222233
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
++.+...+ ...+.+++..|+ .+|++||+++||++.|.
T Consensus 231 ~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33332222 236778899999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=317.97 Aligned_cols=261 Identities=22% Similarity=0.297 Sum_probs=196.3
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecC------ce
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 675 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------~~ 675 (927)
..|++.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 46777899999999999999875 58899999987532 33456788999999999999999999987543 35
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
.++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred eEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 7899999965 6776664 247888999999999999999998 999999999999999999999999999998
Q ss_pred cccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhH-HH-------------
Q 002410 756 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI-VH------------- 821 (927)
Q Consensus 756 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l-~~------------- 821 (927)
...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...+..+.... ..
T Consensus 168 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 168 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 654322 12234589999999999998999999999999999999999999975443211110 00
Q ss_pred --HHHHhhhcC-Ceeeeccccc-----c---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 822 --WARSMIKKG-DVISIVDPVL-----I---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 822 --~~~~~~~~~-~~~~~~d~~l-----~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
......... .......+.. . ..........+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000011000 0000000000 0 00111123467899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=310.96 Aligned_cols=196 Identities=26% Similarity=0.388 Sum_probs=160.1
Q ss_pred cccccccccEEEEEEEECC---CcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeee--cCceEEEEEEecC
Q 002410 610 CKKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQRILVYEYMH 684 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~~---g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~--~~~~~~LV~E~~~ 684 (927)
..+||+|+||.||+|+.++ ++.||+|.+.... ....+.+|++++++++||||+++++++. .+...++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3579999999999998763 5789999987542 2345788999999999999999999884 4567889999986
Q ss_pred CCCHHHHhccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc----cCCCcEEEeecccc
Q 002410 685 NGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLS 754 (927)
Q Consensus 685 ~gsL~~~L~~~~------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl----d~~~~~kL~DFGla 754 (927)
++|.+++.... ....+++..+..++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 57877764321 23358899999999999999999998 999999999999999 56678999999999
Q ss_pred ccccccccc--cccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 002410 755 RQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVE 811 (927)
Q Consensus 755 ~~~~~~~~~--~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~ 811 (927)
+........ ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876443221 1223457899999999876 45899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=306.53 Aligned_cols=262 Identities=23% Similarity=0.282 Sum_probs=198.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|++.+.||+|++|.||+|..+ +|+.||+|++.... ....+.+.+|++++++++|+|++++++++......++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 566789999999999999987 58999999986432 223456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
+++.|..++. ....+++..++.++.|++.||+|||+ ++++||||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 83 DHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred CccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 9998888776 24468999999999999999999998 9999999999999999999999999999987644321
Q ss_pred cccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhh-HHHHHHHhhh-------cCCe-e
Q 002410 764 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHWARSMIK-------KGDV-I 833 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~-l~~~~~~~~~-------~~~~-~ 833 (927)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+... +......... .... .
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 1122346789999999865 567899999999999999999999997443322111 1110000000 0000 0
Q ss_pred eeccccccCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 834 SIVDPVLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 834 ~~~d~~l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
....+....... ......+.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000011000000 112346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=309.18 Aligned_cols=245 Identities=26% Similarity=0.395 Sum_probs=198.2
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCH
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 688 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL 688 (927)
...||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999875 6899999998755445566788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccccccc
Q 002410 689 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 768 (927)
Q Consensus 689 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 768 (927)
.+++. ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........ .....
T Consensus 106 ~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~ 177 (297)
T cd06659 106 TDIVS----QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSL 177 (297)
T ss_pred HHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccce
Confidence 99875 3458899999999999999999998 8999999999999999999999999999876543322 12234
Q ss_pred ccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHH
Q 002410 769 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 848 (927)
Q Consensus 769 ~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 848 (927)
.++..|+|||.+.+..++.++|||||||++|||++|+.||...+... ...... ...... .. .....
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~~~----~~~~~~-----~~--~~~~~ 243 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKRLR----DSPPPK-----LK--NAHKI 243 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHh----ccCCCC-----cc--ccCCC
Confidence 58899999999998889999999999999999999999997432211 111111 111000 00 00112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 849 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 849 ~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
...+.+++.+|++.+|++||+++|+++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 2367899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.46 Aligned_cols=263 Identities=23% Similarity=0.333 Sum_probs=198.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
+|++.++||+|++|.||+|.++ +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 3556789999999999999987 589999999865322 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++++|.++... ...+++.+++.++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 82 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 82 VDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred CCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999999887763 3458999999999999999999998 8999999999999999999999999999887544322
Q ss_pred ccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchh-hHHHHHHH-------hhhcCCee
Q 002410 763 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARS-------MIKKGDVI 833 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~-~l~~~~~~-------~~~~~~~~ 833 (927)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. .+..+... ........
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 1222347889999999865 45788999999999999999999999743321110 11110000 00000000
Q ss_pred -eeccccccC-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 834 -SIVDPVLIG-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 834 -~~~d~~l~~-----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
....+.... .........+.+++.+||+.+|++||+++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000 001123457889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=318.63 Aligned_cols=261 Identities=22% Similarity=0.289 Sum_probs=195.7
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecC------ce
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 675 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------~~ 675 (927)
..|.+.+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 45777899999999999999876 58899999987532 33456788999999999999999999987543 35
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
.++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred EEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 7999999964 7777765 247888999999999999999998 999999999999999999999999999998
Q ss_pred cccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHH-H-------------
Q 002410 756 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-H------------- 821 (927)
Q Consensus 756 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~-~------------- 821 (927)
...... ......++..|+|||++.+..++.++|||||||++|||++|+.||...+..+..... .
T Consensus 175 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 175 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 654322 122345899999999999999999999999999999999999999754432111100 0
Q ss_pred --HHHHhhhcCC-eeee----cccccc----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 822 --WARSMIKKGD-VISI----VDPVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 822 --~~~~~~~~~~-~~~~----~d~~l~----~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.......... .... ..+... ..........+.+++.+||+.||.+|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000 0000 000000 00011123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=319.26 Aligned_cols=240 Identities=27% Similarity=0.310 Sum_probs=186.6
Q ss_pred ccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHhc---CCCceeeeeeeeecCceEEEEEEecCC
Q 002410 613 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI---HHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 613 LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l---~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
||+|+||+||+|+.+ +++.||||++..... .....+..|..++.+. +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999876 589999999864321 2234455677777665 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
|+|.+++.. ...+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~ 153 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TT 153 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Cc
Confidence 999999873 5678999999999999999999998 9999999999999999999999999999876432221 12
Q ss_pred cccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCC
Q 002410 766 SVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 844 (927)
....||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+... . . ..+..+.. .+...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~---~---~-~~i~~~~~------~~~~~- 219 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ---M---Y-RNIAFGKV------RFPKN- 219 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH---H---H-HHHHcCCC------CCCCc-
Confidence 334589999999998654 57999999999999999999999997433211 1 1 11111111 01000
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 002410 845 KIESIWRIAEVAIQCVEQRGFSRPK----MQEIVL 875 (927)
Q Consensus 845 ~~~~~~~l~~Li~~Cl~~dP~~RPs----~~eVl~ 875 (927)
.....+.+++.+||+.||++||+ +.|+++
T Consensus 220 --~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 --VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11236779999999999999994 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=306.32 Aligned_cols=245 Identities=27% Similarity=0.388 Sum_probs=198.4
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCH
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 688 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL 688 (927)
...||+|+||.||++... +++.||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 467999999999999875 5889999998765555667789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccccccc
Q 002410 689 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 768 (927)
Q Consensus 689 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 768 (927)
.+++. ...+++.++..++.||+.||+|||+ ++|+||||||+||++++++.++|+|||++......... ....
T Consensus 107 ~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~ 178 (292)
T cd06658 107 TDIVT----HTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSL 178 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Ccee
Confidence 99885 2358899999999999999999998 89999999999999999999999999998765433221 2234
Q ss_pred ccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHH
Q 002410 769 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 848 (927)
Q Consensus 769 ~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 848 (927)
.++..|+|||.+.+..++.++||||||+++|||++|+.||...+... ....+... ..+.+.. ....
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~~~---------~~~~~~~--~~~~ 244 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMRRIRDN---------LPPRVKD--SHKV 244 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhc---------CCCcccc--cccc
Confidence 57889999999988889999999999999999999999997432211 11111110 1111111 0112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 849 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 849 ~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
...+.+++.+|+..||++|||++|+++.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 2367789999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=330.75 Aligned_cols=261 Identities=19% Similarity=0.278 Sum_probs=190.5
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCC------CceeeeeeeeecC-ce
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH------RNLVPLIGYCEEE-HQ 675 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~H------pnIv~l~~~~~~~-~~ 675 (927)
...|++.++||+|+||+||+|... .++.||||+++... ...+.+..|+++++.++| .+++++++++..+ ++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 345777899999999999999876 57889999986532 233455667887777754 4588898888654 57
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC-----------
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----------- 744 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~----------- 744 (927)
.++|||++ +++|.+++.. ...+++..+..|+.||+.||+|||+ +.+|+||||||+|||++.++
T Consensus 207 ~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 207 MCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred EEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccccccc
Confidence 88999988 7789888873 4578999999999999999999996 25999999999999998765
Q ss_pred -----cEEEeeccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhH
Q 002410 745 -----RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 819 (927)
Q Consensus 745 -----~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l 819 (927)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 499999998764322 12345689999999999999999999999999999999999999975443222221
Q ss_pred HHHHHH-----------------hhh-cCCeeeecccccc----CCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 002410 820 VHWARS-----------------MIK-KGDVISIVDPVLI----GNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIV 874 (927)
Q Consensus 820 ~~~~~~-----------------~~~-~~~~~~~~d~~l~----~~~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl 874 (927)
...... ... .+......++... ... .......+.+|+.+||+.||++|||++|++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 111100 000 0000000000000 000 001123577999999999999999999998
Q ss_pred H
Q 002410 875 L 875 (927)
Q Consensus 875 ~ 875 (927)
+
T Consensus 437 ~ 437 (467)
T PTZ00284 437 T 437 (467)
T ss_pred c
Confidence 7
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=299.52 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=201.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|++.+.||+|+||.||++... +|+.||+|.+... .....+++.+|++++++++||||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 566789999999999999875 6889999998643 2334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++++|.+++... ....+++.+++.++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 82 EGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 999999998743 23457899999999999999999998 89999999999999999999999999999765443221
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
.....|+..|+|||.+.+...+.++|||||||++++|++|+.||...+.. +....... +....
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~-~~~~~--------- 220 (256)
T cd08218 158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKIIR-GSYPP--------- 220 (256)
T ss_pred -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHhc-CCCCC---------
Confidence 22334788999999999888999999999999999999999999733221 11111111 11111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
........+.+++.+|++.+|.+||+++||++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11122346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=299.40 Aligned_cols=253 Identities=27% Similarity=0.394 Sum_probs=201.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeec--CceEEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYE 681 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~~~~LV~E 681 (927)
|++.+.||.|++|.||++... +++.+|+|.+... .....+++.+|++++++++|+||+++++++.. +...+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 456788999999999999875 6789999998643 23445678899999999999999999997753 456789999
Q ss_pred ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 682 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC--NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~--~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
|+++++|.+++.... ....+++..++.++.||+.||+|||..+ ..+++|+||||+||+++.++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 999999999987532 2467899999999999999999999321 2899999999999999999999999999998765
Q ss_pred ccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 759 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 759 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
..... .....++..|+|||.+.+..++.++||||||+++++|++|+.||...+. ..+.+ .+..+...
T Consensus 162 ~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~----~~~~~~~~----- 228 (265)
T cd08217 162 HDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLAS----KIKEGKFR----- 228 (265)
T ss_pred CCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHH----HHhcCCCC-----
Confidence 43321 2233578999999999988899999999999999999999999974431 11111 12222111
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
..+......+.+++.+|++.+|++||+++||++.
T Consensus 229 ----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 ----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1112234578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=306.65 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=194.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|++.+.||+|++|.||+|+.. +|+.||+|.++.... .....+.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 456789999999999999986 689999999864322 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
+ ++|.+++... ...+++..++.++.||++||+|||+ ++++||||||+||+++.++.+||+|||+++........
T Consensus 82 ~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 82 D-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred C-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 7 5888877642 4568999999999999999999998 99999999999999999999999999998865432221
Q ss_pred cccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCC------eeeec
Q 002410 764 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD------VISIV 836 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~------~~~~~ 836 (927)
.....++..|+|||.+.+. .++.++|||||||++|||+||+.|+...... .. ..+.......... .....
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DD-QLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-HH-HHHHHHHHhCCCChHHhHHhhhcc
Confidence 1223468899999988664 4789999999999999999999986422211 11 1111111110000 00000
Q ss_pred c----ccccC-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 837 D----PVLIG-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 837 d----~~l~~-----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+ +.... .........+.+++.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 00000 011122346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=304.24 Aligned_cols=246 Identities=22% Similarity=0.346 Sum_probs=205.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
-|.+.+.||+|.|+.|-+|++- .|..||||++.+..-. ....+.+|++.|+.++|||||++|.+......+|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3556688999999999999875 7999999999765433 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc-cCCCcEEEeeccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl-d~~~~~kL~DFGla~~~~~~~ 761 (927)
-++|+|+++|.+. ...+.+....+++.||+.|+.|+|+ ..+|||||||+||.+ ..-|-+||+|||++-.+.+..
T Consensus 99 GD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred cCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999999864 5679999999999999999999998 999999999999876 567899999999998776543
Q ss_pred cccccccccCCCccCCCccCCCCCC-cchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
. -...+|+..|-|||++.+..|. ++.|||||||+||-|++|+.||+.....+... -++|-..
T Consensus 174 k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDCKY 236 (864)
T KOG4717|consen 174 K--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDCKY 236 (864)
T ss_pred h--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhcccc
Confidence 3 3345699999999999998875 68999999999999999999998444333221 1222211
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..+.....++.+||..||..||++|.+.+||+.
T Consensus 237 --tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 --TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 123344568899999999999999999999874
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=302.45 Aligned_cols=248 Identities=28% Similarity=0.428 Sum_probs=201.1
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
..+.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45667789999999999999875 68899999976432 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999999863 458899999999999999999998 9999999999999999999999999999876543221
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
......++..|+|||.+.+...+.++|||||||++|+|++|..||..... ..... .+..+.. +.+
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~----~~~~~~~-----~~~-- 221 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLF----LIPKNNP-----PTL-- 221 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHH----HHhcCCC-----CCC--
Confidence 12223578899999999888889999999999999999999999963221 11111 1111111 111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.......+.+++.+|++.+|.+||+++++++.
T Consensus 222 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 --EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11223467899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=304.39 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=195.9
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeee-----cCceEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCE-----EEHQRI 677 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~-----~~~~~~ 677 (927)
.+|++.+.||+|+||.||+|... +++.+|+|++... .....++.+|+.+++++ +||||+++++++. .++..+
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 96 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW 96 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence 35567789999999999999876 5789999987643 22346688899999999 6999999999873 445789
Q ss_pred EEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
+||||+++++|.+++.... ....+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 173 (286)
T cd06638 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173 (286)
T ss_pred EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceee
Confidence 9999999999999876432 34568899999999999999999998 8999999999999999999999999999876
Q ss_pred ccccccccccccccCCCccCCCccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCC
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 831 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 831 (927)
...... ......|+..|+|||++.. ..++.++||||+||++|||++|+.||....... .+.. .....
T Consensus 174 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~-----~~~~~ 245 (286)
T cd06638 174 LTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALFK-----IPRNP 245 (286)
T ss_pred cccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhh-----ccccC
Confidence 543221 1223458899999998853 457889999999999999999999997332211 1111 00111
Q ss_pred eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 832 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 832 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.....++. .....+.+++.+||+.+|++||+++||++.
T Consensus 246 ~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 246 PPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 11111111 112368899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=299.57 Aligned_cols=254 Identities=26% Similarity=0.369 Sum_probs=203.2
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
|++.+.||.|++|+||+|... ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|+|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 567889999999999999865 57899999986532 3356789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc-
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH- 763 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~- 763 (927)
+++|.++++.......+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999754334568999999999999999999998 99999999999999999999999999998775543222
Q ss_pred --cccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 764 --ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 764 --~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
......++..|+|||.+... .++.++|+|||||++|||++|+.||....... .... ..... .+.+
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~----~~~~~------~~~~ 227 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLML----TLQND------PPSL 227 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHH----HhcCC------CCCc
Confidence 22334578899999998776 78999999999999999999999997332211 1111 11110 0111
Q ss_pred cCCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 841 IGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 841 ~~~~-~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.... .......+.+++.+|++.||++||+++||++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1100 1123457889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=299.73 Aligned_cols=252 Identities=28% Similarity=0.382 Sum_probs=203.0
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
+++.+.||+|++|.||++..+ +++.+|+|.+.... ....+++.+|++++++++||||+++++.+..++..++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 456789999999999999987 58999999987653 3445678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+++|.+++... ...+++..+..++.|++.||+|||+ ..+++|+||||+||++++++.++|+|||.+.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 83 GGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred CCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 99999999753 2678899999999999999999996 379999999999999999999999999998765432221
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 844 (927)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. .....+..+...... . +.+...
T Consensus 158 --~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~-~-----~~~~~~- 227 (265)
T cd06605 158 --TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEP-P-----PRLPSG- 227 (265)
T ss_pred --cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCC-C-----CCCChh-
Confidence 145788999999999889999999999999999999999999743221 112222222222111 1 111100
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 845 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 845 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.....+.+++.+||..+|++||++.|+++
T Consensus 228 --~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 228 --KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred --hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 13346889999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=301.29 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=192.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-----chhHHHHHHHHHHHHhcCCCceeeeeeeeec--CceEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRIL 678 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~~~~L 678 (927)
|...+.||+|+||.||+|... +++.|++|++.... ......+.+|+.++++++||||+++++++.+ ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 445789999999999999875 58899999886421 2234578899999999999999999998865 356789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
++||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 84 FMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999999973 3468899999999999999999998 999999999999999999999999999987653
Q ss_pred cccc--ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 759 EDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 759 ~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
.... .......++..|+|||.+.+..++.++|||||||++|||++|+.||...+.. ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~~----- 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQPT----- 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCCC-----
Confidence 3211 1112234788999999999888999999999999999999999999733211 11111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.+.+ +......+.+++ +|+..+|++||+++||++
T Consensus 227 ~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1111 112223455666 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=297.77 Aligned_cols=250 Identities=29% Similarity=0.435 Sum_probs=200.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|...+.||+|++|.||+|... +++.|++|.++.... ...+.+.+|++++++++|+||+++++.+...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 456789999999999999876 688999999876543 35678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 82 SGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999973 4457889999999999999999998 99999999999999999999999999998876543332
Q ss_pred ccc---ccccCCCccCCCccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 764 ISS---VARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 764 ~~~---~~~gt~~Y~APE~l~~~~---~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
... ...++..|+|||.+.+.. .+.++||||||+++|||++|+.||...+.. ...... +..+. .
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~~~----~~~~~-----~ 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFH----VGAGH-----K 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHHHH----HhcCC-----C
Confidence 221 245788999999998766 889999999999999999999999733211 111111 11111 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+.+.. .......+.+++.+||+.+|++||++.|++.
T Consensus 225 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11110 0111346779999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=312.80 Aligned_cols=257 Identities=22% Similarity=0.322 Sum_probs=193.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecC------ce
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 675 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------~~ 675 (927)
..|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 45777899999999999999875 688999999875322 2345678899999999999999999987533 35
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
.++++|++ +++|.+++. ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 95 VYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred EEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccce
Confidence 68999988 789988876 3468999999999999999999998 999999999999999999999999999998
Q ss_pred cccccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCC---
Q 002410 756 QAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD--- 831 (927)
Q Consensus 756 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~--- 831 (927)
...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+.... +.. .........
T Consensus 167 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~ 239 (343)
T cd07878 167 QADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKR-IMEVVGTPSPEV 239 (343)
T ss_pred ecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHH-HHHHhCCCCHHH
Confidence 754322 23458899999999876 5789999999999999999999999974332111 111 100000000
Q ss_pred --------eeeecc--ccccC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 832 --------VISIVD--PVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 832 --------~~~~~d--~~l~~----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
...... +.... .........+.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00000 0000111246799999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=336.67 Aligned_cols=257 Identities=23% Similarity=0.356 Sum_probs=197.9
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeec--Cce
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQ 675 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~~ 675 (927)
+.....|.+.+.||+|+||+||+|... .++.||+|++... .......+..|+.++++++||||+++++++.+ ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 444456788899999999999999987 4778999988643 23345678999999999999999999998754 456
Q ss_pred EEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEecCCCCCcccccC--------
Q 002410 676 RILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC----NPGIIHRDVKSSNILLDI-------- 742 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~----~~~ivH~DLkp~NILld~-------- 742 (927)
.++||||+++|+|.++|.... ....+++..++.|+.||+.||+|||+.. .++|+||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999997532 2356999999999999999999999722 145999999999999964
Q ss_pred ---------CCcEEEeeccccccccccccccccccccCCCccCCCccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 002410 743 ---------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVE 811 (927)
Q Consensus 743 ---------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~~~ 811 (927)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2358999999998754322 1233468999999999854 45889999999999999999999999733
Q ss_pred cccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 812 DFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 812 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.. ...+. . .+...... .+ . .....+.+||..||+.+|.+||++.|+++
T Consensus 247 ~~--~~qli---~-~lk~~p~l-----pi-~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NN--FSQLI---S-ELKRGPDL-----PI-K----GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred Cc--HHHHH---H-HHhcCCCC-----Cc-C----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 21 11111 1 11111100 00 0 11246889999999999999999999984
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=300.67 Aligned_cols=254 Identities=28% Similarity=0.426 Sum_probs=197.6
Q ss_pred hhcccccccccEEEEEEEEC----CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCc------e
Q 002410 608 NFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------Q 675 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~----~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~------~ 675 (927)
.+.+.||+|+||.||+|.+. .++.||||++.... ....+++.+|++++++++||||+++++++...+ .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 45688999999999999864 36889999987542 334567899999999999999999999885432 2
Q ss_pred EEEEEEecCCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecc
Q 002410 676 RILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 752 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 752 (927)
.++++||+++|+|.+++.... ....+++..+++++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence 478899999999998875322 22357889999999999999999998 899999999999999999999999999
Q ss_pred ccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcC
Q 002410 753 LSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 830 (927)
Q Consensus 753 la~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 830 (927)
+++........ ......++..|++||.+.+..++.++|||||||++|||++ |+.||...+. ..+..+.. .+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~----~~ 231 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI----KG 231 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH----cC
Confidence 98865432211 1122235678999999988889999999999999999999 8888863322 12222111 11
Q ss_pred CeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 831 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 831 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
.... ........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 232 ~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1100 0112234788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=305.35 Aligned_cols=261 Identities=22% Similarity=0.317 Sum_probs=195.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
.|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++.+++..++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 4566789999999999999876 689999999865332 22345778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
+ ++|.+++... ...+++..+..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~-~~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 86 D-TDLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred C-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 7 4999988743 3468899999999999999999998 99999999999999999999999999998754322111
Q ss_pred cccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc---CCeee-----
Q 002410 764 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVIS----- 834 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~---~~~~~----- 834 (927)
.....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||....... ............ .....
T Consensus 160 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 160 -YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred -ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhcc
Confidence 122236788999998865 467899999999999999999999996443111 111111110000 00000
Q ss_pred --------ec-cccccCCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 835 --------IV-DPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 835 --------~~-d~~l~~~~-~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.. ...+.... .......+.+++.+||+.+|++||+++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 00000000 0111246789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=305.91 Aligned_cols=260 Identities=20% Similarity=0.238 Sum_probs=198.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccch-----hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~-----~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
|++.+.||+|++|.||+|... +++.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 456788999999999999876 6899999999754322 3456778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+ +|+|.+++... ...+++..++.++.||++||+|||+ ++++|+||||+||+++.++.++|+|||+++.....
T Consensus 82 e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 82 EFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred ccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 999 89999999743 2378999999999999999999998 99999999999999999999999999999876543
Q ss_pred ccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc---------C
Q 002410 761 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---------G 830 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~---------~ 830 (927)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|..||......+. +.. ....... .
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGK-IFEALGTPTEENWPGVT 231 (298)
T ss_pred Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHH-HHHHcCCCchhhhhhcc
Confidence 221 122346788999998854 4678999999999999999999888764332111 111 1110000 0
Q ss_pred CeeeeccccccCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 831 DVISIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 831 ~~~~~~d~~l~~~-----~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
............. ........+.+++.+||+.+|++||+++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000 111224578899999999999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=305.67 Aligned_cols=254 Identities=23% Similarity=0.285 Sum_probs=199.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
|++.+.||+|+||.||++... .++.|++|.+..... ...+.+.+|+++++.++||||+++++.+..++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 456789999999999999987 478999999875432 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc-
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 761 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~- 761 (927)
+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 83 VEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999974 4568999999999999999999998 899999999999999999999999999986421100
Q ss_pred -------------cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhh
Q 002410 762 -------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 828 (927)
Q Consensus 762 -------------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 828 (927)
........++..|+|||.+.+..++.++|||||||++|||++|..||...... +.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~~ 230 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVIS 230 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh
Confidence 00111234678999999998888999999999999999999999999743221 11111111
Q ss_pred cCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 829 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 829 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
+... .+... ......+.+++.+|++.+|++||++.++.+.|+.-
T Consensus 231 -~~~~---~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 231 -DDIE---WPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred -cccC---CCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 1110 01100 01234678999999999999999987777777654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=309.39 Aligned_cols=250 Identities=26% Similarity=0.331 Sum_probs=198.8
Q ss_pred HhhcccccccccEEEEEEEECC-CcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
|++.+.||+|++|.||+|...+ ++.||+|.+..... ...+.+.+|++++++++|+||+++++.+.+.+..++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 4567899999999999998874 89999999875432 2456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++++|.+++... ....+++..+..++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 83 CPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred cCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999999998743 34578999999999999999999998 9999999999999999999999999999876432211
Q ss_pred c----------------------------cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 002410 763 H----------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 814 (927)
Q Consensus 763 ~----------------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~ 814 (927)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 011235788999999999888999999999999999999999999744321
Q ss_pred chhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 002410 815 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK----MQEIVL 875 (927)
Q Consensus 815 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs----~~eVl~ 875 (927)
. .+.. ... .... .. ........+.+++.+||+.+|++||+ ++|+++
T Consensus 239 ~--~~~~----~~~-~~~~------~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 E--TFSN----ILK-KEVT------FP--GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred H--HHHH----Hhc-CCcc------CC--CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 1111 111 1100 00 01113457899999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=300.21 Aligned_cols=252 Identities=25% Similarity=0.417 Sum_probs=196.5
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCccc----------hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 608 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS----------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~----------~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
...+.||+|++|.||+|... +|+.||+|.++.... ...+.+.+|+.++++++|+|++++++++...+..
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 34678999999999999865 689999998753211 1134678899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++|+||+++++|.++++. ...+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred EEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999974 3578999999999999999999998 8999999999999999999999999999876
Q ss_pred cccccccc-ccccccCCCccCCCccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCee
Q 002410 757 AEEDLTHI-SSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 833 (927)
Q Consensus 757 ~~~~~~~~-~~~~~gt~~Y~APE~l~~~~--~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 833 (927)
........ .....++..|+|||.+.... ++.++||||||+++|||++|..||....... ... .... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~----~~~~-~~~~ 230 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMF----KLGN-KRSA 230 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHH----Hhhc-cccC
Confidence 54322111 22334788999999987654 7899999999999999999999996322111 111 1111 1111
Q ss_pred eeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 834 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 834 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
..+... ........+.+++.+|+..+|++||+++||++.
T Consensus 231 ~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 PPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111 111234578899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=295.79 Aligned_cols=248 Identities=26% Similarity=0.387 Sum_probs=199.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|++.+.||+|++|.||++... +++.+|+|.+... .....+.+.+|++++++++|||++++++.+..++..++|+||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 556789999999999999875 6889999998653 2334577899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC-CcEEEeecccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFGla~~~~~~~~ 762 (927)
++++|.+++... ....+++..+..++.|++.||+|||+ ++++|+||||+||+++.+ +.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 82 PGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 999999999753 24568999999999999999999998 999999999999999855 4689999999987644321
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. .... .... +....+
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~---~~~~-~~~~~~------- 221 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVL---KIMS-GTFAPI------- 221 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHH---HHHh-cCCCCC-------
Confidence 22345788999999999888999999999999999999999999743321 1111 1111 111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.......+.+++.+||+.+|++|||++|+++.
T Consensus 222 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 --SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11123468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.20 Aligned_cols=248 Identities=25% Similarity=0.385 Sum_probs=208.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
.-+.+.++||+|.||.||+|.++ .|+.+|+|.+.- ..+.+++..|+.++++...|++|+++|.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 44567899999999999999887 599999999864 356788999999999999999999999988888999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
..|++.++++. .++++++.++..+++.-++||+|||. ..-+|||||+.|||++.+|.+||+|||.|..+.+....
T Consensus 111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 99999999985 46889999999999999999999998 78899999999999999999999999999877654332
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc--cccc
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD--PVLI 841 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d--~~l~ 841 (927)
.....||+.|||||+++.-.|..++||||+|++..||..|++||..-.. -+..-.+. |...
T Consensus 186 -RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP----------------MRAIFMIPT~PPPT 248 (502)
T KOG0574|consen 186 -RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP----------------MRAIFMIPTKPPPT 248 (502)
T ss_pred -hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc----------------cceeEeccCCCCCC
Confidence 3456799999999999999999999999999999999999999972111 00011111 1111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
...+.+...++.+++++||-++|++|-|+-++++.
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 22345566789999999999999999999888763
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=296.72 Aligned_cols=247 Identities=24% Similarity=0.354 Sum_probs=193.5
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-----chhHHHHHHHHHHHHhcCCCceeeeeeeeecC--ceEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 678 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~~~L 678 (927)
+++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 455789999999999999876 58999999875321 22346788999999999999999999988663 46789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
++||+++++|.+++.. ...+++..+++++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 84 FMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 9999999999999873 3457888999999999999999998 999999999999999999999999999988653
Q ss_pred ccccc--cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 759 EDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 759 ~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
..... ......++..|+|||.+.+..++.++|||||||++|||++|+.||....... .. ........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~----~~~~~~~~----- 226 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA--AI----FKIATQPT----- 226 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH--HH----HHHhcCCC-----
Confidence 32111 1122347889999999988889999999999999999999999997332111 11 11111100
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.+ ..+......+.+++.+|+. +|++||+++||++
T Consensus 227 ~~----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 NP----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CC----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 11 1122334467889999995 8999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=302.51 Aligned_cols=242 Identities=26% Similarity=0.373 Sum_probs=198.2
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
|.+.+.||+|++|.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 566789999999999999876 58999999986532 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 83 VPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999974 4678999999999999999999998 99999999999999999999999999999876543
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...+.. ...+ .+..+.. .+..
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~----~~~~~~~------~~~~ 219 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYE----KILEGKV------RFPS 219 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHhcCCc------cCCc
Confidence 22345789999999998888899999999999999999999999743311 1111 1111111 0111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 875 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~ 875 (927)
.....+.+++.+||+.+|.+|+ +++|+++
T Consensus 220 ----~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 220 ----FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ----cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1134678999999999999999 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=323.87 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=210.5
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CC----cEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DG----KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g----~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
+...+-.++||+|+||+||+|.+- +| -+||+|++.... .+...++++|+-+|.+++|||+++++++|.... ..
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 333445689999999999999864 33 479999987643 345688999999999999999999999998766 78
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
||++||+.|+|.++++.. +..+-.+..+.|..|||+||.|||+ ++++||||.++||||..-..+||.|||+++..
T Consensus 774 lvtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 999999999999999874 5678889999999999999999998 99999999999999999999999999999987
Q ss_pred cccccccccc-cccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 758 EEDLTHISSV-ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 758 ~~~~~~~~~~-~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
..+....... ..-.+.|||=|.+....++.++|||||||++||++| |..|+++....+..++. +.+..
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-------e~geR--- 918 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-------EKGER--- 918 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-------hcccc---
Confidence 6654443322 223568999999999999999999999999999999 99999865544433332 22221
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
+ ..++-...++..++.+||..|+..||+++++...+.+..
T Consensus 919 ----L--sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 919 ----L--SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred ----C--CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 1 123334557889999999999999999999999888754
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=295.08 Aligned_cols=251 Identities=29% Similarity=0.392 Sum_probs=205.3
Q ss_pred HhhcccccccccEEEEEEEECC-CcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
+++.+.||+|++|.||+|+.+. ++.|++|++..... ...+.+.+|++.+++++|+||+++++++...+..++|+||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 4567899999999999999874 99999999876543 456789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+++|.+++.. ...+++..++.++.|+++||+|||+ ..+++||||+|+||+++.++.++|+|||.+..........
T Consensus 83 ~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 83 GGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 9999999974 3678999999999999999999995 2899999999999999999999999999988764433221
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 844 (927)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||................ ..... ..
T Consensus 158 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~~-----~~---- 223 (264)
T cd06623 158 -NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPPP-----SL---- 223 (264)
T ss_pred -cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCCC-----CC----
Confidence 23347889999999999899999999999999999999999997443222222222221 11111 11
Q ss_pred CHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 845 KIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 845 ~~~-~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
... ....+.+++.+||..+|++||++.|+++.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 33578899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=311.06 Aligned_cols=240 Identities=32% Similarity=0.464 Sum_probs=198.2
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
.+.||+|+||.||-|+.. +.+.||||++.-.. .+.-.+++.|++.|++++|||++.+-|++..+...||||||| -
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-l 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-L 109 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-h
Confidence 578999999999999865 67889999986433 334467999999999999999999999999999999999999 5
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
|+-.|++.- ..+++-+.++..|+.+.+.||+|||+ ++.||||||+.|||+++.|.+||+|||.|....+.
T Consensus 110 GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----- 179 (948)
T KOG0577|consen 110 GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----- 179 (948)
T ss_pred ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-----
Confidence 688887764 36789999999999999999999999 99999999999999999999999999999876553
Q ss_pred cccccCCCccCCCcc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 766 SVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l---~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
..++|||.|||||++ ..+.|+-|+||||+|++..||.-.++|+...... ..+.. +..+. .|.+.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM--SALYH-----IAQNe-----sPtLq- 246 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYH-----IAQNE-----SPTLQ- 246 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH--HHHHH-----HHhcC-----CCCCC-
Confidence 345799999999987 4578999999999999999999999997532221 11111 11111 12222
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..+....+.+++..||++-|.+|||.+++++
T Consensus 247 --s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 247 --SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 3456678899999999999999999998765
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=301.21 Aligned_cols=251 Identities=25% Similarity=0.416 Sum_probs=195.7
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeee------cCce
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCE------EEHQ 675 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~------~~~~ 675 (927)
...|++.+.||+|+||.||+|... +++.+|+|++.... ....++..|+.+++++ +|+||+++++++. ....
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 356777899999999999999885 58899999986542 3346688899999998 6999999999884 3467
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
.+++|||+++|+|.+++.... ...+++..+..++.||+.||+|||+ .+|+|+||||+||++++++.++|+|||++.
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 899999999999999987532 3457888899999999999999998 999999999999999999999999999987
Q ss_pred cccccccccccccccCCCccCCCccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcC
Q 002410 756 QAEEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 830 (927)
Q Consensus 756 ~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 830 (927)
....... ......|+..|+|||.+. +..++.++|||||||++|||++|+.||......... . . ....
T Consensus 170 ~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~--~----~-~~~~ 241 (282)
T cd06636 170 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL--F----L-IPRN 241 (282)
T ss_pred hhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh--h----h-HhhC
Confidence 6543221 122345788999999875 346788999999999999999999999633211110 0 0 0000
Q ss_pred CeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 831 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 831 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.. +... .......+.+++.+||+.||.+||++.|+++
T Consensus 242 ~~-----~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 242 PP-----PKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CC-----CCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 1110 1122347889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=303.25 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=201.9
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
.+|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 46677899999999999999865 68899999987554555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++++|.+++.. ..+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999999873 357889999999999999999998 99999999999999999999999999988765433221
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||......... . .....+. +.. .
T Consensus 172 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--~----~~~~~~~------~~~--~ 236 (293)
T cd06647 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--Y----LIATNGT------PEL--Q 236 (293)
T ss_pred -cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--e----ehhcCCC------CCC--C
Confidence 22335788999999998888999999999999999999999999743221110 0 0000000 000 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
........+.+++.+||+.+|++||++.+++.+
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223468899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=302.18 Aligned_cols=260 Identities=20% Similarity=0.283 Sum_probs=195.5
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|+..+.||.|++|.||+|+.+ +|+.||||++..... .....+.+|++++++++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 455788999999999999876 689999999865332 23357889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
. ++|.+++... ....+++..+..++.|++.||+|||+ ++++|+||+|+||+++.++.+||+|||++.........
T Consensus 82 ~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 82 H-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred c-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 5 6898888654 34568999999999999999999998 89999999999999999999999999998765432221
Q ss_pred cccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc-------------
Q 002410 764 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------------- 829 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~------------- 829 (927)
.....++..|+|||.+.+. .++.++||||||+++|||+||+.||...+... ...+.....-..
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHHH
Confidence 1223467889999988654 46889999999999999999999997433211 111111100000
Q ss_pred --CCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 830 --GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 830 --~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..........+. .........+.+++.+|++.||++||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 000111235779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=299.35 Aligned_cols=246 Identities=27% Similarity=0.418 Sum_probs=198.0
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc-cchhHHHHHHHHHHHHhcC---CCceeeeeeeeecCceEEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~L~~l~---HpnIv~l~~~~~~~~~~~LV~E 681 (927)
|++.+.||+|+||.||+|.+. +++.||+|.+... .....+++.+|++++++++ |||++++++++..+...++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 456789999999999999975 6899999998654 2344567889999999997 9999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++++|.++++. ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 83 YAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred cCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 9999999999863 368999999999999999999998 999999999999999999999999999988765433
Q ss_pred cccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
.. .....|+..|+|||.+.++ .++.++|||||||++|+|++|+.||....... ... .+.... .+.+
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~-~~~~~~-----~~~~ 222 (277)
T cd06917 156 SK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMM-LIPKSK-----PPRL 222 (277)
T ss_pred cc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhh-ccccCC-----CCCC
Confidence 22 2233588899999988654 56899999999999999999999997432211 110 011110 1111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
... .....+.+++.+||+.||++||++.|+++
T Consensus 223 ~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 EDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111 13347889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=300.37 Aligned_cols=259 Identities=24% Similarity=0.278 Sum_probs=197.8
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecC--ceEEEEEEe
Q 002410 608 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYEY 682 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~~~LV~E~ 682 (927)
++.+.||+|++|.||+|... +++.+|+|++.... ......+.+|++++++++|+|++++++++... +..++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 45788999999999999887 48899999998653 33346788999999999999999999999887 889999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++ +|.+++... ...+++..++.++.||+.||+|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 82 MDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 974 898888643 2578999999999999999999998 8999999999999999999999999999987654432
Q ss_pred ccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhh---cCCeeeec--
Q 002410 763 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---KGDVISIV-- 836 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~---~~~~~~~~-- 836 (927)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ........ ........
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL---EKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCchhhccccccc
Confidence 22223346788999997754 46789999999999999999999999744432111 11111110 00000000
Q ss_pred ------------cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 837 ------------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 837 ------------d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
...+...........+.+++.+||+.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000001112457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=316.43 Aligned_cols=245 Identities=27% Similarity=0.446 Sum_probs=196.5
Q ss_pred hcccccccccEEEEEEEEC-CCcEEEEEEcc--C--ccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCce--EEEEEE
Q 002410 609 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA--D--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ--RILVYE 681 (927)
Q Consensus 609 ~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~--~--~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~--~~LV~E 681 (927)
+.++||+|+|-+||+|.+. +|.+||--.++ + ......++|..|+.+|+.|+||||++++.+..+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4678999999999999876 47777643222 1 223445889999999999999999999999876554 679999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc-CCCcEEEeecccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld-~~~~~kL~DFGla~~~~~~ 760 (927)
.+..|+|+.++++ .+.++.+.+..|++||++||.|||+ .+++|+|||||-+||||+ ..|.+||+|+|+|......
T Consensus 124 L~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999984 5678899999999999999999998 478999999999999997 4689999999999886543
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
. ....+|||.|||||.+. ..|.+..||||||++++||+|+..||..-.. ...+...+..-++...+..+-||
T Consensus 200 ~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~AQIYKKV~SGiKP~sl~kV~dP-- 271 (632)
T KOG0584|consen 200 H---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--PAQIYKKVTSGIKPAALSKVKDP-- 271 (632)
T ss_pred c---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--HHHHHHHHHcCCCHHHhhccCCH--
Confidence 2 22367999999999987 7899999999999999999999999972221 12233323222333333344444
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
++.++|.+|+.. ..+|||+.|+|+.
T Consensus 272 ----------evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 272 ----------EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ----------HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 577999999999 8999999999864
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=300.03 Aligned_cols=263 Identities=21% Similarity=0.300 Sum_probs=198.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
|++.++||+|++|.||+|+.. +|+.||||+++.... ...+.+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 456789999999999999986 588999999875432 234667889999999999999999999999999999999998
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+ +|.+++........+++..+..++.|++.||+|||+ ++++||||||+||++++++.++|+|||++........ .
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 5 898888754444578999999999999999999998 8999999999999999999999999999876543221 1
Q ss_pred ccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhh-HHHHHH-------Hhhhc-CCee-
Q 002410 765 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHWAR-------SMIKK-GDVI- 833 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~-l~~~~~-------~~~~~-~~~~- 833 (927)
.....++..|++||.+.+ ..++.++|||||||++|+|++|+.||...+..+... +.+... ..+.. ....
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 122346889999998865 457889999999999999999999997544322111 100000 00000 0000
Q ss_pred ---eeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 834 ---SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 834 ---~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
...+... ..........+.+++.+|++.||.+||+++|+++
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0011122346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=300.81 Aligned_cols=263 Identities=21% Similarity=0.245 Sum_probs=197.2
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecC--ceEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVY 680 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~~~LV~ 680 (927)
.|++.+.||+|++|.||+|..+ +++.+++|.++.... .....+.+|+.++++++||||+++++++... +..++|+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 5677899999999999999987 588999999875332 2234577899999999999999999998776 8899999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||++ ++|.+++... ...+++..++.++.||+.||+|||+ ++++|+||||+||+++.++.+||+|||++......
T Consensus 86 e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 86 EYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred hhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9997 5999988743 3468999999999999999999998 89999999999999999999999999998876543
Q ss_pred ccccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhh-HHHHHH-----------Hh-
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHWAR-----------SM- 826 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~-l~~~~~-----------~~- 826 (927)
... .....++..|+|||.+.+. .++.++|+||+|+++|||++|+.||.......... +..... ..
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred ccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 221 1223468899999998654 46899999999999999999999997443221111 000000 00
Q ss_pred -hhcCCeeeeccccccCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 827 -IKKGDVISIVDPVLIGNVKIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 827 -~~~~~~~~~~d~~l~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.............+....... ....+.+++.+||+.+|++||+++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000001111111111 2456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=298.05 Aligned_cols=256 Identities=25% Similarity=0.327 Sum_probs=200.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeec--CceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~~~~LV~E~ 682 (927)
+++.+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||+++++++.+ .+..++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 345689999999999999986 588999999875433 445778999999999999999999998854 3468999999
Q ss_pred cCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 683 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 683 ~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
+++++|.+++.... ....++...+..++.||+.||+|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 99999998876422 34568899999999999999999998 999999999999999999999999999987654322
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc--cchhhHHHHHHHhhhcCCeeeecccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF--GAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~--~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
. ....++..|+|||.+.+..++.++||||+||++|+|++|+.||..... ........+... .......+.
T Consensus 160 ~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~- 231 (287)
T cd06621 160 A---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELKDE- 231 (287)
T ss_pred c---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhccC-
Confidence 1 123467899999999988999999999999999999999999985432 111222222221 111111110
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
. .........+.+++.+||+.+|.+|||+.||++
T Consensus 232 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 001123457889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=298.39 Aligned_cols=245 Identities=26% Similarity=0.370 Sum_probs=198.7
Q ss_pred hcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCC
Q 002410 609 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 687 (927)
Q Consensus 609 ~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gs 687 (927)
..+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++++||+++++
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~ 102 (285)
T cd06648 23 NFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102 (285)
T ss_pred cceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCC
Confidence 3578999999999999875 688999999875545556678999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccccc
Q 002410 688 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 767 (927)
Q Consensus 688 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 767 (927)
|.+++.. ..+++..+..++.|++.||+|||+ ++++||||+|+||+++.++.++|+|||.+........ ....
T Consensus 103 L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 174 (285)
T cd06648 103 LTDIVTH----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKS 174 (285)
T ss_pred HHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccc
Confidence 9999873 468899999999999999999998 9999999999999999999999999998876543322 1223
Q ss_pred cccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHH
Q 002410 768 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 847 (927)
Q Consensus 768 ~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 847 (927)
..|+..|+|||.+.+..++.++||||||+++|||++|+.||...+.. ..... +..... +.... ...
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~-~~~~~~-----~~~~~--~~~ 240 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKR-IRDNLP-----PKLKN--LHK 240 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHH-HHhcCC-----CCCcc--ccc
Confidence 45889999999998888999999999999999999999999633221 11111 111111 01100 111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 848 SIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 848 ~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
....+.+++.+||+.+|++||+++|+++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 2347889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=290.62 Aligned_cols=248 Identities=29% Similarity=0.481 Sum_probs=203.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
|...+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++.+...+..++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 445688999999999999986 6889999999876555667899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
++|.+++... ...+++..+..++.|++.||++||+ .+++||||+|+||++++++.++|+|||.+........ .
T Consensus 82 ~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 82 GSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 9999998753 2578999999999999999999998 9999999999999999999999999999887654432 2
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+... ...... .........+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----~~~~~~~~~~------- 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK---ALFKIA----TNGPPGLRNP------- 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHH----hcCCCCcCcc-------
Confidence 33457889999999988889999999999999999999999997432211 111111 1111111111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 846 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 846 ~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
......+.+++.+|++.||++||++.|+++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111346889999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=298.06 Aligned_cols=246 Identities=25% Similarity=0.327 Sum_probs=200.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
|++.+.||.|+||.||+|..+ +++.||+|.+.... ....+.+.+|++++++++||||+++++.+.++...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 456789999999999999987 58999999987532 23467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++++|.+++.. ...+++..+..++.|+++||.|||+ ++++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 82 LLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 999999999974 3578999999999999999999998 899999999999999999999999999988754432
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..........+. ..... .. .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~--~~--------~ 219 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----AKQET--AD--------V 219 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----HHhcc--cc--------c
Confidence 122344788999999998888999999999999999999999999844432111111 11111 00 0
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCH--HHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKM--QEIV 874 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~--~eVl 874 (927)
..+......+.+++.+||+.||.+||++ +|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1111223578899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=303.87 Aligned_cols=254 Identities=25% Similarity=0.367 Sum_probs=201.0
Q ss_pred HHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCc--cchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~L 678 (927)
+....|++.++||+||.+.||++...+.+.+|+|++... .......|.+|+..|.+|+ |.+|+++++|-..++.+|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 344567788999999999999999988899999887543 2345678999999999995 9999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
||||- ..+|..+|++.. .....| .++.+..|++.++.+.|+ +||||.||||.|+|+ -.|.+||+|||+|..+.
T Consensus 438 vmE~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeecc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEE-EeeeEEeeeechhcccC
Confidence 99976 569999998642 222333 778899999999999998 999999999999998 46899999999999987
Q ss_pred cccccc-ccccccCCCccCCCccCCC-----------CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh
Q 002410 759 EDLTHI-SSVARGTVGYLDPEYYGNQ-----------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 826 (927)
Q Consensus 759 ~~~~~~-~~~~~gt~~Y~APE~l~~~-----------~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 826 (927)
.+.+.. ....+||+.||+||.+... ..++++||||+||+||+|+.|+.||. +..+....
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~-----~~~n~~aK---- 581 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG-----QIINQIAK---- 581 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH-----HHHHHHHH----
Confidence 766554 3456799999999988422 36789999999999999999999997 22222222
Q ss_pred hhcCCeeeeccccccCCCC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 827 IKKGDVISIVDPVLIGNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 827 ~~~~~~~~~~d~~l~~~~~-~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+..+.||.-.-+++ ....++++++++.||+.||.+||++.|+++.
T Consensus 582 -----l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 -----LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 22233432211111 1122348999999999999999999999874
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=299.19 Aligned_cols=252 Identities=28% Similarity=0.384 Sum_probs=195.8
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecC-----ceEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE-----HQRI 677 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~-----~~~~ 677 (927)
..|.+.+.||+|+||.||++..+ +++.+|+|++.... .....+.+|+.+++++ +|||++++++++... +..+
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 34566789999999999999875 68899999986532 2346678899999999 799999999998643 3589
Q ss_pred EEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
+|+||+++++|.++++... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 9999999999999886432 34568999999999999999999998 8999999999999999999999999999886
Q ss_pred ccccccccccccccCCCccCCCccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCC
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQ-----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 831 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-----~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 831 (927)
....... .....++..|+|||.+... .++.++|||||||++|||++|+.||...... ..+.. +..+.
T Consensus 178 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~~-----~~~~~ 249 (291)
T cd06639 178 LTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLFK-----IPRNP 249 (291)
T ss_pred ccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHHH-----HhcCC
Confidence 5432211 2233578899999998543 3688999999999999999999999733221 11111 11111
Q ss_pred eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 832 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 832 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.....++ ......+.+++.+|++.+|++||++.|+++
T Consensus 250 ~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 250 PPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111111 122346889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=293.28 Aligned_cols=242 Identities=24% Similarity=0.337 Sum_probs=195.3
Q ss_pred ccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCH
Q 002410 613 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 688 (927)
Q Consensus 613 LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL 688 (927)
||.|++|.||+++.. +++.+|+|++.... ....+.+.+|++++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999987 48899999986532 23456799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccccccc
Q 002410 689 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 768 (927)
Q Consensus 689 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 768 (927)
.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 999974 3458999999999999999999998 999999999999999999999999999998765432 12233
Q ss_pred ccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHH
Q 002410 769 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 848 (927)
Q Consensus 769 ~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 848 (927)
.++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... .. +........... ...+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~---~~~~~~~~~~~~---------~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PM---EIYNDILKGNGK---------LEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HH---HHHHHHhccCCC---------CCCCccc
Confidence 5788999999998888999999999999999999999999744321 11 111111110000 0111112
Q ss_pred HHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 002410 849 IWRIAEVAIQCVEQRGFSRPK-----MQEIVL 875 (927)
Q Consensus 849 ~~~l~~Li~~Cl~~dP~~RPs-----~~eVl~ 875 (927)
...+.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 347889999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=296.12 Aligned_cols=252 Identities=28% Similarity=0.408 Sum_probs=197.9
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCc------eE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH------QR 676 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~------~~ 676 (927)
..|++.+.||+|++|.||+|..+ +++.+++|++..... ..+++.+|+.+++++ +|+||+++++++.... ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 45677899999999999999986 578999999875433 346789999999999 6999999999986543 58
Q ss_pred EEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
++||||+++++|.+++.... .+..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 99999999999999887432 24678999999999999999999998 999999999999999999999999999987
Q ss_pred cccccccccccccccCCCccCCCccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcC
Q 002410 756 QAEEDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 830 (927)
Q Consensus 756 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 830 (927)
....... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..... ...+.+ +..+
T Consensus 162 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~-----~~~~ 233 (275)
T cd06608 162 QLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--MRALFK-----IPRN 233 (275)
T ss_pred ecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--HHHHHH-----hhcc
Confidence 6543222 1223457889999998753 3567899999999999999999999963221 111111 1111
Q ss_pred CeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 831 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 831 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
...... ........+.+++.+||..||++|||++|+++
T Consensus 234 ~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 PPPTLK-------SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCCCCC-------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111 11123457889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=304.26 Aligned_cols=264 Identities=21% Similarity=0.271 Sum_probs=195.8
Q ss_pred HhhcccccccccEEEEEEEECC---CcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecC--ceEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 678 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~---g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~~~L 678 (927)
|++.++||+|++|.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 4567889999999999999764 7899999998633 33346778899999999999999999999887 78999
Q ss_pred EEEecCCCCHHHHhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC----CCcEEEeecc
Q 002410 679 VYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFG 752 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~----~~~~kL~DFG 752 (927)
||||+++ +|.+.+.... ....+++..+..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 6777665332 22468899999999999999999998 99999999999999999 9999999999
Q ss_pred cccccccccc--ccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccc-------hhhHHHH
Q 002410 753 LSRQAEEDLT--HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA-------ELNIVHW 822 (927)
Q Consensus 753 la~~~~~~~~--~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~-------~~~l~~~ 822 (927)
++........ .......++..|+|||.+.+ ..++.++|||||||+++||++|+.||....... ...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9987543322 11223357889999998766 457899999999999999999999997544322 0011111
Q ss_pred HHHhhhc------------CCeeeeccccccCCCC---------H--HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 823 ARSMIKK------------GDVISIVDPVLIGNVK---------I--ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 823 ~~~~~~~------------~~~~~~~d~~l~~~~~---------~--~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+. .+.. .......+........ . .....+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FE-VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HH-HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 10 0000 0000000000000000 0 22346889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=299.42 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=195.5
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 608 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
++.+.||.|++|.||+|... +|+.||+|++.... ......+.+|++++++++|||++++++++.+++..++++||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 45688999999999999876 69999999986542 2233568889999999999999999999999999999999995
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
++|.+++.... ...+++..++.++.|+++||+|||+ ++++||||+|+||+++.++.++|+|||++.........
T Consensus 82 -~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 82 -LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred -cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 68999987432 2468999999999999999999998 89999999999999999999999999998765432211
Q ss_pred ccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcC-------------
Q 002410 765 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG------------- 830 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~------------- 830 (927)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||...+... .+....+......
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1222467899999987654 57899999999999999999999997443211 1111111000000
Q ss_pred --CeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 831 --DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 831 --~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.......+.. ..........+.+++.+|++.+|++||+++|+++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 0011112246889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=314.16 Aligned_cols=270 Identities=27% Similarity=0.410 Sum_probs=209.0
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCc------eEEEEEE
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QRILVYE 681 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~------~~~LV~E 681 (927)
.+.||+|+||.||+|+.+ .|+.||||.++... ....+...+|+++|++++|+|||+++++-++.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 578999999999999965 69999999998743 345577899999999999999999999865543 5679999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc--CCC--cEEEeeccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INM--RAKVSDFGLSRQA 757 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld--~~~--~~kL~DFGla~~~ 757 (927)
||.+|||+..|.+-.+...+++.+.+.++.+++.||.|||+ ++|+||||||.||++- .+| ..||+|||.|+..
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 99999999999988788899999999999999999999998 9999999999999993 334 3799999999988
Q ss_pred cccccccccccccCCCccCCCccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
.++. ......||..|.+||.+. .+.|+..+|.|||||++||++||..||.....+.......|....-+...+....
T Consensus 175 ~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~ 252 (732)
T KOG4250|consen 175 DDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGA 252 (732)
T ss_pred CCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEee
Confidence 7654 344567999999999998 5889999999999999999999999997443332111122211111111111111
Q ss_pred cccc------------cCCCCHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHhhhhhc
Q 002410 837 DPVL------------IGNVKIESIWRIAEVAIQCVEQRGFSRP--KMQEIVLAIQDSIKIE 884 (927)
Q Consensus 837 d~~l------------~~~~~~~~~~~l~~Li~~Cl~~dP~~RP--s~~eVl~~L~~~~~~e 884 (927)
.+.. ...........+-+.+..+|..+|++|. ...+....+.+++...
T Consensus 253 ~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 253 QEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred ecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 1111 1112233444667888899999999999 7777777777776543
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=297.65 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=192.0
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHH-HHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVAL-LSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~-L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
+++.+.||+|+||.||+|+.+ +|+.||+|+++... .....++..|+.. ++.++||||+++++++..++..+++|||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 456789999999999999986 58999999987543 2334556666665 56678999999999999999999999999
Q ss_pred CCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 684 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 684 ~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~-~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
+ |+|.+++.... ....+++..++.++.||+.||+|||+ + +++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 6 68888876432 34578999999999999999999997 5 99999999999999999999999999988654322
Q ss_pred cccccccccCCCccCCCccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 762 THISSVARGTVGYLDPEYYGN----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~----~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
. .....++..|+|||.+.+ ..++.++|+|||||++|||++|+.||...... ...+ ...... ..
T Consensus 159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~----~~~~~~-~~----- 225 (283)
T cd06617 159 A--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQL----KQVVEE-PS----- 225 (283)
T ss_pred c--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHH----HHHHhc-CC-----
Confidence 1 122347889999998864 45688999999999999999999999632211 1111 111111 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+.+. .......+.+++.+||..+|++||+++++++
T Consensus 226 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 PQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1110 0112346889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=296.59 Aligned_cols=249 Identities=25% Similarity=0.394 Sum_probs=201.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.|++.+.||+|++|.||+|.++ +++.+++|++..... ..+.+.+|++++++++|+|++++++.+...+..++|+||++
T Consensus 20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 98 (286)
T cd06614 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD 98 (286)
T ss_pred cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence 3556788999999999999987 688999999976544 56778899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 99 ~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 172 (286)
T cd06614 99 GGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K 172 (286)
T ss_pred CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence 999999998532 379999999999999999999998 9999999999999999999999999998876543221 1
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 844 (927)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... .... .. ........+
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~~~~----~~-~~~~~~~~~------- 238 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--ALFL----IT-TKGIPPLKN------- 238 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--HHHH----HH-hcCCCCCcc-------
Confidence 122347789999999988889999999999999999999999997332211 1111 11 111111111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 845 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 845 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.......+.+++.+|++.+|.+||++.++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112346889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=299.20 Aligned_cols=246 Identities=30% Similarity=0.428 Sum_probs=196.1
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
..|++.+.||+|++|.||+|... +++.||+|++.... ....+++.+|+++++.++||||+++++++.+++..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 44777899999999999999876 58999999986432 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||++ |+|.+.+... ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 5777776532 3468999999999999999999998 89999999999999999999999999998765332
Q ss_pred ccccccccccCCCccCCCccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 761 LTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
....++..|+|||.+. ...++.++||||||+++|||++|+.||...+... ... . +.....
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~---~~~---~-~~~~~~----- 231 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALY---H-IAQNDS----- 231 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH---HHH---H-HhcCCC-----
Confidence 1234788999999874 4568899999999999999999999996332211 111 1 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+.+ ........+.+++.+||+.+|++||++.+|++.
T Consensus 232 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011 011234578999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=293.69 Aligned_cols=248 Identities=28% Similarity=0.434 Sum_probs=199.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|.+.+.||+|+||.||+|..+ +|+.+|+|.+.... ....+.+.+|++++++++|+||+++++.+...+..++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 456789999999999999987 58899999986532 234467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC-cEEEeecccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla~~~~~~~~ 762 (927)
++++|.+++... ....+++..+..++.|+++||+|||+ .+++|+||||+||++++++ .+||+|||.+........
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 82 DGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 999999998753 23457999999999999999999998 8999999999999999875 469999999887654322
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
......|++.|+|||.+.+..++.++||||||++++||++|+.||..... .+....... +.... .
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~~-~------ 222 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQ-GYFAP-I------ 222 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-ccCCC-C------
Confidence 22234578899999999888899999999999999999999999963321 122222221 11111 1
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.......+.+++.+|++.+|++||+++|+++
T Consensus 223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 --SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=299.66 Aligned_cols=264 Identities=23% Similarity=0.272 Sum_probs=197.7
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCc----
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH---- 674 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~---- 674 (927)
.....|.+.+.||+|++|.||+|..+ +|+.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34556778899999999999999987 58899999987532 223356788999999999999999999887654
Q ss_pred ------eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEE
Q 002410 675 ------QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 748 (927)
Q Consensus 675 ------~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL 748 (927)
..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEe
Confidence 78999999976 777776642 3468999999999999999999998 89999999999999999999999
Q ss_pred eeccccccccccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhh
Q 002410 749 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 827 (927)
Q Consensus 749 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~ 827 (927)
+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...+....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~---~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ---LELISRLC 234 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHh
Confidence 9999998764433222222345778999998764 4578999999999999999999999974332111 11111111
Q ss_pred hcC---Ceeeec--------cc------cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 828 KKG---DVISIV--------DP------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 828 ~~~---~~~~~~--------d~------~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
... ....+. ++ ..... ....+..+.+++.+||+.+|.+||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 100 000000 00 00000 0012457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=299.23 Aligned_cols=255 Identities=27% Similarity=0.357 Sum_probs=195.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEEEEEe
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
.+...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445678999999999999876 58999999987532 344567889999999996 99999999999988999999999
Q ss_pred cCCCCHHHHhcc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 683 MHNGTLRDRLHG--SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 683 ~~~gsL~~~L~~--~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
++ +++.++... ......+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 86 455544321 1124678999999999999999999997 359999999999999999999999999998765432
Q ss_pred ccccccccccCCCccCCCccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~---~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
... ....|+..|+|||.+.+. .++.++|||||||++|||++|+.||.... ...+........ . .
T Consensus 162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~-~-----~ 228 (288)
T cd06616 162 IAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG-D-----P 228 (288)
T ss_pred Ccc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC-C-----C
Confidence 211 223478899999998766 68899999999999999999999997332 111111211111 1 1
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+.+...........+.+++.+|++.+|++||+++||++.
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111112234578899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=295.94 Aligned_cols=242 Identities=23% Similarity=0.286 Sum_probs=187.4
Q ss_pred cccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHh---cCCCceeeeeeeeecCceEEEEEEecC
Q 002410 612 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSR---IHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 612 ~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~---l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..+++. .+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 588999998865321 222334455544444 479999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 9999999873 4569999999999999999999998 9999999999999999999999999999876533221
Q ss_pred ccccccCCCccCCCccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 765 SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~-~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
....|+..|+|||.+. +..++.++||||+||++|||++|+.||..........+.. .... ....+
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~~------~~~~~--- 218 (279)
T cd05633 153 -HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLT------VNVEL--- 218 (279)
T ss_pred -cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH----Hhhc------CCcCC---
Confidence 2235899999999986 4568899999999999999999999997443222111111 1100 01111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 876 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~~ 876 (927)
+......+.+++.+||+.||++|| +++|+++.
T Consensus 219 -~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 -PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 112234788999999999999999 59888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=296.40 Aligned_cols=257 Identities=23% Similarity=0.263 Sum_probs=193.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcC-CCceeeeeeeeecC--ceEEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQRILVYE 681 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~--~~~~LV~E 681 (927)
|++.++||+|+||.||+|... +++.||+|+++... ........+|+.+++++. |+|++++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 346788999999999999876 68899999987542 222334567899999885 99999999999877 88999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|++ |+|.+.+... ...+++.+++.++.|++.||+|||+ .+++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 5888887642 3568999999999999999999998 89999999999999999 999999999998764332
Q ss_pred cccccccccCCCccCCCccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhh-----------hc
Q 002410 762 THISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI-----------KK 829 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~-----------~~ 829 (927)
.. ....++..|+|||.+. +..++.++|||||||++|||++|+.||...+..+ ...+..... ..
T Consensus 154 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 PY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred Cc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcc
Confidence 21 2234788999999764 4567899999999999999999999997543221 111111111 00
Q ss_pred CCeeeeccccccC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 830 GDVISIVDPVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 830 ~~~~~~~d~~l~~----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
........+.... .........+.+++.+||+.+|++||+++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000000 001123568899999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-32 Score=288.09 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=202.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecC--ceEEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYE 681 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~~~LV~E 681 (927)
|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+... ...++|+|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 345688999999999999987 689999999876542 4567899999999999999999999999888 88999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 82 YVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred ecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999984 3388999999999999999999998 999999999999999999999999999988765543
Q ss_pred cc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 TH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
.. ......++..|+|||.+.+...+.++||||||+++++|++|..||...+. ..............
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~-------- 222 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGSSGEP-------- 222 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccccCCC--------
Confidence 21 12234578899999999888899999999999999999999999974431 11111111110111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
...+......+.+++.+|++.+|++||++.|+++
T Consensus 223 -~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 -PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1111222457889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=296.37 Aligned_cols=261 Identities=21% Similarity=0.278 Sum_probs=193.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
.|.+.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+++.++|+||+++++++..++..++|+||+
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 3556789999999999999875 688999999865432 22346788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
. ++|.+++... ...+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||+++........
T Consensus 86 ~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 86 H-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred c-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 5 6777776532 3457888899999999999999998 89999999999999999999999999998764332211
Q ss_pred cccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhh------------cC
Q 002410 764 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK------------KG 830 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~------------~~ 830 (927)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ..+.+ ...... ..
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 160 -YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEK-IWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred -CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHH-HHHHcCCCChhhhhhhhhcc
Confidence 1223468899999998654 57889999999999999999999997433211 11111 100000 00
Q ss_pred Ceeeeccccc-cCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 831 DVISIVDPVL-IGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 831 ~~~~~~d~~l-~~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.......+.. .... .......+.+++.+|++.||++|||++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000 0000 0011346789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=293.54 Aligned_cols=245 Identities=29% Similarity=0.374 Sum_probs=196.3
Q ss_pred ccccccEEEEEEEECC-CcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCH
Q 002410 613 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 688 (927)
Q Consensus 613 LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL 688 (927)
||.|+||.||+++..+ |+.+++|.+..... ...+.+.+|++++++++|+||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999874 89999999875433 3456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc------
Q 002410 689 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT------ 762 (927)
Q Consensus 689 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~------ 762 (927)
.+++.. ...+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999974 3478999999999999999999998 9999999999999999999999999999876433211
Q ss_pred -ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 763 -HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 763 -~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
.......++..|+|||...+...+.++||||||+++|||++|+.||...... ..... +..+.... +
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~----~~~~~~~~---~--- 221 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQN----ILNGKIEW---P--- 221 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HhcCCcCC---C---
Confidence 1122334788999999998888999999999999999999999999743321 11111 11111100 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
. .......+.+++.+|++.+|++||+++++.+.|+
T Consensus 222 ~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 E--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred c--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 0001347789999999999999999966666555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=299.55 Aligned_cols=261 Identities=21% Similarity=0.272 Sum_probs=193.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--hhHHHHHHHHHHHHhcC-CCceeeeeeeeecCce-----EE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQ-----RI 677 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~-----~~ 677 (927)
|++.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.++++++ |+||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 556789999999999999976 689999998765322 23457888999999995 6999999999876665 89
Q ss_pred EEEEecCCCCHHHHhccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC-CCcEEEeecccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVN--QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLS 754 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~--~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFGla 754 (927)
+||||+++ +|.+++..... ...+++..++.++.||++||+|||+ ++|+||||||+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999985 89888865332 3568999999999999999999998 99999999999999998 899999999998
Q ss_pred ccccccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCC--
Q 002410 755 RQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD-- 831 (927)
Q Consensus 755 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~-- 831 (927)
+........ .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....... .+..... .+....
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~-~~~~~~~~ 234 (295)
T cd07837 159 RAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFK-LLGTPTEQ 234 (295)
T ss_pred eecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHH-HhCCCChh
Confidence 765332111 112246788999998865 467899999999999999999999997433211 1111111 100000
Q ss_pred -eeeecc-------cc----ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 832 -VISIVD-------PV----LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 832 -~~~~~d-------~~----l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.....+ +. ............+.+++.+||+.||++||+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 00 000001123346889999999999999999999885
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=323.17 Aligned_cols=269 Identities=18% Similarity=0.223 Sum_probs=189.8
Q ss_pred HHHHHhhcccccccccEEEEEEEECC--CcEEEEE------------------EccCccchhHHHHHHHHHHHHhcCCCc
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMKD--GKEVAVK------------------IMADSCSHRTQQFVTEVALLSRIHHRN 662 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~~--g~~vAvK------------------~l~~~~~~~~~~~~~E~~~L~~l~Hpn 662 (927)
....|++.++||+|+||+||++.++. +...++| .+. ........+.+|+++|++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 34678889999999999999987642 2222222 111 11223456889999999999999
Q ss_pred eeeeeeeeecCceEEEEEEecCCCCHHHHhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc
Q 002410 663 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 740 (927)
Q Consensus 663 Iv~l~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl 740 (927)
|+++++++...+..++|+|++. ++|.+++.... .........+..++.||+.||+|||+ ++|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence 9999999999999999999985 57777765322 12223456778899999999999998 999999999999999
Q ss_pred cCCCcEEEeeccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc-cchhhH
Q 002410 741 DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF-GAELNI 819 (927)
Q Consensus 741 d~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~-~~~~~l 819 (927)
+.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|+.++..... .....+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999987655433333345689999999999999999999999999999999998754332222 111222
Q ss_pred HHHHHHhh-hcCCee-------eecccc-cc---CCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 820 VHWARSMI-KKGDVI-------SIVDPV-LI---GNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 820 ~~~~~~~~-~~~~~~-------~~~d~~-l~---~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.+.+.... ....+. ..++.. .. ... .......+.+++.+||+.||++|||+.|+++.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 22111100 000000 000000 00 000 00112356788999999999999999999874
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=302.15 Aligned_cols=266 Identities=20% Similarity=0.256 Sum_probs=195.5
Q ss_pred cccccc--ccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G--~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.||+| +||+||++.+. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999875 69999999986432 33457789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc-
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI- 764 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~- 764 (927)
++|.+++.... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999987542 3458899999999999999999998 899999999999999999999999998654322111100
Q ss_pred -----ccccccCCCccCCCccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhh----------
Q 002410 765 -----SSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI---------- 827 (927)
Q Consensus 765 -----~~~~~gt~~Y~APE~l~~~--~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~---------- 827 (927)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||...... ....+......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccccccc
Confidence 0112245679999998763 4789999999999999999999999743321 11111100000
Q ss_pred ----------------------hcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhh
Q 002410 828 ----------------------KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK 882 (927)
Q Consensus 828 ----------------------~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~--L~~~~~ 882 (927)
..+......+..+...........+.+++.+||+.||++|||++|+++. ++++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0000000111111111223345678999999999999999999999754 444443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=293.99 Aligned_cols=244 Identities=23% Similarity=0.287 Sum_probs=191.7
Q ss_pred ccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCH
Q 002410 613 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 688 (927)
Q Consensus 613 LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL 688 (927)
||+|+||+||++..+ +|+.+|+|.+.... ......+.+|++++++++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999866 58899999986432 22345677899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccccccc
Q 002410 689 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 768 (927)
Q Consensus 689 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 768 (927)
.+++.... ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||.+....... .....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR 154 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence 99987542 3468999999999999999999998 999999999999999999999999999987654321 12233
Q ss_pred ccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHH
Q 002410 769 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 848 (927)
Q Consensus 769 ~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 848 (927)
.++..|+|||.+.+..++.++|||||||++|+|++|+.||........... +....... .. ......
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~------~~----~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE---LKRRTLEM------AV----EYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH---HHhccccc------cc----cCCccC
Confidence 477899999999888899999999999999999999999974433111110 11111000 00 011112
Q ss_pred HHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 002410 849 IWRIAEVAIQCVEQRGFSRP-----KMQEIVL 875 (927)
Q Consensus 849 ~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~ 875 (927)
...+.+++.+||+.+|++|| ++.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 34678999999999999999 5555553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=295.54 Aligned_cols=244 Identities=26% Similarity=0.371 Sum_probs=197.5
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCH
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 688 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL 688 (927)
..+||+|+||.||++..+ +++.||+|++..........+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 468999999999999885 6899999998655555667799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccccccc
Q 002410 689 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 768 (927)
Q Consensus 689 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 768 (927)
.+++. ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++........ .....
T Consensus 105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 99875 2357899999999999999999998 8999999999999999999999999998876543322 12234
Q ss_pred ccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHH
Q 002410 769 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 848 (927)
Q Consensus 769 ~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 848 (927)
.++..|+|||.+.+..++.++||||+|+++|||++|..||...... ........... +.+.. ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~~~---------~~~~~--~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDNLP---------PKLKN--LHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhhCC---------cccCC--cccC
Confidence 5788999999998888899999999999999999999999743221 11111111110 00000 0112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 849 IWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 849 ~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
...+.+++.+||+.+|.+||++.|+++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 235778999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=306.65 Aligned_cols=250 Identities=21% Similarity=0.357 Sum_probs=204.0
Q ss_pred HHhhcccccccccEEEEEEEECCC-cEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKDG-KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~g-~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
-.++...||.|+||.||+|..++. -..|.|++........++|+-|++||....||+||++++.+..++.++++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 345677899999999999998753 4456788877777788999999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
||-...++-. -+..+.+.++.-+++|++.||.|||+ ++|||||||+.|||++-+|.++|+|||.+....... ..
T Consensus 113 GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qk 186 (1187)
T KOG0579|consen 113 GGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QK 186 (1187)
T ss_pred CchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhHH-hh
Confidence 9999888765 36789999999999999999999998 999999999999999999999999999886543322 22
Q ss_pred ccccccCCCccCCCcc-----CCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 765 SSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l-----~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
...++|||.|||||+. ...+|+.++||||||++|.||..+.+|-.... ... +.-.+.......++.|
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln------pMR-VllKiaKSePPTLlqP- 258 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN------PMR-VLLKIAKSEPPTLLQP- 258 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc------hHH-HHHHHhhcCCCcccCc-
Confidence 3456799999999986 45689999999999999999999999975211 111 1111222222233332
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
......+.+++.+||.+||+.||++.++++
T Consensus 259 ------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 259 ------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 234557889999999999999999999875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=301.14 Aligned_cols=260 Identities=23% Similarity=0.238 Sum_probs=193.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecC--ceEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVY 680 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~~~LV~ 680 (927)
.|++.+.||+|+||.||+|..+ +|+.||+|+++..... ....+.+|+.++++++|+||+++++++... +..++||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 4567789999999999999986 5899999998643222 234567899999999999999999998654 5689999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||++ ++|.+++... ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 88 e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 88 EYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred ecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9996 5888888743 3568999999999999999999998 99999999999999999999999999999876543
Q ss_pred ccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc--CCee-e--
Q 002410 761 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK--GDVI-S-- 834 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~--~~~~-~-- 834 (927)
... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+. ...+...... .... .
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChhhchhhh
Confidence 211 122235778999999865 4678999999999999999999999974432221 1111111100 0000 0
Q ss_pred ------ec--cccccCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 835 ------IV--DPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 835 ------~~--d~~l~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.. ........ .......+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 00000000 0012346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=307.96 Aligned_cols=264 Identities=23% Similarity=0.329 Sum_probs=195.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----ceEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 678 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-----~~~~L 678 (927)
.|.+.++||+|++|.||+|... +|+.||+|++.... ......+.+|+.++++++|+||+++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 4667899999999999999875 68999999986432 23446688899999999999999999987543 35799
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
|+||++ ++|.+.+. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 86 VQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred Eehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999996 58888775 3468999999999999999999998 999999999999999999999999999987654
Q ss_pred ccccc--cccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCC---e
Q 002410 759 EDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---V 832 (927)
Q Consensus 759 ~~~~~--~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~---~ 832 (927)
..... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||...+.... ...+........ .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHHH
Confidence 32211 1122457889999998654 5688999999999999999999999974432111 111111111000 0
Q ss_pred eeecccc-------cc--CCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhh
Q 002410 833 ISIVDPV-------LI--GNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDS 880 (927)
Q Consensus 833 ~~~~d~~-------l~--~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~--L~~~ 880 (927)
..+.+.. .. ... .......+.+++.+||+.+|++||+++|+++. ++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0000000 00 000 01123468899999999999999999999986 5543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=287.03 Aligned_cols=246 Identities=26% Similarity=0.437 Sum_probs=201.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|.+.+.||+|++|.||++... +++.|++|.+..... ...+.+.+|++++++++|+|++++++++.+++..++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 456789999999999999876 578999999976543 45578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 82 ENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999999874 3678999999999999999999998 99999999999999999999999999999876543332
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||..... ...... .. .... +.+
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--~~~~~~----~~-~~~~-----~~~--- 219 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP--MAALFR----IV-QDDH-----PPL--- 219 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--HHHHHH----Hh-ccCC-----CCC---
Confidence 2233578899999999888889999999999999999999999973321 111111 11 1111 011
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+......+.+++.+||..+|++||++.|++.
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 -PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1112347789999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=290.84 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=202.0
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|++.++||+|++|.||+++.+ +++.+++|.+.... ......+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 456789999999999999866 67899999987532 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 684 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 684 ~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
++++|.+++.... ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~- 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM- 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence 9999999986532 24568999999999999999999998 999999999999999999999999999998765541
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
.....++..|+|||.+.+..++.++|+||+|+++|||++|+.||...+.. .+.. ....+....
T Consensus 158 --~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~----~~~~~~~~~-------- 220 (256)
T cd08530 158 --AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRY----KVQRGKYPP-------- 220 (256)
T ss_pred --cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHhcCCCCC--------
Confidence 22234788999999999989999999999999999999999999744321 1111 111111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
........+.+++.+|++.+|++||++.|+++
T Consensus 221 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 -IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11233457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=305.68 Aligned_cols=262 Identities=23% Similarity=0.294 Sum_probs=196.9
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecC------c
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------H 674 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------~ 674 (927)
...|+..+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++|+||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 355777899999999999999876 6899999998643 223445678899999999999999999987543 3
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccc
Q 002410 675 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 754 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 754 (927)
..++||||+. ++|.+.+.. .++...+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 5799999995 588888762 28889999999999999999998 89999999999999999999999999999
Q ss_pred ccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhh-HH-----------HH
Q 002410 755 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IV-----------HW 822 (927)
Q Consensus 755 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~-l~-----------~~ 822 (927)
+....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+...... +. ..
T Consensus 166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 166 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 87544322 223347889999999999999999999999999999999999997443211110 00 00
Q ss_pred ----HHHhhhcCC------eeeeccccc----cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 823 ----ARSMIKKGD------VISIVDPVL----IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 823 ----~~~~~~~~~------~~~~~d~~l----~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
......... +........ ...........+.+++.+||+.||++||+++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 000000000 001111234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=295.66 Aligned_cols=258 Identities=21% Similarity=0.269 Sum_probs=199.0
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 608 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
++.+.||+|++|.||+|... +++.+++|.+..... .....+.+|++++++++|+||+++++++..++..++|+||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 45678999999999999876 688999999875433 245678899999999999999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+ +|.+++... ...+++..+..++.|++.||+|||+ ++|+|+||||+||+++.++.++|+|||.+........ .
T Consensus 82 ~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-~ 154 (283)
T cd05118 82 T-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-P 154 (283)
T ss_pred C-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-c
Confidence 5 888888743 3578999999999999999999998 9999999999999999999999999999877654331 1
Q ss_pred ccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcC---Ceeeecc---
Q 002410 765 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVISIVD--- 837 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d--- 837 (927)
.....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...+..+. ........... ......+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhhhh
Confidence 2223477889999998776 789999999999999999999999964432211 11111111000 0000000
Q ss_pred ---cccc-------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 838 ---PVLI-------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 838 ---~~l~-------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.... .........++.+++.+||+.||.+||+++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0111223457899999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=299.34 Aligned_cols=264 Identities=20% Similarity=0.235 Sum_probs=193.2
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCc--------
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-------- 674 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-------- 674 (927)
.|++.++||+|+||.||+|..+ +++.||||.+..... .....+.+|++++++++||||+++++++...+
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 4677899999999999999876 589999998864322 22345678999999999999999999986543
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccc
Q 002410 675 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 754 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 754 (927)
..++||||+. ++|.+.+... ...+++.+++.++.||+.||+|||+ ++++|+||||+||+++.++.+||+|||++
T Consensus 93 ~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 93 SFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred eEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 4599999996 5888887642 3468999999999999999999998 89999999999999999999999999999
Q ss_pred ccccccccc---cccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcC
Q 002410 755 RQAEEDLTH---ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 830 (927)
Q Consensus 755 ~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 830 (927)
......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...+..........+.......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 865432211 11223467889999988654 47889999999999999999999997544322222222111111100
Q ss_pred Ceeee-----ccc-cccCCC---------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 831 DVISI-----VDP-VLIGNV---------KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 831 ~~~~~-----~d~-~l~~~~---------~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..... .+. ...... .......+.+++.+||..||++||+++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 000 000000 0001235679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=296.83 Aligned_cols=249 Identities=31% Similarity=0.432 Sum_probs=197.1
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
..+...+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++|+|++++++++.+++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34667789999999999999875 58899999986432 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||++ |+|.+.+... ...+++.++..++.|++.||.|||+ ++|+||||+|+||+++.++.++|+|||++......
T Consensus 105 e~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 105 EYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred eCCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 9996 5787777532 4568999999999999999999998 99999999999999999999999999988754332
Q ss_pred ccccccccccCCCccCCCccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 761 LTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
....++..|+|||.+. ...++.++|||||||++|||++|+.||....... .+.. ....+.. .
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~----~~~~~~~-~--- 243 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYH----IAQNESP-T--- 243 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--HHHH----HHhccCC-C---
Confidence 2234788999999973 4578899999999999999999999986332111 1111 1111110 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
. ........+.+++.+|++.+|.+||++.||++.+-.
T Consensus 244 --~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 244 --L---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred --C---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 0 011223468899999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=295.37 Aligned_cols=255 Identities=22% Similarity=0.310 Sum_probs=200.2
Q ss_pred HhhcccccccccEEEEEEEEC----CCcEEEEEEccCcc----chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~----~g~~vAvK~l~~~~----~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~ 677 (927)
|++.+.||+|++|.||+++.. +++.||||.++... ....+.+.+|+++++++ +||||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 456789999999999999753 57889999987432 22345688999999999 5999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+||||+++|+|.+++.. ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||+++..
T Consensus 82 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 82 LILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999999873 4568899999999999999999998 99999999999999999999999999998775
Q ss_pred cccccccccccccCCCccCCCccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~~~~--~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
............++..|+|||.+.+.. .+.++||||||+++|||++|..||....... ...+..+......
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~----- 228 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKSK----- 228 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHccC-----
Confidence 443322223345788999999987654 7889999999999999999999996332211 1111111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
+.. +......+.+++.+||+.+|++|||++++.+.|+..
T Consensus 229 --~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 --PPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --CCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 111 111223678999999999999999999988877754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=289.48 Aligned_cols=244 Identities=27% Similarity=0.309 Sum_probs=189.3
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHH-HhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALL-SRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L-~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.||+|++|.||+|... +|+.||+|.+..... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999875 589999999865322 2223445555544 445899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||+++.... .
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 999999973 3568899999999999999999998 8999999999999999999999999999876433 1
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
....++..|+|||.+.+..++.++||||||+++|||++|..||...+... ... . +..+... ..+.. .
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~---~-~~~~~~~--~~~~~----~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFD---N-ILSRRIN--WPEEV----K 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHH---H-HHhcccC--CCCcc----c
Confidence 23347889999999988888999999999999999999999997433211 111 1 1111110 00000 1
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 846 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 846 ~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
......+.+++.+||+.+|++||++.++.+.|.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 122346889999999999999998876655444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=287.25 Aligned_cols=249 Identities=30% Similarity=0.459 Sum_probs=203.5
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|.+.+.||+|++|.||++... +++.+++|++..... ...+.+.+|++++++++|+|++++++.+...+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 456788999999999999986 588999999875433 45677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 684 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 684 ~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
++++|.+++.... ....+++..+..++.+++.||+|||+ .+++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 9999999997532 24678999999999999999999998 899999999999999999999999999998765433
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
.......+++.|+|||.+.+..++.++||||+|+++++|++|+.||...+.. .+ ...... ..... +
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~---~~~~~~-~~~~~-----~-- 223 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---EL---ALKILK-GQYPP-----I-- 223 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HH---HHHHhc-CCCCC-----C--
Confidence 1223345788999999998888999999999999999999999999743311 11 111111 11111 1
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+......+.+++.+||..+|++||++.|+++
T Consensus 224 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 --PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1122347889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=289.02 Aligned_cols=240 Identities=24% Similarity=0.317 Sum_probs=186.2
Q ss_pred Hhhcccc--cccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKI--GKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~L--G~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
+.+.+.+ |+|+||.||++..+ +++.+|+|.+....... .|+.....+ +||||+++++.+...+..++||||
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~ 90 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDY 90 (267)
T ss_pred hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEc
Confidence 3455554 99999999999876 57889999986532211 122222223 699999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC-cEEEeeccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla~~~~~~~ 761 (927)
+++++|.+++.. ...+++.++..++.|+++||+|||+ .+++||||||+||+++.++ .++|+|||++.......
T Consensus 91 ~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 164 (267)
T PHA03390 91 IKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS 164 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc
Confidence 999999999974 3478999999999999999999998 8999999999999999988 99999999987654321
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
...++..|+|||++.+..++.++||||||+++|||++|+.||.... ........+...........
T Consensus 165 -----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~-------- 230 (267)
T PHA03390 165 -----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE-DEELDLESLLKRQQKKLPFI-------- 230 (267)
T ss_pred -----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-cchhhHHHHHHhhcccCCcc--------
Confidence 2347889999999998889999999999999999999999997332 22222222222211000000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVL 875 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-~~eVl~ 875 (927)
......+.+++.+||+.+|.+||+ ++|+++
T Consensus 231 ----~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 231 ----KNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 122346889999999999999996 688874
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=296.07 Aligned_cols=260 Identities=20% Similarity=0.275 Sum_probs=193.2
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|++.+.||+|++|.||+|..+ +|+.||+|++..... ...+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 556789999999999999876 688999999865322 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC-CCcEEEeecccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFGla~~~~~~~~ 762 (927)
+ ++|.+++... .....++..+..++.||+.||+|||+ ++++|+||+|+||+++. ++.+||+|||++........
T Consensus 84 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 84 D-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred c-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 6 5888877643 23346788889999999999999998 89999999999999985 56799999999976543221
Q ss_pred ccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcC--Ce-------
Q 002410 763 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--DV------- 832 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~--~~------- 832 (927)
. .....+++.|+|||.+.+ ..++.++||||+||++|+|+||+.||...+..+. +.+.. ...... ..
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 159 T-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFKIF-RILGTPNEETWPGVTSL 234 (294)
T ss_pred c-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHhCCCChhhccccccc
Confidence 1 122346789999998865 4578999999999999999999999974332211 11100 000000 00
Q ss_pred eeecc--ccccC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 833 ISIVD--PVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 833 ~~~~d--~~l~~----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..... +.... .........+.+++.+|++.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 00000 001112346789999999999999999999986
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=305.39 Aligned_cols=265 Identities=19% Similarity=0.308 Sum_probs=197.1
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeec----CceEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRI 677 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~----~~~~~ 677 (927)
..|.+.+.||+|++|.||+|..+ +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 45666789999999999999876 58999999987542 2345677889999999999999999998753 35689
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+|+||+. ++|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 85 lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 689998873 4568999999999999999999998 89999999999999999999999999998765
Q ss_pred cccccc---cccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH--------
Q 002410 758 EEDLTH---ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS-------- 825 (927)
Q Consensus 758 ~~~~~~---~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~-------- 825 (927)
...... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 432211 1123357889999998765 4688999999999999999999999975443221111110000
Q ss_pred hhhcCCeeeecc---cccc---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 826 MIKKGDVISIVD---PVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 826 ~~~~~~~~~~~d---~~l~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
...........+ .... ..........+.+++.+||+.+|++||+++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000000000 0000 00011224578999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=303.77 Aligned_cols=266 Identities=23% Similarity=0.325 Sum_probs=202.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCc-----eEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRIL 678 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-----~~~L 678 (927)
|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+++++.++|+||+++++++...+ ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 566789999999999999986 48999999987643 344577899999999999999999999987765 7899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
||||++ ++|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.++|+|||++....
T Consensus 82 v~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 82 VTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred Eecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 999997 589888873 3479999999999999999999998 999999999999999999999999999998765
Q ss_pred cccc--ccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcC-----
Q 002410 759 EDLT--HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG----- 830 (927)
Q Consensus 759 ~~~~--~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~----- 830 (927)
.... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+... .+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN---LIVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHH---HHHHhcCCCChhHh
Confidence 4321 112233478899999999887 88999999999999999999999997544321111 111100000
Q ss_pred ------Ceeeecc---cc---ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhh
Q 002410 831 ------DVISIVD---PV---LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK 882 (927)
Q Consensus 831 ------~~~~~~d---~~---l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~--L~~~~~ 882 (927)
.....+. .. -...........+.+++.+||+.+|++||+++++++. +++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000000 00 0000011123468899999999999999999999975 554433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=304.77 Aligned_cols=266 Identities=23% Similarity=0.312 Sum_probs=197.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----ceEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRI 677 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-----~~~~ 677 (927)
.|.+.+.||+|+||+||+|... +++.||||.+... .......+.+|+.+++.++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 3556789999999999999875 5899999998753 233345678899999999999999999987644 3479
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++..
T Consensus 86 lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 86 IVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 9999995 789888873 4579999999999999999999998 89999999999999999999999999999876
Q ss_pred cccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh--------hh
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM--------IK 828 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~--------~~ 828 (927)
..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.............. +.
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 159 SEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 43321 1223347889999998764 46889999999999999999999999754322111111000000 00
Q ss_pred cCCeeee-------ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhh
Q 002410 829 KGDVISI-------VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDS 880 (927)
Q Consensus 829 ~~~~~~~-------~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~--L~~~ 880 (927)
....... .++... .........+.+++.+||+.+|++||+++|+++. ++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred chhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000000 000000 0011233567899999999999999999999987 5543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=294.67 Aligned_cols=261 Identities=21% Similarity=0.244 Sum_probs=193.5
Q ss_pred hcccccccccEEEEEEEECCCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCC
Q 002410 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 686 (927)
Q Consensus 609 ~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~g 686 (927)
+.+.+|.|+++.||++.. +++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 445566666666666655 5899999998754 3445678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc----
Q 002410 687 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT---- 762 (927)
Q Consensus 687 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~---- 762 (927)
+|.+++.... ...+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999998542 3458899999999999999999998 8999999999999999999999999998875432111
Q ss_pred --ccccccccCCCccCCCccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhh----cC----
Q 002410 763 --HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK----KG---- 830 (927)
Q Consensus 763 --~~~~~~~gt~~Y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~----~~---- 830 (927)
.......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ....+....... ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhh
Confidence 11122346778999999865 35789999999999999999999999743221 111111110000 00
Q ss_pred ---Ceee----ecccccc----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 831 ---DVIS----IVDPVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 831 ---~~~~----~~d~~l~----~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.... ..++... ..........+.+++.+||+.||++||+++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 0000000 01112233578899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=301.61 Aligned_cols=265 Identities=25% Similarity=0.334 Sum_probs=196.3
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhc-CCCceeeeeeeeecC--ceEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE--HQRI 677 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~--~~~~ 677 (927)
...|.+.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456778899999999999999876 5889999988542 223345677899999999 999999999988643 4689
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+|+||++ ++|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 599998873 268889999999999999999998 99999999999999999999999999999875
Q ss_pred cccccc----cccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH-------
Q 002410 758 EEDLTH----ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS------- 825 (927)
Q Consensus 758 ~~~~~~----~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~------- 825 (927)
...... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 433221 2223457889999998754 5678999999999999999999999974432211110000000
Q ss_pred -hhhcCCeeeeccccc------cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 826 -MIKKGDVISIVDPVL------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 826 -~~~~~~~~~~~d~~l------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.+.......+++... ...........+.+++.+|++.+|++||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000000000 000001124578899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=292.05 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=196.0
Q ss_pred HhhcccccccccEEEEEEEEC----CCcEEEEEEccCcc----chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~----~g~~vAvK~l~~~~----~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~ 677 (927)
|++.+.||+|+||.||+|... +|+.||+|+++... ....+.+.+|+++++++ +|+||+++++.+..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 456789999999999999863 68899999987532 22346688899999999 5999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+|+||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.+||+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 82 LILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999874 4568899999999999999999998 99999999999999999999999999999875
Q ss_pred cccccccccccccCCCccCCCccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
............|+..|+|||.+.+. .++.++||||||+++|+|++|+.||....... ..............
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~---- 229 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSEP---- 229 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccCC----
Confidence 44332222234578899999998653 46789999999999999999999996332211 11121221111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 876 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~~ 876 (927)
. .+......+.+++.+|++.+|++|| ++++++..
T Consensus 230 ---~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 230 ---P----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---C----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0 1111233678999999999999997 66777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=295.28 Aligned_cols=260 Identities=19% Similarity=0.233 Sum_probs=186.1
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEECC----CcEEEEEEccCccchh-----------HHHHHHHHHHHHhcCCCcee
Q 002410 600 PELEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSHR-----------TQQFVTEVALLSRIHHRNLV 664 (927)
Q Consensus 600 ~el~~~~~~~~~~LG~G~~G~Vy~a~~~~----g~~vAvK~l~~~~~~~-----------~~~~~~E~~~L~~l~HpnIv 664 (927)
.++....|.+.++||+|+||.||+|...+ +..+|+|+........ ......+...+..+.|+|++
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 34455567888999999999999999764 3456666543221110 01122344455667899999
Q ss_pred eeeeeeecCc----eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc
Q 002410 665 PLIGYCEEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 740 (927)
Q Consensus 665 ~l~~~~~~~~----~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl 740 (927)
++++.+.... ..++++|++. .++.+.+.. ....++..+..++.|++.||+|||+ ++|+||||||+|||+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill 159 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMV 159 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence 9998765433 3467888764 466666653 2335678889999999999999998 899999999999999
Q ss_pred cCCCcEEEeeccccccccccccc------cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 002410 741 DINMRAKVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 814 (927)
Q Consensus 741 d~~~~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~ 814 (927)
+.++.++|+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 99999999999999875322111 112235899999999999999999999999999999999999999754322
Q ss_pred ch-hhH--HHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 815 AE-LNI--VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 815 ~~-~~l--~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
.. ... .++.. .+..+... ....+..+.+++..|++.+|++||++.++++.|+
T Consensus 240 ~~~~~~~~~~~~~-~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 240 GNLIHAAKCDFIK-RLHEGKIK-----------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHHHhHHHHHH-Hhhhhhhc-----------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11 110 11111 11111110 0112356889999999999999999999998763
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=289.38 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=194.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc-----cchhHHHHHHHHHHHHhcCCCceeeeeeeeecC--ceEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 678 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~-----~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~~~L 678 (927)
|++.+.||+|++|.||+|... +++.||+|.+... .......+.+|++++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 566789999999999999875 5899999987532 123446788999999999999999999998653 46789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
++||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 84 FVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 9999999999999873 3458899999999999999999998 899999999999999999999999999998653
Q ss_pred cccc--ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 759 EDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 759 ~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
.... .......++..|+|||.+.+..++.++|||||||++|||++|+.||...... ... ....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~----~~~~~~~-~~--- 227 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AAI----FKIATQP-TK--- 227 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HHH----HHHHcCC-CC---
Confidence 2111 1112234788999999998888999999999999999999999999733211 111 1111111 00
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
...+......+.+++.+|++ +|.+||++.+++.
T Consensus 228 -----~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 -----PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11122233468899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=299.80 Aligned_cols=256 Identities=20% Similarity=0.207 Sum_probs=193.2
Q ss_pred hcccccccccEEEEEEEEC-CCcEEEEEEccCccchh--------------HHHHHHHHHHHHhcCCCceeeeeeeeecC
Q 002410 609 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR--------------TQQFVTEVALLSRIHHRNLVPLIGYCEEE 673 (927)
Q Consensus 609 ~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~--------------~~~~~~E~~~L~~l~HpnIv~l~~~~~~~ 673 (927)
+.+.||+|+||+||+|..+ +++.||||+++...... ...+.+|++++++++|+||+++++++..+
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 3577999999999999876 68999999986532211 12577899999999999999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccc
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 753 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 753 (927)
+..++||||++ |+|.+++. ....+++.....++.|++.||+|||+ ++++|+||+|+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred CcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999996 68999887 34568999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccc-------------cccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhH
Q 002410 754 SRQAEEDL-------------THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 819 (927)
Q Consensus 754 a~~~~~~~-------------~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l 819 (927)
+....... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||...+..+ .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~---~ 242 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---Q 242 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence 87654110 1111122367889999998764 46899999999999999999999997443321 1
Q ss_pred HHHHHHhhhcCC---eeeec------------cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 820 VHWARSMIKKGD---VISIV------------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 820 ~~~~~~~~~~~~---~~~~~------------d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
...+........ ..... .+... .........+.+++.+||+.+|++||+++|++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 111111111100 00000 00000 000112346889999999999999999999986
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=289.38 Aligned_cols=241 Identities=22% Similarity=0.280 Sum_probs=186.9
Q ss_pred cccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHH---HHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 612 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVAL---LSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 612 ~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~---L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.||+|+||.||+|... +++.||+|.+..... .....+..|..+ ++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 588999999865321 222234444443 444579999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+|+|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 9999998873 4579999999999999999999998 9999999999999999999999999999876533221
Q ss_pred ccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 765 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
....|+..|+|||.+.++ .++.++||||+||++|||++|+.||............. .... ..+.+..
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~------~~~~~~~- 220 (278)
T cd05606 153 -HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLT------MAVELPD- 220 (278)
T ss_pred -cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH----Hhhc------cCCCCCC-
Confidence 233588999999998754 68999999999999999999999997443222111111 1100 0111111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 875 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~ 875 (927)
.....+.+++.+|+..+|.+|| +++|+++
T Consensus 221 ---~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 ---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ---cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1234788999999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=291.16 Aligned_cols=259 Identities=22% Similarity=0.275 Sum_probs=194.2
Q ss_pred hhcccccccccEEEEEEEECC-CcEEEEEEccCccc--hhHHHHHHHHHHHHhc---CCCceeeeeeeeecCce-----E
Q 002410 608 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCEEEHQ-----R 676 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l---~HpnIv~l~~~~~~~~~-----~ 676 (927)
++.+.||+|++|.||+|+.+. ++.||+|+++.... .....+.+|+.+++++ +|+|++++++++...+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 456889999999999999874 89999999974322 2234566788877766 59999999999987776 8
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
+++|||+. ++|.+++.... ...+++..++.++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred EEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 99999997 58998887532 3468999999999999999999998 8999999999999999999999999999877
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCe--e-
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV--I- 833 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~--~- 833 (927)
....... ....++..|+|||.+.+..++.++|||||||++|||++|+.||......+ .+............. .
T Consensus 157 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcCC
Confidence 6433211 22346888999999998899999999999999999999999987433221 111111111000000 0
Q ss_pred ------eecccccc---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 834 ------SIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 834 ------~~~d~~l~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
........ ..........+.+++.+||+.||.+||+++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 0111123457789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=291.74 Aligned_cols=246 Identities=27% Similarity=0.401 Sum_probs=199.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc---cchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~LV~E 681 (927)
|.+.+.||+|++|.||+|... +++.||+|++... .....+.+.+|++++++++ |+||+++++++..++..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 556789999999999999876 6899999998653 2233467889999999998 9999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
++++++|.+++.. ...+++..++.++.|++.||++||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 83 YAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999974 4479999999999999999999998 999999999999999999999999999988754432
Q ss_pred c-------------------ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHH
Q 002410 762 T-------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 822 (927)
Q Consensus 762 ~-------------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~ 822 (927)
. .......++..|+|||......++.++||||||++++++++|+.||..... ....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~- 232 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTFQ- 232 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHHH-
Confidence 2 112233478899999999888899999999999999999999999974431 11111
Q ss_pred HHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 002410 823 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM----QEIVL 875 (927)
Q Consensus 823 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~----~eVl~ 875 (927)
..... . ...+......+.+++.+||+.+|.+||++ +|+++
T Consensus 233 --~~~~~-~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 --KILKL-E----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHhc-C----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11110 0 01111123468899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=290.73 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=195.6
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEEEEEecC
Q 002410 608 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.+.+.||+|++|+||+|... +++.|+||++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 45788999999999999986 478899999875432 23344567999999998 999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+|+|.+++.... ...+++..++.++.|++.+|.|||+ ++++|+||+|+||++++++.++|+|||.+.........
T Consensus 81 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (283)
T cd07830 81 EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY- 155 (283)
T ss_pred CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc-
Confidence 889999887532 3578999999999999999999998 89999999999999999999999999999865443221
Q ss_pred ccccccCCCccCCCccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhh-HHH---------HHHHhhhcCCee
Q 002410 765 SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVH---------WARSMIKKGDVI 833 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~-~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~-l~~---------~~~~~~~~~~~~ 833 (927)
....++..|+|||.+. +..++.++|+||||++++||++|+.||......+... ... |...........
T Consensus 156 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 156 -TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred -CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 2234788999999874 4567899999999999999999999996443221110 000 000000000000
Q ss_pred eecccccc---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 834 SIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 834 ~~~d~~l~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..+..... ..........+.+++.+|++.+|++||+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000 0000111357889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=302.40 Aligned_cols=245 Identities=28% Similarity=0.409 Sum_probs=203.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
..|.+.+.||+|.|+.|.+|++. .+..||+|.+.+.... ..+.+.+|+++|+.++|||||+++.+......+|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 34556789999999999999876 5999999999875433 33558899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+.+|.+++++.. .....+.....++.|+.+|++|||+ +.|+|||||++|||++.+.++||+|||++..+..
T Consensus 136 ya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 136 YASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred eccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecc--
Confidence 9999999999984 4556668889999999999999998 9999999999999999999999999999988763
Q ss_pred cccccccccCCCccCCCccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
........|++.|.|||++.+..+ ++++|+||+|+++|-|+.|..||++....+ .-++.+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------------------Lr~rvl 268 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------------------LRPRVL 268 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------------------ccchhe
Confidence 334456679999999999988765 689999999999999999999998544321 111111
Q ss_pred cCCC--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 841 IGNV--KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 841 ~~~~--~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.+.+ +....-++.++++++|..+|.+|++++++.+.
T Consensus 269 ~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 269 RGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111 11112267799999999999999999999865
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=291.49 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=193.9
Q ss_pred HHHhhcccccccccEEEEEEEECC-CcEEEEEEccCcc-chhHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~LV~E 681 (927)
..+.+.+.||+|++|.||+|.+++ ++.||||.++... ......+..|+.++.+.. |+||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 446678999999999999999875 8999999987543 234456777887777775 9999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|++ ++|.+.+... ...+++..+..++.|++.||+|||+ ..+|+||||+|+||++++++.+||+|||++.......
T Consensus 95 ~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 985 5777776542 3478999999999999999999996 2599999999999999999999999999987654322
Q ss_pred cccccccccCCCccCCCccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQ----LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~----~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
.. ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... ... ........ ......
T Consensus 170 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~---~~~~~~~~-~~~~~~ 241 (296)
T cd06618 170 AK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEV---LTKILQEE-PPSLPP 241 (296)
T ss_pred cc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHH---HHHHhcCC-CCCCCC
Confidence 21 2234678999999987553 788999999999999999999999632211 111 11111111 100000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.......+.+++.+||..||++||+++++++.
T Consensus 242 -------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 -------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00123468899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=274.12 Aligned_cols=249 Identities=24% Similarity=0.415 Sum_probs=196.3
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCc-cchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEEEEEecC
Q 002410 608 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
++...||.|..|.|++++.+ .|..+|||.+... ..+..++++..+.++.+-+ +|.||+.+|+|..+...++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 35678999999999999987 4899999999764 3455678888888877664 8999999999999988999999883
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
..+..+++.. .+++++..+-++...+.+||.||.+ +++|+|||+||+|||+|+.|++||||||++-.+.+...+
T Consensus 175 -~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh- 248 (391)
T KOG0983|consen 175 -TCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH- 248 (391)
T ss_pred -HHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc-
Confidence 3455555542 4668888889999999999999998 699999999999999999999999999999887654433
Q ss_pred ccccccCCCccCCCccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 765 SSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~---~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
...+|-+.|||||.+. ...|+.++||||||+.++||.||+.||.+.+.+- .... ....+ .. |.+.
T Consensus 249 -trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~lt---kvln~-eP-----P~L~ 316 (391)
T KOG0983|consen 249 -TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVLT---KVLNE-EP-----PLLP 316 (391)
T ss_pred -ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHHH---HHHhc-CC-----CCCC
Confidence 3445889999999985 4578899999999999999999999998644321 1111 11111 11 2222
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
... .....+.+++..||++|+.+||...++++.
T Consensus 317 ~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 317 GHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 111 123468899999999999999999998864
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=292.28 Aligned_cols=250 Identities=29% Similarity=0.414 Sum_probs=196.5
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc---cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~L 678 (927)
...++...+.||+|++|.||+|... +++.+|+|.+... .....+++.+|+++++.++|+|++++++++...+..++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 4455667789999999999999976 5788999988642 22344678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
|+||+. |+|.+.+... ...+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 93 v~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 93 VMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 999996 6887777532 3458899999999999999999998 899999999999999999999999999987654
Q ss_pred ccccccccccccCCCccCCCccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 759 EDLTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 759 ~~~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
.. ....++..|+|||.+. ...++.++|||||||++|||++|+.||....... .... ...+.....
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~-----~~~~~~~~~ 234 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYH-----IAQNESPAL 234 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--HHHH-----HhhcCCCCc
Confidence 32 1234788999999874 3567889999999999999999999986332111 1111 111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
. .......+.+++.+||+.+|++||+++++++..-
T Consensus 235 -----~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 235 -----Q---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -----C---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 0 1122346789999999999999999999987633
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=294.82 Aligned_cols=243 Identities=24% Similarity=0.304 Sum_probs=198.0
Q ss_pred hcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 609 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 609 ~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.-++||+|+||.||..+.+ +|+.+|.|.+.+.. .......++|-.+|.+++.+.||.+--.++..+.+++|+..|.
T Consensus 189 ~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMN 268 (591)
T KOG0986|consen 189 VYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMN 268 (591)
T ss_pred eeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeec
Confidence 3578999999999999876 59999999886532 2344567889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
||+|.-+|... ....+++..++-++.+|+.||+|||+ .+||.||+||+|||+|+.|+++|+|+|+|..+.......
T Consensus 269 GGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~ 344 (591)
T KOG0986|consen 269 GGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR 344 (591)
T ss_pred CCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCccc
Confidence 99999888754 35689999999999999999999998 999999999999999999999999999999887655443
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 844 (927)
. .+||.+|||||++.+..|+...|-||+||+||||+.|+.||........... +.+.+.+. + ..+
T Consensus 345 ~--rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE---vdrr~~~~-------~---~ey 409 (591)
T KOG0986|consen 345 G--RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE---VDRRTLED-------P---EEY 409 (591)
T ss_pred c--ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH---HHHHHhcc-------h---hhc
Confidence 3 3699999999999999999999999999999999999999973322211101 11111111 0 122
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCH
Q 002410 845 KIESIWRIAEVAIQCVEQRGFSRPKM 870 (927)
Q Consensus 845 ~~~~~~~l~~Li~~Cl~~dP~~RPs~ 870 (927)
+....++..++....|+.||++|...
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhccC
Confidence 33334467788999999999998743
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=294.75 Aligned_cols=264 Identities=22% Similarity=0.268 Sum_probs=192.2
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecC--------
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEE-------- 673 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-------- 673 (927)
..|++.++||+|++|.||+|..+ +++.+|+|++...... ....+.+|++++++++|+||+++++++...
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 45667889999999999999976 5889999998643222 234677899999999999999999987443
Q ss_pred ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccc
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 753 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 753 (927)
...++|+||+++ +|.+.+.. ....+++.++..++.|+++||+|||+ ++++|+||||+||++++++.++|+|||+
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 346899999964 67777653 24579999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccccc----------ccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHH
Q 002410 754 SRQAEEDLTHI----------SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 822 (927)
Q Consensus 754 a~~~~~~~~~~----------~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~ 822 (927)
+.......... .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 97654322111 112346788999998765 4578999999999999999999999974433221111110
Q ss_pred HHHhhhcC------Ceeeec--------cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 823 ARSMIKKG------DVISIV--------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 823 ~~~~~~~~------~~~~~~--------d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
........ ...... .+.+.. ........+.+++.+||+.+|++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000 000000 000000 00112246889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=288.25 Aligned_cols=244 Identities=30% Similarity=0.425 Sum_probs=192.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
+...++||+|++|+||+|+.. +++.|++|++.... ....+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 344578999999999999875 58899999986432 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+. |+|.+.+... ...+++.+++.++.||+.||+|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-- 174 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-- 174 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence 95 5787777642 4568999999999999999999998 89999999999999999999999999988653221
Q ss_pred ccccccccCCCccCCCccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 763 HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
....|+..|+|||.+. ...++.++|||||||++|||++|..||...+... ... ..... ......
T Consensus 175 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~---~~~---~~~~~-~~~~~~--- 241 (313)
T cd06633 175 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALY---HIAQN-DSPTLQ--- 241 (313)
T ss_pred ---CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHH---HHHhc-CCCCCC---
Confidence 2335788999999984 4568889999999999999999999986432211 111 11111 111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.......+.+++.+||+.+|++||++.++++.
T Consensus 242 -----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 -----SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122357899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=288.10 Aligned_cols=257 Identities=25% Similarity=0.311 Sum_probs=197.2
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 608 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
++.+.||+|++|.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|+|++++++++.+.+..++|+||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 34678999999999999987 48999999987653 2334677889999999999999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||+|+||++++++.++|+|||.+.........
T Consensus 82 -~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 154 (282)
T cd07829 82 -MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT- 154 (282)
T ss_pred -cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-
Confidence 5999999843 2468999999999999999999998 89999999999999999999999999998876443221
Q ss_pred ccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhh---------------
Q 002410 765 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK--------------- 828 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~--------------- 828 (927)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||........ ...+.....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhccccc
Confidence 1223356789999998766 889999999999999999999999975432211 111111000
Q ss_pred -cCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 829 -KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 829 -~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
............ ..........+.+++.+||+.+|++||++++++.
T Consensus 232 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000000 0000112447899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=327.10 Aligned_cols=244 Identities=28% Similarity=0.389 Sum_probs=195.9
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 687 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gs 687 (927)
.+||.|.||.||-|... +|+..|+|.++-.. ....+.+.+|..++..|+|||+|+++|+-.+.+..+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 57999999999999754 68899999886432 3344678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc---
Q 002410 688 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI--- 764 (927)
Q Consensus 688 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~--- 764 (927)
|.+.+. .+...++.....+..|++.|++|||+ +|||||||||.||+++.+|.+|++|||.|..+.......
T Consensus 1321 La~ll~---~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1321 LASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 999998 45567777778889999999999998 999999999999999999999999999999876553222
Q ss_pred ccccccCCCccCCCccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 765 SSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~---~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
-....||+.|||||++.+. ....+.||||+|||+.||+||+.||...+. +..+.. .+..|....+
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--e~aIMy----~V~~gh~Pq~------ 1462 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--EWAIMY----HVAAGHKPQI------ 1462 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--hhHHHh----HHhccCCCCC------
Confidence 1234699999999999654 345689999999999999999999973332 222222 2222322222
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+.....+=.+++.+||+.||++|.++.|+++
T Consensus 1463 ---P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1463 ---PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ---chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 1122234568999999999999999887765
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=315.28 Aligned_cols=264 Identities=26% Similarity=0.440 Sum_probs=211.9
Q ss_pred hHHHHHHhhcccccccccEEEEEEEECC--------CcEEEEEEccCccc-hhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYC 670 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~~--------g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l-~HpnIv~l~~~~ 670 (927)
|+......+.+.||+|.||.|++|.... ...||||.++.... .+.+.+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 4555555677799999999999998541 35799999986543 4567899999999999 699999999999
Q ss_pred ecCceEEEEEEecCCCCHHHHhccCC-----CC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 002410 671 EEEHQRILVYEYMHNGTLRDRLHGSV-----NQ--------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 737 (927)
Q Consensus 671 ~~~~~~~LV~E~~~~gsL~~~L~~~~-----~~--------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~N 737 (927)
..++..++|+||++.|+|.++|+..+ .. ..++....+.++.|||.|++||++ ++++||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhh
Confidence 99999999999999999999998654 01 248899999999999999999998 999999999999
Q ss_pred ccccCCCcEEEeecccccccccccccccccccc--CCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccc
Q 002410 738 ILLDINMRAKVSDFGLSRQAEEDLTHISSVARG--TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFG 814 (927)
Q Consensus 738 ILld~~~~~kL~DFGla~~~~~~~~~~~~~~~g--t~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~ 814 (927)
||+..+..+||+|||+|+..............+ ...|||||.+....++.|+|||||||+||||+| |..||.+-.
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-- 526 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-- 526 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--
Confidence 999999999999999999755544333222222 456999999999999999999999999999999 889986411
Q ss_pred chhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 815 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 815 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
....+.+ .+++|...+ .+..+..++.++++.||+.+|++||+..|+.+.++..+.
T Consensus 527 ~~~~l~~----~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 PTEELLE----FLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred cHHHHHH----HHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1222233 233332211 122234578899999999999999999999999999643
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=278.70 Aligned_cols=236 Identities=30% Similarity=0.396 Sum_probs=192.5
Q ss_pred ccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCH
Q 002410 613 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 688 (927)
Q Consensus 613 LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL 688 (927)
||+|++|.||++... +++.+|+|.+..... .....+.+|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999987 489999999875432 2456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccccccc
Q 002410 689 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 768 (927)
Q Consensus 689 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 768 (927)
.+++.. ...+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTF 153 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCC
Confidence 999974 3468999999999999999999998 9999999999999999999999999999887544321 12334
Q ss_pred ccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHH
Q 002410 769 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 848 (927)
Q Consensus 769 ~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 848 (927)
.++..|+|||...+...+.++|+||||+++|+|++|+.||...+. ..... .... ... ..+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~---~~~~-~~~----------~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYE---KILK-DPL----------RFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHhc-CCC----------CCCCCC
Confidence 578899999999888889999999999999999999999974332 11111 1111 110 011111
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHH
Q 002410 849 IWRIAEVAIQCVEQRGFSRPKMQE 872 (927)
Q Consensus 849 ~~~l~~Li~~Cl~~dP~~RPs~~e 872 (927)
...+.+++.+||..||++||++++
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 347789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=283.82 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=193.6
Q ss_pred HhhcccccccccEEEEEEEECC-CcEEEEEEccCc-----cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~-----~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
|.+.++||+|+||.||++.... +..+++|+++.. ......++..|+.++++++||||+++++++.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 5667899999999999998764 445666665432 1223345778999999999999999999999989999999
Q ss_pred EecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 681 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
||+++++|.+++.... ....+++..++.++.|++.||.|||+ .+++|+||||+||++++ +.++|+|||.+.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 9999999999886432 34578999999999999999999998 99999999999999975 5699999999876543
Q ss_pred cccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 760 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ........ .+.. +.
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~-~~~~-----~~ 224 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIV-EGPT-----PS 224 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHH-cCCC-----CC
Confidence 222 12234478899999999888889999999999999999999999963221 11111111 1111 11
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.+......+.+++.+|++.+|++||++.|+++
T Consensus 225 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 ----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11233457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=299.64 Aligned_cols=261 Identities=21% Similarity=0.306 Sum_probs=191.8
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC----------
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE---------- 673 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~---------- 673 (927)
.+|.+.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 35667889999999999999876 5889999998766556667889999999999999999999876543
Q ss_pred ----ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc-CCCcEEE
Q 002410 674 ----HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKV 748 (927)
Q Consensus 674 ----~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld-~~~~~kL 748 (927)
...++|+||++ ++|.+++. ...+++..++.++.||+.||+|||+ .+|+||||||+||+++ +++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 58988875 3458899999999999999999998 8999999999999997 4567899
Q ss_pred eecccccccccccccc--ccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 002410 749 SDFGLSRQAEEDLTHI--SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 825 (927)
Q Consensus 749 ~DFGla~~~~~~~~~~--~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 825 (927)
+|||+++......... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... .....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~--~~~~~ 234 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ--LILES 234 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHh
Confidence 9999997654322211 122346889999997654 567889999999999999999999996433211110 00000
Q ss_pred hhh--c---CCeeeeccccc-----cC-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 826 MIK--K---GDVISIVDPVL-----IG-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 826 ~~~--~---~~~~~~~d~~l-----~~-----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
... . ........... .. .........+.+++.+||+.||++||+++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 0 00000000000 00 000112346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=272.93 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=198.5
Q ss_pred cccccccccEEEEEEE-ECCCcEEEEEEccCccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEEEEEecCCCC
Q 002410 610 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGT 687 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~LV~E~~~~gs 687 (927)
.+.||+|+++.|--+. +.+|.++|||++.+...+...+..+|++++.+.+ |+||+.++++|+++...|||||.|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 5789999999998875 5689999999999888888899999999999995 9999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCc---EEEeeccccccccc--ccc
Q 002410 688 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEE--DLT 762 (927)
Q Consensus 688 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~---~kL~DFGla~~~~~--~~~ 762 (927)
|..+|+ ..+.+++.++.++.++|+.||.+||. +||.||||||+|||..+... +|||||.+..-+.. +..
T Consensus 163 lLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 163 LLSHIQ---KRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999998 46779999999999999999999997 99999999999999976543 89999988765322 111
Q ss_pred c----cccccccCCCccCCCcc-----CCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc-------ch-hhHHHHHHH
Q 002410 763 H----ISSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-------AE-LNIVHWARS 825 (927)
Q Consensus 763 ~----~~~~~~gt~~Y~APE~l-----~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~-------~~-~~l~~~~~~ 825 (927)
. .-...+|+..|||||+. ....|+.++|.||||||||-|+.|.+||.+.-.. +. ..=.+.+-.
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 1 11234588899999986 2346889999999999999999999999744321 10 011111222
Q ss_pred hhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 826 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 826 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.+++|.. ++-|.. -.....+..+++...+..|+.+|-++.++++
T Consensus 317 sIQEGkY-eFPdkd-----WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SIQEGKY-EFPDKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHhccCC-cCChhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 3333332 111110 0112235668888999999999999999987
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=294.11 Aligned_cols=260 Identities=21% Similarity=0.281 Sum_probs=190.6
Q ss_pred HhhcccccccccEEEEEEEEC-C--CcEEEEEEccCcc--chhHHHHHHHHHHHHhc-CCCceeeeeeeeec----CceE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-D--GKEVAVKIMADSC--SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQR 676 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~--g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~----~~~~ 676 (927)
|++.+.||+|+||.||+++.. . ++.||+|++.... ....+.+.+|+++++++ +||||+++++.+.. ....
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 456789999999999999976 3 6789999987532 22346788899999999 59999999987532 2457
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++++|++. ++|.+++. ....+++..++.++.||+.||+|||+ ++++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 82 YLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 88888885 68999886 35678999999999999999999998 9999999999999999999999999999986
Q ss_pred ccccccc---cccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhh----
Q 002410 757 AEEDLTH---ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---- 828 (927)
Q Consensus 757 ~~~~~~~---~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~---- 828 (927)
....... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||...+.... .........
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~ 231 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ---LNQILQVLGTPDE 231 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH---HHHHHHHhCCCCH
Confidence 5432211 1122357899999998765 4689999999999999999999999974432111 110000000
Q ss_pred -------cCCeee------eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 829 -------KGDVIS------IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 829 -------~~~~~~------~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
...... .................+.+++.+||+.||++||+++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 000000000001123468899999999999999999998743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=273.83 Aligned_cols=204 Identities=26% Similarity=0.377 Sum_probs=171.1
Q ss_pred HHhhcccccccccEEEEEEEECC-----CcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeec-CceEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRI 677 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~-----g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-~~~~~ 677 (927)
.|+.+..||+|.+|.||+|.-++ .+.+|+|+++.... .-.....+|+.+++.++|||++.+..++.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 46678899999999999996542 34799999986532 223567899999999999999999998876 78899
Q ss_pred EEEEecCCCCHHHHhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC----CcEEEeec
Q 002410 678 LVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN----MRAKVSDF 751 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~----~~~kL~DF 751 (927)
+++||.+. +|.++++-.. ..+.++...+..|+.||+.|+.|||+ +=|+||||||.|||+..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999976 8888886443 34678999999999999999999998 789999999999999877 89999999
Q ss_pred ccccccccccccc--ccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 002410 752 GLSRQAEEDLTHI--SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDF 813 (927)
Q Consensus 752 Gla~~~~~~~~~~--~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~ 813 (927)
|+++.+.+..... ...++-|..|+|||++.+. .|+++.||||.||+..||+|-++.|.+...
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE 245 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence 9999987654433 2345679999999998765 789999999999999999999988875543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=273.31 Aligned_cols=246 Identities=24% Similarity=0.352 Sum_probs=200.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
..+|.++||+|.||.|.+++-+ .++.+|+|++++..- .....-+.|-++|+..+||.+..+--.|+..+++|+|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 4567899999999999999876 699999999987532 334556779999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|..||.|.-+|. ....+++....-+-..|..||.|||+ ++||.||||.+|.|+|.+|++||+|||+++..-..
T Consensus 249 yanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~- 321 (516)
T KOG0690|consen 249 YANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY- 321 (516)
T ss_pred EccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcccc-
Confidence 999999998887 35678888888999999999999998 99999999999999999999999999999863222
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
.......+|||.|+|||++....|..+.|-|.+||++|||++|+.||...+...-..++- ..+-++...+.
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-----~ed~kFPr~ls---- 392 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-----MEDLKFPRTLS---- 392 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-----hhhccCCccCC----
Confidence 233456789999999999999999999999999999999999999997544332111111 11111211111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 875 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~ 875 (927)
.+...|+...|.+||.+|. .++||.+
T Consensus 393 --------~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 393 --------PEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred --------HHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 2456888999999999997 4555544
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=291.85 Aligned_cols=259 Identities=22% Similarity=0.321 Sum_probs=193.3
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeec-CceEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-~~~~~LV~ 680 (927)
..|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....++++
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~ 89 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT 89 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence 34566789999999999999866 68999999876432 2234678899999999999999999998865 56788999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+ +++|.++++ ...+++..+..++.|+++||+|||+ ++|+||||+|+||++++++.++|+|||++......
T Consensus 90 e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 90 ELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred ehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 998 568988886 3457888889999999999999998 99999999999999999999999999998764332
Q ss_pred ccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhh-HHHH--------HHHhhhcC
Q 002410 761 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHW--------ARSMIKKG 830 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~-l~~~--------~~~~~~~~ 830 (927)
. ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......... +.+. ...... +
T Consensus 162 ~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 236 (328)
T cd07856 162 M----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS-E 236 (328)
T ss_pred c----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc-h
Confidence 1 22346788999998765 578999999999999999999999997443211111 1110 000000 0
Q ss_pred Ceeeeccc-cccCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 831 DVISIVDP-VLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 831 ~~~~~~d~-~l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
...+.+.. ......+ ......+.+++.+||+.+|++||+++|++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 0000000 1123578899999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=295.64 Aligned_cols=265 Identities=23% Similarity=0.339 Sum_probs=193.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecC------ceE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQR 676 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------~~~ 676 (927)
.|.+.+.||+|++|.||+|... +|+.||+|++.... ......+.+|++++++++||||+++++++... ...
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 95 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence 4555789999999999999875 68999999986532 22345688999999999999999999988654 346
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++|+||+. .+|.+++. ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++.
T Consensus 96 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 96 YLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 89999996 47776643 358889999999999999999998 8999999999999999999999999999876
Q ss_pred ccccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH--------Hhh
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMI 827 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~--------~~~ 827 (927)
..... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+............ ...
T Consensus 167 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 167 ADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 53321 12346788999999866 468899999999999999999999997543221111000000 000
Q ss_pred hcCCeeeecc--ccc-cCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhhh
Q 002410 828 KKGDVISIVD--PVL-IGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIKI 883 (927)
Q Consensus 828 ~~~~~~~~~d--~~l-~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~--L~~~~~~ 883 (927)
.......... +.. .... .......+.+++.+||+.||++||+++|+++. +++....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 0000000000 000 0000 00122357899999999999999999999955 7766543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=290.81 Aligned_cols=257 Identities=23% Similarity=0.335 Sum_probs=192.3
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCc------e
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------Q 675 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~------~ 675 (927)
.+|.+.+.||+|++|.||+|... +++.||||++.... ......+.+|++++++++||||+++++++..+. .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 34667889999999999999865 68999999986432 223456889999999999999999999886543 4
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
.++||||+ +++|.+++. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++.
T Consensus 95 ~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred EEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 58999999 779988876 3468999999999999999999998 999999999999999999999999999988
Q ss_pred cccccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH---------
Q 002410 756 QAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS--------- 825 (927)
Q Consensus 756 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~--------- 825 (927)
...... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+... ........
T Consensus 167 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 167 QTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGTPSKEFV 240 (343)
T ss_pred ccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHH
Confidence 654322 22346889999998865 468899999999999999999999997443211 11110000
Q ss_pred -hhhcCCeeeecc--cccc----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 826 -MIKKGDVISIVD--PVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 826 -~~~~~~~~~~~d--~~l~----~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.+.......... +... ..........+.+++.+|++.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000 0000 0000112235789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=272.37 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=193.7
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeeec----CceEEEEEEec
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQRILVYEYM 683 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~----~~~~~LV~E~~ 683 (927)
.++||-|-.|.|-...++ .++.+|+|++.+. ...++|+++.-.. .|||||.+++++.+ ...+.+|||.|
T Consensus 67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 378999999999999877 6889999999754 3345788776555 59999999998754 45678999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC---CCcEEEeecccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~---~~~~kL~DFGla~~~~~~ 760 (927)
+||.|.+.++.. ....+++.++..|++||+.|+.|||+ .+|.||||||+|+|... |-.+||+|||+|+.....
T Consensus 142 eGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 142 EGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred cchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 999999999865 46679999999999999999999998 99999999999999964 556999999999986543
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
.. .....-|+.|.|||++...+|+..+|+||+||++|-|++|.+||-.... ..+.--++..+..+... +-++
T Consensus 218 ~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gqy~-FP~p-- 289 (400)
T KOG0604|consen 218 GD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQYE-FPEP-- 289 (400)
T ss_pred cc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccCcc-CCCh--
Confidence 22 2234469999999999999999999999999999999999999962221 11222223333333221 1011
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
--....+...++|+.+|..+|.+|.|+.|+++.
T Consensus 290 ---EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 290 ---EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ---hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 012334567899999999999999999999863
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=277.37 Aligned_cols=260 Identities=25% Similarity=0.375 Sum_probs=207.9
Q ss_pred HHHHHHhhcccccccccEEEEEEEECC------CcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeec-C
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEE-E 673 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~------g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-~ 673 (927)
+.+.+.+....+-+|.||+||+|.|.+ .+.|.+|.++.... -....++.|.-++..+.|||+..+.+++.+ .
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 344444556779999999999997653 45688888876543 355778999999999999999999998855 4
Q ss_pred ceEEEEEEecCCCCHHHHhc-----cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEE
Q 002410 674 HQRILVYEYMHNGTLRDRLH-----GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 748 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~-----~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL 748 (927)
...++++.++.-|+|..+|. +....+.++..+...++.|++.|++|||. ++|||.||.++|++||+..++||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEe
Confidence 56788999999999999998 33345668888999999999999999998 99999999999999999999999
Q ss_pred eeccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHh
Q 002410 749 SDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 826 (927)
Q Consensus 749 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 826 (927)
+|=.+++..-+...+ .......+..||+||.+.+..|+.++|||||||+||||+| |+.|+..-+..+ .. ..
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE---m~----~y 510 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE---ME----HY 510 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH---HH----HH
Confidence 999999986554333 3333446779999999999999999999999999999999 999997333211 11 12
Q ss_pred hhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 827 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 827 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
++.|.. + ..+..+++++..++.-||...|++||+.++++.-|.+-
T Consensus 511 lkdGyR-------l--aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 511 LKDGYR-------L--AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred Hhccce-------e--cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 222211 1 12345677899999999999999999999999888753
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=308.97 Aligned_cols=245 Identities=28% Similarity=0.408 Sum_probs=183.2
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeee-----------------
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYC----------------- 670 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~----------------- 670 (927)
.+.||+||||.||+++.+ ||+.+|||++.-.. ......+.+|++.|++|+|||||+++...
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 468999999999999988 89999999997543 33346788999999999999999986110
Q ss_pred -------------------------------------------e-----------------------------c------
Q 002410 671 -------------------------------------------E-----------------------------E------ 672 (927)
Q Consensus 671 -------------------------------------------~-----------------------------~------ 672 (927)
. +
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence 0 0
Q ss_pred ----------------C--------ceEEEEEEecCCCCHHHHhccCCCCCCC-CHHHHHHHHHHHHHHHHHHHhcCCCC
Q 002410 673 ----------------E--------HQRILVYEYMHNGTLRDRLHGSVNQKPL-DWLTRLQIAHDAAKGLEYLHTGCNPG 727 (927)
Q Consensus 673 ----------------~--------~~~~LV~E~~~~gsL~~~L~~~~~~~~l-~~~~~~~i~~qia~gL~~LH~~~~~~ 727 (927)
+ ..+|+-||||+...|.++++... .. .....++++.+|++||+|+|+ +|
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~---~~~~~d~~wrLFreIlEGLaYIH~---~g 717 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH---FNSQRDEAWRLFREILEGLAYIHD---QG 717 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc---cchhhHHHHHHHHHHHHHHHHHHh---Cc
Confidence 0 12578899999988888887532 22 466789999999999999998 99
Q ss_pred eEecCCCCCcccccCCCcEEEeecccccccc------c-----------cccccccccccCCCccCCCccCCC---CCCc
Q 002410 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAE------E-----------DLTHISSVARGTVGYLDPEYYGNQ---QLTE 787 (927)
Q Consensus 728 ivH~DLkp~NILld~~~~~kL~DFGla~~~~------~-----------~~~~~~~~~~gt~~Y~APE~l~~~---~~s~ 787 (927)
||||||||.|||+|++..+||+|||+|.... . ......+..+||.-|+|||++.+. .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998721 0 001122345699999999999765 4999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCC
Q 002410 788 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR 867 (927)
Q Consensus 788 ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R 867 (927)
|+|+||+|||++||+. ||.. ..+...... .++.+.+... ..+.......=.++|++|++.||.+|
T Consensus 798 KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~----~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGT--SMERASILT----NLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCc--hHHHHHHHH----hcccCCCCCC------cccccccchHHHHHHHHHhcCCCccC
Confidence 9999999999999985 4641 112222222 2333433332 11111222234589999999999999
Q ss_pred CCHHHHHH
Q 002410 868 PKMQEIVL 875 (927)
Q Consensus 868 Ps~~eVl~ 875 (927)
||+.|+++
T Consensus 863 PtA~eLL~ 870 (1351)
T KOG1035|consen 863 PTATELLN 870 (1351)
T ss_pred CCHHHHhh
Confidence 99999885
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=293.78 Aligned_cols=256 Identities=22% Similarity=0.305 Sum_probs=190.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecC------ceE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQR 676 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------~~~ 676 (927)
.|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (345)
T cd07877 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 97 (345)
T ss_pred ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccE
Confidence 4555789999999999999864 68999999987532 22346688899999999999999999987543 346
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
+++++++ +++|.+++. ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 98 ~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 98 YLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred EEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 7888876 789988876 2458999999999999999999998 9999999999999999999999999999876
Q ss_pred ccccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh---------
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM--------- 826 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~--------- 826 (927)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.... +....+..
T Consensus 170 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 170 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGTPGAELLK 243 (345)
T ss_pred cccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHh
Confidence 5332 123357889999998866 5688999999999999999999999964332111 11100000
Q ss_pred -hhcCC-------eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 827 -IKKGD-------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 827 -~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+.... .......... .........+.+++.+|++.||.+||++.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 0000000000 0000123367899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=295.67 Aligned_cols=256 Identities=21% Similarity=0.306 Sum_probs=193.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCce------E
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------R 676 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~------~ 676 (927)
.|.+.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+|++++++++...+. .
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 4566789999999999999986 57899999986532 2334667889999999999999999998766554 8
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.++|+|||++..
T Consensus 96 ~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 96 YLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred EEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 9999998 6799998873 468999999999999999999998 8999999999999999999999999999987
Q ss_pred ccccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc------
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------ 829 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~------ 829 (927)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ..........
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~---~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ---LKRIMNLVGTPDEELL 240 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHhcCCCCHHHH
Confidence 5432 122347888999998865 4678999999999999999999999974332111 1111110000
Q ss_pred -----CCeeeecc---ccccCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 830 -----GDVISIVD---PVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 830 -----~~~~~~~d---~~l~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
......+. ......+ .......+.+++.+||+.+|++|||+.||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000 0000000 00123478899999999999999999999763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=270.84 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=194.3
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEecCCCC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGT 687 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~~gs 687 (927)
..||.|.||+|++-.++ .|+..|||+++.... ...++++.|.+...+- +.||||+++|.+..++..|+.||.|. .|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence 57999999999999987 599999999986554 4567888888875554 79999999999999999999999994 46
Q ss_pred HHHHhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 688 LRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 688 L~~~L~~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
|..+.+.- ..+..+++..+-.|......||.||.+ +.+||||||||+|||+|..|.+||||||.+-.+.+... .
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA--k 224 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA--K 224 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH--h
Confidence 65443211 135678888888999999999999998 58999999999999999999999999999877654322 2
Q ss_pred cccccCCCccCCCccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 766 SVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
+.-+|-..|||||.+.. ..|+.+|||||||++|||+.||+.|+..-+ ++.+.+..... ++...+..+.
T Consensus 225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~-gdpp~l~~~~---- 294 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVI-GDPPILLFDK---- 294 (361)
T ss_pred hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHc-CCCCeecCcc----
Confidence 33458889999999854 348899999999999999999999997322 22333333332 3322222111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
-..+....+..++..||.+|-.+||...++++.
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 112344578899999999999999999998764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=308.22 Aligned_cols=144 Identities=32% Similarity=0.459 Sum_probs=129.1
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|.+.++||+|+||.||+|... +++.||||+++... ......+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 3556789999999999999987 68999999987532 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
|+++++|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 85 y~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999973 3468889999999999999999998 899999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=272.99 Aligned_cols=221 Identities=22% Similarity=0.204 Sum_probs=176.1
Q ss_pred cccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCHHHHhcc
Q 002410 616 GSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 694 (927)
Q Consensus 616 G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL~~~L~~ 694 (927)
|.+|.||+++.. +++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999876 68899999987542 233455555566799999999999999999999999999999999874
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccccccccCCCc
Q 002410 695 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 774 (927)
Q Consensus 695 ~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y 774 (927)
...+++..+..++.|+++||+|||+ ++++||||||+||+++.++.++++|||.+....... ....++..|
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y 148 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY 148 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence 3458999999999999999999998 999999999999999999999999999876654321 122356789
Q ss_pred cCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHH
Q 002410 775 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 854 (927)
Q Consensus 775 ~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 854 (927)
+|||.+.+..++.++||||+|+++|||++|+.|+...... .... ....+ +......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~~-----~~~~~----~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INTH-----TTLNI----PEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------cccc-----cccCC----cccCCHHHHH
Confidence 9999998888899999999999999999999887522110 0000 00001 1112246789
Q ss_pred HHHHhhccCCCCCCCHHH
Q 002410 855 VAIQCVEQRGFSRPKMQE 872 (927)
Q Consensus 855 Li~~Cl~~dP~~RPs~~e 872 (927)
++.+|++.||++||++.+
T Consensus 208 li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 208 LLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHccCCHHHhcCCCc
Confidence 999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=306.95 Aligned_cols=255 Identities=26% Similarity=0.317 Sum_probs=206.7
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
+....+.+.++||+|+||.|..++++ .++.+|+|++.+.. .....-|..|-.+|..-+.+-|+.++-.|.++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 34567788999999999999999987 58899999998742 344567899999999989999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+|||||+||+|-.++... ..+++..+..++..|..||.-||+ .|+|||||||+|||||..|++||+|||.+-.+
T Consensus 152 lVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred EEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhc
Confidence 999999999999999853 379999999999999999999998 99999999999999999999999999999888
Q ss_pred cccccccccccccCCCccCCCccC----C-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCe
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYG----N-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~----~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 832 (927)
..+....+...+|||.|++||+++ + +.|++.+|-||+||++|||+.|..||..+.. ++--...+.-...
T Consensus 226 ~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------veTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 226 DADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------VETYGKIMNHKES 299 (1317)
T ss_pred CCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------HHHHHHHhchhhh
Confidence 877777777888999999999984 3 6799999999999999999999999973332 2222222221111
Q ss_pred eeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 002410 833 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVLA 876 (927)
Q Consensus 833 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs---~~eVl~~ 876 (927)
..+-+. ........+||.+.+. +|+.|.. ++|+...
T Consensus 300 l~FP~~-------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 300 LSFPDE-------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred cCCCcc-------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 111110 1123356677777665 4778877 8887654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=291.86 Aligned_cols=238 Identities=25% Similarity=0.379 Sum_probs=192.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEe
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
..|.+...+|.|+|+.|-.+.+. +++..+||++.+. ..+-.+|+.++... +||||+++.+.+.++.+.++|||.
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 45677788999999999988776 5889999999765 22334577666665 699999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc-cCCCcEEEeeccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl-d~~~~~kL~DFGla~~~~~~~ 761 (927)
+.|+-+.+.+... ... ..++..|+.+|+.|+.|||+ +||+||||||+|||+ ++.++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~~---~~~-~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSK---PEF-CSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred ccccHHHHHHHhc---chh-HHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999888887632 222 26777899999999999998 999999999999999 68999999999999887655
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
....+-|..|.|||++....+++++|+||||++||+|++|+.||.....+ .+ +...+..+....
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~e----i~~~i~~~~~s~------- 533 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IE----IHTRIQMPKFSE------- 533 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HH----HHHhhcCCcccc-------
Confidence 11223578999999999999999999999999999999999999844433 12 222333333321
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.......+|+.+||+.||.+||+|.++..
T Consensus 534 -----~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 534 -----CVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -----ccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 22236679999999999999999999875
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=283.97 Aligned_cols=244 Identities=26% Similarity=0.399 Sum_probs=195.7
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCC
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 686 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~g 686 (927)
.+.||.|.||+||-|.++ +|+.||||++.+. ......++++|+.+|++++||.||.+...|+..+..++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 578999999999999876 6999999999763 234557899999999999999999999999999999999999965
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC---CcEEEeeccccccccccccc
Q 002410 687 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 687 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~---~~~kL~DFGla~~~~~~~~~ 763 (927)
+..+.+-.. ..+.+++..-..++.||+.||.|||. ++|+|+||||+|||+... -++||||||+|+.+++..
T Consensus 648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 544444333 46778998888999999999999998 999999999999999643 479999999999987643
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
.....+||+.|+|||+++...|...-|+||.||++|--++|..||..+.. +-+ ++++..+ +..+....+
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----Ind----QIQNAaF--MyPp~PW~e 790 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----IND----QIQNAAF--MYPPNPWSE 790 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhH----Hhhcccc--ccCCCchhh
Confidence 34456799999999999999999999999999999999999999972221 111 1222111 122222222
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.+ ...++||...|+..-++|-+.+.-+.
T Consensus 791 is----~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 791 IS----PEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred cC----HHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 22 35678888999999999999877653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=275.57 Aligned_cols=269 Identities=20% Similarity=0.268 Sum_probs=206.7
Q ss_pred cChhhHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcC-C-C----ceeeeeee
Q 002410 597 IPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-H-R----NLVPLIGY 669 (927)
Q Consensus 597 ~~~~el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-H-p----nIv~l~~~ 669 (927)
+...+....+|.+...+|+|.||.|-..... .+..||||+++.. ....+..+-|+++|+++. + | -++.+.++
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 3455677888999999999999999998765 4789999999854 333455677999999993 2 2 37888889
Q ss_pred eecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC-------
Q 002410 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI------- 742 (927)
Q Consensus 670 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~------- 742 (927)
|...++.++|+|.+ |-|+.++|..+ +..+++...+..|+.|+++++++||+ .+++|-||||+|||+-+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEe
Confidence 99999999999998 67999999865 46778999999999999999999998 99999999999999932
Q ss_pred -------------CCcEEEeeccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 002410 743 -------------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 809 (927)
Q Consensus 743 -------------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~ 809 (927)
+..++|+|||.|....+.. ...+.|..|+|||++.+-.++.++||||+||||+|+.||...|.
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 3358999999998765543 34567999999999999999999999999999999999999998
Q ss_pred cccccchhhHHHHHHHh--------------hhcCCe-----------eeeccc-c-c--cCCCCHHHHHHHHHHHHHhh
Q 002410 810 VEDFGAELNIVHWARSM--------------IKKGDV-----------ISIVDP-V-L--IGNVKIESIWRIAEVAIQCV 860 (927)
Q Consensus 810 ~~~~~~~~~l~~~~~~~--------------~~~~~~-----------~~~~d~-~-l--~~~~~~~~~~~l~~Li~~Cl 860 (927)
..+..+.....+.+... ...+++ ....++ . + .......+..+|.+|+++||
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 65533333222221111 001100 000000 0 0 00112345567999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 002410 861 EQRGFSRPKMQEIVL 875 (927)
Q Consensus 861 ~~dP~~RPs~~eVl~ 875 (927)
..||.+|+|+.|++.
T Consensus 391 ~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 391 EFDPARRITLREALS 405 (415)
T ss_pred ccCccccccHHHHhc
Confidence 999999999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=262.80 Aligned_cols=238 Identities=32% Similarity=0.451 Sum_probs=193.2
Q ss_pred ccEEEEEEEECC-CcEEEEEEccCccchh-HHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCHHHHhcc
Q 002410 617 SFGSVYYGKMKD-GKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 694 (927)
Q Consensus 617 ~~G~Vy~a~~~~-g~~vAvK~l~~~~~~~-~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL~~~L~~ 694 (927)
+||.||+|...+ |+.+++|++....... .+.+.+|++.+++++|+|++++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999874 8999999997654444 68899999999999999999999999999999999999999999999874
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccccccccCCCc
Q 002410 695 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 774 (927)
Q Consensus 695 ~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y 774 (927)
. ..+++..+..++.+++.++.+||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++..|
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 2 338899999999999999999998 899999999999999999999999999998765432 22234578899
Q ss_pred cCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHH
Q 002410 775 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 854 (927)
Q Consensus 775 ~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 854 (927)
++||.+.+..++.++||||||+++++|++|..||.... ......+... .+..... .. .......+.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~~~~~~----~~~~~~~-~~------~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLELFKKIG----KPKPPFP-PP------EWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHh----ccCCCCc-cc------cccCCHHHHH
Confidence 99999988888999999999999999999999997321 1112222211 1111000 00 0002347889
Q ss_pred HHHHhhccCCCCCCCHHHHHH
Q 002410 855 VAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 855 Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=242.14 Aligned_cols=260 Identities=20% Similarity=0.266 Sum_probs=200.5
Q ss_pred hcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 609 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 609 ~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
-.++||+|.+|+|++|+.+ .++.||+|.++-+. .......++|+-+|+.++|.|||++++....+....+|+|||.
T Consensus 6 kmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd- 84 (292)
T KOG0662|consen 6 KMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD- 84 (292)
T ss_pred HHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-
Confidence 3478999999999999866 57889999987533 2234667899999999999999999999999999999999995
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
.+|..+.... .+.++.+....++.|+++||.++|+ +++.|||+||.|.||+.+|++|++|||+++-++-.... .
T Consensus 85 qdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvrc-y 158 (292)
T KOG0662|consen 85 QDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-Y 158 (292)
T ss_pred HHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-e
Confidence 5788777653 5678999999999999999999998 99999999999999999999999999999987654332 2
Q ss_pred cccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeee---ccccc
Q 002410 766 SVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI---VDPVL 840 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~---~d~~l 840 (927)
+..+-|..|++|.++.+. -|+...|+||-||++.|+.. |++.|.+.+..++..-+-|......+.....+ -|-..
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 233468999999998775 57899999999999999997 66667766555544444444333333332222 12111
Q ss_pred cCCCCH-----HH----HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 841 IGNVKI-----ES----IWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 841 ~~~~~~-----~~----~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
...++. +. ...=.+++++.+.-+|.+|.++++.++
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111211 11 112357888999999999999998876
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=269.56 Aligned_cols=262 Identities=24% Similarity=0.348 Sum_probs=198.7
Q ss_pred hhhHHHHHHhhcccccccccEEEEEEEE-CCCcEEEEEEccC--ccch-----hHHHHHHHHHHHHhcCCCceeeeeeee
Q 002410 599 LPELEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMAD--SCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYC 670 (927)
Q Consensus 599 ~~el~~~~~~~~~~LG~G~~G~Vy~a~~-~~g~~vAvK~l~~--~~~~-----~~~~~~~E~~~L~~l~HpnIv~l~~~~ 670 (927)
...+...+|-+.+.||+|||+.||+|.. ...+.||||+-.- ...+ ..+...+|.++.+.|.||.||++++++
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 3445667788889999999999999964 4678899998532 2111 224577899999999999999999998
Q ss_pred e-cCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc---CCCcE
Q 002410 671 E-EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRA 746 (927)
Q Consensus 671 ~-~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld---~~~~~ 746 (927)
. +.+..|-|+|||+|.+|.-+|+ ..+.+++.++..|+.||+.||.||.+. ..+|||-||||.|||+- .-|.+
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeI 612 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEI 612 (775)
T ss_pred eeccccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccccee
Confidence 5 5667899999999999999998 467799999999999999999999974 58999999999999994 45789
Q ss_pred EEeeccccccccccccc------cccccccCCCccCCCccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccch
Q 002410 747 KVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYG----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 816 (927)
Q Consensus 747 kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~ 816 (927)
||+|||+++.+.++... ..+...||..|++||.+- ....+.|.||||.||++|+.+.|+.||..... .
T Consensus 613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--Q 690 (775)
T KOG1151|consen 613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--Q 690 (775)
T ss_pred EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--H
Confidence 99999999987654322 234567999999999873 34678899999999999999999999973322 1
Q ss_pred hhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 817 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 817 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..+.+ +..+...-+-.+.. .+....+...+|++||+.--++|....++..
T Consensus 691 QdILq-------eNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 691 QDILQ-------ENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHHHh-------hhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 12222 11111111111110 1111225668999999999999987766653
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=260.68 Aligned_cols=266 Identities=21% Similarity=0.318 Sum_probs=195.8
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccC--ccchhHHHHHHHHHHHHhcCCCceeeeeeeeec--------C
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------E 673 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~--~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--------~ 673 (927)
.+|+-..+||+|.||.||+|+.+ .|+.||+|++-- ....-.....+|+++|+.++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34445578999999999999877 477889877532 112223456789999999999999999998843 2
Q ss_pred ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccc
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 753 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 753 (927)
...++|+.+|+. +|..+|.. ....++..++.+++.++..||.|+|. ..|+|||+||.|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccc
Confidence 357999999975 88888874 24678899999999999999999998 8999999999999999999999999999
Q ss_pred ccccccccccc---ccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc
Q 002410 754 SRQAEEDLTHI---SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 829 (927)
Q Consensus 754 a~~~~~~~~~~---~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 829 (927)
++.+....... ....+.|..|++||.+.+ ..++++.|||+-||++.||+|+.+-+++........++......+..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 97654322211 223446899999998765 58999999999999999999999999865544444443333222222
Q ss_pred CCeeee--------c--cccccCCCC--HHHHH------HHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 830 GDVISI--------V--DPVLIGNVK--IESIW------RIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 830 ~~~~~~--------~--d~~l~~~~~--~~~~~------~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+.+... + +|...+.+. .+... ...+|+.+++..||.+|+.+++++..
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111111 1 111111110 01111 46789999999999999999998753
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=271.08 Aligned_cols=245 Identities=25% Similarity=0.330 Sum_probs=196.4
Q ss_pred hHHHHHHhhcccccccccEEEEEEEECC-CcEEEEEEccCccc---hhHHHHHHHHHHHHhc-CCCceeeeeeeeecCce
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS---HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 675 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~ 675 (927)
.+.....+|..+||+|+||.|-+|..+. .+.+|||+++++.- .+.+--+.|-++|+.. +-|.+++++.+|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 5566778899999999999999998774 67799999987532 2333345677777766 57889999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
+|+||||+.||+|--++++ -+.+.+..+.-++..||-||-+||+ ++|+.||||.+|||+|.+|++||+|||+++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeeEEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccc
Confidence 9999999999999888873 4567777888999999999999998 999999999999999999999999999998
Q ss_pred cccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 756 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 756 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
.---+. .......||+.|+|||++....|+.++|-|||||+||||+.|++||++++..+- .+- +.+..
T Consensus 499 Eni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el---F~a----I~ehn---- 566 (683)
T KOG0696|consen 499 ENIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQA----IMEHN---- 566 (683)
T ss_pred ccccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH----HHHcc----
Confidence 632221 234456799999999999999999999999999999999999999986654321 111 11111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK 869 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs 869 (927)
-.++.....+...+....|.+.|.+|..
T Consensus 567 ------vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 ------VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ------CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 1223333446678888899999999863
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=293.97 Aligned_cols=259 Identities=20% Similarity=0.248 Sum_probs=168.3
Q ss_pred HHHhhcccccccccEEEEEEEECC-----CcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeee------eecC
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY------CEEE 673 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~-----g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~------~~~~ 673 (927)
..|.+.++||+|+||.||+|++.+ ++.||+|++...... +.+..| .++...+.++..++.. +..+
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence 346678999999999999999864 689999987643211 111111 1122222222222221 2456
Q ss_pred ceEEEEEEecCCCCHHHHhccCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSVN-----------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 736 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~~-----------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~ 736 (927)
...++|+||+++++|.+++..... ........+..++.||+.||+|||+ ++|+||||||+
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~ 284 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQ 284 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHH
Confidence 688999999999999999874311 0111234466899999999999998 89999999999
Q ss_pred cccccC-CCcEEEeeccccccccccccccccccccCCCccCCCccCCC----------------------CCCcchhHHH
Q 002410 737 NILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ----------------------QLTEKSDVYS 793 (927)
Q Consensus 737 NILld~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----------------------~~s~ksDVwS 793 (927)
|||++. ++.+||+|||+++..............+++.|+|||.+... .+..++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999985 68999999999987654444444456689999999965321 2345679999
Q ss_pred HHHHHHHHHhCCCCCCcccccc-------hhhHHHHHHHhhhcCCeeeeccccccCCCC--HHHHHHHHHHHHHhhccCC
Q 002410 794 FGVVLLELISGKKPVSVEDFGA-------ELNIVHWARSMIKKGDVISIVDPVLIGNVK--IESIWRIAEVAIQCVEQRG 864 (927)
Q Consensus 794 lGvlL~eLltG~~Pf~~~~~~~-------~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~Li~~Cl~~dP 864 (927)
|||++|||+++..+++...... ......|...... ...+.+...+. ........+|+.+||+.||
T Consensus 365 lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP------RASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc------ccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 9999999999877654110000 0011111111000 00000000000 0011234589999999999
Q ss_pred CCCCCHHHHHHH
Q 002410 865 FSRPKMQEIVLA 876 (927)
Q Consensus 865 ~~RPs~~eVl~~ 876 (927)
++|||++|+++.
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999975
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=285.62 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=201.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeee-----cCceEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCE-----EEHQRILV 679 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~-----~~~~~~LV 679 (927)
.+|.+.||.|.+|.||+++.. +++.+|+|++.... ...+++..|..+|+.. .|||++.++|++. .++.+|||
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV 99 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV 99 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence 456789999999999999865 68899999987553 3346677899999988 6999999999884 36789999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
||||.+||..|+++... +..+.|..+.-|++.++.||.|||. ..++|||||-.|||++.++.+||+|||.+.....
T Consensus 100 MEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred eeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 99999999999999775 7889999999999999999999997 8999999999999999999999999999987755
Q ss_pred cccccccccccCCCccCCCccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 760 DLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
... ......||+.|||||++.. ..|+..+|+||||++..||.-|.+|+.+... .. +.-.+.....
T Consensus 176 T~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP------mr-aLF~IpRNPP-- 245 (953)
T KOG0587|consen 176 TVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP------MR-ALFLIPRNPP-- 245 (953)
T ss_pred ccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch------hh-hhccCCCCCC--
Confidence 433 3345679999999999843 3567799999999999999999999863221 11 1111111111
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..-..+....+++.++|..||.+|-++||++.++++
T Consensus 246 -----PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 246 -----PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -----ccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 111223456678999999999999999999998875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=283.14 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=178.9
Q ss_pred HHHhhcccccccccEEEEEEEE-----------------CCCcEEEEEEccCccchhHHHH--------------HHHHH
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKM-----------------KDGKEVAVKIMADSCSHRTQQF--------------VTEVA 653 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~-----------------~~g~~vAvK~l~~~~~~~~~~~--------------~~E~~ 653 (927)
..+.+.++||+|+||+||+|.+ .+++.||||++........++| ..|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 3456689999999999999964 2356899999875433322333 34777
Q ss_pred HHHhcCCCce-----eeeeeeeec--------CceEEEEEEecCCCCHHHHhccCC---------------------CCC
Q 002410 654 LLSRIHHRNL-----VPLIGYCEE--------EHQRILVYEYMHNGTLRDRLHGSV---------------------NQK 699 (927)
Q Consensus 654 ~L~~l~HpnI-----v~l~~~~~~--------~~~~~LV~E~~~~gsL~~~L~~~~---------------------~~~ 699 (927)
++.+++|.++ ++++++|.. .+..+|||||+++++|.++++... ...
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 7777876554 677777643 356899999999999999987421 112
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccccccccCCCccCCCc
Q 002410 700 PLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 779 (927)
Q Consensus 700 ~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~ 779 (927)
.+++..+..++.|++.+|+|||+ .+|+||||||+|||++.++.+||+|||++...............+++.|+|||.
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 35677889999999999999998 899999999999999999999999999997654332222222335789999998
Q ss_pred cCCCCC----------------------CcchhHHHHHHHHHHHHhCCC-CCCccccc-ch-----hhHHHHHHHhhhcC
Q 002410 780 YGNQQL----------------------TEKSDVYSFGVVLLELISGKK-PVSVEDFG-AE-----LNIVHWARSMIKKG 830 (927)
Q Consensus 780 l~~~~~----------------------s~ksDVwSlGvlL~eLltG~~-Pf~~~~~~-~~-----~~l~~~~~~~~~~~ 830 (927)
+..... ..+.||||+||+++||++|.. |+.....- .. .....|.. ....
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~~ 459 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKGQ 459 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hccc
Confidence 754321 134799999999999999875 66422110 00 11111111 1111
Q ss_pred CeeeeccccccCCCCHHHHHHHHHHHHHhhccCC---CCCCCHHHHHHH
Q 002410 831 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRG---FSRPKMQEIVLA 876 (927)
Q Consensus 831 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP---~~RPs~~eVl~~ 876 (927)
.. +-.. .........+++.+||..+| .+|+|++|++++
T Consensus 460 ~~----~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 KY----DFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CC----Cccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 10 0000 11122367789999999766 689999999863
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=275.17 Aligned_cols=241 Identities=22% Similarity=0.295 Sum_probs=199.6
Q ss_pred HHhhcccccccccEEEEEEEECCCc-EEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~g~-~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
..+....||-|+||.|=++..+..+ .+|+|++++.. ....+.+..|-.+|...+.|.||+++..|.++...|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3345567999999999999887543 38899887642 3345667889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
-|-||.|...|+ ..+.++.....-++..+.+|++|||+ ++||+|||||+|.++|.+|-+||.|||+|+.+....
T Consensus 501 aClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 501 ACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999999998 46778888999999999999999998 999999999999999999999999999999986543
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
...+.+||+.|.|||++.+...+.++|.||||+++|||++|.+||.+.+.....++.-.-...+ .
T Consensus 575 --KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i---~---------- 639 (732)
T KOG0614|consen 575 --KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI---E---------- 639 (732)
T ss_pred --ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh---h----------
Confidence 3446789999999999999999999999999999999999999999766544433332111111 1
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPK 869 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs 869 (927)
++....+...+|+++.+..+|.+|..
T Consensus 640 --~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 640 --FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred --cccccchhHHHHHHHHHhcCcHhhhc
Confidence 11122335678999999999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-29 Score=284.07 Aligned_cols=242 Identities=26% Similarity=0.429 Sum_probs=186.4
Q ss_pred cccccccccE-EEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEecCCCC
Q 002410 610 CKKIGKGSFG-SVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGT 687 (927)
Q Consensus 610 ~~~LG~G~~G-~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~~gs 687 (927)
.+.+|.|+.| .||+|..+ |++||||++-.. -.+-..+|++.|+.- +|||||++++.-.+++..|+..|.|. .+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS 588 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence 3578999987 56999997 899999998643 234567899999988 59999999999999999999999994 69
Q ss_pred HHHHhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC-----CCcEEEeeccccccccccc
Q 002410 688 LRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-----NMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 688 L~~~L~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~-----~~~~kL~DFGla~~~~~~~ 761 (927)
|.++++.. ...........+.++.|+++||+|||+ .+||||||||.||||+. ...++|+|||+++....+.
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 99999863 111111214557789999999999998 99999999999999975 2579999999999987665
Q ss_pred cccc--cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 762 THIS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 762 ~~~~--~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
...+ ....||-+|+|||++....-+.++||||+||++|..++| .+||. +....+.++.. ...-...+.+
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG-d~~~R~~NIl~-------~~~~L~~L~~ 737 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG-DSLERQANILT-------GNYTLVHLEP 737 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC-chHHhhhhhhc-------Cccceeeecc
Confidence 4433 345699999999999998888899999999999999995 99997 22222222211 1111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
. .++ ...+||.+|+.++|..||++.+|+.
T Consensus 738 ~------~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 738 L------PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred C------chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1 111 5679999999999999999999974
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=251.13 Aligned_cols=246 Identities=22% Similarity=0.353 Sum_probs=195.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.++.++||+|.++.|-.++++ ..+.+|+|++++.. .++.+-.+.|-.+..+. +||.+|-+..+|..+..+++|.|
T Consensus 252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie 331 (593)
T KOG0695|consen 252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE 331 (593)
T ss_pred ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence 455789999999999999987 57889999998642 23345566777777766 79999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|++||+|--+++ .+..++++.+.-+...|+-||.|||+ +||+.||||.+|||+|..|++||+|+|+++.--..
T Consensus 332 yv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~- 404 (593)
T KOG0695|consen 332 YVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP- 404 (593)
T ss_pred EecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCC-
Confidence 999999977776 46789999999999999999999998 99999999999999999999999999999874322
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc-chhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
....+...||+.|+|||++++..|....|-|++||+++||+.|+.||+.-... .+.+-.++.-+.+.+..+. +
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir------i 478 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR------I 478 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc------c
Confidence 22345678999999999999999999999999999999999999999844332 2233334443333322210 1
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPK 869 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs 869 (927)
.. ....+...+++.-|.+||.+|..
T Consensus 479 pr----slsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 479 PR----SLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred cc----eeehhhHHHHHHhhcCCcHHhcC
Confidence 11 11124457888899999999863
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=237.30 Aligned_cols=201 Identities=24% Similarity=0.373 Sum_probs=167.2
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
+....-.+.||+|++|.|-+-++. +|+..|+|.++... .+..++.++|+.+..+- .+|.+|.++|........++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 333444678999999999888876 69999999997643 34557788888876655 6999999999998899999999
Q ss_pred EecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 681 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
|.|. .||..+-++.. .+..+++..+-+|+..+..||.|||+ +..++|||+||+||||+.+|++|+||||.+-.+.+
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9995 57776654322 56789999999999999999999999 58999999999999999999999999999987654
Q ss_pred cccccccccccCCCccCCCccCC----CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 002410 760 DLTHISSVARGTVGYLDPEYYGN----QQLTEKSDVYSFGVVLLELISGKKPVS 809 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~----~~~s~ksDVwSlGvlL~eLltG~~Pf~ 809 (927)
... .+...|-..|||||.+.. ..|+.|+||||||+.+.||.+++.||+
T Consensus 202 SiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 202 SIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred hhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 322 122347789999998843 478999999999999999999999997
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-29 Score=252.39 Aligned_cols=261 Identities=22% Similarity=0.286 Sum_probs=196.0
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----ceEEEEEE
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRILVYE 681 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-----~~~~LV~E 681 (927)
.+.||.|+||.||.++.. +|+.||+|++.... -...+.+.+|+++|.-++|.|++..+++..-. ++.|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 478999999999999875 79999999987532 23457889999999999999999998876543 35678888
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
.|. .+|..++- ....++...+.-++.||++||+|||+ .+|.||||||.|.|++.+-.+||||||+++....+.
T Consensus 138 LmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 884 57887776 56788999999999999999999998 999999999999999999999999999999876655
Q ss_pred cccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHH---------HHHhhhcCC
Q 002410 762 THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW---------ARSMIKKGD 831 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~---------~~~~~~~~~ 831 (927)
.......+-|..|+|||++++. .|+.+.||||.||++.||+..+..|......+..+++.. ++... +|.
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC-EGA 289 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC-EGA 289 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh-hhh
Confidence 5444445578899999999875 789999999999999999999999874443332222211 11111 111
Q ss_pred eeeecc-----ccccCCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 832 VISIVD-----PVLIGNV----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 832 ~~~~~d-----~~l~~~~----~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
...++. |.+..-+ ....-.+-..+..+++..||++|.+.++.+..+.
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 000000 1110000 0111224567888999999999999999887654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=264.43 Aligned_cols=280 Identities=21% Similarity=0.257 Sum_probs=217.1
Q ss_pred cccCCcccccChhhHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcC------C
Q 002410 588 FMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH------H 660 (927)
Q Consensus 588 ~~~~~~~~~~~~~el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~------H 660 (927)
|.+....+.+.+.|+....|.+....|+|-|++|.+|... .|+.||||++..... ..+.=+.|+++|++|+ -
T Consensus 415 WdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk 493 (752)
T KOG0670|consen 415 WDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDK 493 (752)
T ss_pred cccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhh
Confidence 3444566778889999999999999999999999999876 488999999986432 2344467999999995 3
Q ss_pred CceeeeeeeeecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc
Q 002410 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 740 (927)
Q Consensus 661 pnIv~l~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl 740 (927)
.|+++++..|...+++|||+|-+ ..+|.+.|+.......|....+..++.|+.-||.+|.. -+|+|.||||+|||+
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLV 569 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILV 569 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEe
Confidence 57999999999999999999988 56999999988777889999999999999999999997 899999999999999
Q ss_pred cCC-CcEEEeeccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhH
Q 002410 741 DIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 819 (927)
Q Consensus 741 d~~-~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l 819 (927)
++. ..+||||||.|....+.... ....+..|.|||++.+-.|+...|+||.||+||||.||+..|.+........+
T Consensus 570 NE~k~iLKLCDfGSA~~~~eneit---PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 570 NESKNILKLCDFGSASFASENEIT---PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred ccCcceeeeccCcccccccccccc---HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence 875 45899999999876543221 12235579999999999999999999999999999999999986554333222
Q ss_pred HHHHHHh-----hhcCCe---------------------------eeeccc------cccC--CCC---HHHHHHHHHHH
Q 002410 820 VHWARSM-----IKKGDV---------------------------ISIVDP------VLIG--NVK---IESIWRIAEVA 856 (927)
Q Consensus 820 ~~~~~~~-----~~~~~~---------------------------~~~~d~------~l~~--~~~---~~~~~~l~~Li 856 (927)
..-++.. ++.+.+ ...+.| .+.+ .++ ......|.+|+
T Consensus 647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLL 726 (752)
T KOG0670|consen 647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLL 726 (752)
T ss_pred HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHH
Confidence 2222111 111110 001111 0111 122 23455788999
Q ss_pred HHhhccCCCCCCCHHHHHH
Q 002410 857 IQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 857 ~~Cl~~dP~~RPs~~eVl~ 875 (927)
.+||..||++|.+..+.|+
T Consensus 727 dkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 727 DKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHhccChhhcCCHHHHhc
Confidence 9999999999999999875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=236.16 Aligned_cols=210 Identities=38% Similarity=0.618 Sum_probs=183.6
Q ss_pred ccccccEEEEEEEECC-CcEEEEEEccCccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCHHH
Q 002410 613 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD 690 (927)
Q Consensus 613 LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~~-~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL~~ 690 (927)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999875 899999999765332 35779999999999999999999999999899999999999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC-CCcEEEeeccccccccccccccccccc
Q 002410 691 RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVAR 769 (927)
Q Consensus 691 ~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFGla~~~~~~~~~~~~~~~ 769 (927)
++... ...+++..+..++.+++++|++||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKEN--EGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 98743 1468899999999999999999998 89999999999999999 89999999999987644321 122234
Q ss_pred cCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHH
Q 002410 770 GTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 848 (927)
Q Consensus 770 gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 848 (927)
+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 67899999999877 888999999999999999
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 849 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 849 ~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 267799999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=262.47 Aligned_cols=199 Identities=25% Similarity=0.376 Sum_probs=168.3
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
.+.||-|+||.|.+++-. ....+|+|.+++.. .........|-.||..-..+-||+|+-.|.+++.+|+||+|++|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 467999999999999754 46679999997643 23345577899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc-------
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE------- 758 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~------- 758 (927)
|++-.+|. ..+.+++..++.++..+..|+++.|. .|+|||||||+|||||.+|++||+|||++.-+.
T Consensus 714 GDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 714 GDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred ccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 99999987 35678888888899999999999998 999999999999999999999999999985321
Q ss_pred --cccc-------------c-------------------cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhC
Q 002410 759 --EDLT-------------H-------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG 804 (927)
Q Consensus 759 --~~~~-------------~-------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG 804 (927)
.... . .....+||+.|+|||++....++..+|.||.|||||||+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 0000 0 00123599999999999999999999999999999999999
Q ss_pred CCCCCccccc
Q 002410 805 KKPVSVEDFG 814 (927)
Q Consensus 805 ~~Pf~~~~~~ 814 (927)
+.||......
T Consensus 868 ~~pf~~~tp~ 877 (1034)
T KOG0608|consen 868 QPPFLADTPG 877 (1034)
T ss_pred CCCccCCCCC
Confidence 9999855544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=250.33 Aligned_cols=139 Identities=26% Similarity=0.448 Sum_probs=117.8
Q ss_pred cChhhHHH-HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcC-----C---Cceeee
Q 002410 597 IPLPELEE-ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----H---RNLVPL 666 (927)
Q Consensus 597 ~~~~el~~-~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-----H---pnIv~l 666 (927)
+...|+.. .+|-+.++||-|.|++||++... ..+.||+|+.+.. .+..+..+.|+++|++++ | .+||+|
T Consensus 69 V~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 69 VRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred eeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 33456655 88888999999999999999765 5778999998743 455677889999999984 2 469999
Q ss_pred eeeeec----CceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc
Q 002410 667 IGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 740 (927)
Q Consensus 667 ~~~~~~----~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl 740 (927)
++.|.. +.+.+||+|++ |.+|..+|... ..+.++...+.+|++||+.||.|||. +-+|||-||||+|||+
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 999854 56899999999 77898888865 46779999999999999999999999 4699999999999999
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=231.25 Aligned_cols=258 Identities=19% Similarity=0.303 Sum_probs=194.2
Q ss_pred HHHHhhcccccccccEEEEEEEE-CCCcEEEEEEccCccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecC--ceEEEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQRILV 679 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~--~~~~LV 679 (927)
...|++.+++|+|.++.|+.|.. .+++.++||+++. ...+.+.+|+++|+.|+ ||||++++++..+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 45788899999999999999974 4688999999984 34567889999999997 99999999998664 456799
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC-CcEEEeecccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAE 758 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFGla~~~~ 758 (927)
+||+++.+...+.. .++...+..++.+++.||.|+|+ +||.|||+||.|++||.. -.++|+|+|+|.+..
T Consensus 114 FE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99999988776543 57778889999999999999999 999999999999999964 569999999999876
Q ss_pred ccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc------CC
Q 002410 759 EDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------GD 831 (927)
Q Consensus 759 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~------~~ 831 (927)
+..... ..+.+..|--||++-. ..|+..-|+|||||++..|+..+.||-. ......+++..++-.-.. ..
T Consensus 185 p~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh-G~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC-CCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 654432 2335778899998854 5678899999999999999999999862 222333333332211000 00
Q ss_pred eeeeccccccC----------------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 832 VISIVDPVLIG----------------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 832 ~~~~~d~~l~~----------------~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
..-.+||...+ +...-...+.++++.+.|..|-++|+|++|.+..
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00012222111 0000112367899999999999999999998764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-27 Score=257.42 Aligned_cols=195 Identities=25% Similarity=0.426 Sum_probs=167.8
Q ss_pred HHhhcccccccccEEEEEEEECC-CcEEEEEEccCccch--------hHHHHHHHHHHHHhcC---CCceeeeeeeeecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH--------RTQQFVTEVALLSRIH---HRNLVPLIGYCEEE 673 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~~--------~~~~~~~E~~~L~~l~---HpnIv~l~~~~~~~ 673 (927)
.|...+.+|+|+||.|+.+.++. ..+|+||.+.+..-- ..-..-.|+++|..++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 45557899999999999999884 567999998753211 1122456999999997 99999999999999
Q ss_pred ceEEEEEEec-CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecc
Q 002410 674 HQRILVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 752 (927)
Q Consensus 674 ~~~~LV~E~~-~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 752 (927)
+..||+||-. ++-+|.+++. -+..+++.+...|++|++.|++|||+ .+|||||||-+||.++.+|-+||+|||
T Consensus 642 d~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeecc
Confidence 9999999975 5669999998 46789999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCCCC-CcchhHHHHHHHHHHHHhCCCCCC
Q 002410 753 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVS 809 (927)
Q Consensus 753 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~ 809 (927)
.+...... .....+||.+|.|||++.+..| +..-|||++|++||.++..+.||-
T Consensus 716 saa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98876443 3345679999999999999877 567899999999999999999984
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-26 Score=230.25 Aligned_cols=252 Identities=18% Similarity=0.323 Sum_probs=188.3
Q ss_pred HHHhhcccccccccEEEEEEEECC-CcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeee-eecCceEEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY-CEEEHQRILVYE 681 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~-~~~~~~~~LV~E 681 (927)
..|++.+.||+|.||.+-+++++. .+.+++|.+... ....++|.+|..---.| .|.||+.-++. |+..+..++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 457788999999999999999984 678999988754 34467899988765555 58999988874 677788889999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc--CCCcEEEeeccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld--~~~~~kL~DFGla~~~~~ 759 (927)
|++.|+|.+-+. ...+-+....+++.|+++||.|+|+ +++||||||.+||||- +..++||||||+.+..+.
T Consensus 103 ~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999998876 3557788889999999999999998 9999999999999993 345899999999876543
Q ss_pred cccccccccccCCCccCCCccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc-CCee
Q 002410 760 DLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK-GDVI 833 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~-~~~~ 833 (927)
.-.. ..-+..|.+||.... -...+.+|||.||+++|.++||+.||+ ..........+|.+-.-+. ....
T Consensus 176 tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 176 TVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred eehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHHHHhcccCccCc
Confidence 2221 123567999997632 245788999999999999999999998 3333333444443322111 1111
Q ss_pred eeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 834 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 834 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
+.+.+ ....+..+.++-+.++|++|-.+.++.++-+
T Consensus 251 ~~F~~---------fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 251 KKFNP---------FSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred hhhcc---------cCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 11111 1225678888999999999966666655543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=232.99 Aligned_cols=196 Identities=37% Similarity=0.618 Sum_probs=171.8
Q ss_pred hhcccccccccEEEEEEEECC-CcEEEEEEccCccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 608 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~~-~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
.+.+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 456889999999999999875 899999999876554 677899999999999999999999999998999999999999
Q ss_pred CCHHHHhccCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 686 gsL~~~L~~~~~~~~-l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
++|.+++... .. +++..+..++.+++.+|.+||+ .+++|+||+|+||+++.++.++|+|||.+..........
T Consensus 82 ~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 82 GDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999999743 23 8899999999999999999998 899999999999999999999999999988765442112
Q ss_pred ccccccCCCccCCCcc-CCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 002410 765 SSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVS 809 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l-~~~~~s~ksDVwSlGvlL~eLltG~~Pf~ 809 (927)
.....++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 2234467889999998 66678889999999999999999999996
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-26 Score=235.33 Aligned_cols=255 Identities=24% Similarity=0.294 Sum_probs=189.2
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecC------ceEEEEE
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRILVY 680 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------~~~~LV~ 680 (927)
.+.+|.|.- .|..|... .+++||+|++... .....++..+|..++..++|+||++++.++.-. ...|+||
T Consensus 22 L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~ 100 (369)
T KOG0665|consen 22 LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM 100 (369)
T ss_pred ecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence 356788887 55555433 5889999988643 123346677899999999999999999988543 3578999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
|+| ..+|.+.+. -.++...+..|+.|++.|++|||+ .+|+||||||+||++..+..+||.|||+|+.....
T Consensus 101 e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 101 ELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred Hhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc
Confidence 999 468888876 347788999999999999999998 99999999999999999999999999999876544
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhH----------------HHHHH
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI----------------VHWAR 824 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l----------------~~~~~ 824 (927)
...+..+.+..|.|||++.+..+.+.+||||.||++.||++|+..|.+.+.-+.... ...++
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 344556688999999999888899999999999999999999999985543222111 11111
Q ss_pred HhhhcC------Ceeeec-cccccC--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 825 SMIKKG------DVISIV-DPVLIG--NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 825 ~~~~~~------~~~~~~-d~~l~~--~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
...++. .+.+.+ |..... +.+.-......+++.+||..||++|.+++++++.
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111100 000111 000000 1111223457799999999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-26 Score=255.81 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=203.9
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
..|++...+|.|.+|.||+++.+ .++..|+|+++-....+..-..+|+-+++..+||||+.++|.+...+..++.||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 34567789999999999999876 68999999998877777888889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
.+|+|.+.-+ ...++++.++..+++..++||+|||+ ++-+|||||-.||++++.|.+|++|||.+..+.....
T Consensus 95 gggslQdiy~---~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~- 167 (829)
T KOG0576|consen 95 GGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA- 167 (829)
T ss_pred CCCcccceee---ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhhh-
Confidence 9999999887 46789999999999999999999998 8999999999999999999999999999887654333
Q ss_pred cccccccCCCccCCCcc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc-c
Q 002410 764 ISSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP-V 839 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l---~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~-~ 839 (927)
......||+.|||||+. +.+.|..++|||++|+...|+---++|..... ... +...+.. ...+| .
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh--pmr-----~l~LmTk----S~~qpp~ 236 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH--PMR-----ALFLMTK----SGFQPPT 236 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc--hHH-----HHHHhhc----cCCCCCc
Confidence 23446799999999986 56688999999999999999988887753111 111 1111111 11111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+.+ .......+.++++.|+.++|++||+++.+++
T Consensus 237 lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 237 LKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111 1223346789999999999999999987664
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-24 Score=229.84 Aligned_cols=259 Identities=25% Similarity=0.334 Sum_probs=191.1
Q ss_pred HHhhcccccccccEEEEEEEEC----CCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~----~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
.+...++||+|.|++||++.+. .++.||+|.+.... ...++.+|+++|..+ .+.||+++.+++..++...+|+
T Consensus 37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl 114 (418)
T KOG1167|consen 37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL 114 (418)
T ss_pred hhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence 3455789999999999999754 36789999986532 345688999999999 5999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC-CCcEEEeeccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFGla~~~~~ 759 (927)
||++.....++... ++...+..+++.++.||+++|+ +|||||||||+|+|.+. .+.-.|.|||+|...+.
T Consensus 115 p~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 115 PYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred cccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 99999999888763 5688899999999999999998 99999999999999975 56789999999972110
Q ss_pred cc-------------c------------------------------ccccccccCCCccCCCccCC-CCCCcchhHHHHH
Q 002410 760 DL-------------T------------------------------HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFG 795 (927)
Q Consensus 760 ~~-------------~------------------------------~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlG 795 (927)
.. . .......||+||+|||++.. +.-+.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 0 00112359999999999865 4668899999999
Q ss_pred HHHHHHHhCCCCCCcccccchhhHHHHHH---------HhhhcCC--eee------e---------cc-ccccC------
Q 002410 796 VVLLELISGKKPVSVEDFGAELNIVHWAR---------SMIKKGD--VIS------I---------VD-PVLIG------ 842 (927)
Q Consensus 796 vlL~eLltG~~Pf~~~~~~~~~~l~~~~~---------~~~~~~~--~~~------~---------~d-~~l~~------ 842 (927)
|+++-+++++.||-....+ ...+.+.+. -....|. +.+ + ++ ..+..
T Consensus 266 VI~Lslls~~~PFf~a~dd-~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDD-ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred ceeehhhccccccccCccc-cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 9999999999999633222 222222111 0111122 111 0 00 00000
Q ss_pred ---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 843 ---NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 843 ---~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
......+..+.+++.+|++.||.+|.|++|.|+.
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0011122267899999999999999999998863
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-24 Score=264.23 Aligned_cols=195 Identities=19% Similarity=0.269 Sum_probs=138.5
Q ss_pred hcCC-Cceeeeeeee-------ecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 002410 657 RIHH-RNLVPLIGYC-------EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728 (927)
Q Consensus 657 ~l~H-pnIv~l~~~~-------~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~i 728 (927)
.++| +||++++++| .+....++++|++ +++|.++|.. ....+++.+++.++.||++||+|||+ ++|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHS---QGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 3455 6888888877 2234567888887 6699999974 24569999999999999999999998 999
Q ss_pred EecCCCCCcccccCC-------------------CcEEEeecccccccccccc---------------ccccccccCCCc
Q 002410 729 IHRDVKSSNILLDIN-------------------MRAKVSDFGLSRQAEEDLT---------------HISSVARGTVGY 774 (927)
Q Consensus 729 vH~DLkp~NILld~~-------------------~~~kL~DFGla~~~~~~~~---------------~~~~~~~gt~~Y 774 (927)
+||||||+||||+.. +.+|++|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 4456666666653211000 000113478889
Q ss_pred cCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHH
Q 002410 775 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 854 (927)
Q Consensus 775 ~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 854 (927)
||||++.+..++.++|||||||+||||++|..|+.... ...... ... ...+... .......+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~-~~~--------~~~~~~~-----~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSL-RHR--------VLPPQIL-----LNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHH-HHh--------hcChhhh-----hcCHHHHH
Confidence 99999999999999999999999999999988875211 011111 000 0111110 11224568
Q ss_pred HHHHhhccCCCCCCCHHHHHH
Q 002410 855 VAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 855 Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
++.+||+++|.+||+|.||++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 889999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-23 Score=209.16 Aligned_cols=169 Identities=21% Similarity=0.205 Sum_probs=127.2
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
|+|.++++.. +..+++.+++.|+.||+.||+|||+ ++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc----
Confidence 6899999742 4569999999999999999999998 44 999999999999999 99988754422
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...... ...+...... ..... +... ...
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~-~~~~~------~~~~-~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-SAILEILLNG-MPADD------PRDR-SNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-cHHHHHHHHH-hccCC------cccc-ccH
Confidence 24789999999999999999999999999999999999999633221 1111111111 11100 0000 001
Q ss_pred HHHH--HHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 846 IESI--WRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 846 ~~~~--~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
.... ..+.+++.+||+.+|++||++.|+++.+.....
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 1112 258999999999999999999999999876654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.7e-23 Score=208.91 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=190.3
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccC--ccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~--~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
...++.-+|.+...|..|+|+|. |..+++|+++- ......++|..|.-.|+.+.||||+.+++.|....+..++..|
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 34556778999999999999998 56677777753 2233447899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEe--ecccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS--DFGLSRQAEED 760 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~--DFGla~~~~~~ 760 (927)
|+.|+|+..|++. ..-..+..+..+++.++|+|++|||+. ++-|..--|..+.|+||++..++|+ |--++..
T Consensus 269 mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq---- 342 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---- 342 (448)
T ss_pred ccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee----
Confidence 9999999999965 355678889999999999999999983 2334455789999999999998875 3222211
Q ss_pred ccccccccccCCCccCCCccCCCCC---CcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~---s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
.....-.+.||+||.++..+- -.++|+|||++++|||.|.+.||..-...+.. ..+.-+
T Consensus 343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-------mkiale------- 404 (448)
T KOG0195|consen 343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-------MKIALE------- 404 (448)
T ss_pred ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-------hhhhhc-------
Confidence 111224688999999976543 35899999999999999999999733322110 011111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
.++...++.....+.+|+.-|+..||.+||.+..|+-.|++++
T Consensus 405 -glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 -GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1122223333346778999999999999999999999998865
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.5e-21 Score=211.77 Aligned_cols=262 Identities=23% Similarity=0.279 Sum_probs=197.8
Q ss_pred HHhhcccccccccEEEEEEEECCC--cEEEEEEccCccchhHHHHHHHHHHHHhcCC----Cceeeeeeee-ecCceEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKDG--KEVAVKIMADSCSHRTQQFVTEVALLSRIHH----RNLVPLIGYC-EEEHQRIL 678 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~g--~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~H----pnIv~l~~~~-~~~~~~~L 678 (927)
.|.+.++||+|+||.||++..... ..+|+|............+..|..++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 567789999999999999997753 4789998765433333367889999988863 6888888888 57778999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC-----CcEEEeeccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-----MRAKVSDFGL 753 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~-----~~~kL~DFGl 753 (927)
||+.+ |.+|.++..... .+.++..+.+.|+.|++.+|++||+ .|++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 889999876543 6789999999999999999999998 999999999999999764 4699999999
Q ss_pred cc--ccccccc----cc---ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH
Q 002410 754 SR--QAEEDLT----HI---SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 824 (927)
Q Consensus 754 a~--~~~~~~~----~~---~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~ 824 (927)
++ ....... .. .....||..|++++...+...+.+.|+||++.++.|++.|..||.............
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~--- 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE--- 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH---
Confidence 98 3221111 11 223559999999999999999999999999999999999999996444322211111
Q ss_pred HhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 825 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 825 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
.......... ... ..+..+.++...+-..+..++|....+...|++....+
T Consensus 251 ~~~~~~~~~~------~~~---~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 251 KDPRKLLTDR------FGD---LKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHhhhhcccc------ccC---CChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111111100 011 11234556666666689999999999999998887765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=215.90 Aligned_cols=173 Identities=18% Similarity=0.156 Sum_probs=131.2
Q ss_pred HHHHhhcccccccccEEEEEEEEC--CCcEEEEEEccCc-----cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~--~g~~vAvK~l~~~-----~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
...|.+.+.||+|+||+||+|.++ +++.||||++... .....+.+.+|+++|++++|+|+++.+.. .+..
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~ 93 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKD 93 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCc
Confidence 345777899999999999999875 4777899986533 12235668999999999999999853322 2457
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcccccCCCcEEEeeccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV-KSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DL-kp~NILld~~~~~kL~DFGla~ 755 (927)
++||||++|++|... .. .. ...++.|++++|+|||+ ++|+|||| ||+|||++.++.+||+|||+|+
T Consensus 94 ~LVmE~~~G~~L~~~-~~---~~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 94 GLVRGWTEGVPLHLA-RP---HG------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred EEEEEccCCCCHHHh-Cc---cc------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 999999999999732 11 11 14678999999999998 99999999 9999999999999999999999
Q ss_pred cccccccccc-------cccccCCCccCCCccCCC------CCCcchhHH
Q 002410 756 QAEEDLTHIS-------SVARGTVGYLDPEYYGNQ------QLTEKSDVY 792 (927)
Q Consensus 756 ~~~~~~~~~~-------~~~~gt~~Y~APE~l~~~------~~s~ksDVw 792 (927)
.......... ....+++.|+|||.+... ..+..+|-|
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 7654321111 234578889999998543 233446666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.7e-20 Score=199.75 Aligned_cols=260 Identities=29% Similarity=0.435 Sum_probs=198.3
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCccch---hHHHHHHHHHHHHhcCCC-ceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHR-NLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~---~~~~~~~E~~~L~~l~Hp-nIv~l~~~~~~~~~~~LV~E~ 682 (927)
+.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 345678999999999999987 88999998764333 367899999999999988 799999999777778999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC-cEEEeeccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla~~~~~~~ 761 (927)
+.++++.+++........+.......++.|++.+++|+|+ .+++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 9999999777632111368899999999999999999998 8999999999999999988 79999999998654433
Q ss_pred cc-----cccccccCCCccCCCccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCccccc-chhhHHHHHHHhhhcCCe
Q 002410 762 TH-----ISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARSMIKKGDV 832 (927)
Q Consensus 762 ~~-----~~~~~~gt~~Y~APE~l~~---~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~-~~~~l~~~~~~~~~~~~~ 832 (927)
.. ......|+..|+|||.+.+ .......|+||+|++++++++|..||...... ........+... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~----~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL----PT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc----CC
Confidence 22 2345568999999999987 68899999999999999999999997643321 011111111111 11
Q ss_pred eeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 833 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 833 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
. .................+.+++.+|+..+|..|.++.+....
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000000001223467899999999999999999988775
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.7e-20 Score=190.62 Aligned_cols=262 Identities=19% Similarity=0.249 Sum_probs=200.8
Q ss_pred HHHhhcccccccccEEEEEEEE-CCCcEEEEEEccCccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEEEEEe
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
--|+++++||+|.||.++.|+. -+++.||||.-.. ..+..++..|.+..+.|. .+.|..++-+-.++.+..||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 3467789999999999999973 4799999998543 234467888999999884 79999998888888899999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC-----CCcEEEeeccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-----NMRAKVSDFGLSRQA 757 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~-----~~~~kL~DFGla~~~ 757 (927)
+ |-||.|+..- .+..++.++++.+|.|++.-++|+|+ +.+|.|||||+|+||.. ...+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 7899988875 36789999999999999999999998 99999999999999964 345899999999987
Q ss_pred ccccccc------ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCC
Q 002410 758 EEDLTHI------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 831 (927)
Q Consensus 758 ~~~~~~~------~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 831 (927)
.+..+.. .....||.+||+-....+.+-+.+.|+=|+|-+++..+-|..||.+...+....-.+.+.+.-+...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP 259 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence 6544332 2234599999999999999999999999999999999999999997665533222222211111111
Q ss_pred eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 832 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 832 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
+.+ +... .++++..-+.-.-..+-.+-|..+-+...+.++++.
T Consensus 260 i~~-----Lc~g----~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 260 IEV-----LCEG----FPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred HHH-----HHhc----CHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 111 1111 233444555555567778899998888887777654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=223.61 Aligned_cols=251 Identities=22% Similarity=0.267 Sum_probs=185.9
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEcc----Ccc-c-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMA----DSC-S-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~----~~~-~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
.+.+|.|++|.|+..... ..+..+.|..+ ... . .....+..|+-+-..++|+|++..+..+.+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 578999999988777544 33434444332 111 1 1122266677777888999999888888777766667999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
|++ +|..++.. ...+...++..+++|+..|++|||+ .||.|||+|++|+++..+|.+||+|||.+....-...
T Consensus 403 ~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 403 CPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred ccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 999 99999983 3568888999999999999999998 9999999999999999999999999999887544333
Q ss_pred ---ccccccccCCCccCCCccCCCCCCc-chhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 763 ---HISSVARGTVGYLDPEYYGNQQLTE-KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 763 ---~~~~~~~gt~~Y~APE~l~~~~~s~-ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
.......|+..|+|||.+.+..|.+ ..||||.|+++..|.+|+.||......+... ......+.......+
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNIFEGP 550 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccccccccCh
Confidence 4455667999999999999988876 6899999999999999999998554432211 000000000000000
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.......+.....++.+||+.+|.+|.|+++|++
T Consensus 551 ---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 551 ---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ---HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0111233456789999999999999999999986
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-20 Score=220.83 Aligned_cols=244 Identities=22% Similarity=0.327 Sum_probs=181.1
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCcc-chhHHHH---HHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC-SHRTQQF---VTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~-~~~~~~~---~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.+.+.+.||.++|=+|.+|++++|. |+||++-+.. .-..+.| ++|++ ...++|||.+++.-....+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 3455789999999999999999887 8999986543 2233333 44455 555689999999888777888889999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc--cc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EE 759 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~--~~ 759 (927)
|+. -+|+|.|. .+..+...+.+.|+.|++.||..+|. .||+|||||.+||||+.-.-+.|+||..-+.. .+
T Consensus 102 yvk-hnLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVK-HNLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHh-hhhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 985 49999998 56778888999999999999999998 99999999999999999889999999865542 22
Q ss_pred ccc----ccccccccCCCccCCCccCC-----------CCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHH
Q 002410 760 DLT----HISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 823 (927)
Q Consensus 760 ~~~----~~~~~~~gt~~Y~APE~l~~-----------~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~ 823 (927)
+.. ....+...-..|+|||.+-. ...+++.||||+||++.||++ |++||. +.+..
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~---------LSQL~ 245 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT---------LSQLL 245 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc---------HHHHH
Confidence 211 11122234457999998732 126789999999999999998 688885 11111
Q ss_pred HHhhhcC-C----eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 824 RSMIKKG-D----VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 824 ~~~~~~~-~----~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
...-.+. . +..+-|+ .+.+++..|++.||.+|.++++.++.-..
T Consensus 246 aYr~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 246 AYRSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred hHhccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 1110000 0 0111111 56799999999999999999999988443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-19 Score=178.81 Aligned_cols=263 Identities=21% Similarity=0.282 Sum_probs=197.1
Q ss_pred hHHHHHHhhcccccccccEEEEEEEE-CCCcEEEEEEccCccchhHHHHHHHHHHHHhcCC-CceeeeeeeeecCceEEE
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~H-pnIv~l~~~~~~~~~~~L 678 (927)
.+....|.+.++||.|+||.+|.|.. .+|++||||+-+.... ..++..|.++.+.|++ ..|..+..+..+.....+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 34456678899999999999999975 5799999998665433 3467789999999975 677777888888899999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC---CCcEEEeeccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSR 755 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~---~~~~kL~DFGla~ 755 (927)
||+.+ |.+|.+...-. ...++..+++-++-|++.-++|+|. ++++||||||+|+|..- ..++.++|||+|+
T Consensus 89 VMdLL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeecc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchh
Confidence 99998 78999887643 5678889999999999999999998 99999999999999964 4568999999999
Q ss_pred ccccccccc------ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc
Q 002410 756 QAEEDLTHI------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 829 (927)
Q Consensus 756 ~~~~~~~~~------~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 829 (927)
.+.+..+.. .....||..|.+-....+..-+.+.|+=|+|.+|..+.-|..||++..........+.+. +
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~----E 238 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS----E 238 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH----H
Confidence 865433221 233469999999888888788999999999999999999999998655443322222221 1
Q ss_pred CCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 830 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 830 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
......+ ..+...++ .++.-.+.-|-..--++-|...-+-+.+.-+
T Consensus 239 kK~s~~i-e~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 239 KKMSTPI-EVLCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred hhcCCCH-HHHhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 1111111 11222232 3455667777777778888776665555543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-19 Score=188.32 Aligned_cols=175 Identities=15% Similarity=0.190 Sum_probs=136.2
Q ss_pred hhhHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHH---H------HHHHHHHHHhcCCCceeeeeee
Q 002410 599 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ---Q------FVTEVALLSRIHHRNLVPLIGY 669 (927)
Q Consensus 599 ~~el~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~---~------~~~E~~~L~~l~HpnIv~l~~~ 669 (927)
.+++....|+..+.||.|+||.||++.. +++.+|+|++++....... . +.+|++.+.+++|++|..+.++
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 3566778888899999999999999766 5778999999764333222 2 6789999999999999999888
Q ss_pred eecC--------ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc
Q 002410 670 CEEE--------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 741 (927)
Q Consensus 670 ~~~~--------~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld 741 (927)
+... +..++||||++|.+|.++.. ++. ....+++.+|..+|+ .|++|||+||+||+++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~ 169 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVS 169 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEe
Confidence 5532 35789999999999988742 222 245699999999998 9999999999999999
Q ss_pred CCCcEEEeeccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHH
Q 002410 742 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI 802 (927)
Q Consensus 742 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLl 802 (927)
.++ ++|+|||........... ..+.....+..++|+|+||+.+..+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988 999999988765322111 01334445667999999999987554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=3e-19 Score=183.50 Aligned_cols=140 Identities=18% Similarity=0.187 Sum_probs=109.4
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCccch--h-------H-----------------HHHHHHHHHHHhcCCCce
Q 002410 610 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--R-------T-----------------QQFVTEVALLSRIHHRNL 663 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~--~-------~-----------------~~~~~E~~~L~~l~HpnI 663 (927)
.+.||+|++|.||+|...+|+.||||+++..... . . ....+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999888999999999754211 0 1 122359999999988776
Q ss_pred eeeeeeeecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCcccccC
Q 002410 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL-HTGCNPGIIHRDVKSSNILLDI 742 (927)
Q Consensus 664 v~l~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~L-H~~~~~~ivH~DLkp~NILld~ 742 (927)
.....+.. ...++||||++++++..... ....++......++.|++.+|+++ |+ .+|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-
Confidence 44333322 22389999999887765432 235688899999999999999999 56 8999999999999998
Q ss_pred CCcEEEeecccccccc
Q 002410 743 NMRAKVSDFGLSRQAE 758 (927)
Q Consensus 743 ~~~~kL~DFGla~~~~ 758 (927)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 5789999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.8e-18 Score=174.26 Aligned_cols=141 Identities=21% Similarity=0.253 Sum_probs=111.8
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCccch--------------------------hHHHHHHHHHHHHhcCCCce
Q 002410 610 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--------------------------RTQQFVTEVALLSRIHHRNL 663 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~--------------------------~~~~~~~E~~~L~~l~HpnI 663 (927)
.+.||+|++|.||+|...+|+.||||+++..... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999888999999998754211 01224578999999999987
Q ss_pred eeeeeeeecCceEEEEEEecCCCCHHHH-hccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC
Q 002410 664 VPLIGYCEEEHQRILVYEYMHNGTLRDR-LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 742 (927)
Q Consensus 664 v~l~~~~~~~~~~~LV~E~~~~gsL~~~-L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~ 742 (927)
.....+... ..++||||++++++... +. ...++......++.|++.++.+||+ ..||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence 554443332 24899999998865433 33 3457788899999999999999996 37999999999999998
Q ss_pred CCcEEEeeccccccccc
Q 002410 743 NMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 743 ~~~~kL~DFGla~~~~~ 759 (927)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 89999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.2e-18 Score=181.87 Aligned_cols=230 Identities=21% Similarity=0.303 Sum_probs=149.7
Q ss_pred hcccccccccEEEEEEEECC-CcEEEEEEccCcc---chhHHHHHHHHHHHHhcC----------CCceeeeeeeee---
Q 002410 609 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC---SHRTQQFVTEVALLSRIH----------HRNLVPLIGYCE--- 671 (927)
Q Consensus 609 ~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~----------HpnIv~l~~~~~--- 671 (927)
..+.||.|+++.||.+++.+ |+++|||++.-.. ....+++.+|.-....+. |-.++..++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 35789999999999999874 8999999975322 234567777765555432 222222222221
Q ss_pred ------cC---c-----eEEEEEEecCCCCHHHHhccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 002410 672 ------EE---H-----QRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV 733 (927)
Q Consensus 672 ------~~---~-----~~~LV~E~~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DL 733 (927)
.. . ..+++|+-+ .++|.+++.... ....+....++.+..|+++.+++||+ .|++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEeccc
Confidence 11 1 236788877 568887765211 12334556667788999999999999 99999999
Q ss_pred CCCcccccCCCcEEEeeccccccccccccccccccccCCCccCCCccCC--------CCCCcchhHHHHHHHHHHHHhCC
Q 002410 734 KSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--------QQLTEKSDVYSFGVVLLELISGK 805 (927)
Q Consensus 734 kp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~s~ksDVwSlGvlL~eLltG~ 805 (927)
||+|++++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|++|+++|.|++|.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999999877665543222 224578999997633 35788999999999999999999
Q ss_pred CCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCC
Q 002410 806 KPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR 867 (927)
Q Consensus 806 ~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R 867 (927)
.||........... ....+. +.++.+..||..+|+.+|++|
T Consensus 248 lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99984433211110 112333 667789999999999999988
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.5e-18 Score=193.25 Aligned_cols=218 Identities=28% Similarity=0.408 Sum_probs=165.6
Q ss_pred HHhcCCCceeeeeeeeecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EecCC
Q 002410 655 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI-IHRDV 733 (927)
Q Consensus 655 L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~i-vH~DL 733 (927)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.. ....+++.-...++++|+.||+|||. ..| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeee
Confidence 3568899999999999999999999999999999999985 36678999999999999999999998 444 99999
Q ss_pred CCCcccccCCCcEEEeecccccccccccc-ccccccccCCCccCCCccCCC-------CCCcchhHHHHHHHHHHHHhCC
Q 002410 734 KSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQ-------QLTEKSDVYSFGVVLLELISGK 805 (927)
Q Consensus 734 kp~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~-------~~s~ksDVwSlGvlL~eLltG~ 805 (927)
++.|+++|....+||+|||+......... .......-..-|.|||.++.. ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999877642100 011111134569999998763 2467899999999999999999
Q ss_pred CCCCcccccch-hhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 806 KPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 806 ~Pf~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
.||........ ..++.+++. .....+-|.+.... +....+..++.+||..+|++||++++|-..++.+....
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred CccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 99985433322 233333332 11111122221111 33347899999999999999999999999888776643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=170.00 Aligned_cols=185 Identities=15% Similarity=0.142 Sum_probs=140.1
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCccch----hHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEEEEEecC
Q 002410 610 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH----RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~----~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
...|++|+||+||.+.. ++..++.+.+.....- ....+.+|+++|++|+ |+++++++++ +..+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46899999999997766 5788888777654321 1235789999999995 5889999886 34699999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcccccCCCcEEEeeccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV-KSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DL-kp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
|.+|.+.+.. ....++.|++++|+++|+ .||+|||| ||.|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 82 GAAMYQRPPR----------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred CccHHhhhhh----------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 9998764321 113578899999999998 99999999 799999999999999999999865433210
Q ss_pred ----c--------ccccccCCCccCCCccCCC-CCC-cchhHHHHHHHHHHHHhCCCCCCccc
Q 002410 764 ----I--------SSVARGTVGYLDPEYYGNQ-QLT-EKSDVYSFGVVLLELISGKKPVSVED 812 (927)
Q Consensus 764 ----~--------~~~~~gt~~Y~APE~l~~~-~~s-~ksDVwSlGvlL~eLltG~~Pf~~~~ 812 (927)
. ......++.|++|+...-- ..+ ...+-++-|.-+|.++|+..+...+.
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 1112357788888754322 233 56788899999999999999876443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.7e-18 Score=193.45 Aligned_cols=225 Identities=26% Similarity=0.344 Sum_probs=178.2
Q ss_pred cccccccEEEEEEE----ECCCcEEEEEEccCccch--hHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEEEEEecC
Q 002410 612 KIGKGSFGSVYYGK----MKDGKEVAVKIMADSCSH--RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 612 ~LG~G~~G~Vy~a~----~~~g~~vAvK~l~~~~~~--~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.+|+|.+|.|++++ .+.|+.+|+|++++.... .......|..++...+ ||.++++.-.++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999764 334788999988764321 1124556888888886 9999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+|.|...+. ......+.........++-+++++|+ .+|+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999998887 35567777788888999999999998 99999999999999999999999999999875443222
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 844 (927)
+||..|||||++. ....++|-||||++++||+||..||.. +.++...+. ....
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~-----------~~~~ 206 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKA-----------ELEM 206 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhh-----------ccCC
Confidence 6899999999998 457889999999999999999999983 111221110 0112
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCH
Q 002410 845 KIESIWRIAEVAIQCVEQRGFSRPKM 870 (927)
Q Consensus 845 ~~~~~~~l~~Li~~Cl~~dP~~RPs~ 870 (927)
+.+......+++..++..+|..|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 23334456788888899999988865
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.8e-17 Score=194.00 Aligned_cols=253 Identities=22% Similarity=0.252 Sum_probs=182.7
Q ss_pred hHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcC---CCceeeeeeeeecCceEE
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~---HpnIv~l~~~~~~~~~~~ 677 (927)
++....+.+.+.||+|+||+||+|...+|+.||+|+-+...... |.--.+++.+|+ -+-|..+.....-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 34445556678999999999999999999999999977654432 111223333333 234455555555567788
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC-------CCcEEEee
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-------NMRAKVSD 750 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~-------~~~~kL~D 750 (927)
||+||.+.|+|.+++. ..+.+++..++.++.|++..+++||. .+||||||||+|+||.. ...++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999998 57789999999999999999999998 99999999999999942 34589999
Q ss_pred cccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc
Q 002410 751 FGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 829 (927)
Q Consensus 751 FGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 829 (927)
||.+..+.--.. .......+|-.+-.+|...|+.++.+.|.|.++.+++-||.|+.-- ..+
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------~~~ 906 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------VKN 906 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------------hcC
Confidence 999876432211 2233445788999999999999999999999999999999986431 111
Q ss_pred CCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 830 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 830 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
|... .++..+......+ .+-++...+|..|-..=|...++...|++.+...
T Consensus 907 g~~~-~~~~~~~Ry~~~~---~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 907 GSSW-MVKTNFPRYWKRD---MWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred Ccce-eccccchhhhhHH---HHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 2111 1122221111112 2335666666777777788888888888876643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-16 Score=164.40 Aligned_cols=134 Identities=16% Similarity=0.166 Sum_probs=105.1
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhc-----CCCceeeeeeeeecCc---e-EEEEE
Q 002410 610 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-----HHRNLVPLIGYCEEEH---Q-RILVY 680 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-----~HpnIv~l~~~~~~~~---~-~~LV~ 680 (927)
.+.||+|++|.||. +.+....+||++........+.+.+|+++++.+ .||||++++|++.++. . ..+|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 36899999999996 443333479988765444567899999999999 5799999999998763 3 33789
Q ss_pred Ee--cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCcccccC----CCcEEEeeccc
Q 002410 681 EY--MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL-EYLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFGL 753 (927)
Q Consensus 681 E~--~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL-~~LH~~~~~~ivH~DLkp~NILld~----~~~~kL~DFGl 753 (927)
|| +++|+|.+++.. ..+++. ..++.|++.++ +|||+ ++|+||||||+|||++. +.+++|+||+.
T Consensus 85 e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 85 DFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred cCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 99 567999999974 234444 35678888777 99998 99999999999999974 34799999543
Q ss_pred c
Q 002410 754 S 754 (927)
Q Consensus 754 a 754 (927)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.4e-16 Score=166.35 Aligned_cols=141 Identities=21% Similarity=0.244 Sum_probs=110.2
Q ss_pred HhhcccccccccEEEEEEE--ECCCcEEEEEEccCccch------------------------hHHHHHHHHHHHHhcCC
Q 002410 607 NNFCKKIGKGSFGSVYYGK--MKDGKEVAVKIMADSCSH------------------------RTQQFVTEVALLSRIHH 660 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~--~~~g~~vAvK~l~~~~~~------------------------~~~~~~~E~~~L~~l~H 660 (927)
+.+.+.||+|++|.||+|. ..+|+.||+|+++..... ....+.+|++.++++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5677899999999999998 558999999998743210 11235689999999975
Q ss_pred Cc--eeeeeeeeecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCc
Q 002410 661 RN--LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-IIHRDVKSSN 737 (927)
Q Consensus 661 pn--Iv~l~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~-ivH~DLkp~N 737 (927)
.. +.++++. ...++||||+++++|..... ........+...++.|++.+|++||+ .+ ++||||||+|
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 33 3344432 23589999999988876543 23345666778999999999999998 88 9999999999
Q ss_pred ccccCCCcEEEeecccccccc
Q 002410 738 ILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 738 ILld~~~~~kL~DFGla~~~~ 758 (927)
|+++ ++.++|+|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.2e-16 Score=160.76 Aligned_cols=134 Identities=25% Similarity=0.407 Sum_probs=113.7
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCccc--------hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~--------~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
+.||+|++|.||+|.+ +|..+++|+...... .....+.+|++++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 578899998654221 1124578899999999999988877777777788999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++|++|.+.+... . . .+..++.+++.+|.+||+ .+++|||++|+||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~---~---~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN---G---M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc---c---H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998632 1 1 788999999999999998 9999999999999999 78999999998765
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.3e-15 Score=157.77 Aligned_cols=131 Identities=24% Similarity=0.426 Sum_probs=107.5
Q ss_pred cccccccEEEEEEEECCCcEEEEEEccCccc--------hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 612 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 612 ~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~--------~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
.||+|++|.||+|.+. |+.|++|+...... ....++.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999964 78899998653211 12356788999999999887665555566666779999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+|++|.+.+... .. .++.+++.+|.+||+ .+++|||++|+||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEG---ND-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhc---HH-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999987632 10 789999999999998 9999999999999999 899999999988763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=2e-15 Score=156.53 Aligned_cols=137 Identities=20% Similarity=0.214 Sum_probs=109.0
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCccc----------------------hhHHHHHHHHHHHHhcCCCc--
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS----------------------HRTQQFVTEVALLSRIHHRN-- 662 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~----------------------~~~~~~~~E~~~L~~l~Hpn-- 662 (927)
+.+.+.||+|+||.||++..++|+.||||++..... .....+..|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 666789999999999999998899999998654220 01123677899999998774
Q ss_pred eeeeeeeeecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC
Q 002410 663 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 742 (927)
Q Consensus 663 Iv~l~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~ 742 (927)
+.+.++ ....++||||+++++|.+.... .....++.+++.++.++|+ .+++||||||+||++++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcC
Confidence 444443 2345899999999998765431 2356788999999999998 99999999999999999
Q ss_pred CCcEEEeeccccccccc
Q 002410 743 NMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 743 ~~~~kL~DFGla~~~~~ 759 (927)
++.++|+|||++.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999966543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2e-15 Score=161.36 Aligned_cols=197 Identities=21% Similarity=0.242 Sum_probs=137.9
Q ss_pred CCCceeeeeeeeec---------------------------CceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHH
Q 002410 659 HHRNLVPLIGYCEE---------------------------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH 711 (927)
Q Consensus 659 ~HpnIv~l~~~~~~---------------------------~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~ 711 (927)
+|||||++.++|.+ ...+|+||..++ .+|.+++- ....+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHh----cCCCchHHHHHHHH
Confidence 59999999887633 235789999885 48988886 34466677788999
Q ss_pred HHHHHHHHHHhcCCCCeEecCCCCCcccc--cCCC--cEEEeeccccccccc-----cccccccccccCCCccCCCccCC
Q 002410 712 DAAKGLEYLHTGCNPGIIHRDVKSSNILL--DINM--RAKVSDFGLSRQAEE-----DLTHISSVARGTVGYLDPEYYGN 782 (927)
Q Consensus 712 qia~gL~~LH~~~~~~ivH~DLkp~NILl--d~~~--~~kL~DFGla~~~~~-----~~~~~~~~~~gt~~Y~APE~l~~ 782 (927)
|+++|..|||+ +||.|||+|++|||+ |+|+ .+.|+|||++---.. ......-...|.-.-||||+...
T Consensus 349 QlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999998 999999999999999 3444 478899998753222 11111112346778999999753
Q ss_pred CC------CCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHH
Q 002410 783 QQ------LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVA 856 (927)
Q Consensus 783 ~~------~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li 856 (927)
.. .-.|+|.|+.|.+.||+++...||...... ..+... .++..+ |.+ +...+..+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-----Yqe~qL-----Pal----p~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-----YQESQL-----PAL----PSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-----hhhhhC-----CCC----cccCChHHHHHH
Confidence 21 235899999999999999999999732110 001111 111111 111 222334678999
Q ss_pred HHhhccCCCCCCCHHHHHHHHH
Q 002410 857 IQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 857 ~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
...|+.||.+|++..-....|+
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999999887777665
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.3e-16 Score=175.89 Aligned_cols=174 Identities=27% Similarity=0.395 Sum_probs=133.2
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccc
Q 002410 675 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 754 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 754 (927)
..++.|++|...+|.++|.........++...+.++.|++.|++| ++.+|+|+||.||+...+.++||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999877677788899999999999999999 58899999999999999999999999998
Q ss_pred ccccccc-----cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhh
Q 002410 755 RQAEEDL-----THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIK 828 (927)
Q Consensus 755 ~~~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 828 (927)
....... ........||..||+||.+.+..|+.|+||||||++|+|++. =..++. ... ...-++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------r~~----t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------RIA----TLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------HHH----hhhhhh
Confidence 7765443 222344569999999999999999999999999999999997 222221 000 011122
Q ss_pred cCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 002410 829 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI 873 (927)
Q Consensus 829 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eV 873 (927)
.+. ++|....+++.+ ..++.+++.+.|.+||++.++
T Consensus 474 ~g~----ip~~~~~d~p~e-----~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 DGI----IPPEFLQDYPEE-----YTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cCC----CChHHhhcCcHH-----HHHHHHhcCCCcccCchHHHH
Confidence 222 222333333322 378899999999999944443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.6e-15 Score=176.94 Aligned_cols=133 Identities=24% Similarity=0.370 Sum_probs=109.5
Q ss_pred hcccccccccEEEEEEEECCCcEEEEEE-ccCccc-------hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKI-MADSCS-------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 609 ~~~~LG~G~~G~Vy~a~~~~g~~vAvK~-l~~~~~-------~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
..+.||+|+||.||+|.+.+.. +++|+ ..+... ...+.+.+|++++++++|++++....++......++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 3688999999999999887544 44443 222111 12356889999999999999998888777777789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
||+++++|.+++. ....++.+++++|.+||+ .+++||||||+||++ +++.++|+|||+++..
T Consensus 416 E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 416 EYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999875 356789999999999998 999999999999999 6789999999998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.4e-15 Score=176.91 Aligned_cols=210 Identities=26% Similarity=0.334 Sum_probs=141.6
Q ss_pred hhcccccccccEEEEEEEECC-CcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCC
Q 002410 608 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 686 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~g 686 (927)
+.++.|..|++|.||.++++. .+.+|+|+-++. .+.+- ++.....|.+| |
T Consensus 86 ~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv---------------------g 136 (1205)
T KOG0606|consen 86 NTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV---------------------G 136 (1205)
T ss_pred ceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee---------------------c
Confidence 446889999999999999884 677888543321 11110 22222333333 3
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc-----
Q 002410 687 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL----- 761 (927)
Q Consensus 687 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~----- 761 (927)
+=...++ .-++++... +.+++|||+ .+|+|||+||+|.+|+.-|++|++|||+++......
T Consensus 137 Dc~tllk---~~g~lPvdm--------vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 137 DCATLLK---NIGPLPVDM--------VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred hhhhhcc---cCCCCcchh--------hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 3334444 233444332 788999998 999999999999999999999999999987632111
Q ss_pred ---------cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCe
Q 002410 762 ---------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832 (927)
Q Consensus 762 ---------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 832 (927)
.......+||+.|+|||++....|....|.|++|+++||.+.|+.||.++..++- +-+.+...+ .+
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel--fg~visd~i---~w 277 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--FGQVISDDI---EW 277 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH--Hhhhhhhhc---cc
Confidence 1112345799999999999999999999999999999999999999985543221 111111111 11
Q ss_pred eeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 002410 833 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 874 (927)
Q Consensus 833 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl 874 (927)
.+- | .....+..+++.+.|+.+|..|--....+
T Consensus 278 pE~-d--------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 278 PEE-D--------EALPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred ccc-C--------cCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence 111 2 22233678999999999999997544433
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.5e-13 Score=162.68 Aligned_cols=129 Identities=25% Similarity=0.462 Sum_probs=99.2
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCc-ccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSL-PNLQELH 486 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l-~~L~~L~ 486 (927)
++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|+ +++|++|+.|+|++|+|+|.+|..++.+ .++..++
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~ 521 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN 521 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence 5899999999999999999999999999999999999999996 9999999999999999999999998864 5678899
Q ss_pred ccccCCCCCCCccccCCceeeeecCCCCCcccc-cccceeeeeeeechhhhHHHHHHhhhhheeeee
Q 002410 487 IENNSFVGEIPPALLTGKVIFKYDNNPKLHKES-RRRMRFKLILGTSIGVLAILLVLFLCSLIVLRK 552 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~~~~~~~~~~N~~~c~~~-~~~~~~~iil~~~ig~l~vllvl~l~~~~~~rr 552 (927)
+++|.....+|. + ..|... .......++++++++++++++.++.+ +...++
T Consensus 522 ~~~N~~lc~~p~-l-------------~~C~~~~~~~~~i~~~~~~~~~~l~~~~~~~~~-~~~r~~ 573 (623)
T PLN03150 522 FTDNAGLCGIPG-L-------------RACGPHLSVGAKIGIAFGVSVAFLFLVICAMCW-WKRRQN 573 (623)
T ss_pred ecCCccccCCCC-C-------------CCCcccCCCceEEEEEhHHHHHHHHHHHHHhhh-eeehhh
Confidence 999986544443 1 112211 12335566667666655555555444 444443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.9e-14 Score=137.17 Aligned_cols=135 Identities=22% Similarity=0.207 Sum_probs=114.8
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCC--CceeeeeeeeecCceEEEEEEecCCCC
Q 002410 610 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYEYMHNGT 687 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~H--pnIv~l~~~~~~~~~~~LV~E~~~~gs 687 (927)
.+.||+|.++.||++...+ +.+++|....... ...+.+|+..++.++| .++.+++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999864 7899999876433 5678899999999976 589999998888888999999998876
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 688 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 688 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+... +......++.+++++|++||.....+++|+|++|+||+++..+.+++.|||.+...
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 6543 45667888999999999999844458999999999999999899999999988653
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=7.4e-14 Score=143.04 Aligned_cols=137 Identities=22% Similarity=0.302 Sum_probs=98.6
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCccch--hHHH----------------------HHHHHHHHHhcCCCc--e
Q 002410 610 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQ----------------------FVTEVALLSRIHHRN--L 663 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~--~~~~----------------------~~~E~~~L~~l~Hpn--I 663 (927)
.+.||+|+||+||+|...+|+.||||+++..... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999998753221 1111 134666666664432 3
Q ss_pred eeeeeeeecCceEEEEEEecCCCCHHHH-hccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC
Q 002410 664 VPLIGYCEEEHQRILVYEYMHNGTLRDR-LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 742 (927)
Q Consensus 664 v~l~~~~~~~~~~~LV~E~~~~gsL~~~-L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~ 742 (927)
.+.++. ...++||||++++.+... +... ... .....++.+++.++.++|+ ..+|+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence 344432 235899999998543211 1110 011 5678899999999999996 38999999999999999
Q ss_pred CCcEEEeecccccccc
Q 002410 743 NMRAKVSDFGLSRQAE 758 (927)
Q Consensus 743 ~~~~kL~DFGla~~~~ 758 (927)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.5e-13 Score=144.70 Aligned_cols=136 Identities=18% Similarity=0.243 Sum_probs=106.0
Q ss_pred ccccc-ccccEEEEEEEECCCcEEEEEEccCcc-------------chhHHHHHHHHHHHHhcCCCce--eeeeeeeecC
Q 002410 610 CKKIG-KGSFGSVYYGKMKDGKEVAVKIMADSC-------------SHRTQQFVTEVALLSRIHHRNL--VPLIGYCEEE 673 (927)
Q Consensus 610 ~~~LG-~G~~G~Vy~a~~~~g~~vAvK~l~~~~-------------~~~~~~~~~E~~~L~~l~HpnI--v~l~~~~~~~ 673 (927)
...|| .|+.|+||.+... +..++||.+.... ......+.+|++++.+|+|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35787 8999999999886 7789998875311 1233567889999999998775 6677764432
Q ss_pred c----eEEEEEEecCC-CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEE
Q 002410 674 H----QRILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 748 (927)
Q Consensus 674 ~----~~~LV~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL 748 (927)
. ..++|+|+++| .+|.+++.. ..++.. .+.+|+.+|.+||+ .||+||||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 699988863 234443 36789999999998 99999999999999999899999
Q ss_pred eeccccccc
Q 002410 749 SDFGLSRQA 757 (927)
Q Consensus 749 ~DFGla~~~ 757 (927)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.1e-14 Score=173.20 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=186.4
Q ss_pred HhhcccccccccEEEEEEEECC--CcEEEEEEccCcc--chhHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC--SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~--g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~LV~E 681 (927)
+++.+.||+|.++.|-...... ...+|+|.+.... .........|..+-+.+. |+|++.+++...+.+..+++++
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 4556779999999998887643 4456677665432 223344556777777776 9999999999999999999999
Q ss_pred ecCCCCHHHHh-ccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCcccccCCC-cEEEeecccccccc
Q 002410 682 YMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLH-TGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAE 758 (927)
Q Consensus 682 ~~~~gsL~~~L-~~~~~~~~l~~~~~~~i~~qia~gL~~LH-~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla~~~~ 758 (927)
|..++++.+.+ +.. ....+....-.++.|+..++.|+| . .++.|+||||+|.+++..+ ..+++|||+|....
T Consensus 102 ~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cccccccccccccCC--ccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999888 422 224566667788999999999999 6 8999999999999999999 99999999998865
Q ss_pred c--ccccccccccc-CCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 759 E--DLTHISSVARG-TVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 759 ~--~~~~~~~~~~g-t~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
. +.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....... .....|.... +..
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~---~~~-- 250 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK---GRF-- 250 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc---ccc--
Confidence 5 33333334557 9999999998874 55788999999999999999999997444322 1111221111 000
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
...... .......+++.+++..+|..|.+.+++..
T Consensus 251 --~~~~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 251 --TQLPWN----SISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --ccCccc----cCChhhhhcccccccCCchhccccccccc
Confidence 000111 11224568888999999999999988754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.2e-13 Score=141.74 Aligned_cols=202 Identities=25% Similarity=0.374 Sum_probs=144.1
Q ss_pred HHHHhcCCCceeeeeeeeecC-----ceEEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 002410 653 ALLSRIHHRNLVPLIGYCEEE-----HQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726 (927)
Q Consensus 653 ~~L~~l~HpnIv~l~~~~~~~-----~~~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~ 726 (927)
..|-++-|-|||+++.|..+. .+..++.|||..|++.++|++.. .+..+......+|+-||..||.|||+ |++
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 344556799999999987543 35789999999999999998654 56778889999999999999999997 889
Q ss_pred CeEecCCCCCcccccCCCcEEEeecccccc---ccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh
Q 002410 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 803 (927)
Q Consensus 727 ~ivH~DLkp~NILld~~~~~kL~DFGla~~---~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt 803 (927)
.|+|+++..+-|++..+|-+|+.----... .............+-++|.+||.-.....+-++|||+||+...||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 999999999999999999888853211111 00111111223346789999999877788889999999999999998
Q ss_pred CCCCCCccccc--chhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 804 GKKPVSVEDFG--AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 804 G~~Pf~~~~~~--~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+..--...... .+.++.. -+...-++ +. ..++.+|++..|..||+|.+++..
T Consensus 278 lEiq~tnseS~~~~ee~ia~---------~i~~len~-lq-----------r~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIAN---------VIIGLENG-LQ-----------RGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcceeehhhhhhh---------heeeccCc-cc-----------cCcCcccccCCCCCCcchhhhhcC
Confidence 76542211111 1111110 01111111 11 257789999999999999998754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.9e-12 Score=149.67 Aligned_cols=141 Identities=24% Similarity=0.301 Sum_probs=101.5
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCccchhH----------------------------------------HHHHH
Q 002410 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT----------------------------------------QQFVT 650 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~----------------------------------------~~~~~ 650 (927)
+.||.|++|.||+|++++|+.||||+.+....... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 56999999999999999999999999865321110 12555
Q ss_pred HHHHHHhcC----CCceeeeeeee-ecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 002410 651 EVALLSRIH----HRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-GLEYLHTGC 724 (927)
Q Consensus 651 E~~~L~~l~----HpnIv~l~~~~-~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~-gL~~LH~~~ 724 (927)
|++.+.+++ |.+-+.+-.++ ......+|||||++|++|.+...... ... .+.+++.+++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~---~~~~ia~~~~~~~l~ql~~-- 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGL---DRKALAENLARSFLNQVLR-- 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCC---CHHHHHHHHHHHHHHHHHh--
Confidence 666666653 22223333333 22445799999999999988765321 112 23456666666 4678887
Q ss_pred CCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 725 ~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
.|++|+|+||.||+++.+++++++|||++....+
T Consensus 276 -~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 -DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred -CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.9e-11 Score=156.84 Aligned_cols=139 Identities=31% Similarity=0.535 Sum_probs=94.6
Q ss_pred hHHHHHHHhhhhcc-----CCCCC-CCCCCCCCCccEEEeCCCCCceEEEEecCCCCcccCCccccCCcccceecccCCC
Q 002410 371 WQDEALRSISDESE-----RTNDR-GDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNF 444 (927)
Q Consensus 371 ~~~~al~~~~~~~~-----~~~w~-gdpC~~~~w~~~~c~~~~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~ 444 (927)
.+..||..++..+. ..+|+ .+.|| .|.|+.|+.. .+|+.|+|++|+++|.+|..|..|++|+.|+|++|+
T Consensus 29 ~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c--~w~gv~c~~~--~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~ 104 (968)
T PLN00113 29 EELELLLSFKSSINDPLKYLSNWNSSADVC--LWQGITCNNS--SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ 104 (968)
T ss_pred HHHHHHHHHHHhCCCCcccCCCCCCCCCCC--cCcceecCCC--CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc
Confidence 44589999998764 35785 34454 6999888643 589999999999998888888888888888888888
Q ss_pred CCCCCCC--cCcccccceeecccccccCCC----------------------CCcCCCccccccccccccCCCCCCCccc
Q 002410 445 LTGPLPD--MSRLIDLRIVHLENNELTGSL----------------------PSYMGSLPNLQELHIENNSFVGEIPPAL 500 (927)
Q Consensus 445 l~g~~p~--~~~l~~L~~L~Ls~N~l~g~i----------------------P~~l~~l~~L~~L~l~~N~l~g~iP~~~ 500 (927)
++|.+|. +.++++|++|+|++|+++|.+ |..++++++|+.|+|++|.+.+.+|..+
T Consensus 105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~ 184 (968)
T PLN00113 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184 (968)
T ss_pred cCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhh
Confidence 8887774 446666666666666665544 4455555555555555555555555544
Q ss_pred cC--CceeeeecCCC
Q 002410 501 LT--GKVIFKYDNNP 513 (927)
Q Consensus 501 ~~--~~~~~~~~~N~ 513 (927)
.+ .+..+.+.+|.
T Consensus 185 ~~l~~L~~L~L~~n~ 199 (968)
T PLN00113 185 TNLTSLEFLTLASNQ 199 (968)
T ss_pred hhCcCCCeeeccCCC
Confidence 33 34444455543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.6e-11 Score=140.07 Aligned_cols=253 Identities=23% Similarity=0.243 Sum_probs=184.2
Q ss_pred hhHHHHHHhhcccccc--cccEEEEEEEE---CCCcEEEEEEccCccc--hhHHHHHHHHHHHHhcC-CCceeeeeeeee
Q 002410 600 PELEEATNNFCKKIGK--GSFGSVYYGKM---KDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIH-HRNLVPLIGYCE 671 (927)
Q Consensus 600 ~el~~~~~~~~~~LG~--G~~G~Vy~a~~---~~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~ 671 (927)
.+.......+.+.+|. |.+|.||.+.. .++..+|+|+-+.... .....=.+|+....+++ |+|.++....+.
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 3555666677889999 99999999987 3688899998543322 33334456777777774 999999888899
Q ss_pred cCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCcccccCC-CcE
Q 002410 672 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK----GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRA 746 (927)
Q Consensus 672 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~----gL~~LH~~~~~~ivH~DLkp~NILld~~-~~~ 746 (927)
..+..++-+|.+ +.+|.++.+.. ...++....+.+..+..+ ||.++|+ .+++|-|+||.||+...+ ...
T Consensus 189 ~~~~lfiqtE~~-~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 189 GSGILFIQTELC-GESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred cCCcceeeeccc-cchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheeccccccee
Confidence 999999999988 47888887742 334677778888888888 9999998 999999999999999999 889
Q ss_pred EEeeccccccccccccc----cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHH
Q 002410 747 KVSDFGLSRQAEEDLTH----ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 822 (927)
Q Consensus 747 kL~DFGla~~~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~ 822 (927)
+++|||+...+.+..-. ......|...|++||..++ .++.+.|+|++|.+..+..++..+........ |
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W 335 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS------W 335 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC------c
Confidence 99999999887654311 1122257888999998865 67889999999999999999877665221110 1
Q ss_pred HHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 823 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 823 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
. .++.+- + ..++-......+...+..|++.+|..|++.+++..
T Consensus 336 ~--~~r~~~---i-----p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 S--QLRQGY---I-----PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred c--cccccc---C-----chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 000000 0 00111111124455889999999999999888765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.6e-10 Score=132.96 Aligned_cols=166 Identities=20% Similarity=0.223 Sum_probs=128.5
Q ss_pred ECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHH
Q 002410 626 MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 705 (927)
Q Consensus 626 ~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~ 705 (927)
..++.+|.|+..+...........+-++.|+.++||||+++++..+.++..|||+|.+. .|..+++. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 34688899988876655445667788999999999999999999999999999999984 67777763 22556
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccccccccCCCccCCCccCCCCC
Q 002410 706 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 785 (927)
Q Consensus 706 ~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 785 (927)
+.-.+.||+.||.+||. +.+++|++|.-..|+|+..|+.||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 67789999999999997 58999999999999999999999999988765432211 111111123466666553322
Q ss_pred CcchhHHHHHHHHHHHHhC
Q 002410 786 TEKSDVYSFGVVLLELISG 804 (927)
Q Consensus 786 s~ksDVwSlGvlL~eLltG 804 (927)
-..|.|.|||+++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 456999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.3e-11 Score=119.14 Aligned_cols=130 Identities=18% Similarity=0.176 Sum_probs=96.2
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCcee-eeeeeeecCceEEEEEEecCCCCHH
Q 002410 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV-PLIGYCEEEHQRILVYEYMHNGTLR 689 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv-~l~~~~~~~~~~~LV~E~~~~gsL~ 689 (927)
+.|+.|.++.||+++.. ++.+++|+...... ....+.+|+++++.+.+.+++ +++.+.. ...++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 57899999999999976 78899999765432 223567899999998655544 4444432 3457999999998775
Q ss_pred HHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 690 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC--NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 690 ~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~--~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
+. . .....++.+++++|+.||+.. ..+++|||++|.||+++ ++.++++|||.+..
T Consensus 80 ~~-~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE-D----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc-c----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 43 0 112345789999999999821 12359999999999998 67899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.8e-11 Score=140.52 Aligned_cols=139 Identities=20% Similarity=0.287 Sum_probs=91.8
Q ss_pred ccccccccEEEEEEEECC-CcEEEEEEccCccchh----------------------------------HH------HHH
Q 002410 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHR----------------------------------TQ------QFV 649 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~~~----------------------------------~~------~~~ 649 (927)
+.||.|++|.||+|++++ |+.||||+.++..... .+ ++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999987 9999999997542110 11 244
Q ss_pred HHHHHHHhcC----CCceeeeeeeeec-CceEEEEEEecCCCCHHHHh--ccCC-CCCCCCHHHHHHHHHHHHHHHHHHH
Q 002410 650 TEVALLSRIH----HRNLVPLIGYCEE-EHQRILVYEYMHNGTLRDRL--HGSV-NQKPLDWLTRLQIAHDAAKGLEYLH 721 (927)
Q Consensus 650 ~E~~~L~~l~----HpnIv~l~~~~~~-~~~~~LV~E~~~~gsL~~~L--~~~~-~~~~l~~~~~~~i~~qia~gL~~LH 721 (927)
+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+++.+.- .... ....+....+..++.| ++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VF 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HH
Confidence 4555555542 3333333333332 45678999999999998742 2110 0011222222223333 33
Q ss_pred hcCCCCeEecCCCCCcccccCCC----cEEEeeccccccccc
Q 002410 722 TGCNPGIIHRDVKSSNILLDINM----RAKVSDFGLSRQAEE 759 (927)
Q Consensus 722 ~~~~~~ivH~DLkp~NILld~~~----~~kL~DFGla~~~~~ 759 (927)
. .|++|+|+||.||+++.++ ++++.|||++.....
T Consensus 278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3 8999999999999999888 999999999987654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.7e-09 Score=110.58 Aligned_cols=136 Identities=15% Similarity=0.174 Sum_probs=98.9
Q ss_pred ccccccccEEEEEEEECC-------CcEEEEEEccCcc----------------------chhHHHHH----HHHHHHHh
Q 002410 611 KKIGKGSFGSVYYGKMKD-------GKEVAVKIMADSC----------------------SHRTQQFV----TEVALLSR 657 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~-------g~~vAvK~l~~~~----------------------~~~~~~~~----~E~~~L~~ 657 (927)
..||.|--+.||.|...+ +..+|||+.+... ....+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 4799999974210 01122333 79999999
Q ss_pred cCC--CceeeeeeeeecCceEEEEEEecCCCCHHH-HhccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCC
Q 002410 658 IHH--RNLVPLIGYCEEEHQRILVYEYMHNGTLRD-RLHGSVNQKPLDWLTRLQIAHDAAKGLEYL-HTGCNPGIIHRDV 733 (927)
Q Consensus 658 l~H--pnIv~l~~~~~~~~~~~LV~E~~~~gsL~~-~L~~~~~~~~l~~~~~~~i~~qia~gL~~L-H~~~~~~ivH~DL 733 (927)
+.. -++.+++++ ...++||||+.+..+.. .++ ...++..+...+..+++.+|..| |+ .+++||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence 853 455566654 45689999997654422 222 22344556778889999999999 76 89999999
Q ss_pred CCCcccccCCCcEEEeecccccccc
Q 002410 734 KSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 734 kp~NILld~~~~~kL~DFGla~~~~ 758 (927)
++.||+++ ++.++|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999996 5789999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.6e-09 Score=113.71 Aligned_cols=142 Identities=21% Similarity=0.322 Sum_probs=111.4
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCC--CceeeeeeeeecC---ceEEEEEEecC
Q 002410 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHH--RNLVPLIGYCEEE---HQRILVYEYMH 684 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~H--pnIv~l~~~~~~~---~~~~LV~E~~~ 684 (927)
+.|+.|..+.||+++..+|+.+++|+...... .....+.+|+++++.+++ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999988778999999765332 134578899999999975 3456777777654 25689999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG----------------------------------------- 723 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~----------------------------------------- 723 (927)
|.++.+.+. ...++..+...++.+++++|..||+.
T Consensus 84 G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 988876553 13467778888889999999999852
Q ss_pred ------------CCCCeEecCCCCCcccccC--CCcEEEeecccccc
Q 002410 724 ------------CNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQ 756 (927)
Q Consensus 724 ------------~~~~ivH~DLkp~NILld~--~~~~kL~DFGla~~ 756 (927)
....++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1256799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=8.4e-09 Score=102.10 Aligned_cols=131 Identities=24% Similarity=0.369 Sum_probs=100.9
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEcc-Cccc-------hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCS-------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g~~vAvK~l~-~~~~-------~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
..+++|+-+.+|.+.+. |..+++|.-. +... -...+-.+|++++.+++--.|...+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999886 4446666532 2211 1234567899999998765655555566677778899999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++|-.|.+.+... ...++..+-.-+.-||. .+|+||||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888742 25667778888889998 9999999999999997654 99999999875
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.9e-10 Score=110.62 Aligned_cols=84 Identities=31% Similarity=0.481 Sum_probs=80.7
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
...++.|.||+|+|+ .+|+.+..|.+|+.|+|++|+++..+++++.|++|+.|+++-|+|. .+|..||.+|.|+.|||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 357889999999999 9999999999999999999999999999999999999999999999 99999999999999999
Q ss_pred cccCCC
Q 002410 488 ENNSFV 493 (927)
Q Consensus 488 ~~N~l~ 493 (927)
++|+++
T Consensus 110 tynnl~ 115 (264)
T KOG0617|consen 110 TYNNLN 115 (264)
T ss_pred cccccc
Confidence 999987
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.90 E-value=9.2e-10 Score=125.91 Aligned_cols=242 Identities=22% Similarity=0.233 Sum_probs=172.5
Q ss_pred hhcccccccccEEEEEEEEC--CCcEEEEEEccCccchhHHH--HHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEe
Q 002410 608 NFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ--FVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~--~g~~vAvK~l~~~~~~~~~~--~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
.++..||.|.|+.|+....+ ++..+++|.+.+.......+ -..|+.+...+ .|.++++....+......++=.||
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF 347 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence 34678999999999988644 57789999887654332222 34577777766 488888888877777778899999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC-CcEEEeeccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFGla~~~~~~~ 761 (927)
++++++...+. -...++...++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.|||++..+.-.
T Consensus 348 ~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~- 420 (524)
T KOG0601|consen 348 CEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS- 420 (524)
T ss_pred hcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccccccee-
Confidence 99998876663 34557788889999999999999998 999999999999999876 77899999988642111
Q ss_pred cccccccccCCCcc--CCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 762 THISSVARGTVGYL--DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~--APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
........++. +|+......+..+.|++|||.-+.|..++..--.. ..+|.. +..+.. +.
T Consensus 421 ---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~--------~~~~~~--i~~~~~-----p~ 482 (524)
T KOG0601|consen 421 ---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES--------GVQSLT--IRSGDT-----PN 482 (524)
T ss_pred ---cccccccccccccchhhccccccccccccccccccccccccCcccCcc--------ccccee--eecccc-----cC
Confidence 11111233344 55666677888999999999999999998654331 011100 111111 11
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
+. .. ...+..+...+..+++..||.+.++....+.
T Consensus 483 ~~----~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 483 LP----GL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred CC----ch-HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 11 11 1466788889999999999999888765543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2e-08 Score=98.83 Aligned_cols=142 Identities=20% Similarity=0.239 Sum_probs=104.6
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEc-cCccc-------hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 610 CKKIGKGSFGSVYYGKMKDGKEVAVKIM-ADSCS-------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~~g~~vAvK~l-~~~~~-------~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
...|-+|+-+.|+++.+. |+..+||.- .+... -..++..+|++.|.+++--.|.-..-++.+...-.++||
T Consensus 12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 367889999999999987 777666643 22221 123567889999999875555444445666667789999
Q ss_pred ecCC-CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC---cEEEeecccccc
Q 002410 682 YMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAKVSDFGLSRQ 756 (927)
Q Consensus 682 ~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~---~~kL~DFGla~~ 756 (927)
|++| -++.+++..... ...........+.+|-+.+.-||. .+|+||||..+||++..++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~-~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTME-DESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHcc-CcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9977 478888765432 222333347888999999999997 9999999999999996544 358999999865
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.5e-07 Score=105.48 Aligned_cols=170 Identities=21% Similarity=0.297 Sum_probs=130.8
Q ss_pred ccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeee----cCceEEEEEEecCC-CCHHH
Q 002410 617 SFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE----EEHQRILVYEYMHN-GTLRD 690 (927)
Q Consensus 617 ~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~----~~~~~~LV~E~~~~-gsL~~ 690 (927)
...+.|++..+ ||..|++|+++............-+++++++.|.|+|++.+++. .+...++||+|+++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 44678999866 89999999996543333333345688899999999999999875 35578899999986 56776
Q ss_pred HhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 691 RLHGSV------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 691 ~L~~~~------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
.--... .+...++..++.++.|+..||.++|+ .|+.-+-|.+++|+++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 543211 23457789999999999999999998 899999999999999999999999888776655
Q ss_pred ccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 002410 759 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807 (927)
Q Consensus 759 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~P 807 (927)
.+.. |.+.+ -.+-|.=.||.+++.|.||..-
T Consensus 445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 4321 11111 2467889999999999999654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.1e-10 Score=106.77 Aligned_cols=107 Identities=33% Similarity=0.579 Sum_probs=95.4
Q ss_pred CCceEEEEecCCCCcc-cCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g-~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.+.+..|||+.|+|+. .+|..|..++.|+.|+|+.|.+.-.+|++++|++|+.|.|..|.|- ++|.+++.|..|++|+
T Consensus 101 ~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelh 179 (264)
T KOG0617|consen 101 FPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELH 179 (264)
T ss_pred CchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHh
Confidence 5678999999999985 4888999999999999999999999999999999999999999998 8999999999999999
Q ss_pred ccccCCCCCCCccccC-----CceeeeecCCCCCc
Q 002410 487 IENNSFVGEIPPALLT-----GKVIFKYDNNPKLH 516 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~-----~~~~~~~~~N~~~c 516 (927)
+++|+++ .+|+++.. ....+....|||..
T Consensus 180 iqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~ 213 (264)
T KOG0617|consen 180 IQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVN 213 (264)
T ss_pred cccceee-ecChhhhhhhhhhhHHHHhhhhCCCCC
Confidence 9999999 99998865 33455678889864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.3e-07 Score=102.11 Aligned_cols=141 Identities=16% Similarity=0.161 Sum_probs=100.7
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCccch-hH----------HHHHHHHHHHHhcCCCce--eeeeeeeec-----
Q 002410 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RT----------QQFVTEVALLSRIHHRNL--VPLIGYCEE----- 672 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~-~~----------~~~~~E~~~L~~l~HpnI--v~l~~~~~~----- 672 (927)
+.+-+-....|.++.+. |+.+.||........ .. ..+.+|...+.++...+| .+++++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 33443344457777764 788999977443211 11 247789999988854333 344555432
Q ss_pred CceEEEEEEecCCC-CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC-------CC
Q 002410 673 EHQRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-------NM 744 (927)
Q Consensus 673 ~~~~~LV~E~~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~-------~~ 744 (927)
....++|+|++++. +|.+++.... ....+...+..++.+++..+..||. .||+|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCc
Confidence 23578999999886 8999885321 2345567778999999999999998 99999999999999975 46
Q ss_pred cEEEeecccccc
Q 002410 745 RAKVSDFGLSRQ 756 (927)
Q Consensus 745 ~~kL~DFGla~~ 756 (927)
.+.|+||+.+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 799999997753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=5e-09 Score=125.45 Aligned_cols=296 Identities=21% Similarity=0.234 Sum_probs=183.1
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCc---cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
.+.+-+|.++.+..+.-. .|...+.|+.... ...+.+....+-.++-..+||-+++..--+.-....+|+++|+.+
T Consensus 809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG 888 (1205)
T ss_pred cccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence 356788888888876533 2333333333221 111222233333333334557677665555556778999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc-----
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED----- 760 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~----- 760 (927)
++|...|+. ....+.......+..+.+++++||. ..+.|+|++|.|.++..++..+++|||......-.
T Consensus 889 ~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 889 GDLPSKLHN---SGCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred CCchhhhhc---CCCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 999999984 3455666666777888999999997 66899999999999999999999999843221100
Q ss_pred c-------------------------cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc
Q 002410 761 L-------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 815 (927)
Q Consensus 761 ~-------------------------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~ 815 (927)
. ........+|+.|.+||.+.+......+|.|+.|++++|.++|..||.......
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 0 011223458999999999999999999999999999999999999998433221
Q ss_pred hhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHH---HHHHH------------HHhh
Q 002410 816 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ---EIVLA------------IQDS 880 (927)
Q Consensus 816 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~---eVl~~------------L~~~ 880 (927)
. . +. +.++.+. ......+......+++.+.+..+|.+|-.|. ++-.. ++.+
T Consensus 1043 ~---f---~n-i~~~~~~-------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~~ 1108 (1205)
T KOG0606|consen 1043 I---F---EN-ILNRDIP-------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQKA 1108 (1205)
T ss_pred h---h---hc-cccCCCC-------CCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccccccC
Confidence 1 1 11 1111110 0111122223556788888899999998877 22111 1111
Q ss_pred hhhccCC----CCccccCCC-CCCCcccccccccccccCCCCCcccccCC
Q 002410 881 IKIEKGG----DQKFSSSSS-KGQSSRKTLLTSFLEIESPDLSNECLAPA 925 (927)
Q Consensus 881 ~~~e~~~----~~~~s~~~s-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (927)
-.+.-.. ...|.+--+ ....+..+....+....+.++..+|.-|.
T Consensus 1109 ~~~p~~~s~~dtS~~~~r~~~~~~~e~~sg~s~~~~~~s~~~~~~~~~pe 1158 (1205)
T KOG0606|consen 1109 EFVPQPESTQDTSYFESRFSEESQDETVSGSSSGSKLDSPDESPECTTPE 1158 (1205)
T ss_pred ccCCCCCCCCccchhhcccccccccccccCCCcccCccCccccccccCcc
Confidence 1110001 111111111 11223455666788888888888887664
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=6e-08 Score=98.94 Aligned_cols=126 Identities=25% Similarity=0.309 Sum_probs=83.6
Q ss_pred EEEEEEECCCcEEEEEEccCcc--------------c------------hhHHHHHHHHHHHHhcCCC--ceeeeeeeee
Q 002410 620 SVYYGKMKDGKEVAVKIMADSC--------------S------------HRTQQFVTEVALLSRIHHR--NLVPLIGYCE 671 (927)
Q Consensus 620 ~Vy~a~~~~g~~vAvK~l~~~~--------------~------------~~~~~~~~E~~~L~~l~Hp--nIv~l~~~~~ 671 (927)
.||.|...+|..+|||+.+... . .......+|.+.|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899999999999999974210 0 0123467899999999755 455665442
Q ss_pred cCceEEEEEEecC--CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCcccccCCCcEEE
Q 002410 672 EEHQRILVYEYMH--NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY-LHTGCNPGIIHRDVKSSNILLDINMRAKV 748 (927)
Q Consensus 672 ~~~~~~LV~E~~~--~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~-LH~~~~~~ivH~DLkp~NILld~~~~~kL 748 (927)
..+|||||++ |..+..+... .++......++.+++..+.. +|. .||+||||++.||+++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEE
Confidence 3479999998 6555443331 12234556778888886666 466 899999999999999877 9999
Q ss_pred eecccccccc
Q 002410 749 SDFGLSRQAE 758 (927)
Q Consensus 749 ~DFGla~~~~ 758 (927)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.4e-09 Score=120.50 Aligned_cols=84 Identities=30% Similarity=0.366 Sum_probs=61.3
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
...|+.||||+|+|. ..|..+-.-+++-.|+||+|+|..++.. |-+|+.|-.||||+|+|. .+|+.+..|.+|+.|.
T Consensus 102 l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~ 179 (1255)
T KOG0444|consen 102 LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLK 179 (1255)
T ss_pred cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhh
Confidence 345777777777777 7777777777777777777777665554 677777777777777777 7777777777777777
Q ss_pred ccccCCC
Q 002410 487 IENNSFV 493 (927)
Q Consensus 487 l~~N~l~ 493 (927)
|++|.|.
T Consensus 180 Ls~NPL~ 186 (1255)
T KOG0444|consen 180 LSNNPLN 186 (1255)
T ss_pred cCCChhh
Confidence 7777653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=8.6e-07 Score=97.06 Aligned_cols=265 Identities=15% Similarity=0.141 Sum_probs=161.0
Q ss_pred hcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeee------eec-CceEEEEE
Q 002410 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY------CEE-EHQRILVY 680 (927)
Q Consensus 609 ~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~------~~~-~~~~~LV~ 680 (927)
.++.||+|+.+.+|-.-.- ...+.|+.+........+. +..|.+. .||-+-.-+.+ -.+ +...-++|
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh--hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3578999999999964321 1235577665433332322 2333333 45543321111 111 22356788
Q ss_pred EecCCC-CHHHHhccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 681 EYMHNG-TLRDRLHGS---VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 681 E~~~~g-sL~~~L~~~---~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
+.+.+. .+..++... +.-...+|.-.++.+..+|.+.+-||+ .|.+-||+.++|+|+.+++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceee
Confidence 887664 233333221 123457899999999999999999998 9999999999999999999999998554333
Q ss_pred ccccccccccccccCCCccCCCccC-----CCCCCcchhHHHHHHHHHHHHhC-CCCCCccccc-chhhHHHHHHHhhhc
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFG-AELNIVHWARSMIKK 829 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG-~~Pf~~~~~~-~~~~l~~~~~~~~~~ 829 (927)
...+.. ....+|...|.+||.-. +..-+...|-|.+|+++++++.| ++||.+-... ...+-.+ ..+..
T Consensus 167 ~~ng~~--~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia~ 241 (637)
T COG4248 167 NANGTL--HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIAH 241 (637)
T ss_pred ccCCce--EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhhc
Confidence 222222 22345888999999754 33557789999999999999986 9999744322 1111110 01111
Q ss_pred CCeeeecccccc-----CCCCHH-HHHHHHHHHHHhhcc--CCCCCCCHHHHHHHHHhhhhhccC
Q 002410 830 GDVISIVDPVLI-----GNVKIE-SIWRIAEVAIQCVEQ--RGFSRPKMQEIVLAIQDSIKIEKG 886 (927)
Q Consensus 830 ~~~~~~~d~~l~-----~~~~~~-~~~~l~~Li~~Cl~~--dP~~RPs~~eVl~~L~~~~~~e~~ 886 (927)
+.+....+.... ...+-+ .+..+.-+..+|+.. ++.-||+++..+..|..+-....+
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 222211111100 111111 123566778888876 367899999999888776655443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.8e-07 Score=94.90 Aligned_cols=135 Identities=23% Similarity=0.213 Sum_probs=98.2
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCcc----------------------chhHHHHHHHHHHHHhcCCC--c
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC----------------------SHRTQQFVTEVALLSRIHHR--N 662 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~----------------------~~~~~~~~~E~~~L~~l~Hp--n 662 (927)
+.++.+||.|--+.||.|....|.++|||.=+... ........+|.++|++|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999999999999999742110 01123467899999998644 5
Q ss_pred eeeeeeeeecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC
Q 002410 663 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 742 (927)
Q Consensus 663 Iv~l~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~ 742 (927)
+.+.++ .+..++|||+++|-.|...- ++....-.++..|++-+..+-. .||||||+++-||++++
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEec
Confidence 666654 34568999999986664321 1233344455555555555555 89999999999999999
Q ss_pred CCcEEEeecccccc
Q 002410 743 NMRAKVSDFGLSRQ 756 (927)
Q Consensus 743 ~~~~kL~DFGla~~ 756 (927)
+|.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999975544
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.8e-08 Score=81.26 Aligned_cols=58 Identities=41% Similarity=0.536 Sum_probs=29.7
Q ss_pred ccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCccccccccccccC
Q 002410 434 ALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 491 (927)
Q Consensus 434 ~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~N~ 491 (927)
+|+.|+|++|+|+...++ |..+++|++|+|++|+++...|..|..+++|+.|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 344555555555544443 4555555555555555554444455555555555555554
|
... |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.5e-08 Score=114.36 Aligned_cols=105 Identities=28% Similarity=0.500 Sum_probs=95.1
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCC--CCCCCcCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT--GPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~--g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.+|.+|+||+|+|+ .+|..+..|++|+.|.+.+|+|+ |++..++.|.+|+.+.+++|+|. ..|++++.|..|+.|.
T Consensus 268 ~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~ 345 (1255)
T KOG0444|consen 268 ENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLK 345 (1255)
T ss_pred hhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhc
Confidence 37889999999999 99999999999999999999885 54446999999999999999999 9999999999999999
Q ss_pred ccccCCCCCCCccc--cCCceeeeecCCCCCc
Q 002410 487 IENNSFVGEIPPAL--LTGKVIFKYDNNPKLH 516 (927)
Q Consensus 487 l~~N~l~g~iP~~~--~~~~~~~~~~~N~~~c 516 (927)
|++|+|- ++|+.+ +..+..+.+..||.+-
T Consensus 346 L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLV 376 (1255)
T KOG0444|consen 346 LDHNRLI-TLPEAIHLLPDLKVLDLRENPNLV 376 (1255)
T ss_pred cccccee-echhhhhhcCCcceeeccCCcCcc
Confidence 9999999 899875 5578888999999875
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.8e-07 Score=107.54 Aligned_cols=141 Identities=23% Similarity=0.296 Sum_probs=94.1
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCccchhH----------------------------------------HHHHH
Q 002410 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT----------------------------------------QQFVT 650 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~----------------------------------------~~~~~ 650 (927)
+.|+.++-|.||+|++++|+.||||+.+....... -++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999999999999999754321110 12445
Q ss_pred HHHHHHhcC-----CCceeeeeeeee-cCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHH-HHHHHhc
Q 002410 651 EVALLSRIH-----HRNLVPLIGYCE-EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG-LEYLHTG 723 (927)
Q Consensus 651 E~~~L~~l~-----HpnIv~l~~~~~-~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~g-L~~LH~~ 723 (927)
|...+.+++ .+++ ++=.++. -.....|+|||++|-.+.+...-. ....+.. .++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~--~~g~d~k---~ia~~~~~~f~~q~~~- 283 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALK--SAGIDRK---ELAELLVRAFLRQLLR- 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHH--hcCCCHH---HHHHHHHHHHHHHHHh-
Confidence 555555552 2332 2223332 356678999999999888874321 2334432 233333332 222222
Q ss_pred CCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 724 ~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
.|++|+|.+|.||+++.+|++.+.|||+...+.+.
T Consensus 284 --dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 284 --DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred --cCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 79999999999999999999999999998876543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.45 E-value=9.4e-08 Score=78.89 Aligned_cols=60 Identities=37% Similarity=0.509 Sum_probs=54.7
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNEL 468 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l 468 (927)
++|+.|+|++|+|+...+..|.++++|++|+|++|+|+...|+ |.+|++|+.|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4789999999999955557899999999999999999988885 99999999999999986
|
... |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=4e-08 Score=114.01 Aligned_cols=151 Identities=18% Similarity=0.256 Sum_probs=105.3
Q ss_pred HHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc--------ccccccCCCccCCCccC
Q 002410 710 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI--------SSVARGTVGYLDPEYYG 781 (927)
Q Consensus 710 ~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~--------~~~~~gt~~Y~APE~l~ 781 (927)
+.+++.||.|+|. ..++||++|.|++|.++.++..||+.|+.+.......... .....-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455599999998 5899999999999999999999999999876544311111 11122456799999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhh
Q 002410 782 NQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCV 860 (927)
Q Consensus 782 ~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl 860 (927)
+...+.++|+||+||++|.+.. |+.-+............. ..+..-...+..+.+.++.+-+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-------------~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-------------NLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-------------cccccccccccccCcHHHHHHHHHHh
Confidence 9888999999999999999995 554444222221111111 01111111223344567888899999
Q ss_pred ccCCCCCCCHHHHHH
Q 002410 861 EQRGFSRPKMQEIVL 875 (927)
Q Consensus 861 ~~dP~~RPs~~eVl~ 875 (927)
..++..||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998877653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.2e-06 Score=88.08 Aligned_cols=137 Identities=20% Similarity=0.236 Sum_probs=103.5
Q ss_pred cccccEEEEEEEECCCcEEEEEEccCcc------chhHHHHHHHHHHHHhcCCCc--eeeeeeeee-c----CceEEEEE
Q 002410 614 GKGSFGSVYYGKMKDGKEVAVKIMADSC------SHRTQQFVTEVALLSRIHHRN--LVPLIGYCE-E----EHQRILVY 680 (927)
Q Consensus 614 G~G~~G~Vy~a~~~~g~~vAvK~l~~~~------~~~~~~~~~E~~~L~~l~Hpn--Iv~l~~~~~-~----~~~~~LV~ 680 (927)
|+||-+.|++..+. |+.+-+|.-.... ......|.+|...|++|...+ +.+++ ++. . ....+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 56899999998876 4578888765211 235678999999999995322 44444 332 1 22467999
Q ss_pred EecCC-CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCc--EEEeecccccc
Q 002410 681 EYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQ 756 (927)
Q Consensus 681 E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~--~kL~DFGla~~ 756 (927)
|-+++ -+|.+++... .-.+.+...+..++.++++.++-||. .|+.|+|+.++||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98864 5898888643 23356778888999999999999998 99999999999999986667 99999986654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.42 E-value=9.3e-08 Score=96.06 Aligned_cols=102 Identities=27% Similarity=0.454 Sum_probs=39.5
Q ss_pred CceEEEEecCCCCcccCCcccc-CCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcC-CCcccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELH 486 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~-~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l-~~l~~L~~L~ 486 (927)
-++++|+|++|+++ .|. .++ .|++|+.|||++|+|+. ++.+..|+.|+.|+|++|+++ .+++.+ ..+++|+.|+
T Consensus 19 ~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 19 VKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LEGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred cccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-ccCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 36899999999999 554 566 58999999999999997 457889999999999999999 676655 4689999999
Q ss_pred ccccCCCCCCCc----cccCCceeeeecCCCCC
Q 002410 487 IENNSFVGEIPP----ALLTGKVIFKYDNNPKL 515 (927)
Q Consensus 487 l~~N~l~g~iP~----~~~~~~~~~~~~~N~~~ 515 (927)
|++|++. .+-. .-+..+..+.+.|||..
T Consensus 95 L~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 95 LSNNKIS-DLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -TTS----SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CcCCcCC-ChHHhHHHHcCCCcceeeccCCccc
Confidence 9999997 4432 12336778889999864
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.8e-08 Score=105.70 Aligned_cols=105 Identities=26% Similarity=0.326 Sum_probs=84.5
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCC-cCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~-~l~~l~~L~~L~ 486 (927)
.++++.|+|++|-|. .+|.+++.+..|+.||||+|+|.-.+.-+..+..|+.+-.++|++. .+|. .+.+|.+|..||
T Consensus 434 l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~-~vd~~~l~nm~nL~tLD 511 (565)
T KOG0472|consen 434 LQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIG-SVDPSGLKNMRNLTTLD 511 (565)
T ss_pred hhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhcccccc-ccChHHhhhhhhcceec
Confidence 468999999998888 9999999999999999999987654444566666777777778887 5554 488888888888
Q ss_pred ccccCCCCCCCccccC--CceeeeecCCCCC
Q 002410 487 IENNSFVGEIPPALLT--GKVIFKYDNNPKL 515 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~--~~~~~~~~~N~~~ 515 (927)
|.+|.+. .||+.+++ .+..+.++|||..
T Consensus 512 L~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 512 LQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cCCCchh-hCChhhccccceeEEEecCCccC
Confidence 8888888 88888876 6677788888875
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.3e-06 Score=89.31 Aligned_cols=107 Identities=27% Similarity=0.305 Sum_probs=83.4
Q ss_pred HHHHHHHHHHHHhcCCC--ceeeeeeeeecC----ceEEEEEEecCCC-CHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 002410 645 TQQFVTEVALLSRIHHR--NLVPLIGYCEEE----HQRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 717 (927)
Q Consensus 645 ~~~~~~E~~~L~~l~Hp--nIv~l~~~~~~~----~~~~LV~E~~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL 717 (927)
.....+|...+.+|... ...+.+++.... ...++|+|++++. +|.+++... ...+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence 34677888888888533 244555555442 2458999999884 899998742 2266677889999999999
Q ss_pred HHHHhcCCCCeEecCCCCCcccccCCC---cEEEeeccccccc
Q 002410 718 EYLHTGCNPGIIHRDVKSSNILLDINM---RAKVSDFGLSRQA 757 (927)
Q Consensus 718 ~~LH~~~~~~ivH~DLkp~NILld~~~---~~kL~DFGla~~~ 757 (927)
+-||+ .||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99998 9999999999999999887 8999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.7e-08 Score=106.59 Aligned_cols=101 Identities=22% Similarity=0.356 Sum_probs=65.6
Q ss_pred eEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCccccccccccc
Q 002410 411 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 489 (927)
Q Consensus 411 l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~ 489 (927)
+.-|+|.+|++. .+| +|..|..|.+|+++.|++.-.+-+ ..+|.+|.+|||..|++. +.|++++-|.+|..||+|+
T Consensus 208 L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSN 284 (565)
T KOG0472|consen 208 LELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSN 284 (565)
T ss_pred hHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccC
Confidence 344444444444 444 444444444444444444443334 346777888888888888 8888888888888888888
Q ss_pred cCCCCCCCccccC-CceeeeecCCCCC
Q 002410 490 NSFVGEIPPALLT-GKVIFKYDNNPKL 515 (927)
Q Consensus 490 N~l~g~iP~~~~~-~~~~~~~~~N~~~ 515 (927)
|.++ .+|.++++ .+..+.+.|||..
T Consensus 285 N~is-~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 285 NDIS-SLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred Cccc-cCCcccccceeeehhhcCCchH
Confidence 8888 77877776 4555667788754
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=7.7e-08 Score=108.41 Aligned_cols=106 Identities=20% Similarity=0.295 Sum_probs=86.8
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCC---cCCCcccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS---YMGSLPNLQE 484 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~---~l~~l~~L~~ 484 (927)
++|.+|+|++|+|+..-+.+|..|..|+.|+|++|.++..-.. |..|++|+.|||++|.|++.|-+ .|..|++|+.
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk 396 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK 396 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence 5799999999999977777899999999999999998877664 88899999999999999887765 4667889999
Q ss_pred ccccccCCCCCCCccccC---CceeeeecCCCCC
Q 002410 485 LHIENNSFVGEIPPALLT---GKVIFKYDNNPKL 515 (927)
Q Consensus 485 L~l~~N~l~g~iP~~~~~---~~~~~~~~~N~~~ 515 (927)
|.|.+|+|. .||...+. ++..+++.+|+..
T Consensus 397 L~l~gNqlk-~I~krAfsgl~~LE~LdL~~Naia 429 (873)
T KOG4194|consen 397 LRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIA 429 (873)
T ss_pred eeecCceee-ecchhhhccCcccceecCCCCcce
Confidence 999999998 88887665 4556677777654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.2e-07 Score=112.33 Aligned_cols=105 Identities=29% Similarity=0.409 Sum_probs=91.8
Q ss_pred CCceEEEEecCCCCcccCCc-cccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~-~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
..+|+.|+|++|.|. ++|. .+.+|..|+.|+||+|+|+..+-.+.++..|++|...+|+|. ..| ++..++.|+.+|
T Consensus 382 ~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lD 458 (1081)
T KOG0618|consen 382 FKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLD 458 (1081)
T ss_pred ccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEe
Confidence 368999999999999 7775 589999999999999999998877999999999999999999 888 899999999999
Q ss_pred ccccCCC-CCCCcccc-CCceeeeecCCCCC
Q 002410 487 IENNSFV-GEIPPALL-TGKVIFKYDNNPKL 515 (927)
Q Consensus 487 l~~N~l~-g~iP~~~~-~~~~~~~~~~N~~~ 515 (927)
+|.|+|+ +.+|..+- ..+.-+++.||++.
T Consensus 459 lS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 459 LSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred cccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 9999987 34555555 46778889999864
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.25 E-value=1e-05 Score=85.54 Aligned_cols=133 Identities=14% Similarity=0.124 Sum_probs=86.0
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCc--eeeeeeeeecCceEEEEEEecCCCC-
Q 002410 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGYCEEEHQRILVYEYMHNGT- 687 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~Hpn--Iv~l~~~~~~~~~~~LV~E~~~~gs- 687 (927)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 25568889876533 3345688999999986433 4667777777777889999999863
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHH---------------------------------------HHHHh-cCCCC
Q 002410 688 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGL---------------------------------------EYLHT-GCNPG 727 (927)
Q Consensus 688 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL---------------------------------------~~LH~-~~~~~ 727 (927)
+...+.. +......++.++++.+ .+|.. .....
T Consensus 82 ~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 2211110 0011111111111111 12211 11345
Q ss_pred eEecCCCCCcccccCCCcEEEeecccccc
Q 002410 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 728 ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++|+|+.|.||++++++ +.++||+.+..
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 78999999999999888 99999997754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.19 E-value=4.7e-06 Score=84.28 Aligned_cols=135 Identities=21% Similarity=0.417 Sum_probs=73.9
Q ss_pred EEEecCCCCCccCCCCCeEEecCCccccCCcee--e-------ecC----C-CCCcccccccccccCCCccceeeecccC
Q 002410 26 ISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSV--K-------VEN----P-SGNWMQYRTRRDLPIDNKKYCYNLITKE 91 (927)
Q Consensus 26 ~~idcg~~~~~~~~~~~~~~~~d~~~~~~g~~~--~-------~~~----~-~~~~~~~~tlr~fp~~~~~~cy~l~~~~ 91 (927)
+.|+||+... +| ..|+.|.+|..|..++..- . ... . ....+.+.|-|+=| ...-|.+|+.+
T Consensus 3 ~~IN~Gg~~~-~~-~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~---~~f~Y~ip~~~ 77 (174)
T PF11721_consen 3 LRINAGGPAY-TD-SSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGP---SSFSYDIPVVP 77 (174)
T ss_dssp EEEEETSSSE-EE-TTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----S---SSEEEEEE--S
T ss_pred EEEECCCCcc-cC-CCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCC---CceEEEEecCC
Confidence 5799998776 55 8899999999996555510 0 000 0 00123456777744 35799999999
Q ss_pred CceeEEEEEe---eecCCCCCCCCC---eEEEEEcCce-eEEEEecC---Ccc-ceEEEE-EEecCCCCcccceec----
Q 002410 92 RRRYLVRATF---QYGSLGSEASYP---KFQLYLDATL-WSTVTVLD---ASR-VYAKEM-IIRAPSDSIDVCICC---- 155 (927)
Q Consensus 92 ~~~ylvr~~~---~yg~yd~~~~~p---~fd~~~~~~~-w~~v~~~~---~~~-~~~~e~-~~~~~~~~~~vcl~~---- 155 (927)
.|.|-||..| +++. ++..+.| +||+.++|+. ...+++.. ... ....+. -+.+.+..+.++|..
T Consensus 78 ~G~Y~V~L~FaE~~~~~-~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~~~ 156 (174)
T PF11721_consen 78 NGTYTVRLHFAELYFGA-SGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAGKG 156 (174)
T ss_dssp -EEEEEEEEEE-SSS---------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE--S
T ss_pred CcEEEEEEEeccccccc-cccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecCCC
Confidence 9999999999 3443 4444444 7999999954 33333321 111 233333 233477889999986
Q ss_pred -------ccCCCceeeee
Q 002410 156 -------AVTGSPFISTL 166 (927)
Q Consensus 156 -------~~~~~pfis~l 166 (927)
...|.|.||+|
T Consensus 157 ~~~i~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 157 TLCIPFIGSYGNPLISAI 174 (174)
T ss_dssp EEEEEEESSSSSSSEEEE
T ss_pred cEEeeccccCCCcEEeeC
Confidence 44566888876
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.4e-05 Score=82.44 Aligned_cols=140 Identities=17% Similarity=0.206 Sum_probs=91.1
Q ss_pred hHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHH---------HHHHHHHHhcCC---Cceeeeee
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQF---------VTEVALLSRIHH---RNLVPLIG 668 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~---------~~E~~~L~~l~H---pnIv~l~~ 668 (927)
++....+...+.+-......|.+...+ |+.+++|..+.......+.| .+++..+.+++. .....++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 444555555667777766677666665 78899999876443322222 334444444432 22223222
Q ss_pred ee-----ecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC
Q 002410 669 YC-----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 743 (927)
Q Consensus 669 ~~-----~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~ 743 (927)
+. .-....+++|||++|..|.+... ++. .++..+.+++.-||+ .|++|||.+|.|++++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC
Confidence 22 22345579999999988766532 222 345677888999998 999999999999999855
Q ss_pred CcEEEeecccccc
Q 002410 744 MRAKVSDFGLSRQ 756 (927)
Q Consensus 744 ~~~kL~DFGla~~ 756 (927)
.+++.||+..+.
T Consensus 172 -~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 -GIRIIDTQGKRM 183 (229)
T ss_pred -cEEEEECccccc
Confidence 499999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.9e-05 Score=82.40 Aligned_cols=137 Identities=25% Similarity=0.325 Sum_probs=95.1
Q ss_pred cccccccEEEEEEEECCCcEEEEEEccCccchhH------------------------HHHHHHHHHHHhcC--CCceee
Q 002410 612 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT------------------------QQFVTEVALLSRIH--HRNLVP 665 (927)
Q Consensus 612 ~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~------------------------~~~~~E~~~L~~l~--HpnIv~ 665 (927)
.|+.|.-+.||+|...++..+|||+++....... .-..+|...|+++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 5788999999999988899999999864321110 11345777777773 334444
Q ss_pred eeeeeecCceEEEEEEecCCCCH-HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC
Q 002410 666 LIGYCEEEHQRILVYEYMHNGTL-RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 744 (927)
Q Consensus 666 l~~~~~~~~~~~LV~E~~~~gsL-~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~ 744 (927)
.+++. ...|||||+....+ .-.| ..-++...+...+..++++.+.-|-. ..++||+||+.-|||+. ++
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CC
Confidence 45443 34799999954311 1111 12233333677778888888888875 47999999999999998 88
Q ss_pred cEEEeeccccccccc
Q 002410 745 RAKVSDFGLSRQAEE 759 (927)
Q Consensus 745 ~~kL~DFGla~~~~~ 759 (927)
.+.|+|+|-|....+
T Consensus 204 ~p~iID~~QaV~~~h 218 (268)
T COG1718 204 EPYIIDVSQAVTIDH 218 (268)
T ss_pred eEEEEECccccccCC
Confidence 999999998876543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.12 E-value=6e-07 Score=97.40 Aligned_cols=103 Identities=28% Similarity=0.377 Sum_probs=79.3
Q ss_pred CCCCCCCCCccEEEeCCC----------CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCccccc
Q 002410 390 GDPCVPVPWEWVTCSTTT----------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDL 458 (927)
Q Consensus 390 gdpC~~~~w~~~~c~~~~----------~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L 458 (927)
..||.+..-+|..+.|.. |+..++|+|..|+|+-..|..|+.|.+|+.||||+|+|+-+-|+ |..|++|
T Consensus 38 P~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l 117 (498)
T KOG4237|consen 38 PAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASL 117 (498)
T ss_pred CCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhh
Confidence 456765444455556642 67889999999999954556799999999999999999999886 8888887
Q ss_pred ceeec-ccccccCCCCC-cCCCccccccccccccCCC
Q 002410 459 RIVHL-ENNELTGSLPS-YMGSLPNLQELHIENNSFV 493 (927)
Q Consensus 459 ~~L~L-s~N~l~g~iP~-~l~~l~~L~~L~l~~N~l~ 493 (927)
..|-| ++|+++ .+|. .|++|.+|+.|.+.-|++.
T Consensus 118 ~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNan~i~ 153 (498)
T KOG4237|consen 118 LSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNANHIN 153 (498)
T ss_pred hHHHhhcCCchh-hhhhhHhhhHHHHHHHhcChhhhc
Confidence 76655 448888 5654 6778888887777777766
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.11 E-value=5e-07 Score=102.03 Aligned_cols=103 Identities=22% Similarity=0.336 Sum_probs=89.9
Q ss_pred ceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccccc
Q 002410 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 489 (927)
Q Consensus 410 ~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~ 489 (927)
-|+.|-+++|+++ .+|++++.+..|..||.+.|++...++.++.|.+|+.|++..|++. .+|++++.| .|..||+|+
T Consensus 144 pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfSc 220 (722)
T KOG0532|consen 144 PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSC 220 (722)
T ss_pred cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeeccc
Confidence 3788899999998 9999999889999999999999999889999999999999999998 788888854 588899999
Q ss_pred cCCCCCCCccccC--CceeeeecCCCCCc
Q 002410 490 NSFVGEIPPALLT--GKVIFKYDNNPKLH 516 (927)
Q Consensus 490 N~l~g~iP~~~~~--~~~~~~~~~N~~~c 516 (927)
|+++ .||-.+.. .+..+.+++||...
T Consensus 221 Nkis-~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 221 NKIS-YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred Ccee-ecchhhhhhhhheeeeeccCCCCC
Confidence 9998 89988876 66778889998764
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.4e-05 Score=93.20 Aligned_cols=143 Identities=20% Similarity=0.239 Sum_probs=91.9
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCccchh-------------------------------------HHHHHHHHH
Q 002410 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR-------------------------------------TQQFVTEVA 653 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~-------------------------------------~~~~~~E~~ 653 (927)
+.||.-..|.||+|++++|+.||||+-++..... +-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999965432111 012455655
Q ss_pred HHHhc----CCCce---eeeeeeee-cCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 002410 654 LLSRI----HHRNL---VPLIGYCE-EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725 (927)
Q Consensus 654 ~L~~l----~HpnI---v~l~~~~~-~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ 725 (927)
...+. +|-+. |.+=.++. -.....|+||||+|..+.|.-.- ....++...+. ..+.++.. +....
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~---~~l~~~~~--~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDIL---NKLVEAYL--EQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHH---HHHHHHHH--HHHHh
Confidence 54444 34441 11222222 23468999999999877654221 23345544333 33333322 21123
Q ss_pred CCeEecCCCCCcccccC----CCcEEEeecccccccccc
Q 002410 726 PGIIHRDVKSSNILLDI----NMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 726 ~~ivH~DLkp~NILld~----~~~~kL~DFGla~~~~~~ 760 (927)
.|++|+|-+|.||+++. ++++.+.|||+...+...
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 68999999999999984 678999999998876543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.3e-06 Score=87.90 Aligned_cols=82 Identities=24% Similarity=0.390 Sum_probs=42.2
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCc-CcccccceeecccccccCCCC--CcCCCccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP--SYMGSLPNLQEL 485 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~-~~l~~L~~L~Ls~N~l~g~iP--~~l~~l~~L~~L 485 (927)
.+++.|+|++|+|+ .++ .+..|+.|+.|+|++|+|+...+.+ ..+++|+.|+|++|++.. +- ..+..|++|+.|
T Consensus 42 ~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L~~l~~L~~L 118 (175)
T PF14580_consen 42 DKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISD-LNELEPLSSLPKLRVL 118 (175)
T ss_dssp TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---S-CCCCGGGGG-TT--EE
T ss_pred cCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCC-hHHhHHHHcCCCccee
Confidence 57999999999999 554 5888999999999999999865555 469999999999999983 33 367789999999
Q ss_pred cccccCCC
Q 002410 486 HIENNSFV 493 (927)
Q Consensus 486 ~l~~N~l~ 493 (927)
+|.+|.++
T Consensus 119 ~L~~NPv~ 126 (175)
T PF14580_consen 119 SLEGNPVC 126 (175)
T ss_dssp E-TT-GGG
T ss_pred eccCCccc
Confidence 99999987
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.8e-06 Score=96.18 Aligned_cols=105 Identities=23% Similarity=0.291 Sum_probs=84.3
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcc-cccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRL-IDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l-~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
|..+..|||++|+|+..-+..|.+|.+|+.++|.+|.|+. ||.|+.. ..|+.|+|.+|.++..-.+++.-++.|+.||
T Consensus 77 p~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~-IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslD 155 (873)
T KOG4194|consen 77 PSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTR-IPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLD 155 (873)
T ss_pred ccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhh-cccccccccceeEEeeeccccccccHHHHHhHhhhhhhh
Confidence 4567899999999998888889999999999999999976 5665554 4599999999998855566888889999999
Q ss_pred ccccCCCCCCCccccC---CceeeeecCCCC
Q 002410 487 IENNSFVGEIPPALLT---GKVIFKYDNNPK 514 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~---~~~~~~~~~N~~ 514 (927)
||.|.++ +||..-+. ....+.+++|..
T Consensus 156 LSrN~is-~i~~~sfp~~~ni~~L~La~N~I 185 (873)
T KOG4194|consen 156 LSRNLIS-EIPKPSFPAKVNIKKLNLASNRI 185 (873)
T ss_pred hhhchhh-cccCCCCCCCCCceEEeeccccc
Confidence 9999998 88876554 344556666643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.07 E-value=3.9e-05 Score=80.80 Aligned_cols=143 Identities=20% Similarity=0.258 Sum_probs=85.5
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCC--ceeeeeeeee---cCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR--NLVPLIGYCE---EEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~Hp--nIv~l~~~~~---~~~~~~LV~E~~~~ 685 (927)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.... .....+++|++++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578999999999999987 69999997654 4556788899999888533 3456665442 23357899999999
Q ss_pred CCHHH----------------Hh---ccC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 002410 686 GTLRD----------------RL---HGS-VNQKPLDWLT---------RLQI------------AHDAAK-GLEYLHT- 722 (927)
Q Consensus 686 gsL~~----------------~L---~~~-~~~~~l~~~~---------~~~i------------~~qia~-gL~~LH~- 722 (927)
..+.. .+ +.. .......... .... ...+.+ .++.+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88776 11 111 0011111100 0000 112222 2333332
Q ss_pred ---cCCCCeEecCCCCCccccc-CCCcEEEeecccccc
Q 002410 723 ---GCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQ 756 (927)
Q Consensus 723 ---~~~~~ivH~DLkp~NILld-~~~~~kL~DFGla~~ 756 (927)
.....++|+|+.|.||+++ +++.+.|.||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1346799999999999999 666668999987653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.3e-06 Score=102.35 Aligned_cols=97 Identities=25% Similarity=0.380 Sum_probs=67.3
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
++.++.|+|++|+|+ .+|..+. ++|+.|+|++|+|+..+..+. ..|+.|+|++|+++ .+|..+. .+|+.|+|
T Consensus 198 p~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~L 269 (754)
T PRK15370 198 PEQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDL 269 (754)
T ss_pred ccCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEEC
Confidence 456888888888888 6777664 478888888888886443343 35777777777777 6676654 36777777
Q ss_pred cccCCCCCCCccccCCceeeeecCCC
Q 002410 488 ENNSFVGEIPPALLTGKVIFKYDNNP 513 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~~~~~~~~~~N~ 513 (927)
++|+|+ .+|..+..++..+.+++|.
T Consensus 270 s~N~L~-~LP~~l~~sL~~L~Ls~N~ 294 (754)
T PRK15370 270 FHNKIS-CLPENLPEELRYLSVYDNS 294 (754)
T ss_pred cCCccC-ccccccCCCCcEEECCCCc
Confidence 777777 5676666566666666653
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=6.4e-07 Score=83.91 Aligned_cols=107 Identities=25% Similarity=0.319 Sum_probs=87.2
Q ss_pred CCceEEEEecCCCCcccCCccccCC-cccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNM-EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l-~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
..+++.++|++|.|. .+|+.|... +.++.|+|++|.|+..+-++..++.|+.|+++.|.|. ..|.-+..|.+|..|+
T Consensus 52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld 129 (177)
T KOG4579|consen 52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD 129 (177)
T ss_pred CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence 357889999999999 788777554 6899999999999998888999999999999999999 7888888899999999
Q ss_pred ccccCCCCCCCccccCC--ceeeeecCCCCCcc
Q 002410 487 IENNSFVGEIPPALLTG--KVIFKYDNNPKLHK 517 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~~--~~~~~~~~N~~~c~ 517 (927)
..+|.+. +||-.++.. .....+.++|+...
T Consensus 130 s~~na~~-eid~dl~~s~~~al~~lgnepl~~~ 161 (177)
T KOG4579|consen 130 SPENARA-EIDVDLFYSSLPALIKLGNEPLGDE 161 (177)
T ss_pred CCCCccc-cCcHHHhccccHHHHHhcCCccccc
Confidence 9999998 888776552 22334455666543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.5e-06 Score=94.33 Aligned_cols=112 Identities=23% Similarity=0.334 Sum_probs=90.9
Q ss_pred EEeCCCCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcc
Q 002410 402 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLP 480 (927)
Q Consensus 402 ~c~~~~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~ 480 (927)
.|.|++.. =...+.++-+|+ .+|..+- ..-+.|+|..|+|+.++|. |+.+++|+.||||+|+++-.-|+.|..|+
T Consensus 40 pC~Cs~~~-g~~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~ 115 (498)
T KOG4237|consen 40 PCTCSDVE-GGIVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLA 115 (498)
T ss_pred CcccCCCC-CceEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhH
Confidence 57887633 567899999999 8887654 3567899999999999995 99999999999999999988899999999
Q ss_pred ccccccc-cccCCCCCCCccccCCceeee-ecCCCCCccc
Q 002410 481 NLQELHI-ENNSFVGEIPPALLTGKVIFK-YDNNPKLHKE 518 (927)
Q Consensus 481 ~L~~L~l-~~N~l~g~iP~~~~~~~~~~~-~~~N~~~c~~ 518 (927)
+|..|-+ ++|+|+ .+|...+.++..+. +..|++.|.+
T Consensus 116 ~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNan~i~C 154 (498)
T KOG4237|consen 116 SLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNANHINC 154 (498)
T ss_pred hhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcChhhhcc
Confidence 9877655 559999 99999988654433 4567766643
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.7e-06 Score=103.67 Aligned_cols=76 Identities=28% Similarity=0.384 Sum_probs=51.5
Q ss_pred cccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccccccCCCCCCCccccC--Cceeeeec
Q 002410 433 EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYD 510 (927)
Q Consensus 433 ~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~~--~~~~~~~~ 510 (927)
.+|+.|+|++|+|++.++. .++|+.|+|++|+|+ .+|..+ .+|+.|+|++|+|+ .||..+.. .+..+.+.
T Consensus 382 ~~L~~LdLs~N~Lt~LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 382 SGLKELIVSGNRLTSLPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 453 (788)
T ss_pred cccceEEecCCcccCCCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence 3567777777777763332 246777888888887 467542 46777888888887 78876644 55667777
Q ss_pred CCCCCc
Q 002410 511 NNPKLH 516 (927)
Q Consensus 511 ~N~~~c 516 (927)
+|+..+
T Consensus 454 ~N~Ls~ 459 (788)
T PRK15387 454 GNPLSE 459 (788)
T ss_pred CCCCCc
Confidence 777654
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=97.99 E-value=6.8e-06 Score=100.22 Aligned_cols=92 Identities=27% Similarity=0.436 Sum_probs=63.2
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 488 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~ 488 (927)
.+|+.|+|++|+|+ .+|... .+|+.|+|++|+|++ +|.+ +.+|+.|+|++|+|+ .+|... ++|+.|+++
T Consensus 342 ~~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~~-LP~l--~~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS 410 (788)
T PRK15387 342 SGLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLTS-LPAL--PSGLKELIVSGNRLT-SLPVLP---SELKELMVS 410 (788)
T ss_pred cccceEecCCCccC-CCCCCC---cccceehhhcccccc-Cccc--ccccceEEecCCccc-CCCCcc---cCCCEEEcc
Confidence 46788888888888 466532 456677888888875 4543 246888888888888 477543 578888999
Q ss_pred ccCCCCCCCccccCCceeeeecCCC
Q 002410 489 NNSFVGEIPPALLTGKVIFKYDNNP 513 (927)
Q Consensus 489 ~N~l~g~iP~~~~~~~~~~~~~~N~ 513 (927)
+|+|+ .+|.. ...+..+.+.+|.
T Consensus 411 ~N~Ls-sIP~l-~~~L~~L~Ls~Nq 433 (788)
T PRK15387 411 GNRLT-SLPML-PSGLLSLSVYRNQ 433 (788)
T ss_pred CCcCC-CCCcc-hhhhhhhhhccCc
Confidence 99988 67753 2334455555554
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.94 E-value=6.7e-05 Score=80.33 Aligned_cols=140 Identities=19% Similarity=0.163 Sum_probs=85.8
Q ss_pred cccccc-EEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEEEEEecCCCCHHH
Q 002410 613 IGKGSF-GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTLRD 690 (927)
Q Consensus 613 LG~G~~-G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~LV~E~~~~gsL~~ 690 (927)
|..|.+ ..||+.... +..++||+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 789999765 4788899876542 345678999988884 4445677777776667899999999987764
Q ss_pred Hh-------------------ccCCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----cC
Q 002410 691 RL-------------------HGSVN-QKPLDW--LTRLQIAH--------------------DAAKGLEYLHT----GC 724 (927)
Q Consensus 691 ~L-------------------~~~~~-~~~l~~--~~~~~i~~--------------------qia~gL~~LH~----~~ 724 (927)
.. +.... ..+... ........ .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 11100 001110 00000000 01111122211 11
Q ss_pred CCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 725 ~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
...++|+|+.|.|||++++....|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 35589999999999999987788999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=97.93 E-value=9.2e-06 Score=99.54 Aligned_cols=97 Identities=20% Similarity=0.333 Sum_probs=70.1
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 488 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~ 488 (927)
..|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++.++.+. ++|+.|+|++|+|+ .+|..+. ++|+.|+++
T Consensus 262 s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls 333 (754)
T PRK15370 262 SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAG 333 (754)
T ss_pred CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccccCcccch--hhHHHHHhcCCccc-cCCcccc--ccceecccc
Confidence 36778888888887 5776654 478888888888876544443 46788888888888 5666543 578888888
Q ss_pred ccCCCCCCCccccCCceeeeecCCCC
Q 002410 489 NNSFVGEIPPALLTGKVIFKYDNNPK 514 (927)
Q Consensus 489 ~N~l~g~iP~~~~~~~~~~~~~~N~~ 514 (927)
+|.|+ .+|..+...+..+.+.+|..
T Consensus 334 ~N~Lt-~LP~~l~~sL~~L~Ls~N~L 358 (754)
T PRK15370 334 ENALT-SLPASLPPELQVLDVSKNQI 358 (754)
T ss_pred CCccc-cCChhhcCcccEEECCCCCC
Confidence 88888 58877766777777777753
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.86 E-value=7.2e-07 Score=103.02 Aligned_cols=127 Identities=23% Similarity=0.253 Sum_probs=96.1
Q ss_pred CCCCCCCCCCCcc---EEEeCCC----------CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCC-CcC
Q 002410 388 DRGDPCVPVPWEW---VTCSTTT----------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMS 453 (927)
Q Consensus 388 w~gdpC~~~~w~~---~~c~~~~----------~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p-~~~ 453 (927)
-.||-|....|.- ..|+|.. .+.++.|||++|+++..- .+..|++|++|||++|.|.-.+- ...
T Consensus 153 cggd~~ns~~Wn~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~ 230 (1096)
T KOG1859|consen 153 CGGDISNSPVWNKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMV 230 (1096)
T ss_pred hccccccchhhhhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchh
Confidence 4467777666654 4666643 467899999999999433 88999999999999999987554 355
Q ss_pred cccccceeecccccccCCCCCcCCCccccccccccccCCCCC---CCccccCCceeeeecCCCCCcccc
Q 002410 454 RLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGE---IPPALLTGKVIFKYDNNPKLHKES 519 (927)
Q Consensus 454 ~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~---iP~~~~~~~~~~~~~~N~~~c~~~ 519 (927)
.+. |+.|+|.||-++ ++- .+.+|.+|+.|||++|-|.+- .|-+.+..+..+.+.|||..|...
T Consensus 231 gc~-L~~L~lrnN~l~-tL~-gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~ 296 (1096)
T KOG1859|consen 231 GCK-LQLLNLRNNALT-TLR-GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW 296 (1096)
T ss_pred hhh-heeeeecccHHH-hhh-hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence 566 999999999988 332 477899999999999998743 122333356677889999998643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.84 E-value=4.3e-06 Score=96.18 Aligned_cols=184 Identities=20% Similarity=0.230 Sum_probs=134.9
Q ss_pred hcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCc-eeeeeeeeecCceEEEEEEecCCC-
Q 002410 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEHQRILVYEYMHNG- 686 (927)
Q Consensus 609 ~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~Hpn-Iv~l~~~~~~~~~~~LV~E~~~~g- 686 (927)
+.+.+++|+.+.++|.+-.-.+....+.+... ....-++++|.+++||| .+..++-++.++..+++++++.++
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 34667899999999987554444446665433 34456899999999999 777777777788889999999776
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccccc
Q 002410 687 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 766 (927)
Q Consensus 687 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 766 (927)
+-..-.. .....+...+...+...-+++|++||+ ..=+|+| ||+..+ +..+..||+....+.... ...
T Consensus 321 s~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 321 SSALEMT--VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred cccccCC--hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 2211111 122334445566677788899999997 3347888 777654 788999999887766544 234
Q ss_pred ccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 002410 767 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 809 (927)
Q Consensus 767 ~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~ 809 (927)
...+++.++|||+.....+..+.|+|+.|+-..+|.-|.+|-.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 4568999999999999999999999999998778887777754
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=97.80 E-value=2.9e-05 Score=101.13 Aligned_cols=106 Identities=19% Similarity=0.334 Sum_probs=88.6
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
+.+|+.|+|++|+|. .+|..+..|++|+.|+|++|...+.+|+++.+++|+.|+|++|.....+|.++++|++|+.|++
T Consensus 610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 468999999999988 7898999999999999999887788899999999999999998777799999999999999999
Q ss_pred cccCCCCCCCccc-cCCceeeeecCCCC
Q 002410 488 ENNSFVGEIPPAL-LTGKVIFKYDNNPK 514 (927)
Q Consensus 488 ~~N~l~g~iP~~~-~~~~~~~~~~~N~~ 514 (927)
++|..-+.+|... ...+..+.+.+|..
T Consensus 689 ~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~ 716 (1153)
T PLN03210 689 SRCENLEILPTGINLKSLYRLNLSGCSR 716 (1153)
T ss_pred CCCCCcCccCCcCCCCCCCEEeCCCCCC
Confidence 9876555888765 23555666666643
|
syringae 6; Provisional |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.77 E-value=6.7e-06 Score=97.96 Aligned_cols=90 Identities=28% Similarity=0.461 Sum_probs=84.3
Q ss_pred ceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccccc
Q 002410 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 489 (927)
Q Consensus 410 ~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~ 489 (927)
.|++|+|++|.++ ..|..+..+.+|+.|+++.|.+...+-+.+++.+|++|+|.+|++. .+|.++..+.+|+.|+++.
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence 4999999999988 9999999999999999999999998878999999999999999999 9999999999999999999
Q ss_pred cCCCCCCCccccC
Q 002410 490 NSFVGEIPPALLT 502 (927)
Q Consensus 490 N~l~g~iP~~~~~ 502 (927)
|+|. .+|..+..
T Consensus 124 N~f~-~~Pl~i~~ 135 (1081)
T KOG0618|consen 124 NHFG-PIPLVIEV 135 (1081)
T ss_pred hccC-CCchhHHh
Confidence 9998 89987643
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00024 Score=89.42 Aligned_cols=79 Identities=13% Similarity=0.304 Sum_probs=58.1
Q ss_pred cccccccccEEEEEEEECCC---cEEEEEEccCcc-chhHHHHHHHHHHHHhcC-CCce--eeeeeeeecC---ceEEEE
Q 002410 610 CKKIGKGSFGSVYYGKMKDG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNL--VPLIGYCEEE---HQRILV 679 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~~g---~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~-HpnI--v~l~~~~~~~---~~~~LV 679 (927)
.+.++.|.+..+|+.+..++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999987754 467788764322 123457889999999995 6664 7778887664 467899
Q ss_pred EEecCCCCH
Q 002410 680 YEYMHNGTL 688 (927)
Q Consensus 680 ~E~~~~gsL 688 (927)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988643
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.72 E-value=3.6e-06 Score=95.32 Aligned_cols=91 Identities=21% Similarity=0.391 Sum_probs=84.5
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.+.+..||.+.|++. .+|+.+++|++|+.|++..|++...++++. .-.|..||+|.|+++ .||..|.+|..|++|-|
T Consensus 165 ~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~L 241 (722)
T KOG0532|consen 165 LPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQL 241 (722)
T ss_pred chhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeee
Confidence 457889999999999 999999999999999999999999999988 556899999999999 99999999999999999
Q ss_pred cccCCCCCCCccccC
Q 002410 488 ENNSFVGEIPPALLT 502 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~ 502 (927)
.+|.|+ +-|..++.
T Consensus 242 enNPLq-SPPAqIC~ 255 (722)
T KOG0532|consen 242 ENNPLQ-SPPAQICE 255 (722)
T ss_pred ccCCCC-CChHHHHh
Confidence 999999 78887765
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.71 E-value=6.6e-06 Score=86.24 Aligned_cols=84 Identities=24% Similarity=0.309 Sum_probs=58.6
Q ss_pred CCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 407 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 407 ~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
+-..+++||||+|.++ .|.++..-++.++.|+||+|.|...-. +..|++|+.||||+|.|+ .+-.+-.+|-+++.|.
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 3346777888888777 777777777788888888887765433 777777788888888777 5555555556666666
Q ss_pred ccccCCC
Q 002410 487 IENNSFV 493 (927)
Q Consensus 487 l~~N~l~ 493 (927)
|+.|.+.
T Consensus 359 La~N~iE 365 (490)
T KOG1259|consen 359 LAQNKIE 365 (490)
T ss_pred hhhhhHh
Confidence 6666654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00012 Score=75.08 Aligned_cols=105 Identities=25% Similarity=0.231 Sum_probs=83.3
Q ss_pred HHHHHHHHhcCC-CceeeeeeeeecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 002410 649 VTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727 (927)
Q Consensus 649 ~~E~~~L~~l~H-pnIv~l~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ 727 (927)
..|.-+++.+++ +++.+++|+|- .++|.||...+++...-.....-...+|..+.+|+.++++.+.+|+++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999976 69999999994 3689999987766432110001234689999999999999999999865556
Q ss_pred eEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 728 ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+.-.|++++|+-+++++++|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 788999999999999999999999876554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=1.2e-06 Score=82.08 Aligned_cols=95 Identities=19% Similarity=0.248 Sum_probs=79.3
Q ss_pred CCCCCceEEEEecCCCCcccCCccc---cCCcccceecccCCCCCCCCCCcCcc-cccceeecccccccCCCCCcCCCcc
Q 002410 405 TTTPPRITKIALSGKNLKGEIPPEL---KNMEALTELWLDGNFLTGPLPDMSRL-IDLRIVHLENNELTGSLPSYMGSLP 480 (927)
Q Consensus 405 ~~~~~~l~~L~L~~n~l~g~ip~~l---~~l~~L~~L~Ls~N~l~g~~p~~~~l-~~L~~L~Ls~N~l~g~iP~~l~~l~ 480 (927)
|.....+-.++|+++.|. .|++.. .....|+.++|++|.|...++.|... +-+++|+|++|+++ .+|+++..++
T Consensus 23 cedakE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~ 100 (177)
T KOG4579|consen 23 CEDAKELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMP 100 (177)
T ss_pred hHHHHHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhH
Confidence 444456778899999887 777654 45567778899999999999987654 58999999999999 9999999999
Q ss_pred ccccccccccCCCCCCCccccC
Q 002410 481 NLQELHIENNSFVGEIPPALLT 502 (927)
Q Consensus 481 ~L~~L~l~~N~l~g~iP~~~~~ 502 (927)
.|+.|+++.|.|. ..|..++.
T Consensus 101 aLr~lNl~~N~l~-~~p~vi~~ 121 (177)
T KOG4579|consen 101 ALRSLNLRFNPLN-AEPRVIAP 121 (177)
T ss_pred HhhhcccccCccc-cchHHHHH
Confidence 9999999999999 77776655
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00024 Score=70.44 Aligned_cols=128 Identities=23% Similarity=0.326 Sum_probs=88.6
Q ss_pred hhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceee-eeeeeecCceEEEEEEecCCC
Q 002410 608 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIGYCEEEHQRILVYEYMHNG 686 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~-l~~~~~~~~~~~LV~E~~~~g 686 (927)
+..+.|++|.+|.||++.+. |..+|+|+-+.+ .....+..|+++|..+.-.++-+ ++.|-. -.+.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 44678999999999999998 668999986654 34567889999999987555433 333322 23559999988
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC--CcccccCCCcEEEeecccccc
Q 002410 687 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKS--SNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 687 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp--~NILld~~~~~kL~DFGla~~ 756 (927)
+|.+.-... +..++ ..+++.---|.. .||-|+.|+- +||++ .++.+.|+||..|+.
T Consensus 98 ~L~~~~~~~------~rk~l----~~vlE~a~~LD~---~GI~H~El~~~~k~vlv-~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG------DRKHL----LRVLEKAYKLDR---LGIEHGELSRPWKNVLV-NDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc------cHHHH----HHHHHHHHHHHH---hccchhhhcCCceeEEe-cCCcEEEEEccchhh
Confidence 887764421 22333 344444333454 8999999874 45555 455999999998874
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.68 E-value=8.3e-06 Score=85.52 Aligned_cols=83 Identities=23% Similarity=0.372 Sum_probs=52.1
Q ss_pred CCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 407 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 407 ~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
-.|.+..|+||+|++. .+-. +..|.+|+.||||+|.|+...--=..|-++++|.|+.|.+. .+ ..+++|-+|..||
T Consensus 305 L~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N~iE-~L-SGL~KLYSLvnLD 380 (490)
T KOG1259|consen 305 LAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQNKIE-TL-SGLRKLYSLVNLD 380 (490)
T ss_pred hccceeEEecccccee-eehh-hhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhhhHh-hh-hhhHhhhhheecc
Confidence 3678999999999998 5554 88899999999999998764332223334444455555443 11 1233444444455
Q ss_pred ccccCCC
Q 002410 487 IENNSFV 493 (927)
Q Consensus 487 l~~N~l~ 493 (927)
+++|++.
T Consensus 381 l~~N~Ie 387 (490)
T KOG1259|consen 381 LSSNQIE 387 (490)
T ss_pred ccccchh
Confidence 5555443
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.65 E-value=1.7e-05 Score=60.54 Aligned_cols=36 Identities=36% Similarity=0.506 Sum_probs=18.6
Q ss_pred ccceecccCCCCCCCCCCcCcccccceeeccccccc
Q 002410 434 ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 469 (927)
Q Consensus 434 ~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~ 469 (927)
+|++|+|++|+|+...|.+++|++|+.|+|++|+++
T Consensus 2 ~L~~L~l~~N~i~~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQITDLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-SSHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCcccCchHhCCCCCCEEEecCCCCC
Confidence 455555555555543333555555555555555555
|
... |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.63 E-value=2.3e-05 Score=90.21 Aligned_cols=102 Identities=28% Similarity=0.506 Sum_probs=87.4
Q ss_pred CceEEEEecCCCCcccCCccccCCc-ccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNME-ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~-~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
..++.|++.+|+++ .||+....++ +|+.|++++|++...+..+..++.|+.|++++|+++ .+|...+.+++|+.|++
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchhhhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 46899999999999 8998888885 999999999999888777899999999999999999 88888778899999999
Q ss_pred cccCCCCCCCcc--ccCCceeeeecCCC
Q 002410 488 ENNSFVGEIPPA--LLTGKVIFKYDNNP 513 (927)
Q Consensus 488 ~~N~l~g~iP~~--~~~~~~~~~~~~N~ 513 (927)
++|+++ .+|.. ....+..+.+.+|+
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 999999 88886 44456666677775
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 927 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-59 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-58 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-55 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-36 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-35 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-34 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-24 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-24 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-24 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-24 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-24 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-23 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-23 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-22 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-22 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-22 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-22 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-22 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-22 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-22 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-22 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-22 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-22 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-22 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-22 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-22 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-22 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-22 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-22 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-22 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-22 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-22 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-22 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-22 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-22 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-22 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-22 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-22 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-22 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-22 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-22 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-21 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-21 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-21 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-21 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-21 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-21 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-21 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-19 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-19 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-19 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-19 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-19 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-19 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-19 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-19 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-19 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-19 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-19 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-19 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-18 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-18 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-18 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-18 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-18 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-18 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-18 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-18 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-18 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-18 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-17 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-17 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-14 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-13 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-11 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-11 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-08 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 5e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-06 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 9e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 457 bits (1179), Expect = e-155
Identities = 127/319 (39%), Positives = 193/319 (60%), Gaps = 7/319 (2%)
Query: 571 TSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKK--IGKGSFGSVYYGKMKD 628
+ + + + A ++ +Y +PL +LEEATNNF K IG G FG VY G ++D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 629 GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 688
G +VA+K S ++F TE+ LS H +LV LIG+C+E ++ IL+Y+YM NG L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 689 RDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 747
+ L+GS + W RL+I AA+GL YLHT IIHRDVKS NILLD N K
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 748 VSDFGLSRQA-EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK 806
++DFG+S++ E D TH+S+V +GT+GY+DPEY+ +LTEKSDVYSFGVVL E++ +
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 807 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS 866
+ +N+ WA G + IVDP L ++ ES+ + + A++C+
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSED 299
Query: 867 RPKMQEIVLAIQDSIKIEK 885
RP M +++ ++ ++++++
Sbjct: 300 RPSMGDVLWKLEYALRLQE 318
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 384 bits (989), Expect = e-126
Identities = 112/282 (39%), Positives = 173/282 (61%), Gaps = 6/282 (2%)
Query: 601 ELEEATNNFCK--KIGKGSFGSVYYGKMKDGKEVAVK-IMADSCSHRTQQFVTEVALLSR 657
EL+ A++NF +G+G FG VY G++ DG VAVK + + QF TEV ++S
Sbjct: 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISM 83
Query: 658 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKG 716
HRNL+ L G+C +R+LVY YM NG++ L +P LDW R +IA +A+G
Sbjct: 84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG 143
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 776
L YLH C+P IIHRDVK++NILLD A V DFGL++ + TH+++ RGT+G++
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 203
Query: 777 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--LNIVHWARSMIKKGDVIS 834
PEY + +EK+DV+ +GV+LLELI+G++ + + + ++ W + ++K+ + +
Sbjct: 204 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263
Query: 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876
+VD L GN K E + ++ +VA+ C + RPKM E+V
Sbjct: 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 370 bits (952), Expect = e-121
Identities = 102/292 (34%), Positives = 153/292 (52%), Gaps = 26/292 (8%)
Query: 601 ELEEATNNF--------CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQ----F 648
EL+ TNNF K+G+G FG VY G + + VAVK +A T++ F
Sbjct: 19 ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 77
Query: 649 VTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ 708
E+ ++++ H NLV L+G+ + LVY YM NG+L DRL PL W R +
Sbjct: 78 DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 709 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSV 767
IA AA G+ +LH IHRD+KS+NILLD AK+SDFGL+R + + T ++S
Sbjct: 138 IAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR 194
Query: 768 ARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARS 825
GT Y+ PE G ++T KSD+YSFGVVLLE+I+G V D ++
Sbjct: 195 IVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAV---DEHREPQLLLDIKEE 249
Query: 826 MIK-KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876
+ + + +D + + S+ + VA QC+ ++ RP ++++
Sbjct: 250 IEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 2e-86
Identities = 74/308 (24%), Positives = 118/308 (38%), Gaps = 31/308 (10%)
Query: 597 IPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 654
+ L + + +G FG V+ ++ + VAVKI ++ Q EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ-DKQSWQNEYEVYS 71
Query: 655 LSRIHHRNLVPLIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 710
L + H N++ IG + + L+ + G+L D L + W IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIA 127
Query: 711 HDAAKGLEYLHT-------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763
A+GL YLH G P I HRD+KS N+LL N+ A ++DFGL+ + E +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 764 ISSVAR-GTVGYLDPEY-----YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 817
+ + GT Y+ PE + + D+Y+ G+VL EL S L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 818 NIVHWARSMIKKGDVISIV-----DPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQ 871
D+ +V PVL K + + E +C + +R
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 872 EIVLAIQD 879
+ I
Sbjct: 308 CVGERITQ 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 2e-73
Identities = 86/213 (40%), Positives = 123/213 (57%), Gaps = 10/213 (4%)
Query: 597 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 654
IP +L +KIG GSFG+V+ + G +VAVKI+ + H R +F+ EVA+
Sbjct: 34 IPWCDLN-----IKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 655 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 714
+ R+ H N+V +G + +V EY+ G+L LH S ++ LD RL +A+D A
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 715 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 774
KG+ YLH NP I+HR++KS N+L+D KV DFGLSR S A GT +
Sbjct: 148 KGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEW 205
Query: 775 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
+ PE ++ EKSDVYSFGV+L EL + ++P
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 2e-72
Identities = 84/328 (25%), Positives = 144/328 (43%), Gaps = 39/328 (11%)
Query: 595 YFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 654
+ I E+E + +G+G+FG V K + K+VA+K + + F+ E+
Sbjct: 3 HMIDYKEIE-----VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQ 54
Query: 655 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 714
LSR++H N+V L G C LV EY G+L + LHG+ + +
Sbjct: 55 LSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 715 KGLEYLHTGCNPGIIHRDVKSSNILLDINMR-AKVSDFGLSRQAEEDLTHISSVARGTVG 773
+G+ YLH+ +IHRD+K N+LL K+ DFG + + +T+ +G+
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN----NKGSAA 168
Query: 774 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--- 830
++ PE + +EK DV+S+G++L E+I+ +KP ++ G + WA + G
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--FDEIGGPAFRIMWA---VHNGTRP 223
Query: 831 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQK 890
+I + I + +C + RP M+EIV + ++ G D+
Sbjct: 224 PLIKNLPK------------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
Query: 891 F----SSSSSKGQSSRKTLLTSFLEIES 914
S G+ R F E
Sbjct: 272 LQYPCQHSLPPGEDGRVEPYVDFAEFYR 299
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-68
Identities = 75/240 (31%), Positives = 120/240 (50%), Gaps = 29/240 (12%)
Query: 583 ARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC 641
A GG + + E+E + K+IGKG FG V+ G++ D VA+K +
Sbjct: 2 AMGGSEFPKSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56
Query: 642 SH-------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 694
S + Q+F EV ++S ++H N+V L G +V E++ G L RL
Sbjct: 57 SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD 114
Query: 695 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-----INMRAKVS 749
P+ W +L++ D A G+EY+ NP I+HRD++S NI L + AKV+
Sbjct: 115 --KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 750 DFGLSRQAEEDLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
DFGLS+Q+ ++ G ++ PE + TEK+D YSF ++L +++G+ P
Sbjct: 172 DFGLSQQSVHSVSG----LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 6e-66
Identities = 48/218 (22%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 597 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 654
I +L F K+ + G ++ G+ + G ++ VK++ +++ F E
Sbjct: 7 IDFKQLN-----FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 655 LSRIHHRNLVPLIGYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 712
L H N++P++G C+ + +M G+L + LH +D ++ A D
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALD 119
Query: 713 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 772
A+G+ +LHT P I + S ++++D +M A++S + + S
Sbjct: 120 MARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAP 172
Query: 773 GYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKP 807
++ PE + +D++SF V+L EL++ + P
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 7e-66
Identities = 75/223 (33%), Positives = 103/223 (46%), Gaps = 25/223 (11%)
Query: 597 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIM----ADSCSHRTQQFVTEV 652
I EL + IG G FG VY G EVAVK + S + E
Sbjct: 4 IDFAELT-----LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 653 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 712
L + + H N++ L G C +E LV E+ G L L G K + + A
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQ 113
Query: 713 AAKGLEYLHTGCNPGIIHRDVKSSNILLD--------INMRAKVSDFGLSRQAEEDLTHI 764
A+G+ YLH IIHRD+KSSNIL+ N K++DFGL+R E T
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTK 171
Query: 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
S A G ++ PE ++ SDV+S+GV+L EL++G+ P
Sbjct: 172 MSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 1e-65
Identities = 72/339 (21%), Positives = 128/339 (37%), Gaps = 48/339 (14%)
Query: 597 IPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTE--V 652
E +N + IG+G +G+VY G + D + VAVK+ + Q F+ E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNI 58
Query: 653 ALLSRIHHRNLVPLIGYCEE-----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL 707
+ + H N+ I E + +LV EY NG+L L DW++
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----LHTSDWVSSC 114
Query: 708 QIAHDAAKGLEYLHT------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR------ 755
++AH +GL YLHT P I HRD+ S N+L+ + +SDFGLS
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 756 -QAEEDLTHISSVARGTVGYLDPEY-------YGNQQLTEKSDVYSFGVVLLELISGKKP 807
+ + + GT+ Y+ PE + ++ D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 808 VSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV--KIESIWR--------IAEVAI 857
+ + E + + + + V K W+ + E
Sbjct: 235 LFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 858 QCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSS 896
C +Q +R Q + + + I + ++
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 3e-63
Identities = 68/217 (31%), Positives = 113/217 (52%), Gaps = 19/217 (8%)
Query: 597 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 654
IP ++ ++IG GSFG+VY GK +VAVK++ + + Q F EV +
Sbjct: 21 IPDGQIT-----VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGV 73
Query: 655 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 714
L + H N++ +GY I V ++ +L LH ++ + + IA A
Sbjct: 74 LRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTA 130
Query: 715 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVG 773
+G++YLH IIHRD+KS+NI L + K+ DFGL+ ++ +H G++
Sbjct: 131 RGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 774 YLDPE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
++ PE + + +SDVY+FG+VL EL++G+ P
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 4e-63
Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 597 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIM--ADSCSHRTQQFVTEVAL 654
IP +LE + IGKG FG VY+G+ EVA++++ + + F EV
Sbjct: 30 IPFEQLE-----IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMA 82
Query: 655 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 714
+ H N+V +G C ++ TL + + LD QIA +
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIV 140
Query: 715 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR----QAEEDLTHISSVARG 770
KG+ YLH GI+H+D+KS N+ D N + ++DFGL + G
Sbjct: 141 KGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 771 TVGYLDPEYYGNQQL---------TEKSDVYSFGVVLLELISGKKP 807
+ +L PE ++ SDV++ G + EL + + P
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 5e-61
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 609 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 667
+ +GKG FG ++ G+ + +K + + F+ EV ++ + H N++ I
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
G ++ + + EY+ GTLR + W R+ A D A G+ YLH +
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---SMN 128
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-------------GTVGY 774
IIHRD+ S N L+ N V+DFGL+R ++ T + G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 775 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
+ PE + EK DV+SFG+VL E+I
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 3e-60
Identities = 77/324 (23%), Positives = 130/324 (40%), Gaps = 44/324 (13%)
Query: 599 LPELEEATNN----FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 654
LP L + T K+IGKG +G V+ GK + G++VAVK+ + + TE+
Sbjct: 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-EASWFRETEIYQ 84
Query: 655 LSRIHHRNLVPLIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 710
+ H N++ I + L+ +Y NG+L D L LD + L++A
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLA 140
Query: 711 HDAAKGLEYLHT-----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765
+ + GL +LHT P I HRD+KS NIL+ N ++D GL+ + D +
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 766 SVARGTVG---YLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 816
VG Y+ PE + Q +D+YSFG++L E+ E
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS----GGIVE 256
Query: 817 LNIVHWARSMIKKGDVISIVDPVLIGNV--KIESIWR-------IAEVAIQCVEQRGFSR 867
+ + + + + V I + + W + ++ +C SR
Sbjct: 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316
Query: 868 PKMQEIVLAIQDSIKIEKGGDQKF 891
+ + K+ + D K
Sbjct: 317 LTALRVKKTLA---KMSESQDIKL 337
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 7e-58
Identities = 78/318 (24%), Positives = 136/318 (42%), Gaps = 40/318 (12%)
Query: 599 LPELEEATN----NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 654
LP L + T + IGKG FG V+ GK + G+EVAVKI S R+ E+
Sbjct: 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIF-SSREERSWFREAEIYQ 89
Query: 655 LSRIHHRNLVPLIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 710
+ H N++ I +++ LV +Y +G+L D L+ + + +++A
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLA 145
Query: 711 HDAAKGLEYLH-----TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLT 762
A GL +LH T P I HRD+KS NIL+ N ++D GL+ A + +
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205
Query: 763 HISSVARGTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 816
+ GT Y+ PE + + +++D+Y+ G+V E+ + + +
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE-DYQ 264
Query: 817 LNIVHWARSMIKKGDVISIVD------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 870
L S ++ +V + E++ +A++ +C G +R
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324
Query: 871 QEIV-----LAIQDSIKI 883
I L+ Q+ IK+
Sbjct: 325 LRIKKTLSQLSQQEGIKM 342
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-57
Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 28/224 (12%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFV--TEVALLSRIHHRNLVPL 666
+ +GKG +G V+ G + G+ VAVKI + S + + TE+ + H N++
Sbjct: 12 LLECVGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGF 67
Query: 667 IGYC----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
I Q L+ Y G+L D L LD ++ L+I A GL +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 723 -----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGY 774
P I HRD+KS NIL+ N + ++D GL+ Q+ L ++ GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 775 LDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
+ PE ++ D+++FG+VL E+ + +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 667
+IG+GSF +VY G + EVA + D ++ Q+F E +L + H N+V
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 668 GY----CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
+ + +LV E M +GTL+ L + K L R QI KGL++LH
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR-QIL----KGLQFLH 146
Query: 722 TGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 780
T P IIHRD+K NI + K+ D GL+ + +V GT ++ PE Y
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAV-IGTPEFMAPEMY 202
Query: 781 GNQQLTEKSDVYSFGVVLLELISGKKP 807
++ E DVY+FG+ +LE+ + + P
Sbjct: 203 -EEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-42
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPL 666
++IG+G+FG V+ G+++ VAVK ++ + F+ E +L + H N+V L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
IG C ++ +V E + G L L T LQ+ DAA G+EYL +
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL-----DPEYYG 781
IHRD+ + N L+ K+SDFG+SR+ + A G + + PE
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG----VYAASGGLRQVPVKWTAPEALN 288
Query: 782 NQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ + +SDV+SFG++L E S G P
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASP 315
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-42
Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 7/200 (3%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
K++G G FG V GK K +VAVK++ + +F E + ++ H LV G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYG 70
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
C +E+ +V EY+ NG L + L + K L+ L++ +D +G+ +L +
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLE---SHQF 125
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
IHRD+ + N L+D ++ KVSDFG++R +D S + V + PE + + + K
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 789 SDVYSFGVVLLELIS-GKKP 807
SDV++FG+++ E+ S GK P
Sbjct: 186 SDVWAFGILMWEVFSLGKMP 205
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
F ++IG G FG V+ G + +VA+K + + + F+ E ++ ++ H LV L G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYG 70
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
C E+ LV E+M +G L D L + L L + D +G+ YL +
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL--LGMCLDVCEGMAYL---EEACV 125
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
IHRD+ + N L+ N KVSDFG++R +D S+ + V + PE + + + K
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 789 SDVYSFGVVLLELIS-GKKP 807
SDV+SFGV++ E+ S GK P
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP 205
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-41
Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 7/201 (3%)
Query: 609 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 667
K+G G +G VY G K VAVK + + ++F+ E A++ I H NLV L+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 282
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
G C E ++ E+M G L D L N++ + + L +A + +EYL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLE---KKN 338
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 787
IHR++ + N L+ N KV+DFGLSR D + A+ + + PE + +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 788 KSDVYSFGVVLLELIS-GKKP 807
KSDV++FGV+L E+ + G P
Sbjct: 399 KSDVWAFGVLLWEIATYGMSP 419
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-41
Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
K+G+G FG V+ G VA+K + + F+ E ++ ++ H LV L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 246
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
EE I V EYM G+L D L G K L + +A A G+ Y+
Sbjct: 247 VVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
+HRD++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 789 SDVYSFGVVLLELIS-GKKP 807
SDV+SFG++L EL + G+ P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 3e-41
Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
F K++G G FG V YGK + +VA+K++ + +F+ E ++ + H LV L G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYG 86
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
C ++ ++ EYM NG L + L + L++ D + +EYL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 141
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
+HRD+ + N L++ KVSDFGLSR +D S ++ V + PE + + K
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 789 SDVYSFGVVLLELIS-GKKP 807
SD+++FGV++ E+ S GK P
Sbjct: 202 SDIWAFGVLMWEIYSLGKMP 221
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-41
Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
+++G G FG V+ G +VAVK + F+ E L+ ++ H+ LV L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA 75
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
+E I + EYM NG+L D L + L L +A A+G+ ++
Sbjct: 76 VVTQEPIYI-ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
IHRD++++NIL+ + K++DFGL+R E++ A+ + + PE T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 789 SDVYSFGVVLLELIS-GKKP 807
SDV+SFG++L E+++ G+ P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-41
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
+ IG G FG V+ K + DGK +K + + ++ EV L+++ H N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 670 CEEEHQRI----------------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 713
+ + E+ GTL + + LD + L++
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQI 131
Query: 714 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 773
KG++Y+H + +I+RD+K SNI L + K+ DFGL + D S GT+
Sbjct: 132 TKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--GTLR 186
Query: 774 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
Y+ PE +Q ++ D+Y+ G++L EL+
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 5e-41
Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
K+G+G FG V+ G VA+K + + F+ E ++ ++ H LV L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 329
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
EE I V EYM G+L D L G K L + +A A G+ Y+
Sbjct: 330 VVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 384
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
+HRD++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 789 SDVYSFGVVLLELIS-GKKP 807
SDV+SFG++L EL + G+ P
Sbjct: 445 SDVWSFGILLTELTTKGRVP 464
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 7/201 (3%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 667
K+G G +G VY G K VAVK + + ++F+ E A++ I H NLV L+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 75
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
G C E ++ E+M G L D L N++ + + L +A + +EYL
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 787
IHRD+ + N L+ N KV+DFGLSR D + A+ + + PE + +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 788 KSDVYSFGVVLLELIS-GKKP 807
KSDV++FGV+L E+ + G P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP 212
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-40
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 7/200 (3%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
KK+G G FG V+ +VAVK M + F+ E ++ + H LV L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHA 250
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
+E I + E+M G+L D L + + A+G+ ++
Sbjct: 251 VVTKEPIYI-ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNY 305
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
IHRD++++NIL+ ++ K++DFGL+R E++ A+ + + PE T K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 789 SDVYSFGVVLLELIS-GKKP 807
SDV+SFG++L+E+++ G+ P
Sbjct: 366 SDVWSFGILLMEIVTYGRIP 385
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-40
Identities = 53/226 (23%), Positives = 109/226 (48%), Gaps = 19/226 (8%)
Query: 590 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHR 644
++ + + E + K +G G+FG+VY G E VA+K + ++ S +
Sbjct: 5 NQALLRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59
Query: 645 TQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW 703
+ + E +++ + + ++ L+G C L+ + M G L D + ++ +
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGS 116
Query: 704 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLT 762
L AKG+ YL + ++HRD+ + N+L+ K++DFGL++ E+
Sbjct: 117 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ + + + ++ E ++ T +SDV+S+GV + EL++ G KP
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-40
Identities = 66/201 (32%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
+ IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 253
Query: 669 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
EE + +V EYM G+L D L + L L+ + D + +EYL
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 309
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 787
+HRD+ + N+L+ + AKVSDFGL++ + + + V + PE ++ +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 788 KSDVYSFGVVLLELIS-GKKP 807
KSDV+SFG++L E+ S G+ P
Sbjct: 366 KSDVWSFGILLWEIYSFGRVP 386
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 612 KIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLI 667
++G G+FGSV G + K+ VA+K++ + + E ++ ++ + +V LI
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
G C+ E +LV E G L L G ++ + ++ H + G++YL
Sbjct: 77 GVCQAE-ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQL 785
+HRD+ + N+LL AK+SDFGLS+ A++ S + + + PE ++
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 786 TEKSDVYSFGVVLLELIS-GKKP 807
+ +SDV+S+GV + E +S G+KP
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 611 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVP 665
+ IG+G FG V+ G + VA+K + S ++ F+ E + + H ++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
LIG E I + E G LR L + LD + + A+ + L YL +
Sbjct: 81 LIGVITENPVWI-IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE---S 134
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 785
+HRD+ + N+L+ N K+ DFGLSR E+ + +S + + ++ PE ++
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 786 TEKSDVYSFGVVLLELIS-GKKP 807
T SDV+ FGV + E++ G KP
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
+ +G+G FG V+ K K D A+K + + ++ + EV L+++ H +V
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 669 YCEEEH---------QRILVY---EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 716
E++ ++ +Y + L+D ++G + + L I A+
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR------- 769
+E+LH + G++HRD+K SNI ++ KV DFGL ++D + +
Sbjct: 131 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 770 ----GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI 802
GT Y+ PE + K D++S G++L EL+
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 601 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALL 655
+ + +G+G FG VY G + K VAVK C+ ++ F++E ++
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67
Query: 656 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 715
+ H ++V LIG EEE I + E G L L N+ L LT + + K
Sbjct: 68 KNLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICK 124
Query: 716 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 775
+ YL + +HRD+ NIL+ K+ DFGLSR E++ + +SV R + ++
Sbjct: 125 AMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 776 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
PE ++ T SDV+ F V + E++S GK+P
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-39
Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNL 663
K IG G G V YG+++ + VA+K + + R ++ F++E +++ + H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
+ L G ++V EYM NG+L L + + + + G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSD- 169
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE--Y 779
G +HRD+ + N+L+D N+ KVSDFGLSR + + D + ++ + + + PE
Sbjct: 170 --LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 780 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ + SDV+SFGVV+ E+++ G++P
Sbjct: 228 FR--TFSSASDVWSFGVVMWEVLAYGERP 254
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 20/214 (9%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
+K+G+G F V + + DG A+K + ++ E + +H N++ L+ Y
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 670 CEEEHQR----ILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
C E L+ + GTL + + L L + +GLE +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--- 151
Query: 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--------GTVGYLD 776
G HRD+K +NILL + + D G QA + T+ Y
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 777 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
PE + + E++DV+S G VL ++ G+ P
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-39
Identities = 66/228 (28%), Positives = 98/228 (42%), Gaps = 21/228 (9%)
Query: 590 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYG--KMKDGKE--VAVKIM-ADSCSHR 644
+ + I +L +K+G GSFG V G GK VAVK + D S
Sbjct: 8 LQSLTCLIGEKDLR-----LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP 62
Query: 645 TQQ--FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD 702
F+ EV + + HRNL+ L G ++ V E G+L DRL L
Sbjct: 63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG 121
Query: 703 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEED 760
L + A A+G+ YL + IHRD+ + N+LL K+ DFGL R +D
Sbjct: 122 TL--SRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176
Query: 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ + + PE + + SD + FGV L E+ + G++P
Sbjct: 177 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-39
Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 15/219 (6%)
Query: 599 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVA 653
+ +F + IG+G FG VY+G + D AVK + F+TE
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78
Query: 654 LLSRIHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 712
++ H N++ L+G C E ++V YM +G LR+ + +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQ 136
Query: 713 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHISSVAR 769
AKG++YL + +HRD+ + N +LD KV+DFGL+R + H + A+
Sbjct: 137 VAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 770 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
V ++ E Q+ T KSDV+SFGV+L EL++ G P
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-38
Identities = 70/296 (23%), Positives = 126/296 (42%), Gaps = 24/296 (8%)
Query: 530 GTSIGVLAILLVLFLC--------SLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYS 581
+I L+ C S I+ + + + + A++ + + + S
Sbjct: 303 SLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVS 362
Query: 582 IARG-GHFMDEGVAYFIPLP---ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VA 633
+DE Y +P E++ + IG+G FG V+ G + VA
Sbjct: 363 ETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVA 422
Query: 634 VKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL 692
+K + S ++ F+ E + + H ++V LIG E ++ E G LR L
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL 481
Query: 693 HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 752
+ LD + + A+ + L YL + +HRD+ + N+L+ N K+ DFG
Sbjct: 482 QV--RKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFG 536
Query: 753 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
LSR E+ + +S + + ++ PE ++ T SDV+ FGV + E++ G KP
Sbjct: 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 67/201 (33%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
+ IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G
Sbjct: 25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 81
Query: 669 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
EE + +V EYM G+L D L + L L+ + D + +EYL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 137
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 787
+HRD+ + N+L+ + AKVSDFGL+++A + V + PE ++ +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFST 193
Query: 788 KSDVYSFGVVLLELIS-GKKP 807
KSDV+SFG++L E+ S G+ P
Sbjct: 194 KSDVWSFGILLWEIYSFGRVP 214
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 611 KKIGKGSFGSVYYGKMKDGK---EVAVKIM-ADSCSHRTQQ-FVTEVALLSRIHHRNLVP 665
K++G G+FG+V G + K VAVKI+ ++ + + E ++ ++ + +V
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
+IG CE E + V E G L L + + +++ H + G++YL
Sbjct: 83 MIGICEAESWML-VMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE---E 135
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQ 783
+HRD+ + N+LL AK+SDFGLS+ +A+E+ + + V + PE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 784 QLTEKSDVYSFGVVLLELIS-GKKP 807
+ + KSDV+SFGV++ E S G+KP
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-38
Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 601 ELEEATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALL 655
+ EE F +++GKG+FGSV + G+ VAVK + S + F E+ +L
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 656 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 713
+ H N+V G C +R L+ EY+ G+LRD L +++ +D + LQ
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 123
Query: 714 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 771
KG+EYL T IHRD+ + NIL++ R K+ DFGL++ +++ +
Sbjct: 124 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 772 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 803
+ + PE + + SDV+SFGVVL EL +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-38
Identities = 53/226 (23%), Positives = 109/226 (48%), Gaps = 19/226 (8%)
Query: 590 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHR 644
++ + + E + K +G G+FG+VY G E VA+K + ++ S +
Sbjct: 5 NQALLRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59
Query: 645 TQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW 703
+ + E +++ + + ++ L+G C L+ + M G L D + ++ +
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGS 116
Query: 704 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLT 762
L AKG+ YL + ++HRD+ + N+L+ K++DFGL++ E+
Sbjct: 117 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ + + + ++ E ++ T +SDV+S+GV + EL++ G KP
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-38
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT----QQFVTEVALLSRIHHRNLVP 665
+KIG+GSFG K DG++ +K + + S + ++ EVA+L+ + H N+V
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEI--NISRMSSKEREESRREVAVLANMKHPNIVQ 87
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEYL 720
EE +V +Y G L R++ + LDW QI L+++
Sbjct: 88 YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV--QICL----ALKHV 141
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 780
H + I+HRD+KS NI L + ++ DFG++R + + GT YL PE
Sbjct: 142 H---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEIC 197
Query: 781 GNQQLTEKSDVYSFGVVLLELISGKKP 807
N+ KSD+++ G VL EL + K
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-38
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 662
K IG G FG VY G +K VA+K + + + + F+ E ++ + H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 663 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
++ L G + +++ EYM NG L L L + + A G++YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA- 164
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYY 780
N +HRD+ + NIL++ N+ KVSDFGLSR + + + T+ +S + + + PE
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 781 GNQQLTEKSDVYSFGVVLLELIS-GKKP 807
++ T SDV+SFG+V+ E+++ G++P
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 54/229 (23%), Positives = 101/229 (44%), Gaps = 32/229 (13%)
Query: 599 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQFVT 650
++ F + +G+G+F ++ G ++ EV +K++ + + ++ F
Sbjct: 2 FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 651 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 710
+++S++ H++LV G C + ILV E++ G+L L + N + W L++A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVA 119
Query: 711 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--------NMRAKVSDFGLSRQAEEDLT 762
A + +L +IH +V + NILL K+SD G+S
Sbjct: 120 KQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-- 174
Query: 763 HISSVARGTVGYLDPE---YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ + + ++ PE N L +D +SFG L E+ S G KP
Sbjct: 175 ---DILQERIPWVPPECIENPKN--LNLATDKWSFGTTLWEICSGGDKP 218
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 16/220 (7%)
Query: 601 ELEEATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQ-FVTEVAL 654
E+ + +G+G FG V + G++VAVK + E+ +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76
Query: 655 LSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 712
L ++H N+V G C E+ L+ E++ +G+L++ L N+ ++ +L+ A
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQ 134
Query: 713 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARG 770
KG++YL + +HRD+ + N+L++ + K+ DFGL++ + +++ +
Sbjct: 135 ICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191
Query: 771 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 809
V + PE + SDV+SFGV L EL++ S
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-38
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 15/217 (6%)
Query: 601 ELEEATNNFCKKIGKGSFGSVYYG-----KMKDGKEVAVKIMADSCSHRTQQFVTEVALL 655
EE + ++GKG+FGSV G VAVK + S + + F E+ +L
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78
Query: 656 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 713
+H +V G ++ LV EY+ +G LRD L ++ LD L +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQI 136
Query: 714 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 771
KG+EYL + +HRD+ + NIL++ K++DFGL++ ++D + +
Sbjct: 137 CKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 772 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ + PE + + +SDV+SFGVVL EL + K
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-38
Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 13/204 (6%)
Query: 611 KKIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPL 666
++G G+FGSV G + K+ VA+K++ + + E ++ ++ + +V L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
IG C+ E +LV E G L L G ++ + ++ H + G++YL
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEK 455
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQ 784
+HR++ + N+LL AK+SDFGLS+ A++ S + + + PE ++
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 785 LTEKSDVYSFGVVLLELIS-GKKP 807
+ +SDV+S+GV + E +S G+KP
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-38
Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 32/235 (13%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRT-QQFVTEVALLSRIHHRNLVPL 666
KKIG+G F VY DG VA+K + D + + E+ LL +++H N++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-------LDWLTRLQIAHDAAKGLEY 719
E+++ +V E G L + QK + Q+ LE+
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV--QLCS----ALEH 151
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLD 776
+H + ++HRD+K +N+ + K+ D GL R + ++ A VG Y+
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMS 204
Query: 777 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 831
PE KSD++S G +L E+ + + P F + ++ I++ D
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSP-----FYGDKMNLYSLCKKIEQCD 254
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-38
Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 601 ELEEATNNFCKKIGKGSFGSVYYG-----KMKDGKEVAVKIMADSCSHRTQQFVTEVALL 655
+ EE F +++GKG+FGSV + G+ VAVK + S + F E+ +L
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 656 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 713
+ H N+V G C +R L+ EY+ G+LRD L +++ +D + LQ
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 154
Query: 714 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 771
KG+EYL T IHRD+ + NIL++ R K+ DFGL++ +++ +
Sbjct: 155 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 772 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 803
+ + PE + + SDV+SFGVVL EL +
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-37
Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 15/219 (6%)
Query: 599 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVA 653
+ +F + IG+G FG VY+G + D AVK + QF+TE
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142
Query: 654 LLSRIHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 712
++ H N++ L+G C E ++V YM +G LR+ + +
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQ 200
Query: 713 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVAR 769
AKG+++L + +HRD+ + N +LD KV+DFGL+R E D H + A+
Sbjct: 201 VAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 770 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
V ++ E Q+ T KSDV+SFGV+L EL++ G P
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 9/205 (4%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 667
IG GS+G + K DGK + K + S + Q V+EV LL + H N+V
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 668 GYCEEEHQRIL--VYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
+ L V EY G L + G+ ++ LD L++ L+ H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 725 NPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
+ G ++HRD+K +N+ LD K+ DFGL+R D + + GT Y+ PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNR 190
Query: 783 QQLTEKSDVYSFGVVLLELISGKKP 807
EKSD++S G +L EL + P
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 54/205 (26%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 611 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLV 664
K +G G FG+V+ G E V +K++ D ++ Q + + + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
L+G C ++ V +Y+ G+L D + ++ L L AKG+ YL
Sbjct: 79 RLLGLCPGSSLQL-VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLE--- 132
Query: 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQ 783
G++HR++ + N+LL + +V+DFG++ +D + S A+ + ++ E
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 784 QLTEKSDVYSFGVVLLELIS-GKKP 807
+ T +SDV+S+GV + EL++ G +P
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-37
Identities = 59/207 (28%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNL 663
K +G G FG V G++K + VA+K + + + ++ F+ E +++ + H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
+ L G + ++V EYM NG+L L + + + + A G++YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSD- 165
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYG 781
G +HRD+ + NIL++ N+ KVSDFGL R + + + + + + + + PE
Sbjct: 166 --MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 782 NQQLTEKSDVYSFGVVLLELIS-GKKP 807
++ T SDV+S+G+VL E++S G++P
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 48/231 (20%)
Query: 609 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 667
+G+G+FG V + D + A+K + + ++EV LL+ ++H+ +V
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 668 G-YCEEEHQRI------------LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHD 712
+ E + + EY NGTL D + Q+ W QI
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL-- 126
Query: 713 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--- 769
+ L Y+H + GIIHRD+K NI +D + K+ DFGL++ L + ++
Sbjct: 127 --EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 770 ----------GTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISG 804
GT Y+ E +Y EK D+YS G++ E+I
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYN-----EKIDMYSLGIIFFEMIYP 227
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 611 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLVP 665
+ IGKG FG VY+G+ D + A+K ++ + + F+ E L+ ++H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 666 LIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
LIG E ++ YM +G L + Q+ + A+G+EYL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLA--- 141
Query: 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT---VGYLDPEYYG 781
+HRD+ + N +LD + KV+DFGL+R + + R V + E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 782 NQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ T KSDV+SFGV+L EL++ G P
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 665
K+G G +VY + +VA+K + ++ + EV S++ H+N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
+I EE+ LV EY+ TL + + + PL T + + G+++ H +
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAH---D 129
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQQ 784
I+HRD+K NIL+D N K+ DFG+++ +E LT + V GTV Y PE +
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEA 188
Query: 785 LTEKSDVYSFGVVLLELISGKKP 807
E +D+YS G+VL E++ G+ P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-37
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY 669
+G G+ G++ Y M D ++VAVK + C + EV LL H N++
Sbjct: 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVIRYFCT 86
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 729
++ + + E TL++ + L + + GL +LH + I+
Sbjct: 87 EKDRQFQYIAIELC-AATLQEYVEQ--KDFAHLGLEPITLLQQTTSGLAHLH---SLNIV 140
Query: 730 HRDVKSSNILL-----DINMRAKVSDFGLSRQAEED---LTHISSVARGTVGYLDPEYY- 780
HRD+K NIL+ ++A +SDFGL ++ + S V GT G++ PE
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GTEGWIAPEMLS 199
Query: 781 --GNQQLTEKSDVYSFGVVLLELISGKKP 807
+ T D++S G V +IS
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-37
Identities = 56/251 (22%), Positives = 97/251 (38%), Gaps = 46/251 (18%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVAVKIM-----------------ADSCSHRTQQFVTEVA 653
+ + +G F + + KD K A+K S + F E+
Sbjct: 37 RTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 654 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQ--- 708
+++ I + + G + ++YEYM N ++ +++ ++
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 709 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 768
I Y+H I HRDVK SNIL+D N R K+SDFG S + S
Sbjct: 156 IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS--- 210
Query: 769 RGTVGYLDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 821
RGT ++ PE Y G K D++S G+ L + P F ++++V
Sbjct: 211 RGTYEFMPPEFFSNESSYNG-----AKVDIWSLGICLYVMFYNVVP-----FSLKISLVE 260
Query: 822 WARSMIKKGDV 832
+ I+ ++
Sbjct: 261 -LFNNIRTKNI 270
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 18/220 (8%)
Query: 601 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVAL 654
+ + +G+G FG V + VAVK + + + + E+ +
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 655 LSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 712
L ++H +++ G CE+ LV EY+ G+LRD L + + L A
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP----RHSIGLAQLLLFAQQ 142
Query: 713 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARG 770
+G+ YLH IHRD+ + N+LLD + K+ DFGL++ + +
Sbjct: 143 ICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199
Query: 771 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 809
V + PE + SDV+SFGV L EL++ S
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 19/237 (8%)
Query: 587 HFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADS 640
+ + L E+ + +G G+FG VY G++ +VAVK + +
Sbjct: 12 YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 71
Query: 641 CSHRTQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGS 695
CS + + F+ E ++S+ +H+N+V IG + R ++ E M G LR+
Sbjct: 72 CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 131
Query: 696 VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFG 752
L L L +A D A G +YL IHRD+ + N LL AK+ DFG
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 753 LSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
++R A V ++ PE + T K+D +SFGV+L E+ S G P
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 19/215 (8%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 661
+++G+GSFG VY G K + VA+K + ++ S R + F+ E +++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 662 NLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGSVNQKPLDWLTR---LQIAHDAA 714
++V L+G + +++ E M G LR N L + +Q+A + A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 715 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVG 773
G+ YL+ +HRD+ + N ++ + K+ DFG++R E D V
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 774 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
++ PE + T SDV+SFGVVL E+ + ++P
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNL 663
F IG+G+FG V ++K A+K M + S + F E+ +L ++ HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIA 710
+ L+G CE L EY +G L D L S L L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 711 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 770
D A+G++YL IHRD+ + NIL+ N AK++DFGLSR +++ ++ R
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 203
Query: 771 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
V ++ E T SDV+S+GV+L E++S G P
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPL 666
+ +GKG FG+VY + K +A+K++ + + Q EV + S + H N++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
GY + + L+ EY GT+ L D + A L Y H +
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH---SK 128
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 786
+IHRD+K N+LL K++DFG S A GT+ YL PE +
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYLPPEMIEGRMHD 185
Query: 787 EKSDVYSFGVVLLELISGKKP 807
EK D++S GV+ E + GK P
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPP 206
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 611 KKIGKGSFGSVYYGKMKDGKE----VAVKIM-ADSCSHRTQQ-FVTEVALLSRIHHRNLV 664
K +G+G FGSV G +K VAVK M D+ S R + F++E A + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 665 PLIGYCEEEHQRI-----LVYEYMHNGTLRDRLHGSVNQKPLDWLTR---LQIAHDAAKG 716
L+G C E + ++ +M G L L S + + L+ D A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYL 775
+EYL +HRD+ + N +L +M V+DFGLS++ D +A+ V ++
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 776 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
E ++ T KSDV++FGV + E+ + G P
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-36
Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 19/279 (6%)
Query: 545 CSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEE 604
I + S ++ + S ++T + + + L E+
Sbjct: 11 DYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPR 70
Query: 605 ATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADSCSHRTQQ-FVTEVALLSR 657
+ +G G+FG VY G++ +VAVK + + CS + + F+ E ++S+
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 658 IHHRNLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGSVNQKPLDWLTRLQIAHDA 713
+H+N+V IG + R ++ E M G LR+ L L L +A D
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 714 AKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ-AEEDLTHISSVAR 769
A G +YL IHRD+ + N LL AK+ DFG++R A
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 770 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
V ++ PE + T K+D +SFGV+L E+ S G P
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 611 KKIGKGSFGSVYYGKMKDGKE----VAVKIM-ADSCSHR-TQQFVTEVALLSRIHHRNLV 664
+ +GKG FGSV ++K VAVK++ AD + ++F+ E A + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 665 PLIGYCEEEHQRI------LVYEYMHNGTLRDRLHGS---VNQKPLDWLTRLQIAHDAAK 715
L+G + ++ +M +G L L S N L T ++ D A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 716 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGY 774
G+EYL + IHRD+ + N +L +M V+DFGLSR+ D ++ V +
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 775 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
L E + T SDV++FGV + E+++ G+ P
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 665
+ +G+G G VY + + VA+K+M+++ S F T E R+ ++VP
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
+ + E + Q + ++ L L Q PL + I L+ H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQQ 784
G HRDVK NIL+ + A + DFG++ +E LT + + GT+ Y+ PE +
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESH 211
Query: 785 LTEKSDVYSFGVVLLELISGKKP 807
T ++D+Y+ VL E ++G P
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP 234
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 24/220 (10%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 668
+ + +G F VY + + G+E A+K + + + + + EV + ++ H N+V
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 669 YCEEEHQR-------ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
+ L+ + G L + L ++ PL T L+I + + ++++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-----------RG 770
P IIHRD+K N+LL K+ DFG + + S
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 771 TVGYLDPE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
T Y PE Y N + EK D+++ G +L L + P
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 33/243 (13%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRIHHRNL--VPL 666
K+IG G V+ + + A+K + + ++T + E+A L+++ + + L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
Y + +V E N L L +K +D R + + + +H
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 146
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 778
GI+H D+K +N L+ + K+ DFG++ Q + D T + S V GTV Y+ PE
Sbjct: 147 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDM 203
Query: 779 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832
+++ KSDV+S G +L + GK P F +N + ++I
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 258
Query: 833 ISI 835
I
Sbjct: 259 IEF 261
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 15/202 (7%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 666
+ +GKG FG+VY + K +A+K++ S Q E+ + S + H N++ +
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGLEYLHTGCN 725
Y + + L+ E+ G L L D + + A L Y H
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSA-TFMEELADALHYCH---E 132
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 785
+IHRD+K N+L+ K++DFG S A GT+ YL PE +
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGKTH 189
Query: 786 TEKSDVYSFGVVLLELISGKKP 807
EK D++ GV+ E + G P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP 211
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 666
+GKGSF VY + + G EVA+K++ + Q+ EV + ++ H +++ L
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 722
Y E+ + LV E HNG + L KP R QI G+ YLH
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQII----TGMLYLH- 129
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEY 779
+ GI+HRD+ SN+LL NM K++DFGL+ Q + GT Y+ PE
Sbjct: 130 --SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP----HEKHYTLCGTPNYISPEI 183
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKP 807
+SDV+S G + L+ G+ P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-35
Identities = 59/241 (24%), Positives = 98/241 (40%), Gaps = 41/241 (17%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY 669
K +G GS G+V + G+ VAVK M E+ LL+ H N++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIRYYCS 77
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLEYLHT 722
+ + E N L+D + ++ D +LQ ++ G+ +LH
Sbjct: 78 ETTDRFLYIALELC-NLNLQDLV---ESKNVSDENLKLQKEYNPISLLRQIASGVAHLH- 132
Query: 723 GCNPGIIHRDVKSSNILLDI-------------NMRAKVSDFGLSRQAEEDLTHISSVAR 769
+ IIHRD+K NIL+ N+R +SDFGL ++ + + +
Sbjct: 133 --SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 770 ---GTVGYLDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 819
GT G+ PE ++LT D++S G V ++S K + + E NI
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 820 V 820
+
Sbjct: 251 I 251
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
+GKG++G VY G+ +A+K + + S +Q E+AL + H+N+V +G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEYLHTGC 724
E + E + G+L L + + T+ QI GL+YLH
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILE----GLKYLH--- 139
Query: 725 NPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--YYG 781
+ I+HRD+K N+L++ + K+SDFG S++ + GT+ Y+ PE G
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKG 198
Query: 782 NQQLTEKSDVYSFGVVLLELISGKKP 807
+ + +D++S G ++E+ +GK P
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-35
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
++G+GSFG V+ K K G + AVK + E+ + + +VPL G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGA 118
Query: 670 CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
E + E + G+L + G + + + Q +GLEYLH
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG-QAL----EGLEYLH---TRR 170
Query: 728 IIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEYYGN 782
I+H DVK+ N+LL + RA + DFG + + D S + GT ++ PE
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 783 QQLTEKSDVYSFGVVLLELISGKKP 807
+ K D++S ++L +++G P
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-35
Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 599 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQFVTEV 652
+ ++ ++G+G+FG V+ + + VAVK + ++ Q F E
Sbjct: 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREA 94
Query: 653 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG----------SVNQKP 700
LL+ + H+++V G C E ++V+EYM +G L R HG V P
Sbjct: 95 ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 701 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEE 759
L L +A A G+ YL +HRD+ + N L+ + K+ DFG+SR
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 760 DLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
D + + ++ PE Y + T +SDV+SFGVVL E+ + GK+P
Sbjct: 212 DYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 9e-35
Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQFVTEVALLSRIHHRN 662
+++G+G+FG V+ + + VAVK + D + F E LL+ + H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 663 LVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG-----------SVNQKPLDWLTRLQI 709
+V G C + I+V+EYM +G L R HG + L L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 710 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVA 768
A A G+ YL + +HRD+ + N L+ N+ K+ DFG+SR D +
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 769 RGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ ++ PE Y + T +SDV+SFGV+L E+ + GK+P
Sbjct: 196 MLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 57/233 (24%), Positives = 108/233 (46%), Gaps = 29/233 (12%)
Query: 599 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTE 651
L E+ + F +++G+ FG VY G + VA+K + D ++ F E
Sbjct: 3 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 652 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG-----------SVNQ 698
L +R+ H N+V L+G ++ +++ Y +G L + + +
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 699 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-A 757
L+ + + A G+EYL + ++H+D+ + N+L+ + K+SD GL R+
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 758 EEDLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
D + + + ++ PE YG + + SD++S+GVVL E+ S G +P
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 33/243 (13%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRI--HHRNLVPL 666
K+IG G V+ + + A+K + + ++T + E+A L+++ H ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
Y + +V E N L L +K +D R + + + +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 127
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 778
GI+H D+K +N L+ + K+ DFG++ Q + D T + S V GTV Y+ PE
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDM 184
Query: 779 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832
+++ KSDV+S G +L + GK P F +N + ++I
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 239
Query: 833 ISI 835
I
Sbjct: 240 IEF 242
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 20/209 (9%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 665
+ +G G V+ + ++D ++VAVK++ + R F E + ++H +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 666 LIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
+ E E +V EY+ TLRD +H + P+ +++ DA + L + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSH 133
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPE 778
GIIHRDVK +NI++ KV DFG++R + +T ++V GT YL PE
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPE 189
Query: 779 YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
+ +SDVYS G VL E+++G+ P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 660
F K +G G+FG V + VAVK++ S ++ ++E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------HGSVNQKPLDWLT 705
N+V L+G C +++ EY G L + L ++ LD
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 706 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHI 764
L ++ AKG+ +L + IHRD+ + NILL K+ DFGL+R + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
AR V ++ PE N T +SDV+S+G+ L EL S G P
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 608 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 665
+G+G+ +V+ G+ K G A+K+ S + E +L +++H+N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 666 LIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
L EE R +L+ E+ G+L L N L L + D G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 724 CNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 779
GI+HR++K NI+ D K++DFG +R+ E+D +S GT YL P+
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDM 186
Query: 780 Y--------GNQQLTEKSDVYSFGVVLLELISGKKP 807
Y ++ D++S GV +G P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 666
+ +GKG F + + A KI+ S H+ ++ E+++ + H+++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 722
G+ E+ +V E +L + +K L R QI G +YLH
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIV----LGCQYLH- 132
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
+IHRD+K N+ L+ ++ K+ DFGL+ + E D V GT Y+ PE
Sbjct: 133 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSK 189
Query: 783 QQLTEKSDVYSFGVVLLELISGKKP 807
+ + + DV+S G ++ L+ GK P
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-34
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 666
+ +GKG F + + A KI+ S H+ ++ E+++ + H+++V
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 722
G+ E+ +V E +L + +K L R QI G +YLH
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIV----LGCQYLH- 158
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
+IHRD+K N+ L+ ++ K+ DFGL+ + E D V GT Y+ PE
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSK 215
Query: 783 QQLTEKSDVYSFGVVLLELISGKKP 807
+ + + DV+S G ++ L+ GK P
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-34
Identities = 71/285 (24%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 554 RRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN--FCK 611
R+ + +S +S + + S A P+ E + K
Sbjct: 28 RQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGK 87
Query: 612 KIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHR 661
+G+G FG V K K+ VAVK++ D + + V+E+ ++ I H+
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 662 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTRLQ 708
N++ L+G C ++ ++ EY G LR+ L V ++ + + +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 709 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 768
+ A+G+EYL + IHRD+ + N+L+ N K++DFGL+R D+ +I
Sbjct: 208 CTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYK 260
Query: 769 RGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ T G L PE ++ T +SDV+SFGV++ E+ + G P
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
+KIG+G+ G+VY G+EVA++ M + + + E+ ++ + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 726
+ +V EY+ G+L D + + + QIA + + LE+LH+
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN--- 135
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 786
+IHRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 787 EKSDVYSFGVVLLELISGKKP 807
K D++S G++ +E+I G+ P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 36/228 (15%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKE--------VAVKIMADSCSHRTQQ-FVTEVALLSRI- 658
K +G+G+FG V + + VAVK++ D + + V+E+ ++ I
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 659 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLT 705
H+N++ L+G C ++ ++ EY G LR+ L V ++ + +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 706 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765
+ + A+G+EYL + IHRD+ + N+L+ N K++DFGL+R D+ +I
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 766 SVARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ T G L PE ++ T +SDV+SFGV++ E+ + G P
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-34
Identities = 57/243 (23%), Positives = 102/243 (41%), Gaps = 33/243 (13%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRIHHRNL--VPL 666
K+IG G V+ + + A+K + + ++T + E+A L+++ + + L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
Y + +V E N L L +K +D R + + + +H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 174
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 778
GI+H D+K +N L+ + K+ DFG++ Q + D T + S V G V Y+ PE
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GAVNYMPPEAIKDM 231
Query: 779 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832
+++ KSDV+S G +L + GK P F +N + ++I
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 286
Query: 833 ISI 835
I
Sbjct: 287 IEF 289
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 41/233 (17%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 661
K +G+G FG V K VAVK++ ++ S + ++E +L +++H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 662 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------------HGSVNQKP 700
+++ L G C ++ +L+ EY G+LR L +++
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 701 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760
L + A ++G++YL ++HRD+ + NIL+ + K+SDFGLSR D
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSR----D 199
Query: 761 LTHISSVARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ S + + G + E + T +SDV+SFGV+L E+++ G P
Sbjct: 200 VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-34
Identities = 67/252 (26%), Positives = 110/252 (43%), Gaps = 21/252 (8%)
Query: 609 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT-EVALLSRIHHRNLVPL 666
+++G G FG V +D G++VA+K S + ++ E+ ++ +++H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 667 IGYCEEE------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
+ +L EY G LR L+ N L + D + L YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 721 HTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 777
H IIHRD+K NI+L + K+ D G +++ ++ V GT+ YL P
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--GTLQYLAP 192
Query: 778 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837
E ++ T D +SFG + E I+G +P F V W + +K + +V
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRP-----FLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 838 PVLIGNVKIESI 849
L G VK S+
Sbjct: 248 DDLTGAVKFSSV 259
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 35/227 (15%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 660
K +G+G+FG V + VAVK++ + +H + ++E+ +L I HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 661 RNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTR 706
N+V L+G C + +++ E+ G L L + + L
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 707 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 766
+ + AKG+E+L + IHRD+ + NILL K+ DFGL+R D+
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPD 203
Query: 767 VARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
R L PE ++ T +SDV+SFGV+L E+ S G P
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 70/278 (25%), Positives = 118/278 (42%), Gaps = 39/278 (14%)
Query: 560 QKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFG 619
Q YE + T S+ Y ++D + E F K +G G+FG
Sbjct: 6 QFRYESQLQMVQVTGSSDNEY------FYVDFREYEYDLKWEFPRENLEFGKVLGSGAFG 59
Query: 620 SVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLIGYCE 671
V + VAVK++ + ++ ++E+ +++++ H N+V L+G C
Sbjct: 60 KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119
Query: 672 EEHQRILVYEYMHNGTLRDRL-----------------HGSVNQKPLDWLTR---LQIAH 711
L++EY G L + L ++ L+ LT L A+
Sbjct: 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179
Query: 712 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARG 770
AKG+E+L +HRD+ + N+L+ K+ DFGL+R + + AR
Sbjct: 180 QVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL 236
Query: 771 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
V ++ PE T KSDV+S+G++L E+ S G P
Sbjct: 237 PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 50/201 (24%), Positives = 76/201 (37%), Gaps = 13/201 (6%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRTQQFVTEVALLSRI-HHRNLVPL 666
++G GS+G V+ + K DG+ AVK + + EV ++ H V L
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
EE L E +L+ L D L +LH +
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLH---SQ 176
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 786
G++H DVK +NI L R K+ DFGL + G Y+ PE
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPELL-QGSYG 233
Query: 787 EKSDVYSFGVVLLELISGKKP 807
+DV+S G+ +LE+ +
Sbjct: 234 TAADVFSLGLTILEVACNMEL 254
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-34
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 608 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 665
+G+G+ +V+ G+ K G A+K+ S + E +L +++H+N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 666 LIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
L EE R +L+ E+ G+L L N L L + D G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 724 CNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 779
GI+HR++K NI+ D K++DFG +R+ E+D +S GT YL P+
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDM 186
Query: 780 Y--------GNQQLTEKSDVYSFGVVLLELISGKKP 807
Y ++ D++S GV +G P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-34
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 24/220 (10%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 660
F K +G G+FG V + VAVK++ + ++ ++E+ ++S + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQ---------KPLDWLTRLQI 709
N+V L+G C +++ EY G L + R V + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 710 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVA 768
+ A+G+ +L + IHRDV + N+LL AK+ DFGL+R + + A
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 769 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
R V ++ PE + T +SDV+S+G++L E+ S G P
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 68/246 (27%), Positives = 101/246 (41%), Gaps = 67/246 (27%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 661
+ + IG+G+FG V+ + VAVK++ + S Q F E AL++ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 662 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------------HGSVNQKP 700
N+V L+G C L++EYM G L + L S P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 701 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760
L +L IA A G+ YL +HRD+ + N L+ NM K++DFGLSR
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 761 LTHISSVARGTVGYLDPEYY---GNQQL---------------TEKSDVYSFGVVLLELI 802
+YY GN + T +SDV+++GVVL E+
Sbjct: 228 -----------------DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
Query: 803 S-GKKP 807
S G +P
Sbjct: 271 SYGLQP 276
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
KIG+GS G V + K G++VAVK+M R + EV ++ H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 726
+ ++ E++ G L D + L QIA + L YLH
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVR-------LNEEQIATVCEAVLQALAYLH---AQ 160
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 786
G+IHRD+KS +ILL ++ R K+SDFG Q +D+ S+ GT ++ PE
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYA 219
Query: 787 EKSDVYSFGVVLLELISGKKP 807
+ D++S G++++E++ G+ P
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPP 240
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-33
Identities = 62/226 (27%), Positives = 109/226 (48%), Gaps = 36/226 (15%)
Query: 611 KKIGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 660
K +G+G+FG V + +VAVK++ + + ++E+ ++ I H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTRL 707
+N++ L+G C ++ ++ EY G LR+ L ++ L +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 708 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 767
A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+R D+ HI
Sbjct: 195 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 247
Query: 768 ARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
+ T G L PE ++ T +SDV+SFGV+L E+ + G P
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 9e-33
Identities = 40/263 (15%), Positives = 82/263 (31%), Gaps = 28/263 (10%)
Query: 567 DSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFC--KKIGKGSFGSVYYG 624
L + ++Y + P E + + +G+G+F VY
Sbjct: 28 FKLLSGLSKPVSSYP---NTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEA 84
Query: 625 KMKD------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 678
D ++ +K+ + + L + ++ +L
Sbjct: 85 TQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144
Query: 679 VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 736
V E GTL + + + + +K + + A +E +H IIH D+K
Sbjct: 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPD 201
Query: 737 NILL-----------DINMRAKVSDFGLSRQAEEDLTHISSVAR-GTVGYLDPEYYGNQQ 784
N +L D++ + D G S + A+ T G+ E N+
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP 261
Query: 785 LTEKSDVYSFGVVLLELISGKKP 807
+ D + + ++ G
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTYM 284
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
+KIGKGSFG V+ G K VA+KI+ + + E+ +LS+ + G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCN 725
++ + ++ EY+ G+ D L L QIA + KGL+YLH +
Sbjct: 88 SYLKDTKLWIIMEYLGGGSALDLLEPGP-------LDETQIATILREILKGLDYLH---S 137
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGN 782
IHRD+K++N+LL + K++DFG++ Q LT VG ++ PE
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQ----LTDTQIKRNTFVGTPFWMAPEVIKQ 193
Query: 783 QQLTEKSDVYSFGVVLLELISGKKP 807
K+D++S G+ +EL G+ P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP 218
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
+ IG G+ V ++VA+K + + C + + E+ +S+ HH N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW--LTRLQIA---HDAAKGLEYLHTG 723
+ + LV + + G++ D + V + L IA + +GLEYLH
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-- 138
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT-VG---YLDPE- 778
G IHRDVK+ NILL + +++DFG+S + R T VG ++ PE
Sbjct: 139 -KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 779 -----YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
Y K+D++SFG+ +EL +G P
Sbjct: 198 MEQVRGYD-----FKADIWSFGITAIELATGAAP 226
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-32
Identities = 43/204 (21%), Positives = 77/204 (37%), Gaps = 23/204 (11%)
Query: 612 KIGKGSFGSVYYGK--MKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLIG 668
I G G +Y +G+ V +K + S Q + E L+ + H ++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 669 YCEEEHQRI-----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
+ E + +V EY+ +L+ L + + L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH-- 199
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 783
+ G+++ D+K NI+L + K+ D G + + + GT G+ PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR----INSFGYLY-GTPGFQAPEIVRTG 252
Query: 784 QLTEKSDVYSFGVVLLELISGKKP 807
T +D+Y+ G L L
Sbjct: 253 P-TVATDIYTVGRTLAALTLDLPT 275
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
++G G+FG VY K K+ G A K++ + ++ E+ +L+ H +V L+G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 726
+ + ++ E+ G + + LT QI + L +LH+
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRG-----LTEPQIQVVCRQMLEALNFLHSK--- 136
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 786
IIHRD+K+ N+L+ + +++DFG+S + + L S GT ++ PE + +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMK 195
Query: 787 E-----KSDVYSFGVVLLELISGKKP 807
+ K+D++S G+ L+E+ + P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 24/232 (10%), Positives = 59/232 (25%), Gaps = 42/232 (18%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 666
+ + G V+ + + ++ A+K+ A++ ++ +R+ +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 667 IGYC--------------------------EEEHQRILVYEYMH--NGTLRDRLH-GSVN 697
+L+ L L V
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 698 QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757
+ L + + L + G++H N+ + + R + D +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 758 EEDLTHISSVARGTVGYLDPEYYG--NQQLTEKSDVYSFGVVLLELISGKKP 807
S V Y E+ T + + G+ + + P
Sbjct: 245 GTRGPASS----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
+K+G+GS+GSVY K+ G+ VA+K + Q+ + E++++ + ++V G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 726
+ +V EY G++ D + + K L +IA KGLEYLH
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLT---EDEIATILQSTLKGLEYLHFM--- 144
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 786
IHRD+K+ NILL+ AK++DFG++ Q + + ++V GT ++ PE
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYN 203
Query: 787 EKSDVYSFGVVLLELISGKKP 807
+D++S G+ +E+ GK P
Sbjct: 204 CVADIWSLGITAIEMAEGKPP 224
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 43/222 (19%), Positives = 79/222 (35%), Gaps = 33/222 (14%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRTQQFVTEVALLSRI-HHRNLVPL 666
+KIG G FGSV+ + DG A+K + S Q + EV + + H ++V
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
E+ ++ EY + G+L D + + +GL Y+H +
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---S 133
Query: 726 PGIIHRDVKSSNILLDIN-------------------MRAKVSDFGLSRQAEEDLTHISS 766
++H D+K SNI + + K+ D G +
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-- 191
Query: 767 VARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
G +L E N K+D+++ + ++ +
Sbjct: 192 ---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 7e-31
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 33/220 (15%)
Query: 609 FCKKIGKG--SFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNL 663
IGKG +V + K G+ V V+ + ++CS+ F+ E+ + +H N+
Sbjct: 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 88
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYL 720
VP +++ +V +M G+ +D + + L IA K L+Y+
Sbjct: 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG----MNELAIAYILQGVLKALDYI 144
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR------GTVGY 774
H + G +HR VK+S+IL+ ++ + +S + V + +
Sbjct: 145 H---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 775 LDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
L PE Y KSD+YS G+ EL +G P
Sbjct: 202 LSPEVLQQNLQGYD-----AKSDIYSVGITACELANGHVP 236
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 56/232 (24%), Positives = 104/232 (44%), Gaps = 23/232 (9%)
Query: 590 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRT 645
+ + + E+ ++G G+ G V+ K+ G +A K++ +
Sbjct: 23 QKQKVGELKDDDFEK-----ISELGAGNGGVVF--KVSHKPSGLVMARKLIHLEIKPAIR 75
Query: 646 QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 705
Q + E+ +L + +V G + + + E+M G+L D++ + P L
Sbjct: 76 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILG 134
Query: 706 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL--TH 763
+ ++ KGL YL I+HRDVK SNIL++ K+ DFG+S Q + + +
Sbjct: 135 K--VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 190
Query: 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 815
+ GT Y+ PE + +SD++S G+ L+E+ G+ P+ D
Sbjct: 191 V-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-30
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 608 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNL 663
+ +GKGSFG V K K G+E AVK+++ + + EV LL ++ H N+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
+ L + E++ LV E G L D + ++ + R Q+ G+ Y+H
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR-QV----LSGITYMH 143
Query: 722 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 778
I+HRD+K N+LL + ++ DFGLS E + GT Y+ PE
Sbjct: 144 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPE 198
Query: 779 YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
+ EK DV+S GV+L L+SG P
Sbjct: 199 VL-HGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 668
+ +G G++G VY G+ G+ A+K+M D ++ E+ +L + HHRN+ G
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 669 ------YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 719
+ Q LV E+ G++ D + + L IA + +GL +
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT----LKEEWIAYICREILRGLSH 144
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLD 776
LH +IHRD+K N+LL N K+ DFG+S Q L +G ++
Sbjct: 145 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ----LDRTVGRRNTFIGTPYWMA 197
Query: 777 PEYYGNQQLTE-----KSDVYSFGVVLLELISGKKP 807
PE + + KSD++S G+ +E+ G P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 41/272 (15%), Positives = 88/272 (32%), Gaps = 61/272 (22%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH--- 660
+G+ + + G+ V + + + ++ V + LL I +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 661 -----RNLVPLIGYCEEEHQRI----------------LVYEYMH--NGTLRDRL-HGSV 696
R + P + + +++ +Y M T + L S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 697 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756
K L RLQ+ + L LH + G++H ++ +I+LD ++ F +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 757 AEEDLTHISSVARGTVGYLDPEY-----------YGNQQLTEKSDVYSFGVVLLELISGK 805
+ + + G+ PE +T D ++ G+V+ +
Sbjct: 256 DGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 806 KP--------VSVEDFGAELNIVHWARSMIKK 829
P S F + NI R++++
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIPQPVRALLEG 342
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 611 KKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRTQQFVTEVA-LLSRIHHRNLVP 665
++G+G++G V KM+ G+ +AVK + A S ++ + ++ + + V
Sbjct: 13 MELGRGAYGVVE--KMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT 70
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLH 721
G E + E M + +L D+ + V K P D L + IA K LE+LH
Sbjct: 71 FYGALFREGDVWICMELM-DTSL-DKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLH 126
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 777
+ +IHRDVK SN+L++ + K+ DFG+S + VA+ G Y+ P
Sbjct: 127 S--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDIDAGCKPYMAP 178
Query: 778 E----YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
E + + KSD++S G+ ++EL + P
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-30
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 609 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVP 665
KK+G G++G V + K E A+KI+ + + + + EVA+L + H N++
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
L + E++ LV E G L D + N+ + + Q+ G+ YLH
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK-QV----LSGVTYLH-- 153
Query: 724 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 780
I+HRD+K N+LL + + K+ DFGLS E + GT Y+ PE
Sbjct: 154 -KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVL 210
Query: 781 GNQQLTEKSDVYSFGVVLLELISGKKP 807
++ EK DV+S GV+L L++G P
Sbjct: 211 -RKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 60/249 (24%), Positives = 90/249 (36%), Gaps = 53/249 (21%)
Query: 609 FCKKIGKGSFGSVYYGKMKD-GKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRN 662
IG+GS+G V A+KI + ++ TEV L+ ++HH N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 663 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----------- 711
+ L E+E LV E H G L D+L+ ++ +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 712 -------------------DAAK-------GLEYLHTGCNPGIIHRDVKSSNILL--DIN 743
+ L YLH N GI HRD+K N L + +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKS 206
Query: 744 MRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE--YYGNQQLTEKSDVYSFGVVL 798
K+ DFGLS++ + GT ++ PE N+ K D +S GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 799 LELISGKKP 807
L+ G P
Sbjct: 267 HLLLMGAVP 275
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 608 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 666
F + +G G+F V+ K + GK A+K + S + R E+A+L +I H N+V L
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
E LV + + G L DR+ G +K + + Q+ ++YLH
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ-QV----LSAVKYLH--- 123
Query: 725 NPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 781
GI+HRD+K N+L + N + ++DFGLS+ + + +S+ GT GY+ PE
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGYVAPEVLA 180
Query: 782 NQQLTEKSDVYSFGVVLLELISGKKP 807
+ ++ D +S GV+ L+ G P
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-29
Identities = 59/238 (24%), Positives = 99/238 (41%), Gaps = 34/238 (14%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIHHR 661
K +G G+ G V + K+VA++I++ + TE+ +L +++H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 662 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 719
++ + + + E +V E M G L D++ + + + Q+ ++Y
Sbjct: 201 CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QMLL----AVQY 254
Query: 720 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 776
LH GIIHRD+K N+LL + + K++DFG S+ E + GT YL
Sbjct: 255 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLA 309
Query: 777 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 831
PE G D +S GV+L +SG P S L + I G
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------KDQITSGK 361
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 68/207 (32%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 666
++IG GSFG+VY+ + + VA+K M + + Q + EV L ++ H N +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTG 723
G EH LV EY G+ D L V++KPL ++IA H A +GL YLH+
Sbjct: 120 RGCYLREHTAWLVMEYC-LGSASDLLE--VHKKPLQ---EVEIAAVTHGALQGLAYLHSH 173
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 783
+IHRDVK+ NILL K+ DFG + + + GT ++ PE
Sbjct: 174 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAM 225
Query: 784 QLTE---KSDVYSFGVVLLELISGKKP 807
+ K DV+S G+ +EL K P
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-29
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 609 FCKKIGKGSFGSVYYGKMK-DGKEVAVKI-------------MADSCSHRTQQFVTEVAL 654
+K+G G++G V K K E A+K+ + ++ E++L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 655 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHD 712
L + H N++ L E++ LV E+ G L +++ ++ + + QI
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK-QI--- 155
Query: 713 AAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVAR 769
G+ YLH I+HRD+K NILL + + K+ DFGLS +D +
Sbjct: 156 -LSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL-- 209
Query: 770 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
GT Y+ PE ++ EK DV+S GV++ L+ G P
Sbjct: 210 GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 5e-29
Identities = 28/236 (11%), Positives = 66/236 (27%), Gaps = 42/236 (17%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHHRNL 663
+G+ + + G+ V + + + ++ V + LL I ++
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 664 ------------------VPLIGYCEEEHQRILVYEY--------MHNGTLRDRLHGSV- 696
+ + + + V + T + L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 697 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756
K L RLQ+ + L LH + G++H ++ +I+LD ++ F +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 757 AEEDLTHISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
+ +T D ++ G+ + + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---------ADSCSHRTQQFVTEVALLSRI-H 659
+ +G+G V K KE AVKI+ A+ + + EV +L ++
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 660 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 717
H N++ L E LV++ M G L D L ++++K + R + + +
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR-ALL----EVI 137
Query: 718 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 777
LH I+HRD+K NILLD +M K++DFG S Q + GT YL P
Sbjct: 138 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--GTPSYLAP 192
Query: 778 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
E + ++ D++S GV++ L++G P
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 611 KKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRTQQFVTEVA-LLSRIHHRNLVP 665
+IG+G++GSV KM G+ +AVK + + +Q + ++ ++ +V
Sbjct: 28 GEIGRGAYGSVN--KMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLH 721
G E + E M + + + P + L + I K L +L
Sbjct: 86 FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKALNHLK 142
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 777
N IIHRD+K SNILLD + K+ DFG+S Q + S+A+ G Y+ P
Sbjct: 143 E--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL------VDSIAKTRDAGCRPYMAP 194
Query: 778 E----YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
E Q +SDV+S G+ L EL +G+ P
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 48/210 (22%), Positives = 81/210 (38%), Gaps = 25/210 (11%)
Query: 608 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 666
IG+GS+G V K A K + +F E+ ++ + H N++ L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
E+ LV E G L +R+ + + + + + Y H
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK-DV----LSAVAYCH--- 123
Query: 725 NPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--- 778
+ HRD+K N L + K+ DFGL+ + + + V GT Y+ P+
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLE 181
Query: 779 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
YG + D +S GV++ L+ G P
Sbjct: 182 GLYG-----PECDEWSAGVMMYVLLCGYPP 206
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 36/238 (15%)
Query: 586 GHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSC 641
G+ G Y + +LE ++G G+ G V+ KM+ G +AVK M
Sbjct: 11 GYLTIGGQRYQAEINDLEN-----LGEMGSGTCGQVW--KMRFRKTGHVIAVKQMRRSGN 63
Query: 642 SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQ 698
++ + ++ +L +V G + E M + R+ G + +
Sbjct: 64 KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE 123
Query: 699 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758
+ L ++ K L YL G+IHRDVK SNILLD + K+ DFG+S +
Sbjct: 124 RILG-----KMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL- 175
Query: 759 EDLTHISSVAR----GTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
+ A+ G Y+ PE ++DV+S G+ L+EL +G+ P
Sbjct: 176 -----VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 608 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLV 664
N +GKGSFG V K + +E AVK++ + + T + EV LL ++ H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
L E+ +V E G L D + ++ + + Q+ G+ Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK-QV----FSGITYMH- 138
Query: 723 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 779
I+HRD+K NILL + + K+ DFGLS +++ + GT Y+ PE
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKP 807
EK DV+S GV+L L+SG P
Sbjct: 195 L-RGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 608 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 665
F +K+G G+FG V+ + + G E +K + D +Q E+ +L + H N++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLE 718
+ E+ H +V E G L +R+ + + L+ A+ L
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARG--KALSE----GYVAELMKQMMNALA 138
Query: 719 YLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 775
Y H + ++H+D+K NIL + K+ DFGL+ + D ++ GT Y+
Sbjct: 139 YFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYM 193
Query: 776 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
PE + + +T K D++S GVV+ L++G P
Sbjct: 194 APEVF-KRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 608 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLV 664
N +GKGSFG V K + +E AVK++ + + T + EV LL ++ H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
L E+ +V E G L D + ++ + + Q+ G+ Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK-QV----FSGITYMH- 138
Query: 723 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE- 778
I+HRD+K NILL + + K+ DFGLS +++ + GT Y+ PE
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194
Query: 779 ---YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
Y EK DV+S GV+L L+SG P
Sbjct: 195 LRGTYD-----EKCDVWSAGVILYILLSGTPP 221
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 30/217 (13%)
Query: 609 FCKKIGKGSFGSVYYGKMKD-GKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRN 662
C+ IGKG F V ++ G++ AVKI S T+ E ++ + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 663 LVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAK----- 715
+V L+ + +V+E+M L + + A+
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV----YSE----AVASHYMRQI 139
Query: 716 --GLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARG 770
L Y H + IIHRDVK +LL + + K+ FG++ Q E G
Sbjct: 140 LEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-G 195
Query: 771 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
T ++ PE + + DV+ GV+L L+SG P
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 19/228 (8%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 668
K +G+GSF K + AVKI++ TQ+ E+ L H N+V L
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHE 73
Query: 669 YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
++ LV E ++ G L +R+ ++ ++ R ++ + ++H +
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR-KL----VSAVSHMH---DV 125
Query: 727 GIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 783
G++HRD+K N+L + N+ K+ DFG +R D + + T+ Y PE
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQN 184
Query: 784 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 831
E D++S GV+L ++SG+ P D IKKGD
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 608 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNLV 664
+ +++GKG+F V K G E A KI+ S R Q + E + ++ H N+V
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
L +EE LV++ + G L + + ++ + QI + + Y H
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QI----LESIAYCH- 122
Query: 723 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 779
+ GI+HR++K N+LL K++DFGL+ + + GT GYL PE
Sbjct: 123 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEV 178
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKP 807
++ D+++ GV+L L+ G P
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIH-H 660
IG+G V + G E AVKIM + + E +L ++ H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 718
+++ LI E LV++ M G L D L ++++K + R + + +
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR-SLL----EAVS 214
Query: 719 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 778
+LH I+HRD+K NILLD NM+ ++SDFG S E GT GYL PE
Sbjct: 215 FLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC--GTPGYLAPE 269
Query: 779 ------YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
+ ++ D+++ GV+L L++G P
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 48/206 (23%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 608 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 666
+ +++G G+FG V+ K G+ K + E+++++++HH L+ L
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTG 723
E++++ +L+ E++ G L DR+ + ++ ++ + A +GL+++H
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRI---AAED--YKMSEAEVINYMRQACEGLKHMH-- 166
Query: 724 CNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 781
I+H D+K NI+ K+ DFGL+ + D I V T + PE
Sbjct: 167 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVD 223
Query: 782 NQQLTEKSDVYSFGVVLLELISGKKP 807
+ + +D+++ GV+ L+SG P
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 608 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH 660
+ +++G G F V + K G E A K + A ++ EV++L ++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 718
N++ L E +L+ E + G L D L S++++ + QI G+
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-QI----LDGVN 129
Query: 719 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 774
YLH I H D+K NI+L K+ DFGL+ + E+ GT +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEF 184
Query: 775 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
+ PE + L ++D++S GV+ L+SG P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 50/234 (21%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--------ADSCSHRTQQFVT----------- 650
+IGKGS+G V D A+K++ A +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 651 -------EVALLSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPL 701
E+A+L ++ H N+V L+ ++ ++ +V+E ++ G + + KPL
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV----PTLKPL 134
Query: 702 DWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761
D KG+EYLH IIHRD+K SN+L+ + K++DFG+S + +
Sbjct: 135 SEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 762 THISSVARGTVGYLDPE--------YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
+S+ GT ++ PE + G + DV++ GV L + G+ P
Sbjct: 192 ALLSNTV-GTPAFMAPESLSETRKIFSG-----KALDVWAMGVTLYCFVFGQCP 239
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-27
Identities = 54/265 (20%), Positives = 106/265 (40%), Gaps = 21/265 (7%)
Query: 554 RRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATN-----N 608
+K D + +++ + + P P + + +
Sbjct: 101 LIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYD 160
Query: 609 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 667
+++G G+FG V+ + G A K + + E+ +S + H LV L
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
E++++ +++YE+M G L +++ H +++ R Q+ KGL ++H
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR-QV----CKGLCHMH--- 272
Query: 725 NPGIIHRDVKSSNILLDINMRA--KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
+H D+K NI+ K+ DFGL+ + V GT + PE
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEG 330
Query: 783 QQLTEKSDVYSFGVVLLELISGKKP 807
+ + +D++S GV+ L+SG P
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 34/238 (14%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIHHR 661
K +G G+ G V + K+VA+KI++ + TE+ +L +++H
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 662 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 719
++ + + + E +V E M G L D++ + + + Q+ ++Y
Sbjct: 76 CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QML----LAVQY 129
Query: 720 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 776
LH GIIHRD+K N+LL + + K++DFG S+ E + GT YL
Sbjct: 130 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLA 184
Query: 777 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 831
PE G D +S GV+L +SG P S L + I G
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------KDQITSGK 236
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 668
+G+G+ V +E AVKI+ H + EV +L + HRN++ LI
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
+ EEE + LV+E M G++ +H N+ + + + A L++LH N
Sbjct: 79 FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-DV----ASALDFLH---NK 130
Query: 727 GIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVAR------GTVGYLDP 777
GI HRD+K NIL + K+ DF L + + G+ Y+ P
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 778 E-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
E ++ D++S GV+L L+SG P
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-27
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 17/207 (8%)
Query: 609 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVP 665
+++GKG+F V G+E A I+ + Q+ E + + H N+V
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
L EE L+++ + G L + + ++ + QI + + + H
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-QI----LEAVLHCH-- 127
Query: 724 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 780
G++HR++K N+LL K++DFGL+ + E + A GT GYL PE
Sbjct: 128 -QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVL 185
Query: 781 GNQQLTEKSDVYSFGVVLLELISGKKP 807
+ D+++ GV+L L+ G P
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 608 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHH 660
+++G G F V + K GKE A K + ++ EV +L I H
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 718
N++ L E + +L+ E + G L D L S+ + + QI G+
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-QI----LDGVH 122
Query: 719 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 774
YLH + I H D+K NI+L N R K+ DFG++ + E + GT +
Sbjct: 123 YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFGTPEF 177
Query: 775 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
+ PE + L ++D++S GV+ L+SG P
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 608 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHH 660
+ +++G G F V + K G + A K + + EV++L I H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 718
N++ L E + IL+ E + G L D L S+ ++ + QI G+
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-QI----LNGVY 128
Query: 719 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 774
YLH + I H D+K NI+L R K+ DFGL+ + + + GT +
Sbjct: 129 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEF 183
Query: 775 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
+ PE + L ++D++S GV+ L+SG P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 50/267 (18%), Positives = 90/267 (33%), Gaps = 73/267 (27%)
Query: 611 KKIGKGSFGSVYYGKMK-DG-----KEVA--------------VKIMA------------ 638
+ +G+G FG V+ K K D K + VK +A
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 639 ---------------------------DSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 671
S ++ + +N V +
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 672 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 731
+ + + L+D ++ + + + L I A+ +E+LH + G++HR
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHR 188
Query: 732 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----------GTVGYLDPEYY 780
D+K SNI ++ KV DFGL ++D + + GT Y+ PE
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
Query: 781 GNQQLTEKSDVYSFGVVLLELISGKKP 807
+ K D++S G++L EL+
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 609 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNLVP 665
+++GKG+F V K G E A KI+ S R Q + E + ++ H N+V
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
L +EE LV++ + G L + + ++ + QI + + Y H
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QI----LESIAYCH-- 145
Query: 724 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 780
+ GI+HR++K N+LL K++DFGL+ + + GT GYL PE
Sbjct: 146 -SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEVL 202
Query: 781 GNQQLTEKSDVYSFGVVLLELISGKKP 807
++ D+++ GV+L L+ G P
Sbjct: 203 KKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 608 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH 660
+ +++G G F V + K G E A K + A ++ EV++L ++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 718
N++ L E +L+ E + G L D L S++++ + QI G+
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-QI----LDGVN 129
Query: 719 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 774
YLH I H D+K NI+L K+ DFGL+ + E+ GT +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEF 184
Query: 775 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
+ PE + L ++D++S GV+ L+SG P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 43/207 (20%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 608 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV-TEVALLSRIHHRNLVP 665
+ +G+G FG V+ K K + Q V E+++L+ HRN++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFV--KVKGTDQVLVKKEISILNIARHRNILH 65
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
L E + ++++E++ + +R+ +N++ + Q+ + L++LH
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-QV----CEALQFLH- 119
Query: 723 GCNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 780
+ I H D++ NI+ + K+ +FG +RQ + + Y PE +
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVH 175
Query: 781 GNQQLTEKSDVYSFGVVLLELISGKKP 807
+ ++ +D++S G ++ L+SG P
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 45/222 (20%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA----DSCSHRTQQFVTEVALLSRIHHRNLVP 665
+G+GS+G V + AVKI+ + E+ LL R+ H+N++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 666 L--IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------G 716
L + Y EE+ + +V EY G + SV +K R + A G
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEK------RFPV-CQAHGYFCQLIDG 121
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTV 772
LEYLH + GI+H+D+K N+LL K+S G++ A +D S G+
Sbjct: 122 LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ---GSP 175
Query: 773 GYLDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
+ PE + G K D++S GV L + +G P
Sbjct: 176 AFQPPEIANGLDTFSG-----FKVDIWSAGVTLYNITTGLYP 212
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 57/257 (22%), Positives = 100/257 (38%), Gaps = 52/257 (20%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 661
+G G+FG V+ + KEV VK + + + E+A+LSR+ H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 662 NLVPLIGYCEEEHQRILVYEYMHNGT-LRDRL--HGSVNQKPLDWLTRL---QIAHDAAK 715
N++ ++ E + LV E +G L + H +++ L Q+
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP----LASYIFRQLVS---- 141
Query: 716 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 775
+ YL IIHRD+K NI++ + K+ DFG + E + GT+ Y
Sbjct: 142 AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCGTIEYC 196
Query: 776 DPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF----GAELNIVHW--- 822
PE Y G + +++S GV L L+ + P + A ++ +
Sbjct: 197 APEVLMGNPYRG-----PELEMWSLGVTLYTLVFEENP--FCELEETVEAAIHPPYLVSK 249
Query: 823 -ARSMIKKGDVISIVDP 838
S++ + P
Sbjct: 250 ELMSLVSG---LLQPVP 263
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 40/216 (18%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
+ +G+G++G V + VAVKI+ + E+ + ++H N+V G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLEYLH 721
+ E + + L EY G L DR+ + DA + G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI---EPDIGMP-------EPDAQRFFHQLMAGVVYLH 122
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTVGYLDP 777
GI HRD+K N+LLD K+SDFGL+ E L + GT+ Y+ P
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTLPYVAP 176
Query: 778 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
E ++ E DV+S G+VL +++G+ P
Sbjct: 177 ELLKRREFHA-----EPVDVWSCGIVLTAMLAGELP 207
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 36/222 (16%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQ----QFVTEVALLSRI-HHRNLV 664
K++G+G F V K G+E A K + R Q + + E+A+L ++
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFL--KKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GL 717
L E + IL+ EY G + + + ++ +D + G+
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSL----CLPELAEMVSE----NDVIRLIKQILEGV 144
Query: 718 EYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 774
YLH I+H D+K NILL K+ DFG+SR+ GT Y
Sbjct: 145 YYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEY 199
Query: 775 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 816
L PE +T +D+++ G++ L++ P F E
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTHTSP-----FVGE 236
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLI 667
K IGKG+F V + + G+EVA+KI+ + Q+ EV ++ ++H N+V L
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
E E L+ EY G + D L HG + +K R QI ++Y H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVS----AVQYCH---Q 132
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------Y 779
I+HRD+K+ N+LLD +M K++DFG S + G Y PE Y
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQGKKY 190
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKP 807
G + DV+S GV+L L+SG P
Sbjct: 191 DG-----PEVDVWSLGVILYTLVSGSLP 213
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 63/264 (23%), Positives = 114/264 (43%), Gaps = 37/264 (14%)
Query: 554 RRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKI 613
R + ++++ A + P + A+ G Y + E +
Sbjct: 51 RMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSF---YTVSKTE----------IL 97
Query: 614 GKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 672
G G FG V+ + G ++A KI+ ++ E+++++++ H NL+ L E
Sbjct: 98 GGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES 157
Query: 673 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNPGII 729
++ +LV EY+ G L DR+ +++ LT L +G+ ++H I+
Sbjct: 158 KNDIVLVMEYVDGGELFDRI---IDES--YNLTELDTILFMKQICEGIRHMH---QMYIL 209
Query: 730 HRDVKSSNILL------DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 783
H D+K NIL I K+ DFGL+R+ + V GT +L PE
Sbjct: 210 HLDLKPENILCVNRDAKQI----KIIDFGLARRYKPR--EKLKVNFGTPEFLAPEVVNYD 263
Query: 784 QLTEKSDVYSFGVVLLELISGKKP 807
++ +D++S GV+ L+SG P
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 40/216 (18%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
+ +G+G++G V + VAVKI+ + E+ + ++H N+V G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLEYLH 721
+ E + + L EY G L DR+ + DA + G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI---EPDIGMP-------EPDAQRFFHQLMAGVVYLH 122
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTVGYLDP 777
GI HRD+K N+LLD K+SDFGL+ E L + GT+ Y+ P
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTLPYVAP 176
Query: 778 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
E ++ E DV+S G+VL +++G+ P
Sbjct: 177 ELLKRREFHA-----EPVDVWSCGIVLTAMLAGELP 207
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 27/209 (12%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 668
+ +G G G V + G++ A+K++ DS R EV + ++V ++
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-----EVDHHWQASGGPHIVCILD 89
Query: 669 YCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 721
E H ++ E M G L R+ ++ T + I D +++LH
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQ----ERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 722 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 778
+ I HRDVK N+L + + K++DFG +++ ++ + + T Y+ PE
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPE 199
Query: 779 YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
G ++ + D++S GV++ L+ G P
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 608 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADS-CSHRTQQFVTEVALLSR-IHHRNLV 664
+ IG GS+ K E AVKI+ S E+ +L R H N++
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----EIEILLRYGQHPNII 79
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
L ++ +V E M G L D++ +++ + I K +EYLH
Sbjct: 80 TLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLF-TI----TKTVEYLH- 133
Query: 723 GCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 778
G++HRD+K SNIL ++ DFG ++Q + + + T ++ PE
Sbjct: 134 --AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPE 190
Query: 779 YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
Q D++S GV+L +++G P
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 41/219 (18%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-----DSCSHRTQQFVT-EVALLSRIHHR-- 661
+G G FGSVY G + D VA+K + D V EV LL ++
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 662 NLVPLIGYCEEEHQRILVYEYMHN-GTLRDRL--HGSVNQKPLDWLTRL---QIAHDAAK 715
++ L+ + E +L+ E L D + G++ ++ L R Q+
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE----LARSFFWQVLE---- 160
Query: 716 GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGY 774
+ + H N G++HRD+K NIL+D+N K+ DFG ++ + GT Y
Sbjct: 161 AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVY 214
Query: 775 LDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
PE Y+G + V+S G++L +++ G P
Sbjct: 215 SPPEWIRYHRYHG-----RSAAVWSLGILLYDMVCGDIP 248
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 38/237 (16%)
Query: 609 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 667
++G+G+ VY K K K A+K++ + + TE+ +L R+ H N++ L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAK-------GLE 718
E + LV E + G L DR+ G +++ DAA +
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSER------------DAADAVKQILEAVA 162
Query: 719 YLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 775
YLH GI+HRD+K N+L + K++DFGLS+ E + + GT GY
Sbjct: 163 YLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYC 217
Query: 776 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832
PE + D++S G++ L+ G +P E + I +
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF------RRILNCEY 268
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 666
+G G+FG V G+ G +VAVKI+ + E+ L H +++ L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
+V EY+ G L D + HG V + L + QI ++Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ-QILS----AVDYCH--- 128
Query: 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------ 778
++HRD+K N+LLD +M AK++DFGLS + + G+ Y PE
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRL 186
Query: 779 YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
Y G + D++S GV+L L+ G P
Sbjct: 187 YAG-----PEVDIWSCGVILYALLCGTLP 210
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 34/119 (28%), Positives = 58/119 (48%), Gaps = 6/119 (5%)
Query: 387 NDRGDPCVPVPWEWVTCSTTT-PPRITKIALSGKNLKGE--IPPELKNMEALTELWL-DG 442
D C W V C T T R+ + LSG NL IP L N+ L L++
Sbjct: 28 LPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI 86
Query: 443 NFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
N L GP+P +++L L +++ + ++G++P ++ + L L N+ G +PP++
Sbjct: 87 NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 28/106 (26%), Positives = 46/106 (43%), Gaps = 1/106 (0%)
Query: 411 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 470
+ + LS L+G+ + + ++ L N L L + +L + L NN + G
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYG 258
Query: 471 SLPSYMGSLPNLQELHIENNSFVGEIPPAL-LTGKVIFKYDNNPKL 515
+LP + L L L++ N+ GEIP L + Y NN L
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 1e-18
Identities = 27/91 (29%), Positives = 40/91 (43%), Gaps = 3/91 (3%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEAL-TELWLDGNFLTGPLP-DMSRLIDLRIVHLENN 466
P + I G + G IP + L T + + N LTG +P + L +L V L N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRN 207
Query: 467 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP 497
L G GS N Q++H+ NS ++
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 24/93 (25%), Positives = 41/93 (44%), Gaps = 7/93 (7%)
Query: 412 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD----MSRLIDLRIVHLENNE 467
+ S L G +PP + ++ L + DGN ++G +PD S+L + + N
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL--FTSMTISRNR 185
Query: 468 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
LTG +P +L NL + + N G+
Sbjct: 186 LTGKIPPTFANL-NLAFVDLSRNMLEGDASVLF 217
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 1e-11
Identities = 22/88 (25%), Positives = 39/88 (44%), Gaps = 3/88 (3%)
Query: 411 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELT 469
KI L+ +L ++ ++ + L L L N + G LP +++L L +++ N L
Sbjct: 223 TQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 470 GSLPSYMGSLPNLQELHIENNSFVGEIP 497
G +P G+L NN + P
Sbjct: 282 GEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 2e-06
Identities = 17/69 (24%), Positives = 27/69 (39%), Gaps = 2/69 (2%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE-NN 466
+ + L + G +P L ++ L L + N L G +P L + N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 467 ELTGS-LPS 474
L GS LP+
Sbjct: 303 CLCGSPLPA 311
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 23/214 (10%), Positives = 58/214 (27%), Gaps = 40/214 (18%)
Query: 612 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLI 667
G + ++VA+ + Q+ ++ LSRI + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
++V E++ G+L++ + ++ A + H G
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA---G 149
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 787
+ S + + I+ ++ +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA-------NP 181
Query: 788 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 821
+ D+ G L L+ + P+ + L
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE 215
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 59/258 (22%), Positives = 106/258 (41%), Gaps = 52/258 (20%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-----DSCSHRTQQFVT-EVALLSRIH---- 659
+GKG FG+V+ G + D +VA+K++ EVALL ++
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 660 HRNLVPLIGYCEEEHQRILVYEYMHNGT-LRDRL--HGSVNQKPLDWLTRL---QIAHDA 713
H ++ L+ + E + +LV E L D + G + + +R Q+
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG----PSRCFFGQVVA-- 150
Query: 714 AKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTV 772
+++ H + G++HRD+K NIL+D+ AK+ DFG ++ GT
Sbjct: 151 --AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTR 202
Query: 773 GYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED--FGAELNIVHW-- 822
Y PE Y+ + V+S G++L +++ G P + AEL+
Sbjct: 203 VYSPPEWISRHQYHA-----LPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVS 257
Query: 823 --ARSMIKKGDVISIVDP 838
++I++ P
Sbjct: 258 PDCCALIRR---CLAPKP 272
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 37/218 (16%)
Query: 608 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 663
F K +G+GSF +V + +E A+KI+ + + E ++SR+ H
Sbjct: 33 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAK------- 715
V L +++ + Y NG L L ++ ++ +
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIV 140
Query: 716 -GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----- 769
LEYLH GIIHRD+K NILL+ +M +++DFG ++ + S AR
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE----SKQARANSFV 193
Query: 770 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
GT Y+ PE + + SD+++ G ++ +L++G P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 26/209 (12%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 668
+ +G G G V K ++ A+K++ D R EV L R ++V ++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVD 122
Query: 669 YCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 721
E + +V E + G L R+ + T + I + ++YLH
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 722 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 778
+ I HRDVK N+L N K++DFG +++ + + T Y+ PE
Sbjct: 179 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPE 233
Query: 779 YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
G ++ + D++S GV++ L+ G P
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 31/211 (14%)
Query: 610 CKKIGKGSFGSVYYGKMKDGKEVAVK-IMADSC-SHRTQQFVTEVALLSRIHHRNLVPLI 667
CK IG GSFG V+ K+ + EVA+K ++ D +R E+ ++ + H N+V L
Sbjct: 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR------ELQIMRIVKHPNVVDLK 98
Query: 668 ------GYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRL---QIAHDAAKG 716
G ++E LV EY+ T+ R + + Q L +L Q+ +
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQL----LRS 153
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGYL 775
L Y+H+ GI HRD+K N+LLD K+ DFG ++ ++S + + Y
Sbjct: 154 LAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYR 208
Query: 776 DPE-YYGNQQLTEKSDVYSFGVVLLELISGK 805
PE +G T D++S G V+ EL+ G+
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-23
Identities = 61/212 (28%), Positives = 89/212 (41%), Gaps = 18/212 (8%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQ--QFVTEVALLSRIHHRNL 663
K IG+G+F V KMK +V A+KIM R + F E +L R +
Sbjct: 64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123
Query: 664 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
L + ++ + LV EY G L L + P + R +A + ++ +H
Sbjct: 124 TQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLA-EIVMAIDSVH- 179
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
G +HRD+K NILLD +++DFG + D T S VA GT YL PE
Sbjct: 180 --RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 783 QQLTEKSDVY-------SFGVVLLELISGKKP 807
+ Y + GV E+ G+ P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 17/208 (8%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIHHRNL 663
+ IGKGSFG V + D K++ A+K M C R + E+ ++ + H L
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 664 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
V L Y ++ + + +V + + G LR L N + +L I + L+YL
Sbjct: 78 VNLW-YSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFIC-ELVMALDYLQ- 132
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
N IIHRD+K NILLD + ++DF ++ + +++A GT Y+ PE + +
Sbjct: 133 --NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI-TTMA-GTKPYMAPEMFSS 188
Query: 783 QQLTEKS---DVYSFGVVLLELISGKKP 807
++ S D +S GV EL+ G++P
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-22
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVT--EVALLSRIHHRNL 663
+ +GKG FG V +++ ++ A K + R + + E +L +++ R +
Sbjct: 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV 246
Query: 664 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
V L Y E + LV M+ G L+ ++ + A GLE LH
Sbjct: 247 VSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH- 303
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
I++RD+K NILLD + ++SD GL+ E T V GTVGY+ PE N
Sbjct: 304 --RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKN 359
Query: 783 QQLTEKSDVYSFGVVLLELISGKKPVSVED 812
++ T D ++ G +L E+I+G+ P
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
K IG G+FG + + VAVK + + + + E+ + H N+V
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 670 CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
++ EY G L +R+ G ++ + + Q+ G+ Y H +
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ-QLLS----GVSYCH---SMQ 136
Query: 728 IIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------Y 779
I HRD+K N LLD + R K+ DFG S+ + S+V GT Y+ PE Y
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLRQEY 194
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKP 807
G + +DV+S GV L ++ G P
Sbjct: 195 DG-----KIADVWSCGVTLYVMLVGAYP 217
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 61/239 (25%), Positives = 106/239 (44%), Gaps = 29/239 (12%)
Query: 585 GGHFMDEGVAYFIPLPELEEATN-NFCKKIGKGSFGSVYYGKMKD-GKEVAVK-IMAD-S 640
G M A +E + G+G+FG+V GK K G VA+K ++ D
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 641 CSHRTQQFVTEVALLSRIHHRNLVPLIGY----CEEEHQRI---LVYEYMHNGTLRD--R 691
+R Q + L+ +HH N+V L Y E + + I +V EY+ TL R
Sbjct: 62 FRNRELQ---IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCR 117
Query: 692 LHGSVNQKPLDWLTRL---QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAK 747
+ P L ++ Q+ + + LH + HRD+K N+L++ + K
Sbjct: 118 NYYRRQVAPPPILIKVFLFQLI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLK 172
Query: 748 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 805
+ DFG +++ +++ + + Y PE +GNQ T D++S G + E++ G+
Sbjct: 173 LCDFGSAKKLSPSEPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 666
+ +G+GSFG V K ++VA+K ++ S + E++ L + H +++ L
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
++V EY G L D + + + + QI +EY H
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQ-QIIC----AIEYCH--- 125
Query: 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------ 778
I+HRD+K N+LLD N+ K++DFGLS + + + G+ Y PE
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVINGKL 183
Query: 779 YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
Y G + DV+S G+VL ++ G+ P
Sbjct: 184 YAG-----PEVDVWSCGIVLYVMLVGRLP 207
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 11/206 (5%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVT--EVALLSRIHHRNL 663
+ +G+G FG V+ +MK ++ A K + R E +L+++H R +
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI 247
Query: 664 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKGLEYLH 721
V L Y E + LV M+ G +R ++ P R GLE+LH
Sbjct: 248 VSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 781
II+RD+K N+LLD + ++SD GL+ + + T A GT G++ PE
Sbjct: 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLL 362
Query: 782 NQQLTEKSDVYSFGVVLLELISGKKP 807
++ D ++ GV L E+I+ + P
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 666
+G G+FG V GK G +VAVKI+ + E+ L H +++ L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
+V EY+ G L D + +G +++K L + QI G++Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ-QILS----GVDYCH--- 133
Query: 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPE----- 778
++HRD+K N+LLD +M AK++DFGLS ++ + S G+ Y PE
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGR 190
Query: 779 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 807
Y G + D++S GV+L L+ G P
Sbjct: 191 LYAG-----PEVDIWSSGVILYALLCGTLP 215
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-22
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 32/212 (15%)
Query: 610 CKKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSC-SHRTQQFVTEVALLSRIHHRNLVPL 666
K IG GSFG VY K+ D G+ VA+K ++ D +R E+ ++ ++ H N+V L
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 112
Query: 667 IGYCEEEHQRI------LVYEYMHNGTLRD--RLHGSVNQKPLDWLTRL---QIAHDAAK 715
+ ++ LV +Y+ T+ R + Q +L Q+ +
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF----R 167
Query: 716 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGY 774
L Y+H+ GI HRD+K N+LLD + K+ DFG ++Q ++S + + Y
Sbjct: 168 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYY 222
Query: 775 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 805
PE +G T DV+S G VL EL+ G+
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-21
Identities = 41/107 (38%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 395 PVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MS 453
+P + S ++ + L L+GEIP EL ++ L L LD N LTG +P +S
Sbjct: 433 TIPSSLGSLS-----KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487
Query: 454 RLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
+L + L NN LTG +P ++G L NL L + NNSF G IP L
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 7e-21
Identities = 39/150 (26%), Positives = 64/150 (42%), Gaps = 14/150 (9%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE 467
+ + L +L GEIP L N L + L N LTG +P + RL +L I+ L NN
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 468 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL-----------LTGKVIFKYDNNPKLH 516
+G++P+ +G +L L + N F G IP A+ + GK N+
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKK 585
Query: 517 K--ESRRRMRFKLILGTSIGVLAILLVLFL 544
+ + + F+ I + L+ +
Sbjct: 586 ECHGAGNLLEFQGIRSEQLNRLSTRNPCNI 615
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-20
Identities = 26/119 (21%), Positives = 50/119 (42%), Gaps = 5/119 (4%)
Query: 395 PVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSR 454
WV + +A+SG + G++ + L L + N + +P +
Sbjct: 166 ANVVGWVLSDGCG--ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGD 221
Query: 455 LIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG-KVIFKYDNN 512
L+ + + N+L+G + + L+ L+I +N FVG IPP L + + +N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENK 280
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-20
Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 1/96 (1%)
Query: 406 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLE 464
+ ++ L G+IPP L N L L L N+L+G +P + L LR + L
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450
Query: 465 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
N L G +P + + L+ L ++ N GEIP L
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL 486
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 9e-19
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 466
+T + LSG + G +PP + L L L N +G LP + ++ L+++ L N
Sbjct: 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN 353
Query: 467 ELTGSLPSYMGSL-PNLQELHIENNSFVGEIPPAL 500
E +G LP + +L +L L + +N+F G I P L
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-18
Identities = 35/96 (36%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 408 PPRITKIALSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLE 464
+ + LS N G I P L L EL+L N TG +P +S +L +HL
Sbjct: 367 SASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426
Query: 465 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
N L+G++PS +GSL L++L + N GEIP L
Sbjct: 427 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-18
Identities = 26/120 (21%), Positives = 49/120 (40%), Gaps = 11/120 (9%)
Query: 387 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLK---GEIPPELKNMEALTELWLDGN 443
+ +PC ++ VTC ++T I LS K L + L ++ L L+L +
Sbjct: 34 SSNKNPCT---FDGVTCRDD---KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNS 87
Query: 444 FLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM--GSLPNLQELHIENNSFVGEIPPALL 501
+ G + L + L N L+G + + GS L+ L++ +N+ +
Sbjct: 88 HINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGG 147
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-18
Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 4/95 (4%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 466
+ + +S G IPP +++L L L N TG +PD L + L N
Sbjct: 247 TELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304
Query: 467 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL 501
G++P + GS L+ L + +N+F GE+P L
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-17
Identities = 28/95 (29%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 409 PRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN 466
+ ++L+ GEIP L + LT L L GN G +P L + L +N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 467 ELTGSLP-SYMGSLPNLQELHIENNSFVGEIPPAL 500
+G LP + + L+ L + N F GE+P +L
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL 363
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 9e-17
Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD-MSRL-IDLRIVHLEN 465
+ +ALS N GE+P + L M L L L N +G LP+ ++ L L + L +
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 466 NELTGSLPSYMG--SLPNLQELHIENNSFVGEIPPAL 500
N +G + + LQEL+++NN F G+IPP L
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-16
Identities = 31/133 (23%), Positives = 56/133 (42%), Gaps = 26/133 (19%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 467
++ + G P N ++ L + N L+G +P + + L I++L +N+
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 468 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL---------------LTGKV----IFK 508
++GS+P +G L L L + +N G IP A+ L+G + F+
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 727
Query: 509 ------YDNNPKL 515
+ NNP L
Sbjct: 728 TFPPAKFLNNPGL 740
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-15
Identities = 20/101 (19%), Positives = 37/101 (36%), Gaps = 7/101 (6%)
Query: 409 PRITKIALSGKNLKGEIPP--ELKNMEALTELWLDGNFLTG--PLPDMSRLIDLRIVHLE 464
+T + LS +L G + L + L L + N L + +L L ++ L
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159
Query: 465 NNELTGSLPS---YMGSLPNLQELHIENNSFVGEIPPALLT 502
N ++G+ L+ L I N G++ +
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCV 200
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-14
Identities = 17/88 (19%), Positives = 33/88 (37%), Gaps = 1/88 (1%)
Query: 414 IALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSL 472
A + +G +L + + G + + + N L+G +
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 648
Query: 473 PSYMGSLPNLQELHIENNSFVGEIPPAL 500
P +GS+P L L++ +N G IP +
Sbjct: 649 PKEIGSMPYLFILNLGHNDISGSIPDEV 676
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 4e-13
Identities = 15/89 (16%), Positives = 30/89 (33%), Gaps = 3/89 (3%)
Query: 415 ALSGKNLKGEIPPELKNMEALTELWLDGNF--LTGPLP-DMSRLIDLRIVHLENNELTGS 471
++ + G+ +KN E GN G ++RL ++ + G
Sbjct: 564 KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGH 623
Query: 472 LPSYMGSLPNLQELHIENNSFVGEIPPAL 500
+ ++ L + N G IP +
Sbjct: 624 TSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIM--ADSCSHR-TQQFVTEVALLSRIHHRNL 663
K IG+G+FG V K+K+ +V A+KI+ + T F E +L + +
Sbjct: 77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136
Query: 664 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
L Y ++ + LV +Y G L L ++ P + R +A + ++ +H
Sbjct: 137 TTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLA-EMVIAIDSVH- 192
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
+HRD+K NIL+D+N +++DFG + ED T SSVA GT Y+ PE
Sbjct: 193 --QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 783 QQLTEKS-----DVYSFGVVLLELISGKKP 807
+ + D +S GV + E++ G+ P
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 667
+G G++GSV + G++VA+K ++ ++ E+ LL + H N++ L+
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 668 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRL---QIAHDAAKGLE 718
LV +M D L + K + + Q+ KGL+
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQT----D-LQKIMGLKFSEEKIQYLVYQML----KGLK 140
Query: 719 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 778
Y+H+ G++HRD+K N+ ++ + K+ DFGL+R A+ ++T V T Y PE
Sbjct: 141 YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG--YVV--TRWYRAPE 193
Query: 779 -YYGNQQLTEKSDVYSFGVVLLELISGK 805
+ D++S G ++ E+++GK
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 3e-21
Identities = 64/268 (23%), Positives = 109/268 (40%), Gaps = 37/268 (13%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 667
K IG G+ G V + VA+K ++ ++T ++ E+ L+ ++H+N++ L+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 668 ------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
EE LV E M + L V Q LD + + G+++LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDA----N-LC-QVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 781
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 182 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 236
Query: 782 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841
E D++S G ++ E++ K D+ + N +++ +
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK---------------VIE--QL 279
Query: 842 GNVKIESIWRIAEVAIQCVEQRGFSRPK 869
G E + ++ VE R
Sbjct: 280 GTPCPEFMKKLQPTVRNYVENRPKYAGL 307
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 5e-21
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIH---H 660
+ + IG+G FG VY + D ++ A+K + + + + E +LS +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 661 RNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 717
+V + Y ++ + + M+ G L L HG ++ R A + GL
Sbjct: 252 PFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYAA-EIILGL 305
Query: 718 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 777
E++H N +++RD+K +NILLD + ++SD GL+ + H +SV GT GY+ P
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-ASV--GTHGYMAP 359
Query: 778 EYYGNQQLTEKS-DVYSFGVVLLELISGKKP 807
E + S D +S G +L +L+ G P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 6e-21
Identities = 65/268 (24%), Positives = 110/268 (41%), Gaps = 37/268 (13%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 667
K IG G+ G V + VA+K ++ ++T ++ E+ L+ ++H+N++ L+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 668 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
EE Q + +V E M + L V Q LD + + G+++LH
Sbjct: 91 NVFTPQKSLEEFQDVYIVMELMDA----N-LC-QVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 781
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 145 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 199
Query: 782 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841
E D++S G ++ E+I G D + N +++ +
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK---------------VIE--QL 242
Query: 842 GNVKIESIWRIAEVAIQCVEQRGFSRPK 869
G E + ++ VE R
Sbjct: 243 GTPCPEFMKKLQPTVRTYVENRPKYAGY 270
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 7e-21
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 34/211 (16%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 667
+G G++GSV K G VAVK ++ ++ E+ LL + H N++ L+
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 668 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
EE + LV M G D L+ V + L + + +GL+Y+H
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLM--GA--D-LNNIVKCQKLTDDHVQFLIYQILRGLKYIH 149
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY- 780
+ IIHRD+K SN+ ++ + K+ DFGL+R +++T GY+ +Y
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT----------GYVATRWYR 196
Query: 781 ------GNQQLTEKSDVYSFGVVLLELISGK 805
+ D++S G ++ EL++G+
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 667
+ +G G++G+V + G +VA+K + ++ E+ LL + H N++ L+
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 668 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
++ LV +M D L + + L + + KGL Y+H
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFMGT----D-LGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 145
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-Y 780
GIIHRD+K N+ ++ + K+ DFGL+RQA+ ++T V T Y PE
Sbjct: 146 AA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG--YVV--TRWYRAPEVIL 198
Query: 781 GNQQLTEKSDVYSFGVVLLELISGK 805
+ T+ D++S G ++ E+I+GK
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHHRNL 663
K IG+G+FG V + K ++V A+K+++ + F E +++ + +
Sbjct: 72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 131
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------- 715
V L +++ +V EYM G L ++ ++ + A+
Sbjct: 132 VQLFYAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEKWARFYTAEVVL 179
Query: 716 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 775
L+ +H + G IHRDVK N+LLD + K++DFG + ++ A GT Y+
Sbjct: 180 ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 776 DPE---YYGNQQLTEKS-DVYSFGVVLLELISGKKP 807
PE G + D +S GV L E++ G P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 31/215 (14%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT-----------EVALLSRIH 659
+ I GS+G+V G +G VA+K + ++ S + E+ LL+ H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 660 HRNLVPL----IGYCEEEHQRI-LVYEYMHNGTLRDRLHG--SVNQKPLDWLTRLQ-IAH 711
H N++ L + + E ++ LV E M D L + + +Q +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT----D-LAQVIHDQRIVIS-PQHIQYFMY 141
Query: 712 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 771
GL LH G++HRD+ NILL N + DF L+R+ D V
Sbjct: 142 HILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT--H 196
Query: 772 VGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 805
Y PE + T+ D++S G V+ E+ + K
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-20
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 12/210 (5%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHR--TQQFVTEVALLSRIHHRNL 663
+ K +GKG+FG V K K A+KI+ + + +TE +L H L
Sbjct: 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 664 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
L Y + H R+ V EY + G L H S + + R A + L+YLH+
Sbjct: 211 TALK-YSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALDYLHS 266
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
+++RD+K N++LD + K++DFGL ++ +D + + GT YL PE +
Sbjct: 267 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLED 323
Query: 783 QQLTEKSDVYSFGVVLLELISGKKPVSVED 812
D + GVV+ E++ G+ P +D
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 50/206 (24%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL-- 666
+K+G+G + V+ + + ++V VKI+ + ++ E+ +L + N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLAD 98
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTG 723
I LV+E+++N + + LT I ++ K L+Y H+
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFK---------QLYQTLTDYDIRFYMYEILKALDYCHSM 149
Query: 724 CNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
GI+HRDVK N+++D R ++ D+GL+ + VA + + PE +
Sbjct: 150 ---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKGPELLVD 204
Query: 783 QQLTEKS-DVYSFGVVLLELISGKKP 807
Q+ + S D++S G +L +I K+P
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQF-----VT---EVALLSRIHHRN 662
+K+G+G++G VY K G+ VA+K + R T E++LL +HH N
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRI------RLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 663 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKG 716
+V LI E LV+E+M D L +++ Q+ +G
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK----D-LKKVLDENKTGLQDSQIKIYLYQLL----RG 131
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 773
+ + H I+HRD+K N+L++ + K++DFGL+R TH V T+
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE--VV--TLW 184
Query: 774 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 805
Y P+ G+++ + D++S G + E+I+GK
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 47/211 (22%), Positives = 80/211 (37%), Gaps = 47/211 (22%)
Query: 609 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL 666
+ +G G G V K ++ A+K++ D R EV L R ++V +
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRI 76
Query: 667 IGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEY 719
+ E + +V E + G L R+ + T + I + ++Y
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEAIQY 132
Query: 720 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 776
LH + I HRDVK N+L N K++DFG +++
Sbjct: 133 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------------------TT 171
Query: 777 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
E Y + D++S GV++ L+ G P
Sbjct: 172 GEKYD-----KSCDMWSLGVIMYILLCGYPP 197
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 612 KIGKGSFGSVYYGKMKD-GKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIHHRNL 663
K+G G++ +VY G K G VA+K + S + R E++L+ + H N+
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR------EISLMKELKHENI 65
Query: 664 VPLIGYCEEEHQRILVYEYMHN--GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
V L E++ LV+E+M N D + L+ +GL + H
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 778
I+HRD+K N+L++ + K+ DFGL+R + V T+ Y P+
Sbjct: 126 EN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE--VV--TLWYRAPD 178
Query: 779 Y-YGNQQLTEKSDVYSFGVVLLELISGK 805
G++ + D++S G +L E+I+GK
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 7e-19
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 71/270 (26%)
Query: 609 FCKKIGKGSFGSVYYG------KMKDGKEVAVKIMADSCSHR-TQQFVTEVALLSRI-HH 660
K +G+G+FG V K + VAVK++ + +H + ++E+ +L I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 661 RNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQ--------------------- 698
N+V L+G C + +++ E+ G L L N+
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 699 -----KPLDWLTRLQIAHDAA----KGLEYLHTGCNPGIIHRDVKSSNILLDI------- 742
+ LD +T Q + + K L + P +++D + L+
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 743 -----------------------NMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPE 778
K+ DFGL+R +D ++ AR + ++ PE
Sbjct: 206 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265
Query: 779 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 807
++ T +SDV+SFGV+L E+ S G P
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 661
KIG+GS+G V+ + +D G+ VA+K + R E+ +L ++ H
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR------EIRMLKQLKHP 62
Query: 662 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
NLV L+ + + LV+EY + T+ L Q+ + I + + + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 778
IHRDVK NIL+ + K+ DFG +R + VA T Y PE
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD--EVA--TRWYRSPE 172
Query: 779 Y-YGNQQLTEKSDVYSFGVVLLELISGK 805
G+ Q DV++ G V EL+SG
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 50/243 (20%), Positives = 91/243 (37%), Gaps = 62/243 (25%)
Query: 610 CKKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPL- 666
K +G GSFG V + GK A+K ++ D + E+ ++ + H N++ L
Sbjct: 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKNR---ELDIMKVLDHVNIIKLV 66
Query: 667 -IGYCEEEHQRI------------------------------------LVYEYMHNGTLR 689
Y + + ++ EY+ TL
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLH 125
Query: 690 D--RLHGSVNQKPLDWLTRL---QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 744
+ + L + Q+ + + ++H+ GI HRD+K N+L++
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHSL---GICHRDIKPQNLLVNSKD 178
Query: 745 -RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELI 802
K+ DFG +++ ++ + + Y PE G + T D++S G V ELI
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
Query: 803 SGK 805
GK
Sbjct: 237 LGK 239
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 661
+G+GS+G V + KD G+ VA+K + R E+ LL ++ H
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR------EIKLLKQLRHE 84
Query: 662 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
NLV L+ C+++ + LV+E++ + T+ D L + LD+ + G+ + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 778
+ IIHRD+K NIL+ + K+ DFG +R E VA T Y PE
Sbjct: 142 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VA--TRWYRAPE 194
Query: 779 Y-YGNQQLTEKSDVYSFGVVLLELISGK 805
G+ + + DV++ G ++ E+ G+
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 40/212 (18%)
Query: 612 KIGKGSFGSVYYGKMKDGKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHRNL 663
KIG+G++G VY + G+ A+K + S + R E+++L + H N+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR------EISILKELKHSNI 62
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKGL 717
V L + + +LV+E++ D L ++ + LQ+ G+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ----D-LKKLLDVCEGGLESVTAKSFLLQLL----NGI 113
Query: 718 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGY 774
Y H ++HRD+K N+L++ K++DFGL+R TH + T+ Y
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IV--TLWY 166
Query: 775 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 805
P+ G+++ + D++S G + E+++G
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-- 667
K +G G G V+ K VA+K + + + + E+ ++ R+ H N+V +
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 668 ------------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 715
G E + +V EYM T D L + Q PL + +
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYM--ET--D-LANVLEQGPLLEEHARLFMYQLLR 131
Query: 716 GLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISS----VARG 770
GL+Y+H+ ++HRD+K +N+ ++ ++ K+ DFGL+R + +H +
Sbjct: 132 GLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-- 186
Query: 771 TVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGK 805
T Y P + T+ D+++ G + E+++GK
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 41/215 (19%)
Query: 612 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF-----VT---EVALLSRIHHRN 662
KIG+G++G+V+ K ++ + VA+K + R + E+ LL + H+N
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLLKELKHKN 62
Query: 663 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKG 716
+V L + + LV+E+ D L + D Q+ KG
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ----D-LKKYFDSCNGDLDPEIVKSFLFQLL----KG 113
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 773
L + H+ ++HRD+K N+L++ N K+++FGL+R + V T+
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA--EVV--TLW 166
Query: 774 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKP 807
Y P+ +G + + D++S G + EL + +P
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 9e-18
Identities = 50/217 (23%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLI- 667
+G+G++G V G+ VA+K I + + E+ +L H N++ +
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 668 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLE 718
E ++ ++ E M T D LH ++ + L + Q + ++
Sbjct: 77 IQRPDSFENFNEVYIIQELM--QT--D-LHRVISTQMLSDDHIQYFIY-QTL----RAVK 126
Query: 719 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV---GYL 775
LH +IHRD+K SN+L++ N KV DFGL+R +E S ++
Sbjct: 127 VLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 776 DPEYY-------GNQQLTEKSDVYSFGVVLLELISGK 805
+Y + + + DV+S G +L EL +
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 45/227 (19%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIH-HRNLVPL 666
KK+GKG++G V+ + G+ VAVK + D+ + T Q+ E+ +L+ + H N+V L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 667 --IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEY 719
+ + + LV++YM T D LH + L+ ++ Q+ K ++Y
Sbjct: 75 LNVLRADNDRDVYLVFDYM--ET--D-LHAVIRANILEPVHKQYVVY-QLI----KVIKY 124
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 779
LH+G G++HRD+K SNILL+ KV+DFGLSR +++ +
Sbjct: 125 LHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 780 YGNQQLTE---------------------KSDVYSFGVVLLELISGK 805
LT+ D++S G +L E++ GK
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMA-DSCSH--RTQQFVTEVALLSRIHHRNLVP 665
IG+G++G V + VA+K I + ++ RT + E+ +L R H N++
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT---LREIKILLRFRHENIIG 89
Query: 666 LI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
+ E+ +V + M T D L+ + + L + +GL+Y+
Sbjct: 90 INDIIRAPTIEQMKDVYIVQDLM--ET--D-LYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS----VARGTVGYLD 776
H+ ++HRD+K SN+LL+ K+ DFGL+R A+ D H VA T Y
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRWYRA 199
Query: 777 PEYYGN-QQLTEKSDVYSFGVVLLELISGK 805
PE N + T+ D++S G +L E++S +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 27/212 (12%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 668
+KIG GSFG +Y G + G+EVA+K+ H Q E + + +P +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 72
Query: 669 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
E ++V E + G L + + K T L +A +EY+H
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLK-----TVLLLADQMISRIEYIH--- 122
Query: 725 NPGIIHRDVKSSNILLDINMRAK---VSDFGLSRQ--AEEDLTHISSVA----RGTVGYL 775
+ IHRDVK N L+ + + + DFGL+++ HI GT Y
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 776 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
+ + + + D+ S G VL+ G P
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 612 KIGKGSFGSVYYGKMKD---GKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 667
K+G+G++G VY K KD K+ A+K I S E+ALL + H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQ 84
Query: 668 GYCEEEHQRI--LVYEYMHN--GTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEYL 720
R L+++Y + + S K L R + + G+ YL
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 721 HTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 773
H ++HRD+K +NIL+ R K++D G +R + L + V T
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200
Query: 774 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 805
Y PE G + T+ D+++ G + EL++ +
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-17
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 43/225 (19%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIHHRNL 663
++ K +GKG+FG V + K A+KI+ + + + VTE +L H L
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 664 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK--- 715
L Y + H R+ V EY + G L L + A+
Sbjct: 68 TALK-YAFQTHDRLCFVMEYANGGEL---------------FFHLSRERVFTEERARFYG 111
Query: 716 -----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR- 769
LEYLH + +++RD+K N++LD + K++DFGL + E ++ + +
Sbjct: 112 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISD-GATMKT 164
Query: 770 --GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
GT YL PE + D + GVV+ E++ G+ P +D
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 2e-17
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 663
+ +G GSFG V+ + + A+K++ R +Q E +LS + H +
Sbjct: 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 68
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK---- 715
+ + G ++ Q ++ +Y+ G L + L+ + AK
Sbjct: 69 IRMWGTFQDAQQIFMIMDYIEGGEL---------------FSLLRKSQRFPNPVAKFYAA 113
Query: 716 ----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 771
LEYLH + II+RD+K NILLD N K++DFG ++ D+T+ GT
Sbjct: 114 EVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY-VPDVTY---TLCGT 166
Query: 772 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
Y+ PE + + D +SFG+++ E+++G P
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-17
Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 55/226 (24%)
Query: 612 KIGKGSFGSVYYGKMKD-GKEVAVK------------IMADSCSHRTQQFVTEVALLSRI 658
KIG+G+FG V+ + + G++VA+K I A + E+ +L +
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA----------LREIKILQLL 73
Query: 659 HHRNLVPLIGYCEEEHQRI--------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 710
H N+V LI C + LV+++ + D L G ++ + T +I
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----D-LAGLLSNVLVK-FTLSEIK 127
Query: 711 HDAA---KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-------QAEED 760
GL Y+H I+HRD+K++N+L+ + K++DFGL+R
Sbjct: 128 RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 761 LTHISSVARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 805
T+ V T+ Y PE G + D++ G ++ E+ +
Sbjct: 185 YTNR--VV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 38/216 (17%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 663
+ K +G GSFG V K K+ A+KI+ + +Q + E +L ++ L
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK---- 715
V L ++ +V EY+ G + + L+ A+
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEM---------------FSHLRRIGRFSEPHARFYAA 148
Query: 716 ----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 771
EYLH + +I+RD+K N+L+D +V+DFG +++ + T GT
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTW---TLCGT 201
Query: 772 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
L PE ++ + D ++ GV++ E+ +G P
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 39/224 (17%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV----AVKIM--ADSCSHRTQQFVTEVALLSRIHHR 661
K +G+GSFG V+ K G + A+K++ A + E +L ++H
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHP 86
Query: 662 NLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK- 715
+V L Y + ++ L+ +++ G L TRL + K
Sbjct: 87 FIVKLH-YAFQTEGKLYLILDFLRGGDL---------------FTRLSKEVMFTEEDVKF 130
Query: 716 -------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 768
L++LH + GII+RD+K NILLD K++DFGLS+++ + S
Sbjct: 131 YLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC 187
Query: 769 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
GTV Y+ PE + T+ +D +SFGV++ E+++G P +D
Sbjct: 188 -GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 4e-17
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 38/214 (17%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQF-VT---EVALLSRIHHRNLV 664
+G+G F +VY + + VA+K I S T E+ LL + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 665 PLIGYCEEEHQRILVYEYMHN---GTLRDRLHGSVNQKPLD------WLTRLQIAHDAAK 715
L+ + LV+++M ++D N L ++ L +
Sbjct: 76 GLLDAFGHKSNISLVFDFMETDLEVIIKD------NSLVLTPSHIKAYM--LMTL----Q 123
Query: 716 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTV 772
GLEYLH I+HRD+K +N+LLD N K++DFGL++ TH V T
Sbjct: 124 GLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ--VV--TR 176
Query: 773 GYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 805
Y PE +G + D+++ G +L EL+
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 7e-17
Identities = 52/243 (21%), Positives = 87/243 (35%), Gaps = 55/243 (22%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 667
IG+GS+G VY K VA+K + ++ + E+ +L+R+ ++ L
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 668 GYCEEEHQRI-----LVYEYMHNGTLRDRLHGSV--NQKPLDWLTRL-------QIAHDA 713
+ +V E + D L LT +
Sbjct: 92 DLIIPDDLLKFDELYIVLEIA--DS--D-LKKLFKTPIF----LTEEHIKTILYNLL--- 139
Query: 714 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTV 772
G ++H GIIHRD+K +N LL+ + KV DFGL+R + T+I +
Sbjct: 140 -LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 773 GYLDPEYYGNQQLTE--------------------KS-DVYSFGVVLLELISGKKPVSVE 811
+QLT KS D++S G + EL++ + +
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 812 DFG 814
Sbjct: 256 PTN 258
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 9e-17
Identities = 52/228 (22%), Positives = 97/228 (42%), Gaps = 45/228 (19%)
Query: 608 NFCKKIGKGSFGSVY---YGKMKDGKEV-AVKIMA-DSCSHRTQQFV---TEVALLSRIH 659
+ +GKG +G V+ + ++ A+K++ + E +L +
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 660 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAA 714
H +V LI Y + ++ L+ EY+ G L +L+ D A
Sbjct: 80 HPFIVDLI-YAFQTGGKLYLILEYLSGGEL---------------FMQLEREGIFMEDTA 123
Query: 715 K--------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHI 764
L +LH GII+RD+K NI+L+ K++DFGL +++ + +TH
Sbjct: 124 CFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH- 179
Query: 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
+ GT+ Y+ PE D +S G ++ ++++G P + E+
Sbjct: 180 -TFC-GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 42/219 (19%)
Query: 607 NNFCK--KIGKGSFGSVYYGK-MKDGKEVAVKIM-------ADSCSHRTQQFVTEVALLS 656
+ K K+G+G++ +VY GK VA+K + A + R EV+LL
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR------EVSLLK 55
Query: 657 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIA 710
+ H N+V L E LV+EY+ +D L ++ Q+
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYLD----KD-LKQYLDDCGNIINMHNVKLFLFQLL 110
Query: 711 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSV 767
+GL Y H ++HRD+K N+L++ K++DFGL+R + + V
Sbjct: 111 ----RGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE--V 161
Query: 768 ARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 805
T+ Y P+ G+ + + D++ G + E+ +G+
Sbjct: 162 V--TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 44/197 (22%), Positives = 80/197 (40%), Gaps = 33/197 (16%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 667
IG GS+G V + + VA+K + ++ + E+A+L+R++H ++V ++
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 668 -----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH------DAAKG 716
E+ + +V E D K L H + G
Sbjct: 119 DIVIPKDVEKFDELYVVLEIAD----SD-FK-----KLFRTPVYLTELHIKTLLYNLLVG 168
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG------ 770
++Y+H+ GI+HRD+K +N L++ + KV DFGL+R + S +
Sbjct: 169 VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 771 TVGYLDPEYYGNQQLTE 787
+ +QLT
Sbjct: 226 NLVTFPHTKNLKRQLTG 242
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 38/157 (24%), Positives = 63/157 (40%), Gaps = 23/157 (14%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 668
KKIG G+FG + GK + + VA+K+ Q E ++ + +P +
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYY 72
Query: 669 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
+ +V E + G L D + + K T L IA +EY+H
Sbjct: 73 FGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLK-----TVLMIAIQLISRMEYVH--- 122
Query: 725 NPGIIHRDVKSSNILLDINMRAKVS-----DFGLSRQ 756
+ +I+RDVK N L+ DF L+++
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-16
Identities = 61/226 (26%), Positives = 93/226 (41%), Gaps = 44/226 (19%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVTEV---ALLSRIHHRN 662
+F K IGKGSFG V + K + AVK++ + + ++ LL + H
Sbjct: 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 663 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK-- 715
LV L + + ++ V +Y++ G L LQ A+
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGEL---------------FYHLQRERCFLEPRARFY 144
Query: 716 ------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 769
L YLH + I++RD+K NILLD ++DFGL + E++ H +S
Sbjct: 145 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEH-NSTTS 197
Query: 770 ---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
GT YL PE Q D + G VL E++ G P +
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 43/214 (20%), Positives = 84/214 (39%), Gaps = 29/214 (13%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 668
++IG+GSFG ++ G + + ++VA+K Q E + +P +
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYY 73
Query: 669 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
+ +E +LV + + G L D + K T A ++ +H
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVK-----TVAMAAKQMLARVQSIH--- 123
Query: 725 NPGIIHRDVKSSNILLDINMRAK-----VSDFGLSRQAEEDLT--HISSVA----RGTVG 773
+++RD+K N L+ V DFG+ + + +T HI GT
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 774 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
Y+ + ++ + + D+ + G V + + G P
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 35/212 (16%)
Query: 612 KIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHRN 662
K+G+G++G VY + VA+K + + R EV+LL + HRN
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR------EVSLLKELQHRN 94
Query: 663 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
++ L H+ L++EY N L+ + + + G+ + H+
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 723 GCNPGIIHRDVKSSNILLDINMRA-----KVSDFGLSRQ---AEEDLTHISSVARGTVGY 774
+HRD+K N+LL ++ + K+ DFGL+R TH + T+ Y
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE--II--TLWY 203
Query: 775 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 805
PE G++ + D++S + E++
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 37/220 (16%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---------- 659
+K+G G F +V+ K M + VA+KI+ + + E+ LL R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSM 83
Query: 660 -HRNLVPLIGY-----CEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHD 712
+++ L+ + H ++V+E + L + ++ PL + QI+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHV-VMVFEVLGE-NLLALIKKYEHRGIPLI-YVK-QISKQ 139
Query: 713 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA------KVSDFGLSRQAEEDLT-HIS 765
GL+Y+H C IIH D+K N+L++I K++D G + +E T I
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 805
+ Y PE +D++S ++ ELI+G
Sbjct: 198 TRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 6e-16
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 668
+KIG GSFG +Y G ++ +EVA+K+ H Q + E + + +P +
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRW 70
Query: 669 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
+ E +LV + + G L + ++ K T L +A +E++H
Sbjct: 71 FGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLK-----TVLMLADQMINRVEFVH--- 120
Query: 725 NPGIIHRDVKSSNILLDINMRAK---VSDFGLSRQAEEDLT--HISSVA----RGTVGYL 775
+ +HRD+K N L+ + RA + DFGL+++ + T HI GT Y
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 776 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
+ + + + D+ S G VL+ + G P
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 49/232 (21%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV----AVKIMA-DSCSHRTQQFV---TEVALLSRI- 658
K +G G++G V+ + G + A+K++ + + + TE +L I
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 659 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DA 713
LV L Y + ++ L+ +Y++ G L T L
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGEL---------------FTHLSQRERFTEHE 160
Query: 714 AK--------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765
+ LE+LH GII+RD+K NILLD N ++DFGLS+ E + +
Sbjct: 161 VQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK---EFVADET 214
Query: 766 SVAR---GTVGYLDPE-YYGNQQLTEKS-DVYSFGVVLLELISGKKPVSVED 812
A GT+ Y+ P+ G +K+ D +S GV++ EL++G P +V+
Sbjct: 215 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 612 KIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQF-VT---EVALLSRIH---HRN 662
+IG G++G+VY + G VA+K + + ++ EVALL R+ H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 663 LVPLI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAA 714
+V L+ + E + LV+E++ +D L +++ P L I
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVD----QD-LRTYLDKAPPPGLPAETIKDLMRQFL 130
Query: 715 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 774
+GL++LH I+HRD+K NIL+ K++DFGL+R + V T+ Y
Sbjct: 131 RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWY 185
Query: 775 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 805
PE + T D++S G + E+ K
Sbjct: 186 RAPEVLLQSTYATP-VDMWSVGCIFAEMFRRK 216
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 659
+ + IG+GS+ V ++K + A+K + D Q TE + + +
Sbjct: 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ---TEKHVFEQASN 68
Query: 660 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGL 717
H LV L C + R+ V EY++ G L + Q+ L R A + + L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSA-EISLAL 123
Query: 718 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYL 775
YLH GII+RD+K N+LLD K++D+G+ ++ D T GT Y+
Sbjct: 124 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYI 177
Query: 776 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
PE + D ++ GV++ E+++G+ P
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 1e-15
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 659
NF +GKGSFG V + K E+ AVK ++ D T E +L+
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM---VEKRVLALPGK 400
Query: 660 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 718
L L C + R+ V EY++ G L H + + A + A GL
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLM--YHIQQVGRFKEPHAVFYAA-EIAIGLF 456
Query: 719 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 778
+L + GII+RD+K N++LD K++DFG+ ++ D + GT Y+ PE
Sbjct: 457 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPE 512
Query: 779 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
Q + D ++FGV+L E+++G+ P ED
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 659
+ + IG+GS+ V ++K + A++ + D Q TE + + +
Sbjct: 55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQ---TEKHVFEQASN 111
Query: 660 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGL 717
H LV L C + R+ V EY++ G L + Q+ L R A + + L
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSA-EISLAL 166
Query: 718 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYL 775
YLH GII+RD+K N+LLD K++D+G+ ++ D T GT Y+
Sbjct: 167 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYI 220
Query: 776 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
PE + D ++ GV++ E+++G+ P
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 659
F + +GKGSFG V ++K+ ++ AVK I+ D T TE +LS +
Sbjct: 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM---TEKRILSLARN 82
Query: 660 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 718
H L L C + R+ V E+++ G L H +++ + R A + L
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLM--FHIQKSRRFDEARARFYAA-EIISALM 138
Query: 719 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLD 776
+LH GII+RD+K N+LLD K++DFG+ ++ T ++ GT Y+
Sbjct: 139 FLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFC-GTPDYIA 192
Query: 777 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
PE D ++ GV+L E++ G P E+
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVTEV---ALLSRIHHRN 662
K +GKGSFG V+ + K + A+K + D T V L H
Sbjct: 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 663 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
L + + + + V EY++ G L + K A + GL++LH
Sbjct: 80 LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAA-EIILGLQFLH 135
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE 778
+ GI++RD+K NILLD + K++DFG+ + E++ + GT Y+ PE
Sbjct: 136 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLG-DAKTNTFCGTPDYIAPE 188
Query: 779 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
Q+ D +SFGV+L E++ G+ P +D
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 659
NF +GKGSFG V + K E+ AVK ++ D T E +L+
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM---VEKRVLALPGK 79
Query: 660 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 718
L L C + R+ V EY++ G L + V + A + A GL
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPH-AVFYAA-EIAIGLF 135
Query: 719 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYL 775
+L + GII+RD+K N++LD K++DFG+ + E++ + GT Y+
Sbjct: 136 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWD-GVTTKTFCGTPDYI 188
Query: 776 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
PE Q + D ++FGV+L E+++G+ P ED
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 40/231 (17%), Positives = 80/231 (34%), Gaps = 45/231 (19%)
Query: 611 KKIGKGSFGSVYYGK---------MKDGKEVAVKI-MADSCSHRTQQF------VTEVAL 654
+ + G +Y ++ ++K+ D Q F +V
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 655 LSRIHHRNL--VPLIGYC--EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 710
+++ L +P ++ R LV + G + L + LQ+A
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVA 165
Query: 711 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV--SDFGLSRQAEEDLTHI---- 764
LE+LH +H +V + NI +D +++V + +G + + H+
Sbjct: 166 CRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 765 --SSVARGTVGYLDPEY------YGNQQLTEKSDVYSFGVVLLELISGKKP 807
S G + E+ G + +SD+ S G +L+ + G P
Sbjct: 223 GSRSPHEGDL-----EFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLP 267
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 53/254 (20%), Positives = 92/254 (36%), Gaps = 60/254 (23%)
Query: 597 IPLPELEEATNNFC------KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFV 649
+P PE + + KKIG G FG +Y ++ A ++
Sbjct: 23 MPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVE-YQENGPLF 81
Query: 650 TEVALLSRIHHRNL--------------VPLIGYC-----EEEHQRILVYEYMHNGT-LR 689
+E+ R+ ++ +PL + R +V E + G L+
Sbjct: 82 SELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQ 139
Query: 690 D--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 747
+G+ + T LQ+ LEY+H +H D+K++N+LL +
Sbjct: 140 KISGQNGTFKKS-----TVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ 191
Query: 748 V--SDFGLSRQAEEDLTHISSVAR------GTVGYLDPEY------YGNQQLTEKSDVYS 793
V +D+GLS + + H GT+ E+ G + +SDV
Sbjct: 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTI-----EFTSLDAHKGVAL-SRRSDVEI 245
Query: 794 FGVVLLELISGKKP 807
G +L + GK P
Sbjct: 246 LGYCMLRWLCGKLP 259
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-14
Identities = 20/136 (14%), Positives = 41/136 (30%), Gaps = 12/136 (8%)
Query: 387 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 446
N + + V+ ++ R+T ++L G G +P + + L L L +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNG--RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK 118
Query: 447 GP-----LPDMSRLIDLRIVHLENNELTGSLPSYMG--SLPNLQELHIENNSFVGEIPPA 499
+S + + Y +L + I ++ I +
Sbjct: 119 VNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS 178
Query: 500 ---LLTGKVIFKYDNN 512
L I + NN
Sbjct: 179 SRITLKDTQIGQLSNN 194
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-14
Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 2/95 (2%)
Query: 411 ITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 469
I I + NLK + L+ M+ L L N L G LP I L ++L N++T
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQIT 366
Query: 470 GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGK 504
++ G ++ L +N IP
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKS 400
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-13
Identities = 16/98 (16%), Positives = 36/98 (36%), Gaps = 10/98 (10%)
Query: 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP---------LPDMSRLIDLRI 460
+T + + ++P LK + + + + N L D ++I
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 461 VHLENNEL-TGSLPSYMGSLPNLQELHIENNSFVGEIP 497
+++ N L T + + + + L L N G++P
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-11
Identities = 16/126 (12%), Positives = 38/126 (30%), Gaps = 22/126 (17%)
Query: 412 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--------------------D 451
T+I N+ + + + L + ++ +
Sbjct: 186 TQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLK 244
Query: 452 MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDN 511
L DL V + N LP+++ +LP +Q +++ N + + +
Sbjct: 245 WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS-GEQLKDDWQALADAPV 303
Query: 512 NPKLHK 517
K+
Sbjct: 304 GEKIQI 309
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-11
Identities = 15/110 (13%), Positives = 36/110 (32%), Gaps = 19/110 (17%)
Query: 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 469
+ K ++ + I + T++ N +T + RL LR ++ N+
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 470 G-------------------SLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
+ +L +L ++ + N + ++P L
Sbjct: 220 AENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-11
Identities = 18/103 (17%), Positives = 33/103 (32%), Gaps = 12/103 (11%)
Query: 409 PRITKIALSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPD----MSRLIDLRIVH 462
+T I L L + + + + L + L N + P S L I +
Sbjct: 488 YLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRN 545
Query: 463 ---LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 502
+ N P + P+L +L I +N + +
Sbjct: 546 QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITP 587
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 21/98 (21%), Positives = 32/98 (32%), Gaps = 10/98 (10%)
Query: 412 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG--------PLPDMSRLIDLRIVHL 463
+ I LS + L+ + L GN LT + L + L
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495
Query: 464 ENNELTGSLPS-YMGSLPNLQELHIENNSFVGEIPPAL 500
N+LT +LP L + + NSF + P
Sbjct: 496 RFNKLTKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQP 532
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-10
Identities = 20/116 (17%), Positives = 42/116 (36%), Gaps = 19/116 (16%)
Query: 405 TTTPPRI-------TKIALSGKNLKGEIPP--ELKNMEALTELWLDGNFLTG-------P 448
T P ++ + LK IP + K++ ++ + N + P
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
Query: 449 LP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
L + I++ ++L NN+++ + L +++ N EIP L
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML-TEIPKNSLKD 479
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-10
Identities = 11/89 (12%), Positives = 31/89 (34%), Gaps = 4/89 (4%)
Query: 416 LSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPDMSRL-IDLRIVHLENNELTGSL 472
+ + + L + ++ + + SR+ + + +N +T +
Sbjct: 140 KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FV 198
Query: 473 PSYMGSLPNLQELHIENNSFVGEIPPALL 501
+ L L++ ++ N+ FV E
Sbjct: 199 SKAVMRLTKLRQFYMGNSPFVAENICEAW 227
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-09
Identities = 11/95 (11%), Positives = 32/95 (33%), Gaps = 10/95 (10%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELT----- 469
+ N++ LT++ + LP + L +++++++ N
Sbjct: 232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQL 291
Query: 470 ---GSLPSYMGSLPNLQELHIENNSF-VGEIPPAL 500
+ +Q ++I N+ + +L
Sbjct: 292 KDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSL 326
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 20/118 (16%), Positives = 39/118 (33%), Gaps = 15/118 (12%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTEL------WLDGNFLTGPLPD-MSRLIDLRIV 461
P + I LS + P + N L GN P+ ++ L +
Sbjct: 513 PYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL 571
Query: 462 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT----GKVIFKYDNNPKL 515
+ +N++ + PN+ L I++N + + G + YD +
Sbjct: 572 QIGSNDIR-KVNE--KITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDI 626
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 43/218 (19%)
Query: 612 KIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQF-----VT---EVALL---S 656
+IG+G++G V+ K +D K VA+K + R Q ++ EVA+L
Sbjct: 18 EIGEGAYGKVF--KARDLKNGGRFVALKRV------RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 657 RIHHRNLVPLI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-- 709
H N+V L + E + LV+E++ +D L +++ P + I
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QD-LTTYLDKVPEPGVPTETIKD 124
Query: 710 -AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 768
+GL++LH+ ++HRD+K NIL+ + + K++DFGL+R + S V
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 769 RGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 805
T+ Y PE + T D++S G + E+ K
Sbjct: 182 --TLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRK 216
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 48/253 (18%), Positives = 84/253 (33%), Gaps = 57/253 (22%)
Query: 598 PLPELEEATNNFC------KKIGKGSFGSVYYGKMKDGKEVAVKI--MADSCSHRTQQFV 649
E T+ IG+G FG +Y M + V +
Sbjct: 22 QFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF 81
Query: 650 TEVALLSRIHHRNL--------------VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS 695
TE+ R VP + Y +M + DR
Sbjct: 82 TELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFM----IMDRFGSD 137
Query: 696 VNQKPLDWLTR-------LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 748
+ QK + + LQ++ LEY+H +H D+K+SN+LL+ +V
Sbjct: 138 L-QKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV 193
Query: 749 --SDFGLSRQAEEDLTHISSVAR------GTVGYLDPEY------YGNQQLTEKSDVYSF 794
D+GL+ + + H + A GT+ E+ G + + D+
Sbjct: 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTI-----EFTSIDAHNGVAP-SRRGDLEIL 247
Query: 795 GVVLLELISGKKP 807
G +++ ++G P
Sbjct: 248 GYCMIQWLTGHLP 260
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 37/213 (17%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------NL 663
K IGKGSFG V K + VA+K++ + Q E+ +L + + N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-EIRILEHLRKQDKDNTMNV 161
Query: 664 VPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAK 715
+ ++ C + +E + L + + + + L ++ AH +
Sbjct: 162 IHMLENFTFRNHIC-------MTFELLSM-NLYELIKKN-KFQGFS-LPLVRKFAHSILQ 211
Query: 716 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA--KVSDFGLSRQAEEDL-THISSVARGTV 772
L+ LH IIH D+K NILL R+ KV DFG S + + T+I S R
Sbjct: 212 CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS--R--- 263
Query: 773 GYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 805
Y PE + D++S G +L EL++G
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-12
Identities = 19/96 (19%), Positives = 36/96 (37%), Gaps = 1/96 (1%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 467
P + + LS ++ +++ L+ L L GN + S L L+ +
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 468 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
L +G L L+EL++ +N P +
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-12
Identities = 17/87 (19%), Positives = 32/87 (36%), Gaps = 2/87 (2%)
Query: 416 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 473
++G + + P+ + LT L L L P + L L+++++ +N
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 474 SYMGSLPNLQELHIENNSFVGEIPPAL 500
L +LQ L N + L
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQEL 538
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-12
Identities = 17/94 (18%), Positives = 36/94 (38%), Gaps = 2/94 (2%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 467
++ + L+G ++ + +L +L L L L+ +++ +N
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 468 LTG-SLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
+ LP Y +L NL+ L + +N L
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-12
Identities = 16/97 (16%), Positives = 31/97 (31%), Gaps = 3/97 (3%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 466
+ + LS + + +E L L + L L +L + + +
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 467 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
+ L +L+ L + NSF P + T
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 17/91 (18%), Positives = 32/91 (35%), Gaps = 2/91 (2%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 467
+T + LS L+ P ++ +L L + N L L+++ N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 468 LTGSLPSYMGSLP-NLQELHIENNSFVGEIP 497
+ S + P +L L++ N F
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 8e-11
Identities = 16/82 (19%), Positives = 25/82 (30%), Gaps = 1/82 (1%)
Query: 420 NLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP-SYMGS 478
+ KG +L L L N + + L L + +++ L S S
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 479 LPNLQELHIENNSFVGEIPPAL 500
L NL L I +
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIF 441
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-10
Identities = 17/86 (19%), Positives = 26/86 (30%), Gaps = 4/86 (4%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 474
N +IP L + L L N L +L+++ L E+
Sbjct: 14 CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 475 YMGSLPNLQELHIENNSFVGEIPPAL 500
SL +L L + N A
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAF 96
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 8e-10
Identities = 19/98 (19%), Positives = 37/98 (37%), Gaps = 6/98 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDM-SRLIDLRIVHLENN 466
+ K+ NL + +++ L EL + N + LP+ S L +L + L +N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 467 ELTGSLPSYMGSLPNLQ----ELHIENNSFVGEIPPAL 500
++ + + L + L + N P A
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-07
Identities = 12/96 (12%), Positives = 30/96 (31%), Gaps = 4/96 (4%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLI--DLRIVHLENN 466
+ + +S N K + +L L N + + L ++L N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 467 ELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPAL 500
+ + ++ + + ++L +E P
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 8e-07
Identities = 16/94 (17%), Positives = 33/94 (35%), Gaps = 5/94 (5%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALT----ELWLDGNFLTGPLPDMSRLIDLRIVHLE 464
+ + LS ++ +L+ + + L L N + P + I L + L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208
Query: 465 NNELTGSLPSY-MGSLPNLQELHIENNSFVGEIP 497
NN + ++ + L L+ + F E
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 15/114 (13%), Positives = 30/114 (26%), Gaps = 11/114 (9%)
Query: 410 RITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG----PLPDMSRLIDLRIVHLE 464
R+ K+ L + ++ + L L D S L L + +E
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 465 NNELT------GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 512
L + L N+ + + + + G + N
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNC 314
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 54/258 (20%), Positives = 91/258 (35%), Gaps = 73/258 (28%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--------HR 661
+K+G G F +V+ ++ K VA+K++ S H T+ + E+ LL +
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 662 NLVPLIGY-----CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 716
+V L+ H +V+E + + L + S N + L +I +G
Sbjct: 102 MVVQLLDDFKISGVNGTHI-CMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKKIIQQVLQG 158
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDIN--------------------------------- 743
L+YLHT C IIH D+K NILL +N
Sbjct: 159 LDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 744 ----------------MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 787
++ K++D G + + T T Y E
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNT 272
Query: 788 KSDVYSFGVVLLELISGK 805
+D++S + EL +G
Sbjct: 273 PADIWSTACMAFELATGD 290
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.4 bits (166), Expect = 2e-12
Identities = 33/193 (17%), Positives = 57/193 (29%), Gaps = 54/193 (27%)
Query: 610 CKKIGKGSFGSVYYGKMKDGKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIH-- 659
C+KIG+G FG V+ D VA+KI+A S ++ + E+ + +
Sbjct: 25 CEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLL 83
Query: 660 -------HRNLVPLIGYC------------------------------EEEHQRILVYEY 682
+ L ++ Q +V E+
Sbjct: 84 SGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEF 143
Query: 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 742
G +++ K T I H L + HRD+ N+LL
Sbjct: 144 EFGGIDLEQMR----TKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKK 197
Query: 743 NMRAKVSDFGLSR 755
K+ +
Sbjct: 198 TSLKKLHYTLNGK 210
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 27/95 (28%), Positives = 41/95 (43%), Gaps = 4/95 (4%)
Query: 407 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN 465
T P + L L + P + + L + +D L LPD M + L + L
Sbjct: 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLAR 136
Query: 466 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
N L +LP+ + SL L+EL I + E+P L
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPL 170
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 21/95 (22%), Positives = 41/95 (43%), Gaps = 12/95 (12%)
Query: 416 LSGKNLKGEIPPELKNMEA---------LTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN 465
+ E+P L + +A L L L+ + LP ++ L +L+ + + N
Sbjct: 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRN 215
Query: 466 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
+ L+ +L + LP L+EL + + + PP
Sbjct: 216 SPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIF 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 19/106 (17%), Positives = 39/106 (36%), Gaps = 3/106 (2%)
Query: 412 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS 471
+ L ++ +P + N++ L L + + L+ P + L L + L +
Sbjct: 186 QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRN 244
Query: 472 LPSYMGSLPNLQELHIENNSFVGEIPPAL--LTGKVIFKYDNNPKL 515
P G L+ L +++ S + +P + LT L
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 7e-11
Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 4/89 (4%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWL-DGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLP 473
L G PP L L L D + L LP + RL L + L LP
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 474 SYMGSLPNLQELHIENNSFVGEIPPALLT 502
S + LP + + + ++
Sbjct: 295 SLIAQLPANCIILVPPH-LQAQLDQHRPV 322
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 26/100 (26%), Positives = 40/100 (40%), Gaps = 15/100 (15%)
Query: 412 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHL-ENNELT 469
+ + L E+P ++ L L L N L LP ++ L LR + + ELT
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELT 164
Query: 470 GSLPSYMGS---------LPNLQELHIENNSFVGEIPPAL 500
LP + S L NLQ L +E +P ++
Sbjct: 165 -ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASI 202
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 4e-05
Identities = 13/69 (18%), Positives = 27/69 (39%), Gaps = 4/69 (5%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN---ELTGS 471
L + +P ++ + L +L L G LP +++L I+ + + +L
Sbjct: 260 LKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
Query: 472 LPSYMGSLP 480
P + P
Sbjct: 320 RPVARPAEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 11/107 (10%), Positives = 23/107 (21%), Gaps = 24/107 (22%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRL-------------------- 455
G L + + + +
Sbjct: 19 FQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDA 78
Query: 456 --IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
+ L + L P L +LQ + I+ + E+P +
Sbjct: 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-11
Identities = 17/98 (17%), Positives = 34/98 (34%), Gaps = 6/98 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELK---NMEALTELWLDGNFLTGPLPDM---SRLIDLRIVH 462
R+ + L+ L + +L ++ L L + L+ + +L ++
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 463 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
L N L LP L+ +E N+ +L
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-11
Identities = 18/111 (16%), Positives = 33/111 (29%), Gaps = 9/111 (8%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM---SRLIDLRIVHLEN 465
+ + LS L +E L EL L N + + L+ + L +
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 466 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 516
N++ P ++ L L + N + L N +
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL------CLELANTSIR 225
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-11
Identities = 22/93 (23%), Positives = 33/93 (35%), Gaps = 1/93 (1%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 467
P + + L L LTEL L N + + + +L + L +N
Sbjct: 73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132
Query: 468 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
L+ + L NLQEL + NN L
Sbjct: 133 LSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-11
Identities = 23/94 (24%), Positives = 41/94 (43%), Gaps = 1/94 (1%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 466
P IT + L+ L+ LT L + N ++ P++ +L L++++L++N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 467 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
EL+ NL ELH+ +NS
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 8e-11
Identities = 15/93 (16%), Positives = 31/93 (33%), Gaps = 1/93 (1%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 467
++T + + + P + + L L L N L+ + +L +HL +N
Sbjct: 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 468 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
+ + NL L + +N
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQ 141
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 18/89 (20%), Positives = 31/89 (34%), Gaps = 1/89 (1%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 474
L G LK + L L L+ N ++ L +L+I+ L N L S
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 475 YMGSLPNLQELHIENNSFVGEIPPALLTG 503
+ +L+ L+++ N
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPA 607
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 27/139 (19%), Positives = 44/139 (31%), Gaps = 4/139 (2%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG---PLPDMSRLIDLRIVHLEN 465
I +I LS + +L L L L L +L I+ L N
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 466 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRF 525
N + + L L+ L +++N+ + G I+ LH + F
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLA-RLWKHANPGGPIYFLKGLSHLHILNLESNGF 548
Query: 526 KLILGTSIGVLAILLVLFL 544
I L L ++ L
Sbjct: 549 DEIPVEVFKDLFELKIIDL 567
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-10
Identities = 16/96 (16%), Positives = 37/96 (38%), Gaps = 3/96 (3%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 466
+T++ L +++ + L L L N L+ +L +L+ + L NN
Sbjct: 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155
Query: 467 ELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPAL 500
++ + + +L++L + +N P
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-10
Identities = 19/99 (19%), Positives = 36/99 (36%), Gaps = 6/99 (6%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM----SRLIDLRIVHL 463
+ K+ LS +K P + L L+L+ L L + +R + L
Sbjct: 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSL 229
Query: 464 ENNELTGSLPSYMGSL--PNLQELHIENNSFVGEIPPAL 500
N++L+ + + L NL L + N+ +
Sbjct: 230 SNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 16/103 (15%), Positives = 33/103 (32%), Gaps = 4/103 (3%)
Query: 402 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLR 459
T + + + L+ + + L L L N + L L ++
Sbjct: 374 TFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIF 433
Query: 460 IVHLENNELTGSLPSYMGSLPNLQELHIENNSF--VGEIPPAL 500
++L N+ + +P+LQ L + + V P
Sbjct: 434 EIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-10
Identities = 22/101 (21%), Positives = 36/101 (35%), Gaps = 9/101 (8%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT---------GPLPDMSRLIDLR 459
+T + LS N+ L+ +E L L L N L GP+ + L L
Sbjct: 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539
Query: 460 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
I++LE+N L L+ + + N+
Sbjct: 540 ILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVF 580
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-10
Identities = 15/100 (15%), Positives = 32/100 (32%), Gaps = 5/100 (5%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS-----RLIDLRIVHL 463
+ + + ++ G + L L L +F + L I++L
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 464 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
N+++ L +L+ L + N E+ G
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG 428
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-09
Identities = 19/90 (21%), Positives = 35/90 (38%), Gaps = 7/90 (7%)
Query: 416 LSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP 473
S L ++P +L N +T L L N L + +R L + + N ++ P
Sbjct: 11 CSHLKLT-QVPDDLPTN---ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEP 66
Query: 474 SYMGSLPNLQELHIENNSFVGEIPPALLTG 503
LP L+ L++++N +
Sbjct: 67 ELCQKLPMLKVLNLQHNELSQ-LSDKTFAF 95
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-09
Identities = 26/146 (17%), Positives = 49/146 (33%), Gaps = 15/146 (10%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD----------MSRLIDL 458
P++ L N++ L + + L L +F + L L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 459 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKE 518
+++E+N++ G + L NL+ L + N+ F + LH
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNE-----TFVSLAHSPLHIL 386
Query: 519 SRRRMRFKLILGTSIGVLAILLVLFL 544
+ + + I + L L VL L
Sbjct: 387 NLTKNKISKIESDAFSWLGHLEVLDL 412
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 18/110 (16%), Positives = 31/110 (28%), Gaps = 5/110 (4%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENN 466
+ I L NL N +L L L N +T + +L + + N
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
Query: 467 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP---PALLTGKVIFKYDNNP 513
+ S + + E H P G + +D +
Sbjct: 620 PFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTSS 669
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 10/81 (12%), Positives = 29/81 (35%), Gaps = 4/81 (4%)
Query: 420 NLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSL 479
N I ++ + L ++ + T +D + + + + +L
Sbjct: 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNI----AVDWEDANSDYAKQYENEELSWSNL 490
Query: 480 PNLQELHIENNSFVGEIPPAL 500
+L ++ + N + ++P L
Sbjct: 491 KDLTDVELYNCPNMTQLPDFL 511
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 17/103 (16%), Positives = 31/103 (30%), Gaps = 13/103 (12%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP---------LPDM-SRLIDL 458
+T + L ++P L ++ L L + N L D +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
Query: 459 RIVHLENNELTGSLPSY-MGSLPNLQELHIENNSFVGEIPPAL 500
+I ++ N L S + + L L +N A
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAF 591
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 8e-10
Identities = 21/110 (19%), Positives = 41/110 (37%), Gaps = 12/110 (10%)
Query: 416 LSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPD----MSRLIDLRIVH---LENN 466
L L + + + + L+ + + N + P S+L I H E N
Sbjct: 735 LRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGN 792
Query: 467 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 516
+ P+ + + P+L +L I +N ++ L I +NP +
Sbjct: 793 RILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNIS 841
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 8e-10
Identities = 22/100 (22%), Positives = 35/100 (35%), Gaps = 14/100 (14%)
Query: 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLENN 466
+T I +N KN LT + L N LT L D + L L + + N
Sbjct: 708 LMTSIP---ENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYN 763
Query: 467 ELTGSLPSYMGSLPNLQELHIE------NNSFVGEIPPAL 500
+ S P+ + L+ I N + + P +
Sbjct: 764 CFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 9e-10
Identities = 13/108 (12%), Positives = 32/108 (29%), Gaps = 4/108 (3%)
Query: 387 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 446
N + + V R+T ++L+G KG +P + + L L + T
Sbjct: 303 NFNKELDMWGDQPGVDLDNNG--RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSET 360
Query: 447 GPLPDMSRL-IDLRIVHLENNELTGSLPS-YMGSLPNLQELHIENNSF 492
+ + + + ++ L + ++
Sbjct: 361 VSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAI 408
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 2e-09
Identities = 19/104 (18%), Positives = 36/104 (34%), Gaps = 10/104 (9%)
Query: 409 PRITKIALSGKNLKGEIPP--ELKNMEALTELWLDGNFLTGPLPDMS------RLIDLRI 460
++ + S LK IP K++ + + N + ++S + I+
Sbjct: 619 DQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST 677
Query: 461 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGK 504
V L NE+ + + + + NN IP L K
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLM-TSIPENSLKPK 720
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 3e-09
Identities = 20/99 (20%), Positives = 35/99 (35%), Gaps = 7/99 (7%)
Query: 409 PRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 466
P+I + NL+ E P L+ M L L N + L + L + L+ N
Sbjct: 548 PKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLDYN 605
Query: 467 ELTGSLPSYMGS-LPNLQELHIENNSFVGEIPPALLTGK 504
++ +P + ++ L +N IP
Sbjct: 606 QIE-EIPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKS 642
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 20/118 (16%), Positives = 41/118 (34%), Gaps = 15/118 (12%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTEL------WLDGNFLTGPLPD-MSRLIDLRIV 461
P ++ + +S P + N L +GN + P ++ L +
Sbjct: 753 PYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811
Query: 462 HLENNELTGSLPSYMGSLPNLQELHIENNSF----VGEIPPALLTGKVIFKYDNNPKL 515
+ +N++ + + P L L I +N V + P + G + YD +
Sbjct: 812 QIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDI 866
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 11/94 (11%), Positives = 29/94 (30%), Gaps = 8/94 (8%)
Query: 416 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG---- 470
++ L + L L + + P+M + + L++ ++
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKPIKKDSRISLKDTQIGNLTNR 436
Query: 471 --SLPSYMGSLPNLQELHIENNSFVGEIPPALLT 502
+ + L LQ ++ N+ F +
Sbjct: 437 ITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWE 470
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 24/148 (16%), Positives = 43/148 (29%), Gaps = 8/148 (5%)
Query: 413 KIALSGKNLK-----GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 467
AL GKN + N EL + G+ L + R+ L L
Sbjct: 278 WEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL---SLAGFG 334
Query: 468 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKL 527
G +P +G L L+ L +S + + ++M
Sbjct: 335 AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDY 394
Query: 528 ILGTSIGVLAILLVLFLCSLIVLRKLRR 555
++ L + + ++K R
Sbjct: 395 DQRLNLSDLLQDAINRNPEMKPIKKDSR 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 14/97 (14%), Positives = 24/97 (24%), Gaps = 3/97 (3%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG--PLPDMSRLIDLRIVHLENN 466
+ + LS + +E L L + L L L + +
Sbjct: 376 NSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 467 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
L +L L + NSF +
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 8e-10
Identities = 19/97 (19%), Positives = 38/97 (39%), Gaps = 3/97 (3%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 467
++ + L+G ++ P + +L L L +LI L+ +++ +N
Sbjct: 80 HHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNF 139
Query: 468 LTG-SLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
+ LP+Y +L NL + + N I L
Sbjct: 140 IHSCKLPAYFSNLTNLVHVDLSYNYIQT-ITVNDLQF 175
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 18/88 (20%), Positives = 30/88 (34%), Gaps = 3/88 (3%)
Query: 416 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 473
++G + K N LT L L L + L L+++++ +N L
Sbjct: 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514
Query: 474 SYMGSLPNLQELHIENNSFVGEIPPALL 501
S+ L +L L N L
Sbjct: 515 SHYNQLYSLSTLDCSFNRIET-SKGILQ 541
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 15/89 (16%), Positives = 29/89 (32%), Gaps = 5/89 (5%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 474
+ L ++P ++ + + L N L S +L+ + L E+
Sbjct: 18 CMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDK 74
Query: 475 YMGSLPNLQELHIENNSFVGEIPPALLTG 503
L +L L + N P +G
Sbjct: 75 AWHGLHHLSNLILTGNPIQS-FSPGSFSG 102
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-09
Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 1/96 (1%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 467
+ + LS ++ + L+ L L GN + P S L L + +
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 468 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
L +G L L++L++ +N PA +
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-08
Identities = 18/94 (19%), Positives = 24/94 (25%), Gaps = 1/94 (1%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 466
P I LS LK N L L L + L L + L N
Sbjct: 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90
Query: 467 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
+ P L +L+ L +
Sbjct: 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPI 124
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 16/86 (18%), Positives = 28/86 (32%), Gaps = 1/86 (1%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 466
+T + LS L+ + L L + N L ++L L + N
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531
Query: 467 ELTGSLPSYMGSLPNLQELHIENNSF 492
+ S +L ++ NNS
Sbjct: 532 RIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 18/101 (17%), Positives = 30/101 (29%), Gaps = 7/101 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPD-MSRLIDLRIVHLENN 466
+ + L + + L +L + NF+ LP S L +L V L N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163
Query: 467 ELTGSLPSYMGSLPNL----QELHIENNSFVGEIPPALLTG 503
+ + + L L + N I G
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPI-DFIQDQAFQG 203
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 16/85 (18%), Positives = 29/85 (34%), Gaps = 4/85 (4%)
Query: 422 KGEIPPELKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLENNELTGSLPSYMGS 478
KG I + + +L+ L L N L+ LR + L N + +
Sbjct: 339 KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMG 397
Query: 479 LPNLQELHIENNSFVGEIPPALLTG 503
L LQ L ++++ +
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLS 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 9e-06
Identities = 13/77 (16%), Positives = 30/77 (38%), Gaps = 4/77 (5%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 475
L+ N + + + ++ + L G + L D+ + + + + +L P+
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRCQLK-QFPT- 324
Query: 476 MGSLPNLQELHIENNSF 492
LP L+ L + N
Sbjct: 325 -LDLPFLKSLTLTMNKG 340
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 65/247 (26%), Positives = 101/247 (40%), Gaps = 25/247 (10%)
Query: 570 RTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKD 628
+S K Y+ + D+ Y + E IGKGSFG V +
Sbjct: 23 MSSHKKERKVYN----DGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVE 78
Query: 629 GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------NLVPLIGYCEEEHQRILVYEY 682
+ VA+KI+ + + Q EV LL ++ +V L + + LV+E
Sbjct: 79 QEWVAIKIIKNKKAFL-NQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM 137
Query: 683 MHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 741
+ L D L + N + + L + A L +L T IIH D+K NILL
Sbjct: 138 LSY-NLYDLLRNT-NFRGVS-LNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLC 193
Query: 742 INMRA--KVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVL 798
R+ K+ DFG S Q + + +I S R Y PE D++S G +L
Sbjct: 194 NPKRSAIKIVDFGSSCQLGQRIYQYIQS--R---FYRSPEVLLGMPYDLAIDMWSLGCIL 248
Query: 799 LELISGK 805
+E+ +G+
Sbjct: 249 VEMHTGE 255
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 22/154 (14%), Positives = 46/154 (29%), Gaps = 6/154 (3%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
+ + L + ++ ++ L L L N L P+ + + L NN+L
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKY---DNNPKLHKESRRRMRF 525
+ + NL+ + N F + + KL ++
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 526 KLILGTSIGVLAILLVLFLCSLIVLRKLRRKISN 559
+ L F LI L++ + +
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLS 319
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 9e-10
Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 7/95 (7%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
+ ++ LSG L +L L L L N L D+ L LR + L NN +
Sbjct: 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYV 92
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
L P+++ LH NN+ + + G
Sbjct: 93 Q-ELL----VGPSIETLHAANNNI-SRVSCSRGQG 121
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 20/91 (21%), Positives = 37/91 (40%), Gaps = 4/91 (4%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 467
R ++ +LK + ++ + EL L GN L+ + L +++L +N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 468 LTGSLPSYMGSLPNLQELHIENNSFVGEIPP 498
L + SL L+ L + NN E+
Sbjct: 70 LY-ETLD-LESLSTLRTLDLNNNYV-QELLV 97
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 16/76 (21%), Positives = 30/76 (39%), Gaps = 3/76 (3%)
Query: 428 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487
EL ++ L N ++ + SR + ++L NN++T G +Q L +
Sbjct: 94 ELLVGPSIETLHAANNNISR-VSC-SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 488 ENNSFVGEIPPALLTG 503
+ N + A L
Sbjct: 152 KLNEID-TVNFAELAA 166
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 11/87 (12%), Positives = 29/87 (33%), Gaps = 5/87 (5%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDM-SRLIDLRIVHLENNELTGSLP 473
L+ + + + L L N + ++ + L ++L+ N + +
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK 185
Query: 474 SYMGSLPNLQELHIENNSFVGEIPPAL 500
+ L+ L + +N + P
Sbjct: 186 GQV-VFAKLKTLDLSSNKLA-FMGPEF 210
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 10/69 (14%), Positives = 24/69 (34%), Gaps = 2/69 (2%)
Query: 431 NMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 489
N + + L L + +++ + L N L+ + + L+ L++ +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 490 NSFVGEIPP 498
N E
Sbjct: 68 NVLY-ETLD 75
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 18/94 (19%), Positives = 29/94 (30%)
Query: 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 469
+ I L L EL L L+ + L L+ + L N+
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFE 314
Query: 470 GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
+ P+L L I+ N+ E+ L
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN 348
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 19/91 (20%), Positives = 30/91 (32%), Gaps = 2/91 (2%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENN 466
+ + LS K L L L L L L++++L ++
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435
Query: 467 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP 497
L S LP LQ L+++ N F
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 19/99 (19%), Positives = 38/99 (38%), Gaps = 4/99 (4%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLE 464
P +T +++ G + E+ L+N+E L EL L + + ++ L L+ ++L
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 465 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
NE P L+ L + + +
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 16/97 (16%), Positives = 23/97 (23%), Gaps = 2/97 (2%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 466
P + S L + LT L L + D L + L N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 467 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
L + + L+ L I L
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISS-IDFIPLHN 127
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 8e-09
Identities = 15/84 (17%), Positives = 35/84 (41%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
R+ + LS +L +++ + + L N LT + + ++L +N +
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHI 535
Query: 469 TGSLPSYMGSLPNLQELHIENNSF 492
+ LPS + L + +++ N
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 8e-09
Identities = 14/96 (14%), Positives = 32/96 (33%), Gaps = 2/96 (2%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 467
R+ + L+ L L +AL L+ ++ L ++L +N
Sbjct: 81 HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140
Query: 468 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
++ L+ L +NN+ + ++
Sbjct: 141 ISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSS 175
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 13/93 (13%), Positives = 29/93 (31%), Gaps = 1/93 (1%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 467
+T + L+ + ++ L L L N L S L+ +
Sbjct: 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTG 116
Query: 468 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
++ + + L+ L++ +N P
Sbjct: 117 ISSIDFIPLHNQKTLESLYLGSNHISSIKLPKG 149
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-08
Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 5/89 (5%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 474
L EIP L + L N L SRLI+L + L ++
Sbjct: 19 CENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75
Query: 475 YMGSLPNLQELHIENNSFVGEIPPALLTG 503
S L L + N + + L+G
Sbjct: 76 TFQSQHRLDTLVLTANPLIF-MAETALSG 103
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 17/99 (17%), Positives = 31/99 (31%), Gaps = 4/99 (4%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 466
P + + + L N + L L+L N ++ L+++ +NN
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163
Query: 467 ELTGSLPSYMGSLPNLQ--ELHIENNSFVGEIPPALLTG 503
+ M SL L++ N I P
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDS 201
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 18/97 (18%), Positives = 30/97 (30%), Gaps = 4/97 (4%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHL 463
+ + LS L + AL L L GN + + L I+ L
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483
Query: 464 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
+L+ SL + + + +N AL
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 5e-07
Identities = 20/99 (20%), Positives = 39/99 (39%), Gaps = 5/99 (5%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 466
+ K+ LS + N +LT L + GN L + L +LR + L ++
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360
Query: 467 ELTGSLPSYM--GSLPNLQELHIENNSFVGEIPPALLTG 503
++ S + +L +LQ L++ N + +
Sbjct: 361 DIETSDCCNLQLRNLSHLQSLNLSYNEPLS-LKTEAFKE 398
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 9e-06
Identities = 15/97 (15%), Positives = 30/97 (30%), Gaps = 6/97 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPDM---SRLIDLRIVHL 463
+ G I LKN +++L + P + + + ++L
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINL 261
Query: 464 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
+ + + LQEL + E+P L
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGL 297
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 13/99 (13%), Positives = 32/99 (32%), Gaps = 7/99 (7%)
Query: 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM---SRLIDLRIVHLENN 466
+ L+G ++ I P + L G + S + L + E+
Sbjct: 180 TNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 467 ELTGSLPSYMGSLP--NLQELHIENNSFVGEIPPALLTG 503
+ P+ L +++ ++++ + F I
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFN-ISSNTFHC 276
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 17/99 (17%), Positives = 35/99 (35%), Gaps = 7/99 (7%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS---RLIDLRIVHLEN 465
+ + LS + + +E L L + L + + S L +L + + +
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISH 135
Query: 466 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
+ + L +L+ L + NSF P + T
Sbjct: 136 THTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 18/95 (18%), Positives = 37/95 (38%), Gaps = 7/95 (7%)
Query: 408 PPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTG---PLPDMSRLIDLRIVHL 463
P T++ L L+ +P + LT+L L N L+ L+ + L
Sbjct: 27 PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85
Query: 464 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 498
N + ++ S L L+ L ++++ ++
Sbjct: 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSE 118
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 13/100 (13%), Positives = 31/100 (31%), Gaps = 8/100 (8%)
Query: 409 PRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLE 464
++ + NLK ++ ++ L L + + + L L ++ +
Sbjct: 101 EQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMA 158
Query: 465 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
N + + L NL L + ++ P
Sbjct: 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNS 197
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 14/80 (17%), Positives = 25/80 (31%), Gaps = 4/80 (5%)
Query: 426 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM--GSLPNLQ 483
+L L L N + + L L + +++ L + + SL NL
Sbjct: 71 SQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLI 129
Query: 484 ELHIENNSFVGEIPPALLTG 503
L I + + G
Sbjct: 130 YLDISHTHTR-VAFNGIFNG 148
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 18/88 (20%), Positives = 35/88 (39%), Gaps = 6/88 (6%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 465
+T + LS L+ ++ P ++ +L L + N L L L+++
Sbjct: 175 RNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSL 232
Query: 466 NELTGSLPSYMGSLP-NLQELHIENNSF 492
N + S + P +L L++ N F
Sbjct: 233 NHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 9e-10
Identities = 20/91 (21%), Positives = 36/91 (39%), Gaps = 11/91 (12%)
Query: 410 RITKI-ALSG-KNLKG--------EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 459
+IT + L+ L +K++ L L + N ++ + ++ L L
Sbjct: 232 KITDLSPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLN 290
Query: 460 IVHLENNELTGSLPSYMGSLPNLQELHIENN 490
+ L NN+L +G L NL L + N
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 8e-09
Identities = 16/83 (19%), Positives = 31/83 (37%), Gaps = 5/83 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 467
++ + + + L N+ L L+L+ N L ++ L +L + L N
Sbjct: 265 TKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
Query: 468 LTGSLPSYMGSLPNLQELHIENN 490
+T P + SL + N
Sbjct: 323 ITDIRP--LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 9e-09
Identities = 18/92 (19%), Positives = 42/92 (45%), Gaps = 5/92 (5%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
R+ + + + + P L N+ LT L + N ++ + + L L+++++ +N++
Sbjct: 221 TRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQI 277
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
+ S + +L L L + NN E +
Sbjct: 278 SD--ISVLNNLSQLNSLFLNNNQLGNEDMEVI 307
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 2e-08
Identities = 17/92 (18%), Positives = 38/92 (41%), Gaps = 15/92 (16%)
Query: 410 RITKI-ALSG-KNLK---------GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDL 458
++ + ++ +L +I P L ++ +L N +T + ++ + L
Sbjct: 166 KVKDVTPIANLTDLYSLSLNYNQIEDISP-LASLTSLHYFTAYVNQITD-ITPVANMTRL 223
Query: 459 RIVHLENNELTGSLPSYMGSLPNLQELHIENN 490
+ + NN++T P + +L L L I N
Sbjct: 224 NSLKIGNNKITDLSP--LANLSQLTWLEIGTN 253
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 23/90 (25%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
ITK+ ++G+ + ++ + L L L+GN +T + +S L+ L +++ N++
Sbjct: 44 ESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKI 100
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPP 498
T S + +L NL+EL++ ++ I P
Sbjct: 101 TD--ISALQNLTNLRELYLNEDNISD-ISP 127
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 7e-08
Identities = 14/82 (17%), Positives = 37/82 (45%), Gaps = 4/82 (4%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
++T + + + L+N+ L EL+L+ + ++ + ++ L + ++L N
Sbjct: 88 VKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHN 144
Query: 469 TGSLPSYMGSLPNLQELHIENN 490
S S + ++ L L + +
Sbjct: 145 L-SDLSPLSNMTGLNYLTVTES 165
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 21/94 (22%), Positives = 39/94 (41%), Gaps = 4/94 (4%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
+ ++ L+ N+ I P L N+ + L L N L +S + L + + +++
Sbjct: 110 TNLRELYLNEDNISD-ISP-LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKV 167
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 502
P + +L +L L + N P A LT
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIEDISPLASLT 199
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 2e-07
Identities = 18/76 (23%), Positives = 31/76 (40%), Gaps = 3/76 (3%)
Query: 427 PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486
+ N+ L L L+ N + + ++ L L N++T P + ++ L L
Sbjct: 171 TPIANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLK 227
Query: 487 IENNSFVGEIPPALLT 502
I NN P A L+
Sbjct: 228 IGNNKITDLSPLANLS 243
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 3e-06
Identities = 13/80 (16%), Positives = 29/80 (36%), Gaps = 4/80 (5%)
Query: 423 GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 482
+I P ++ L +T + L + + + ++ S+ + L NL
Sbjct: 13 NQIFP-DADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGEKVA-SIQG-IEYLTNL 68
Query: 483 QELHIENNSFVGEIPPALLT 502
+ L++ N P + L
Sbjct: 69 EYLNLNGNQITDISPLSNLV 88
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 11/61 (18%), Positives = 24/61 (39%), Gaps = 1/61 (1%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
++ + L+ L E + + LT L+L N +T + ++ L + N +
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLASLSKMDSADFANQVI 345
Query: 469 T 469
Sbjct: 346 K 346
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 18/105 (17%), Positives = 36/105 (34%), Gaps = 5/105 (4%)
Query: 402 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS---RLIDL 458
+ S + + LS + + +E L L + L + + S L +L
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNL 423
Query: 459 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
+ + + + L +L+ L + NSF P + T
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 5e-08
Identities = 19/99 (19%), Positives = 41/99 (41%), Gaps = 7/99 (7%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 465
++ + L+G ++ + + +L +L L L + + L L+ +++ +
Sbjct: 76 SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAH 133
Query: 466 NELT-GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
N + LP Y +L NL+ L + +N I L
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 6e-08
Identities = 18/87 (20%), Positives = 41/87 (47%), Gaps = 4/87 (4%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 466
+ + ++G + + P+ + LT L L L P + L L+++++ +N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504
Query: 467 ELTGSLPSYM-GSLPNLQELHIENNSF 492
+L S+P + L +LQ++ + N +
Sbjct: 505 QLK-SVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 17/89 (19%), Positives = 28/89 (31%), Gaps = 5/89 (5%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 474
N +IP L + L L N L +L+++ L E+
Sbjct: 14 CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 475 YMGSLPNLQELHIENNSFVGEIPPALLTG 503
SL +L L + N + +G
Sbjct: 71 AYQSLSHLSTLILTGNPIQ-SLALGAFSG 98
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 8e-07
Identities = 16/99 (16%), Positives = 30/99 (30%), Gaps = 6/99 (6%)
Query: 408 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLE 464
P + LS L+ + + L L L + + D + L L + L
Sbjct: 27 PFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILT 84
Query: 465 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
N + L +LQ+L + + +
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGH 122
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 19/101 (18%), Positives = 37/101 (36%), Gaps = 7/101 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-GPLPD-MSRLIDLRIVHLENN 466
+ K+ NL + +++ L EL + N + LP+ S L +L + L +N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 467 ELTGSLPSYMGSLPNLQ----ELHIENNSFVGEIPPALLTG 503
++ + + L + L + N I P
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKE 199
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 5e-06
Identities = 20/97 (20%), Positives = 37/97 (38%), Gaps = 3/97 (3%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 466
P + + LS ++ I +++ L+ L L GN + S L L+ +
Sbjct: 52 PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 467 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
L +G L L+EL++ +N P +
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 16/95 (16%), Positives = 37/95 (38%), Gaps = 7/95 (7%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLE 464
+ ++ + N G E+ ++ +L L L N L+ S L+ + L
Sbjct: 324 LKSLKRLTFTS-NKGGNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 465 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPA 499
N + ++ S L L+ L ++++ ++
Sbjct: 382 FNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEF 414
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-05
Identities = 21/99 (21%), Positives = 33/99 (33%), Gaps = 6/99 (6%)
Query: 409 PRITKIALSGKNL--KGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 466
P + + LS L KG +L L L N + + L L + +++
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
Query: 467 ELTGSLP--SYMGSLPNLQELHIENNSFVGEIPPALLTG 503
L + S SL NL L I + + G
Sbjct: 407 NLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNG 443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 467
PP + + +S L+ ++P EL+N L + +D N L LPD+ L + NN+
Sbjct: 130 PPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNNQ 184
Query: 468 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
L LP + +LP L ++ +NNS ++P
Sbjct: 185 LE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLP 214
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 29/99 (29%), Positives = 40/99 (40%), Gaps = 10/99 (10%)
Query: 405 TTTPPRI---TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIV 461
P I L E PEL+N+ LT ++ D N L LPD+ L +
Sbjct: 208 KKLPDLPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLKT-LPDL--PPSLEAL 262
Query: 462 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
++ +N LT LP SL L + E+PP L
Sbjct: 263 NVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-ELPPNL 299
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 22/96 (22%), Positives = 36/96 (37%), Gaps = 12/96 (12%)
Query: 405 TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE 464
+ PP + + S ++ + + L EL + N L LP + L +
Sbjct: 293 SELPPNLYYLNASSNEIR-SLCDLPPS---LEELNVSNNKLIE-LPAL--PPRLERLIAS 345
Query: 465 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
N L +P NL++LH+E N E P
Sbjct: 346 FNHLA-EVPE---LPQNLKQLHVEYNPLR-EFPDIP 376
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 26/110 (23%), Positives = 42/110 (38%), Gaps = 25/110 (22%)
Query: 407 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 466
PP + ++ +S L E+P L L N L +P++ +L+ +H+E N
Sbjct: 315 LPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPEL--PQNLKQLHVEYN 367
Query: 467 ELTGSLPSYMGSL----------------PNLQELHIENNSFVGEIPPAL 500
L P S+ NL++LH+E N E P
Sbjct: 368 PLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIP 415
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 26/99 (26%), Positives = 39/99 (39%), Gaps = 20/99 (20%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP---------DMSRLID-----LRIV 461
NL E+P E +N+++ TE + + P +SRL D +
Sbjct: 18 RHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHEL 76
Query: 462 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
L N L+ SLP P+L+ L NS E+P
Sbjct: 77 ELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELP 110
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 21/105 (20%), Positives = 33/105 (31%), Gaps = 18/105 (17%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEA-------------LTELWLDGNFLTGPLPDMSRL 455
T+ + + PP EL L+ L+ LP+
Sbjct: 34 KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPE--LP 90
Query: 456 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
L + N LT LP SL +L + + ++PP L
Sbjct: 91 PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL-SDLPPLL 133
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 16/88 (18%), Positives = 32/88 (36%), Gaps = 9/88 (10%)
Query: 405 TTTPPRITKI-ALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVH 462
P + L + E+P +N L +L ++ N L PD + DLR
Sbjct: 370 REFPDIPESVEDLRMNSHLAEVPELPQN---LKQLHVETNPLRE-FPDIPESVEDLR--- 422
Query: 463 LENNELTGSLPSYMGSLPNLQELHIENN 490
+ + + + L++ E++
Sbjct: 423 MNSERVVDPYEFAHETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 6e-05
Identities = 26/129 (20%), Positives = 49/129 (37%), Gaps = 28/129 (21%)
Query: 407 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRI----- 460
PPR+ ++ S +L E+P +N L +L ++ N L PD + DLR+
Sbjct: 335 LPPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLRE-FPDIPESVEDLRMNSHLA 389
Query: 461 -----------VHLENNELTGSLPSYMGSLPNLQELHIENNSFVG--EIPPALLTGKVIF 507
+H+E N L P ++++L + + V E
Sbjct: 390 EVPELPQNLKQLHVETNPLR-EFPD---IPESVEDLRMNSERVVDPYEFAHETTDKLEDD 445
Query: 508 KYDNNPKLH 516
++++ H
Sbjct: 446 VFEHHHHHH 454
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 15/104 (14%), Positives = 42/104 (40%), Gaps = 6/104 (5%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
+T + L N+ P + ++ L L+ N ++ + ++ L ++ + +N++
Sbjct: 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQI 365
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 512
+ P + +L + +L + + ++ P I N
Sbjct: 366 SDLTP--LANLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKN 406
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-09
Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 5/89 (5%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
+ +++L+G LK L ++ LT+L L N ++ L +S L L + L N++
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQI 277
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIP 497
+ P + L L L + N P
Sbjct: 278 SNISP--LAGLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 24/94 (25%), Positives = 41/94 (43%), Gaps = 5/94 (5%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
+T + L+ + P L + LTEL L N ++ + ++ L L + L N+L
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQL 299
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 502
S + +L NL L + N+ P + LT
Sbjct: 300 ED--ISPISNLKNLTYLTLYFNNISDISPVSSLT 331
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 24/82 (29%), Positives = 38/82 (46%), Gaps = 5/82 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
++T++ L + P L + ALT L L+ N L + +S L +L + L N +
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNI 321
Query: 469 TGSLPSYMGSLPNLQELHIENN 490
+ P + SL LQ L NN
Sbjct: 322 SDISP--VSSLTKLQRLFFYNN 341
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-08
Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 5/94 (5%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
+ ++ +S + L + L L N ++ + + L +L + L N+L
Sbjct: 177 TTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSLNGNQL 233
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 502
+ SL NL +L + NN P + LT
Sbjct: 234 KD--IGTLASLTNLTDLDLANNQISNLAPLSGLT 265
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 5e-08
Identities = 20/94 (21%), Positives = 39/94 (41%), Gaps = 5/94 (5%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
++T + +K ++ + LT++ N LT + + L L + + NN++
Sbjct: 46 DQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQI 102
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 502
+ + +L NL L + NN P LT
Sbjct: 103 AD--ITPLANLTNLTGLTLFNNQITDIDPLKNLT 134
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-07
Identities = 21/89 (23%), Positives = 37/89 (41%), Gaps = 5/89 (5%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
+ + + + P L + L EL L+GN L + ++ L +L + L NN++
Sbjct: 199 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQI 255
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIP 497
+ P + L L EL + N P
Sbjct: 256 SNLAP--LSGLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 21/92 (22%), Positives = 39/92 (42%), Gaps = 5/92 (5%)
Query: 411 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 470
K L N+ + +++ +T L D + + + L +L ++ NN+LT
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTD 82
Query: 471 SLPSYMGSLPNLQELHIENNSFVGEIPPALLT 502
P + +L L ++ + NN P A LT
Sbjct: 83 ITP--LKNLTKLVDILMNNNQIADITPLANLT 112
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-07
Identities = 23/81 (28%), Positives = 43/81 (53%), Gaps = 5/81 (6%)
Query: 411 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 470
+T+I S L I P LKN+ L ++ ++ N + + ++ L +L + L NN++T
Sbjct: 70 LTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITD 126
Query: 471 SLPSYMGSLPNLQELHIENNS 491
P + +L NL L + +N+
Sbjct: 127 IDP--LKNLTNLNRLELSSNT 145
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 19/94 (20%), Positives = 37/94 (39%), Gaps = 6/94 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
+ ++ LS + L + +L +L L ++ L L + + +N++
Sbjct: 134 TNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD--LKPLANLTTLERLDISSNKV 189
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 502
+ S + L NL+ L NN P +LT
Sbjct: 190 SD--ISVLAKLTNLESLIATNNQISDITPLGILT 221
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 14/107 (13%), Positives = 31/107 (28%), Gaps = 10/107 (9%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
I ++ + P L N+ +T+L L+ T + + +
Sbjct: 353 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGA 410
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 515
P+ + + E I N T +V + + +
Sbjct: 411 L-IAPATISDGGSYTEPDITWNL-------PSYTNEVSYTFSQPVTI 449
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.6 bits (146), Expect = 2e-09
Identities = 113/701 (16%), Positives = 196/701 (27%), Gaps = 202/701 (28%)
Query: 75 DLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASR 134
D +Y Y I F+ F D V D +
Sbjct: 8 DFETGEHQYQYKDILS---------VFE----------DAFVDNFDCK-----DVQDMPK 43
Query: 135 -VYAKE---MIIRAPSDSIDVCICCAVTGSPFI-STLELRPLNLSMYATDFEDNFFLKVA 189
+ +KE II + V+G+ + TL + M F++
Sbjct: 44 SILSKEEIDHIIMSKDA---------VSGTLRLFWTLLSKQEE--MVQK------FVEEV 86
Query: 190 ARVNFGALTKDALRY----PDDPYDRIWDSDLDRRPNFVVGAASGTV-RINTTKNIETRT 244
R+N+ L ++ P + DR N A V R+ +
Sbjct: 87 LRINYKFLM-SPIKTEQRQPSMMTRM-YIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL 144
Query: 245 REYPPVKVMQTAVVGTEG----VL------SYRLNLEDFPANARAFAYF--------AEI 286
E P K + + G G + SY++ F F +
Sbjct: 145 LELRPAKNV--LIDGVLGSGKTWVALDVCLSYKV-QCKMD-----FKIFWLNLKNCNSPE 196
Query: 287 QDLGPSETRKFKLEQPYFADYSNAVVNIAENANG-----SYTLYEPSYMNVTLNFVL--- 338
L + ++++ + S+ NI + L Y N L VL
Sbjct: 197 TVLEMLQKLLYQIDPNW-TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL--VLLNV 253
Query: 339 -------SFSF-----VKTRDSTLGPLLNAIEISKY-QKIAAKTEWQDEALRSISDESER 385
+F+ + TR + L+A + + T DE +
Sbjct: 254 QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL----- 308
Query: 386 TNDRGDPCVPVPWEWVTCSTTT-PPRITKI---ALSGKNLKGEIPPELKNMEALTELWLD 441
+++ C P + LS I +++ A + W
Sbjct: 309 -------------KYLDCRPQDLPREVLTTNPRRLSI------IAESIRDGLATWDNWKH 349
Query: 442 GNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI-ENNSFVGEIPPAL 500
N ++ +I+ + LE E L + ++ IP L
Sbjct: 350 VNC-----DKLTTIIESSLNVLEPAEYR----------KMFDRLSVFPPSA---HIPTIL 391
Query: 501 LTGKVIFKYDNNP--------KLHKES---RRRMRFKLILGTSIGVLAILLVLFLCSLIV 549
L + +D KLHK S ++ +I + +I L L L
Sbjct: 392 L---SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKES------TISIPSIYLEL-KVKLEN 441
Query: 550 LRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNF 609
L R I + + K P Y + GH + E E F
Sbjct: 442 EYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNI--------EHPERMTLF 493
Query: 610 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
V+ D + + KI DS + + L ++ + P I
Sbjct: 494 RM---------VFL----DFRFLEQKIRHDSTAWNASGSILN--TLQQL--KFYKPYICD 536
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 710
+ +++R LV + L + K D L+IA
Sbjct: 537 NDPKYER-LVNAILDF--LPKIEENLICSKYTDL---LRIA 571
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 5e-06
Identities = 50/319 (15%), Positives = 88/319 (27%), Gaps = 101/319 (31%)
Query: 636 IMADSCSHRTQQFVTEVA------LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 689
+ Q+FV EV L+S I P + Y R
Sbjct: 70 TLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM--------YIEQ-----R 116
Query: 690 DRLHGSVNQKPLDWLTRLQIAHDAAKGLE--------YLH--TGCNPGIIHRDVKSS--- 736
DRL+ ++RLQ + L + G G K+
Sbjct: 117 DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS--G------KTWVAL 168
Query: 737 NILLDINMRAKVSD------FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 790
++ L ++ K+ E L + + +DP + T +SD
Sbjct: 169 DVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY----QIDPNW------TSRSD 218
Query: 791 VYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS--IVDPVLIGNVKIES 848
S + + AEL R + K ++ NV+
Sbjct: 219 -----------HSSNIKLRIHSIQAELR-----RLLKSKPYENCLLVLL-----NVQNAK 257
Query: 849 IWRIAEVAIQCVEQRGFSRPKMQEIVL----AIQDSIKIEKGGD---QKFSSSSSKGQSS 901
W + C K+ ++ + D + S + + +
Sbjct: 258 AWN--AFNLSC---------KI--LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV- 303
Query: 902 RKTLLTSFLEIESPDLSNE 920
K+LL +L+ DL E
Sbjct: 304 -KSLLLKYLDCRPQDLPRE 321
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 25/98 (25%), Positives = 41/98 (41%), Gaps = 7/98 (7%)
Query: 408 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLEN 465
PP + L + EI KN++ L L L N ++ P + L+ L ++L
Sbjct: 51 PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109
Query: 466 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
N+L LP LQEL + N ++ ++ G
Sbjct: 110 NQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNG 143
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 23/112 (20%), Positives = 46/112 (41%), Gaps = 9/112 (8%)
Query: 407 TPPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHL 463
PP +T++ L G + ++ LK + L +L L N ++ + + ++ LR +HL
Sbjct: 190 LPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHL 247
Query: 464 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 515
NN+L +P + +Q +++ NN+ I
Sbjct: 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYN--TKKASY 295
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 17/101 (16%), Positives = 41/101 (40%), Gaps = 9/101 (8%)
Query: 407 TPPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLT-GPLPDM--SRLIDLRIVH 462
P + ++ + + ++ + + + L N L + + + L +
Sbjct: 119 MPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 177
Query: 463 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
+ + +T ++P G P+L ELH++ N ++ A L G
Sbjct: 178 IADTNIT-TIPQ--GLPPSLTELHLDGNKI-TKVDAASLKG 214
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 12/91 (13%), Positives = 33/91 (36%), Gaps = 10/91 (10%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-------GPLPDMSRLIDLRIV 461
P + ++ L+ L ++P L + + + ++L N ++ P ++ V
Sbjct: 240 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGV 298
Query: 462 HLENNELT-GSLPSYM-GSLPNLQELHIENN 490
L +N + + + + + N
Sbjct: 299 SLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 21/103 (20%), Positives = 40/103 (38%), Gaps = 9/103 (8%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 467
+ K+ LS ++ + L N L EL L+ N L ++ +++V+L NN
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 274
Query: 468 LTG------SLPSYMGSLPNLQELHIENNSF-VGEIPPALLTG 503
++ P Y + + + +N EI P+
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 22/98 (22%), Positives = 42/98 (42%), Gaps = 7/98 (7%)
Query: 408 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLEN 465
P T + L ++ E+ + K ++ L L L N ++ S L L+ +++
Sbjct: 53 SPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111
Query: 466 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
N L +P +L EL I +N ++P + +G
Sbjct: 112 NHLV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSG 145
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 14/91 (15%), Positives = 32/91 (35%), Gaps = 10/91 (10%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-------GPLPDMSRLIDLRIV 461
P + ++ L L +P L +++ L ++L N +T P+ + +
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGI 299
Query: 462 HLENNELT-GSLPSYM-GSLPNLQELHIENN 490
L NN + + + + + N
Sbjct: 300 SLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 28/87 (32%), Positives = 42/87 (48%), Gaps = 7/87 (8%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 474
+S L IP +L E L EL LD N + L D+ R L + L +N++ + +
Sbjct: 179 ISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIEN 234
Query: 475 YM-GSLPNLQELHIENNSFVGEIPPAL 500
LP L+ELH++NN +P L
Sbjct: 235 GSLSFLPTLRELHLDNNKLS-RVPAGL 260
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 16/98 (16%), Positives = 34/98 (34%), Gaps = 7/98 (7%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 467
+ + L N +I + + L +L++ N L +P L + + +N
Sbjct: 78 QHLYALVLVN-NKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNL-PSSLVELRIHDNR 134
Query: 468 LTGSLPSYM-GSLPNLQELHIENNSF-VGEIPPALLTG 503
+ +P + L N+ + + N P G
Sbjct: 135 IR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 15/95 (15%), Positives = 31/95 (32%), Gaps = 3/95 (3%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
+ + L + ++ ++ L L L N L P+ + + L NN+L
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
+ + NL+ + N F +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 15/93 (16%), Positives = 35/93 (37%), Gaps = 8/93 (8%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 466
P I + + N+ + + ++L N +T L D ++ + L+ N
Sbjct: 99 PSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLN 154
Query: 467 ELTG-SLPSYMGSLPNLQELHIENNSFVGEIPP 498
E+ + S L+ L+++ N ++
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG 186
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 21/91 (23%), Positives = 39/91 (42%), Gaps = 4/91 (4%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNE 467
R ++ +LK + ++ + EL L GN L+ D++ L +++L +N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 468 LTGSLPSYMGSLPNLQELHIENNSFVGEIPP 498
L + SL L+ L + NN E+
Sbjct: 70 LY-ETLD-LESLSTLRTLDLNNNYV-QELLV 97
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 16/77 (20%), Positives = 30/77 (38%), Gaps = 3/77 (3%)
Query: 428 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487
EL ++ L N ++ + SR + ++L NN++T G +Q L +
Sbjct: 94 ELLVGPSIETLHAANNNISR-VSC-SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 488 ENNSFVGEIPPALLTGK 504
+ N + A L
Sbjct: 152 KLNEID-TVNFAELAAS 167
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 11/75 (14%), Positives = 26/75 (34%), Gaps = 2/75 (2%)
Query: 425 IPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 483
I +N + + L L + +++ + L N L+ + + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 484 ELHIENNSFVGEIPP 498
L++ +N E
Sbjct: 62 LLNLSSNVLY-ETLD 75
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 14/71 (19%), Positives = 35/71 (49%), Gaps = 1/71 (1%)
Query: 429 LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487
+ + L L + G +T +P++S L L ++ + ++ S+ + + +LP + + +
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 488 ENNSFVGEIPP 498
N + +I P
Sbjct: 144 SYNGAITDIMP 154
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 15/90 (16%), Positives = 38/90 (42%), Gaps = 3/90 (3%)
Query: 411 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 470
+T I L+ N+ ++ ++ + +L ++ T +S L +L + + ++T
Sbjct: 46 LTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTS 102
Query: 471 SLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
+ L +L L I +++ I +
Sbjct: 103 DKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 10/82 (12%), Positives = 32/82 (39%), Gaps = 2/82 (2%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
+T + +S I ++ + + + L N + + L +L+ ++++ + +
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGV 171
Query: 469 TGSLPSYMGSLPNLQELHIENN 490
+ P L +L+ +
Sbjct: 172 HDY--RGIEDFPKLNQLYAFSQ 191
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-08
Identities = 21/86 (24%), Positives = 35/86 (40%), Gaps = 5/86 (5%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 467
P + + +S NL L L EL++ N L LPD S L ++ + N+
Sbjct: 430 PQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLKT-LPDASLFPVLLVMKISRNQ 484
Query: 468 LTGSLPSYMGSLPNLQELHIENNSFV 493
L L +LQ++ + N +
Sbjct: 485 LKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 7e-08
Identities = 22/154 (14%), Positives = 47/154 (30%), Gaps = 4/154 (2%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENN 466
+ + + EI + +L EL + L + + D+ + L +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 467 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFK 526
E L + L +++ L + + + + L + F
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNL-ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241
Query: 527 LILGTSIGVLAILLVLFL-CSLIVLRKLRRKISN 559
+L +L + V F C+L L S+
Sbjct: 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESD 275
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 21/100 (21%), Positives = 37/100 (37%), Gaps = 7/100 (7%)
Query: 408 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLE 464
+ + LS + I L+ L L L + + + L L + L
Sbjct: 25 TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLS 82
Query: 465 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
+N L+ SL S G L +L+ L++ N + +L
Sbjct: 83 DNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 11/98 (11%), Positives = 29/98 (29%), Gaps = 4/98 (4%)
Query: 409 PRITKIALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRIVHLEN 465
+ + L G + + N+ L L + + D + L L + ++
Sbjct: 98 SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157
Query: 466 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
L + S+ ++ L + + +
Sbjct: 158 LSLRNYQSQSLKSIRDIHHLTLHLSES-AFLLEIFADI 194
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 16/101 (15%), Positives = 35/101 (34%), Gaps = 6/101 (5%)
Query: 402 TCSTTTPPRITKIALSGKNLK--GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 459
+ P + + LS +L+ + L ++ LT L + N +R
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMR 413
Query: 460 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
++L + + + + L+ L + NN+ L
Sbjct: 414 FLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNL-DSFSLFL 450
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 20/100 (20%), Positives = 39/100 (39%), Gaps = 11/100 (11%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHL 463
++ +I + + +P +++++L L L N + S L+ + L
Sbjct: 310 EKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368
Query: 464 ENNELTGSLPSYMG---SLPNLQELHIENNSFVGEIPPAL 500
N L S+ +L NL L I N+F +P +
Sbjct: 369 SQNHLR-SMQKTGEILLTLKNLTSLDISRNTF-HPMPDSC 406
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 34/111 (30%), Positives = 43/111 (38%), Gaps = 11/111 (9%)
Query: 401 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM 452
V C T PP + T + LS L L LT+L LD LT L
Sbjct: 15 VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD 73
Query: 453 SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
L L + L +N+L SLP +LP L L + N +P L G
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRG 122
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 27/86 (31%), Positives = 41/86 (47%), Gaps = 7/86 (8%)
Query: 409 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 465
P +T + +S L +P + + L EL+L GN L LP ++ L + L N
Sbjct: 100 PALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLAN 157
Query: 466 NELTGSLPSYM-GSLPNLQELHIENN 490
N LT LP+ + L NL L ++ N
Sbjct: 158 NNLT-ELPAGLLNGLENLDTLLLQEN 182
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 2e-08
Identities = 22/84 (26%), Positives = 37/84 (44%), Gaps = 5/84 (5%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
+T + LS L+ +PP L + L L N L + ++ L L+ + L NN L
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRL 520
Query: 469 TGSLPS--YMGSLPNLQELHIENN 490
+ + S P L L+++ N
Sbjct: 521 Q-QSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 1e-07
Identities = 28/125 (22%), Positives = 51/125 (40%), Gaps = 9/125 (7%)
Query: 370 EWQDEALRSISD----ESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEI 425
++ E L+ S + R D E + + + L+ K+L +
Sbjct: 399 LYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLEN-SVLKMEYADVRVLHLAHKDL--TV 455
Query: 426 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 485
L+ + +T L L N L P ++ L L ++ +N L ++ + +LP LQEL
Sbjct: 456 LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQEL 513
Query: 486 HIENN 490
+ NN
Sbjct: 514 LLCNN 518
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 5e-04
Identities = 13/65 (20%), Positives = 24/65 (36%), Gaps = 7/65 (10%)
Query: 427 PELKNMEALTELWLDGNFLTGP--LPDMSRLIDLRIVHLENNELTGSLPSY----MGSLP 480
+ N+ L EL L N L + + L +++L+ N L LP
Sbjct: 502 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLP 560
Query: 481 NLQEL 485
++ +
Sbjct: 561 SVSSI 565
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 17/97 (17%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 467
P + ++ L I + + L L L + +P+++ L+ L + + N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNH 229
Query: 468 LTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
+ L +L++L + N+ V I G
Sbjct: 230 FP-EIRPGSFHGLSSLKKLWVMNSQ-VSLIERNAFDG 264
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-07
Identities = 23/98 (23%), Positives = 39/98 (39%), Gaps = 5/98 (5%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 466
+ + L +++ +I + +L L L N+LT L LR + L NN
Sbjct: 99 HHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNN 157
Query: 467 ELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
+ S+PSY +P+L L + + I G
Sbjct: 158 PIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 21/91 (23%), Positives = 43/91 (47%), Gaps = 11/91 (12%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHL 463
+ ++ +SG + EI P + +L +LW+ + ++ ++ L ++L
Sbjct: 218 VGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL---VELNL 273
Query: 464 ENNELTGSLPSYM-GSLPNLQELHIENNSFV 493
+N L+ SLP + L L ELH+ +N +
Sbjct: 274 AHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 19/79 (24%), Positives = 35/79 (44%), Gaps = 4/79 (5%)
Query: 427 PELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQE 484
P L + L EL + GN P L L+ + + N++++ + L +L E
Sbjct: 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVE 270
Query: 485 LHIENNSFVGEIPPALLTG 503
L++ +N+ +P L T
Sbjct: 271 LNLAHNNLS-SLPHDLFTP 288
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 467
P + ++ L I + + L L L L +P+++ LI L + L N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNH 218
Query: 468 LTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
L+ ++ L +LQ+L + + I
Sbjct: 219 LS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDN 253
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 24/99 (24%), Positives = 41/99 (41%), Gaps = 7/99 (7%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 465
+ + LS +++ I + L L L N LT +P+ L L+ + L N
Sbjct: 88 RHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRN 145
Query: 466 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
N + S+PSY +P+L+ L + + I G
Sbjct: 146 NPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 21/88 (23%), Positives = 43/88 (48%), Gaps = 5/88 (5%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 466
++ ++ LSG +L I P + + L +LW+ + + + L L ++L +N
Sbjct: 207 IKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265
Query: 467 ELTGSLPSYM-GSLPNLQELHIENNSFV 493
LT LP + L +L+ +H+ +N +
Sbjct: 266 NLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 24/94 (25%), Positives = 38/94 (40%), Gaps = 9/94 (9%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHL-E 464
+ + L L IP + L ELWL N + +P +R+ LR + L E
Sbjct: 112 ANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGE 169
Query: 465 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIP 497
L+ + L NL+ L++ + EIP
Sbjct: 170 LKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP 201
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 19/82 (23%), Positives = 35/82 (42%), Gaps = 10/82 (12%)
Query: 427 PELKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPN 481
P L + L EL L GN L+ G + L L + +++ + +L +
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKL---WMIQSQIQ-VIERNAFDNLQS 256
Query: 482 LQELHIENNSFVGEIPPALLTG 503
L E+++ +N+ +P L T
Sbjct: 257 LVEINLAHNNLT-LLPHDLFTP 277
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 25/115 (21%), Positives = 39/115 (33%), Gaps = 10/115 (8%)
Query: 408 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLEN 465
+ + LS + I L+ L L L N + D S L L + L
Sbjct: 51 TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109
Query: 466 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPA----LLTGKVIFKYDNNPKL 515
N L+ +L S L +L L++ N + + LT I + N
Sbjct: 110 NYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTF 162
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 11/65 (16%), Positives = 27/65 (41%), Gaps = 2/65 (3%)
Query: 429 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHI 487
L + + L + ++++ L + N+L S+P + L +LQ++ +
Sbjct: 250 LIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWL 308
Query: 488 ENNSF 492
N +
Sbjct: 309 HTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 23/99 (23%), Positives = 36/99 (36%), Gaps = 6/99 (6%)
Query: 409 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLT--GPLPDMSRLIDLRIVHLEN 465
+ + LS L + K + +LT L L GN G S L L+I+ + N
Sbjct: 100 GSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN 158
Query: 466 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
+ + L L+EL I+ + P L
Sbjct: 159 MDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKS 196
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 19/110 (17%), Positives = 44/110 (40%), Gaps = 8/110 (7%)
Query: 404 STTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHL 463
S +T + ++ ++ ++ + LT+L N +T D+S+ +L +
Sbjct: 37 SEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITT--LDLSQNTNLTYLAC 92
Query: 464 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 513
++N+LT +L + L L L+ + N ++ + N
Sbjct: 93 DSNKLT-NLD--VTPLTKLTYLNCDTNKL-TKLDVSQNPLLTYLNCARNT 138
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 24/107 (22%), Positives = 39/107 (36%), Gaps = 9/107 (8%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
+ ++ N+ ++ L LT L N LT D++ L L N L
Sbjct: 191 KLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE--IDVTPLTQLTYFDCSVNPL 245
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 515
T L + +L L LH + EI T + F+ + K+
Sbjct: 246 T-ELD--VSTLSKLTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCRKI 288
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 15/82 (18%), Positives = 30/82 (36%), Gaps = 7/82 (8%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
++T++ ++ LT L N +T D+S+ L ++ + N +
Sbjct: 148 TQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKITE--LDVSQNKLLNRLNCDTNNI 203
Query: 469 TGSLPSYMGSLPNLQELHIENN 490
T L + L L +N
Sbjct: 204 T-KLD--LNQNIQLTFLDCSSN 222
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-06
Identities = 16/75 (21%), Positives = 28/75 (37%), Gaps = 5/75 (6%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 475
+ + ++ + L L +T L D+S+ L ++L N ELT L
Sbjct: 280 FQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-EL-DLSQNPKLVYLYLNNTELT-ELD-- 334
Query: 476 MGSLPNLQELHIENN 490
+ L+ L N
Sbjct: 335 VSHNTKLKSLSCVNA 349
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 19/94 (20%), Positives = 34/94 (36%), Gaps = 8/94 (8%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
++ + + E+ L L L+L+ LT L D+S L+ + N +
Sbjct: 297 TQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE-L-DVSHNTKLKSLSCVNAHI 351
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 502
S +G +P L + +P LT
Sbjct: 352 Q-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLT 382
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 19/97 (19%), Positives = 37/97 (38%), Gaps = 8/97 (8%)
Query: 406 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 465
+T ++T + +L EI L + L +G L D++ L ++ +
Sbjct: 251 STLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL-DVTHNTQLYLLDCQA 306
Query: 466 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 502
+T L + P L L++ N E+ + T
Sbjct: 307 AGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVSHNT 339
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 16/84 (19%), Positives = 26/84 (30%), Gaps = 7/84 (8%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
++T + L ++ + LT L N LT D+S L + N+
Sbjct: 106 TKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT--EIDVSHNTQLTELDCHLNKK 160
Query: 469 TGSLPSYMGSLPNLQELHIENNSF 492
L + L L N
Sbjct: 161 ITKLD--VTPQTQLTTLDCSFNKI 182
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 20/99 (20%), Positives = 37/99 (37%), Gaps = 8/99 (8%)
Query: 409 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 465
+TK+ +S + + + +++ L L + N L + S L L + LE
Sbjct: 104 SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEK 161
Query: 466 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
LT S+P+ L L L + + + I
Sbjct: 162 CNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKR 198
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 22/100 (22%), Positives = 40/100 (40%), Gaps = 8/100 (8%)
Query: 408 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLE 464
P + L +K + + + L EL L+ N ++ + + L +LR + L
Sbjct: 31 PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSA-VEPGAFNNLFNLRTLGLR 88
Query: 465 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
+N L +P + L NL +L I N V + +
Sbjct: 89 SNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQD 126
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 18/97 (18%), Positives = 35/97 (36%), Gaps = 4/97 (4%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 466
+ ++ L NL IP E L ++ L L L + RL L+++ + +
Sbjct: 152 NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210
Query: 467 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
++ NL L I + + +P +
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRH 246
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 20/91 (21%), Positives = 39/91 (42%), Gaps = 11/91 (12%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHL 463
+ + LS + I L + L E+ L G L ++ L R++++
Sbjct: 248 VYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYL---RVLNV 303
Query: 464 ENNELTGSLPSYM-GSLPNLQELHIENNSFV 493
N+LT +L + S+ NL+ L +++N
Sbjct: 304 SGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 18/98 (18%), Positives = 41/98 (41%), Gaps = 6/98 (6%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 466
+T ++++ NL +P ++++ L L L N ++ M L+ L+ + L
Sbjct: 224 LNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGG 282
Query: 467 ELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
+L + Y L L+ L++ N + ++
Sbjct: 283 QLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 7e-08
Identities = 22/85 (25%), Positives = 36/85 (42%), Gaps = 2/85 (2%)
Query: 407 TPPRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 465
TP + ++ L K+ G+I L L L L + ++ +L L+ + L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSE 80
Query: 466 NELTGSLPSYMGSLPNLQELHIENN 490
N + G L LPNL L++ N
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGN 105
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 9e-08
Identities = 15/84 (17%), Positives = 36/84 (42%), Gaps = 4/84 (4%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
R+ ++ +S L + + + L L L N L + + L ++L++N +
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSI 336
Query: 469 TGSLPSYMGSLPNLQELHIENNSF 492
+L + + L+ L + +N +
Sbjct: 337 V-TLK--LSTHHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 22/99 (22%), Positives = 42/99 (42%), Gaps = 8/99 (8%)
Query: 409 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 465
I K+ + ++ +PP + +N+ LT L L+ N L+ LP L + + N
Sbjct: 99 HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSN 156
Query: 466 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
N L + + +LQ L + +N + +L+
Sbjct: 157 NNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPS 193
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 14/100 (14%), Positives = 37/100 (37%), Gaps = 6/100 (6%)
Query: 407 TPPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLE 464
T + ++ ++P L + + L L+ + + ++ +++
Sbjct: 49 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 107
Query: 465 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
N + LP ++ ++P L L +E N +P +
Sbjct: 108 FNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 145
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 21/99 (21%), Positives = 41/99 (41%), Gaps = 8/99 (8%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 465
++ + L+ ++ EI + +L++ N + LP + L ++ LE
Sbjct: 75 RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLER 132
Query: 466 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
N+L+ SLP + + P L L + NN+ I
Sbjct: 133 NDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQA 169
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 21/94 (22%), Positives = 35/94 (37%), Gaps = 7/94 (7%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 467
P + ++ S ++ + + LT L L N LT + L V L NE
Sbjct: 210 PIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNE 265
Query: 468 LTGSLPSYM-GSLPNLQELHIENNSFVGEIPPAL 500
L + + + L+ L+I NN V +
Sbjct: 266 LE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYG 297
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 8e-06
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 8/87 (9%)
Query: 409 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 465
P +T + L +L +P + N LT L + N L + D L+ + L +
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 180
Query: 466 NELTGSLPSYMGSLPNLQELHIENNSF 492
N LT + +P+L ++ N
Sbjct: 181 NRLT-HVDL--SLIPSLFHANVSYNLL 204
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 10/98 (10%)
Query: 406 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 465
+ P + +S L L A+ EL N + + ++L I+ L++
Sbjct: 189 SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV-NVELTILKLQH 241
Query: 466 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
N LT + + P L E+ + N +I
Sbjct: 242 NNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVK 276
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 10/80 (12%), Positives = 31/80 (38%), Gaps = 6/80 (7%)
Query: 427 PELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQ 483
E + + + + LP + + +++L + ++ + +Y +Q
Sbjct: 45 FEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQ 102
Query: 484 ELHIENNSFVGEIPPALLTG 503
+L++ N+ +PP +
Sbjct: 103 KLYMGFNAIR-YLPPHVFQN 121
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 20/85 (23%), Positives = 39/85 (45%), Gaps = 2/85 (2%)
Query: 407 TPPRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 465
TP + ++ L ++ +G++ E L L LT + ++ +L L+ + L +
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSD 73
Query: 466 NELTGSLPSYMGSLPNLQELHIENN 490
N ++G L PNL L++ N
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGN 98
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 22/83 (26%), Positives = 37/83 (44%), Gaps = 7/83 (8%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP--LPDMSRLIDLRIVHLENN 466
++ K+ LS + G + + LT L L GN + + + +L +L+ + L N
Sbjct: 64 NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
Query: 467 ELTGSLPSY----MGSLPNLQEL 485
E+T +L Y LP L L
Sbjct: 124 EVT-NLNDYRENVFKLLPQLTYL 145
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 22/115 (19%), Positives = 39/115 (33%), Gaps = 13/115 (11%)
Query: 391 DPCVPVPWEWVTCS----TTTPPRI------TKIALSGKNLKGEIPPE-LKNMEALTELW 439
D C P + C+ + + T++ + + + L+ + L L
Sbjct: 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 440 LDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 493
+ + L PD L ++L N L SL +LQEL + N
Sbjct: 63 IVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 2e-05
Identities = 18/95 (18%), Positives = 33/95 (34%), Gaps = 7/95 (7%)
Query: 424 EIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMGS-LP 480
+ L E LTEL+++ L + L +LR + + + L + P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 481 NLQELHIENNSFVGEIPPALLTGK--VIFKYDNNP 513
L L++ N+ + + G NP
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNP 114
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 8/88 (9%)
Query: 408 PPRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHL 463
P + LS NL + E + L L L N L + + +LR + L
Sbjct: 38 PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDL 95
Query: 464 ENNELTGSLPSYM-GSLPNLQELHIENN 490
+N L +L ++ L L+ L + NN
Sbjct: 96 SSNHLH-TLDEFLFSDLQALEVLLLYNN 122
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 35/174 (20%), Positives = 60/174 (34%), Gaps = 25/174 (14%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 465
+ + LS +L I E + L L L N L L + S L L ++ L N
Sbjct: 64 TNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYN 121
Query: 466 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMR 524
N + + + LQ+L++ N P L+ + PKL +
Sbjct: 122 NHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKD-----GNKLPKLMLLDLSSNK 174
Query: 525 FKLILGTSIGVLAILLVLFL----------CSLIVLRK--LRRKISNQKSYEKA 566
K + T + L + L C L L R++S+ +++
Sbjct: 175 LKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFSHWQYRQLSSVMDFQED 228
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 13/99 (13%), Positives = 37/99 (37%), Gaps = 8/99 (8%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLEN 465
+ ++ ++P L + + L L+ + + + ++ +++
Sbjct: 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGF 102
Query: 466 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
N + LP ++ ++P L L +E N +P +
Sbjct: 103 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 139
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 21/93 (22%), Positives = 36/93 (38%), Gaps = 5/93 (5%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNE 467
+T + L NL L N L E+ L N L ++ L +++ NN
Sbjct: 226 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283
Query: 468 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
L +L Y +P L+ L + +N + +
Sbjct: 284 LV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQ 314
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 8/87 (9%)
Query: 409 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 465
P +T + L +L +P + N LT L + N L + D L+ + L +
Sbjct: 117 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 174
Query: 466 NELTGSLPSYMGSLPNLQELHIENNSF 492
N LT + +P+L ++ N
Sbjct: 175 NRLT-HVDL--SLIPSLFHANVSYNLL 198
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 10/98 (10%)
Query: 406 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 465
+ P + +S L L A+ EL N + + ++L I+ L++
Sbjct: 183 SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV-NVELTILKLQH 235
Query: 466 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
N LT + + P L E+ + N +I
Sbjct: 236 NNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVK 270
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 19/95 (20%), Positives = 37/95 (38%), Gaps = 5/95 (5%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
P + + LS +L + + L L+LD N + L +S L+ + L +N+
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHNDW 351
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
+ S N+ +++ +I L G
Sbjct: 352 DCN--SLRALFRNVARPAVDDADQHCKIDYQLEHG 384
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 25/99 (25%), Positives = 40/99 (40%), Gaps = 8/99 (8%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 465
R+ + L L+ E+ P + + AL L+L N L LPD L +L + L
Sbjct: 105 GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHG 162
Query: 466 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
N ++ S+P L +L L + N + P
Sbjct: 163 NRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD 199
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 21/84 (25%), Positives = 31/84 (36%), Gaps = 7/84 (8%)
Query: 424 EIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSL 479
+ P + L L LD L L L L+ ++L++N L +LP L
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDL 152
Query: 480 PNLQELHIENNSFVGEIPPALLTG 503
NL L + N +P G
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRG 175
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 20/104 (19%), Positives = 41/104 (39%), Gaps = 9/104 (8%)
Query: 402 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRI 460
C + + L+ +P + A ++L GN ++ P +L I
Sbjct: 7 VCYNEPK---VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTI 60
Query: 461 VHLENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
+ L +N L + + L L++L + +N+ + + PA G
Sbjct: 61 LWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHG 103
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 21/89 (23%), Positives = 39/89 (43%), Gaps = 7/89 (7%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 465
+T + L G + +P + + +L L L N + + L L ++L
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFA 210
Query: 466 NELTGSLPSY-MGSLPNLQELHIENNSFV 493
N L+ +LP+ + L LQ L + +N +V
Sbjct: 211 NNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 26/96 (27%), Positives = 38/96 (39%), Gaps = 12/96 (12%)
Query: 405 TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE 464
P + K+ + G L +P L EL + N L LP + +L +
Sbjct: 117 PALPSGLCKLWIFGNQLT-SLPVLPPG---LQELSVSDNQLAS-LPAL--PSELCKLWAY 169
Query: 465 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
NN+LT SLP LQEL + +N +P
Sbjct: 170 NNQLT-SLPM---LPSGLQELSVSDNQLA-SLPTLP 200
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 5e-07
Identities = 22/89 (24%), Positives = 32/89 (35%), Gaps = 8/89 (8%)
Query: 412 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS 471
+ + L +P L +T L + N LT LP +LR + + N+LT S
Sbjct: 43 AVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTS-LPA--LPPELRTLEVSGNQLT-S 95
Query: 472 LPSYMGSLPNLQELHIENNSFVGEIPPAL 500
LP L L +P L
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLP-ALPSGL 123
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 26/95 (27%), Positives = 38/95 (40%), Gaps = 12/95 (12%)
Query: 406 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 465
T P + K+ L +P L EL + GN LT LP + +L+ + +
Sbjct: 198 TLPSELYKLWAYNNRLT-SLPALPSG---LKELIVSGNRLTS-LPVL--PSELKELMVSG 250
Query: 466 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
N LT SLP L L + N +P +L
Sbjct: 251 NRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESL 280
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 26/110 (23%), Positives = 41/110 (37%), Gaps = 26/110 (23%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNM-----------------EALTELWLDGNFLTGPLP 450
PP + + +SG L +P + L +LW+ GN LT LP
Sbjct: 80 PPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTS-LP 137
Query: 451 DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
L+ + + +N+L SLP+ L +L NN +P
Sbjct: 138 V--LPPGLQELSVSDNQLA-SLPA---LPSELCKLWAYNNQLT-SLPMLP 180
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 28/108 (25%), Positives = 40/108 (37%), Gaps = 22/108 (20%)
Query: 402 TCSTTT---------------PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFL 445
TCS P IT+I L +K IPP + L + L N +
Sbjct: 10 TCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQI 68
Query: 446 TGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 490
+ L L L + L N++T LP + L +LQ L + N
Sbjct: 69 SE-LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNAN 114
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 20/84 (23%), Positives = 36/84 (42%), Gaps = 5/84 (5%)
Query: 412 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNEL 468
+ L G + E+P L + + +L L L+ N + L L +L ++ L +N+L
Sbjct: 83 NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKL 140
Query: 469 TGSLPSYMGSLPNLQELHIENNSF 492
L +Q +H+ N F
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 47/236 (19%), Positives = 87/236 (36%), Gaps = 65/236 (27%)
Query: 611 KKIGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------N 662
+G+G+FG V + +VA+KI+ + +R + E+ +L +I +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKKIKEKDKENKFL 83
Query: 663 LVPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAA 714
V + + C + +E + + L + N +P L ++ +A+
Sbjct: 84 CVLMSDWFNFHGHMC-------IAFELLGK-NTFEFLKEN-NFQPYP-LPHVRHMAYQLC 133
Query: 715 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------KVSDFGLSR 755
L +LH + H D+K NIL + +V+DFG +
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 756 QAEEDL-THISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGK 805
E T +++ R Y PE + + DV+S G +L E G
Sbjct: 191 FDHEHHTTIVAT--R---HYRPPEVILELGWA-----QPCDVWSIGCILFEYYRGF 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 20/82 (24%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
++ ++L + +I L ++ L L+L N +T + +SRL L + LE+N++
Sbjct: 112 KKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 168
Query: 469 TGSLPSYMGSLPNLQELHIENN 490
+ + + L LQ L++ N
Sbjct: 169 S-DIVP-LAGLTKLQNLYLSKN 188
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 17/62 (27%), Positives = 33/62 (53%), Gaps = 3/62 (4%)
Query: 429 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 488
LK+++ L L L+ N ++ + + L L ++L NN++T + + L L L +E
Sbjct: 108 LKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLE 164
Query: 489 NN 490
+N
Sbjct: 165 DN 166
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 16/85 (18%), Positives = 37/85 (43%), Gaps = 3/85 (3%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
++ ++L + +I P L + L L+L N ++ L ++ L +L ++ L + E
Sbjct: 156 TKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQEC 212
Query: 469 TGSLPSYMGSLPNLQELHIENNSFV 493
++ +L + + S V
Sbjct: 213 LNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 21/82 (25%), Positives = 45/82 (54%), Gaps = 5/82 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
I +I + ++K + ++ + +T+L+L+GN LT + ++ L +L + L+ N++
Sbjct: 46 NSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTD-IKPLANLKNLGWLFLDENKV 102
Query: 469 TGSLPSYMGSLPNLQELHIENN 490
L S + L L+ L +E+N
Sbjct: 103 K-DLSS-LKDLKKLKSLSLEHN 122
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 27/82 (32%), Positives = 46/82 (56%), Gaps = 5/82 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
P +TK+ L+G L +I P L N++ L L+LD N + L + L L+ + LE+N +
Sbjct: 68 PNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGI 124
Query: 469 TGSLPSYMGSLPNLQELHIENN 490
+ + + LP L+ L++ NN
Sbjct: 125 S-DING-LVHLPQLESLYLGNN 144
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 18/106 (16%), Positives = 37/106 (34%), Gaps = 16/106 (15%)
Query: 398 WEWVTCS----TTTPPRI----TKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTG 447
V CS P I ++ L+ + K + L ++ N +T
Sbjct: 13 GTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITD 71
Query: 448 PLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 490
+ + + + L +N L ++ M L +L+ L + +N
Sbjct: 72 -IEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSN 115
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 22/86 (25%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 412 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELT 469
+I L+ L+ + ++ K +E+L L L N +T D L +R++ L +N++T
Sbjct: 84 NEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142
Query: 470 GSLPSYMG---SLPNLQELHIENNSF 492
++ G +L +L L++ N F
Sbjct: 143 -TVAP--GAFDTLHSLSTLNLLANPF 165
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 21/106 (19%), Positives = 46/106 (43%), Gaps = 6/106 (5%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
+ +++ + ++ P L N+ LT L D N ++ + ++ L +L VHL+NN++
Sbjct: 151 TNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQI 207
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPK 514
+ + + + NL + + N + P V+ P
Sbjct: 208 S-DVSP-LANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPS 250
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 23/105 (21%), Positives = 44/105 (41%), Gaps = 5/105 (4%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
+ + L + I P L + L L + ++ L ++ L L + ++N++
Sbjct: 129 SNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKI 185
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 513
+ + + SLPNL E+H++NN P A + I N
Sbjct: 186 S-DISP-LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQT 228
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 18/82 (21%), Positives = 39/82 (47%), Gaps = 5/82 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
I + L+ ++ P L + L L+LD N +T + ++ L +L+ + + N ++
Sbjct: 107 QSIKTLDLTS-TQITDVTP-LAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYLSIGNAQV 163
Query: 469 TGSLPSYMGSLPNLQELHIENN 490
+ L + +L L L ++N
Sbjct: 164 S-DLTP-LANLSKLTTLKADDN 183
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 17/90 (18%), Positives = 39/90 (43%), Gaps = 6/90 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
IT ++ G + I ++ + L L L N +T L + L + + L N L
Sbjct: 41 DGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPL 97
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPP 498
++ + + L +++ L + + + ++ P
Sbjct: 98 K-NVSA-IAGLQSIKTLDLTSTQ-ITDVTP 124
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 23/90 (25%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
+ + L + ++ P LKN+ +TEL L GN L + ++ L ++ + L + ++
Sbjct: 63 NNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQI 119
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPP 498
T + + L NLQ L+++ N + I P
Sbjct: 120 TD--VTPLAGLSNLQVLYLDLNQ-ITNISP 146
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 18/82 (21%), Positives = 37/82 (45%), Gaps = 5/82 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
KIA N+ + +++ +T L G +T + + L +L + L++N++
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQI 75
Query: 469 TGSLPSYMGSLPNLQELHIENN 490
T L + +L + EL + N
Sbjct: 76 T-DLAP-LKNLTKITELELSGN 95
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 21/103 (20%), Positives = 43/103 (41%), Gaps = 6/103 (5%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
++T + + +I P L ++ L E+ L N ++ + ++ +L IV L N +
Sbjct: 173 SKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTNQTI 229
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDN 511
T + P + NL ++ I PA ++ + N
Sbjct: 230 T-NQPVFY--NNNLVVPNVVKGPSGAPIAPATISDNGTYASPN 269
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 15/87 (17%), Positives = 33/87 (37%), Gaps = 6/87 (6%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLEN 465
+ T + +S + ++ ++ L L + N + L +L + L +
Sbjct: 20 SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLSH 78
Query: 466 NELTGSLPSYMGSLPNLQELHIENNSF 492
N+L + NL+ L + N+F
Sbjct: 79 NKLV-KISC--HPTVNLKHLDLSFNAF 102
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 15/100 (15%), Positives = 31/100 (31%), Gaps = 6/100 (6%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHL 463
+ S L + ++ L L L N L L ++ + L+ + +
Sbjct: 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDI 381
Query: 464 ENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLT 502
N ++ +L L++ +N I L
Sbjct: 382 SQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP 421
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 17/86 (19%), Positives = 37/86 (43%), Gaps = 4/86 (4%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 467
+ + +S L I L + L L N + + +L L+ +++ +N+
Sbjct: 398 TKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQ 455
Query: 468 LTGSLPSYM-GSLPNLQELHIENNSF 492
L S+P + L +LQ++ + N +
Sbjct: 456 LK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 27/142 (19%), Positives = 45/142 (31%), Gaps = 10/142 (7%)
Query: 435 LTELWLDGNFLTGPLPDM---SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 491
L L L N LP + L+ + L L S + L + L + +
Sbjct: 92 LKHLDLSFNAFDA-LPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150
Query: 492 FVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLR 551
+ + P L + N LH F IL S+ +A L + + ++
Sbjct: 151 YGEKEDPEGL------QDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN 204
Query: 552 KLRRKISNQKSYEKADSLRTST 573
K +S + L T
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLT 226
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 17/90 (18%), Positives = 33/90 (36%), Gaps = 7/90 (7%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 474
NL ++P L L L N++ L L+++ L + ++
Sbjct: 11 YRFCNLT-QVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 475 YM-GSLPNLQELHIENNSFVGEIPPALLTG 503
+LPNL+ L + ++ + P G
Sbjct: 67 EAFRNLPNLRILDLGSSKIY-FLHPDAFQG 95
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 27/112 (24%), Positives = 44/112 (39%), Gaps = 9/112 (8%)
Query: 408 PPRITKIALSGKNLKGEIPPEL-----KNMEALTELWLDGNFLTGPLPDM-SRLIDLRIV 461
P + ++ L L+ EL + + L L+L+ N+L P + S L LR +
Sbjct: 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGL 509
Query: 462 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 513
L +N LT L NL+ L I N + P + + +N
Sbjct: 510 SLNSNRLT-VLSHND-LPANLEILDISRNQLL-APNPDVFVSLSVLDITHNK 558
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 18/100 (18%), Positives = 35/100 (35%), Gaps = 7/100 (7%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLE 464
P + + L + + P+ + + L EL L L+ + L L + L
Sbjct: 73 PNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLS 131
Query: 465 NNELTG-SLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
N++ L G L +L+ + +N + L
Sbjct: 132 KNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEP 170
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 16/85 (18%), Positives = 34/85 (40%), Gaps = 5/85 (5%)
Query: 411 ITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNEL 468
+ + LS + + + ++ L L L N + + L +L++++L N L
Sbjct: 268 VRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 469 TGSLPSYM-GSLPNLQELHIENNSF 492
L S LP + + ++ N
Sbjct: 327 G-ELYSSNFYGLPKVAYIDLQKNHI 350
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 18/103 (17%), Positives = 34/103 (33%), Gaps = 10/103 (9%)
Query: 409 PRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTG------PLPDMSRLIDLRI 460
P + + L+ + +L +L+L N L L L++
Sbjct: 426 PHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV 484
Query: 461 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 503
++L +N L P L L+ L + +N + L
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPA 526
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 22/146 (15%), Positives = 44/146 (30%), Gaps = 10/146 (6%)
Query: 416 LSGKNLKGEIPPE--LKNMEALTELWLDGNFLT--GPLPDMSRLIDLRIVHLENNELTGS 471
L L + + +N++ALT L L N + P +L L+ + +N++
Sbjct: 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163
Query: 472 LPSYMGSL--PNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLIL 529
+ L L + NS + F+ N L + + +
Sbjct: 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFR---NMVLEILDVSGNGWTVDI 220
Query: 530 -GTSIGVLAILLVLFLCSLIVLRKLR 554
G ++ L +
Sbjct: 221 TGNFSNAISKSQAFSLILAHHIMGAG 246
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 16/86 (18%), Positives = 31/86 (36%), Gaps = 3/86 (3%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENN 466
+ + L+ + +I E ++ L L L N L + L + + L+ N
Sbjct: 290 KDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 467 ELTGSLPSYMGSLPNLQELHIENNSF 492
+ L LQ L + +N+
Sbjct: 349 HIAIIQDQTFKFLEKLQTLDLRDNAL 374
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 18/92 (19%), Positives = 30/92 (32%), Gaps = 5/92 (5%)
Query: 404 STTTPPRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDMSRLIDLRIVH 462
++ + LS +L+ L L L L + L ++
Sbjct: 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPA--KLSVLD 280
Query: 463 LENNELTGSLPSYMGSLPNLQELHIENNSFVG 494
L N L PS LP + L ++ N F+
Sbjct: 281 LSYNRLD-RNPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 15/99 (15%), Positives = 32/99 (32%), Gaps = 8/99 (8%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--------DMSRLIDLR 459
P + ++++ + +++ AL+ L L N G L L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 460 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 498
+ + +G + + LQ L + +NS
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 21/114 (18%), Positives = 39/114 (34%), Gaps = 4/114 (3%)
Query: 391 DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP 450
+PC + P + E+ +++E L +D G
Sbjct: 4 EPCELDEESCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYL-LKRVDTEADLGQFT 62
Query: 451 DMSRLIDLRIVHLENNELTGSLPSYM---GSLPNLQELHIENNSFVGEIPPALL 501
D+ + + L+ + + + + + LQEL +EN G PP LL
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL 116
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 16/96 (16%), Positives = 30/96 (31%), Gaps = 7/96 (7%)
Query: 409 PRITKIALSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPDMSRLID-----LRIV 461
+ ++ L + G PP L L L L ++ L L+++
Sbjct: 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154
Query: 462 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 497
+ + P L L + +N +GE
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 52/241 (21%), Positives = 91/241 (37%), Gaps = 71/241 (29%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-----HHRNLV 664
+K+G G+FG V + + + K AVK++ + + + E +L +I ++ N+V
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT-RSAKIEADILKKIQNDDINNNNIV 99
Query: 665 PLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKG 716
G C L++E + +L + + + N + ++ + K
Sbjct: 100 KYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRN-NYNGFH-IEDIKLYCIEILKA 149
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------------KVSDF 751
L YL + H D+K NILLD K+ DF
Sbjct: 150 LNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 752 GLSRQAEEDL-THISSVARGTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISG 804
G + + + I++ R Y PE + SD++SFG VL EL +G
Sbjct: 207 GCATFKSDYHGSIINT--R---QYRAPEVILNLGW------DVSSDMWSFGCVLAELYTG 255
Query: 805 K 805
Sbjct: 256 S 256
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 20/115 (17%), Positives = 38/115 (33%), Gaps = 17/115 (14%)
Query: 391 DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PL 449
DP CS + L ++P + + + L N +
Sbjct: 2 DPGTS------ECSVIG----YNAICINRGLH-QVPELPAH---VNYVDLSLNSIAELNE 47
Query: 450 PDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
SRL DL+ + +E + + L +L L ++ N F+ ++ G
Sbjct: 48 TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNG 101
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 20/86 (23%), Positives = 36/86 (41%), Gaps = 7/86 (8%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLEN 465
+ ++ L+ + +I + L +L L NFL + L L ++ L
Sbjct: 299 TDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSY 356
Query: 466 NELTGSLPSYM-GSLPNLQELHIENN 490
N + +L LPNL+EL ++ N
Sbjct: 357 NHIR-ALGDQSFLGLPNLKELALDTN 381
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 24/85 (28%), Positives = 42/85 (49%), Gaps = 7/85 (8%)
Query: 412 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLENNEL 468
K+ LS L I + +N++ L L L N + L D S L +L+ + L+ N+L
Sbjct: 326 LKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQL 383
Query: 469 TGSLPSYM-GSLPNLQELHIENNSF 492
S+P + L +LQ++ + N +
Sbjct: 384 K-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 14/87 (16%), Positives = 27/87 (31%), Gaps = 6/87 (6%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLE 464
+ + L ++ + L L L L G L L L ++ L
Sbjct: 79 SSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137
Query: 465 NNELTGSLPSYM-GSLPNLQELHIENN 490
+N + P+ ++ L + N
Sbjct: 138 DNNIKKIQPASFFLNMRRFHVLDLTFN 164
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 22/100 (22%), Positives = 39/100 (39%), Gaps = 6/100 (6%)
Query: 409 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGN-FLTGPLPDM-SRLIDLRIVHLEN 465
P I++I +S ++ N+ +T + + LT PD L L+ + + N
Sbjct: 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFN 114
Query: 466 NELTGSLP--SYMGSLPNLQELHIENNSFVGEIPPALLTG 503
L P + + S L I +N ++ IP G
Sbjct: 115 TGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQG 153
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 19/108 (17%), Positives = 37/108 (34%), Gaps = 19/108 (17%)
Query: 402 TCSTTTPPRITKIALSGKNLKG--EIPPELKNMEALTELWLDGNFLTGPLPDM--SRLID 457
C ++ K+++ +PP L L L +P S L +
Sbjct: 9 ECHQEE-----DFRVTCKDIQRIPSLPPST------QTLKLIETHLRT-IPSHAFSNLPN 56
Query: 458 LRIVHL-ENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
+ +++ + L L S+ +L + + I N + I P L
Sbjct: 57 ISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKE 103
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 21/101 (20%), Positives = 40/101 (39%), Gaps = 16/101 (15%)
Query: 405 TTTPPRI-----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 459
+ +++ L+ NL +P L +T L + N L LP++ L
Sbjct: 50 VSLLKECLINQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPEL--PASLE 103
Query: 460 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
+ +N L+ +LP +L+ L ++NN +P
Sbjct: 104 YLDACDNRLS-TLPE---LPASLKHLDVDNNQLT-MLPELP 139
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 23/104 (22%), Positives = 34/104 (32%), Gaps = 16/104 (15%)
Query: 405 TTTPPRI---TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIV 461
T P I L +P + L L + N LT LP++ L +
Sbjct: 133 TMLPELPALLEYINADNNQLT-MLPELPTS---LEVLSVRNNQLTF-LPEL--PESLEAL 185
Query: 462 HLENNELTGSLPSYMGSLPNLQE----LHIENNSFVGEIPPALL 501
+ N L SLP+ + +E N IP +L
Sbjct: 186 DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENIL 227
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 21/82 (25%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
++ ++L + +I L ++ L L+L N +T + +SRL L + LE+N++
Sbjct: 109 KKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 165
Query: 469 TGSLPSYMGSLPNLQELHIENN 490
+ + G L LQ L++ N
Sbjct: 166 S-DIVPLAG-LTKLQNLYLSKN 185
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 19/82 (23%), Positives = 40/82 (48%), Gaps = 5/82 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
+ + L +K ++ LK+++ L L L+ N ++ + + L L ++L NN++
Sbjct: 87 KNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKI 143
Query: 469 TGSLPSYMGSLPNLQELHIENN 490
T + + L L L +E+N
Sbjct: 144 TD--ITVLSRLTKLDTLSLEDN 163
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 13/82 (15%), Positives = 35/82 (42%), Gaps = 5/82 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
K L K++ + + ++ ++ + + + + + L ++ + L N+L
Sbjct: 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKL 77
Query: 469 TGSLPSYMGSLPNLQELHIENN 490
T + + +L NL L ++ N
Sbjct: 78 T-DI-KPLTNLKNLGWLFLDEN 97
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 17/92 (18%), Positives = 39/92 (42%), Gaps = 5/92 (5%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
P++ + L + +I L + L L L+ N ++ + ++ L L+ ++L N +
Sbjct: 131 PQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHI 187
Query: 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
+ L + L NL L + + + +
Sbjct: 188 S-DL-RALAGLKNLDVLELFSQECLNKPINHQ 217
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 3e-04
Identities = 27/82 (32%), Positives = 47/82 (57%), Gaps = 5/82 (6%)
Query: 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 468
P +TK+ L+G L +I P L N++ L L+LD N + L + L L+ + LE+N +
Sbjct: 65 PNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKD-LSSLKDLKKLKSLSLEHNGI 121
Query: 469 TGSLPSYMGSLPNLQELHIENN 490
+ + + + LP L+ L++ NN
Sbjct: 122 S-DI-NGLVHLPQLESLYLGNN 141
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-06
Identities = 49/236 (20%), Positives = 90/236 (38%), Gaps = 65/236 (27%)
Query: 611 KKIGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------N 662
+G+G+FG V G+ VAVKI+ + + + +E+ +L ++
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC-EAARSEIQVLEHLNTTDPNSTFR 78
Query: 663 LVPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAA 714
V ++ + C +V+E + + D + + P L ++ +A+
Sbjct: 79 CVQMLEWFEHHGHIC-------IVFELLGL-STYDFIKEN-GFLPFR-LDHIRKMAYQIC 128
Query: 715 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------KVSDFGLSR 755
K + +LH + + H D+K NIL + KV DFG +
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 756 QAEEDL-THISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGK 805
+E T +S+ R Y PE + + DV+S G +L+E G
Sbjct: 186 YDDEHHSTLVST--R---HYRAPEVILALGWS-----QPCDVWSIGCILIEYYLGF 231
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 24/83 (28%), Positives = 40/83 (48%), Gaps = 7/83 (8%)
Query: 412 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNEL 468
+ L+ L+ +P + K ++ L LW+ N L LP +L++L + L+ N+L
Sbjct: 64 RLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQL 121
Query: 469 TGSLPSYM-GSLPNLQELHIENN 490
SLP + SL L L + N
Sbjct: 122 K-SLPPRVFDSLTKLTYLSLGYN 143
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 29/102 (28%), Positives = 44/102 (43%), Gaps = 15/102 (14%)
Query: 401 VTCS----TTTPPRI----TKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD 451
V CS T P I K+ L L +P + + L L+L+ N L LP
Sbjct: 21 VDCSSKKLTAIPSNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQT-LPA 78
Query: 452 M--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 490
L +L + + +N+L +LP + L NL EL ++ N
Sbjct: 79 GIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRN 119
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 27/108 (25%), Positives = 46/108 (42%), Gaps = 19/108 (17%)
Query: 402 TCSTTTPPRITKIALSGKNLK---GEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLI 456
+C+ + S K L IP + +L L N L+ LP RL
Sbjct: 13 SCNNNK----NSVDCSSKKLTAIPSNIPADT------KKLDLQSNKLSS-LPSKAFHRLT 61
Query: 457 DLRIVHLENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
LR+++L +N+L +LP+ + L NL+ L + +N +P +
Sbjct: 62 KLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQ 107
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 18/100 (18%), Positives = 39/100 (39%), Gaps = 9/100 (9%)
Query: 409 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 465
++ + L+G ++ + + +L +L L L + L L+ +++ +
Sbjct: 76 SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAH 133
Query: 466 NELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPALLTG 503
N + S Y +L NL+ L + +N I L
Sbjct: 134 NLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 22/119 (18%), Positives = 33/119 (27%), Gaps = 28/119 (23%)
Query: 391 DPCVPVPWEWVTCSTTT---------------PPRITKIALSGKNLKGEIPPE-LKNMEA 434
+PCV T P + LS L+ + +
Sbjct: 1 EPCV------EVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSFFSFPE 53
Query: 435 LTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 490
L L L + + D L L + L N + SL L +LQ+L
Sbjct: 54 LQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVET 110
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 17/83 (20%), Positives = 31/83 (37%), Gaps = 2/83 (2%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 467
R ++ L G + I ++ + N + L L L+ + + NN
Sbjct: 18 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNR 75
Query: 468 LTGSLPSYMGSLPNLQELHIENN 490
+ +LP+L EL + NN
Sbjct: 76 ICRIGEGLDQALPDLTELILTNN 98
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 17/56 (30%), Positives = 29/56 (51%), Gaps = 2/56 (3%)
Query: 436 TELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 490
TEL+LDGN T ++S L ++ L NN ++ +L + ++ L L + N
Sbjct: 34 TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN 88
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 8e-05
Identities = 27/101 (26%), Positives = 41/101 (40%), Gaps = 14/101 (13%)
Query: 401 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 451
V CS P I T++ L G +P EL N + LT + L N ++ L +
Sbjct: 15 VRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQ 72
Query: 452 -MSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 490
S + L + L N L +P L +L+ L + N
Sbjct: 73 SFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGN 112
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 29/103 (28%), Positives = 39/103 (37%), Gaps = 17/103 (16%)
Query: 401 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 451
V C + P I K+ L L + + LT L LD N L L
Sbjct: 19 VDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAG 77
Query: 452 -MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIENN 490
L +L + L NN+L SLP G L L +L++ N
Sbjct: 78 VFDDLTELGTLGLANNQLA-SLPL--GVFDHLTQLDKLYLGGN 117
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 19/88 (21%), Positives = 37/88 (42%), Gaps = 8/88 (9%)
Query: 408 PPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLE 464
PPR ++LS ++ E+ ++ + L L L N + L DL + +
Sbjct: 51 PPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVS 108
Query: 465 NNELTGSLPSYMGSLPNLQELHIENNSF 492
+N L ++ + +L+ L + N F
Sbjct: 109 HNRLQ-NISC--CPMASLRHLDLSFNDF 133
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 15/77 (19%), Positives = 24/77 (31%), Gaps = 2/77 (2%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 474
LS + + + T L N T S L L+ + L+ N L +
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFK 394
Query: 475 YMGSLPNLQELHIENNS 491
N+ L + S
Sbjct: 395 VALMTKNMSSLETLDVS 411
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 20/91 (21%), Positives = 39/91 (42%), Gaps = 4/91 (4%)
Query: 403 CSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVH 462
+ I + LS L G + L + L L N + D++ L L+ ++
Sbjct: 422 RTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELN 479
Query: 463 LENNELTGSLP-SYMGSLPNLQELHIENNSF 492
+ +N+L S+P L +LQ + + +N +
Sbjct: 480 VASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 22/91 (24%), Positives = 39/91 (42%), Gaps = 11/91 (12%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 474
S +NL +P +L L L N ++ +PD+S L +LR++ L +N + SL
Sbjct: 38 YSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDF 93
Query: 475 YMG---SLPNLQELHIENNSFVGEIPPALLT 502
+L+ L + +N I +
Sbjct: 94 --HVFLFNQDLEYLDVSHNRLQ-NISCCPMA 121
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 9e-05
Identities = 20/99 (20%), Positives = 37/99 (37%), Gaps = 5/99 (5%)
Query: 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWL-DGNFLTGPLPDM-SRLIDLRIVHLEN 465
+ KI +S ++ I + N+ L E+ + N L P+ L +L+ + + N
Sbjct: 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 113
Query: 466 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 503
+ LP L I++N + I G
Sbjct: 114 TGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 17/103 (16%)
Query: 401 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 451
V C T+ P I T + L +LK + +LT+L+L GN L LP+
Sbjct: 12 VECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNG 70
Query: 452 -MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIENN 490
++L L ++L N+L SLP+ G L L+EL + N
Sbjct: 71 VFNKLTSLTYLNLSTNQLQ-SLPN--GVFDKLTQLKELALNTN 110
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 16/100 (16%), Positives = 38/100 (38%), Gaps = 13/100 (13%)
Query: 401 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM 452
+T S P K L K++ + + + ++ ++ + + + + +
Sbjct: 3 ITVSTPIKQIFPDDAFAETIKANLKKKSVT-DAVTQ-NELNSIDQIIANNSDIKS-VQGI 59
Query: 453 SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 492
L ++R + L N+L + + L NL L + N
Sbjct: 60 QYLPNVRYLALGGNKLH-DISAL-KELTNLTYLILTGNQL 97
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 24/83 (28%), Positives = 37/83 (44%), Gaps = 7/83 (8%)
Query: 411 ITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 469
I +I + ++K L N + L L GN L + + L +L + L N+L
Sbjct: 43 IDQIIANNSDIKSVQGIQYLPN---VRYLALGGNKLH-DISALKELTNLTYLILTGNQLQ 98
Query: 470 GSLPS-YMGSLPNLQELHIENNS 491
SLP+ L NL+EL + N
Sbjct: 99 -SLPNGVFDKLTNLKELVLVENQ 120
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 9e-04
Identities = 24/61 (39%), Positives = 31/61 (50%), Gaps = 9/61 (14%)
Query: 435 LTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIEN 489
L EL L N L LPD +L +L ++L +N+L SLP G L NL EL +
Sbjct: 111 LKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQ-SLPK--GVFDKLTNLTELDLSY 166
Query: 490 N 490
N
Sbjct: 167 N 167
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 28/103 (27%), Positives = 40/103 (38%), Gaps = 17/103 (16%)
Query: 401 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 451
V C + P I + L + P ++ L EL+L N L LP
Sbjct: 24 VDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVG 82
Query: 452 -MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIENN 490
L L ++ L N+LT LPS L +L+EL + N
Sbjct: 83 VFDSLTQLTVLDLGTNQLT-VLPS--AVFDRLVHLKELFMCCN 122
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 9e-04
Identities = 21/58 (36%), Positives = 30/58 (51%), Gaps = 4/58 (6%)
Query: 435 LTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 490
LT L L N LT LP RL+ L+ + + N+LT LP + L +L L ++ N
Sbjct: 90 LTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 26/102 (25%), Positives = 50/102 (49%), Gaps = 15/102 (14%)
Query: 410 RITKIA-LSG-KNLK---------GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDL 458
I KI+ LSG +NL+ +I + L ELW+ N + L + +L++L
Sbjct: 59 NIEKISSLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LSGIEKLVNL 117
Query: 459 RIVHLENNELT--GSLPSYMGSLPNLQELHIENNSFVGEIPP 498
R++++ NN++T G + + +L L++L + N +
Sbjct: 118 RVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKE 158
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 927 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.71 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.63 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.57 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.56 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.49 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.48 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.45 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.43 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.41 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.37 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.35 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.33 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.31 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.3 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.3 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.3 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.27 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.26 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.26 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.25 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.24 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.23 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.21 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.21 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.21 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.18 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.18 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.18 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.17 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.16 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.16 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.16 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.15 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.14 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.13 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.12 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.12 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.12 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.11 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.08 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.08 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.07 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.06 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.06 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.06 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.04 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.04 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.02 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.02 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.02 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.01 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.01 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.0 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.0 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 98.99 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.99 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.98 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.97 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 98.97 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 98.96 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.96 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 98.95 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.94 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.94 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.93 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.93 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.91 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.91 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.91 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.9 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.9 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.9 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.9 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.89 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.89 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.88 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.88 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.88 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.88 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.87 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.86 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.86 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.86 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.85 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.85 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.84 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.83 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.83 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 98.83 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.82 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.81 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.8 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.8 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.79 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.78 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.77 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.75 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.75 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.74 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.73 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.73 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.72 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.72 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.71 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.71 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.71 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.7 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.65 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.63 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.62 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.62 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.62 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.59 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.59 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.58 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.58 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.58 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.56 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.55 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.54 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.51 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.48 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 98.46 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.45 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.45 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.41 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.4 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.39 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.39 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.34 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.32 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.31 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.31 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.3 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.29 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.26 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.24 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.23 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.2 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.2 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.06 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.05 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.03 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 97.99 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.71 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.71 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.7 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.64 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.58 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.53 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.52 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.51 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.38 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.34 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.01 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.01 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 96.93 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 96.91 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.91 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.86 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.82 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 96.73 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.68 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.56 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.49 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.47 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 96.45 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.43 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.34 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.27 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.07 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.99 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.76 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 95.74 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 95.69 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 95.6 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 94.89 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 94.61 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.22 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.55 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 90.69 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 87.77 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 86.76 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 86.54 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 85.47 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 83.26 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 82.1 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 80.56 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=444.58 Aligned_cols=260 Identities=26% Similarity=0.426 Sum_probs=208.8
Q ss_pred HHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~L 678 (927)
..+.+.++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34456789999999999999875 478899999987766677889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcE
Q 002410 679 VYEYMHNGTLRDRLHGSV------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 746 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~ 746 (927)
|||||++|+|.++++... ...++++.+++.|+.|||+||+|||+ ++|+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 999999999999997543 13469999999999999999999998 999999999999999999999
Q ss_pred EEeeccccccccccc-cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHH
Q 002410 747 KVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 824 (927)
Q Consensus 747 kL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 824 (927)
||+|||+++...... ........||+.|||||++.+..++.++|||||||++|||+| |+.||...... .+...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~-- 272 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAIDC-- 272 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHHHH--
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHHHH--
Confidence 999999998764432 223344569999999999999999999999999999999999 89999743321 22222
Q ss_pred HhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 825 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 825 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
+..+.... .+...+..+.+|+.+||+.||++|||++||++.|+.+.+.
T Consensus 273 --i~~g~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 273 --ITQGRELE---------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp --HHHTCCCC---------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HHcCCCCC---------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 22222111 1112334788999999999999999999999999988764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=442.45 Aligned_cols=261 Identities=28% Similarity=0.457 Sum_probs=215.3
Q ss_pred HHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
...+.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 345567899999999999999874 47789999998776667788999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEE
Q 002410 678 LVYEYMHNGTLRDRLHGSV----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 747 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~----------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~k 747 (927)
||||||++|+|.++|+... ....+++.+++.|+.|||+||+|||+ ++|+||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEE
Confidence 9999999999999997532 24579999999999999999999998 9999999999999999999999
Q ss_pred Eeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHH
Q 002410 748 VSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 825 (927)
Q Consensus 748 L~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 825 (927)
|+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||..... ..+..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~---- 241 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIE---- 241 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHH----
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----
Confidence 999999987544322 22333468999999999999999999999999999999999 8999974332 12222
Q ss_pred hhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 826 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 826 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
.+..+.... .+...+..+.+|+.+||+.||++|||++||++.|+++.+.
T Consensus 242 ~i~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 242 CITQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 222222211 1122334788999999999999999999999999987654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=442.47 Aligned_cols=264 Identities=24% Similarity=0.414 Sum_probs=215.9
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeec
Q 002410 600 PELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEE 672 (927)
Q Consensus 600 ~el~~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~ 672 (927)
.|+...+++|.++||+|+||+||+|++. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 4455566778999999999999999873 467899999976433 345789999999999999999999999999
Q ss_pred CceEEEEEEecCCCCHHHHhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccc
Q 002410 673 EHQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 739 (927)
Q Consensus 673 ~~~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NIL 739 (927)
++..+||||||++|+|.++|..... ...+++.+++.|+.|||+||+|||+ ++||||||||+|||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVL 177 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceE
Confidence 9999999999999999999964321 2468999999999999999999999 99999999999999
Q ss_pred ccCCCcEEEeeccccccccccc-cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchh
Q 002410 740 LDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAEL 817 (927)
Q Consensus 740 ld~~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~ 817 (927)
|++++.+||+|||+++...... ........||+.|||||++.++.++.++|||||||++|||+| |+.||..... .
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~ 254 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---Q 254 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---H
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---H
Confidence 9999999999999998764432 223344568999999999999999999999999999999999 8999974432 2
Q ss_pred hHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 818 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 818 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
.+.+ .+..+.... .+...+..+.+|+.+||+.||++|||++||++.|+....
T Consensus 255 ~~~~----~i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 255 DVVE----MIRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp HHHH----HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred HHHH----HHHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 2222 222232211 112234578899999999999999999999999986543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=429.80 Aligned_cols=259 Identities=31% Similarity=0.511 Sum_probs=203.3
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
..+.+.++||+|+||+||+|++++ .||||+++.. .....+.|.+|+++|++++|||||++++++.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 345678999999999999999763 6999998743 33456789999999999999999999999865 568999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc-
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 761 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~- 761 (927)
|++|+|.++|+.. ...+++.+++.|+.|||+||+|||+ ++||||||||+||||++++.+||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999999743 4579999999999999999999998 999999999999999999999999999998764322
Q ss_pred cccccccccCCCccCCCccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 762 THISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
........||+.|||||++.+ ..++.++|||||||++|||+||+.||...... ..+.. .+..+.. .|
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~----~~~~~~~----~p 257 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIF----MVGRGYA----SP 257 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHH----HHHTTCC----CC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHH----HHhcCCC----CC
Confidence 223344579999999999853 46899999999999999999999999743321 11111 2222211 11
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
.+ .......+..+.+|+.+||+.||++|||++||++.|+.+..
T Consensus 258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11 11122334578899999999999999999999999987653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=428.00 Aligned_cols=260 Identities=24% Similarity=0.262 Sum_probs=209.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.+.++||+|+||.||+|+++ +|+.||||+++.... ..+|+.+|++++|||||++++++.+++..+||||||+|
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 455788999999999999986 589999999975422 24799999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC-cEEEeeccccccccccccc-
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTH- 763 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla~~~~~~~~~- 763 (927)
|+|.++|+. ...+++.++..++.||+.||+|||+ ++|+||||||+||||+.++ ++||+|||+|+........
T Consensus 135 g~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 135 GSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999984 4579999999999999999999998 9999999999999999987 6999999999876543221
Q ss_pred ---cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 764 ---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 764 ---~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
......||+.|||||++.+..++.++|||||||++|||+||+.||......... ..+ ........
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~i---~~~~~~~~------ 276 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---LKI---ASEPPPIR------ 276 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---HHH---HHSCCGGG------
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---HHH---HcCCCCch------
Confidence 122356999999999999999999999999999999999999999754433211 111 11111000
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhccCCCCcc
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF 891 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~~~~~~~ 891 (927)
..+......+.+++.+||+.||++|||++|+++.|.+++........+|
T Consensus 277 --~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw 325 (336)
T 4g3f_A 277 --EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW 325 (336)
T ss_dssp --GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCS
T ss_pred --hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCC
Confidence 1112223468899999999999999999999999998887655544444
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=428.78 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=202.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
.|++.+.||+|+||+||+|+++ +|+.||||++... .....+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4778899999999999999986 6999999999754 234457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
|+||+|.++|... ....+++.+++.|+.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 105 ~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 105 CEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 9999999999753 34567899999999999999999998 9999999999999999999999999999987654322
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
......||+.|||||++.+..|+.++|||||||++|||+||+.||...+.. +...... .+.... +..
T Consensus 181 -~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~-~~~~~~-----~~~ 247 (350)
T 4b9d_A 181 -LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLVLKII-SGSFPP-----VSL 247 (350)
T ss_dssp -HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHH-HTCCCC-----CCT
T ss_pred -cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHH-cCCCCC-----CCc
Confidence 223456999999999999999999999999999999999999999744321 1112222 222211 111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.....+.+|+.+||+.||++|||++|+++.
T Consensus 248 ----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 248 ----HYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 123468899999999999999999999863
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=428.57 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=206.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.|++.++||+|+||+||+|+++ +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||+
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 154 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 3666789999999999999987 699999999976555556678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
||+|.+++.. ..+++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+........
T Consensus 155 gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~- 226 (346)
T 4fih_A 155 GGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR- 226 (346)
T ss_dssp TEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-
T ss_pred CCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc-
Confidence 9999999973 459999999999999999999999 99999999999999999999999999999876544332
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 844 (927)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .....+ ..+.....-.
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i----~~~~~~~~~~------- 292 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMI----RDNLPPRLKN------- 292 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHH----HHSSCCCCSC-------
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHH----HcCCCCCCCc-------
Confidence 33457999999999999999999999999999999999999999743321 122211 1111111100
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 845 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 845 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.......+.+|+.+||+.||++|||++|+++
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1122346889999999999999999999876
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=413.77 Aligned_cols=244 Identities=29% Similarity=0.435 Sum_probs=197.1
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeec----CceEEEEE
Q 002410 608 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVY 680 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~----~~~~~LV~ 680 (927)
++.++||+|+||+||+|.+. +++.||+|++... .....+.|.+|+++|++++|||||++++++.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999987 5889999998653 23445779999999999999999999999864 45689999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcccccC-CCcEEEeeccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDI-NMRAKVSDFGLSRQA 757 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivH~DLkp~NILld~-~~~~kL~DFGla~~~ 757 (927)
|||++|+|.+++.. ...+++..+..|+.||+.||+|||+ ++ |+||||||+||||+. ++.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99999999999984 4679999999999999999999998 66 999999999999984 799999999999864
Q ss_pred cccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
... ......||+.|||||++.+ .++.++|||||||++|||+||+.||..... ...+. ..+..+......+
T Consensus 183 ~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~----~~i~~~~~~~~~~ 252 (290)
T 3fpq_A 183 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIY----RRVTSGVKPASFD 252 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHH----HHHTTTCCCGGGG
T ss_pred CCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHHH----HHHHcCCCCCCCC
Confidence 332 2334579999999999875 699999999999999999999999963322 11111 2222222111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+ .. ..++.+|+.+||+.||++|||++|+++
T Consensus 253 ~----~~----~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 K----VA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G----CC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c----cC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 11 235789999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=419.69 Aligned_cols=268 Identities=26% Similarity=0.365 Sum_probs=202.1
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCc----eEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~----~~~LV~E~ 682 (927)
+.+.++||+|+||+||+|+++ |+.||||+++... .....+..|+..+.+++|||||+++++|.+++ ..+|||||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 456789999999999999985 8999999997532 22223345666667889999999999997653 57999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG-----CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-----~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
|++|+|.++|+. ..+++..+.+++.|+++||+|||+. ++++|+||||||+||||+.++++||+|||+|+..
T Consensus 83 ~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 83 HEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 999999999973 4689999999999999999999972 1349999999999999999999999999999876
Q ss_pred cccccc---cccccccCCCccCCCccCCC------CCCcchhHHHHHHHHHHHHhCCCCCCcccccch--------hhHH
Q 002410 758 EEDLTH---ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--------LNIV 820 (927)
Q Consensus 758 ~~~~~~---~~~~~~gt~~Y~APE~l~~~------~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~--------~~l~ 820 (927)
...... ......||+.|||||++.+. .++.++|||||||++|||+||+.||........ ....
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 543322 12234699999999998754 467899999999999999999887753322110 0011
Q ss_pred HHHHHhhhcCCeeeeccccccCC-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 821 HWARSMIKKGDVISIVDPVLIGN-VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 821 ~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
+.+...+..+.. +|.+... ...+.+..+.+|+.+||+.||++||||+||++.|+++.+.+
T Consensus 239 ~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 239 EEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 112222222211 2222211 13356678899999999999999999999999999887643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=429.68 Aligned_cols=267 Identities=26% Similarity=0.412 Sum_probs=216.3
Q ss_pred hHHHHHHhhcccccccccEEEEEEEECC------CcEEEEEEccCccc-hhHHHHHHHHHHHHhcCC-Cceeeeeeeeec
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHH-RNLVPLIGYCEE 672 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~~------g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~H-pnIv~l~~~~~~ 672 (927)
|+....+++.++||+|+||+||+|++.. ++.||||+++.... ...+.|.+|+++|++++| ||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 4555677889999999999999998753 36899999976543 345789999999999965 899999999966
Q ss_pred -CceEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcc
Q 002410 673 -EHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 738 (927)
Q Consensus 673 -~~~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NI 738 (927)
++..++|||||++|+|.++|+... ....+++.+++.++.|||+||+|||+ ++||||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccce
Confidence 456899999999999999997532 13458999999999999999999999 9999999999999
Q ss_pred cccCCCcEEEeeccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccch
Q 002410 739 LLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 816 (927)
Q Consensus 739 Lld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~ 816 (927)
|+++++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||......+
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~- 295 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 295 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence 9999999999999999976544332 2334568999999999999999999999999999999998 999997443321
Q ss_pred hhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 817 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 817 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
.+. ..+..+..... +.....++.+++.+||+.||++|||++||++.|+++++...
T Consensus 296 -~~~----~~i~~g~~~~~---------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 296 -EFC----RRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp -HHH----HHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred -HHH----HHHHcCCCCCC---------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 122 22222221111 11223468899999999999999999999999999987543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=430.26 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=207.1
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.|++.++||+|+||.||+|+++ +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||+
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~ 231 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 231 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCC
Confidence 3667789999999999999987 699999999976555556778999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
||+|.++++. ..+++.++..|+.||+.||+|||+ ++|+||||||+||||+.+|.+||+|||+|+........
T Consensus 232 gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~- 303 (423)
T 4fie_A 232 GGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR- 303 (423)
T ss_dssp TEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-
T ss_pred CCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-
Confidence 9999999973 458999999999999999999999 99999999999999999999999999999876544332
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 844 (927)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .....+ ..+.....-.
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i----~~~~~~~~~~------- 369 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMI----RDNLPPRLKN------- 369 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHH----HHSCCCCCSC-------
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHH----HcCCCCCCcc-------
Confidence 33456999999999999999999999999999999999999999743321 122211 1111111100
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 845 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 845 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.......+.+|+.+||+.||++|||++|+++
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0112246789999999999999999999876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=419.48 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=206.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.+.||+|+||+||+|+.+ +|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4788999999999999999986 68999999997532 2345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
||+||+|.+++.. .+.+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 113 y~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 113 YAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred cCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999984 4679999999999999999999999 999999999999999999999999999999865432
Q ss_pred -cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 -THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 -~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
.......+||+.|||||++.+..++.++||||+||++|||++|+.||...+.. .+.. . +..+.. .+
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~---~-i~~~~~------~~ 253 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LIFA---K-IIKLEY------DF 253 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---H-HHHTCC------CC
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HHcCCC------CC
Confidence 22344567999999999999999999999999999999999999999744321 1111 1 112221 11
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 874 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl 874 (927)
.... ..++.+|+.+||+.||++|||++|++
T Consensus 254 p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 PEKF----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CTTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred Cccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1112 23678999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=404.60 Aligned_cols=244 Identities=25% Similarity=0.383 Sum_probs=190.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.+.||+|+||+||+|+.+ +|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 5778899999999999999976 69999999997542 2234679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+ +|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+......
T Consensus 94 y~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 94 YA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp CC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred CC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 99 6899999974 4679999999999999999999999 999999999999999999999999999998764432
Q ss_pred cccccccccCCCccCCCccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
......||+.|||||++.+..+ +.++||||+||++|||+||+.||...+.. .+.+ .+..+.. .+
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~~----~i~~~~~------~~ 231 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLFK----NISNGVY------TL 231 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHTCC------CC
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHH----HHHcCCC------CC
Confidence 2234569999999999988776 58999999999999999999999743321 1111 1222221 11
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.... ...+.+|+.+||+.||++|||++|+++
T Consensus 232 p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 PKFL----SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCC----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111 236789999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=411.64 Aligned_cols=246 Identities=26% Similarity=0.329 Sum_probs=194.9
Q ss_pred HHhhcccccccccEEEEEEEEC----CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~----~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
.|++.+.||+|+||+||+|+.. .++.||||+++... ......+.+|+++|++++|||||++++++.+++..++|
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4778899999999999999863 47899999997542 22334688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
||||+||+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 105 mEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp ECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999984 4579999999999999999999999 9999999999999999999999999999987543
Q ss_pred cccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 760 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
... ......||+.|||||++.+..++.++||||+||++|||+||+.||...+..+ +.. . +..+.. .
T Consensus 179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~---~-i~~~~~------~ 244 (304)
T 3ubd_A 179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMT---M-ILKAKL------G 244 (304)
T ss_dssp --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---H-HHHCCC------C
T ss_pred CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHH---H-HHcCCC------C
Confidence 322 2234569999999999999999999999999999999999999997443221 111 1 111211 1
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL 875 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~-----~eVl~ 875 (927)
+... ....+.+|+.+||+.||++|||+ +|+++
T Consensus 245 ~p~~----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 MPQF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCTT----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCc----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1111 22367899999999999999984 56553
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=401.39 Aligned_cols=249 Identities=23% Similarity=0.358 Sum_probs=188.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCc---------
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--------- 674 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~--------- 674 (927)
.|++.+.||+|+||+||+|+.+ +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 4677899999999999999986 689999999875433 34567999999999999999999999986543
Q ss_pred ---eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeec
Q 002410 675 ---QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF 751 (927)
Q Consensus 675 ---~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DF 751 (927)
..++|||||++|+|.+++.........++..++.|+.||++||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccC
Confidence 368999999999999999854333445667789999999999999999 99999999999999999999999999
Q ss_pred cccccccccccc-----------cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHH
Q 002410 752 GLSRQAEEDLTH-----------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 820 (927)
Q Consensus 752 Gla~~~~~~~~~-----------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~ 820 (927)
|+|+........ .....+||+.|||||++.+..++.++|||||||++|||++ ||.... ...
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~~ 234 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ERV 234 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HHH
Confidence 999876543221 1123469999999999999999999999999999999996 775211 111
Q ss_pred HHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 821 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 821 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..+. .+......... ......+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~-~~~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 RTLT-DVRNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHH-HHHTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH-HHhcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 11222221111 112234678999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=386.37 Aligned_cols=277 Identities=41% Similarity=0.716 Sum_probs=241.8
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
.|++.+.||+|+||.||+|++++|+.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 40 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 119 (321)
T 2qkw_B 40 NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119 (321)
T ss_dssp CCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTT
T ss_pred ccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCC
Confidence 34557899999999999999988999999999876666778899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc-cc
Q 002410 686 GTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-TH 763 (927)
Q Consensus 686 gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~-~~ 763 (927)
|+|.+++.... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 120 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 196 (321)
T 2qkw_B 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196 (321)
T ss_dssp CBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC
T ss_pred CcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 99999997543 23468999999999999999999998 999999999999999999999999999998654322 22
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+......|.......+.....+++.+...
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (321)
T 2qkw_B 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK 276 (321)
T ss_dssp CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTC
T ss_pred cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccc
Confidence 22334589999999999888999999999999999999999999986555555566677666666777777888877777
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
...+....+.+++.+||+.||++|||++||++.|+++++..+
T Consensus 277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 788889999999999999999999999999999999988654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=397.73 Aligned_cols=261 Identities=19% Similarity=0.307 Sum_probs=200.1
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeec------CceE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQR 676 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~------~~~~ 676 (927)
.|++.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+..
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 4778899999999999999986 69999999997543 3345678899999999999999999998753 4678
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
|||||||+ |+|.+++. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.
T Consensus 135 ~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 99999996 68999997 35679999999999999999999999 9999999999999999999999999999987
Q ss_pred ccccc---cccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCe
Q 002410 757 AEEDL---THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832 (927)
Q Consensus 757 ~~~~~---~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 832 (927)
..... ........||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+.... +.........
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~---I~~~~g~p~~ 284 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQL---IMMVLGTPSP 284 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH---HHHHHCCCCG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHH---HHHhcCCCCh
Confidence 64321 2223446799999999998775 569999999999999999999999985543222111 1111110000
Q ss_pred ---eeecc-------ccccC--CCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 833 ---ISIVD-------PVLIG--NVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 833 ---~~~~d-------~~l~~--~~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
..... ..+.. ..+ ......+.+|+.+||+.||++|||++|+++.
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 00000 000 0112367899999999999999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=384.03 Aligned_cols=287 Identities=39% Similarity=0.699 Sum_probs=241.6
Q ss_pred cChhhHHHHH--HhhcccccccccEEEEEEEECCCcEEEEEEccCccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q 002410 597 IPLPELEEAT--NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEE 673 (927)
Q Consensus 597 ~~~~el~~~~--~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~-~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~ 673 (927)
+++.++.... |.+.+.||+|+||.||+|+.++|+.||||++...... ....+.+|++++++++||||+++++++.+.
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 4455555444 4457899999999999999888999999999764322 234689999999999999999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecc
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 752 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 752 (927)
+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+..+|+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 99999999999999999998654 34459999999999999999999999323399999999999999999999999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc--cchhhHHHHHHHhhhcC
Q 002410 753 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF--GAELNIVHWARSMIKKG 830 (927)
Q Consensus 753 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~--~~~~~l~~~~~~~~~~~ 830 (927)
+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......+|........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred cccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence 9987765544445555699999999999888899999999999999999999999963322 23445667777777777
Q ss_pred CeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 831 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 831 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
......+..+......+....+.+++.+||+.||++|||++||+++|++....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 77778888888888888999999999999999999999999999999975443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=385.15 Aligned_cols=194 Identities=25% Similarity=0.416 Sum_probs=167.4
Q ss_pred HHhhcccccccccEEEEEEEEC----CCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~----~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
.|++.++||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|+.+ +||||+++++++.++++.++||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 4778899999999999999864 46789999987543 345678999999998 6999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC-CcEEEeeccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEE 759 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFGla~~~~~ 759 (927)
||+++|+|.+++. .+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 100 E~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 100 PYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp ECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred eCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999999985 38899999999999999999999 999999999999999876 7999999999986543
Q ss_pred cccc---------------------------cccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCc
Q 002410 760 DLTH---------------------------ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSV 810 (927)
Q Consensus 760 ~~~~---------------------------~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~ 810 (927)
.... .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 2111 11234699999999998765 589999999999999999999999963
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=405.22 Aligned_cols=250 Identities=21% Similarity=0.341 Sum_probs=207.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.|++.+.||+|+||.||+|+.+ +|+.||+|++........+.+.+|+++|+.++|||||++++++.+++..++|||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 4678899999999999999986 699999999987666667789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC--CcEEEeecccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~--~~~kL~DFGla~~~~~~~~ 762 (927)
||+|.++|... ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 238 gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 238 GGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred CCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 99999998642 4579999999999999999999999 999999999999999854 8999999999998754322
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
.....||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+ ... .+...... +.+....
T Consensus 313 --~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~---~~~----~i~~~~~~--~~~~~~~ 381 (573)
T 3uto_A 313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLR----NVKSCDWN--MDDSAFS 381 (573)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH----HHHTTCCC--CCSGGGT
T ss_pred --eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHH----HHHhCCCC--CCccccc
Confidence 234569999999999999999999999999999999999999997443321 111 11111110 1111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.. ...+.+|+.+||+.||++|||++|+++
T Consensus 382 ~~----s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 382 GI----SEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12 236789999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=400.17 Aligned_cols=247 Identities=22% Similarity=0.273 Sum_probs=197.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHH---HHHHHHHhcCCCceeeeeeeeecCceEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFV---TEVALLSRIHHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~---~E~~~L~~l~HpnIv~l~~~~~~~~~~~L 678 (927)
.|++.++||+|+||+||+|+.+ +|+.||||++.+.. ........ +++.+++.++|||||++++++.+.+..|+
T Consensus 190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl 269 (689)
T 3v5w_A 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269 (689)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence 3567899999999999999987 59999999996432 11222333 34666777799999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
|||||+||+|.++|.. ...+++..+..++.||+.||+|||+ ++||||||||+||||+.+|++||+|||+|+...
T Consensus 270 VmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 270 ILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999984 4679999999999999999999998 999999999999999999999999999998765
Q ss_pred ccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 759 EDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 759 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
... ....+||+.|||||++.+ ..|+.++|+||+||++|||++|+.||......+...+... +.....
T Consensus 344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~----i~~~~~----- 411 (689)
T 3v5w_A 344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----TLTMAV----- 411 (689)
T ss_dssp SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH----HHHCCC-----
T ss_pred CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----hcCCCC-----
Confidence 432 234579999999999964 5799999999999999999999999975443332222221 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 875 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~eVl~ 875 (927)
.+.... ...+.+|+.+||+.||++|++ ++||++
T Consensus 412 -~~p~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 -ELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -CCCTTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -CCCccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111112 236789999999999999998 677765
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=367.83 Aligned_cols=263 Identities=34% Similarity=0.508 Sum_probs=204.6
Q ss_pred HHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
+....|++.+.||+|+||+||+|+.. |+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 33456778899999999999999874 8899999987643 33456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
|||+++|+|.+++........+++..++.++.|++.||+|||+ ++ |+||||||+||+++.++.+||+|||+++..
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 9999999999999854323348999999999999999999998 78 999999999999999999999999999865
Q ss_pred cccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.. .....
T Consensus 190 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~~~~---~~~~~---- 258 (309)
T 3p86_A 190 ASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVAAVGF---KCKRL---- 258 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHHHHHH---SCCCC----
T ss_pred ccccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh---cCCCC----
Confidence 43322 2233468999999999999999999999999999999999999997433211 1111111 11110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
.+ +......+.+++.+||+.||++|||++|+++.|+.++...
T Consensus 259 -~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 259 -EI----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp -CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred -CC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 11 1122246889999999999999999999999999988753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=366.55 Aligned_cols=258 Identities=25% Similarity=0.380 Sum_probs=212.6
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
..|.+.+.||+|+||+||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 34667899999999999999986 58999999987766677788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++|+|.+++... ...+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 999999999853 4679999999999999999999998 99999999999999999999999999999876443221
Q ss_pred c-------------ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccch---hhHHHHHHHhh
Q 002410 764 I-------------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE---LNIVHWARSMI 827 (927)
Q Consensus 764 ~-------------~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~---~~l~~~~~~~~ 827 (927)
. .....||+.|+|||++.+..++.++||||||+++|||++|..|+........ .........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-- 242 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR-- 242 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH--
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc--
Confidence 1 1134689999999999999999999999999999999999999874322211 111111111
Q ss_pred hcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 828 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 828 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
.. +...+..+.+++.+||+.||++|||++|+++.|+++....
T Consensus 243 -----------~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 243 -----------YC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp -----------TC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----------cC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 1111235789999999999999999999999999887654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=372.53 Aligned_cols=264 Identities=24% Similarity=0.450 Sum_probs=214.5
Q ss_pred HHHHhhcccccccccEEEEEEEEC--------CCcEEEEEEccCccc-hhHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 673 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~--------~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~ 673 (927)
...|.+.+.||+|+||.||+|++. ++..||||+++.... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 355677899999999999999863 356799999976533 3457899999999999 899999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 740 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl 740 (927)
+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 99999999999999999997543 12458999999999999999999998 999999999999999
Q ss_pred cCCCcEEEeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhh
Q 002410 741 DINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELN 818 (927)
Q Consensus 741 d~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~ 818 (927)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999986544322 12223446789999999999999999999999999999999 999997543322
Q ss_pred HHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhccC
Q 002410 819 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 886 (927)
Q Consensus 819 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~~ 886 (927)
+... +..+.... .+......+.+++.+||+.||++||+++|+++.|++++.....
T Consensus 314 ~~~~----~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 314 LFKL----LKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp HHHH----HHTTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHH----HhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 1111 11221111 1112234788999999999999999999999999999887654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=355.68 Aligned_cols=257 Identities=29% Similarity=0.475 Sum_probs=212.7
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
..|++.+.||+|+||.||+|.+.+++.||+|++..... ..+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 45677899999999999999998899999999986433 34678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.........
T Consensus 89 ~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 89 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 99999999743 4568999999999999999999998 999999999999999999999999999998765443333
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
.....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...... ..... +..+.. ...+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~~----~~~~~~--~~~~----- 229 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVED----ISTGFR--LYKP----- 229 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH----HHTTCC--CCCC-----
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHHH----HhcCcc--CCCC-----
Confidence 334456788999999998899999999999999999999 99999743321 11111 111110 0111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
......+.+++.+||+.||++||+++|+++.|+++.+.
T Consensus 230 --~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 230 --RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11234688999999999999999999999999998763
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=359.51 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=205.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.|++.+.||+|+||+||+|... +|+.||||++........+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 4666789999999999999864 689999999976555566789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+|+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 101 ~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 172 (297)
T 3fxz_A 101 GGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (297)
T ss_dssp TCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-
Confidence 9999999974 358999999999999999999998 99999999999999999999999999999876543332
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 844 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. .....+.. ... .
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~----~~~~~~~~-~~~-------~ 238 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LY----LIATNGTP-ELQ-------N 238 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH----HHHHHCSC-CCS-------C
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHhCCCC-CCC-------C
Confidence 2344689999999999999999999999999999999999999974332111 11 11111111 000 0
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 845 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 845 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+......+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1122346889999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=367.66 Aligned_cols=264 Identities=26% Similarity=0.494 Sum_probs=213.1
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC----CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCce
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 675 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~----~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~ 675 (927)
++....|++.+.||+|+||.||+|.+. .+..||||+++... ....+.+.+|++++++++||||+++++++.+++.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 445567788899999999999999985 35569999998653 3445789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
.++||||+++|+|.++++.. ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred cEEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999999999743 4579999999999999999999998 999999999999999999999999999998
Q ss_pred cccccccc--cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCe
Q 002410 756 QAEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 832 (927)
Q Consensus 756 ~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 832 (927)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ..... +..+..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~----~~~~~~ 272 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVISS----VEEGYR 272 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHH----HHTTCC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH----HHcCCC
Confidence 76543222 1222345778999999998899999999999999999999 99999743321 11111 111111
Q ss_pred eeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 833 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 833 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
. ..+......+.+++.+||+.||++||+++||++.|++++....
T Consensus 273 ~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 273 L---------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred C---------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 0 0111223478899999999999999999999999999987544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=356.67 Aligned_cols=260 Identities=28% Similarity=0.468 Sum_probs=213.3
Q ss_pred HHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
....|++.+.||+|+||.||+|+++++..||+|+++.... ..+++.+|++++++++||||+++++++.+++..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 3456778899999999999999999888999999976433 346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999999753 3468999999999999999999998 9999999999999999999999999999987655443
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ... . +..+.. ...+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~---~-~~~~~~--~~~~--- 227 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---VVL---K-VSQGHR--LYRP--- 227 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH---H-HHTTCC--CCCC---
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH---HHH---H-HHcCCC--CCCC---
Confidence 33334456778999999998889999999999999999999 999997433221 111 1 111111 0011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
......+.+++.+||+.||++|||++|+++.|+++...+
T Consensus 228 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 228 ----HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp ----TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred ----CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 111236889999999999999999999999999887644
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=355.29 Aligned_cols=280 Identities=36% Similarity=0.586 Sum_probs=225.5
Q ss_pred cccChhhHHHHHHhhc--------ccccccccEEEEEEEECCCcEEEEEEccCcc----chhHHHHHHHHHHHHhcCCCc
Q 002410 595 YFIPLPELEEATNNFC--------KKIGKGSFGSVYYGKMKDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRN 662 (927)
Q Consensus 595 ~~~~~~el~~~~~~~~--------~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~----~~~~~~~~~E~~~L~~l~Hpn 662 (927)
..+++.++...+.+|. +.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 3466788888888874 5699999999999987 58899999986532 234578999999999999999
Q ss_pred eeeeeeeeecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC
Q 002410 663 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 742 (927)
Q Consensus 663 Iv~l~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~ 742 (927)
|+++++++.+.+..++||||+++|+|.+++........+++..++.++.|++.||+|||+ ++|+||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcC
Confidence 999999999999999999999999999999765455679999999999999999999998 99999999999999999
Q ss_pred CCcEEEeeccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHH
Q 002410 743 NMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 821 (927)
Q Consensus 743 ~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~ 821 (927)
++.+||+|||+++........ ......|++.|+|||.+.+ .++.++||||||+++|||++|+.||........ +..
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLD 245 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHH
Confidence 999999999999875443222 2233468999999998875 588999999999999999999999975443321 111
Q ss_pred HHHHhhh-cCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 822 WARSMIK-KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 822 ~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
+...... ...+...+++.+ ..........+.+++.+||+.||++||+++||++.|+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1111111 112233333333 23456677889999999999999999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=367.89 Aligned_cols=267 Identities=25% Similarity=0.332 Sum_probs=208.5
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCc----eEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~----~~~LV~ 680 (927)
..|++.++||+|+||.||+|++. ++.||||++.... .....+.+|+.++++++||||+++++++.... ..++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 35667899999999999999987 8999999997542 33455667999999999999999999997643 479999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CeEecCCCCCcccccCCCcEEEee
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP----------GIIHRDVKSSNILLDINMRAKVSD 750 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~----------~ivH~DLkp~NILld~~~~~kL~D 750 (927)
||+++|+|.++++. ..+++..++.++.|++.||+|||+ . +|+||||||+|||++.++.+||+|
T Consensus 102 e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 102 AFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred ecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 99999999999974 358999999999999999999998 7 999999999999999999999999
Q ss_pred ccccccccccccc-cccccccCCCccCCCccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhh------
Q 002410 751 FGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN------ 818 (927)
Q Consensus 751 FGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~-----~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~------ 818 (927)
||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999876543322 2223468999999999976 356678999999999999999999997543321111
Q ss_pred ----HHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 819 ----IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 819 ----l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
...+... .........+.... ........+.+++.+||+.||++|||++||++.|+++.+..
T Consensus 255 ~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 255 QHPSLEDMQEV-VVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp SSCCHHHHHHH-HTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCchhhhhhh-hhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111 11111111111111 12245567999999999999999999999999999987653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=358.36 Aligned_cols=264 Identities=27% Similarity=0.411 Sum_probs=209.2
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc---cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
..|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 45677899999999999999976 6899999998543 2334578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++++|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 91 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 91 EYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp ECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999974 4579999999999999999999998 99999999999999999999999999999876554
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
.........||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .....+... .... ..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~-~~~~-~~-- 234 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQDS-VPNV-TT-- 234 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSSC-CCCH-HH--
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhcc-CCCc-ch--
Confidence 4333444568999999999999999999999999999999999999997433211 111111111 1110 01
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhhhhccC
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKIEKG 886 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-s~~eVl~~L~~~~~~e~~ 886 (927)
......+..+.+++.+||+.||++|| +++++.+.|++++.....
T Consensus 235 --~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 235 --DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp --HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred --hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 11112234788999999999999999 999999999988765543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=367.22 Aligned_cols=267 Identities=28% Similarity=0.457 Sum_probs=209.3
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-----CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeec--Cc
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EH 674 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~-----~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~ 674 (927)
+....|++.+.||+|+||.||+|++. +++.||||++........+.+.+|++++++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 34456778899999999999999852 588999999987766677889999999999999999999999855 34
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccc
Q 002410 675 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 754 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 754 (927)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred ceEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 589999999999999999753 3458999999999999999999998 99999999999999999999999999999
Q ss_pred cccccccc--ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc---------chhhHHHHH
Q 002410 755 RQAEEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG---------AELNIVHWA 823 (927)
Q Consensus 755 ~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~---------~~~~l~~~~ 823 (927)
+....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... .........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 87654322 1222334677899999999889999999999999999999999998733211 001111111
Q ss_pred HHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 824 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 824 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
...+..+... ..+...+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 242 ~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 242 IELLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhccCcC---------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 1222221111 1112233578899999999999999999999999998875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=355.69 Aligned_cols=261 Identities=27% Similarity=0.464 Sum_probs=211.9
Q ss_pred HHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
+....|++.+.||+|+||.||+|.+++++.||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 34456777899999999999999999888999999986533 34678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 100 YMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred ccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 99999999999752 3568999999999999999999998 999999999999999999999999999998765433
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... +..+.. ...
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~~~~~--~~~--- 242 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEH----IAQGLR--LYR--- 242 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHH----HHTTCC--CCC---
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHHH----HhcccC--CCC---
Confidence 333333446788999999998889999999999999999998 99999743321 11111 111110 000
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
+......+.+++.+||+.||++||+++|+++.|++++..+
T Consensus 243 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 243 ----PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp ----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 1111246889999999999999999999999999988754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=356.11 Aligned_cols=260 Identities=25% Similarity=0.375 Sum_probs=201.6
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHh--cCCCceeeeeeeeec----CceEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSR--IHHRNLVPLIGYCEE----EHQRIL 678 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~--l~HpnIv~l~~~~~~----~~~~~L 678 (927)
..|++.+.||+|+||+||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++.. ....++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 4567789999999999999998 5899999998643 34556677777776 789999999998644 356899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCcccccCCCcEEEee
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH--------TGCNPGIIHRDVKSSNILLDINMRAKVSD 750 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH--------~~~~~~ivH~DLkp~NILld~~~~~kL~D 750 (927)
||||+++|+|.++++ ...+++..++.++.|++.||+||| + ++|+||||||+|||++.++.+||+|
T Consensus 84 v~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECC
T ss_pred ehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEee
Confidence 999999999999996 346999999999999999999999 6 8999999999999999999999999
Q ss_pred cccccccccccccc---ccccccCCCccCCCccCCC------CCCcchhHHHHHHHHHHHHhC----------CCCCCcc
Q 002410 751 FGLSRQAEEDLTHI---SSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISG----------KKPVSVE 811 (927)
Q Consensus 751 FGla~~~~~~~~~~---~~~~~gt~~Y~APE~l~~~------~~s~ksDVwSlGvlL~eLltG----------~~Pf~~~ 811 (927)
||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997654433221 2234689999999999876 456799999999999999999 8888633
Q ss_pred cccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 812 DFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 812 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
.... ................... .+ ..........+.+++.+||+.||++|||++||++.|+++
T Consensus 237 ~~~~-~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPND-PSFEDMRKVVCVDQQRPNI-PN---RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSS-CCHHHHHHHHTTSCCCCCC-CG---GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC-cchhhhhHHHhccCCCCCC-Ch---hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2221 1111111111111111111 11 112234567899999999999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=356.29 Aligned_cols=247 Identities=25% Similarity=0.395 Sum_probs=204.5
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCC
Q 002410 608 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 686 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~g 686 (927)
...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 48 ~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 127 (321)
T 2c30_A 48 DSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGG 127 (321)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred hccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCC
Confidence 34568999999999999987 69999999998666666778999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccccc
Q 002410 687 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 766 (927)
Q Consensus 687 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 766 (927)
+|.+++. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++......... ..
T Consensus 128 ~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~ 199 (321)
T 2c30_A 128 ALTDIVS----QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RK 199 (321)
T ss_dssp BHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-BC
T ss_pred CHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc-cc
Confidence 9999987 3468999999999999999999998 99999999999999999999999999999876543222 23
Q ss_pred ccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCH
Q 002410 767 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 846 (927)
Q Consensus 767 ~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 846 (927)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+. ......... ..
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~~~~~----~~~~~~~~~-------~~ 265 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLR----DSPPPKLKN-------SH 265 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHH----HSSCCCCTT-------GG
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh----cCCCCCcCc-------cc
Confidence 446899999999999999999999999999999999999999743221 1111111 111111100 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 847 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 847 ~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.....+.+++.+||+.||++|||++|+++.
T Consensus 266 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 266 KVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 123468899999999999999999999863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=361.20 Aligned_cols=246 Identities=25% Similarity=0.409 Sum_probs=203.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
.|++.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 4667899999999999999984 7999999998654 234457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 96 ASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp CTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 999999999974 4568999999999999999999998 999999999999999999999999999998754432
Q ss_pred ccccccccCCCccCCCccCCCCCC-cchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s-~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
......||+.|+|||++.+..+. .++||||+||++|||++|+.||....... +.. .+..+... +
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~----~i~~~~~~------~- 233 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRE----RVLRGKYR------I- 233 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCCCC------C-
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhCCCC------C-
Confidence 23345699999999999887764 89999999999999999999997443221 111 11112110 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+......+.+++.+||+.||++|||++|+++.
T Consensus 234 ---p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 ---PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11122367899999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=369.16 Aligned_cols=273 Identities=24% Similarity=0.435 Sum_probs=218.8
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC--------CCcEEEEEEccCccc-hhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYC 670 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~--------~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l-~HpnIv~l~~~~ 670 (927)
++....+.+.+.||+|+||.||+|+.. .++.||||+++.... ...+++.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 444567778899999999999999863 245799999976533 3457899999999999 899999999999
Q ss_pred ecCceEEEEEEecCCCCHHHHhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 002410 671 EEEHQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 737 (927)
Q Consensus 671 ~~~~~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~N 737 (927)
..++..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ ++|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcce
Confidence 999999999999999999999975431 2469999999999999999999998 899999999999
Q ss_pred ccccCCCcEEEeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccc
Q 002410 738 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 815 (927)
Q Consensus 738 ILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~ 815 (927)
||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~- 300 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 300 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999987654322 22233457889999999999999999999999999999999 99999743321
Q ss_pred hhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhccCCCCccc
Q 002410 816 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFS 892 (927)
Q Consensus 816 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~~~~~~~s 892 (927)
.+.+ .+..+..... .......+.+++.+||+.||++||+++||++.|++++......+....
T Consensus 301 --~~~~----~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 362 (382)
T 3tt0_A 301 --ELFK----LLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362 (382)
T ss_dssp --HHHH----HHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred --HHHH----HHHcCCCCCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 1222 1222211111 111234688999999999999999999999999999988766555543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=352.00 Aligned_cols=273 Identities=22% Similarity=0.312 Sum_probs=214.2
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCc--eEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~--~~~LV~E 681 (927)
.|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 4567899999999999999987 48999999997543 234577889999999999999999999987655 7899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc----cCCCcEEEeeccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQA 757 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl----d~~~~~kL~DFGla~~~ 757 (927)
|+++|+|.+++........+++..++.++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999999999865445559999999999999999999998 999999999999999 78888999999999876
Q ss_pred cccccccccccccCCCccCCCccC--------CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc-hhhHHHHHHHhhh
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYG--------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA-ELNIVHWARSMIK 828 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~--------~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~-~~~l~~~~~~~~~ 828 (927)
..... .....||+.|+|||++. +..++.++|||||||++|||++|+.||....... .......+.....
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 54332 22345899999999885 5788999999999999999999999997433321 1122221111111
Q ss_pred cCCeeeec-----------cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 829 KGDVISIV-----------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 829 ~~~~~~~~-----------d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
........ +..............+.+++.+||+.||++|||++|+++...+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 11111100 00111234556777899999999999999999999999999876654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=370.08 Aligned_cols=263 Identities=27% Similarity=0.493 Sum_probs=202.2
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC----CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCce
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 675 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~----~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~ 675 (927)
++....+.+.+.||+|+||.||+|+++ ++..||||+++... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 334456777899999999999999875 57789999997643 3445789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
.++||||+++|+|.++++.. ...+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 99999999999999999743 4569999999999999999999998 899999999999999999999999999998
Q ss_pred ccccccccc--ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCe
Q 002410 756 QAEEDLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 832 (927)
Q Consensus 756 ~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 832 (927)
......... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .+... +..+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~~----i~~~~~ 268 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIKA----VDEGYR 268 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHHH----HHTTEE
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCC
Confidence 765432221 112235678999999998899999999999999999998 99999743321 12221 111111
Q ss_pred eeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 833 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 833 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
. ......+..+.+++.+||+.||++||+++||++.|++++...
T Consensus 269 ~---------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 269 L---------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp C---------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred C---------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 0 011123347889999999999999999999999999987643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=370.68 Aligned_cols=259 Identities=29% Similarity=0.433 Sum_probs=210.5
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
...+.+.+.||+|+||.||+|+++ +++.||||+++.... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 345667899999999999999987 689999999876433 334578999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++|+|.++++.. +..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999999999742 3468999999999999999999998 999999999999999999999999999998654322
Q ss_pred cccc-cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 762 THIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 762 ~~~~-~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
.... ....+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ...+ .+..+....
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~~----- 335 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTRE----FVEKGGRLP----- 335 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHH----HHHTTCCCC-----
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCCC-----
Confidence 1111 12235678999999998899999999999999999998 99999743321 1111 222221111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
.+...+..+.+++.+||+.||++|||++||++.|+++.+.
T Consensus 336 ----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 336 ----CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1112234688999999999999999999999999988653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=382.46 Aligned_cols=259 Identities=29% Similarity=0.446 Sum_probs=214.4
Q ss_pred HHHHHhhcccccccccEEEEEEEECC-CcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
....+.+.++||+|+||.||+|.++. ++.||||+++... ...++|.+|+++|++++||||++++++|...+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34456778999999999999999885 8899999997643 346789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++|+|.++++.. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999754 34568999999999999999999998 999999999999999999999999999998765433
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
........++..|+|||++.+..++.++|||||||++|||++ |+.||...+... +.+.+ ..+..
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~~-------- 437 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL----EKDYR-------- 437 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH----HTTCC--------
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcCCC--------
Confidence 332333446789999999998899999999999999999999 999997544322 22211 11111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
...+...+..+.+|+.+||+.||++||+++||++.|+++..
T Consensus 438 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 438 -MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred -CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 01112233478899999999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=380.58 Aligned_cols=260 Identities=24% Similarity=0.418 Sum_probs=211.8
Q ss_pred HHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
....+++.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|+++|++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 344567789999999999999999989999999998643 34678999999999999999999999987 5678999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.++++.. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 9999999999743 12367889999999999999999998 8999999999999999999999999999987654322
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
.......++..|+|||++....++.++|||||||++|||+| |+.||...... .+...+. .+....
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~----~~~~~~------- 405 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALE----RGYRMP------- 405 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHH----HTCCCC-------
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----cCCCCC-------
Confidence 22233346788999999988899999999999999999999 99999743322 1222111 111100
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
.+...+..+.+++.+||+.||++|||+++|++.|+++....
T Consensus 406 --~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 406 --RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred --CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 11122347889999999999999999999999999887643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.26 Aligned_cols=264 Identities=16% Similarity=0.191 Sum_probs=212.9
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEe
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
..|++.+.||+|+||.||+|+.. +|+.||||++.... ..+.+.+|+++++++ +|+|++++++++.+....++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 35667899999999999999974 68999999986532 334678899999999 799999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCc-----EEEeeccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-----AKVSDFGLSRQA 757 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~-----~kL~DFGla~~~ 757 (927)
+ +++|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++. +||+|||+++..
T Consensus 88 ~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 88 L-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 9 99999999853 4569999999999999999999998 99999999999999987776 999999999876
Q ss_pred cccccc------cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCC
Q 002410 758 EEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 831 (927)
Q Consensus 758 ~~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 831 (927)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+........
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 543221 22345689999999999999999999999999999999999999986544333332222222111111
Q ss_pred eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 832 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 832 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
... +.. ..+..+.+++.+||+.||++||++++|++.|++++....
T Consensus 242 ~~~-----~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 242 LRE-----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HHH-----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHH-----HHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 111 111 123478899999999999999999999999999987543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=352.06 Aligned_cols=261 Identities=24% Similarity=0.394 Sum_probs=200.3
Q ss_pred HHHHHHhhcccccccccEEEEEEEECC----CcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~----g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
+....|++.+.||+|+||.||+|.+.. +..||+|+++... ....+.+.+|+.++++++||||+++++++. ++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 334567788999999999999998753 4579999987643 334567999999999999999999999985 4568
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccc
Confidence 8999999999999999753 4568999999999999999999998 9999999999999999999999999999987
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
.............+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ ....+ ..+....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~i----~~~~~~~- 237 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI----ENGERLP- 237 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTTCCCC-
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHHH----HcCCCCC-
Confidence 65543333334456789999999988889999999999999999997 999997443322 12211 1111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
. +......+.+++.+||+.||++||+++|+++.|++++..+
T Consensus 238 ----~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 238 ----M----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1 1122346889999999999999999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=357.22 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=203.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.+.||+|+||.||+|+.+ +|+.||+|++++.. ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 4567899999999999999987 58999999997532 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 86 YANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp CCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999999974 4568999999999999999999998 999999999999999999999999999998643322
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.+ .... +.. .+.
T Consensus 160 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~---~i~~-~~~------~~p 225 (337)
T 1o6l_A 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE---LILM-EEI------RFP 225 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHH-CCC------CCC
T ss_pred C-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHH---HHHc-CCC------CCC
Confidence 2 223456899999999999999999999999999999999999999743321 1111 1111 111 111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 876 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~~ 876 (927)
. .....+.+++.+||+.||++|| +++||++.
T Consensus 226 ~----~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 226 R----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp T----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C----CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1 1224678999999999999999 89999764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=346.09 Aligned_cols=256 Identities=29% Similarity=0.470 Sum_probs=211.2
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
..|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 35667899999999999999998899999999986533 34678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+++|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++..........
T Consensus 87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 99999999753 4568999999999999999999998 999999999999999999999999999998764432222
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... +..+... ..+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----i~~~~~~--~~~----- 227 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVED----ISTGFRL--YKP----- 227 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH----HHTTCCC--CCC-----
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHHH----HhcCCcC--CCC-----
Confidence 233456788999999988889999999999999999999 89999743321 11111 1111110 001
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
......+.+++.+||+.||++||+++|+++.|+++.+
T Consensus 228 --~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 228 --RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1123468899999999999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=353.06 Aligned_cols=261 Identities=21% Similarity=0.288 Sum_probs=200.9
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
..|++.++||+|+||+||+|+..+|+.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 34667899999999999999998899999999875432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
++ |+|.+.+... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 101 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 101 ME-KDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp CS-EEHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred CC-CCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 97 4888888743 4568999999999999999999998 9999999999999999999999999999987643322
Q ss_pred ccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCC---eee----
Q 002410 763 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---VIS---- 834 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~---~~~---- 834 (927)
. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+... . +........ ...
T Consensus 175 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~-i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 175 S-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP--K-IFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH--H-HHHHHCCCCTTTSGGGTTS
T ss_pred c-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH--H-HHHHHCCCChHHhhhhhcc
Confidence 2 223458999999999876 568999999999999999999999997544432211 1 111111100 000
Q ss_pred ---------eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 835 ---------IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 835 ---------~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..+.............++.+|+.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000001112246789999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=351.90 Aligned_cols=263 Identities=29% Similarity=0.445 Sum_probs=218.0
Q ss_pred hHHHHHHhhcccccccccEEEEEEEECC-CcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
++....|++.+.||+|+||.||+|.++. ++.||+|++... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 4455667788999999999999999874 889999999754 34467899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
|||+++++|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 88 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 9999999999999754 34668999999999999999999998 8999999999999999999999999999987765
Q ss_pred cccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 760 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
..........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+... ..+.... ...
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~~~~----~~~------ 230 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEK----DYR------ 230 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHT----TCC------
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhc----cCC------
Confidence 44444444557889999999998899999999999999999999 999997544322 1221111 100
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
..........+.+++.+||+.||++||+++|+++.|+++....
T Consensus 231 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 231 ---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0111122347889999999999999999999999999887643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=359.18 Aligned_cols=268 Identities=24% Similarity=0.397 Sum_probs=209.0
Q ss_pred hHHHHHHhhcccccccccEEEEEEEE-----CCCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecC-
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE- 673 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~- 673 (927)
.+....|++.+.||+|+||.||+|++ .+++.||||+++... ....+.+.+|++++++++||||+++++++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 33445577789999999999999984 358899999997543 23457789999999999999999999999876
Q ss_pred -ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecc
Q 002410 674 -HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 752 (927)
Q Consensus 674 -~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 752 (927)
...++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CceEEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccc
Confidence 6689999999999999999643 4568999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccc--ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc--------chhhHHHH
Q 002410 753 LSRQAEEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG--------AELNIVHW 822 (927)
Q Consensus 753 la~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~--------~~~~l~~~ 822 (927)
++........ .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+...... ........
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 9987654332 2233345788899999999889999999999999999999999987522100 00011111
Q ss_pred HHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 823 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 823 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
....+..+... ..+......+.+++.+||+.||++|||++|+++.|+++++
T Consensus 252 ~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 252 LVNTLKEGKRL---------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHhccCCC---------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 11112211111 1112233478899999999999999999999999998763
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=351.96 Aligned_cols=262 Identities=29% Similarity=0.499 Sum_probs=204.0
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
..+++.+.||+|+||.||+|++. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 34567899999999999999986 789999998743 345789999999999999999999998874 4789999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCc-EEEeeccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-AKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~-~kL~DFGla~~~~~~~~~ 763 (927)
+|+|.+++........+++..++.++.|+++||+|||+.+.++|+||||||+||+++.++. +||+|||++.......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-- 160 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-- 160 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence 9999999986543345788999999999999999999754478999999999999998886 7999999997654322
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..... . ...+.... ....
T Consensus 161 --~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~---~-~~~~~~~~-----~~~~ 228 (307)
T 2eva_A 161 --TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-FRIMW---A-VHNGTRPP-----LIKN 228 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-HHHHH---H-HHTTCCCC-----CBTT
T ss_pred --ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-HHHHH---H-HhcCCCCC-----cccc
Confidence 22358999999999999999999999999999999999999997432221 11111 1 11111111 1111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhccCCCC
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQ 889 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~~~~~ 889 (927)
....+.+++.+||+.||++|||++|+++.|+++...-...+.
T Consensus 229 ----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 229 ----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred ----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 224688999999999999999999999999998876544443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=354.62 Aligned_cols=262 Identities=26% Similarity=0.421 Sum_probs=212.9
Q ss_pred HHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCce
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 675 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~ 675 (927)
....|.+.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3455677899999999999999862 45789999997643 3445789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 002410 676 RILVYEYMHNGTLRDRLHGSVN---------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK 734 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~---------------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLk 734 (927)
.++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ ++|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence 9999999999999999985432 2348999999999999999999998 999999999
Q ss_pred CCcccccCCCcEEEeeccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccc
Q 002410 735 SSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVED 812 (927)
Q Consensus 735 p~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~ 812 (927)
|+||+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876443222 2223446788999999988889999999999999999999 999997443
Q ss_pred ccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 813 FGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 813 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
... +... +..+.... ........+.+++.+||+.||++||+++|+++.|++++..
T Consensus 258 ~~~---~~~~----~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PER---LFNL----LKTGHRME---------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGG---HHHH----HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHH---HHHH----hhcCCcCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 322 1121 11111111 1112234788999999999999999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=355.72 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=201.2
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
.|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 4567899999999999999987 689999999865432 23466889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc-c
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-T 762 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~-~ 762 (927)
++|+|.+++. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 88 ~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 88 SGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp TTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999997 35679999999999999999999998 999999999999999999999999999998654322 1
Q ss_pred ccccccccCCCccCCCccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 763 HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .....+... .... .+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~----~~~~---~~--- 230 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK----KTYL---NP--- 230 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHHTT----CTTS---TT---
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhcc----cccC---Cc---
Confidence 22234568999999999977665 789999999999999999999997443321 222222111 1000 00
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.......+.+|+.+||+.||++|||++|+++.
T Consensus 231 ---~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 ---WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01123467899999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=347.59 Aligned_cols=250 Identities=30% Similarity=0.434 Sum_probs=193.6
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCccc----hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS----HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~----~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
..|++.+.||+|+||.||+|.+. ++.||||+++.... ...+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 34667899999999999999986 89999999875432 23467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC---eEecCCCCCcccccC--------CCcEEEe
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG---IIHRDVKSSNILLDI--------NMRAKVS 749 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~---ivH~DLkp~NILld~--------~~~~kL~ 749 (927)
||+++++|.+++. ...+++..++.++.|++.||+|||+ ++ |+||||||+||+++. ++.+||+
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 9999999999986 4568999999999999999999998 67 999999999999986 7789999
Q ss_pred eccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc
Q 002410 750 DFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 829 (927)
Q Consensus 750 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 829 (927)
|||+++....... ....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+... ... ....
T Consensus 159 Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~---~~~~- 228 (271)
T 3dtc_A 159 DFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---VAY---GVAM- 228 (271)
T ss_dssp CCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHH---HHHT-
T ss_pred cCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---hhhc-
Confidence 9999986544322 23458999999999998889999999999999999999999997433211 111 1111
Q ss_pred CCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 830 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 830 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
..... ..+......+.+++.+||+.||++|||++|+++.|+++
T Consensus 229 ~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 NKLAL--------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp SCCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCC--------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11110 11122234788999999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=357.97 Aligned_cols=262 Identities=27% Similarity=0.445 Sum_probs=211.3
Q ss_pred HHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
...|++.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 345667899999999999999985 348899999986533 3457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 002410 677 ILVYEYMHNGTLRDRLHGSVN---------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKS 735 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~---------------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp 735 (927)
++||||+++|+|.+++..... ...+++.+++.++.||++||+|||+ ++|+||||||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp 202 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLAT 202 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCc
Confidence 999999999999999975321 2578999999999999999999998 9999999999
Q ss_pred CcccccCCCcEEEeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccc
Q 002410 736 SNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDF 813 (927)
Q Consensus 736 ~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~ 813 (927)
+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 999999999999999999987543321 22233457889999999988889999999999999999999 9999974332
Q ss_pred cchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 814 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 814 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
. .... .+..+..... +......+.+++.+||+.||++||+++||++.|+++....
T Consensus 283 ~---~~~~----~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 283 E---EVIY----YVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp H---HHHH----HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred H---HHHH----HHhCCCcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 1 1111 2222222111 1122346889999999999999999999999999987643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=363.99 Aligned_cols=264 Identities=27% Similarity=0.429 Sum_probs=210.5
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCccc-hhHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 673 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~ 673 (927)
+....|++.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 34456778899999999999999842 467899999976433 3457799999999999 799999999998775
Q ss_pred c-eEEEEEEecCCCCHHHHhccCCC-------------------------------------------------------
Q 002410 674 H-QRILVYEYMHNGTLRDRLHGSVN------------------------------------------------------- 697 (927)
Q Consensus 674 ~-~~~LV~E~~~~gsL~~~L~~~~~------------------------------------------------------- 697 (927)
+ ..++||||+++|+|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 5 48999999999999999975431
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc-cccccc
Q 002410 698 --------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVA 768 (927)
Q Consensus 698 --------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~ 768 (927)
...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ......
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 1228999999999999999999999 9999999999999999999999999999987543322 223344
Q ss_pred ccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHH
Q 002410 769 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 847 (927)
Q Consensus 769 ~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 847 (927)
.||+.|+|||++.+..++.++|||||||++|||++ |+.||....... .... .+..+..... +..
T Consensus 256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~~~~~~~---------~~~ 320 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKEGTRMRA---------PDY 320 (359)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHH----HHHHTCCCCC---------CTT
T ss_pred CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHH----HHHcCCCCCC---------CCC
Confidence 57889999999998899999999999999999998 999997443322 1111 1111111111 111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 848 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 848 ~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
....+.+++.+||+.||++|||++||+++|++++..
T Consensus 321 ~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 321 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 223688999999999999999999999999998864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=359.05 Aligned_cols=255 Identities=23% Similarity=0.318 Sum_probs=207.0
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
......|++.+.||+|+||.||+|..+ +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 344567888999999999999999986 58999999997542 334567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC---CcEEEeecccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLS 754 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~---~~~kL~DFGla 754 (927)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||++
T Consensus 105 lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EEECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 99999999999999873 4578999999999999999999998 999999999999999865 45999999999
Q ss_pred ccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 755 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 755 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+... +..+....
T Consensus 179 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~----i~~~~~~~ 249 (362)
T 2bdw_A 179 IEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQ----IKAGAYDY 249 (362)
T ss_dssp BCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHTCCCC
T ss_pred eEecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHH----HHhCCCCC
Confidence 87654322 22346899999999999999999999999999999999999999743321 11111 11121110
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
..+ .. ......+.+++.+||+.||++||++.|+++.
T Consensus 250 -~~~-~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 -PSP-EW----DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -CTT-GG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -Ccc-cc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00 1123468899999999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=376.13 Aligned_cols=261 Identities=27% Similarity=0.435 Sum_probs=206.9
Q ss_pred HHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
....+++.++||+|+||.||+|.++++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 344567789999999999999999988899999998643 235689999999999999999999999876 678999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999999743 23468999999999999999999998 9999999999999999999999999999987654332
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .... .+..+...
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~----~i~~~~~~-------- 400 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD----QVERGYRM-------- 400 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTTCCC--------
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC--------
Confidence 22233446789999999988899999999999999999999 99999743321 1111 11222110
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
..+...+..+.+++.+||+.||++|||+++|++.|+++.....
T Consensus 401 -~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 401 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 0112234478899999999999999999999999999876443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=357.15 Aligned_cols=259 Identities=23% Similarity=0.408 Sum_probs=203.1
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCc----EEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~----~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
....|++.+.||+|+||+||+|++. +++ .||+|.++... ....+.+.+|+.++++++||||+++++++.++. .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 3455677899999999999999975 344 36888886433 344578999999999999999999999998765 7
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++|+||+++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 92 ~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 8999999999999999853 4578999999999999999999998 8999999999999999999999999999987
Q ss_pred ccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 757 AEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 757 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +... +..+....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~----~~~~~~~~ 239 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LEKGERLP 239 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTCCCC
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHH----HHcCCCCC
Confidence 6443222 2223346889999999999999999999999999999999 999997544322 1111 11111100
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
........+.+++.+||+.||++||+++|+++.|+++...
T Consensus 240 ---------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 240 ---------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ---------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 1112234688999999999999999999999999988754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=353.47 Aligned_cols=261 Identities=19% Similarity=0.229 Sum_probs=210.2
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEec
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
.|++.+.||+|+||.||+|+.. +|+.||||++..... .+.+.+|+++++++ +||||+++++++..++..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 4567899999999999999974 689999999875422 34688999999999 9999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCc-----EEEeecccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-----AKVSDFGLSRQAE 758 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~-----~kL~DFGla~~~~ 758 (927)
+++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++. +||+|||+++...
T Consensus 88 -~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 88 -GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred -CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999999853 4679999999999999999999998 89999999999999998887 9999999998754
Q ss_pred ccccc------cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCe
Q 002410 759 EDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832 (927)
Q Consensus 759 ~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 832 (927)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 43221 123456999999999999999999999999999999999999999855433322222222111111000
Q ss_pred eeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 833 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 833 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
..+.. ..+ .+.+++.+|++.||.+||++++|++.|+++....
T Consensus 242 -----~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 242 -----EVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp -----HHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----HHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 00000 112 7889999999999999999999999999887653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=352.96 Aligned_cols=252 Identities=22% Similarity=0.294 Sum_probs=205.3
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccch------hHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~------~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
...|.+.+.||+|+||.||+|..+ +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456788999999999999999987 5899999998754321 357799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC----cEEEeecc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFG 752 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~----~~kL~DFG 752 (927)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999973 4679999999999999999999998 9999999999999998887 89999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCe
Q 002410 753 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832 (927)
Q Consensus 753 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 832 (927)
+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+. ....
T Consensus 164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~----~~~~ 234 (326)
T 2y0a_A 164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVS----AVNY 234 (326)
T ss_dssp TCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH----HTCC
T ss_pred CCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHH----hcCC
Confidence 9987643322 233458999999999999999999999999999999999999997433211 111111 1110
Q ss_pred eeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 833 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 833 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
. ....... .....+.+++.+||+.||++|||++|+++.
T Consensus 235 ~--~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 E--FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp C--CCHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C--cCccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0000111 112367899999999999999999999873
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=366.04 Aligned_cols=266 Identities=27% Similarity=0.452 Sum_probs=213.1
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 673 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~ 673 (927)
++....+++.+.||+|+||.||+|++. +++.||||+++... .....++.+|+.++++++||||+++++++.+.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 444566778899999999999999854 46789999997543 34556789999999999999999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC---cE
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RA 746 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~---~~ 746 (927)
+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999997543 23468999999999999999999999 9999999999999999555 59
Q ss_pred EEeeccccccccccc-cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHH
Q 002410 747 KVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 824 (927)
Q Consensus 747 kL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 824 (927)
||+|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .+...
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~~-- 298 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEF-- 298 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH--
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH--
Confidence 999999998653322 122233457899999999988899999999999999999998 99999743321 12221
Q ss_pred HhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 825 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 825 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
+..+.... ........+.+++.+||+.||++||+++||++.|+.+.....
T Consensus 299 --i~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 299 --VTSGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp --HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred --HHcCCCCC---------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 11111111 111223468899999999999999999999999998876543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=355.66 Aligned_cols=249 Identities=24% Similarity=0.329 Sum_probs=203.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccch------hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~------~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~L 678 (927)
.|++.+.||+|+||.||+|+.+ +|+.||+|+++..... ..+.+.+|+.+|++++||||+++++++.+.+..++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 4667899999999999999987 5899999999754322 34678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC----cEEEeecccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFGLS 754 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~----~~kL~DFGla 754 (927)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||++
T Consensus 93 v~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 93 ILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999973 5679999999999999999999998 9999999999999998776 7999999999
Q ss_pred ccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 755 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 755 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
+....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+ ... . +..+...
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~~~---~-i~~~~~~- 236 (361)
T 2yab_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLA---N-ITAVSYD- 236 (361)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH---H-HHTTCCC-
T ss_pred eEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H-HHhcCCC-
Confidence 87654322 233469999999999999999999999999999999999999997443211 111 1 1111110
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.++..... ....+.+++.+||..||++|||++|+++
T Consensus 237 -~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 -FDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -CCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111111 1236789999999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=355.26 Aligned_cols=264 Identities=26% Similarity=0.423 Sum_probs=197.1
Q ss_pred HHHHHhhcccccccccEEEEEEEECCC----cEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMKDG----KEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~~g----~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
....|++.+.||+|+||.||+|++... ..||||+++.. .....+.+.+|++++++++||||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 345677889999999999999987643 27999999764 344567899999999999999999999999876655
Q ss_pred ------EEEEEecCCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEE
Q 002410 677 ------ILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 747 (927)
Q Consensus 677 ------~LV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~k 747 (927)
++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEE
Confidence 99999999999999986432 22368999999999999999999998 9999999999999999999999
Q ss_pred Eeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHH
Q 002410 748 VSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 825 (927)
Q Consensus 748 L~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 825 (927)
|+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+ .....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~-- 252 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYNYL-- 252 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH--
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHHHH--
Confidence 999999987644322 12223346788999999998899999999999999999999 999997443322 11111
Q ss_pred hhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 826 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 826 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
. .+.... ........+.+++.+||+.||++|||+.|+++.|++++.-..
T Consensus 253 -~-~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 253 -I-GGNRLK---------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp -H-TTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred -h-cCCCCC---------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 1 111100 111223478899999999999999999999999999987543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=345.38 Aligned_cols=254 Identities=31% Similarity=0.532 Sum_probs=202.9
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchh-------HHHHHHHHHHHHhcCCCceeeeeeeeecCc
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR-------TQQFVTEVALLSRIHHRNLVPLIGYCEEEH 674 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~-------~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~ 674 (927)
....|++.+.||+|+||.||+|++. +++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3355677899999999999999985 68999999986532211 167899999999999999999999997665
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcccccCCCc-----EE
Q 002410 675 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMR-----AK 747 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivH~DLkp~NILld~~~~-----~k 747 (927)
++||||+++|+|.+.+... ...+++..++.++.|++.||+|||+ ++ |+||||||+||+++.++. +|
T Consensus 97 --~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred --eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 6999999999999988743 4579999999999999999999998 78 999999999999988776 99
Q ss_pred EeeccccccccccccccccccccCCCccCCCcc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 002410 748 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY--GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 825 (927)
Q Consensus 748 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l--~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 825 (927)
|+|||+++..... .....||+.|+|||.+ ....++.++|||||||++|||++|+.||........ .......
T Consensus 170 l~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~- 243 (287)
T 4f0f_A 170 VADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINMIR- 243 (287)
T ss_dssp ECCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHHHHHH-
T ss_pred eCCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHHHHHh-
Confidence 9999999854432 2334689999999998 455678999999999999999999999974443221 1111111
Q ss_pred hhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 826 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 826 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
..+ .. +.+ .......+.+++.+||+.||++||+++|+++.|+++
T Consensus 244 --~~~-~~----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 --EEG-LR----PTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp --HSC-CC----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred --ccC-CC----CCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111 11 111 112234788999999999999999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=362.73 Aligned_cols=269 Identities=25% Similarity=0.372 Sum_probs=211.4
Q ss_pred HHHHhhcccccccccEEEEEEEE-----CCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeee--cCceE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQR 676 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~-----~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~--~~~~~ 676 (927)
...|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 34567789999999999999985 358899999998776667788999999999999999999999886 55678
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999999753 3468999999999999999999998 9999999999999999999999999999987
Q ss_pred ccccccc--cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccch--------hhHHHHHHHh
Q 002410 757 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--------LNIVHWARSM 826 (927)
Q Consensus 757 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~--------~~l~~~~~~~ 826 (927)
....... ......++..|+|||.+.+..++.++|||||||++|||++|+.||........ ..........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6443321 22334578889999999988899999999999999999999999863322100 0000111111
Q ss_pred hhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhccC
Q 002410 827 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 886 (927)
Q Consensus 827 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~~ 886 (927)
+..+.. ..........+.+++.+||+.||++|||++|+++.|+++......
T Consensus 257 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 257 LEEGQR---------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred hhcccC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 111111 111223345788999999999999999999999999998775543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=351.90 Aligned_cols=265 Identities=28% Similarity=0.435 Sum_probs=214.3
Q ss_pred HHHHHHhhcccccccccEEEEEEEE------CCCcEEEEEEccCccc-hhHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 673 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~------~~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~ 673 (927)
+....|.+.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3345677889999999999999985 2467899999976543 3457899999999999 899999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcc
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSVN---------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 738 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~~---------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NI 738 (927)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ ++|+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceE
Confidence 999999999999999999975432 2258999999999999999999998 9999999999999
Q ss_pred cccCCCcEEEeeccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccch
Q 002410 739 LLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 816 (927)
Q Consensus 739 Lld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~ 816 (927)
+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 255 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS- 255 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-
Confidence 9999999999999999876544322 2223447789999999988899999999999999999999 999997443321
Q ss_pred hhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 817 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 817 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
........ +.. .. ........+.+++.+||+.||++||+++|+++.|++++...
T Consensus 256 -~~~~~~~~----~~~-~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 256 -KFYKMIKE----GFR-ML--------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp -HHHHHHHH----TCC-CC--------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -HHHHHhcc----CCC-CC--------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 11111111 110 00 01112347889999999999999999999999999988753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=370.42 Aligned_cols=253 Identities=30% Similarity=0.489 Sum_probs=207.2
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCc-eEEEEEEec
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRILVYEYM 683 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-~~~LV~E~~ 683 (927)
..+++.+.||+|+||.||+|.++ |+.||||+++... ..+.|.+|+++|++++||||+++++++...+ ..++||||+
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 45667899999999999999987 7899999998643 4578999999999999999999999986654 789999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp TTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 999999999854 23457899999999999999999998 999999999999999999999999999998643321
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
....+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+ .... +..+....
T Consensus 344 --~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~----i~~~~~~~-------- 406 (450)
T 1k9a_A 344 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYKMD-------- 406 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHH----HHTTCCCC--------
T ss_pred --cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCCCCC--------
Confidence 12246889999999999999999999999999999998 999997443322 1111 11221111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
.+...+..+.+++.+||+.||++|||++||++.|+++...+
T Consensus 407 -~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 407 -APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred -CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 11223347889999999999999999999999999887643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=360.25 Aligned_cols=269 Identities=19% Similarity=0.271 Sum_probs=204.5
Q ss_pred HHhhccccccc--ccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 606 TNNFCKKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 606 ~~~~~~~LG~G--~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
.|++.++||+| +||.||+|+.+ +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 46778999999 99999999987 69999999997543 334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++|+|.+++... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||.+......
T Consensus 106 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 106 SFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp ECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999999999754 23568999999999999999999998 99999999999999999999999999988654322
Q ss_pred cc------ccccccccCCCccCCCccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhh----
Q 002410 761 LT------HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---- 828 (927)
Q Consensus 761 ~~------~~~~~~~gt~~Y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~---- 828 (927)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +.........
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLD 259 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC----------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCcccc
Confidence 11 11122358899999999987 6799999999999999999999999975433221 1110000000
Q ss_pred c-----C-------------Ceeeec---ccc------ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHh
Q 002410 829 K-----G-------------DVISIV---DPV------LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQD 879 (927)
Q Consensus 829 ~-----~-------------~~~~~~---d~~------l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~--L~~ 879 (927)
. . ...... .+. ............+.+|+.+||+.||++|||++|+++. +++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 0 0 000000 000 0000111223468899999999999999999999865 444
Q ss_pred h
Q 002410 880 S 880 (927)
Q Consensus 880 ~ 880 (927)
+
T Consensus 340 ~ 340 (389)
T 3gni_B 340 I 340 (389)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=347.45 Aligned_cols=261 Identities=26% Similarity=0.434 Sum_probs=211.9
Q ss_pred HHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
+....|++.+.||+|+||.||+|..++++.||||+++... ...+.+.+|++++++++||||+++++++.. +..++|||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 3345677889999999999999999988899999997543 335789999999999999999999999874 45899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++++|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 88 YMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp CCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred cCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 99999999999742 12368999999999999999999998 999999999999999999999999999998765443
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... +..+.. ...
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~----~~~~~~-----~~~ 231 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQN----LERGYR-----MVR 231 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----HHTTCC-----CCC
T ss_pred cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHH----HhcccC-----CCC
Confidence 333334456789999999988889999999999999999999 99999743321 11111 111111 001
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
.......+.+++.+||+.||++||+++++++.|+++....
T Consensus 232 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 232 ----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 1122347889999999999999999999999999987654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=351.44 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=198.6
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCc--------
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-------- 674 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-------- 674 (927)
..|++.+.||+|+||.||+|+++ +|+.||||+++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 45677899999999999999987 79999999997543 335578999999999999999999999885433
Q ss_pred -------------------------------------------------eEEEEEEecCCCCHHHHhccCCCCCCCCHHH
Q 002410 675 -------------------------------------------------QRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 705 (927)
Q Consensus 675 -------------------------------------------------~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~ 705 (927)
..++||||+++|+|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 3799999999999999998655455567778
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc-----------ccccccccCCCc
Q 002410 706 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-----------HISSVARGTVGY 774 (927)
Q Consensus 706 ~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~-----------~~~~~~~gt~~Y 774 (927)
++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 99999999999999998 9999999999999999999999999999987654321 112234589999
Q ss_pred cCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHH
Q 002410 775 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 854 (927)
Q Consensus 775 ~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 854 (927)
+|||++.+..++.++|||||||++|||++|..|+. ..... . ........... .......+.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~---~-~~~~~~~~~~~---------~~~~~~~~~~ 304 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRI---I-TDVRNLKFPLL---------FTQKYPQEHM 304 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHH---H-HHHHTTCCCHH---------HHHHCHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHH---H-HHhhccCCCcc---------cccCChhHHH
Confidence 99999999999999999999999999999877753 11111 1 11111111110 1122346789
Q ss_pred HHHHhhccCCCCCCCHHHHHH
Q 002410 855 VAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 855 Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
++.+||+.||++||+++|+++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCCCcCCCHHHHhh
Confidence 999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=358.68 Aligned_cols=256 Identities=23% Similarity=0.309 Sum_probs=205.3
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-----chhHHHHHHHHHHHHhcCCCceeeeeeeeecCce
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 675 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~ 675 (927)
+....|++.+.||+|+||.||+|..+ +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 44567889999999999999999886 68999999986421 1235779999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCc---EEEeec
Q 002410 676 RILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDF 751 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~---~kL~DF 751 (927)
.++||||+++|+|.+.+.... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecC
Confidence 999999999999988876432 34468999999999999999999998 99999999999999987655 999999
Q ss_pred cccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCC
Q 002410 752 GLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 831 (927)
Q Consensus 752 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 831 (927)
|+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.. . +..+.
T Consensus 178 g~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~---~-i~~~~ 248 (351)
T 3c0i_A 178 GVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFE---G-IIKGK 248 (351)
T ss_dssp TTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHH---H-HHHTC
T ss_pred cceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHH---H-HHcCC
Confidence 99987654322 2233468999999999999999999999999999999999999997432 11111 1 11111
Q ss_pred eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 832 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 832 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.. ..+..... ....+.+++.+||+.||++||++.|+++
T Consensus 249 ~~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 YK--MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC--CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 01111111 1246889999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=348.84 Aligned_cols=256 Identities=22% Similarity=0.396 Sum_probs=205.1
Q ss_pred HHHHHHhhcccccccccEEEEEEEECC-C-------cEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKD-G-------KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 673 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~-g-------~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~ 673 (927)
+....|.+.+.||+|+||.||+|+... + +.||+|++........+.+.+|++++++++||||+++++++.++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 344567788999999999999998763 3 57999999876666778899999999999999999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCc--------
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-------- 745 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~-------- 745 (927)
+..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccce
Confidence 9999999999999999999853 3448999999999999999999998 99999999999999998887
Q ss_pred EEEeeccccccccccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH
Q 002410 746 AKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 824 (927)
Q Consensus 746 ~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~ 824 (927)
+||+|||++...... ....+++.|+|||.+.+ ..++.++|||||||++|||++|..|+...... ........
T Consensus 160 ~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~~~~~~ 232 (289)
T 4fvq_A 160 IKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRKLQFYE 232 (289)
T ss_dssp EEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHH
T ss_pred eeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--HHHHHHhh
Confidence 999999998765432 12347889999999987 67899999999999999999965544322111 11111111
Q ss_pred HhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 825 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 825 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
......... ...+.+++.+||+.||++|||++|+++.|++++.-.
T Consensus 233 ---~~~~~~~~~------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 233 ---DRHQLPAPK------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp ---TTCCCCCCS------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred ---ccCCCCCCC------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 111111111 125779999999999999999999999999988743
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=346.67 Aligned_cols=259 Identities=19% Similarity=0.289 Sum_probs=198.6
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~--~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
|++.+.||+|+||.||+|+..+|+.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 5677899999999999999988999999998654322 24678899999999999999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+ +|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 84 ~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 156 (288)
T 1ob3_A 84 Q-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK- 156 (288)
T ss_dssp E-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred C-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc-
Confidence 5 999988743 4568999999999999999999998 99999999999999999999999999999865432221
Q ss_pred ccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcC---Ceee-----e
Q 002410 765 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVIS-----I 835 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~---~~~~-----~ 835 (927)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+.. +....... .... .
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMR-IFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHHCCCCTTTSTTGGGSTT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHHCCCChhhchhhhcccc
Confidence 223458999999999876 468999999999999999999999997443221 1111 11111100 0000 0
Q ss_pred cccccc-------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 836 VDPVLI-------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 836 ~d~~l~-------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.++... ..........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 011000 0111123346789999999999999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=357.01 Aligned_cols=267 Identities=27% Similarity=0.420 Sum_probs=210.6
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeec
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE 672 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~ 672 (927)
++....|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+++++++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 444566778899999999999999962 46689999997543 33457899999999999 89999999999999
Q ss_pred CceEEEEEEecCCCCHHHHhccCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 002410 673 EHQRILVYEYMHNGTLRDRLHGSVNQ--------------------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRD 732 (927)
Q Consensus 673 ~~~~~LV~E~~~~gsL~~~L~~~~~~--------------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~D 732 (927)
.+..++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+ ++|+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCC
Confidence 99999999999999999999854321 347999999999999999999998 9999999
Q ss_pred CCCCcccccCCCcEEEeeccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCc
Q 002410 733 VKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSV 810 (927)
Q Consensus 733 Lkp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~ 810 (927)
|||+|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++|||||||++|||+| |..||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999999999999876543322 2233457889999999988899999999999999999998 9999974
Q ss_pred ccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 811 EDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 811 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
..... ..... +..+... ..+......+.+++.+||+.||++||+++||++.|+.++....
T Consensus 278 ~~~~~--~~~~~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 278 IPVDA--NFYKL----IQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCCSH--HHHHH----HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CCcHH--HHHHH----HhcCCCC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 43321 12221 1111110 0111123478899999999999999999999999999887543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=346.10 Aligned_cols=247 Identities=27% Similarity=0.372 Sum_probs=194.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--------------------------hhHHHHHHHHHHHHhc
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------------------------HRTQQFVTEVALLSRI 658 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--------------------------~~~~~~~~E~~~L~~l 658 (927)
.|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 4667899999999999999876 588999999865421 1135688999999999
Q ss_pred CCCceeeeeeeeec--CceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 002410 659 HHRNLVPLIGYCEE--EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 736 (927)
Q Consensus 659 ~HpnIv~l~~~~~~--~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~ 736 (927)
+||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.||+.||+|||+ ++|+||||||+
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 166 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS 166 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence 99999999999976 668899999999999988654 4579999999999999999999998 89999999999
Q ss_pred cccccCCCcEEEeeccccccccccccccccccccCCCccCCCccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 002410 737 NILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDF 813 (927)
Q Consensus 737 NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---~s~ksDVwSlGvlL~eLltG~~Pf~~~~~ 813 (927)
|||++.++.+||+|||+++........ .....||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 999999999999999999876543222 23346899999999997654 47899999999999999999999974322
Q ss_pred cchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 814 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 814 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
. .+.. .+......... . ......+.+++.+||+.||++||+++|+++
T Consensus 246 ~---~~~~----~~~~~~~~~~~----~----~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 M---CLHS----KIKSQALEFPD----Q----PDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp H---HHHH----HHHHCCCCCCS----S----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred H---HHHH----HHhcccCCCCC----c----cccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 1111 11111111000 0 112246889999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=356.01 Aligned_cols=261 Identities=25% Similarity=0.388 Sum_probs=208.1
Q ss_pred hhcccccccccEEEEEEEEC-----CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeec--CceEEEE
Q 002410 608 NFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILV 679 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~-----~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~~~~LV 679 (927)
++.+.||+|+||.||++.++ +++.||||+++.... ...+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 67899999999999998754 588999999986543 445779999999999999999999999977 4678999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 114 ~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp ECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999974 348999999999999999999998 9999999999999999999999999999987654
Q ss_pred ccc--ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc--------hhhHHHHHHHhhhc
Q 002410 760 DLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--------ELNIVHWARSMIKK 829 (927)
Q Consensus 760 ~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~--------~~~l~~~~~~~~~~ 829 (927)
... .......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ...........+..
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 332 12233457888999999998889999999999999999999999997332110 00001111111221
Q ss_pred CCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 830 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 830 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
+.. ..........+.+++.+||+.||++|||++|+++.|+++...-
T Consensus 267 ~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 267 GER---------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccC---------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 111 1112223357889999999999999999999999999887654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=353.06 Aligned_cols=250 Identities=19% Similarity=0.304 Sum_probs=204.1
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.|.+.+.||+|+||.||+|... +++.||+|++... ......+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 4667899999999999999987 5889999998754 3445678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC--CCcEEEeecccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~--~~~~kL~DFGla~~~~~~~~ 762 (927)
+|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+++.......
T Consensus 85 g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 85 GLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 99999999742 3568999999999999999999998 99999999999999987 78999999999987654322
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .... +... .++....
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~---~i~~-~~~~--~~~~~~~ 228 (321)
T 1tki_A 160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIE---NIMN-AEYT--FDEEAFK 228 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH---HHHH-TCCC--CCHHHHT
T ss_pred --cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHH---HHHc-CCCC--CChhhhc
Confidence 23345899999999999988999999999999999999999999743321 1111 1111 1110 0000011
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
. ....+.+++.+||+.||++|||+.|+++.
T Consensus 229 ~----~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 229 E----ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp T----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c----CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 12468899999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.75 Aligned_cols=259 Identities=28% Similarity=0.447 Sum_probs=206.3
Q ss_pred HHHhhcccccccccEEEEEEEECC----CcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~----g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
..|.+.+.||+|+||.||+|++.+ +..||+|++.... ....+.+.+|++++++++||||+++++++.++ ..++|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEE
Confidence 456678999999999999998653 3469999997653 34567899999999999999999999998754 56899
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
|||+++++|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.....
T Consensus 91 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 91 MELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 9999999999999753 4568999999999999999999998 9999999999999999999999999999987655
Q ss_pred cccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 760 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
..........+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ...... .+.....
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~~----~~~~~~~--- 235 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVLE----KGDRLPK--- 235 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHHH----HTCCCCC---
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHHh----cCCCCCC---
Confidence 43333344457889999999988899999999999999999998 999997433322 111111 1111100
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
.......+.+++.+||+.||++||+++|+++.|+++...+.
T Consensus 236 ------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 236 ------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence 11122468899999999999999999999999999987654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=365.04 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=204.7
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
...|++.+.||+|+||.||+|... +|+.+|+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 466888999999999999999876 68999999987543 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc---CCCcEEEeeccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQA 757 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld---~~~~~kL~DFGla~~~ 757 (927)
||+++|+|.+.+.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||++...
T Consensus 90 E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999874 4569999999999999999999998 9999999999999998 4678999999999876
Q ss_pred cccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
...... .....||+.|+|||++.+..++.++||||+||++|+|++|..||...+.. .+.. .+..+... ...
T Consensus 164 ~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~----~i~~~~~~-~~~ 234 (444)
T 3soa_A 164 EGEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQ----QIKAGAYD-FPS 234 (444)
T ss_dssp CTTCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH----HHHHTCCC-CCT
T ss_pred cCCCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHH----HHHhCCCC-CCc
Confidence 543322 23356999999999999999999999999999999999999999743321 1111 11122111 001
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+ ... .....+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~-~~~----~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 235 P-EWD----TVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp T-TTT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred c-ccc----cCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1 001 123468899999999999999999999873
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=354.27 Aligned_cols=266 Identities=24% Similarity=0.447 Sum_probs=213.5
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC--------CCcEEEEEEccCccc-hhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCE 671 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~--------~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~ 671 (927)
+....|.+.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|+++++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34456778899999999999999874 467899999976533 4457799999999999 8999999999999
Q ss_pred cCceEEEEEEecCCCCHHHHhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcc
Q 002410 672 EEHQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 738 (927)
Q Consensus 672 ~~~~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NI 738 (927)
+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ ++|+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceE
Confidence 99999999999999999999985431 2348999999999999999999998 9999999999999
Q ss_pred cccCCCcEEEeeccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccch
Q 002410 739 LLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 816 (927)
Q Consensus 739 Lld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~ 816 (927)
+++.++.+||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-- 266 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 266 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--
Confidence 9999999999999999876543221 1223346788999999988889999999999999999999 99999743321
Q ss_pred hhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhccC
Q 002410 817 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 886 (927)
Q Consensus 817 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~~ 886 (927)
.+... +..+.... ........+.+++.+||+.||++||+++|+++.|++++.....
T Consensus 267 -~~~~~----~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 267 -ELFKL----LKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp -HHHHH----HHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -HHHHH----HhcCCCCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 11111 11111111 1112234688999999999999999999999999999887654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=345.78 Aligned_cols=260 Identities=21% Similarity=0.295 Sum_probs=198.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|++.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 567889999999999999986 58999999997543 234477889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++ +|.+.+.. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 84 DQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp SE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred CC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence 75 56555543 24679999999999999999999999 8999999999999999999999999999987643322
Q ss_pred cccccccCCCccCCCccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc---CCeeeec---
Q 002410 764 ISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVISIV--- 836 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~-~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~---~~~~~~~--- 836 (927)
......||+.|+|||++.+.. ++.++|||||||++|||++|..||..... .. .....+...... .......
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~-~~-~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VD-DQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-HH-HHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC-HH-HHHHHHHHHhCCCChhhhhhhcccc
Confidence 223345899999999997765 79999999999999999999888642221 11 111111111110 0000000
Q ss_pred c---------ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 837 D---------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 837 d---------~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+ ..............+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 00000111223446789999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=347.89 Aligned_cols=269 Identities=25% Similarity=0.377 Sum_probs=205.5
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhc--CCCceeeeeeeeecC----
Q 002410 600 PELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEE---- 673 (927)
Q Consensus 600 ~el~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l--~HpnIv~l~~~~~~~---- 673 (927)
.+.....|++.+.||+|+||.||+|++. ++.||||++... ....+.+|.+++..+ +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 4455678888999999999999999987 899999998643 234455566666655 899999999998776
Q ss_pred ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC--------CeEecCCCCCcccccCCCc
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP--------GIIHRDVKSSNILLDINMR 745 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~--------~ivH~DLkp~NILld~~~~ 745 (927)
...++||||+++|+|.++++. ..+++..++.++.|++.||+|||+ + +|+||||||+|||++.++.
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCCCC
Confidence 789999999999999999973 368999999999999999999997 6 9999999999999999999
Q ss_pred EEEeecccccccccccccc---ccccccCCCccCCCccCCCCCCcc------hhHHHHHHHHHHHHhC----------CC
Q 002410 746 AKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPEYYGNQQLTEK------SDVYSFGVVLLELISG----------KK 806 (927)
Q Consensus 746 ~kL~DFGla~~~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~k------sDVwSlGvlL~eLltG----------~~ 806 (927)
+||+|||+++......... .....||+.|+|||++.+.....+ +|||||||++|||++| +.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 9999999997654432221 123468999999999987766655 9999999999999999 66
Q ss_pred CCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 807 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 807 Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
||........ .... .................. ........+.+++.+||+.||++|||++||++.|+++.+..
T Consensus 261 p~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 261 PYHDLVPSDP-SYED-MREIVCIKKLRPSFPNRW---SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTTTSCSSC-CHHH-HHHHHTTSCCCCCCCGGG---GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cHhhhcCCCC-chhh-hHHHHhhhccCccccccc---hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 6653222111 1111 111111111111111110 12256678999999999999999999999999999988754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=360.07 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=199.4
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~ 676 (927)
+....|++.+.||+|+||.||+|+.+ +|+.||||++++.. ....+.+.+|.++++.+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 33455777899999999999999987 58999999997532 23446688999999988 699999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 999999999999999974 4569999999999999999999998 9999999999999999999999999999986
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.+ ... .+..
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~---~i~-~~~~---- 241 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DLFE---AIL-NDEV---- 241 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHH-HCCC----
T ss_pred cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HHHH---HHH-cCCC----
Confidence 43222 2233456999999999999889999999999999999999999999744322 1111 111 1111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCH------HHHHH
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM------QEIVL 875 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~------~eVl~ 875 (927)
.. +......+.+++.+||+.||++||++ +|+++
T Consensus 242 --~~----p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 --VY----PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --CC----CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --CC----CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 01 11122367899999999999999998 67765
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=338.97 Aligned_cols=252 Identities=22% Similarity=0.375 Sum_probs=204.1
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecC--ceEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~~~LV~ 680 (927)
..|++.+.||+|+||.||+|+++ ++.||||+++... ....+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 45667899999999999999986 8999999997543 34456799999999999999999999999876 7889999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
||+++|+|.+++... ....+++..++.++.|++.||+|||+ ++ |+||||||+||+++.++.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999853 23468999999999999999999998 78 9999999999999999999999998876532
Q ss_pred ccccccccccccCCCccCCCccCCCCCCc---chhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 759 EDLTHISSVARGTVGYLDPEYYGNQQLTE---KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 759 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~---ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
. ....||+.|+|||.+.+...+. ++|||||||++|||++|+.||....... . .......+..
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~---~~~~~~~~~~--- 229 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME---I---GMKVALEGLR--- 229 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH---H---HHHHHHSCCC---
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH---H---HHHHHhcCCC---
Confidence 2 2235789999999998765544 8999999999999999999997433211 1 1111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
+.. +......+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 230 --~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 230 --PTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111 11223468899999999999999999999999998754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=359.13 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=198.4
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV 679 (927)
..|++.++||+|+||.||+|+.+ +++.||+|++++.. ....+.+.+|..+++++ +||||+++++++.+.+..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 34667899999999999999987 57899999997542 22335688899999887 899999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 132 ~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999974 4579999999999999999999998 9999999999999999999999999999986332
Q ss_pred cccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc--hhhHHHHHHHhhhcCCeeeecc
Q 002410 760 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--ELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d 837 (927)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .....+.....+.....
T Consensus 206 ~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----- 279 (396)
T 4dc2_A 206 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----- 279 (396)
T ss_dssp TT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-----
T ss_pred CC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-----
Confidence 22 22334569999999999999999999999999999999999999996433221 11111222222222211
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 870 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 870 (927)
.+ +......+.+|+.+||+.||++||++
T Consensus 280 -~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 -RI----PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -CC----CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -CC----CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11 11122367899999999999999996
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=351.90 Aligned_cols=249 Identities=24% Similarity=0.318 Sum_probs=180.7
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEEEEEecCCCCH
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTL 688 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~LV~E~~~~gsL 688 (927)
+.||+|+||.||+|.++ +++.||||++... ....+.+|+.++++++ ||||+++++++.+++..++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 78999999999999986 5899999998643 3466788999999997 99999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC---cEEEeeccccccccccccccc
Q 002410 689 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 689 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~---~~kL~DFGla~~~~~~~~~~~ 765 (927)
.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++........ .
T Consensus 94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-~ 166 (325)
T 3kn6_A 94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-L 166 (325)
T ss_dssp HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-c
Confidence 999984 4679999999999999999999998 9999999999999997765 8999999999865443222 2
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..............+..+.... .... .
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~----~ 240 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF--EGEA----W 240 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC--CSHH----H
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC--Cccc----c
Confidence 334579999999999999999999999999999999999999975443211111111222222222110 0000 0
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 846 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 846 ~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
......+.+|+.+||+.||++|||++|+++
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 112346889999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=345.62 Aligned_cols=264 Identities=30% Similarity=0.532 Sum_probs=199.4
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 600 PELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 600 ~el~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
.|+....|++.++||+|+||.||+|+.. ..||||+++... ....+.+.+|++++++++||||+++++++. .+..+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccE
Confidence 3555667788899999999999999865 359999987543 344578999999999999999999999764 45689
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 96 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccc
Confidence 999999999999999643 4668999999999999999999998 99999999999999999999999999999865
Q ss_pred cccc-cccccccccCCCccCCCccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCee
Q 002410 758 EEDL-THISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 833 (927)
Q Consensus 758 ~~~~-~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 833 (927)
.... ........||+.|+|||.+. +..++.++||||||+++|||++|+.||...... ..+.+. +..+...
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~----~~~~~~~ 244 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEM----VGRGSLS 244 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHH----HHHTSCC
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHH----hcccccC
Confidence 4321 12223345899999999986 567888999999999999999999999743321 122222 2222211
Q ss_pred eeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 834 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 834 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
.... ......+..+.+++.+||+.||++||+++|+++.|+++.+
T Consensus 245 ~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 245 PDLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cchh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1111 1112233578899999999999999999999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=365.18 Aligned_cols=254 Identities=23% Similarity=0.290 Sum_probs=203.6
Q ss_pred HHhhcccccccccEEEEEEEECC-CcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.++||+|+||+||+|+++. ++.||+|++++... ...+.+.+|..+++.++||||+++++++.+++..++|||
T Consensus 75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~E 154 (437)
T 4aw2_A 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154 (437)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEe
Confidence 45667899999999999999874 78999999875321 122348899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 155 y~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 155 YYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp CCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred cCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 99999999999842 4679999999999999999999998 999999999999999999999999999998765544
Q ss_pred cccccccccCCCccCCCccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 762 THISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
........||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+. ...+......-....
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~---~~~i~~~~~~~~~p~-- 304 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIMNHKERFQFPT-- 304 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTHHHHCCCCS--
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---HHhhhhccccccCCc--
Confidence 44444567999999999986 56789999999999999999999999974433221 111111000001111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 876 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPs~~eVl~~ 876 (927)
.... ....+.+|+.+||..+|++ ||+++|+++.
T Consensus 305 ---~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 305 ---QVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ---SCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ---cccc----CCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0011 1236789999999888888 9999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=356.63 Aligned_cols=251 Identities=21% Similarity=0.338 Sum_probs=206.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.|++.+.||+|+||.||+|..+ +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 4677899999999999999986 689999999987655666789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC--CCcEEEeecccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~--~~~~kL~DFGla~~~~~~~~ 762 (927)
+|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+++.......
T Consensus 132 gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 132 GGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 99999998742 4568999999999999999999998 99999999999999974 57799999999987654322
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+. ..... .++....
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~i~----~~~~~--~~~~~~~ 275 (387)
T 1kob_A 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVK----RCDWE--FDEDAFS 275 (387)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHH----HCCCC--CCSSTTT
T ss_pred --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHHHHH----hCCCC--CCccccc
Confidence 22345899999999999999999999999999999999999999743321 1111111 11110 1111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.....+.+++.+||+.||++|||++|+++.
T Consensus 276 ----~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 276 ----SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ----TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ----cCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 223468899999999999999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=348.15 Aligned_cols=270 Identities=25% Similarity=0.387 Sum_probs=212.9
Q ss_pred hhhHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHh--cCCCceeeeeeeeecCc--
Q 002410 599 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSR--IHHRNLVPLIGYCEEEH-- 674 (927)
Q Consensus 599 ~~el~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~--l~HpnIv~l~~~~~~~~-- 674 (927)
..+.....|.+.+.||+|+||.||+|++. |+.||||++... ..+.+.+|.++++. ++||||+++++++...+
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 34566778888999999999999999985 899999998643 34667889999887 68999999999998765
Q ss_pred --eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCcccccCCC
Q 002410 675 --QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH--------TGCNPGIIHRDVKSSNILLDINM 744 (927)
Q Consensus 675 --~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH--------~~~~~~ivH~DLkp~NILld~~~ 744 (927)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+||| + ++|+||||||+|||++.++
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTS
T ss_pred cceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCC
Confidence 78999999999999999974 35899999999999999999999 6 8999999999999999999
Q ss_pred cEEEeeccccccccccccc---cccccccCCCccCCCccCCC------CCCcchhHHHHHHHHHHHHhC----------C
Q 002410 745 RAKVSDFGLSRQAEEDLTH---ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISG----------K 805 (927)
Q Consensus 745 ~~kL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~------~~s~ksDVwSlGvlL~eLltG----------~ 805 (927)
.+||+|||++......... ......||+.|+|||++.+. .++.++|||||||++|||++| +
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 9999999999876543322 12344689999999998765 334789999999999999999 7
Q ss_pred CCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 806 KPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 806 ~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
.||....... .....+.. .+........+.... ...+....+.+++.+||+.||++||+++||++.|+++...+
T Consensus 265 ~p~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 265 LPYYDLVPSD-PSVEEMRK-VVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CTTTTTSCSS-CCHHHHHH-HHTTSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cCccccCcCc-ccHHHHHH-HHHHHHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 7886432221 11112222 121111111111111 13356678999999999999999999999999999987654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=358.14 Aligned_cols=274 Identities=22% Similarity=0.308 Sum_probs=214.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCc--eEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~--~~~LV~E 681 (927)
.|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 4567899999999999999987 48999999997543 234567889999999999999999999987655 7899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc----cCCCcEEEeeccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQA 757 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl----d~~~~~kL~DFGla~~~ 757 (927)
|+++|+|.+++........+++..++.++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 99999999999865444559999999999999999999998 999999999999999 78888999999999876
Q ss_pred cccccccccccccCCCccCCCccCC--------CCCCcchhHHHHHHHHHHHHhCCCCCCcccccc-hhhHHHHHHHhhh
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYGN--------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA-ELNIVHWARSMIK 828 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~-~~~l~~~~~~~~~ 828 (927)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .......+.....
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp CCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred cCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 54322 223458999999999864 567889999999999999999999997433321 1111111111111
Q ss_pred cCCeeeec-----------cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 829 KGDVISIV-----------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 829 ~~~~~~~~-----------d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
........ +..............+.+++.+||+.||++||+++|+++.+++++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 11111000 001112334667778999999999999999999999999999988754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=348.15 Aligned_cols=263 Identities=21% Similarity=0.308 Sum_probs=190.6
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
..|++.+.||+|+||.||+|..+ +|+.||+|+++.... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 35677899999999999999876 589999999875432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 683 MHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 683 ~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
++ |+|.+++.... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 98 69999886432 23468999999999999999999998 9999999999999999999999999999987643
Q ss_pred cccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcC---Ceeee
Q 002410 760 DLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVISI 835 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~---~~~~~ 835 (927)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. ...+....... .....
T Consensus 161 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 161 PVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp CCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCGGG
T ss_pred Cccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhhhh
Confidence 3221 223458999999999876 4689999999999999999999999975443221 11111111100 00000
Q ss_pred -----ccccc------------cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 836 -----VDPVL------------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 836 -----~d~~l------------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..+.. ...........+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000 00001112346889999999999999999999886
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=351.33 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=199.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
.|++.+.||+|+||.||+|+.+ +++.||+|+++... ....+.+.+|..+++++ +||||+++++++.+.+..++||
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 4667899999999999999987 58899999997542 23456788999999988 8999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 90 EYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999974 3568999999999999999999998 99999999999999999999999999999864322
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccch--hhHHHHHHHhhhcCCeeeeccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--LNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..........+.....
T Consensus 164 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 236 (345)
T 3a8x_A 164 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 236 (345)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------
T ss_pred CC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------
Confidence 21 23345699999999999999999999999999999999999999974322111 0111112222222211
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 870 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 870 (927)
.+. ......+.+++.+||+.||++||++
T Consensus 237 ~~p----~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 RIP----RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCC----TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCC----CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 111 1123467899999999999999996
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=353.27 Aligned_cols=270 Identities=17% Similarity=0.231 Sum_probs=207.2
Q ss_pred HHHHhhcccccccccEEEEEEEECC------CcEEEEEEccCccchh-----------HHHHHHHHHHHHhcCCCceeee
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHR-----------TQQFVTEVALLSRIHHRNLVPL 666 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~~------g~~vAvK~l~~~~~~~-----------~~~~~~E~~~L~~l~HpnIv~l 666 (927)
...|++.+.||+|+||.||+|.++. ++.||||++....... ...+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 3457778999999999999999875 4789999987543211 1224456667778889999999
Q ss_pred eeeeecC----ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc-
Q 002410 667 IGYCEEE----HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD- 741 (927)
Q Consensus 667 ~~~~~~~----~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld- 741 (927)
++++... ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEec
Confidence 9998764 4589999999 99999999752 4679999999999999999999999 8999999999999999
Q ss_pred -CCCcEEEeecccccccccccccc------ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 002410 742 -INMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 814 (927)
Q Consensus 742 -~~~~~kL~DFGla~~~~~~~~~~------~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~ 814 (927)
.++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 88999999999998764432211 12344999999999999999999999999999999999999999843322
Q ss_pred chhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 815 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 815 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
............ ..+..++++.+.. ...+..+.+++..|++.+|++||++++|++.|++++....
T Consensus 268 --~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 268 --PKYVRDSKIRYR-ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp --HHHHHHHHHHHH-HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --HHHHHHHHHHhh-hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 122222221111 1222233322211 1123478899999999999999999999999999887543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=346.16 Aligned_cols=244 Identities=22% Similarity=0.359 Sum_probs=202.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.+.||+|+||.||+|+.+ +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 4667899999999999999987 68999999997532 1234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 87 YIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp CCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 9999999999984 4568999999999999999999998 99999999999999999999999999999875432
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .. ...... +.. .+.
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~---~~~i~~-~~~------~~p 223 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KT---YEKILN-AEL------RFP 223 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HH---HHHHHH-CCC------CCC
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HH---HHHHHh-CCC------CCC
Confidence 23356899999999999999999999999999999999999999743321 11 111111 111 011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 876 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~~ 876 (927)
. .....+.+++.+||+.||++|| +++|+++.
T Consensus 224 ~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 224 P----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp T----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C----CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1 1223678999999999999999 88888753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=350.44 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=202.7
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcE----EEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKE----VAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~----vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~L 678 (927)
..|++.+.||+|+||.||+|++. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 34567899999999999999976 3443 7888875432 233456788999999999999999999986 456889
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999999753 3578899999999999999999998 899999999999999999999999999998765
Q ss_pred ccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 759 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 759 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
..... ......++..|+|||++.+..++.++|||||||++|||++ |+.||....... .... +..+.....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~~~~~~- 238 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDL----LEKGERLAQ- 238 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHH----HHTTCBCCC-
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHH----HHcCCCCCC-
Confidence 43322 2234457889999999998899999999999999999999 999997543322 1111 111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
+ ......+.+++.+||+.||++||+++|+++.|+++...
T Consensus 239 -~-------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 239 -P-------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp -C-------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred -C-------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 00112467899999999999999999999999988754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.20 Aligned_cols=259 Identities=22% Similarity=0.322 Sum_probs=200.1
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
..|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 35677899999999999999986 688999999875432 23477899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++++|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 114 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 114 RLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp ECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999984 3568999999999999999999998 99999999999999999999999999999876544
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCe-eeecccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV-ISIVDPV 839 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~-~~~~d~~ 839 (927)
.........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+..... ....
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~--- 257 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPRPSTV--- 257 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCCGGGT---
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCCcccc---
Confidence 333333456899999999999999999999999999999999999999743221 11111211110 0011
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhhhhc
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKIE 884 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-s~~eVl~~L~~~~~~e 884 (927)
....+..+.+++.+||+.||++|| +++++++.|++++...
T Consensus 258 -----~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 258 -----RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp -----STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred -----CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 111223688999999999999999 9999999999887654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=379.56 Aligned_cols=261 Identities=27% Similarity=0.439 Sum_probs=212.2
Q ss_pred HHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
+....+++.++||+|+||.||+|.++++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3344567789999999999999999988899999998643 235689999999999999999999999876 67899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++|+|.++++.. ....+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 342 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999999743 23458999999999999999999998 999999999999999999999999999998765432
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
........++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.+ .+..+....
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~----~i~~~~~~~------ 484 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD----QVERGYRMP------ 484 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHH----HHHTTCCCC------
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCCC------
Confidence 222223346788999999988899999999999999999999 99999743321 1222 122221110
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
........+.+|+.+||+.||++||++++|++.|+++....
T Consensus 485 ---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 485 ---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 11122347889999999999999999999999999887543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=349.99 Aligned_cols=261 Identities=21% Similarity=0.284 Sum_probs=193.9
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcC-CCceeeeeeee--------e
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYC--------E 671 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~--------~ 671 (927)
+....|++.++||+|+||.||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++ .
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 33446778899999999999999976 68999999987666666788999999999996 99999999998 3
Q ss_pred cCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcccccCCCcEEEe
Q 002410 672 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVS 749 (927)
Q Consensus 672 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivH~DLkp~NILld~~~~~kL~ 749 (927)
.....++|+||++ |+|.+++........+++..++.++.||+.||+|||+ ++ |+||||||+|||++.++.+||+
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEe
Confidence 4456899999995 7999988754445679999999999999999999998 77 9999999999999999999999
Q ss_pred ecccccccccccccc-----------ccccccCCCccCCCcc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc
Q 002410 750 DFGLSRQAEEDLTHI-----------SSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 815 (927)
Q Consensus 750 DFGla~~~~~~~~~~-----------~~~~~gt~~Y~APE~l---~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~ 815 (927)
|||+++......... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~- 259 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL- 259 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-
Confidence 999998765432211 1133589999999998 5667899999999999999999999999732211
Q ss_pred hhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 816 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 816 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
.... +.... .... .....+.+++.+||+.||++||+++|+++.|+++.....
T Consensus 260 -----~~~~-----~~~~~----~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 260 -----RIVN-----GKYSI----PPHD----TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ----------------CCC----CTTC----CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred -----Hhhc-----CcccC----Cccc----ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 0000 00000 0001 111247799999999999999999999999999876543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=340.72 Aligned_cols=258 Identities=24% Similarity=0.417 Sum_probs=209.2
Q ss_pred Hhhcc-cccccccEEEEEEEEC---CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 607 NNFCK-KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 607 ~~~~~-~LG~G~~G~Vy~a~~~---~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
+.+.+ .||+|+||.||+|.+. +++.||||+++... ....+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus 11 ~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 89 (287)
T 1u59_A 11 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVME 89 (287)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEE
Confidence 34444 8999999999999864 57889999998643 34567899999999999999999999999 4566899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++++|.+++.. ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 90 MAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp CCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred eCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 9999999999974 24569999999999999999999998 999999999999999999999999999998764432
Q ss_pred ccc--ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 762 THI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 762 ~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... +..+....
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~----i~~~~~~~---- 233 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQGKRME---- 233 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH----HHTTCCCC----
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH----HhcCCcCC----
Confidence 221 223346889999999988889999999999999999999 99999744322 12221 11221111
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhccC
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 886 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~~ 886 (927)
.+......+.+++.+||+.||++||++.|+++.|+++......
T Consensus 234 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 234 -----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp -----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred -----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 1112234788999999999999999999999999999876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=354.56 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=203.6
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
..|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 45677899999999999999987 58899999986532 233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999983 5679999999999999999999998 99999999999999999999999999999876433
Q ss_pred ccccccccccCCCccCCCccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 761 LTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........+...... ...
T Consensus 169 ~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----~~~----- 237 (384)
T 4fr4_A 169 T--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----TVV----- 237 (384)
T ss_dssp C--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----CCC-----
T ss_pred C--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----ccc-----
Confidence 2 2234569999999999864 4589999999999999999999999975444333222222111 110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVL 875 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-~~eVl~ 875 (927)
.++......+.+|+.+||+.||++||+ +++|++
T Consensus 238 -----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 -----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 011122346889999999999999998 676654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.46 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=206.5
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeee-ecCceEEEEEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC-EEEHQRILVYE 681 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~-~~~~~~~LV~E 681 (927)
...|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++|++++..+..+ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 356778899999999999999974 68999999875432 224578899999999988877777665 66778899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc---cCCCcEEEeecccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFGla~~~~ 758 (927)
|+ +++|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred cc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 99 99999998743 4569999999999999999999998 999999999999999 789999999999998765
Q ss_pred ccccc------cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCe
Q 002410 759 EDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832 (927)
Q Consensus 759 ~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 832 (927)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 43321 123456899999999999999999999999999999999999999854443222222221111111110
Q ss_pred eeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 833 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 833 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
+.+... .+..+.+++.+||+.||++||+++||++.|+++.....
T Consensus 240 -----~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 240 -----EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -----HHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -----hhhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 000011 12478899999999999999999999999999987544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=362.84 Aligned_cols=251 Identities=23% Similarity=0.297 Sum_probs=201.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.++||+|+||+||+|+.+ +++.||+|++++... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 149 (410)
T 3v8s_A 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 149 (410)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4566789999999999999987 588999999865221 123457899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++|+|.++++. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 150 ~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 150 YMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp CCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 9999999999973 358999999999999999999998 999999999999999999999999999998765544
Q ss_pred cccccccccCCCccCCCccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQ----LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~----~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+... ....+......-.... .
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~~~~~~~~~p~--~ 297 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TYSKIMNHKNSLTFPD--D 297 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHTHHHHCCCCT--T
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh---HHHHHHhccccccCCC--c
Confidence 33344567999999999987654 7899999999999999999999997443221 1111111000000000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 876 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPs~~eVl~~ 876 (927)
......+.+|+.+||+.+|++ ||+++||++.
T Consensus 298 --------~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 298 --------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --------CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --------ccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 011236789999999999988 9999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=343.07 Aligned_cols=263 Identities=21% Similarity=0.304 Sum_probs=201.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc---cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.+.||+|+||.||+|... +|+.||||+++.. .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 5778899999999999999975 6899999998752 23455778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 682 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
|+++++|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 999999999986422 35668999999999999999999998 99999999999999999999999999999875443
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ...+.. .+..........
T Consensus 190 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~----~~~~~~~~~~~~--- 260 (310)
T 2wqm_A 190 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK----KIEQCDYPPLPS--- 260 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHH----HHHTTCSCCCCT---
T ss_pred Ccc-ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHH----HhhcccCCCCcc---
Confidence 221 22345899999999999999999999999999999999999999743321 111211 122222211111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
......+.+++.+||+.||++||+++||++.|+++.....
T Consensus 261 -----~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 261 -----DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -----cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 1123468899999999999999999999999999887654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=349.15 Aligned_cols=249 Identities=23% Similarity=0.351 Sum_probs=193.8
Q ss_pred HHHHhhcccccccccEEEEEEEE----CCCcEEEEEEccCcc----chhHHHHHHHHHHHHhcCCCceeeeeeeeecCce
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 675 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~ 675 (927)
...|++.+.||+|+||.||+|+. .+|+.||+|+++... ......+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 34577889999999999999987 468999999997642 2234568889999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999974 4568899999999999999999998 899999999999999999999999999997
Q ss_pred cccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 756 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 756 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .... ...
T Consensus 170 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~---~i~~-~~~--- 238 (327)
T 3a62_A 170 ESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTID---KILK-CKL--- 238 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH---HHHH-TCC---
T ss_pred ccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHHH---HHHh-CCC---
Confidence 6433222 223346899999999999999999999999999999999999999744321 1111 1111 111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 876 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~~ 876 (927)
.+ +......+.+++.+||+.||++|| +++|+++.
T Consensus 239 ---~~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 ---NL----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ---CC----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ---CC----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 01 111234688999999999999999 77787763
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=340.73 Aligned_cols=258 Identities=29% Similarity=0.461 Sum_probs=203.0
Q ss_pred HhhcccccccccEEEEEEEECC----CcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeee-ecCceEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYC-EEEHQRILVY 680 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~----g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~-~~~~~~~LV~ 680 (927)
|++.+.||+|+||.||+|++.+ ...+|+|.+.... ....+.+.+|+.++++++||||+++++++ ..++..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 5567899999999999998753 2368999987643 34557899999999999999999999986 4566789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++|+|.+++.. ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 107 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 107 PYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp ECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999974 24568999999999999999999998 99999999999999999999999999999876443
Q ss_pred cc---ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 761 LT---HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 761 ~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
.. .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||......+ ...... .+... .
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~~~----~~~~~--~ 252 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLL----QGRRL--L 252 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHHHH----TTCCC--C
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHHh----cCCCC--C
Confidence 21 11223457788999999998899999999999999999999 555665332211 111111 11110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
. +......+.+++.+||+.||++||+++|+++.|++++..-.
T Consensus 253 ~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 253 Q-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred C-------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0 11122468899999999999999999999999999887543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=355.61 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=199.1
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCH
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 688 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL 688 (927)
.+.||+|+||.||+|... +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 467999999999999876 6899999999876666678899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc--cCCCcEEEeecccccccccccccccc
Q 002410 689 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISS 766 (927)
Q Consensus 689 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl--d~~~~~kL~DFGla~~~~~~~~~~~~ 766 (927)
.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++....... ..
T Consensus 174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~ 246 (373)
T 2x4f_A 174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LK 246 (373)
T ss_dssp HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CC
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cc
Confidence 9988642 3568999999999999999999998 999999999999999 5678999999999987654322 22
Q ss_pred ccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCH
Q 002410 767 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 846 (927)
Q Consensus 767 ~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 846 (927)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+. ..... .. .. .+....
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~----~i~~~-~~-~~-~~~~~~---- 313 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE--TLN----NILAC-RW-DL-EDEEFQ---- 313 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHH----HHHHT-CC-CS-CSGGGT----
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHHhc-cC-CC-Chhhhc----
Confidence 3458999999999999999999999999999999999999997443221 111 11111 10 00 001111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHh
Q 002410 847 ESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQD 879 (927)
Q Consensus 847 ~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~--~L~~ 879 (927)
.....+.+++.+||+.||++||+++|+++ .+++
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 12346889999999999999999999987 4443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=337.39 Aligned_cols=263 Identities=23% Similarity=0.313 Sum_probs=207.4
Q ss_pred HHhhcccccccccEEEEEEEE-CCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeee-ecCceEEEEEEec
Q 002410 606 TNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC-EEEHQRILVYEYM 683 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~-~~~~~~~LV~E~~ 683 (927)
.|++.+.||+|+||.||+|+. .+|+.||||++..... .+++.+|++++++++|++++..+..+ ...+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 456789999999999999997 4789999999865432 34688999999999988877766655 5667789999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc---cCCCcEEEeecccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFGla~~~~~~ 760 (927)
+++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 88 -~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 88 -GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred -CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999999743 4569999999999999999999998 999999999999999 48899999999999876543
Q ss_pred ccc------cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 761 LTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 761 ~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+.........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 239 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-- 239 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH--
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch--
Confidence 321 123456899999999999999999999999999999999999999854433222222222111111000
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
+.+... .+..+.+++.+||+.||++||+++||++.|+++.....
T Consensus 240 ---~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 240 ---EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ---HHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ---HHHHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 001111 12468899999999999999999999999999877543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=345.99 Aligned_cols=263 Identities=22% Similarity=0.312 Sum_probs=205.8
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeee----cCceEEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE----EEHQRIL 678 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~----~~~~~~L 678 (927)
...|++.+.||+|+||.||+++.. +|+.||||++........+.+.+|++++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 345677899999999999999984 68999999987665666788999999999999999999999986 3457899
Q ss_pred EEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999987532 24679999999999999999999998 89999999999999999999999999998765
Q ss_pred cccccc--------cccccccCCCccCCCccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh
Q 002410 758 EEDLTH--------ISSVARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 826 (927)
Q Consensus 758 ~~~~~~--------~~~~~~gt~~Y~APE~l~~~~---~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 826 (927)
...... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||....... .......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~--- 260 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVALAV--- 260 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHHHH---
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhHHh---
Confidence 322111 011234799999999987553 6899999999999999999999996321111 1111111
Q ss_pred hhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 827 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 827 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
... .. . + ........+.+++.+||+.||++||+++|+++.|+++...
T Consensus 261 -~~~-~~-~--~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 261 -QNQ-LS-I--P-----QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp -HCC----C--C-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred -hcc-CC-C--C-----ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 110 00 0 0 0111234688999999999999999999999999987643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=342.66 Aligned_cols=250 Identities=22% Similarity=0.290 Sum_probs=198.1
Q ss_pred hhhHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCc
Q 002410 599 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 674 (927)
Q Consensus 599 ~~el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~ 674 (927)
..++....|++.++||+|+||+||+|++. +|+.||||++.... ......+..|+..+.++ +||||+++++++.+++
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 34666778889999999999999999987 69999999986532 23344556666666665 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccc
Q 002410 675 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 754 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 754 (927)
..++||||+ +++|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLL 204 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred EEEEEEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceee
Confidence 999999999 77999988753 4569999999999999999999998 89999999999999999999999999998
Q ss_pred ccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 755 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 755 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
....... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... .. ..+..+...
T Consensus 205 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~-----~~~~~~~~~- 270 (311)
T 3p1a_A 205 VELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----GW-----QQLRQGYLP- 270 (311)
T ss_dssp EECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----HH-----HHHTTTCCC-
T ss_pred eecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HH-----HHHhccCCC-
Confidence 8764432 2233458999999999876 78999999999999999999977765221 11 111111111
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+.... .....+.+++.+||+.||++|||++|+++
T Consensus 271 ---~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 ---PEFTA----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---ccccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11111 12346889999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=346.42 Aligned_cols=266 Identities=24% Similarity=0.296 Sum_probs=198.6
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-----hhHHHHHHHHHHHHhcC---CCceeeeeeee
Q 002410 600 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-----HRTQQFVTEVALLSRIH---HRNLVPLIGYC 670 (927)
Q Consensus 600 ~el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-----~~~~~~~~E~~~L~~l~---HpnIv~l~~~~ 670 (927)
.++....|++.++||+|+||+||+|+.. +++.||||++..... .....+.+|++++++++ ||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 3455667888999999999999999975 689999999864321 12345677888777765 99999999998
Q ss_pred ecCc-----eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCc
Q 002410 671 EEEH-----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 745 (927)
Q Consensus 671 ~~~~-----~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~ 745 (927)
.... ..++||||++ |+|.+++... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSC
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCC
Confidence 7654 5789999997 6999999854 23459999999999999999999999 99999999999999999999
Q ss_pred EEEeeccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 002410 746 AKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 825 (927)
Q Consensus 746 ~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 825 (927)
+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+..
T Consensus 159 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~ 233 (308)
T 3g33_A 159 VKLADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFD 233 (308)
T ss_dssp EEECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---HHHHHH
T ss_pred EEEeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHH
Confidence 99999999987643322 2344689999999999989999999999999999999999999974433221 111111
Q ss_pred hhh---cCCeeeec---ccccc-------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 826 MIK---KGDVISIV---DPVLI-------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 826 ~~~---~~~~~~~~---d~~l~-------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
... ........ ..... .....+....+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 111 00000000 00000 0001122347889999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.43 Aligned_cols=255 Identities=24% Similarity=0.376 Sum_probs=207.9
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeec------
Q 002410 600 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------ 672 (927)
Q Consensus 600 ~el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~------ 672 (927)
+......|++.+.||+|+||.||+|.+. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 4556677888999999999999999987 79999999997543 356789999999999999999998754
Q ss_pred ----------CceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC
Q 002410 673 ----------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 742 (927)
Q Consensus 673 ----------~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~ 742 (927)
....++||||+++|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+||+++.
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVD 157 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcC
Confidence 45589999999999999999753 24578999999999999999999998 89999999999999999
Q ss_pred CCcEEEeeccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHH
Q 002410 743 NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 822 (927)
Q Consensus 743 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~ 822 (927)
++.+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+... ....
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~-- 228 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFF-- 228 (284)
T ss_dssp TTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHH--
T ss_pred CCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHH--
Confidence 99999999999987654322 22345899999999999989999999999999999999999887411 1111
Q ss_pred HHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 823 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 823 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
..+..+... ..+ ...+.+++.+||+.||++||++.|+++.|+.+....+
T Consensus 229 --~~~~~~~~~--------~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 229 --TDLRDGIIS--------DIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp --HHHHTTCCC--------TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred --HHhhccccc--------ccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 111122111 111 2357899999999999999999999999998876544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=338.77 Aligned_cols=250 Identities=20% Similarity=0.278 Sum_probs=204.3
Q ss_pred HHHHhhcccccccccEEEEEEEECC-CcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
...|.+.+.||+|+||.||+|..+. ++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 3567788999999999999999874 779999999876566678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc---cCCCcEEEeeccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFGla~~~~~ 759 (927)
+++++|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999999874 4568999999999999999999998 999999999999999 7889999999999987654
Q ss_pred cccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 760 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
... .....||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+ ... .+..+.... ...
T Consensus 162 ~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~----~~~~~~~~~--~~~ 229 (277)
T 3f3z_A 162 GKM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---VML----KIREGTFTF--PEK 229 (277)
T ss_dssp TSC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCCCCC--CHH
T ss_pred ccc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH---HHH----HHHhCCCCC--Cch
Confidence 322 2334589999999998764 8999999999999999999999997433211 111 111111100 000
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
... .....+.+++.+||+.||++||++.|+++
T Consensus 230 ~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 230 DWL----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 11346889999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=350.89 Aligned_cols=264 Identities=24% Similarity=0.429 Sum_probs=212.7
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 673 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~ 673 (927)
++....|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 344456778899999999999999865 367899999976433 3456789999999999999999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcE
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 746 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~-------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~ 746 (927)
+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeE
Confidence 99999999999999999987432 12467899999999999999999998 899999999999999999999
Q ss_pred EEeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHH
Q 002410 747 KVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 824 (927)
Q Consensus 747 kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 824 (927)
||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~--- 251 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVLR--- 251 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHHH---
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HHHH---
Confidence 9999999987544322 12223346889999999988889999999999999999999 89999743321 1111
Q ss_pred HhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 825 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 825 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
.+..+..... .......+.+++.+||+.||++||++.|+++.|++++..
T Consensus 252 -~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 252 -FVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp -HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred -HHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 1112221111 112234688999999999999999999999999988663
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=345.20 Aligned_cols=264 Identities=23% Similarity=0.297 Sum_probs=198.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
.|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 3567889999999999999987 489999999865433 2356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++++|.+++. ....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 84 CDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp CSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 99999999887 34668999999999999999999998 9999999999999999999999999999987653322
Q ss_pred ccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH--------hhhcCCee
Q 002410 763 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS--------MIKKGDVI 833 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~ 833 (927)
. .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.......... ........
T Consensus 158 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 158 Y-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred c-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 2 223458999999999865 6789999999999999999999999975443322211111000 00000000
Q ss_pred ---eeccccccCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 834 ---SIVDPVLIGN---VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 834 ---~~~d~~l~~~---~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
...++..... ........+.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000 001223468899999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=354.68 Aligned_cols=246 Identities=25% Similarity=0.373 Sum_probs=201.2
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV 679 (927)
..|.+.+.||+|+||.||+|+.+ +|+.||||+++... ....+.+..|..+++.+ +||||+++++++.+.+..++|
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv 96 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 96 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence 45667899999999999999987 58999999997532 23346678899999887 899999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 999999999999974 3568999999999999999999998 9999999999999999999999999999986432
Q ss_pred cccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 760 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.+. +..+.. .
T Consensus 171 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~----i~~~~~------~ 236 (345)
T 1xjd_A 171 GDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHS----IRMDNP------F 236 (345)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHCCC------C
T ss_pred CCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HHhCCC------C
Confidence 221 233456999999999999999999999999999999999999999744321 11111 111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 874 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~-eVl 874 (927)
... .....+.+++.+||+.||++||++. ||+
T Consensus 237 ~p~----~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 237 YPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCc----ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111 1224678999999999999999997 654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=349.77 Aligned_cols=259 Identities=23% Similarity=0.399 Sum_probs=201.3
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCc----EEEEEEccCc-cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~----~vAvK~l~~~-~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
...|++.+.||+|+||.||+|++. +++ .||+|.+... .....+.+.+|+.++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 345677899999999999999975 344 3577777543 2345678999999999999999999999998765 78
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999999753 4568999999999999999999998 99999999999999999999999999999876
Q ss_pred cccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 758 EEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 758 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
...... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... +... +..+....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~----~~~~~~~~- 239 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LEKGERLP- 239 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTCCCC-
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCCCCC-
Confidence 443221 2223346788999999999999999999999999999999 999997544322 1111 11111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
........+.+++.+||+.||++||+++|+++.|+++....
T Consensus 240 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 240 --------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp --------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred --------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 11112336889999999999999999999999999987543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=349.63 Aligned_cols=264 Identities=29% Similarity=0.488 Sum_probs=205.7
Q ss_pred hHHHHHHhhcccccccccEEEEEEEECC-----CcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCc
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 674 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~~-----g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~ 674 (927)
++....+.+.+.||+|+||.||+|.+.. +..||||+++.... .....+.+|++++++++||||+++++++.+.+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 3344455667899999999999998763 24699999976433 34567999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccc
Q 002410 675 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 754 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 754 (927)
..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CcEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 999999999999999999753 4578999999999999999999998 89999999999999999999999999999
Q ss_pred ccccccccc--cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCC
Q 002410 755 RQAEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 831 (927)
Q Consensus 755 ~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 831 (927)
+........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+.. .+..+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~----~~~~~~ 267 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMK----AINDGF 267 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH----HHHTTC
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHH----HHHCCC
Confidence 876543221 1122335778999999998899999999999999999999 99999743221 1111 112211
Q ss_pred eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 832 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 832 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
... ........+.+++.+||+.||++||++.|+++.|++++....
T Consensus 268 ~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 268 RLP---------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp CCC---------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred cCC---------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 100 011223468899999999999999999999999999886543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=360.57 Aligned_cols=254 Identities=24% Similarity=0.249 Sum_probs=201.6
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
..|++.+.||+|+||.||+|+.+ +|+.||||++++.. ....+.+.+|..++.+++||||+++++++.+.+..++||
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm 140 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 34566789999999999999986 68999999997532 122345889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++|+|.+++... +..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++.....
T Consensus 141 E~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 141 EYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp CCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred cCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 999999999999742 3468999999999999999999998 99999999999999999999999999999876554
Q ss_pred ccccccccccCCCccCCCccC-------CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCee
Q 002410 761 LTHISSVARGTVGYLDPEYYG-------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 833 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~-------~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 833 (927)
.........||+.|+|||++. +..++.++|||||||++|||++|+.||...+..+. ...+......-..
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i~~~~~~~~~- 291 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET---YGKIVHYKEHLSL- 291 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTHHHHCCC-
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH---HHHHHhcccCcCC-
Confidence 433334457999999999986 45789999999999999999999999974433211 1111110000001
Q ss_pred eeccccccCCCCHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 002410 834 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR---PKMQEIVLA 876 (927)
Q Consensus 834 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R---Ps~~eVl~~ 876 (927)
+.... .....+.+++.+||. +|++| |+++|+++.
T Consensus 292 ----p~~~~----~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 292 ----PLVDE----GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ----C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ----Ccccc----CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 10111 122367899999999 99998 589988754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=345.62 Aligned_cols=265 Identities=26% Similarity=0.428 Sum_probs=211.4
Q ss_pred HHHHHhhcccccccccEEEEEEEE------CCCcEEEEEEccCccc-hhHHHHHHHHHHHHhc-CCCceeeeeeeeecCc
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 674 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~------~~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~ 674 (927)
....|++.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 345677889999999999999985 2468899999976543 3456799999999999 7999999999987654
Q ss_pred -eEEEEEEecCCCCHHHHhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc
Q 002410 675 -QRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 740 (927)
Q Consensus 675 -~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl 740 (927)
..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+ ++|+||||||+||++
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILL 181 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEE
Confidence 58999999999999999985432 2238899999999999999999998 999999999999999
Q ss_pred cCCCcEEEeeccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhh
Q 002410 741 DINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELN 818 (927)
Q Consensus 741 d~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~ 818 (927)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... .
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~ 259 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E 259 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--H
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH--H
Confidence 99999999999999876443222 2233457889999999988899999999999999999998 999997443321 1
Q ss_pred HHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 819 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 819 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
... .+..+.... . .......+.+++.+||+.||++||+++||++.|++++....
T Consensus 260 ~~~----~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 260 FCR----RLKEGTRMR-----A----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp HHH----HHHHTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHH----HhccCccCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 111 111111111 1 11122368899999999999999999999999999987543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=353.14 Aligned_cols=245 Identities=23% Similarity=0.308 Sum_probs=200.1
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|.+.+.||+|+||.||+|.+. +++.||||++..... .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 4667899999999999999985 689999999865321 223578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+ +|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 90 YA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred CC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99 7899998874 4579999999999999999999998 899999999999999999999999999998765432
Q ss_pred cccccccccCCCccCCCccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
. .....||+.|+|||++.+..+ ++++|||||||++|+|++|+.||......... ..+..+.
T Consensus 163 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------~~i~~~~--------- 224 (336)
T 3h4j_B 163 F--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------KKVNSCV--------- 224 (336)
T ss_dssp T--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------CCCCSSC---------
T ss_pred c--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------HHHHcCC---------
Confidence 2 233468999999999988776 78999999999999999999999743322110 0000000
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
...+......+.+++.+||+.||.+|||++|+++.
T Consensus 225 -~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 -YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00111223467899999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=338.19 Aligned_cols=259 Identities=27% Similarity=0.396 Sum_probs=205.2
Q ss_pred hhcccccccccEEEEEEEECC----CcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE-EEEEE
Q 002410 608 NFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR-ILVYE 681 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~~----g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~-~LV~E 681 (927)
...++||+|+||.||+|.+.+ +..||+|++..... ...+.+.+|++++++++||||+++++++.+.+.. ++|+|
T Consensus 24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 103 (298)
T 3pls_A 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP 103 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence 345889999999999998643 23799999876433 4557899999999999999999999999766655 99999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+.+|+|.+++.. ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 104 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 104 YMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp CCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred cccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999975 35678999999999999999999998 899999999999999999999999999998654322
Q ss_pred c---ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 762 T---HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 762 ~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
. .......+++.|+|||.+.+..++.++||||||+++|||++|..|+...... ........ .+....
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~----~~~~~~---- 248 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFLA----QGRRLP---- 248 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHHH----TTCCCC----
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHhh----cCCCCC----
Confidence 1 1222345788999999999999999999999999999999966554322221 12222211 111100
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhccC
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 886 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~~ 886 (927)
.+......+.+++.+||+.||++|||++|+++.|++++.....
T Consensus 249 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 249 -----QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred -----CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 0111234688999999999999999999999999999876543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=348.19 Aligned_cols=271 Identities=24% Similarity=0.394 Sum_probs=198.0
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHH--HHhcCCCceeeeeeeee-----cCceEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL--LSRIHHRNLVPLIGYCE-----EEHQRI 677 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~--L~~l~HpnIv~l~~~~~-----~~~~~~ 677 (927)
..|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+. .....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 3466789999999999999987 58999999987432 3344445444 44589999999998542 334678
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CeEecCCCCCcccccCCCcEEE
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP---------GIIHRDVKSSNILLDINMRAKV 748 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~---------~ivH~DLkp~NILld~~~~~kL 748 (927)
+||||+++|+|.+++.. ...++..++.++.||+.||+|||+ . +|+||||||+|||++.++.+||
T Consensus 89 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEE
Confidence 99999999999999974 345889999999999999999998 6 9999999999999999999999
Q ss_pred eecccccccccccc-------ccccccccCCCccCCCccCC-------CCCCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 002410 749 SDFGLSRQAEEDLT-------HISSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 814 (927)
Q Consensus 749 ~DFGla~~~~~~~~-------~~~~~~~gt~~Y~APE~l~~-------~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~ 814 (927)
+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987643221 11223458999999999977 45678999999999999999997776422221
Q ss_pred ch-hh-H---------HHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 815 AE-LN-I---------VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 815 ~~-~~-l---------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
.. .. . ................+.... .........+.+++.+||+.||++|||++|+++.|++++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 11 00 0 001111111111111111111 11224566799999999999999999999999999999876
Q ss_pred ccCCC
Q 002410 884 EKGGD 888 (927)
Q Consensus 884 e~~~~ 888 (927)
-....
T Consensus 320 ~~~~~ 324 (336)
T 3g2f_A 320 WERNK 324 (336)
T ss_dssp CCC--
T ss_pred HHhcc
Confidence 44433
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=350.91 Aligned_cols=244 Identities=23% Similarity=0.299 Sum_probs=202.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.+.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 4567899999999999999987 68999999986532 2234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 122 ~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 122 YVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp CCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999984 3568999999999999999999998 99999999999999999999999999999876432
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+ . +..+.. .+.
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~---~-i~~~~~------~~p 258 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYE---K-IVSGKV------RFP 258 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---H-HHHCCC------CCC
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---HHHH---H-HHcCCC------CCC
Confidence 22346899999999999999999999999999999999999999743321 1111 1 111211 011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA 876 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~eVl~~ 876 (927)
. .....+.+++.+||+.||++||+ ++||++.
T Consensus 259 ~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 259 S----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp T----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred C----CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1 12346889999999999999998 7887653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=353.33 Aligned_cols=266 Identities=28% Similarity=0.445 Sum_probs=211.2
Q ss_pred HHHHhhcccccccccEEEEEEEE-----CCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCc--eE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QR 676 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~-----~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~--~~ 676 (927)
...+++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 44567789999999999999985 358899999998776667788999999999999999999999986644 68
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999999853 3568999999999999999999998 9999999999999999999999999999987
Q ss_pred ccccccc--cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc---------chhhHHHHHHH
Q 002410 757 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG---------AELNIVHWARS 825 (927)
Q Consensus 757 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~---------~~~~l~~~~~~ 825 (927)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ...........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 6543321 122334677899999998888999999999999999999999998632110 00111111112
Q ss_pred hhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 826 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 826 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
.+..+.... .....+..+.+++.+||+.||++||+++||++.|+++.+.
T Consensus 275 ~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 275 LLKNNGRLP---------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHTTCCCC---------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhhcCCCCC---------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 222211111 1112334788999999999999999999999999988653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=346.30 Aligned_cols=261 Identities=25% Similarity=0.370 Sum_probs=197.2
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCce----E
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ----R 676 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~----~ 676 (927)
..|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 45677899999999999999974 68999999997643 2334678999999999999999999999876543 4
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 92 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred EEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 999999999999999974 4578999999999999999999998 9999999999999999999999999999987
Q ss_pred ccccccc--cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 757 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 757 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .............
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~ 239 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIPP 239 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCCH
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCCCc
Confidence 6443221 2223458999999999999999999999999999999999999997433211 1111122111110
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHH-HHHHHHhhhhhc
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQE-IVLAIQDSIKIE 884 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e-Vl~~L~~~~~~e 884 (927)
. .. .......+.+++.+||+.||++||++.+ +.+.+.+....+
T Consensus 240 ~---~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 283 (311)
T 3ork_A 240 S---AR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283 (311)
T ss_dssp H---HH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred c---cc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence 0 00 0112346889999999999999996555 455566555443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=350.75 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=188.1
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
..|++.+.||+|+||.||+|+.+ +++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 34667899999999999999987 57899999997542 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC---CCcEEEeecccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~---~~~~kL~DFGla~~~~~~ 760 (927)
++|+|.+++.. ...+++.+++.++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 131 ~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 131 TGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999973 4568999999999999999999998 89999999999999975 889999999999875432
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... .+...... ...+
T Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~----~i~~~~~~-~~~~-- 273 (349)
T 2w4o_A 205 V--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFR----RILNCEYY-FISP-- 273 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHH----HHHTTCCC-CCTT--
T ss_pred c--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHH----HHHhCCCc-cCCc--
Confidence 2 1233458999999999999999999999999999999999999997333211 1111 11111111 1111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
........+.+++.+||+.||++|||+.|+++
T Consensus 274 ---~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 274 ---WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ---TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11122346889999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=341.28 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=205.4
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccch------hHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~------~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
...|++.+.||+|+||.||+|+.. +|+.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 466888999999999999999987 5899999998754321 357799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC----cEEEeecc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFG 752 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~----~~kL~DFG 752 (927)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999973 4678999999999999999999998 9999999999999999887 79999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCe
Q 002410 753 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832 (927)
Q Consensus 753 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 832 (927)
++........ .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ ... . +.....
T Consensus 165 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~---~-i~~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLA---N-ITSVSY 235 (321)
T ss_dssp TCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH---H-HHTTCC
T ss_pred cceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---HHH---H-HHhccc
Confidence 9987654322 233458999999999999999999999999999999999999997433211 111 1 111111
Q ss_pred eeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 833 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 833 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..++..... ....+.+++.+||+.||++|||++|+++
T Consensus 236 --~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 --DFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --CCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --ccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 011111111 1236789999999999999999999987
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=349.02 Aligned_cols=257 Identities=25% Similarity=0.295 Sum_probs=199.2
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc-----cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~-----~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
...|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 466788999999999999999986 6889999998643 2344578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCC-------------------------------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 002410 678 LVYEYMHNGTLRDRLHGSV-------------------------------------NQKPLDWLTRLQIAHDAAKGLEYL 720 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~-------------------------------------~~~~l~~~~~~~i~~qia~gL~~L 720 (927)
+||||+++|+|.+++.... ....+++..+..++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999999999999985211 012246778889999999999999
Q ss_pred HhcCCCCeEecCCCCCcccccCCC--cEEEeecccccccccccc---ccccccccCCCccCCCccCC--CCCCcchhHHH
Q 002410 721 HTGCNPGIIHRDVKSSNILLDINM--RAKVSDFGLSRQAEEDLT---HISSVARGTVGYLDPEYYGN--QQLTEKSDVYS 793 (927)
Q Consensus 721 H~~~~~~ivH~DLkp~NILld~~~--~~kL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~--~~~s~ksDVwS 793 (927)
|+ ++|+||||||+||+++.++ .+||+|||+++....... .......||+.|+|||.+.+ ..++.++||||
T Consensus 185 H~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 98 8999999999999998776 899999999986543221 12234568999999999865 67899999999
Q ss_pred HHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 002410 794 FGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI 873 (927)
Q Consensus 794 lGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eV 873 (927)
|||++|||++|+.||......+ . .......... ...+. .......+.+++.+||+.||++||++.|+
T Consensus 262 lG~il~el~~g~~pf~~~~~~~--~----~~~~~~~~~~--~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDAD--T----ISQVLNKKLC--FENPN-----YNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHH--H----HHHHHHCCCC--TTSGG-----GGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHHCCCCCCCCChHH--H----HHHHHhcccc--cCCcc-----cccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 9999999999999997443221 1 1111111110 00010 01123468899999999999999999999
Q ss_pred HHH
Q 002410 874 VLA 876 (927)
Q Consensus 874 l~~ 876 (927)
++.
T Consensus 329 l~h 331 (345)
T 3hko_A 329 LQH 331 (345)
T ss_dssp HHS
T ss_pred hcC
Confidence 873
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=351.31 Aligned_cols=249 Identities=25% Similarity=0.339 Sum_probs=202.1
Q ss_pred HHHHhhcccccccccEEEEEEEECC-CcEEEEEEccCcc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~L 678 (927)
...|++.+.||+|+||.||+|+.+. |+.||||+++... ....+.+.+|..+++.+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 3456778999999999999999874 7899999997542 23446788999999988 79999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999974 3568999999999999999999998 999999999999999999999999999998643
Q ss_pred ccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 759 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 759 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.+ .... +..
T Consensus 173 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~---~i~~-~~~------ 238 (353)
T 2i0e_A 173 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ---SIME-HNV------ 238 (353)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHH-CCC------
T ss_pred cCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHHH---HHHh-CCC------
Confidence 2221 233456999999999999999999999999999999999999999743321 1111 1111 111
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA 876 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~eVl~~ 876 (927)
.+ +......+.+++.+||+.||++||+ ++||++.
T Consensus 239 ~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 239 AY----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CC----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01 1112346889999999999999995 5666643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=348.83 Aligned_cols=265 Identities=16% Similarity=0.196 Sum_probs=207.1
Q ss_pred HHHhhcccccccccEEEEEEEECC---------CcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceee----------
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKD---------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP---------- 665 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~---------g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~---------- 665 (927)
..|.+.+.||+|+||.||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 356678999999999999999874 789999998754 46789999999999999988
Q ss_pred -----eeeeeec-CceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccc
Q 002410 666 -----LIGYCEE-EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 739 (927)
Q Consensus 666 -----l~~~~~~-~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NIL 739 (927)
+++++.. ++..++||||+ +++|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence 5666655 67889999999 99999999853 23679999999999999999999999 89999999999999
Q ss_pred ccCCC--cEEEeeccccccccccccc------cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 002410 740 LDINM--RAKVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 811 (927)
Q Consensus 740 ld~~~--~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~ 811 (927)
++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 8999999999876543221 112346899999999999999999999999999999999999999744
Q ss_pred cccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 812 DFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 812 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
... ...+......... ......+.... .......+.+++.+||+.||++||+++||++.|++++....
T Consensus 272 ~~~-~~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 272 LPN-TEDIMKQKQKFVD--KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TTC-HHHHHHHHHHHHH--SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CcC-HHHHHHHHHhccC--Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 322 1222222221111 11111111100 00112468899999999999999999999999999987654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=347.62 Aligned_cols=249 Identities=22% Similarity=0.332 Sum_probs=194.8
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCC--CceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~H--pnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|++++++++| +||+++++++.+++..++|||
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 89 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 89 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence 466789999999999999999889999999986532 3345789999999999976 999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
+.+++|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++ ++.+||+|||+++......
T Consensus 90 -~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 90 -CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp -CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred -CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 568899999984 4678999999999999999999998 8999999999999997 6789999999998765433
Q ss_pred cc-cccccccCCCccCCCccCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc
Q 002410 762 TH-ISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 829 (927)
Q Consensus 762 ~~-~~~~~~gt~~Y~APE~l~~-----------~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 829 (927)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... . .......+..
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~---~~~~~~~~~~ 236 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--Q---ISKLHAIIDP 236 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--H---HHHHHHHHCT
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--H---HHHHHHHhcC
Confidence 22 2234569999999999854 6789999999999999999999999973221 1 1111111111
Q ss_pred CCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 830 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 830 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.. ....+......+.+++.+||+.||++|||++|+++.
T Consensus 237 ~~---------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 237 NH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Cc---------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11 111111112367899999999999999999999875
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=332.59 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=204.1
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
..|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 56778899999999999999987 68999999986433 33457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++++|.+++. ....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999987 34678999999999999999999998 9999999999999999999999999999986543221
Q ss_pred -ccccccccCCCccCCCccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 763 -HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 763 -~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
.......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||....... .....+... ... ..+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~----~~~---~~~-- 230 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK----KTY---LNP-- 230 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHHTT----CTT---STT--
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhhhc----ccc---cCc--
Confidence 12234468999999999987665 789999999999999999999997443321 122222111 000 000
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.......+.+++.+||+.||++|||++|+++
T Consensus 231 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 ----WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0112346789999999999999999999876
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=353.58 Aligned_cols=265 Identities=24% Similarity=0.268 Sum_probs=203.7
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcC-----CCceeeeeeeeecCc
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----HRNLVPLIGYCEEEH 674 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-----HpnIv~l~~~~~~~~ 674 (927)
++....|.+.++||+|+||.||+|+.. +++.||||+++.. ....+.+..|+.++++++ ||||+++++++...+
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 444556788899999999999999985 6899999999753 344567788999999996 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC------------
Q 002410 675 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI------------ 742 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~------------ 742 (927)
..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred eeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhc
Confidence 999999999 99999999854 23468999999999999999999998 99999999999999975
Q ss_pred -------------CCcEEEeeccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 002410 743 -------------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 809 (927)
Q Consensus 743 -------------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~ 809 (927)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 789999999999864432 223468999999999999999999999999999999999999997
Q ss_pred cccccchhhHHHHHHHhhh--------cCCeeeecc-ccc----cCCC-CH---------------HHHHHHHHHHHHhh
Q 002410 810 VEDFGAELNIVHWARSMIK--------KGDVISIVD-PVL----IGNV-KI---------------ESIWRIAEVAIQCV 860 (927)
Q Consensus 810 ~~~~~~~~~l~~~~~~~~~--------~~~~~~~~d-~~l----~~~~-~~---------------~~~~~l~~Li~~Cl 860 (927)
.....+............. ........+ ..+ .... .. .....+.+|+.+||
T Consensus 261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 340 (360)
T 3llt_A 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL 340 (360)
T ss_dssp CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence 5443222111111100000 000000000 000 0000 00 01146779999999
Q ss_pred ccCCCCCCCHHHHHH
Q 002410 861 EQRGFSRPKMQEIVL 875 (927)
Q Consensus 861 ~~dP~~RPs~~eVl~ 875 (927)
+.||++|||++|+++
T Consensus 341 ~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 341 QIDPTLRPSPAELLK 355 (360)
T ss_dssp CSSGGGSCCHHHHTT
T ss_pred cCChhhCCCHHHHhc
Confidence 999999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=351.20 Aligned_cols=251 Identities=23% Similarity=0.279 Sum_probs=192.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.|++.+.||+|+||.||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 5677899999999999999987 689999999975432 33668899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCc--EEEeecccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~--~kL~DFGla~~~~~~~~ 762 (927)
+|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++. +||+|||+++......
T Consensus 100 ~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~- 172 (361)
T 3uc3_A 100 GGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 172 (361)
T ss_dssp SCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence 9999999973 4569999999999999999999998 99999999999999987765 9999999997533221
Q ss_pred ccccccccCCCccCCCccCCCCCCcc-hhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEK-SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~k-sDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
......||+.|+|||++.+..+..+ +|||||||++|||++|+.||........ ........... ......
T Consensus 173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~-~~~~~~----- 243 (361)
T 3uc3_A 173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSV-KYSIPD----- 243 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTT-CCCCCT-----
T ss_pred -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcC-CCCCCC-----
Confidence 1233458999999999988777655 8999999999999999999975433221 11112221111 110000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.......+.+|+.+||+.||++|||++|+++.
T Consensus 244 ---~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 ---DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00112367899999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=351.55 Aligned_cols=269 Identities=19% Similarity=0.212 Sum_probs=201.8
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC----CCcEEEEEEccCccch-----------hHHHHHHHHHHHHhcCCCceee
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSH-----------RTQQFVTEVALLSRIHHRNLVP 665 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~----~g~~vAvK~l~~~~~~-----------~~~~~~~E~~~L~~l~HpnIv~ 665 (927)
++....|.+.+.||+|+||.||+|... ++..+|||++...... ....+.+|+..++.++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 344456778899999999999999986 5788999998754321 1134678889999999999999
Q ss_pred eeeeeec----CceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc
Q 002410 666 LIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 741 (927)
Q Consensus 666 l~~~~~~----~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld 741 (927)
+++++.. ....++||||+ +++|.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLG 185 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEE
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEc
Confidence 9999877 77899999999 99999999843 379999999999999999999998 8999999999999999
Q ss_pred CCC--cEEEeeccccccccccccc------cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 002410 742 INM--RAKVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 813 (927)
Q Consensus 742 ~~~--~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~ 813 (927)
.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 887 9999999999876433211 11344689999999999998999999999999999999999999963222
Q ss_pred cchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 814 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 814 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
. ...... ........ ....+..... ....+..+.+++.+||+.||++||++++|++.|+++..
T Consensus 266 ~-~~~~~~-~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 266 D-PVAVQT-AKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp C-HHHHHH-HHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred c-cHHHHH-HHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1 111111 11111111 0000000000 00123478899999999999999999999999997654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=343.98 Aligned_cols=263 Identities=26% Similarity=0.431 Sum_probs=200.0
Q ss_pred HHHHHHhhcccccccccEEEEEEEECC----CcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCc-
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH- 674 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~----g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~- 674 (927)
+....|.+.+.||+|+||.||+|.+.. ++.||+|+++... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 334566778999999999999998652 4589999987542 334577999999999999999999999997655
Q ss_pred ----eEEEEEEecCCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEE
Q 002410 675 ----QRILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 747 (927)
Q Consensus 675 ----~~~LV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~k 747 (927)
..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEE
Confidence 3499999999999999985322 34679999999999999999999998 8999999999999999999999
Q ss_pred Eeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHH
Q 002410 748 VSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 825 (927)
Q Consensus 748 L~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 825 (927)
|+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... .....
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~-- 262 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYDYL-- 262 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH--
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHHH--
Confidence 999999987644322 12223446889999999999999999999999999999999 889997443322 11111
Q ss_pred hhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 826 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 826 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
..+.... . .......+.+++.+||+.||++||+++|+++.|++++..
T Consensus 263 --~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 263 --LHGHRLK-----Q----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp --HTTCCCC-----C----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HcCCCCC-----C----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111 1 112234688999999999999999999999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=337.03 Aligned_cols=245 Identities=26% Similarity=0.414 Sum_probs=199.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 89 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence 4667899999999999999887 477999999865321 224678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++|+|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 90 YAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999974 3568999999999999999999998 999999999999999999999999999986644322
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||........ ... +..... ..
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~----~~~~~~------~~- 226 (279)
T 3fdn_A 164 ---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YKR----ISRVEF------TF- 226 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHH----HHHTCC------CC-
T ss_pred ---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH---HHH----HHhCCC------CC-
Confidence 2234589999999999999999999999999999999999999974432211 111 111110 01
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+......+.+++.+||+.||++||+++|+++.
T Consensus 227 ---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 227 ---PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11123467899999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=348.77 Aligned_cols=252 Identities=24% Similarity=0.324 Sum_probs=200.9
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
...|++.+.||+|+||.||++..+ +|+.||||++..... ...+|++++.++ +||||+++++++.+++..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 456778899999999999999987 588999999975432 235688888888 79999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC----CcEEEeeccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLSRQA 757 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~----~~~kL~DFGla~~~ 757 (927)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||+.++ +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999973 4679999999999999999999998 999999999999998432 35999999999876
Q ss_pred cccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+.. .+..+...
T Consensus 171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~----~i~~~~~~---- 241 (342)
T 2qr7_A 171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA----RIGSGKFS---- 241 (342)
T ss_dssp BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH----HHHHCCCC----
T ss_pred cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH----HHccCCcc----
Confidence 54322 2233468999999999988889999999999999999999999997433222222222 22222211
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+...........+.+++.+||+.||++||++.|+++.
T Consensus 242 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 --LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp --CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred --cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111111223468899999999999999999999863
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=353.52 Aligned_cols=258 Identities=29% Similarity=0.455 Sum_probs=197.2
Q ss_pred HhhcccccccccEEEEEEEECC--C--cEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeee-cCceEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKD--G--KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCE-EEHQRILVY 680 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~--g--~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~-~~~~~~LV~ 680 (927)
+++.+.||+|+||.||+|++.+ + ..||||.++... ....+++.+|+.++++++||||+++++++. .++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 4557899999999999998752 2 368999987543 345678999999999999999999999875 456789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++|+|.+++... ...+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 171 e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp ECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred ECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 999999999999743 4568899999999999999999998 99999999999999999999999999999875432
Q ss_pred ccc---cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 761 LTH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 761 ~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+ ..... ..+... .
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~----~~~~~~--~ 316 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL----LQGRRL--L 316 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHH----HTTCCC--C
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHH----HcCCCC--C
Confidence 211 1223346788999999999999999999999999999999 677776433322 11111 111110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
. +...+..+.+++.+||+.||++||+++|+++.|++++..-.
T Consensus 317 ~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 317 Q-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1 11123468899999999999999999999999999887544
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.94 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=205.4
Q ss_pred HHhhcc-cccccccEEEEEEEEC---CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 606 TNNFCK-KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 606 ~~~~~~-~LG~G~~G~Vy~a~~~---~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
.|.+.+ .||+|+||.||+|.+. .++.||||+++... ....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 455556 8999999999999653 46889999997543 23357899999999999999999999999 55678999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
|||+++++|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 999999999999984 4568999999999999999999998 8999999999999999999999999999987654
Q ss_pred ccccc--ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 760 DLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 760 ~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
..... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .... .+..+....
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~----~~~~~~~~~-- 240 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA----MLEKGERMG-- 240 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTTCCCC--
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHHcCCCCC--
Confidence 33221 122346788999999988889999999999999999999 99999743321 1222 122221111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
.+......+.+++.+||+.||++||++.||++.|+++.....
T Consensus 241 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 241 -------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 111223478899999999999999999999999999887654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=348.66 Aligned_cols=264 Identities=30% Similarity=0.508 Sum_probs=208.8
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEEC-CCcE--EEEEEccCcc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCc
Q 002410 600 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKE--VAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 674 (927)
Q Consensus 600 ~el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~--vAvK~l~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~ 674 (927)
+.+....|++.+.||+|+||.||+|+.. +++. +|+|.++... ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 3444456778899999999999999876 4554 4999887532 33456789999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc
Q 002410 675 QRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 741 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld 741 (927)
..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+||+++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEc
Confidence 9999999999999999997532 23478999999999999999999998 9999999999999999
Q ss_pred CCCcEEEeeccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHH
Q 002410 742 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIV 820 (927)
Q Consensus 742 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~ 820 (927)
.++.+||+|||+++....... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+.
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~ 251 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELY 251 (327)
T ss_dssp GGGCEEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH
T ss_pred CCCeEEEcccCcCcccccccc--ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---HHH
Confidence 999999999999875432211 222346889999999988889999999999999999998 99999743321 111
Q ss_pred HHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 821 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 821 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
..+..+... .........+.+++.+||+.||++||+++|+++.|++++...
T Consensus 252 ----~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 252 ----EKLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp ----HHGGGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ----HHhhcCCCC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 112221110 011122346889999999999999999999999999988754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=351.40 Aligned_cols=265 Identities=26% Similarity=0.407 Sum_probs=211.9
Q ss_pred HHHHHHhhcccccccccEEEEEEEECC------CcEEEEEEccCccc-hhHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 673 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~------g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~ 673 (927)
+....|.+.+.||+|+||.||+|.... .+.||+|++..... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 334556778999999999999999753 24799999976533 3457799999999999 899999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSV-----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 742 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~-----------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~ 742 (927)
+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECC
Confidence 99999999999999999987432 13468999999999999999999998 89999999999999999
Q ss_pred CCcEEEeeccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHH
Q 002410 743 NMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIV 820 (927)
Q Consensus 743 ~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~ 820 (927)
++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||....... ...
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~ 277 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFY 277 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHH
Confidence 999999999999876443222 2233446789999999988899999999999999999999 999997443321 111
Q ss_pred HHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 821 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 821 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
..... +.... .+......+.+++.+||+.||.+||+++||++.|+++....
T Consensus 278 ~~~~~----~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 278 KLVKD----GYQMA---------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HHHHH----TCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhc----CCCCC---------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 21111 11000 01112346889999999999999999999999999887653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=335.69 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=197.7
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
..|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56788999999999999999986 58899999987543 23457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc---cCCCcEEEeecccccccc
Q 002410 683 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 683 ~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFGla~~~~ 758 (927)
+++|+|.+.+.... ....+++..++.++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999886432 24679999999999999999999998 999999999999999 456789999999998754
Q ss_pred ccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 759 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 759 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
.... .....|++.|+|||.+. ..++.++||||||+++|||++|+.||....... ..... ......... ..
T Consensus 179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~---~~~~~---~~~~~~~~~-~~ 248 (285)
T 3is5_A 179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE---VQQKA---TYKEPNYAV-EC 248 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HHCCCCCCC---
T ss_pred Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH---HHhhh---ccCCccccc-cc
Confidence 4322 23345899999999986 468899999999999999999999997443221 11111 111100000 00
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.. ....+.+++.+||+.||++|||++|+++
T Consensus 249 ---~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 249 ---RP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---Cc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 1236789999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=338.05 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=202.5
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
...|.+.+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456778899999999999999986 6899999999866555567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc---cCCCcEEEeeccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFGla~~~~~ 759 (927)
+++++|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999999874 3568999999999999999999998 899999999999999 7889999999999976543
Q ss_pred cccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 760 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
.. .....|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .+.. .+..+... ....
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~----~i~~~~~~--~~~~ 229 (304)
T 2jam_A 162 GI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFE----KIKEGYYE--FESP 229 (304)
T ss_dssp BT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH----HHHHCCCC--CCTT
T ss_pred Cc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH----HHHcCCCC--CCcc
Confidence 21 22345899999999999999999999999999999999999999743321 1111 11111110 0111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
. .......+.+++.+||+.||++||+++|+++
T Consensus 230 ~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 230 F----WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp T----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred c----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 1122346889999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=371.82 Aligned_cols=252 Identities=25% Similarity=0.424 Sum_probs=202.8
Q ss_pred cccccccEEEEEEEEC---CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCC
Q 002410 612 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 687 (927)
Q Consensus 612 ~LG~G~~G~Vy~a~~~---~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gs 687 (927)
.||+|+||.||+|.++ ++..||||+++... ....+++.+|+++|++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 46679999998643 3356789999999999999999999999976 56899999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc--c
Q 002410 688 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI--S 765 (927)
Q Consensus 688 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~--~ 765 (927)
|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......... .
T Consensus 422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 99999743 4569999999999999999999998 999999999999999999999999999998765432221 1
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 844 (927)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ +.+ .+..+.... .
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~----~i~~~~~~~---------~ 560 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMA----FIEQGKRME---------C 560 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHH----HHHTTCCCC---------C
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCCCC---------C
Confidence 22335689999999998899999999999999999998 999997443321 222 222222111 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 845 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 845 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
+...+..+.+++.+||+.||++||++++|++.|+++.....
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 12233578899999999999999999999999999876543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=335.29 Aligned_cols=247 Identities=27% Similarity=0.424 Sum_probs=181.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 4667889999999999999975 689999999865322 224678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 92 MCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp CCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred cCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 99999999999842 3578999999999999999999998 899999999999999999999999999998754322
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......... .... .. +...
T Consensus 167 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~-~~------~~~~- 231 (278)
T 3cok_A 167 EK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------NKVV-LA------DYEM- 231 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC-SS------CCCC-
T ss_pred Cc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------HHHh-hc------ccCC-
Confidence 21 22345899999999999989999999999999999999999999744322110 0000 00 0011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+......+.+++.+||+.||++||+++|+++
T Consensus 232 ---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 ---PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1112346789999999999999999999985
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=334.95 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=202.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
.|++.+.||+|+||.||+|..+ +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 4567899999999999999986 58999999986542 33457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCc---EEEeeccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEE 759 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~---~kL~DFGla~~~~~ 759 (927)
+++++|.+.+.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||++.....
T Consensus 87 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 87 VTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999998874 4568999999999999999999998 99999999999999986655 99999999977654
Q ss_pred cccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 760 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ..... +..+.... ..+.
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~----~~~~~~~~-~~~~ 230 (284)
T 3kk8_A 161 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQ----IKAGAYDY-PSPE 230 (284)
T ss_dssp SCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHTCCCC-CTTT
T ss_pred Ccc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHH----HHhccccC-Cchh
Confidence 322 22345899999999999999999999999999999999999999743321 11111 11111100 0000
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.......+.+++.+||+.||++|||++|+++.
T Consensus 231 -----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 231 -----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 01122468899999999999999999999873
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=335.59 Aligned_cols=258 Identities=24% Similarity=0.313 Sum_probs=205.2
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc------hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~------~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
...|++.+.||+|+||.||+|+.. +|+.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 456788999999999999999987 689999999865322 1357899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC----cEEEeecc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFG 752 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~----~~kL~DFG 752 (927)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999973 4568999999999999999999998 9999999999999998877 89999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCe
Q 002410 753 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832 (927)
Q Consensus 753 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 832 (927)
++........ .....|++.|+|||++.+..++.++||||||+++|+|++|+.||......+ ... . +.....
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~-~~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---TLT---N-ISAVNY 228 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---H-HHTTCC
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---HHH---H-hHhccc
Confidence 9987644322 223458999999999999999999999999999999999999997433211 111 1 111111
Q ss_pred eeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhhhh
Q 002410 833 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDSIK 882 (927)
Q Consensus 833 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~--~L~~~~~ 882 (927)
. .++.... .....+.+++.+||+.||++||++.|+++ .++++..
T Consensus 229 ~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 229 D--FDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp C--CCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred C--Ccchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 0 0111111 11246889999999999999999999997 3555433
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=339.48 Aligned_cols=257 Identities=24% Similarity=0.339 Sum_probs=196.7
Q ss_pred Hhh-cccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEec
Q 002410 607 NNF-CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 607 ~~~-~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
|++ .+.||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+++..++||||+
T Consensus 14 y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (316)
T 2ac3_A 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM 93 (316)
T ss_dssp CEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcC
Confidence 444 368999999999999865 6899999999876555667899999999985 7999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCc---EEEeecccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEED 760 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~---~kL~DFGla~~~~~~ 760 (927)
++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++. +||+|||++......
T Consensus 94 ~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 94 RGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred CCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999974 3568999999999999999999998 89999999999999988776 999999998765322
Q ss_pred cc------ccccccccCCCccCCCccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCcccccch--------hhHHH
Q 002410 761 LT------HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--------LNIVH 821 (927)
Q Consensus 761 ~~------~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~--------~~l~~ 821 (927)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. .....
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 11 11123358999999999865 5688999999999999999999999975432210 00011
Q ss_pred HHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 822 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 822 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.....+..+... .... ... .....+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~i~~~~~~-~~~~-~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 248 MLFESIQEGKYE-FPDK-DWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHCCCC-CCHH-HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhccCcc-cCch-hcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 111122222110 0000 000 11246889999999999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=340.76 Aligned_cols=254 Identities=30% Similarity=0.467 Sum_probs=199.8
Q ss_pred HHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC-ceEEEEEEe
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-HQRILVYEY 682 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-~~~~LV~E~ 682 (927)
...|++.+.||+|+||.||+|+.+ |+.||||+++... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 345677899999999999999886 8899999997543 457789999999999999999999987544 578999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++++|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 9999999999743 12337889999999999999999998 999999999999999999999999999988654322
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ... .+..+.. +..
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~----~~~~~~~-----~~~- 235 (278)
T 1byg_A 172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEKGYK-----MDA- 235 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHH----HHTTTCC-----CCC-
T ss_pred ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHhcCCC-----CCC-
Confidence 22346889999999988899999999999999999998 999997443221 111 1111111 111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
.......+.+++.+||+.||++||+++|+++.|+++...+
T Consensus 236 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 236 ---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 1122347889999999999999999999999999987644
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=363.43 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=193.7
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc---cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
..|++.+.||+|+||.||+|... +|+.||||+++.. .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 35677899999999999999976 6899999998753 2234466788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .++|+||||||+|||++.++.+||+|||+++.....
T Consensus 228 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 228 EYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp CCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred eeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999999974 4578999999999999999999995 278999999999999999999999999999864332
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+...+ .. ... .+
T Consensus 303 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i---~~-~~~------~~ 368 (446)
T 4ejn_A 303 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELI---LM-EEI------RF 368 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HH-CCC------CC
T ss_pred Cc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHH---Hh-CCC------CC
Confidence 22 223456999999999999999999999999999999999999999743321 111111 11 111 01
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 875 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~ 875 (927)
.. .....+.+++.+||+.||++|| +++|+++
T Consensus 369 p~----~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 PR----TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred Cc----cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11 1224678999999999999999 9999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=344.23 Aligned_cols=247 Identities=29% Similarity=0.397 Sum_probs=199.9
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
...|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 345677889999999999999974 68999999987532 23346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
|||++ |+|.+.+... ...+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 6888887642 4578999999999999999999999 8999999999999999999999999999987543
Q ss_pred cccccccccccCCCccCCCccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 760 DLTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
. ....||+.|+|||++. +..++.++|||||||++|||++|+.||....... ......... .....
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~~~~~~-~~~~~ 274 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE-SPALQ 274 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSC-CCCCC
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcC-CCCCC
Confidence 2 2345899999999983 5678999999999999999999999997432211 111111111 11111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
. ......+.+++.+||+.||++|||++|+++.
T Consensus 275 ~--------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 S--------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp C--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C--------CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 1122467899999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=353.25 Aligned_cols=250 Identities=26% Similarity=0.356 Sum_probs=194.1
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHH-HHhcCCCceeeeeeeeecCceEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVAL-LSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~-L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
..|++.+.||+|+||.||+|+.+ +++.||||++++... .....+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 45778899999999999999987 588999999976432 234556677776 5678999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999974 4568899999999999999999998 9999999999999999999999999999986433
Q ss_pred cccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 760 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ... ..... ... .
T Consensus 192 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~---~~i~~-~~~------~ 257 (373)
T 2r5t_A 192 HNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMY---DNILN-KPL------Q 257 (373)
T ss_dssp CCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---HHH---HHHHH-SCC------C
T ss_pred CCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHH---HHHHh-ccc------C
Confidence 221 233456999999999999999999999999999999999999999743321 111 11111 111 0
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
+... ....+.+++.+||+.||++||++.+.++.+.
T Consensus 258 ~~~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 258 LKPN----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp CCSS----SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred CCCC----CCHHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence 1111 2236789999999999999999865544444
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=350.06 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=195.8
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCcc--chhHHHHHHHHHHHHhcC--CCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~--HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+++|++++ ||||+++++++..++..++|||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E 136 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence 467789999999999999999889999999986532 345578999999999996 5999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
+.+++|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++ ++.+||+|||+++......
T Consensus 137 -~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 137 -CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp -CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred -cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 668899999984 4578899999999999999999998 9999999999999995 6899999999998765433
Q ss_pred cc-cccccccCCCccCCCccCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc
Q 002410 762 TH-ISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 829 (927)
Q Consensus 762 ~~-~~~~~~gt~~Y~APE~l~~-----------~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 829 (927)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .. ......+..
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~---~~~~~~~~~ 283 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QI---SKLHAIIDP 283 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HH---HHHHHHHCT
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--HH---HHHHHHhCc
Confidence 22 2334569999999999864 4688999999999999999999999973221 11 111111111
Q ss_pred CCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 830 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 830 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
... ...+......+.+++.+||+.||++||+++|+++.
T Consensus 284 ~~~---------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 284 NHE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TSC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccc---------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111 01111112467899999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=336.20 Aligned_cols=247 Identities=23% Similarity=0.356 Sum_probs=203.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence 4566899999999999999987 47899999986532 3345778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++++|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 96 LCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp CCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999873 4578999999999999999999998 899999999999999999999999999998764322
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+. ... +..... .+.
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~-~~~~~~------~~~ 235 (294)
T 2rku_A 170 ER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLR-IKKNEY------SIP 235 (294)
T ss_dssp CC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH-HHTTCC------CCC
T ss_pred cc-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HhhccC------CCc
Confidence 22 2334589999999999998999999999999999999999999974332211 111 111111 011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
. .....+.+++.+||+.||++||+++|+++.
T Consensus 236 ~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 236 K----HINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp T----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred c----ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 122367899999999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=358.89 Aligned_cols=245 Identities=24% Similarity=0.379 Sum_probs=202.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|.+.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4667899999999999999987 699999999975321 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 97 YVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp CCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999973 4679999999999999999999998 999999999999999999999999999998765432
Q ss_pred cccccccccCCCccCCCccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .+.. .+..+... .
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~----~i~~~~~~------~ 235 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFK----KICDGIFY------T 235 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHH----HHHTTCCC------C
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHH----HHhcCCcC------C
Confidence 2234468999999999988765 78999999999999999999999744322 1111 11122110 0
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+......+.+++.+||+.||++|||++|+++
T Consensus 236 ----p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 ----PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0111236789999999999999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=346.52 Aligned_cols=261 Identities=18% Similarity=0.250 Sum_probs=192.2
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
..|++.++||+|+||+||+|+.. +++.||||+++..... ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence 35777899999999999999876 6899999999754322 34567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc-----CCCcEEEeecccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-----INMRAKVSDFGLSRQ 756 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld-----~~~~~kL~DFGla~~ 756 (927)
|++ |+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||+++.
T Consensus 114 ~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 114 YAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp CCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred cCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 997 599999974 4568999999999999999999999 9999999999999994 555699999999987
Q ss_pred ccccccccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhh--hcCCee
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI--KKGDVI 833 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~--~~~~~~ 833 (927)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+........ ......
T Consensus 187 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 187 FGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTTST
T ss_pred cCCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHHHhCCCchhhhh
Confidence 6433222 2234579999999999774 58999999999999999999999997443221 1111111100 000000
Q ss_pred eec--------cccccCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 834 SIV--------DPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 834 ~~~--------d~~l~~~-----~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
... .+..... ........+.+|+.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 0000000 00112346789999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=333.68 Aligned_cols=248 Identities=24% Similarity=0.372 Sum_probs=197.8
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCCCH
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 688 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL 688 (927)
...||+|+||.||+|... +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 358999999999999975 6889999999876666678899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC-CCcEEEeeccccccccccccccccc
Q 002410 689 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSV 767 (927)
Q Consensus 689 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFGla~~~~~~~~~~~~~ 767 (927)
.+++........+++..+..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||++........ ....
T Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 182 (295)
T 2clq_A 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTET 182 (295)
T ss_dssp HHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred HHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-cccc
Confidence 9999865445567889999999999999999998 99999999999999987 89999999999987543221 1233
Q ss_pred cccCCCccCCCccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 768 ARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 768 ~~gt~~Y~APE~l~~~--~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
..|++.|+|||++.+. .++.++||||||+++|||++|+.||........ .... ..... ..+.+ +
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~---~~~~~------~~~~~----~ 248 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFK---VGMFK------VHPEI----P 248 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-HHHH---HHHHC------CCCCC----C
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-HHHh---hcccc------ccccc----c
Confidence 4589999999998664 378999999999999999999999973322111 1111 10100 01111 1
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 846 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 846 ~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
......+.+++.+||+.||++||+++|+++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 122346789999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=346.31 Aligned_cols=267 Identities=27% Similarity=0.454 Sum_probs=209.2
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeec
Q 002410 600 PELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 672 (927)
Q Consensus 600 ~el~~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~ 672 (927)
+++....|++.+.||+|+||.||+|++. +++.||||++.... .....++.+|+.++++++||||+++++++.+
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 3455667788999999999999999842 47789999997543 3455679999999999999999999999999
Q ss_pred CceEEEEEEecCCCCHHHHhccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC---CCc
Q 002410 673 EHQRILVYEYMHNGTLRDRLHGSVN----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMR 745 (927)
Q Consensus 673 ~~~~~LV~E~~~~gsL~~~L~~~~~----~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~---~~~ 745 (927)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++. +..
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCC
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcce
Confidence 9999999999999999999986431 2458999999999999999999998 99999999999999984 446
Q ss_pred EEEeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHH
Q 002410 746 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 823 (927)
Q Consensus 746 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~ 823 (927)
+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ...+.
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~- 257 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEF- 257 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH-
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHH-
Confidence 99999999876433221 12233457889999999988899999999999999999998 99999743221 12221
Q ss_pred HHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 824 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 824 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
+..+.... . .......+.+++.+||+.||++||++.||++.|+.+.....
T Consensus 258 ---~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 258 ---VTSGGRMD-----P----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp ---HHTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred ---HhcCCCCC-----C----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 11111111 1 11123468899999999999999999999999998876443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=345.51 Aligned_cols=262 Identities=23% Similarity=0.339 Sum_probs=198.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
.|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 4667899999999999999987 489999999865432 3346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++++|.+++. ....+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 106 ~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 106 VDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp CSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred CCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999998876 34569999999999999999999998 9999999999999999999999999999987544322
Q ss_pred ccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH----------hhhcCC
Q 002410 763 HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS----------MIKKGD 831 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~----------~~~~~~ 831 (927)
......|++.|+|||++.+. .++.++|||||||++|||++|+.||......+. +...... ......
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHHHCG
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhhhHhhhcc
Confidence 22234589999999998775 789999999999999999999999975433221 1111100 000000
Q ss_pred -eeeeccccccCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 832 -VISIVDPVLIGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 832 -~~~~~d~~l~~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
......+.+.... .......+.+++.+||+.||++|||++|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000001111000 11234578899999999999999999998863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=349.52 Aligned_cols=267 Identities=22% Similarity=0.304 Sum_probs=204.8
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEE
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~L 678 (927)
++....|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 344456777899999999999999987 68999999997653 3445779999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~-~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+ + +|+||||||+|||++.++.+||+|||++...
T Consensus 109 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp EECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEECCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 9999999999999974 3568999999999999999999998 5 8999999999999999999999999998765
Q ss_pred cccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH-hh--------h
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS-MI--------K 828 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~-~~--------~ 828 (927)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+............. .. .
T Consensus 183 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 183 IDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp HHHC-------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred cccc---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 3321 2234689999999999999999999999999999999999999974432211100000000 00 0
Q ss_pred --------------cCCeeeecc----ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 829 --------------KGDVISIVD----PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 829 --------------~~~~~~~~d----~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.....+..+ ..............+.+++.+||+.||++|||++|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000000 000000011123468899999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=345.38 Aligned_cols=242 Identities=23% Similarity=0.323 Sum_probs=200.8
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--------hhHHHHHHHHHHHHhcCCCceeeeeeeeecCc
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 674 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--------~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~ 674 (927)
...|++.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 456778899999999999999875 688999999875421 13346778999999999999999999999999
Q ss_pred eEEEEEEecCCC-CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccc
Q 002410 675 QRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 753 (927)
Q Consensus 675 ~~~LV~E~~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 753 (927)
..++||||+.+| +|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999777 99999983 4579999999999999999999998 8999999999999999999999999999
Q ss_pred cccccccccccccccccCCCccCCCccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCe
Q 002410 754 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832 (927)
Q Consensus 754 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 832 (927)
++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ... ..
T Consensus 177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~~~-~~- 240 (335)
T 3dls_A 177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------TVE-AA- 240 (335)
T ss_dssp CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------GTT-TC-
T ss_pred ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------HHh-hc-
Confidence 987654322 223458999999999988776 8899999999999999999999973211 000 00
Q ss_pred eeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 833 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 833 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
..+ +......+.+++.+||+.||++|||++|+++.
T Consensus 241 ---~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 241 ---IHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---CCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---cCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00122368899999999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=349.26 Aligned_cols=254 Identities=26% Similarity=0.355 Sum_probs=203.2
Q ss_pred HHHhhcccccccccEEEEEEEE----CCCcEEEEEEccCcc----chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCce
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 675 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~ 675 (927)
..|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4577789999999999999998 368999999987532 22345677899999999 69999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999974 3568999999999999999999998 899999999999999999999999999998
Q ss_pred cccccccccccccccCCCccCCCccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCee
Q 002410 756 QAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 833 (927)
Q Consensus 756 ~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 833 (927)
..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ...........
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~--- 282 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE--- 282 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHCC---
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhccC---
Confidence 765444434444569999999999975 35789999999999999999999999744332211 11112211110
Q ss_pred eeccccccCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 002410 834 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLAI 877 (927)
Q Consensus 834 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~~L 877 (927)
+. .+......+.+++.+||+.||++|| +++|+++..
T Consensus 283 ----~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ----PP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----CC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----CC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11 1112234678999999999999999 999988753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=352.12 Aligned_cols=264 Identities=25% Similarity=0.328 Sum_probs=192.1
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcC-CCceeeeeeeeecC--ce
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQ 675 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~--~~ 675 (927)
.....|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++++. ||||+++++++... ..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 33456778899999999999999876 6899999998653 2345567889999999997 99999999998654 37
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
.++||||++ |+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999997 689999873 468999999999999999999998 999999999999999999999999999998
Q ss_pred cccccc--------------------cccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 002410 756 QAEEDL--------------------THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 814 (927)
Q Consensus 756 ~~~~~~--------------------~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~ 814 (927)
...... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 653211 111233468999999999876 67899999999999999999999999754432
Q ss_pred chhhHHHHHHHhhhcCCeeee---c------------------cccccCC------------CCHHHHHHHHHHHHHhhc
Q 002410 815 AELNIVHWARSMIKKGDVISI---V------------------DPVLIGN------------VKIESIWRIAEVAIQCVE 861 (927)
Q Consensus 815 ~~~~l~~~~~~~~~~~~~~~~---~------------------d~~l~~~------------~~~~~~~~l~~Li~~Cl~ 861 (927)
+.. ..+...+.......+ . ....... ........+.+|+.+||+
T Consensus 238 ~~~---~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 238 NQL---ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp HHH---HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred HHH---HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 211 111111110000000 0 0000000 000123468899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 002410 862 QRGFSRPKMQEIVLA 876 (927)
Q Consensus 862 ~dP~~RPs~~eVl~~ 876 (927)
.||++|||++|+++.
T Consensus 315 ~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 315 FNPNKRISANDALKH 329 (388)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred cCcccCCCHHHHhCC
Confidence 999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=372.42 Aligned_cols=249 Identities=27% Similarity=0.460 Sum_probs=200.0
Q ss_pred ccccccccEEEEEEEEC---CCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~---~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
++||+|+||.||+|.+. .++.||||+++.... ...+++.+|+++|++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999764 467899999976432 335789999999999999999999999965 458899999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc--
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-- 763 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~-- 763 (927)
|+|.+++.. ...+++..++.|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999973 4678999999999999999999998 99999999999999999999999999999876543221
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+.+ .+..+....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~----~i~~~~~~~-------- 592 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA----MLEKGERMG-------- 592 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTTCCCC--------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCCC--------
Confidence 2223346788999999998899999999999999999998 99999744322 1111 222222111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
.+...+..+.+++.+||+.||++||++++|++.|+++..
T Consensus 593 -~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 593 -CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111233578899999999999999999999999998754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.97 Aligned_cols=245 Identities=29% Similarity=0.436 Sum_probs=196.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeec----CceEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILV 679 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~----~~~~~LV 679 (927)
+.+.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 456778999999999999886 5789999998753 23456779999999999999999999998764 4568999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCccccc-CCCcEEEeecccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLD-INMRAKVSDFGLSRQ 756 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivH~DLkp~NILld-~~~~~kL~DFGla~~ 756 (927)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+ .+ |+||||||+||+++ .++.+||+|||++..
T Consensus 108 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 108 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999974 3568999999999999999999998 77 99999999999997 789999999999976
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
..... .....|++.|+|||++.+ .++.++|||||||++|+|++|+.||...... ..... .+..+......
T Consensus 182 ~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~----~~~~~~~~~~~ 251 (290)
T 1t4h_A 182 KRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYR----RVTSGVKPASF 251 (290)
T ss_dssp CCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHH----HHTTTCCCGGG
T ss_pred ccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--HHHHH----HHhccCCcccc
Confidence 44322 223458999999998874 5899999999999999999999999743221 11111 11111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+. .....+.+++.+||+.||++|||++|+++
T Consensus 252 ~~--------~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 252 DK--------VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG--------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC--------CCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 11236889999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=347.96 Aligned_cols=259 Identities=21% Similarity=0.311 Sum_probs=193.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~-~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
|.+.+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 566789999999999999987 6899999998754322 12245679999999999999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 84 -~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~- 156 (324)
T 3mtl_A 84 -KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT- 156 (324)
T ss_dssp -EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred -cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc-
Confidence 5899988753 4568999999999999999999998 99999999999999999999999999999865433222
Q ss_pred ccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc---CCeeeeccc--
Q 002410 765 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVISIVDP-- 838 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~---~~~~~~~d~-- 838 (927)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. ...+...... .........
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHhchhhhcchh
Confidence 223457999999999876 5789999999999999999999999975443222 1212111111 001000000
Q ss_pred -------cccC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 839 -------VLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 839 -------~l~~----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.... .........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 000112346789999999999999999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=355.20 Aligned_cols=260 Identities=22% Similarity=0.285 Sum_probs=194.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecC------ceE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQR 676 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------~~~ 676 (927)
.|++.+.||+|+||.||+|... +|+.||||++... .....+++.+|+++++.++||||+++++++... ...
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 4667899999999999999876 5899999999754 334457789999999999999999999998654 467
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 143 ~lv~E~~~~-~l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 143 YLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEECCSE-EHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred EEEEeCCCC-CHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 999999976 4666664 238899999999999999999999 8999999999999999999999999999987
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHH-HH-------------
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-HW------------- 822 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~-~~------------- 822 (927)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+..... +.
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 214 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ---CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred cCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 65432 223456899999999999999999999999999999999999999855432211111 00
Q ss_pred --HHHhhhcCC------eeeeccccccCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 823 --ARSMIKKGD------VISIVDPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 823 --~~~~~~~~~------~~~~~d~~l~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.+....... ........+.... .......+.+|+.+||+.||++|||++|+++.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 0000000000000 01124578999999999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=334.40 Aligned_cols=246 Identities=20% Similarity=0.286 Sum_probs=199.4
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~L 678 (927)
....|++.+.||+|+||.||+|... +++.||+|++... ......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467788899999999999999987 7999999998753 234557788999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC--------------
Q 002410 679 VYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-------------- 743 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~-------------- 743 (927)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999997532 12568999999999999999999998 999999999999999844
Q ss_pred -----CcEEEeeccccccccccccccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchh
Q 002410 744 -----MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 817 (927)
Q Consensus 744 -----~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~ 817 (927)
..+||+|||++....... ...||+.|+|||.+.+. .++.++|||||||++|||++|..|+....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 479999999998765432 23489999999999765 66789999999999999999998775221
Q ss_pred hHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 818 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 818 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
... .+..+.... +... ....+.+++.+||+.||++||+++|+++
T Consensus 236 ~~~-----~~~~~~~~~-----~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 QWH-----EIRQGRLPR-----IPQV----LSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHH-----HHHTTCCCC-----CSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH-----HHHcCCCCC-----CCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111 111222111 1111 2246889999999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=333.26 Aligned_cols=245 Identities=24% Similarity=0.365 Sum_probs=202.0
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
..|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 35677899999999999999987 57889999986532 122467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999974 3468999999999999999999998 99999999999999999999999999998765432
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ .. .. +..... .+
T Consensus 168 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~-~~~~~~------~~ 231 (284)
T 2vgo_A 168 R---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---TH---RR-IVNVDL------KF 231 (284)
T ss_dssp C---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HH-HHTTCC------CC
T ss_pred c---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---HH---HH-Hhcccc------CC
Confidence 2 223458999999999999999999999999999999999999997433211 11 11 111111 11
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+......+.+++.+||+.||++||+++|+++
T Consensus 232 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 232 ----PPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1112346789999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=362.10 Aligned_cols=251 Identities=25% Similarity=0.315 Sum_probs=204.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.+++.+.||+|+||.||+|+.+ +|+.||||++.... ......+.+|+++|++++||||+++++++.+.+..++|||
T Consensus 185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE 264 (576)
T 2acx_A 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 264 (576)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEE
Confidence 3556789999999999999986 69999999986532 2234668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 265 y~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 265 LMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp CCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred cCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 99999999999753 24458999999999999999999998 999999999999999999999999999998765432
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccch-hhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+... +..... ..
T Consensus 341 ~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~----i~~~~~------~~ 408 (576)
T 2acx_A 341 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL----VKEVPE------EY 408 (576)
T ss_dssp C--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH----HHHCCC------CC
T ss_pred c--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH----hhcccc------cC
Confidence 2 2234699999999999999999999999999999999999999985443211 112221 111110 01
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 876 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~~ 876 (927)
+......+.+|+.+||+.||++|| +++||++.
T Consensus 409 ----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 409 ----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 111224688999999999999999 78888754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=336.08 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=201.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeee--cCceEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQRILVY 680 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~--~~~~~~LV~ 680 (927)
.|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++. ..+..++||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 4567899999999999999987 68999999997532 344577999999999999999999999874 467899999
Q ss_pred EecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCcccccCCCcEEEeecccc
Q 002410 681 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-----IIHRDVKSSNILLDINMRAKVSDFGLS 754 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~-----ivH~DLkp~NILld~~~~~kL~DFGla 754 (927)
||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++.+||+|||++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 9999999999997532 34558999999999999999999998 67 999999999999999999999999999
Q ss_pred ccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 755 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 755 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
+....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+.. .+..+....
T Consensus 164 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~----~i~~~~~~~ 235 (279)
T 2w5a_A 164 RILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAG----KIREGKFRR 235 (279)
T ss_dssp HHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHTCCCC
T ss_pred eeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHH----HHhhccccc
Confidence 87644322 12234589999999999988999999999999999999999999974332 11211 222222211
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~ 878 (927)
+. ......+.+++.+||+.||++||+++||++.+.
T Consensus 236 -----~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 236 -----IP----YRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -----CC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -----CC----cccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 11 122346889999999999999999999998654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=341.02 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=203.8
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
..|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 35667899999999999999987 47899999986532 345577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++++|.+++.. ...+++.+++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 121 e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 121 ELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp CCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999873 4578999999999999999999998 89999999999999999999999999999876433
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
.. ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+. .. . +..... .+
T Consensus 195 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~---~-~~~~~~------~~ 260 (335)
T 2owb_A 195 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET---YL---R-IKKNEY------SI 260 (335)
T ss_dssp TC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH---H-HHHTCC------CC
T ss_pred cc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH---HH---H-HhcCCC------CC
Confidence 22 22334589999999999988899999999999999999999999974332111 11 1 111111 01
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
... ....+.+++.+||+.||++||+++|+++.
T Consensus 261 ~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 261 PKH----INPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CTT----SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred Ccc----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 12367899999999999999999999873
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=335.13 Aligned_cols=247 Identities=29% Similarity=0.433 Sum_probs=204.1
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
.|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 3566789999999999999876 68999999987543 344678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++++|.+++. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 103 ~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 174 (303)
T 3a7i_A 103 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 174 (303)
T ss_dssp TTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence 9999999986 3568999999999999999999998 9999999999999999999999999999987654322
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... +..+.. +.+...
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~----~~~~~~-----~~~~~~ 242 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLFL----IPKNNP-----PTLEGN 242 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH----HHHSCC-----CCCCSS
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHHH----hhcCCC-----CCCccc
Confidence 223345899999999999999999999999999999999999999743221 11111 111111 111112
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+ ...+.+++.+||+.||++||+++|+++.
T Consensus 243 ~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 243 Y----SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp C----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred c----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 2 2368899999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=343.46 Aligned_cols=254 Identities=16% Similarity=0.165 Sum_probs=205.1
Q ss_pred HHHHhhcccccccccEEEEEEE------ECCCcEEEEEEccCccchhHHHHHHHHHHHHhcC---CCceeeeeeeeecCc
Q 002410 604 EATNNFCKKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEH 674 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~------~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~---HpnIv~l~~~~~~~~ 674 (927)
...|.+.+.||+|+||.||+|. ..+++.||||+++... ..++.+|++++++++ |+||+++++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 3456678899999999999994 4468899999997543 456777888888886 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC----------
Q 002410 675 QRILVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---------- 742 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~---------- 742 (927)
..++||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+ ++|+||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccccc
Confidence 9999999999999999997422 35679999999999999999999998 99999999999999998
Q ss_pred -CCcEEEeecccccccccc-ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHH
Q 002410 743 -NMRAKVSDFGLSRQAEED-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 820 (927)
Q Consensus 743 -~~~~kL~DFGla~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~ 820 (927)
++.+||+|||+++..... .........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence 899999999999765322 1222344569999999999999999999999999999999999999996322210
Q ss_pred HHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHHhhhhhc
Q 002410 821 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR-PKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 821 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R-Ps~~eVl~~L~~~~~~e 884 (927)
..+...+.... ....+.+++..|++.+|.+| |+++++.+.|++.+...
T Consensus 293 -------------~~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 -------------CKPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp -------------EEECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -------------eeechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 00111111111 13467789999999999998 68999999999888753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=339.87 Aligned_cols=259 Identities=21% Similarity=0.254 Sum_probs=203.8
Q ss_pred hhhHHHHHHhhc-ccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q 002410 599 LPELEEATNNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 673 (927)
Q Consensus 599 ~~el~~~~~~~~-~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~ 673 (927)
..+.....|.+. +.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++++ +||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 345555666665 88999999999999987 58999999987643 23357889999999999 469999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC---CCcEEEee
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSD 750 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~---~~~~kL~D 750 (927)
+..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred CeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEee
Confidence 9999999999999999998643 34679999999999999999999998 99999999999999987 78999999
Q ss_pred ccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcC
Q 002410 751 FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 830 (927)
Q Consensus 751 FGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 830 (927)
||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ...+.. .
T Consensus 178 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~----~ 248 (327)
T 3lm5_A 178 FGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET---YLNISQ----V 248 (327)
T ss_dssp GGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH----T
T ss_pred CccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHHHh----c
Confidence 999987654322 2234589999999999999999999999999999999999999974432211 111111 1
Q ss_pred CeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 831 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 831 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
... ............+.+++.+||+.||++|||++|+++.
T Consensus 249 ~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 NVD------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCC------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ccc------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 000 0001111223468899999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=346.43 Aligned_cols=245 Identities=22% Similarity=0.318 Sum_probs=188.4
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHh-cCCCceeeeeeeeec----CceEEEEEEecC
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSR-IHHRNLVPLIGYCEE----EHQRILVYEYMH 684 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~-l~HpnIv~l~~~~~~----~~~~~LV~E~~~ 684 (927)
+.||+|+||+||+|..+ +|+.||||+++.. ..+.+|++++.+ .+||||+++++++.. .+..++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 68999999999999987 5899999998642 456788888754 489999999998865 667899999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC---CCcEEEeeccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~---~~~~kL~DFGla~~~~~~~ 761 (927)
+|+|.+++... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+++......
T Consensus 143 gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 143 GGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp SEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 99999999853 24569999999999999999999998 99999999999999987 7899999999998654322
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccch-hhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...... +..+... ...+ .
T Consensus 219 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----i~~~~~~-~~~~-~ 290 (400)
T 1nxk_A 219 S--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQYE-FPNP-E 290 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----HHHTCCC-CCTT-T
T ss_pred c--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----HHcCccc-CCCc-c
Confidence 1 2344589999999999999999999999999999999999999974433211 111111 1111110 0000 0
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.......+.+|+.+||+.||++|||++|+++.
T Consensus 291 ----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 291 ----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01123468899999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=342.68 Aligned_cols=263 Identities=20% Similarity=0.214 Sum_probs=197.6
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccch-----hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~-----~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
...|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 356778899999999999999986 5899999998753221 1246889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+||||+++ +|.+++... ...+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 89 lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 99999985 898888742 4568889999999999999999998 99999999999999999999999999999876
Q ss_pred cccccccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc---CCee
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVI 833 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~---~~~~ 833 (927)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|..||......+ .+..... .... ....
T Consensus 163 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~i~~-~~~~~~~~~~~ 238 (346)
T 1ua2_A 163 GSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFE-TLGTPTEEQWP 238 (346)
T ss_dssp TSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-HHCCCCTTTSS
T ss_pred cCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHH-HcCCCChhhhh
Confidence 44322 22334589999999998654 58999999999999999999999997443221 1111111 1110 0000
Q ss_pred ee------ccccccCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 834 SI------VDPVLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 834 ~~------~d~~l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.. +........+ ......+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 0000000000 1223578899999999999999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=343.00 Aligned_cols=265 Identities=20% Similarity=0.259 Sum_probs=198.6
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeec--------C
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------E 673 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--------~ 673 (927)
..|++.+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 35777899999999999999985 689999999865432 234678899999999999999999999876 4
Q ss_pred ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccc
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 753 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 753 (927)
+..++||||+++ +|.+.+... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 568999999975 777777643 3569999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccc---cccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc
Q 002410 754 SRQAEEDL---THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 829 (927)
Q Consensus 754 a~~~~~~~---~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 829 (927)
++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....................
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 98754322 112233458999999999876 46899999999999999999999999854432222211111111111
Q ss_pred CCeeeecccccc--------CCCCH-HH------HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 830 GDVISIVDPVLI--------GNVKI-ES------IWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 830 ~~~~~~~d~~l~--------~~~~~-~~------~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
......-..... ..... +. ...+.+|+.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 000000000000 00000 00 235789999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=334.40 Aligned_cols=260 Identities=28% Similarity=0.422 Sum_probs=197.9
Q ss_pred HHHHhhcccccccccEEEEEEEEC--CCc--EEEEEEccCc---cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK--DGK--EVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~--~g~--~vAvK~l~~~---~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
...|++.+.||+|+||.||+|++. +++ .||||+++.. .....+.+.+|++++++++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 345778899999999999999864 233 6899998754 2345678999999999999999999999998765 8
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++|+||+++++|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999999753 3568999999999999999999998 9999999999999999999999999999987
Q ss_pred ccccccc--cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCee
Q 002410 757 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 833 (927)
Q Consensus 757 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 833 (927)
....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... .........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~---~~~~~~~~~ 244 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILH---KIDKEGERL 244 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---HHHTSCCCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHHH---HHHccCCCC
Confidence 6543221 1223447788999999988889999999999999999999 99999743321 1111 111111110
Q ss_pred eeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 834 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 834 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
. ........+.+++.+||+.||++||+++|+++.|+++....
T Consensus 245 ~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 245 P---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred C---------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 0 01122347889999999999999999999999999887543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=330.36 Aligned_cols=246 Identities=24% Similarity=0.392 Sum_probs=194.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4667899999999999999987 69999999986532 2234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++++|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 92 YVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred ccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999974 3568999999999999999999998 899999999999999999999999999998765432
Q ss_pred cccccccccCCCccCCCccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
. .....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...... ...+ .+..+.. .+
T Consensus 166 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~----~~~~~~~------~~ 230 (276)
T 2h6d_A 166 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFK----KIRGGVF------YI 230 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCC------CC
T ss_pred c--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHH----HhhcCcc------cC
Confidence 1 223458999999999987765 68999999999999999999999743221 1111 1111111 01
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+......+.+++.+||+.||++||+++|+++.
T Consensus 231 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 ----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11122467899999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=352.61 Aligned_cols=254 Identities=24% Similarity=0.336 Sum_probs=193.2
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--------hhHHHHHHHHHHHHhcCCCceeeeeeeee
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCE 671 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--------~~~~~~~~E~~~L~~l~HpnIv~l~~~~~ 671 (927)
+.....|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+++|++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 445567888999999999999999876 589999999865321 12235889999999999999999999986
Q ss_pred cCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC---cEEE
Q 002410 672 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAKV 748 (927)
Q Consensus 672 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~---~~kL 748 (927)
. +..++||||+++|+|.+++. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++ .+||
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred c-CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEE
Confidence 5 45799999999999999887 35679999999999999999999998 8999999999999997544 5999
Q ss_pred eeccccccccccccccccccccCCCccCCCccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 002410 749 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 825 (927)
Q Consensus 749 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 825 (927)
+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+..
T Consensus 284 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~---- 355 (419)
T 3i6u_A 284 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKD---- 355 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHH----
T ss_pred eecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHH----
Confidence 9999998765432 2234568999999999853 577889999999999999999999997433221 1111
Q ss_pred hhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 826 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 826 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.+..+.... .+.... .....+.+++.+||+.||++||+++|+++
T Consensus 356 ~i~~~~~~~--~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 356 QITSGKYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHTTCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCCC--Cchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 111111110 001111 12346889999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=351.65 Aligned_cols=262 Identities=21% Similarity=0.289 Sum_probs=207.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCC-CceeeeeeeeecCceEEEEEEec
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~H-pnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
.|++.++||+|+||.||+|++. +++.||||++..... ..++.+|+++++.++| +++..+..++...+..++||||+
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 4667899999999999999975 689999998765432 2457889999999976 55666666677788899999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc---cCCCcEEEeecccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFGla~~~~~~ 760 (927)
+++|.+++... ...+++..++.|+.||+.||+|||+ ++|+||||||+|||| +.++.+||+|||+++.....
T Consensus 86 -g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 86 -GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred -CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999999743 4569999999999999999999998 999999999999999 68899999999999876543
Q ss_pred ccc------cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 761 LTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 761 ~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+...........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 321 12245699999999999999999999999999999999999999986544333332222222111111111
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
+... .+.++.+++.+||+.+|++||++++|++.|++++..+
T Consensus 240 -----l~~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 240 -----LCRG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp -----HHTT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----HhcC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 1111 1247889999999999999999999999999987654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=335.85 Aligned_cols=251 Identities=20% Similarity=0.358 Sum_probs=197.8
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
..|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 34667899999999999999987 58999999998765566788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++++|.+++... ...+++..+..++.||+.||+|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 172 (302)
T 2j7t_A 99 PGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ- 172 (302)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH-
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc-
Confidence 999999988742 4568999999999999999999998 8999999999999999999999999998764322111
Q ss_pred cccccccCCCccCCCcc-----CCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 764 ISSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l-----~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
......|++.|+|||++ .+..++.++||||||+++|||++|+.||....... . ....... .......
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~---~~~~~~~-~~~~~~~- 244 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---V---LLKIAKS-DPPTLLT- 244 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---HHHHHHS-CCCCCSS-
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH---H---HHHHhcc-CCcccCC-
Confidence 11234589999999998 46778999999999999999999999997433211 1 1111111 1111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+......+.+++.+||+.||++|||++|+++
T Consensus 245 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 245 ------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1122346889999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=353.83 Aligned_cols=191 Identities=26% Similarity=0.388 Sum_probs=153.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeec-----CceEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQRI 677 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-----~~~~~ 677 (927)
.|++.+.||+|+||+||+|+.+ +++.||||++... .....+++.+|+++|++++||||+++++++.. ....+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 5777899999999999999876 6899999998653 23345789999999999999999999999843 35789
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+||||+ +|+|.+++. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 134 lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 999998 579999987 35679999999999999999999999 99999999999999999999999999999876
Q ss_pred ccccc--------------------------ccccccccCCCccCCCcc-CCCCCCcchhHHHHHHHHHHHHh
Q 002410 758 EEDLT--------------------------HISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELIS 803 (927)
Q Consensus 758 ~~~~~--------------------------~~~~~~~gt~~Y~APE~l-~~~~~s~ksDVwSlGvlL~eLlt 803 (927)
..... .......||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 43211 112234689999999976 56679999999999999999999
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=334.25 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=199.5
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
.....|++.+.||+|+||.||+|... +|+.||+|++.... ..+.+.+|++++++++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34456777899999999999999987 58999999987542 3467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++++|.+++.. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999863 24578999999999999999999998 99999999999999999999999999999876543
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ... . +..........
T Consensus 179 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~-~~~~~~~~~~~--- 247 (314)
T 3com_A 179 MAK-RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR---AIF---M-IPTNPPPTFRK--- 247 (314)
T ss_dssp BSC-BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH---H-HHHSCCCCCSS---
T ss_pred ccc-cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---HHH---H-HhcCCCcccCC---
Confidence 222 233458999999999999999999999999999999999999997432211 111 1 11111111111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.......+.+++.+||+.||++||+++|+++
T Consensus 248 ----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 ----PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ----GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1112346889999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=333.93 Aligned_cols=256 Identities=20% Similarity=0.284 Sum_probs=198.2
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcC-CCceeeeeeeeec--CceEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEE--EHQRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~--~~~~~LV~ 680 (927)
..|++.+.||+|+||.||+|+.. +++.||||+++.. ..+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 45777899999999999999875 6899999998743 3467889999999997 9999999999987 66789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC-cEEEeeccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEE 759 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla~~~~~ 759 (927)
||+++++|.+++. .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999885 37889999999999999999998 9999999999999999776 899999999987544
Q ss_pred cccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH--------HhhhcC
Q 002410 760 DLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMIKKG 830 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~--------~~~~~~ 830 (927)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...+..... ..+...
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHHhcCCchhhhHHHHh
Confidence 322 233458999999999877 67899999999999999999999999532221 111111110 000000
Q ss_pred C--------------eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 831 D--------------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 831 ~--------------~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
. ....................+.+++.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 00000000111111123457889999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=344.73 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=193.2
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCc------eE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 676 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~------~~ 676 (927)
.|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 4667889999999999999985 69999999986532 334567899999999999999999999987653 46
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp EEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 9999999 8899999873 468999999999999999999998 9999999999999999999999999999987
Q ss_pred ccccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCC----
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---- 831 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~---- 831 (927)
.... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+... .+........
T Consensus 178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~---~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK---EIMKVTGTPPAEFV 250 (367)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCHHHH
T ss_pred cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCCHHHH
Confidence 5432 223458999999999876 689999999999999999999999998544322111 1111000000
Q ss_pred --------------eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 832 --------------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 832 --------------~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
........+ ..........+.+|+.+||+.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000000 00111223468899999999999999999999873
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=346.32 Aligned_cols=267 Identities=22% Similarity=0.273 Sum_probs=205.0
Q ss_pred hhhHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcC--------CCceeeeeee
Q 002410 599 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--------HRNLVPLIGY 669 (927)
Q Consensus 599 ~~el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~--------HpnIv~l~~~ 669 (927)
..++....|++.++||+|+||+||+|+.. +++.||||+++.. ....+.+.+|++++++++ |+||++++++
T Consensus 31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 34444567888999999999999999876 5889999999754 344577889999999995 7889999999
Q ss_pred ee----cCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCcccccCCC
Q 002410 670 CE----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINM 744 (927)
Q Consensus 670 ~~----~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~-~ivH~DLkp~NILld~~~ 744 (927)
+. .....++||||+ +++|.+.+... ....+++..++.++.||+.||+|||+ + +|+||||||+|||++.++
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCH
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccc
Confidence 87 566899999999 56666666543 23569999999999999999999998 7 999999999999998775
Q ss_pred -------------------------------------------------cEEEeeccccccccccccccccccccCCCcc
Q 002410 745 -------------------------------------------------RAKVSDFGLSRQAEEDLTHISSVARGTVGYL 775 (927)
Q Consensus 745 -------------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~ 775 (927)
.+||+|||+++...... ....||+.|+
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~gt~~y~ 260 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTRQYR 260 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----CSCCSCGGGC
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----ccCCCCCccc
Confidence 79999999998765432 2345899999
Q ss_pred CCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccch---hhHHHHHHHhhhc--------CC-----------ee
Q 002410 776 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE---LNIVHWARSMIKK--------GD-----------VI 833 (927)
Q Consensus 776 APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~---~~l~~~~~~~~~~--------~~-----------~~ 833 (927)
|||++.+..++.++|||||||++|||++|+.||........ ......+...... +. ..
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 99999998999999999999999999999999975443221 1111111111110 00 00
Q ss_pred eeccccc---------cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 834 SIVDPVL---------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 834 ~~~d~~l---------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.+.+... ...........+.+|+.+||+.||++|||++|+++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000000 01234556678999999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=347.10 Aligned_cols=197 Identities=25% Similarity=0.350 Sum_probs=166.1
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----ceEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRI 677 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-----~~~~ 677 (927)
.|.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+++|++++||||+++++++... +..+
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 5677899999999999999986 5889999999753 234457899999999999999999999998765 5789
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+||||++ |+|.+++. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 107 lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 9999986 69999997 35679999999999999999999999 89999999999999999999999999999876
Q ss_pred cccccc---------------------cccccccCCCccCCCcc-CCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 002410 758 EEDLTH---------------------ISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVS 809 (927)
Q Consensus 758 ~~~~~~---------------------~~~~~~gt~~Y~APE~l-~~~~~s~ksDVwSlGvlL~eLltG~~Pf~ 809 (927)
...... ......||+.|+|||++ .+..++.++||||+||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 443211 12345689999999986 56679999999999999999998655554
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=356.78 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=199.6
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
....|++.+.||+|+||+||+|+.+ +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567888999999999999999987 68899999987543 23357789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC---CCcEEEeecccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ 756 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~---~~~~kL~DFGla~~ 756 (927)
|||+++|+|.+.+.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999998873 4568999999999999999999998 99999999999999976 45599999999987
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
...... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .+.. .+..+.... .
T Consensus 189 ~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~----~i~~~~~~~-~ 257 (494)
T 3lij_A 189 FENQKK--MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EILR----KVEKGKYTF-D 257 (494)
T ss_dssp CBTTBC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHTCCCC-C
T ss_pred CCCCcc--ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhCCCCC-C
Confidence 654322 233468999999999874 6899999999999999999999999744322 1111 111111110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.+ .... ....+.+++.+||+.||++|||++|+++.
T Consensus 258 ~~-~~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 SP-EWKN----VSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SG-GGTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ch-hccc----CCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11 1111 12367899999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=356.41 Aligned_cols=252 Identities=27% Similarity=0.369 Sum_probs=202.8
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
....|++.++||+|+||+||+|..+ +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467888999999999999999987 68999999986432 23457789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc---CCCcEEEeecccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQ 756 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld---~~~~~kL~DFGla~~ 756 (927)
|||+++|+|.+.+.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999998874 4568999999999999999999998 9999999999999995 456799999999987
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
...... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .+... +..+......
T Consensus 174 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~----i~~~~~~~~~ 243 (486)
T 3mwu_A 174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKR----VETGKYAFDL 243 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHTCCCSCS
T ss_pred CCCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhCCCCCCC
Confidence 644322 233468999999999876 5899999999999999999999999744321 11111 1112111100
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+. . ......+.+++.+||+.||++|||+.|+++.
T Consensus 244 -~~-~----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 -PQ-W----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -GG-G----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -cc-c----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0 1123467899999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=332.33 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=186.2
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-h-hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-H-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~-~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
...|++.+.||+|+||.||+|+.. +|+.||||+++.... . ..+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 345677899999999999999985 689999999976432 2 2334455555688889999999999999999999999
Q ss_pred EecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 681 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~-~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
||++ |+|.+++.... ....+++..++.++.|++.||+|||+ + +|+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 58877775321 35679999999999999999999998 7 99999999999999999999999999998765
Q ss_pred ccccccccccccCCCccCCCcc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 759 EDLTHISSVARGTVGYLDPEYY----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 759 ~~~~~~~~~~~gt~~Y~APE~l----~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
.... .....||+.|+|||.+ .+..++.++|||||||++|||++|+.||...... ...+. ........ .
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~----~~~~~~~~-~ 233 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-FQQLK----QVVEEPSP-Q 233 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-HHHHH----HHHHSCCC-C
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-HHHHH----HHhccCCC-C
Confidence 4322 2233589999999996 5667899999999999999999999999732221 11111 11221111 1
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.. .......+.+++.+||+.||++|||++|+++
T Consensus 234 ~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 LP--------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CC--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cc--------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 10 0112346889999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=335.32 Aligned_cols=254 Identities=25% Similarity=0.348 Sum_probs=198.7
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--------hhHHHHHHHHHHHHhcCCCceeeeeeeee
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCE 671 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--------~~~~~~~~E~~~L~~l~HpnIv~l~~~~~ 671 (927)
......|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 445677889999999999999999986 588999999865321 12345889999999999999999999987
Q ss_pred cCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCc---EEE
Q 002410 672 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKV 748 (927)
Q Consensus 672 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~---~kL 748 (927)
.++ .++||||+++++|.+++. ....+++..+..++.||+.||+|||+ ++|+||||||+||+++.++. +||
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred CCc-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEE
Confidence 665 899999999999999987 35678999999999999999999998 99999999999999987664 999
Q ss_pred eeccccccccccccccccccccCCCccCCCcc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 002410 749 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 825 (927)
Q Consensus 749 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l---~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 825 (927)
+|||+++...... ......||+.|+|||++ ....++.++|||||||++|||++|+.||....... .+...+
T Consensus 159 ~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~-- 232 (322)
T 2ycf_A 159 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI-- 232 (322)
T ss_dssp CCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH--
T ss_pred ccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH--
Confidence 9999998764322 12234589999999997 35678999999999999999999999997443321 111111
Q ss_pred hhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 826 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 826 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..+.... .+.... .....+.+++.+||+.||++||+++|+++
T Consensus 233 --~~~~~~~--~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 --TSGKYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --HHTCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HhCcccc--Cchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111110 011111 12346889999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=357.77 Aligned_cols=253 Identities=27% Similarity=0.382 Sum_probs=206.0
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
.....|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 44567888999999999999999987 68999999986532 334678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc---cCCCcEEEeecccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLS 754 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFGla 754 (927)
+||||+.+|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 103 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EEECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 99999999999999873 5679999999999999999999999 999999999999999 56789999999999
Q ss_pred ccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 755 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 755 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
+....... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .+... +..+....
T Consensus 177 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~----i~~~~~~~ 246 (484)
T 3nyv_A 177 THFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILKK----VEKGKYTF 246 (484)
T ss_dssp HHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHCCCCC
T ss_pred EEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHHH----HHcCCCCC
Confidence 87654322 223458999999999876 6899999999999999999999999744321 12211 12221111
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.. +. .......+.+++.+||+.||++|||++|+++.
T Consensus 247 ~~-~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 247 EL-PQ-----WKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CS-GG-----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CC-cc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00 00 01123468899999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=355.44 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=202.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
|.+.+.||+|+||.||+|+.+ +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 187 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~ 266 (543)
T 3c4z_A 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTI 266 (543)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 445678999999999999986 599999999975322 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 683 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 683 ~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
++||+|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 267 ~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp CTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 99999999987543 24579999999999999999999998 999999999999999999999999999998765433
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc-hhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA-ELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+.+ .... ... .
T Consensus 344 ~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~---~i~~-~~~------~- 411 (543)
T 3c4z_A 344 TK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---RVLE-QAV------T- 411 (543)
T ss_dssp CC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH---HHHH-CCC------C-
T ss_pred cc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH---HHhh-ccc------C-
Confidence 22 233469999999999999999999999999999999999999997543221 111211 1111 111 0
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL 875 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~-----~eVl~ 875 (927)
++......+.+++.+||+.||++||++ +||++
T Consensus 412 ---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 412 ---YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ---CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 111223467899999999999999975 55553
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=328.64 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=196.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc----chhHHHHHHHHHHHHhcCCCceeeeeeee--ecCceEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYC--EEEHQRIL 678 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~----~~~~~~~~~E~~~L~~l~HpnIv~l~~~~--~~~~~~~L 678 (927)
.|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++ .+.+..++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 4667899999999999999986 58899999987532 23457799999999999999999999998 45567899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
||||++++ |.+++... ....+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 99999876 77777644 35679999999999999999999998 999999999999999999999999999998754
Q ss_pred ccc-cccccccccCCCccCCCccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 759 EDL-THISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 759 ~~~-~~~~~~~~gt~~Y~APE~l~~~~--~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
... ........|++.|+|||++.+.. .+.++||||||+++|||++|+.||...... ...+ .+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~----~i~~~~~--- 230 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLFE----NIGKGSY--- 230 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH----HHHHCCC---
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHH----HHhcCCC---
Confidence 322 22223445899999999987643 478999999999999999999999743321 1111 1111211
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.+.. .....+.+++.+||+.||++||+++|+++.
T Consensus 231 ---~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ---AIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---CCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---CCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 123467899999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=338.31 Aligned_cols=250 Identities=26% Similarity=0.363 Sum_probs=200.7
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--------hhHHHHHHHHHHHHhc-CCCceeeeeeeeecCc
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 674 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--------~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~ 674 (927)
..|++.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 45666789999999999999986 699999999865321 1245688999999999 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccc
Q 002410 675 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 754 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 754 (927)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCcc
Confidence 99999999999999999973 4578999999999999999999998 89999999999999999999999999999
Q ss_pred ccccccccccccccccCCCccCCCccC------CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhh
Q 002410 755 RQAEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 828 (927)
Q Consensus 755 ~~~~~~~~~~~~~~~gt~~Y~APE~l~------~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 828 (927)
........ .....||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..... +.
T Consensus 248 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~----i~ 318 (365)
T 2y7j_A 248 CHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LMLRM----IM 318 (365)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HH
T ss_pred cccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHHHH----HH
Confidence 87654322 23356899999999885 336889999999999999999999999743221 11111 11
Q ss_pred cCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 829 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 829 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.+.... ..+. ... ....+.+++.+||+.||++||+++|+++
T Consensus 319 ~~~~~~-~~~~-~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 319 EGQYQF-SSPE-WDD----RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HTCCCC-CHHH-HSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hCCCCC-CCcc-ccc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111100 0000 011 1236889999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=351.70 Aligned_cols=240 Identities=17% Similarity=0.158 Sum_probs=185.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc---cchhHHHHHHHHH---HHHhcCCCceeeee-------eeee
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVA---LLSRIHHRNLVPLI-------GYCE 671 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~---~L~~l~HpnIv~l~-------~~~~ 671 (927)
.|.+.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|++ ++++++||||++++ +++.
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~ 153 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence 4556789999999999999974 6999999998742 3345678999994 55555899999998 5555
Q ss_pred cCc-----------------eEEEEEEecCCCCHHHHhccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 002410 672 EEH-----------------QRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 730 (927)
Q Consensus 672 ~~~-----------------~~~LV~E~~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH 730 (927)
+.+ ..++||||+ +|+|.+++.... ....+++..++.|+.||+.||+|||+ ++|+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH 229 (377)
T 3byv_A 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVH 229 (377)
T ss_dssp CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEEC
T ss_pred ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence 443 278999999 689999997431 11234468888999999999999999 89999
Q ss_pred cCCCCCcccccCCCcEEEeeccccccccccccccccccccCCCccCCCccCCC-----------CCCcchhHHHHHHHHH
Q 002410 731 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-----------QLTEKSDVYSFGVVLL 799 (927)
Q Consensus 731 ~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-----------~~s~ksDVwSlGvlL~ 799 (927)
|||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++|
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 99999999999999999999999986433 2233457 999999999877 8999999999999999
Q ss_pred HHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 800 ELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 800 eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
||++|+.||.......... .+.. . ... ....+.+++.+||+.||++||++.|+++
T Consensus 305 elltg~~Pf~~~~~~~~~~---------------~~~~-~-~~~----~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSE---------------WIFR-S-CKN----IPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHSSCCC------CCSG---------------GGGS-S-CCC----CCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHCCCCCcccccccchh---------------hhhh-h-ccC----CCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999997433211100 0000 0 011 1246889999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=336.24 Aligned_cols=261 Identities=23% Similarity=0.309 Sum_probs=184.3
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
..|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 44667899999999999999865 68999999986543 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 683 MHNGTLRDRLHGS-----VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 683 ~~~gsL~~~L~~~-----~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+++++|.+++... .....+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 9999999998631 124568999999999999999999998 89999999999999999999999999998765
Q ss_pred ccccc----ccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCe
Q 002410 758 EEDLT----HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832 (927)
Q Consensus 758 ~~~~~----~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 832 (927)
..... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ ... ..........
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~ 248 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LML-TLQNDPPSLE 248 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHH-HHTSSCCCTT
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HHH-HhccCCCccc
Confidence 43211 11223458999999999865 5689999999999999999999999974433221 111 1000000000
Q ss_pred eeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 833 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 833 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
....++..... ....+.+++.+||+.||++||++.|+++
T Consensus 249 ~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 249 TGVQDKEMLKK----YGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp C-----CCCCC----CCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccchhhhh----hhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00111111112 2346889999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=342.36 Aligned_cols=261 Identities=23% Similarity=0.270 Sum_probs=192.3
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCccc-----------hhHHHHHHHHHHHHhcCCCceeeeeeeee--
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-----------HRTQQFVTEVALLSRIHHRNLVPLIGYCE-- 671 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~-----------~~~~~~~~E~~~L~~l~HpnIv~l~~~~~-- 671 (927)
..|.+.+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++||||+++++++.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 45566899999999999999998899999999864322 12377999999999999999999999984
Q ss_pred ---cCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEE
Q 002410 672 ---EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 748 (927)
Q Consensus 672 ---~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL 748 (927)
.....++||||++ |+|.+.+.. ....+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEE
Confidence 3446899999997 688888874 34579999999999999999999999 89999999999999999999999
Q ss_pred eeccccccccccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhh
Q 002410 749 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 827 (927)
Q Consensus 749 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~ 827 (927)
+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. ...+....
T Consensus 176 ~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~ 250 (362)
T 3pg1_A 176 CDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ---LNKIVEVV 250 (362)
T ss_dssp CCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHH
T ss_pred EecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHc
Confidence 99999976443322 233458899999999876 6789999999999999999999999985443211 11111111
Q ss_pred hcCCee------------------eeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 828 KKGDVI------------------SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 828 ~~~~~~------------------~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
...... ..................+.+++.+||+.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 100000 0000000000011123468899999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=345.73 Aligned_cols=251 Identities=10% Similarity=0.035 Sum_probs=179.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHhc--CCCceeeee-------eeeecC
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI--HHRNLVPLI-------GYCEEE 673 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l--~HpnIv~l~-------~~~~~~ 673 (927)
|.+.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+++++.+ +||||++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 556789999999999999976 689999999987432 3456678886555555 699988755 333322
Q ss_pred -----------------ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCeEe
Q 002410 674 -----------------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKGLEYLHTGCNPGIIH 730 (927)
Q Consensus 674 -----------------~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~------~~i~~qia~gL~~LH~~~~~~ivH 730 (927)
...++||||++ |+|.+++... +..+.+..+ ..++.||+.||+|||+ ++|+|
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivH 217 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVH 217 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCcc
Confidence 34799999998 8999999853 223455555 6788999999999998 99999
Q ss_pred cCCCCCcccccCCCcEEEeeccccccccccccccccccccCCCccCCCccCC--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 002410 731 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPV 808 (927)
Q Consensus 731 ~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf 808 (927)
|||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998764322 13346799999999987 68999999999999999999999999
Q ss_pred CcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 809 SVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 809 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.......... .........................+.+++.+||+.||++|||++|+++
T Consensus 294 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 8543221100 0000000000000100001122457889999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=338.93 Aligned_cols=260 Identities=21% Similarity=0.288 Sum_probs=199.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----ceEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 678 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-----~~~~L 678 (927)
.|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 4667899999999999999876 68899999997543 33447789999999999999999999998654 46899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
||||++ |+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 108 v~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 999997 599999873 458999999999999999999998 999999999999999999999999999998765
Q ss_pred cccccc--ccccccCCCccCCCccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCee--
Q 002410 759 EDLTHI--SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI-- 833 (927)
Q Consensus 759 ~~~~~~--~~~~~gt~~Y~APE~l~-~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~-- 833 (927)
...... .....||+.|+|||++. +..++.++|||||||++|||++|+.||......+..... ..........
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~ 256 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQEDL 256 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH---HHHHCSCCHHHH
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH---HHHhCCCCHHHH
Confidence 432221 23446899999999865 455899999999999999999999999755433222111 1111000000
Q ss_pred -e------------eccccc--cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 834 -S------------IVDPVL--IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 834 -~------------~~d~~l--~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
. ...+.. ...........+.+|+.+||+.||++|||++|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000000 000001123468899999999999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=333.18 Aligned_cols=263 Identities=22% Similarity=0.296 Sum_probs=203.5
Q ss_pred HHHHhhcccccccccEEEEEEEE-C-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCc------eeeeeeeeecCce
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKM-K-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN------LVPLIGYCEEEHQ 675 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~-~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~Hpn------Iv~l~~~~~~~~~ 675 (927)
...|++.+.||+|+||.||+|.. + +++.||||+++.. ....+.+.+|+++++.++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 44677889999999999999987 3 6889999999754 344577889999999997654 9999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC-------------
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI------------- 742 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~------------- 742 (927)
.++||||+ +++|.+++... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 89999999754 23468999999999999999999998 99999999999999987
Q ss_pred ------CCcEEEeeccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccch
Q 002410 743 ------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 816 (927)
Q Consensus 743 ------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~ 816 (927)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999865432 2234589999999999999999999999999999999999999975443222
Q ss_pred hhHHHHHHHhh-----hcCCeeeec---------------------ccc-ccCCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 002410 817 LNIVHWARSMI-----KKGDVISIV---------------------DPV-LIGNVKIESIWRIAEVAIQCVEQRGFSRPK 869 (927)
Q Consensus 817 ~~l~~~~~~~~-----~~~~~~~~~---------------------d~~-l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs 869 (927)
........... ......... .+. -...........+.+++.+||+.||++|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 21111110000 000000000 000 000112345668999999999999999999
Q ss_pred HHHHHHH
Q 002410 870 MQEIVLA 876 (927)
Q Consensus 870 ~~eVl~~ 876 (927)
++|+++.
T Consensus 323 ~~ell~h 329 (339)
T 1z57_A 323 LREALKH 329 (339)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999853
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=366.36 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=207.7
Q ss_pred HHHHHHhhcccccccccEEEEEEEECC----CcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~----g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~ 676 (927)
+....+++.+.||+|+||.||+|.+.. +..||||+++.... ...+.+.+|+.++++++||||+++++++.+ +..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence 344567788999999999999998753 46799999876433 345789999999999999999999999854 568
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999999753 4568999999999999999999998 9999999999999999999999999999987
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
.............+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .....+ ..+....
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i----~~~~~~~- 612 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI----ENGERLP- 612 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH----HHTCCCC-
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH----HcCCCCC-
Confidence 65543333334457789999999988899999999999999999997 99999743321 122211 1111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
.+...+..+.+++.+||+.||++||++.||++.|++++..+
T Consensus 613 --------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 613 --------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 11122347889999999999999999999999999988654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=328.87 Aligned_cols=249 Identities=26% Similarity=0.316 Sum_probs=200.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---------chhHHHHHHHHHHHHhcC-CCceeeeeeeeecCc
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---------SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH 674 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---------~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~ 674 (927)
.|++.+.||+|+||.||+|..+ +|+.||||++.... ....+.+.+|++++++++ ||||+++++++..++
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 4567889999999999999986 58999999986532 123456889999999995 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccc
Q 002410 675 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 754 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 754 (927)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||+ ++++||||||+||+++.++.+||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999974 4578999999999999999999998 99999999999999999999999999999
Q ss_pred ccccccccccccccccCCCccCCCccC------CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhh
Q 002410 755 RQAEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 828 (927)
Q Consensus 755 ~~~~~~~~~~~~~~~gt~~Y~APE~l~------~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 828 (927)
........ .....|++.|+|||++. ...++.++||||||+++|||++|+.||...... .... .+.
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~----~~~ 242 (298)
T 1phk_A 172 CQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLR----MIM 242 (298)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHH
T ss_pred hhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HHHH----HHh
Confidence 87654322 22345899999999884 456889999999999999999999999743221 1111 111
Q ss_pred cCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 829 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 829 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.+.... ..+ ........+.+++.+||+.||++||+++|+++
T Consensus 243 ~~~~~~-~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 SGNYQF-GSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HTCCCC-CTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCCccc-Ccc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111110 000 01122347889999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=345.98 Aligned_cols=260 Identities=23% Similarity=0.271 Sum_probs=193.2
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCc------eEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QRILV 679 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~------~~~LV 679 (927)
.|.+.+.||+|+||.||+|++..+..||+|++..... ...+|+++++.++||||+++++++...+ ..++|
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 4677899999999999999998777899998865322 1236999999999999999999985433 37899
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc-CCCcEEEeecccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAE 758 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld-~~~~~kL~DFGla~~~~ 758 (927)
|||++++.+............+++..+..++.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||+++...
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 9999875444333222235679999999999999999999998 9999999999999999 79999999999998764
Q ss_pred ccccccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh----------h
Q 002410 759 EDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM----------I 827 (927)
Q Consensus 759 ~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~----------~ 827 (927)
.... .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||...+..+ .+....+.. .
T Consensus 194 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 194 AGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp TTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHH
T ss_pred CCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHhh
Confidence 4322 2234589999999998664 58999999999999999999999998544322 111111110 0
Q ss_pred ----hcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 828 ----KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 828 ----~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
............+...........+.+|+.+||+.||++|||+.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000000000000111233478899999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=355.58 Aligned_cols=250 Identities=27% Similarity=0.381 Sum_probs=199.4
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-------------hhHHHHHHHHHHHHhcCCCceeeeeeee
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-------------HRTQQFVTEVALLSRIHHRNLVPLIGYC 670 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-------------~~~~~~~~E~~~L~~l~HpnIv~l~~~~ 670 (927)
..|.+.++||+|+||+||+|+.+ +++.||||++..... ...+.+.+|++++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 45777899999999999999987 578999999875321 2346789999999999999999999999
Q ss_pred ecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC---cEE
Q 002410 671 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAK 747 (927)
Q Consensus 671 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~---~~k 747 (927)
.+.+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+|
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999999874 4569999999999999999999998 9999999999999998776 699
Q ss_pred EeeccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhh
Q 002410 748 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 827 (927)
Q Consensus 748 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~ 827 (927)
|+|||+++....... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .+.. .+
T Consensus 190 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~----~i 259 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DIIK----KV 259 (504)
T ss_dssp ECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HH
T ss_pred EEECCCCEEcCCCCc--cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HH
Confidence 999999987654322 233458999999999874 6899999999999999999999999744322 1111 11
Q ss_pred hcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 828 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 828 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
..+.... +...... ....+.+++.+||+.||.+|||++|+++.
T Consensus 260 ~~~~~~~--~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 260 EKGKYYF--DFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHCCCCC--CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HcCCCCC--CccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 2221110 0000011 12368899999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=345.45 Aligned_cols=259 Identities=21% Similarity=0.226 Sum_probs=193.8
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeec-----------
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----------- 672 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~----------- 672 (927)
..|.+.+.||+|+||.||+|+.. +|+.||||++..... ...+|+++++.++||||+++++++..
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 35677899999999999999875 689999999865422 23479999999999999999999843
Q ss_pred ---------------------------CceEEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 002410 673 ---------------------------EHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC 724 (927)
Q Consensus 673 ---------------------------~~~~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~ 724 (927)
....++||||++ |+|.+.+.... ....+++..+..++.||+.||+|||+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-- 159 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-- 159 (383)
T ss_dssp ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--
Confidence 334789999998 58777765321 45679999999999999999999998
Q ss_pred CCCeEecCCCCCccccc-CCCcEEEeeccccccccccccccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHH
Q 002410 725 NPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELI 802 (927)
Q Consensus 725 ~~~ivH~DLkp~NILld-~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLl 802 (927)
++|+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++||||+||++|||+
T Consensus 160 -~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 160 -LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp -TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred -CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 9999999999999998 689999999999987644322 2234579999999998764 5899999999999999999
Q ss_pred hCCCCCCcccccchhhHHHHHHHhhhc----------CCeee-----eccccccCCCCHHHHHHHHHHHHHhhccCCCCC
Q 002410 803 SGKKPVSVEDFGAELNIVHWARSMIKK----------GDVIS-----IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR 867 (927)
Q Consensus 803 tG~~Pf~~~~~~~~~~l~~~~~~~~~~----------~~~~~-----~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R 867 (927)
+|+.||......+ .+...+. .... ..... ..........+......+.+|+.+||+.||++|
T Consensus 237 ~g~~pf~~~~~~~--~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 237 LGKPLFSGETSID--QLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HSSCSSCCSSHHH--HHHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred hCCCCCCCCChHH--HHHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 9999998543322 1111111 0000 00000 000000000112233468899999999999999
Q ss_pred CCHHHHHHH
Q 002410 868 PKMQEIVLA 876 (927)
Q Consensus 868 Ps~~eVl~~ 876 (927)
||+.|+++.
T Consensus 314 ~t~~e~l~h 322 (383)
T 3eb0_A 314 INPYEAMAH 322 (383)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhcC
Confidence 999999853
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=337.40 Aligned_cols=258 Identities=22% Similarity=0.275 Sum_probs=190.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCc------eE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 676 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~------~~ 676 (927)
.|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 4667899999999999999876 5889999998753 2344567889999999999999999999987654 78
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++||||++ |+|.+.+. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 106 YIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred EEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 99999997 57888876 248899999999999999999998 9999999999999999999999999999987
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH------------
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR------------ 824 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~------------ 824 (927)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+. +.....
T Consensus 177 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 177 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHC-CCCCCHHHHTT
T ss_pred ccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHH
Confidence 54322 12334689999999999999999999999999999999999999975432211 111000
Q ss_pred ------HhhhcCC------eeeeccccccCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 825 ------SMIKKGD------VISIVDPVLIGN---VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 825 ------~~~~~~~------~~~~~d~~l~~~---~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
....... ............ ........+.+|+.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000000 000000000000 011235578999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.99 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=192.8
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeec-----------
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----------- 672 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~----------- 672 (927)
..|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 45777899999999999999976 6899999999643 3455788999999999999999999998754
Q ss_pred --CceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEee
Q 002410 673 --EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 750 (927)
Q Consensus 673 --~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~D 750 (927)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence 45789999999999999999753 4567889999999999999999998 8999999999999999999999999
Q ss_pred ccccccccccc-------------cccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccch
Q 002410 751 FGLSRQAEEDL-------------THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 816 (927)
Q Consensus 751 FGla~~~~~~~-------------~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~ 816 (927)
||++....... ........|++.|+|||.+.+. .++.++|||||||++|||++ ||.... ..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~~ 234 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--ER 234 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--HH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--hH
Confidence 99998754321 1112234589999999999764 78999999999999999998 554111 11
Q ss_pred hhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 817 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 817 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..... . +.... ..+...........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~---~-~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNILK---K-LRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHH---H-HHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHH---h-ccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11111 1 11111 11112223333456889999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=366.18 Aligned_cols=248 Identities=25% Similarity=0.342 Sum_probs=202.7
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~L 678 (927)
...|++.+.||+|+||.||+|+.+ +++.||||++++.. ....+.+..|..++..+ +||+|+++++++.+.+..++
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 345677899999999999999987 58899999997532 23456788899999988 79999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 420 V~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999984 3569999999999999999999998 999999999999999999999999999998643
Q ss_pred ccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 759 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 759 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+. .... ....
T Consensus 494 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~~~---~~i~-~~~~------ 559 (674)
T 3pfq_A 494 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELF---QSIM-EHNV------ 559 (674)
T ss_dssp CTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHH-SSCC------
T ss_pred cCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---HHH---HHHH-hCCC------
Confidence 3222 233456999999999999999999999999999999999999999744321 111 1111 1111
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL 875 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~-----~eVl~ 875 (927)
. ++......+.+|+.+||+.||++||++ +||++
T Consensus 560 ~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 A----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp C----CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred C----CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 0 111223468899999999999999997 66654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=332.90 Aligned_cols=260 Identities=22% Similarity=0.277 Sum_probs=198.1
Q ss_pred HHhhcccccccccEEEEEEEEC--CCcEEEEEEccCccch--hHHHHHHHHHHHHhc---CCCceeeeeeeee-----cC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSH--RTQQFVTEVALLSRI---HHRNLVPLIGYCE-----EE 673 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~--~g~~vAvK~l~~~~~~--~~~~~~~E~~~L~~l---~HpnIv~l~~~~~-----~~ 673 (927)
.|++.+.||+|+||.||+|+.. +|+.||+|+++..... ....+.+|+.+++.+ +||||+++++++. ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 4667899999999999999983 6889999998643221 223566787777766 8999999999987 56
Q ss_pred ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccc
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 753 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 753 (927)
...++||||++ |+|.+++... ....+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 77899999997 6999999754 24458999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcC---
Q 002410 754 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--- 830 (927)
Q Consensus 754 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~--- 830 (927)
++...... ......|++.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.......
T Consensus 167 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 167 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEE 241 (326)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCGG
T ss_pred cccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCcc
Confidence 98764332 2233458999999999999999999999999999999999999997443221 111111111100
Q ss_pred Ceeee-------c---cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 831 DVISI-------V---DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 831 ~~~~~-------~---d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..... . ...............+.+++.+||+.||++||+++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 0 000000111223346789999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=332.92 Aligned_cols=259 Identities=21% Similarity=0.292 Sum_probs=191.7
Q ss_pred HHhhcccccccccEEEEEEEECC-CcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeee-------------
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE------------- 671 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~------------- 671 (927)
.|++.+.||+|+||.||+|.... ++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 45678899999999999999874 8999999998766666788999999999999999999999873
Q ss_pred -cCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc-CCCcEEEe
Q 002410 672 -EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVS 749 (927)
Q Consensus 672 -~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld-~~~~~kL~ 749 (927)
+....++||||++ |+|.+++. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++ +++.+||+
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEc
Confidence 4467899999997 69999986 3568999999999999999999998 9999999999999997 56799999
Q ss_pred eccccccccccccc--cccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh
Q 002410 750 DFGLSRQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 826 (927)
Q Consensus 750 DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 826 (927)
|||+++........ ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.. ..+...
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~~ 240 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM---QLILES 240 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHh
Confidence 99999876432211 1223457899999998755 67899999999999999999999999754322111 111100
Q ss_pred hhc----------CCeeeecccccc-C-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 827 IKK----------GDVISIVDPVLI-G-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 827 ~~~----------~~~~~~~d~~l~-~-----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
... ......+..... . .........+.+++.+||+.||++||+++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000 000000000000 0 000112347889999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=334.37 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=198.2
Q ss_pred HHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
...|++.+.||+|+||.||+|.+++ .+|+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 3446678999999999999999864 49999987532 2234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++++|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+||+++ ++.+||+|||+++......
T Consensus 110 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred cccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 99999999999752 4568999999999999999999998 9999999999999998 6899999999987643211
Q ss_pred ----cccccccccCCCccCCCccCC---------CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhh
Q 002410 762 ----THISSVARGTVGYLDPEYYGN---------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 828 (927)
Q Consensus 762 ----~~~~~~~~gt~~Y~APE~l~~---------~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 828 (927)
........|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...... .... .+.
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~----~~~ 256 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AIIW----QMG 256 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HHHH----HHH
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----Hhc
Confidence 112223458899999999864 45788999999999999999999999743321 1111 111
Q ss_pred cCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 829 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 829 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
.+......... ....+.+++.+||+.||++||+++|++++|+++....
T Consensus 257 ~~~~~~~~~~~--------~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 257 TGMKPNLSQIG--------MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp TTCCCCCCCSS--------CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred cCCCCCCCcCC--------CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 22111111111 1225789999999999999999999999999987654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=330.74 Aligned_cols=249 Identities=24% Similarity=0.399 Sum_probs=193.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeeec------CceEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE------EHQRI 677 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~------~~~~~ 677 (927)
.|++.+.||+|+||.||+|++. +|+.||||++.... ...+.+.+|+.+++++ +||||+++++++.. .+..+
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 4567899999999999999985 68999999987542 3456788999999999 79999999999876 56789
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+||||+++|+|.+++... ....+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 104 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp EEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 999999999999999854 24568999999999999999999998 89999999999999999999999999999876
Q ss_pred cccccccccccccCCCccCCCccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCe
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 832 (927)
..... ......|++.|+|||++. +..++.++|||||||++|||++|+.||....... ... ... ....
T Consensus 180 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~~~-~~~~ 251 (326)
T 2x7f_A 180 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---ALF---LIP-RNPA 251 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH---HHH-HSCC
T ss_pred CcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHH---Hhh-cCcc
Confidence 43322 122345899999999986 5678999999999999999999999997333211 111 111 1111
Q ss_pred eeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 833 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 833 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..... ......+.+++.+||+.||++||+++|+++
T Consensus 252 ~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 252 PRLKS--------KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCSC--------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCCc--------cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111 112246889999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=335.02 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=202.9
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchh-----------------HHHHHHHHHHHHhcCCCceeeee
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR-----------------TQQFVTEVALLSRIHHRNLVPLI 667 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~-----------------~~~~~~E~~~L~~l~HpnIv~l~ 667 (927)
..|.+.+.||+|+||.||+|.. +|+.||||++....... .+.+.+|++++++++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3567789999999999999999 89999999986432111 17899999999999999999999
Q ss_pred eeeecCceEEEEEEecCCCCHHHH------hccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc
Q 002410 668 GYCEEEHQRILVYEYMHNGTLRDR------LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 741 (927)
Q Consensus 668 ~~~~~~~~~~LV~E~~~~gsL~~~------L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld 741 (927)
+++.+.+..++||||+++|+|.++ +... ....+++..++.++.|++.||+|||+ .++|+||||||+||+++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 999999999999999999999998 5432 25679999999999999999999996 37999999999999999
Q ss_pred CCCcEEEeeccccccccccccccccccccCCCccCCCccCCC-CCCc-chhHHHHHHHHHHHHhCCCCCCcccccchhhH
Q 002410 742 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTE-KSDVYSFGVVLLELISGKKPVSVEDFGAELNI 819 (927)
Q Consensus 742 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~-ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l 819 (927)
.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++|||||||++|||++|+.||...... ...
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~ 261 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VEL 261 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HHH
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHH
Confidence 9999999999999875443 22344689999999999877 6666 999999999999999999999744331 122
Q ss_pred HHHHHHhhhcCCeeeecc------cccc---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 820 VHWARSMIKKGDVISIVD------PVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 820 ~~~~~~~~~~~~~~~~~d------~~l~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.+. +..+......+ +... ..........+.+++.+||+.||++||+++|+++
T Consensus 262 ~~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 FNN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 221 11121110000 0000 0000223347889999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=343.38 Aligned_cols=199 Identities=26% Similarity=0.320 Sum_probs=172.4
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhc------CCCceeeeeeeeecCceEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI------HHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l------~HpnIv~l~~~~~~~~~~~ 677 (927)
..|++.+.||+|+||.||+|... +++.||||+++.. ....+++.+|+++++.+ +|+||+++++++...+..+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 45778899999999999999876 5889999999754 33446778899988887 4679999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCc--EEEeeccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLSR 755 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~--~kL~DFGla~ 755 (927)
+||||+. ++|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++. +||+|||+++
T Consensus 176 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 9999996 6999998754 23458999999999999999999998 89999999999999999887 9999999997
Q ss_pred cccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 002410 756 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 813 (927)
Q Consensus 756 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~ 813 (927)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 65432 2234689999999999999999999999999999999999999975543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=343.60 Aligned_cols=256 Identities=21% Similarity=0.309 Sum_probs=182.0
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecC------ce
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 675 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------~~ 675 (927)
..|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+++++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 34667899999999999999875 6899999998753 233557788999999999999999999998653 56
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
.++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 109 ~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred EEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 79999999 7899888863 569999999999999999999998 999999999999999999999999999998
Q ss_pred cccccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 756 QAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 756 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.. ..+........ .+
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l---~~i~~~~g~p~-~~ 252 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL---KLILRLVGTPG-AE 252 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCC-HH
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCC-HH
Confidence 75432 223468999999999876 68899999999999999999999999754432211 11111110000 00
Q ss_pred eccc-----------ccc--CCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 835 IVDP-----------VLI--GNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 835 ~~d~-----------~l~--~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.+.. .+. .... ......+.+|+.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 000 0000 0112467899999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=341.86 Aligned_cols=264 Identities=20% Similarity=0.280 Sum_probs=182.4
Q ss_pred Hhh-cccccccccEEEEEEEEC---CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeee--ecCceEEEEE
Q 002410 607 NNF-CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC--EEEHQRILVY 680 (927)
Q Consensus 607 ~~~-~~~LG~G~~G~Vy~a~~~---~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~--~~~~~~~LV~ 680 (927)
|++ .++||+|+||.||+|+++ +++.||||++.... ....+.+|+++|++++||||+++++++ ......++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 568999999999999976 47899999997542 235688999999999999999999999 4477899999
Q ss_pred EecCCCCHHHHhccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc----cCCCcEEEee
Q 002410 681 EYMHNGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSD 750 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl----d~~~~~kL~D 750 (927)
||++ |+|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 58887775321 22358999999999999999999998 999999999999999 6789999999
Q ss_pred cccccccccccc--ccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccc------hhhHHH
Q 002410 751 FGLSRQAEEDLT--HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA------ELNIVH 821 (927)
Q Consensus 751 FGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~------~~~l~~ 821 (927)
||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ......
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999987654322 12234568999999999877 458999999999999999999999997443310 011111
Q ss_pred HHHHhhhcC---Ceeeec------------cccccCCCC---------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 822 WARSMIKKG---DVISIV------------DPVLIGNVK---------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 822 ~~~~~~~~~---~~~~~~------------d~~l~~~~~---------~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.+...+... ....+. ......... ......+.+|+.+||+.||++|||++|+++.
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111111100 000000 000000000 0012367899999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=333.84 Aligned_cols=271 Identities=20% Similarity=0.325 Sum_probs=203.7
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcC-----------CCceeeeeeeee
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----------HRNLVPLIGYCE 671 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-----------HpnIv~l~~~~~ 671 (927)
...|.+.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 356778899999999999999975 6899999999753 334567889999999886 899999999987
Q ss_pred cCc----eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCccccc-----
Q 002410 672 EEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLD----- 741 (927)
Q Consensus 672 ~~~----~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~-~ivH~DLkp~NILld----- 741 (927)
..+ ..++|||++ +++|.+++... ....+++..+..++.||+.||+|||+ + +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCC
Confidence 654 789999999 89999999754 24568999999999999999999998 7 999999999999994
Q ss_pred -CCCcEEEeeccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc---hh
Q 002410 742 -INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA---EL 817 (927)
Q Consensus 742 -~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~---~~ 817 (927)
..+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 34589999999998765432 23458999999999999899999999999999999999999998543221 11
Q ss_pred hHHHHHHHhhhc--------C----------Ceeeeccc-c---------ccCCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 002410 818 NIVHWARSMIKK--------G----------DVISIVDP-V---------LIGNVKIESIWRIAEVAIQCVEQRGFSRPK 869 (927)
Q Consensus 818 ~l~~~~~~~~~~--------~----------~~~~~~d~-~---------l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs 869 (927)
.....+...+.. + .....+.. . -....+......+.+|+.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 111111111100 0 00000000 0 001234566778999999999999999999
Q ss_pred HHHHHHH--HHhhhhhc
Q 002410 870 MQEIVLA--IQDSIKIE 884 (927)
Q Consensus 870 ~~eVl~~--L~~~~~~e 884 (927)
++|+++. +++....+
T Consensus 328 ~~ell~hp~f~~~~~~~ 344 (373)
T 1q8y_A 328 AGGLVNHPWLKDTLGME 344 (373)
T ss_dssp HHHHHTCGGGTTCTTCT
T ss_pred HHHHhhChhhhcccCcc
Confidence 9999873 55544433
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.94 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=195.4
Q ss_pred HHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCc--cchhHHHHHHHHHHHHhcC--CCceeeeeeeeecCceEEE
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~--HpnIv~l~~~~~~~~~~~L 678 (927)
....|++.+.||+|+||.||++...+++.||||++... .....+.+.+|++++++++ |+||+++++++.+++..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 33456778999999999999999988999999998653 2345578999999999997 5999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
||| +.+++|.+++.. ...+++..++.++.|+++||+|||+ ++|+||||||+||+++ ++.+||+|||+++...
T Consensus 106 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 999 668899999984 4578999999999999999999998 8999999999999996 4899999999998765
Q ss_pred ccccc-cccccccCCCccCCCccCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh
Q 002410 759 EDLTH-ISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 826 (927)
Q Consensus 759 ~~~~~-~~~~~~gt~~Y~APE~l~~-----------~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 826 (927)
..... ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .. ......
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~----~~~~~~ 252 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QI----SKLHAI 252 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-HH----HHHHHH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-HH----HHHHHH
Confidence 43221 1233458999999999865 4788899999999999999999999973221 11 111111
Q ss_pred hhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 827 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 827 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
....... ..+......+.+++.+||+.||++||+++|+++.
T Consensus 253 ~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 253 IDPNHEI---------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HCTTSCC---------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Hhccccc---------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1111110 1111112468899999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=346.52 Aligned_cols=259 Identities=24% Similarity=0.273 Sum_probs=192.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeec------CceEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQRIL 678 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~------~~~~~L 678 (927)
.|++.+.||+|+||.||+|++. +|+.||||++.... +...+|+++|++++||||+++++++.. ....++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 4566789999999999999986 58999999986532 223479999999999999999998843 223679
Q ss_pred EEEecCCCCHHHHhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC-CcEEEeecccccc
Q 002410 679 VYEYMHNGTLRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQ 756 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFGla~~ 756 (927)
||||+++ +|.+.+... .....+++..+..++.||++||+|||+ ++|+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999975 666655421 135679999999999999999999998 999999999999999955 6789999999987
Q ss_pred ccccccccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh-------hh
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM-------IK 828 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~-------~~ 828 (927)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+.+.++.. +.
T Consensus 207 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 207 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHH
T ss_pred cccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHH
Confidence 543322 2234689999999998764 78999999999999999999999997543221 222222110 00
Q ss_pred --cCCeeeeccccccC-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 829 --KGDVISIVDPVLIG-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 829 --~~~~~~~~d~~l~~-----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.....+..-+.+.. .+.......+.+|+.+||+.||++||++.|+++.
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00111111111100 0111223578899999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=338.43 Aligned_cols=265 Identities=19% Similarity=0.254 Sum_probs=186.6
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCce------
Q 002410 603 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------ 675 (927)
Q Consensus 603 ~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~------ 675 (927)
....|++.+.||+|+||.||+|+.. +|+.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 3455677899999999999999986 68999999986542 223456778888999999999999999865333
Q ss_pred -EEEEEEecCCCCHHHHhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCcccccC-CCcEEEee
Q 002410 676 -RILVYEYMHNGTLRDRLHG-SVNQKPLDWLTRLQIAHDAAKGLEYLH--TGCNPGIIHRDVKSSNILLDI-NMRAKVSD 750 (927)
Q Consensus 676 -~~LV~E~~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~qia~gL~~LH--~~~~~~ivH~DLkp~NILld~-~~~~kL~D 750 (927)
.++||||+++ +|.+.+.. ......+++..+..++.|++.||+||| + ++|+||||||+|||++. ++.+||+|
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEee
Confidence 7899999986 44443332 224567899999999999999999999 7 99999999999999996 89999999
Q ss_pred ccccccccccccccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh---
Q 002410 751 FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM--- 826 (927)
Q Consensus 751 FGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~--- 826 (927)
||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +....+..
T Consensus 176 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~ 251 (360)
T 3e3p_A 176 FGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIVRVLGCP 251 (360)
T ss_dssp CTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCC
T ss_pred CCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHHHHcCCC
Confidence 999987654332 2234589999999998654 489999999999999999999999975433221 11111110
Q ss_pred -------hhc-CCeeeecc------ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 827 -------IKK-GDVISIVD------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 827 -------~~~-~~~~~~~d------~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+.. .......+ ..............+.+|+.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 00000000 000011122245678999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=323.53 Aligned_cols=253 Identities=27% Similarity=0.366 Sum_probs=203.2
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
......|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 445678888999999999999999987 68999999986532 234578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC---CcEEEeecccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLS 754 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~---~~~kL~DFGla 754 (927)
+|+||+++++|.+.+.. ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999998874 3568999999999999999999998 899999999999999754 46999999999
Q ss_pred ccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 755 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 755 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
........ .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||...... .... .+..+....
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~----~~~~~~~~~ 241 (287)
T 2wei_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILK----RVETGKYAF 241 (287)
T ss_dssp GTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCCCC
T ss_pred eeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHcCCCCC
Confidence 87644322 122347889999999876 4899999999999999999999999743321 1111 111221111
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.. + ... .....+.+++.+||+.||++|||++|+++
T Consensus 242 ~~-~-~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 DL-P-QWR----TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CS-G-GGT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cc-h-hhh----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 0 001 12346889999999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=335.21 Aligned_cols=259 Identities=21% Similarity=0.261 Sum_probs=196.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----ceEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 678 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-----~~~~L 678 (927)
.|.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++... ...++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 4567889999999999999987 68999999997543 33456788999999999999999999987654 67899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
||||++ |+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 92 IQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 999997 699999873 468999999999999999999998 999999999999999999999999999998764
Q ss_pred ccccc---------cccccccCCCccCCCccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhh
Q 002410 759 EDLTH---------ISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 828 (927)
Q Consensus 759 ~~~~~---------~~~~~~gt~~Y~APE~l~-~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 828 (927)
..... ......||+.|+|||++. +..++.++|||||||++|||++|+.||...+...... .+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~ 240 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL---LIFGIIG 240 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHHHhC
Confidence 32211 112245899999999875 4678999999999999999999999998544321111 1111110
Q ss_pred cCC----eeeeccc-------ccc-------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 829 KGD----VISIVDP-------VLI-------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 829 ~~~----~~~~~d~-------~l~-------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
... ......+ .+. ..........+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 0000000 000 0000122346789999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=333.47 Aligned_cols=200 Identities=28% Similarity=0.314 Sum_probs=170.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcC-CC-----ceeeeeeeeecCceEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HR-----NLVPLIGYCEEEHQRI 677 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-Hp-----nIv~l~~~~~~~~~~~ 677 (927)
..|++.+.||+|+||+||+|... +++.||||+++.. .....++.+|+++++.++ |+ +|+++++++...+..+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 45777899999999999999877 5889999999753 334567788999998885 44 4999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc--CCCcEEEeeccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSR 755 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld--~~~~~kL~DFGla~ 755 (927)
+||||++ |+|.+++... ....+++..+..++.|++.||+|||+ ++.+|+||||||+|||++ .++.+||+|||+++
T Consensus 133 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 9999996 5999999854 23568999999999999999999994 137999999999999994 47889999999998
Q ss_pred cccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 002410 756 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812 (927)
Q Consensus 756 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~ 812 (927)
...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 210 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 210 QLGQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp ETTCCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccccc----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 764332 23468999999999999999999999999999999999999998543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=331.86 Aligned_cols=265 Identities=19% Similarity=0.250 Sum_probs=201.3
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CC-cEEEEEEccCccchhHHHHHHHHHHHHhcCCCc------eeeeeeeeec
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK-DG-KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN------LVPLIGYCEE 672 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g-~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~Hpn------Iv~l~~~~~~ 672 (927)
+.....|++.+.||+|+||.||+|... ++ +.||+|+++.. ....+.+.+|++++++++|++ ++.+++++..
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 333456788899999999999999976 34 68999999754 344567889999999997766 8999999999
Q ss_pred CceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc------------
Q 002410 673 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL------------ 740 (927)
Q Consensus 673 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl------------ 740 (927)
.+..++||||+ +++|.+.+... ....+++..++.++.||+.||+|||+ ++|+||||||+|||+
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred CCeEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccc
Confidence 99999999999 66777777643 23568999999999999999999998 899999999999999
Q ss_pred -------cCCCcEEEeeccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 002410 741 -------DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 813 (927)
Q Consensus 741 -------d~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~ 813 (927)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 568899999999998644322 234689999999999999999999999999999999999999974433
Q ss_pred cchhhHHHHHHHhh-----hcCCeee-ecccc---------------------ccCCCCHHHHHHHHHHHHHhhccCCCC
Q 002410 814 GAELNIVHWARSMI-----KKGDVIS-IVDPV---------------------LIGNVKIESIWRIAEVAIQCVEQRGFS 866 (927)
Q Consensus 814 ~~~~~l~~~~~~~~-----~~~~~~~-~~d~~---------------------l~~~~~~~~~~~l~~Li~~Cl~~dP~~ 866 (927)
.+............ ....... ..... ............+.+|+.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 22111111110000 0000000 00000 000112234557899999999999999
Q ss_pred CCCHHHHHH
Q 002410 867 RPKMQEIVL 875 (927)
Q Consensus 867 RPs~~eVl~ 875 (927)
|||++|+++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=332.21 Aligned_cols=254 Identities=21% Similarity=0.296 Sum_probs=193.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCce------E
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------R 676 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~------~ 676 (927)
.|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+. .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 4566789999999999999986 68999999987542 2345678999999999999999999999977653 4
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++||||++ ++|.+++. ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 105 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp EEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 99999997 68887764 348999999999999999999998 9999999999999999999999999999987
Q ss_pred ccccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcC-----
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG----- 830 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~----- 830 (927)
.... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+. ...+.......
T Consensus 176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTEFV 248 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHHHH
T ss_pred CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHH
Confidence 5432 223458999999999876 6789999999999999999999999975443211 11111100000
Q ss_pred -------------CeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 831 -------------DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 831 -------------~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.......+.+ ..........+.+++.+||+.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000 01112234578899999999999999999999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=333.03 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=193.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceE------
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR------ 676 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~------ 676 (927)
.|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 5667889999999999999876 68999999997642 33457789999999999999999999999876654
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++||||++ ++|.+.+. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 123 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp EEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred EEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999997 68888874 348999999999999999999998 8999999999999999999999999999986
Q ss_pred ccccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+. +.. +....... ..+.
T Consensus 194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~-i~~~~~~~-~~~~ 265 (371)
T 4exu_A 194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQ-ILKVTGVP-GTEF 265 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCC-CHHH
T ss_pred cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCCC-cHHH
Confidence 5433 223458999999999877 6889999999999999999999999975433211 111 11100000 0000
Q ss_pred ---------------ccccccC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 836 ---------------VDPVLIG---NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 836 ---------------~d~~l~~---~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+...... .........+.+|+.+||+.||++|||++|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000 0001123478899999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=327.82 Aligned_cols=253 Identities=26% Similarity=0.345 Sum_probs=177.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHH-HHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~-~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
.|++.+.||+|+||.||+|..+ +|+.||||+++.... ....++..|+. +++.++||||+++++++...+..++||||
T Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3aln_A 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102 (327)
T ss_dssp SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence 4556789999999999999986 689999999976432 33455666666 67778999999999999999999999999
Q ss_pred cCCCCHHHHhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 683 MHNGTLRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 683 ~~~gsL~~~L~~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~-~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
+++ +|.+++... .....+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||+++....
T Consensus 103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 975 887777531 125678999999999999999999998 7 999999999999999999999999999987644
Q ss_pred cccccccccccCCCccCCCcc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 760 DLTHISSVARGTVGYLDPEYY----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l----~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
... .....|++.|+|||++ .+..++.++|||||||++|||++|+.||...... .+...... .+..
T Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~-~~~~--- 247 (327)
T 3aln_A 179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-----FDQLTQVV-KGDP--- 247 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCC-CSCC---
T ss_pred ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-----HHHHHHHh-cCCC---
Confidence 322 2223589999999998 4567899999999999999999999999732211 01111111 1111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+.+...........+.+++.+||+.||++||++.|+++
T Consensus 248 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 --PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111111123347889999999999999999999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=327.22 Aligned_cols=250 Identities=20% Similarity=0.274 Sum_probs=170.8
Q ss_pred HHhhc-ccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeec----CceEEEE
Q 002410 606 TNNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILV 679 (927)
Q Consensus 606 ~~~~~-~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~----~~~~~LV 679 (927)
.|.+. +.||+|+||.||+|..+ +|+.||||++.... ....+....++.++||||+++++++.. +...++|
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 104 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence 45553 56999999999999987 68999999987531 122223334566799999999999865 4568999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC---CCcEEEeecccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ 756 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~---~~~~kL~DFGla~~ 756 (927)
|||+++|+|.+++... ....+++.+++.++.||+.||+|||+ ++|+||||||+||+++. ++.+||+|||+++.
T Consensus 105 ~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 105 MECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 9999999999999854 34579999999999999999999998 89999999999999976 45599999999986
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
..... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||......... ......+..+..
T Consensus 181 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~---- 250 (336)
T 3fhr_A 181 TTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS---PGMKRRIRLGQY---- 250 (336)
T ss_dssp C-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------
T ss_pred ccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh---hhHHHhhhcccc----
Confidence 54322 22345799999999999889999999999999999999999999743322110 000111111000
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.............+.+++.+||+.||++|||++|+++
T Consensus 251 --~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 251 --GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000001122346889999999999999999999997
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=338.19 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=185.4
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEecCCCCH
Q 002410 610 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTL 688 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~~gsL 688 (927)
.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+++..++||||++ |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 5789999999998777778999999998643 235678899999987 89999999999999999999999995 699
Q ss_pred HHHhccCCCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC-------------CcEEEeec
Q 002410 689 RDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-------------MRAKVSDF 751 (927)
Q Consensus 689 ~~~L~~~~~~~----~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~-------------~~~kL~DF 751 (927)
.+++....... ...+..++.++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 99998542111 11334567899999999999998 999999999999999754 48999999
Q ss_pred cccccccccccc---cccccccCCCccCCCccCC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHH
Q 002410 752 GLSRQAEEDLTH---ISSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIV 820 (927)
Q Consensus 752 Gla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~-------~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~ 820 (927)
|+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||..... .. .
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-~~---~ 248 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS-RE---S 248 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT-HH---H
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh-hH---H
Confidence 999876543322 1223468999999999865 678999999999999999999 9999963322 11 1
Q ss_pred HHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 821 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 821 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
........ . +.............+.+++.+||+.||++||++.||++
T Consensus 249 ~i~~~~~~---~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 NIIRGIFS---L-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHTCCC---C-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhcCCCC---c-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11111111 0 01111123345568899999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=324.56 Aligned_cols=244 Identities=26% Similarity=0.412 Sum_probs=190.6
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccch------hHHHHHHHHHHHHhc----CCCceeeeeee
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRI----HHRNLVPLIGY 669 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~------~~~~~~~E~~~L~~l----~HpnIv~l~~~ 669 (927)
+.....|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 455677888999999999999999875 6889999999754321 223466799999998 89999999999
Q ss_pred eecCceEEEEEEe-cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc-CCCcEE
Q 002410 670 CEEEHQRILVYEY-MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAK 747 (927)
Q Consensus 670 ~~~~~~~~LV~E~-~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld-~~~~~k 747 (927)
+...+..++|+|+ +++++|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 789999999984 4568999999999999999999998 8999999999999999 889999
Q ss_pred EeeccccccccccccccccccccCCCccCCCccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh
Q 002410 748 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 826 (927)
Q Consensus 748 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 826 (927)
|+|||+++...... .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||.... .. .
T Consensus 181 l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~---~--- 246 (312)
T 2iwi_A 181 LIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EI---L--- 246 (312)
T ss_dssp ECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH---H---
T ss_pred EEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HH---h---
Confidence 99999998765432 223458999999999876665 458999999999999999999997221 11 0
Q ss_pred hhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 827 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 827 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
. ... .+. ......+.+++.+||+.||++||+++|+++.
T Consensus 247 -~-~~~------~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 -E-AEL------HFP----AHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -H-TCC------CCC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -h-hcc------CCc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000 011 1122467899999999999999999999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.76 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=179.1
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccch-h-HHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-R-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~-~-~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
..|++.+.||+|+||.||+|... +|+.||||++...... . .+.+.++..+++.++||||+++++++.+++..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 34667889999999999999986 6899999999764332 2 2344555567888899999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~-~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
|+ ++.+..+... ....+++..+..++.|++.||+|||+ + +|+||||||+||+++.++.+||+|||++......
T Consensus 105 ~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 105 LM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 99 5566555542 24568999999999999999999997 5 9999999999999999999999999999765443
Q ss_pred ccccccccccCCCccCCCccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 761 LTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
.. .....+++.|+|||++. +..++.++|||||||++|||++|+.||...... .... ......... .
T Consensus 179 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~---~~~~~~~~~-~- 249 (318)
T 2dyl_A 179 KA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVL---TKVLQEEPP-L- 249 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHH---HHHHHSCCC-C-
T ss_pred cc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHH---HHHhccCCC-C-
Confidence 22 22345899999999984 557889999999999999999999999732221 1111 111211111 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
+.. .......+.+++.+||+.||++||+++|+++.
T Consensus 250 ----~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 250 ----LPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp ----CCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ----CCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000 00122368899999999999999999999873
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=349.65 Aligned_cols=270 Identities=22% Similarity=0.319 Sum_probs=207.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc-cchhHHHHHHHHHHHHhcCCCceeeeeeeeec------CceE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQR 676 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~------~~~~ 676 (927)
..|++.+.||+|+||.||+|.+. +|+.||||+++.. .....+.+.+|++++++++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 57888999999999999999875 5899999998764 33445779999999999999999999998765 6778
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCc---EEEeeccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGL 753 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~---~kL~DFGl 753 (927)
++||||+++|+|.+++........+++..++.++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 9999999999999999865555579999999999999999999998 99999999999999997665 99999999
Q ss_pred cccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCee
Q 002410 754 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 833 (927)
Q Consensus 754 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 833 (927)
+........ .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..|...........
T Consensus 171 a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC------
T ss_pred ccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccchh
Confidence 987654322 23346899999999999999999999999999999999999999743211 11111110000000
Q ss_pred eecc----------c--cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHH-----HHHHHHhhhhhc
Q 002410 834 SIVD----------P--VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQE-----IVLAIQDSIKIE 884 (927)
Q Consensus 834 ~~~d----------~--~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e-----Vl~~L~~~~~~e 884 (927)
.... . .............+.+++.+||+.||++|||++| ..+.+++++...
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 0000 0 0112234456678999999999999999999988 566777766544
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=325.71 Aligned_cols=240 Identities=24% Similarity=0.379 Sum_probs=196.4
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccch------hHHHHHHHHHHHHhcC--CCceeeeeeeeecCc
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIH--HRNLVPLIGYCEEEH 674 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~------~~~~~~~E~~~L~~l~--HpnIv~l~~~~~~~~ 674 (927)
...|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++ |+||+++++++...+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 345677899999999999999875 6889999998754221 2245778999999996 599999999999999
Q ss_pred eEEEEEEecCC-CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc-CCCcEEEeecc
Q 002410 675 QRILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFG 752 (927)
Q Consensus 675 ~~~LV~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld-~~~~~kL~DFG 752 (927)
..++|+|++.+ ++|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++ +++.+||+|||
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999976 899999974 4578999999999999999999998 9999999999999999 78999999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCC
Q 002410 753 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 831 (927)
Q Consensus 753 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 831 (927)
+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .. .. +.
T Consensus 196 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~~----~~-~~ 259 (320)
T 3a99_A 196 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EI----IR-GQ 259 (320)
T ss_dssp TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HH----HH-CC
T ss_pred ccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------hh----hc-cc
Confidence 998765432 223458999999999876655 688999999999999999999997321 00 11 11
Q ss_pred eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 832 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 832 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
. . .... ....+.+++.+||+.||++||+++||++
T Consensus 260 ~--~----~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 V--F----FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp C--C----CSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c--c----cccc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0 1111 1246889999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=332.01 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=184.8
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.+++.+.||+|+||+||.....+|+.||||++..... ..+.+|+++|+++ +||||+++++++.+.+..++||||++
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 3556789999999997766666799999999875432 2356799999999 79999999999999999999999996
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC-----CCcEEEeeccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-----NMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~-----~~~~kL~DFGla~~~~~ 759 (927)
|+|.+++... .....+..++.++.||+.||+|||+ ++|+||||||+|||++. ...+||+|||+++....
T Consensus 102 -g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 102 -ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp -EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred -CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 6999999854 2334555678999999999999999 99999999999999953 33588999999987654
Q ss_pred ccc--ccccccccCCCccCCCccC---CCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCee
Q 002410 760 DLT--HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 833 (927)
Q Consensus 760 ~~~--~~~~~~~gt~~Y~APE~l~---~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 833 (927)
... .......||+.|+|||++. ...++.++|||||||++|||++ |..||..... .. .. ........
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-~~---~~---~~~~~~~~- 247 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-RQ---AN---ILLGACSL- 247 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-HH---HH---HHTTCCCC-
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-HH---HH---HHhccCCc-
Confidence 321 1223456999999999997 4567889999999999999999 9999963221 11 11 11111111
Q ss_pred eeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 834 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 834 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.... ........+.+|+.+||+.||++|||++||++
T Consensus 248 ~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 DCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111 11223445789999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.62 Aligned_cols=237 Identities=14% Similarity=0.196 Sum_probs=185.2
Q ss_pred HHHHHHhhcccccccccEEEEEEEECC-CcEEEEEEccCccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
+....|++.+.||+|+||.||+|+... ++.||||++..... ...+.+.+|+.++++++||||+++++++.+++..+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 334567788999999999999999874 89999999976432 33478999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+||||+++++|.++++. . ....++.+++.|++.||+|||+ ++|+||||||+|||++.++.+||++++
T Consensus 108 lv~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 99999999999999963 2 3556788999999999999998 999999999999999999999998443
Q ss_pred cccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
|++| ++.++|||||||++|||++|+.||............ .... .+... .
T Consensus 175 ----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~-~~~~~---~ 224 (286)
T 3uqc_A 175 ----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDT-AGQPI---E 224 (286)
T ss_dssp ----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCT-TSCBC---C
T ss_pred ----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHh-ccCCC---C
Confidence 3333 688999999999999999999999854332110000 0000 00000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
+ ..........+.+++.+||+.||++| |+.|+++.|+++...+.
T Consensus 225 ~---~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 225 P---ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp H---HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred h---hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0 00111223468899999999999999 99999999999877654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=347.58 Aligned_cols=241 Identities=18% Similarity=0.287 Sum_probs=194.3
Q ss_pred HHHHhhcccccccccEEEEEEEEC--CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCce-----
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ----- 675 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~--~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~----- 675 (927)
...|++.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 356778899999999999999986 58999999987543 3445678999999999999999999999987655
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 676 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 676 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
.++||||+++++|.+++.. .+++.+++.++.||+.||+|||+ ++|+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999887652 68999999999999999999998 999999999999999875 89999999998
Q ss_pred cccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 756 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 756 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
..... ....||+.|+|||++.+.. +.++|||||||++|||++|..||....... ..
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~~-- 285 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------LP-- 285 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------CC--
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------------cc--
Confidence 76543 3345899999999987654 889999999999999999998886321110 00
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhhh
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIK 882 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-s~~eVl~~L~~~~~ 882 (927)
...........+.+++.+||+.||++|| +++++.+.|...+.
T Consensus 286 -----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 286 -----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp -----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred -----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0000011224688999999999999999 57777777776653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=314.32 Aligned_cols=243 Identities=19% Similarity=0.246 Sum_probs=184.0
Q ss_pred HHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcc--------chhHHHHHHHHHHHHhcC---------CCcee
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--------SHRTQQFVTEVALLSRIH---------HRNLV 664 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~--------~~~~~~~~~E~~~L~~l~---------HpnIv 664 (927)
+....|++.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|++++++++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3456788999999999999999998 58999999997542 223477889999999886 55555
Q ss_pred ee-----------------eeeeec-------------CceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 002410 665 PL-----------------IGYCEE-------------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 714 (927)
Q Consensus 665 ~l-----------------~~~~~~-------------~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia 714 (927)
++ ++++.+ .+..++||||+++|++.+.+. ...+++..++.++.||+
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLT 171 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHH
Confidence 55 444443 678999999999997766664 25689999999999999
Q ss_pred HHHHHHH-hcCCCCeEecCCCCCcccccCCC--------------------cEEEeeccccccccccccccccccccCCC
Q 002410 715 KGLEYLH-TGCNPGIIHRDVKSSNILLDINM--------------------RAKVSDFGLSRQAEEDLTHISSVARGTVG 773 (927)
Q Consensus 715 ~gL~~LH-~~~~~~ivH~DLkp~NILld~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~ 773 (927)
.||+||| + ++|+||||||+|||++.++ .+||+|||+++..... ...||+.
T Consensus 172 ~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 8 8999999999999999887 8999999999876532 2368999
Q ss_pred ccCCCccCCCCCCcchhHHHHHHH-HHHHHhCCCCCCcccccchhhHHHHHH-HhhhcCCeeeeccccccCCCCHHHHHH
Q 002410 774 YLDPEYYGNQQLTEKSDVYSFGVV-LLELISGKKPVSVEDFGAELNIVHWAR-SMIKKGDVISIVDPVLIGNVKIESIWR 851 (927)
Q Consensus 774 Y~APE~l~~~~~s~ksDVwSlGvl-L~eLltG~~Pf~~~~~~~~~~l~~~~~-~~~~~~~~~~~~d~~l~~~~~~~~~~~ 851 (927)
|+|||++.+.. +.++||||+|++ .+++++|..||... ....... ......... ..............
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTFK----TKCNTPAMKQIKRK 311 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCCS----SCCCSHHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhccC----cccchhhhhhcCHH
Confidence 99999998766 899999998777 77899999998521 0001111 111111110 00011112345668
Q ss_pred HHHHHHHhhccCCCCCCCHHHHH
Q 002410 852 IAEVAIQCVEQRGFSRPKMQEIV 874 (927)
Q Consensus 852 l~~Li~~Cl~~dP~~RPs~~eVl 874 (927)
+.+|+.+||+.| |++|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999976 899887
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=301.30 Aligned_cols=225 Identities=21% Similarity=0.303 Sum_probs=176.1
Q ss_pred Hhhc-ccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHH-HhcCCCceeeeeeeeec----CceEEEE
Q 002410 607 NNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALL-SRIHHRNLVPLIGYCEE----EHQRILV 679 (927)
Q Consensus 607 ~~~~-~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L-~~l~HpnIv~l~~~~~~----~~~~~LV 679 (927)
|.+. +.||+|+||.||+|... +++.||+|+++.. ..+.+|+.++ +.++||||+++++++.. ....++|
T Consensus 19 y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 93 (299)
T 3m2w_A 19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 93 (299)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred hhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence 3444 77999999999999985 6899999998642 4567888888 55589999999999876 6788999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC---CCcEEEeecccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ 756 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~---~~~~kL~DFGla~~ 756 (927)
|||+++|+|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||++..
T Consensus 94 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 94 MECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp ECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 9999999999999854 34579999999999999999999998 99999999999999998 78899999998864
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
.. +..++.++|||||||++|||++|+.||........ .......+.
T Consensus 170 ~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~~~ 215 (299)
T 3m2w_A 170 TT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTRIR 215 (299)
T ss_dssp CT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSC
T ss_pred cc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHHHh
Confidence 32 23567899999999999999999999973322110 000000000
Q ss_pred cccccCCCC----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 837 DPVLIGNVK----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 837 d~~l~~~~~----~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.... ... ......+.+++.+||+.||++|||++|+++.
T Consensus 216 ~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 216 MGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp TTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000 001 1123478899999999999999999999873
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.6e-33 Score=318.27 Aligned_cols=238 Identities=16% Similarity=0.123 Sum_probs=177.9
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHHHHHHHHhcCC-Cceeee---------eee----
Q 002410 608 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHH-RNLVPL---------IGY---- 669 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~L~~l~H-pnIv~l---------~~~---- 669 (927)
...+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.+++.++| +|.... ...
T Consensus 81 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (413)
T 3dzo_A 81 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160 (413)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECC
T ss_pred EEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccC
Confidence 34678999999999999965 699999999874322 235779999999999977 322111 111
Q ss_pred --------eec-----CceEEEEEEecCCCCHHHHhccC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 002410 670 --------CEE-----EHQRILVYEYMHNGTLRDRLHGS----VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRD 732 (927)
Q Consensus 670 --------~~~-----~~~~~LV~E~~~~gsL~~~L~~~----~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~D 732 (927)
+.. ....+++|+++ +++|.++++.. .....+++..++.++.||++||+|||+ ++|+|||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrD 236 (413)
T 3dzo_A 161 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTY 236 (413)
T ss_dssp C---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSC
T ss_pred CCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCC
Confidence 111 12356677765 68999988421 134568888999999999999999998 9999999
Q ss_pred CCCCcccccCCCcEEEeeccccccccccccccccccccCCCccCCCcc----------CCCCCCcchhHHHHHHHHHHHH
Q 002410 733 VKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY----------GNQQLTEKSDVYSFGVVLLELI 802 (927)
Q Consensus 733 Lkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l----------~~~~~s~ksDVwSlGvlL~eLl 802 (927)
|||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|||+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999998875543 233457 999999999 6667899999999999999999
Q ss_pred hCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 803 SGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 803 tG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+|+.||.......... .++.. ... .+..+.+|+.+||+.||++||++.|+++
T Consensus 312 tg~~Pf~~~~~~~~~~---------------~~~~~--~~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 312 CADLPNTDDAALGGSE---------------WIFRS--CKN----IPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HSSCCCCTTGGGSCSG---------------GGGSS--CCC----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HCCCCCCCcchhhhHH---------------HHHhh--ccc----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999997433221100 00100 001 1246889999999999999999877753
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=284.91 Aligned_cols=187 Identities=17% Similarity=0.138 Sum_probs=131.7
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc----------chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEE
Q 002410 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC----------SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~----------~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~L 678 (927)
...+.|+.|.+..++.. -|+.+++|++.... ....++|.+|+++|+++ .|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 35667777776665432 48899999996531 12346799999999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
||||++|++|.++|.. ..+++.. +|+.||+.||+|||+ +|||||||||+|||++.+|++||+|||+|+...
T Consensus 320 VMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999984 4556654 588999999999999 999999999999999999999999999998765
Q ss_pred ccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 002410 759 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 808 (927)
Q Consensus 759 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf 808 (927)
..... .....||++|||||++.+ .+..++|+||+|+++++|.++..++
T Consensus 391 ~~~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 QDCSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCcc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 44332 233569999999999976 4677899999999988887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.9e-24 Score=253.47 Aligned_cols=183 Identities=17% Similarity=0.204 Sum_probs=146.5
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCccc--------hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 610 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~--------~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.+.||+|+||.||+|... ++.+++|+...... ...+++.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 568999999999999554 78899988643211 123568999999999999999977666667777899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++++|.+++.. +..++.|+++||+|||+ ++|+||||||+|||++. .+||+|||+++......
T Consensus 420 ~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 420 YINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp CCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred CCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 9999999999973 56899999999999998 99999999999999998 99999999999875532
Q ss_pred ccc------ccccccCCCccCCCccCC--CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 002410 762 THI------SSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVS 809 (927)
Q Consensus 762 ~~~------~~~~~gt~~Y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~ 809 (927)
... .....||+.|||||++.. ..|+.++|+|+..+-..+.+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 211 234569999999999976 567888999999999998888877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.3e-21 Score=210.80 Aligned_cols=141 Identities=15% Similarity=0.113 Sum_probs=116.2
Q ss_pred hcccccccccEEEEEEEECCCcEEEEEEccCccc------------------hhHHHHHHHHHHHHhcCCCceeeeeeee
Q 002410 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS------------------HRTQQFVTEVALLSRIHHRNLVPLIGYC 670 (927)
Q Consensus 609 ~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~------------------~~~~~~~~E~~~L~~l~HpnIv~l~~~~ 670 (927)
+.+.||+|+||.||+|.+.+|+.||||+++.... .....+.+|++++++++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 4589999999999999997799999999864321 13467899999999999 5 6677755
Q ss_pred ecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEee
Q 002410 671 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 750 (927)
Q Consensus 671 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~D 750 (927)
.. +..++||||+++|+|.+ +.. .....++.|++.||+|||+ ++|+||||||+|||++ ++.+||+|
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECC
T ss_pred ec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 44 55699999999999988 531 2345799999999999998 9999999999999999 99999999
Q ss_pred ccccccccccccccccccccCCCccCCCccC
Q 002410 751 FGLSRQAEEDLTHISSVARGTVGYLDPEYYG 781 (927)
Q Consensus 751 FGla~~~~~~~~~~~~~~~gt~~Y~APE~l~ 781 (927)
||+++. +..++|||++.
T Consensus 236 FG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE--------------TTSTTHHHHHH
T ss_pred CCCCeE--------------CCCCCHHHHHH
Confidence 999863 34578888874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.3e-17 Score=178.79 Aligned_cols=135 Identities=23% Similarity=0.246 Sum_probs=105.8
Q ss_pred hhcccccccccEEEEEEEE-CCCcE--EEEEEccCccch------------------------hHHHHHHHHHHHHhcCC
Q 002410 608 NFCKKIGKGSFGSVYYGKM-KDGKE--VAVKIMADSCSH------------------------RTQQFVTEVALLSRIHH 660 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~-~~g~~--vAvK~l~~~~~~------------------------~~~~~~~E~~~L~~l~H 660 (927)
.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+++|++++|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 4568899999999999998 67989 999987543111 12368899999999988
Q ss_pred Cce--eeeeeeeecCceEEEEEEecCC-C----CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecC
Q 002410 661 RNL--VPLIGYCEEEHQRILVYEYMHN-G----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH-TGCNPGIIHRD 732 (927)
Q Consensus 661 pnI--v~l~~~~~~~~~~~LV~E~~~~-g----sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH-~~~~~~ivH~D 732 (927)
+++ ..+++. +..+|||||+.+ | +|.+.... .++..+..++.|++.||.||| + .+|+|||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~givHrD 196 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE---AELVHAD 196 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT---SCEECSS
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH---CCEEeCC
Confidence 764 333332 356899999942 4 67766542 234567889999999999999 7 8999999
Q ss_pred CCCCcccccCCCcEEEeeccccccc
Q 002410 733 VKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 733 Lkp~NILld~~~~~kL~DFGla~~~ 757 (927)
|||+|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999988 9999999999754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.63 E-value=4.3e-16 Score=171.74 Aligned_cols=147 Identities=27% Similarity=0.512 Sum_probs=126.1
Q ss_pred CChhHHHHHHHhhhhcc----CCCCCC-CCCCCCCCccEEEeCCC-CCceEEEEecCCCCcc--cCCccccCCcccceec
Q 002410 368 KTEWQDEALRSISDESE----RTNDRG-DPCVPVPWEWVTCSTTT-PPRITKIALSGKNLKG--EIPPELKNMEALTELW 439 (927)
Q Consensus 368 ~t~~~~~al~~~~~~~~----~~~w~g-dpC~~~~w~~~~c~~~~-~~~l~~L~L~~n~l~g--~ip~~l~~l~~L~~L~ 439 (927)
+...+.+||.++|..+. ..+|.. .+||.+.|.||.|+... ..+|+.|+|++|+++| .+|..|+++++|++|+
T Consensus 3 c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~ 82 (313)
T 1ogq_A 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEE
T ss_pred CCHHHHHHHHHHHHhcCCcccccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeee
Confidence 34456689999998874 368963 34544569999997642 3689999999999999 9999999999999999
Q ss_pred ccC-CCCCCCCCC-cCcccccceeecccccccCCCCCcCCCccccccccccccCCCCCCCccccC--CceeeeecCCCC
Q 002410 440 LDG-NFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPK 514 (927)
Q Consensus 440 Ls~-N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~~--~~~~~~~~~N~~ 514 (927)
|++ |++++.+|. |+++++|++|+|++|+++|.+|..++++++|+.|+|++|.++|.+|..+.. .+..+.+.+|..
T Consensus 83 L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 161 (313)
T 1ogq_A 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred CCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcc
Confidence 995 999999985 999999999999999999999999999999999999999999999988754 677778888764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.57 E-value=3.1e-15 Score=185.45 Aligned_cols=140 Identities=20% Similarity=0.275 Sum_probs=120.9
Q ss_pred HHHHHHHhhhhccCCCCCCCC------CCCCCC------------ccEEEeCCCCCceEEEEecCCCCcccCCccccCCc
Q 002410 372 QDEALRSISDESERTNDRGDP------CVPVPW------------EWVTCSTTTPPRITKIALSGKNLKGEIPPELKNME 433 (927)
Q Consensus 372 ~~~al~~~~~~~~~~~w~gdp------C~~~~w------------~~~~c~~~~~~~l~~L~L~~n~l~g~ip~~l~~l~ 433 (927)
+..||.+++..+...+|+.+. |++|.| .||.|++. .+|+.|+|++|+|+|.+|++|++|+
T Consensus 270 d~~ALl~~k~~l~~~~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~--~~V~~L~Ls~~~L~G~ip~~l~~L~ 347 (876)
T 4ecn_A 270 DYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNN--GRVTGLSLAGFGAKGRVPDAIGQLT 347 (876)
T ss_dssp HHHHHHHHHHHTTGGGCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTT--SCEEEEECTTTCCEEEECGGGGGCT
T ss_pred HHHHHHHHHHHcCCCCCCcCCCcccccCCccccccccccccccCcCceEecCC--CCEEEEECccCCCCCcCchHHhccc
Confidence 448999999998777896432 223689 99999883 6999999999999999999999999
Q ss_pred ccceecc-cCCCCCCC----------------------------------------------------------------
Q 002410 434 ALTELWL-DGNFLTGP---------------------------------------------------------------- 448 (927)
Q Consensus 434 ~L~~L~L-s~N~l~g~---------------------------------------------------------------- 448 (927)
+|+.|+| ++|.++|.
T Consensus 348 ~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~ 427 (876)
T 4ecn_A 348 ELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKD 427 (876)
T ss_dssp TCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCT
T ss_pred cceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccccchhh
Confidence 9999999 88766554
Q ss_pred ------------CC-CcCcccccceeecccccccC-----------------CCCCcCC--CccccccccccccCCCCCC
Q 002410 449 ------------LP-DMSRLIDLRIVHLENNELTG-----------------SLPSYMG--SLPNLQELHIENNSFVGEI 496 (927)
Q Consensus 449 ------------~p-~~~~l~~L~~L~Ls~N~l~g-----------------~iP~~l~--~l~~L~~L~l~~N~l~g~i 496 (927)
+| .|++|++|+.|+|++|+|+| .+|..++ +|++|+.|+|++|++.|.+
T Consensus 428 l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~i 507 (876)
T 4ecn_A 428 TQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507 (876)
T ss_dssp TTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSC
T ss_pred ceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccC
Confidence 66 48999999999999999998 4999988 9999999999999999999
Q ss_pred CccccC--CceeeeecCCC
Q 002410 497 PPALLT--GKVIFKYDNNP 513 (927)
Q Consensus 497 P~~~~~--~~~~~~~~~N~ 513 (927)
|..+.. .+..+.+.+|.
T Consensus 508 P~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 508 PDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp CGGGGGCSSCCEEECTTCT
T ss_pred hHHHhCCCCCCEEECcCCC
Confidence 987765 67778888887
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.4e-15 Score=170.27 Aligned_cols=137 Identities=16% Similarity=0.148 Sum_probs=98.2
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCccc--------------hhHHH--------HHHHHHHHHhcCCCcee
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------------HRTQQ--------FVTEVALLSRIHHRNLV 664 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~--------------~~~~~--------~~~E~~~L~~l~HpnIv 664 (927)
|++.+.||+|++|.||+|...+|+.||||+++.... ..... ..+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 556789999999999999999999999998753210 00111 23456666666444332
Q ss_pred eeeeeeecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC
Q 002410 665 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 744 (927)
Q Consensus 665 ~l~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~ 744 (927)
...-+.. ...+|||||++|++|.++... .....++.||+.+|.+||+ .|||||||||.|||+++++
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEE
T ss_pred CCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCC
Confidence 1111111 223799999999888765431 1345688999999999998 8999999999999998877
Q ss_pred ----------cEEEeeccccccc
Q 002410 745 ----------RAKVSDFGLSRQA 757 (927)
Q Consensus 745 ----------~~kL~DFGla~~~ 757 (927)
.+.|+||+-+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 3899999976543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=5.2e-14 Score=143.74 Aligned_cols=110 Identities=23% Similarity=0.318 Sum_probs=99.6
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
++.++.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+. |.+|++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 30 ~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 108 (193)
T 2wfh_A 30 PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLS 108 (193)
T ss_dssp CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEE
Confidence 458999999999999 8999999999999999999999999885 99999999999999999988888999999999999
Q ss_pred ccccCCCCCCCccccC---CceeeeecCCCCCcccc
Q 002410 487 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES 519 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~---~~~~~~~~~N~~~c~~~ 519 (927)
|++|.|+ .+|...+. .+..+.+.+||+.|.+.
T Consensus 109 L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 109 LHGNDIS-VVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCSSCCC-BCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CCCCCCC-eeChhhhhcCccccEEEeCCCCeecCCc
Confidence 9999999 67765443 67788999999998753
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.48 E-value=2.4e-14 Score=173.24 Aligned_cols=138 Identities=20% Similarity=0.247 Sum_probs=117.1
Q ss_pred HHHHHHHhhhhccCC-------------CCCCCCCCCCCC---ccEEEeCCCCCceEEEEecCCCCcccCCccccCCccc
Q 002410 372 QDEALRSISDESERT-------------NDRGDPCVPVPW---EWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEAL 435 (927)
Q Consensus 372 ~~~al~~~~~~~~~~-------------~w~gdpC~~~~w---~~~~c~~~~~~~l~~L~L~~n~l~g~ip~~l~~l~~L 435 (927)
+..||.+++...+.. +|+.+.. +|.| .||.|+.. .+|+.|+|++|+++|.+|++|++|++|
T Consensus 31 d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~-~c~w~~~~GV~C~~~--~~V~~L~L~~~~l~g~lp~~l~~L~~L 107 (636)
T 4eco_A 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKE-LDMWGAQPGVSLNSN--GRVTGLSLEGFGASGRVPDAIGQLTEL 107 (636)
T ss_dssp HHHHHHHHHHHTTGGGCCCCC------CCCCCSSC-GGGTTCCTTEEECTT--CCEEEEECTTSCCEEEECGGGGGCTTC
T ss_pred HHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCC-cccccCCCCeEEcCC--CCEEEEEecCcccCCcCChHHhcCccc
Confidence 448999998876533 4653321 2469 99999765 699999999999999999999999999
Q ss_pred ceecccCCC-----------------------------------------------------------------------
Q 002410 436 TELWLDGNF----------------------------------------------------------------------- 444 (927)
Q Consensus 436 ~~L~Ls~N~----------------------------------------------------------------------- 444 (927)
+.|+|++|.
T Consensus 108 ~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~ 187 (636)
T 4eco_A 108 EVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ 187 (636)
T ss_dssp CEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTT
T ss_pred eEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhh
Confidence 999999984
Q ss_pred -------CCCCCC-CcCcccccceeecccccccCC-----------------CCCcCC--CccccccccccccCCCCCCC
Q 002410 445 -------LTGPLP-DMSRLIDLRIVHLENNELTGS-----------------LPSYMG--SLPNLQELHIENNSFVGEIP 497 (927)
Q Consensus 445 -------l~g~~p-~~~~l~~L~~L~Ls~N~l~g~-----------------iP~~l~--~l~~L~~L~l~~N~l~g~iP 497 (927)
|+| +| .+++|++|++|+|++|+|+|. +|..++ ++++|+.|+|++|++.|.+|
T Consensus 188 l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p 266 (636)
T 4eco_A 188 IGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP 266 (636)
T ss_dssp TTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCC
T ss_pred hccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccCh
Confidence 445 56 499999999999999999986 999999 99999999999999999999
Q ss_pred ccccC--CceeeeecCCC
Q 002410 498 PALLT--GKVIFKYDNNP 513 (927)
Q Consensus 498 ~~~~~--~~~~~~~~~N~ 513 (927)
..+.. .+..+.+.+|.
T Consensus 267 ~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 267 TFLKALPEMQLINVACNR 284 (636)
T ss_dssp TTTTTCSSCCEEECTTCT
T ss_pred HHHhcCCCCCEEECcCCC
Confidence 88765 67778888886
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.45 E-value=8.9e-14 Score=141.83 Aligned_cols=123 Identities=19% Similarity=0.222 Sum_probs=106.7
Q ss_pred CCCccEEEeCC--------CCCceEEEEecCCCCcccCCc-cccCCcccceecccCCCCCCCCCC-cCcccccceeeccc
Q 002410 396 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN 465 (927)
Q Consensus 396 ~~w~~~~c~~~--------~~~~l~~L~L~~n~l~g~ip~-~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~ 465 (927)
|.|..+.|+.. .+.+++.|+|++|++++..+. .|+++++|+.|+|++|+|++.+|. |.++++|+.|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45766776542 234899999999999976665 489999999999999999999885 99999999999999
Q ss_pred ccccCCCCCcCCCccccccccccccCCCCCCCccccC--CceeeeecCCCCCccc
Q 002410 466 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKLHKE 518 (927)
Q Consensus 466 N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~~--~~~~~~~~~N~~~c~~ 518 (927)
|+|++..|..|..+++|+.|+|++|+|++.+|..+.. .+..+.+.+|++.|.+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 9999888888999999999999999999887877654 6778899999999864
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=3.7e-14 Score=175.52 Aligned_cols=111 Identities=32% Similarity=0.442 Sum_probs=102.0
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.+.++.|+|++|+++|.+|.+|++|++|+.|+|++|+|+|.+|+ +++|++|+.|||++|+|+|.||..++++++|+.|+
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 35789999999999999999999999999999999999999995 99999999999999999999999999999999999
Q ss_pred ccccCCCCCCCccc-cCCceeeeecCCCCCccc
Q 002410 487 IENNSFVGEIPPAL-LTGKVIFKYDNNPKLHKE 518 (927)
Q Consensus 487 l~~N~l~g~iP~~~-~~~~~~~~~~~N~~~c~~ 518 (927)
|++|+|+|.||..- +.......+.|||.+|+.
T Consensus 711 ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp CCSSEEEEECCSSSSGGGSCGGGGCSCTEEEST
T ss_pred CcCCcccccCCCchhhccCCHHHhcCCchhcCC
Confidence 99999999999753 334455678999999964
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.41 E-value=4.4e-13 Score=134.49 Aligned_cols=126 Identities=20% Similarity=0.305 Sum_probs=107.0
Q ss_pred CCCCCCCCccEEEeCC--------CCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCccccccee
Q 002410 391 DPCVPVPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIV 461 (927)
Q Consensus 391 dpC~~~~w~~~~c~~~--------~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L 461 (927)
+.|. |.|.++.|+.. .+++++.|+|++|++++..+..|.++++|+.|+|++|+|++.++. +..+++|+.|
T Consensus 3 ~~C~-C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 81 (177)
T 2o6r_A 3 SRCS-CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTIL 81 (177)
T ss_dssp TTCE-EETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCE-eCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEE
Confidence 3463 57888888653 246899999999999977667789999999999999999998886 7999999999
Q ss_pred ecccccccCCCCCcCCCccccccccccccCCCCCCCccccC---CceeeeecCCCCCccc
Q 002410 462 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 518 (927)
Q Consensus 462 ~Ls~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~~---~~~~~~~~~N~~~c~~ 518 (927)
+|++|+|++..|..+..+++|+.|+|++|+++ .+|...+. .+..+.+.+|++.|..
T Consensus 82 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 82 YLHENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred ECCCCCccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeeccC
Confidence 99999999777778899999999999999999 67766533 6778889999998754
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=6.8e-13 Score=138.35 Aligned_cols=112 Identities=19% Similarity=0.191 Sum_probs=97.2
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.+|. |..+++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 56 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 135 (220)
T 2v70_A 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLS 135 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEE
T ss_pred CCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEE
Confidence 35789999999999977777899999999999999999998886 89999999999999999988899999999999999
Q ss_pred ccccCCCCCCCccccC--CceeeeecCCCCCcccc
Q 002410 487 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHKES 519 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~--~~~~~~~~~N~~~c~~~ 519 (927)
|++|+|++..|..+.. .+..+.+.+|++.|.+.
T Consensus 136 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 136 LYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 9999999666766644 67788899999998643
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1.3e-12 Score=136.14 Aligned_cols=111 Identities=19% Similarity=0.255 Sum_probs=87.5
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|+..++. |..+++|+.|+|++|+|++..|..|..+++|+.|+|
T Consensus 56 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 135 (220)
T 2v9t_B 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSL 135 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEEC
Confidence 5788888888888877788888888888888888888877765 678888888888888888777888888888888888
Q ss_pred cccCCCCCCCccccC--CceeeeecCCCCCcccc
Q 002410 488 ENNSFVGEIPPALLT--GKVIFKYDNNPKLHKES 519 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~--~~~~~~~~~N~~~c~~~ 519 (927)
++|+|++..|..+.. .+..+.+.+|++.|.+.
T Consensus 136 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 136 YDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 888888433333332 56678889999988643
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.33 E-value=2e-12 Score=135.60 Aligned_cols=116 Identities=22% Similarity=0.304 Sum_probs=90.3
Q ss_pred CCccEEEeCC--------CCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeeccccc
Q 002410 397 PWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 467 (927)
Q Consensus 397 ~w~~~~c~~~--------~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~ 467 (927)
.|.++.|+.. .+++++.|+|++|++++..|..|.++++|+.|+|++|+|++.++. |..+++|+.|+|++|+
T Consensus 20 s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 20 SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 5888888653 246789999999999988888899999999999999999877765 7888888888888888
Q ss_pred ccCCCCCcCCCccccccccccccCCCCCCCccccC--CceeeeecCCC
Q 002410 468 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNP 513 (927)
Q Consensus 468 l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~~--~~~~~~~~~N~ 513 (927)
|++..+..|..+++|+.|+|++|+|+ .+|..+.. .+..+.+.+|.
T Consensus 100 l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~ 146 (229)
T 3e6j_A 100 LTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ 146 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSC
T ss_pred CCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCc
Confidence 88666666778888888888888887 77766543 44455555553
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.31 E-value=2.8e-12 Score=128.05 Aligned_cols=109 Identities=28% Similarity=0.354 Sum_probs=90.8
Q ss_pred EEeCCCCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcc
Q 002410 402 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLP 480 (927)
Q Consensus 402 ~c~~~~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~ 480 (927)
.|.|. .+.|++++|+|+ .+|..+. ++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..|..++
T Consensus 6 ~C~C~----~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~ 78 (170)
T 3g39_A 6 QCSCS----GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLT 78 (170)
T ss_dssp CCEEE----TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCT
T ss_pred cCCcC----CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCC
Confidence 36663 357999999998 6887774 8899999999999999886 89999999999999999976666789999
Q ss_pred ccccccccccCCCCCCCcc-cc--CCceeeeecCCCCCccc
Q 002410 481 NLQELHIENNSFVGEIPPA-LL--TGKVIFKYDNNPKLHKE 518 (927)
Q Consensus 481 ~L~~L~l~~N~l~g~iP~~-~~--~~~~~~~~~~N~~~c~~ 518 (927)
+|+.|+|++|+|+ .+|.. +. ..+..+.+.+|++.|.+
T Consensus 79 ~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 79 QLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp TCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CCCEEECCCCccC-EeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 9999999999999 56654 33 26778889999998864
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=1.4e-12 Score=161.41 Aligned_cols=124 Identities=25% Similarity=0.253 Sum_probs=79.3
Q ss_pred hhHHHHHHHhhhhcc----CCCCC-CCCCCCCCCccEEEeCCCCCceEEEEecCCCCccc---CCccc------------
Q 002410 370 EWQDEALRSISDESE----RTNDR-GDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGE---IPPEL------------ 429 (927)
Q Consensus 370 ~~~~~al~~~~~~~~----~~~w~-gdpC~~~~w~~~~c~~~~~~~l~~L~L~~n~l~g~---ip~~l------------ 429 (927)
..+.+||.++|..+. ..+|. +.+| |.|.||+|+ ..+|+.|+|+++++.|. +|+.+
T Consensus 11 ~~~~~all~~k~~~~~~~~l~~W~~~~~~--C~w~gv~C~---~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~ 85 (768)
T 3rgz_A 11 YREIHQLISFKDVLPDKNLLPDWSSNKNP--CTFDGVTCR---DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLS 85 (768)
T ss_dssp HHHHHHHHHHHTTCSCTTSSTTCCTTSCG--GGSTTEEEE---TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECT
T ss_pred HHHHHHHHHHHhhCCCcccccCCCCCCCC--cCCcceEEC---CCcEEEEECCCCCcCCccCccChhHhccCcccccCCc
Confidence 345589999998764 57896 3444 379999998 36999999999999998 66544
Q ss_pred -----------cCCcccceecccCCCCCCCCC---CcCcccccceeecccccccCCCCCcC-CCccccccccccccCCCC
Q 002410 430 -----------KNMEALTELWLDGNFLTGPLP---DMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENNSFVG 494 (927)
Q Consensus 430 -----------~~l~~L~~L~Ls~N~l~g~~p---~~~~l~~L~~L~Ls~N~l~g~iP~~l-~~l~~L~~L~l~~N~l~g 494 (927)
++|++|++|+|++|.++|.+| .+++|++|++|+|++|+++|.+|..+ .++++|+.|+|++|++++
T Consensus 86 ~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~ 165 (768)
T 3rgz_A 86 NSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165 (768)
T ss_dssp TSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEE
T ss_pred CCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCC
Confidence 445555555555555555444 24555555555555555555555544 455555555555555554
Q ss_pred CCCc
Q 002410 495 EIPP 498 (927)
Q Consensus 495 ~iP~ 498 (927)
.+|.
T Consensus 166 ~~~~ 169 (768)
T 3rgz_A 166 ANVV 169 (768)
T ss_dssp ETHH
T ss_pred cCCh
Confidence 4443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.30 E-value=5.3e-13 Score=147.97 Aligned_cols=140 Identities=21% Similarity=0.275 Sum_probs=113.8
Q ss_pred hhHHHHHHHhhhhcc--C----CCCC----CCCCCCCCCccEEEeC-------CCCCceEEEEecCCCCcccCCccccCC
Q 002410 370 EWQDEALRSISDESE--R----TNDR----GDPCVPVPWEWVTCST-------TTPPRITKIALSGKNLKGEIPPELKNM 432 (927)
Q Consensus 370 ~~~~~al~~~~~~~~--~----~~w~----gdpC~~~~w~~~~c~~-------~~~~~l~~L~L~~n~l~g~ip~~l~~l 432 (927)
..+..||.+|+.... . .+|. +.+. .|.|.|++|.. ....+|+.|+|++|+++ .+|+.+++|
T Consensus 26 ~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~-~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~l 103 (328)
T 4fcg_A 26 RPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQ-IETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRL 103 (328)
T ss_dssp CCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTT-SCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGGG
T ss_pred chHHHHHHHHHHhccCCchhhhhhhccccccccc-ccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhhC
Confidence 345689999998653 2 3462 2221 23699988852 23578999999999999 999999999
Q ss_pred cccceecccCCCCCCCCC-CcCcccccceeecccccccCCCCCcCCCccccccccccccCCCCCCCcccc----------
Q 002410 433 EALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL---------- 501 (927)
Q Consensus 433 ~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~---------- 501 (927)
++|++|+|++|+|+ .+| .++++++|++|+|++|+++ .+|..++++++|+.|+|++|++.|.+|..+.
T Consensus 104 ~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~ 181 (328)
T 4fcg_A 104 SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181 (328)
T ss_dssp TTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEE
T ss_pred CCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhcc
Confidence 99999999999999 566 5999999999999999999 8999999999999999999999999998773
Q ss_pred -CCceeeeecCCC
Q 002410 502 -TGKVIFKYDNNP 513 (927)
Q Consensus 502 -~~~~~~~~~~N~ 513 (927)
..+..+.+.+|.
T Consensus 182 l~~L~~L~L~~n~ 194 (328)
T 4fcg_A 182 LVNLQSLRLEWTG 194 (328)
T ss_dssp STTCCEEEEEEEC
T ss_pred CCCCCEEECcCCC
Confidence 355666666654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.30 E-value=4e-12 Score=127.43 Aligned_cols=109 Identities=23% Similarity=0.376 Sum_probs=92.8
Q ss_pred EEeCCCCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcc
Q 002410 402 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLP 480 (927)
Q Consensus 402 ~c~~~~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~ 480 (927)
.|+|.. +.|++++|+|. .+|..+. ++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..+..|..++
T Consensus 9 ~C~C~~----~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~ 81 (174)
T 2r9u_A 9 QCSCDQ----TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLT 81 (174)
T ss_dssp TSEECS----SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred CCEECC----cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcc
Confidence 466643 68999999997 8998775 8999999999999999885 89999999999999999975556679999
Q ss_pred ccccccccccCCCCCCCccccC---CceeeeecCCCCCccc
Q 002410 481 NLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 518 (927)
Q Consensus 481 ~L~~L~l~~N~l~g~iP~~~~~---~~~~~~~~~N~~~c~~ 518 (927)
+|+.|+|++|+|+ .+|...+. .+..+.+.+|++.|.+
T Consensus 82 ~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 82 QLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp TCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred hhhEEECCCCccc-eeCHHHhccccCCCEEEeCCCCccccc
Confidence 9999999999999 66665332 6778889999999864
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.27 E-value=7e-12 Score=131.48 Aligned_cols=109 Identities=23% Similarity=0.227 Sum_probs=96.6
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++|+.|+|++|+|.+..+..|.++++|+.|+|++|+|++.++. |..+++|+.|+|++|+|+ .+|..+..+++|+.|+
T Consensus 63 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 141 (229)
T 3e6j_A 63 LINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141 (229)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEE
T ss_pred ccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEE
Confidence 46899999999999855556689999999999999999998886 799999999999999999 8999999999999999
Q ss_pred ccccCCCCCCCccccC---CceeeeecCCCCCccc
Q 002410 487 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 518 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~---~~~~~~~~~N~~~c~~ 518 (927)
|++|+|+ .+|...+. .+..+.+.+||+.|.+
T Consensus 142 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 142 LDQNQLK-SIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CCCCcCC-ccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 9999999 56654433 6778889999999865
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.26 E-value=5.5e-12 Score=125.89 Aligned_cols=102 Identities=23% Similarity=0.265 Sum_probs=89.4
Q ss_pred CCCccEEEeCC--------CCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccc
Q 002410 396 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN 466 (927)
Q Consensus 396 ~~w~~~~c~~~--------~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N 466 (927)
|.|..+.|+.. .+..++.|+|++|+|++..|..|.+|++|+.|+|++|+|++.+|. |..+++|+.|+|++|
T Consensus 9 C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 9 CSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 45666666542 246799999999999988899999999999999999999998886 799999999999999
Q ss_pred cccCCCCCcCCCccccccccccccCCCCCCC
Q 002410 467 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP 497 (927)
Q Consensus 467 ~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP 497 (927)
+|++..|..|..+++|+.|+|++|.+++..+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9997667789999999999999999986544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.26 E-value=9.9e-12 Score=127.97 Aligned_cols=122 Identities=23% Similarity=0.339 Sum_probs=96.9
Q ss_pred CCCCCCCCccEEEeCC--------CCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCccccccee
Q 002410 391 DPCVPVPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIV 461 (927)
Q Consensus 391 dpC~~~~w~~~~c~~~--------~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L 461 (927)
+.| .|.|.++.|+.. .+++++.|+|++|++++..+..|.++++|+.|+|++|+|++.++. |..+++|++|
T Consensus 3 ~~C-~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 81 (208)
T 2o6s_A 3 SRC-SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYL 81 (208)
T ss_dssp TTC-EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCC-EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEE
Confidence 345 357888888653 245799999999999976666789999999999999999988776 7899999999
Q ss_pred ecccccccCCCCCcCCCccccccccccccCCCCCCCccc-c--CCceeeeecCCCC
Q 002410 462 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL-L--TGKVIFKYDNNPK 514 (927)
Q Consensus 462 ~Ls~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~-~--~~~~~~~~~~N~~ 514 (927)
+|++|++++..+..+..+++|+.|+|++|+++ .+|... . ..+..+.+.+|..
T Consensus 82 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l 136 (208)
T 2o6s_A 82 NLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136 (208)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred ECCCCcCCccCHhHhcCccCCCEEEcCCCcCc-ccCHhHhccCCcCCEEECCCCcc
Confidence 99999999666667889999999999999998 455543 2 2566677777754
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.25 E-value=8.3e-12 Score=130.05 Aligned_cols=120 Identities=23% Similarity=0.216 Sum_probs=100.0
Q ss_pred CCCccEEEeCC--------CCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccc
Q 002410 396 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN 466 (927)
Q Consensus 396 ~~w~~~~c~~~--------~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N 466 (927)
|.|..+.|+.. .+++++.|+|++|+|++..+..|.++++|+.|+|++|+|++..|+ |.++++|+.|+|++|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 45666676542 245799999999999987777999999999999999999999885 999999999999999
Q ss_pred cccCCCCCcCCCccccccccccccCCCCCCCccccC--CceeeeecCCCCC
Q 002410 467 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 515 (927)
Q Consensus 467 ~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~~--~~~~~~~~~N~~~ 515 (927)
+|++..+..|..+++|+.|+|++|++++..|..+.. .+..+.+.+|...
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 141 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC
Confidence 999555556789999999999999999665665543 6677888888644
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.24 E-value=1.2e-11 Score=134.47 Aligned_cols=110 Identities=27% Similarity=0.325 Sum_probs=98.5
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++++.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. |..+++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 99 l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~ 178 (290)
T 1p9a_G 99 LPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178 (290)
T ss_dssp CTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEE
Confidence 46899999999999977778899999999999999999998886 78999999999999999955555678999999999
Q ss_pred ccccCCCCCCCccccC--CceeeeecCCCCCccc
Q 002410 487 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHKE 518 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~--~~~~~~~~~N~~~c~~ 518 (927)
|++|+|+ .+|..++. .+..+.+.+||+.|.+
T Consensus 179 L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 9999999 89998876 4667888999999975
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.23 E-value=6.8e-12 Score=139.85 Aligned_cols=104 Identities=18% Similarity=0.206 Sum_probs=91.0
Q ss_pred EEEecCC-CCcccCCccccCCcccceecccC-CCCCCCCCC-cCcccccceeecccccccCCCCCcCCCccccccccccc
Q 002410 413 KIALSGK-NLKGEIPPELKNMEALTELWLDG-NFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 489 (927)
Q Consensus 413 ~L~L~~n-~l~g~ip~~l~~l~~L~~L~Ls~-N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~ 489 (927)
.++++++ +|+ .||. |..+++|+.|+|++ |+|++.+|. |.+|++|+.|+|++|+|+|.+|..|.+|++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3577777 888 6888 99999999999996 999999985 99999999999999999998899999999999999999
Q ss_pred cCCCCCCCccccC--CceeeeecCCCCCcccc
Q 002410 490 NSFVGEIPPALLT--GKVIFKYDNNPKLHKES 519 (927)
Q Consensus 490 N~l~g~iP~~~~~--~~~~~~~~~N~~~c~~~ 519 (927)
|+|+ .+|...+. .+..+.+.+|++.|.+.
T Consensus 90 N~l~-~~~~~~~~~~~L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 90 NALE-SLSWKTVQGLSLQELVLSGNPLHCSCA 120 (347)
T ss_dssp SCCS-CCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred Cccc-eeCHHHcccCCceEEEeeCCCccCCCc
Confidence 9999 67776655 36778889999998643
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.21 E-value=2.5e-11 Score=128.96 Aligned_cols=110 Identities=20% Similarity=0.214 Sum_probs=96.0
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++|+.|+|++|++++..+..|.++++|+.|+|++|+|++.++. |..+++|+.|+|++|+|++..|..|+.+++|+.|+
T Consensus 82 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 161 (251)
T 3m19_A 82 LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLS 161 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEE
Confidence 46899999999999977778889999999999999999998886 79999999999999999977777899999999999
Q ss_pred ccccCCCCCCCccccC--CceeeeecCCCCCcc
Q 002410 487 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHK 517 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~--~~~~~~~~~N~~~c~ 517 (927)
|++|++++..|..+.. .+..+.+.+|++.|.
T Consensus 162 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 162 LSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9999999544434432 677889999999885
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.21 E-value=2.5e-12 Score=141.56 Aligned_cols=108 Identities=26% Similarity=0.309 Sum_probs=99.5
Q ss_pred eEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccccccc
Q 002410 411 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 490 (927)
Q Consensus 411 l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~N 490 (927)
++.|+|++|++++.+|..|.++++|+.|+|++|++++.+|.+..+++|+.|+|++|+++|.+|..+..+++|+.|+|++|
T Consensus 199 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 278 (313)
T 1ogq_A 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278 (313)
T ss_dssp CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSS
T ss_pred ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCC
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCccc-cCCceeeeecCCCCCccc
Q 002410 491 SFVGEIPPAL-LTGKVIFKYDNNPKLHKE 518 (927)
Q Consensus 491 ~l~g~iP~~~-~~~~~~~~~~~N~~~c~~ 518 (927)
+++|.+|... +..+..+.+.+|+++|+.
T Consensus 279 ~l~~~ip~~~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 279 NLCGEIPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp EEEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred cccccCCCCccccccChHHhcCCCCccCC
Confidence 9999999862 125667788999999964
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.5e-11 Score=128.17 Aligned_cols=120 Identities=14% Similarity=0.162 Sum_probs=100.6
Q ss_pred CCCccEEEeCCC--------CCceEEEEecCCCCcccCCc-cccCCcccceecccCCCCCCCCC-CcCcccccceeeccc
Q 002410 396 VPWEWVTCSTTT--------PPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLEN 465 (927)
Q Consensus 396 ~~w~~~~c~~~~--------~~~l~~L~L~~n~l~g~ip~-~l~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~ 465 (927)
|.|..+.|+... +..++.|+|++|+|++..|. .|.++++|+.|+|++|+|++.+| .|.++++|+.|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 456666665421 34688999999999987664 58999999999999999999988 599999999999999
Q ss_pred ccccCCCCCcCCCccccccccccccCCCCCCCccccC--CceeeeecCCCCC
Q 002410 466 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 515 (927)
Q Consensus 466 N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~~--~~~~~~~~~N~~~ 515 (927)
|+|++..|..|..+++|+.|+|++|+|++..|..+.. .+..+.+.+|...
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 142 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCC
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCC
Confidence 9999888888999999999999999999766766653 6677888888543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.18 E-value=4.9e-11 Score=122.71 Aligned_cols=110 Identities=21% Similarity=0.274 Sum_probs=95.5
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++|+.|+|++|++++..+..|.++++|++|+|++|+|++.++. +..+++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 130 (208)
T 2o6s_A 51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR 130 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEE
Confidence 46899999999999966666789999999999999999988886 79999999999999999977777789999999999
Q ss_pred ccccCCCCCCCcccc---CCceeeeecCCCCCccc
Q 002410 487 IENNSFVGEIPPALL---TGKVIFKYDNNPKLHKE 518 (927)
Q Consensus 487 l~~N~l~g~iP~~~~---~~~~~~~~~~N~~~c~~ 518 (927)
|++|.++ .+|...+ ..+..+.+.+|++.|..
T Consensus 131 l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~ 164 (208)
T 2o6s_A 131 LYQNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTC 164 (208)
T ss_dssp CCSSCCS-CCCTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred CCCCccc-eeCHHHhccCCCccEEEecCCCeecCC
Confidence 9999999 5565433 26778889999988753
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.18 E-value=3.3e-11 Score=120.76 Aligned_cols=87 Identities=20% Similarity=0.311 Sum_probs=80.5
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
+.+++.|+|++|+|++..|..|.+|++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 32 ~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~ 111 (174)
T 2r9u_A 32 PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIY 111 (174)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEE
Confidence 46799999999999988899999999999999999999998886 79999999999999999966556699999999999
Q ss_pred ccccCCCC
Q 002410 487 IENNSFVG 494 (927)
Q Consensus 487 l~~N~l~g 494 (927)
|++|.+..
T Consensus 112 L~~N~~~c 119 (174)
T 2r9u_A 112 LYNNPWDC 119 (174)
T ss_dssp CCSSCBCT
T ss_pred eCCCCccc
Confidence 99999983
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.18 E-value=4.9e-11 Score=128.32 Aligned_cols=112 Identities=18% Similarity=0.162 Sum_probs=97.9
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++|+.|+|++|++++..|..|.++++|+.|+|++|+|++.+|. +..+++|+.|+|++|++++..|..++.+++|+.|+
T Consensus 108 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 187 (272)
T 3rfs_A 108 LTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLR 187 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEE
Confidence 46899999999999977777899999999999999999998886 79999999999999999987777889999999999
Q ss_pred ccccCCCCCCCcccc--CCceeeeecCCCCCcccc
Q 002410 487 IENNSFVGEIPPALL--TGKVIFKYDNNPKLHKES 519 (927)
Q Consensus 487 l~~N~l~g~iP~~~~--~~~~~~~~~~N~~~c~~~ 519 (927)
+++|++++..|..+. ..+..+.+.+|++.|..+
T Consensus 188 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 188 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 999999965554443 367788999999987643
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.17 E-value=1.6e-11 Score=124.92 Aligned_cols=91 Identities=22% Similarity=0.341 Sum_probs=86.6
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++.+|..+..+++|+.|+
T Consensus 53 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 132 (192)
T 1w8a_A 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132 (192)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEE
T ss_pred CCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEE
Confidence 46899999999999999999999999999999999999999996 99999999999999999999999999999999999
Q ss_pred ccccCCCCCCCc
Q 002410 487 IENNSFVGEIPP 498 (927)
Q Consensus 487 l~~N~l~g~iP~ 498 (927)
|++|.+++..+.
T Consensus 133 L~~N~l~c~c~l 144 (192)
T 1w8a_A 133 LASNPFNCNCHL 144 (192)
T ss_dssp CTTCCBCCSGGG
T ss_pred eCCCCccCcCcc
Confidence 999999987764
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.16 E-value=4e-11 Score=128.84 Aligned_cols=107 Identities=21% Similarity=0.266 Sum_probs=83.5
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
++.++.|+|++|++++..+..|.++++|++|+|++|+|+..++. |.++++|++|+|++|++++..+..+..+++|+.|+
T Consensus 36 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 115 (270)
T 2o6q_A 36 PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELR 115 (270)
T ss_dssp CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEE
T ss_pred CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEE
Confidence 34688899999999866666888999999999999999877776 68899999999999999866666778889999999
Q ss_pred ccccCCCCCCCcccc--CCceeeeecCCCC
Q 002410 487 IENNSFVGEIPPALL--TGKVIFKYDNNPK 514 (927)
Q Consensus 487 l~~N~l~g~iP~~~~--~~~~~~~~~~N~~ 514 (927)
|++|.+++..|..+. ..+..+.+.+|..
T Consensus 116 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 145 (270)
T 2o6q_A 116 LDRNQLKSLPPRVFDSLTKLTYLSLGYNEL 145 (270)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCccCeeCHHHhCcCcCCCEEECCCCcC
Confidence 999998844333332 2566677777643
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=2e-11 Score=146.63 Aligned_cols=106 Identities=15% Similarity=0.058 Sum_probs=91.4
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
|..++.|||++|+|++..|..|.+|++|++|+|++|+|++.+|+ |.+|++|++|+|++|+|++..|..|.+|++|+.|+
T Consensus 51 p~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 51 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 130 (635)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred CcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence 45899999999999977778999999999999999999998885 99999999999999999966667899999999999
Q ss_pred ccccCCCCCCCcc-ccC--CceeeeecCCCC
Q 002410 487 IENNSFVGEIPPA-LLT--GKVIFKYDNNPK 514 (927)
Q Consensus 487 l~~N~l~g~iP~~-~~~--~~~~~~~~~N~~ 514 (927)
|++|+++ .+|.. +.. .+..+.+.+|..
T Consensus 131 Ls~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l 160 (635)
T 4g8a_A 131 AVETNLA-SLENFPIGHLKTLKELNVAHNLI 160 (635)
T ss_dssp CTTSCCC-CSTTCCCTTCTTCCEEECCSSCC
T ss_pred CCCCcCC-CCChhhhhcCcccCeeccccCcc
Confidence 9999999 56654 332 566777777754
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=3e-11 Score=145.22 Aligned_cols=113 Identities=16% Similarity=0.168 Sum_probs=100.9
Q ss_pred CCCceEEEEecCCCCc-ccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccc
Q 002410 407 TPPRITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQE 484 (927)
Q Consensus 407 ~~~~l~~L~L~~n~l~-g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~ 484 (927)
..+.++.|+|++|++. +.+|..|..|++|+.|+|++|+|++.+|. |.+|++|+.|+|++|+|++..|..|..+++|+.
T Consensus 467 ~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~ 546 (635)
T 4g8a_A 467 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 546 (635)
T ss_dssp TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCE
T ss_pred cchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCE
Confidence 3568999999999854 45788899999999999999999999996 999999999999999999888889999999999
Q ss_pred ccccccCCCCCCCccccC---CceeeeecCCCCCcccc
Q 002410 485 LHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES 519 (927)
Q Consensus 485 L~l~~N~l~g~iP~~~~~---~~~~~~~~~N~~~c~~~ 519 (927)
|+|++|+|++..|..+.. .+..+.+.+||+.|.+.
T Consensus 547 L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 547 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp EECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred EECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 999999999877776643 57788999999999864
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.15 E-value=2.9e-11 Score=119.94 Aligned_cols=105 Identities=22% Similarity=0.267 Sum_probs=91.1
Q ss_pred CCceEEEEecCCCCc-ccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~-g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
+++++.|+|++|+++ |.+|..+..+++|+.|+|++|+|++. +.+..+++|+.|+|++|++++.+|..+..+++|+.|+
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 468999999999998 89999999999999999999999988 7799999999999999999988888888899999999
Q ss_pred ccccCCCCCCC--ccccC--CceeeeecCCCC
Q 002410 487 IENNSFVGEIP--PALLT--GKVIFKYDNNPK 514 (927)
Q Consensus 487 l~~N~l~g~iP--~~~~~--~~~~~~~~~N~~ 514 (927)
|++|.++ .+| ..+.. .+..+.+.+|+.
T Consensus 102 Ls~N~l~-~~~~~~~l~~l~~L~~L~l~~N~l 132 (168)
T 2ell_A 102 LSGNKLK-DISTLEPLKKLECLKSLDLFNCEV 132 (168)
T ss_dssp CBSSSCC-SSGGGGGGSSCSCCCEEECCSSGG
T ss_pred ccCCccC-cchhHHHHhcCCCCCEEEeeCCcC
Confidence 9999998 554 34433 566677777754
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.14 E-value=7.8e-11 Score=126.50 Aligned_cols=111 Identities=22% Similarity=0.282 Sum_probs=98.4
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++|+.|+|++|++++..|..|.++++|+.|+|++|+|++.++. |..+++|+.|+|++|++++..|..|..+++|+.|+
T Consensus 108 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 187 (270)
T 2o6q_A 108 LVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLK 187 (270)
T ss_dssp CSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred ccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEE
Confidence 36899999999999988888899999999999999999998886 89999999999999999977777899999999999
Q ss_pred ccccCCCCCCCccccC---CceeeeecCCCCCcccc
Q 002410 487 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES 519 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~---~~~~~~~~~N~~~c~~~ 519 (927)
|++|+++ .+|...+. .+..+.+.+||+.|.+.
T Consensus 188 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 188 LDNNQLK-RVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred CCCCcCC-cCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 9999999 56665433 67788999999998753
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.13 E-value=2.3e-11 Score=118.12 Aligned_cols=106 Identities=20% Similarity=0.242 Sum_probs=89.5
Q ss_pred CCceEEEEecCCCCc-ccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~-g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
+++++.|+|++|+++ |.+|..+..+++|+.|+|++|++++. +.+..+++|+.|+|++|++++.+|..++.+++|+.|+
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 357999999999998 89999999999999999999999988 7799999999999999999988888888899999999
Q ss_pred ccccCCCCC-CCccccC--CceeeeecCCCC
Q 002410 487 IENNSFVGE-IPPALLT--GKVIFKYDNNPK 514 (927)
Q Consensus 487 l~~N~l~g~-iP~~~~~--~~~~~~~~~N~~ 514 (927)
+++|.+++. .|..+.. .+..+.+.+|+.
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l 125 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGG
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcc
Confidence 999999842 2244433 566777777754
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.12 E-value=5.2e-11 Score=131.89 Aligned_cols=108 Identities=16% Similarity=0.236 Sum_probs=93.1
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.++|+.|+|++|+++ .+|..++++++|+.|+|++|++++.++.+..+++|+.|+|++|++.+.+|..++.+++|+.|+|
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L 260 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEEC
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEEC
Confidence 467899999999998 8898899999999999999999987778899999999999999999999999999999999999
Q ss_pred cccCCCCCCCccccC--CceeeeecCCCCCc
Q 002410 488 ENNSFVGEIPPALLT--GKVIFKYDNNPKLH 516 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~--~~~~~~~~~N~~~c 516 (927)
++|++.+.+|..+.. .+..+.+.+|+...
T Consensus 261 ~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 291 (328)
T 4fcg_A 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291 (328)
T ss_dssp TTCTTCCBCCTTGGGCTTCCEEECTTCTTCC
T ss_pred CCCCchhhcchhhhcCCCCCEEeCCCCCchh
Confidence 999988899987654 56777888877543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.12 E-value=1e-10 Score=124.26 Aligned_cols=106 Identities=23% Similarity=0.289 Sum_probs=89.0
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
++.++.|+|++|++++..|..|.++++|+.|+|++|+|++.+|. |..+++|+.|+|++|+|++..|..+..+++|+.|+
T Consensus 34 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 113 (251)
T 3m19_A 34 PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLY 113 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEE
Confidence 45789999999999988888899999999999999999998886 88999999999999999977777888999999999
Q ss_pred ccccCCCCCCCcccc---CCceeeeecCCCC
Q 002410 487 IENNSFVGEIPPALL---TGKVIFKYDNNPK 514 (927)
Q Consensus 487 l~~N~l~g~iP~~~~---~~~~~~~~~~N~~ 514 (927)
|++|+|+ .+|...+ ..+..+.+.+|..
T Consensus 114 L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l 143 (251)
T 3m19_A 114 LGGNQLK-SLPSGVFDRLTKLKELRLNTNQL 143 (251)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred cCCCcCC-CcChhHhccCCcccEEECcCCcC
Confidence 9999998 5665543 3566677777743
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=3.1e-10 Score=113.53 Aligned_cols=141 Identities=14% Similarity=0.187 Sum_probs=95.1
Q ss_pred eEEEecCCCCCccCCCCCeEEecCCccccCCceeeecCC------C-CCcccccccccccCCCccceeeecccCCceeEE
Q 002410 25 FISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENP------S-GNWMQYRTRRDLPIDNKKYCYNLITKERRRYLV 97 (927)
Q Consensus 25 ~~~idcg~~~~~~~~~~~~~~~~d~~~~~~g~~~~~~~~------~-~~~~~~~tlr~fp~~~~~~cy~l~~~~~~~ylv 97 (927)
-+.||||+.. .+| ..+.+|.+|..|...|........ . ...+.+.|-|.|| .+.+|.+|+.++++|+|
T Consensus 7 ~~~INcGg~~-~~d-~~gr~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~---~~~tY~f~v~~~G~Y~V 81 (174)
T 2jwp_A 7 IWAVNAGGES-HVD-VHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNE---DSFGYDIPIKEEGEYVL 81 (174)
T ss_dssp EEEEEETSSS-EEE-TTTEEECSSCSSTTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCC---SCEEEEEECCSCEEEEE
T ss_pred EEEEECCCCC-ccC-CCCCEEcCCcCcccCCcccccccceEecccCCCCchhhhhhccCC---CCeEEEEEeCCCeEEEE
Confidence 3679999765 455 578999999988644532211110 0 1134678999998 37899999999999999
Q ss_pred EEEeeecCCCCCCCCCeEEEEEcCcee-EEEEec---CCccceEEEEEEe-------------cCCCCcccceecccCCC
Q 002410 98 RATFQYGSLGSEASYPKFQLYLDATLW-STVTVL---DASRVYAKEMIIR-------------APSDSIDVCICCAVTGS 160 (927)
Q Consensus 98 r~~~~yg~yd~~~~~p~fd~~~~~~~w-~~v~~~---~~~~~~~~e~~~~-------------~~~~~~~vcl~~~~~~~ 160 (927)
|.-|.--.|.+ .....||++++|..- .-.++. .....+..+..+. .....+.|.|.....+.
T Consensus 82 rLhF~ei~~~~-~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~~~~ 160 (174)
T 2jwp_A 82 VLKFAEVYFAQ-SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDN 160 (174)
T ss_dssp EEEEECCSCCC-SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSSSCS
T ss_pred EEEEeccccCC-CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccCCCC
Confidence 99997666653 566799999999542 222221 1223444554443 24456777777544568
Q ss_pred ceeeeeeeeec
Q 002410 161 PFISTLELRPL 171 (927)
Q Consensus 161 pfis~le~~~l 171 (927)
|||++||+.+-
T Consensus 161 a~inaIEI~~~ 171 (174)
T 2jwp_A 161 PKVCALFIMKG 171 (174)
T ss_dssp SSEEEEEEESS
T ss_pred cEEEEEEEEeC
Confidence 99999999874
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=4.6e-11 Score=141.51 Aligned_cols=117 Identities=18% Similarity=0.215 Sum_probs=100.6
Q ss_pred CCCccEEEeCCC----------CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecc
Q 002410 396 VPWEWVTCSTTT----------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLE 464 (927)
Q Consensus 396 ~~w~~~~c~~~~----------~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls 464 (927)
|+|.++ |+|.. +++++.|+|++|++++..|..|.++++|++|+|++|++++.+|+ |.++++|++|+|+
T Consensus 4 C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls 82 (549)
T 2z81_A 4 CDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82 (549)
T ss_dssp ECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred CCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECC
Confidence 578888 88752 35899999999999988899999999999999999999999885 9999999999999
Q ss_pred cccccCCCCCcCCCccccccccccccCCCC-CCCccccC--CceeeeecCCC
Q 002410 465 NNELTGSLPSYMGSLPNLQELHIENNSFVG-EIPPALLT--GKVIFKYDNNP 513 (927)
Q Consensus 465 ~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g-~iP~~~~~--~~~~~~~~~N~ 513 (927)
+|++++..|..++++++|+.|+|++|.+++ .+|..+.. .+..+.+.+|.
T Consensus 83 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 134 (549)
T 2z81_A 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134 (549)
T ss_dssp TSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS
T ss_pred CCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCc
Confidence 999998777779999999999999999985 35555533 56677777775
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=1.3e-10 Score=124.02 Aligned_cols=141 Identities=13% Similarity=0.075 Sum_probs=110.6
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEEEEEecCC
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
+.+...++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++.+.+..++||||++|
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 445667888888999999865 7899999987532233346889999999995 67788899999888899999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG------------------------------------------ 723 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~------------------------------------------ 723 (927)
.+|.+.+.. ......++.+++++|+.||+.
T Consensus 95 ~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 95 VLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp EEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred eehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 999876421 122357889999999999971
Q ss_pred --------------CCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 724 --------------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 724 --------------~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
....++|||++|.||+++++..+.|+||+.+..
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 014589999999999998766677999997653
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=5.2e-11 Score=137.57 Aligned_cols=125 Identities=15% Similarity=0.157 Sum_probs=99.9
Q ss_pred CCCCC-CCCccEEEeCCC---------CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCC--CcCccccc
Q 002410 391 DPCVP-VPWEWVTCSTTT---------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--DMSRLIDL 458 (927)
Q Consensus 391 dpC~~-~~w~~~~c~~~~---------~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p--~~~~l~~L 458 (927)
|||.. |.|.+..+.|.. +++++.|+|++|++++..|..|++|++|++|+|++|.+.+.+| .|.++++|
T Consensus 2 ~p~~~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L 81 (455)
T 3v47_A 2 DPGTSECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81 (455)
T ss_dssp -----CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTC
T ss_pred CCccceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccC
Confidence 45543 455664444431 4679999999999999889999999999999999999997765 39999999
Q ss_pred ceeecccccccCCCCCcCCCccccccccccccCCCCCCCcc--cc--CCceeeeecCCCCC
Q 002410 459 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPA--LL--TGKVIFKYDNNPKL 515 (927)
Q Consensus 459 ~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~--~~--~~~~~~~~~~N~~~ 515 (927)
++|+|++|++++.+|..|+++++|+.|+|++|.+++.+|.. +. ..+..+.+.+|...
T Consensus 82 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~ 142 (455)
T 3v47_A 82 IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142 (455)
T ss_dssp CEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCC
T ss_pred CEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccC
Confidence 99999999999888999999999999999999999766654 33 25667777777543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.08 E-value=1.2e-10 Score=130.79 Aligned_cols=120 Identities=21% Similarity=0.158 Sum_probs=94.1
Q ss_pred CCCccEEEeCC--------CCCceEEEEecCCCCcccCCcccc-CCcccceecccCCCCCCCCCC-cCcccccceeeccc
Q 002410 396 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN 465 (927)
Q Consensus 396 ~~w~~~~c~~~--------~~~~l~~L~L~~n~l~g~ip~~l~-~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~ 465 (927)
|.+..+.|+.. .+..++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..|. |.++++|+.|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 34555666542 144688999999999977777777 899999999999999998885 89999999999999
Q ss_pred ccccCCCCCcCCCccccccccccccCCCCCCCccccC--CceeeeecCCCCC
Q 002410 466 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 515 (927)
Q Consensus 466 N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~~--~~~~~~~~~N~~~ 515 (927)
|+|++..+..|..+++|+.|+|++|+|++..|..+.. .+..+.+.+|...
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 149 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC
Confidence 9999766778889999999999999998554555443 5666777777543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=1.1e-10 Score=134.67 Aligned_cols=111 Identities=20% Similarity=0.244 Sum_probs=99.1
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++|+.|+|++|++++..|..|.++++|+.|+|++|++++.+|. +.++++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 298 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 377 (455)
T 3v47_A 298 FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELA 377 (455)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEE
Confidence 46899999999999998899999999999999999999998885 89999999999999999988899999999999999
Q ss_pred ccccCCCCCCCcccc---CCceeeeecCCCCCcccc
Q 002410 487 IENNSFVGEIPPALL---TGKVIFKYDNNPKLHKES 519 (927)
Q Consensus 487 l~~N~l~g~iP~~~~---~~~~~~~~~~N~~~c~~~ 519 (927)
|++|+++ .+|...+ ..+..+.+.+|+..|.++
T Consensus 378 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 378 LDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCccc-cCCHhHhccCCcccEEEccCCCcccCCC
Confidence 9999999 5666543 367788999999998654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=1e-10 Score=126.39 Aligned_cols=111 Identities=19% Similarity=0.275 Sum_probs=97.3
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++|+.|+|++|++++..+..|.++++|+.|+|++|++++.++. +..+++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 128 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 207 (285)
T 1ozn_A 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (285)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEee
Confidence 46899999999999977777799999999999999999988885 99999999999999999988899999999999999
Q ss_pred ccccCCCCCCCcc-cc--CCceeeeecCCCCCcccc
Q 002410 487 IENNSFVGEIPPA-LL--TGKVIFKYDNNPKLHKES 519 (927)
Q Consensus 487 l~~N~l~g~iP~~-~~--~~~~~~~~~~N~~~c~~~ 519 (927)
|++|.+++ +|.. +. ..+..+.+.+|++.|.+.
T Consensus 208 l~~n~l~~-~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 208 LFANNLSA-LPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp CCSSCCSC-CCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred CCCCcCCc-CCHHHcccCcccCEEeccCCCccCCCC
Confidence 99999995 5543 43 267788999999988643
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.06 E-value=1.3e-10 Score=127.04 Aligned_cols=112 Identities=16% Similarity=0.169 Sum_probs=100.2
Q ss_pred CCceEEEEecCCCCcc-cCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCccccccc
Q 002410 408 PPRITKIALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 485 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g-~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L 485 (927)
.++++.|+|++|.+++ .+|..+.++++|+.|+|++|++++.+|. +..+++|+.|+|++|++++..+..+..+++|+.|
T Consensus 149 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 228 (306)
T 2z66_A 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 228 (306)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEE
T ss_pred CcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEe
Confidence 4689999999999997 6899999999999999999999999885 8999999999999999997777789999999999
Q ss_pred cccccCCCCCCCccccC---CceeeeecCCCCCcccc
Q 002410 486 HIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES 519 (927)
Q Consensus 486 ~l~~N~l~g~iP~~~~~---~~~~~~~~~N~~~c~~~ 519 (927)
+|++|++++.+|..+.. .+..+.+.+|++.|.+.
T Consensus 229 ~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 229 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp ECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred ECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 99999999888877654 56788899999988643
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.06 E-value=1.3e-10 Score=129.91 Aligned_cols=117 Identities=21% Similarity=0.249 Sum_probs=98.3
Q ss_pred CCCCccEEEeCCC----------CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeec
Q 002410 395 PVPWEWVTCSTTT----------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHL 463 (927)
Q Consensus 395 ~~~w~~~~c~~~~----------~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L 463 (927)
.|+|.++ |+|+. +++++.|+|++|++++..+..|.++++|+.|+|++|++++.+|. |.++++|++|+|
T Consensus 29 ~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 29 SCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp EECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 4578887 88752 35899999999999976667899999999999999999998885 999999999999
Q ss_pred ccccccCCCCCcCCCccccccccccccCCCCCCCc-ccc---CCceeeeecCCC
Q 002410 464 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP-ALL---TGKVIFKYDNNP 513 (927)
Q Consensus 464 s~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~-~~~---~~~~~~~~~~N~ 513 (927)
++|++++..+..++++++|+.|+|++|+++ .+|. ..+ ..+..+.+.+|.
T Consensus 108 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~ 160 (353)
T 2z80_A 108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160 (353)
T ss_dssp CSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESS
T ss_pred CCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCc
Confidence 999999544445899999999999999999 6776 333 256677777774
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.06 E-value=1.6e-10 Score=128.67 Aligned_cols=103 Identities=20% Similarity=0.234 Sum_probs=86.3
Q ss_pred CCCCCCCccEEEeCC-C---------CCceEEEEecC-CCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccc
Q 002410 392 PCVPVPWEWVTCSTT-T---------PPRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLR 459 (927)
Q Consensus 392 pC~~~~w~~~~c~~~-~---------~~~l~~L~L~~-n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~ 459 (927)
.|..|.|..+.|+.. . ..+|+.|+|++ |+|++..|..|++|++|+.|+|++|+|++.+|. |.+|++|+
T Consensus 4 ~c~~C~~~~v~~~~~n~l~~ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 83 (347)
T 2ifg_A 4 ACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83 (347)
T ss_dssp SSCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred cCccccCCEEEcCCCCCCCccCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCC
Confidence 353457777877654 1 24599999996 999988888999999999999999999999996 89999999
Q ss_pred eeecccccccCCCCCcCCCccccccccccccCCCCC
Q 002410 460 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGE 495 (927)
Q Consensus 460 ~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ 495 (927)
.|+|++|+|++..|..+..++ |+.|+|.+|.|...
T Consensus 84 ~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 84 RLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp EEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred EEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 999999999965555666665 99999999999843
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=2.1e-10 Score=123.40 Aligned_cols=107 Identities=15% Similarity=0.030 Sum_probs=91.4
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
++.++.|+|++|++++..+..|.++++|+.|+|++|++++..+. |.++++|+.|+|++|++++..|..+.++++|+.|+
T Consensus 27 ~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (276)
T 2z62_A 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (276)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred CCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEE
Confidence 45699999999999987777999999999999999999998884 99999999999999999988888999999999999
Q ss_pred ccccCCCCCCCccccC--CceeeeecCCCC
Q 002410 487 IENNSFVGEIPPALLT--GKVIFKYDNNPK 514 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~--~~~~~~~~~N~~ 514 (927)
+++|.+++..+..+.. .+..+.+.+|..
T Consensus 107 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 136 (276)
T 2z62_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLI 136 (276)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCC
T ss_pred CCCCCccccCchhcccCCCCCEEECcCCcc
Confidence 9999999544434432 566777777754
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.04 E-value=1.9e-10 Score=132.62 Aligned_cols=109 Identities=24% Similarity=0.332 Sum_probs=97.8
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++..|. |.++++|+.|+|++|++++..|..|.++++|+.|+
T Consensus 184 l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 261 (440)
T 3zyj_A 184 LSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEIN 261 (440)
T ss_dssp CSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEE
T ss_pred ccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEE
Confidence 468999999999999 676 589999999999999999999885 99999999999999999998899999999999999
Q ss_pred ccccCCCCCCCccccC---CceeeeecCCCCCcccc
Q 002410 487 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES 519 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~---~~~~~~~~~N~~~c~~~ 519 (927)
|++|+|+ .+|...+. .+..+.+.+||+.|.+.
T Consensus 262 L~~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 262 LAHNNLT-LLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp CTTSCCC-CCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred CCCCCCC-ccChhHhccccCCCEEEcCCCCccCCCC
Confidence 9999999 66665543 67788999999999764
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.02 E-value=4.5e-10 Score=122.09 Aligned_cols=107 Identities=28% Similarity=0.350 Sum_probs=95.2
Q ss_pred CCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCccccccc
Q 002410 407 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 485 (927)
Q Consensus 407 ~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L 485 (927)
..++++.|+|++|+|+ .+|..+.++++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..|..+++|+.|
T Consensus 75 ~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 153 (290)
T 1p9a_G 75 TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153 (290)
T ss_dssp CCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEE
Confidence 3568999999999999 8999999999999999999999999886 9999999999999999997777788999999999
Q ss_pred cccccCCCCCCCccccC---CceeeeecCCCCC
Q 002410 486 HIENNSFVGEIPPALLT---GKVIFKYDNNPKL 515 (927)
Q Consensus 486 ~l~~N~l~g~iP~~~~~---~~~~~~~~~N~~~ 515 (927)
+|++|+|+ .+|...+. .+..+.+.+|...
T Consensus 154 ~L~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~ 185 (290)
T 1p9a_G 154 SLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185 (290)
T ss_dssp ECTTSCCS-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCC-ccCHHHhcCcCCCCEEECCCCcCC
Confidence 99999999 78876643 5677788888654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.02 E-value=1.6e-10 Score=121.57 Aligned_cols=125 Identities=20% Similarity=0.265 Sum_probs=100.4
Q ss_pred CCCCCCCCCCCccEEEeCC-------CCCceEEEEecCCCCcccCCccccCCcccceecccCCC-CCCCCC-CcCccccc
Q 002410 388 DRGDPCVPVPWEWVTCSTT-------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNF-LTGPLP-DMSRLIDL 458 (927)
Q Consensus 388 w~gdpC~~~~w~~~~c~~~-------~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~-l~g~~p-~~~~l~~L 458 (927)
|..++|.+..|.++.++|. .+..++.|+|++|++++..+..|.++++|+.|+|++|+ +++..+ .|.++++|
T Consensus 3 ~cp~~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L 82 (239)
T 2xwt_C 3 CSSPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKV 82 (239)
T ss_dssp CCSSSCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTC
T ss_pred CCCCCCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCC
Confidence 3345676544566665553 24589999999999997777789999999999999997 888877 49999999
Q ss_pred ceeeccc-ccccCCCCCcCCCccccccccccccCCCCCCCccccC--Cce---eeeecCCCC
Q 002410 459 RIVHLEN-NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKV---IFKYDNNPK 514 (927)
Q Consensus 459 ~~L~Ls~-N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~~--~~~---~~~~~~N~~ 514 (927)
+.|+|++ |++++..|..|.++++|+.|++++|.+++ +|. +.. .+. .+.+.+|+.
T Consensus 83 ~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~ 142 (239)
T 2xwt_C 83 THIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPY 142 (239)
T ss_dssp CEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTT
T ss_pred cEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcc
Confidence 9999999 99996666789999999999999999994 886 322 333 677788843
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=1.5e-10 Score=138.90 Aligned_cols=111 Identities=19% Similarity=0.144 Sum_probs=99.9
Q ss_pred CCceEEEEecCCCCcc-cCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCccccccc
Q 002410 408 PPRITKIALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 485 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g-~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L 485 (927)
.++++.|+|++|++++ .+|..++++++|+.|+|++|++++.+|. +.++++|+.|+|++|++++.+|..++++++|+.|
T Consensus 447 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 526 (606)
T 3vq2_A 447 LTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTL 526 (606)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEE
T ss_pred CCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEE
Confidence 4689999999999998 4788999999999999999999999886 8999999999999999999889999999999999
Q ss_pred cccccCCCCCCCccccC---CceeeeecCCCCCcccc
Q 002410 486 HIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES 519 (927)
Q Consensus 486 ~l~~N~l~g~iP~~~~~---~~~~~~~~~N~~~c~~~ 519 (927)
+|++|+++ .+|..+.. .+..+.+.+||+.|.+.
T Consensus 527 ~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 527 DCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp ECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred ECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 99999999 89987544 36788999999998754
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.01 E-value=5.4e-10 Score=120.10 Aligned_cols=108 Identities=21% Similarity=0.215 Sum_probs=89.9
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++|+.|+|++|++++..+..+.++++|+.|+|++|++++.+|. +..+++|+.|+|++|++++..|..++.+++|+.|+
T Consensus 84 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 84 LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 46899999999999977777789999999999999999988886 79999999999999999977777789999999999
Q ss_pred ccccCCCCCCCcccc--CCceeeeecCCCCC
Q 002410 487 IENNSFVGEIPPALL--TGKVIFKYDNNPKL 515 (927)
Q Consensus 487 l~~N~l~g~iP~~~~--~~~~~~~~~~N~~~ 515 (927)
+++|++++..|..+. ..+..+.+.+|...
T Consensus 164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (272)
T 3rfs_A 164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK 194 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence 999999954443333 36677777777643
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.01 E-value=3.3e-10 Score=131.04 Aligned_cols=106 Identities=21% Similarity=0.220 Sum_probs=92.4
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
+++++.|+|++|++++..|..|.+|++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..+..|..+++|+.|+
T Consensus 74 ~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 153 (452)
T 3zyi_A 74 PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELW 153 (452)
T ss_dssp CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEE
T ss_pred CCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEE
Confidence 45899999999999998999999999999999999999999885 99999999999999999977777799999999999
Q ss_pred ccccCCCCCCCccccC---CceeeeecCCCC
Q 002410 487 IENNSFVGEIPPALLT---GKVIFKYDNNPK 514 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~---~~~~~~~~~N~~ 514 (927)
|++|.++ .+|...+. .+..+.+.+|..
T Consensus 154 L~~N~l~-~~~~~~~~~l~~L~~L~l~~~~~ 183 (452)
T 3zyi_A 154 LRNNPIE-SIPSYAFNRVPSLMRLDLGELKK 183 (452)
T ss_dssp CCSCCCC-EECTTTTTTCTTCCEEECCCCTT
T ss_pred CCCCCcc-eeCHhHHhcCCcccEEeCCCCCC
Confidence 9999999 67765443 555666666543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.00 E-value=3.2e-10 Score=127.22 Aligned_cols=108 Identities=22% Similarity=0.290 Sum_probs=51.6
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCc-C---CCccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSY-M---GSLPNLQ 483 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~-l---~~l~~L~ 483 (927)
++|+.|+|++|+|++..+..|.+|++|+.|+|++|+|++..|. |..+++|+.|+|++|+|++ +|.. + ..+++|+
T Consensus 88 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~~~~l~~L~ 166 (361)
T 2xot_A 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLM 166 (361)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGGGTC----CTTCC
T ss_pred CCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHHHhcCcccCCcCC
Confidence 3455555555555544444455555555555555555554442 5555555555555555552 3332 2 3455555
Q ss_pred cccccccCCCCCCCccccCC-----ceeeeecCCCCCccc
Q 002410 484 ELHIENNSFVGEIPPALLTG-----KVIFKYDNNPKLHKE 518 (927)
Q Consensus 484 ~L~l~~N~l~g~iP~~~~~~-----~~~~~~~~N~~~c~~ 518 (927)
.|+|++|+|+ .+|...+.. +..+.+.+||+.|.+
T Consensus 167 ~L~L~~N~l~-~l~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 167 LLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp EEECCSSCCC-CCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred EEECCCCCCC-ccCHHHhhhccHhhcceEEecCCCccCCc
Confidence 5555555555 344322111 123556666666653
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.00 E-value=3.7e-10 Score=113.02 Aligned_cols=90 Identities=22% Similarity=0.338 Sum_probs=81.4
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++|+.|+|++|+|++..+..+.++++|+.|+|++|+|++.++. +..+++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 130 (177)
T 2o6r_A 51 LTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIW 130 (177)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred cccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEE
Confidence 46899999999999976667789999999999999999998886 79999999999999999966566678999999999
Q ss_pred ccccCCCCCCC
Q 002410 487 IENNSFVGEIP 497 (927)
Q Consensus 487 l~~N~l~g~iP 497 (927)
|++|.+.+..|
T Consensus 131 l~~N~~~~~~~ 141 (177)
T 2o6r_A 131 LHTNPWDCSCP 141 (177)
T ss_dssp CCSSCBCCCHH
T ss_pred ecCCCeeccCc
Confidence 99999998776
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=5.6e-10 Score=118.36 Aligned_cols=131 Identities=17% Similarity=0.088 Sum_probs=99.2
Q ss_pred ccc-ccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCc--eeeeeeeeecCceEEEEEEecCCCCH
Q 002410 612 KIG-KGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGYCEEEHQRILVYEYMHNGTL 688 (927)
Q Consensus 612 ~LG-~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~Hpn--Iv~l~~~~~~~~~~~LV~E~~~~gsL 688 (927)
.++ .|..+.||++...+|+.+++|+.... ....+.+|+++++.+++.+ +.+++++...++..++||||++|.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 55569999998877888999997653 2345778999999996544 45688888887889999999999888
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 002410 689 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-------------------------------------------- 724 (927)
Q Consensus 689 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~-------------------------------------------- 724 (927)
. ... . ....++.++++.|+.||+..
T Consensus 103 ~--~~~------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 103 L--SSH------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp T--TSC------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred C--cCc------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 3 221 1 12367788888888888621
Q ss_pred -----------CCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 725 -----------NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 725 -----------~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
...++|||++|.||++++++.+.|+||+.+..
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12299999999999998776677999998754
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=98.99 E-value=4.6e-10 Score=135.69 Aligned_cols=108 Identities=16% Similarity=0.213 Sum_probs=99.0
Q ss_pred CCceEEEEecCCCCcccCCcccc--CCcccceecccCCCCCCCCCCcCcccccceeec------ccccccCCCCCcCCCc
Q 002410 408 PPRITKIALSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHL------ENNELTGSLPSYMGSL 479 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~--~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L------s~N~l~g~iP~~l~~l 479 (927)
.++++.|+|++|+|+ .+|..+. ++++|+.|+|++|+|++.++.+.++++|+.|+| ++|++.+.+|..++++
T Consensus 487 l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l 565 (636)
T 4eco_A 487 TYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLC 565 (636)
T ss_dssp GGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGC
T ss_pred cCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCCcChhhhcCCCCCEEECCCCcccccCcccccChHHHhcC
Confidence 348999999999999 8999998 999999999999999994446999999999999 5688999999999999
Q ss_pred cccccccccccCCCCCCCccccCCceeeeecCCCCCcc
Q 002410 480 PNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHK 517 (927)
Q Consensus 480 ~~L~~L~l~~N~l~g~iP~~~~~~~~~~~~~~N~~~c~ 517 (927)
++|+.|+|++|++ +.||..+...+..+.+++|+..|-
T Consensus 566 ~~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 566 PSLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPNISI 602 (636)
T ss_dssp SSCCEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCEE
T ss_pred CCCCEEECCCCcC-CccCHhHhCcCCEEECcCCCCccc
Confidence 9999999999999 699999888889999999998873
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.99 E-value=3e-10 Score=131.47 Aligned_cols=109 Identities=23% Similarity=0.306 Sum_probs=97.4
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++|+.|+|++|++++ +| .+..+++|+.|+|++|+|++.+|. |.++++|+.|+|++|++++..|..|..+++|+.|+
T Consensus 195 l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 272 (452)
T 3zyi_A 195 LFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELN 272 (452)
T ss_dssp CTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEE
Confidence 4689999999999995 55 689999999999999999999885 99999999999999999998899999999999999
Q ss_pred ccccCCCCCCCccccC---CceeeeecCCCCCcccc
Q 002410 487 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES 519 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~---~~~~~~~~~N~~~c~~~ 519 (927)
|++|+|+ .+|...+. .+..+.+.+||+.|.+.
T Consensus 273 L~~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 273 LAHNNLS-SLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp CCSSCCS-CCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred CCCCcCC-ccChHHhccccCCCEEEccCCCcCCCCC
Confidence 9999999 66665543 67788999999999764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=3.9e-10 Score=134.08 Aligned_cols=100 Identities=25% Similarity=0.324 Sum_probs=60.5
Q ss_pred eEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccccccc
Q 002410 411 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 490 (927)
Q Consensus 411 l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~N 490 (927)
++.|+|++|+|++ +|. |++|++|+.|+|++|+|+..++.+++|++|+.|+|++|+|++ +| .++.|++|+.|+|++|
T Consensus 443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N 518 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 518 (567)
T ss_dssp CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred ceEEEecCCCCCC-CcC-ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCC
Confidence 5566666666664 554 666666666666666666332346666666666666666664 55 5666666666666666
Q ss_pred CCCCCC-CccccC--CceeeeecCCCC
Q 002410 491 SFVGEI-PPALLT--GKVIFKYDNNPK 514 (927)
Q Consensus 491 ~l~g~i-P~~~~~--~~~~~~~~~N~~ 514 (927)
+|++.+ |..+.. .+..+.+.+|+.
T Consensus 519 ~l~~~~~p~~l~~l~~L~~L~L~~N~l 545 (567)
T 1dce_A 519 RLQQSAAIQPLVSCPRLVLLNLQGNSL 545 (567)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred CCCCCCCcHHHhcCCCCCEEEecCCcC
Confidence 666444 555433 455555666553
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.97 E-value=5e-10 Score=137.21 Aligned_cols=105 Identities=27% Similarity=0.360 Sum_probs=84.9
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
...|+.|+|++|++. .+|..+++|++|+.|+|++|+|+..++.|++|++|+.|+|++|+|+ .||..|++|++|+.|+|
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 300 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYF 300 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEEC
T ss_pred CCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEEC
Confidence 457888888888888 7888888888888888888888843335888888888888888888 78888888888888888
Q ss_pred cccCCCCCCCccccC--CceeeeecCCCCC
Q 002410 488 ENNSFVGEIPPALLT--GKVIFKYDNNPKL 515 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~--~~~~~~~~~N~~~ 515 (927)
++|.|+ .||..+.. .+..+.+.+|+..
T Consensus 301 ~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 301 FDNMVT-TLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp CSSCCC-CCCSSTTSCTTCCCEECTTSCCC
T ss_pred CCCCCC-ccChhhhcCCCccEEeCCCCccC
Confidence 888887 88887654 5667777888754
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=5.5e-10 Score=133.93 Aligned_cols=107 Identities=18% Similarity=0.068 Sum_probs=85.8
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
+++++.|+|++|++++..|..|.++++|++|+|++|++++.+|. |.++++|++|+|++|++++..|..|+++++|+.|+
T Consensus 31 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 46788999999999987888889999999999999999888775 88899999999999998877788888888888888
Q ss_pred ccccCCCCCCCccccC--CceeeeecCCCC
Q 002410 487 IENNSFVGEIPPALLT--GKVIFKYDNNPK 514 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~--~~~~~~~~~N~~ 514 (927)
|++|.+++..|..+.. .+..+.+.+|..
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 140 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFI 140 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCC
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcc
Confidence 8888888444344433 555666666653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=9.6e-10 Score=118.77 Aligned_cols=107 Identities=21% Similarity=0.290 Sum_probs=89.7
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeeccccc-ccCCCCCcCCCccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE-LTGSLPSYMGSLPNLQEL 485 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~-l~g~iP~~l~~l~~L~~L 485 (927)
+++++.|+|++|++++..+..|.++++|+.|+|++|++++..|. |..+++|+.|+|++|+ +++..|..+..+++|+.|
T Consensus 31 ~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 56899999999999987778899999999999999999998774 8999999999999997 776668889999999999
Q ss_pred cccccCCCCCCCccccC--CceeeeecCCCC
Q 002410 486 HIENNSFVGEIPPALLT--GKVIFKYDNNPK 514 (927)
Q Consensus 486 ~l~~N~l~g~iP~~~~~--~~~~~~~~~N~~ 514 (927)
++++|.+++..|..+.. .+..+.+.+|..
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 141 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcc
Confidence 99999999655555433 566777777754
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.96 E-value=5.4e-10 Score=113.80 Aligned_cols=88 Identities=25% Similarity=0.283 Sum_probs=80.9
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++|+.|+|++|+|++..+..|.+|++|+.|+|++|+|++.+|. |..+++|+.|+|++|+|++..+..|..+++|+.|+
T Consensus 53 l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 132 (193)
T 2wfh_A 53 YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLA 132 (193)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred ccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEE
Confidence 36899999999999988888899999999999999999999995 99999999999999999966666799999999999
Q ss_pred ccccCCCCC
Q 002410 487 IENNSFVGE 495 (927)
Q Consensus 487 l~~N~l~g~ 495 (927)
|++|.+...
T Consensus 133 L~~N~~~C~ 141 (193)
T 2wfh_A 133 IGANPLYCD 141 (193)
T ss_dssp CCSSCEECS
T ss_pred eCCCCeecC
Confidence 999999754
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.96 E-value=7.7e-10 Score=128.71 Aligned_cols=117 Identities=22% Similarity=0.258 Sum_probs=98.3
Q ss_pred CccEEEeCC--------CCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccc
Q 002410 398 WEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNEL 468 (927)
Q Consensus 398 w~~~~c~~~--------~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l 468 (927)
|..+.|+.. .+.+++.|+|++|++++..|..|.++++|+.|+|++|++++..|. |.+|++|+.|+|++|++
T Consensus 13 ~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l 92 (477)
T 2id5_A 13 DRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92 (477)
T ss_dssp TTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcC
Confidence 455666543 246899999999999988889999999999999999999999885 99999999999999999
Q ss_pred cCCCCCcCCCccccccccccccCCCCCCCccccC--CceeeeecCCCC
Q 002410 469 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPK 514 (927)
Q Consensus 469 ~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~~--~~~~~~~~~N~~ 514 (927)
++..+..|.++++|+.|+|++|.+++..|..+.. .+..+.+.+|..
T Consensus 93 ~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l 140 (477)
T 2id5_A 93 KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL 140 (477)
T ss_dssp CSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTC
T ss_pred CccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCcc
Confidence 9655567899999999999999999666665543 566777777754
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.95 E-value=7.6e-10 Score=137.30 Aligned_cols=106 Identities=17% Similarity=0.269 Sum_probs=95.9
Q ss_pred CceEEEEecCCCCcccCCcccc--CCcccceecccCCCCCCCCCCcCcccccceeeccc------ccccCCCCCcCCCcc
Q 002410 409 PRITKIALSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN------NELTGSLPSYMGSLP 480 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~--~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~------N~l~g~iP~~l~~l~ 480 (927)
++|+.|+|++|+|+ .+|..+. ++++|+.|+|++|+|++.++.+.+|++|+.|+|++ |++.+.+|..|++|+
T Consensus 728 ~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~ 806 (876)
T 4ecn_A 728 YLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCP 806 (876)
T ss_dssp GGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCS
T ss_pred CCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCC
Confidence 38999999999999 8999997 99999999999999999544699999999999976 889999999999999
Q ss_pred ccccccccccCCCCCCCccccCCceeeeecCCCCCc
Q 002410 481 NLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 516 (927)
Q Consensus 481 ~L~~L~l~~N~l~g~iP~~~~~~~~~~~~~~N~~~c 516 (927)
+|+.|+|++|+| +.||..+...+..+.+++|+...
T Consensus 807 ~L~~L~Ls~N~L-~~Ip~~l~~~L~~LdLs~N~l~~ 841 (876)
T 4ecn_A 807 SLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNIS 841 (876)
T ss_dssp SCCEEECCSSCC-CBCCSCCCSSSCEEECCSCTTCE
T ss_pred CCCEEECCCCCC-CccCHhhcCCCCEEECCCCCCCc
Confidence 999999999999 69999988888889999998764
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.94 E-value=6.1e-10 Score=133.55 Aligned_cols=107 Identities=15% Similarity=-0.011 Sum_probs=92.7
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
+..++.|+|++|++++..|..|+++++|++|+|++|++++..|. |.++++|++|+|++|++++..|..|+++++|+.|+
T Consensus 32 ~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 111 (606)
T 3t6q_A 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLF 111 (606)
T ss_dssp CTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEE
T ss_pred CCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEee
Confidence 56899999999999988899999999999999999999998885 99999999999999999988899999999999999
Q ss_pred ccccCCCCCCCccccC--CceeeeecCCCC
Q 002410 487 IENNSFVGEIPPALLT--GKVIFKYDNNPK 514 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~--~~~~~~~~~N~~ 514 (927)
+++|.+++..|..+.. .+..+.+.+|..
T Consensus 112 L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l 141 (606)
T 3t6q_A 112 FIQTGISSIDFIPLHNQKTLESLYLGSNHI 141 (606)
T ss_dssp CTTSCCSCGGGSCCTTCTTCCEEECCSSCC
T ss_pred ccccCcccCCcchhccCCcccEEECCCCcc
Confidence 9999999533444432 566677777654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.94 E-value=5.5e-10 Score=132.79 Aligned_cols=88 Identities=28% Similarity=0.334 Sum_probs=82.7
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCC-CCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSL-PSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~i-P~~l~~l~~L~~L~ 486 (927)
.++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +|.+++|++|+.|+|++|+|++.+ |..|+.|++|+.|+
T Consensus 462 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~ 539 (567)
T 1dce_A 462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539 (567)
T ss_dssp GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred cccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence 468999999999999 999999999999999999999999 569999999999999999999887 99999999999999
Q ss_pred ccccCCCCCCC
Q 002410 487 IENNSFVGEIP 497 (927)
Q Consensus 487 l~~N~l~g~iP 497 (927)
|++|.|++.+|
T Consensus 540 L~~N~l~~~~~ 550 (567)
T 1dce_A 540 LQGNSLCQEEG 550 (567)
T ss_dssp CTTSGGGGSSS
T ss_pred ecCCcCCCCcc
Confidence 99999996544
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.94 E-value=1.1e-09 Score=126.27 Aligned_cols=106 Identities=19% Similarity=0.189 Sum_probs=91.4
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
++.++.|+|++|++++..+..|.+|++|+.|+|++|+|++..+. |.++++|+.|+|++|+|++..+..|..+++|+.|+
T Consensus 63 ~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 142 (440)
T 3zyj_A 63 STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELW 142 (440)
T ss_dssp CTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEE
T ss_pred CCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceee
Confidence 45789999999999988889999999999999999999998875 99999999999999999966666899999999999
Q ss_pred ccccCCCCCCCccccC---CceeeeecCCCC
Q 002410 487 IENNSFVGEIPPALLT---GKVIFKYDNNPK 514 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~---~~~~~~~~~N~~ 514 (927)
|++|.++ .+|...+. .+..+.+.+|..
T Consensus 143 L~~N~i~-~~~~~~~~~l~~L~~L~l~~~~~ 172 (440)
T 3zyj_A 143 LRNNPIE-SIPSYAFNRIPSLRRLDLGELKR 172 (440)
T ss_dssp CCSCCCC-EECTTTTTTCTTCCEEECCCCTT
T ss_pred CCCCccc-ccCHHHhhhCcccCEeCCCCCCC
Confidence 9999999 66654433 556666766543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.93 E-value=1.3e-09 Score=130.87 Aligned_cols=104 Identities=14% Similarity=0.186 Sum_probs=59.0
Q ss_pred ceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccccc
Q 002410 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 488 (927)
Q Consensus 410 ~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~ 488 (927)
+|+.|+|++|++++..|..|+++++|+.|+|++|.|++.+|. |+++++|+.|+|++|+|++..|..|+++++|+.|+|+
T Consensus 76 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls 155 (597)
T 3oja_B 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS 155 (597)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEee
Confidence 455666666666655555666666666666666666665554 5666666666666666663333344566666666666
Q ss_pred ccCCCCCCCccccC--CceeeeecCCC
Q 002410 489 NNSFVGEIPPALLT--GKVIFKYDNNP 513 (927)
Q Consensus 489 ~N~l~g~iP~~~~~--~~~~~~~~~N~ 513 (927)
+|.+++..|..+.. .+..+.+.+|.
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~L~~N~ 182 (597)
T 3oja_B 156 NNNLERIEDDTFQATTSLQNLQLSSNR 182 (597)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECTTSC
T ss_pred CCcCCCCChhhhhcCCcCcEEECcCCC
Confidence 66666444443332 34445555553
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.93 E-value=6.9e-10 Score=113.19 Aligned_cols=104 Identities=14% Similarity=0.193 Sum_probs=84.4
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++++.|+|++|++++..|..+++|++|+.|+|++|++++..|. +..+++|+.|+|++|++.+.+| .+..+++|+.|+
T Consensus 87 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~ 165 (197)
T 4ezg_A 87 LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLN 165 (197)
T ss_dssp CTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEE
T ss_pred CCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEE
Confidence 46799999999999988888999999999999999999987664 8899999999999998444777 688899999999
Q ss_pred ccccCCCCCCC-ccccCCceeeeecCCC
Q 002410 487 IENNSFVGEIP-PALLTGKVIFKYDNNP 513 (927)
Q Consensus 487 l~~N~l~g~iP-~~~~~~~~~~~~~~N~ 513 (927)
+++|.+++ +| -.-...+..+.+.+|+
T Consensus 166 l~~n~i~~-~~~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 166 IQFDGVHD-YRGIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp CTTBCCCC-CTTGGGCSSCCEEEECBC-
T ss_pred CCCCCCcC-hHHhccCCCCCEEEeeCcc
Confidence 99999984 54 2223366777777776
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.91 E-value=8e-10 Score=110.54 Aligned_cols=104 Identities=22% Similarity=0.242 Sum_probs=84.7
Q ss_pred CCceEEEEecCCCCcccCCccccCCc-ccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNME-ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~-~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
+.+++.|+|++|+++ .+|. +..+. +|+.|+|++|+|++. +.+..+++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 18 ~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 18 AVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred cCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 357999999999999 5654 66665 999999999999987 7899999999999999999954334458999999999
Q ss_pred ccccCCCCCCCc--cccC--CceeeeecCCCCC
Q 002410 487 IENNSFVGEIPP--ALLT--GKVIFKYDNNPKL 515 (927)
Q Consensus 487 l~~N~l~g~iP~--~~~~--~~~~~~~~~N~~~ 515 (927)
|++|.++ .+|. .+.. .+..+.+.+|+..
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence 9999996 7886 4433 5677788888754
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=1.4e-09 Score=120.00 Aligned_cols=106 Identities=23% Similarity=0.283 Sum_probs=94.1
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCC-CcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
++++.|+|++|++++..|..|.++++|+.|+|++|++++.++ .+..+++|+.|+|++|+++ .+|..+..+++|+.|++
T Consensus 192 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 270 (330)
T 1xku_A 192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270 (330)
T ss_dssp TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEEC
Confidence 589999999999999889999999999999999999999888 4999999999999999999 89999999999999999
Q ss_pred cccCCCCCCCccccC---------CceeeeecCCCCCc
Q 002410 488 ENNSFVGEIPPALLT---------GKVIFKYDNNPKLH 516 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~---------~~~~~~~~~N~~~c 516 (927)
++|+++ .+|...+. ....+.+.+||..+
T Consensus 271 ~~N~i~-~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 271 HNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp CSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred CCCcCC-ccChhhcCCcccccccccccceEeecCcccc
Confidence 999999 56655442 33456788888754
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.91 E-value=8.5e-10 Score=131.05 Aligned_cols=112 Identities=19% Similarity=0.207 Sum_probs=97.6
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCC-CCCCC-cCcccccceeecccccccCCCCCcCCCccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-GPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 485 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~-g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L 485 (927)
.++++.|+|++|.+.+.+|..+.++++|+.|+|++|+++ +.+|. +..+++|+.|+|++|++++.+|..++.+++|+.|
T Consensus 420 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 499 (570)
T 2z63_A 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499 (570)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEE
Confidence 468999999999999999999999999999999999998 56774 8999999999999999998889999999999999
Q ss_pred cccccCCCCCCCccccC--CceeeeecCCCCCcccc
Q 002410 486 HIENNSFVGEIPPALLT--GKVIFKYDNNPKLHKES 519 (927)
Q Consensus 486 ~l~~N~l~g~iP~~~~~--~~~~~~~~~N~~~c~~~ 519 (927)
++++|++++..|..+.. .+..+.+.+|++.|.+.
T Consensus 500 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred eCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 99999999655554433 67788899999988643
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.90 E-value=7e-10 Score=129.67 Aligned_cols=107 Identities=21% Similarity=0.188 Sum_probs=91.1
Q ss_pred CCceEEEEecCCCCcccCCcccc-CCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~-~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++|+.|+|++|.+++.+|..+. +|++|+.|+|++|.|++. |.+..+++|+.|+|++|+|++ +|..+..+++|+.|+
T Consensus 143 l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~ 220 (487)
T 3oja_A 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWIS 220 (487)
T ss_dssp GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEE
T ss_pred CCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEE
Confidence 35899999999999998888886 799999999999999887 445569999999999999995 555689999999999
Q ss_pred ccccCCCCCCCccccC--CceeeeecCCCCCcc
Q 002410 487 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHK 517 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~--~~~~~~~~~N~~~c~ 517 (927)
|++|.|+ .+|..+.. .+..+.+.+|+..|.
T Consensus 221 Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp CTTSCCC-EECTTCCCCTTCCEEECTTCCBCHH
T ss_pred ecCCcCc-ccchhhccCCCCCEEEcCCCCCcCc
Confidence 9999999 58877644 667888999999875
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.90 E-value=5.7e-10 Score=126.29 Aligned_cols=108 Identities=18% Similarity=0.199 Sum_probs=96.8
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.++++.|+|++|.+++..|..|.++++|+.|+|++|++++..+.+..+++|+.|+|++|+++ .+|..+..+++|+.|+|
T Consensus 247 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L 325 (390)
T 3o6n_A 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 325 (390)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEEC
T ss_pred CCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEEC
Confidence 46899999999999998899999999999999999999987667888999999999999999 78888899999999999
Q ss_pred cccCCCCCCCccccCCceeeeecCCCCCcc
Q 002410 488 ENNSFVGEIPPALLTGKVIFKYDNNPKLHK 517 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~~~~~~~~~~N~~~c~ 517 (927)
++|.++ .+|......+..+.+.+|++.|.
T Consensus 326 ~~N~i~-~~~~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 326 DHNSIV-TLKLSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp CSSCCC-CCCCCTTCCCSEEECCSSCEEHH
T ss_pred CCCccc-eeCchhhccCCEEEcCCCCccch
Confidence 999998 67766666788899999999874
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.90 E-value=8e-10 Score=128.58 Aligned_cols=110 Identities=17% Similarity=0.192 Sum_probs=97.1
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.+|+.|+|++|++++..+..+.++++|+.|+|++|++++..+. |..+++|+.|+|++|++++..|..|..+++|+.|+|
T Consensus 224 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 303 (477)
T 2id5_A 224 LNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNV 303 (477)
T ss_dssp CCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEEC
T ss_pred ccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEEC
Confidence 3799999999999954446799999999999999999998885 999999999999999999999999999999999999
Q ss_pred cccCCCCCCCccccC---CceeeeecCCCCCcccc
Q 002410 488 ENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES 519 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~---~~~~~~~~~N~~~c~~~ 519 (927)
++|+|+ .+|...+. .+..+.+.+|++.|.+.
T Consensus 304 ~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~c~c~ 337 (477)
T 2id5_A 304 SGNQLT-TLEESVFHSVGNLETLILDSNPLACDCR 337 (477)
T ss_dssp CSSCCS-CCCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred CCCcCc-eeCHhHcCCCcccCEEEccCCCccCccc
Confidence 999999 56665543 56788899999998753
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.90 E-value=1.1e-09 Score=136.71 Aligned_cols=107 Identities=16% Similarity=0.166 Sum_probs=79.8
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCC-CC-cCcccccceeecccccccCCCCCcCCCccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPL-PD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 485 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~-p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L 485 (927)
+++++.|+|++|.+++..|..|.+|++|++|+|++|.+.+.+ |+ |.+|++|++|+|++|++++..|..|++|++|+.|
T Consensus 23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 102 (844)
T 3j0a_A 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102 (844)
T ss_dssp CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCE
T ss_pred CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEe
Confidence 567888888888888877888888888888888888666665 43 7888888888888888887778888888888888
Q ss_pred cccccCCCCCCCcc--ccC--CceeeeecCCCC
Q 002410 486 HIENNSFVGEIPPA--LLT--GKVIFKYDNNPK 514 (927)
Q Consensus 486 ~l~~N~l~g~iP~~--~~~--~~~~~~~~~N~~ 514 (927)
+|++|.+++.+|.. +.. .+..+.+.+|..
T Consensus 103 ~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l 135 (844)
T 3j0a_A 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135 (844)
T ss_dssp ECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCC
T ss_pred eCcCCCCCcccccCccccccCCCCEEECCCCcc
Confidence 88888887766654 222 455566666643
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.89 E-value=2e-09 Score=115.64 Aligned_cols=105 Identities=19% Similarity=0.241 Sum_probs=67.5
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
++++.|+|++|++++..+..|.++++|+.|+|++|++++..|. |.++++|+.|+|++|++++..+..++.+++|+.|++
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 4666777777777655555666777777777777777666654 666777777777777776555556666777777777
Q ss_pred cccCCCC-CCCccccC--CceeeeecCCC
Q 002410 488 ENNSFVG-EIPPALLT--GKVIFKYDNNP 513 (927)
Q Consensus 488 ~~N~l~g-~iP~~~~~--~~~~~~~~~N~ 513 (927)
++|.+++ .+|..+.. .+..+.+.+|.
T Consensus 132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~ 160 (276)
T 2z62_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160 (276)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred cCCccceecCchhhccCCCCCEEECCCCC
Confidence 7777664 24555443 45555555554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.89 E-value=9.9e-10 Score=131.74 Aligned_cols=111 Identities=21% Similarity=0.211 Sum_probs=84.0
Q ss_pred CCceEEEEecCCCCccc---CCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCccccc
Q 002410 408 PPRITKIALSGKNLKGE---IPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 483 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~---ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~ 483 (927)
.++++.|+|++|.+++. .+..+..+++|+.|+|++|++++.+|. |..+++|+.|+|++|++++.+|..+.++++|
T Consensus 448 l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L- 526 (606)
T 3t6q_A 448 LPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI- 526 (606)
T ss_dssp CTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-
T ss_pred CCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-
Confidence 45778888888888762 235677888888888888888887774 7888888888888888888888888888888
Q ss_pred cccccccCCCCCCCcccc--CCceeeeecCCCCCcccc
Q 002410 484 ELHIENNSFVGEIPPALL--TGKVIFKYDNNPKLHKES 519 (927)
Q Consensus 484 ~L~l~~N~l~g~iP~~~~--~~~~~~~~~~N~~~c~~~ 519 (927)
.|+|++|++++.+|..+. ..+..+.+.+||+.|.+.
T Consensus 527 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 527 YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 888888888855554443 266778888899888643
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.88 E-value=1.8e-09 Score=128.46 Aligned_cols=104 Identities=17% Similarity=0.217 Sum_probs=88.6
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
+++++.|+|++|++++..|..|.++++|++|+|++|+|++..|+ |.++++|++|+|++|+++ .+|.. .+++|+.|+
T Consensus 51 ~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 51 PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 46899999999999987778999999999999999999998886 899999999999999999 78887 899999999
Q ss_pred ccccCCCC-CCCccccC--CceeeeecCCCC
Q 002410 487 IENNSFVG-EIPPALLT--GKVIFKYDNNPK 514 (927)
Q Consensus 487 l~~N~l~g-~iP~~~~~--~~~~~~~~~N~~ 514 (927)
|++|++++ .+|..+.. .+..+.+.+|..
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l 158 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKF 158 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBC
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCcc
Confidence 99999985 34555544 566777777754
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.88 E-value=5.4e-10 Score=136.90 Aligned_cols=93 Identities=31% Similarity=0.399 Sum_probs=85.5
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|+..+..|++|++|+.|+|++|+|+ .||..|++|++|+.|+|
T Consensus 246 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L 323 (727)
T 4b8c_D 246 YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGV 323 (727)
T ss_dssp CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEEC
T ss_pred CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeC
Confidence 468999999999999 9999999999999999999999955446999999999999999998 89999999999999999
Q ss_pred cccCCCCCCCccccC
Q 002410 488 ENNSFVGEIPPALLT 502 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~ 502 (927)
++|.|+|.+|..+..
T Consensus 324 ~~N~l~~~~p~~~~~ 338 (727)
T 4b8c_D 324 EGNPLEKQFLKILTE 338 (727)
T ss_dssp TTSCCCSHHHHHHHH
T ss_pred CCCccCCCChHHHhh
Confidence 999999988877643
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.88 E-value=2.2e-09 Score=130.69 Aligned_cols=106 Identities=23% Similarity=0.293 Sum_probs=74.6
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
+++++.|+|++|++++..+..|.++++|++|+|++|++++.+|+ |.+|++|++|+|++|++++..+..|+++++|+.|+
T Consensus 24 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103 (680)
T ss_dssp CTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence 45788888888888876666788888888888888888887775 77777788888877777744444677777777777
Q ss_pred ccccCCCCCCCccccC--CceeeeecCCC
Q 002410 487 IENNSFVGEIPPALLT--GKVIFKYDNNP 513 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~--~~~~~~~~~N~ 513 (927)
|++|.+++..|..+.. .+..+.+.+|.
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 132 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNG 132 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSC
T ss_pred CCCCccCccChhHccccCCCCEEECCCCc
Confidence 7777777433333432 45555555553
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.88 E-value=5.5e-10 Score=122.61 Aligned_cols=107 Identities=18% Similarity=0.211 Sum_probs=82.8
Q ss_pred CCceEEEEecCCCCcccCCccc--cCCcccceecccCCCCCCCCCCcCcc-----cccceeecccccccCCCCCcCCCcc
Q 002410 408 PPRITKIALSGKNLKGEIPPEL--KNMEALTELWLDGNFLTGPLPDMSRL-----IDLRIVHLENNELTGSLPSYMGSLP 480 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l--~~l~~L~~L~Ls~N~l~g~~p~~~~l-----~~L~~L~Ls~N~l~g~iP~~l~~l~ 480 (927)
.++++.|+|++|+++|.+|..+ .++++|+.|+|++|++++.++.++.+ ++|++|+|++|++++..|..++.++
T Consensus 94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 3578888999999888888876 88888999999999888883346666 8888999999988877778888888
Q ss_pred ccccccccccCCCCCC--Cccc----cCCceeeeecCCCC
Q 002410 481 NLQELHIENNSFVGEI--PPAL----LTGKVIFKYDNNPK 514 (927)
Q Consensus 481 ~L~~L~l~~N~l~g~i--P~~~----~~~~~~~~~~~N~~ 514 (927)
+|+.|+|++|++.|.+ |..+ ...+..+.+.+|..
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l 213 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCC
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcC
Confidence 8999999988887653 3333 22556666666643
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=98.87 E-value=1.3e-09 Score=107.93 Aligned_cols=83 Identities=22% Similarity=0.227 Sum_probs=48.4
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCC-CCcCCCcccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSL-PSYMGSLPNLQELH 486 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~i-P~~l~~l~~L~~L~ 486 (927)
++|+.|+|++|.+++. ..+..+++|+.|+|++|++++.+|. +..+++|+.|+|++|++++.. +..+..+++|+.|+
T Consensus 49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~ 126 (168)
T 2ell_A 49 VNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126 (168)
T ss_dssp GGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEE
T ss_pred CCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEE
Confidence 4566666666666543 5566666666666666666665554 344666666666666665321 14556666666666
Q ss_pred ccccCCC
Q 002410 487 IENNSFV 493 (927)
Q Consensus 487 l~~N~l~ 493 (927)
+++|.++
T Consensus 127 l~~N~l~ 133 (168)
T 2ell_A 127 LFNCEVT 133 (168)
T ss_dssp CCSSGGG
T ss_pred eeCCcCc
Confidence 6666666
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.86 E-value=1.9e-09 Score=119.29 Aligned_cols=106 Identities=22% Similarity=0.197 Sum_probs=93.6
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
++++.|+|++|.+++..|..+.++++|+.|+|++|++++.+|. +..+++|+.|+|++|+++ .+|..+..+++|+.|++
T Consensus 193 ~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 271 (332)
T 2ft3_A 193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271 (332)
T ss_dssp SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEEC
Confidence 5899999999999988889999999999999999999999885 999999999999999999 89999999999999999
Q ss_pred cccCCCCCCCccccC---------CceeeeecCCCCCc
Q 002410 488 ENNSFVGEIPPALLT---------GKVIFKYDNNPKLH 516 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~---------~~~~~~~~~N~~~c 516 (927)
++|+++ .+|...+. .+..+.+.+||..+
T Consensus 272 ~~N~l~-~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~ 308 (332)
T 2ft3_A 272 HTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPY 308 (332)
T ss_dssp CSSCCC-BCCTTSSSCSSCCSSSCCBSEEECCSSSSCG
T ss_pred CCCCCC-ccChhHccccccccccccccceEeecCcccc
Confidence 999999 56554332 24567788998764
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.86 E-value=6.3e-10 Score=111.30 Aligned_cols=87 Identities=22% Similarity=0.201 Sum_probs=79.2
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCC--cCCCccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQEL 485 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~--~l~~l~~L~~L 485 (927)
++++.|+|++|+|++. +.|.++++|+.|+|++|+|++.+|. +..+++|+.|+|++|+++ .+|. .+..+++|+.|
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 4899999999999975 7899999999999999999988777 499999999999999996 7887 89999999999
Q ss_pred cccccCCCCCCCcc
Q 002410 486 HIENNSFVGEIPPA 499 (927)
Q Consensus 486 ~l~~N~l~g~iP~~ 499 (927)
++++|.++ .+|..
T Consensus 119 ~l~~N~i~-~~~~~ 131 (176)
T 1a9n_A 119 CILRNPVT-NKKHY 131 (176)
T ss_dssp ECCSSGGG-GSTTH
T ss_pred EecCCCCC-CcHhH
Confidence 99999998 67764
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.86 E-value=2.8e-09 Score=117.90 Aligned_cols=115 Identities=22% Similarity=0.341 Sum_probs=95.3
Q ss_pred CCCccEEEeCC--------CCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccc
Q 002410 396 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN 466 (927)
Q Consensus 396 ~~w~~~~c~~~--------~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N 466 (927)
|.|..+.|+.. .+++++.|+|++|++++..|..|.++++|+.|+|++|++++.+|. |.++++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 46777777642 245799999999999987788999999999999999999998885 999999999999999
Q ss_pred cccCCCCCcCCCccccccccccccCCCCCCCccccC---CceeeeecCCCC
Q 002410 467 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPK 514 (927)
Q Consensus 467 ~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~~---~~~~~~~~~N~~ 514 (927)
+++ .+|..+. ++|+.|++++|.++ .+|...+. .+..+.+.+|..
T Consensus 113 ~l~-~l~~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l 159 (332)
T 2ft3_A 113 HLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPL 159 (332)
T ss_dssp CCC-SCCSSCC--TTCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCC
T ss_pred cCC-ccCcccc--ccCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCcc
Confidence 999 7888776 79999999999999 56654332 566677777765
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=98.85 E-value=6.7e-10 Score=107.71 Aligned_cols=88 Identities=18% Similarity=0.186 Sum_probs=78.6
Q ss_pred CCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCC-CCCcCCCcccccc
Q 002410 407 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGS-LPSYMGSLPNLQE 484 (927)
Q Consensus 407 ~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~-iP~~l~~l~~L~~ 484 (927)
..++++.|+|++|++++. ..++++++|+.|+|++|++++.+|. +..+++|+.|+|++|++++. .|..++.+++|+.
T Consensus 40 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~ 117 (149)
T 2je0_A 40 EFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKS 117 (149)
T ss_dssp TCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCE
T ss_pred hcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCE
Confidence 346899999999999966 8899999999999999999998886 67799999999999999963 4588999999999
Q ss_pred ccccccCCCCCC
Q 002410 485 LHIENNSFVGEI 496 (927)
Q Consensus 485 L~l~~N~l~g~i 496 (927)
|++++|.+++..
T Consensus 118 L~l~~N~l~~~~ 129 (149)
T 2je0_A 118 LDLFNCEVTNLN 129 (149)
T ss_dssp EECTTCGGGGST
T ss_pred EeCcCCcccchH
Confidence 999999999543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.85 E-value=1.1e-09 Score=136.88 Aligned_cols=108 Identities=22% Similarity=0.303 Sum_probs=92.5
Q ss_pred CCceEEEEecCCCCc-----ccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCccc
Q 002410 408 PPRITKIALSGKNLK-----GEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPN 481 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~-----g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~ 481 (927)
.++++.|+|++|.++ +..|..|.+|++|+.|+|++|+|++.+|. |..+++|+.|+|++|+|++..|..+. ++
T Consensus 450 ~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~ 527 (844)
T 3j0a_A 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--AN 527 (844)
T ss_dssp CTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SC
T ss_pred CCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--cc
Confidence 467899999999987 44556788999999999999999999986 89999999999999999976666665 89
Q ss_pred cccccccccCCCCCCCccccCCceeeeecCCCCCccc
Q 002410 482 LQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKE 518 (927)
Q Consensus 482 L~~L~l~~N~l~g~iP~~~~~~~~~~~~~~N~~~c~~ 518 (927)
|+.|+|++|+|+|.+|..+ ..+..+.+.+||+.|.+
T Consensus 528 L~~L~Ls~N~l~~~~~~~~-~~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 528 LEILDISRNQLLAPNPDVF-VSLSVLDITHNKFICEC 563 (844)
T ss_dssp CCEEEEEEECCCCCCSCCC-SSCCEEEEEEECCCCSS
T ss_pred ccEEECCCCcCCCCChhHh-CCcCEEEecCCCccccc
Confidence 9999999999998777654 46778899999999854
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.84 E-value=1.7e-09 Score=118.87 Aligned_cols=107 Identities=21% Similarity=0.196 Sum_probs=92.2
Q ss_pred CCceEEEEecCCCCcccCCcccc-CCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~-~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++++.|+|++|++++..|..+. .+++|+.|+|++|+|++. |....+++|+.|+|++|+++ .+|..+..+++|+.|+
T Consensus 143 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~ 220 (317)
T 3o53_A 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220 (317)
T ss_dssp GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEE
T ss_pred cCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCEEECCCCcCC-cchhhhcccCcccEEE
Confidence 36899999999999988888774 789999999999999887 55556999999999999999 5666799999999999
Q ss_pred ccccCCCCCCCccccC--CceeeeecCCCCCcc
Q 002410 487 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHK 517 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~--~~~~~~~~~N~~~c~ 517 (927)
|++|+++ .+|..+.. .+..+.+.+|+..|.
T Consensus 221 L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp CTTSCCC-EECTTCCCCTTCCEEECTTCCCBHH
T ss_pred CcCCccc-chhhHhhcCCCCCEEEccCCCccCc
Confidence 9999999 78887644 677888999999874
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.83 E-value=3.4e-09 Score=126.11 Aligned_cols=107 Identities=21% Similarity=0.319 Sum_probs=77.6
Q ss_pred CceEEEEecCCCCcccCCcc-ccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~-l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
++++.|+|++|++++.+|.. +..+++|+.|+|++|+|++.+|. +. ++|+.|+|++|+++ .+|..+..+++|+.|+
T Consensus 403 ~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~ 479 (562)
T 3a79_B 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELN 479 (562)
T ss_dssp TTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEE
T ss_pred CCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEE
Confidence 45666666666666545543 55666666666666666665553 32 67888888888888 7888888999999999
Q ss_pred ccccCCCCCCCccccC---CceeeeecCCCCCcccc
Q 002410 487 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES 519 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~---~~~~~~~~~N~~~c~~~ 519 (927)
|++|+|+ .+|...+. .+..+.+.+||+.|.+.
T Consensus 480 L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 480 VASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp CCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred CCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 9999999 78877332 56678889999998643
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.83 E-value=4.6e-09 Score=125.95 Aligned_cols=106 Identities=19% Similarity=0.190 Sum_probs=93.7
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++|+.|+|++|.+++..|..|++|++|+.|+|++|.|++.++. |+++++|+.|+|++|++++..|..|+.+++|+.|+
T Consensus 98 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 177 (597)
T 3oja_B 98 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 177 (597)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEE
Confidence 46899999999999988888899999999999999999988887 69999999999999999998899999999999999
Q ss_pred ccccCCCCCCCccccCCceeeeecCCCC
Q 002410 487 IENNSFVGEIPPALLTGKVIFKYDNNPK 514 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~~~~~~~~~~N~~ 514 (927)
|++|.++ .+|...+..+..+.+.+|..
T Consensus 178 L~~N~l~-~~~~~~l~~L~~L~l~~n~l 204 (597)
T 3oja_B 178 LSSNRLT-HVDLSLIPSLFHANVSYNLL 204 (597)
T ss_dssp CTTSCCS-BCCGGGCTTCSEEECCSSCC
T ss_pred CcCCCCC-CcChhhhhhhhhhhcccCcc
Confidence 9999999 45666666666666666643
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.83 E-value=2.4e-09 Score=116.83 Aligned_cols=108 Identities=19% Similarity=0.259 Sum_probs=93.6
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCC-CCC-CcCcccccceeecccccccCCCCCcCCCccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 485 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g-~~p-~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L 485 (927)
.++|+.|+|++|.+.+..|..+.++++|+.|+|++|.+++ .+| .+..+++|+.|+|++|++++..|..+..+++|+.|
T Consensus 125 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 204 (306)
T 2z66_A 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 204 (306)
T ss_dssp CTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEE
Confidence 4689999999999999999999999999999999999998 456 49999999999999999998889999999999999
Q ss_pred cccccCCCCCCCcccc--CCceeeeecCCCCC
Q 002410 486 HIENNSFVGEIPPALL--TGKVIFKYDNNPKL 515 (927)
Q Consensus 486 ~l~~N~l~g~iP~~~~--~~~~~~~~~~N~~~ 515 (927)
+|++|.+++..+..+. ..+..+.+.+|...
T Consensus 205 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 236 (306)
T 2z66_A 205 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236 (306)
T ss_dssp ECTTSCCSBCCSGGGTTCTTCCEEECTTSCCC
T ss_pred ECCCCccCccChhhccCcccCCEeECCCCCCc
Confidence 9999999954443443 36677888888654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.82 E-value=7.3e-09 Score=115.91 Aligned_cols=142 Identities=15% Similarity=0.230 Sum_probs=107.3
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEcc--Ccc-chhHHHHHHHHHHHHhcC--CCceeeeeeeeecC---ceEEEEEE
Q 002410 610 CKKIGKGSFGSVYYGKMKDGKEVAVKIMA--DSC-SHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEE---HQRILVYE 681 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~--~~~-~~~~~~~~~E~~~L~~l~--HpnIv~l~~~~~~~---~~~~LV~E 681 (927)
.+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+++++.++ +..+.+++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 357899999999999876 4678888876 322 123456888999999997 45678888888766 45899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC------------------------------------- 724 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~------------------------------------- 724 (927)
|++|..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99998775421 234678888999999999999999720
Q ss_pred ------------------CCCeEecCCCCCcccccCCCc--EEEeeccccccc
Q 002410 725 ------------------NPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQA 757 (927)
Q Consensus 725 ------------------~~~ivH~DLkp~NILld~~~~--~kL~DFGla~~~ 757 (927)
...++|||+++.||+++.++. +.|.||+.+...
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999987753 689999988753
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=4.9e-09 Score=115.72 Aligned_cols=116 Identities=24% Similarity=0.366 Sum_probs=90.1
Q ss_pred CCCccEEEeCC--------CCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccc
Q 002410 396 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN 466 (927)
Q Consensus 396 ~~w~~~~c~~~--------~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N 466 (927)
|.|..+.|+.. .++.++.|+|++|++++..+..|.++++|++|+|++|++++..|. |.++++|++|+|++|
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCC
Confidence 45666766532 245789999999999977777899999999999999999998774 899999999999999
Q ss_pred cccCCCCCcCCCccccccccccccCCCCCCCcccc--CCceeeeecCCCC
Q 002410 467 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL--TGKVIFKYDNNPK 514 (927)
Q Consensus 467 ~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~--~~~~~~~~~~N~~ 514 (927)
+++ .+|..+. ++|+.|++++|.+++..|..+. ..+..+.+.+|..
T Consensus 111 ~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 157 (330)
T 1xku_A 111 QLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPL 157 (330)
T ss_dssp CCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCC
T ss_pred cCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcC
Confidence 998 7887765 7899999999999844333332 2556667776654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.80 E-value=8e-09 Score=116.83 Aligned_cols=105 Identities=19% Similarity=0.198 Sum_probs=87.0
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++|+.|+|++|++++..|..|+++++|+.|+|++|+++..++. |.++++|+.|+|++|++++..|..++.+++|+.|+
T Consensus 92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 171 (390)
T 3o6n_A 92 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 171 (390)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEE
T ss_pred CCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEE
Confidence 46789999999999987778889999999999999999877766 68899999999999999977788889999999999
Q ss_pred ccccCCCCCCCccccCCceeeeecCCC
Q 002410 487 IENNSFVGEIPPALLTGKVIFKYDNNP 513 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~~~~~~~~~~N~ 513 (927)
+++|.++ .++......+..+.+.+|.
T Consensus 172 l~~n~l~-~~~~~~l~~L~~L~l~~n~ 197 (390)
T 3o6n_A 172 LSSNRLT-HVDLSLIPSLFHANVSYNL 197 (390)
T ss_dssp CCSSCCS-BCCGGGCTTCSEEECCSSC
T ss_pred CCCCcCC-ccccccccccceeeccccc
Confidence 9999988 4565555566666666664
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.80 E-value=3.3e-09 Score=108.10 Aligned_cols=102 Identities=17% Similarity=0.219 Sum_probs=60.8
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 488 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~ 488 (927)
++++.|+|++|+++ .+| .+..+++|+.|+|++|.++. ++.+..+++|+.|+|++|++++..|..++.+++|+.|+++
T Consensus 44 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 35666666666666 555 56666666666666664433 2356666666666666666666566666666666666666
Q ss_pred ccCCCCCCCccccC--CceeeeecCCC
Q 002410 489 NNSFVGEIPPALLT--GKVIFKYDNNP 513 (927)
Q Consensus 489 ~N~l~g~iP~~~~~--~~~~~~~~~N~ 513 (927)
+|.+++..|..+.. .+..+.+.+|.
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~ 147 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNG 147 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCC
Confidence 66666555544432 34445555554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.79 E-value=2.8e-09 Score=125.39 Aligned_cols=108 Identities=14% Similarity=0.154 Sum_probs=89.5
Q ss_pred CCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCC--CCCC-cCcccccceeecccccccCCCCCc-CCCcccc
Q 002410 407 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG--PLPD-MSRLIDLRIVHLENNELTGSLPSY-MGSLPNL 482 (927)
Q Consensus 407 ~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g--~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~-l~~l~~L 482 (927)
..++++.|+|++|++++.+|..++++++|+.|+|++|++++ .+|. +..+++|+.|+|++|++++.+|.. +..+++|
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC
Confidence 34678899999999998888889999999999999999987 4454 888999999999999999767764 7788899
Q ss_pred ccccccccCCCCCCCccccCCceeeeecCCCC
Q 002410 483 QELHIENNSFVGEIPPALLTGKVIFKYDNNPK 514 (927)
Q Consensus 483 ~~L~l~~N~l~g~iP~~~~~~~~~~~~~~N~~ 514 (927)
+.|++++|++++.+|..+...+..+.+++|..
T Consensus 402 ~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l 433 (520)
T 2z7x_B 402 LSLNMSSNILTDTIFRCLPPRIKVLDLHSNKI 433 (520)
T ss_dssp CEEECCSSCCCGGGGGSCCTTCCEEECCSSCC
T ss_pred CEEECcCCCCCcchhhhhcccCCEEECCCCcc
Confidence 99999999998888887766677777777754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.78 E-value=2.4e-09 Score=125.87 Aligned_cols=103 Identities=15% Similarity=0.135 Sum_probs=78.7
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
++++.|+|++|++++..|..|.++++|++|+|++|++++.+|+ |.++++|++|+|++|+++ .+|.. .+++|+.|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 5788888888888876667788888888888888888887774 788888888888888888 67766 7788888888
Q ss_pred cccCCCC-CCCccccC--CceeeeecCCCC
Q 002410 488 ENNSFVG-EIPPALLT--GKVIFKYDNNPK 514 (927)
Q Consensus 488 ~~N~l~g-~iP~~~~~--~~~~~~~~~N~~ 514 (927)
++|.+++ .+|..+.. .+..+.+.+|..
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l 127 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHL 127 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSC
T ss_pred cCCccccccchhhhccCCcceEEEecCccc
Confidence 8888875 46666644 556666666654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.77 E-value=2.5e-09 Score=117.20 Aligned_cols=107 Identities=17% Similarity=0.185 Sum_probs=79.2
Q ss_pred CCceEEEEecCCCCccc--CC--ccccCCcccceecccCCCCCCCCCC----cCcccccceeecccccccCCCCCcCCCc
Q 002410 408 PPRITKIALSGKNLKGE--IP--PELKNMEALTELWLDGNFLTGPLPD----MSRLIDLRIVHLENNELTGSLPSYMGSL 479 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~--ip--~~l~~l~~L~~L~Ls~N~l~g~~p~----~~~l~~L~~L~Ls~N~l~g~iP~~l~~l 479 (927)
.++|+.|+|++|++.|. ++ ..++++++|++|+|++|+|+...+. +..+++|+.|+|++|+|++.+|..++.+
T Consensus 168 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 168 FPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp CTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 45788888888887753 32 2346788888888888888644331 4677888888888888887778777776
Q ss_pred ---cccccccccccCCCCCCCccccCCceeeeecCCCCC
Q 002410 480 ---PNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 515 (927)
Q Consensus 480 ---~~L~~L~l~~N~l~g~iP~~~~~~~~~~~~~~N~~~ 515 (927)
++|+.|+|++|+|+ .+|..+...+..+.+++|...
T Consensus 248 ~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~ 285 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLN 285 (310)
T ss_dssp CCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCCC
T ss_pred cCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcCC
Confidence 58888888888888 788877777777777777543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=5.4e-09 Score=123.65 Aligned_cols=107 Identities=19% Similarity=0.183 Sum_probs=78.5
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccC-CCCCcCCCccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTG-SLPSYMGSLPNLQEL 485 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g-~iP~~l~~l~~L~~L 485 (927)
.++++.|+|++|++++..|..|++|++|++|+|++|++++.+|+ |+++++|++|+|++|++++ .+|..++++++|+.|
T Consensus 49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 35788888888888877777788888888888888888887776 7888888888888888876 456777888888888
Q ss_pred cccccCCCCCCCccccC---CceeeeecCCCC
Q 002410 486 HIENNSFVGEIPPALLT---GKVIFKYDNNPK 514 (927)
Q Consensus 486 ~l~~N~l~g~iP~~~~~---~~~~~~~~~N~~ 514 (927)
++++|.+.+.+|...+. .+..+.+.+|..
T Consensus 129 ~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l 160 (549)
T 2z81_A 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160 (549)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred ECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence 88888765577653332 344555565543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=9.4e-09 Score=125.04 Aligned_cols=106 Identities=22% Similarity=0.193 Sum_probs=80.8
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
++|+.|+|++|++++..+..|++|++|++|+|++|++++.+|. |+++++|++|+|++|++++..|..++++++|+.|++
T Consensus 73 ~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 152 (680)
T 1ziw_A 73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLL 152 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEEC
T ss_pred cCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEc
Confidence 5788888888888854444688888888888888888887774 888888888888888888888888888888888888
Q ss_pred cccCCCCCCCcccc----CCceeeeecCCCC
Q 002410 488 ENNSFVGEIPPALL----TGKVIFKYDNNPK 514 (927)
Q Consensus 488 ~~N~l~g~iP~~~~----~~~~~~~~~~N~~ 514 (927)
++|.+++..|..+. ..+..+.+.+|..
T Consensus 153 ~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l 183 (680)
T 1ziw_A 153 SNNKIQALKSEELDIFANSSLKKLELSSNQI 183 (680)
T ss_dssp CSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred cCCcccccCHHHhhccccccccEEECCCCcc
Confidence 88888855554332 2455666677643
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.74 E-value=1.2e-08 Score=113.94 Aligned_cols=104 Identities=19% Similarity=0.203 Sum_probs=85.8
Q ss_pred CCCCccEEEeCC--------CCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC--cCcccccce-eec
Q 002410 395 PVPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRI-VHL 463 (927)
Q Consensus 395 ~~~w~~~~c~~~--------~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~--~~~l~~L~~-L~L 463 (927)
.|.|..+.|+.. .+.+++.|+|++|+|+...+..|.+|++|+.|+|++|++.+.+|. |.+|++|+. +.+
T Consensus 8 ~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 8 HCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp EEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred EeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 356677778653 245799999999999944445799999999999999999888774 889998765 777
Q ss_pred ccccccCCCCCcCCCccccccccccccCCCCCCCcc
Q 002410 464 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPA 499 (927)
Q Consensus 464 s~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~ 499 (927)
+.|+|++..|..|..+++|+.|++++|+++ .+|..
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~-~~~~~ 122 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDV 122 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCS-SCCCC
T ss_pred cCCcccccCchhhhhccccccccccccccc-cCCch
Confidence 889999777889999999999999999999 55543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.73 E-value=4.1e-09 Score=115.15 Aligned_cols=183 Identities=22% Similarity=0.237 Sum_probs=122.4
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcC-CCc--eeeeeeeeecCc---eEEEEEEecC
Q 002410 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRN--LVPLIGYCEEEH---QRILVYEYMH 684 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-Hpn--Iv~l~~~~~~~~---~~~LV~E~~~ 684 (927)
+.++.|....||+.. +.+++|+.... .....+.+|.++|+.+. +.. +.+++......+ ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 568999999999864 56889986532 34567889999999884 332 344444443333 3478999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG----------------------------------------- 723 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~----------------------------------------- 723 (927)
|.+|.+... ..++..++..++.++++.|+.||+.
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 988765332 2366777888888999999888861
Q ss_pred --------------CCCCeEecCCCCCcccccC--CCcEEEeeccccccccccccccccccccCCCc---cCCCccCC--
Q 002410 724 --------------CNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVARGTVGY---LDPEYYGN-- 782 (927)
Q Consensus 724 --------------~~~~ivH~DLkp~NILld~--~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y---~APE~l~~-- 782 (927)
....++|+|++|.||++++ +..+.|+||+.+........- .. ...+ ..|+....
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-~~----~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-IS----LMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-HT----TCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-HH----HHhhccccCHHHHHHHH
Confidence 1145899999999999998 566889999988654321110 00 0001 12221100
Q ss_pred ---C---------CCCcchhHHHHHHHHHHHHhCCCCCC
Q 002410 783 ---Q---------QLTEKSDVYSFGVVLLELISGKKPVS 809 (927)
Q Consensus 783 ---~---------~~s~ksDVwSlGvlL~eLltG~~Pf~ 809 (927)
+ ......+.|+++.++|.+.+|..+|-
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0 01123689999999999999988764
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.73 E-value=5.8e-09 Score=109.55 Aligned_cols=103 Identities=21% Similarity=0.260 Sum_probs=72.9
Q ss_pred CceEEEEecC-CCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccc---eeecccc-cccCCCCCcCCCccccc
Q 002410 409 PRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR---IVHLENN-ELTGSLPSYMGSLPNLQ 483 (927)
Q Consensus 409 ~~l~~L~L~~-n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~---~L~Ls~N-~l~g~iP~~l~~l~~L~ 483 (927)
++++.|+|++ |++++..+..|.++++|+.|+|++|++++ +|.+..+++|+ .|+|++| ++++..+..|..+++|+
T Consensus 80 ~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~ 158 (239)
T 2xwt_C 80 SKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNET 158 (239)
T ss_dssp TTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCCCTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSE
T ss_pred cCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccccccccccccccEEECCCCcchhhcCcccccchhcce
Confidence 4677888877 77776555677778888888888888777 45576676666 8888888 77755555677778888
Q ss_pred -cccccccCCCCCCCccccC--CceeeeecCCC
Q 002410 484 -ELHIENNSFVGEIPPALLT--GKVIFKYDNNP 513 (927)
Q Consensus 484 -~L~l~~N~l~g~iP~~~~~--~~~~~~~~~N~ 513 (927)
.|++++|.++ .+|...+. .+..+.+.+|+
T Consensus 159 ~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 159 LTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp EEEECCSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred eEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence 8888888877 77766554 34445556664
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.72 E-value=1.2e-08 Score=121.02 Aligned_cols=91 Identities=18% Similarity=0.303 Sum_probs=61.0
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCC-CcCcccccceeecccccccC-CCCCcCCCcccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTG-SLPSYMGSLPNLQELH 486 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~g-~iP~~l~~l~~L~~L~ 486 (927)
++|+.|+|++|++++..|..|++|++|++|+|++|++++..+ .+++|++|++|+|++|++++ .+|..++++++|+.|+
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~ 155 (570)
T 2z63_A 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155 (570)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEE
T ss_pred hhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEe
Confidence 466777777777766666667777777777777777766655 36777777777777777765 4567777777777777
Q ss_pred ccccCCCCCCCcc
Q 002410 487 IENNSFVGEIPPA 499 (927)
Q Consensus 487 l~~N~l~g~iP~~ 499 (927)
+++|.+++..|..
T Consensus 156 l~~n~l~~~~~~~ 168 (570)
T 2z63_A 156 LSSNKIQSIYCTD 168 (570)
T ss_dssp CTTSCCCEECGGG
T ss_pred CcCCccceecHHH
Confidence 7777776444433
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.72 E-value=2.1e-09 Score=117.91 Aligned_cols=106 Identities=18% Similarity=0.160 Sum_probs=74.2
Q ss_pred CCceEEEEecCCCCcccCCccccCC-----cccceecccCCCCCCCCCC-cCcccccceeecccccccCC--CCCcC--C
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNM-----EALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGS--LPSYM--G 477 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l-----~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~--iP~~l--~ 477 (927)
.++++.|+|++|++++. |..++.+ ++|++|+|++|++++.+|. |+++++|+.|+|++|++.|. +|..+ +
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 45788888888888866 7777776 7888888888888887764 77888888888888887765 33344 7
Q ss_pred CccccccccccccCCCC--CCCcccc---CCceeeeecCCCC
Q 002410 478 SLPNLQELHIENNSFVG--EIPPALL---TGKVIFKYDNNPK 514 (927)
Q Consensus 478 ~l~~L~~L~l~~N~l~g--~iP~~~~---~~~~~~~~~~N~~ 514 (927)
.+++|+.|+|++|++++ .+|..++ ..+..+.+++|..
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l 240 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSL 240 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCC
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcC
Confidence 77888888888888772 2333332 3556666666654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.71 E-value=5.7e-09 Score=121.89 Aligned_cols=106 Identities=14% Similarity=0.071 Sum_probs=90.4
Q ss_pred CCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cC-cccccceeecccccccCCCCCcCCCcccccc
Q 002410 407 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MS-RLIDLRIVHLENNELTGSLPSYMGSLPNLQE 484 (927)
Q Consensus 407 ~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~-~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~ 484 (927)
..++|+.|+|++|+|++..|..++++++|+.|+|++|.|++.+|. +. .+++|+.|+|++|+|++. |. +..+++|+.
T Consensus 118 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 195 (487)
T 3oja_A 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKT 195 (487)
T ss_dssp CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCE
T ss_pred ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCE
Confidence 346899999999999999999999999999999999999998885 65 899999999999999966 33 346999999
Q ss_pred ccccccCCCCCCCccccC--CceeeeecCCCCC
Q 002410 485 LHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 515 (927)
Q Consensus 485 L~l~~N~l~g~iP~~~~~--~~~~~~~~~N~~~ 515 (927)
|+|++|.|++ +|+.+.. .+..+.+++|...
T Consensus 196 L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~ 227 (487)
T 3oja_A 196 LDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227 (487)
T ss_dssp EECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC
T ss_pred EECCCCCCCC-CCHhHcCCCCccEEEecCCcCc
Confidence 9999999995 5555543 6777888888644
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.71 E-value=6.5e-09 Score=113.81 Aligned_cols=85 Identities=18% Similarity=0.221 Sum_probs=58.1
Q ss_pred ceEEEEecCCCCcccCCccc--cCCcccceecccCCCCCCCCCC-----cCcccccceeecccccccCCCCCcCCCcccc
Q 002410 410 RITKIALSGKNLKGEIPPEL--KNMEALTELWLDGNFLTGPLPD-----MSRLIDLRIVHLENNELTGSLPSYMGSLPNL 482 (927)
Q Consensus 410 ~l~~L~L~~n~l~g~ip~~l--~~l~~L~~L~Ls~N~l~g~~p~-----~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L 482 (927)
+++.|+|++|++.+.+|..+ .++++|+.|+|++|++++..|. +..+++|+.|+|++|++++..|..++.+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 46677777777777777666 6677777777777777765552 3456677777777777776666667777777
Q ss_pred ccccccccCCCC
Q 002410 483 QELHIENNSFVG 494 (927)
Q Consensus 483 ~~L~l~~N~l~g 494 (927)
+.|+|++|++.+
T Consensus 172 ~~L~Ls~N~l~~ 183 (310)
T 4glp_A 172 TSLDLSDNPGLG 183 (310)
T ss_dssp CEEECCSCTTCH
T ss_pred CEEECCCCCCcc
Confidence 777777776654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.71 E-value=6.2e-09 Score=123.38 Aligned_cols=109 Identities=25% Similarity=0.364 Sum_probs=67.9
Q ss_pred CCCCCCC--CCccE-EEeCCCCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccc
Q 002410 390 GDPCVPV--PWEWV-TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 466 (927)
Q Consensus 390 gdpC~~~--~w~~~-~c~~~~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N 466 (927)
++||... .|.++ .|.|. +++.|+|++|+|++ +|..+. ++|+.|+|++|+|+. +| ..+++|+.|+|++|
T Consensus 40 ~~~~~~~~~~~~~l~~C~~~---~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~-ip--~~l~~L~~L~Ls~N 110 (571)
T 3cvr_A 40 ALPGENRNEAVSLLKECLIN---QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALIS-LP--ELPASLEYLDACDN 110 (571)
T ss_dssp CCTTCCHHHHHHHHHHHHHT---TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSC-CC--CCCTTCCEEECCSS
T ss_pred CCccccccchhhhccccccC---CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcc-cc--cccCCCCEEEccCC
Confidence 4566321 46776 67654 57777777777775 666553 667777777777773 44 44666777777777
Q ss_pred cccCCCCCcCCCccccccccccccCCCCCCCccccCCceeeeecCCC
Q 002410 467 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 513 (927)
Q Consensus 467 ~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~~~~~~~~~~~N~ 513 (927)
+|++ +|. +.+ +|+.|+|++|+|++ +|. ....+..+.+++|.
T Consensus 111 ~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~ 151 (571)
T 3cvr_A 111 RLST-LPE-LPA--SLKHLDVDNNQLTM-LPE-LPALLEYINADNNQ 151 (571)
T ss_dssp CCSC-CCC-CCT--TCCEEECCSSCCSC-CCC-CCTTCCEEECCSSC
T ss_pred CCCC-cch-hhc--CCCEEECCCCcCCC-CCC-cCccccEEeCCCCc
Confidence 7765 666 544 66666666666664 665 44445555555553
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.70 E-value=1.2e-08 Score=113.91 Aligned_cols=105 Identities=18% Similarity=0.220 Sum_probs=82.3
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCC--cCCCcccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQE 484 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~--~l~~l~~L~~ 484 (927)
.++|+.|+|++|++++..|..|.++++|++|+|++|++++.++. +.++++|++|+|++|+++ .+|. .+..+++|+.
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~ 153 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQI 153 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCE
T ss_pred CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcE
Confidence 46789999999999987788899999999999999999887776 888999999999999998 5655 7888999999
Q ss_pred ccccccC-CCCCCCc-cccC--CceeeeecCCCC
Q 002410 485 LHIENNS-FVGEIPP-ALLT--GKVIFKYDNNPK 514 (927)
Q Consensus 485 L~l~~N~-l~g~iP~-~~~~--~~~~~~~~~N~~ 514 (927)
|++++|+ +. .+|. .+.. .+..+.+.+|..
T Consensus 154 L~l~~n~~~~-~~~~~~~~~l~~L~~L~l~~n~l 186 (353)
T 2z80_A 154 LRVGNMDTFT-KIQRKDFAGLTFLEELEIDASDL 186 (353)
T ss_dssp EEEEESSSCC-EECTTTTTTCCEEEEEEEEETTC
T ss_pred EECCCCcccc-ccCHHHccCCCCCCEEECCCCCc
Confidence 9999985 55 5544 3332 445566666653
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.65 E-value=1.5e-08 Score=110.89 Aligned_cols=104 Identities=21% Similarity=0.326 Sum_probs=69.9
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.++|+.|+|++|++++..+ +.++++|+.|+|++|++++..+ +..+++|+.|+|++|++++. |. +..+++|+.|+|
T Consensus 128 l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~L 202 (308)
T 1h6u_A 128 LSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDI-SP-LASLPNLIEVHL 202 (308)
T ss_dssp CTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEEC
T ss_pred CCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCcC-hh-hcCCCCCCEEEc
Confidence 4567777777777774433 7777777777777777777555 77777777788877777743 33 677777778888
Q ss_pred cccCCCCCCCccccCCceeeeecCCCCCc
Q 002410 488 ENNSFVGEIPPALLTGKVIFKYDNNPKLH 516 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~~~~~~~~~~N~~~c 516 (927)
++|++++..|-.-...+..+.+.+|+..+
T Consensus 203 ~~N~l~~~~~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 203 KNNQISDVSPLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp TTSCCCBCGGGTTCTTCCEEEEEEEEEEC
T ss_pred cCCccCccccccCCCCCCEEEccCCeeec
Confidence 88877744332222355566666666543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.63 E-value=1.7e-08 Score=111.96 Aligned_cols=103 Identities=21% Similarity=0.288 Sum_probs=79.5
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.++++.|+|++|.+++ + +.+..+++|+.|+|++|++++. |.+..+++|+.|+|++|++++..|..++.+++|+.|++
T Consensus 242 l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 318 (347)
T 4fmz_A 242 LSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318 (347)
T ss_dssp CTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEEC
T ss_pred CCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEc
Confidence 4578888888888885 3 4678888888888888888875 66888888888888888888877888888888888888
Q ss_pred cccCCCCCCCccccCCceeeeecCCC
Q 002410 488 ENNSFVGEIPPALLTGKVIFKYDNNP 513 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~~~~~~~~~~N~ 513 (927)
++|.+++..|-.-...+..+.+.+|+
T Consensus 319 ~~n~l~~~~~~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 319 SQNHITDIRPLASLSKMDSADFANQV 344 (347)
T ss_dssp CSSSCCCCGGGGGCTTCSEESSSCC-
T ss_pred cCCccccccChhhhhccceeehhhhc
Confidence 88888866553444466677777775
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.62 E-value=4.5e-08 Score=104.58 Aligned_cols=101 Identities=26% Similarity=0.317 Sum_probs=69.6
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.++|+.|+|++|++++. |+ +.+|++|+.|+|++|+|++. |.+.. ++|+.|+|++|++++ +| .+..+++|+.|+|
T Consensus 62 l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~~N~l~~l-~~~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~L 135 (263)
T 1xeu_A 62 FTNLKELHLSHNQISDL-SP-LKDLTKLEELSVNRNRLKNL-NGIPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSI 135 (263)
T ss_dssp CTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCSSCCSCC-TTCCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEEC
T ss_pred CCCCCEEECCCCccCCC-hh-hccCCCCCEEECCCCccCCc-Ccccc-CcccEEEccCCccCC-Ch-hhcCcccccEEEC
Confidence 35788888888888854 43 88888888888888888774 33333 778888888888874 43 4777888888888
Q ss_pred cccCCCCCCCc-cccCCceeeeecCCCCC
Q 002410 488 ENNSFVGEIPP-ALLTGKVIFKYDNNPKL 515 (927)
Q Consensus 488 ~~N~l~g~iP~-~~~~~~~~~~~~~N~~~ 515 (927)
++|++++ +|. .-...+..+.+.+|...
T Consensus 136 s~N~i~~-~~~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 136 RNNKLKS-IVMLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp TTSCCCB-CGGGGGCTTCCEEECTTSCCC
T ss_pred CCCcCCC-ChHHccCCCCCEEECCCCcCc
Confidence 8888873 442 11235566666666543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.62 E-value=2.7e-08 Score=107.93 Aligned_cols=101 Identities=23% Similarity=0.384 Sum_probs=78.7
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.++|+.|+|++|++++ + +.+.++++|+.|+|++|++++. +.+..+++|+.|+|++|++++..| +..+++|+.|+|
T Consensus 111 l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L 185 (291)
T 1h6t_A 111 LKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 185 (291)
T ss_dssp CTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEEC
Confidence 4678888999988885 3 5688888899999999988886 678888889999999998886544 888888999999
Q ss_pred cccCCCCCCCccccC--CceeeeecCCCCC
Q 002410 488 ENNSFVGEIPPALLT--GKVIFKYDNNPKL 515 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~--~~~~~~~~~N~~~ 515 (927)
++|.++ .+|. +.. .+..+.+.+|+..
T Consensus 186 ~~N~i~-~l~~-l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 186 SKNHIS-DLRA-LAGLKNLDVLELFSQECL 213 (291)
T ss_dssp CSSCCC-BCGG-GTTCTTCSEEEEEEEEEE
T ss_pred CCCcCC-CChh-hccCCCCCEEECcCCccc
Confidence 999888 4554 322 5566677777644
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.62 E-value=4.2e-08 Score=106.46 Aligned_cols=102 Identities=24% Similarity=0.294 Sum_probs=66.0
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.++|+.|+|++|.+++ +| .+.++++|+.|+|++|++++. +.+..+++|+.|+|++|++++. ..++.+++|+.|++
T Consensus 89 l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L 163 (291)
T 1h6t_A 89 LKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 163 (291)
T ss_dssp CTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEEC
T ss_pred CCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEc
Confidence 3567777777777764 33 377777777777777777764 5677777777777777777743 45677777777777
Q ss_pred cccCCCCCCCccccCCceeeeecCCCC
Q 002410 488 ENNSFVGEIPPALLTGKVIFKYDNNPK 514 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~~~~~~~~~~N~~ 514 (927)
++|++++..|-.-...+..+.+++|..
T Consensus 164 ~~N~l~~~~~l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 164 EDNQISDIVPLAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp CSSCCCCCGGGTTCTTCCEEECCSSCC
T ss_pred cCCccccchhhcCCCccCEEECCCCcC
Confidence 777777443312222455566666643
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.59 E-value=4.7e-08 Score=116.95 Aligned_cols=100 Identities=22% Similarity=0.370 Sum_probs=65.9
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.++|+.|+|++|+|++ + +.+.+|++|+.|+|++|+|++. +.+..|++|+.|+|++|+|++.+| +..|++|+.|+|
T Consensus 108 l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L 182 (605)
T 1m9s_A 108 LKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 182 (605)
T ss_dssp CTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEEC
Confidence 3567777777777774 3 4577777777777777777765 567777777777777777775555 677777777777
Q ss_pred cccCCCCCCCcccc--CCceeeeecCCCC
Q 002410 488 ENNSFVGEIPPALL--TGKVIFKYDNNPK 514 (927)
Q Consensus 488 ~~N~l~g~iP~~~~--~~~~~~~~~~N~~ 514 (927)
++|+|++ +|. +. ..+..+.+.+|+.
T Consensus 183 s~N~i~~-l~~-l~~l~~L~~L~L~~N~l 209 (605)
T 1m9s_A 183 SKNHISD-LRA-LAGLKNLDVLELFSQEC 209 (605)
T ss_dssp CSSCCCB-CGG-GTTCTTCSEEECCSEEE
T ss_pred cCCCCCC-ChH-HccCCCCCEEEccCCcC
Confidence 7777773 432 22 2455555555543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.59 E-value=4.9e-08 Score=106.83 Aligned_cols=103 Identities=23% Similarity=0.389 Sum_probs=81.6
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.++|+.|+|++|++++ +|. +.++++|+.|+|++|++++..+ +..+++|+.|+|++|++++ +|. +..+++|+.|++
T Consensus 106 l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 180 (308)
T 1h6u_A 106 LQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKA 180 (308)
T ss_dssp CTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEEC
Confidence 4689999999999985 443 8899999999999999988665 8889999999999999985 444 889999999999
Q ss_pred cccCCCCCCCccccCCceeeeecCCCCC
Q 002410 488 ENNSFVGEIPPALLTGKVIFKYDNNPKL 515 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~~~~~~~~~~N~~~ 515 (927)
++|.+++..|-.-...+..+.+.+|...
T Consensus 181 ~~n~l~~~~~l~~l~~L~~L~L~~N~l~ 208 (308)
T 1h6u_A 181 DDNKISDISPLASLPNLIEVHLKNNQIS 208 (308)
T ss_dssp CSSCCCCCGGGGGCTTCCEEECTTSCCC
T ss_pred CCCccCcChhhcCCCCCCEEEccCCccC
Confidence 9999984333222336667777777654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.58 E-value=6.5e-08 Score=103.33 Aligned_cols=100 Identities=20% Similarity=0.292 Sum_probs=84.5
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.++|+.|+|++|+++ .+| .+..+++|+.|+|++|+|++..| +..+++|+.|+|++|++++ +|.... ++|+.|+|
T Consensus 40 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L 113 (263)
T 1xeu_A 40 LSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFL 113 (263)
T ss_dssp HTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEEC
T ss_pred cCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEc
Confidence 468999999999999 677 79999999999999999999887 9999999999999999995 665443 89999999
Q ss_pred cccCCCCCCCcccc--CCceeeeecCCCCC
Q 002410 488 ENNSFVGEIPPALL--TGKVIFKYDNNPKL 515 (927)
Q Consensus 488 ~~N~l~g~iP~~~~--~~~~~~~~~~N~~~ 515 (927)
++|++++ +|. +. ..+..+.+++|...
T Consensus 114 ~~N~l~~-~~~-l~~l~~L~~L~Ls~N~i~ 141 (263)
T 1xeu_A 114 DNNELRD-TDS-LIHLKNLEILSIRNNKLK 141 (263)
T ss_dssp CSSCCSB-SGG-GTTCTTCCEEECTTSCCC
T ss_pred cCCccCC-Chh-hcCcccccEEECCCCcCC
Confidence 9999994 553 33 36677788887643
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.58 E-value=3.9e-08 Score=117.64 Aligned_cols=100 Identities=24% Similarity=0.335 Sum_probs=51.0
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 488 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~ 488 (927)
++|+.|+|++|.|++ +| .|.+|++|+.|+|++|+|++ +|.+..|++|+.|+|++|+|++. ..++.|++|+.|+|+
T Consensus 87 ~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls 161 (605)
T 1m9s_A 87 KNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLE 161 (605)
T ss_dssp TTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CGGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECC
T ss_pred CCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-CccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECc
Confidence 345555555555553 22 45555555555555555554 24455555555555555555532 345555555555555
Q ss_pred ccCCCCCCCccccCCceeeeecCCC
Q 002410 489 NNSFVGEIPPALLTGKVIFKYDNNP 513 (927)
Q Consensus 489 ~N~l~g~iP~~~~~~~~~~~~~~N~ 513 (927)
+|.|++..|-.-+..+..+.+.+|.
T Consensus 162 ~N~l~~~~~l~~l~~L~~L~Ls~N~ 186 (605)
T 1m9s_A 162 DNQISDIVPLAGLTKLQNLYLSKNH 186 (605)
T ss_dssp SSCCCCCGGGTTCTTCCEEECCSSC
T ss_pred CCcCCCchhhccCCCCCEEECcCCC
Confidence 5555544332122244444454443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.58 E-value=9.7e-10 Score=112.16 Aligned_cols=103 Identities=23% Similarity=0.203 Sum_probs=72.4
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.++++.|+|++|++++ +| .+.++++|+.|+|++|+|+..++.+..+++|+.|+|++|++++ +| .+..+++|+.|++
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l 122 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEE
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEEC
Confidence 3567888888888875 66 7788888888888888887433336667888888888888874 55 5777788888888
Q ss_pred cccCCCCCCCc--ccc--CCceeeeecCCCCC
Q 002410 488 ENNSFVGEIPP--ALL--TGKVIFKYDNNPKL 515 (927)
Q Consensus 488 ~~N~l~g~iP~--~~~--~~~~~~~~~~N~~~ 515 (927)
++|+++ .+|. .+. ..+..+.+.+|+..
T Consensus 123 ~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~l~ 153 (198)
T 1ds9_A 123 SNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SEEECC-CHHHHHHHTTTTTCSEEEECSCHHH
T ss_pred CCCcCC-chhHHHHHhcCCCCCEEEecCCccc
Confidence 888887 4443 222 24556666777644
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.56 E-value=1.5e-09 Score=110.75 Aligned_cols=103 Identities=22% Similarity=0.327 Sum_probs=85.7
Q ss_pred CceEEEEecCCCCcccCCc------cccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccc
Q 002410 409 PRITKIALSGKNLKGEIPP------ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 482 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~------~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L 482 (927)
.+++.++|+.++++|.+|. .+.++++|+.|+|++|+|++ +|.+.++++|+.|+|++|+++ .+|..+..+++|
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 3667777888888888887 89999999999999999999 568999999999999999999 789888888999
Q ss_pred ccccccccCCCCCCCccccC--CceeeeecCCCCC
Q 002410 483 QELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 515 (927)
Q Consensus 483 ~~L~l~~N~l~g~iP~~~~~--~~~~~~~~~N~~~ 515 (927)
+.|+|++|++++ +| .+.. .+..+.+.+|...
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~ 128 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKIT 128 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECC
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCC
Confidence 999999999994 66 3332 5666777777544
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.55 E-value=3.9e-08 Score=108.03 Aligned_cols=105 Identities=14% Similarity=0.076 Sum_probs=89.0
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-c-CcccccceeecccccccCCCCCcCCCccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-M-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 485 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~-~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L 485 (927)
.++++.|+|++|++++..|..++.+++|+.|+|++|++++..|. + ..+++|+.|+|++|++++. |. ...+++|+.|
T Consensus 119 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L 196 (317)
T 3o53_A 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTL 196 (317)
T ss_dssp CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEE
T ss_pred cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEE
Confidence 46899999999999988888999999999999999999998775 5 5799999999999999954 44 3358999999
Q ss_pred cccccCCCCCCCccccC--CceeeeecCCCCC
Q 002410 486 HIENNSFVGEIPPALLT--GKVIFKYDNNPKL 515 (927)
Q Consensus 486 ~l~~N~l~g~iP~~~~~--~~~~~~~~~N~~~ 515 (927)
+|++|+++ .+|..+.. .+..+.+.+|...
T Consensus 197 ~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~ 227 (317)
T 3o53_A 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227 (317)
T ss_dssp ECCSSCCC-EECGGGGGGTTCSEEECTTSCCC
T ss_pred ECCCCcCC-cchhhhcccCcccEEECcCCccc
Confidence 99999999 56666543 6777888888644
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.54 E-value=9e-08 Score=113.41 Aligned_cols=96 Identities=23% Similarity=0.301 Sum_probs=67.7
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccc------
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL------ 482 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L------ 482 (927)
++|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|.|. ++|+.|+|++|+|+ .+|. +.. +|
T Consensus 140 ~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~ 208 (571)
T 3cvr_A 140 ALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPELP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEET 208 (571)
T ss_dssp TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCC--TTCCEEECCSSCCS-SCCC-CC----------C
T ss_pred ccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cchhh--CCCCEEECcCCCCC-chhh-HHH--hhhccccc
Confidence 567888888888875 665 56778888888888877 44455 77888888888887 6777 554 66
Q ss_pred -ccccccccCCCCCCCccccC--CceeeeecCCCCCc
Q 002410 483 -QELHIENNSFVGEIPPALLT--GKVIFKYDNNPKLH 516 (927)
Q Consensus 483 -~~L~l~~N~l~g~iP~~~~~--~~~~~~~~~N~~~c 516 (927)
+.|+|++|+|+ .||..++. .+..+.+.+|+..+
T Consensus 209 L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~ 244 (571)
T 3cvr_A 209 EIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSS 244 (571)
T ss_dssp CEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCH
T ss_pred ceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCC
Confidence 78888888887 67776654 55667777777654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.51 E-value=6.4e-08 Score=112.24 Aligned_cols=104 Identities=24% Similarity=0.278 Sum_probs=70.1
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.++++.|+|++|++.+..| +..+++|+.|+|++|++++.+| +..+++|+.|+|++|++++. ..+.++++|+.|++
T Consensus 286 l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l 360 (466)
T 1o6v_A 286 LTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSA 360 (466)
T ss_dssp CTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEEC
T ss_pred CCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCCc--hhhccCCCCCEEeC
Confidence 3567777777777775433 6777777777777777777665 66777777777777777753 35677777777777
Q ss_pred cccCCCCCCCccccCCceeeeecCCCCCc
Q 002410 488 ENNSFVGEIPPALLTGKVIFKYDNNPKLH 516 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~~~~~~~~~~N~~~c 516 (927)
++|++++.+|-.-...+..+.+.+|++..
T Consensus 361 ~~n~l~~~~~~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 361 GHNQISDLTPLANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CSSCCCBCGGGTTCTTCCEEECCCEEEEC
T ss_pred CCCccCccchhhcCCCCCEEeccCCcccC
Confidence 77777766663333355566666665543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.48 E-value=1.2e-07 Score=110.02 Aligned_cols=98 Identities=28% Similarity=0.369 Sum_probs=47.5
Q ss_pred ceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccccc
Q 002410 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 489 (927)
Q Consensus 410 ~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~ 489 (927)
+++.|+|++|.+++..| +.++++|+.|+|++|++++.+| +..+++|+.|+|++|++++..| ++.+++|+.|+|++
T Consensus 244 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~ 318 (466)
T 1o6v_A 244 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYF 318 (466)
T ss_dssp TCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCS
T ss_pred CCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcC
Confidence 45555555555554332 4555555555555555554433 4555555555555555553322 44555555555555
Q ss_pred cCCCCCCCccccCCceeeeecCC
Q 002410 490 NSFVGEIPPALLTGKVIFKYDNN 512 (927)
Q Consensus 490 N~l~g~iP~~~~~~~~~~~~~~N 512 (927)
|++++..|-.-...+..+.+.+|
T Consensus 319 n~l~~~~~~~~l~~L~~L~l~~n 341 (466)
T 1o6v_A 319 NNISDISPVSSLTKLQRLFFYNN 341 (466)
T ss_dssp SCCSCCGGGGGCTTCCEEECCSS
T ss_pred CcCCCchhhccCccCCEeECCCC
Confidence 55554433222233444444444
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.7e-07 Score=93.45 Aligned_cols=152 Identities=19% Similarity=0.096 Sum_probs=88.3
Q ss_pred EEeeccCCCCCCcccCCCCCCCCcccCCCCCCCCcccccCCceeeeeecccccCCCCCCChhhhhccceecCCceEEEee
Q 002410 189 AARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEGVLSYRL 268 (927)
Q Consensus 189 ~~r~~~g~~~~~~~~~~~d~~dR~W~~~~~~~~~~~~~~~~~~~~i~~~~~i~~~~~~~pP~~v~qtA~~~~~~~~~~~~ 268 (927)
.-|+|+|+.. +. |..+|.|+++...... +..+.+ ...+.....+.+|..|+|||-... .++++..
T Consensus 7 ~~~INcGg~~---~~---d~~gr~w~~D~~~~~~---g~~~~~-----~~~~~~~~~~~~~~~lY~TaR~~~-~~~tY~f 71 (174)
T 2jwp_A 7 IWAVNAGGES---HV---DVHGIHYRKDPLEGRV---GRASDY-----GMKLPILRSNPEDQVLYQTERYNE-DSFGYDI 71 (174)
T ss_dssp EEEEEETSSS---EE---ETTTEEECSSCSSTTC---CCCCCC-----CTTSCCSSSCHHHHHTTTCCCCCC-SCEEEEE
T ss_pred EEEEECCCCC---cc---CCCCCEEcCCcCcccC---Cccccc-----ccceEecccCCCCchhhhhhccCC-CCeEEEE
Confidence 4599999843 21 6789999998532111 111100 001111122446889999997753 4678887
Q ss_pred cCCCCCccceEEEecccccccCCCcceeEeeecCcccccCCceeeeeecCCCceeeecccccee------------eeee
Q 002410 269 NLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSYTLYEPSYMNV------------TLNF 336 (927)
Q Consensus 269 ~~~~~~~~~~~~lyFae~~~~~~~~~R~F~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~ 336 (927)
+.. .+-.|.+-|||+|+.. +..+.|.|||+++...- ...+++...+++...++.--..++ +..+
T Consensus 72 ~v~-~~G~Y~VrLhF~ei~~-~~~~~rvFdV~ing~~~--l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g 147 (174)
T 2jwp_A 72 PIK-EEGEYVLVLKFAEVYF-AQSQQKVFDVRVNGHTV--VKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTG 147 (174)
T ss_dssp ECC-SCEEEEEEEEEECCSC-CCSSSSCEEEEETTEEE--EEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCS
T ss_pred EeC-CCeEEEEEEEEecccc-CCCCCeEeEEEECCEEe--ecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCC
Confidence 753 2346777799999974 45789999996554322 234555443332111111000111 2356
Q ss_pred EEEEEeeecCCCCccchhhhhhhhh
Q 002410 337 VLSFSFVKTRDSTLGPLLNAIEISK 361 (927)
Q Consensus 337 ~~~~~~~~~~~s~l~p~~~~~e~~~ 361 (927)
.+.+++.|. ..-.|+|||+||+.
T Consensus 148 ~L~I~f~p~--~~~~a~inaIEI~~ 170 (174)
T 2jwp_A 148 KLSVEFVKG--YYDNPKVCALFIMK 170 (174)
T ss_dssp EEEEEEECS--SSCSSSEEEEEEES
T ss_pred eEEEEEecc--CCCCcEEEEEEEEe
Confidence 788888874 34579999999964
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.45 E-value=2e-07 Score=107.84 Aligned_cols=56 Identities=23% Similarity=0.214 Sum_probs=23.0
Q ss_pred ceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccC
Q 002410 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 470 (927)
Q Consensus 410 ~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g 470 (927)
+++.|+|++|++++. .++++++|+.|+|++|+|++ +| +..+++|+.|+|++|+|+|
T Consensus 192 ~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip-~~~l~~L~~L~l~~N~l~~ 247 (457)
T 3bz5_A 192 LLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID-VTPLTQLTYFDCSVNPLTE 247 (457)
T ss_dssp TCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC-CTTCTTCSEEECCSSCCSC
T ss_pred CCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC-ccccCCCCEEEeeCCcCCC
Confidence 344444444444432 23444444444444444444 22 3444444444444444443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.45 E-value=2.4e-07 Score=107.17 Aligned_cols=95 Identities=25% Similarity=0.262 Sum_probs=50.9
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 488 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~ 488 (927)
++++.|+|++|++++ +| ++++++|++|+|++|+|++. | ++++++|++|+|++|++++ +| ++.+++|+.|+++
T Consensus 64 ~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~-~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~ 135 (457)
T 3bz5_A 64 TGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D-VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCA 135 (457)
T ss_dssp TTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C-CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECT
T ss_pred CCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e-cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECC
Confidence 455555555555554 23 55555555556655555553 2 5555566666666666554 33 5555666666666
Q ss_pred ccCCCCCCCccccCCceeeeecCC
Q 002410 489 NNSFVGEIPPALLTGKVIFKYDNN 512 (927)
Q Consensus 489 ~N~l~g~iP~~~~~~~~~~~~~~N 512 (927)
+|++++ +|-.-...+..+.+.+|
T Consensus 136 ~N~l~~-l~l~~l~~L~~L~l~~n 158 (457)
T 3bz5_A 136 RNTLTE-IDVSHNTQLTELDCHLN 158 (457)
T ss_dssp TSCCSC-CCCTTCTTCCEEECTTC
T ss_pred CCccce-eccccCCcCCEEECCCC
Confidence 666653 34222234444555554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.41 E-value=1.9e-07 Score=103.47 Aligned_cols=104 Identities=18% Similarity=0.292 Sum_probs=85.1
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.++++.|+|++|++++. |. +..+++|+.|+|++|.+++. +.+..+++|+.|+|++|++++ + ..+..+++|+.|++
T Consensus 220 ~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L 294 (347)
T 4fmz_A 220 MTRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFL 294 (347)
T ss_dssp CTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CCcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCCccCCC-hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEEC
Confidence 46899999999999854 44 88999999999999999884 678899999999999999985 4 45888999999999
Q ss_pred cccCCCCCCCccccC--CceeeeecCCCCCc
Q 002410 488 ENNSFVGEIPPALLT--GKVIFKYDNNPKLH 516 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~--~~~~~~~~~N~~~c 516 (927)
++|.+++..|..+.. .+..+.+.+|+...
T Consensus 295 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 325 (347)
T 4fmz_A 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325 (347)
T ss_dssp CSSCCCGGGHHHHHTCTTCSEEECCSSSCCC
T ss_pred cCCcCCCcChhHhhccccCCEEEccCCcccc
Confidence 999998766665543 66778888887543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.40 E-value=4.3e-07 Score=104.95 Aligned_cols=97 Identities=30% Similarity=0.403 Sum_probs=76.9
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 488 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~ 488 (927)
++++.|+|++|++++ +| +|+++++|++|+|++|++++ +|.. ..+|+.|+|++|++++ +| .++++++|+.|+++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~--~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC--cccccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence 579999999999996 88 69999999999999999987 4442 2489999999999986 77 58899999999999
Q ss_pred ccCCCCCCCccccCCceeeeecCCCC
Q 002410 489 NNSFVGEIPPALLTGKVIFKYDNNPK 514 (927)
Q Consensus 489 ~N~l~g~iP~~~~~~~~~~~~~~N~~ 514 (927)
+|++++ +|... ..+..+.+.+|..
T Consensus 204 ~N~l~~-l~~~~-~~L~~L~l~~n~l 227 (454)
T 1jl5_A 204 NNSLKK-LPDLP-LSLESIVAGNNIL 227 (454)
T ss_dssp SSCCSS-CCCCC-TTCCEEECCSSCC
T ss_pred CCcCCc-CCCCc-CcccEEECcCCcC
Confidence 999984 66533 3556666666643
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.39 E-value=1.9e-07 Score=107.86 Aligned_cols=85 Identities=28% Similarity=0.498 Sum_probs=45.3
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccC--CCCCcCCCc-------
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG--SLPSYMGSL------- 479 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g--~iP~~l~~l------- 479 (927)
.+++.|+|++|++++ +|.. +++|+.|+|++|++++ +|. .+++|+.|+|++|+++| .+|.+++.|
T Consensus 317 ~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~--~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~ 389 (454)
T 1jl5_A 317 PSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE--LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLA 389 (454)
T ss_dssp TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC---
T ss_pred CcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc--hhhhccEEECCCCCCCcCCCChHHHHhhhhccccc
Confidence 467777777777775 6654 4677777777777775 444 46777777777777777 677777776
Q ss_pred ------cccccccccccCCCC--CCCccc
Q 002410 480 ------PNLQELHIENNSFVG--EIPPAL 500 (927)
Q Consensus 480 ------~~L~~L~l~~N~l~g--~iP~~~ 500 (927)
++|+.|++++|+++| .+|.++
T Consensus 390 ~i~~~~~~L~~L~ls~N~l~~~~~iP~sl 418 (454)
T 1jl5_A 390 EVPELPQNLKQLHVETNPLREFPDIPESV 418 (454)
T ss_dssp -----------------------------
T ss_pred ccccccCcCCEEECCCCcCCccccchhhH
Confidence 677777777777776 666554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.34 E-value=2.1e-07 Score=111.60 Aligned_cols=84 Identities=26% Similarity=0.320 Sum_probs=54.9
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 488 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~ 488 (927)
++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+..++ .+++|+.|+|++|+|+ .+|..+.++++|+.|+|+
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 456677777777764 55 445666777777777764333 5566777777777777 667667777777777777
Q ss_pred ccCCCCCCCccc
Q 002410 489 NNSFVGEIPPAL 500 (927)
Q Consensus 489 ~N~l~g~iP~~~ 500 (927)
+|.++|.+|..+
T Consensus 293 ~N~l~~~~~~~l 304 (622)
T 3g06_A 293 GNPLSERTLQAL 304 (622)
T ss_dssp SCCCCHHHHHHH
T ss_pred CCCCCCcCHHHH
Confidence 777776665543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.32 E-value=2.2e-07 Score=103.47 Aligned_cols=104 Identities=19% Similarity=0.248 Sum_probs=83.8
Q ss_pred EeCCCCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCC-cCCCcc
Q 002410 403 CSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS-YMGSLP 480 (927)
Q Consensus 403 c~~~~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~-~l~~l~ 480 (927)
|.|+. +++++++++|+ .||..+ .++|+.|+|++|+|+..++. |.+|++|+.|+|++|++.+.+|. .|.+++
T Consensus 7 C~C~~----~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~ 79 (350)
T 4ay9_X 7 CHCSN----RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79 (350)
T ss_dssp SEEET----TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCT
T ss_pred cEeeC----CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcch
Confidence 77764 35899999999 899877 36899999999999988775 99999999999999999878875 678899
Q ss_pred cccc-ccccccCCCCCCCccccC---CceeeeecCCCC
Q 002410 481 NLQE-LHIENNSFVGEIPPALLT---GKVIFKYDNNPK 514 (927)
Q Consensus 481 ~L~~-L~l~~N~l~g~iP~~~~~---~~~~~~~~~N~~ 514 (927)
+|+. +.+++|+++ .+|+..+. .+..+.+.+|..
T Consensus 80 ~l~~~l~~~~N~l~-~l~~~~f~~l~~L~~L~l~~n~l 116 (350)
T 4ay9_X 80 KLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGI 116 (350)
T ss_dssp TCCEEEEEEETTCC-EECTTSBCCCTTCCEEEEEEECC
T ss_pred hhhhhhcccCCccc-ccCchhhhhcccccccccccccc
Confidence 8875 667789999 56554433 556677777654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.31 E-value=3.9e-08 Score=111.03 Aligned_cols=85 Identities=21% Similarity=0.349 Sum_probs=42.7
Q ss_pred ceEEEEecCCCCc-ccCC---ccccCCcccceecccCCCCC--C---CCC-CcCcccccceeeccccccc----CCCCCc
Q 002410 410 RITKIALSGKNLK-GEIP---PELKNMEALTELWLDGNFLT--G---PLP-DMSRLIDLRIVHLENNELT----GSLPSY 475 (927)
Q Consensus 410 ~l~~L~L~~n~l~-g~ip---~~l~~l~~L~~L~Ls~N~l~--g---~~p-~~~~l~~L~~L~Ls~N~l~----g~iP~~ 475 (927)
+|+.|+|++|+++ +.+| ..+..+++|+.|+|++|+|+ | .+| .+..+++|+.|+|++|+++ +.+|..
T Consensus 160 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~ 239 (386)
T 2ca6_A 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239 (386)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred CCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHH
Confidence 4555555555554 3333 34445555555555555554 2 233 3455555555555555553 344555
Q ss_pred CCCccccccccccccCCCC
Q 002410 476 MGSLPNLQELHIENNSFVG 494 (927)
Q Consensus 476 l~~l~~L~~L~l~~N~l~g 494 (927)
+..+++|+.|+|++|.+++
T Consensus 240 l~~~~~L~~L~L~~n~i~~ 258 (386)
T 2ca6_A 240 LKSWPNLRELGLNDCLLSA 258 (386)
T ss_dssp GGGCTTCCEEECTTCCCCH
T ss_pred HccCCCcCEEECCCCCCch
Confidence 5555555555555555543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=2.5e-06 Score=90.89 Aligned_cols=136 Identities=17% Similarity=0.107 Sum_probs=100.8
Q ss_pred ccccccccE-EEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEEEEEecCCCC
Q 002410 611 KKIGKGSFG-SVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGT 687 (927)
Q Consensus 611 ~~LG~G~~G-~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~LV~E~~~~gs 687 (927)
+.+..|..| .||+.... ++..+++|+-.. .....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345556655 68988765 467799998653 34456888999999884 3346778888888899999999999988
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 002410 688 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG-------------------------------------------- 723 (927)
Q Consensus 688 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-------------------------------------------- 723 (927)
+.+.... .......+..+++..|+.||+.
T Consensus 107 ~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 8776542 1223456777788888888851
Q ss_pred -----------CCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 724 -----------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 724 -----------~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
....++|||+++.||++++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999887778999997754
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.30 E-value=7.6e-07 Score=106.68 Aligned_cols=95 Identities=26% Similarity=0.386 Sum_probs=66.5
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 488 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~ 488 (927)
++++.|+|++|.++ .+|.. +++|+.|+|++|+|++. | ..+++|+.|+|++|+|+ .+|. .+++|+.|+|+
T Consensus 201 ~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~l-p--~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls 269 (622)
T 3g06_A 201 SELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTSL-P--VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVY 269 (622)
T ss_dssp TTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCC-C--CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECC
T ss_pred chhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCcC-C--CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCC
Confidence 35555566666555 34432 36778888888888774 3 45577888888888888 6776 56788888888
Q ss_pred ccCCCCCCCccccC--CceeeeecCCCCC
Q 002410 489 NNSFVGEIPPALLT--GKVIFKYDNNPKL 515 (927)
Q Consensus 489 ~N~l~g~iP~~~~~--~~~~~~~~~N~~~ 515 (927)
+|+|+ .||..+.. .+..+.+.+|+..
T Consensus 270 ~N~L~-~lp~~l~~l~~L~~L~L~~N~l~ 297 (622)
T 3g06_A 270 RNQLT-RLPESLIHLSSETTVNLEGNPLS 297 (622)
T ss_dssp SSCCC-SCCGGGGGSCTTCEEECCSCCCC
T ss_pred CCCCC-cCCHHHhhccccCEEEecCCCCC
Confidence 88888 78876654 5666777888765
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.29 E-value=4e-08 Score=110.92 Aligned_cols=108 Identities=16% Similarity=0.191 Sum_probs=89.7
Q ss_pred CceEEEEecCCCCc--c---cCCccccCCcccceecccCCCCC----CCCCC-cCcccccceeecccccccCC----CCC
Q 002410 409 PRITKIALSGKNLK--G---EIPPELKNMEALTELWLDGNFLT----GPLPD-MSRLIDLRIVHLENNELTGS----LPS 474 (927)
Q Consensus 409 ~~l~~L~L~~n~l~--g---~ip~~l~~l~~L~~L~Ls~N~l~----g~~p~-~~~l~~L~~L~Ls~N~l~g~----iP~ 474 (927)
++|+.|+|++|+++ | .+|..+.++++|+.|+|++|.|+ +.+|. +..+++|+.|+|++|++++. +|.
T Consensus 187 ~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~ 266 (386)
T 2ca6_A 187 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 266 (386)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred CCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHH
Confidence 48999999999998 4 45558899999999999999996 55664 88999999999999999876 677
Q ss_pred cC--CCccccccccccccCCCC----CCCccc---cCCceeeeecCCCCCc
Q 002410 475 YM--GSLPNLQELHIENNSFVG----EIPPAL---LTGKVIFKYDNNPKLH 516 (927)
Q Consensus 475 ~l--~~l~~L~~L~l~~N~l~g----~iP~~~---~~~~~~~~~~~N~~~c 516 (927)
.+ +.+++|+.|+|++|.+++ .+|..+ ...+..+.+.+|+...
T Consensus 267 ~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 267 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 77 448999999999999997 488877 3567788888887653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=5e-06 Score=90.70 Aligned_cols=135 Identities=15% Similarity=0.187 Sum_probs=96.1
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCC---ceeeeeeeee-cCceEEEEEEecCCC
Q 002410 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR---NLVPLIGYCE-EEHQRILVYEYMHNG 686 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~Hp---nIv~l~~~~~-~~~~~~LV~E~~~~g 686 (927)
+.++.|....||+. |+.+++|+-.. ......+.+|.++|+.+.+. .+.+++.++. ..+..++|||+++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 56788999999988 56788888432 23456789999999999642 3556666663 455678999999998
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 002410 687 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG------------------------------------------- 723 (927)
Q Consensus 687 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~------------------------------------------- 723 (927)
+|.+..- ..++..+...++.++++.|+.||+.
T Consensus 99 ~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 8876322 1234555566666666666666641
Q ss_pred --------------CCCCeEecCCCCCcccccC---CCc-EEEeecccccc
Q 002410 724 --------------CNPGIIHRDVKSSNILLDI---NMR-AKVSDFGLSRQ 756 (927)
Q Consensus 724 --------------~~~~ivH~DLkp~NILld~---~~~-~kL~DFGla~~ 756 (927)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235699999999999987 455 48999998764
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.23 E-value=1.4e-07 Score=105.64 Aligned_cols=105 Identities=19% Similarity=0.183 Sum_probs=69.9
Q ss_pred CceEEEEecCCCCcccCC----ccccCCc-ccceecccCCCCCCCCCC-cCcc-----cccceeecccccccCCCCCcCC
Q 002410 409 PRITKIALSGKNLKGEIP----PELKNME-ALTELWLDGNFLTGPLPD-MSRL-----IDLRIVHLENNELTGSLPSYMG 477 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip----~~l~~l~-~L~~L~Ls~N~l~g~~p~-~~~l-----~~L~~L~Ls~N~l~g~iP~~l~ 477 (927)
.+++.|+|++|++++..+ ..+.+++ +|+.|+|++|+|++..+. +..+ ++|+.|+|++|++++..+..++
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 457788888888775555 5667777 788888888877777663 5444 7788888888887766666444
Q ss_pred Cc-----cccccccccccCCCCCCCcccc-------CCceeeeecCCC
Q 002410 478 SL-----PNLQELHIENNSFVGEIPPALL-------TGKVIFKYDNNP 513 (927)
Q Consensus 478 ~l-----~~L~~L~l~~N~l~g~iP~~~~-------~~~~~~~~~~N~ 513 (927)
.. ++|+.|+|++|.+++..+..+. ..+..+.+++|.
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~ 149 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGND 149 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSC
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCc
Confidence 43 6778888888887744443321 245556666664
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.20 E-value=1.2e-07 Score=104.56 Aligned_cols=104 Identities=12% Similarity=0.078 Sum_probs=73.8
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCC-CCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP-LPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~-~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
++++.|+|++|.+.+.++. +.++++|+.|+|++|.+++. +|. +..+++|+.|+|++|++++.+|..++.+++|+.|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 5677888888888766554 56778888888888887765 554 67788888888888888777777777788888888
Q ss_pred cccc-CCCCC-CCcccc--CCceeeeecCCC
Q 002410 487 IENN-SFVGE-IPPALL--TGKVIFKYDNNP 513 (927)
Q Consensus 487 l~~N-~l~g~-iP~~~~--~~~~~~~~~~N~ 513 (927)
|++| .+++. +|..+. ..+..+.+.+|+
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~ 179 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCF 179 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCT
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCC
Confidence 8888 56642 444332 255566666663
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.20 E-value=4.5e-07 Score=96.53 Aligned_cols=77 Identities=22% Similarity=0.378 Sum_probs=40.8
Q ss_pred CceEEEEecCCCCcc--cCCccccCCcccceecccCCCCCCCCCCcCccc--ccceeecccccccCCCCC-------cCC
Q 002410 409 PRITKIALSGKNLKG--EIPPELKNMEALTELWLDGNFLTGPLPDMSRLI--DLRIVHLENNELTGSLPS-------YMG 477 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g--~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~--~L~~L~Ls~N~l~g~iP~-------~l~ 477 (927)
++|+.|+|++|+|++ .+|..+..|++|+.|+|++|+|++. .++..+. +|+.|+|++|.+++.+|. .+.
T Consensus 170 ~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~ 248 (267)
T 3rw6_A 170 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRE 248 (267)
T ss_dssp TTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHH
T ss_pred CCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHH
Confidence 455666666666665 4445555566666666666666554 2222222 556666666666555542 234
Q ss_pred Ccccccccc
Q 002410 478 SLPNLQELH 486 (927)
Q Consensus 478 ~l~~L~~L~ 486 (927)
.+|+|+.||
T Consensus 249 ~~P~L~~LD 257 (267)
T 3rw6_A 249 RFPKLLRLD 257 (267)
T ss_dssp HCTTCCEES
T ss_pred HCcccCeEC
Confidence 455555543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=5.4e-06 Score=92.27 Aligned_cols=80 Identities=5% Similarity=0.037 Sum_probs=56.7
Q ss_pred ccc-cccccEEEEEEEEC-------CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcC-C--CceeeeeeeeecC---
Q 002410 611 KKI-GKGSFGSVYYGKMK-------DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH-H--RNLVPLIGYCEEE--- 673 (927)
Q Consensus 611 ~~L-G~G~~G~Vy~a~~~-------~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~-H--pnIv~l~~~~~~~--- 673 (927)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88999999998765 26789999865432 101245778999998884 3 3567788877655
Q ss_pred ceEEEEEEecCCCCHHH
Q 002410 674 HQRILVYEYMHNGTLRD 690 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~ 690 (927)
+..++|||+++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999876643
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.05 E-value=4.7e-07 Score=99.69 Aligned_cols=112 Identities=19% Similarity=0.291 Sum_probs=93.8
Q ss_pred CCccEEEeCCCCCceEEEEecCCCCcccCCccccCC--cccceecccCCCCCCCCCCcCcccccceeecccccccCC-CC
Q 002410 397 PWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNM--EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS-LP 473 (927)
Q Consensus 397 ~w~~~~c~~~~~~~l~~L~L~~n~l~g~ip~~l~~l--~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~-iP 473 (927)
.|..+.|+ +..++.|+|++|++. |..+..+ ++|+.|+|++|.+++.++.+..+++|+.|+|++|++++. +|
T Consensus 38 ~W~~~~~~---~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~ 111 (336)
T 2ast_B 38 RWYRLASD---ESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLH 111 (336)
T ss_dssp HHHHHHTC---STTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHH
T ss_pred HHHHHhcC---chhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHH
Confidence 35544432 345789999999987 5677888 899999999999999999988999999999999999876 89
Q ss_pred CcCCCccccccccccccCCCCCCCccccC--CceeeeecCCCC
Q 002410 474 SYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPK 514 (927)
Q Consensus 474 ~~l~~l~~L~~L~l~~N~l~g~iP~~~~~--~~~~~~~~~N~~ 514 (927)
..+..+++|+.|+|++|.+++.+|..+.. .+..+.+.+|..
T Consensus 112 ~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~ 154 (336)
T 2ast_B 112 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSG 154 (336)
T ss_dssp HHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBS
T ss_pred HHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCC
Confidence 89999999999999999999877776644 566777777743
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.03 E-value=4.8e-07 Score=101.15 Aligned_cols=102 Identities=14% Similarity=0.043 Sum_probs=86.6
Q ss_pred EEEecCCCCcccCCccccCCcccceecccCCCCCCCCC----C-cCccc-ccceeecccccccCCCCCcCCCc-----cc
Q 002410 413 KIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP----D-MSRLI-DLRIVHLENNELTGSLPSYMGSL-----PN 481 (927)
Q Consensus 413 ~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p----~-~~~l~-~L~~L~Ls~N~l~g~iP~~l~~l-----~~ 481 (927)
.++|++|+++|.+|..+...++|+.|+|++|+|++..+ + +..++ +|+.|+|++|++++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 47899999999999988888899999999999999886 3 77888 89999999999998888888776 99
Q ss_pred cccccccccCCCCCCCcccc-------CCceeeeecCCCC
Q 002410 482 LQELHIENNSFVGEIPPALL-------TGKVIFKYDNNPK 514 (927)
Q Consensus 482 L~~L~l~~N~l~g~iP~~~~-------~~~~~~~~~~N~~ 514 (927)
|+.|+|++|.+++..+..+. ..+..+.+.+|..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l 121 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF 121 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCG
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcC
Confidence 99999999999976665432 3466677777763
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=97.99 E-value=6.9e-07 Score=95.11 Aligned_cols=83 Identities=22% Similarity=0.298 Sum_probs=63.6
Q ss_pred EEecCCCCc---ccCCccccCCcccceecccCCCCCCC--CCC-cCcccccceeecccccccCCCCCcCCCcc--ccccc
Q 002410 414 IALSGKNLK---GEIPPELKNMEALTELWLDGNFLTGP--LPD-MSRLIDLRIVHLENNELTGSLPSYMGSLP--NLQEL 485 (927)
Q Consensus 414 L~L~~n~l~---g~ip~~l~~l~~L~~L~Ls~N~l~g~--~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~--~L~~L 485 (927)
++++.|... +.++-...+|++|+.|+|++|+|++. +|+ +..+++|+.|+|++|+|++. ..+..+. +|+.|
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L 225 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL 225 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence 556666432 22222335788999999999999994 455 67999999999999999965 4455555 89999
Q ss_pred cccccCCCCCCCc
Q 002410 486 HIENNSFVGEIPP 498 (927)
Q Consensus 486 ~l~~N~l~g~iP~ 498 (927)
+|++|.+++.+|.
T Consensus 226 ~L~~Npl~~~~~~ 238 (267)
T 3rw6_A 226 WLDGNSLCDTFRD 238 (267)
T ss_dssp ECTTSTTGGGCSS
T ss_pred EccCCcCccccCc
Confidence 9999999988773
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=7.4e-05 Score=84.41 Aligned_cols=75 Identities=15% Similarity=0.187 Sum_probs=49.6
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCccc-------hhHHHHHHHHHHHHhcCC--Cc-eeeeeeeeecCceEEE
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-------HRTQQFVTEVALLSRIHH--RN-LVPLIGYCEEEHQRIL 678 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-------~~~~~~~~E~~~L~~l~H--pn-Iv~l~~~~~~~~~~~L 678 (927)
.+.||.|..+.||++... +++.++||....... ....++..|.++|+.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357999999999999765 468899998653221 123456789999988742 33 3455544 2344689
Q ss_pred EEEecCCC
Q 002410 679 VYEYMHNG 686 (927)
Q Consensus 679 V~E~~~~g 686 (927)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.71 E-value=9.2e-05 Score=81.32 Aligned_cols=140 Identities=16% Similarity=0.232 Sum_probs=80.4
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCC--Cceeeeee------eeecCceEEEEEEe
Q 002410 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH--RNLVPLIG------YCEEEHQRILVYEY 682 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~H--pnIv~l~~------~~~~~~~~~LV~E~ 682 (927)
+.|+.|..+.||+....+| .+++|+.... ...+..|..+++.|.. -.+.+++. +....+..++++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677889999988755 4899988752 2334455666665531 12333333 12345678999999
Q ss_pred cCCCCHH--------------HHhccCCC----C-------CCCCHHHH-------------------------------
Q 002410 683 MHNGTLR--------------DRLHGSVN----Q-------KPLDWLTR------------------------------- 706 (927)
Q Consensus 683 ~~~gsL~--------------~~L~~~~~----~-------~~l~~~~~------------------------------- 706 (927)
++|..+. ..++.... . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986532 11111100 0 00122110
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 707 LQIAHDAAKGLEYLHT----------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 707 ~~i~~qia~gL~~LH~----------~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
..+..++..++++|++ .....++|||+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111224445666652 124789999999999999888899999999764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.70 E-value=8.4e-07 Score=102.21 Aligned_cols=105 Identities=19% Similarity=0.173 Sum_probs=65.6
Q ss_pred CceEEEEecCCCCccc----CCccccCCcccceecccCCCCCCCCCC-cC-----cccccceeecccccccCC----CCC
Q 002410 409 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGPLPD-MS-----RLIDLRIVHLENNELTGS----LPS 474 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~----ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~-----~l~~L~~L~Ls~N~l~g~----iP~ 474 (927)
++++.|+|++|++++. ++..+.++++|+.|+|++|.+++..+. +. ..++|+.|+|++|++++. +|.
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 335 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence 4677777777777754 566666777777777777776554332 22 235777777777777754 455
Q ss_pred cCCCccccccccccccCCCCCCCcccc-------CCceeeeecCCC
Q 002410 475 YMGSLPNLQELHIENNSFVGEIPPALL-------TGKVIFKYDNNP 513 (927)
Q Consensus 475 ~l~~l~~L~~L~l~~N~l~g~iP~~~~-------~~~~~~~~~~N~ 513 (927)
.+..+++|+.|+|++|.+++..+..+. ..+..+.+.+|.
T Consensus 336 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~ 381 (461)
T 1z7x_W 336 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381 (461)
T ss_dssp HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence 666667777777777777644333332 144455555553
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.64 E-value=2.1e-06 Score=98.91 Aligned_cols=106 Identities=18% Similarity=0.210 Sum_probs=63.1
Q ss_pred CceEEEEecCCCCcccCCccccCC-----cccceecccCCCCCCC----CCC-cCcccccceeecccccccCCCCCcCCC
Q 002410 409 PRITKIALSGKNLKGEIPPELKNM-----EALTELWLDGNFLTGP----LPD-MSRLIDLRIVHLENNELTGSLPSYMGS 478 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l-----~~L~~L~Ls~N~l~g~----~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~ 478 (927)
++++.|+|++|.+.+..+..+... ++|+.|+|++|.+++. ++. +..+++|+.|+|++|++++..+..+..
T Consensus 284 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 363 (461)
T 1z7x_W 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 363 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred CCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHH
Confidence 457777777777765444444332 5677777777776654 232 556677777777777766544443332
Q ss_pred -----ccccccccccccCCCC----CCCcccc--CCceeeeecCCCC
Q 002410 479 -----LPNLQELHIENNSFVG----EIPPALL--TGKVIFKYDNNPK 514 (927)
Q Consensus 479 -----l~~L~~L~l~~N~l~g----~iP~~~~--~~~~~~~~~~N~~ 514 (927)
+++|+.|+|++|.+++ .+|..+. ..+..+.+.+|+.
T Consensus 364 ~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i 410 (461)
T 1z7x_W 364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSC
T ss_pred HHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCC
Confidence 4567777777777764 5555443 2455566666653
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.58 E-value=3.9e-05 Score=84.35 Aligned_cols=91 Identities=15% Similarity=0.094 Sum_probs=77.3
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccc-eeecccccccCCCCCcCCCcccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLR-IVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~-~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
++|+.|+|++|+++..-+..|.+|++|+.|+|++| ++...+. |.++++|+ .|+|++ +++..-+..|.+|++|+.|+
T Consensus 226 ~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~ 303 (329)
T 3sb4_A 226 PNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL 303 (329)
T ss_dssp TTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred CCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence 47999999999999444457999999999999998 6665554 99999999 999999 77734457899999999999
Q ss_pred ccccCCCCCCCccccC
Q 002410 487 IENNSFVGEIPPALLT 502 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~ 502 (927)
+++|+++ .|+...+.
T Consensus 304 l~~n~i~-~I~~~aF~ 318 (329)
T 3sb4_A 304 ATGDKIT-TLGDELFG 318 (329)
T ss_dssp ECSSCCC-EECTTTTC
T ss_pred eCCCccC-ccchhhhc
Confidence 9999999 88877665
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00034 Score=76.26 Aligned_cols=137 Identities=18% Similarity=0.219 Sum_probs=91.2
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcC---CCceeeeeeeeecCceEEEEEEecCCCC
Q 002410 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRILVYEYMHNGT 687 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~---HpnIv~l~~~~~~~~~~~LV~E~~~~gs 687 (927)
+.|+.|....+|+.... ++.+++|+.... ....+..|.+.|+.|. ...+.++++++...+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 46899999999999864 678899987532 3567889999999884 3568888888887888999999999876
Q ss_pred HH--------H---HhccCCC-C------------------CCCCHHHHH---HHH----------------HHHHHHH-
Q 002410 688 LR--------D---RLHGSVN-Q------------------KPLDWLTRL---QIA----------------HDAAKGL- 717 (927)
Q Consensus 688 L~--------~---~L~~~~~-~------------------~~l~~~~~~---~i~----------------~qia~gL- 717 (927)
+. . .|+.... . -.-+|.... ++. .+++..+
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 41 1 2222111 0 012343221 111 1122222
Q ss_pred HHHHh-cCCCCeEecCCCCCcccccCCCcEEEeecc
Q 002410 718 EYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFG 752 (927)
Q Consensus 718 ~~LH~-~~~~~ivH~DLkp~NILld~~~~~kL~DFG 752 (927)
..|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 1246899999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.0001 Score=84.01 Aligned_cols=79 Identities=11% Similarity=0.095 Sum_probs=49.1
Q ss_pred CCCeEecCCCCCcccccCCCcEEEeeccccccccccccccccccccCCCccCCCccCCC---CCCcchhHHHHHHHHHHH
Q 002410 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLEL 801 (927)
Q Consensus 725 ~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~s~ksDVwSlGvlL~eL 801 (927)
...++|||+++.|||++.++ ++|+||+.+........-......-...|++|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 47899999999999998776 99999998876432211110000011345666554311 112345566788888887
Q ss_pred HhC
Q 002410 802 ISG 804 (927)
Q Consensus 802 ltG 804 (927)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00023 Score=76.48 Aligned_cols=74 Identities=19% Similarity=0.275 Sum_probs=54.9
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCC---ceeeeeeeeecCceEEEEEEecCCC
Q 002410 610 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR---NLVPLIGYCEEEHQRILVYEYMHNG 686 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~Hp---nIv~l~~~~~~~~~~~LV~E~~~~g 686 (927)
.+.+|.|..+.||+.++.||+.|++|+-..........|..|++.|+.|... -+.+++++. ..++||||++++
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~ 95 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDER 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCC
T ss_pred EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeeccc
Confidence 3678999999999999999999999987654433445688899999988421 234444432 247899999876
Q ss_pred C
Q 002410 687 T 687 (927)
Q Consensus 687 s 687 (927)
.
T Consensus 96 ~ 96 (288)
T 3f7w_A 96 P 96 (288)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.38 E-value=8.6e-06 Score=91.43 Aligned_cols=84 Identities=23% Similarity=0.216 Sum_probs=40.2
Q ss_pred ceEEEEecCCCCcc----cCCccccCCcccceecccCCCCCCCC----C-CcCcccccceeecccccccCC----CCCcC
Q 002410 410 RITKIALSGKNLKG----EIPPELKNMEALTELWLDGNFLTGPL----P-DMSRLIDLRIVHLENNELTGS----LPSYM 476 (927)
Q Consensus 410 ~l~~L~L~~n~l~g----~ip~~l~~l~~L~~L~Ls~N~l~g~~----p-~~~~l~~L~~L~Ls~N~l~g~----iP~~l 476 (927)
.|+.|+|++|+|+. .++..+..+++|++|+|++|+|+..- + .+..+++|+.|+|++|+++.. ++..+
T Consensus 156 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L 235 (372)
T 3un9_A 156 QITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAA 235 (372)
T ss_dssp CCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHH
T ss_pred ccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHH
Confidence 45555555555543 13333445555555555555554321 1 134444555555555555421 22233
Q ss_pred CCccccccccccccCCC
Q 002410 477 GSLPNLQELHIENNSFV 493 (927)
Q Consensus 477 ~~l~~L~~L~l~~N~l~ 493 (927)
..+++|+.|+|++|.|+
T Consensus 236 ~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 236 REHPSLELLHLYFNELS 252 (372)
T ss_dssp HHCSSCCEEECTTSSCC
T ss_pred HhCCCCCEEeccCCCCC
Confidence 33455555555555554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.34 E-value=8.7e-06 Score=91.37 Aligned_cols=61 Identities=25% Similarity=0.239 Sum_probs=27.5
Q ss_pred cccceecccCCCCCCC----CC-CcCcccccceeecccccccCC----CCCcCCCccccccccccccCCC
Q 002410 433 EALTELWLDGNFLTGP----LP-DMSRLIDLRIVHLENNELTGS----LPSYMGSLPNLQELHIENNSFV 493 (927)
Q Consensus 433 ~~L~~L~Ls~N~l~g~----~p-~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~l~~N~l~ 493 (927)
++|+.|+|++|.|+.. ++ .+..+++|+.|+|++|+|+.. ++..+..+++|+.|+|++|.|+
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence 4455555555544331 11 123444555555555554421 2333444445555555555554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0028 Score=69.38 Aligned_cols=142 Identities=12% Similarity=0.070 Sum_probs=74.5
Q ss_pred ccccccccEE-EEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCC--CceeeeeeeeecCceEEEEEEecCCCC
Q 002410 611 KKIGKGSFGS-VYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYEYMHNGT 687 (927)
Q Consensus 611 ~~LG~G~~G~-Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~H--pnIv~l~~~~~~~~~~~LV~E~~~~gs 687 (927)
+.|+.|.... +|+....+|+.+++|....... ..+..|+.+++.+.. -.+.+++.+....+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4566665555 6677654477788886543211 234456777776642 23455666544433 78999997766
Q ss_pred HHHHhccC---------------------CCC--CCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 002410 688 LRDRLHGS---------------------VNQ--KPLDWLTRL-------Q-------------IAHDAAKGLEYLH--- 721 (927)
Q Consensus 688 L~~~L~~~---------------------~~~--~~l~~~~~~-------~-------------i~~qia~gL~~LH--- 721 (927)
+.+.+... ... ..++..... . ....+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65443211 000 111111100 0 0011112222221
Q ss_pred hcCCCCeEecCCCCCcccccCC----CcEEEeeccccccc
Q 002410 722 TGCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLSRQA 757 (927)
Q Consensus 722 ~~~~~~ivH~DLkp~NILld~~----~~~kL~DFGla~~~ 757 (927)
......++|||+++.||+++.+ +.+.|+||+.+...
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1124689999999999999874 68999999988653
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.00037 Score=76.47 Aligned_cols=37 Identities=16% Similarity=0.162 Sum_probs=19.8
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCC
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 446 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~ 446 (927)
.+|+.|+|.+ +++..-+..|.+|++|+.|+|++|.++
T Consensus 101 ~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~ 137 (329)
T 3sb4_A 101 QTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAP 137 (329)
T ss_dssp TTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCC
T ss_pred CCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCcc
Confidence 3455666665 555333334566666666666666554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0013 Score=75.10 Aligned_cols=71 Identities=15% Similarity=0.309 Sum_probs=49.8
Q ss_pred ccccccccEEEEEEEECC--------CcEEEEEEccCccchhHHHHHHHHHHHHhcCCCce-eeeeeeeecCceEEEEEE
Q 002410 611 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~--------g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnI-v~l~~~~~~~~~~~LV~E 681 (927)
+.|+.|....+|++...+ ++.+++|+...... ...+.+|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 567888899999998763 57899998854211 1455679999998853333 566666543 28999
Q ss_pred ecCCCC
Q 002410 682 YMHNGT 687 (927)
Q Consensus 682 ~~~~gs 687 (927)
|++|.+
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 998644
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=96.93 E-value=5.7e-05 Score=89.76 Aligned_cols=105 Identities=15% Similarity=0.093 Sum_probs=52.4
Q ss_pred CceEEEEec----CCCCccc-----CCccccCCcccceecccCC--CCCCCCCC-c-CcccccceeecccccccC-CCCC
Q 002410 409 PRITKIALS----GKNLKGE-----IPPELKNMEALTELWLDGN--FLTGPLPD-M-SRLIDLRIVHLENNELTG-SLPS 474 (927)
Q Consensus 409 ~~l~~L~L~----~n~l~g~-----ip~~l~~l~~L~~L~Ls~N--~l~g~~p~-~-~~l~~L~~L~Ls~N~l~g-~iP~ 474 (927)
++++.|+|+ .|.+++. ++..+.++++|+.|+|+++ .+++..+. + ..+++|+.|+|++|++++ .++.
T Consensus 403 ~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~ 482 (592)
T 3ogk_B 403 KNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLME 482 (592)
T ss_dssp CSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHH
T ss_pred CCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHH
Confidence 356666664 4555542 3333555666666666532 24443332 2 235556666666666654 2344
Q ss_pred cCCCccccccccccccCCCCCCCccc---cCCceeeeecCCC
Q 002410 475 YMGSLPNLQELHIENNSFVGEIPPAL---LTGKVIFKYDNNP 513 (927)
Q Consensus 475 ~l~~l~~L~~L~l~~N~l~g~iP~~~---~~~~~~~~~~~N~ 513 (927)
.+..+++|+.|+|++|.+++.....+ ...+..+.+.+|.
T Consensus 483 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 483 FSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred HHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 44555666666666666543322221 2244455555554
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.91 E-value=7.1e-05 Score=75.11 Aligned_cols=85 Identities=21% Similarity=0.289 Sum_probs=65.5
Q ss_pred CceEEEEecCC-CCccc----CCccccCCcccceecccCCCCCCCC----C-CcCcccccceeecccccccCC----CCC
Q 002410 409 PRITKIALSGK-NLKGE----IPPELKNMEALTELWLDGNFLTGPL----P-DMSRLIDLRIVHLENNELTGS----LPS 474 (927)
Q Consensus 409 ~~l~~L~L~~n-~l~g~----ip~~l~~l~~L~~L~Ls~N~l~g~~----p-~~~~l~~L~~L~Ls~N~l~g~----iP~ 474 (927)
+.+++|+|++| ++... +...+...+.|++|+|++|+|+..- . .+...+.|+.|+|++|+++.. +..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 47899999998 87643 4556777889999999999986531 1 255667899999999998743 456
Q ss_pred cCCCccccccccc--cccCCC
Q 002410 475 YMGSLPNLQELHI--ENNSFV 493 (927)
Q Consensus 475 ~l~~l~~L~~L~l--~~N~l~ 493 (927)
.+...++|+.|+| ++|.+.
T Consensus 116 ~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp GGGGCSSCCEEECCCCSSCCC
T ss_pred HHHhCCCceEEEecCCCCCCC
Confidence 6777788999999 778887
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0015 Score=70.47 Aligned_cols=139 Identities=15% Similarity=0.134 Sum_probs=75.5
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCce-eeeeeeeecCceEEEEEEec-CCCC
Q 002410 610 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVYEYM-HNGT 687 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnI-v~l~~~~~~~~~~~LV~E~~-~~gs 687 (927)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+....+ .++++++. +.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCcc
Confidence 467888999999998 55888887643211 1123568888887743233 45555443 3347899999 5544
Q ss_pred HHH------------------HhccCCCC--CCCC-HHHHHHHHH--------------HHHHHHH----HHHh-cCCCC
Q 002410 688 LRD------------------RLHGSVNQ--KPLD-WLTRLQIAH--------------DAAKGLE----YLHT-GCNPG 727 (927)
Q Consensus 688 L~~------------------~L~~~~~~--~~l~-~~~~~~i~~--------------qia~gL~----~LH~-~~~~~ 727 (927)
+.. .+|..... .... +..+..+.. .+.+.+. .|.. .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 321 11111000 0001 111111110 0111111 1111 12355
Q ss_pred eEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 728 ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
++|+|+.+.||+ ..++.+.|+||..+...
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 56778899999987653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0049 Score=66.94 Aligned_cols=143 Identities=15% Similarity=0.222 Sum_probs=80.8
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCc--eeeeeee------eecCceEEEEEEe
Q 002410 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGY------CEEEHQRILVYEY 682 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~Hpn--Iv~l~~~------~~~~~~~~LV~E~ 682 (927)
+.|+.|....+|+....+| .+++|+.... .....+..|+.+++.+.... +.+++.. ....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4577788899999988766 6889988652 12234566888877774222 2333321 1223567899999
Q ss_pred cCCCCHHH--------------HhccCC---CCC---CC---CHHHHHH------------HHHHHHHHHHHHHhc----
Q 002410 683 MHNGTLRD--------------RLHGSV---NQK---PL---DWLTRLQ------------IAHDAAKGLEYLHTG---- 723 (927)
Q Consensus 683 ~~~gsL~~--------------~L~~~~---~~~---~l---~~~~~~~------------i~~qia~gL~~LH~~---- 723 (927)
++|..+.. .++... ... .. .|..... +...+.+.++.+++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99865311 111110 000 01 1221100 011244455555531
Q ss_pred CCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 724 ~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
...+++|+|+++.||+++.+..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 235799999999999998876668999997653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0058 Score=66.58 Aligned_cols=141 Identities=11% Similarity=0.162 Sum_probs=81.6
Q ss_pred cccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCc--eeeeeee-----eecCceEEEEEEecC
Q 002410 612 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGY-----CEEEHQRILVYEYMH 684 (927)
Q Consensus 612 ~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~Hpn--Iv~l~~~-----~~~~~~~~LV~E~~~ 684 (927)
.++ |....||+....+|+.+++|+..... .....+..|..+++.+.... +.+++.. ....+..++++|+++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 466 77889999888778889999986331 12356677888888774222 3444443 122456688999998
Q ss_pred CCCHH-----H------H---hcc----CC--CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc--
Q 002410 685 NGTLR-----D------R---LHG----SV--NQKPLDWLTR----LQI---------------AHDAAKGLEYLHTG-- 723 (927)
Q Consensus 685 ~gsL~-----~------~---L~~----~~--~~~~l~~~~~----~~i---------------~~qia~gL~~LH~~-- 723 (927)
|..+. . . ++. .. .....++... ..+ ...+...++.+.+.
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75431 0 0 111 00 0111222111 000 11111222333221
Q ss_pred --CCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 724 --CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 724 --~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
....++|||+++.||+++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 236789999999999998 4 899999987754
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.73 E-value=7.7e-05 Score=74.85 Aligned_cols=85 Identities=15% Similarity=0.246 Sum_probs=67.5
Q ss_pred CceEEEEecCCCCccc----CCccccCCcccceecccCCCCCCC----CC-CcCcccccceeec--ccccccCC----CC
Q 002410 409 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGP----LP-DMSRLIDLRIVHL--ENNELTGS----LP 473 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~----ip~~l~~l~~L~~L~Ls~N~l~g~----~p-~~~~l~~L~~L~L--s~N~l~g~----iP 473 (927)
+.|+.|+|++|+|... +...+...+.|++|+|++|+|+.. +. .+...+.|+.|+| ++|.++.. +.
T Consensus 65 ~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~ 144 (185)
T 1io0_A 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 144 (185)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHH
Confidence 5799999999999753 445566678999999999999864 22 4777889999999 88998743 34
Q ss_pred CcCCCccccccccccccCCC
Q 002410 474 SYMGSLPNLQELHIENNSFV 493 (927)
Q Consensus 474 ~~l~~l~~L~~L~l~~N~l~ 493 (927)
..+...++|+.|+|++|.+.
T Consensus 145 ~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 145 NMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCcCEEeccCCCCC
Confidence 45556689999999999875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0037 Score=69.91 Aligned_cols=141 Identities=17% Similarity=0.186 Sum_probs=84.6
Q ss_pred ccccccccEEEEEEEEC--------CCcEEEEEEccCccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEEEEE
Q 002410 611 KKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~--------~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~LV~E 681 (927)
+.|..|....+|+.... +++.+++|+.... ......+.+|.++++.+. +.-..++++.+.+ .+|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45777888889999875 2578999986432 223456678999998884 3333566766654 29999
Q ss_pred ecCCCCHHH-----------------HhccCC--CCCCC--CHHHHHHHHHHHHH-------------------HHHHHH
Q 002410 682 YMHNGTLRD-----------------RLHGSV--NQKPL--DWLTRLQIAHDAAK-------------------GLEYLH 721 (927)
Q Consensus 682 ~~~~gsL~~-----------------~L~~~~--~~~~l--~~~~~~~i~~qia~-------------------gL~~LH 721 (927)
|++|..|.. .|+... ..+.. -+.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999865421 111110 11122 24555555544422 223332
Q ss_pred h-----cCCCCeEecCCCCCcccccCC----CcEEEeecccccc
Q 002410 722 T-----GCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLSRQ 756 (927)
Q Consensus 722 ~-----~~~~~ivH~DLkp~NILld~~----~~~kL~DFGla~~ 756 (927)
+ .....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 123578999999999999876 7899999998754
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.56 E-value=0.002 Score=60.57 Aligned_cols=55 Identities=31% Similarity=0.408 Sum_probs=39.8
Q ss_pred EEEecCCCCc-ccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeeccccccc
Q 002410 413 KIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELT 469 (927)
Q Consensus 413 ~L~L~~n~l~-g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~ 469 (927)
.++.++++|+ ..+|..|. ++|+.|+|++|+|+...+. |..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 7888888886 46775433 3577888888888777665 677777777777777654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.49 E-value=0.0041 Score=69.21 Aligned_cols=72 Identities=13% Similarity=0.173 Sum_probs=44.6
Q ss_pred ccccccccEEEEEEEECC---------CcEEEEEEccCccchhHHHHHHHHHHHHhcCCCc-eeeeeeeeecCceEEEEE
Q 002410 611 KKIGKGSFGSVYYGKMKD---------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~---------g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~Hpn-Iv~l~~~~~~~~~~~LV~ 680 (927)
+.|+.|....+|+....+ ++.+++|+....... ......|.++++.+...+ ..++++... -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 567888888999998764 268999987643221 112357888888885333 345665442 26899
Q ss_pred EecCCCC
Q 002410 681 EYMHNGT 687 (927)
Q Consensus 681 E~~~~gs 687 (927)
||++|..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.00028 Score=83.71 Aligned_cols=102 Identities=12% Similarity=0.157 Sum_probs=69.8
Q ss_pred CceEEEEecCCCCcccCCcccc-CCcccceecccCC-CCCCC-CCC-cCcccccceeecccccccCCCCCcCC----Ccc
Q 002410 409 PRITKIALSGKNLKGEIPPELK-NMEALTELWLDGN-FLTGP-LPD-MSRLIDLRIVHLENNELTGSLPSYMG----SLP 480 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~-~l~~L~~L~Ls~N-~l~g~-~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~----~l~ 480 (927)
++|+.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++. +.++++|+.|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4788888888888877777775 6888888888888 55442 344 34788888888888888765544443 566
Q ss_pred ccccccccccCCCCCCCccc-------cCCceeeeecCC
Q 002410 481 NLQELHIENNSFVGEIPPAL-------LTGKVIFKYDNN 512 (927)
Q Consensus 481 ~L~~L~l~~N~l~g~iP~~~-------~~~~~~~~~~~N 512 (927)
+|+.|++++|. +.++... ...+..+.+.+|
T Consensus 185 ~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 185 SLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp CCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred cCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 88888888886 2333221 134556666655
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=96.45 E-value=0.00074 Score=80.06 Aligned_cols=78 Identities=14% Similarity=0.145 Sum_probs=38.0
Q ss_pred ceEEEEecCCCCccc----CCccccCCcccceecccCCCCCCCCC----C-cCcccccceeecccccccCCCCCcCCCcc
Q 002410 410 RITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGPLP----D-MSRLIDLRIVHLENNELTGSLPSYMGSLP 480 (927)
Q Consensus 410 ~l~~L~L~~n~l~g~----ip~~l~~l~~L~~L~Ls~N~l~g~~p----~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~ 480 (927)
+|+.|+|++|.+++. ++..+.++++|+.|+|++|.+++..+ . +.++++|+.|+|++|.+.+ +|..+.+++
T Consensus 165 ~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~ 243 (592)
T 3ogk_B 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAA 243 (592)
T ss_dssp TCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCT
T ss_pred CCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhh
Confidence 455555555555443 33334445555555555555553221 1 3445555555555555553 444444444
Q ss_pred cccccccc
Q 002410 481 NLQELHIE 488 (927)
Q Consensus 481 ~L~~L~l~ 488 (927)
+|+.|+++
T Consensus 244 ~L~~L~l~ 251 (592)
T 3ogk_B 244 NLEEFCGG 251 (592)
T ss_dssp TCCEEEEC
T ss_pred HHHhhccc
Confidence 44444444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0094 Score=68.38 Aligned_cols=73 Identities=11% Similarity=0.079 Sum_probs=48.0
Q ss_pred ccccccccEEEEEEEECC-CcEEEEEEccCccchhHHHHHHHHHHHHhcCCCce-eeeeeeeecCceEEEEEEecCCCCH
Q 002410 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVYEYMHNGTL 688 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnI-v~l~~~~~~~~~~~LV~E~~~~gsL 688 (927)
+.|+.|....+|+....+ ++.+++|+........ -...+|..+++.|...++ .++++.+.. .+|+||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 568889999999999875 5788999875432111 112579999998864444 567776632 259999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.34 E-value=0.013 Score=64.47 Aligned_cols=68 Identities=13% Similarity=0.244 Sum_probs=44.6
Q ss_pred cccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcC---CCceeeeeee------eecCceEEEEEEecC
Q 002410 614 GKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGY------CEEEHQRILVYEYMH 684 (927)
Q Consensus 614 G~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~---HpnIv~l~~~------~~~~~~~~LV~E~~~ 684 (927)
|.|....||+....+| .+++|+...... ..|+.+++.|. -|.+.+++.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444689999988777 899998765432 35666666663 1224454432 233567899999999
Q ss_pred CCCH
Q 002410 685 NGTL 688 (927)
Q Consensus 685 ~gsL 688 (927)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8755
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.27 E-value=0.00022 Score=84.59 Aligned_cols=105 Identities=14% Similarity=0.111 Sum_probs=69.3
Q ss_pred CceEEEEec--C----CCCcc-----cCCccccCCcccceecccCCCCCCCCC-CcCc-ccccceeecccccccCCCCCc
Q 002410 409 PRITKIALS--G----KNLKG-----EIPPELKNMEALTELWLDGNFLTGPLP-DMSR-LIDLRIVHLENNELTGSLPSY 475 (927)
Q Consensus 409 ~~l~~L~L~--~----n~l~g-----~ip~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~-l~~L~~L~Ls~N~l~g~iP~~ 475 (927)
++++.|+|+ + +++++ .++.-+.++++|+.|+|++ ++++..+ .+.. +++|+.|+|++|.+++..+..
T Consensus 397 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~ 475 (594)
T 2p1m_B 397 PNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHH 475 (594)
T ss_dssp TTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHH
T ss_pred CCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHH
Confidence 578888888 3 55552 1222366778888888876 5555433 3444 788888888888887655554
Q ss_pred C-CCccccccccccccCCCCCCCcccc---CCceeeeecCCCC
Q 002410 476 M-GSLPNLQELHIENNSFVGEIPPALL---TGKVIFKYDNNPK 514 (927)
Q Consensus 476 l-~~l~~L~~L~l~~N~l~g~iP~~~~---~~~~~~~~~~N~~ 514 (927)
+ ..+++|+.|+|++|.+++..+..+. ..+..+.+.+|+.
T Consensus 476 l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 476 VLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 4 5678888888888888644333222 2556667777654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.07 E-value=0.064 Score=54.44 Aligned_cols=103 Identities=12% Similarity=0.054 Sum_probs=68.8
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccccc
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 765 (927)
-+|.++|... +.++++.+++.++.|.+.+|.-+-.. +.-..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc----------
Confidence 3789998864 68899999999999999998776211 1111334456889999999888764 1111
Q ss_pred cccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 002410 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807 (927)
Q Consensus 766 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~P 807 (927)
.....+.|||... ...+.+.=|||+|++||.-+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0123466888764 3557889999999999999875555
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.76 E-value=0.0011 Score=65.58 Aligned_cols=83 Identities=12% Similarity=0.103 Sum_probs=62.5
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCC-CCCC-CCCcCcc----cccceeeccccc-ccCCCCCcCCCccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNF-LTGP-LPDMSRL----IDLRIVHLENNE-LTGSLPSYMGSLPN 481 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~-l~g~-~p~~~~l----~~L~~L~Ls~N~-l~g~iP~~l~~l~~ 481 (927)
.+|++|||+++.++-.==..+.+|++|+.|+|+++. ++.. +-.+..+ ++|+.|+|++|. ++..==..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999875444567899999999999985 6542 2235553 479999999984 66332235678899
Q ss_pred cccccccccC
Q 002410 482 LQELHIENNS 491 (927)
Q Consensus 482 L~~L~l~~N~ 491 (927)
|+.|+|++..
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 9999998875
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=95.74 E-value=0.0013 Score=73.27 Aligned_cols=86 Identities=15% Similarity=0.272 Sum_probs=50.7
Q ss_pred CceEEEEecCCCCcccCCcccc--CCcccceecccC--CCCCCC--C----CCc--CcccccceeecccccccCCCCCcC
Q 002410 409 PRITKIALSGKNLKGEIPPELK--NMEALTELWLDG--NFLTGP--L----PDM--SRLIDLRIVHLENNELTGSLPSYM 476 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~--~l~~L~~L~Ls~--N~l~g~--~----p~~--~~l~~L~~L~Ls~N~l~g~iP~~l 476 (927)
++|+.|+|..+++....-..+. .|++|+.|+|+. |...+. + +.+ ..+++|+.|+|.+|.+.+..+..+
T Consensus 193 ~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~l 272 (362)
T 2ra8_A 193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMF 272 (362)
T ss_dssp TTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHH
T ss_pred CCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHH
Confidence 4677777777766544333443 677777777753 222221 1 112 246777777777777664333322
Q ss_pred ---CCccccccccccccCCCC
Q 002410 477 ---GSLPNLQELHIENNSFVG 494 (927)
Q Consensus 477 ---~~l~~L~~L~l~~N~l~g 494 (927)
..+++|+.|+|+.|.+.+
T Consensus 273 a~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 273 LESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp HHCSSGGGCSEEECCSSCCBH
T ss_pred HhCccCCCCCEEECCCCCCCh
Confidence 246777777787777764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=95.69 E-value=0.0091 Score=55.97 Aligned_cols=49 Identities=29% Similarity=0.399 Sum_probs=26.7
Q ss_pred eecccCCCCC-CCCC-CcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 437 ELWLDGNFLT-GPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 437 ~L~Ls~N~l~-g~~p-~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.++.++++|+ ..+| .+. .+|+.|+|++|+|+..-+..|..+++|+.|+|
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 62 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHL 62 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEEC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEe
Confidence 6777777776 2333 322 24667777777777332334455555554433
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=95.60 E-value=0.001 Score=73.99 Aligned_cols=103 Identities=17% Similarity=0.156 Sum_probs=60.4
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCC-Cc--Ccccccceeeccc--ccccCC-----CCCcC-
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DM--SRLIDLRIVHLEN--NELTGS-----LPSYM- 476 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p-~~--~~l~~L~~L~Ls~--N~l~g~-----iP~~l- 476 (927)
.++|+.|+|++|.-. .++. + .+++|+.|+|..|.++...- .+ ..+++|+.|+|+. |...|. +-..+
T Consensus 171 ~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~ 247 (362)
T 2ra8_A 171 MPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS 247 (362)
T ss_dssp CTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC
T ss_pred CCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHh
Confidence 468888888877311 2443 3 37888888888777654322 23 3678888888753 222221 11122
Q ss_pred -CCccccccccccccCCCCCCCcccc-----CCceeeeecCCC
Q 002410 477 -GSLPNLQELHIENNSFVGEIPPALL-----TGKVIFKYDNNP 513 (927)
Q Consensus 477 -~~l~~L~~L~l~~N~l~g~iP~~~~-----~~~~~~~~~~N~ 513 (927)
..+++|+.|+|.+|.+....+..+. ..+..+.++.|.
T Consensus 248 ~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~ 290 (362)
T 2ra8_A 248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGV 290 (362)
T ss_dssp TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSC
T ss_pred cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCC
Confidence 2478888888888887644333222 245566666554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=94.89 E-value=0.022 Score=64.23 Aligned_cols=100 Identities=14% Similarity=0.133 Sum_probs=65.1
Q ss_pred ceEEEEecCCCCcccCCccccCCcccceecccCCCCCC----CCC--CcCcccccceeecccccccCCCCCcCCCccccc
Q 002410 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG----PLP--DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 483 (927)
Q Consensus 410 ~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g----~~p--~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~ 483 (927)
.|+.|.| .++++..-+..|.+|++|+.|+|.+|.+.. .++ .|.+|++|+.++|.+ +++-.-...|.+|++|+
T Consensus 249 ~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~ 326 (401)
T 4fdw_A 249 GITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVT 326 (401)
T ss_dssp CCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCC
T ss_pred CccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCcc
Confidence 5777777 455663445678888888888888887761 233 378888888888884 46623334677788888
Q ss_pred cccccccCCCCCCCccccC--CceeeeecCCC
Q 002410 484 ELHIENNSFVGEIPPALLT--GKVIFKYDNNP 513 (927)
Q Consensus 484 ~L~l~~N~l~g~iP~~~~~--~~~~~~~~~N~ 513 (927)
.|.|.+| ++ .|+...+. .+..+.+.+|.
T Consensus 327 ~l~lp~~-l~-~I~~~aF~~~~L~~l~l~~n~ 356 (401)
T 4fdw_A 327 QLTIPAN-VT-QINFSAFNNTGIKEVKVEGTT 356 (401)
T ss_dssp EEEECTT-CC-EECTTSSSSSCCCEEEECCSS
T ss_pred EEEECcc-cc-EEcHHhCCCCCCCEEEEcCCC
Confidence 8888554 55 56655544 34455555553
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=94.61 E-value=0.034 Score=62.66 Aligned_cols=90 Identities=11% Similarity=0.101 Sum_probs=69.8
Q ss_pred CceEEEEecCCCCc-----ccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccc
Q 002410 409 PRITKIALSGKNLK-----GEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNL 482 (927)
Q Consensus 409 ~~l~~L~L~~n~l~-----g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L 482 (927)
.+|+.|+|.+|.+. ..-+..|.+|++|+.|+|.+ +++..... |.+|++|+.|+|.+| ++-.-+..|.++ +|
T Consensus 271 ~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L 347 (401)
T 4fdw_A 271 PELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GI 347 (401)
T ss_dssp TTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CC
T ss_pred CCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CC
Confidence 47899999888765 23446799999999999994 56665553 999999999999766 663345688899 99
Q ss_pred ccccccccCCCCCCCccccC
Q 002410 483 QELHIENNSFVGEIPPALLT 502 (927)
Q Consensus 483 ~~L~l~~N~l~g~iP~~~~~ 502 (927)
+.|++++|.+. .++...+.
T Consensus 348 ~~l~l~~n~~~-~l~~~~F~ 366 (401)
T 4fdw_A 348 KEVKVEGTTPP-QVFEKVWY 366 (401)
T ss_dssp CEEEECCSSCC-BCCCSSCC
T ss_pred CEEEEcCCCCc-cccccccc
Confidence 99999999887 56654443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.22 E-value=0.13 Score=58.25 Aligned_cols=140 Identities=14% Similarity=0.191 Sum_probs=84.5
Q ss_pred ccccccccEEEEEEEECC--------CcEEEEEEccCccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEEEEE
Q 002410 611 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~--------g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~LV~E 681 (927)
+.+..|-...+|+....+ ++.+++|+..... ...-+..+|.++++.+. +.-..++++.+. -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 567778888999998763 5789999865432 11122357888888885 322345555432 268999
Q ss_pred ecCCCCHHH--------------H---hccC-------C---CCCCCCHHHHHHHHHHHH-------------------H
Q 002410 682 YMHNGTLRD--------------R---LHGS-------V---NQKPLDWLTRLQIAHDAA-------------------K 715 (927)
Q Consensus 682 ~~~~gsL~~--------------~---L~~~-------~---~~~~l~~~~~~~i~~qia-------------------~ 715 (927)
|++|..|.. . ++.. . ...+.-+.++.++..++- .
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999865311 0 1100 0 111112444444433321 2
Q ss_pred HHHHHHh---------------------cCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 716 GLEYLHT---------------------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 716 gL~~LH~---------------------~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
.+..|.+ .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2333321 11356899999999999 8888999999998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.55 E-value=0.53 Score=52.71 Aligned_cols=30 Identities=30% Similarity=0.383 Sum_probs=25.2
Q ss_pred CeEecCCCCCcccc------cCCCcEEEeecccccc
Q 002410 727 GIIHRDVKSSNILL------DINMRAKVSDFGLSRQ 756 (927)
Q Consensus 727 ~ivH~DLkp~NILl------d~~~~~kL~DFGla~~ 756 (927)
.++|+|+.+.||++ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567799999998865
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=90.69 E-value=0.026 Score=56.74 Aligned_cols=83 Identities=13% Similarity=0.192 Sum_probs=58.8
Q ss_pred CceEEEEecCC-CCcc----cCCccccCCcccceecccCCCCCCCC----CC-cCcccccceeecccccccCC----CCC
Q 002410 409 PRITKIALSGK-NLKG----EIPPELKNMEALTELWLDGNFLTGPL----PD-MSRLIDLRIVHLENNELTGS----LPS 474 (927)
Q Consensus 409 ~~l~~L~L~~n-~l~g----~ip~~l~~l~~L~~L~Ls~N~l~g~~----p~-~~~l~~L~~L~Ls~N~l~g~----iP~ 474 (927)
+.|++|+|++| ++.. .+-..+..-+.|+.|+|++|+|...- -+ +..-+.|+.|+|++|+|... |-+
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 46889999986 6642 24456777789999999999986421 12 44557899999999998732 223
Q ss_pred cCCCccccccccccccC
Q 002410 475 YMGSLPNLQELHIENNS 491 (927)
Q Consensus 475 ~l~~l~~L~~L~l~~N~ 491 (927)
.+..-+.|+.|+|++|.
T Consensus 121 aL~~N~tL~~L~L~n~~ 137 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQR 137 (197)
T ss_dssp HTTTTCCCSEEECCCCS
T ss_pred HHhhCCceeEEECCCCc
Confidence 45445679999998764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=87.77 E-value=0.51 Score=52.09 Aligned_cols=87 Identities=13% Similarity=0.145 Sum_probs=58.4
Q ss_pred ceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCC-CcCCCccccccccc
Q 002410 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQELHI 487 (927)
Q Consensus 410 ~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~L~~L~l 487 (927)
.++.+.+.. ++...-...|.++++|+.+.|.+|.++..-.. |.++.+|+.+.|.++ ++ .|. ..|.+|.+|+.+.+
T Consensus 264 ~l~~i~l~~-~i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 264 ALKTLNFYA-KVKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTISY 340 (379)
T ss_dssp TCCEEEECC-CCSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCCC
T ss_pred hhccccccc-cceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEE
Confidence 466666654 35523334677888888888888877765553 888888888888755 55 454 46778888888887
Q ss_pred cccCCCCCCCcccc
Q 002410 488 ENNSFVGEIPPALL 501 (927)
Q Consensus 488 ~~N~l~g~iP~~~~ 501 (927)
..| ++ .|....+
T Consensus 341 p~~-v~-~I~~~aF 352 (379)
T 4h09_A 341 PKS-IT-LIESGAF 352 (379)
T ss_dssp CTT-CC-EECTTTT
T ss_pred CCc-cC-EEchhHh
Confidence 654 44 4554444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=86.76 E-value=0.51 Score=52.55 Aligned_cols=77 Identities=12% Similarity=0.085 Sum_probs=47.0
Q ss_pred ceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCC-CcCcccccceeecccccccCCCC-CcCCCccccccccc
Q 002410 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQELHI 487 (927)
Q Consensus 410 ~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~L~~L~l 487 (927)
.|+.+.+.++ +...-...|.++++|+.++|.++ ++..-. .|.++.+|+.++|..| ++ .|+ ..|.+|++|+.++|
T Consensus 298 ~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~l 373 (394)
T 4fs7_A 298 SLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKVEL 373 (394)
T ss_dssp TCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEEEE
T ss_pred cccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEEEE
Confidence 5666666543 55222345777777777777644 443333 3777777777777666 55 343 46677777777777
Q ss_pred ccc
Q 002410 488 ENN 490 (927)
Q Consensus 488 ~~N 490 (927)
..|
T Consensus 374 p~~ 376 (394)
T 4fs7_A 374 PKR 376 (394)
T ss_dssp EGG
T ss_pred CCC
Confidence 544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=86.54 E-value=0.92 Score=50.40 Aligned_cols=86 Identities=13% Similarity=0.225 Sum_probs=41.6
Q ss_pred ceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCC-CcCcccccceeecccccccCCC-CCcCCCccccccccc
Q 002410 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSL-PSYMGSLPNLQELHI 487 (927)
Q Consensus 410 ~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~g~i-P~~l~~l~~L~~L~l 487 (927)
.++.+.+.++-.. .-...|.+++.|+.+.+. +.++.... .|.++.+|+.++|..| ++ .| ...|.+|.+|+.+.|
T Consensus 266 ~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~i 341 (394)
T 4gt6_A 266 YLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAI 341 (394)
T ss_dssp SCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEE
T ss_pred cccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEE
Confidence 3445555433221 223345556666666664 23333222 2566666666666543 33 23 235556666666666
Q ss_pred cccCCCCCCCcccc
Q 002410 488 ENNSFVGEIPPALL 501 (927)
Q Consensus 488 ~~N~l~g~iP~~~~ 501 (927)
..+ ++ .|+...+
T Consensus 342 p~s-v~-~I~~~aF 353 (394)
T 4gt6_A 342 PSS-VT-KIPESAF 353 (394)
T ss_dssp CTT-CC-BCCGGGG
T ss_pred Ccc-cC-EEhHhHh
Confidence 433 44 4554433
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=85.47 E-value=0.12 Score=50.88 Aligned_cols=70 Identities=10% Similarity=0.125 Sum_probs=49.1
Q ss_pred cCCccccCCcccceecccCCCCCCC-CCCcCcccccceeeccccc-ccCCCCCcCCCc----cccccccccccC-CC
Q 002410 424 EIPPELKNMEALTELWLDGNFLTGP-LPDMSRLIDLRIVHLENNE-LTGSLPSYMGSL----PNLQELHIENNS-FV 493 (927)
Q Consensus 424 ~ip~~l~~l~~L~~L~Ls~N~l~g~-~p~~~~l~~L~~L~Ls~N~-l~g~iP~~l~~l----~~L~~L~l~~N~-l~ 493 (927)
.+|.....--.|+.|||+++.++.. +..+..+++|+.|+|+++. ++..-=..++.+ ++|+.|+|+++. ++
T Consensus 52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT 128 (176)
T 3e4g_A 52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT 128 (176)
T ss_dssp GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC
T ss_pred cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC
Confidence 3455433335799999999987653 3457899999999999995 653222234443 479999999875 55
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=83.26 E-value=1.2 Score=49.10 Aligned_cols=88 Identities=16% Similarity=0.120 Sum_probs=64.8
Q ss_pred ceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCC-CcCcccccceeecccccccCCCC-CcCCCccccccccc
Q 002410 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQELHI 487 (927)
Q Consensus 410 ~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~L~~L~l 487 (927)
.|+.+.+..+ ++..-...|.++.+|+.+.+..+ +..... .|.++.+|+.+.|.+|.++ .|+ ..|.+|.+|+.+.|
T Consensus 241 ~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~aF~~c~~L~~i~l 317 (379)
T 4h09_A 241 ALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIE-TLEPRVFMDCVKLSSVTL 317 (379)
T ss_dssp SCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCC-EECTTTTTTCTTCCEEEC
T ss_pred cceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccc-eehhhhhcCCCCCCEEEc
Confidence 5777777665 55333456888999999998755 443333 3899999999999999888 554 57889999999999
Q ss_pred cccCCCCCCCccccC
Q 002410 488 ENNSFVGEIPPALLT 502 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~ 502 (927)
.++ ++ .|+...+.
T Consensus 318 p~~-l~-~I~~~aF~ 330 (379)
T 4h09_A 318 PTA-LK-TIQVYAFK 330 (379)
T ss_dssp CTT-CC-EECTTTTT
T ss_pred Ccc-cc-EEHHHHhh
Confidence 755 65 67665543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=82.10 E-value=1.1 Score=49.88 Aligned_cols=80 Identities=14% Similarity=0.213 Sum_probs=58.5
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCC-CcCcccccceeecccccccCCCC-CcCCCcccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQELH 486 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~L~~L~ 486 (927)
..|+.+.+. +++...-...|.+|++|+.++|..| ++..-. .|.++.+|+.+.|..+ ++ .|. ..|.+|++|+.++
T Consensus 288 ~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~ 363 (394)
T 4gt6_A 288 PALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIE 363 (394)
T ss_dssp TTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEE
T ss_pred cccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEE
Confidence 357778875 5566333456888999999999865 444333 3889999999999765 66 554 4788999999999
Q ss_pred ccccCC
Q 002410 487 IENNSF 492 (927)
Q Consensus 487 l~~N~l 492 (927)
+.+|..
T Consensus 364 ~~~~~~ 369 (394)
T 4gt6_A 364 YSGSRS 369 (394)
T ss_dssp ESSCHH
T ss_pred ECCcee
Confidence 887754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=80.56 E-value=0.11 Score=52.27 Aligned_cols=83 Identities=17% Similarity=0.167 Sum_probs=55.4
Q ss_pred CceEEEEecCCCCccc----CCccccCCcccceecccCCCCCCCCC-----CcCcccccceeecccccc---cC----CC
Q 002410 409 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGPLP-----DMSRLIDLRIVHLENNEL---TG----SL 472 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~----ip~~l~~l~~L~~L~Ls~N~l~g~~p-----~~~~l~~L~~L~Ls~N~l---~g----~i 472 (927)
..|+.|+|++|+|... |...+..-+.|+.|+|++|+|+..-- .+..-+.|+.|+|++|.. .. .|
T Consensus 70 ~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~i 149 (197)
T 1pgv_A 70 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 149 (197)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHH
Confidence 5799999999999743 33445566899999999999975321 255556799999997633 21 12
Q ss_pred CCcCCCccccccccccccC
Q 002410 473 PSYMGSLPNLQELHIENNS 491 (927)
Q Consensus 473 P~~l~~l~~L~~L~l~~N~ 491 (927)
-+.+..-+.|+.|+++.|.
T Consensus 150 a~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 150 MMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HHHHHHCSSCCEEECCCCC
T ss_pred HHHHHhCCCcCeEeccCCC
Confidence 2233334566666665544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 927 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-44 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.002 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-04 | |
| d1j7la_ | 263 | d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 1e-66
Identities = 78/276 (28%), Positives = 137/276 (49%), Gaps = 25/276 (9%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPL 666
++IG GSFG+VY GK +VAVK++ + + Q F EV +L + H N++
Sbjct: 12 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
+GY +V ++ +L LH + + + + IA A+G++YLH
Sbjct: 70 MGYSTAPQ-LAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLH---AK 123
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQ- 784
IIHRD+KS+NI L ++ K+ DFGL+ + +H G++ ++ PE Q
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 785 --LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842
+ +SDVY+FG+VL EL++G+ P S +N M+ +G + P L
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRG----YLSPDL-S 232
Query: 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878
V+ + + +C++++ RP +I+ +I+
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 4e-64
Identities = 67/271 (24%), Positives = 122/271 (45%), Gaps = 21/271 (7%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
+++G G FG V+ G +VAVK + S F+ E L+ ++ H+ LV L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
+E ++ EYM NG+L D L + L L +A A+G+ ++
Sbjct: 76 VVTQEP-IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
IHRD++++NIL+ + K++DFGL+R E++ A+ + + PE T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 789 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 848
SDV+SFG++L E+++ + E+ +++G + D
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERGYRMVRPDNCP-------- 236
Query: 849 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879
+ ++ C ++R RP + ++D
Sbjct: 237 -EELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 1e-63
Identities = 72/272 (26%), Positives = 124/272 (45%), Gaps = 21/272 (7%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 667
F ++IG G FG V+ G + +VA+K + + + F+ E ++ ++ H LV L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLY 66
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
G C E+ LV+E+M +G L D + + T L + D +G+ YL
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYL---EEAC 121
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 787
+IHRD+ + N L+ N KVSDFG++R +D S+ + V + PE + + +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 788 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 847
KSDV+SFGV++ E+ S K +E+ I G + P L
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDISTG--FRLYKPRLAST---- 229
Query: 848 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879
+ ++ C ++R RP ++ + +
Sbjct: 230 ---HVYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 2e-63
Identities = 74/301 (24%), Positives = 132/301 (43%), Gaps = 34/301 (11%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 670
+ IGKG FG V+ GK + G+EVAVKI S R+ E+ + H N++ I
Sbjct: 9 ESIGKGRFGEVWRGKWR-GEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 671 EEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-- 724
+++ Q LV +Y +G+L D L+ + + +++A A GL +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 725 ---NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE 778
P I HRD+KS NIL+ N ++D GL+ + + I GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 779 YY------GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG----AELNIVHWARSMIK 828
+ + +++D+Y+ G+V E+ + + +L + ++
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 829 KGDVISIVDPVLIGNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIV-----LAIQDSIK 882
K + P + + E++ +A++ +C G +R I L+ Q+ IK
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302
Query: 883 I 883
+
Sbjct: 303 M 303
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 4e-63
Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 21/272 (7%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 667
F K++G G FG V YGK + +VA+K++ + S +F+ E ++ + H LV L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
G C ++ ++ EYM NG L + L + L++ D + +EYL +
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQ 120
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 787
+HRD+ + N L++ KVSDFGLSR +D S ++ V + PE + +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 788 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 847
KSD+++FGV++ E+ S K +E I +G + + P L
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIAQG--LRLYRPHLASE---- 228
Query: 848 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879
++ + C ++ RP + ++ I D
Sbjct: 229 ---KVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 4e-62
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 12/215 (5%)
Query: 602 LEEATNNF--CKKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLSR 657
+E ++F ++G G+ G V+ K G +A K++ + Q + E+ +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 658 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 717
+ +V G + + + E+M G+L L + +++ KGL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117
Query: 718 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 777
YL I+HRDVK SNIL++ K+ DFG+S Q + + + GT Y+ P
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSP 172
Query: 778 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 812
E + +SD++S G+ L+E+ G+ P+ D
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-60
Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 27/272 (9%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
+ IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G
Sbjct: 11 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLG 67
Query: 669 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
EE + +V EYM G+L D L + L L+ + D + +EYL
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 123
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 787
+HRD+ + N+L+ + AKVSDFGL+++A + V + PE ++ +
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFST 179
Query: 788 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 847
KSDV+SFG++L E+ S + ++ ++KG + D
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPDGCP------- 226
Query: 848 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879
+ EV C RP ++ ++
Sbjct: 227 --PAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 4e-59
Identities = 69/274 (25%), Positives = 120/274 (43%), Gaps = 21/274 (7%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
K+G+G FG V+ G VA+K + + + F+ E ++ ++ H LV L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
EE +V EYM G+L D L G K L + +A A G+ Y+
Sbjct: 80 VVSEEP-IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 134
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
+HRD++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T K
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194
Query: 789 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 848
SDV+SFG++L EL + + E+ +++G +
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYRMPCPPECPE------- 241
Query: 849 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882
+ ++ QC + RP + + ++D
Sbjct: 242 --SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (511), Expect = 1e-58
Identities = 77/311 (24%), Positives = 123/311 (39%), Gaps = 49/311 (15%)
Query: 599 LPELEEATNNF--CKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQ-QFV 649
L LE NN + IG+G+FG V+ + VAVK++ + S Q F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 650 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG--------------- 694
E AL++ + N+V L+G C L++EYM G L + L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 695 ------SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 748
S PL +L IA A G+ YL +HRD+ + N L+ NM K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKI 181
Query: 749 SDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
+DFGLSR D + ++ PE + T +SDV+++GVVL E+ S
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 808 VSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR 867
E+ ++ G++++ + + + + C + R
Sbjct: 242 PYYGMAHEEV------IYYVRDGNILACPENCPL---------ELYNLMRLCWSKLPADR 286
Query: 868 PKMQEIVLAIQ 878
P I +Q
Sbjct: 287 PSFCSIHRILQ 297
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 4e-58
Identities = 67/276 (24%), Positives = 124/276 (44%), Gaps = 29/276 (10%)
Query: 611 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 665
K++G G+FG+V G + K VAVKI+ + + + + E ++ ++ + +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
+IG CE E +LV E G L L + + +++ H + G++YL
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE---E 125
Query: 726 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVGYLDPEYYGNQ 783
+HRD+ + N+LL AK+SDFGLS+ D + + + V + PE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 784 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843
+ + KSDV+SFGV++ E S + G+E+ +M++KG+ +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------TAMLEKGERMGCPAGCP--- 236
Query: 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879
+ ++ C +RP + L +++
Sbjct: 237 ------REMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (504), Expect = 6e-58
Identities = 73/276 (26%), Positives = 118/276 (42%), Gaps = 21/276 (7%)
Query: 608 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 666
K+G G +G VY G K VAVK + + + ++F+ E A++ I H NLV L
Sbjct: 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL 78
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
+G C E ++ E+M G L D L N++ + + L +A + +EYL
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KK 134
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 786
IHRD+ + N L+ N KV+DFGLSR D + A+ + + PE + +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 787 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 846
KSDV++FGV+L E+ + I V +++
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQVYELLEKDYRMERPE 239
Query: 847 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882
++ E+ C + RP EI A + +
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 6e-58
Identities = 75/274 (27%), Positives = 116/274 (42%), Gaps = 30/274 (10%)
Query: 609 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 665
F +IG+GSF +VY G + EVA + D ++ Q+F E +L + H N+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 666 LIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
E + +LV E M +GTL+ L K + KGL++LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 722 TGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 780
T P IIHRD+K NI + K+ D GL+ GT ++ PE Y
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMY 185
Query: 781 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840
++ E DVY+FG+ +LE+ + + P S E + G + D V
Sbjct: 186 -EEKYDESVDVYAFGMCMLEMATSEYPYS------ECQNAAQIYRRVTSGVKPASFDKVA 238
Query: 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 874
I VK E+ C+ Q R +++++
Sbjct: 239 IPEVK--------EIIEGCIRQNKDERYSIKDLL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 9e-58
Identities = 63/288 (21%), Positives = 123/288 (42%), Gaps = 30/288 (10%)
Query: 601 ELEEATNNFC---KKIGKGSFGSVYYGKMK---DGKEVAVKIM-ADSCSHRTQQFVTEVA 653
+L +N ++G G+FGSV G + +VA+K++ + T++ + E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 654 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 713
++ ++ + +V LIG C+ +LV E G L L G ++ + ++ H
Sbjct: 62 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQV 118
Query: 714 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGT 771
+ G++YL +HRD+ + N+LL AK+SDFGLS+ D S +
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 772 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 831
+ + PE ++ + +SDV+S+GV + E +S + + G E+ + I++G
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------MAFIEQGK 229
Query: 832 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879
+ + + C + RP + ++
Sbjct: 230 RMECPPECP---------PELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (500), Expect = 3e-57
Identities = 72/303 (23%), Positives = 136/303 (44%), Gaps = 42/303 (13%)
Query: 601 ELEEATNNFC-----------KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT 645
+ EA F + IG G FG V G +K + VA+K + + +
Sbjct: 11 DPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ 70
Query: 646 -QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWL 704
+ F++E +++ + H N++ L G + +++ E+M NG+L L N +
Sbjct: 71 RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVI 128
Query: 705 TRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764
+ + A G++YL + +HRD+ + NIL++ N+ KVSDFGLSR E+D +
Sbjct: 129 QLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185
Query: 765 SSVA----RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 819
+ + + + + PE ++ T SDV+S+G+V+ E++S G++P +N
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245
Query: 820 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879
+ + D S + ++ + C ++ RPK +IV +
Sbjct: 246 IEQDYRLPPPMDCPS----------------ALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289
Query: 880 SIK 882
I+
Sbjct: 290 MIR 292
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 8e-57
Identities = 68/275 (24%), Positives = 110/275 (40%), Gaps = 25/275 (9%)
Query: 608 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLV 664
IG GS+G + K DGK + K + Q V+EV LL + H N+V
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 665 PLIGYCEEEHQRIL--VYEYMHNGTLRDRLH-GSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
+ L V EY G L + G+ ++ LD L++ L+ H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 722 --TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 779
+ ++HRD+K +N+ LD K+ DFGL+R D + + GT Y+ PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF-VGTPYYMSPEQ 185
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839
EKSD++S G +L EL + P + I++G I
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG-------KIREGKFRRIPYRY 238
Query: 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 874
+ E+ + + + + RP ++EI+
Sbjct: 239 SD---------ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 1e-56
Identities = 68/271 (25%), Positives = 113/271 (41%), Gaps = 33/271 (12%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 666
++IG GSFG+VY+ + + + VA+K M + + Q + EV L ++ H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
G EH LV EY ++KPL + + H A +GL YLH +
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY---GNQ 783
+IHRDVK+ NILL K+ DFG + + + GT ++ PE
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEG 189
Query: 784 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843
Q K DV+S G+ +EL K P+ + + L I + + ++
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------HIAQNESPALQSGHWSEY 242
Query: 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 874
+ C+++ RP + ++
Sbjct: 243 FR--------NFVDSCLQKIPQDRPTSEVLL 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-56
Identities = 75/286 (26%), Positives = 121/286 (42%), Gaps = 29/286 (10%)
Query: 603 EEATNNFCKKIGKGSFGSVYYGKMKDGK----EVAVKIM-ADSCSHRTQQFVTEVALLSR 657
+F + IG+G FG VY+G + D AVK + + QF+TE ++
Sbjct: 25 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84
Query: 658 IHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 716
H N++ L+G C E ++V YM +G LR+ + AKG
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKG 142
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVG 773
+ + +HRD+ + N +LD KV+DFGL+R E D H + A+ V
Sbjct: 143 M---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 774 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 833
++ E Q+ T KSDV+SFGV+L EL++ P ++N + +G +
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITV-YLLQGRRL 253
Query: 834 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879
+ + EV ++C + RP E+V I
Sbjct: 254 LQPE---------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-56
Identities = 58/269 (21%), Positives = 114/269 (42%), Gaps = 26/269 (9%)
Query: 611 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
++G G+FG VY + K+ A K++ + ++ E+ +L+ H N+V L+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 729
E+ ++ E+ G + + ++PL + L YLH + II
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLH---DNKII 132
Query: 730 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-----YGNQQ 784
HRD+K+ NIL ++ K++DFG+S + + S GT ++ PE ++
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-IGTPYWMAPEVVMCETSKDRP 191
Query: 785 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844
K+DV+S G+ L+E+ + P + L I K + ++ P +
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL-------KIAKSEPPTLAQPSRWSS- 243
Query: 845 KIESIWRIAEVAIQCVEQRGFSRPKMQEI 873
+ +C+E+ +R ++
Sbjct: 244 ------NFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-55
Identities = 75/280 (26%), Positives = 129/280 (46%), Gaps = 28/280 (10%)
Query: 611 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLV 664
K IG G FG VY G +K VA+K + + + + F+ E ++ + H N++
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
L G + +++ EYM NG L L L + + A G++YL
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA--- 127
Query: 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYYGN 782
N +HRD+ + NIL++ N+ KVSDFGLSR E+D T+ +S + + + PE
Sbjct: 128 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187
Query: 783 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842
++ T SDV+SFG+V+ E+++ + E +V+ ++
Sbjct: 188 RKFTSASDVWSFGIVMWEVMTYGERPYWEL---------------SNHEVMKAINDGFRL 232
Query: 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882
++ I ++ +QC +Q RPK +IV + I+
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-55
Identities = 67/268 (25%), Positives = 109/268 (40%), Gaps = 30/268 (11%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPL 666
+ +GKG FG+VY + K +A+K++ + + Q EV + S + H N++ L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
GY + + L+ EY GT+ L D + A L Y H +
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCH---SK 125
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 786
+IHRD+K N+LL K++DFG S A GT+ YL PE +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPEMIEGRMHD 182
Query: 787 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 846
EK D++S GV+ E + GK P F A + R + V
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPP-----FEANTYQETYKRISRVEFTFPDFVTEGAR----- 232
Query: 847 ESIWRIAEVAIQCVEQRGFSRPKMQEIV 874
++ + ++ RP ++E++
Sbjct: 233 -------DLISRLLKHNPSQRPMLREVL 253
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 3e-55
Identities = 74/298 (24%), Positives = 124/298 (41%), Gaps = 41/298 (13%)
Query: 609 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 660
F K +G G+FG V VAVK++ + + ++E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG---------------SVNQKPLDWLT 705
N+V L+G C +++ EY G L + L ++ LD
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 706 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-I 764
L ++ AKG+ +L + IHRD+ + NILL K+ DFGL+R + D + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 824
AR V ++ PE N T +SDV+S+G+ L EL S + +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGMPVDSKFY 258
Query: 825 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882
MIK+G + + + ++ C + RP ++IV I+ I
Sbjct: 259 KMIKEGFRMLSPEHAP---------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-54
Identities = 54/198 (27%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
+KIG+G+ G+VY G+EVA++ M + + + E+ ++ + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 729
+ +V EY+ G+L D + + +D + + + LE+LH + +I
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 730 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 789
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 790 DVYSFGVVLLELISGKKP 807
D++S G++ +E+I G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-54
Identities = 77/296 (26%), Positives = 128/296 (43%), Gaps = 38/296 (12%)
Query: 608 NFCKKIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHR-TQQFVTEVALLSRI-HHRN 662
F IG+G+FG V ++K + A+K M + S + F E+ +L ++ HH N
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 663 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTRLQI 709
++ L+G CE L EY +G L D L + L L
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 710 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 769
A D A+G++YL IHRD+ + NIL+ N AK++DFGLSR E + ++ R
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGR 187
Query: 770 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 829
V ++ E T SDV+S+GV+L E++S AEL + +
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEKLPQ 241
Query: 830 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885
G + + ++ QC ++ + RP +I++++ ++ K
Sbjct: 242 GYRLEKPLNCD---------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-53
Identities = 64/295 (21%), Positives = 113/295 (38%), Gaps = 46/295 (15%)
Query: 609 FCKKIGKGSFGSVYYGKMKD------GKEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 660
F K +G G+FG V +VAVK++ + S + ++E+ +++++ H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 661 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG--------------------SVNQKP 700
N+V L+G C L++EY G L + L +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 701 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760
L + L A+ AKG+E+L +HRD+ + N+L+ K+ DFGL+R D
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 761 LTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 819
+ + AR V ++ PE T KSDV+S+G++L E+ S
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------------ 265
Query: 820 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 874
+ + ++ + + I + C RP +
Sbjct: 266 --PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 8e-53
Identities = 68/281 (24%), Positives = 112/281 (39%), Gaps = 29/281 (10%)
Query: 609 FCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHR 661
+K+G GSFG V G+ VAVK + + + F+ EV + + HR
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 662 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
NL+ L G ++ V E G+L DRL +Q T + A A+G+ YL
Sbjct: 72 NLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYLDPEY 779
+ IHRD+ + N+LL K+ DFGL R ++ H + + + PE
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839
+ + SD + FGV L E+ + + LN + K+G+ + +
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880
I V +QC + RP + + ++
Sbjct: 241 ---------PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 1e-52
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 12/211 (5%)
Query: 599 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLS 656
+P +E+ + +G+G++G V + + VAVKI+ + E+ +
Sbjct: 1 VPFVEDWD--LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 58
Query: 657 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 716
++H N+V G+ E + + L EY G L DR+ + + H G
Sbjct: 59 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAG 115
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYL 775
+ YLH GI HRD+K N+LLD K+SDFGL+ + + + GT+ Y+
Sbjct: 116 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 776 DPEYYGNQQL-TEKSDVYSFGVVLLELISGK 805
PE ++ E DV+S G+VL +++G+
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 203
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-52
Identities = 63/282 (22%), Positives = 117/282 (41%), Gaps = 26/282 (9%)
Query: 609 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNL 663
+ IG+G FG V+ G + VA+K + S ++F+ E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
V LIG E ++ E G LR V + LD + + A+ + L YL
Sbjct: 71 VKLIGVITENP-VWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLE-- 125
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 783
+ +HRD+ + N+L+ N K+ DFGLSR E+ + +S + + ++ PE +
Sbjct: 126 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 784 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843
+ T SDV+ FGV + E++ ++ I+ G+ + +
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGERLPMPPNCPP-- 236
Query: 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885
+ + +C RP+ E+ + ++ EK
Sbjct: 237 -------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 6e-51
Identities = 65/289 (22%), Positives = 123/289 (42%), Gaps = 33/289 (11%)
Query: 609 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHR 661
+++G+GSFG VY G K VA+K + ++ S R +F+ E +++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 662 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------GSVNQKPLDWLTRLQIAHDAA 714
++V L+G + +++ E M G L+ L + P +Q+A + A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 715 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVG 773
G+ YL +HRD+ + N ++ + K+ DFG++R E D V
Sbjct: 144 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 774 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 833
++ PE + T SDV+SFGVVL E+ + + ++ + +G ++
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------LRFVMEGGLL 254
Query: 834 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882
D + E+ C + RP EI+ +I++ ++
Sbjct: 255 DKPDNCP---------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (453), Expect = 3e-50
Identities = 45/200 (22%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
+++G G+FG V+ G+ K + E+++++++HH L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 729
E++++ +L+ E++ G L DR+ + + A +GL+++H I+
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH---EHSIV 149
Query: 730 HRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 787
H D+K NI+ + K+ DFGL+ + D + T + PE + +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGF 207
Query: 788 KSDVYSFGVVLLELISGKKP 807
+D+++ GV+ L+SG P
Sbjct: 208 YTDMWAIGVLGYVLLSGLSP 227
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (451), Expect = 6e-50
Identities = 46/200 (23%), Positives = 90/200 (45%), Gaps = 10/200 (5%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
+++G G+FG V+ + G A K + + E+ +S + H LV L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 729
E++++ +++YE+M G L +++ + ++ KGL ++H +
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYV 146
Query: 730 HRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 787
H D+K NI+ + K+ DFGL+ + + + GT + PE + +
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGY 204
Query: 788 KSDVYSFGVVLLELISGKKP 807
+D++S GV+ L+SG P
Sbjct: 205 YTDMWSVGVLSYILLSGLSP 224
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-49
Identities = 60/271 (22%), Positives = 127/271 (46%), Gaps = 28/271 (10%)
Query: 611 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLV 664
K +G G+FG+VY G E VA+K + ++ S + ++ + E +++ + + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
L+G C + L+ + M G L D + ++ + L AKG+ YL
Sbjct: 75 RLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL---E 128
Query: 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQ 783
+ ++HRD+ + N+L+ K++DFGL++ E+ + + + + ++ E ++
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 784 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843
T +SDV+S+GV + EL++ +E+ S+++KG+ + I
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------SSILEKGERLPQPPICTI-- 240
Query: 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 874
+ + ++C SRPK +E++
Sbjct: 241 -------DVYMIMVKCWMIDADSRPKFRELI 264
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 8e-49
Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 40/297 (13%)
Query: 609 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 660
K +G+G+FG V + VAVK++ + +H + ++E+ +L I HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 661 RNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTR 706
N+V L+G C + + ++ E+ G L L + + L
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 707 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-S 765
+ + AKG+E+L + IHRD+ + NILL K+ DFGL+R +D ++
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 766 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 825
AR + ++ PE ++ T +SDV+SFGV+L E+ S + I
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCR 248
Query: 826 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882
+K+G + D + + + C RP E+V + + ++
Sbjct: 249 RLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-48
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 609 FCKKIGKGSFGSVYYGK-MKDGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLV 664
F K +G+GSF +V + + +E A+KI+ ++ E ++SR+ H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
L +++ + Y NG L + D + LEYLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH--- 125
Query: 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQ 783
GIIHRD+K NILL+ +M +++DFG ++ + E ++ GT Y+ PE +
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 784 QLTEKSDVYSFGVVLLELISGKKP 807
+ SD+++ G ++ +L++G P
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-47
Identities = 64/294 (21%), Positives = 123/294 (41%), Gaps = 42/294 (14%)
Query: 609 FCKKIGKGSFGSVYYGKMK--------DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRI- 658
K +G+G+FG V + +VAVK++ +D+ ++E+ ++ I
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 659 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------------GSVNQKPLDWLT 705
H+N++ L+G C ++ ++ EY G LR+ L ++ L
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 706 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 765
+ A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+R +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 766 S-VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 824
+ R V ++ PE ++ T +SDV+SFGV+L E+ + V
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY------PGVPVEELF 247
Query: 825 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 878
++K+G + + + C RP +++V +
Sbjct: 248 KLLKEGHRMDKPSNCT---------NELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 6e-47
Identities = 61/322 (18%), Positives = 136/322 (42%), Gaps = 36/322 (11%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
+ +G+G FG V+ K K + + + E+++L+ HRN++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHES 69
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 729
E + ++++E++ + +R++ + L+ + H + L++LH + I
Sbjct: 70 FESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH---SHNIG 124
Query: 730 HRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 787
H D++ NI+ + K+ +FG +RQ + Y PE + + ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVST 182
Query: 788 KSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSMIKKG------DVISIVDPVL 840
+D++S G ++ L+SG P E + NI++ + ++ + + VD +L
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLL 242
Query: 841 IGNVK--------------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 886
+ K + I R++ I+ ++ R + +++ + + + +I G
Sbjct: 243 VKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCG 302
Query: 887 GDQKFSSSSSKGQSSRKTLLTS 908
G + S KG S K + S
Sbjct: 303 G----AIRSQKGVSVAKVKVAS 320
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (415), Expect = 5e-46
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 666
+ +G G V+ + ++ ++VAVK++ + +F E + ++H +V +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 667 IGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
E E +V EY+ TLRD +H + P+ +++ DA + L +
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFS-- 127
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYY 780
GIIHRDVK +NI++ KV DFG++R + ++ A GT YL PE
Sbjct: 128 -HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 781 GNQQLTEKSDVYSFGVVLLELISGKKP 807
+ +SDVYS G VL E+++G+ P
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (412), Expect = 2e-45
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIM---------ADSCSHRTQQFVTEVALLSRIH- 659
+ +G+G V K KE AVKI+ A+ + + EV +L ++
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 660 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 719
H N++ L E LV++ M G L D L + L +I + +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICA 125
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 779
LH I+HRD+K NILLD +M K++DFG S Q + GT YL PE
Sbjct: 126 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAPEI 180
Query: 780 Y------GNQQLTEKSDVYSFGVVLLELISGKKP 807
+ ++ D++S GV++ L++G P
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 164 bits (417), Expect = 3e-45
Identities = 56/230 (24%), Positives = 92/230 (40%), Gaps = 19/230 (8%)
Query: 607 NNF--CKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSR 657
N+F + IG+G FG VY + D GK A+K + ++L+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 658 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 717
+V + + + + M+ G L L A + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 718 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 777
E++H N +++RD+K +NILLD + ++SD GL+ + H S GT GY+ P
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 174
Query: 778 EYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 826
E +D +S G +L +L+ G P + I +M
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 3e-45
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 608 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 665
+F +G G+F V + + K VA+K +A + + E+A+L +I H N+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 666 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 725
L E L+ + + G L DR+ + ++ ++YLH
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG- 127
Query: 726 PGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
I+HRD+K N+L D + + +SDFGLS+ + ++ GT GY+ PE
Sbjct: 128 --IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC--GTPGYVAPEVLAQ 183
Query: 783 QQLTEKSDVYSFGVVLLELISGKKP 807
+ ++ D +S GV+ L+ G P
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-44
Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 12/227 (5%)
Query: 609 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR---TQQFVTEVALLSR-IHHRNL 663
K +GKGSFG V+ + K + A+K + + + E +LS H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
+ + + V EY++ G L + + D A + GL++L
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFL--- 119
Query: 724 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 783
+ GI++RD+K NILLD + K++DFG+ ++ ++ GT Y+ PE Q
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ 178
Query: 784 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 830
+ D +SFGV+L E++ G+ P +D + + +
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 225
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (407), Expect = 2e-44
Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 666
+ +G GSFG V+ + + +G+ A+K++ R +Q E +LS + H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
G ++ Q ++ +Y+ G L L + A + LEYLH +
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLH---SK 123
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 786
II+RD+K NILLD N K++DFG ++ + + GT Y+ PE +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL----CGTPDYIAPEVVSTKPYN 179
Query: 787 EKSDVYSFGVVLLELISGKKP 807
+ D +SFG+++ E+++G P
Sbjct: 180 KSIDWWSFGILIYEMLAGYTP 200
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 4e-44
Identities = 61/283 (21%), Positives = 97/283 (34%), Gaps = 28/283 (9%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
+KIG GSFG +Y G + G+EVA+K+ H Q E + + +P I +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 70
Query: 670 C-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
C E ++V E + + T L +A +EY+H +
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH---SKNF 124
Query: 729 IHRDVKSSNIL---LDINMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPEY 779
IHRDVK N L + DFGL+++ + TH + GT Y
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839
+ + + + D+ S G VL+ G P + +S V
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----MSTPIEV 239
Query: 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882
L E A C R +P + ++
Sbjct: 240 LCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 158 bits (400), Expect = 7e-44
Identities = 42/199 (21%), Positives = 89/199 (44%), Gaps = 8/199 (4%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIG 668
+KIG+G++G VY + G+ A+K + + E+++L + H N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
+ + +LV+E++ + + L+ +T G+ Y H + +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 788
+HRD+K N+L++ K++DFGL+R + + G+++ +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 789 SDVYSFGVVLLELISGKKP 807
D++S G + E+++G
Sbjct: 182 IDIWSVGCIFAEMVNGTPL 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-42
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 603 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 661
+E + K IG GSFG VY K+ D G+ VA+K + + E+ ++ ++ H
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 662 NLVPLIGYCEEEHQR------ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 715
N+V L + ++ LV +Y+ R H S ++ L + + +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 716 GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGY 774
L Y+H + GI HRD+K N+LLD + K+ DFG ++Q ++S + Y
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--YY 188
Query: 775 LDP-EYYGNQQLTEKSDVYSFGVVLLELISGKKP 807
P +G T DV+S G VL EL+ G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 155 bits (392), Expect = 1e-42
Identities = 42/284 (14%), Positives = 91/284 (32%), Gaps = 28/284 (9%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
++IG+GSFG ++ G + + ++VA+K Q E + +P + Y
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 670 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 729
+E ++ + +L D L + + T A ++ +H ++
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLD--LCGRKFSVKTVAMAAKQMLARVQSIH---EKSLV 123
Query: 730 HRDVKSSNILLD-----INMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPE 778
+RD+K N L+ V DFG+ + + +T GT Y+
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 779 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838
+ ++ + + D+ + G V + + G P + +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL-----R 238
Query: 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882
L E + + P + ++
Sbjct: 239 ELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-42
Identities = 43/200 (21%), Positives = 88/200 (44%), Gaps = 8/200 (4%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 667
+KIG+G++G VY + K G+ VA+K + + E++LL ++H N+V L+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
E++ LV+E++H + + +GL + +
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC---HSHR 122
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 787
++HRD+K N+L++ K++DFGL+R + + G + +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 788 KSDVYSFGVVLLELISGKKP 807
D++S G + E+++ +
Sbjct: 183 AVDIWSLGCIFAEMVTRRAL 202
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 9e-42
Identities = 49/231 (21%), Positives = 90/231 (38%), Gaps = 15/231 (6%)
Query: 611 KKIGKGSFGSVYYGKMK--DGKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNL 663
+IG+G++G V+ + G+ VA+K + + T + V + L H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 720
V L C + + V + + T + +GL++L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 721 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 780
H + ++HRD+K NIL+ + + K++DFGL+R + S V T+ Y PE
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPEVL 187
Query: 781 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 831
D++S G + E+ K +L + + + D
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 14/204 (6%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNLV 664
+G+G F +VY + K + VA+K + +++ + + E+ LL + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
L+ + LV+++M N L +GLEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH--- 117
Query: 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQ 783
I+HRD+K +N+LLD N K++DFGL++ + T Y PE G +
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176
Query: 784 QLTEKSDVYSFGVVLLELISGKKP 807
D+++ G +L EL+
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPF 200
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 2e-41
Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 23/231 (9%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 668
+ +G G G V K ++ A+K++ D + EV L R ++V ++
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD 72
Query: 669 YCE----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
E ++V E + G L R+ + +I + ++YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLH--- 128
Query: 725 NPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 781
+ I HRDVK N+L N K++DFG +++ + + T Y+ PE G
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLG 186
Query: 782 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832
++ + D++S GV++ L+ G P L I ++ I+ G
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---GLAISPGMKTRIRMGQY 234
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 4e-41
Identities = 54/232 (23%), Positives = 103/232 (44%), Gaps = 8/232 (3%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 668
IG+G++G V + VA+K + Q+ + E+ +L R H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 669 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 728
+ Y+ + L+ + + L + +GL+Y+H + +
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 130
Query: 729 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQL- 785
+HRD+K SN+LL+ K+ DFGL+R A+ D H + T Y PE N +
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 786 TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837
T+ D++S G +L E++S + + + +LN + + D+ I++
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-40
Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 9/200 (4%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 667
+KIG+G++G+V+ K + + VA+K + D + E+ LL + H+N+V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 727
+ + LV+E+ + LD KGL + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121
Query: 728 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 787
++HRD+K N+L++ N K+++FGL+R + S+ +G + +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 788 KSDVYSFGVVLLELISGKKP 807
D++S G + EL + +P
Sbjct: 182 SIDMWSAGCIFAELANAGRP 201
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-40
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT------QQFVTEVALLSRIHHRNL 663
+++G G F V + K G + A K + + + + EV++L I H N+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 664 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 723
+ L E + IL+ E + G L D L ++ L + G+ YLH
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLH-- 130
Query: 724 CNPGIIHRDVKSSNILLD----INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 779
+ I H D+K NI+L R K+ DFGL+ + + + GT ++ PE
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEI 187
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKP 807
+ L ++D++S GV+ L+SG P
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-40
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 11/216 (5%)
Query: 609 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLV 664
+ K +GKG+FG V + K G+ A+KI+ VTE +L H L
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 665 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
L + + V EY + G L L T + A+ + L
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLH 122
Query: 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 784
+ +++RD+K N++LD + K++DFGL ++ D + + GT YL PE +
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDND 181
Query: 785 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 820
D + GVV+ E++ G+ P +D ++
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 49/223 (21%), Positives = 87/223 (39%), Gaps = 24/223 (10%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIH--HR 661
+G G FGSVY G + D VA+K + + EV LL ++
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 662 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
++ L+ + E +L+ E + L + + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC- 126
Query: 722 TGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 780
N G++HRD+K NIL+D+N K+ DFG ++ + GT Y PE+
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRVYSPPEWI 181
Query: 781 -GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 822
++ + V+S G++L +++ G P F + I+
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRG 219
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (368), Expect = 7e-39
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 14/218 (6%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 666
K +G GSFG V K K G A+KI+ + +Q + E +L ++ LV L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 667 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
++ +V EY+ G + L A EYLH +
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 786
+I+RD+K N+L+D +V+DFG +++ + + GT L PE ++
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL----CGTPEALAPEIILSKGYN 216
Query: 787 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 824
+ D ++ GV++ E+ +G P + + +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-38
Identities = 50/225 (22%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 667
KIG+G+FG V+ + K G++VA+K + + + E+ +L + H N+V LI
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 668 GYCEE--------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 719
C + LV+++ + + L T +I L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN------VLVKFTLSEIKRVMQMLLNG 129
Query: 720 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLD 776
L+ I+HRD+K++N+L+ + K++DFGL+R A+ + + T+ Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 777 PEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 820
PE G + D++ G ++ E+ + + +L ++
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-36
Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 10/201 (4%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 667
+ +G G++G+V + G +VA+K + ++ E+ LL + H N++ L+
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 668 GYCEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 726
+ ++ G + + L + + KGL Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AA 140
Query: 727 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 786
GIIHRD+K N+ ++ + K+ DFGL+RQA+ ++T + T
Sbjct: 141 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---GYVVTRWYRAPEVILNWMRYT 197
Query: 787 EKSDVYSFGVVLLELISGKKP 807
+ D++S G ++ E+I+GK
Sbjct: 198 QTVDIWSVGCIMAEMITGKTL 218
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (338), Expect = 4e-35
Identities = 45/205 (21%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 609 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL 666
+K+G+G + V+ + ++V VKI+ + ++ E+ +L + N++ L
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITL 95
Query: 667 IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 724
++ R LV+E+++N + + L ++ K L+Y H
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH--- 146
Query: 725 NPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GN 782
+ GI+HRDVK N+++D + + ++ D+GL+ + V + + PE
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDY 204
Query: 783 QQLTEKSDVYSFGVVLLELISGKKP 807
Q D++S G +L +I K+P
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 4e-35
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 611 KKIGKGSFGSVYYGK----MKDGKEVAVKIM----ADSCSHRTQQFVTEVALLSRI-HHR 661
K +G G++G V+ + GK A+K++ + T+ TE +L I
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 662 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
LV L + E + L+ +Y++ G L L + T ++ + + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALE 143
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--Y 779
GII+RD+K NILLD N ++DFGLS++ D T + GT+ Y+ P+
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 780 YGNQQLTEKSDVYSFGVVLLELISGKKP 807
G+ + D +S GV++ EL++G P
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-31
Identities = 44/205 (21%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 667
+G G++GSV K G VAVK ++ ++ E+ LL + H N++ L+
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 668 GYCEE-----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 722
E + + ++ L + + + L + + +GL+Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIH- 138
Query: 723 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 782
+ IIHRD+K SN+ ++ + K+ DFGL+R + ++
Sbjct: 139 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNW 193
Query: 783 QQLTEKSDVYSFGVVLLELISGKKP 807
+ D++S G ++ EL++G+
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-31
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 20/217 (9%)
Query: 611 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 667
K IG G+ G V + VA+K ++ ++T ++ E+ L+ ++H+N++ L+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 668 GYC------EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 721
EE LV E M + Q LD + + G+++LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLH 136
Query: 722 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 781
+ IHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 137 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--VTRYYRAPEVIL 191
Query: 782 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 818
E D++S G ++ E++ K D+ + N
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 123 bits (308), Expect = 7e-31
Identities = 50/238 (21%), Positives = 94/238 (39%), Gaps = 27/238 (11%)
Query: 611 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 669
+K+G G F +V+ K M + VA+KI+ T+ E+ LL R++ +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 670 CEEEHQRILVY-------------EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 716
++L + + G L + + + QI+ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDIN------MRAKVSDFGLSRQAEEDLTHISSVARG 770
L+Y+H GIIH D+K N+L++I ++ K++D G + +E T+
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS----IQ 191
Query: 771 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 828
T Y PE +D++S ++ ELI+G ++ + +I+
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.4 bits (226), Expect = 1e-21
Identities = 24/163 (14%), Positives = 49/163 (30%), Gaps = 28/163 (17%)
Query: 611 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS----------HRTQQFVTEVALLSRIHH 660
K +G+G +V+ + E VK + + F +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 661 RNLVPLIGYCEEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 716
R L L G + ++ E + + ++ +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEE 115
Query: 717 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759
+ + + GI+H D+ N+L+ + DF S + E
Sbjct: 116 VAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 67.3 bits (163), Expect = 3e-12
Identities = 12/93 (12%), Positives = 37/93 (39%), Gaps = 5/93 (5%)
Query: 398 WEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID 457
+ +T + L N+ P + ++ L L+ N ++ ++ L +
Sbjct: 296 QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV-SSLANLTN 352
Query: 458 LRIVHLENNELTGSLPSYMGSLPNLQELHIENN 490
+ + +N+++ P + +L + +L + +
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 56.2 bits (134), Expect = 8e-09
Identities = 21/72 (29%), Positives = 35/72 (48%), Gaps = 3/72 (4%)
Query: 431 NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 490
N++ LT L L N ++ P +S L L+ + NN+++ S + +L N+ L +N
Sbjct: 305 NLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 491 SFVGEIPPALLT 502
P A LT
Sbjct: 362 QISDLTPLANLT 373
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 2e-05
Identities = 17/78 (21%), Positives = 35/78 (44%), Gaps = 5/78 (6%)
Query: 413 KIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSL 472
K L N+ + +++ +T L D + + + L +L ++ NN+LT
Sbjct: 26 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDIT 82
Query: 473 PSYMGSLPNLQELHIENN 490
P + +L L ++ + NN
Sbjct: 83 P--LKNLTKLVDILMNNN 98
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 2e-04
Identities = 12/73 (16%), Positives = 26/73 (35%), Gaps = 3/73 (4%)
Query: 430 KNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 489
+ + L +T + + L + + + + S+ + L NL +++ N
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQ-TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75
Query: 490 NSFVGEIPPALLT 502
N P LT
Sbjct: 76 NQLTDITPLKNLT 88
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 0.001
Identities = 28/125 (22%), Positives = 49/125 (39%), Gaps = 23/125 (18%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 467
+ +++L+G LK L ++ LT+L L N ++ L +S L L + L N+
Sbjct: 218 LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQ 274
Query: 468 LTGSLP--------------------SYMGSLPNLQELHIENNSFVGEIPPALLTGKVIF 507
++ P S + +L NL L + N+ P + LT
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRL 334
Query: 508 KYDNN 512
+ NN
Sbjct: 335 FFANN 339
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.002
Identities = 16/67 (23%), Positives = 25/67 (37%), Gaps = 3/67 (4%)
Query: 431 NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 490
+ L L N ++ P +L + L N+L + SL NL +L + NN
Sbjct: 195 KLTNLESLIATNNQISDITPLGIL-TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 491 SFVGEIP 497
P
Sbjct: 252 QISNLAP 258
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.9 bits (146), Expect = 2e-10
Identities = 18/84 (21%), Positives = 29/84 (34%), Gaps = 2/84 (2%)
Query: 393 CVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM 452
+ + + L + G +P L ++ L L + N L G +P
Sbjct: 228 LAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287
Query: 453 SRLIDLRIVHLENN-ELTGS-LPS 474
L + NN L GS LP+
Sbjct: 288 GNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.8 bits (138), Expect = 2e-09
Identities = 31/119 (26%), Positives = 55/119 (46%), Gaps = 6/119 (5%)
Query: 387 NDRGDPCVPVPWEWVTCS-TTTPPRITKIALSGKNLKG--EIPPELKNMEALTELWLDG- 442
D C W V C T R+ + LSG NL IP L N+ L L++ G
Sbjct: 28 LPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI 86
Query: 443 -NFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 500
N + P +++L L +++ + ++G++P ++ + L L N+ G +PP++
Sbjct: 87 NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.7 bits (135), Expect = 4e-09
Identities = 19/55 (34%), Positives = 26/55 (47%), Gaps = 1/55 (1%)
Query: 462 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP-ALLTGKVIFKYDNNPKL 515
L NN + G+LP + L L L++ N+ GEIP L + Y NN L
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.3 bits (134), Expect = 5e-09
Identities = 16/60 (26%), Positives = 26/60 (43%), Gaps = 2/60 (3%)
Query: 439 WLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 497
L N + G LP +++L L +++ N L G +P G+L NN + P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.1 bits (126), Expect = 6e-08
Identities = 23/112 (20%), Positives = 40/112 (35%), Gaps = 11/112 (9%)
Query: 402 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRI 460
C + S L+ ++P +L L L N +T D L +L
Sbjct: 9 QCHLRV------VQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHT 59
Query: 461 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 512
+ L NN+++ P L L+ L++ N E+P + + N
Sbjct: 60 LILINNKISKISPGAFAPLVKLERLYLSKNQL-KELPEKMPKTLQELRVHEN 110
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.8 bits (94), Expect = 6e-04
Identities = 22/124 (17%), Positives = 41/124 (33%), Gaps = 31/124 (25%)
Query: 407 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNF---------------------- 444
PP +T++ L G + LK + L +L L N
Sbjct: 169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 228
Query: 445 --LTGPLPDMSRLIDLRIVHLENNELTG------SLPSYMGSLPNLQELHIENNSF-VGE 495
L ++ +++V+L NN ++ P Y + + + +N E
Sbjct: 229 NKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 288
Query: 496 IPPA 499
I P+
Sbjct: 289 IQPS 292
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 19/84 (22%), Positives = 36/84 (42%), Gaps = 8/84 (9%)
Query: 400 WVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 459
+ PP + ++ +S L E+P L L N L +P++ + +L+
Sbjct: 275 EIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPELPQ--NLK 327
Query: 460 IVHLENNELTGSLPSYMGSLPNLQ 483
+H+E N L P S+ +L+
Sbjct: 328 QLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 6e-06
Identities = 22/116 (18%), Positives = 37/116 (31%), Gaps = 9/116 (7%)
Query: 387 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 446
+ P + + + EI +L EL + N L
Sbjct: 238 DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 297
Query: 447 GPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF--VGEIPPAL 500
LP + L + N L +P NL++LH+E N +IP ++
Sbjct: 298 E-LPAL--PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.004
Identities = 15/53 (28%), Positives = 26/53 (49%), Gaps = 4/53 (7%)
Query: 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRI 460
PPR+ ++ S +L E+P +N L +L ++ N L + DLR+
Sbjct: 303 PPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLREFPDIPESVEDLRM 351
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 4e-07
Identities = 23/103 (22%), Positives = 38/103 (36%), Gaps = 25/103 (24%)
Query: 416 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDL----------------- 458
L+ K+L + L+ + +T L L N L P ++ L L
Sbjct: 5 LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62
Query: 459 -----RIVHLENNELTG-SLPSYMGSLPNLQELHIENNSFVGE 495
+ + L NN L + + S P L L+++ NS E
Sbjct: 63 NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 2e-06
Identities = 18/64 (28%), Positives = 33/64 (51%), Gaps = 3/64 (4%)
Query: 426 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 485
L N+ LT L D N ++ + ++ L +L VHL+NN+++ P + + NL +
Sbjct: 166 LTPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 486 HIEN 489
+ N
Sbjct: 223 TLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 15/53 (28%), Positives = 28/53 (52%), Gaps = 2/53 (3%)
Query: 450 PDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 502
++ L L + ++N+++ P + SLPNL E+H++NN P A +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTS 217
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 15/75 (20%), Positives = 30/75 (40%), Gaps = 6/75 (8%)
Query: 435 LTELWLDGNFLT-GPLPDM-SRLIDLRIVHLENNELTG----SLPSYMGSLPNLQELHIE 488
+ L + L+ ++ L ++V L++ LT + S + P L EL++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 489 NNSFVGEIPPALLTG 503
+N +L G
Sbjct: 64 SNELGDVGVHCVLQG 78
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 15/94 (15%), Positives = 29/94 (30%), Gaps = 4/94 (4%)
Query: 423 GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 482
+I + L +T + + L + + N+++ + LPN+
Sbjct: 15 KQIFS-DDAFAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQG--IQYLPNV 70
Query: 483 QELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 516
+L + N P A L D N
Sbjct: 71 TKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD 104
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 5e-04
Identities = 23/127 (18%), Positives = 39/127 (30%), Gaps = 19/127 (14%)
Query: 391 DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP 450
D C P + C+ + L E LTEL+++ L
Sbjct: 3 DACCPHGSSGLRCT-------------RDGAL-DSLHHLPGAENLTELYIENQQHLQHLE 48
Query: 451 D--MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG--KVI 506
+ L +LR + + + L P P L L++ N+ + + G
Sbjct: 49 LRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQE 107
Query: 507 FKYDNNP 513
NP
Sbjct: 108 LVLSGNP 114
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 8e-04
Identities = 16/75 (21%), Positives = 29/75 (38%), Gaps = 2/75 (2%)
Query: 428 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487
E+ + + E+ D LT PD+ + D I+HL N L + + L +L++
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 488 ENNSFVGEIPPALLT 502
+ L
Sbjct: 63 DRAELTKLQVDGTLP 77
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Score = 38.4 bits (88), Expect = 0.003
Identities = 17/135 (12%), Positives = 45/135 (33%), Gaps = 10/135 (7%)
Query: 600 PELEEATNNF-CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI 658
PEL++ + C K +G + Y + + + + +K+ T E ++ +
Sbjct: 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWL 66
Query: 659 HHRNLVP-LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 717
+ VP ++ + + L+ + D + +I A+ +
Sbjct: 67 EGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE--------YEDEQSPEKIIELYAECI 118
Query: 718 EYLHTGCNPGIIHRD 732
H+ + +
Sbjct: 119 RLFHSIDISDCPYTN 133
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.004
Identities = 17/112 (15%), Positives = 33/112 (29%), Gaps = 29/112 (25%)
Query: 416 LSGKNLK---------GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 466
+ GK+LK + L +++ E+ L GN +
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIG-------------------T 45
Query: 467 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFK-YDNNPKLHK 517
E L + S +L+ + +++ + PKLH
Sbjct: 46 EAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHT 97
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 927 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.66 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.4 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.16 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.14 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.13 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.1 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.04 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.03 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.0 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.98 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 98.98 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.89 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.61 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.6 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.58 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.43 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.41 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.39 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.31 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.29 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.26 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.26 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.25 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.17 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.17 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.11 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.05 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 97.97 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.82 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.8 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.6 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.55 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.19 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.12 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.92 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 96.76 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 96.64 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.16 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 95.85 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 95.68 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 95.56 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 95.54 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 95.13 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.06 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 93.22 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 88.42 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 85.21 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=414.72 Aligned_cols=254 Identities=28% Similarity=0.468 Sum_probs=200.0
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCC
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 686 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~g 686 (927)
+++.+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++||||++++|+|.+++..++||||+++|
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 45678999999999999999989999999997643 34578999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccccc
Q 002410 687 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 766 (927)
Q Consensus 687 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 766 (927)
+|.+++... ...+++..++.++.|||+||+|||+ ++|+||||||+|||+++++.+||+|||+++...........
T Consensus 86 ~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 86 CLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp BHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred cHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 999998753 4668999999999999999999998 99999999999999999999999999999887655444444
Q ss_pred ccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 767 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 767 ~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
...||+.|+|||++.+..++.++|||||||++|||+|+ ++||.... ...+.+.+. .+.. ...|
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~~~i~----~~~~--~~~p------- 224 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDIS----TGFR--LYKP------- 224 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHHHHHH----HTCC--CCCC-------
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---HHHHHHHHH----hcCC--CCCc-------
Confidence 45689999999999999999999999999999999995 55554221 122222222 1111 1111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 846 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 846 ~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
......+.+++.+||+.||++||||+||++.|+++.+
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1123468899999999999999999999999998864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=413.87 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=211.2
Q ss_pred HHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
+....+++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 3345677889999999999999999988999999997543 345789999999999999999999998865 45789999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++|+|.+++... ....+++..+++|+.||++||+|||+ ++|+||||||+||||++++.+||+|||+|+......
T Consensus 88 y~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 88 YMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred eCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999999987643 23468999999999999999999998 999999999999999999999999999999876554
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
........||+.|+|||++.+..++.++|||||||++|||+||..|+..... ...+.+. +..+.... .
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~----i~~~~~~~-----~- 231 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQN----LERGYRMV-----R- 231 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHH----HHTTCCCC-----C-
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHH----HHhcCCCC-----C-
Confidence 4444455689999999999988999999999999999999997666542221 1122222 22221111 1
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
+...+..+.+|+.+||+.||++||||+||++.|++...
T Consensus 232 ---p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 232 ---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 11223468899999999999999999999999998654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.5e-48 Score=419.37 Aligned_cols=262 Identities=28% Similarity=0.417 Sum_probs=216.0
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
|+....+++.++||+|+||+||+|+++ +|+.||||+++... ...++|.+|+++|++++|||||+++++|.+++..++|
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 344456778899999999999999987 58899999997643 3457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
|||+++|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 92 ~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 92 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 9999999999999754 35679999999999999999999998 9999999999999999999999999999998765
Q ss_pred cccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 760 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
..........|++.|+|||++.+..++.++|||||||++|||++|+.|+..... ...+.+ .+..+...
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~~----~i~~~~~~------ 235 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYE----LLEKDYRM------ 235 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHH----HHHTTCCC------
T ss_pred CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHHH----HHhcCCCC------
Confidence 544444445689999999999999999999999999999999998777642221 112222 22222111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
..+...+..+.+|+.+||+.||++|||++||++.|+.+..
T Consensus 236 ---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 236 ---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111223478899999999999999999999999987754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=411.24 Aligned_cols=259 Identities=29% Similarity=0.516 Sum_probs=203.1
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
..+.+.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|+++|++++|||||++++++.+ +..++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 34567899999999999999875 36999998653 34456789999999999999999999998865 468999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+++|+|.+++... +..+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 85 CEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999999999743 4569999999999999999999998 9999999999999999999999999999987654322
Q ss_pred -ccccccccCCCccCCCccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 763 -HISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 763 -~~~~~~~gt~~Y~APE~l~~---~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
.......||+.|||||++.+ ..++.++|||||||++|||+||+.||....... .+.. .+..+.......
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~----~~~~~~~~p~~~- 232 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIF----MVGRGYLSPDLS- 232 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHH----HHHHTSCCCCGG-
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHH----HHhcCCCCCcch-
Confidence 23344569999999999864 357899999999999999999999997433211 1111 122221111110
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
......+..+.+|+.+||+.||++|||++||++.|+.+.+
T Consensus 233 ----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 233 ----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp ----GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1112233578899999999999999999999999998765
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.5e-47 Score=412.88 Aligned_cols=257 Identities=26% Similarity=0.459 Sum_probs=199.8
Q ss_pred HhhcccccccccEEEEEEEECC-C---cEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~-g---~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
+++.++||+|+||+||+|+++. + ..||||++.... ....++|.+|+++|++++|||||++++++.+++..++|||
T Consensus 28 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~E 107 (299)
T d1jpaa_ 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITE 107 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 4445789999999999999863 3 358999987643 3455789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
||++|+|.+++... ...+++.+++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++......
T Consensus 108 y~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 108 FMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp CCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred ecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 99999999988742 4569999999999999999999998 999999999999999999999999999998765432
Q ss_pred ccc----ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeec
Q 002410 762 THI----SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 836 (927)
Q Consensus 762 ~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 836 (927)
... .....||+.|||||.+.+..++.++|||||||++|||+| |+.||..... ..+...+ ..+....
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i----~~~~~~~-- 253 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAI----EQDYRLP-- 253 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH----HTTCCCC--
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCCCCC--
Confidence 221 112347899999999999999999999999999999998 8999974332 1222222 2221111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 837 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 837 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
.+...+..+.+|+.+||+.||++|||++||++.|+++++-+
T Consensus 254 -------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 254 -------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 11223457889999999999999999999999999987643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=408.79 Aligned_cols=248 Identities=24% Similarity=0.358 Sum_probs=206.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.|++.++||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++||||+++++++.+++..++||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 4677899999999999999875 699999999976555556789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+|+|.+++.. ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+....... .
T Consensus 101 gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 172 (293)
T d1yhwa1 101 GGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (293)
T ss_dssp TCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence 9999998863 469999999999999999999998 9999999999999999999999999999987654332 2
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 844 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 844 (927)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........+... .. .
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~~~~-~~-------~ 238 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTPE-LQ-------N 238 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSCC-CS-------S
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCCCCC-CC-------C
Confidence 334569999999999999999999999999999999999999997433211 111112221111 10 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 845 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 845 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+......+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122346889999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=402.02 Aligned_cols=252 Identities=28% Similarity=0.479 Sum_probs=211.3
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCCC
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 686 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~g 686 (927)
+++.++||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||++++|+|.+++..++||||+++|
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g 84 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 84 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence 457899999999999999999889999999986533 4578999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccccc
Q 002410 687 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 766 (927)
Q Consensus 687 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 766 (927)
+|.+++... ...+++..+++++.|+++||+|||+ ++|+||||||+||++++++.+||+|||+++...........
T Consensus 85 ~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 85 CLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp EHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred cHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 999997643 4568899999999999999999998 99999999999999999999999999999876554444444
Q ss_pred ccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCCCC
Q 002410 767 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 845 (927)
Q Consensus 767 ~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 845 (927)
...||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+.. .+..+... ..|
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~----~i~~~~~~--~~p------- 223 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAE----HIAQGLRL--YRP------- 223 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHH----HHHTTCCC--CCC-------
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHHH----HHHhCCCC--CCc-------
Confidence 4568999999999999999999999999999999998 89999744322 1222 22222111 111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 846 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 846 ~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
......+.+|+.+||+.||++|||++||++.|.++
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 11224788999999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=404.49 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=201.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
.|++.+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+++|++++||||+++++++.+++..++||||+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 3677899999999999999986 689999999875432 33467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc-c
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-T 762 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~-~ 762 (927)
++|+|.+++. ....+++.+++.++.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+...... .
T Consensus 86 ~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 86 SGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp TTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999997 45679999999999999999999998 999999999999999999999999999998765432 2
Q ss_pred ccccccccCCCccCCCccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 763 HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
.......||+.|||||++.+..+ +.++||||+||++|||++|+.||....... ...... ........
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~~~----~~~~~~~~------- 227 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW----KEKKTYLN------- 227 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-HHHHHH----HTTCTTST-------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-HHHHHH----hcCCCCCC-------
Confidence 22344579999999999987765 678999999999999999999997443221 111111 11111000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
........+.+|+.+||+.||++|||++|+++
T Consensus 228 --~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 --PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111236779999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=403.29 Aligned_cols=244 Identities=26% Similarity=0.427 Sum_probs=204.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.+.||+|+||+||+|+.+ +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 3678899999999999999986 68999999986432 2335678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 87 y~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 87 YAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred ecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 9999999999984 4579999999999999999999998 999999999999999999999999999998765432
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+ ... .+..... .+.
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~----~i~~~~~------~~p 224 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYK----RISRVEF------TFP 224 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH----HHHTTCC------CCC
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HHH----HHHcCCC------CCC
Confidence 234569999999999999999999999999999999999999997433211 111 1112211 111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
. .....+.+|+.+||+.||++|||++|+++
T Consensus 225 ~----~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 225 D----FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c----cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1 12246789999999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=405.54 Aligned_cols=250 Identities=22% Similarity=0.357 Sum_probs=205.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.|++.+.||+|+||+||+|+++ +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++||||++
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 3667889999999999999986 689999999987666677889999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+|+|.+++... ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....... .
T Consensus 93 ~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~ 166 (288)
T d2jfla1 93 GGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 166 (288)
T ss_dssp TEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-H
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc-c
Confidence 99999987642 4569999999999999999999998 9999999999999999999999999999976543322 2
Q ss_pred ccccccCCCccCCCccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 765 SSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
.....||+.|+|||++. +..++.++|||||||++|||+||+.||......+ ... .... +.......
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~---~i~~-~~~~~~~~-- 237 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLL---KIAK-SEPPTLAQ-- 237 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH---HHHH-SCCCCCSS--
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHH---HHHc-CCCCCCCc--
Confidence 23456999999999984 4568899999999999999999999997443322 111 1111 11111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
+......+.+|+.+||+.||++|||++|+++
T Consensus 238 -----~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 238 -----PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122347889999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=401.69 Aligned_cols=253 Identities=26% Similarity=0.381 Sum_probs=193.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeec--CceEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVY 680 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~~~~LV~ 680 (927)
.|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+ ++..++||
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 4677899999999999999986 68999999987543 3345678999999999999999999998864 45689999
Q ss_pred EecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 681 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC--NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~--~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
||+++|+|.+++.... ....+++..++.++.||+.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 9999999999986432 3567999999999999999999999821 134999999999999999999999999999886
Q ss_pred cccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
...... .....||+.|||||++.+..++.++|||||||++|||+||+.||...+.. .+.. .+..+....+
T Consensus 165 ~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~----~i~~~~~~~~-- 234 (269)
T d2java1 165 NHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAG----KIREGKFRRI-- 234 (269)
T ss_dssp ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH----HHHHTCCCCC--
T ss_pred ccCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHH----HHHcCCCCCC--
Confidence 543322 23456999999999999999999999999999999999999999743321 1211 2222322211
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
... ...++.+|+.+||+.||++|||++|+++
T Consensus 235 ---~~~----~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 ---PYR----YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---Ccc----cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111 2246889999999999999999999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=406.58 Aligned_cols=259 Identities=29% Similarity=0.455 Sum_probs=202.9
Q ss_pred HHhhcccccccccEEEEEEEECCC-----cEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKDG-----KEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~g-----~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
.+++.++||+|+||.||+|.+++. ..||||+++.... ....+|.+|++++++++|||||+++|++.+.+..++|
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v 87 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 87 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence 345678999999999999988642 3799999975433 3456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
|||+.+|++.+.+... ...+++.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 88 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 88 TEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 9999999999988753 4679999999999999999999998 9999999999999999999999999999987654
Q ss_pred ccc--ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 760 DLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 760 ~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
... .......||+.|+|||++.+..++.++|||||||++|||++|..|+..... ...+.+. +..+...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~~----i~~~~~~---- 232 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKA----INDGFRL---- 232 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHH----HHTTCCC----
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHHHH----HhccCCC----
Confidence 322 222334589999999999999999999999999999999997666542221 1122222 2222111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
..+...+..+.+|+.+||+.||++||||+||++.|+++++..
T Consensus 233 -----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 233 -----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp -----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 111223357889999999999999999999999999988753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=395.71 Aligned_cols=244 Identities=29% Similarity=0.440 Sum_probs=196.3
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeec----CceEEEEE
Q 002410 608 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVY 680 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~----~~~~~LV~ 680 (927)
++.++||+|+||+||+|++. +++.||+|++... .....+.+.+|+++|++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45678999999999999986 5889999998653 23445679999999999999999999999854 45679999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCccccc-CCCcEEEeeccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLD-INMRAKVSDFGLSRQA 757 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivH~DLkp~NILld-~~~~~kL~DFGla~~~ 757 (927)
||+++|+|.+++.. ...+++..++.++.||++||+|||+ ++ |+||||||+|||++ +++.+||+|||+++..
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 99999999999974 4578999999999999999999998 66 99999999999996 5789999999999864
Q ss_pred cccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
... ......||+.|||||++.+ .++.++|||||||++|||++|+.||..... ...+.+ .+..+......+
T Consensus 166 ~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~~----~i~~~~~~~~~~ 235 (270)
T d1t4ha_ 166 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYR----RVTSGVKPASFD 235 (270)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHH----HHTTTCCCGGGG
T ss_pred cCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHHHHH----HHHcCCCCcccC
Confidence 432 2234569999999999876 599999999999999999999999973322 111111 222222111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
. . ...++.+|+.+||+.||++|||++|+++
T Consensus 236 ~----~----~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 K----V----AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp G----C----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c----c----CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1 1 1235789999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-46 Score=401.06 Aligned_cols=252 Identities=25% Similarity=0.437 Sum_probs=206.0
Q ss_pred hcc-cccccccEEEEEEEEC---CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 609 FCK-KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 609 ~~~-~LG~G~~G~Vy~a~~~---~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
+.+ +||+|+||+||+|.++ ++..||||+++... ....++|.+|+++|++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~ 90 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA 90 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence 445 4999999999999875 35579999997644 3456789999999999999999999999975 4589999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++|+|.+++.. .+..+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 91 ~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 91 GGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp TTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred CCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence 99999999864 24679999999999999999999998 99999999999999999999999999999876543322
Q ss_pred --cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 764 --ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 764 --~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+.. .+..+.....
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~----~i~~~~~~~~----- 233 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA----FIEQGKRMEC----- 233 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHH----HHHTTCCCCC-----
T ss_pred cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCCCC-----
Confidence 2233458899999999998999999999999999999998 99999744322 2222 2223322111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
+...+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 234 ----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 234 ----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp ----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11223478899999999999999999999999987654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-46 Score=399.99 Aligned_cols=248 Identities=27% Similarity=0.467 Sum_probs=200.4
Q ss_pred ccccccccEEEEEEEECC---CcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecCC
Q 002410 611 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 685 (927)
Q Consensus 611 ~~LG~G~~G~Vy~a~~~~---g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~~ 685 (927)
++||+|+||+||+|.+++ ++.||||+++... ....++|.+|+++|++++|||||+++++|..+ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 579999999999998753 4689999997532 23457899999999999999999999999654 57899999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc--
Q 002410 686 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-- 763 (927)
Q Consensus 686 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~-- 763 (927)
|+|.++++. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999984 5679999999999999999999998 99999999999999999999999999999876543322
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+.. .+..+.....
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~----~i~~~~~~~~------- 231 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA----MLEKGERMGC------- 231 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTTCCCCC-------
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHH----HHHcCCCCCC-------
Confidence 2233468999999999999999999999999999999998 89999743321 2222 2222221111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
+...+..+.+|+.+||+.||++|||++||++.|+...
T Consensus 232 --p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 232 --PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp --CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 1122347889999999999999999999999988753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=412.05 Aligned_cols=266 Identities=23% Similarity=0.339 Sum_probs=206.3
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
...|++.++||+|+||+||+|+.. +|+.||+|+++... ....+++.+|+.+|++++|||||+++++|.++++.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 446777899999999999999986 68999999997543 3345779999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++|+|.+++.+ ...+++..+..++.||+.||+|||+ .++|+||||||+|||++.++.+||+|||+|+......
T Consensus 85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 9999999999974 4569999999999999999999997 1489999999999999999999999999998764432
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHH-HHHHHhhhc--------CC-
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-HWARSMIKK--------GD- 831 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~-~~~~~~~~~--------~~- 831 (927)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+........ ......... ..
T Consensus 160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 23457999999999999999999999999999999999999999754432110000 000000000 00
Q ss_pred -------------eeeec-------cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhh
Q 002410 832 -------------VISIV-------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDS 880 (927)
Q Consensus 832 -------------~~~~~-------d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~--L~~~ 880 (927)
..+.. .+.+. ......++.+++.+||+.||++|||++|+++. +++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCC---BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00000 00000 00112468899999999999999999999873 5543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=405.61 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=205.0
Q ss_pred HHHHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
...+++.+.||+|+||.||+|++++++.||||+++... ...+.|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 34678899999999999999999988899999997543 345789999999999999999999999965 5578999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
++|+|.+++... ....+++.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 999999988753 24569999999999999999999998 89999999999999999999999999999876554444
Q ss_pred cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 764 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
......||+.|+|||++.++.++.++|||||||++|||++|+.|+..... ...+...+. .+....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~----~~~~~~--------- 234 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVE----RGYRMP--------- 234 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH----TTCCCC---------
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHH----hcCCCC---------
Confidence 44445689999999999999999999999999999999997776642222 122222222 111111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
.+.....++.+++.+||+.||++||++++|+++|++....
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 1112234788999999999999999999999999987653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-46 Score=409.77 Aligned_cols=260 Identities=27% Similarity=0.431 Sum_probs=207.3
Q ss_pred HHHHHHhhcccccccccEEEEEEEECC------CcEEEEEEccCcc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 673 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~~------g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~ 673 (927)
+....+++.++||+|+||+||+|++.. ...||||++.... ......+.+|+.+|+++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 334567788999999999999998753 2369999986543 33456799999999998 899999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSVN--------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV 733 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~~--------------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DL 733 (927)
+..++||||+++|+|.++|+.... ...+++..++.++.||++||+|||+ ++|+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccC
Confidence 999999999999999999975421 2358999999999999999999999 99999999
Q ss_pred CCCcccccCCCcEEEeeccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 002410 734 KSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVE 811 (927)
Q Consensus 734 kp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~ 811 (927)
||+|||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876544332 2234458999999999999999999999999999999998 89999744
Q ss_pred cccchhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 002410 812 DFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 879 (927)
Q Consensus 812 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~ 879 (927)
.... .+.. .+..+... ..+......+.+|+.+||+.||++|||++||++.|..
T Consensus 271 ~~~~--~~~~----~~~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 271 PVDA--NFYK----LIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCSH--HHHH----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHH--HHHH----HHhcCCCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 3322 2222 22222111 1111223478899999999999999999999999963
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=401.25 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=202.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+++..++|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 4778899999999999999986 68999999986432 2334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++|+|.+++.. .+.+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 89 y~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 89 YAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999873 4679999999999999999999999 999999999999999999999999999998765432
Q ss_pred -cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 762 -THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 762 -~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. .+.+ .+..+.. .+
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~----~i~~~~~------~~ 229 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LIFQ----KIIKLEY------DF 229 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHTTCC------CC
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---HHHH----HHHcCCC------CC
Confidence 22233456999999999999999999999999999999999999999743321 1111 1112211 11
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
... ....+.+|+.+||+.||++|||++|+++
T Consensus 230 p~~----~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 230 PEK----FFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CTT----CCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred Ccc----CCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 111 2236789999999999999999999754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=395.64 Aligned_cols=259 Identities=25% Similarity=0.401 Sum_probs=200.6
Q ss_pred HHHHhhcccccccccEEEEEEEECC----CcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEE
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~~----g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~L 678 (927)
...|++.+.||+|+||.||+|++.. +..||||+++.... ...+.|.+|++++++++||||+++++++.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 3457788999999999999998753 35689999875433 345679999999999999999999999964 67899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
||||+++|+|.+++.. ....+++..++.++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999998764 35678999999999999999999999 999999999999999999999999999998866
Q ss_pred ccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 759 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 759 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
...........||+.|+|||.+.+..++.++|||||||++|||++ |..||......+ +... +..+....
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~----i~~~~~~~--- 229 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR----IENGERLP--- 229 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTCCCC---
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHH----HHcCCCCC---
Confidence 544444455568999999999999999999999999999999998 899997443322 2221 22222111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
. +...+..+.+|+.+||+.||++|||++||++.|+++++.+
T Consensus 230 --~----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 230 --M----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp --C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --C----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1 1122347889999999999999999999999999987654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-45 Score=399.29 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=190.2
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
..|++.+.||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|+++|++++||||+++++++.+++..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 34778899999999999999986 689999999975432 3346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc---CCCcEEEeeccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld---~~~~~kL~DFGla~~~~~ 759 (927)
++||+|.+++. ....+++..+..++.||+.||+|||+ ++|+||||||+|||+. +++.+||+|||+++....
T Consensus 89 ~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 89 VSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred cCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999997 35679999999999999999999998 9999999999999994 578999999999987644
Q ss_pred cccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccc
Q 002410 760 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 839 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 839 (927)
... .....||+.|||||++.+..++.++|||||||++|||++|+.||...... ..... +..+... ....
T Consensus 163 ~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~----i~~~~~~--~~~~ 231 (307)
T d1a06a_ 163 GSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQ----ILKAEYE--FDSP 231 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHH----HHTTCCC--CCTT
T ss_pred CCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHHH----HhccCCC--CCCc
Confidence 322 23456999999999999999999999999999999999999999743321 11111 1111110 0111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 840 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 840 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
. .......+.+|+.+||+.||++|||++|+++.
T Consensus 232 ~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 232 Y----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp T----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred c----ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1 11223468899999999999999999999873
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.7e-45 Score=404.17 Aligned_cols=251 Identities=20% Similarity=0.322 Sum_probs=207.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.|++.+.||+|+||.||+|+.+ +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 5778899999999999999986 689999999987666667889999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc--CCCcEEEeecccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld--~~~~~kL~DFGla~~~~~~~~ 762 (927)
+|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||+++.......
T Consensus 107 gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 107 GGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp SCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 99999998642 4569999999999999999999999 9999999999999995 468899999999987654332
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
.....||+.|||||++.+..++.++|||||||++|||++|+.||.+.+.. .... ... ..... .+....
T Consensus 182 --~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~---~i~-~~~~~--~~~~~~- 249 (350)
T d1koaa2 182 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLR---NVK-SCDWN--MDDSAF- 249 (350)
T ss_dssp --EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHH-HTCCC--SCCGGG-
T ss_pred --cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHHH---HHH-hCCCC--CCcccc-
Confidence 23456899999999999999999999999999999999999999744321 1111 111 11110 011111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
......+.+|+.+||+.||++|||++|+++.
T Consensus 250 ---~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 250 ---SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122467899999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-44 Score=396.42 Aligned_cols=245 Identities=27% Similarity=0.374 Sum_probs=201.3
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
..|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45777899999999999999976 68899999987543 234467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
|||++|+|..++. ....+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 9999999987765 34679999999999999999999998 99999999999999999999999999999875432
Q ss_pred ccccccccccCCCccCCCccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 761 LTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
....||+.|||||++.+ ..++.++|||||||++|||++|+.||...... +........ .......
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~-~~~~~~~ 236 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN-ESPALQS 236 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-CCCCCSC
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhC-CCCCCCC
Confidence 23469999999999864 46899999999999999999999999743221 111111221 1111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
. .....+.+|+.+||+.||++|||++|+++
T Consensus 237 ~--------~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 G--------HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp T--------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C--------CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 12246889999999999999999999976
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2e-44 Score=401.86 Aligned_cols=251 Identities=21% Similarity=0.332 Sum_probs=207.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.|++.+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..++|||||+
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4778899999999999999986 699999999987666666788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc--CCCcEEEeecccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld--~~~~~kL~DFGla~~~~~~~~ 762 (927)
+|+|.+++.. ....+++.+++.|+.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||+|+.......
T Consensus 110 gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 110 GGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 9999998764 24569999999999999999999998 9999999999999997 578999999999988755322
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.+..+ .... +..+... ..+..
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~----i~~~~~~--~~~~~-- 251 (352)
T d1koba_ 185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQN----VKRCDWE--FDEDA-- 251 (352)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHH----HHHCCCC--CCSST--
T ss_pred --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----HHhCCCC--CCccc--
Confidence 334568999999999999999999999999999999999999997443221 1111 1111110 01111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.......+.+|+.+||+.||++|||++|+++.
T Consensus 252 --~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 252 --FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp --TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11223467899999999999999999999873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=393.72 Aligned_cols=250 Identities=30% Similarity=0.481 Sum_probs=198.3
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeec-CceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-~~~~~LV~E~~~ 684 (927)
.+++.+.||+|+||.||+|+++ |+.||||+++.. ...++|.+|++++++++||||++++|+|.+ .+..++||||++
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 3567899999999999999996 789999999754 345779999999999999999999999854 466899999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 764 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 764 (927)
+|+|.+++... ....+++..+++|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 85 KGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 99999999743 23458999999999999999999998 999999999999999999999999999998754432
Q ss_pred ccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccCC
Q 002410 765 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 843 (927)
Q Consensus 765 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 843 (927)
....++..|+|||++.+..+++++|||||||++|||+| |+.||...... .+...+ .++...++
T Consensus 158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i----~~~~~~~~-------- 221 (262)
T d1byga_ 158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EKGYKMDA-------- 221 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH----TTTCCCCC--------
T ss_pred -ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HcCCCCCC--------
Confidence 23357889999999998999999999999999999998 67777643322 233322 22221111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 844 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 844 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
+......+.+|+.+||+.||++|||++||+++|+++..
T Consensus 222 -~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 222 -PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 11222467899999999999999999999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=391.98 Aligned_cols=250 Identities=23% Similarity=0.300 Sum_probs=204.0
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc------hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 677 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~------~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~ 677 (927)
..|++.+.||+|+||+||+|+.+ +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 35778899999999999999985 689999999864321 23578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC----cEEEeeccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFGL 753 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~----~~kL~DFGl 753 (927)
+|||||++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999974 4579999999999999999999998 9999999999999998776 599999999
Q ss_pred cccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCee
Q 002410 754 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 833 (927)
Q Consensus 754 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 833 (927)
++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+ ... .+..+...
T Consensus 164 a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~----~i~~~~~~ 234 (293)
T d1jksa_ 164 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLA----NVSAVNYE 234 (293)
T ss_dssp CEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHTTCCC
T ss_pred hhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HHH----HHHhcCCC
Confidence 987654322 234468999999999999999999999999999999999999997443211 111 11111110
Q ss_pred eeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 834 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 834 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
..+..... ....+.+|+.+||+.||++|||++|+++
T Consensus 235 --~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 --FEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --CCHHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCchhcCC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001111 1236789999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-44 Score=395.55 Aligned_cols=257 Identities=27% Similarity=0.443 Sum_probs=208.4
Q ss_pred HHhhcccccccccEEEEEEEEC------CCcEEEEEEccCccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~~~-~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~L 678 (927)
.+++.+.||+|+||+||+|+++ +++.||||+++..... ..++|.+|+++|++++||||++++++|...+..++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 4667899999999999999875 3578999999765433 45679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 002410 679 VYEYMHNGTLRDRLHGSV---------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 737 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~N 737 (927)
||||+++|+|.+++.... ....+++..++.|+.|++.||+|||+ ++|+||||||+|
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~N 170 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRN 170 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccc
Confidence 999999999999986422 12358899999999999999999998 999999999999
Q ss_pred ccccCCCcEEEeeccccccccccc-cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCcccccc
Q 002410 738 ILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGA 815 (927)
Q Consensus 738 ILld~~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~-~Pf~~~~~~~ 815 (927)
||++.++.+||+|||+++...... ........|++.|+|||.+.+..++.++|||||||++|||++|. +||...+..
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~- 249 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE- 249 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH-
Confidence 999999999999999998654432 22333456889999999999999999999999999999999986 567633221
Q ss_pred hhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 002410 816 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 881 (927)
Q Consensus 816 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~ 881 (927)
.+.. .+..+..... +...+..+.+|+.+||+.||++||||.||+++|+++.
T Consensus 250 --e~~~----~v~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 250 --EVIY----YVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp --HHHH----HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --HHHH----HHHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 2222 2233332211 1122346889999999999999999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=393.16 Aligned_cols=246 Identities=24% Similarity=0.362 Sum_probs=204.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.+.||+|+||.||+|+.+ +|+.||||++++.. ....+.+.+|+.+|++++||||+++++++.+++..++|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 3677899999999999999986 69999999997532 2345778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.+|.+||+|||+|+......
T Consensus 86 y~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 86 YANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp CCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred ccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999999984 4678999999999999999999999 999999999999999999999999999998754432
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. .+.+ .+..+.. .+.
T Consensus 160 ~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~----~i~~~~~------~~p 225 (337)
T d1o6la_ 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE----LILMEEI------RFP 225 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCC------CCC
T ss_pred c-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HHHH----HHhcCCC------CCC
Confidence 2 233456999999999999999999999999999999999999999854432 1111 1212211 111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 875 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~eVl~ 875 (927)
... ...+.+|+.+||+.||++||+ ++|+++
T Consensus 226 ~~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 226 RTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ccC----CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 122 235789999999999999995 888876
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=390.01 Aligned_cols=256 Identities=29% Similarity=0.462 Sum_probs=205.3
Q ss_pred hhcccccccccEEEEEEEECCC----cEEEEEEccCc-cchhHHHHHHHHHHHHhcCCCceeeeeeeeec-CceEEEEEE
Q 002410 608 NFCKKIGKGSFGSVYYGKMKDG----KEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYE 681 (927)
Q Consensus 608 ~~~~~LG~G~~G~Vy~a~~~~g----~~vAvK~l~~~-~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-~~~~~LV~E 681 (927)
+|.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++||||++++|++.. ++..++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 4467899999999999998642 26899999753 34456789999999999999999999999865 568899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
||++|+|.+++... ...+++..+++++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 110 ~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999998753 4567888999999999999999998 999999999999999999999999999998765432
Q ss_pred cc---cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 762 TH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 762 ~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
.. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||..... ...+..++ ..+.... .|
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i----~~g~~~~--~p 256 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYL----LQGRRLL--QP 256 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTCCCC--CC
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHH----HcCCCCC--Cc
Confidence 22 22234689999999999999999999999999999999998888763221 11222222 2222111 11
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
......+.+|+.+||+.||++||+|+||++.|++++..
T Consensus 257 -------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 257 -------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11234688999999999999999999999999998753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-44 Score=391.62 Aligned_cols=264 Identities=26% Similarity=0.405 Sum_probs=200.7
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeec-
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE- 672 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~- 672 (927)
+....|++.++||+|+||.||+|++. +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++..
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 33456778899999999999999864 24689999997543 34456788888888887 68999999998765
Q ss_pred CceEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccc
Q 002410 673 EHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 739 (927)
Q Consensus 673 ~~~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NIL 739 (927)
++..++|||||++|+|.++++... ....+++.+++.++.||++||+|||+ ++|+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCcccee
Confidence 456899999999999999997532 13458999999999999999999998 99999999999999
Q ss_pred ccCCCcEEEeeccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCcccccchh
Q 002410 740 LDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAEL 817 (927)
Q Consensus 740 ld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~-~Pf~~~~~~~~~ 817 (927)
|++++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||.......
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-- 244 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-- 244 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH--
Confidence 999999999999999875443322 233456899999999999999999999999999999999975 5776333221
Q ss_pred hHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 818 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 818 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
.+.. .+..+..... +......+.+++.+||+.||++|||++||+++|+++++.
T Consensus 245 ~~~~----~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 245 EFCR----RLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHH----HHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH----HHhcCCCCCC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1222 2222222111 111234688999999999999999999999999998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.9e-43 Score=381.85 Aligned_cols=257 Identities=25% Similarity=0.363 Sum_probs=201.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCc----eEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRI 677 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~----~~~ 677 (927)
.|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++...+ ..+
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 4678899999999999999975 69999999997543 234567999999999999999999999986543 478
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
+||||++||+|.+++.. ...+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++..+|+|||.+...
T Consensus 88 lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhh
Confidence 99999999999998873 4679999999999999999999998 99999999999999999999999999998765
Q ss_pred ccccc--ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 758 EEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 758 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +.....+..+.....
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~~~~ 235 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIPPS 235 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCCGG
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCCCCc
Confidence 33222 2233456999999999999999999999999999999999999999743321 112222322221110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhh
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSI 881 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-s~~eVl~~L~~~~ 881 (927)
.... ..+..+.+++.+||+.||++|| |++|+++.|.++.
T Consensus 236 ---~~~~----~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 236 ---ARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ---GTSS----SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---hhcc----CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0111 1234688999999999999999 8999999988764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-44 Score=384.07 Aligned_cols=254 Identities=28% Similarity=0.421 Sum_probs=196.6
Q ss_pred HHhhcccccccccEEEEEEEECC--C--cEEEEEEccCc---cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKD--G--KEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~--g--~~vAvK~l~~~---~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~L 678 (927)
.|++.+.||+|+||.||+|+++. + ..||||+++.. .....++|.+|+++|++++||||++++|++.+ +..++
T Consensus 9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l 87 (273)
T d1u46a_ 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM 87 (273)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence 46778999999999999998752 2 37899998753 23445789999999999999999999999976 46789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 758 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 758 (927)
||||+++|++.+.+... ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 99999999999987743 4569999999999999999999999 999999999999999999999999999999865
Q ss_pred ccccc--cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 759 EDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 759 ~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
..... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||...+.. .... ...+.+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~~---~i~~~~~~~~~ 236 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILH---KIDKEGERLPR 236 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---HHHTSCCCCCC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHHH---HHHhCCCCCCC
Confidence 44322 2233457889999999999999999999999999999998 89999743322 1222 22222211111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 880 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~ 880 (927)
....+..+.+|+.+||+.||++|||++||++.|+++
T Consensus 237 ---------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 237 ---------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 112234688999999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=390.33 Aligned_cols=255 Identities=23% Similarity=0.409 Sum_probs=202.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCc----EEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~----~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
.|++.++||+|+||+||+|++. +|+ .||+|+++... ....++|.+|++++++++|||||+++++|.++ ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 3677899999999999999876 343 58999886533 34567899999999999999999999999875 56788
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
+|++.+|+|.+++.. ....+++..+++++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 89 TQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 999999999998875 35679999999999999999999998 9999999999999999999999999999987654
Q ss_pred cccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhhhcCCeeeecc
Q 002410 760 DLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 837 (927)
Q Consensus 760 ~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 837 (927)
.... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+ +...+ ..+....
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i----~~~~~~~--- 233 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL----EKGERLP--- 233 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHH----HHTCCCC---
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcCCCCC---
Confidence 3332 2233458999999999999999999999999999999999 788987544322 22211 1221111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 838 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 838 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
.+...+..+.+|+.+||+.||++|||++||++.|+++..
T Consensus 234 ------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 234 ------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 111223468899999999999999999999999988754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-43 Score=388.64 Aligned_cols=244 Identities=22% Similarity=0.356 Sum_probs=203.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.+.||+|+||+||+|+.+ +|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+++..++|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 3677899999999999999986 69999999987532 2345778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|++||+|..++. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 85 YIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp CCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred ecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 999999999988 35678889999999999999999998 999999999999999999999999999998765432
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
....||+.|||||++.+..++.++||||+||++|||++|+.||...+..+ . ..... .+.. ...
T Consensus 159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~---~~~i~-~~~~------~~p 221 (316)
T d1fota_ 159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---T---YEKIL-NAEL------RFP 221 (316)
T ss_dssp ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHHHH-HCCC------CCC
T ss_pred ----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH---H---HHHHH-cCCC------CCC
Confidence 24569999999999999999999999999999999999999997433211 1 11111 1111 011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 876 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~~ 876 (927)
. .....+.+++.+||+.||.+|| |++|+++.
T Consensus 222 ~----~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 222 P----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp T----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C----CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1 1123678999999999999996 89999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-44 Score=388.52 Aligned_cols=262 Identities=24% Similarity=0.436 Sum_probs=209.0
Q ss_pred HHHHhhcccccccccEEEEEEEECC--------CcEEEEEEccCccc-hhHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q 002410 604 EATNNFCKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 673 (927)
Q Consensus 604 ~~~~~~~~~LG~G~~G~Vy~a~~~~--------g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~ 673 (927)
...|++.+.||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3467788999999999999998642 34799999976544 3457889999999888 799999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccc
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 740 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILl 740 (927)
+..++||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+ ++|+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence 99999999999999999997543 13468999999999999999999999 999999999999999
Q ss_pred cCCCcEEEeeccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccchhh
Q 002410 741 DINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELN 818 (927)
Q Consensus 741 d~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~ 818 (927)
+.++.+||+|||+++........ ......+++.|+|||.+.++.++.++|||||||++|||++ |+.||...... .
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~ 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---H
Confidence 99999999999999986554332 2334568899999999999999999999999999999998 68888633321 1
Q ss_pred HHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 819 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 819 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
+. ..+..+..... .. .....+.+|+.+||+.||++|||++||++.|++++...
T Consensus 246 ~~----~~i~~~~~~~~-----p~----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~ 298 (299)
T d1fgka_ 246 LF----KLLKEGHRMDK-----PS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298 (299)
T ss_dssp HH----HHHHTTCCCCC-----CS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HH----HHHHcCCCCCC-----Cc----cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence 22 22223322111 11 12246889999999999999999999999999998753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=392.62 Aligned_cols=258 Identities=29% Similarity=0.489 Sum_probs=205.3
Q ss_pred HHHhhcccccccccEEEEEEEECC-Cc--EEEEEEccCc-cchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCceEEEE
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMKD-GK--EVAVKIMADS-CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~~-g~--~vAvK~l~~~-~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~LV 679 (927)
..+++.++||+|+||.||+|++++ |. .||||+++.. .....+.|.+|+++|+++ +||||+++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 445678999999999999999874 44 5788887643 233456799999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHhccC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcE
Q 002410 680 YEYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 746 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~-------------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~ 746 (927)
|||+++|+|.++|+.. .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 9999999999999753 134679999999999999999999998 999999999999999999999
Q ss_pred EEeeccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCC-CCCcccccchhhHHHHHHH
Q 002410 747 KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK-PVSVEDFGAELNIVHWARS 825 (927)
Q Consensus 747 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~-Pf~~~~~~~~~~l~~~~~~ 825 (927)
||+|||+++........ ....||..|+|||.+.+..++.++|||||||++|||++|.. ||...+. ..+.+
T Consensus 167 kl~DfG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~---- 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYE---- 237 (309)
T ss_dssp EECCTTCEESSCEECCC------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH----
T ss_pred EEccccccccccccccc--cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHHH----
Confidence 99999999875443222 23458999999999999999999999999999999999765 6653321 12222
Q ss_pred hhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 826 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 826 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
.+..+.... .+......+.+|+.+||+.||++||||+||++.|+++++.
T Consensus 238 ~i~~~~~~~---------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 238 KLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HGGGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHhcCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 122221111 1112234788999999999999999999999999998864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=387.23 Aligned_cols=265 Identities=28% Similarity=0.419 Sum_probs=212.9
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCccc-hhHHHHHHHHHHHHhc-CCCceeeeeeeeec
Q 002410 601 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEE 672 (927)
Q Consensus 601 el~~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~ 672 (927)
|+....+++.++||+|+||.||+|++. +++.||||+++.... .....|.+|+.+++++ +|||||+++++|.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 344456778999999999999999863 467899999976433 3456799999999999 69999999999999
Q ss_pred CceEEEEEEecCCCCHHHHhccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 002410 673 EHQRILVYEYMHNGTLRDRLHGSV---------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 737 (927)
Q Consensus 673 ~~~~~LV~E~~~~gsL~~~L~~~~---------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~N 737 (927)
.+..++||||+++|+|.++++... ....+++..+..++.||++||+|||+ ++++||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccc
Confidence 999999999999999999997543 23368999999999999999999998 999999999999
Q ss_pred ccccCCCcEEEeecccccccccccc-ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCcccccc
Q 002410 738 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGA 815 (927)
Q Consensus 738 ILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG-~~Pf~~~~~~~ 815 (927)
|+++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+|+ .+||......
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~- 254 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD- 254 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999998654433 233345689999999999999999999999999999999995 5555432221
Q ss_pred hhhHHHHHHHhhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 816 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 816 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
..+...+ ..+.... .+......+.+|+.+||+.||++|||++||+++|++++..
T Consensus 255 -~~~~~~i----~~~~~~~---------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 255 -SKFYKMI----KEGFRML---------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp -HHHHHHH----HHTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHH----hcCCCCC---------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 1122222 2221111 1112234788999999999999999999999999988764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=384.63 Aligned_cols=267 Identities=25% Similarity=0.374 Sum_probs=202.1
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHH--HHHHHHhcCCCceeeeeeeeecCc----eEEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLIGYCEEEH----QRILVY 680 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~--E~~~L~~l~HpnIv~l~~~~~~~~----~~~LV~ 680 (927)
+.+.+.||+|+||.||+|+++ |+.||||+++... .+.+.+ |+..+.+++||||+++++++.+++ ..++||
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 445788999999999999975 8999999986432 233344 555556789999999999997643 689999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCcccccCCCcEEEeeccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG-----CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 755 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-----~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 755 (927)
||+++|+|.+++++ ..+++..+++++.|+|.||+|||+. .+++|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999984 4689999999999999999999962 14799999999999999999999999999998
Q ss_pred cccccccc---cccccccCCCccCCCccCCC------CCCcchhHHHHHHHHHHHHhCCCCCCcccccch--------hh
Q 002410 756 QAEEDLTH---ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--------LN 818 (927)
Q Consensus 756 ~~~~~~~~---~~~~~~gt~~Y~APE~l~~~------~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~--------~~ 818 (927)
........ ......||+.|+|||++.+. .++.++|||||||++|||+||..|+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 76543322 22345699999999998754 367799999999999999999988753222110 01
Q ss_pred HHHHHHHhhhcCCeeeeccccccCCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhcc
Q 002410 819 IVHWARSMIKKGDVISIVDPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 885 (927)
Q Consensus 819 l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e~ 885 (927)
..+........+.. .|.+.... ..+.+..+.+|+.+||+.||++|||+.||++.|+++.+.+.
T Consensus 237 ~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 237 SVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp CHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 11112222222221 12221111 33456779999999999999999999999999998876553
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=382.23 Aligned_cols=256 Identities=20% Similarity=0.207 Sum_probs=195.6
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCccch-----hHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 610 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~-----~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
.++||+|+||+||+|+.+ +|+.||||+++..... ..+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999976 5899999998653322 1346889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
+++++..+.. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 9888777665 45678999999999999999999998 99999999999999999999999999999876544332
Q ss_pred cccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc---CCeeeecc--
Q 002410 764 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVISIVD-- 837 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~---~~~~~~~d-- 837 (927)
.....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ....+...... ........
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSST
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhccc
Confidence 223468999999999865 467999999999999999999999997443322 11111111110 00000000
Q ss_pred -cc---ccCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 838 -PV---LIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 838 -~~---l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.. .....+ ......+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00 000000 112346889999999999999999999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.9e-43 Score=376.79 Aligned_cols=249 Identities=26% Similarity=0.324 Sum_probs=202.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc---------hhHHHHHHHHHHHHhcC-CCceeeeeeeeecCc
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---------HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH 674 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---------~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~ 674 (927)
.|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 4667899999999999999985 689999999865321 12346889999999997 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccc
Q 002410 675 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 754 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 754 (927)
..++||||+++|+|.++++. ...+++.+++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999974 4579999999999999999999998 99999999999999999999999999999
Q ss_pred ccccccccccccccccCCCccCCCccC------CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhh
Q 002410 755 RQAEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 828 (927)
Q Consensus 755 ~~~~~~~~~~~~~~~gt~~Y~APE~l~------~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 828 (927)
+....... .....||+.|+|||.+. ...++.++||||+||++|||++|+.||....... ..+ .+.
T Consensus 158 ~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---~~~----~i~ 228 (277)
T d1phka_ 158 CQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLR----MIM 228 (277)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHH
T ss_pred eEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---HHH----HHH
Confidence 88655322 23456999999999984 3457889999999999999999999998443211 111 111
Q ss_pred cCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 829 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 829 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.+... ...+ .......++.+|+.+||+.||++|||++||++
T Consensus 229 ~~~~~-~~~~-----~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 SGNYQ-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HTCCC-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hCCCC-CCCc-----ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 12111 0000 11122346889999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-43 Score=384.21 Aligned_cols=262 Identities=24% Similarity=0.406 Sum_probs=211.4
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCc
Q 002410 602 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 674 (927)
Q Consensus 602 l~~~~~~~~~~LG~G~~G~Vy~a~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~ 674 (927)
+....+++.+.||+|+||+||+|.++ +++.||||+++... ......|.+|++++++++||||+++++++..++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 33456678899999999999999874 25789999997643 334567999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEE
Q 002410 675 QRILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 747 (927)
Q Consensus 675 ~~~LV~E~~~~gsL~~~L~~~~-------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~k 747 (927)
..++||||+++|+|.+++.... ....+++..+.+++.|+|+||.|||+ ++|+||||||+|||++.++++|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEE
Confidence 9999999999999999886421 23457899999999999999999998 8999999999999999999999
Q ss_pred Eeeccccccccccccc-cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCcccccchhhHHHHHHH
Q 002410 748 VSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAELNIVHWARS 825 (927)
Q Consensus 748 L~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~-~Pf~~~~~~~~~~l~~~~~~ 825 (927)
|+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+||. .||..... .+...
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~~- 246 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLR- 246 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHHH-
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHHH-
Confidence 9999999876544332 233345899999999999999999999999999999999985 66653222 11111
Q ss_pred hhhcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 002410 826 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 882 (927)
Q Consensus 826 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 882 (927)
.+..+...... ...+..+.+++.+||+.+|++|||++||++.|++.++
T Consensus 247 ~i~~~~~~~~p---------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 247 FVMEGGLLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHhCCCCCCc---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 12222221111 1123468899999999999999999999999988765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.9e-42 Score=387.89 Aligned_cols=246 Identities=22% Similarity=0.273 Sum_probs=196.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc---hhHHHHHH---HHHHHHhcCCCceeeeeeeeecCceEEEE
Q 002410 607 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVT---EVALLSRIHHRNLVPLIGYCEEEHQRILV 679 (927)
Q Consensus 607 ~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~---E~~~L~~l~HpnIv~l~~~~~~~~~~~LV 679 (927)
|++.+.||+|+||.||+|+.. +|+.||||++..... .....+.+ |+++++.++|||||++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 667899999999999999986 699999999864221 12233444 46677777899999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 mE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp ECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999974 4678899999999999999999998 9999999999999999999999999999987654
Q ss_pred cccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccc
Q 002410 760 DLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 838 (927)
Q Consensus 760 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 838 (927)
.. .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||..........+.. ...... .
T Consensus 160 ~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~----~~~~~~------~ 226 (364)
T d1omwa3 160 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLTMA------V 226 (364)
T ss_dssp SC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH----HSSSCC------C
T ss_pred Cc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hcccCC------C
Confidence 32 234569999999999864 568999999999999999999999998544333222111 111111 0
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 002410 839 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 875 (927)
Q Consensus 839 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~eVl~ 875 (927)
...... ...+.+|+.+||+.||++||| ++|+++
T Consensus 227 ~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 ELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111112 236789999999999999999 688875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-42 Score=387.44 Aligned_cols=243 Identities=23% Similarity=0.298 Sum_probs=203.2
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E 681 (927)
.|++.+.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+.+..++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 5677899999999999999986 69999999986432 2334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 761 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 761 (927)
|+.+|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 122 ~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 122 YVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp CCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred cccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 9999999999974 4579999999999999999999998 999999999999999999999999999998765432
Q ss_pred cccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeecccccc
Q 002410 762 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 841 (927)
Q Consensus 762 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 841 (927)
....||+.|||||++.+..++.++|||||||++|||+||+.||...+.. .+.. . +..+.. ...
T Consensus 196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~---~-i~~~~~------~~p 258 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYE---K-IVSGKV------RFP 258 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---H-HHHCCC------CCC
T ss_pred ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---HHHH---H-HhcCCC------CCC
Confidence 2356999999999999999999999999999999999999999743321 1111 1 111211 011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 002410 842 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 875 (927)
Q Consensus 842 ~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~eVl~ 875 (927)
. .....+.+++.+||+.||.+|+ |++|+++
T Consensus 259 ~----~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 S----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp T----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred c----cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1 1223678999999999999994 8999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-42 Score=379.93 Aligned_cols=249 Identities=19% Similarity=0.309 Sum_probs=203.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEecC
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 684 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 684 (927)
.|.+.+.||+|+||+||+|.++ +|+.||||+++... .....+.+|+++|++++||||+++++++.+++..++|||||+
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 3677899999999999999986 68899999997653 344668899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCC--CcEEEeecccccccccccc
Q 002410 685 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 685 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~--~~~kL~DFGla~~~~~~~~ 762 (927)
||+|.+++... +..+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ ..+||+|||+++.......
T Consensus 85 gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 85 GLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 99999999742 3469999999999999999999998 999999999999999854 5799999999987644322
Q ss_pred ccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccccC
Q 002410 763 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 842 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 842 (927)
.....+++.|+|||.+.+..++.++||||+||++|||++|+.||...... .... .... +... .+.....
T Consensus 160 --~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~~~---~i~~-~~~~--~~~~~~~ 228 (321)
T d1tkia_ 160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIE---NIMN-AEYT--FDEEAFK 228 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH---HHHH-TCCC--CCHHHHT
T ss_pred --ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHh-CCCC--CChhhcc
Confidence 23345899999999999999999999999999999999999999744321 1111 1111 1110 0111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 843 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 843 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.. ...+.+|+.+||+.||++|||++|+++
T Consensus 229 ~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 EI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 235789999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-43 Score=385.06 Aligned_cols=246 Identities=25% Similarity=0.377 Sum_probs=200.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---chhHHHHHHHHHHHH-hcCCCceeeeeeeeecCceEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLS-RIHHRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~L~-~l~HpnIv~l~~~~~~~~~~~LV~ 680 (927)
.|++.+.||+|+||+||+|+.+ +|+.||||++++.. ....+.+..|..++. .++||||+++++++.+++..++||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 3667899999999999999987 68999999997532 223456677777665 689999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccc
Q 002410 681 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 681 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 760 (927)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++.....
T Consensus 83 Ey~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 83 EYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred eecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999984 4568999999999999999999999 99999999999999999999999999999875543
Q ss_pred ccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeeeccccc
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 840 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 840 (927)
... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+... +.. .+..+.. ..
T Consensus 157 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~----~i~~~~~------~~ 222 (320)
T d1xjda_ 157 DAK-TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFH----SIRMDNP------FY 222 (320)
T ss_dssp TCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCCC------CC
T ss_pred ccc-ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHH----HHHcCCC------CC
Confidence 322 233569999999999999999999999999999999999999997443221 111 1222211 11
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 002410 841 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ-EIVL 875 (927)
Q Consensus 841 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~-eVl~ 875 (927)
... ....+.+|+.+||+.||++||++. |+++
T Consensus 223 p~~----~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 PRW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred Ccc----CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111 123678999999999999999996 6754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=381.88 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=196.4
Q ss_pred HHhhc-ccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhc-CCCceeeeeeeeec----CceEEE
Q 002410 606 TNNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQRIL 678 (927)
Q Consensus 606 ~~~~~-~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~----~~~~~L 678 (927)
.|.+. +.||+|+||+||+|++. +++.||||+++.. ..+.+|++++.++ +||||+++++++.+ +...++
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 35554 56999999999999975 6899999998643 4567899987655 89999999999865 467899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC---CCcEEEeeccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSR 755 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~---~~~~kL~DFGla~ 755 (927)
|||||+||+|.+++... ....+++.+++.|+.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+
T Consensus 87 vmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceee
Confidence 99999999999999753 34579999999999999999999998 99999999999999975 5679999999998
Q ss_pred cccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeeee
Q 002410 756 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 835 (927)
Q Consensus 756 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 835 (927)
....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||........ ...+...+..+..
T Consensus 163 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~~--- 234 (335)
T d2ozaa1 163 ETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQY--- 234 (335)
T ss_dssp ECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS---
T ss_pred eccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCCC---
Confidence 7654322 2345699999999999999999999999999999999999999974432211 1111111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 836 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 836 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.+...........+.+|+.+||+.||++|||+.|+++.
T Consensus 235 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 ---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00000011223478899999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.8e-42 Score=372.56 Aligned_cols=260 Identities=18% Similarity=0.269 Sum_probs=199.4
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEec
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
.|++.++||+|+||+||+|++++|+.||||+++.... ...+++.+|+.+|++++||||+++++++.+++..++++|++
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 3567789999999999999999999999999975432 23578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 763 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 763 (927)
.++.+..+.. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||.+.........
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 83 DQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp SEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred hhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 8877777665 45779999999999999999999998 99999999999999999999999999999876543222
Q ss_pred cccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc---CCee------
Q 002410 764 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVI------ 833 (927)
Q Consensus 764 ~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~---~~~~------ 833 (927)
.....+++.|+|||.+.+. .++.++||||+||++|||++|+.||......+. +..... .... ....
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~i~~-~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 157 -YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFR-ILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHH-HHCCCCTTTSTTGGGST
T ss_pred -cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHHHHH-hhCCCChhhccchhhhh
Confidence 2334589999999998654 568999999999999999999999974432211 111111 1100 0000
Q ss_pred ------eeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 834 ------SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 834 ------~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
....+.............+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000111122346789999999999999999999984
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-42 Score=372.44 Aligned_cols=263 Identities=20% Similarity=0.277 Sum_probs=197.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
.|++.+.||+|+||+||+|++. +|+.||||+++.... ...+++.+|+++|++++||||+++++++.+++..++||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 3566789999999999999975 699999999965432 2357899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+.++ +.+.+... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~-~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 83 LHQD-LKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CSEE-HHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred cCCc-hhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 9754 44444322 35679999999999999999999998 9999999999999999999999999999987654332
Q ss_pred ccccccccCCCccCCCccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhh--cCCeeeec-cc
Q 002410 763 HISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK--KGDVISIV-DP 838 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~-~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~--~~~~~~~~-d~ 838 (927)
. .....||+.|+|||.+.... ++.++||||+||++|||++|+.||...+..+ .+......... +....... .+
T Consensus 158 ~-~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 T-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp C-TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred c-ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhcccccccc
Confidence 2 33346899999999876654 5889999999999999999999997443221 11111111000 00000000 00
Q ss_pred cccCC------C-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 839 VLIGN------V-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 839 ~l~~~------~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
..... . .......+.+|+.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 0 01122467899999999999999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-42 Score=367.86 Aligned_cols=238 Identities=25% Similarity=0.397 Sum_probs=194.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccc------hhHHHHHHHHHHHHhcC--CCceeeeeeeeecCceE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQR 676 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~------~~~~~~~~E~~~L~~l~--HpnIv~l~~~~~~~~~~ 676 (927)
.|++.+.||+|+||+||+|+.. +|+.||||+++.... ....++.+|+.+|++++ ||||+++++++.+++..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 4677899999999999999986 689999999864321 12244678999999996 89999999999999999
Q ss_pred EEEEEecCC-CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC-CCcEEEeecccc
Q 002410 677 ILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLS 754 (927)
Q Consensus 677 ~LV~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFGla 754 (927)
++||||+.+ +++.+++.. ...+++.+++.++.||++||+|||+ ++|+||||||+|||++. ++.+||+|||+|
T Consensus 85 ~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence 999999976 688888873 4679999999999999999999998 99999999999999985 579999999999
Q ss_pred ccccccccccccccccCCCccCCCccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCee
Q 002410 755 RQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 833 (927)
Q Consensus 755 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 833 (927)
+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... .+ .. +..
T Consensus 159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i-------~~-~~~- 221 (273)
T d1xwsa_ 159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI-------IR-GQV- 221 (273)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH-------HH-CCC-
T ss_pred eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HH-------hh-ccc-
Confidence 865433 2234569999999999977655 678999999999999999999997321 11 11 110
Q ss_pred eeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 834 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 834 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.+.... ..++.+++.+||+.||++|||++|+++
T Consensus 222 -----~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 -----FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -----CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 011112 236789999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-41 Score=368.02 Aligned_cols=262 Identities=21% Similarity=0.263 Sum_probs=196.0
Q ss_pred HHHhhcccccccccEEEEEEEEC-C-CcEEEEEEccCccc--hhHHHHHHHHHHHHhc---CCCceeeeeeeee-----c
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-D-GKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCE-----E 672 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~-g~~vAvK~l~~~~~--~~~~~~~~E~~~L~~l---~HpnIv~l~~~~~-----~ 672 (927)
..|++.++||+|+||+||+|++. + ++.||||+++.... .....+.+|+.+|+.| +||||++++++|. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 35677899999999999999974 4 66799999865322 2233566788777766 7999999999984 3
Q ss_pred CceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecc
Q 002410 673 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 752 (927)
Q Consensus 673 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 752 (927)
....++++||++++++...... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence 4578999999998877654442 45678999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcC--
Q 002410 753 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG-- 830 (927)
Q Consensus 753 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-- 830 (927)
+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+. +.. +.......
T Consensus 162 ~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~-i~~~~~~~~~ 236 (305)
T d1blxa_ 162 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGK-ILDVIGLPGE 236 (305)
T ss_dssp SCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCG
T ss_pred hhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--HHH-HHHhhCCCch
Confidence 988654332 23445699999999999999999999999999999999999999975433221 111 11111000
Q ss_pred -Cee------eec----cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 831 -DVI------SIV----DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 831 -~~~------~~~----d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
... ... ...............+.+|+.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 000 0000001111223467899999999999999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-40 Score=363.68 Aligned_cols=266 Identities=19% Similarity=0.236 Sum_probs=195.2
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeec--------C
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------E 673 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--------~ 673 (927)
..|++.++||+|+||+||+|++. +|+.||||++.... ....+++.+|+++|++++||||+++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 45677899999999999999985 79999999986432 2345778999999999999999999998854 3
Q ss_pred ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccc
Q 002410 674 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 753 (927)
Q Consensus 674 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 753 (927)
+..++||||++++.+..... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence 46899999998877765554 45678899999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccc---ccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhc
Q 002410 754 SRQAEEDLT---HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 829 (927)
Q Consensus 754 a~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 829 (927)
++....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.....................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 976543221 122234689999999998765 6899999999999999999999999744332221111111111000
Q ss_pred CCeeee--------ccccccCCCCHH-------HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 830 GDVISI--------VDPVLIGNVKIE-------SIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 830 ~~~~~~--------~d~~l~~~~~~~-------~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
...... ............ ....+++|+.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000 000000000110 12256789999999999999999999863
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-40 Score=368.41 Aligned_cols=264 Identities=24% Similarity=0.256 Sum_probs=195.1
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeeeeeeeec------CceEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQRIL 678 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~------~~~~~L 678 (927)
+|+..++||+|+||+||+|++. +|+.||||++..... ...+|+++|++++||||+++++++.. ....++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4566789999999999999986 699999999975432 23479999999999999999999843 335789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC-cEEEeeccccccc
Q 002410 679 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQA 757 (927)
Q Consensus 679 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla~~~ 757 (927)
||||++++.+............+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99999876544443322246679999999999999999999998 9999999999999999775 8999999999876
Q ss_pred cccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH-----------H
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR-----------S 825 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~-----------~ 825 (927)
..... .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +....+ .
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHHhhhh
Confidence 54322 233468999999998764 5789999999999999999999999974433221 111111 0
Q ss_pred hh---hcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhh
Q 002410 826 MI---KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDS 880 (927)
Q Consensus 826 ~~---~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~--L~~~ 880 (927)
.. ........................+.+|+.+||+.||++|||++|+++. ++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 00 0000000000000001111223468899999999999999999999864 5544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-39 Score=353.74 Aligned_cols=262 Identities=16% Similarity=0.193 Sum_probs=209.1
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCC-CceeeeeeeeecCceEEEEEEec
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYEYM 683 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~H-pnIv~l~~~~~~~~~~~LV~E~~ 683 (927)
.|++.++||+|+||+||+|++. +|+.||||++.... ....+.+|++.++.++| +|++.+++++.++...++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 4677899999999999999976 68999999986532 23457789999999965 89999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccC-----CCcEEEeecccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-----NMRAKVSDFGLSRQAE 758 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~-----~~~~kL~DFGla~~~~ 758 (927)
+++|.+++... ...+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 84 -~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 84 -GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred -CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 78999988753 4578999999999999999999998 99999999999999964 5789999999998765
Q ss_pred ccccc------cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCe
Q 002410 759 EDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 832 (927)
Q Consensus 759 ~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 832 (927)
..... ......||+.|||||++.+..++.++|||||||++|||+||+.||..............+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 43221 223456999999999999999999999999999999999999999865554333322222221111111
Q ss_pred eeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhc
Q 002410 833 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 884 (927)
Q Consensus 833 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~e 884 (927)
. .+.... +.++.+++..|+..+|++||+++.+.+.|++++...
T Consensus 238 ~-----~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 238 R-----ELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp H-----HHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H-----HhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 1 111112 246889999999999999999999999999887543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=360.82 Aligned_cols=260 Identities=21% Similarity=0.275 Sum_probs=194.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCc----eEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILV 679 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~----~~~LV 679 (927)
.|++.++||+|+||+||+|+.+ +|+.||||++.... ....+++.+|+++|++++||||+++++++.... ..+++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 3667899999999999999875 79999999997543 344578899999999999999999999986543 23455
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccccc
Q 002410 680 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 759 (927)
Q Consensus 680 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 759 (927)
++++.+|+|.+++.. ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 667779999999973 368999999999999999999998 9999999999999999999999999999987544
Q ss_pred cccc--cccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhh---------
Q 002410 760 DLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI--------- 827 (927)
Q Consensus 760 ~~~~--~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~--------- 827 (927)
.... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+............
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 3222 2344568999999999854 467899999999999999999999997544322111111100000
Q ss_pred ---------hcCCeeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 828 ---------KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 828 ---------~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.........-..+... ...++.+|+.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPN----ADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccCCccCCCCHHHhCCC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000000011 11357899999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-39 Score=352.42 Aligned_cols=260 Identities=22% Similarity=0.290 Sum_probs=198.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCceeee-eeeeecCceEEEEEEec
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-IGYCEEEHQRILVYEYM 683 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnIv~l-~~~~~~~~~~~LV~E~~ 683 (927)
.|++.+.||+|+||.||+|++. +|+.||||++.... ..+++.+|++++++++|+|++.. .++..+++..++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 4678899999999999999975 68999999987543 23457889999999987765554 55557778889999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCccccc---CCCcEEEeecccccccccc
Q 002410 684 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEED 760 (927)
Q Consensus 684 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld---~~~~~kL~DFGla~~~~~~ 760 (927)
+++|.+.+.. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+|+.....
T Consensus 86 -~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 86 -GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp -CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred -CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 5667666553 35679999999999999999999999 9999999999999875 4567999999999986543
Q ss_pred ccc------cccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHH-HHHHHhhhcCCee
Q 002410 761 LTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-HWARSMIKKGDVI 833 (927)
Q Consensus 761 ~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~-~~~~~~~~~~~~~ 833 (927)
... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||............ ........ ...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~- 237 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPI- 237 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SCH-
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CCh-
Confidence 321 223456999999999999999999999999999999999999999754433222211 11111111 010
Q ss_pred eeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 002410 834 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 883 (927)
Q Consensus 834 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 883 (927)
+.+... .+.++.+++.+|++.+|++||+++++.+.|+++...
T Consensus 238 ----~~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 238 ----EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ----HHHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ----hHhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 111111 224688999999999999999999999999987654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=363.43 Aligned_cols=263 Identities=22% Similarity=0.305 Sum_probs=194.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCc------eE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 676 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~------~~ 676 (927)
.|++.++||+|+||+||+|..+ +|+.||||+++... ....+.+.+|+++|++++|||||+++++|...+ ..
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 5677899999999999999976 59999999997532 334567899999999999999999999997654 57
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
++||||+ +.+|..+++ ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp EEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceec
Confidence 9999999 667888775 3469999999999999999999998 9999999999999999999999999999987
Q ss_pred ccccccccccccccCCCccCCCccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh-----hhcC
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM-----IKKG 830 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~-----~~~~ 830 (927)
..... ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+.............. ....
T Consensus 171 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 171 ADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 65432 23468999999999865 46789999999999999999999999754332211111100000 0000
Q ss_pred C----------eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhh
Q 002410 831 D----------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSI 881 (927)
Q Consensus 831 ~----------~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~--L~~~~ 881 (927)
. ........+. .........+.+|+.+||+.||++|||++|+++. ++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred cchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0 0000000000 0011112357799999999999999999999985 66544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-39 Score=350.08 Aligned_cols=261 Identities=20% Similarity=0.253 Sum_probs=201.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCceEEEEEEe
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 682 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~LV~E~ 682 (927)
.|++.++||+|+||+||+|++. +|+.||||+++... ....+++.+|+.+|++++||||+++++++.+.+..++|+|+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 3667899999999999999986 68999999986533 33467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccccccccc
Q 002410 683 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 762 (927)
Q Consensus 683 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 762 (927)
+.+++|..++. ..+.+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.++.......
T Consensus 83 ~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 83 CDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ccccccccccc---cccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 99999988877 45678999999999999999999998 9999999999999999999999999999987654333
Q ss_pred ccccccccCCCccCCCccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcC---Cee---ee
Q 002410 763 HISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVI---SI 835 (927)
Q Consensus 763 ~~~~~~~gt~~Y~APE~l~~~~-~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~---~~~---~~ 835 (927)
. .....+++.|+|||.+.+.. ++.++||||+||++|||++|+.||..... .......+....... ... ..
T Consensus 157 ~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp C-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred c-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 2 22334778999999987654 68999999999999999999999752221 111111111111100 000 00
Q ss_pred cc---------ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 836 VD---------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 836 ~d---------~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.+ ..-...........+.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000111122346789999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=359.46 Aligned_cols=251 Identities=26% Similarity=0.358 Sum_probs=201.6
Q ss_pred HHhhcccccccccEEEEEEEEC----CCcEEEEEEccCcc----chhHHHHHHHHHHHHhcCC-CceeeeeeeeecCceE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQR 676 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~----~g~~vAvK~l~~~~----~~~~~~~~~E~~~L~~l~H-pnIv~l~~~~~~~~~~ 676 (927)
.|++.++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++| |||+++++++.+....
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 3778999999999999999863 47899999986532 2234678899999999976 8999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
+++|||+.+|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999984 4567888999999999999999998 9999999999999999999999999999987
Q ss_pred ccccccccccccccCCCccCCCccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCCeee
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 834 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 834 (927)
.............|++.|+|||.+.+. .++.++||||+||+||||++|+.||............ .+..... .
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~~~-~--- 252 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKS-E--- 252 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHHC-C---
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcccC-C---
Confidence 655544444556799999999998654 4688999999999999999999999755443222111 1111111 1
Q ss_pred eccccccCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 002410 835 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 875 (927)
Q Consensus 835 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~eVl~ 875 (927)
+.. +......+.+++.+||+.||++||| ++|+++
T Consensus 253 ---~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ---PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---CCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 011 1122347889999999999999994 788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-38 Score=352.73 Aligned_cols=256 Identities=20% Similarity=0.291 Sum_probs=194.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcC-CCceeeeeeeeec--CceEEEEEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEE--EHQRILVYE 681 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~--~~~~~LV~E 681 (927)
.|++.++||+|+||+||+|+.. +|+.||||+++.. ..+++.+|+++|++++ ||||+++++++.. ....++|||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 5778899999999999999985 6899999998753 3467889999999995 9999999999864 456899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC-cEEEeecccccccccc
Q 002410 682 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEED 760 (927)
Q Consensus 682 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla~~~~~~ 760 (927)
|+++++|.++. +.+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 113 ~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 113 HVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp CCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred ecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999997654 358999999999999999999998 9999999999999998655 6999999999876543
Q ss_pred ccccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchh--hHHHHH-----HHhhhcCCe
Q 002410 761 LTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVHWA-----RSMIKKGDV 832 (927)
Q Consensus 761 ~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~--~l~~~~-----~~~~~~~~~ 832 (927)
.. .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||......... .+.... .........
T Consensus 184 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred Cc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 22 2344589999999998765 5799999999999999999999999744332111 110000 000000000
Q ss_pred ------eeec--------cccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002410 833 ------ISIV--------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 875 (927)
Q Consensus 833 ------~~~~--------d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~ 875 (927)
.... ..............++.+|+.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000000111122346789999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-38 Score=352.12 Aligned_cols=260 Identities=22% Similarity=0.272 Sum_probs=188.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeec------CceE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQR 676 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~------~~~~ 676 (927)
.|++.++||+|+||+||+|++. +|+.||||+++... ....+++.+|+.+|++++||||+++++++.. ....
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 3667889999999999999987 69999999997543 3345678999999999999999999999853 4688
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 677 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 677 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
|+||||+.++.+ +.+. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+|++|||+++.
T Consensus 98 ~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 98 YLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeccchHHH-Hhhh-----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhc
Confidence 999999976544 4443 347899999999999999999999 9999999999999999999999999999887
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHH-H--------------
Q 002410 757 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-H-------------- 821 (927)
Q Consensus 757 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~-~-------------- 821 (927)
..... ......+|+.|+|||++.+..+++++||||+||++|||++|+.||.+.+........ .
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 54432 223445899999999999999999999999999999999999999754322111100 0
Q ss_pred -HHHHhhhcCC-e-----eeeccccccCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 822 -WARSMIKKGD-V-----ISIVDPVLIGN---VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 822 -~~~~~~~~~~-~-----~~~~d~~l~~~---~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
.......... . ........... ........+.+|+.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000001000 0 00000011110 112334578999999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=355.49 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=192.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--chhHHHHHHHHHHHHhcCCCceeeeeeeeec-----CceEE
Q 002410 606 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQRI 677 (927)
Q Consensus 606 ~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-----~~~~~ 677 (927)
+|++.++||+|+||+||+|+.. +|+.||||+++... ....+++.+|+++|++++||||+++++++.. ....+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 4777899999999999999975 69999999997543 3345678999999999999999999999853 33456
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEeeccccccc
Q 002410 678 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 757 (927)
Q Consensus 678 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 757 (927)
++++++.+|+|.+++. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++...
T Consensus 99 ~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp EEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhccc
Confidence 7778888999999986 3469999999999999999999998 99999999999999999999999999999765
Q ss_pred cccccccccccccCCCccCCCccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhhhcCC-----
Q 002410 758 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD----- 831 (927)
Q Consensus 758 ~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~----- 831 (927)
... .....|++.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.+....... +........
T Consensus 172 ~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~---i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 172 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTPGAELLK 244 (348)
T ss_dssp TGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCHHHHT
T ss_pred Ccc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCChHHhh
Confidence 432 2334588999999987665 568999999999999999999999975443221111 111100000
Q ss_pred -------------eeeeccccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002410 832 -------------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 876 (927)
Q Consensus 832 -------------~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eVl~~ 876 (927)
........+. .........+.+|+.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000000000 0000112357899999999999999999999873
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.9e-35 Score=326.98 Aligned_cols=279 Identities=20% Similarity=0.278 Sum_probs=199.2
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCccchhHHHHHHHHHHHHhcC-----------CCceeeeeeeeec
Q 002410 605 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----------HRNLVPLIGYCEE 672 (927)
Q Consensus 605 ~~~~~~~~LG~G~~G~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-----------HpnIv~l~~~~~~ 672 (927)
.+|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|++++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 34788999999999999999985 69999999998643 33467788999988875 5789999988754
Q ss_pred --CceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCC------
Q 002410 673 --EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM------ 744 (927)
Q Consensus 673 --~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~------ 744 (927)
....+++++++..+..............+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence 34566777776655433333333356778999999999999999999997 48899999999999998665
Q ss_pred cEEEeeccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccchh----hHH
Q 002410 745 RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL----NIV 820 (927)
Q Consensus 745 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~----~l~ 820 (927)
.++++|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||......... .+.
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 3999999998765432 23456899999999999999999999999999999999999999754332111 111
Q ss_pred HHHHHh-------hhcCC----------eeeeccc----------cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 002410 821 HWARSM-------IKKGD----------VISIVDP----------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI 873 (927)
Q Consensus 821 ~~~~~~-------~~~~~----------~~~~~d~----------~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~eV 873 (927)
..+... ..... ....+.. .............+.+|+.+||+.||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 111100 00000 0000000 00112234566789999999999999999999999
Q ss_pred HHH--HHhhhhhccCCCCc
Q 002410 874 VLA--IQDSIKIEKGGDQK 890 (927)
Q Consensus 874 l~~--L~~~~~~e~~~~~~ 890 (927)
++. +++....++-..+.
T Consensus 326 L~Hp~f~~~~~~~~~~~p~ 344 (362)
T d1q8ya_ 326 VNHPWLKDTLGMEEIRVPD 344 (362)
T ss_dssp HTCGGGTTCTTCTTCCCTT
T ss_pred hcCcccCCCCCcccCCCCC
Confidence 885 66665554433333
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=2.3e-21 Score=195.84 Aligned_cols=168 Identities=15% Similarity=0.128 Sum_probs=120.1
Q ss_pred hcccccccccEEEEEEEECCCcEEEEEEccCccc------------------hhHHHHHHHHHHHHhcCCCceeeeeeee
Q 002410 609 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS------------------HRTQQFVTEVALLSRIHHRNLVPLIGYC 670 (927)
Q Consensus 609 ~~~~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~------------------~~~~~~~~E~~~L~~l~HpnIv~l~~~~ 670 (927)
+.++||+|+||+||+|+..+|+.||||+++.... .......+|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 5689999999999999999999999998753111 1123456788999999999999887654
Q ss_pred ecCceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcccccCCCcEEEee
Q 002410 671 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 750 (927)
Q Consensus 671 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~D 750 (927)
. .+++|||+++..+.+ ++......++.|++++|+|||+ ++|+||||||+|||++++ .++|+|
T Consensus 84 ~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 84 G----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp T----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECC
T ss_pred C----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEE
Confidence 2 379999998765433 3334467899999999999998 999999999999999865 489999
Q ss_pred ccccccccccccccccccccCCCccCCCccCCCCCCcchhHHHHHHHH
Q 002410 751 FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVL 798 (927)
Q Consensus 751 FGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGvlL 798 (927)
||+|........... ...+...+ .|. ....|+.++|+||..--+
T Consensus 146 FG~a~~~~~~~~~~~--l~rd~~~~-~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWREI--LERDVRNI-ITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHHHH--HHHHHHHH-HHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcHHH--HHHHHHHH-HHH-HcCCCCCcccHHHHHHHH
Confidence 999976543221100 00000000 011 135678899999976443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.66 E-value=4.6e-17 Score=176.63 Aligned_cols=147 Identities=27% Similarity=0.509 Sum_probs=125.5
Q ss_pred ChhHHHHHHHhhhhcc----CCCCC-CCCCCCCCCccEEEeCC-CCCceEEEEecCCCCcc--cCCccccCCcccceecc
Q 002410 369 TEWQDEALRSISDESE----RTNDR-GDPCVPVPWEWVTCSTT-TPPRITKIALSGKNLKG--EIPPELKNMEALTELWL 440 (927)
Q Consensus 369 t~~~~~al~~~~~~~~----~~~w~-gdpC~~~~w~~~~c~~~-~~~~l~~L~L~~n~l~g--~ip~~l~~l~~L~~L~L 440 (927)
...+.+||.++|+.+. ..+|. +..||.+.|.||+|+.. ...||+.|+|++|+++| .+|++|++|++|++|+|
T Consensus 4 ~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~L 83 (313)
T d1ogqa_ 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYI 83 (313)
T ss_dssp CHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEE
T ss_pred CHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccccc
Confidence 4456699999998764 46895 44555668999999865 34589999999999998 58999999999999999
Q ss_pred cC-CCCCCCCCC-cCcccccceeecccccccCCCCCcCCCccccccccccccCCCCCCCccccC--CceeeeecCCCCC
Q 002410 441 DG-NFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 515 (927)
Q Consensus 441 s~-N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~~--~~~~~~~~~N~~~ 515 (927)
++ |+++|.+|. |++|++|++|+|++|+|.|..|..+..+.+|+.+++++|.+.+.+|..+.. ....+.+.+|...
T Consensus 84 s~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~ 162 (313)
T d1ogqa_ 84 GGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162 (313)
T ss_dssp EEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCE
T ss_pred ccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccccc
Confidence 97 899999985 999999999999999999999999999999999999999999999988865 4556677777543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.40 E-value=1.4e-13 Score=138.00 Aligned_cols=122 Identities=19% Similarity=0.224 Sum_probs=103.1
Q ss_pred CCCccEEEeCC--------CCCceEEEEecCCCCcccCC-ccccCCcccceecccCCCCCCCCCC-cCcccccceeeccc
Q 002410 396 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN 465 (927)
Q Consensus 396 ~~w~~~~c~~~--------~~~~l~~L~L~~n~l~g~ip-~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~ 465 (927)
|.|..|.|+.. .+..++.|+|++|+|++.++ ..|.++++|+.|+|++|++++.++. +..+++|+.|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 34565666532 24579999999999997664 5679999999999999999999986 89999999999999
Q ss_pred ccccCCCCCcCCCccccccccccccCCCCCCCccccC---CceeeeecCCCCCccc
Q 002410 466 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 518 (927)
Q Consensus 466 N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~~---~~~~~~~~~N~~~c~~ 518 (927)
|+|++..|..|.++++|+.|+|++|+|+ .||...+. .+..+.+.+|++.|..
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred ccccccCHHHHhCCCcccccccCCcccc-ccCHHHhcCCccccccccccccccccc
Confidence 9999777788999999999999999999 66665543 6778889999998864
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.16 E-value=2e-11 Score=117.69 Aligned_cols=105 Identities=17% Similarity=0.172 Sum_probs=89.5
Q ss_pred EEEecCCCCcccCCccccCCcccceecccCC-CCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccccccc
Q 002410 413 KIALSGKNLKGEIPPELKNMEALTELWLDGN-FLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 490 (927)
Q Consensus 413 ~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N-~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~N 490 (927)
.++++++++. .+|..+..+++|+.|+|++| .|+...+. |.+|++|+.|+|++|+|+...|..|..+++|+.|+|++|
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 3666777777 77888999999999999876 48877664 999999999999999999666788999999999999999
Q ss_pred CCCCCCCccccC--CceeeeecCCCCCcccc
Q 002410 491 SFVGEIPPALLT--GKVIFKYDNNPKLHKES 519 (927)
Q Consensus 491 ~l~g~iP~~~~~--~~~~~~~~~N~~~c~~~ 519 (927)
+|+ .+|...+. .+..+.+.+||+.|.+.
T Consensus 91 ~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C~ 120 (156)
T d2ifga3 91 ALE-SLSWKTVQGLSLQELVLSGNPLHCSCA 120 (156)
T ss_dssp CCS-CCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred CCc-ccChhhhccccccccccCCCcccCCch
Confidence 999 88887765 56678899999998653
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.14 E-value=2.6e-11 Score=112.12 Aligned_cols=98 Identities=26% Similarity=0.344 Sum_probs=79.0
Q ss_pred EEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccccccCC
Q 002410 413 KIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 492 (927)
Q Consensus 413 ~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~N~l 492 (927)
.|+|++|+++ .++ .+.+|++|++|+|++|+|+..++.++.+++|+.|+|++|+++ .+| .++.+++|+.|++++|++
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL 77 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCcc
Confidence 6899999998 665 488999999999999999876667899999999999999998 565 488999999999999999
Q ss_pred CCCCCc--cccC--CceeeeecCCCCC
Q 002410 493 VGEIPP--ALLT--GKVIFKYDNNPKL 515 (927)
Q Consensus 493 ~g~iP~--~~~~--~~~~~~~~~N~~~ 515 (927)
+ .+|. .+.. .+..+.+.+|+..
T Consensus 78 ~-~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 78 Q-QSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp C-SSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred C-CCCCchhhcCCCCCCEEECCCCcCC
Confidence 8 5553 2322 5667778888754
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.13 E-value=4.5e-12 Score=136.58 Aligned_cols=109 Identities=26% Similarity=0.307 Sum_probs=97.6
Q ss_pred ceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccccc
Q 002410 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 489 (927)
Q Consensus 410 ~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~ 489 (927)
....++++++.+.|.+|..++.+++|+.|++++|.+++.+|+++.+++|+.|+|++|+|+|.+|..|++|++|+.|+|++
T Consensus 198 ~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~ 277 (313)
T d1ogqa_ 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277 (313)
T ss_dssp CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcC
Confidence 34579999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCccc-cCCceeeeecCCCCCccc
Q 002410 490 NSFVGEIPPAL-LTGKVIFKYDNNPKLHKE 518 (927)
Q Consensus 490 N~l~g~iP~~~-~~~~~~~~~~~N~~~c~~ 518 (927)
|+|+|.||... ...+..+.+.+|+.+|+.
T Consensus 278 N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 278 NNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp SEEEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred CcccccCCCcccCCCCCHHHhCCCccccCC
Confidence 99999999632 235566778999988864
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.10 E-value=7.8e-11 Score=123.79 Aligned_cols=112 Identities=28% Similarity=0.328 Sum_probs=101.7
Q ss_pred CCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCccccccc
Q 002410 407 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 485 (927)
Q Consensus 407 ~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L 485 (927)
..++++.|+|++|.+.+..+..+..+.+|+.|++++|.++..++. +..++.|+.|++++|+|++..|..|..+++|+.|
T Consensus 98 ~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L 177 (266)
T d1p9ag_ 98 TLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177 (266)
T ss_dssp TCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEE
T ss_pred cccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCcccccccccccee
Confidence 346899999999999987888899999999999999999998886 7889999999999999998888889999999999
Q ss_pred cccccCCCCCCCccccC--CceeeeecCCCCCcccc
Q 002410 486 HIENNSFVGEIPPALLT--GKVIFKYDNNPKLHKES 519 (927)
Q Consensus 486 ~l~~N~l~g~iP~~~~~--~~~~~~~~~N~~~c~~~ 519 (927)
+|++|+|+ .||.+++. .+..+.+.||||.|.+.
T Consensus 178 ~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp ECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred ecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence 99999999 99998876 56788999999999753
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.04 E-value=7.5e-11 Score=125.06 Aligned_cols=111 Identities=19% Similarity=0.235 Sum_probs=98.5
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
...++.+++++|+|++..+..|.++++|+.|+|++|+|++.++. |.++++|+.|+|++|++++..|..|..+++|+.|+
T Consensus 128 ~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~ 207 (284)
T d1ozna_ 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (284)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred hcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccc
Confidence 45799999999999976677899999999999999999998885 89999999999999999998999999999999999
Q ss_pred ccccCCCCCCCccccC--CceeeeecCCCCCccc
Q 002410 487 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHKE 518 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~--~~~~~~~~~N~~~c~~ 518 (927)
+++|.+.+..|..+.. .+..+.+++||+.|.+
T Consensus 208 l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp CCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred ccccccccccccccccccccCEEEecCCCCCCCc
Confidence 9999999555555433 5778899999999864
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.03 E-value=1.5e-10 Score=111.30 Aligned_cols=102 Identities=23% Similarity=0.241 Sum_probs=85.7
Q ss_pred CCCCCCCCccEEEeCC----------CCCceEEEEecCCC-CcccCCccccCCcccceecccCCCCCCCCCC-cCccccc
Q 002410 391 DPCVPVPWEWVTCSTT----------TPPRITKIALSGKN-LKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDL 458 (927)
Q Consensus 391 dpC~~~~w~~~~c~~~----------~~~~l~~L~L~~n~-l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L 458 (927)
+.|.++.++++.|+.. ..+++++|+|++|+ |+..-+..|.+|++|+.|+|++|+|+...|. |..+++|
T Consensus 3 ~~C~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L 82 (156)
T d2ifga3 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82 (156)
T ss_dssp SSSCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCC
T ss_pred CCCCcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccc
Confidence 5687777888888752 13578999998775 8854556799999999999999999999886 9999999
Q ss_pred ceeecccccccCCCCCcCCCccccccccccccCCC
Q 002410 459 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 493 (927)
Q Consensus 459 ~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~N~l~ 493 (927)
++|+|++|+|+ .+|..+....+|+.|+|++|.+.
T Consensus 83 ~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 99999999999 77776655668999999999985
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.00 E-value=1.6e-10 Score=106.57 Aligned_cols=83 Identities=28% Similarity=0.345 Sum_probs=76.0
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCC--CcCCCccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP--SYMGSLPNLQEL 485 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP--~~l~~l~~L~~L 485 (927)
..++++|+|++|+|+ .+|+.++.+++|+.|+|++|+|++. |++..+++|+.|++++|+++. +| ..++.+++|+.|
T Consensus 19 l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~l~~N~i~~-~~~~~~l~~~~~L~~L 95 (124)
T d1dcea3 19 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQQ-SAAIQPLVSCPRLVLL 95 (124)
T ss_dssp GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCCS-SSTTGGGGGCTTCCEE
T ss_pred CCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-CccccccccCeEECCCCccCC-CCCchhhcCCCCCCEE
Confidence 357999999999999 7899999999999999999999975 679999999999999999994 44 578999999999
Q ss_pred cccccCCC
Q 002410 486 HIENNSFV 493 (927)
Q Consensus 486 ~l~~N~l~ 493 (927)
++++|.++
T Consensus 96 ~l~~N~i~ 103 (124)
T d1dcea3 96 NLQGNSLC 103 (124)
T ss_dssp ECTTSGGG
T ss_pred ECCCCcCC
Confidence 99999998
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.98 E-value=1.6e-10 Score=112.00 Aligned_cols=105 Identities=21% Similarity=0.233 Sum_probs=87.1
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
+.++++|+|++|+|+ .||..+..+++|+.|+|++|+|+.. +.+..+++|+.|+|++|+++...+..+..+++|+.|++
T Consensus 17 ~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred cCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 357999999999999 6787778899999999999999864 77999999999999999999443444568999999999
Q ss_pred cccCCCCCCCc--ccc--CCceeeeecCCCCC
Q 002410 488 ENNSFVGEIPP--ALL--TGKVIFKYDNNPKL 515 (927)
Q Consensus 488 ~~N~l~g~iP~--~~~--~~~~~~~~~~N~~~ 515 (927)
++|+++ .++. .+. ..+..+.+.+|+..
T Consensus 95 ~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 95 TNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cccccc-ccccccccccccccchhhcCCCccc
Confidence 999998 6654 222 36677888888753
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=98.98 E-value=1.7e-10 Score=115.02 Aligned_cols=90 Identities=22% Similarity=0.353 Sum_probs=83.5
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++|+.|+|++|++.+..+..+..+++|+.|+|++|+|+..+|+ |.+|++|+.|+|++|+|++..|+.|..+++|+.|+
T Consensus 53 l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~ 132 (192)
T d1w8aa_ 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132 (192)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEE
T ss_pred CceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccc
Confidence 46899999999999999999999999999999999999999886 99999999999999999987788899999999999
Q ss_pred ccccCCCCCCC
Q 002410 487 IENNSFVGEIP 497 (927)
Q Consensus 487 l~~N~l~g~iP 497 (927)
|++|.+....+
T Consensus 133 L~~N~~~~~~~ 143 (192)
T d1w8aa_ 133 LASNPFNCNCH 143 (192)
T ss_dssp CTTCCBCCSGG
T ss_pred ccccccccccc
Confidence 99999985443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.92 E-value=5.9e-10 Score=116.88 Aligned_cols=103 Identities=29% Similarity=0.260 Sum_probs=82.6
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
++.++.|+|++|+|++..+..|.++++|+.|+|++|+|+. +|.++.+++|+.|+|++|+++ .+|..+..+++|+.|++
T Consensus 30 p~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CcCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-ccccccccccccccccccccc-ccccccccccccccccc
Confidence 4578999999999996666789999999999999999985 566788999999999999998 56778889999999999
Q ss_pred cccCCCCCCCccccC---CceeeeecCCC
Q 002410 488 ENNSFVGEIPPALLT---GKVIFKYDNNP 513 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~---~~~~~~~~~N~ 513 (927)
++|.+. .++...+. ....+.+.+|.
T Consensus 108 ~~~~~~-~~~~~~~~~l~~l~~L~l~~n~ 135 (266)
T d1p9ag_ 108 SFNRLT-SLPLGALRGLGELQELYLKGNE 135 (266)
T ss_dssp CSSCCC-CCCSSTTTTCTTCCEEECTTSC
T ss_pred cccccc-eeeccccccccccccccccccc
Confidence 999988 55554433 34455555554
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.89 E-value=1e-09 Score=117.25 Aligned_cols=107 Identities=23% Similarity=0.302 Sum_probs=96.3
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++++.|+|++|.+++..+..+.+++.++.|++++|.+++..+. +.++++|+.|+|++|+|+ .+|..|.++++|+.|+
T Consensus 170 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~ 248 (305)
T d1xkua_ 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248 (305)
T ss_dssp CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEE
Confidence 46899999999999999999999999999999999999998885 899999999999999999 8899999999999999
Q ss_pred ccccCCCCCCCccccC---------CceeeeecCCCCCc
Q 002410 487 IENNSFVGEIPPALLT---------GKVIFKYDNNPKLH 516 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~---------~~~~~~~~~N~~~c 516 (927)
|++|+|+ .|+...+. .+..+.+.+||+.+
T Consensus 249 Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 249 LHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp CCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred CCCCccC-ccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 9999999 78765432 35567889999875
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.61 E-value=6.3e-09 Score=100.36 Aligned_cols=85 Identities=22% Similarity=0.250 Sum_probs=75.6
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCC--cCCCccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQEL 485 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~--~l~~l~~L~~L 485 (927)
++++.|+|++|+|+ .++ .|..|++|+.|+|++|+++...+. +..+++|+.|+|++|+++ .+++ .+..+++|+.|
T Consensus 41 ~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~L 117 (162)
T d1a9na_ 41 DQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 117 (162)
T ss_dssp TCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred ccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc-ccccccccccccccchh
Confidence 57999999999999 564 589999999999999999998887 578999999999999998 5553 68899999999
Q ss_pred cccccCCCCCCC
Q 002410 486 HIENNSFVGEIP 497 (927)
Q Consensus 486 ~l~~N~l~g~iP 497 (927)
++++|.++ .+|
T Consensus 118 ~l~~N~i~-~~~ 128 (162)
T d1a9na_ 118 CILRNPVT-NKK 128 (162)
T ss_dssp ECCSSGGG-GST
T ss_pred hcCCCccc-ccc
Confidence 99999998 555
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.60 E-value=2.5e-08 Score=106.06 Aligned_cols=95 Identities=23% Similarity=0.318 Sum_probs=50.7
Q ss_pred EEecCCCCcccCCccccCCcccceecccCCCCCCCCC-CcCcccccceeecccccccCCCCCcCCCccccccccccccCC
Q 002410 414 IALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 492 (927)
Q Consensus 414 L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~N~l 492 (927)
++.++++|+ ++|..+. +.|++|+|++|+|+..++ .|.++++|+.|++++|.++...|..|.++++|+.|++++|++
T Consensus 15 ~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l 91 (305)
T d1xkua_ 15 VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91 (305)
T ss_dssp EECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCC
T ss_pred EEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCcc
Confidence 444455555 5555442 455555666665555555 255555566666665555544455555555555666655555
Q ss_pred CCCCCccccCCceeeeecCC
Q 002410 493 VGEIPPALLTGKVIFKYDNN 512 (927)
Q Consensus 493 ~g~iP~~~~~~~~~~~~~~N 512 (927)
+ .+|.........+....|
T Consensus 92 ~-~l~~~~~~~l~~L~~~~n 110 (305)
T d1xkua_ 92 K-ELPEKMPKTLQELRVHEN 110 (305)
T ss_dssp S-BCCSSCCTTCCEEECCSS
T ss_pred C-cCccchhhhhhhhhcccc
Confidence 5 455544444444444333
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.58 E-value=3.7e-08 Score=103.77 Aligned_cols=108 Identities=20% Similarity=0.204 Sum_probs=94.6
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCCcCCCcccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 486 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 486 (927)
.++++.|+|++|++.+..+..+..+++|+.+++++|+|++.++. |..+++|+.|+|++|+|++..|..|.++++|+.|+
T Consensus 104 l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~ 183 (284)
T d1ozna_ 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (284)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred cccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhh
Confidence 35899999999999977778899999999999999999998875 88999999999999999987788999999999999
Q ss_pred ccccCCCCCCCccccC--CceeeeecCCCCC
Q 002410 487 IENNSFVGEIPPALLT--GKVIFKYDNNPKL 515 (927)
Q Consensus 487 l~~N~l~g~iP~~~~~--~~~~~~~~~N~~~ 515 (927)
+++|++++..|..+.. .+..+.+.+|...
T Consensus 184 l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~ 214 (284)
T d1ozna_ 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214 (284)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred hhhccccccChhHhhhhhhcccccccccccc
Confidence 9999999766776654 5667777777654
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.43 E-value=2.9e-09 Score=106.37 Aligned_cols=103 Identities=24% Similarity=0.217 Sum_probs=83.5
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
..+|+.|+|++|+|+ .++ .|.+|++|+.|+|++|+|+...+-+..+++|+.|+|++|+++ .++ .+..+++|+.|++
T Consensus 47 L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L 122 (198)
T d1m9la_ 47 LKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEE
T ss_pred ccccceeECcccCCC-Ccc-cccCCccccChhhccccccccccccccccccccccccccccc-ccc-ccccccccccccc
Confidence 568999999999999 665 599999999999999999865433556778999999999999 454 4788999999999
Q ss_pred cccCCCCCCCc--ccc--CCceeeeecCCCCC
Q 002410 488 ENNSFVGEIPP--ALL--TGKVIFKYDNNPKL 515 (927)
Q Consensus 488 ~~N~l~g~iP~--~~~--~~~~~~~~~~N~~~ 515 (927)
++|+++ .++. .+. ..+..+.+.+||..
T Consensus 123 ~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 123 SNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SEEECC-CHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccchhc-cccccccccCCCccceeecCCCccc
Confidence 999998 5553 232 36777888888743
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.41 E-value=1.7e-07 Score=93.18 Aligned_cols=100 Identities=23% Similarity=0.331 Sum_probs=59.3
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 488 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~ 488 (927)
.+++.|+|++|+++ .++ .+..|++|++|+|++|+|++..| +.++++|+.|++++|.+. .+|. +.++++|+.|+++
T Consensus 40 ~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~ 114 (199)
T d2omxa2 40 DQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLF 114 (199)
T ss_dssp TTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECC
T ss_pred cCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc-ccCCcccccccccccccc-cccc-ccccccccccccc
Confidence 45666777777666 343 46666777777777777766443 666777777777777666 3442 5666677777777
Q ss_pred ccCCCCCCCccccCCceeeeecCCC
Q 002410 489 NNSFVGEIPPALLTGKVIFKYDNNP 513 (927)
Q Consensus 489 ~N~l~g~iP~~~~~~~~~~~~~~N~ 513 (927)
+|.+....+-.-...+..+.+++|.
T Consensus 115 ~~~~~~~~~~~~l~~L~~L~l~~n~ 139 (199)
T d2omxa2 115 NNQITDIDPLKNLTNLNRLELSSNT 139 (199)
T ss_dssp SSCCCCCGGGTTCTTCSEEECCSSC
T ss_pred ccccccccccchhhhhHHhhhhhhh
Confidence 6666632222222344455555553
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.39 E-value=7e-08 Score=105.40 Aligned_cols=76 Identities=14% Similarity=0.364 Sum_probs=38.4
Q ss_pred ceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccccc
Q 002410 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 489 (927)
Q Consensus 410 ~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~ 489 (927)
.++.|+|++|++++. + .+..+++|+.|+|++|+|++ +|.+.+|++|++|+|++|+|++.+| +.+|++|+.|+|++
T Consensus 308 ~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~ 382 (384)
T d2omza2 308 NLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382 (384)
T ss_dssp TCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCC
T ss_pred ccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCC
Confidence 445555555555532 1 24555555555555555544 2345555555555555555553332 45555555555555
Q ss_pred c
Q 002410 490 N 490 (927)
Q Consensus 490 N 490 (927)
|
T Consensus 383 N 383 (384)
T d2omza2 383 Q 383 (384)
T ss_dssp E
T ss_pred C
Confidence 4
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.31 E-value=2.1e-07 Score=95.13 Aligned_cols=101 Identities=21% Similarity=0.273 Sum_probs=81.9
Q ss_pred CCccEEEeCCC--------CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC--cCcccccceeeccc-
Q 002410 397 PWEWVTCSTTT--------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN- 465 (927)
Q Consensus 397 ~w~~~~c~~~~--------~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~--~~~l~~L~~L~Ls~- 465 (927)
....+.|+... +..++.|+|++|+|+...+..|.+|++|++|+|++|.+...+|. |.+++.++.|.+..
T Consensus 9 ~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 9 SNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp CSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred cCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 44556776532 34799999999999954445789999999999999999887663 88999999998864
Q ss_pred ccccCCCCCcCCCccccccccccccCCCCCCCc
Q 002410 466 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 498 (927)
Q Consensus 466 N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~ 498 (927)
|++....|..|.++++|+.|++++|.+. .+|.
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~-~~~~ 120 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIK-HLPD 120 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCC-SCCC
T ss_pred ccccccccccccccccccccccchhhhc-cccc
Confidence 7888777788999999999999999998 4443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.29 E-value=2.8e-07 Score=100.48 Aligned_cols=100 Identities=22% Similarity=0.267 Sum_probs=80.1
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
...+..+.++.|.+.+ ...+..+++|+.|+|++|++++.. .+..+++|+.|+|++|+|+ .+| .+++|++|+.|++
T Consensus 284 ~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l 358 (384)
T d2omza2 284 LTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSA 358 (384)
T ss_dssp CTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEEC
T ss_pred cccccccccccccccc--ccccchhcccCeEECCCCCCCCCc-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEEC
Confidence 3567888888888885 346888999999999999999864 5889999999999999998 455 6899999999999
Q ss_pred cccCCCCCCCccccCCceeeeecCC
Q 002410 488 ENNSFVGEIPPALLTGKVIFKYDNN 512 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~~~~~~~~~~N 512 (927)
++|++++-.|-.-+..+..+.+++|
T Consensus 359 ~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 359 GHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp CSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CCCcCCCChhhccCCCCCEeeCCCC
Confidence 9999996554232335666666665
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.26 E-value=5.6e-07 Score=90.13 Aligned_cols=79 Identities=25% Similarity=0.464 Sum_probs=49.0
Q ss_pred ceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccccc
Q 002410 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 489 (927)
Q Consensus 410 ~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~ 489 (927)
.++.|++++|+++. ++ .+..|++|+.|+|++|+|++. +.++.|++|+.|+|++|+++ .+| .+..+++|+.|++++
T Consensus 47 ~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l-~~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~ 121 (210)
T d1h6ta2 47 SIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI-KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEH 121 (210)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTT
T ss_pred CccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCc-cccccCcccccccccccccc-ccc-ccccccccccccccc
Confidence 46666666666663 32 356666666666666666653 34566666666666666666 344 356666666666666
Q ss_pred cCCC
Q 002410 490 NSFV 493 (927)
Q Consensus 490 N~l~ 493 (927)
|.+.
T Consensus 122 ~~~~ 125 (210)
T d1h6ta2 122 NGIS 125 (210)
T ss_dssp SCCC
T ss_pred cccc
Confidence 6665
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.26 E-value=4.9e-07 Score=90.56 Aligned_cols=101 Identities=29% Similarity=0.416 Sum_probs=74.5
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.++|+.|+|++|++++ ++ .+++|++|+.|+|++|+|++ +|.+..+++|+.|++++|.+. .++ .+..+++|+.+++
T Consensus 67 l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~ 141 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYL 141 (210)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEEC
T ss_pred CCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-ccccccccccccccccccccc-ccc-ccccccccccccc
Confidence 4578999999999885 44 47888999999999999886 457888888999999988876 343 5777888888888
Q ss_pred cccCCCCCCCccccCCceeeeecCCC
Q 002410 488 ENNSFVGEIPPALLTGKVIFKYDNNP 513 (927)
Q Consensus 488 ~~N~l~g~iP~~~~~~~~~~~~~~N~ 513 (927)
++|.+++..+..-...+..+.+.+|.
T Consensus 142 ~~n~l~~~~~~~~l~~L~~l~l~~n~ 167 (210)
T d1h6ta2 142 GNNKITDITVLSRLTKLDTLSLEDNQ 167 (210)
T ss_dssp CSSCCCCCGGGGGCTTCSEEECCSSC
T ss_pred cccccccccccccccccccccccccc
Confidence 88888743322333355556666654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.25 E-value=2.9e-07 Score=93.34 Aligned_cols=75 Identities=21% Similarity=0.368 Sum_probs=43.7
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCcccccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 488 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~ 488 (927)
++++.|++++|.+.+.. .+.++++|+.|+|++|++++ +|.+.++++|+.|+|++|+++ .+|. ++++++|+.|+++
T Consensus 151 ~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt-~i~~-l~~l~~L~~L~ls 225 (227)
T d1h6ua2 151 TNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLT 225 (227)
T ss_dssp TTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCC-BCGG-GTTCTTCCEEEEE
T ss_pred cccccccccccccccch--hhcccccceecccCCCccCC-ChhhcCCCCCCEEECcCCcCC-CCcc-cccCCCCCEEEee
Confidence 45666666666655322 25666666666666666654 344666666666666666666 3332 5566666666665
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.17 E-value=1.8e-06 Score=89.05 Aligned_cols=132 Identities=14% Similarity=0.092 Sum_probs=94.8
Q ss_pred cccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEEEEEecCCCCHHHHhcc
Q 002410 616 GSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 694 (927)
Q Consensus 616 G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~LV~E~~~~gsL~~~L~~ 694 (927)
+..+.||+.... ++.+++|+...........+.+|...++.+. +--+.+++.+..+++..++||++++|.++.+....
T Consensus 25 ~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 334689998754 6677888876554444456778999888774 43366778888888889999999999888665431
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------------
Q 002410 695 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-------------------------------------------------- 724 (927)
Q Consensus 695 ~~~~~~l~~~~~~~i~~qia~gL~~LH~~~-------------------------------------------------- 724 (927)
. .....++.++++.|+.||+..
T Consensus 104 ~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (263)
T d1j7la_ 104 E--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp C--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred c--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence 1 123345666777777777410
Q ss_pred ------CCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 725 ------NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 725 ------~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
...++|+|+.|.||++++++..-|.||+.+..
T Consensus 176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999877677999997754
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.17 E-value=1e-06 Score=87.24 Aligned_cols=99 Identities=25% Similarity=0.408 Sum_probs=73.2
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.++++.|+|++|++++. ++ +++|++|+.|++++|.+... +.+.+++.|+.|++++|.+... ..+..+++|+.|++
T Consensus 61 l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l 135 (199)
T d2omxa2 61 LNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADI-TPLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLEL 135 (199)
T ss_dssp CTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEEC
T ss_pred CCCcCcCccccccccCc-cc-ccCCcccccccccccccccc-cccccccccccccccccccccc--cccchhhhhHHhhh
Confidence 35789999999999854 33 88999999999999988664 4588888899999988888742 34778888888999
Q ss_pred cccCCCCCCCc-cccCCceeeeecCC
Q 002410 488 ENNSFVGEIPP-ALLTGKVIFKYDNN 512 (927)
Q Consensus 488 ~~N~l~g~iP~-~~~~~~~~~~~~~N 512 (927)
++|++. .+|. .-......+.+.+|
T Consensus 136 ~~n~l~-~~~~l~~~~~L~~L~l~~n 160 (199)
T d2omxa2 136 SSNTIS-DISALSGLTSLQQLNFSSN 160 (199)
T ss_dssp CSSCCC-CCGGGTTCTTCSEEECCSS
T ss_pred hhhhhc-ccccccccccccccccccc
Confidence 888887 5553 11224455555555
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.11 E-value=1.4e-06 Score=88.14 Aligned_cols=96 Identities=20% Similarity=0.346 Sum_probs=75.9
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
.+.+..+.++++.+.... .+.++++|+.|++++|.++... .+.++++|+.|+|++|++++ +|. ++++++|+.|+|
T Consensus 128 ~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~L 202 (227)
T d1h6ua2 128 LSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT-PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHL 202 (227)
T ss_dssp CTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEEC
T ss_pred ccchhhhhchhhhhchhh--hhccccccccccccccccccch-hhcccccceecccCCCccCC-Chh-hcCCCCCCEEEC
Confidence 357788899998887543 4788899999999999997654 48999999999999999994 554 889999999999
Q ss_pred cccCCCCCCCc-cccCCceeeee
Q 002410 488 ENNSFVGEIPP-ALLTGKVIFKY 509 (927)
Q Consensus 488 ~~N~l~g~iP~-~~~~~~~~~~~ 509 (927)
++|+++ .+|+ .-...+..+++
T Consensus 203 s~N~lt-~i~~l~~l~~L~~L~l 224 (227)
T d1h6ua2 203 KNNQIS-DVSPLANTSNLFIVTL 224 (227)
T ss_dssp TTSCCC-BCGGGTTCTTCCEEEE
T ss_pred cCCcCC-CCcccccCCCCCEEEe
Confidence 999999 5653 22234444444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.05 E-value=5.2e-08 Score=97.07 Aligned_cols=83 Identities=22% Similarity=0.421 Sum_probs=73.4
Q ss_pred CceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCC--CcCCCcccccccc
Q 002410 409 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP--SYMGSLPNLQELH 486 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP--~~l~~l~~L~~L~ 486 (927)
++|+.|+|++|.|+ .+|..+..+.+|+.|+|++|+|+.. +.+..+++|+.|+|++|+++ .++ ..+..|++|+.|+
T Consensus 70 ~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 146 (198)
T d1m9la_ 70 ENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLL 146 (198)
T ss_dssp TTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH-HHHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEE
T ss_pred ccccChhhcccccc-ccccccccccccccccccccccccc-ccccccccccccccccchhc-cccccccccCCCccceee
Confidence 58999999999998 7887777778999999999999864 56899999999999999998 555 4689999999999
Q ss_pred ccccCCCC
Q 002410 487 IENNSFVG 494 (927)
Q Consensus 487 l~~N~l~g 494 (927)
|++|.+..
T Consensus 147 L~~N~l~~ 154 (198)
T d1m9la_ 147 LAGNPLYN 154 (198)
T ss_dssp ECSSHHHH
T ss_pred cCCCcccc
Confidence 99999873
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.97 E-value=2.6e-06 Score=86.63 Aligned_cols=105 Identities=21% Similarity=0.288 Sum_probs=82.2
Q ss_pred EEeCCCCCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCC-cCcccccceeecccccccCCCCC-cCCCc
Q 002410 402 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS-YMGSL 479 (927)
Q Consensus 402 ~c~~~~~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~g~iP~-~l~~l 479 (927)
.|+|.. +.+++++++|+ .+|..+. ++++.|+|++|+|+..++. |.++++|++|+|++|.+...+|. .|..+
T Consensus 5 ~C~C~~----~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l 77 (242)
T d1xwdc1 5 ICHCSN----RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNL 77 (242)
T ss_dssp SEEECS----SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESC
T ss_pred cCCCcC----CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccc
Confidence 588864 47899999999 8998764 5899999999999987774 89999999999999999876654 67889
Q ss_pred cccccccccc-cCCCCCCCccccC--CceeeeecCCC
Q 002410 480 PNLQELHIEN-NSFVGEIPPALLT--GKVIFKYDNNP 513 (927)
Q Consensus 480 ~~L~~L~l~~-N~l~g~iP~~~~~--~~~~~~~~~N~ 513 (927)
++++.|.+.. |++....|..+.. .+..+.+.+|.
T Consensus 78 ~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~ 114 (242)
T d1xwdc1 78 PKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTG 114 (242)
T ss_dssp TTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCC
T ss_pred cccccccccccccccccccccccccccccccccchhh
Confidence 9999998764 6777444443332 55566666664
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.82 E-value=2.8e-05 Score=79.31 Aligned_cols=131 Identities=17% Similarity=0.105 Sum_probs=88.1
Q ss_pred ccccccc-EEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCC--CceeeeeeeeecCceEEEEEEecCCCCH
Q 002410 612 KIGKGSF-GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYEYMHNGTL 688 (927)
Q Consensus 612 ~LG~G~~-G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~H--pnIv~l~~~~~~~~~~~LV~E~~~~gsL 688 (927)
.+..|.. +.||+...+++..+++|...... ...+..|...++.+.. -.+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445553 68999998888889999866432 2346678888887743 3356678888888889999999988655
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 002410 689 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG--------------------------------------------- 723 (927)
Q Consensus 689 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~--------------------------------------------- 723 (927)
.+.. .. ....+.++++.|+-||+.
T Consensus 94 ~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3210 11 112233444444444421
Q ss_pred ----------CCCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 724 ----------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 724 ----------~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
....++|+|+.|.||+++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 123479999999999999877778999997653
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.80 E-value=1.4e-05 Score=85.01 Aligned_cols=91 Identities=27% Similarity=0.371 Sum_probs=52.8
Q ss_pred ceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccccc
Q 002410 410 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 489 (927)
Q Consensus 410 ~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l~~ 489 (927)
+++.|+|++|+|+ .+|+. +++|++|+|++|+|+. +|+. +.+|+.|++++|+++ .+++. .+.|+.|++++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~-lp~~--~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTE-LPEL--PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSS-CCCC--CTTCCEEECCSSCCS-CCCSC---CTTCCEEECCS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcc-cccc--hhhhhhhhhhhcccc-hhhhh---ccccccccccc
Confidence 4667777777776 56653 3566777777777773 3432 345666677777666 44431 13467777777
Q ss_pred cCCCCCCCccc-cCCceeeeecCC
Q 002410 490 NSFVGEIPPAL-LTGKVIFKYDNN 512 (927)
Q Consensus 490 N~l~g~iP~~~-~~~~~~~~~~~N 512 (927)
|.++ .+|... ...+..+.+.+|
T Consensus 108 n~l~-~lp~~~~l~~L~~L~l~~~ 130 (353)
T d1jl5a_ 108 NQLE-KLPELQNSSFLKIIDVDNN 130 (353)
T ss_dssp SCCS-SCCCCTTCTTCCEEECCSS
T ss_pred cccc-cccchhhhccceeeccccc
Confidence 7776 555421 123444444444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.60 E-value=3.7e-05 Score=81.72 Aligned_cols=81 Identities=28% Similarity=0.489 Sum_probs=66.5
Q ss_pred CCceEEEEecCCCCcccCCccccCCcccceecccCCCCCCCCCCcCcccccceeecccccccCCCCCcCCCccccccccc
Q 002410 408 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 487 (927)
Q Consensus 408 ~~~l~~L~L~~n~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~l 487 (927)
+++++.|+|++|+|+ .+|..+ .+|+.|++++|+++.. +++. +.|++|+|++|+++ .+|. ++.+++|+.|++
T Consensus 57 ~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l-~~lp--~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l 127 (353)
T d1jl5a_ 57 PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKAL-SDLP--PLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDV 127 (353)
T ss_dssp CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCC-CSCC--TTCCEEECCSSCCS-SCCC-CTTCTTCCEEEC
T ss_pred CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchh-hhhc--cccccccccccccc-cccc-hhhhccceeecc
Confidence 468999999999999 889765 4688889999988753 3332 46999999999999 7885 688999999999
Q ss_pred cccCCCCCCCc
Q 002410 488 ENNSFVGEIPP 498 (927)
Q Consensus 488 ~~N~l~g~iP~ 498 (927)
++|.+. ..|.
T Consensus 128 ~~~~~~-~~~~ 137 (353)
T d1jl5a_ 128 DNNSLK-KLPD 137 (353)
T ss_dssp CSSCCS-CCCC
T ss_pred cccccc-cccc
Confidence 999998 4444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.55 E-value=5.8e-06 Score=78.95 Aligned_cols=73 Identities=25% Similarity=0.214 Sum_probs=45.9
Q ss_pred cCCccccCCcccceecccCCCCCCCCC--C-cCcccccceeecccccccCCCCC-cCCCccccccccccccCCCCCCC
Q 002410 424 EIPPELKNMEALTELWLDGNFLTGPLP--D-MSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHIENNSFVGEIP 497 (927)
Q Consensus 424 ~ip~~l~~l~~L~~L~Ls~N~l~g~~p--~-~~~l~~L~~L~Ls~N~l~g~iP~-~l~~l~~L~~L~l~~N~l~g~iP 497 (927)
.++....+++.|+.|+|++|+|+...+ . +..+++|+.|+|++|+++ .+++ ......+|+.|++++|.++....
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcc
Confidence 344444567777777777777776533 2 566777777777777777 4443 22233467777777777764433
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.19 E-value=0.00034 Score=76.25 Aligned_cols=76 Identities=16% Similarity=0.183 Sum_probs=48.9
Q ss_pred cccccccccEEEEEEEECC-CcEEEEEEccCcc-------chhHHHHHHHHHHHHhcC-C--CceeeeeeeeecCceEEE
Q 002410 610 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC-------SHRTQQFVTEVALLSRIH-H--RNLVPLIGYCEEEHQRIL 678 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~~-g~~vAvK~l~~~~-------~~~~~~~~~E~~~L~~l~-H--pnIv~l~~~~~~~~~~~L 678 (927)
.+.||.|....||++...+ ++.++||.-.... .....+...|.+.|+.+. + ..+.+++.+. .+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 3578999999999998764 6789999643211 112334567888887763 2 3455555543 445679
Q ss_pred EEEecCCCC
Q 002410 679 VYEYMHNGT 687 (927)
Q Consensus 679 V~E~~~~gs 687 (927)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.12 E-value=5.3e-05 Score=71.96 Aligned_cols=63 Identities=22% Similarity=0.285 Sum_probs=31.7
Q ss_pred ceEEEEecCCCCccc--CCccccCCcccceecccCCCCCCCCC-CcCcccccceeecccccccCCC
Q 002410 410 RITKIALSGKNLKGE--IPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSL 472 (927)
Q Consensus 410 ~l~~L~L~~n~l~g~--ip~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~g~i 472 (927)
.++.|+|++|+|+.. ++..+..|++|+.|+|++|.++...+ .+.....|+.|+|++|.++...
T Consensus 66 ~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 66 ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTF 131 (162)
T ss_dssp TCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred CCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCc
Confidence 455566666655532 12334555556666666665555433 1222334555566666555443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.92 E-value=0.0012 Score=69.65 Aligned_cols=135 Identities=12% Similarity=0.137 Sum_probs=79.1
Q ss_pred EEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCce--eeeee-----eeecCceEEEEEEecCCCCHH--
Q 002410 619 GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL--VPLIG-----YCEEEHQRILVYEYMHNGTLR-- 689 (927)
Q Consensus 619 G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnI--v~l~~-----~~~~~~~~~LV~E~~~~gsL~-- 689 (927)
-.||+++.++|+.+++|+.+.. ....+++..|...+..|....+ +..+. .+..++..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4899999999999999998653 2345678889998888853222 11111 224456788999999764321
Q ss_pred ----------------HHhccCC--CCCCCCH-------------------H---HHHHHHHHHHHHHHHH-HhcCCCCe
Q 002410 690 ----------------DRLHGSV--NQKPLDW-------------------L---TRLQIAHDAAKGLEYL-HTGCNPGI 728 (927)
Q Consensus 690 ----------------~~L~~~~--~~~~l~~-------------------~---~~~~i~~qia~gL~~L-H~~~~~~i 728 (927)
....... .....+. . .....+.++...+.-+ .+....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 1111110 0111111 1 1122233333333222 12234678
Q ss_pred EecCCCCCcccccCCCcEEEeecccccc
Q 002410 729 IHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 729 vH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
||+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 45899997764
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.76 E-value=6e-05 Score=82.93 Aligned_cols=84 Identities=31% Similarity=0.396 Sum_probs=40.2
Q ss_pred ceEEEEecCCCCc----ccCCccccCCcccceecccCCCCCCC----CC-CcC-cccccceeecccccccCC----CCCc
Q 002410 410 RITKIALSGKNLK----GEIPPELKNMEALTELWLDGNFLTGP----LP-DMS-RLIDLRIVHLENNELTGS----LPSY 475 (927)
Q Consensus 410 ~l~~L~L~~n~l~----g~ip~~l~~l~~L~~L~Ls~N~l~g~----~p-~~~-~l~~L~~L~Ls~N~l~g~----iP~~ 475 (927)
+++.|+|++|+++ ..|+..+..+++|+.|||++|+|+.. +. .+. ...+|+.|+|++|+++.. ++..
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~ 107 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccch
Confidence 3445555555554 12333445555555555555555321 01 111 123455555555555422 3344
Q ss_pred CCCccccccccccccCCC
Q 002410 476 MGSLPNLQELHIENNSFV 493 (927)
Q Consensus 476 l~~l~~L~~L~l~~N~l~ 493 (927)
+..+++|+.|+|++|.++
T Consensus 108 l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 108 LRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TTSCTTCCEEECCSSBCH
T ss_pred hhccccccccccccccch
Confidence 555555555555555554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.64 E-value=5.4e-05 Score=83.32 Aligned_cols=106 Identities=17% Similarity=0.176 Sum_probs=75.8
Q ss_pred CceEEEEecCCCCccc-CCccccCCcccceecccCCCCCC----CCCC-cCcccccceeecccccccC----CCCCcCC-
Q 002410 409 PRITKIALSGKNLKGE-IPPELKNMEALTELWLDGNFLTG----PLPD-MSRLIDLRIVHLENNELTG----SLPSYMG- 477 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~-ip~~l~~l~~L~~L~Ls~N~l~g----~~p~-~~~l~~L~~L~Ls~N~l~g----~iP~~l~- 477 (927)
.+|+.|||+.|++++. +..-+..+++|+.|+|++|+|+. .+.. +..+++|+.|||++|+++. .+...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 4799999999999864 24456778999999999999873 2232 6788999999999999862 1233333
Q ss_pred CccccccccccccCCCCC----CCcccc--CCceeeeecCCCC
Q 002410 478 SLPNLQELHIENNSFVGE----IPPALL--TGKVIFKYDNNPK 514 (927)
Q Consensus 478 ~l~~L~~L~l~~N~l~g~----iP~~~~--~~~~~~~~~~N~~ 514 (927)
...+|+.|+|++|+++.. ++..+. ..+..+.+.+|..
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i 124 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLL 124 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBC
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccc
Confidence 235799999999999733 233332 2556667777753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.16 E-value=0.006 Score=65.92 Aligned_cols=73 Identities=14% Similarity=0.246 Sum_probs=50.1
Q ss_pred cccccccccEEEEEEEECC--------CcEEEEEEccCccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCceEEEEE
Q 002410 610 CKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVY 680 (927)
Q Consensus 610 ~~~LG~G~~G~Vy~a~~~~--------g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~LV~ 680 (927)
.+.|+.|-.-.+|++...+ .+.|++++.... . ......+|..+++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3568889999999998764 356777776532 2 2234567999999885 4334577777753 5899
Q ss_pred EecCCCCH
Q 002410 681 EYMHNGTL 688 (927)
Q Consensus 681 E~~~~gsL 688 (927)
||++|..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.85 E-value=0.0015 Score=67.51 Aligned_cols=82 Identities=22% Similarity=0.301 Sum_probs=51.8
Q ss_pred CceEEEEecCC--CCccc-CCccccCCcccceecccCC-CCCCCCC-CcCcccccceeeccc-ccccCCCCCcCCCcccc
Q 002410 409 PRITKIALSGK--NLKGE-IPPELKNMEALTELWLDGN-FLTGPLP-DMSRLIDLRIVHLEN-NELTGSLPSYMGSLPNL 482 (927)
Q Consensus 409 ~~l~~L~L~~n--~l~g~-ip~~l~~l~~L~~L~Ls~N-~l~g~~p-~~~~l~~L~~L~Ls~-N~l~g~iP~~l~~l~~L 482 (927)
+.++.|+|++. +++.. +..-+.++++|+.|+|++| .+++... .+.++++|++|+|++ +++++.....++++++|
T Consensus 148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L 227 (284)
T d2astb2 148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227 (284)
T ss_dssp TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred cccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCC
Confidence 46777777653 33321 2223355677777777765 4554443 477777777777777 35666656667777777
Q ss_pred cccccccc
Q 002410 483 QELHIENN 490 (927)
Q Consensus 483 ~~L~l~~N 490 (927)
+.|+++++
T Consensus 228 ~~L~l~~~ 235 (284)
T d2astb2 228 KTLQVFGI 235 (284)
T ss_dssp CEEECTTS
T ss_pred CEEeeeCC
Confidence 77777665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.68 E-value=0.0012 Score=68.19 Aligned_cols=88 Identities=22% Similarity=0.263 Sum_probs=52.8
Q ss_pred CceEEEEecCC-CCcc-cCCccccC-CcccceecccCC--CCCCC-CCC-cCcccccceeecccc-cccCCCCCcCCCcc
Q 002410 409 PRITKIALSGK-NLKG-EIPPELKN-MEALTELWLDGN--FLTGP-LPD-MSRLIDLRIVHLENN-ELTGSLPSYMGSLP 480 (927)
Q Consensus 409 ~~l~~L~L~~n-~l~g-~ip~~l~~-l~~L~~L~Ls~N--~l~g~-~p~-~~~l~~L~~L~Ls~N-~l~g~iP~~l~~l~ 480 (927)
++|++|+|+++ +++. .+...+.. .+.|+.|+|++. .++.. +.. ..++++|+.|+|++| .+++..+..+++++
T Consensus 121 ~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred HhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 46777787774 3432 12233333 357777777753 33321 222 345677888888775 46766677777777
Q ss_pred ccccccccc-cCCCCCC
Q 002410 481 NLQELHIEN-NSFVGEI 496 (927)
Q Consensus 481 ~L~~L~l~~-N~l~g~i 496 (927)
+|+.|+|++ +.++...
T Consensus 201 ~L~~L~L~~C~~i~~~~ 217 (284)
T d2astb2 201 YLQHLSLSRCYDIIPET 217 (284)
T ss_dssp TCCEEECTTCTTCCGGG
T ss_pred cCCEEECCCCCCCChHH
Confidence 888888877 3555433
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=95.56 E-value=0.00068 Score=72.03 Aligned_cols=85 Identities=21% Similarity=0.315 Sum_probs=50.7
Q ss_pred CceEEEEecCCCCcc----cCCccccCCcccceecccCCCCCCC-----C-CCcCcccccceeecccccccCC----CCC
Q 002410 409 PRITKIALSGKNLKG----EIPPELKNMEALTELWLDGNFLTGP-----L-PDMSRLIDLRIVHLENNELTGS----LPS 474 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g----~ip~~l~~l~~L~~L~Ls~N~l~g~-----~-p~~~~l~~L~~L~Ls~N~l~g~----iP~ 474 (927)
+.++.|++++|.+.- .+...+..++.|+.|+|++|+++.. + ..+..+++|+.|+|++|.++.. +..
T Consensus 158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~ 237 (344)
T d2ca6a1 158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237 (344)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence 356667777666542 2333445566677777777776532 1 1255666777777777766422 334
Q ss_pred cCCCccccccccccccCCC
Q 002410 475 YMGSLPNLQELHIENNSFV 493 (927)
Q Consensus 475 ~l~~l~~L~~L~l~~N~l~ 493 (927)
.+..+++|+.|+|++|.++
T Consensus 238 ~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 238 ALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp HGGGCTTCCEEECTTCCCC
T ss_pred cccccccchhhhhhcCccC
Confidence 4556667777777777665
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=95.54 E-value=0.00056 Score=72.71 Aligned_cols=85 Identities=19% Similarity=0.194 Sum_probs=62.5
Q ss_pred CceEEEEecCCCCccc-----CCccccCCcccceecccCCCCCCC----C-CCcCcccccceeecccccccCCCCC----
Q 002410 409 PRITKIALSGKNLKGE-----IPPELKNMEALTELWLDGNFLTGP----L-PDMSRLIDLRIVHLENNELTGSLPS---- 474 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~-----ip~~l~~l~~L~~L~Ls~N~l~g~----~-p~~~~l~~L~~L~Ls~N~l~g~iP~---- 474 (927)
..++.|+|++|++... +...+..+++|+.|+|++|.++.. + ..+..++.|+.|+|++|++++.-..
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 4688999999988642 345577888999999999987643 2 2367888999999999998754222
Q ss_pred cCC--CccccccccccccCCC
Q 002410 475 YMG--SLPNLQELHIENNSFV 493 (927)
Q Consensus 475 ~l~--~l~~L~~L~l~~N~l~ 493 (927)
.+. ..+.|+.|++++|+++
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCB
T ss_pred HhhhccCCCCCEEECCCCcCC
Confidence 222 2357899999999886
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=95.13 E-value=0.0011 Score=62.79 Aligned_cols=85 Identities=14% Similarity=0.191 Sum_probs=62.7
Q ss_pred CceEEEEecCC-CCccc----CCccccCCcccceecccCCCCCCCC--C--C-cCcccccceeecccccccCC----CCC
Q 002410 409 PRITKIALSGK-NLKGE----IPPELKNMEALTELWLDGNFLTGPL--P--D-MSRLIDLRIVHLENNELTGS----LPS 474 (927)
Q Consensus 409 ~~l~~L~L~~n-~l~g~----ip~~l~~l~~L~~L~Ls~N~l~g~~--p--~-~~~l~~L~~L~Ls~N~l~g~----iP~ 474 (927)
+.+++|+|+++ .+... +-..+...+.|+.|+|++|.+...- . + +...+.|+.|+|++|.++.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 57999999975 45432 3345777789999999999886421 1 2 45678899999999998743 223
Q ss_pred cCCCccccccccccccCCC
Q 002410 475 YMGSLPNLQELHIENNSFV 493 (927)
Q Consensus 475 ~l~~l~~L~~L~l~~N~l~ 493 (927)
.+...++|+.|+|++|.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTTTCCCSEEECCCCSSC
T ss_pred HHHhCCcCCEEECCCCcCC
Confidence 4666788999999999776
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.06 E-value=0.075 Score=54.74 Aligned_cols=142 Identities=13% Similarity=0.133 Sum_probs=74.8
Q ss_pred cccccccEEEEEEEECCCcEEEEEEccCccchhHHHHHHHHHHHHhcCCCce--eeeee------eeecCceEEEEEEec
Q 002410 612 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL--VPLIG------YCEEEHQRILVYEYM 683 (927)
Q Consensus 612 ~LG~G~~G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~L~~l~HpnI--v~l~~------~~~~~~~~~LV~E~~ 683 (927)
.|..|---+.|+.+.++|+ +++|+..... ..+++..|++++..|.+.++ ...+. +.........++.++
T Consensus 25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~ 101 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 101 (316)
T ss_dssp EECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred cCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeec
Confidence 4567777889999988665 8999886432 22345557777777643222 11111 112244566777777
Q ss_pred CCCCHHH--------------Hhc----cCCCCC--CC------------------CHHHHHHHHHHHHHHHHHHHh-cC
Q 002410 684 HNGTLRD--------------RLH----GSVNQK--PL------------------DWLTRLQIAHDAAKGLEYLHT-GC 724 (927)
Q Consensus 684 ~~gsL~~--------------~L~----~~~~~~--~l------------------~~~~~~~i~~qia~gL~~LH~-~~ 724 (927)
.+..... .++ ...... .. ........+..+...+...+. ..
T Consensus 102 ~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L 181 (316)
T d2ppqa1 102 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 181 (316)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred ccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccc
Confidence 6643210 000 000000 00 001111222222222332221 23
Q ss_pred CCCeEecCCCCCcccccCCCcEEEeecccccc
Q 002410 725 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 756 (927)
Q Consensus 725 ~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 756 (927)
..++||+|+.++||+++.+...-|.||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCcchhhhhcccccceeEeccccccc
Confidence 57899999999999999888778999998753
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=93.22 E-value=0.0042 Score=58.59 Aligned_cols=83 Identities=17% Similarity=0.153 Sum_probs=58.9
Q ss_pred CceEEEEecCCCCccc----CCccccCCcccceecccCCCCCCCCC-----CcCcccccceeecccccccCC-------C
Q 002410 409 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGPLP-----DMSRLIDLRIVHLENNELTGS-------L 472 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~----ip~~l~~l~~L~~L~Ls~N~l~g~~p-----~~~~l~~L~~L~Ls~N~l~g~-------i 472 (927)
..|+.|+|++|.+... +...+...+.|+.|+|++|.++..-- .+...+.|+.|+|++|++... +
T Consensus 44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l 123 (167)
T d1pgva_ 44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 123 (167)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHH
Confidence 5799999999998743 23445667899999999999886321 367778899999999976521 2
Q ss_pred CCcCCCccccccccccccC
Q 002410 473 PSYMGSLPNLQELHIENNS 491 (927)
Q Consensus 473 P~~l~~l~~L~~L~l~~N~ 491 (927)
...+...++|+.|+++.+.
T Consensus 124 ~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 124 MMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHHHCSSCCEEECCCCC
T ss_pred HHHHHhCCCccEeeCcCCC
Confidence 3334445667777665543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=88.42 E-value=0.024 Score=52.83 Aligned_cols=85 Identities=21% Similarity=0.292 Sum_probs=56.7
Q ss_pred CceEEEEecC-CCCccc----CCccccCCcccceecccCCCCCCCCC-----CcCcccccceeecccccccCC----CCC
Q 002410 409 PRITKIALSG-KNLKGE----IPPELKNMEALTELWLDGNFLTGPLP-----DMSRLIDLRIVHLENNELTGS----LPS 474 (927)
Q Consensus 409 ~~l~~L~L~~-n~l~g~----ip~~l~~l~~L~~L~Ls~N~l~g~~p-----~~~~l~~L~~L~Ls~N~l~g~----iP~ 474 (927)
+.|++|+|++ +.++.. +-..+...+.|+.|+|++|.++..-- .+...+.|+.|++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 5788999987 445422 23445677889999999998865322 145678889999998887532 224
Q ss_pred cCCCccccccccc--cccCCC
Q 002410 475 YMGSLPNLQELHI--ENNSFV 493 (927)
Q Consensus 475 ~l~~l~~L~~L~l--~~N~l~ 493 (927)
.+...++|+.++| ++|.+.
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCC
T ss_pred HHHhCccccEEeeccCCCcCc
Confidence 5666777876444 556554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=85.21 E-value=0.027 Score=52.53 Aligned_cols=84 Identities=14% Similarity=0.231 Sum_probs=60.9
Q ss_pred CceEEEEecCCCCccc----CCccccCCcccceecccCCCCCCCC-----CCcCcccccceeec--ccccccC----CCC
Q 002410 409 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGPL-----PDMSRLIDLRIVHL--ENNELTG----SLP 473 (927)
Q Consensus 409 ~~l~~L~L~~n~l~g~----ip~~l~~l~~L~~L~Ls~N~l~g~~-----p~~~~l~~L~~L~L--s~N~l~g----~iP 473 (927)
+++++|+|++|.++.. +-..+...+.|+.|++++|.++..- ..+...+.|+.++| ++|.+.. .+.
T Consensus 46 ~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La 125 (166)
T d1io0a_ 46 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 125 (166)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHH
Confidence 5799999999998754 3334667789999999999987542 23677788886555 5677642 244
Q ss_pred CcCCCccccccccccccCC
Q 002410 474 SYMGSLPNLQELHIENNSF 492 (927)
Q Consensus 474 ~~l~~l~~L~~L~l~~N~l 492 (927)
..+...++|+.|+++.|..
T Consensus 126 ~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 126 NMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHCSSCCEEECCCSSH
T ss_pred HHHHhCCCcCEEeCcCCCC
Confidence 5566778889988876654
|